PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Wu, TT; Antona-Makoshi, J; Alshareef, A; Giudice, JS; Panzer, MB				Wu, Taotao; Antona-Makoshi, Jacobo; Alshareef, Ahmed; Giudice, J. Sebastian; Panzer, Matthew B.			Investigation of Cross-Species Scaling Methods for Traumatic Brain Injury Using Finite Element Analysis	JOURNAL OF NEUROTRAUMA			English	Article						brain deformation; dimensional analysis; natural frequency; non-human primate model	DIFFUSE AXONAL INJURY; ANIMAL-MODELS; HEAD; RESPONSES; IMPACT	Scaling methods are used to relate animal exposure data to humans by determining equivalent biomechanical impact conditions that result in similar tissue-level mechanics for different species. However, existing scaling methods for traumatic brain injury (TBI) do not account for the anatomical and morphological complexity of the brains for different species and have not been validated based on accurate anatomy and realistic material properties. In this study, the relationship between the TBI condition and brain tissue deformation was investigated using human, baboon, and macaque brain finite element (FE) models, which featured macro- and mesoscale anatomical details. The aim was to evaluate existing scaling methods in predicting similar biomechanical responses in the different species using both idealized and real-world TBI pulses. A second aim was to develop a new method to improve how animal data are scaled to humans. As previously found in humans, the animal's brain response to the rotational head motion was well characterized by single-degree-of-freedom (sDOF) mechanical systems with resonance at certain natural frequency, and this concept was leveraged to develop a new TBI scaling method based the natural frequency of the sDOF models representing each species. Previously described biomechanical scaling methods based on mass or inertia ratios were poor predictors of equivalent strain. The novel frequency-based scaling method was an improved approach to scaling the equivalent loading conditions. The findings of this study enable better interpretation of mechanical-trauma responses obtained from animal data to the human, thus effectively advancing the development of human injury criteria and contributing toward the mitigation of TBI.	[Wu, Taotao; Alshareef, Ahmed; Giudice, J. Sebastian; Panzer, Matthew B.] Univ Virginia, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA; [Panzer, Matthew B.] Univ Virginia, Brain Injury & Sports Concuss Ctr, Charlottesville, VA USA; [Antona-Makoshi, Jacobo] Japan Automobile Res Inst, Tsukuba, Ibaraki, Japan		Panzer, MB (corresponding author), Univ Virginia, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA.	panzer@virginia.edu		Alshareef, Ahmed/0000-0003-4512-1618; Giudice, Sebastian/0000-0003-1074-4890			Abel J.M., 1978, SAE T, V87, P3144; Adluru N, 2012, NEUROIMAGE, V59, P306, DOI 10.1016/j.neuroimage.2011.07.029; Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; ANTONA-MAKOSHI J., 2016, TRAUMATIC BRAIN INJU; Antona-Makoshi J., 2012, P 2012 INT IRCOBI C; Antona-Makoshi J., 2013, INT RES COUNC BIOM I, VIRC-13-55, P509; Atlan LS, 2018, J NEUROSCI RES, V96, P536, DOI 10.1002/jnr.24108; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bowden D., 2000, PRIMATE BRAIN MAPS S, pYork; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cox C.A., 2018, HUM FACTORS MECH ENG, V2, P1, DOI [10.1007/s41314-018-0013-1, DOI 10.1007/S41314-018-0013-1]; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Eppinger R, 1999, DEV IMPROVED INJURY, P1; ESTES MS, 1970, MECH ENG, V92, P58; Gabler LF, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038357; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giudice J.S., 2018, ANN BIOMED ENG, DOI [10.1007/s10439-018-02161-5., DOI 10.1007/S10439-018-02161-5.]; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ibrahim NG, 2010, J NEUROTRAUM, V27, P1021, DOI 10.1089/neu.2009.1212; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; Margulies S.S., 1987, THESIS; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Mendis K., 1992, FINITE ELEMENT MODEL; Olszko AV, 2018, TRAFFIC INJ PREV, V19, pS44, DOI 10.1080/15389588.2017.1390570; Ommaya A.K., 1967, SCALING EXPT DATA CE; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ono K., 1980, SAE T, V89, P3837; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Park G, 2017, COMPUT METHOD BIOMEC, V20, P1151, DOI 10.1080/10255842.2017.1340459; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Wu T., 2019, ANN BIOMED ENG, DOI [10.1007/s10439-019-02239-8., DOI 10.1007/S10439-019-02239-8.]; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634	46	8	8	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					410	422		10.1089/neu.2019.6576		SEP 2019	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000487163900001	31382861				2022-02-06	
J	Bagnato, S; Andriolo, M; Boccagni, C; Lucca, LF; De Tanti, A; Pistarini, C; Barone, T; Galardi, G				Bagnato, Sergio; Andriolo, Maria; Boccagni, Cristina; Lucca, Lucia Francesca; De Tanti, Antonio; Pistarini, Caterina; Barone, Teresa; Galardi, Giuseppe			Reduced Neuron-Specific Enolase Levels in Chronic Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						neurodegeneration; NSE; outcome; TBI; vegetative state	MICROGLIAL ACTIVATION; DEMENTIA; PREDICT; RISK	Growing evidence suggests that pathophysiological mechanisms leading to neurodegeneration and neuronal loss take place during the chronic phase of a severe traumatic brain injury (TBI). In this study we evaluated a well-established marker of brain injury, the neuron-specific enolase (NSE), in the serum of 51 patients with severe TBI (86% males, mean age 33.8 +/- 11.1 years). All patients' samples were available from a previous study and the mean time between TBI and blood sample collection was 23.2 +/- 31.5 months (28 patients were evaluated within 12 months of TBI and 23 patients were evaluated >= 12 months after TBI). Patients' NSE levels were compared with those obtained from 30 age and sex-matched healthy controls (87% males, 33.7 +/- 11.3 years). We found that NSE levels were significantly lower in patients (median 3.2 ng/mL; 25th, 75th percentile 2.5, 5.1) than in healthy controls (median 4.1 ng/mL; 25th, 75th percentile 3.1, 7.5) (p = 0.026). This finding was mainly driven by data from the chronic patients, that is, those who experienced their TBI at least 12 months before the evaluation. Indeed, these patients had significantly lower NSE levels (median 2.6 ng/mL; 25th, 75th percentile 1.9, 4) than healthy controls (p < 0.01). On the other hand, NSE levels evaluated in patients <12 months from TBI (median 3.9 ng/mL; 25th, 75th percentile 2.8, 5.7) did not significantly differ from controls (p = 0.3). These findings possibly reflect a progressive brain atrophy with reduced baseline NSE release in the chronic phase of a severe TBI.	[Bagnato, Sergio; Boccagni, Cristina; Galardi, Giuseppe] Giuseppe Giglio Fdn, Unit Neurophysiol, Cefalu, Italy; [Bagnato, Sergio; Boccagni, Cristina; Galardi, Giuseppe] Giuseppe Giglio Fdn, Unit Severe Acquired Brain Injuries, Rehabil Dept, Cefalu, Italy; [Andriolo, Maria] Giuseppe Giglio Fdn, Clin Pathol & Microbiol Lab, Cefalu, Italy; [Lucca, Lucia Francesca] St Anna Inst, RAN, Crotone, Italy; [De Tanti, Antonio] Cardinal Ferrari Ctr, Fontanellato, Italy; [Pistarini, Caterina] Inst Genoa, Neurorehabil Unit, ICS Maugeri SPA SB, Genoa, Italy; [Barone, Teresa] Immunohematol & Transfus Serv, Cefalu, Italy		Bagnato, S (corresponding author), Giuseppe Giglio Fdn, Rehabil Dept, Viale G Giardina, I-90015 Cefalu, PA, Italy.	sergiobagnato@gmail.com	Bagnato, Sergio/H-6842-2013; Lucca, Lucia Francesca/AAB-8558-2022; Pistarini, CATERINA/K-5234-2018	Bagnato, Sergio/0000-0002-6289-1887; Pistarini, CATERINA/0000-0001-8925-0484; LUCCA, LUCIA FRANCESCA/0000-0002-7602-2711			Bagnato S, 2018, BRAIN INJURY, V32, P1056, DOI 10.1080/02699052.2018.1479042; Bagnato S, 2017, J NEUROTRAUM, V34, P2475, DOI 10.1089/neu.2016.4837; Bagnato S, 2017, NEUROREPORT, V28, P250, DOI 10.1097/WNR.0000000000000748; Bagnato S, 2013, NEUROSCI BIOBEHAV R, V37, P2721, DOI 10.1016/j.neubiorev.2013.09.007; Bagnato S, 2012, J NEUROTRAUM, V29, P2050, DOI 10.1089/neu.2011.2184; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Chabok SY, 2012, J TRAUMA ACUTE CARE, V72, P1654, DOI 10.1097/TA.0b013e318246887e; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chaves ML, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-6; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; Chung-Esaki HM, 2018, J CLIN NEUROSCI, V57, P99, DOI 10.1016/j.jocn.2018.08.020; CUTLER NR, 1986, ARCH NEUROL-CHICAGO, V43, P153, DOI 10.1001/archneur.1986.00520020047017; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gatson JW, 2016, J NEUROSURG, V124, P1646, DOI 10.3171/2015.6.JNS15639; Guldenmund P, 2016, BRAIN INJURY, V30, P343, DOI 10.3109/02699052.2015.1118765; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hinzman JM, 2016, J NEUROTRAUM, V33, P1775, DOI 10.1089/neu.2015.4226; Hu YY, 2018, J NEUROL, V265, P46, DOI 10.1007/s00415-017-8659-9; Isgro MA, 2015, ADV EXP MED BIOL, V867, P125, DOI 10.1007/978-94-017-7215-0_9; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lu KL, 2015, J NEUROL SCI, V359, P202, DOI 10.1016/j.jns.2015.10.034; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Morozova S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8080144; Park SH, 2018, WORLD NEUROSURG, V118, pE534, DOI 10.1016/j.wneu.2018.06.234; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Royal College of Physicians, 2013, PROL DIS CONSC NAT C; Royal College of Physicians, 2003, PERM VEG STAT GUID D; Rundgren Malin, 2014, BMC Res Notes, V7, P726, DOI 10.1186/1756-0500-7-726; Schmidt FM, 2014, NEUROSCI LETT, V570, P81, DOI 10.1016/j.neulet.2014.04.007; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Velazquez A, 2015, BRAIN INJURY, V29, P1126, DOI 10.3109/02699052.2015.1018325; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X	38	8	8	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					423	427		10.1089/neu.2019.6449		SEP 2019	5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000486975200001	31418324				2022-02-06	
J	Thelin, EP; Hall, CE; Tyzack, GE; Frostell, A; Giorgi-Coll, S; Alam, A; Carpenter, KLH; Mitchell, J; Tajsic, T; Hutchinson, PJ; Patani, R; Helmy, A				Thelin, Eric Peter; Hall, Claire E.; Tyzack, Giulia E.; Frostell, Arvid; Giorgi-Coll, Susan; Alam, Aftab; Carpenter, Keri L. H.; Mitchell, Jamie; Tajsic, Tamara; Hutchinson, Peter J.; Patani, Rickie; Helmy, Adel			Delineating Astrocytic Cytokine Responses in a Human Stem Cell Model of Neural Trauma	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						cytokine exposure; human iPSC-derived astrocytes; IL-1 beta; IL-4; IL-6; IL-10; in vitro; TBI; TNF	COLONY-STIMULATING FACTORS; NECROSIS-FACTOR-ALPHA; BRAIN-INJURY; MICROGLIA; LIPOPOLYSACCHARIDE; INFLAMMATION; ACTIVATION; EXPRESSION; PATHOPHYSIOLOGY; INTERLEUKIN-10	Neuroinflammation has been shown to mediate the pathophysiological response following traumatic brain injury (TBI). Accumulating evidence implicates astrocytes as key immune cells within the central nervous system (CNS), displaying both pro- and anti-inflammatory properties. The aim of this study was to investigate how in vitro human astrocyte cultures respond to cytokines across a concentration range that approximates the aftermath of human TBI. To this end, enriched cultures of human induced pluripotent stem cell (iPSC)-derived astrocytes were exposed to interleukin-1 beta (IL-1 beta) (1-10,000 pg/mL), IL-4 (1-10,000 pg/mL), IL-6 (100-1,000,000 pg/mL), IL-10 (1-10,000 pg/mL) and tumor necrosis factor (TNF)-alpha (1-10,000 pg/mL). After 1, 24, 48 and 72 h, cultures were fixed and immunolabeled, and the secretome/supernatant was analyzed at 24, 48, and 72 h using a human cytokine/chemokine 39-plex Luminex assay. Data were compared to previous in vitro studies of neuronal cultures and clinical TBI studies. The secretome revealed concentration-, time- and/or both concentration- and time-dependent production of downstream cytokines (29, 21, and 17 cytokines, respectively, p<0.05). IL-1 beta exposure generated the most profound downstream response (27 cytokines), IL-6 and TNF had intermediate responses (13 and 11 cytokines, respectively), whereas IL-4 and IL-10 only led to weak responses over time or in escalating concentration (8 and 8 cytokines, respectively). Notably, expression of IL-1 beta, IL-6, and TNF cytokine receptor mRNA was higher in astrocyte cultures than in neuronal cultures. Several secreted cytokines had temporal trajectories, which corresponded to those seen in the aftermath of human TBI. In summary, iPSC-derived astrocyte cultures exposed to cytokine concentrations reflecting those in TBI generated an increased downstream cytokine production, particularly IL-1 beta. Although more work is needed to better understand how different cells in the CNS respond to the neuroinflammatory milieu after TBI, our data shows that iPSC-derived astrocytes represent a tractable model to study cytokine stimulation in a cell type-specific manner.	[Thelin, Eric Peter; Giorgi-Coll, Susan; Alam, Aftab; Carpenter, Keri L. H.; Tajsic, Tamara; Hutchinson, Peter J.; Helmy, Adel] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Carpenter, Keri L. H.; Hutchinson, Peter J.] Univ Cambridge, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge, England; [Thelin, Eric Peter; Frostell, Arvid] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Hall, Claire E.; Tyzack, Giulia E.; Mitchell, Jamie; Patani, Rickie] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Patani, Rickie] Francis Crick Inst, London, England		Helmy, A (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.; Patani, R (corresponding author), UCL Inst Neurol, Dept Neuromuscular Dis, Queen Sq, London WC1N 3BG, England.	rickie.patani@ucl.ac.uk; adelhelmy@cantab.net	Alam, Aftab/D-2547-2012; Frostell, Arvid/ABG-5167-2021; Thelin, Eric Peter/K-2144-2012; Helmy, Adel/AAS-3084-2020; Patani, Rickie/J-3107-2018	Alam, Aftab/0000-0001-8089-6721; Thelin, Eric Peter/0000-0002-2338-4364; Helmy, Adel/0000-0002-0531-0556; Patani, Rickie/0000-0002-3825-7675; Mitchell, Jamie/0000-0002-6954-9988	Swedish Society for Medical Research; Swedish Society of Medicine [SLS-587221]; National Institute for Health Research Biomedical Research Centre, CambridgeNational Institute for Health Research (NIHR); National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); NIHR Global Health Research Group on Neurotrauma a European Union Seventh Framework Program grant (Collaborative European NeuroTrauma Effectiveness Research in TBI [CENTER-TBI]) [602150]; Royal College of Surgeons of England; Medical Research Council (MRC)/Motor Neuron Disease Association (MNDA) Lady Edith Wolfson Senior Clinical FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/S006591/1]; National Institute for Health Research University College London Hospital Biomedical Research Centre; Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship; Royal College of Surgeons of England Pump Priming Grant; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986 ID79068]; National Institute of Health ResearchNational Institute for Health Research (NIHR); Newton Fellowship from the Academy of Medical Sciences; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/S006591/1, G0802251, MR/M02492X/1, G0600986] Funding Source: UKRI	E.P.T. is supported by post-doctoral scholarships from the Swedish Society for Medical Research and Swedish Society of Medicine (grant no. SLS-587221). K.L.H.C. is supported by the National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). P.J.H. is supported by a Research Professorship from the National Institute for Health Research (NIHR), the NIHR Cambridge Biomedical Research Centre, the NIHR Global Health Research Group on Neurotrauma a European Union Seventh Framework Program grant (Collaborative European NeuroTrauma Effectiveness Research in TBI [CENTER-TBI]; grant no. 602150), and the Royal College of Surgeons of England. R.P. is supported by an Medical Research Council (MRC)/Motor Neuron Disease Association (MNDA) Lady Edith Wolfson Senior Clinical Fellowship (grant no. MR/S006591/1). We also acknowledge support from the National Institute for Health Research University College London Hospital Biomedical Research Centre. A. H. is supported by the Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship, Royal College of Surgeons of England Pump Priming Grant, and the National Institute for Health Research Biomedical Research Centre, Cambridge. The Luminex 200 analyzer was purchased with MRC funding (grant no. G0600986 ID79068). We acknowledge the Dementias Platform UK (DPUK)/MRC platform for provision of the Opera Phenix for high-throughput iPSC analysis. TT is supported by the National Institute of Health Research. AA is supported by a Newton Fellowship from the Academy of Medical Sciences. The funding bodies did not participate in the design of the study; collection, analysis, and interpretation of data; or writing of the article.	Aloisi F, 1997, J IMMUNOL, V159, P1604; ALOISI F, 1992, J IMMUNOL, V149, P2358; Bellander BM, 2010, EXP BRAIN RES, V205, P103, DOI 10.1007/s00221-010-2342-z; Brodie C, 1998, J NEUROIMMUNOL, V81, P20, DOI 10.1016/S0165-5728(97)00154-9; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Choi SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097093; CHUNG IY, 1990, J IMMUNOL, V144, P2999; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Flynn G, 2003, J NEUROIMMUNOL, V136, P84, DOI 10.1016/S0165-5728(03)00009-2; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hall CE, 2017, CELL REP, V19, P1739, DOI 10.1016/j.celrep.2017.05.024; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kelley KW, 2018, NEURON, V98, P306, DOI 10.1016/j.neuron.2018.03.010; Kim HJ, 2005, EXP NEUROL, V192, P60, DOI 10.1016/j.expneurol.2004.10.014; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Ledeboer A, 2000, GLIA, V30, P134, DOI 10.1002/(SICI)1098-1136(200004)30:2<134::AID-GLIA3>3.0.CO;2-3; LEE SC, 1993, J IMMUNOL, V150, P2659; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Ludtmann MHR, 2017, J BIOL CHEM, V292, P8907, DOI 10.1074/jbc.M116.762898; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MALIPIERO UV, 1990, J IMMUNOL, V144, P3816; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Perriot S, 2018, STEM CELL REP, V11, P1199, DOI 10.1016/j.stemcr.2018.09.015; Pousset F, 1999, GLIA, V26, P12, DOI 10.1002/(SICI)1098-1136(199903)26:1<12::AID-GLIA2>3.0.CO;2-S; Quintana A, 2008, DEV NEUROBIOL, V68, P195, DOI 10.1002/dneu.20584; R Core Team, 2018, STATS PACK LANG ENV; Santos R, 2017, STEM CELL REP, V8, P1757, DOI 10.1016/j.stemcr.2017.05.011; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; SMITH WB, 1994, EXP HEMATOL, V22, P329; TADA M, 1994, J NEUROSURG, V80, P1063, DOI 10.3171/jns.1994.80.6.1063; Thelin EP, 2018, J NEUROTRAUM, V35, P341, DOI 10.1089/neu.2017.5155; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Tyzack G, 2016, CURR STEM CELL REP, V2, P236, DOI 10.1007/s40778-016-0049-1; Tyzack GE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01283-z; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yokoyama T, 1996, ACTA PAEDIATR, V85, P303, DOI 10.1111/j.1651-2227.1996.tb14021.x; YONG VW, 1991, P NATL ACAD SCI USA, V88, P7016, DOI 10.1073/pnas.88.16.7016; Zeiler FA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00331; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	52	8	8	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2019.6480		SEP 2019	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IZ0PZ	WOS:000486794200001	31452443	hybrid, Green Submitted, Green Published			2022-02-06	
J	Estraneo, A; De Bellis, F; Masotta, O; Loreto, V; Fiorenza, S; Lo Sapio, M; Trojano, L				Estraneo, A.; De Bellis, F.; Masotta, O.; Loreto, V.; Fiorenza, S.; Lo Sapio, M.; Trojano, L.			Demographical and clinical indices for long-term evolution of patients in vegetative or in minimally conscious state	BRAIN INJURY			English	Article						Vegetative state; minimally conscious state; prognosis; mortality; rehabilitation	SOMATOSENSORY-EVOKED POTENTIALS; BRAIN-INJURED PATIENTS; LATE RECOVERY; UNRESPONSIVE WAKEFULNESS; FOLLOW-UP; DISORDERS; SCALE; COMA; RESPONSIVENESS; PREDICTORS	Objective. To evaluate the prognostic value of demographical, anamnestic, and clinical findings on long-term outcome (up to 36 months) in individuals with severe brain injury in vegetative state (VS) or in minimally conscious state (MCS). Participants. Patients (N = 216) in VS (N = 159) or in MCS (N = 57) consecutively admitted to a neurorehabilitation unit within 1-3 months after severe anoxic (n = 71), vascular (n = 96), or traumatic (n = 49) brain injury. Main outcome. Mortality and improvements in clinical diagnosis at 12, 24, and 36 months after brain injury. Multivariable logistic regression analyses were performed to verify independent relationships of variables collected at study entry with outcome measures. Results. In patients in VS, at the 12-month follow-up, higher level of responsiveness assessed by the Coma Recovery Scale-Revised (CRS-R) total scores at study entry predicted a higher likelihood of both survival and clinical improvement, whereas younger age predicted survival only. At 24 months, female sex and higher CRS-R total scores tended to be associated with clinical improvements. In patients in MCS, younger age and female predicted consciousness recovery at 12 months. Conclusions. Several patients' features easy to collect in rehabilitation setting might help clinicians in prognostication of long-term mortality and clinical evolution of VS and MCS.	[Estraneo, A.; De Bellis, F.; Masotta, O.; Loreto, V.; Fiorenza, S.; Lo Sapio, M.] IRCCS, Maugeri Sci & Clin Inst, Inst Telese Terme, Disorders Consciousness Lab, Telese Terme, BN, Italy; [Estraneo, A.; Loreto, V.] Santa Maria Pieta Gen Hosp, Dept Neurol, Nola, Italy; [Trojano, L.] Univ Campania Luigi Vanvitelli, Dept Psychol, Neuropsychol Lab, Caserta, Italy		Estraneo, A (corresponding author), Santa Maria Pieta Gen Hosp, Via Seminario 1, I-80035 Nola, NA, Italy.	aestraneo@gmail.com	Trojano, Luigi/F-2396-2016; estraneo, anna/K-5409-2016	Trojano, Luigi/0000-0002-0328-9642; Fiorenza, Salvatore/0000-0002-7035-8628; estraneo, anna/0000-0001-6646-5626; Loreto, Vincenzo/0000-0002-7853-9343			ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bagnato S, 2017, J NEUROTRAUM, V34, P535, DOI 10.1089/neu.2016.4418; Bodien YG, 2016, ARCH PHYS MED REHAB, V97, P490, DOI 10.1016/j.apmr.2015.08.422; Bruno M-A., 2012, COMA DISORDERS CONSC, P11, DOI [DOI 10.1007/978-1-4471-2440-5_2, 10.1007/978-1-4471-2440-5_2]; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Dolce G, 2008, BRAIN INJURY, V22, P617, DOI 10.1080/02699050802132503; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Estraneo A, 2015, EUR J PHYS REHAB MED, V51, P627; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2018, ARCH PHYS MED REHAB, V99, P2523, DOI 10.1016/j.apmr.2018.04.024; Estraneo A, 2014, ARCH PHYS MED REHAB, V95, P711, DOI 10.1016/j.apmr.2013.11.004; Estraneo A, 2013, NEUROLOGY, V81, P1274; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Farace E, 2000, Neurosurg Focus, V8, pe6; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Giacino JT, 2018, NEUROLOGY, V91, P461, DOI 10.1212/WNL.0000000000005928; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gutchess A, 2014, SCIENCE, V346, P579, DOI 10.1126/science.1254604; Hamilton JA, 2020, NEUROPSYCHOL REHABIL, V30, P266, DOI 10.1080/09602011.2018.1461656; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S., 2018, COMA DISORDERS CONSC, P17, DOI 10.1007/978-3-319-55964-3; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Moretta P, 2017, REHABIL PSYCHOL, V62, P208, DOI 10.1037/rep0000144; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Noe E, 2012, ARCH PHYS MED REHAB, V93, P428, DOI 10.1016/j.apmr.2011.08.048; Oh S, 2009, CEREBROVASC DIS, V28, P427, DOI 10.1159/000235986; Pagani M, 2014, J NEUROL, V261, P1144, DOI 10.1007/s00415-014-7309-8; Pascarella A, 2018, FUNCT NEUROL, V33, P19, DOI 10.11138/FNeur/2018.33.1.019; Pascarella A, 2016, J NEUROL, V263, P2048, DOI 10.1007/s00415-016-8232-y; Pistoia F, 2015, J NEUROTRAUM, V32, P682, DOI 10.1089/neu.2014.3659; Portaccio E, 2018, ARCH PHYS MED REHAB, V99, P914, DOI 10.1016/j.apmr.2018.01.015; Portaccio E, 2018, BRAIN INJURY, V32, P730, DOI 10.1080/02699052.2018.1440420; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Robinson LR, 2016, J CRIT CARE, V36, P130, DOI 10.1016/j.jcrc.2016.07.003; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Rodriguez-Blazquez C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010446; Sattin D, 2017, FUNCT NEUROL, V32, P159; Sattin D, 2014, J NEUROL, V261, P2378, DOI 10.1007/s00415-014-7478-5; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Steppacher I, 2014, ANN CLIN TRANSL NEUR, V1, P401, DOI 10.1002/acn3.63; Takeuchi S, 2013, CLIN NEUROL NEUROSUR, V115, P732, DOI 10.1016/j.clineuro.2012.08.022; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016	50	8	9	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2019	33	13-14					1633	1639		10.1080/02699052.2019.1658220		SEP 2019	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KG3JC	WOS:000486934200001	31533482				2022-02-06	
J	Ding, MY; Chen, Y; Luan, HF; Zhang, XB; Zhao, ZB; Wu, Y				Ding, Mengyao; Chen, Ying; Luan, Hengfei; Zhang, Xiaobao; Zhao, Zhibin; Wu, Yong			Dexmedetomidine reduces inflammation in traumatic brain injury by regulating the inflammatory responses of macrophages and splenocytes	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						dexmedetomidine; clinical observation; inflammation; traumatic brain injury; cytokines; macrophages	CYTOKINES; RECEPTOR; MICE; NEUROPROTECTION; RESISTANCE; DEFICIENT; MEDIATORS; CHECKLIST; MONOCYTES; PROPOFOL	Traumatic brain injury (TBI) affects people in all demographics, since it is associated with a variety of chronic degenerative diseases, such as Alzheimer's and Parkinson's disease. In TBI, the central nervous system elicits an immune response involving various immune cells that is necessary for healing and defending the body against pathogens, but can also cause secondary damage to the brain if the response is prolonged. In our clinical practice, it has been identified that administration of dexmedetomidine was associated with reduced production of inflammatory cytokines in patients with TBI, which led to the hypothesis that dexmedetomidine may regulate certain inflammatory responses. To test this hypothesis, the roles of dexmedetomidine in the immune system of mice were investigated. Different biological assays were used to assess the influence of dexmedetomidine on the production of inflammatory cytokines, including tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-8 and IL-1 beta. To understand how dexmedetomidine affects different types of immune cells, the influence of dexmedetomidine on splenocytes was also investigated. Finally, the effects of dexmedetomidine on macrophage activation and inflammatory functions were studied. In the present study, clinical observations and in vivo results using a mouse model of TBI revealed the regulatory functions of dexmedetomidine in TBI-associated immune response.	[Ding, Mengyao; Chen, Ying; Luan, Hengfei; Zhang, Xiaobao; Zhao, Zhibin; Wu, Yong] First Peoples Hosp Lianyungang, Dept Anesthesiol, 182 Tong Guan North Rd, Lianyungang 222002, Jiangsu, Peoples R China		Wu, Y (corresponding author), First Peoples Hosp Lianyungang, Dept Anesthesiol, 182 Tong Guan North Rd, Lianyungang 222002, Jiangsu, Peoples R China.	18961325621@163.com			First People's Hospital of Lianyungang [LYG201605]	The present study was supported by the First People's Hospital of Lianyungang (grant no. LYG201605).	AHO M, 1992, ANESTH ANALG, V75, P940; Banks WA, 2005, CURR PHARM DESIGN, V11, P973, DOI 10.2174/1381612053381684; Behrens V, 2016, ANESTH ANALG, V122, P1484, DOI 10.1213/ANE.0000000000001186; Bekker A, 2006, ANESTH ANALG, V103, P955, DOI 10.1213/01.ane.0000237288.46912.39; Bekker AY, 2004, J NEUROSURG ANESTH, V16, P126, DOI 10.1097/00008506-200404000-00004; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Brough D, 2011, TRENDS PHARMACOL SCI, V32, P617, DOI 10.1016/j.tips.2011.06.002; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Cagle LA, 2017, ANESTHESIOL RES PRAC, V2017, DOI 10.1155/2017/9161040; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Dinkel K, 2004, P NATL ACAD SCI USA, V101, P331, DOI 10.1073/pnas.0303510101; FAN L, 1995, MOL BRAIN RES, V30, P125; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Inada T, 2017, IMMUNOPHARM IMMUNOT, V39, P225, DOI 10.1080/08923973.2017.1327964; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Kawasaki T, 2013, J TRAUMA ACUTE CARE, V74, P1370, DOI 10.1097/TA.0b013e31828db978; Kaygusuz K, 2008, ANESTH ANALG, V106, P114, DOI 10.1213/01.ane.0000296453.75494.64; Kim Y, 2014, J CLIN ANESTH, V26, P281, DOI 10.1016/j.jclinane.2013.11.018; Kushi H, 2002, CRIT CARE MED, V30, pA82, DOI 10.1097/00003246-200212001-00282; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martin Eike, 2003, J Intensive Care Med, V18, P29, DOI 10.1177/0885066602239122; Memis D, 2007, BRIT J ANAESTH, V98, P550, DOI 10.1093/bja/aem017; MORGANTIKOSSMANN MC, 1992, TRENDS PHARMACOL SCI, V13, P286, DOI 10.1016/0165-6147(92)90087-M; Munro HM, 2007, PEDIATR ANESTH, V17, P109, DOI 10.1111/j.1460-9592.2006.02031.x; Naaz Shagufta, 2014, J Clin Diagn Res, V8, pGE01, DOI 10.7860/JCDR/2014/9624.4946; Naguib AN, 2013, PEDIATR CRIT CARE ME, V14, P481, DOI 10.1097/PCC.0b013e31828a742c; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Pan WY, 2016, MOL MED REP, V14, P3237, DOI 10.3892/mmr.2016.5588; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Sukegawa S, 2014, ANESTH ANALG, V118, P473, DOI 10.1213/ANE.0000000000000060; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Taittonen MT, 1997, BRIT J ANAESTH, V78, P400, DOI 10.1093/bja/78.4.400; Talke P, 1997, ANESTH ANALG, V85, P1136, DOI 10.1097/00000539-199711000-00033; Taniguchi T, 2004, CRIT CARE MED, V32, P1322, DOI 10.1097/01.CCM.0000128579.84228.2A; Tasdogan M, 2009, J CLIN ANESTH, V21, P394, DOI 10.1016/j.jclinane.2008.10.010; Tobin JM, 2013, ANESTH ANALG, V117, P1178, DOI 10.1213/ANE.0b013e3182a44d3e; Ueki M, 2014, ANAESTHESIA, V69, P693, DOI 10.1111/anae.12636; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xia R, 2013, CELL BIOCHEM BIOPHYS, V67, P1547, DOI 10.1007/s12013-013-9659-8; Xin J, 2017, ONCOTARGET, V8, P100371, DOI 10.18632/oncotarget.22232; Yagmurdur H, 2008, J HAND SURG-AM, V33A, P941, DOI 10.1016/j.jhsa.2008.01.014; Zhang JX, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0042-8	54	8	9	0	5	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	SEP	2019	18	3					2323	2331		10.3892/etm.2019.7790			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	IZ8MG	WOS:000487358600103	31410183	Green Published, gold			2022-02-06	
J	Dmytriyeva, O; Belmeguenai, A; Bezin, L; Soud, K; Woldbye, DPD; Gotzsche, CR; Pankratova, S				Dmytriyeva, Oksana; Belmeguenai, Amor; Bezin, Laurent; Soud, Katia; Woldbye, David Paul Drucker; Gotzsche, Casper Rene; Pankratova, Stanislava			Short erythropoietin-derived peptide enhances memory, improves long-term potentiation, and counteracts amyloid beta-induced pathology	NEUROBIOLOGY OF AGING			English	Article						Erythropoietin-derived peptide; Neuroprotection; Memory; Beta amyloid peptide(25-35); Hippocampus; Neurite outgrowth	NEUROTRANSMITTER RELEASE PROBABILITY; RECOMBINANT-HUMAN-ERYTHROPOIETIN; TRAUMATIC BRAIN-INJURY; BEHAVIORAL ALTERATIONS; COGNITIVE IMPAIRMENT; SYNAPTIC PLASTICITY; LITHIUM-PILOCARPINE; ALZHEIMERS-DISEASE; SOCIAL RECOGNITION; STATUS EPILEPTICUS	Neurodegenerative disorders such as Alzheimer's disease (AD) are characterized by the irreversible neuronal loss and memory impairment, and current treatments are merely symptomatic. Erythropoietin (EPO) has been shown to possess neurotrophic, neuroprotective, anti-inflammatory, and memory-enhancing effects, which could be therapeutically beneficial in the different aspects of AD. However, the hematopoietic effect of EPO has hampered its potential as a neuroprotective and procognitive agent. In this study, we characterized a novel small peptide, NL100, derived from a conserved C-helix region of EPO. NL100 was shown to bind to the EPO receptor, induce neuritogenesis, and protect hippocampal neurons from oxidative- and A beta(25-35)-induced neurodegeneration in vitro. Importantly, long-term NL100 treatment did not induce hematopoiesis, overcoming this challenge associated with EPO. Memory-enhancing effects were demonstrated after NL100 treatment in social recognition test for short-term memory, in both healthy rats and rats challenged centrally with A beta(25-35) peptide, and in the Morris water maze test for spatial memory. Moreover, NL100 was shown to reverse A beta(25-35)-induced hippocampal degeneration and gliosis as well as pilocarpine-induced suppression of long-term potentiation in rats. In conclusion, NL100 is a novel EPO-derived nonhematopoietic peptide with neuroprotective and memory-enhancing effects and could therefore be a potential candidate for the development of new treatments for neurodegenerative disorders and dementia. (C) 2019 Elsevier Inc. All rights reserved.	[Dmytriyeva, Oksana; Soud, Katia; Woldbye, David Paul Drucker; Gotzsche, Casper Rene; Pankratova, Stanislava] Univ Copenhagen, Dept Neurosci, Lab Neural Plastic, Blegdamsvej 3, DK-2100 Copenhagen, Denmark; [Dmytriyeva, Oksana; Pankratova, Stanislava] Copenhagen Univ Hosp, Bispebjerg Frederiksberg Hosp, Res Lab Stereol & Neurosci, Copenhagen, Denmark; [Belmeguenai, Amor; Bezin, Laurent] TIGER Team, Lyon Neurosci Res Ctr, Bron, France; [Belmeguenai, Amor; Bezin, Laurent] Epilepsy Inst IDEE, Bron, France		Pankratova, S (corresponding author), Univ Copenhagen, Dept Neurosci, Lab Neural Plastic, Blegdamsvej 3, DK-2100 Copenhagen, Denmark.	stasya@sund.ku.dk	Gotzsche, Casper/AAV-2421-2020	Gotzsche, Casper/0000-0003-3063-2853; Pankratova, Stanislava/0000-0002-5406-5163	Velux FoundationVelux Fonden [00010310]; Lundbeck FoundationLundbeckfonden [R83-A8113, R118-A11752, R315-2018-3679]	This work is dedicated to the memory of Prof. Vladimir Berezin, who passed away on the 14th of February 2016. Authors acknowledged Tatiana Novikova for help with stereological evaluation of histological images. This work was supported by fellowships from Velux Foundation to OD (00010310) and Lundbeck Foundation to SP (R83-A8113, R118-A11752 and R315-2018-3679).	Adamcio B, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-37; Almaguer-Melian W, 2016, SYNAPSE, V70, P240, DOI 10.1002/syn.21895; Arabpoor Zohreh, 2012, Adv Biomed Res, V1, P50, DOI 10.4103/2277-9175.100157; Armand-Ugon M, 2015, J ALZHEIMERS DIS, V45, P407, DOI [10.3233/JAD-141389, 10.3233/JAD-150002]; Assaraf MI, 2007, J NEUROPATH EXP NEUR, V66, P389, DOI 10.1097/nen.0b013e3180517b28; Bahcekapili N, 2014, INT J NEUROSCI, V124, P762, DOI 10.3109/00207454.2013.878935; Barichello T, 2014, TRANSL RES, V163, P503, DOI 10.1016/j.trsl.2013.12.008; Bediou B, 2009, J GERIATR PSYCH NEUR, V22, P130, DOI 10.1177/0891988709332939; Belfort T, 2018, J GERIATR PSYCH NEUR, V31, P27, DOI 10.1177/0891988717743587; Belmeguenai A, 2010, J NEUROSCI, V30, P13630, DOI 10.1523/JNEUROSCI.3226-10.2010; Benussi L, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00672; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bond WS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00523; Bonnas C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03167-0; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Byts Nadiya, 2009, Exp Transl Stroke Med, V1, P4, DOI 10.1186/2040-7378-1-4; CAIN DP, 1993, HIPPOCAMPUS, V3, P153, DOI 10.1002/hipo.450030208; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Cerit H, 2015, EUR NEUROPSYCHOPHARM, V25, P2289, DOI 10.1016/j.euroneuro.2015.09.005; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P387, DOI 10.2174/156720205774962683; Chu K, 2008, EPILEPSIA, V49, P1723, DOI 10.1111/j.1528-1167.2008.01644.x; Chung YH, 2004, BRAIN RES, V1018, P141, DOI 10.1016/j.brainres.2004.05.078; Corbett NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071479; D'Amelio M, 2012, PROG NEUROBIOL, V99, P42, DOI 10.1016/j.pneurobio.2012.07.001; Danielyan L, 2009, CELL DEATH DIFFER, V16, P1599, DOI 10.1038/cdd.2009.95; Delobette S, 1997, EUR J PHARMACOL, V319, P1, DOI 10.1016/S0014-2999(96)00922-3; Dhanushkodi A, 2013, GENES BRAIN BEHAV, V12, P224, DOI 10.1111/gbb.12001; Dmytriyeva O, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/1346390; Ehrenreich H, 2007, MOL PSYCHIATR, V12, P206, DOI 10.1038/sj.mp.4001907; Ehrenreich H, 2004, MOL PSYCHIATR, V9, P42, DOI 10.1038/sj.mp.4001442; El-Kordi A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-37; Enevoldsen MN, 2012, NEUROBIOL DIS, V48, P533, DOI 10.1016/j.nbd.2012.07.016; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Fares RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053888; Fedotova J, 2016, BIOMED PHARMACOTHER, V83, P1444, DOI 10.1016/j.biopha.2016.08.065; Gantner D. C, 2017, ANN SURG, V267, P585; GRIMM G, 1990, KIDNEY INT, V38, P480, DOI 10.1038/ki.1990.229; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Jubinsky PT, 1997, BLOOD, V90, P1867, DOI 10.1182/blood.V90.5.1867; Kamal A, 2011, BRAIN RES, V1410, P33, DOI 10.1016/j.brainres.2011.06.059; Kambova L, 1998, NEPHROL DIAL TRANSPL, V13, P229, DOI 10.1093/ndt/13.1.229; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; Klementiev B, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-27; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Kristensen PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059672; Kumral A, 2004, BEHAV BRAIN RES, V153, P77, DOI 10.1016/j.bbr.2003.11.002; Lee ST, 2012, J NEUROCHEM, V120, P115, DOI 10.1111/j.1471-4159.2011.07534.x; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Li WP, 2004, ANN NEUROL, V56, P767, DOI 10.1002/ana.20274; Li X, 2016, EXP GERONTOL, V83, P89, DOI 10.1016/j.exger.2016.07.012; Li ZM, 2016, CLIN NEUROL NEUROSUR, V150, P80, DOI 10.1016/j.clineuro.2016.09.001; Liu Q, 2017, BEHAV BRAIN RES, V324, P51, DOI 10.1016/j.bbr.2017.01.045; Lourhmati A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077182; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Ma R, 2009, NEUROPHARMACOLOGY, V56, P1027, DOI 10.1016/j.neuropharm.2009.02.006; Maiese K, 2012, INT J MOL SCI, V13, P11102, DOI 10.3390/ijms130911102; Maurice T, 2013, J PSYCHOPHARMACOL, V27, P1044, DOI 10.1177/0269881113494939; McCagh J, 2009, EPILEPSY RES, V86, P1, DOI 10.1016/j.eplepsyres.2009.04.007; Meldolesi J, 2011, BRAIN RES REV, V66, P246, DOI 10.1016/j.brainresrev.2010.06.004; Metcalfe SM, 2017, CURR PHARM DESIGN, V23, P776, DOI [10.2174/1381612822666161206, 10.2174/1381612822666161206141744]; Miskowiak K, 2008, NEUROPSYCHOPHARMACOL, V33, P611, DOI 10.1038/sj.npp.1301439; Miskowiak K, 2008, EXP BRAIN RES, V184, P313, DOI 10.1007/s00221-007-1102-1; Miskowiak K, 2007, J NEUROSCI, V27, P2788, DOI 10.1523/JNEUROSCI.5013-06.2007; Miskowiak KW, 2014, J CLIN PSYCHIAT, V75, P1347, DOI 10.4088/JCP.13m08839; Miskowiak KW, 2012, PSYCHOPHARMACOLOGY, V219, P687, DOI 10.1007/s00213-011-2511-1; Mogensen J, 2008, BEHAV BRAIN RES, V186, P215, DOI 10.1016/j.bbr.2007.08.009; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Muller CJ, 2009, EUR J PHARMACOL, V619, P15, DOI 10.1016/j.ejphar.2009.07.020; Nadam J, 2007, NEUROBIOL DIS, V25, P412, DOI 10.1016/j.nbd.2006.10.009; Ning B, 2011, NEUROSCI LETT, V490, P57, DOI 10.1016/j.neulet.2010.12.025; Ostrowski D, 2018, J CLIN MED, V7, DOI 10.3390/jcm7020024; Ott C, 2015, MOL MED, V21, P803, DOI 10.2119/molmed.2015.00192; Pankratova S, 2012, J NEUROCHEM, V121, P915, DOI 10.1111/j.1471-4159.2012.07751.x; Pankratova S, 2010, BRAIN, V133, P2281, DOI 10.1093/brain/awq101; Pickett JL, 1999, AM J KIDNEY DIS, V33, P1122, DOI 10.1016/S0272-6386(99)70150-2; Robertson CS, 2013, J NEUROTRAUM, V30, P765, DOI 10.1089/neu.2012.2431; Rodriguez Cruz Y, 2017, J ALZHEIMERS DIS, V55, P231, DOI 10.3233/JAD-160500; Rudenko O, 2010, NEUROSCI RES, V68, P35, DOI 10.1016/j.neures.2010.05.002; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sanchez PE, 2009, P NATL ACAD SCI USA, V106, P9848, DOI 10.1073/pnas.0901840106; Sargin D, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-27; Sargin D, 2010, BEST PRACT RES-CLIN, V24, P573, DOI 10.1016/j.bpa.2010.10.005; Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P11, DOI 10.1046/j.1440-1681.1999.02986.x; Secher T, 2006, NEUROSCIENCE, V141, P1289, DOI 10.1016/j.neuroscience.2006.04.059; Shang YC, 2012, AGING-US, V4, P187, DOI 10.18632/aging.100440; Shing KSCT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29865-x; Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Sozmen SC, 2012, BRAIN DEV-JPN, V34, P189, DOI 10.1016/j.braindev.2011.05.002; Statler PA, 2007, PEDIATR RES, V61, P671, DOI 10.1203/pdr.0b013e31805341dc; Sun ZK, 2008, J NEUROSCI RES, V86, P3018, DOI 10.1002/jnr.21745; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Tazangi PE, 2015, PHARMACOL BIOCHEM BE, V130, P15, DOI 10.1016/j.pbb.2014.12.011; Upadhyay RK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/869269; Uzum G, 2006, LIFE SCI, V78, P2571, DOI 10.1016/j.lfs.2005.10.027; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang B, 2016, NEUROTHERAPEUTICS, V13, P418, DOI 10.1007/s13311-015-0418-y; Xenocostas A, 2005, EUR J CLIN PHARMACOL, V61, P189, DOI 10.1007/s00228-005-0896-7; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Yang J, 2009, BRAIN RES, V1282, P57, DOI 10.1016/j.brainres.2009.05.062; Yu XB, 2002, DEVELOPMENT, V129, P505; Zellinger C, 2011, EPILEPSY RES, V96, P241, DOI 10.1016/j.eplepsyres.2011.06.009; Zhang SJ, 2019, EUR J PHARMACOL, V849, P1, DOI 10.1016/j.ejphar.2019.01.066; Zinn CG, 2016, P NATL ACAD SCI USA, V113, pE4914, DOI 10.1073/pnas.1609883113; Zussy C, 2011, AM J PATHOL, V179, P315, DOI 10.1016/j.ajpath.2011.03.021	111	8	9	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	SEP	2019	81						88	101		10.1016/j.neurobiolaging.2019.05.003			14	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	IV7GT	WOS:000484435300010	31255922				2022-02-06	
J	Dodds, N; Johnson, R; Walton, B; Bouamra, O; Yates, D; Lecky, FE; Thompson, J				Dodds, Nick; Johnson, Rowena; Walton, Benjamin; Bouamra, Omar; Yates, David; Lecky, Fiona Elizabeth; Thompson, Julian			Evaluating the impact of cycle helmet use on severe traumatic brain injury and death in a national cohort of over 11000 pedal cyclists: a retrospective study from the NHS England Trauma Audit and Research Network dataset	BMJ OPEN			English	Article						trauma management; public health; epidemiology; health policy	BICYCLE HELMET; HEAD-INJURY; OUTCOMES; CHILDREN	Objectives In the last 10 years there has been a significant increase in cycle traffic in the UK, with an associated increase in the overall number of cycling injuries. Despite this, and the significant media, political and public health debate into this issue, there remains an absence of studies from the UK assessing the impact of helmet use on rates of serious injury presenting to the National Health Service (NHS) in cyclists. Setting The NHS England Trauma Audit and Research Network (TARN) Database was interrogated to identify all adult (>= 16 years) patients presenting to hospital with cycling-related major injuries, during a period from 14 March 2012 to 30 September 2017 (the last date for which a validated dataset was available). Participants 11 patients met inclusion criteria. Data on the use of cycling helmets were available in 6621 patients. Outcome measures TARN injury descriptors were used to compare patterns of injury, care and mortality in helmeted versus non-helmeted cohorts. Results Data on cycle helmet use were available for 6621 of the 11192 cycle-related injuries entered onto the TARN Database in the 66 months of this study (93 excluded as not pedal cyclists). There was a significantly higher crude 30-day mortality in un-helmeted cyclists 5.6% (4.8%-6.6%) versus helmeted cyclists 1.8% (1.4%-2.2%) (p<0.001). Cycle helmet use was also associated with a reduction in severe traumatic brain injury (TBI) 19.1% (780, 18.0%-20.4%) versus 47.6% (1211, 45.6%-49.5%) (p<0.001), intensive care unit requirement 19.6% (797, 18.4%-20.8%) versus 27.1% (691, 25.4%-28.9%) (p<0.001) and neurosurgical intervention 2.5% (103, 2.1%-3.1%) versus 8.5% (217, 7.5%-9.7%) (p<0.001). There was a statistically significant increase in chest, spinal, upper and lower limb injury in the helmeted group in comparison to the un-helmeted group (all p<0.001), though in a subsequent analysis of these anatomical injury patterns, those cyclists wearing helmets were still found to have lower rates of TBI. In reviewing TARN injury codes for specific TBI and facial injuries, there was a highly significant decrease in rates of impact injury between cyclists wearing helmets and those not. Conclusions This study suggests that there is a significant correlation between use of cycle helmets and reduction in adjusted mortality and morbidity associated with TBI and facial injury.	[Dodds, Nick; Johnson, Rowena; Walton, Benjamin; Thompson, Julian] North Bristol NHS Trust, Bristol, Avon, England; [Bouamra, Omar; Yates, David] Trauma Audit & Res Network, Inst Populat Hlth, Salford, Lancs, England; [Lecky, Fiona Elizabeth] Univ Sheffield, Sch Related Res, Sheffield, S Yorkshire, England; [Lecky, Fiona Elizabeth] Univ Manchester, Trauma Audit & Res Network, Salford, Lancs, England		Dodds, N (corresponding author), North Bristol NHS Trust, Bristol, Avon, England.	nickdodds@nhs.net		Lecky, Fiona/0000-0001-6806-0921			Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Carone L, 2019, INJURY, V50, P61, DOI 10.1016/j.injury.2018.08.015; Dagher JH, 2016, CAN J NEUROL SCI, V43, P56, DOI 10.1017/cjn.2015.281; DIGUISEPPI CG, 1989, JAMA-J AM MED ASSOC, V262, P2256, DOI 10.1001/jama.262.16.2256; Fagliano JA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002621; Forbes AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185367; Gamble T, 2016, PSYCHOL SCI, V27, P289, DOI 10.1177/0956797615620784; Griggs G, 2012, ANN LEIS RES, V15, P180, DOI 10.1080/11745398.2012.659718; Hollis S, 2006, J TRAUMA, V61, P1255, DOI 10.1097/01.ta.0000243889.07090.da; Kelly FJ, 2016, SCIENCE, V352, P934, DOI 10.1126/science.aaf3420; KRAUS JF, 1987, AM J PUBLIC HEALTH, V77, P76, DOI 10.2105/AJPH.77.1.76; MAIMARIS C, 1994, BRIT MED J, V308, P1537, DOI 10.1136/bmj.308.6943.1537; MCCARTHY M, 1992, BRIT MED J, V305, P881, DOI 10.1136/bmj.305.6858.881; Mills N J, 1990, Br J Sports Med, V24, P55; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Olivier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075424; Pedroso FE, 2016, AM J PUBLIC HEALTH, V106, P2171, DOI 10.2105/AJPH.2016.303454; PITT WR, 1994, BRIT MED J, V308, P177, DOI 10.1136/bmj.308.6922.177; Scholten AC, 2015, ACCIDENT ANAL PREV, V81, P51, DOI 10.1016/j.aap.2015.04.022; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; THOMAS S, 1994, BRIT MED J, V308, P173, DOI 10.1136/bmj.308.6922.173; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Transport DF, 2018, REP ROAD CAS GREAT B, P1; TRIPPE HR, 1992, BRIT MED J, V305, P843, DOI 10.1136/bmj.305.6858.843	25	8	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	SEP	2019	9	9							e027845	10.1136/bmjopen-2018-027845			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JO7XE	WOS:000497787600076	31519669	gold, Green Published, Green Accepted			2022-02-06	
J	Fitts, MS; Bird, K; Gilroy, J; Fleming, J; Clough, AR; Esterman, A; Maruff, P; Fatima, Y; Bohanna, I				Fitts, Michelle S.; Bird, Katrina; Gilroy, John; Fleming, Jennifer; Clough, Alan R.; Esterman, Adrian; Maruff, Paul; Fatima, Yaqoot; Bohanna, India			A Qualitative Study on the Transition Support Needs of Indigenous Australians Following Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						Traumatic brain injury; transitions; Aboriginal and Torres Strait Islander health; Indigenous; qualitative research; disability	NORTH-AMERICAN; HEALTH-CARE; HOME; INDIVIDUALS; EXPERIENCES; PEOPLE; POPULATION; GENDER	Objective: A growing body of qualitative literature globally describes post-hospital experiences during early recovery from a traumatic brain injury. For Indigenous Australians, however, little published information is available. This study aimed to understand the lived experiences of Indigenous Australians during the 6 months post-discharge, identify the help and supports accessed during transition and understand the gaps in service provision or difficulties experienced. Methods and Procedure: Semi-structured interviews were conducted at 6 months after hospital discharge to gain an understanding of the needs and lived experiences of 11 Aboriginal and Torres Strait Islander Australians who had suffered traumatic brain injury in Queensland and Northern Territory, Australia. Data were analysed using thematic analysis. Results: Five major themes were identified within the data. These were labelled 'hospital experiences', 'engaging with medical and community-based supports', 'health and wellbeing impacts from the injury', 'everyday living' and 'family adjustments post-injury'. Conclusions: While some of the transition experiences for Indigenous Australians were similar to those found in other populations, the transition period for Indigenous Australians is influenced by additional factors in hospital and during their recovery process. Lack of meaningful interaction with treating clinicians in hospital, challenges managing direct contact with multiple service providers and the injury-related psychological impacts are some of the factors that could prevent Indigenous Australians from receiving the supports they require to achieve their best possible health outcomes in the long term. A holistic approach to care, with an individualised, coordinated transition support, may reduce the risks for re-admission with further head injuries.	[Fitts, Michelle S.] James Cook Univ, Div Trop Hlth & Med, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Fitts, Michelle S.] La Trobe Univ, Ctr Alcohol Policy Res, Melbourne, Vic, Australia; [Bird, Katrina; Fleming, Jennifer; Bohanna, India] James Cook Univ, Div Trop Hlth & Med, Coll Publ Hlth Med & Vet Sci, Cairns, Qld, Australia; [Gilroy, John] Univ Sydney, Ctr Disabil Res & Policy, Dept Hlth Sci, Sydney, NSW, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia; [Clough, Alan R.] James Cook Univ, Australian Inst Trop Hlth & Med, Community Based Hlth Promot & Prevent Studies Grp, Cairns, Qld, Australia; [Esterman, Adrian] Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA, Australia; [Esterman, Adrian] Univ South Australia, Sch Nursing & Midwifery, Adelaide, SA, Australia; [Esterman, Adrian] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia; [Maruff, Paul] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Fatima, Yaqoot] James Cook Univ, Div Trop Hlth & Med, Ctr Rural & Remote Hlth Mt Isa, Mt Isa, Qld, Australia		Fitts, MS (corresponding author), James Cook Univ, Div Trop Hlth & Med, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia.; Fitts, MS (corresponding author), La Trobe Univ, Ctr Alcohol Policy Res, Melbourne, Vic, Australia.	michelle.fitts1@jcu.edu.au	Maruff, Paul/AAD-2454-2021; Fleming, Jennifer/AAH-5108-2020; Maruff, Paul/ABA-1673-2020	Maruff, Paul/0000-0002-6947-9537; gilroy, john/0000-0002-7934-8485; Esterman, Adrian/0000-0001-7324-9171	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1081947]	The study is funded by a National Health and Medical Research Council project, grant 1081947.	Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; Ahrens TD, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006661; Alfandre DJ, 2009, MAYO CLIN PROC, V84, P255, DOI 10.1016/S0025-6196(11)61143-9; Amery R, 2017, MED J AUSTRALIA, V207, P13, DOI 10.5694/mja17.00042; Australian Government Productivity Commission, 2011, 54 AUSTR GOV PROD CO; 'Australian Health Ministers' Advisory Council, 2012, AB TORR STRAIT ISL H; Bell TM, 2018, J TRAUMA ACUTE CARE, V84, P175, DOI 10.1097/TA.0000000000001671; Blackmer J, 1999, BRAIN INJURY, V13, P627; Bohanna I, 2013, ASSESSMENT ACQUIRED; Bohanna I, 2019, BRAIN IMPAIR, V20, P160, DOI 10.1017/BrImp.2019.25; Bohanna I, 2018, BRAIN IMPAIR, V19, P246, DOI 10.1017/BrImp.2018.1; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Burnette L, 2009, REN SOC AUSTRALAS J, V5, P113; Choi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024459; Claiborne N, 2006, HEALTH SOC WORK, V31, P87, DOI 10.1093/hsw/31.2.87; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; D'Cruz K, 2019, NEUROPSYCHOL REHABIL, V29, P985, DOI 10.1080/09602011.2017.1361844; Dillon Gina, 2013, Int J Family Med, V2013, P313909, DOI 10.1155/2013/313909; Dudley M, 2014, NEW ZEAL J PSYCHOL, V43, P14; Durey A, 2012, INTERN MED J, V42, P17, DOI 10.1111/j.1445-5994.2011.02628.x; Durey A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-151; Einsiedel LJ, 2013, AUST HEALTH REV, V37, P239, DOI 10.1071/AH11087; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Foley Dennis, 2006, INT J HUMANITIES, V3, P12; Franks C, 2002, ABORIGINAL ISLANDER, V26, P3; Gentilello LM, 2007, J TRAUMA, V62, pS44, DOI 10.1097/TA.0b013e3180654678; Gilroy J., 2016, AUSTR INDIGENOUS HLT, V1, P1; Gilroy J, 2013, AUST ABORIG STUD, P42; Hunt L, 2015, NURS EDUC TODAY, V35, P461, DOI 10.1016/j.nedt.2014.11.019; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Jayaraj R, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-33; Juillard C, 2016, J TRAUMA ACUTE CARE, V81, P1156, DOI 10.1097/TA.0000000000001261; Katzenellenbogen JM, 2018, J HEAD TRAUMA REHAB, V33, P412, DOI 10.1097/HTR.0000000000000371; Katzenellenbogen JM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-330; Lakhani A, 2017, BRAIN INJURY, V31, P1718, DOI 10.1080/02699052.2017.1374468; Lee KSK, 2009, DRUG ALCOHOL REV, V28, P623, DOI 10.1111/j.1465-3362.2009.00067.x; Levack WMM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004630; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; Marrone S, 2007, INT J CIRCUMPOL HEAL, V66, P188, DOI 10.3402/ijch.v66i3.18254; Martin K., 2008, PLEASE KNOCK YOU ENT; Moreton-Robinson Aileen., 2004, WHITENING RACE ESSAY, P75; Nakata M., 2004, INDIGENOUS KNOWLEDGE; Nalder E, 2013, BRAIN INJURY, V27, P1294, DOI 10.3109/02699052.2013.823560; Nalder E, 2012, BRAIN INJURY, V26, P1381, DOI 10.3109/02699052.2012.676225; Nalder E, 2012, BRAIN IMPAIR, V13, P108, DOI 10.1017/BrImp.2012.4; National Health and Medical Research Council, 2018, KEEP RES TRACK 2 COM; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Ownsworth T., 2014, SELF IDENTITY BRAIN; Paradies Yin, 2008, 4 COOP RES CTR AB HL; Queensland Health, 2018, NURS NAV; Rutland-Brown W, 2005, J HEAD TRAUMA REHAB, V20, P205, DOI 10.1097/00001199-200505000-00004; Shahid S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-132; Tuhiwai-Smith L., 1999, DECOLONISING METHODO; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; Willis J, 2010, IMPROVING CULTURE HO; Zeiler KJ, 2017, CAN J NEUROL SCI, V44, P525, DOI 10.1017/cjn.2017.49	60	8	8	0	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2019	20	2			SI		137	159	PII S144396461900024X	10.1017/BrImp.2019.24			23	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	IU7UQ	WOS:000483789200004					2022-02-06	
J	Haarbauer-Krupa, J; Haileyesus, T; Gilchrist, J; Mack, KA; Law, CS; Joseph, A				Haarbauer-Krupa, Juliet; Haileyesus, Tadesse; Gilchrist, Julie; Mack, Karin A.; Law, Caitlin S.; Joseph, Andrew			Fall-related traumatic brain injury in children ages 0-4 years	JOURNAL OF SAFETY RESEARCH			English	Article						Traumatic brain injury; Falls; Pediatrics; Young children	EMERGENCY-DEPARTMENTS; SURVEILLANCE SYSTEM; PEDIATRIC INJURIES; RISK; HOME	Introduction: Falls are the leading cause of traumatic brain injury (TBI) for children in the 0-4 year age group. There is limited literature pertaining to fall-related TBIs in children age 4 and under and the circumstances surrounding these TBIs. This study provides a national estimate and describes actions and products associated with fall-related TBI in this age group. Method: Data analyzed were from the 2001-2013 National Electronic Injury Surveillance System-All Injury Program (NEISS-AIP), a nationally representative sample of emergency departments (ED). Case narratives were coded for actions associated with the fall, and product codes were abstracted to determine fall location and product type. All estimates were weighted. Results: An estimated 139,001 children younger than 5 years were treated annually in EDs for nonfatal, unintentional fall-related TBI injuries (total = 1,807,019 during 2001-2013). Overall, child actions (e.g., running) accounted for the greatest proportion of injuries and actions by others (e.g., carrying) was highest for children younger than 1 year. The majority of falls occurred in the home, and involved surfaces, fixtures, furniture, and baby products. Conclusions: Fall-related TBI in young children represents a significant public health burden. The majority of children seen for TBI assessment in EDs were released to home. Prevention efforts that target parent supervision practices and the home environment are indicated. Practical applications: Professionals in contact with parents of young children can remind them to establish a safe home and be attentive to the environment when carrying young children to prevent falls. (C) 2019 National Safety Council and Elsevier Ltd. All rights reserved.	[Haarbauer-Krupa, Juliet; Gilchrist, Julie] Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway NE,MS-F62, Atlanta, GA 30341 USA; [Haileyesus, Tadesse; Mack, Karin A.] Ctr Dis Control & Prevent, Div Anal Res & Practice Integrat, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Law, Caitlin S.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Joseph, Andrew] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA		Haarbauer-Krupa, J (corresponding author), Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway NE,MS-F62, Atlanta, GA 30341 USA.	JHaarbauerKrupa@cdc.gov	Mack, Karin/A-3263-2012	Mack, Karin/0000-0001-9274-3001	Intramural CDC HHS [CC999999] Funding Source: Medline		Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Burrows P, 2015, ARCH DIS CHILD, V100, P1032, DOI 10.1136/archdischild-2014-307119; Centers for Disease Control and Prevention, 2018, C MAN TRAUM BRAIN IN; Chaudhary Sofia, 2018, Inj Epidemiol, V5, P7, DOI 10.1186/s40621-018-0147-x; Cheng T. A., 2016, PEDIATRICS, V117, P1; Consumer Product Safety Commission, 2000, NAT EL INJ SURV SYST; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Flavin MP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-187; Gaw CE, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2503; Haney SB, 2010, PEDIATR EMERG CARE, V26, P914, DOI 10.1097/PEC.0b013e3181fe9139; Ibrahim N. G., 2011, INT J DEV NEUROSCI; Kurinsky R. M., 2013, CLIN PEDIATR, V1, P1; Love PF, 2009, J TRAUMA, V67, pS12, DOI 10.1097/TA.0b013e3181ac7f22; Mack KA, 2008, PEDIATRICS, V121, P930, DOI 10.1542/peds.2007-1731; Morrongiello BA, 2004, J PEDIATR PSYCHOL, V29, P433, DOI 10.1093/jpepsy/jsh047; Morrongiello BA, 2005, J PEDIATR PSYCHOL, V30, P536, DOI 10.1093/jpepsy/jsi041; Morrongiello BA, 2016, DEV PSYCHOBIOL, V58, P909, DOI 10.1002/dev.21451; Morrongiello BA, 2014, ACCIDENT ANAL PREV, V71, P194, DOI 10.1016/j.aap.2014.04.016; Pomerantz WJ, 2012, J TRAUMA ACUTE CARE, V73, pS254, DOI 10.1097/TA.0b013e31826b017c; Quinlan KP, 1999, ANN EMERG MED, V34, P637, DOI 10.1016/S0196-0644(99)70166-6; Schroeder T., 2001, NEISS ALL INJURY PRO; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; Thomas K. E., 2015, STATE INJURY INDICAT; Unni P, 2012, AM J EMERG MED, V30, P1457, DOI 10.1016/j.ajem.2011.12.001; Wang DE, 2013, INT J INJ CONTROL SA, V20, P27, DOI 10.1080/17457300.2012.656316	31	8	8	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	SEP	2019	70						127	133		10.1016/j.jsr.2019.06.003			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	KB8FI	WOS:000506724300015	31847987	Green Accepted			2022-02-06	
J	Kanefsky, R; Motamedi, V; Mithani, S; Mysliwiec, V; Gill, JM; Pattinson, CL				Kanefsky, Rebekah; Motamedi, Vida; Mithani, Sara; Mysliwiec, Vincent; Gill, Jessica M.; Pattinson, Cassandra L.			Mild traumatic brain injuries with loss of consciousness are associated with increased inflammation and pain in military personnel	PSYCHIATRY RESEARCH			English	Article						TBI; Depression; PTSD; Veterans; Biomarkers; LOC; Interleukin-6	POSTTRAUMATIC-STRESS-DISORDER; SERUM CONCENTRATIONS; SLEEP DISTURBANCES; TNF-ALPHA; CLASSIFICATION; INTERLEUKIN-6; PREVALENCE; SYMPTOMS; VETERANS; IRAQ	Mild traumatic brain injuries (mTBI) are a pervasive concern for military personnel. Determining the impact of injury severity, including loss of consciousness (LOC) may provide important insights into the risk of psychological symptoms and inflammation commonly witnessed in military personnel and veterans following mTBI. US military personnel and veterans were categorized into three groups; TBI with LOC (n = 36), TBI without LOC (n = 25), Controls (n = 82). Participants reported their history of mTBI, psychological symptoms (post-traumatic stress disorder [PTSD] and depression), health-related quality of life (HRQOL), and underwent a blood draw. ANCOVA models which controlled for insomnia status and combat exposure indicated that both mTBI groups (with/without LOC) reported significantly greater depression and PTSD symptoms compared to controls; however, they did not differ from each other. The mTBI with LOC did report greater pain than both controls and mTBI without LOC. The TBI with LOC group also had significantly elevated IL-6 concentrations than both TBI without LOC and control groups. Within the mTBI groups, increased TNF alpha concentrations were associated with greater PTSD symptoms. These findings indicate that sustaining an mTBI, with or without LOC is detrimental for psychological wellbeing. However, LOC may be involved in perceptions of pain and concentrations of IL-6.	[Kanefsky, Rebekah; Motamedi, Vida; Mithani, Sara; Gill, Jessica M.; Pattinson, Cassandra L.] NINR, NIH, 1 Cloisters Court,Room 258b, Bethesda, MD 20892 USA; [Mysliwiec, Vincent] San Antonio Mil Med Ctr, Dept Sleep Med, 1100 Wilford Hall Loop,Bldg 4554, Jbsl Lackland, TX 78236 USA		Pattinson, CL (corresponding author), NINR, NIH, 1 Cloisters Court,Room 258b, Bethesda, MD 20892 USA.	cassie.pattinson@nih.gov	Pattinson, Cassandra/AAY-5974-2020; Gill, Gill M/Q-2020-2017; Pattinson, Cassandra/A-5543-2019	Pattinson, Cassandra/0000-0002-5975-7935	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIENR000016] Funding Source: NIH RePORTER	The work was performed at the Madigan Army Medical Center, Tacoma, WA. Partial funding support was provided by the Center for Neuroscience and Regenerative Medicine (#60855).	Armed Forces Health Surveillance Center, 2010, INS ACT COMP, P12; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Brown GC, 2015, BRAIN RES, V1628, P288, DOI 10.1016/j.brainres.2015.08.031; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Collins-Praino LE, 2018, BEHAV BRAIN RES, V336, P22, DOI 10.1016/j.bbr.2017.08.035; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Devoto C, 2017, CELL TRANSPLANT, V26, P1169, DOI 10.1177/0963689717714098; Gao HB, 2017, BRAIN RES, V1657, P1, DOI 10.1016/j.brainres.2016.11.028; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Himmerich H, 2016, PSYCHIAT DANUB, V28, P293; Himmerich H, 2015, EUR CYTOKINE NETW, V26, P57, DOI 10.1684/ecn.2015.0366; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hossain Jamil L, 2002, Sleep Breath, V6, P85, DOI 10.1007/s11325-002-0085-1; Hussein S, 2017, PSYCHIAT DANUB, V29, P407, DOI 10.24869/psyd.2017.407; JENKINSON C, 1994, QUAL LIFE RES, V3, P7, DOI 10.1007/BF00647843; KAY DWK, 1971, LANCET, V2, P1052; Kim EJ, 2015, LEARN MEMORY, V22, P411, DOI 10.1101/lm.037291.114; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Licastro F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00189; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Schmidt FM, 2014, J PSYCHIATR RES, V55, P29, DOI 10.1016/j.jpsychires.2014.04.021; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Stensballe J, 2009, ACTA ANAESTH SCAND, V53, P515, DOI 10.1111/j.1399-6576.2008.01801.x; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Thorpy MJ, 2012, NEUROTHERAPEUTICS, V9, P687, DOI 10.1007/s13311-012-0145-6; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3	41	8	8	2	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	SEP	2019	279						34	39		10.1016/j.psychres.2019.07.001			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	IY0OC	WOS:000486091600005	31280036				2022-02-06	
J	Liu, XY; Yu, XY; He, YC; Wang, L				Liu, Xiangyu; Yu, Xueyuan; He, Youcheng; Wang, Lu			Long noncoding RNA nuclear enriched abundant transcript 1 promotes the proliferation and migration of Schwann cells by regulating the miR-34a/Satb1 axis	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article						long noncoding RNA nuclear enriched abundant transcript 1 (NEAT1); migration; miR-34a; sequence-binding protein-1 (Satb1); proliferation; Schwann cells	NERVE INJURY; NEURITE OUTGROWTH; BINDING-PROTEIN; UP-REGULATION; SATB1; APOPTOSIS; CANCER; NEAT1	The proliferation and migration of Schwann cells contribute to axonal outgrowth and functional recovery after peripheral nerve injury. Studies have found that long noncoding RNAs (lncRNAs) were abnormally expressed after peripheral nerve injury and they played vital roles in peripheral nerve regeneration. LncRNA nuclear enriched abundant transcript 1 (NEAT1) was increased in the cerebral cortex surrounding the injury site of mice after traumatic brain injury, and it promoted the functional recovery in mice. However, its role and mechanism in peripheral nerve injury remain unknown. The expression of NEAT1, miR-34a, and Special AT-rich sequence-binding protein-1 (Satb1) was detected in the sciatic nerve of mice after sciatic nerve crush at 0, 1, 4 and 7 days. The effects of NEAT1 on the proliferation and migration of Schwann cells were detected by 5-Ethynyl-20-deoxyuridine (Edu) and transwell by gain- and loss-of-functions. The mechanism was focused on the miR-34a/Satb1 pathway. In addition, the effect of NEAT1 in Schwann cells on axon outgrowth of dorsal root ganglion neurons was further investigated. We found that the NEAT1 and Satb1 expression was increased, whereas miR-34a was reduced, in injured sciatic nerve at different time points. Overexpression of NEAT1 promoted, whereas knockdown of NEAT1 suppressed the proliferation and migration of Schwann cells. NEAT1 functioned as a competing endogenous RNA to regulate the Satb1 expression via sponging miR-34a. NEAT1 enhanced the axon outgrowth of dorsal root ganglion neurons via regulating the miR-34a and Satb1 expression. In conclusion, NEAT1 promotes the proliferation and migration of Schwann cell via miR-34a/Satb1, which may provide a new approach to peripheral nerve regeneration.	[Liu, Xiangyu; Yu, Xueyuan; He, Youcheng; Wang, Lu] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Aesthet Plast & Craniofacial Surg, Xian, Shaanxi, Peoples R China		Wang, L (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.	luwangl15@163.com					Arthur-Farraj PJ, 2017, CELL REP, V20, P2719, DOI 10.1016/j.celrep.2017.08.064; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Chang HM, 2014, J PINEAL RES, V56, P322, DOI 10.1111/jpi.12125; Cui CL, 2015, CELL BIOL INT, V39, P933, DOI 10.1002/cbin.10461; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Ding N, 2017, ONCOTARGETS THER, V10, P4905, DOI 10.2147/OTT.S142446; Du J, 2018, BIOMATERIALS, V181, P347, DOI 10.1016/j.biomaterials.2018.07.015; Fromberg A, 2018, CANCER LETT, V417, P96, DOI 10.1016/j.canlet.2017.12.031; Hsu CC, 2016, J NUTR BIOCHEM, V38, P102, DOI 10.1016/j.jnutbio.2016.09.003; Lena AM, 2012, BIOCHEM BIOPH RES CO, V423, P509, DOI 10.1016/j.bbrc.2012.05.153; Li YY, 2018, EBIOMEDICINE, V36, P209, DOI 10.1016/j.ebiom.2018.09.006; Liu F, 2017, ONCOTARGET, V8, P62927, DOI 10.18632/oncotarget.17757; Liu HW, 2018, EUR REV MED PHARMACO, V22, P4268, DOI 10.26355/eurrev_201807_15423; Liu R, 2018, INT J MOL MED, V42, P2903, DOI 10.3892/ijmm.2018.3829; Luo Y, 2019, CANCER LETT, V440, P11, DOI 10.1016/j.canlet.2018.10.002; Lv C, 2015, AM J TRANSL RES, V7, P1992; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Pan B, 2017, NEURAL REGEN RES, V12, P2084, DOI 10.4103/1673-5374.221168; Pan B, 2017, INT J MOL MED, V39, P1381, DOI 10.3892/ijmm.2017.2963; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rodriguez-Mateo C, 2017, CELL DEATH DIFFER, V24, P785, DOI 10.1038/cdd.2017.9; Tang YJ, 2017, NAT REV RHEUMATOL, V13, P657, DOI 10.1038/nrrheum.2017.162; Tu W, 2012, LIVER INT, V32, P1064, DOI 10.1111/j.1478-3231.2012.02815.x; Viader A, 2011, J NEUROSCI, V31, P17358, DOI 10.1523/JNEUROSCI.3931-11.2011; Wang HL, 2018, INT J MOL MED, V41, P3477, DOI 10.3892/ijmm.2018.3571; Xia LX, 2018, J CELL PHYSIOL, V233, P7103, DOI 10.1002/jcp.26526; Xu M, 2018, CELL PHYSIOL BIOCHEM, V46, P1286, DOI 10.1159/000489111; Yang ZJ, 2018, MOL THER-ONCOLYTICS, V10, P40, DOI 10.1016/j.omto.2018.07.001; Yao C, 2018, J NEUROSCI, V38, P6574, DOI 10.1523/JNEUROSCI.3790-16.2018; Yao C, 2015, EUR J NEUROSCI, V42, P1718, DOI 10.1111/ejn.12966; Yu B, 2015, PROG NEUROBIOL, V134, P122, DOI 10.1016/j.pneurobio.2015.09.006; Zhang JY, 2018, LIFE SCI, V207, P227, DOI 10.1016/j.lfs.2018.06.011; Zhang M, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0656-7; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhou SL, 2014, J CELL SCI, V127, P967, DOI 10.1242/jcs.131672; Zhou ZB, 2018, MOL THER-NUCL ACIDS, V12, P718, DOI 10.1016/j.omtn.2018.07.011	36	8	8	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	SEP	2019	234	9					16357	16366		10.1002/jcp.28302			10	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	IB3NM	WOS:000470174200174	30747445				2022-02-06	
J	Mikkonen, ED; Skrifvars, MB; Reinikainen, M; Bendel, S; Laitio, R; Hoppu, S; Ala-Kokko, T; Karppinen, A; Raj, R				Mikkonen, Era D.; Skrifvars, Markus B.; Reinikainen, Matti; Bendel, Stepani; Laitio, Ruut; Hoppu, Sanna; Ala-Kokko, Tero; Karppinen, Atte; Raj, Rahul			Validation of prognostic models in intensive care unit-treated pediatric traumatic brain injury patients	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; pediatric; intensive care unit; outcome; prognosis; trauma	CLASSIFICATION; MORTALITY; CHILDREN; SYSTEM	OBJECTIVE There are few specific prognostic models specifically developed for the pediatric traumatic brain injury (TBI) population. In the present study, the authors tested the predictive performance of existing prognostic tools, originally developed for the adult TBI population, in pediatric TBI patients requiring stays in the ICU. METHODS The authors used the Finnish Intensive Care Consortium database to identify pediatric patients (< 18 years of age) treated in 4 academic ICUs in Finland between 2003 and 2013. They tested the predictive performance of 4 classification systems-the International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) TBI model, the Helsinki CT score, the Rotterdam CT score, and the Marshall CT classification-by assessing the area under the receiver operating characteristic curve (AUC) and the explanatory variation (pseudo-R-2 statistic). The primary outcome was 6-month functional outcome (favorable outcome defined as a Glasgow Outcome Scale score of 4-5). RESULTS Overall, 341 patients (median age 14 years) were included; of these, 291 patients had primary head CT scans available. The IMPACT core-based model showed an AUC of 0.85 (95% CI 0.78-0.91) and a pseudo-R-2 value of 0.40. Of the CT scoring systems, the Helsinki CT score displayed the highest performance (AUC 0.84, 95% CI 0.78-0.90; pseudo-R-2 0.39) followed by the Rotterdam CT score (AUG 0.80, 95% CI 0.73-0.86; pseudo-R-2 0.34). CONCLUSIONS Prognostic tools originally developed for the adult TBI population seemed to perform well in pediatric TBI. Of the tested CT scoring systems, the Helsinki CT score yielded the highest predictive value.	[Mikkonen, Era D.] Helsinki Univ Hosp, Dept Anesthesiol Intens Care & Pain Med, Helsinki, Finland; [Mikkonen, Era D.; Skrifvars, Markus B.] Helsinki Univ Hosp, Dept Emergency Care & Serv, Helsinki, Finland; [Mikkonen, Era D.; Skrifvars, Markus B.; Karppinen, Atte; Raj, Rahul] Univ Helsinki, Helsinki, Finland; [Reinikainen, Matti] Kuopio Univ Hosp, Dept Anesthesiol, Kuopio, Finland; [Bendel, Stepani] Kuopio Univ Hosp, Dept Intens Care, Kuopio, Finland; [Bendel, Stepani] Univ Eastern Finland, Kuopio, Finland; [Laitio, Ruut] Turku Univ Hosp, Dept Intens Care, Turku, Finland; [Laitio, Ruut] Univ Turku, Turku, Finland; [Hoppu, Sanna] Tampere Univ Hosp, Emergency Med Serv, Tampere, Finland; [Hoppu, Sanna] Tampere Univ Hosp, Dept Intens Care, Tampere, Finland; [Hoppu, Sanna] Tampere Univ, Tampere, Finland; [Ala-Kokko, Tero] Univ Oulu, Div Intens Care, Med Res Ctr Oulu MRC, Oulu Univ Hosp,Res Unit Anesthesiol Surg Anesthes, Oulu, Finland; [Karppinen, Atte; Raj, Rahul] Helsinki Univ Hosp, Dept Neurosurg, Helsinki, Finland		Mikkonen, ED (corresponding author), Univ Helsinki, Helsinki, Finland.; Mikkonen, ED (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	era.mikkonen@helsinki.fi	Raj, Rahul/K-7693-2012	Raj, Rahul/0000-0003-4243-9591; Mikkonen, Era Daniel/0000-0003-1379-0235; Reinikainen, Matti/0000-0001-6878-3740; Karppinen, Atte/0000-0003-0788-3662			Agrawal Shruti, 2016, World J Crit Care Med, V5, P36, DOI 10.5492/wjccm.v5.i1.36; Appenteng R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201550; Au AK, 2017, CURR OPIN NEUROL, V30, P565, DOI 10.1097/WCO.0000000000000504; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; Hale AT, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.8.FOCUS17773; Kan CH, 2009, MALAYS J MED SCI, V16, P25; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Raj R, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0320-6; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Reinikainen M, 2012, ACTA ANAESTH SCAND, V56, P1114, DOI 10.1111/j.1399-6576.2012.02669.x; Sarnaik A, 2018, NEUROCRIT CARE, V28, P302, DOI 10.1007/s12028-017-0480-x; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Yao S, 2017, WORLD NEUROSURG, V101, P528, DOI 10.1016/j.wneu.2017.02.072; Young AMH, 2016, J NEUROSURG-PEDIATR, V18, P558, DOI 10.3171/2016.5.PEDS15427	23	8	8	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	SEP	2019	24	3					330	337		10.3171/2019.4.PEDS1983			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	IV1QV	WOS:000484053700012	31174193				2022-02-06	
J	Sirbulescu, RF; Chung, JY; Edmiston, WJ; Poznansky, SA; Poznansky, MC; Whalen, MJ				Sirbulescu, Ruxandra F.; Chung, Joon Yong; Edmiston, William J., III; Poznansky, Sonya A.; Poznansky, Mark C.; Whalen, Michael J.			Intraparenchymal Application of Mature B Lymphocytes Improves Structural and Functional Outcome after Contusion Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						B cells; CCI; inflammation; learning and memory; lymphocytes; TBI	CNS INFLAMMATION; CELLS; AUTOIMMUNITY; PATHOGENESIS; ANTIBODIES	Cerebral contusion causes neurological dysfunction mediated in part by inflammatory responses to injury. B lymphocytes are dynamic regulators of the immune system that have not been systematically studied in traumatic brain injury (TBI). We showed previously that topically applied mature B cells have immunomodulatory properties and strongly promote tissue regeneration, including cutaneous nerve growth, in acute and chronic skin wounds. Using a mouse controlled cortical impact (CCI) model, we assessed a possible beneficial role of exogenously applied B cells on histopathological and functional outcome after TBI. Mice were injected intraparenchymally at the lesion site with 2 x 10(6) mature naive syngeneic splenic B cells, then subjected to CCI. Control CCI mice received equal numbers of T cells or saline, and sham-injured mice (craniotomy only) were given B cells or saline. Sham-injured groups performed similarly in motor and learning tests. Injured mice administered B cells showed significantly improved post-injury rotarod, Y maze, and Morris water maze (MWM) performance compared with saline- or T-cell-treated CCI groups. Moreover, lesion volume in mice treated with B cells was significantly reduced by 40% at 35 days post-TBI compared with saline and T cell controls, and astrogliosis and microglial activation were decreased. In vivo tracking of exogenous B cells showed that they have a limited life span of approximately 14 days in situ and do not appear to proliferate. The data suggest proof of principle that local administration of B lymphocytes may represent a therapeutic option for treatment of cerebral contusion, especially when clinical management involves procedures that allow access to the injury site.	[Sirbulescu, Ruxandra F.; Poznansky, Mark C.] Harvard Med Sch, Massachusetts Gen Hosp, Vaccine & Immunotherapy Ctr, Dept Med, Boston, MA 02115 USA; [Chung, Joon Yong; Edmiston, William J., III; Poznansky, Sonya A.; Whalen, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Neurosci Ctr, Boston, MA 02115 USA		Sirbulescu, RF (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Vaccine & Immunotherapy Ctr, 149 13th St,Room 5-246B, Charlestown, MA 02129 USA.	RSIRBULESCU@mgh.harvard.edu	Poznansky, Mark C/M-4996-2015	Poznansky, Mark C/0000-0003-1344-7103; Chung, Joon Yong/0000-0002-3980-2065			Acosta SA, 2015, STROKE, V46, P2616, DOI 10.1161/STROKEAHA.115.009854; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bjarnadottir K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34594; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bodhankar S, 2014, METAB BRAIN DIS, V29, P59, DOI 10.1007/s11011-013-9474-3; Bodhankar S, 2013, METAB BRAIN DIS, V28, P375, DOI 10.1007/s11011-013-9413-3; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fillatreau S, 2015, CURR OPIN PHARMACOL, V23, P1, DOI 10.1016/j.coph.2015.04.006; Fulcher DA, 1997, IMMUNOL CELL BIOL, V75, P446, DOI 10.1038/icb.1997.69; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Goodchild TT, 2009, JACC-CARDIOVASC INTE, V2, P1005, DOI 10.1016/j.jcin.2009.08.010; Serran MG, 2015, FEBS LETT, V589, P3362, DOI 10.1016/j.febslet.2015.08.048; Hoffman W, 2016, CLIN J AM SOC NEPHRO, V11, P137, DOI 10.2215/CJN.09430915; Iwata Y, 2009, AM J PATHOL, V175, P649, DOI 10.2353/ajpath.2009.080355; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Konnecke I, 2014, BONE, V64, P155, DOI 10.1016/j.bone.2014.03.052; Krumbholz M, 2012, NAT REV NEUROL, V8, P613, DOI 10.1038/nrneurol.2012.203; Lehmann-Horn K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-146; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li R, 2018, NAT IMMUNOL, V19, P696, DOI 10.1038/s41590-018-0135-x; Li R, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00626; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Mashkouri S, 2016, NEURAL REGEN RES, V11, P1379, DOI 10.4103/1673-5374.191197; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Nishio N, 2009, IMMUNOLOGY, V128, P369, DOI 10.1111/j.1365-2567.2009.03119.x; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Sirbulescu RF, 2017, WOUND REPAIR REGEN, V25, P774, DOI 10.1111/wrr.12584; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zinn KR, 2008, ILAR J, V49, P103, DOI 10.1093/ilar.49.1.103	35	8	8	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2019	36	17					2579	2589		10.1089/neu.2018.6368			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IW9BT	WOS:000485289000011	30997843				2022-02-06	
J	Zhao, JJ; Wang, B; Huang, TQ; Guo, XY; Yang, ZB; Song, JN; Zhang, M				Zhao, Junjie; Wang, Bo; Huang, Tingqin; Guo, Xiaoye; Yang, Zhongbo; Song, Jinning; Zhang, Ming			Glial response in early stages of traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Global glial reaction; Microglia; Astrocytes	MICROGLIA; NEURODEGENERATION; INFLAMMATION; ACTIVATION; ASTROCYTE	Traumatic brain in jury affects a number of individuals per year and is a major cause of worldwide death and disability. Yet, its pathophysiological mechanism remains unclear. It is well-known that glial cells, including microglia and astrocytes, are activated and involved in tissue damage and repair in the peri-lesion regions after traumatic brain injury; however, global glial responses are rarely reported. The purpose of this study was to investigate the global activation of microglia and astrocytes 1 day after traumatic brain injury. To test this, we used a weight drop device to inflict traumatic brain injury on left side of the brain and performed hematoxylineosin staining to detect tissue damage. We used immunohistochemical staining and western blotting to detect the activation of microglia and astrocytes 1 day after TBI. We found that microglia were significantly activated in ipsilateral regions. Interestingly, we found that astrocytes were also significantly activated in the ipsilateral regions, contralateral cortex, and contralateral corpus callosum. These results suggest that a focal damage can cause a global glial reaction.	[Zhao, Junjie; Wang, Bo; Guo, Xiaoye; Yang, Zhongbo; Song, Jinning] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China; [Huang, Tingqin; Zhang, Ming] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Neurosurg, West Fifth Rd 157, Xian 710004, Shaanxi, Peoples R China		Zhang, M (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Neurosurg, West Fifth Rd 157, Xian 710004, Shaanxi, Peoples R China.	phoenixzhang@126.com			Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [xjj2015018]	This work was supported by the Fundamental Research Funds for the Central Universities [grant number xjj2015018].	Bohman LE, 2016, J NEUROTRAUM, V33, P168, DOI 10.1089/neu.2015.3885; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; DeWalt GJ, 2018, NEUROSCI LETT, V664, P160, DOI 10.1016/j.neulet.2017.11.016; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Donat CK, 2016, NEUROMOL MED, V18, P158, DOI 10.1007/s12017-016-8385-y; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Khan M, 2018, BEHAV BRAIN RES, V340, P63, DOI 10.1016/j.bbr.2016.10.037; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Lian H, 2016, J NEUROSCI, V36, P577, DOI 10.1523/JNEUROSCI.2117-15.2016; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Paolicelli RC, 2019, NEUROSCIENCE, V405, P148, DOI 10.1016/j.neuroscience.2018.04.003; Rudolfson N, 2019, J NEUROSURG, V130, P1149, DOI 10.3171/2017.12.JNS17281; Venneti S, 2013, GLIA, V61, P10, DOI 10.1002/glia.22357; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wen L, 2018, J NEUROTRAUM, V35, P2330, DOI 10.1089/neu.2017.5540; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5	26	8	8	4	16	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	AUG 24	2019	708								134335	10.1016/j.neulet.2019.134335			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IT6SW	WOS:000483006100014	31207278				2022-02-06	
J	El-Gazar, AA; Soubh, AA; Mohamed, EA; Awad, AS; El-Abhar, HS				El-Gazar, Amira A.; Soubh, Ayman A.; Mohamed, Eman A.; Awad, Azza S.; El-Abhar, Hanan S.			Morin post-treatment confers neuroprotection in a novel rat model of mild repetitive traumatic brain injury by targeting dementia markers, APOE, autophagy and Wnt/beta-catenin signaling pathway	BRAIN RESEARCH			English	Article						Repetitive traumatic brain injury models; Apo E; Autophagy; Wnt/beta-catenin; Morin; Tau expression	D-ASPARTATE RECEPTORS; APOLIPOPROTEIN-E; TAU PATHOLOGY; PHOSPHORYLATED TAU; ALZHEIMER-DISEASE; CLEAVED-TAU; MOUSE MODEL; EXPRESSION; NECROSIS; MK-801	Exposure to repetitive brain trauma has gained attention for its similarity to sport-related trauma. The traumatic brain injury (TBI) is strongly associated with neurodegenerative pathology that affects cognition, memory and behavior. The current study developed a novel mild repetitive traumatic brain injury (mRTBI) model to highlight some of the possible molecular pathological mechanisms compared to those of single trauma. Additionally, the study investigated the potential post-traumatic neuroprotective effect of Morin and/or MK-801. mRTBI was induced by weight drop model once daily for 5 days using Sprague-Dawley male rats. Animals were classified into control, mild TBI, mRTBI-5, mRTBI-7, mRTBI-5 + DMSOMK, mRTBI-5 + DMSOMO, mRTBI-5 + Morin, mRTB-I5 + MK801, and mRTBI-5 + Morin + MK801. All treatments, especially the combination regimen, abated the cortical contents/protein expression of dementia markers (APO-E, A beta(42), p(thr231)Tau, and p(Ser33)beta-catenin), inflammatory markers (p(Ser536)NF-kappa Bp65, and TNF-alpha, IL-6), and caspase-3 activity. Moreover, treatments enhanced the protein expression of Wnt-1 and autophagy-related markers (LC3BII/1 and Beclin-1), besides the tissue content of the anti-apoptotic marker Bcl-2. These results entailed an improvement in the behavioral outcome, histological structure, and neuronal survival. In conclusion, the study proved that mRTBI impairs memory and alters APO-E/A beta(42)/p(thr231)Tau via the modulation of Wnt/beta-catenin trajectory, autophagy, apoptosis, and inflammation. Additionally, post-treatment with Morin and/or MK-801 ameliorated these alterations, especially the combined regimen. It is also worth mentioning that Morin alone showed the finest behavioral improvements relative to the normal group. These results are summarized in Fig. 1.	[El-Gazar, Amira A.] October 6 Univ, Dept Pharmacol & Toxicol, Giza, Egypt; [Soubh, Ayman A.; Awad, Azza S.] Ahram Canadian Univ, Dept Pharmacol & Toxicol, Giza, Egypt; [Mohamed, Eman A.] Al Azhar Univ, Dept Pharmacol & Toxicol, Cairo, Egypt; [El-Abhar, Hanan S.] Cairo Univ, Dept Pharmacol & Toxicol, Cairo, Egypt		Soubh, AA (corresponding author), Ahram Canadian Univ, Dept Pharmacol & Toxicol, Fac Pharm, 6 October,4th Ind Area, Giza 12566, Egypt.	dr.aymanar@gmail.com	El-Gazar, Amira/AAV-5190-2021; Soubh, Ayman/L-6157-2019	Soubh, Ayman/0000-0002-9348-0167; El-gazar, Amira/0000-0002-8372-4682			Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Ali A.A., 2017, ALZHEIMERS DEMENTIA, V13, pP618; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Bachurin S, 2001, ANN NY ACAD SCI, V939, P219; Braidy N, 2014, METAB BRAIN DIS, V29, P873, DOI 10.1007/s11011-014-9557-9; Buchanan MM, 2010, J NEUROCHEM, V114, P13, DOI 10.1111/j.1471-4159.2010.06736.x; Cao JQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11654-7; Caselli A, 2016, CURR MED CHEM, V23, P774, DOI 10.2174/0929867323666160106150821; CHEN XR, 2018, J NEUROINFLAMM, V15; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; Dambinova SA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00172; De Ferrari GV, 2014, CNS NEUROL DISORD-DR, V13, P745; Deng YL, 2014, NEUROBIOL AGING, V35, P449, DOI 10.1016/j.neurobiolaging.2013.08.031; Di Meco A, 2016, MOL PSYCHIATR, V21, P403, DOI 10.1038/mp.2015.78; Fan SS, 2004, MOL BRAIN RES, V132, P38, DOI 10.1016/j.molbrainres.2004.09.003; Ferreira IL, 2012, CELL CALCIUM, V51, P95, DOI 10.1016/j.ceca.2011.11.008; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Galluzzi L, 2016, NAT REV NEUROSCI, V17, P467, DOI 10.1038/nrn.2016.51; Garofalo P, 1996, J PHARM PHARMACOL, V48, P1290, DOI 10.1111/j.2042-7158.1996.tb03938.x; Ghribi O, 2006, EXP NEUROL, V200, P460, DOI 10.1016/j.expneurol.2006.03.019; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Gong EJ, 2011, NEUROBIOL DIS, V44, P223, DOI 10.1016/j.nbd.2011.07.005; Gottlieb M, 2006, NEUROBIOL DIS, V23, P374, DOI 10.1016/j.nbd.2006.03.017; Grant DA, 2018, J NEUROTRAUM, V35, P94, DOI 10.1089/neu.2017.5042; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jacob SW, 2009, PHARMACOL REP, V61, P225, DOI 10.1016/S1734-1140(09)70026-X; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24933; Komatsu M, 2006, AUTOPHAGY, V2, P315, DOI 10.4161/auto.2974; Koukourakis MI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137675; Kuo LH, 2008, MOL BIOL CELL, V19, P4201, DOI 10.1091/mbc.E07-09-0987; Lahiri DK, 2003, J ALZHEIMERS DIS, V5, P81, DOI 10.3233/JAD-2003-5203; Lemkul JA, 2010, BIOCHEMISTRY-US, V49, P3935, DOI 10.1021/bi1000855; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Li JG, 2014, ANN NEUROL, V75, P851, DOI 10.1002/ana.24145; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; McFarland AJ, 2018, TOXICOL APPL PHARM, V344, P56, DOI 10.1016/j.taap.2018.03.005; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Noor H, 2012, PROTEIN SCI, V21, P373, DOI 10.1002/pro.2023; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Parr C, 2012, MOL CELL BIOL, V32, P4410, DOI 10.1128/MCB.00930-12; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Silva DD, 2012, ACTA CIR BRAS, V27, P290; Song XQ, 2018, BIOPHYS J, V114, p24A; Sonmez A, 2015, NEUROSCI LETT, V597, P137, DOI 10.1016/j.neulet.2015.05.001; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; Tardiff BE, 1997, ANN THORAC SURG, V64, P715, DOI 10.1016/S0003-4975(97)00757-1; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Turner RC, 2016, BRAIN INJURY, V30, P1279, DOI 10.1080/02699052.2016.1193631; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wan WB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/301575; Wang CX, 2017, CELL BIOL INT, V41, P1039, DOI 10.1002/cbin.10820; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; Wang LS, 2006, J AGR FOOD CHEM, V54, P9798, DOI 10.1021/jf0620719; Wu XM, 2013, INT J CLIN EXP PATHO, V6, P1282; Xu JG, 2014, BRAIN RES, V1582, P237, DOI 10.1016/j.brainres.2014.07.042; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; YUGARANI T, 1992, LIPIDS, V27, P181, DOI 10.1007/BF02536175; Zhang L, 2013, INT J MOL MED, V32, P867, DOI 10.3892/ijmm.2013.1456; Zhang YY, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S40405; Zhang ZT, 2010, ACTA PHARMACOL SIN, V31, P900, DOI 10.1038/aps.2010.77; Zhao LW, 2018, ANN CLIN LAB SCI, V48, P446; Zhou Y, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600966; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	81	8	8	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 15	2019	1717						104	116		10.1016/j.brainres.2019.04.003			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IC2OG	WOS:000470799000012	31002817				2022-02-06	
J	Khetani, A; Rohr, CS; Sojoudi, A; Bray, S; Barlow, KM				Khetani, Aneesh; Rohr, Christiane S.; Sojoudi, Alireza; Bray, Signe; Barlow, Karen M.			Alteration in Cerebral Activation during a Working Memory Task after Pediatric Mild Traumatic Brain Injury: A Prospective Controlled Cohort Study	JOURNAL OF NEUROTRAUMA			English	Article						fMRI; mTBI; PCS; pediatric; TBI; working memory	DEFAULT-MODE NETWORK; SPORTS-RELATED CONCUSSION; HEAD-INJURY; POSTCONCUSSION SYNDROME; EMERGENCY-DEPARTMENT; EXECUTIVE FUNCTIONS; CHILDREN; RECOVERY; FMRI; PATHOPHYSIOLOGY	Mild traumatic brain injuries (mTBIs) commonly occur in children and adolescents and can result in persistent cognitive symptoms. The neurophysiological changes that underlie persistent post-concussive symptoms (PPCS) have not been characterized. Our objective was to compare working-memory related functional magnetic resonance imaging (fMRI) response in children with persistent symptoms after mTBI at one month post-injury to children with typical recovery and healthy controls. This was a prospective, controlled cohort study of children with mTBI at one month post-injury. PPCS was defined as children with a 10-point increase in their post-concussion symptom inventory score (compared with pre-injury score) at one month post-injury and a two-point increase in at least two symptom categories compared with pre-injury. One hundred and seven participants (60 PPCS, 30 recovered mTBI, and 17 controls) with a mean age of 14.2 years (standard deviation [SD] 2.5) (44% male) were assessed 38 (SD 5.9) days after mTBI. The primary outcome measures were visuospatial n-back working memory task performance and fMRI blood oxygen level dependent (BOLD) signal change. Children with PPCS had decreased activation relative to children with typical recovery in the posterior cingulate and precuneus during the one-back working memory condition, despite similar task performance. Differences in cortical activation in children with PPCS at one month highlight the persistent neurobiological consequences of pediatric mTBI on working memory cortical activation. These findings encourage recommendations to avoid contact sports and provide continued care at school for children with persistent symptoms at one month post-injury.	[Khetani, Aneesh] Univ Calgary, Cumming Sch Med, Dept Neurosci, Calgary, AB, Canada; [Rohr, Christiane S.; Bray, Signe] Univ Calgary, Cumming Sch Med, Dept Radiol, Calgary, AB, Canada; [Khetani, Aneesh; Rohr, Christiane S.; Bray, Signe] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Khetani, Aneesh; Rohr, Christiane S.; Bray, Signe] Child & Adolescent Imaging Program, Calgary, AB, Canada; [Rohr, Christiane S.; Bray, Signe] Hotchkiss Brain Inst, Calgary, AB, Canada; [Sojoudi, Alireza] Univ Calgary, Biomed Engn, Calgary, AB, Canada; [Barlow, Karen M.] Univ Queensland, Child Hlth Res Ctr, Fac Med, Brisbane, Qld, Australia		Barlow, KM (corresponding author), Childrens Hlth Res Ctr, Paediat Rehabil, 62 Graham St, South Brisbane, Qld 4010, Australia.	k.barlow@uq.edu.au	Barlow, Karen/I-6492-2019	Barlow, Karen/0000-0003-2612-8507	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [293375]; Faculty of Medicine, University of Calgary Project [10005062]; Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); International and Industrial Imaging Training (I3T) Program at the University of Calgary; Natural Sciences and Engineering Research Council (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Alberta Innovates; NSERC I3T; University of Calgary Eyes High	This study was funded by the Canadian Institutes of Health Research (grant number: 293375) and the Faculty of Medicine, University of Calgary Project number 10005062. AK: Canadian Institute of Health Research, the International and Industrial Imaging Training (I3T) Program at the University of Calgary, and the Natural Sciences and Engineering Research Council (NSERC) for graduate studentship support. CR: Postdoctoral fellowships awarded by Alberta Innovates, NSERC I3T, and University of Calgary Eyes High.	Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beauchamp MH, 2017, J NEUROTRAUM, V34, P2545, DOI 10.1089/neu.2016.4868; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; D'Esposito M, 2015, ANNU REV PSYCHOL, V66, P115, DOI 10.1146/annurev-psych-010814-015031; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Dunkley BT, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00280; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hockey A, 2004, INTELLIGENCE, V32, P591, DOI 10.1016/j.intell.2004.07.009; Holmes J, 2010, APPL COGNITIVE PSYCH, V24, P827, DOI 10.1002/acp.1589; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; Janusz JA, 2012, MILD TRAUMATIC BRAIN, DOI [10.1249/JSR.0b013-31819c7-87, DOI 10.1249/JSR.0B013-31819C7-87]; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Khetani AM, 2018, PEDIATR EMERG CARE, V34, P501, DOI 10.1097/PEC.0000000000000959; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Kumar S, 2013, CLIN NEUROL NEUROSUR, V115, P1326, DOI 10.1016/j.clineuro.2012.12.038; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lindquist MA, 2009, NEUROIMAGE, V45, pS187, DOI 10.1016/j.neuroimage.2008.10.065; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Papoutsis J, 2014, DEV NEUROPSYCHOL, V39, P638, DOI 10.1080/87565641.2014.979926; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Smyth K, 2014, DEV MED CHILD NEUROL, V56, P73, DOI 10.1111/dmcn.12263; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Speck O, 2000, NEUROREPORT, V11, P2581, DOI 10.1097/00001756-200008030-00046; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Takagi M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022098; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; van der Horn HJ, 2016, BRAIN IMAGING BEHAV, V10, P1243, DOI 10.1007/s11682-015-9489-y; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550corr1; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	76	8	9	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2019	36	23					3274	3283		10.1089/neu.2018.6117		AUG 2019	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	JO9FY	WOS:000479936400001	31115273				2022-02-06	
J	Hasjim, BJ; Grigorian, A; Barrios, C; Schubl, S; Nahmias, J; Gabriel, V; Spencer, D; Donayre, C				Hasjim, Bima J.; Grigorian, Areg; Barrios, Cristobal, Jr.; Schubl, Sebastian; Nahmias, Jeffry; Gabriel, Viktor; Spencer, Dean; Donayre, Carlos			National Trends of Thoracic Endovascular Aortic Repair versus Open Thoracic Aortic Repair in Pediatric Blunt Thoracic Aortic Injury	ANNALS OF VASCULAR SURGERY			English	Article; Proceedings Paper	77th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery / 4th World Trauma Congress	SEP 26-29, 2018	San Diego, CA	Amer Assoc Surg Trauma			BALLOON ANGIOPLASTY; MANAGEMENT; ADOLESCENTS; COARCTATION; MORTALITY; RUPTURE; TRAUMA	Background: Blunt thoracic aortic injury (BTAI) occurs in <1% of all trauma admissions. Thoracic endovascular aortic repair (TEVAR) has become the preferred treatment modality in adult patients with BTAI, but its use in pediatrics is currently not supported by device manufacturers and lacks United States Food and Drug Administration approval. We hypothesized that there would also be an increased use of TEVAR in the pediatric population, thus conferring a lower risk of mortality compared with open thoracic aortic repair (OTAR). Methods: The National Trauma Data Bank (2007-2015) was queried for patients <= 17 years with BTAI. The primary outcomes were the incidences of TEVAR and OTAR. Secondary outcome was risk of mortality in those undergoing intervention. A multivariable logistic regression model was used to determine the risk of mortality in OTAR versus TEVAR. Results: We identified 650 pediatric BTAI patients with 159 (24.5%) undergoing intervention. Of these, 124 underwent TEVAR (78.0%) and 35 (22.0%) underwent OTAR. The rate of TEVAR steadily increased from 2007 to 2015 (15.4% vs. 27.1%, P < 0.001). Patients receiving OTAR and TEVAR had a similar injury severity score and rate of hypotension on admission (P > 0.05). Compared with OTAR, TEVAR patients had a higher rate of any traumatic brain injury (TBI) (63.7% vs. 37.1%, P = 0.005) and shorter hospital and intensive care unit length of stay (LOS) (16.4 vs. 21.4 days, P = 0.02; 10.1 vs. 12.2 days, P = 0.01). TEVAR and OTAR, even when stratified by <= 14 years and 15-17 years, had no difference in risk for mortality (odds ratio 1.20, confidence interval 0.29-5.01, P = 0.80). Conclusions: The rate of TEVAR in pediatric BTAI nearly doubled from 2007 to 2015. Compared with OTAR, TEVAR was associated with a shorter hospital LOS despite a higher rate of TBI. There was no difference in risk for mortality between TEVAR and OTAR. Longitudinal studies to determine the long-term efficacy and complication rates, including reintervention, development of endoleak, and/or need for further operations, are needed as this technology is being rapidly adopted for pediatric trauma patients.	[Hasjim, Bima J.; Grigorian, Areg; Gabriel, Viktor; Spencer, Dean] Univ Calif Irvine, Dept Surg, Orange, CA 92668 USA; [Barrios, Cristobal, Jr.; Schubl, Sebastian; Nahmias, Jeffry] Univ Calif Irvine, Dept Surg, Div Trauma Burns & Surg Crit Care, Orange, CA USA; [Donayre, Carlos] Univ Calif Orange, Dept Surg, Div Vasc Surg, Irvine, CA USA		Hasjim, BJ (corresponding author), Univ Calif, Irvine Med Ctr, Dept Surg, Div Trauma Burns & Surg Crit Care, 333 City Blvd West,Suite 1600, Orange, CA 92868 USA.	bjhasjim@gmail.com	Nahmias, Jeffry/ABA-1850-2020	Nahmias, Jeffry/0000-0003-0094-571X; Hasjim, Bima/0000-0003-4301-9011			Alexy RD, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/137985; Arthurs ZM, 2009, J VASC SURG, V49, P988, DOI 10.1016/j.jvs.2008.11.052; Barmparas G, 2010, J PEDIATR SURG, V45, P1404, DOI 10.1016/j.jpedsurg.2009.09.017; Bilimoria KY, 2013, J AM COLL SURGEONS, V217; Bottet B, 2016, INTERACT CARDIOV TH, V23, P970, DOI 10.1093/icvts/ivw247; Branco BC, 2017, J VASC SURG, V66, P1175, DOI 10.1016/j.jvs.2017.04.072; Brinkman AS, 2015, J SURG RES, V193, P523, DOI 10.1016/j.jss.2014.08.058; Fabian TC, 1997, J TRAUMA, V42, P374, DOI 10.1097/00005373-199703000-00003; Fawzy ME, 2004, J AM COLL CARDIOL, V43, P1062, DOI 10.1016/j.jacc.2003.10.040; Grigorian A, 2018, ANN VASC SURG, V52, P72, DOI 10.1016/j.avsg.2018.03.045; Gunabushanam V, 2010, J PEDIATR SURG, V45, pE15, DOI 10.1016/j.jpedsurg.2009.12.021; Haulon S, 2011, THORACO-ABDOMINAL AORTA: SURGICAL AND ANESTHETIC MANAGEMENT, P681; Heckman SR, 2005, J PEDIATR SURG, V40, P98, DOI 10.1016/j.jpedsurg.2004.09.004; Heneghan RE, 2016, J VASC SURG, V64, P171, DOI 10.1016/j.jvs.2016.02.047; Hong MS, 2011, J VASC SURG, V53, P36, DOI 10.1016/j.jvs.2010.08.009; Hoornweg LL, 2006, J VASC SURG, V43, P1096, DOI 10.1016/j.jvs.2006.01.034; Hormuth D, 1999, ARCH SURG-CHICAGO, V134, P759, DOI 10.1001/archsurg.134.7.759; Hosn MA, 2017, ANN VASC SURG, V39, P292; Karmy-Jones R, 2003, ANN THORAC SURG, V75, P1513, DOI 10.1016/S0003-4975(02)04838-5; Keyhani K, 2009, J VASC SURG, V50, P652, DOI 10.1016/j.jvs.2009.04.040; Lee WA, 2011, J VASC SURG, V53, P187, DOI 10.1016/j.jvs.2010.08.027; Malgor RD, 2015, ANN VASC SURG, V29, DOI 10.1016/j.avsg.2014.10.012; Melissano G, 2015, J VASC SURG, V62, P336, DOI 10.1016/j.jvs.2015.02.049; Min Seung-Kee, 2017, Vasc Specialist Int, V33, P47, DOI 10.5758/vsi.2017.33.2.47; Nagpal P, 2017, CARDIOVASC INTER RAD, V40, P643, DOI 10.1007/s00270-017-1572-x; Neschis DG, 2008, NEW ENGL J MED, V359, P1708, DOI 10.1056/NEJMra0706159; PARMLEY LF, 1958, CIRCULATION, V17, P1086, DOI 10.1161/01.CIR.17.6.1086; Pettersen MD, 2008, J AM SOC ECHOCARDIOG, V21, P922, DOI 10.1016/j.echo.2008.02.006; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; Tashiro J, 2015, J SURG RES, V198, P456, DOI 10.1016/j.jss.2015.03.053; Trachiotis GD, 1996, ANN THORAC SURG, V62, P724, DOI 10.1016/S0003-4975(96)00355-4; Walhout RJ, 2009, CATHETER CARDIO INTE, V73, P549, DOI 10.1002/ccd.21842	32	8	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	AUG	2019	59						150	157		10.1016/j.avsg.2018.12.094			8	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery; Cardiovascular System & Cardiology	IO2BL	WOS:000479186900019	30802562				2022-02-06	
J	Howell, DR; Lugade, V; Potter, MN; Walker, G; Wilson, JC				Howell, David R.; Lugade, Vipul; Potter, Morgan N.; Walker, Gregory; Wilson, Julie C.			A multifaceted and clinically viable paradigm to quantify postural control impairments among adolescents with concussion	PHYSIOLOGICAL MEASUREMENT			English	Article						locomotion; postural balance; mild traumatic brain injury; adolescent	HIGH-SCHOOL; DUAL-TASK; CONTROL DEFICITS; GAIT; RELIABILITY; RECOVERY; VALIDITY; CHILDREN; INJURY; SPORTS	Objective: To identify clinically significant postural control measures capable of distinguishing the performance of adolescents with concussion from uninjured controls. Approach: Fifteen adolescents with concussion (67% female; median age = 16.3 years; tested 8 +/- 4 d post-injury) and 31 controls (45% female; median age = 15.2 years) completed a single/dual-task gait evaluation with a smartphone affixed to their lumbar spine, modified balance error scoring system (mBESS), and single/dual-task tandem gait test. Outcome measures were obtained via smartphone (single/dual-task gait speed, cadence, step length), mBESS (double/single/tandem errors), and tandem gait (single/dual-task time). We calculated area under the curve (AUC) values for each measure that demonstrated a significant difference between groups independently, and calculated a comprehensive AUC value for all measures combined. Main results: The concussion group walked significantly slower (mean = 0.89 +/- 0.15 versus 1.05 +/- 0.15 m s(-1); p = 0.002) and with significantly fewer steps per minute (median = 103 [interquartile range = 94-108] versus 116 [104-118] steps/minute; p = 0.002) than the control group under single-task conditions. They also completed single-task (median = 22.0 [16.6-24.2] versus 14.5 [12.4-15.5] s; p < 0.001) and dual-task (median = 30.0 [24.0-35.2] versus 18.6 [16.1-21.7] s; p < 0.001) tandem gait tests significantly slower than controls. The AUC value for single-task gait velocity, single-task cadence, single-task tandem gait time, and dual-task tandem gait time indicated an excellent ability to distinguish between concussion and control groups (AUC = 0.91, 95% CI = 0.80-0.99). Significance: Smartphone-obtained gait measures and tandem gait times allowed for an excellent differentiation between adolescents with concussion versus control participants. This reinforces the need for multimodal approaches to postural control impairment recognition among adolescents with concussion.	[Howell, David R.; Potter, Morgan N.; Walker, Gregory; Wilson, Julie C.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA; [Howell, David R.; Walker, Gregory; Wilson, Julie C.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO 80045 USA; [Lugade, Vipul] Control One LLC, Albuquerque, NM USA; [Lugade, Vipul] Chiang Mai Univ, Dept Phys Therapy, Chiang Mai, Thailand; [Wilson, Julie C.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA.; Howell, DR (corresponding author), Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu		Howell, David/0000-0002-2955-0191	Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R03HD094560-01]; National Institute of Neurological Disorders And StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS100952-01A1, 1R41NS103698-01A1]	Dr Howell has received research support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (1R03HD094560-01), the National Institute of Neurological Disorders And Stroke (1R01NS100952-01A1 and 1R41NS103698-01A1), and from a research contract between Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and ElMindA Ltd. Dr Lugade is the CEO of Control One LLC, but they had no role in any aspect of this study and confirm that there was no conflict of interest. The remaining authors have no conflicts to disclose.	Alkathiry AA, 2018, J ATHL TRAINING, V53, P1166, DOI 10.4085/1062-6050-518-17; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2016, GAIT POSTURE, V49, P176, DOI 10.1016/j.gaitpost.2016.07.008; Johnston William, 2017, Concussion, V2, pCNC28, DOI 10.2217/cnc-2016-0025; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nishiguchi S, 2012, TELEMED E-HEALTH, V18, P292, DOI 10.1089/tmj.2011.0132; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Patterson JA, 2014, INT J SPORTS PHYS TH, V9, P135; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Silsupadol P, 2017, GAIT POSTURE, V58, P516, DOI 10.1016/j.gaitpost.2017.09.030; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	25	8	8	0	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	AUG	2019	40	8							084006	10.1088/1361-6579/ab3552			8	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering; Physiology	IV4RZ	WOS:000484261500006	31342939				2022-02-06	
J	Kazempour, M; Baniassadi, M; Shahsavari, H; Remond, Y; Baghani, M				Kazempour, Morteza; Baniassadi, Majid; Shahsavari, Hamid; Remond, Yves; Baghani, Mostafa			Homogenization of heterogeneous brain tissue under quasi-static loading: a visco-hyperelastic model of a 3D RVE	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Visco-hyperelastic; Traumatic brain injury (TBI); Diffuse axonal injury (DAI); FEM	WHITE-MATTER; MECHANICAL-PROPERTIES; CONSTITUTIVE MODEL; HEAD; ANISOTROPY; BEHAVIOR; STRAINS; ELEMENT; INJURY; GRAY	Researches, in the recent years, reveal the utmost importance of brain tissue assessment regarding its mechanical properties, especially for automatic robotic tools, surgical robots and helmet producing. For this reason, experimental and computational investigation of the brain behavior under different conditions seems crucial. However, experiments do not normally show the distribution of stress and injury in microscopic scale, and due to various factors are costly. Development of micromechanical methods, which could predict the brain behavior more appropriately, could highly be helpful in reducing these costs. This study presents computational analysis of heterogeneous part of the brain tissue under quasi-static loading. Heterogeneity is created by irregular distribution of neurons in a representative volume element (RVE). Considering time-dependent behavior of the tissue, a visco-hyperelastic constitutive model is developed to predict the RVE behavior more realistically. The RVE is studied in different loads and load rates; 1, 2, 3, 10 and 15% strain load are applied at 0.03 and 0.2s on the RVE as tensile and shear loads. Due to complexity in geometry, self-consistent approximation method is employed to increase the volume fraction of neurons and analyze RVE behavior in various NVFs. The results show increasing the load rate leads to a raise in the maximum stress that indicates the tissue is more vulnerable at higher rates. Moreover, stiffness of the tissue is enhanced in higher NVFs. Additionally, it is found that axons undergo higher stresses; hence, they are more sensitive in accidents which lead to axonal death and would cause TBI and DAI.	[Kazempour, Morteza; Baniassadi, Majid; Shahsavari, Hamid; Baghani, Mostafa] Univ Tehran, Coll Engn, Sch Mech Engn, Tehran 111554563, Iran; [Remond, Yves] Univ Strasbourg, CNRS, IMFS, 2 Rue Boussingault, F-67000 Strasbourg, France		Baghani, M (corresponding author), Univ Tehran, Coll Engn, Sch Mech Engn, Tehran 111554563, Iran.	baghani@ut.ac.ir	Baghani, Mostafa/U-2864-2018; Remond, Yves/G-8954-2011; Baniassadi, Majid/U-2890-2018	Baghani, Mostafa/0000-0001-6695-3128; Remond, Yves/0000-0003-3312-8361; Baniassadi, Majid/0000-0002-4434-082X			Abolfathi N, 2009, COMPUT METHOD BIOMEC, V12, P249, DOI [10.1080/10255840802430587, 10.1080/10255840903097871]; Bergstrom JS, 1998, J MECH PHYS SOLIDS, V46, P931, DOI 10.1016/S0022-5096(97)00075-6; Bernick KB, 2011, ACTA BIOMATER, V7, P1210, DOI 10.1016/j.actbio.2010.10.018; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Coudrillier B, 2013, BIOMECH MODEL MECHAN, V12, P941, DOI 10.1007/s10237-012-0455-y; Couper Z, 2008, BIOMECH MODEL MECHAN, V7, P105, DOI 10.1007/s10237-007-0079-9; Dreo J., 2006, METAHEURISTICS HARD; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Forte AE, 2018, BIOMECH MODEL MECHAN, V17, P249, DOI 10.1007/s10237-017-0958-7; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; HASHIN Z, 1983, J APPL MECH-T ASME, V50, P481, DOI 10.1115/1.3167081; Hiscox LV, 2016, PHYS MED BIOL, V61, pR401, DOI 10.1088/0031-9155/61/24/R401; Holzapfel GA., 2000, NONLINEAR SOLID MECH; Horgan CO, 2009, INT J SOLIDS STRUCT, V46, P3078, DOI 10.1016/j.ijsolstr.2009.04.007; Javid S, 2014, J MECH BEHAV BIOMED, V30, P290, DOI 10.1016/j.jmbbm.2013.11.010; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Kanit T, 2003, INT J SOLIDS STRUCT, V40, P3647, DOI 10.1016/S0020-7683(03)00143-4; Karami G, 2009, J MECH BEHAV BIOMED, V2, P243, DOI 10.1016/j.jmbbm.2008.08.003; Karami G, 2010, P ASME BIOM BIOT ENG, P619; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Koser DE, 2015, BIOPHYS J, V108, P2137, DOI 10.1016/j.bpj.2015.03.039; Kyriacou SK, 2002, BIOMECH MODEL MECHAN, V1, P151, DOI 10.1007/s10237-002-0013-0; Labus KM, 2016, J MECH BEHAV BIOMED, V62, P195, DOI 10.1016/j.jmbbm.2016.05.003; Laksari K, 2015, BIOMECH MODEL MECHAN, V14, P459, DOI 10.1007/s10237-014-0616-2; Laksari K, 2012, J BIOMECH, V45, P642, DOI 10.1016/j.jbiomech.2011.12.023; Lee SJ, 2014, J MECH BEHAV BIOMED, V29, P213, DOI 10.1016/j.jmbbm.2013.08.026; Libertiaux V, 2011, J MECH BEHAV BIOMED, V4, P1177, DOI 10.1016/j.jmbbm.2011.03.028; Maltese MR, 2016, COMPUT METHOD BIOMEC, V19, P1618, DOI 10.1080/10255842.2016.1176153; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller K, 1999, J BIOMECH, V32, P531, DOI 10.1016/S0021-9290(99)00010-X; Mura, 2013, MICROMECHANICS DEFEC; Pan Yi, 2013, Front Bioeng Biotechnol, V1, P19, DOI 10.3389/fbioe.2013.00019; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Poli R., 2007, ANAL PUBLICATIONS PA, V1; Rahman RA, 2012, J MECH MATER STRUCT, V7, P593, DOI 10.2140/jomms.2012.7.593; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Remond Y., 2016, APPL RVE RECONSTRUCT; SCHMIDSCHONBEIN GW, 1981, BIOPHYS J, V36, P243, DOI 10.1016/S0006-3495(81)84726-1; Shaoning S, 2014, MECH CHARACTERIZATIO; Sheidaei A, 2013, COMPOS SCI TECHNOL, V80, P47, DOI 10.1016/j.compscitech.2013.03.001; Shulyakov AV, 2009, BIOMECH MODEL MECHAN, V8, P415, DOI 10.1007/s10237-008-0147-9; Sotudeh-Chafi M, 2008, ASME 2008 SUMM BIOEN; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Torquato S, 2013, RANDOM HETEROGENEOUS; Vappou J, 2007, MAGN RESON MATER PHY, V20, P273, DOI 10.1007/s10334-007-0098-7; WANG HC, 1972, J BIOMECH, V5, P431, DOI 10.1016/0021-9290(72)90002-4; Whitford C, 2018, BIOMECH MODEL MECHAN, V17, P19, DOI 10.1007/s10237-017-0942-2; Yousefi E, 2017, COMPOS SCI TECHNOL, V153, P222, DOI 10.1016/j.compscitech.2017.10.025; Zhang MG, 2014, BIOMECH MODEL MECHAN, V13, P1, DOI 10.1007/s10237-013-0481-4	53	8	8	0	12	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	AUG	2019	18	4					969	981		10.1007/s10237-019-01124-6			13	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	IJ2BT	WOS:000475703900007	30762151				2022-02-06	
J	Li, GB; Wang, F; Otte, D; Simms, C				Li, Guibing; Wang, Fang; Otte, Dietmar; Simms, Ciaran			Characteristics of pedestrian head injuries observed from real world collision data	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Pedestrian head injury; Collision data; Injury risk	IN-DEPTH ACCIDENT; FATALITY RISK; BRAIN-INJURY; PARAMETERS; VEHICLE	Head injury is one of the most common injury types in vehicle-to-pedestrian collisions, which leads to death and long-term disabilities. However, detailed analysis of pedestrian head injuries in real world collisions is scarce. Thus the current study used two samples of 120 cases and 184 cases extracted from 1060 pedestrian collision cases captured during 2000-2015 from the GIDAS (German In-Depth-Accident Study) database to investigate the detailed characteristics of AIS2 + pedestrian head injuries. Firstly, the interrelationship between different head injury types (skull fracture, focal brain injury, concussion and diffuse axonal injury (DAI)) was analysed using the sample of 120 cases which each had at least one AIS2 + head injury. Then the influences of impact speed, pedestrian age and car front shape parameters on the injury risk of skull fracture, focal brain injury and concussion were assessed using the logistic regression method, based on the sample of 184 AIS1 + cases where the primary head contact location was within the windscreen glass area. The results show that: skull fractures and focal brain injuries dominate for AIS3 + head injuries and are generally associated with each other; concussion is the most important injury type for AIS2 head injuries and usually occurs in isolation. Further, for head impacts to the windscreen glass area a higher bonnet leading edge helps to reduce concussion odds, and none of the selected car front shape parameters are significant for the odds of skull fracture and focal brain injury, and vehicle impact speed and pedestrian age are insignificant for concussion. These detailed characteristics of pedestrian head injuries provide a basis for future pedestrian head injury prevention strategies with skull fractures and focal brain injuries being the most important injuries to address.	[Li, Guibing] Hunan Univ Sci & Technol, Sch Mech Engn, Xiangtan 411201, Peoples R China; [Wang, Fang] Xiamen Univ Technol, Sch Mech & Automot Engn, Xiamen 361024, Fujian, Peoples R China; [Otte, Dietmar] Hannover Med Sch, Accid Res Unit, D-30625 Hannover, Germany; [Simms, Ciaran] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland		Simms, C (corresponding author), Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland.	csimms@tcd.ie		WANG, FANG/0000-0002-7409-0841; Otte, Dietmar/0000-0002-5927-4060; Li, Guibing/0000-0003-3382-7293; Simms, Ciaran/0000-0001-5564-1620	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51805162, 51605407]; Natural Science Foundation of Hunan Province, ChinaNatural Science Foundation of Hunan Province [2018JJ3532]	This work was supported by the National Natural Science Foundation of China (Grant Nos. 51805162 and 51605407) and Natural Science Foundation of Hunan Province, China (Grant No. 2018JJ3532).	Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Arregui-Dalmases C, 2010, ACCIDENT ANAL PREV, V42, P1164, DOI 10.1016/j.aap.2010.01.005; Badea A, 2010, INT J AUTO TECH-KOR, V11, P711, DOI 10.1007/s12239-010-0084-3; Badea-Romero A, 2013, ACCIDENT ANAL PREV, V50, P1140, DOI 10.1016/j.aap.2012.09.024; Bauza G, 2008, J TRAUMA, V64, P304, DOI 10.1097/TA.0b013e3181634893; Chen H, 2009, 2009011205 SAE; Crocetta G, 2015, ACCIDENT ANAL PREV, V79, P56, DOI 10.1016/j.aap.2015.03.009; Dobson AJ, 2002, INTRO GEN LINEAR MOD; EEVC, 2002, TECHNICAL REPORT; Fildes B, 2004, P INT RES COUNC BIOM; Fredriksson R, 2010, ACCIDENT ANAL PREV, V42, P1672, DOI 10.1016/j.aap.2010.04.006; Gennarelli T, 1971, 710882 SAE; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1972, 720970 SAE; Hosmer D. W., 2004, APPL LOGISTIC REGRES; Huang J, 2018, ACCIDENT ANAL PREV, V119, P91, DOI 10.1016/j.aap.2018.07.012; Kong CY, 2010, ACCIDENT ANAL PREV, V42, P987, DOI 10.1016/j.aap.2009.11.006; Li F, 2017, EUR J APPL MATH, V28, P1, DOI 10.1017/S0956792515000601; Li GB, 2018, ACCIDENT ANAL PREV, V115, P143, DOI 10.1016/j.aap.2018.03.014; Li GB, 2017, ACCIDENT ANAL PREV, V101, P11, DOI 10.1016/j.aap.2017.01.012; Li GB, 2017, ACCIDENT ANAL PREV, V100, P97, DOI 10.1016/j.aap.2017.01.006; Mallory Ann, 2010, Ann Adv Automot Med, V54, P51; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Matsui Y., 1999, 1999010713 SAE; Mizuno K., 2001, P 17 INT TECHN C ENH; Neal-Sturgess C, 2007, P 20 INT TECHN C ENH; Nie J, 2015, TRAFFIC INJ PREV, V16, P76, DOI 10.1080/15389588.2014.881477; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Otte D, 1999, P INT RES COUNC BIOM; Otte D, 2005, P INT RES COUNC BIOM; OTTE D, 2003, P 18 INT TECHN C ENH; Otte D, 2016, P INT RES COUNC BIOM; Otte D, 2012, ACCIDENT ANAL PREV, V44, P149, DOI 10.1016/j.aap.2010.12.006; Richards D, 2012, ACCIDENT ANAL PREV, V47, P16, DOI 10.1016/j.aap.2012.01.009; Schmitt KU, 2010, TRAUMA BIOMECHANICS: ACCIDENTAL INJURY IN TRAFFIC AND SPORTS, THIRD EDITION, P1, DOI 10.1007/978-3-642-03713-9_1; Shang S, 2018, ACCIDENT ANAL PREV, V110, P9, DOI 10.1016/j.aap.2017.10.011; Shi LL, 2019, P I MECH ENG D-J AUT, V233, P3588, DOI 10.1177/0954407019828845; Simms C, 2009, SOLID MECH APPL, V166, P1, DOI 10.1007/978-90-481-2743-6; Tiefang Z, 2018, APPL BIONICS BIOMECH, V2018; Yang J., 2005, INT J VEH SAF, V1, P100, DOI [10.1504/IJVS.2005.007540, 10.1504/ijvs.2005.007540]; Zhang Guanjun, 2008, Ann Adv Automot Med, V52, P199	41	8	8	4	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	AUG	2019	129						362	366		10.1016/j.aap.2019.05.007			5	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	IH7HG	WOS:000474674100034	31130209				2022-02-06	
J	Li, Q; Cheng, K; Wang, AY; Xu, QG; Fu, ZF; He, SY; Xu, PX				Li, Qiang; Cheng, Kai; Wang, Ai-Yue; Xu, Qiong-Guang; Fu, Zhou-Feng; He, Shao-Yu; Xu, Peng-Xiang			microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway	BIOMEDICINE & PHARMACOTHERAPY			English	Article						microRNA-126; EGFL7; PI3K/AKT signaling pathway; Tube formation	ANGIOGENESIS; CANCER; CELLS; NEOVASCULARIZATION; EXPRESSION; REPRESSION; MIGRATION; INJURY; RNA	Its critical for tube formation and angiogenesis to repair ischemic myocardium or stroke. This study aimed to investigate role of microRNA-126 (miR-126) in tube formation in human umbilical vein endothelial cells (HUVECs) and associated mechanisms. Primary neural stem cells (NSCs) and HUVECs were cultured and transfected with microRNA-126 mimics and miR-126 inhibitor. Cell counting kit-8 (CCK-8) and cell cycle assay were conducted for evaluating NSCs viability. Transwell assay was conducted to observe invasive ability of HUVECs. Quantitative real-time PCR (qRT-PCR) assay was used to examine epidermal growth factor like domain 7 (EGFL7) and miR-126 mRNA both in vitro and animal models. Tube forming capability was evaluated in HUVECs. Dual luciferase assay was performed to evaluate interaction between miR-126 and EGFL7 gene. Western blot assay was used to determine phosphoinositide-3-kinase/protein kinase-B (PI3K/AKT) signaling molecules and EGFL7. The results indicated that miR-126 significantly decreased cell viability, inhibited invasive ability and modulated cell cycle of NSCs compared to miR-NC group (p < 0.05). miR-126 significantly inhibited tube formation of HUVECs compared to miR-NC group (p < 0.05). miR-126 significantly down-regulated EGFL7 mRNA and protein expression compared to miR-NC (p < 0.05). Atorvastatin significantly increased CD34 and enhanced EGFL7 expression in traumatic brain injury (FBI) rats brain tissues compared to Model group (p < 0.05). miR-126 significantly down-regulated and atorvastatin up-regulated PI3K/AKT signaling pathway (p < 0.05). Atorvastatin significantly increased EGFL7 and down-regulated miR-126 expression in TBI rats brain tissues compared to Model group (p < 0.05). miR-126 interacted with and negatively correlated with EGFL7 gene both in vitro and in TBI models. In conclusion, microRNA-126 inhibited tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.	[Li, Qiang; Cheng, Kai; Xu, Qiong-Guang; Fu, Zhou-Feng; He, Shao-Yu; Xu, Peng-Xiang] Hainan Med Univ, Affiliated Hosp 2, Dept Neurosurg, Haikou, Hainan, Peoples R China; [Wang, Ai-Yue] Haikou Municipal Peoples Hosp, Dept Neurol, Haikou, Hainan, Peoples R China		Li, Q (corresponding author), Hainan Med Univ, Affiliated Hosp 2, Dept Neurosurg, Haikou, Hainan, Peoples R China.	xjuanxin@yeah.net			Natural Science Foundation of Hainan Province [20168296, 817332]	This study was supported by a grant from the Natural Science Foundation of Hainan Province (Grant No. 20168296, 817332).	Chiavacci E, 2015, CYTOTECHNOLOGY, V67, P969, DOI 10.1007/s10616-014-9735-y; Doganci S, 2016, EUR REV MED PHARMACO, V20, P1384; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; Gong C, 2017, ONCOTARGET, V8, P52527, DOI 10.18632/oncotarget.17283; Hanawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104863; Hansen TF, 2013, BRIT J CANCER, V109, P1243, DOI 10.1038/bjc.2013.448; Ho RXY, 2018, J MOL CELL BIOL, V10, P195, DOI 10.1093/jmcb/mjy002; HOBSON B, 1984, BRIT J CANCER, V49, P405, DOI 10.1038/bjc.1984.66; Hu MH, 2016, ONCOTARGET, V7, P66922, DOI 10.18632/oncotarget.11877; Hu WQ, 2012, CELL RES, V22, P1322, DOI 10.1038/cr.2012.80; Huang JJ, 2015, AM J TRANSL RES, V7, P1106; Jeker LT, 2013, IMMUNOL REV, V253, P65, DOI 10.1111/imr.12061; Jia AY, 2014, BRIT J CANCER, V110, P2945, DOI 10.1038/bjc.2014.245; Kieffer-Kwon P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135560; Lakshmanan R, 2018, J BIOMED MATER RES B, V106, P2072, DOI 10.1002/jbm.b.34000; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Pourgholami MH, 2010, BIOCHEM BIOPH RES CO, V397, P729, DOI 10.1016/j.bbrc.2010.06.019; Qiu YY, 2019, BIOMED PHARMACOTHER, V111, P386, DOI 10.1016/j.biopha.2018.12.080; Ran Y, 2012, MOLECULES, V17, P8091, DOI 10.3390/molecules17078091; Sakai E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05782-3; Sun YQ, 2010, BIOCHEM BIOPH RES CO, V391, P1483, DOI 10.1016/j.bbrc.2009.12.098; Umezu T, 2013, ONCOGENE, V32, P2747, DOI 10.1038/onc.2012.295; Wang HY, 2016, BIOMED PHARMACOTHER, V83, P349, DOI 10.1016/j.biopha.2016.06.047; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang WF, 2015, LIFE SCI, V136, P28, DOI 10.1016/j.lfs.2015.06.025; Wei YY, 2013, ARTERIOSCL THROM VAS, V33, P449, DOI 10.1161/ATVBAHA.112.300279; Wen ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104666; Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003; Yang HH, 2017, CELL PHYSIOL BIOCHEM, V42, P506, DOI 10.1159/000477597; Ye GH, 2018, BIOMED PHARMACOTHER, V107, P1779, DOI 10.1016/j.biopha.2018.05.113; Zhao TQ, 2010, MICROVASC RES, V80, P188, DOI 10.1016/j.mvr.2010.03.014; Zhao YJ, 2015, ONCOLOGIST, V20, P660, DOI 10.1634/theoncologist.2014-0465; Zhou QB, 2014, MOL THER, V22, P378, DOI 10.1038/mt.2013.243	35	8	10	0	4	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	AUG	2019	116								109007	10.1016/j.biopha.2019.109007			10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	ID3QV	WOS:000471592900047	31170663	gold			2022-02-06	
J	McGowan, AL; Bretzin, AC; Savage, JL; Petit, KM; Covassin, T; Pontifex, MB				McGowan, Amanda L.; Bretzin, Abigail C.; Savage, Jennifer L.; Petit, Kyle M.; Covassin, Tracey; Pontifex, Matthew B.			Acute and protracted disruptions to inhibitory control following sports-related concussion	NEUROPSYCHOLOGIA			English	Article						Concussion; Flanker task; Cognitive control; Inhibitory control; Long-term effects; Cognitive functioning; mTBI	TRAUMATIC BRAIN-INJURY; PERSISTENT INFLUENCE; COGNITIVE CONTROL; ATTENTION; PERFORMANCE; DEFICITS; MEMORY; VARIABILITY; FOOTBALL; RECOVERY	Extant evidence demonstrates disruptions to inhibitory control from as little as six months to as long as several years following sports-related concussion. However, the sensitivity of tasks requiring inhibitory control for detecting disruptions to cognition during the acute, subacute, and protracted phases of recovery remains in question. Accordingly, the purpose of this study was to examine concussion-related disruptions to inhibitory control across recovery. Athletes with sports-related concussion (n = 55; 22 female) completed an inhibitory control task within 72 h of injury, after returning to play, and within one month following return to play. Matched control athletes (n = 55; 22 female) were tested at similar intervals. Behavioral indices of performance were analyzed using univariate multi-level modeling. Findings indicated that the concussion group exhibited decrements to inhibitory control immediately after injury and up to one month following return to play, with no such observable differences at the return to play period. In addition to being sensitive to detecting chronic cognitive deficits resulting from sports-related concussion, these findings suggest that inhibitory control measures have the requisite sensitivity to identify the immediate and protracted signs of neurocognitive dysfunction following sports-related concussion. Accordingly, integrating assessments of inhibitory control into baseline, post-injury, and post-season measurement of cognitive function may prove useful for tracking the acute and persistent effects of sports-related concussion across an athlete's career. Athletes exhibiting impaired inhibitory control across the phases of recovery may be at greater risk of reinjury, thereby suggesting that integrating inhibitory control assessments into existing clinical measures may be of interest for informing concussion management and return-to-play decisions.	[McGowan, Amanda L.; Bretzin, Abigail C.; Savage, Jennifer L.; Petit, Kyle M.; Covassin, Tracey; Pontifex, Matthew B.] Michigan State Univ, Dept Kinesiol, 38 IM Sports Circle,308 W Circle Dr, E Lansing, MI 48824 USA		McGowan, AL (corresponding author), Michigan State Univ, Dept Kinesiol, 38 IM Sports Circle,308 W Circle Dr, E Lansing, MI 48824 USA.	mcgowa78@msu.edu	McGowan, Amanda L/G-9746-2016; Pontifex, Matthew B/A-4474-2009	McGowan, Amanda L/0000-0003-3422-0135; Pontifex, Matthew B/0000-0001-9819-9625; Bretzin, Abigail/0000-0003-3730-2849	U.S. Navy [W911QY-14-C-0098]; Summer Research Renewable Fellowship	This study was funded in part by a contract to BrainScope Company from the U.S. Navy contract #W911QY-14-C-0098. Support for the preparation of this manuscript was provided by a Summer Research Renewable Fellowship awarded to A. L. McGowan through the College of Education at Michigan State University.	Abdi H., 2010, ENCY RES DESIGN, V1, P169, DOI DOI 10.4135/9781412961288.N56; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Catena RD, 2009, EXP BRAIN RES, V194, P67, DOI 10.1007/s00221-008-1669-1; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; DeRenzo E G, 1998, J Health Care Law Policy, V1, P66; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; ERIKSEN CW, 1979, PERCEPT PSYCHOPHYS, V25, P249, DOI 10.3758/BF03198804; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fitzpatrick J, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116675272; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldstein H., 2011, MULTILEVEL STAT MODE, V922; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Ivanov I, 2008, AM J DRUG ALCOHOL AB, V34, P239, DOI 10.1080/00952990802013334; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lenth R. V., 2017, EMMEANS ESTIMATED MA; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McGowan AL, 2018, NEUROPSYCHOLOGY, V32, P564, DOI 10.1037/neu0000475; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Ornstein PA, 2004, DEV REV, V24, P374, DOI 10.1016/j.dr.2004.08.004; Parks AC, 2015, INT J PSYCHOPHYSIOL, V98, P426, DOI 10.1016/j.ijpsycho.2015.08.006; Pontifex MB, 2013, J PEDIATR-US, V162, P543, DOI 10.1016/j.jpeds.2012.08.036; Pontifex MB, 2012, RES Q EXERCISE SPORT, V83, P553; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; R Development Core Team, 2012, R LANG ENV STAT COMP; Rhoades BL, 2009, J APPL DEV PSYCHOL, V30, P310, DOI 10.1016/j.appdev.2008.12.012; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Volpert-Esmond HI, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13044; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358	67	8	8	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	AUG	2019	131						223	232		10.1016/j.neuropsychologia.2019.05.026			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	JJ1II	WOS:000493913900022	31152752				2022-02-06	
J	Nawarawong, NN; Slaker, M; Muelbl, M; Shah, AS; Chiariello, R; Nelson, LD; Budde, MD; Stemper, BD; Olsen, CM				Nawarawong, Natalie N.; Slaker, Megan; Muelbl, Matt; Shah, Alok S.; Chiariello, Rachel; Nelson, Lindsay D.; Budde, Matthew D.; Stemper, Brian D.; Olsen, Christopher M.			Repeated blast model of mild traumatic brain injury alters oxycodone self-administration and drug seeking	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						drug seeking; extinction; male Sprague Dawley rats; mild traumatic brain injury; opioid self-administration	PREFRONTAL CORTEX; ENDOGENOUS OPIOIDS; COCAINE-SEEKING; HEROIN-SEEKING; REINSTATEMENT; ADDICTION; ALCOHOL; RISK; RATS; CONSUMPTION	Each year, traumatic brain injuries (TBI) affect millions worldwide. Mild TBIs (mTBI) are the most prevalent and can lead to a range of neurobehavioral problems, including substance abuse. A single blast exposure, inducing mTBI alters the medial prefrontal cortex, an area implicated in addiction, for at least 30 days post injury in rats. Repeated blast exposures result in greater physiological and behavioral dysfunction than single exposure; however, the impact of repeated mTBI on addiction is unknown. In this study, the effect of mTBI on various stages of oxycodone use was examined. Male Sprague Dawley rats were exposed to a blast model of mTBI once per day for 3 days. Rats were trained to self-administer oxycodone during short (2 h) and long (6 h) access sessions. Following abstinence, rats underwent extinction and two cued reinstatement sessions. Sham and rbTBI rats had similar oxycodone intake, extinction responding and cued reinstatement of drug seeking. A second group of rats were trained to self-administer oxycodone with varying reinforcement schedules (fixed ratio (FR)-2 and FR-4). Under an FR-2 schedule, rbTBI-exposed rats earned fewer reinforcers than sham-exposed rats. During 10 extinction sessions, the rbTBI-exposed rats exhibited significantly more seeking for oxycodone than the sham-injured rats. There was a positive correlation between total oxycodone intake and day 1 extinction drug seeking in sham, but not in rbTBI-exposed rats. Together, this suggests that rbTBI-exposed rats are more sensitive to oxycodone-associated cues during reinstatement than sham-exposed rats and that rbTBI may disrupt the relationship between oxycodone intake and seeking.	[Nawarawong, Natalie N.; Slaker, Megan; Muelbl, Matt; Olsen, Christopher M.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Nawarawong, Natalie N.; Slaker, Megan; Muelbl, Matt; Nelson, Lindsay D.; Budde, Matthew D.; Stemper, Brian D.; Olsen, Christopher M.] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA; [Shah, Alok S.; Chiariello, Rachel; Nelson, Lindsay D.; Budde, Matthew D.; Stemper, Brian D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Shah, Alok S.; Chiariello, Rachel; Budde, Matthew D.; Stemper, Brian D.] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA; [Shah, Alok S.; Chiariello, Rachel; Stemper, Brian D.] Marquette Univ, Joint Dept Biomed Engn, Milwaukee, WI 53233 USA		Olsen, CM (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	colsen@mcw.edu	Stemper, Brian/AAX-7611-2020; Olsen, Christopher/G-9595-2013	Olsen, Christopher/0000-0003-2700-0310	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DA039276]; Veterans Affairs Medical ResearchUS Department of Veterans Affairs; Research and Education Initiative Fund, a component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R21DA039276] Funding Source: NIH RePORTER	The authors thank Margaret J. Beatka for providing the artwork in the graphical abstract. This research was supported by NIH DA039276 (CMO, MDB, BDS), Veterans Affairs Medical Research (MDB, BDS) and the Research and Education Initiative Fund, a component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin (CMO). Behavioral studies were performed using equipment from investigator laboratories and the MCW Neuroscience Research Center Rodent Behavior Core. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; ANGERMEIER WF, 1977, NATURWISSENSCHAFTEN, V64, P345, DOI 10.1007/BF00368732; Arguello AA, 2017, PSYCHOPHARMACOLOGY, V234, P2431, DOI 10.1007/s00213-017-4632-7; Badea A, 2018, NEUROIMAGE-CLIN, V18, P60, DOI 10.1016/j.nicl.2018.01.007; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; BOREN JJ, 1961, J EXP PSYCHOL, V61, P304, DOI 10.1037/h0040208; Bossert JM, 2013, PSYCHOPHARMACOLOGY, V229, P453, DOI 10.1007/s00213-013-3120-y; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Contreras M, 2007, SCIENCE, V318, P655, DOI 10.1126/science.1145590; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Covey DP, 2014, EUR J NEUROSCI, V40, P3040, DOI 10.1111/ejn.12726; Cui CH, 2017, TRENDS PHARMACOL SCI, V38, P556, DOI 10.1016/j.tips.2017.03.002; Cui CH, 2014, INT REV NEUROBIOL, V118, P1, DOI 10.1016/B978-0-12-801284-0.00001-4; D'Souza MS, 2003, PHARMACOL BIOCHEM BE, V76, P335, DOI 10.1016/j.pbb.2003.08.004; Defense and Veterans Brain Injury Center, 2017, DEP DEF WORLDW NUMB; DeMar J, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00059; Doherty JM, 2013, NEUROPSYCHOPHARMACOL, V38, P446, DOI 10.1038/npp.2012.200; Doherty JM, 2012, PSYCHOPHARMACOLOGY, V219, P763, DOI 10.1007/s00213-011-2398-x; Droutman V, 2015, TRENDS COGN SCI, V19, P414, DOI 10.1016/j.tics.2015.05.005; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; George O, 2010, NEUROSCI BIOBEHAV R, V35, P232, DOI 10.1016/j.neubiorev.2010.05.002; Golub A, 2013, SUBST USE MISUSE, V48, P811, DOI 10.3109/10826084.2013.796988; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ikegami A, 2007, BEHAV NEUROSCI, V121, P389, DOI 10.1037/0735-7044.121.2.389; James MH, 2018, INT J NEUROPSYCHOPH, V21, P89, DOI 10.1093/ijnp/pyx107; Kenan Kristen, 2012, Open Med, V6, pe41; Koob GF, 2016, LANCET PSYCHIAT, V3, P760, DOI 10.1016/S2215-0366(16)00104-8; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Li Q, 2012, BRAIN RES, V1469, P63, DOI 10.1016/j.brainres.2012.06.024; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Liu L, 2009, PHARMACOGENET GENOM, V19, P869, DOI 10.1097/FPC.0b013e328331e68f; Lowing JL, 2014, J NEUROTRAUM, V31, P1700, DOI 10.1089/neu.2013.3286; MATTHEWS RT, 1984, NEUROSCIENCE, V11, P617, DOI 10.1016/0306-4522(84)90048-4; Mavrikaki M, 2017, PSYCHOPHARMACOLOGY, V234, P977, DOI 10.1007/s00213-017-4536-6; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McFarland K, 2001, J NEUROSCI, V21, P8655; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; Merkel SF, 2017, CELL TRANSPLANT, V26, P1178, DOI 10.1177/0963689717714341; Merkel SF, 2017, J NEUROTRAUM, V34, P165, DOI 10.1089/neu.2015.4275; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Muelbl MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28062-0; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Olianas MC, 2012, NEUROCHEM INT, V61, P1404, DOI 10.1016/j.neuint.2012.10.005; Olsen CM, 2006, BRAIN RES, V1075, P229, DOI 10.1016/j.brainres.2006.01.003; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Paulus MP, 2014, NEUROPHARMACOLOGY, V76, P342, DOI 10.1016/j.neuropharm.2013.07.002; Perez-Garcia G, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00176; PERRY DC, 1992, MOL CHEM NEUROPATHOL, V16, P95, DOI 10.1007/BF03159963; Peters J, 2008, J NEUROSCI, V28, P6046, DOI 10.1523/JNEUROSCI.1045-08.2008; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Pushparaj A, 2013, NEUROPSYCHOPHARMACOL, V38, P690, DOI 10.1038/npp.2012.235; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Schindler AG, 2017, NEUROBIOL DIS, V106, P23, DOI 10.1016/j.nbd.2017.06.004; Schneider BL, 2016, J NEUROTRAUM, V33, P1614, DOI 10.1089/neu.2015.4190; Sell LA, 1999, EUR J NEUROSCI, V11, P1042, DOI 10.1046/j.1460-9568.1999.00522.x; Sessler NE, 2014, PHARMACOEPIDEM DR S, V23, P1238, DOI 10.1002/pds.3658; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Toklu HZ, 2018, BEHAV BRAIN RES, V340, P14, DOI 10.1016/j.bbr.2017.04.025; United Nations Office on Drugs and Crime, 2017, WORLD DRUG REP 2017; Vander Weele CM, 2014, EUR J NEUROSCI, V40, P3041, DOI 10.1111/ejn.12709; Ventura R, 2005, CEREB CORTEX, V15, P1877, DOI 10.1093/cercor/bhi066; Vonder Haar C., 2018, EUR J NEUORSCI; Wade CL, 2015, NEUROPSYCHOPHARMACOL, V40, P421, DOI 10.1038/npp.2014.188; Wang Y, 2017, J NEUROTRAUM, V34, P952, DOI 10.1089/neu.2016.4465; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Yaksh T, 2018, GOODMAN GILMANS PHAR; Yousefzadeh-Fard Y, 2013, BASIC CLIN NEUROSCI, V4, P307; Zijlstra F, 2009, DRUG ALCOHOL DEPEN, V99, P183, DOI 10.1016/j.drugalcdep.2008.07.012	79	8	8	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	AUG	2019	50	3			SI		2101	2112		10.1111/ejn.14281			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IY1UN	WOS:000486177300010	30456793	Green Accepted			2022-02-06	
J	O'Brien, JA; Austin, PJ				O'Brien, Jayden A.; Austin, Paul J.			Effect of Photobiomodulation in Rescuing Lipopolysaccharide-Induced Dopaminergic Cell Loss in the Male Sprague-Dawley Rat	BIOMOLECULES			English	Article						Lipopolysaccharide; low-level light therapy; microglia; neuroinflammation; Parkinson's disease	NEAR-INFRARED LIGHT; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; LEVEL LASER THERAPY; PARKINSONS-DISEASE; MICROGLIAL ACTIVATION; SUBSTANTIA-NIGRA; MOUSE MODEL; 670 NM; NEUROPROTECTION	Photobiomodulation (PBM) provides neuroprotection against dopaminergic cell death and associated motor deficits in rodent and primate models of Parkinson's disease (PD). However, it has not yet been tested in the lipopolysaccharide (LPS) model of PD, which leads to dopaminergic cell death through microglia-evoked neuroinflammation. We investigated whether transcranial PBM could protect against dopaminergic cell death within the substantia nigra in male Sprague-Dawley rats following supranigral LPS injection. PBM fully protected rats from 10 mu g LPS which would have otherwise caused 15% cell loss, but there was no significant neuroprotection at a 20 mu g dose that led to a 50% lesion. Cell loss at this dose varied according to the precise site of injection and correlated with increased local numbers of highly inflammatory amoeboid microglia. Twenty microgram LPS caused motor deficits in the cylinder, adjusted stepping and rotarod tests that correlated with dopaminergic cell loss. While PBM caused no significant improvement at the group level, motor performance on all three tests no longer correlated with the lesion size caused by 20 mu g LPS in PBM-treated rats, suggesting extranigral motor improvements in some animals. These results provide support for PBM as a successful neuroprotective therapy against the inflammatory component of early PD, provided inflammation has not reached a devastating level, as well as potential benefits in other motor circuitries.	[O'Brien, Jayden A.; Austin, Paul J.] Univ Sydney, Discipline Anat & Histol, Sch Med Sci, Fac Med & Hlth, Sydney, NSW 2006, Australia		Austin, PJ (corresponding author), Univ Sydney, Discipline Anat & Histol, Sch Med Sci, Fac Med & Hlth, Sydney, NSW 2006, Australia.	paul.austin@sydney.edu.au		Austin, Paul/0000-0001-5253-6876; O'Brien, Jayden/0000-0001-5305-4350	Tenix corp and the Salteri family	This research was funded by Tenix corp and the Salteri family.	Arimoto T, 2003, NEUROBIOL DIS, V12, P35, DOI 10.1016/S0969-9961(02)00017-7; Ashkan K, 2007, PARKINSONISM RELAT D, V13, P266, DOI 10.1016/j.parkreldis.2006.10.009; Austin PJ, 2010, BRIT J PHARMACOL, V160, P1741, DOI 10.1111/j.1476-5381.2010.00820.x; Balkaya M, 2013, J CEREBR BLOOD F MET, V33, P330, DOI 10.1038/jcbfm.2012.185; Bordt EA, 2014, FREE RADICAL BIO MED, V76, P34, DOI 10.1016/j.freeradbiomed.2014.07.033; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Castano A, 1998, J NEUROCHEM, V70, P1584; Claypoole LD, 2017, BRAIN BEHAV IMMUN, V59, P135, DOI 10.1016/j.bbi.2016.08.017; Croisier E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-14; Darlot F, 2016, ANN NEUROL, V79, P59, DOI 10.1002/ana.24542; Doyle HH, 2017, J NEUROSCI, V37, P3202, DOI 10.1523/JNEUROSCI.2906-16.2017; Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x; El Massri N, 2018, NEUROBIOL AGING, V66, P131, DOI 10.1016/j.neurobiolaging.2018.02.019; El Massri N, 2017, EXP BRAIN RES, V235, P1861, DOI 10.1007/s00221-017-4937-0; El Massri N, 2016, EXP BRAIN RES, V234, P3225, DOI 10.1007/s00221-016-4720-7; El Massri N, 2016, INT J NEUROSCI, V126, P76, DOI 10.3109/00207454.2014.994063; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Girard-Joyal O, 2017, HORM BEHAV, V89, P1, DOI 10.1016/j.yhbeh.2016.12.009; Halliday G, 2011, MOVEMENT DISORD, V26, P1015, DOI 10.1002/mds.23669; Hamilton C, 2018, NEURAL REGEN RES, V13, P1738, DOI 10.4103/1673-5374.238613; Hsieh PF, 2002, NEUROREPORT, V13, P277, DOI 10.1097/00001756-200203040-00006; Iravani MM, 2005, EUR J NEUROSCI, V22, P317, DOI 10.1111/j.1460-9568.2005.04220.x; Iravani MM, 2002, NEUROSCIENCE, V110, P49, DOI 10.1016/S0306-4522(01)00562-0; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Jenkins PA, 2011, PHOTOMED LASER SURG, V29, P785, DOI 10.1089/pho.2011.9895; Johnstone DM, 2014, NEUROSCIENCE, V274, P93, DOI 10.1016/j.neuroscience.2014.05.023; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Liebert AD, 2014, MED HYPOTHESES, V82, P275, DOI 10.1016/j.mehy.2013.12.009; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Naeser MA, 2015, PHOTOMED LASER SURG, V33, P443, DOI 10.1089/pho.2015.3986; Naughton C, 2016, BEHAV BRAIN RES, V296, P451, DOI 10.1016/j.bbr.2015.09.025; OLSSON M, 1995, J NEUROSCI, V15, P3863; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Oueslati A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140880; Paxinos G, 2004, RAT BRAIN STEREOTAXI; Pitzschke A, 2015, PHYS MED BIOL, V60, P2921, DOI 10.1088/0031-9155/60/7/2921; Quirk Brendan J, 2012, Front Biosci (Elite Ed), V4, P818; Reinhart F, 2017, NEUROSCI RES, V117, P42, DOI 10.1016/j.neures.2016.11.006; Reinhart F, 2016, EXP BRAIN RES, V234, P1787, DOI 10.1007/s00221-016-4578-8; Reinhart F, 2016, J NEUROSURG, V124, P1829, DOI 10.3171/2015.5.JNS15735; Rozas G, 1998, J NEUROSCI METH, V83, P165, DOI 10.1016/S0165-0270(98)00078-8; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Sharma N, 2015, NEUROCHEM INT, V87, P92, DOI 10.1016/j.neuint.2015.06.004; Sharma S, 2013, NEUROCHEM INT, V63, P201, DOI 10.1016/j.neuint.2013.06.005; Shaw VE, 2010, J COMP NEUROL, V518, P25, DOI 10.1002/cne.22207; Song S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-219; Surace MJ, 2012, CELL MOL LIFE SCI, V69, P2409, DOI 10.1007/s00018-012-1015-4; Vichaya EG, 2014, NEUROPSYCHOPHARMACOL, V39, P2884, DOI 10.1038/npp.2014.141; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069	51	8	8	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2218-273X		BIOMOLECULES	Biomolecules	AUG	2019	9	8							381	10.3390/biom9080381			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV7OY	WOS:000484457600086	31430990	gold, Green Published, Green Submitted			2022-02-06	
J	Puffer, RC; Yue, JK; Mesley, M; Billigen, JB; Sharpless, J; Fetzick, AL; Puccio, A; Diaz-Arrastia, R; Okonkwo, DO				Puffer, Ross C.; Yue, John K.; Mesley, Matthew; Billigen, Julia B.; Sharpless, Jane; Fetzick, Anita L.; Puccio, Ava; Diaz-Arrastia, Ramon; Okonkwo, David O.			Long-term outcome in traumatic brain injury patients with midline shift: a secondary analysis of the Phase 3 COBRIT clinical trial	JOURNAL OF NEUROSURGERY			English	Article						TBI; midline shift; outcome; clinical trial; trauma; traumatic brain injury	ACUTE SUBDURAL-HEMATOMA; SEVERE HEAD-INJURY; MIDDLE-CEREBRAL-ARTERY; CT-SCAN; MORTALITY; MULTICENTER; PREDICTION; CRITERIA; MODERATE	OBJECTIVE Following traumatic brain injury (TBI), midline shift of the brain at the level of the septum pellucidum is often caused by unilateral space-occupying lesions and is associated with increased intracranial pressure and worsened morbidity and mortality. While outcome has been studied in this population, the recovery trajectory has not been reported in a large cohort of patients with TBI. The authors sought to utilize the Citicoline Brain Injury Treatment (COBRIT) trial to analyze patient recovery over time depending on degree of midline shift at presentation. METHODS Patient data from the COBRIT trial were stratified into 4 groups of midline shift, and outcome measures were analyzed at 30, 90, and 180 days postinjury. A recovery trajectory analysis was performed identifying patients with outcome measures at all 3 time points to analyze the degree of recovery based on midline shift at presentation. RESULTS There were 892, 1169, and 895 patients with adequate outcome data at 30, 90, and 180 days, respectively. Rates of favorable outcome (Glasgow Outcome Scale-Extended [GOS-E] scores 4-8) at 6 months postinjury were 87% for patients with no midline shift, 79% for patients with 1-5 mm of shift, 64% for patients with 6-10 mm of shift, and 47% for patients with > 10 mm of shift. The mean improvement from unfavorable outcome (GOS-E scores 2 and 3) to favorable outcome (GOS-E scores 4-8) from 1 month to 6 months in all groups was 20% (range 4%-29%). The mean GOS-E score for patients in the 6- to 10-mm group crossed from unfavorable outcome (GOS-E scores 2 and 3) into favorable outcome (GOS-E scores 4-8) at 90 days, and the mean GOS-E of patients in the > 10-mm group nearly reached the threshold of favorable outcome by 180 days postinjury. CONCLUSIONS In this secondary analysis of the Phase 3 COBRIT trial, TBI patients with less than 10 mm of midline shift on admission head CT had significantly improved functional outcomes through 180 days after injury compared with those with greater than 10 mm of midline shift. Of note, nearly 50% of patients with > 10 mm of midline shift achieved a favorable outcome (GOS-E score 4-8) by 6 months postinjury.	[Puffer, Ross C.] Mayo Clin, Dept Neurosurg, Rochester, MN USA; [Yue, John K.; Mesley, Matthew; Billigen, Julia B.; Sharpless, Jane; Fetzick, Anita L.; Puccio, Ava; Okonkwo, David O.] UPMC, Dept Neurosurg, Pittsburgh, PA USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Okonkwo, DO (corresponding author), Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA.	okonkwodo@upmc.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722			ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Athiappan S., 1993, Annals Academy of Medicine Singapore, V22, P452; COOK RJ, 1988, ACTA NEUROCHIR, V95, P90, DOI 10.1007/BF01790766; DUHAIME AC, 1994, J NEUROTRAUM, V11, P669, DOI 10.1089/neu.1994.11.669; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; JENKINS A, 1990, British Journal of Neurosurgery, V4, P45, DOI 10.3109/02688699009000681; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; KASE CS, 1982, NEUROLOGY, V32, P1146, DOI 10.1212/WNL.32.10.1146; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Lehmann U, 1997, UNFALLCHIRURG, V100, P705, DOI 10.1007/s001130050180; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; Plaisier BR, 2002, AM SURGEON, V68, P159; QUATTROCCHI KB, 1991, SURG NEUROL, V35, P183, DOI 10.1016/0090-3019(91)90069-L; Rapenne T, 1997, PRESSE MED, V26, P1661; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; SERVADEI F, 1989, ACTA NEUROCHIR, V96, P39, DOI 10.1007/BF01403493; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001; Vedantam A, 2018, J NEUROSURG, V129, P234, DOI 10.3171/2017.3.JNS162720; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WONG CW, 1995, ACTA NEUROCHIR, V135, P131, DOI 10.1007/BF02187756; YAMAKI T, 1990, ACTA NEUROCHIR, V103, P112, DOI 10.1007/BF01407516; YOUNG B, 1981, J NEUROSURG, V54, P300, DOI 10.3171/jns.1981.54.3.0300; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	36	8	9	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2019	131	2					596	603		10.3171/2018.2.JNS173138			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IN4JV	WOS:000478642100035	30074459				2022-02-06	
J	Rafi, S; Tadie, JM; Gacouin, A; Leurent, G; Bedossa, M; Le Tulzo, Y; Maamar, A				Rafi, Sonia; Tadie, Jean-marc; Gacouin, Arnaud; Leurent, Guillaume; Bedossa, Marc; Le Tulzo, Yves; Maamar, Adel			Doppler sonography of cerebral blood flow for early prognostication after out-of-hospital cardiac arrest: DOTAC study	RESUSCITATION			English	Article						Out-of-hospital cardiac arrest; Transcranial Doppler sonography; Cerebrovascular circulation; Prognosis	EUROPEAN RESUSCITATION COUNCIL; TRANSCRANIAL DOPPLER; ULTRASOUND; AUTOREGULATION; HYPOTHERMIA; GUIDELINES; MANAGEMENT; SOCIETY	Aim: To assess the neurological prognosis of comatose survivors of cardiac arrest by early transcranial Doppler sonography (TCD). Methods: This was a prospective study performed between May 2016 and October 2017 in a medical intensive care unit (ICU) and a cardiac ICU of a university teaching hospital. All patients older than 18 years who were successfully resuscitated from an out-of-hospital cardiac arrest (OHCA) with persistent coma after the return of spontaneous circulation (ROSC) were eligible. We excluded patients for whom OHCA was associated with traumatic brain injury, no possibility of TCD measurements, or who were dead before establishing the neurological prognosis. We measured the pulsatility index (PI) and diastolic flow velocity (DFV) of the right and left middle cerebral arteries within 12 h after ICU admission. The lowest DFV and highest PI values were used for the statistical analysis. The neurological outcome at hospital discharge was evaluated by the cerebral performance category. Results: Forty-two patients were included in the final analysis: 15 had good and 27 poor neurological outcomes. The PI was higher in the poor outcome (1.49 vs. 1.12, p = 0.01) than good outcome group and the DFV was lower in the poor outcome group (17.3 cm s(-1) vs. 26.0 cm s(-1); p = 0.01). Conclusion: Data provided by early TCD after ROSC are associated with neurological outcome. The use of TCD could help guide interventions to improve cerebral perfusion after ROSC in patients resuscitated from OHCA.	[Rafi, Sonia; Gacouin, Arnaud; Maamar, Adel] CHU Rennes, Hop Pontchaillou, Serv Malad Infect & Reanimat Med, 2 Rue Henri Le Guilloux, F-35033 Rennes, France; [Tadie, Jean-marc] CHU Rennes, Hop Pontchaillou, Serv Malad Infect & Reanimat Med, MICMAC U1236,Equipe Infectiol CIC Inserm 1414, 2 Rue Henri Le Guilloux, F-35033 Rennes, France; [Le Tulzo, Yves] CHU Rennes, Hop Pontchaillou, Serv Malad Infect & Reanimat Med, Equipe Infectiol CIC Inserm 1414, 2 Rue Henri Le Guilloux, F-35033 Rennes, France; [Leurent, Guillaume; Bedossa, Marc] CHU Rennes, Hop Pontchaillou, Serv Cardiol & Malad Cardiovasc, 2 Rue Henri Le Guilloux, F-35033 Rennes, France		Rafi, S (corresponding author), CHU Rennes, Hop Pontchaillou, Reanimat Med, Serv Malad Infect & Reanimat Med, 2 Rue Henri Le Guilloux, F-35033 Rennes, France.	Sonia.RAFI@chu-rennes.fr; Jeanmarc.TADIE@chu-rennes.fr; arnaud.gacouin@chu-rennes.fr; Guillaume.LEURENT@chu-rennes.fr; Marc.Bedossa@chu-rennes.fr; yves.le.tulzo@chu-rennes.fr; Adel.MAAMAR@chu-rennes.fr	Leurent, Guillaume/AAQ-4697-2021; Maamar, Adel/AAI-2022-2019	Maamar, Adel/0000-0001-8352-3613; RAFI, SONIA/0000-0001-8346-5441			AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Alvarez-Fernandez JA, 2009, RESUSCITATION, V80, P1321, DOI 10.1016/j.resuscitation.2009.07.011; BACIC F, 1992, NEUROCHEM RES, V17, P699, DOI 10.1007/BF00968008; Bisschops LLA, 2010, CRIT CARE MED, V38, P1542, DOI 10.1097/CCM.0b013e3181e2cc1e; Bossaert LL, 2015, RESUSCITATION, V95, P302, DOI 10.1016/j.resuscitation.2015.07.033; Buunk G, 1996, INTENS CARE MED, V22, P1191, DOI 10.1007/s001340050237; Buunk G, CEREBRAL VASOCONSTRI, V6; Doepp F, 2014, RESUSCITATION, V85, P516, DOI 10.1016/j.resuscitation.2013.12.021; Geeraerts T, 2008, NEUROCHIRURGIE, V54, P731, DOI 10.1016/j.neuchi.2008.08.117; GEHLBACH SH, 1975, LANCET, V1, P478; Grasner JT, 2016, RESUSCITATION, V105, P188, DOI 10.1016/j.resuscitation.2016.06.004; Hazinski MSN, RECOMMENDED GUIDELIN; Heradstveit BE, 2011, RESUSCITATION, V82, P549, DOI 10.1016/j.resuscitation.2011.01.018; Hoedemaekers CW, 2017, RESUSCITATION, V120, P45, DOI 10.1016/j.resuscitation.2017.08.218; Iida K, 1997, CRIT CARE MED, V25, P971, DOI 10.1097/00003246-199706000-00013; Iordanova B, FRONT PEDIAT, V20175; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Lemiale V, 2008, RESUSCITATION, V76, P17, DOI 10.1016/j.resuscitation.2007.06.028; Lin JJ, 2015, RESUSCITATION, V89, P182, DOI 10.1016/j.resuscitation.2015.01.029; Moeschler O, 1995, ANN FR ANESTH, P114; Mongardon N, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-45; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Pollock JM, 2008, AM J NEURORADIOL, V29, P1302, DOI 10.3174/ajnr.A1095; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Sandroni C, 2014, INTENS CARE MED, V40, P1816, DOI 10.1007/s00134-014-3470-x; Saqqur M, 2007, CRIT CARE MED, V35, pS216, DOI 10.1097/01.CCM.0000260633.66384.FB; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Sundgreen C, 2001, STROKE, V32, P128, DOI 10.1161/01.STR.32.1.128; Tan CO, 2012, J APPL PHYSIOL, V113, P1194, DOI 10.1152/japplphysiol.00783.2012; van den Brule JMD, 2018, BIOMED RES INT, V2018, P1; Vigue B, 2007, REANIMATION, V16, P538; Wessels T, 2006, ULTRASOUND MED BIOL, V32, P1845, DOI 10.1016/j.ultrasmedbio.2006.06.023; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953	35	8	8	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	AUG	2019	141						188	194		10.1016/j.resuscitation.2019.05.024			7	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	IK5IC	WOS:000476617900024	31145934	Green Submitted			2022-02-06	
J	Signetti, S; Nicotra, M; Colonna, M; Pugno, NM				Signetti, Stefano; Nicotra, Marco; Colonna, Martino; Pugno, Nicola M.			Modeling and simulation of the impact behavior of soft polymeric-foam-based back protectors for winter sports	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article; Proceedings Paper	22nd International Congress on Snow Sports Trauma and Safety / Biennial Meeting of the International-Society-for-Skiing-Safety (ISSS)	APR 17-22, 2017	Univ Innsbruck, Innsbruck, AUSTRIA	Int Soc Skiing Safety	Univ Innsbruck	Back protectors; Winter sports; Back injuries; Soft polymeric foams; Impact testing; FEM modeling	SPINAL-CORD; SNOW SPORTS; INJURY; RISK; HEAD; SKI	Objectives: Winter sports are high-energy outdoor activities involving high velocities and acrobatic maneuvers, thus raising safety concerns. Specific studies on the impact mechanics of back protectors are very limited. In this study analytical and numerical models are developed to rationalize results of impact experiments and propose new design procedures for this kind of equipment. Design: Different soft-shell solutions currently available on the market are compared. In particular, the role of dynamic material constitutive properties and of environmental temperature (which affects mainly material stiffness) on energy absorption capability are evaluated. Methods: Starting from dynamic mechanical-thermal characterization of the closed-cell polymeric foams constituting the protectors, we exploited analytical modeling and Finite Element Method simulations to interpret experimental data from drop weight impact test and to characterize protectors at different temperatures and after multiple impacts. Results: The temperature and frequency dependent properties of these materials characterize their impact behavior. Modeling results are in good agreement with impact tests. Results demonstrate how ergonomic soft-shell solution provides an advantage with respect to traditional hard-shell in terms of impact protection. Moreover, it can maintain nearly unaltered its protective properties after multiple impacts on the same point. Conclusions: The coupled analytical-simulation approach here presented could be extensively used to predict the impact behavior of such equipment, starting from material characterization, allowing to save costs and time for physical prototyping and tests for design and optimization. (C) 2018 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Signetti, Stefano; Pugno, Nicola M.] Univ Trento, Dept Civil Environm & Mech Engn, Lab Bioinspired & Graphene Nanomech, Trento, Italy; [Nicotra, Marco; Colonna, Martino] Univ Bologna, Dept Civil Chem Environm & Mat Engn, Bologna, Italy; [Pugno, Nicola M.] Queen Mary Univ London, Sch Engn & Mat Sci, London, England; [Pugno, Nicola M.] Italian Space Agcy, Ket Lab, Edoardo Amaldi Fdn, Rome, Italy; [Signetti, Stefano] Korea Adv Inst Sci & Technol, Dept Mech Engn, 291 Daehak Ro, Daejeon 34141, South Korea		Pugno, NM (corresponding author), Univ Trento, Dept Civil Environm & Mech Engn, Lab Bioinspired & Graphene Nanomech, Trento, Italy.; Colonna, M (corresponding author), Univ Bologna, Dept Civil Chem Environm & Mat Engn, Bologna, Italy.; Pugno, NM (corresponding author), Queen Mary Univ London, Sch Engn & Mat Sci, London, England.; Pugno, NM (corresponding author), Italian Space Agcy, Ket Lab, Edoardo Amaldi Fdn, Rome, Italy.	martino.colonna@unibo.it; nicola.pugno@unitn.it	Signetti, S./C-5733-2019	Signetti, S./0000-0003-4128-0953; Pugno, Nicola/0000-0003-2136-2396	European Commission under Graphene Flagship Core 2 (WP14 "Composites") [785219]; European Commission under FET Proactive ("Neurofibers") [732344]; Italian Ministry of Education, University and Research (MIUR) under the "Departments of Excellence"Ministry of Education, Universities and Research (MIUR) [L. 232/2016]; Ermenegildo Zegna Founder's Scholarship 2017-2018	NMP is supported by the European Commission under the Graphene Flagship Core 2 (WP14 "Composites", no. 785219) and the FET Proactive ("Neurofibers", no. 732344) and by the Italian Ministry of Education, University and Research (MIUR) under the "Departments of Excellence" grant L. 232/2016. SS acknowledges financial support from Ermenegildo Zegna Founder's Scholarship 2017-2018.	Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; [Anonymous], 2003, 16212 EN; [Anonymous], 2012, D406512 ASTM; [Anonymous], 2000, 66032 ISO; [Anonymous], 2012, 16211 EN; bfu, 2017, 71 BFU; Burtscher M, 2008, CLIN J SPORT MED, V18, P355, DOI 10.1097/MJT.0b013e31815fd0fe; Chen Q, 2016, INT J MECH SCI, V111, P125, DOI 10.1016/j.ijmecsci.2016.03.020; Dotti F, 2016, APPL ERGON, V56, P144, DOI 10.1016/j.apergo.2016.04.002; Engsberg JR, 2009, SPINAL CORD, V47, P634, DOI 10.1038/sc.2009.1; Foster L, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8030354; Graesser EJ, 1991, RELATIONSHIP TRADITI; HARDING JW, 1945, P CAMB PHILOS SOC, V41, P16, DOI 10.1017/S0305004100022325; Hildebrandt C, 2011, ACCIDENT ANAL PREV, V45, P352, DOI [10.1136/bjsm.2011.084038.119, DOI 10.1136/BJSM.2011.084038.119]; Jung CS, 2011, ACTA NEUROCHIR, V153, P101, DOI 10.1007/s00701-010-0704-8; Klempner D, 2004, HDB POLYM FOAMS FOAM; Kostopoulos V, 2002, COMPOS PART B-ENG, V33, P99, DOI 10.1016/S1359-8368(01)00066-X; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; McBeth PB, 2009, AM J SURG, V197, P560, DOI [10.1016/j.amjsurg.2008.12.016, 10.1016/j.amjsurg.2008.08.010]; Michel FI, 2010, PROCEDIA ENGINEER, V2, P2869, DOI 10.1016/j.proeng.2010.04.080; Nasim M, 2017, POLYM TEST, V61, P249, DOI 10.1016/j.polymertesting.2017.05.025; NEILSEN MK, 1995, POLYM ENG SCI, V35, P387, DOI 10.1002/pen.760350503; Nicotra M, 2014, PROCEDIA ENGINEER, V72, P678, DOI 10.1016/j.proeng.2014.06.115; Palmer R. M., 2008, U.S. Patent, Patent No. [7,381,460, 7381460]; Petrone N, 2012, AM SOC TEST MATER, V1553, P153, DOI 10.1520/STP104509; Rodriguez-Perez MA, 2000, J APPL POLYM SCI, V75, P156, DOI 10.1002/(SICI)1097-4628(20000103)75:1<156::AID-APP18>3.0.CO;2-U; Rodriguez-Perez MA, 2002, CELL POLYM, V21, P117, DOI 10.1177/026248930202100202; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Schmitt KU, 2010, BRIT J SPORT MED, V44, P822, DOI 10.1136/bjsm.2010.072728; Signetti S, 2014, J EUR CERAM SOC, V34, P2823, DOI 10.1016/j.jeurceramsoc.2013.12.039; Verdejo R, 2002, ENG SPORT, V4, P580; Yamakawa H, 2001, J TRAUMA, V50, P1101, DOI 10.1097/00005373-200106000-00020	32	8	8	1	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	AUG	2019	22			1			S65	S70		10.1016/j.jsams.2018.10.007			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Sport Sciences	JI6OQ	WOS:000493587000014	30477930	Green Submitted			2022-02-06	
J	Tang-Schomer, MD; Kaplan, DL; Whalen, MJ				Tang-Schomer, Min D.; Kaplan, David L.; Whalen, Michael J.			Film interface for drug testing for delivery to cells in culture and in the brain	ACTA BIOMATERIALIA			English	Article						Silk; Traumatic brain injury; Drug delivery; Dura; Necrosis; Interstitial fluid flow	CONTROLLED CORTICAL IMPACT; SILK FIBROIN; ADENOSINE RELEASE; RAT-BRAIN; INJURY; PHARMACOKINETICS; BIOMATERIALS; PERMEABILITY; PROTEASE; MATER	Brain access remains a major challenge in drug testing. The nearly 'impermeable' blood-brain-barrier (BBB) prevents most drugs from gaining access to brain cells via systematic intravenous (IV) injection. In this study, silk fibroin films were used as drug carrier as well as cell culture substrate to simulate the in vivo interface between drug reservoir and brain cells for testing drug delivery in the brain. In in vitro studies, film-released arabinofuranosyl cytidine (AraC), a mitotic inhibitor, selectively killed glial cells in film-supported mixed neural cell cultures; with widened dosage windows for drug efficacy and tolerance compared to drugs in solution. In the brain, the presence of silk films was well tolerated with no signs of acute neuroinflammation, cell death, or altered brain function. Topical application of silk films on the cortical surface delivered Evans blue, a BBB-impenetrable fluorescent marker, through the intact dura matter into the parenchyma of the ipsilateral hemisphere as deep as the hippocampal region, but not the contralateral hemisphere. In a mouse traumatic brain injury (TBI) model, necrosis markers by film delivery accessed more cells in the lesion core than by con-current IV delivery; whereas the total coverage including the peri-lesional area appeared to be comparable between the two routes. The complementary distribution patterns of co-delivered markers provided direct evidence of the partial confinement of either route's access to brain cells by a restrictive zone near the lesion border. Finally, film-delivered necrostatin-1 reduced overall cell necrosis by approximately 40% in the TBI model. These findings from representative small molecules of delivery route-dependent drug access are broadly applicable for evaluating drug actions both in vitro and in vivo. Combined with its demonstrated role of supporting neuron electrode interfaces, the film system can be further developed for testing a range of neuromodulation approaches (i.e., drug delivery, electrical stimulation, cell graft) in the brain. Statement of Significance This study demonstrated that silk fibroin films can be used to evaluate drug actions both in vitro and in vivo, partially overcoming the significant delivery barriers of the brain. This system can be adapted for efficient drug access to specific brain regions and/or cell types. The film system can be further developed for testing a range of interventions with drugs, electrical signals or cell graft for analysis of treatment outcomes including cell responses and brain function. (C) 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Tang-Schomer, Min D.] Jackson Lab Genom Med, 10 Discovery Dr, Farmington, CT 06032 USA; [Tang-Schomer, Min D.] Univ Connecticut, Ctr Hlth, Farmington, CT 06032 USA; [Tang-Schomer, Min D.] Connecticut Childrens Med Ctr, Dept Pediat, Farmington, CT 06032 USA; [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Whalen, Michael J.] Harvard Med Sch, Acute Brain Injury Res Lab, Massachusetts Gen Hosp Children, Charlestown, MA 02129 USA		Tang-Schomer, MD (corresponding author), Jackson Lab Genom Med, 10 Discovery Dr, Farmington, CT 06032 USA.	Min.Tang-Schomer@jax.org; David.Kaplan@tufts.edu; mwhalen@mgh.harvard.edu	Tang-Schomer, Min/AAD-9501-2020	Tang-Schomer, Min/0000-0001-7585-3890	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS092847, R01NS094218, EB002520, 5RO1NS061255]; Connecticut Children's Medical Center Strategic Research Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092847, R01NS094218] Funding Source: NIH RePORTER	This work was funded by NIH (R01NS092847, R01NS094218, and EB002520) to D.L.K, 5RO1NS061255 to M. J. W., and Connecticut Children's Medical Center Strategic Research Fund to M.D.T.	Ay I, 2008, BRAIN RES, V1234, P198, DOI 10.1016/j.brainres.2008.07.121; Benfenati V, 2010, BIOMATERIALS, V31, P7883, DOI 10.1016/j.biomaterials.2010.07.013; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bible E, 2012, BIOMATERIALS, V33, P7435, DOI 10.1016/j.biomaterials.2012.06.085; CAPIZZI RL, 1983, J CLIN ONCOL, V1, P763, DOI 10.1200/JCO.1983.1.12.763; Cook DJ, 2017, J CEREBR BLOOD F MET, V37, P1030, DOI 10.1177/0271678X16649964; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Devon R. M., 1997, PROTOCOLS NEURAL CEL; Fernandez-Garcia L, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00296; Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3; Gerlai R, 2001, BEHAV BRAIN RES, V125, P269, DOI 10.1016/S0166-4328(01)00296-0; Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017; Govender ST, 2003, J NEUROSURG, V99, P831, DOI 10.3171/jns.2003.99.5.0831; Greenhalgh AD, 2011, EXPERT OPIN DRUG MET, V7, P681, DOI 10.1517/17425255.2011.570259; Hines DJ, 2011, BIOMACROMOLECULES, V12, P804, DOI 10.1021/bm101421r; HO DHW, 1971, CLIN PHARMACOL THER, V12, P944; Hronik-Tupaj M, 2013, J BIOMED MATER RES A, V101, P2559, DOI 10.1002/jbm.a.34565; Hsu BB, 2014, P NATL ACAD SCI USA, V111, P12175, DOI 10.1073/pnas.1323829111; Hu X, 2013, ADV FUNCT MATER, V23, P3875, DOI 10.1002/adfm.201202685; Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a; Huang X, 2001, J CONTROL RELEASE, V73, P121, DOI 10.1016/S0168-3659(01)00248-6; Hurko Orest, 2005, NeuroRx, V2, P671, DOI 10.1602/neurorx.2.4.671; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Iwashita M, 2014, DEVELOPMENT, V141, P3793, DOI 10.1242/dev.109637; Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Kingsmore KM, 2018, APL BIOENG, V2, DOI 10.1063/1.5023503; Lawrence Brian D, 2012, J Vis Exp, DOI 10.3791/3646; Lawrence BD, 2010, MACROMOL BIOSCI, V10, P393, DOI 10.1002/mabi.200900294; Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018; Li TF, 2009, EPILEPSY RES, V84, P238, DOI 10.1016/j.eplepsyres.2009.01.002; Lo EH, 2001, BRAIN RES REV, V38, P140, DOI 10.1016/S0165-0173(01)00083-2; Moshayedi P, 2016, BIOMATERIALS, V105, P145, DOI 10.1016/j.biomaterials.2016.07.028; NELSON RB, 1990, J BIOL CHEM, V265, P3836; NELSON RB, 1993, J NEUROCHEM, V61, P567; Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101; Pritchard EM, 2012, BIOPOLYMERS, V97, P479, DOI 10.1002/bip.22026; Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936; Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Rozniecki JJ, 1999, BRAIN RES, V849, P1, DOI 10.1016/S0006-8993(99)01855-7; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Szybala C, 2009, EXP NEUROL, V219, P126, DOI 10.1016/j.expneurol.2009.05.018; Tang-Schomer MD, 2014, P NATL ACAD SCI USA, V111, P13811, DOI 10.1073/pnas.1324214111; Tang-Schomer MD, 2014, ADV FUNCT MATER, V24, P1938, DOI 10.1002/adfm.201303196; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tien LW, 2013, ADV FUNCT MATER, V23, P3185, DOI 10.1002/adfm.201203716; Vandenabeele F, 1996, J ANAT, V189, P417; Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; White JD, 2015, ACTA BIOMATER, V14, P1, DOI 10.1016/j.actbio.2014.11.045; Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44	53	8	8	1	23	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	AUG	2019	94						306	319		10.1016/j.actbio.2019.02.052			14	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	IN9TI	WOS:000479020900025	30836199	Green Accepted			2022-02-06	
J	Urban, JE; Flood, WC; Zimmerman, BJ; Kelley, ME; Espeland, MA; McNamara, L; Davenport, EM; Powers, AK; Whitlow, CT; Maldjian, JA; Stitzel, JD				Urban, Jillian E.; Flood, William C.; Zimmerman, Barret J.; Kelley, Mireille E.; Espeland, Mark A.; McNamara, Liam; Davenport, Elizabeth M.; Powers, Alexander K.; Whitlow, Christopher T.; Maldjian, Joseph A.; Stitzel, Joel D.			Evaluation of head impact exposure measured from youth football game plays	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						head impacts; biomechanics; pediatrics; head acceleration; football; injury; trauma	HIGH-SCHOOL; PROFESSIONAL FOOTBALL; CONCUSSION; BIOMECHANICS; MAGNITUDE; INJURIES; AGE; EPIDEMIOLOGY; PERFORMANCE; COLLEGIATE	OBJECTIVE There is a growing body of literature informing efforts to improve the safety of football; however, research relating on-field activity to head impacts in youth football is limited. Therefore, the objective of this study was to compare head impact exposure (HIE) measured in game plays among 3 youth football teams. METHODS Head impact and video data were collected from athletes (ages 10-13 years) participating on 3 youth football teams. Video analysis was performed to verify head impacts and assign each to a specific play type. Each play was categorized as a down, punt, kickoff, field goal, or false start. Kickoffs and punts were classified as special teams. Downs were classified as running, passing, or other. HIE was quantified by play type in terms of mean, median, and 95th percentile linear and rotational acceleration. Mixed-effects models were used to assess differences in acceleration among play types. Contact occurring on special teams plays was evaluated using a standardized video abstraction form. RESULTS A total of 3003 head impacts over 27.5 games were analyzed and paired with detailed video coding of plays. Most head impacts were attributed to running (79.6%), followed by passing (14.0%), and special teams (6.4%) plays. The 95th percentile linear acceleration measured during each play type was 52.6g, 50.7g, and 65.5g, respectively. Special teams had significantly greater mean linear acceleration than running and passing plays (both p = 0.03). The most common kick result on special teams was a deep kick, of which 85% were attempted to be returned. No special teams plays resulted in a touchback, and one resulted in a fair catch. One-third of all special teams plays and 92% of all nonreturned kicks resulted in athletes diving toward the ball. CONCLUSIONS The results demonstrate a trend toward higher head impact magnitudes on special teams than for running and passing plays, but a greater number of impacts were measured during running plays. Deep kicks were most common on special teams, and many returned and nonreturned kicks resulted in athletes diving toward the ball. These results support policy changes to youth special teams plays, including modifying the yard line the ball is kicked from and coaching proper return technique. Further investigation into biomechanical exposure measured during game impact scenarios is needed to inform policy relevant to the youth level.	[Urban, Jillian E.; Kelley, Mireille E.; McNamara, Liam; Stitzel, Joel D.] Wake Forest Univ, Bowman Gray Sch Med, Virginia Tech, Sch Biomed Engn & Sci, Winston Salem, NC 27109 USA; [Urban, Jillian E.; Kelley, Mireille E.; McNamara, Liam; Stitzel, Joel D.] Dept Biomed Engn, Winston Salem, NC USA; [Flood, William C.; Whitlow, Christopher T.] Dept Radiol Neuroradiol, Winston Salem, NC USA; [Espeland, Mark A.] Dept Biostat Sci, Winston Salem, NC USA; [Powers, Alexander K.] Dept Neurosurg, Winston Salem, NC USA; [Whitlow, Christopher T.] Clin & Translat Sci Inst, Winston Salem, NC USA; [Zimmerman, Barret J.] Wake Forest Sch Med, Winston Salem, NC USA; [Davenport, Elizabeth M.; Maldjian, Joseph A.] Univ Texas Southwestern, Dept Radiol, Dallas, TX USA		Urban, JE (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Virginia Tech, Sch Biomed Engn & Sci, Winston Salem, NC 27109 USA.	jurban@wakehealth.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410, R01NS082453]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001421]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award nos. R01NS094410 and R01NS082453. The National Center for Advancing Translational Sciences, National Institutes of Health, through grant no. KL2TR001421 supported Dr. Jillian E. Urban. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; We give special thanks to the Childress Institute for Pediatric Trauma at Wake Forest Baptist Medical Center for providing support for this study. We also thank the youth football league's coordinators, coaches, parents, athletes, and athletic trainer whose support made this study possible. We also thank Joeline Kane, Megan Anderson, and Leslie Hoyt for their valuable assistance in this research.	Alosco ML, 2016, ALZHEIMERS DEMENT, V7, P33; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Campolettano ET, 2016, J NEUROSURG-PEDIATR, V18, P536, DOI 10.3171/2016.5.PEDS1696; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Comstock R, 2015, NATL HIGH SCH SPORTS; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dompier TP, 2007, J ATHL TRAINING, V42, P395; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hendricks S, 2015, BMJ OPEN SPORT EXERC, V1, DOI DOI 10.1136/BMJSEM-2015-000046; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Kelley ME, 2019, J NEUROSURG-PEDIATR, V23, P381, DOI 10.3171/2018.9.PEDS18314; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116664500; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116648441; Lynall RC, 2017, J NEUROTRAUM, V34, P2684, DOI 10.1089/neu.2017.5032; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; Mc Fie S., 2016, BMJ OPEN SPORT EXERC, V2, P000053, DOI [10.1136/bmjsem-2015-000053, DOI 10.1136/BMJSEM-2015-000053]; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; North JS, 2016, HUM MOVEMENT SCI, V49, P170, DOI 10.1016/j.humov.2016.06.013; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Rees T, 2016, SPORTS MED, V46, P1041, DOI 10.1007/s40279-016-0476-2; Ruestow PS, 2015, J OCCUP ENVIRON HYG, V12, P875, DOI 10.1080/15459624.2015.1072632; Schmidt JD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4231; Schmidt JD, 2016, J ATHL TRAINING, V51, P366, DOI 10.4085/1062-6050-51.5.04; Sports Marketing Surveys USA, 2013, 2013 SPORTS FITN LEI; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tierney GJ, 2018, MED SCI SPORT EXER, V50, P603, DOI 10.1249/MSS.0000000000001461; Urban JE, 2019, J NEUROTRAUM, V36, P275, DOI 10.1089/neu.2018.5699; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Vanttinen T, 2010, PERCEPT MOTOR SKILL, V110, P675, DOI 10.2466/PMS.110.3.675-692; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Williams AM, 2005, HUM MOVEMENT SCI, V24, P283, DOI 10.1016/j.humov.2005.06.002	43	8	8	1	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	AUG	2019	24	2					190	199		10.3171/2019.2.PEDS18558			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	IN4LJ	WOS:000478646300012	31075762				2022-02-06	
J	Yang, JT; Erickson, SL; Killien, EY; Mills, B; Lele, AV; Vavilala, MS				Yang, Jen-Ting; Erickson, Scott L.; Killien, Elizabeth Y.; Mills, Brianna; Lele, Abhijit, V; Vavilala, Monica S.			Agreement Between Arterial Carbon Dioxide Levels With End-Tidal Carbon Dioxide Levels and Associated Factors in Children Hospitalized With Traumatic Brain Injury	JAMA NETWORK OPEN			English	Article							DIFFERENCE; REGRESSION	IMPORTANCE Alterations in the partial pressure of carbon dioxide, arterial (PaCO2) can affect cerebral perfusion after traumatic brain injury. End-tidal carbon dioxide (EtCO2) monitoring is a noninvasive tool used to estimate PaCO2 values. OBJECTIVE To examine the agreement between PaCO2 and EtCO2 and associated factors in children with traumatic brain injury. DESIGN, SETTING, AND PARTICIPANTS A secondary analysis was conducted using data from a prospective cohort study of 137 patients younger than 18 years with traumatic brain injury who were admitted to the pediatric intensive care unit of a level I trauma center between May 1, 2011, and July 31, 2017. Analysis was performed from December 17, 2018, to January 10, 2019. MAIN OUTCOMES AND MEASURES The closest EtCO2 value obtained within 30 minutes of a PaCO2 value and the closest systolic blood pressure value obtained within 60 minutes prior to a PaCO2 value during the first 24 hours after admission were recorded. The main outcome of PaCO2-EtCO2 agreement was defined as PaCO2 between 0 and 5mmHg greater than the paired EtCO2 value, and it was determined using Bland-Altman analysis, Passing and Bablok regression, and the Pearson correlation coefficient. Multivariable regression models determined which factors were associated with agreement. RESULTS The analysis included 137 patients (34 girls and 103 boys; mean [SD] age, 10.0 [6.3] years) and 445 paired PaCO2-EtCO2 data points. On average, PaCO2 was 2.7mmHg (95% limits of agreement,-11.3 to 16.7) higher than EtCO2. Overall, 187 of all PaCO2-EtCO2 pairs (42.0%) agreed. There was larger variation in the PaCO2-EtCO2 difference during the first 8 hours compared with 9 to 24 hours after admission to the pediatric intensive care unit. Development of pediatric acute respiratory distress syndrome within 24 hours of admission was associated with a lower likelihood of PaCO2-EtCO2 agreement (adjusted odds ratio, 0.20; 95% CI, 0.08-0.51) compared with no development of pediatric acute respiratory distress syndrome. A diagnosis of pediatric acute respiratory distress syndrome 1 to 7 days after admissionwas associated with a larger first-day PaCO2-EtCO2 difference compared with those who never developed pediatric acute respiratory distress syndrome (mean [SD] difference, 4.48 [3.70] vs 0.46 [5.50] mmHg). CONCLUSIONS AND RELEVANCE In this study of pediatric traumatic brain injury, PaCO2-EtCO2 agreement was low, especially among patients with pediatric acute respiratory distress syndrome. Low PaCO2-EtCO2 agreement early in hospitalization may be associated with future development of pediatric acute respiratory distress syndrome. Data on EtCO2 should not be substituted for data on PaCO2 during the first 24 hours.	[Yang, Jen-Ting; Erickson, Scott L.; Killien, Elizabeth Y.; Mills, Brianna; Lele, Abhijit, V; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, 325 Ninth Ave,POB 359724, Seattle, WA 98104 USA; [Yang, Jen-Ting; Lele, Abhijit, V; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Erickson, Scott L.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Killien, Elizabeth Y.; Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98104 USA		Yang, JT (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, 325 Ninth Ave,POB 359724, Seattle, WA 98104 USA.	alanyang@uw.edu	/AAD-2116-2020	Erickson, Scott L/0000-0002-7694-6287	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01NS072308-06]	Dr Vavilala was supported by grant 5R01NS072308-06 from the National Institutes of Health for this study.	*AM COLL SURG, ADV TRAUM LIF SUPP M; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Eipe N, 2010, J CLIN MONIT COMPUT, V24, P261, DOI 10.1007/s10877-010-9243-3; Goonasekera CD, 2014, INDIAN J CRIT CARE M, V18, P711, DOI 10.4103/0972-5229.144011; Hebal F, 2018, J PEDIATR SURG, V53, P794, DOI 10.1016/j.jpedsurg.2017.08.057; Hendrickson CM, 2016, J TRAUMA ACUTE CARE, V80, P989, DOI 10.1097/TA.0000000000000982; Hess D., 1998, PRINCIPLES PRACTICE, P377; Jouvet P, 2015, PEDIATR CRIT CARE ME, V16, P428, DOI 10.1097/PCC.0000000000000350; Khan Fauzia Anis, 2007, J Pak Med Assoc, V57, P446; Killien EY, 2018, CRIT CARE MED, V46, pE1088, DOI 10.1097/CCM.0000000000003379; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P404, DOI 10.1097/PCC.0000000000001945; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Lee SW, 2009, J TRAUMA, V67, P526, DOI 10.1097/TA.0b013e3181866432; LIU Z, 1995, CHEST, V107, P1218, DOI 10.1378/chest.107.5.1218; Martin RF, 2000, CLIN CHEM, V46, P100; Nakayama Y, 2014, ANESTH ANALG, V118, P1019, DOI 10.1213/ANE.0000000000000164; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; R Core Team, R LANG ENV STAT COMP; SHARMA SK, 1995, CAN J ANAESTH, V42, P498, DOI 10.1007/BF03011688; StataCorp LLC, STAT STAT SOFTW REL; Vavilala MS, 2019, LANCET CHILD ADOLESC, V3, P23, DOI 10.1016/S2352-4642(18)30341-9; World Health Organization, NEUR DIS PUBL HLTH C	23	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	AUG	2019	2	8							e199448	10.1001/jamanetworkopen.2019.9448			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IS4SL	WOS:000482143700054	31418806	Green Published, gold			2022-02-06	
J	Zhang, Z; Li, D; Xu, L; Li, HP				Zhang, Zhuo; Li, Dan; Xu, Li; Li, Hong-Peng			Sirt1 improves functional recovery by regulating autophagy of astrocyte and neuron after brain injury	BRAIN RESEARCH BULLETIN			English	Article						Autophagy; Brain injury; Sirt1; Glial activation; Neuroprotection	SIGNALING PATHWAY; PROTECTS; ACTIVATION; APOPTOSIS; SIRTUINS; DISEASE; DAMAGE; RATS; MICE; LC3	Traumatic brain injury (TBI) triggers neuronal death mechanisms that significantly induce neuronal loss and neurological dysfunction. Our previous study revealed that Sirt1 could improve the neuroprotective effect by reducing the astrocyte activation after TBI. Nevertheless, the underlying mechanisms of Sirt1 attenuating astrocyte activation still remain unclear. The following study examined whether the protection of Sirt1 in nigrostriatal pathway injury is associated with autophagy regulation. We established a nigrostriatal pathway injury in the mouse brain in order to mimic the traumatic brain injury and up-regulated Sirt1 expression by resveratrol. Consequently, we analyzed the effect of Sirt1 up-regulation on LC3 and monitored the LC3 localization in the astrocytes, microglial cells and neurons. We found that the Sirt1 up-regulation by resveratrol increased the expression of LC3 around the lesion site after injury. Confocal results showed that Sirt1 up-regulation increased the expression of LC3 in astrocytes and decreased the expression in the neurons, while low effect was found on the microglial cells. Moreover, compared the resveratrol treatment groups, a typical nucleocytoplasmic localization with strong distribution in the nucleus (in astrocyte and neurons) was observed in the control group (treated with DMSO). To sum up, our data suggested that regulation of Sirt1 expression could enhance autophagy in the astrocytes and decrease the expression in the neurons. This mechanism, which may probably relate to the distribution of LC3 in cytoplasm and nucleus, provides a new theoretical basis for exploring the neuroprotective mechanism of Sirt1 after brain injury.	[Zhang, Zhuo; Li, Dan; Li, Hong-Peng] China Med Univ, Coll Basic Med Sci, Dept Human Anat, Shenyang, Liaoning, Peoples R China; [Xu, Li] Forth Peoples Hosp, Dept Ophthalmol, Shenyang, Liaoning, Peoples R China		Xu, L; Li, HP (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Human Anat, Shenyang, Liaoning, Peoples R China.	xu-Ii1149@163.com; hpli@cmu.edu.cn			Hong-Peng Li's Liaoning Provincial Department of Education fund [LZDK-201704, IOS818101239]; Doctoral Start-up Foundation of Liaoning Province [20180540041]	The authors would like to thank Professor Lv for assistance in data analysis. This study was supported by Hong-Peng Li's Liaoning Provincial Department of Education fund (Grant No: LZDK-201704), Dan Li's National Natural Science Foundation of China (No: IOS818101239) and Doctoral Start-up Foundation of Liaoning Province (No: 20180540041).	Awan MUF, 2014, APPL MICROBIOL BIOT, V98, P5319, DOI 10.1007/s00253-014-5721-8; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Cho SH, 2015, J NEUROSCI, V35, P807, DOI 10.1523/JNEUROSCI.2939-14.2015; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Feng XW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059888, 10.1371/journal.pone.0078846]; Feng Y, 2017, NEUROCHEM RES, V42, P3296, DOI 10.1007/s11064-017-2372-z; Gao YY, 2017, AM J TRANSL RES, V9, P887; Guo WJ, 2011, J NEUROSCI RES, V89, P1723, DOI 10.1002/jnr.22725; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Huang R, 2015, MOL CELL, V57, P456, DOI 10.1016/j.molcel.2014.12.013; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0841-6; Li D, 2016, BRAIN RES BULL, V127, P195, DOI 10.1016/j.brainresbull.2016.09.014; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Liu YL, 2017, J NEUROTRAUM, V34, P2119, DOI 10.1089/neu.2016.4764; Meng ZZ, 2015, EXP THER MED, V10, P525, DOI 10.3892/etm.2015.2555; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima Noboru, 2008, V445, P119, DOI 10.1007/978-1-59745-157-4_7; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Solberg N. O., 2014, OPTICAL SPION ENHANC; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Tang CH, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2923182; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Wang LL, 2016, MOL MED REP, V13, P4051, DOI 10.3892/mmr.2016.5027; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Xu JG, 2014, BRAIN RES, V1582, P237, DOI 10.1016/j.brainres.2014.07.042; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Zhang F, 2011, PROG NEUROBIOL, V95, P373, DOI 10.1016/j.pneurobio.2011.09.001; Zhang L, 2017, J LAB PRECIS MED, V2, P2, DOI DOI 10.1155/2017/2032697	41	8	9	1	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	AUG	2019	150				SI		42	49		10.1016/j.brainresbull.2019.05.005			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IM1XI	WOS:000477784800005	31102754				2022-02-06	
J	Abutarboush, R; Gu, M; Kawoos, U; Mullah, SH; Chen, Y; Goodrich, SY; Lashof-Sullivan, M; McCarron, RM; Statz, JK; Bell, RS; Stone, JR; Ahlers, ST				Abutarboush, Rania; Gu, Ming; Kawoos, Usmah; Mullah, Saad H.; Chen, Ye; Goodrich, Samantha Y.; Lashof-Sullivan, Margaret; McCarron, Richard M.; Statz, Jonathan K.; Bell, Randy S.; Stone, James R.; Ahlers, Stephen T.			Exposure to Blast Overpressure Impairs Cerebral Microvascular Responses and Alters Vascular and Astrocytic Structure	JOURNAL OF NEUROTRAUMA			English	Article						blast overpressure; cerebrovascular reactivity; in vivo studies; microcirculation; vascular injury	TRAUMATIC BRAIN-INJURY; RECTIFIER POTASSIUM CHANNELS; PIAL ARTERIOLAR CALIBER; SMOOTH-MUSCLE; NITRIC-OXIDE; BLOOD-FLOW; RAT-BRAIN; DEPENDENT RELAXATION; OXIDATIVE STRESS; MOUSE-BRAIN	Exposure to blast overpressure may result in cerebrovascular impairment, including cerebral vasospasm. The mechanisms contributing to this vascular response are unclear. The aim of this study was to evaluate the relationship between blast and functional alterations of the cerebral microcirculation and to investigate potential underlying changes in vascular microstructure. Cerebrovascular responses were assessed in sham- and blast-exposed male rats at multiple time points from 2 h through 28 days after a single 130-kPa (18.9-psi) exposure. Pial microcirculation was assessed through a cranial window created in the parietal bone of anesthetized rats. Pial arteriolar reactivity was evaluated in vivo using hypercapnia, barium chloride, and serotonin. We found that exposure to blast leads to impairment of arteriolar reactivity >24 h after blast exposure, suggesting delayed injury mechanisms that are not simply attributed to direct mechanical deformation. Observed vascular impairment included a reduction in hypercapnia-induced vasodilation, increase in barium-induced constriction, and reversal of the serotonin effect from constriction to dilation. A reduction in vascular smooth muscle contractile proteins consistent with vascular wall proliferation was observed, as well as delayed reduction in nitric oxide synthase and increase in endothelin-1 B receptors, mainly in astrocytes. Collectively, the data show that exposure to blast results in delayed and prolonged alterations in cerebrovascular reactivity that are associated with changes in the microarchitecture of the vessel wall and astrocytes. These changes may contribute to long-term pathologies involving dysfunction of the neurovascular unit, including cerebral vasospasm.	[Abutarboush, Rania; Gu, Ming; Kawoos, Usmah; Mullah, Saad H.; Chen, Ye; Goodrich, Samantha Y.; Lashof-Sullivan, Margaret; McCarron, Richard M.; Statz, Jonathan K.; Ahlers, Stephen T.] Naval Med Res Ctr, Neurotrauma Dept, Silver Spring, MD USA; [Bell, Randy S.] Walter Reed Natl Mil Med Ctr, Neurosurg Dept, Bethesda, MD USA; [Stone, James R.] Univ Virginia, Med Ctr, Dept Radiol & Med Imaging, Charlottesville, VA USA; [Abutarboush, Rania; Gu, Ming; Kawoos, Usmah; Mullah, Saad H.; Chen, Ye; Goodrich, Samantha Y.; Lashof-Sullivan, Margaret; Statz, Jonathan K.] Adv Mil Med Inc, Henry M Jackson Fdn, Bethesda, MD USA; [McCarron, Richard M.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Abutarboush, R (corresponding author), Naval Med Res Ctr, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	rania.abutarboush.ctr@mail.mil			 [603115HP. 3520.001. A1411]	The authors thank Dr. Enoch Wei for technical advice and expertise with the cranial window model. This work was supported/funded by work unit number 603115HP. 3520.001. A1411. The views expressed in this article reflect the results of research conducted by of the author and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. government. The contents of this publication are the sole responsibility of the author(s) and do not necessarily reflect the views, opinions, or policies of Uniformed Services University of the Health Sciences (USUHS), The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., the Department of Defense (DoD), the Departments of the Army, Navy, or Air Force. Mention of trade names, commercial products, or organizations does not imply endorsement by the U.DS. government. Some of the authors are military Service members [or employees of the U.S. government]. This work was prepared as part of their official duties. Title 17 USC x105 provides that copyright protection under this title is not available for any work of the U.S. government. Title 17 USC x101 defines a U.S. government work as a work prepared by a military service member or employee of the U.S. government as part of that person's official duties. The experiments reported herein were conducted in compliance with the Animal Welfare Act and per the principles set forth in the "Guide for Care and Use of Laboratory Animals,'' Institute of Laboratory Animals Resources, National Research Council, National Academy Press, 2011.	Abutarboush R, 2018, MICROCIRCULATION, V25, DOI 10.1111/micc.12441; Abutarboush R, 2016, J FUNCT BIOMATER, V7, DOI 10.3390/jfb7040029; Abutarboush R, 2014, J FUNCT BIOMATER, V5, P246, DOI 10.3390/jfb5040246; Abutarboush Rania, 2013, Curr Drug Discov Technol, V10, P315; Adeoye OO, 2013, AM J PHYSIOL-CELL PH, V304, pC656, DOI 10.1152/ajpcell.00110.2012; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Asano Y, 1997, AM J PHYSIOL-HEART C, V272, pH2547, DOI 10.1152/ajpheart.1997.272.6.H2547; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; BAUMBACH GL, 1988, HYPERTENSION, V12, P89, DOI 10.1161/01.HYP.12.2.89; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; BELL WH, 1967, J NEUROSURG, V26, P203, DOI 10.3171/jns.1967.26.2.0203; BEVAN JA, 1988, ANNU REV PHARMACOL, V28, P311; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; Borel CO, 2003, STROKE, V34, P427, DOI 10.1161/01.STR.0000053848.06436.AB; Brian JE, 1996, CLIN EXP PHARMACOL P, V23, P449, DOI 10.1111/j.1440-1681.1996.tb02760.x; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Cipolla MJ, 2013, J CEREBR BLOOD F MET, V33, P1486, DOI 10.1038/jcbfm.2013.99; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; de Wit C, 1998, HYPERTENSION, V31, P787, DOI 10.1161/01.HYP.31.3.787; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; EDVINSSON L, 1977, BLOOD VESSELS, V14, P366; Edvinsson LIH, 2011, J CEREBR BLOOD F MET, V31, P1554, DOI 10.1038/jcbfm.2011.70; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; Ezan P, 2012, J CEREBR BLOOD F MET, V32, P1457, DOI 10.1038/jcbfm.2012.45; FARACI FM, 1994, STROKE, V25, P1679, DOI 10.1161/01.STR.25.8.1679; Faraco G, 2013, HYPERTENSION, V62, P759, DOI 10.1161/HYPERTENSIONAHA.113.01761; FIESCHI C, 1972, EUR NEUROL, V8, P192, DOI 10.1159/000114577; Finkel AG, 2017, CEPHALALGIA, V37, P548, DOI 10.1177/0333102416651285; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Hall AA, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00104; HARPER AM, 1966, J NEUROL NEUROSUR PS, V29, P398, DOI 10.1136/jnnp.29.5.398; HARPER AM, 1977, J PHYSIOL-LONDON, V271, P735, DOI 10.1113/jphysiol.1977.sp012023; Horiuchi T, 2002, STROKE, V33, P844, DOI 10.1161/hs0302.104112; Hostenbach S, 2016, PROG NEUROBIOL, V144, P88, DOI 10.1016/j.pneurobio.2016.04.009; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Humphrey JD, 2007, ANN BIOMED ENG, V35, P1485, DOI 10.1007/s10439-007-9321-y; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; IRIKURA K, 1995, P NATL ACAD SCI USA, V92, P6823, DOI 10.1073/pnas.92.15.6823; Johnson TD, 1998, AM J PHYSIOL-REG I, V274, pR541; Kallakuri S, 2010, NEUROSCIENCE, V168, P820, DOI 10.1016/j.neuroscience.2010.01.018; Karkanis T, 2003, AM J PHYSIOL-HEART C, V284, pH2325, DOI 10.1152/ajpheart.00559.2002; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kim I, 2000, NEUROSURGERY, V46, P440, DOI 10.1097/00006123-200002000-00033; Ko Eun A., 2008, Journal of Smooth Muscle Research, V44, P65, DOI 10.1540/jsmr.44.65; Koide M, 2013, ACTA NEUROCHIR SUPPL, V115, P167, DOI 10.1007/978-3-7091-1192-5_32; Kontos H A, 1981, Trans Am Clin Climatol Assoc, V92, P111; Kreipke CW, 2007, NEUROL RES, V29, P369, DOI 10.1179/016164107X204684; Lampl Y, 1997, STROKE, V28, P1951, DOI 10.1161/01.STR.28.10.1951; Larsen CC, 2011, J NEUROSURG, V114, P1143, DOI 10.3171/2010.6.JNS1018; Lavi S, 2006, AM J PHYSIOL-HEART C, V291, pH1856, DOI 10.1152/ajpheart.00014.2006; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; Lindauer U, 2003, J CEREBR BLOOD F MET, V23, P1227, DOI 10.1097/01.WCB.0000088764.02615.B7; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Logsdon AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29341-6; MACKENZIE ET, 1976, CIRC RES, V39, P33, DOI 10.1161/01.RES.39.1.33; Marrelli SP, 1998, STROKE, V29, P1469, DOI 10.1161/01.STR.29.7.1469; MAYHAN WG, 1987, AM J PHYSIOL, V253, pH1435, DOI 10.1152/ajpheart.1987.253.6.H1435; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Moon-Massat P, 2017, J NEUROTRAUM, V34, P2812, DOI 10.1089/neu.2015.3908; Moon-Massat Paula F, 2014, Curr Drug Discov Technol, V11, P220; Mullah SH, 2016, MICROVASC RES, V107, P83, DOI 10.1016/j.mvr.2016.06.001; NAGASAWA S, 1982, STROKE, V13, P595, DOI 10.1161/01.STR.13.5.595; Nakahata K, 2003, ANESTHESIOLOGY, V99, P1333, DOI 10.1097/00000542-200312000-00014; Onoda K, 1996, J NEUROSURG, V85, P846, DOI 10.3171/jns.1996.85.5.0846; Otite F, 2014, STROKE, V45, P677, DOI 10.1161/STROKEAHA.113.002630; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Pohl U, 1999, NEWS PHYSIOL SCI, V14, P74; RAYNOR RB, 1961, NEUROLOGY, V11, P190, DOI 10.1212/WNL.11.3.190; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rebel A, 2006, AM J PHYSIOL-HEART C, V290, pH1027, DOI 10.1152/ajpheart.00500.2005; Rebel A, 2003, AM J PHYSIOL-HEART C, V285, pH1600, DOI 10.1152/ajpheart.00077.2003; Rensen SS, 2008, CIRCULATION, V118, P828, DOI 10.1161/CIRCULATIONAHA.107.743690; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Rogers SD, 1997, EXP NEUROL, V145, P180, DOI 10.1006/exnr.1997.6468; ROSENBLUM WI, 1976, STROKE, V7, P283, DOI 10.1161/01.STR.7.3.283; ROSENBLUM WI, 1963, ARCH NEUROL-CHICAGO, V9, P414, DOI 10.1001/archneur.1963.00460100102012; ROSENBLUM WI, 1986, STROKE, V17, P494, DOI 10.1161/01.STR.17.3.494; ROSENBLUM WI, 1990, AM J PHYSIOL, V259, pH243, DOI 10.1152/ajpheart.1990.259.1.H243; ROSENBLUM WI, 1988, CIRC RES, V63, P837, DOI 10.1161/01.RES.63.4.837; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sato M, 2000, CIRC RES, V87, P195, DOI 10.1161/01.RES.87.3.195; Siren AL, 2000, NEUROCHEM RES, V25, P957, DOI 10.1023/A:1007552408463; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Tani E., 2002, NEUROSURG FOCUS, V12, P1; Toklu HZ, 2015, J CEREBR BLOOD F MET, V35, P1950, DOI 10.1038/jcbfm.2015.151; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; WEI EP, 1980, AM J PHYSIOL, V238, pH697, DOI 10.1152/ajpheart.1980.238.5.H697; Xu HL, 2005, AM J PHYSIOL-HEART C, V288, pH382, DOI 10.1152/ajpheart.00727.2004; Yen WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117133; Zhang FY, 2002, J NEUROSURG, V97, P963, DOI 10.3171/jns.2002.97.4.0963; Zimmermann C, 2003, STROKE, V34, P643, DOI 10.1161/01.STR.0000056526.35630.47	99	8	9	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2019	36	22					3138	3157		10.1089/neu.2019.6423		JUL 2019	20	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JI6MG	WOS:000479791300001	31210096	Green Published, hybrid			2022-02-06	
J	Jadid, KD; Davidsson, J; Lidin, E; Hanell, A; Angeria, M; Mathiesen, T; Risling, M; Gunther, M				Jadid, Kayvan Dehlaghi; Davidsson, Johan; Lidin, Erik; Hanell, Anders; Angeria, Maria; Mathiesen, Tilt; Risling, Marten; Gunther, Mattias			COX-2 Inhibition by Diclofenac Is Associated With Decreased Apoptosis and Lesion Area After Experimental Focal Penetrating Traumatic Brain Injury in Rats	FRONTIERS IN NEUROLOGY			English	Article						cyklooxygenase-2; diclofenac; focal penetrating TBI; NSAID; traumatic brain injury	CYCLOOXYGENASE-2; MODEL; MOTOR	Traumatic brain injury (TBI) is followed by a secondary inflammation in the brain. The inflammatory response includes prostanoid synthesis by the inducible enzyme cyclooxygenase-2 (COX-2). Inhibition of COX-2 is associated with improved functional outcome in experimental TBI models, although central nervous system-specific effects are not fully understood. Animal studies report better outcomes in females than males. The exact mechanisms for this gender dichotomy remain unknown. In an initial study we reported increased COX-2 expression in male rats, compared to female, following experimental TBI. It is possible that COX-2 induction is directly associated with increased cell death after TBI. Therefore, we designed a sequential study to investigate the blocking of COX-2 specifically, using the established COX-2 inhibitor diclofenac. Male Sprague-Dawley rats weighing between 250 and 350 g were exposed to focal penetrating TBI and randomly selected for diclofenac treatment (5 mu g intralesionally, immediately following TBI) (n = 8), controls (n = 8), sham operation (n = 8), and normal (no manipulation) (n = 4). After 24 h, brains were removed, fresh frozen, cut into 14 mu m coronal sections and subjected to COX-2 immunofluorescence, Fluoro Jade, TUNEL, and lesion area analyses. Diclofenac treatment decreased TUNEL staining indicative of apoptosis with a mean change of 54% (p < 0.05) and lesion area with a mean change of 55% (p < 0.005). Neuronal degeneration measured by Fluoro Jade and COX-2 protein expression levels were not affected. In conclusion, COX-2 inhibition by diclofenac was associated with decreased apoptosis and lesion area after focal penetrating TBI and may be of interest for further studies of clinical applications.	[Jadid, Kayvan Dehlaghi; Lidin, Erik; Hanell, Anders; Angeria, Maria; Risling, Marten; Gunther, Mattias] Karolinska Inst, Dept Neurosci, Expt Traumatol Unit, Solna, Sweden; [Davidsson, Johan] Chalmers Univ Technol, Dept Mech & Maritime Sci, Div Vehicle Safety, Gothenburg, Sweden; [Mathiesen, Tilt] Univ Copenhagen, Dept Clin Med, Rigshosp, Copenhagen, Denmark; [Mathiesen, Tilt] Karolinska Inst, Dept Clin Neurosci, Solna, Sweden		Gunther, M (corresponding author), Karolinska Inst, Dept Neurosci, Expt Traumatol Unit, Solna, Sweden.	mattias.gunther@ki.se	, Mattias/A-4442-2013; mathiesen, tiit/ABC-3627-2021; Davidsson, Johan/A-3229-2016	, Mattias/0000-0003-2372-6114; Davidsson, Johan/0000-0002-1717-1514; Lidin, Erik/0000-0001-6800-6677	Swedish Defense	The study was funded by the Swedish Defense.	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bjorkman R, 1995, Acta Anaesthesiol Scand Suppl, V103, P1; BJORKMAN RL, 1992, BRAIN RES, V590, P66, DOI 10.1016/0006-8993(92)91082-P; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Gan TJ, 2010, CURR MED RES OPIN, V26, P1715, DOI 10.1185/03007995.2010.486301; Girgis H, 2013, BRAIN RES, V1491, P78, DOI 10.1016/j.brainres.2012.10.049; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Gunther M, 2015, J CLIN NEUROSCI, V22, P1477, DOI 10.1016/j.jocn.2015.03.025; Gunther M, 2015, ACTA NEUROCHIR, V157, P649, DOI 10.1007/s00701-014-2331-2; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; KU EC, 1986, AM J MED, V80, P18, DOI 10.1016/0002-9343(86)90074-4; Kunz T, 2006, RESTOR NEUROL NEUROS, V24, P55; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2012, LANCET NEUROL, V11, P12, DOI 10.1016/S1474-4422(11)70267-8; Mathiesen T, 1995, ACTA NEUROCHIR, V137, P155, DOI 10.1007/BF02187188; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Negoescu A, 1998, BIOMED PHARMACOTHER, V52, P252, DOI 10.1016/S0753-3322(98)80010-3; Paxinos G., 2013, RAT BRAIN STEREOTAXI; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Steelman AJ, 2013, J BIOL CHEM, V288, P23776, DOI 10.1074/jbc.M113.451658; Thau-Zuchman O, 2012, J NEUROTRAUM, V29, P375, DOI 10.1089/neu.2010.1673; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018	29	8	8	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 30	2019	10								811	10.3389/fneur.2019.00811			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IM2IE	WOS:000477815400001	31417487	Green Submitted, Green Published, gold			2022-02-06	
J	Sorby-Adams, AJ; Leonard, AV; Hoving, JW; Yassi, N; Vink, R; Wells, AJ; Turner, RJ				Sorby-Adams, Annabel J.; Leonard, Anna, V; Hoving, Jan W.; Yassi, Nawaf; Vink, Robert; Wells, Adam J.; Turner, Renee J.			NK1-r Antagonist Treatment Comparable to Decompressive Craniectomy in Reducing Intracranial Pressure Following Stroke	FRONTIERS IN NEUROSCIENCE			English	Article						intracranial pressure; cerebral edema; substance P; decompressive craniectomy; blood-brain barrier; stroke	MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; SUBSTANCE-P; SURGICAL DECOMPRESSION; MALIGNANT INFARCTION; FUNCTIONAL DEFICITS; EDEMA FORMATION; ANIMAL-MODELS; TACHYKININ	Background and Purpose: The morbidity and early mortality associated with stroke is largely attributable to cerebral edema and elevated intracranial pressure (ICP). Existing pharmacotherapies do not target the underlying pathophysiology and are often ineffective in sustainably lowering ICP, whilst decompressive craniectomy (DC) surgery is life-saving yet with surgical/peri-operative risk and increased morbidity in the elderly. Accordingly, there is an urgent need for therapies that directly target the mechanisms of edema genesis. Neurogenic inflammation, mediated by substance P (SP) binding to the tachykinin NK1 receptor (NK1-r), is associated with blood-brain barrier (BBB) disruption, cerebral edema and poor outcome post-stroke. NK1-r antagonist treatment ameliorates BBB dysfunction and cerebral edema in rodent stroke models. However, treatment has not been investigated in a large animal model, an important step toward clinical translation. Consequently, the current study compared the efficacy of NK1-r antagonist treatment to DC surgery in reducing ICP post-stroke in a clinically relevant ovine model. Methods: Anesthetized female Merino sheep (65 +/- 6 kg, 18-24 months) underwent sham surgery (n = 4) or permanent middle cerebral artery occlusion (n = 22). Stroke animals were randomized into one of 5 treatments: 1xNK1 bolus (4 h), 2xNK1 bolus (4 h; 9 h), 3xNK1 bolus (4 h; 9 h; 14 h), DC surgery (performed at 4 h) or saline vehicle. ICP, blood pressure and blood gasses were monitored for 24 h post-stroke. At 24 h post-stroke anesthetized animals underwent MRI followed by perfusion and brains removed and processed for histological assessment. Results: 2xNK1, 3xNK1 administration or DC surgery significantly (p < 0.05) reduced ICP compared to vehicle. 1xNK1 was ineffective in sustainably lowering ICP. On MRI, midline shift and cerebral edema were more marked in vehicles compared to NK1-r treatment groups. Conclusion: Two or three boluses of NK1-r antagonist treatment reduced ICP comparable to DC surgery, suggesting it may provide a novel alternative to invasive surgery for the management of elevated ICP.	[Sorby-Adams, Annabel J.; Leonard, Anna, V; Turner, Renee J.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Sorby-Adams, Annabel J.; Leonard, Anna, V; Turner, Renee J.] Univ Adelaide, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia; [Hoving, Jan W.] Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Dept Med & Neurol, Parkville, Vic, Australia; [Hoving, Jan W.] Univ Amsterdam, Dept Radiol, Amsterdam UMC, Amsterdam, Netherlands; [Yassi, Nawaf] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Vink, Robert] Univ South Australia, Div Hlth Sci, Adelaide, SA, Australia; [Wells, Adam J.] Royal Adelaide Hosp, Dept Neurosurg, Adelaide, SA, Australia		Sorby-Adams, AJ (corresponding author), Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia.; Sorby-Adams, AJ (corresponding author), Univ Adelaide, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia.	annabel.sorby-adams@adelaide.edu.au		Sorby-Adams, Annabel/0000-0003-1648-3898; Yassi, Nawaf/0000-0002-0685-0060	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [GNT1082556]; Neurosurgical Research Foundation (Adelaide, SA, Australia); NHMRC Post-Doctoral Training FellowshipNational Health and Medical Research Council of Australia; NHMRC PostGraduate FellowshipNational Health and Medical Research Council of Australia	This work was supported by the National Health and Medical Research Council (NHMRC; Project grant GNT1082556) and by the Neurosurgical Research Foundation (Adelaide, SA, Australia). RT was supported by the NHMRC Post-Doctoral Training Fellowship. AW was supported by the NHMRC PostGraduate Fellowship.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alves RV, 1999, PEPTIDES, V20, P921, DOI 10.1016/S0196-9781(99)00082-0; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Bardutzky J, 2007, STROKE, V38, P3084, DOI 10.1161/STROKEAHA.107.490193; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Brogan ME, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0327-0; Chen CC, 2007, J CLIN NEUROSCI, V14, P317, DOI 10.1016/j.jocn.2005.05.024; Corrigan F, 2016, BRIT J PHARMACOL, V173, P703, DOI 10.1111/bph.13155; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Corrigan F, 2012, CNS NEUROSCI THER, V18, P513, DOI 10.1111/j.1755-5949.2012.00332.x; Das S, 2019, WORLD NEUROSURG, V123, P8, DOI 10.1016/j.wneu.2018.11.176; Donkin J. D., 2006, EFFECTS NEUROPEPTIDE; Donkin JJ, 2007, PROG BRAIN RES, V161, P97, DOI 10.1016/S0079-6123(06)61007-8; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Dostovic Zikrija, 2016, Med Arch, V70, P339; Funchal BF, 2018, ARQ NEURO-PSIQUIAT, V76, P812, DOI [10.1590/0004-282X20180132, 10.1590/0004-282x20180132]; Geurts M, 2013, STROKE, V44, P2506, DOI 10.1161/STROKEAHA.113.002014; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hofmeijer J, 2012, STROKE, V43, P607, DOI 10.1161/STROKEAHA.111.632943; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; HOKFELT T, 1975, SCIENCE, V190, P889, DOI 10.1126/science.242075; Hudetz JA, 2010, J CARDIOTHOR VASC AN, V24, P131, DOI 10.1053/j.jvca.2009.05.008; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kubale V, 2007, CELL TISSUE RES, V330, P231, DOI 10.1007/s00441-007-0462-y; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Lewis KM, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-5; Lilja-Cyron A, 2020, NEUROSURGERY, V86, P231, DOI 10.1093/neuros/nyz049; Lorente L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060991; Lorente L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0911-z; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Monastyrskaya K, 2005, J BIOL CHEM, V280, P7135, DOI 10.1074/jbc.M405806200; Nag S, 2007, ACTA NEUROPATHOL, V114, P459, DOI 10.1007/s00401-007-0274-x; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Schifilliti D, 2010, CNS DRUGS, V24, P893, DOI 10.2165/11584760-000000000-00000; Shah A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00011; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Sorby-Adams AJ, 2018, AM J PHYSIOL-REG I, V315, pR165, DOI 10.1152/ajpregu.00163.2017; Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788; Stumm RK, 2001, J NEUROSCI, V21, P798, DOI 10.1523/JNEUROSCI.21-03-00798.2001; Turner R.A., 2007, THESIS; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Turner RJ, 2012, NEUROSCIENCE, V220, P1, DOI 10.1016/j.neuroscience.2012.06.047; Turner RJ, 2014, NEUROPEPTIDES, V48, P267, DOI 10.1016/j.npep.2014.07.002; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Vink R, 2003, ACT NEUR S, V86, P257; Vink R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00304; Wells AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130512; Wells AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042157; Xu SY, 2013, MED SCI MONIT BASIC, V19, P37, DOI 10.12659/MSMBR.883750; Yang Xiao-feng, 2005, J Zhejiang Univ Sci B, V6, P644, DOI 10.1631/jzus.2005.B0644; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhang WL, 2019, J NEUROSURG ANESTH, V31, P273, DOI 10.1097/ANA.0000000000000520	56	8	8	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	JUL 5	2019	13								681	10.3389/fnins.2019.00681			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IH1YE	WOS:000474290700001	31333402	Green Accepted, Green Published, gold			2022-02-06	
J	Acosta, G; Race, N; Herr, S; Fernandez, J; Tang, J; Rogers, E; Shi, RY				Acosta, Glen; Race, Nicholas; Herr, Seth; Fernandez, Joseph; Tang, Jonathan; Rogers, Edmond; Shi, Riyi			Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Oxidative stress; Parkinson's disease; Neuroinflammation; Acrolein; Neurodegeneration; Neurotrauma	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE BRAIN; CHAPERONE-LIKE ACTIVITY; SPINAL-CORD-INJURY; TYROSINE-HYDROXYLASE; OXIDATIVE STRESS; LIPID-PEROXIDATION; HEAD-INJURY; RAT MODEL; IN-VITRO	Survivors of blast-induced traumatic brain injury (bTBI) have increased susceptibility to Parkinson's disease (PD), characterized by alpha-synuclein aggregation and the progressive degeneration of nigrostriatal dopaminergic neurons. Using an established bTBI rat model, we evaluated the changes of alpha-synuclein and tyrosine hydroxylase (TH), known hallmarks of PD, and acrolein, a reactive aldehyde and marker of oxidative stress, with the aim of revealing key pathways leading to PD post-bTBI. Indicated in both animal models of PD and TBI, acrolein is likely a point of pathogenic convergence. Here we show that after a single mild bTBI, acrolein is elevated up to a week, systemically in urine, and in whole brain tissue, specifically the substantia nigra and striatum. Acrolein elevation is accompanied by heightened alpha-synuclein oligomerization, dopaminergic dysregulation, and acrolein/alpha-synuclein interaction in the same brain regions. We further show that acrolein can directly modify and oligomerize alpha-synuclein in vitro. Taken together, our data suggests acrolein likely plays an important role in inducing PD pathology following bTBI by encouraging alpha-synuclein aggregation. These results are expected to advance our understanding of the long-term post-bTBI pathological changes leading to the development of PD, and suggest intervention targets to curtail such pathology.	[Acosta, Glen; Herr, Seth; Fernandez, Joseph; Tang, Jonathan; Rogers, Edmond; Shi, Riyi] Purdue Univ, Coll Vet Med, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Race, Nicholas; Fernandez, Joseph; Tang, Jonathan; Rogers, Edmond; Shi, Riyi] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Race, Nicholas; Shi, Riyi] Indiana Univ, Sch Med, Indianapolis, IN USA; [Herr, Seth; Shi, Riyi] Purdue Univ, Interdisciplinary Life Sci Program PULSe, W Lafayette, IN 47907 USA		Shi, RY (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, Dept Basic Med Sci, W Lafayette, IN 47907 USA.	riyi@purdue.edu		Race, Nicholas/0000-0002-2683-1692	Indiana State Department of Health [204200]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS073636]; Eli Lilly Stark Neurosciences Pre-Doctoral Research FellowshipEli Lilly	This work was supported by the Indiana State Department of Health [Grant #204200 to RS], National Institutes of Health [Grant #NS073636 to RS]. Glen Acosta was partially supported by Eli Lilly Stark Neurosciences Pre-Doctoral Research Fellowship. The authors thank Dr. Rob Schuster from the Laboratory of Dr. Chris Rochet at Department of Medicinal Chemistry and Molecular Pharmacology of Purdue University for providing the purified alpha-syn protein.	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Ambaw A, 2018, MOL CELL NEUROSCI, V88, P70, DOI 10.1016/j.mcn.2018.01.006; Bademci G, 2010, HUM MUTAT, V31, pE1767, DOI 10.1002/humu.21351; Beal MF, 2003, ANN NY ACAD SCI, V991, P120; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Bums RS, 1983, P NATL ACAD SCI USA, V80, P4546, DOI DOI 10.1073/PNAS.80.14.4546; Burcham PC, 2002, TOXICOLOGY, V181, P229, DOI 10.1016/S0300-483X(02)00287-1; Butterfield DA, 2016, PROTEOM CLIN APPL, V10, P1191, DOI 10.1002/prca.201600003; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Castellani R, 1996, BRAIN RES, V737, P195, DOI 10.1016/0006-8993(96)00729-9; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Daadi MM, 2006, NEUROREPORT, V17, P201, DOI 10.1097/01.wnr.0000198952.38563.05; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Desmoulin GT, 2009, J TRAUMA, V67, P1113, DOI 10.1097/TA.0b013e3181bb8e84; Due MR, 2014, J NEUROCHEM, V128, P776, DOI 10.1111/jnc.12500; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fujita M, 2006, NEUROPATHOLOGY, V26, P383, DOI 10.1111/j.1440-1789.2006.00732.x; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; Garcia-Gonzalez D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28271-7; GERMAN DC, 1988, NEUROSCIENCE, V24, P161, DOI 10.1016/0306-4522(88)90320-X; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldman SM, 2012, ANN NEUROL, V71, P40, DOI 10.1002/ana.22499; Guingab-Cagmat JD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00061; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hung HC, 1998, FREE RADICAL BIO MED, V24, P76, DOI 10.1016/S0891-5849(97)00206-2; Itagaki C, 1999, BIOCHEMISTRY-US, V38, P15673, DOI 10.1021/bi9914255; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Khan W, 2012, CNS NEUROL DISORD-DR, V11, P456, DOI 10.2174/187152712800792929; Kim TD, 2002, BIOCHEMISTRY-US, V41, P13782, DOI 10.1021/bi026284c; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Laino C., 2005, NEUROLOGY TODAY, V5, P48; Lazarus RC, 2015, FREE RADICAL BIO MED, V78, P89, DOI 10.1016/j.freeradbiomed.2014.10.507; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Leung G, 2011, NEUROSCIENCE, V173, P150, DOI 10.1016/j.neuroscience.2010.11.018; Lindgren N, 2000, J NEUROCHEM, V74, P2470, DOI 10.1046/j.1471-4159.2000.0742470.x; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; Lovell MA, 2001, NEUROBIOL AGING, V22, P187, DOI 10.1016/S0197-4580(00)00235-9; Luo H, 2004, NEUROCHEM INT, V44, P475, DOI 10.1016/j.neuint.2003.09.006; Luo J, 2005, NEUROCHEM INT, V46, P243, DOI 10.1016/j.neuint.2004.09.001; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Maxwell SL, 2005, J ANAT, V207, P209, DOI 10.1111/j.1469-7580.2005.00453.x; Miller G, 2012, SCIENCE, V336, P790, DOI 10.1126/science.336.6083.790; MOGI M, 1988, J NEURAL TRANSM, V72, P77, DOI 10.1007/BF01244634; MORRISH PK, 1995, J NEUROL NEUROSUR PS, V59, P597, DOI 10.1136/jnnp.59.6.597; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Nakashima A, 2013, J NEURAL TRANSM, V120, P49, DOI 10.1007/s00702-012-0828-5; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Owen AD, 1997, J NEURAL TRANSM-SUPP, P167; Park J, 2015, J NEUROCHEM, V135, P987, DOI 10.1111/jnc.13352; Park J, 2014, J NEUROCHEM, V129, P339, DOI 10.1111/jnc.12628; Pivato M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050027; Polanski W, 2011, EXPERT REV NEUROTHER, V11, P845, DOI [10.1586/ern.11.1, 10.1586/ERN.11.1]; Pugazhenthi S, 2006, FREE RADICAL BIO MED, V40, P21, DOI 10.1016/j.freeradbiomed.2005.08.023; Randall MJ, 2013, REDOX BIOL, V1, P265, DOI 10.1016/j.redox.2013.02.001; Ranganna K, 2002, MOL CELL BIOCHEM, V240, P83, DOI 10.1023/A:1020659808981; Rokad D, 2017, BRAIN RES BULL, V133, P60, DOI 10.1016/j.brainresbull.2016.12.003; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Salvatore MF, 2016, ACS CHEM NEUROSCI, V7, P941, DOI 10.1021/acschemneuro.6b00064; Santos A, 2005, NEUROCHEM RES, V30, P625, DOI 10.1007/s11064-005-2750-9; Shahaduzzaman M, 2013, MED HYPOTHESES, V81, P675, DOI 10.1016/j.mehy.2013.07.025; Shamoto-Nagai M, 2007, J NEURAL TRANSM, V114, P1559, DOI 10.1007/s00702-007-0789-2; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Surgucheva I, 2014, MOL CELL NEUROSCI, V63, P114, DOI 10.1016/j.mcn.2014.10.005; SUTHERLAND C, 1993, EUR J BIOCHEM, V217, P715, DOI 10.1111/j.1432-1033.1993.tb18297.x; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takeda A, 1998, LAB INVEST, V78, P1169; Tanel A, 2007, CELL SIGNAL, V19, P968, DOI 10.1016/j.cellsig.2006.10.014; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomas G, 1997, EUR J BIOCHEM, V247, P1180, DOI 10.1111/j.1432-1033.1997.01180.x; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Toska K, 2002, J NEUROCHEM, V83, P775, DOI 10.1046/j.1471-4159.2002.01172.x; Tully M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00420; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Walls MK, 2016, J NEUROSURG, V124, P675, DOI 10.3171/2015.1.JNS141571; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wang YQ, 2017, ADV DIFFER EQU-NY, DOI 10.1186/s13662-016-1062-5; WATERS CM, 1987, BRAIN RES, V412, P244, DOI 10.1016/0006-8993(87)91130-9; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wu AG, 2014, NEUROREHAB NEURAL RE, V28, P75, DOI 10.1177/1545968313498650; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang Y, 2003, HUM GENE THER, V14, P1, DOI 10.1089/10430340360464660; Zheng LX, 2013, J NEUROTRAUM, V30, P1334, DOI 10.1089/neu.2013.2888; Zhu YZ, 2012, CNS NEUROL DISORD-DR, V11, P350, DOI 10.2174/187152712800792901	110	8	8	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	JUL	2019	98						140	154		10.1016/j.mcn.2019.06.004			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IK4RV	WOS:000476574900013	31201929	Green Accepted			2022-02-06	
J	Bleimeister, IH; Wolff, M; Lam, TR; Brooks, DM; Patel, R; Cheng, JP; Bondi, CO; Kline, AE				Bleimeister, Isabel H.; Wolff, Mia; Lam, Tracey R.; Brooks, Derrick M.; Patel, Reece; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.			Environmental enrichment and amantadine confer individual but nonadditive enhancements in motor and spatial learning after controlled cortical impact injury	BRAIN RESEARCH			English	Article						Amantadine; Beam-walk; Controlled cortical impact; Functional recovery; Learning and memory; Morris water maze; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; WATER MAZE PERFORMANCE; COMBINATION THERAPIES; HISTOLOGICAL BENEFITS; BEHAVIORAL RECOVERY; COGNITIVE DEFICITS; TREATMENT REGIMEN; CLINICAL-TRIALS; UNITED-STATES; HALOPERIDOL	Environmental enrichment (EE) and amantadine (AMT) enhance motor and cognitive outcome after experimental traumatic brain injury (TBI). However, there are no data on the effects of combining these two therapies. Hence, the aim of the current study was to combine EE and AMT after TBI to determine if their net effect further enhances motor and cognitive performance. Anesthetized adult male rats received either a cortical impact of moderate severity or sham injury and then were randomly assigned to EE or standard (STD) housing and once daily administration of AMT (20 mg/kg; i.p.) or saline vehicle (VEH, 1 mL/kg; i.p.) beginning 24 h after injury for 19 days. Motor and cognitive function were assessed on post-surgical days 1-5 and 14-19, respectively. Cortical lesion volume was quantified on day 21. There were no statistical differences among the sham groups regardless of therapy, so the data were pooled. EE, AMT, and their combination (EE + AMT) improved beam balance, but only EE and EE + AMT enhanced beam-walking. All three treatment paradigms improved spatial learning and memory relative to the VEH-treated STD controls (p < 0.05). No differences were revealed between the EE groups, regardless of treatment, but both were better than the AMT-treated STD group on beam walking and spatial learning (p < 0.05). Both EE groups equally reduced cortical lesion volume relative to the STD-housed AMT and VEH groups (p < 0.05). The results indicate that although beneficial on their own, EE + AMT do not provide additional benefits after TBI. It is important to note that the lack of additive effects using the current treatment and behavioral protocols does not detract from the benefits of each individual therapy. The findings provide insight for future combination studies.	[Bleimeister, Isabel H.; Wolff, Mia; Lam, Tracey R.; Brooks, Derrick M.; Patel, Reece; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Bleimeister, Isabel H.; Wolff, Mia; Lam, Tracey R.; Brooks, Derrick M.; Patel, Reece; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA 15213 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Brooks, Derrick M.] Thomas Jefferson Univ Hosp, Sidney Kimmel Med Coll, Dept Psychiat & Human Behav, Philadelphia, PA 19107 USA; [Patel, Reece] Univ Cambridge, Dept Med, Cambridge CB5 8BL, England		Kline, AE (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Childrens Hosp Pittsburgh,John G Rangos Res Ctr, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.	klineae@upmc.edu		Bleimeister, Isabel/0000-0003-1565-0017; Patel, Reece/0000-0001-7201-8910	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD069620, HD069620-S1, NS060005, NS084967, NS094950, NS099683]; University of Pittsburgh Physicians/UPMC Academic Foundation; UMPC Rehabilitation Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS099683, R21NS099674, R03NS094950, R01NS084967] Funding Source: NIH RePORTER	This work was supported, in part, by NIH grants HD069620, HD069620-S1, NS060005, NS084967 (AEK), NS094950, NS099683 (COB), the University of Pittsburgh Physicians/UPMC Academic Foundation, and the UMPC Rehabilitation Institute (COB). RP is a visiting student via the Pittsburgh International Research Internship Program.	Besagar S, 2019, EXP NEUROL, V314, P67, DOI 10.1016/j.expneurol.2019.01.010; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; de la Tremblaye PB, 2019, NEUROPHARMACOLOGY, V145, P13, DOI 10.1016/j.neuropharm.2018.02.032; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Folweiler KA, 2017, J NEUROTRAUM, V34, P451, DOI 10.1089/neu.2016.4417; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Ghalaenovi H, 2018, BRAIN INJURY, V32, P1050, DOI 10.1080/02699052.2018.1476733; Ghate Prajakta Suresh, 2018, Asian J Neurosurg, V13, P647, DOI 10.4103/ajns.AJNS_272_16; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hammond FM, 2018, J NEUROTRAUM, V35, P2298, DOI 10.1089/neu.2018.5767; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Kokiko ON, 2007, BRAIN INJURY, V21, P259, DOI 10.1080/02699050701209964; Leary JB, 2017, J NEUROTRAUM, V34, P444, DOI 10.1089/neu.2016.4438; Mala H, 2017, RESTOR NEUROL NEUROS, V35, P25, DOI 10.3233/RNN-160682; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Okigbo AA, 2019, NEUROSCI LETT, V694, P69, DOI 10.1016/j.neulet.2018.11.030; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Ossola B, 2011, NEUROPHARMACOLOGY, V61, P574, DOI 10.1016/j.neuropharm.2011.04.030; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Radabaugh HL, 2016, EXP NEUROL, V286, P61, DOI 10.1016/j.expneurol.2016.09.015; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Spritzer SD, 2015, NEUROLOGIST, V19, P61, DOI 10.1097/NRL.0000000000000001; Stelmaschuk S, 2015, J TRAUMA NURS, V22, P194, DOI 10.1097/JTN.0000000000000138; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wang T, 2014, J NEUROTRAUM, V31, P370, DOI 10.1089/neu.2013.2917; Wheaton P, 2009, J CLIN PSYCHOPHARM, V29, P468, DOI 10.1097/JCP.0b013e3181b66f04; Yang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106683; Yelleswarapu NK, 2012, NEUROSCI LETT, V515, P153, DOI 10.1016/j.neulet.2012.03.033	57	8	8	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 1	2019	1714						227	233		10.1016/j.brainres.2019.03.007			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HY6PK	WOS:000468252000025	30876859	Green Accepted, Bronze			2022-02-06	
J	Cournoyer, J; Hoshizaki, TB				Cournoyer, Janie; Hoshizaki, T. Blaine			Head dynamic response and brain tissue deformation for boxing punches with and without loss of consciousness	CLINICAL BIOMECHANICS			English	Article						Boxing; Biomechanics; Loss of consciousness; Brain trauma	PROFESSIONAL FOOTBALL; HIGH-SCHOOL; CONCUSSION; PREDICTORS; ACCELERATION; BIOMECHANICS; RECOVERY; IMPACTS	Background: Loss of consciousness is a poorly understood indicator of concussion severity. Conflicting results have been published supporting loss of consciousness as a severe concussion as well as having no relationship with severity. Understanding how loss of consciousness relates to brain trauma severity will provide useful insights to guide rule changes and return to sport protocols. The purpose of this study was to compare magnitudes of head acceleration and brain tissue deformation for punches resulting in a loss of consciousness and punches that do not. Methods: Physical representations of boxing punches presenting with and without loss of consciousness were performed using an anthropometric headform and finite element model. The variables measured were peak linear and rotational acceleration, maximum principal strain, cumulative strain damage 10%, and strain rate in five regions of the brain. Findings: Loss of consciousness in boxing resulted from hooks to the side of the mandible creating high levels of rotational acceleration and increased magnitudes of brain trauma in all regions of the brain. Differences between punches resulting in loss of consciousness and no loss of consciousness were distinguished by maximum principal strain for each of the brain region analyzed. Interpretation: This research supports the notion that loss of consciousness in boxing is caused by higher levels of brain trauma and may require a longer recovery time.	[Cournoyer, Janie; Hoshizaki, T. Blaine] Univ Ottawa, Human Kinet, Ottawa, ON, Canada		Cournoyer, J (corresponding author), A-106 200 Lees Ave, Ottawa, ON K1S 5S9, Canada.	jcour016@uottawa.ca		Cournoyer, Janie/0000-0001-9043-7756			Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Cassidy D., 2016, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-097699, DOI 10.1136/BJSPORTS-2017-097699]; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Clark JM, 2017, COMPUT METHOD BIOMEC, V20, P1299, DOI 10.1080/10255842.2017.1341977; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Fredriksson R., 2007, 2007220007 SAE; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Holbourn AHS, 1943, LANCET, V2, P438; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; Kendall M., 2016, THESIS; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; Neidecker J., 2018, BRIT J SPORT MED, P1; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Post A., 2014, P I MECH ENG P-J SPO, P1; Stojsih S., 2010, THESIS; Takhounts EG, 2008, STAPP CAR C, V52, P1; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viceconti M, 2005, CLIN BIOMECH, V20, P451, DOI 10.1016/j.clinbiomech.2005.01.010; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Walsh E., 2018, SPORTS ENG, P1; Walsh E., 2011, SPORTS ENG, P1; Zhang L. Y., 2001, STAPP CAR CRASH J, V45, P1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	33	8	8	1	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	JUL	2019	67						96	101		10.1016/j.clinbiomech.2019.05.003			6	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Orthopedics; Sport Sciences	IU2NG	WOS:000483416500015	31082637				2022-02-06	
J	Curry, AE; Arbogast, KB; Metzger, KB; Kessler, RS; Breiding, MJ; Haarbauer-Krupa, J; DePadilla, L; Greenspan, A; Master, CL				Curry, Allison E.; Arbogast, Kristy B.; Metzger, Kristina B.; Kessler, Ronni S.; Breiding, Matthew J.; Haarbauer-Krupa, Juliet; DePadilla, Lara; Greenspan, Arlene; Master, Christina L.			Risk of Repeat Concussion Among Patients Diagnosed at a Pediatric Care Network	JOURNAL OF PEDIATRICS			English	Article							SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; RECOVERY; SYMPTOMS; CHILDREN; INJURY; PREDICTORS	Objective To quantify the risk of repeat concussions for children and identify demographic and clinical aspects of the index concussion associated with repeat injury. Study design For this retrospective cohort study, we queried the Children's Hospital of Philadelphia healthcare network's unified electronic health record to identify all 5- to 15-year-old patients who had their first clinical visit for an index concussion at a Children's Hospital of Philadelphia location from July 2012 through June 2013. A 25% random sample (n = 536) were selected. Clinical data were abstracted for their index concussion and all concussion-related visits for 2 years following the index concussion. Results Overall, 16.2% (n = 87) of patients experienced at least 1 repeat concussion within 2 years of their index concussion. The risk of repeat concussion increased with patient age (9.5% for ages 5-8 years; 10.7% for ages 9-11 years; and 19.8% for ages 12-15 years). After we adjusted for other factors, risk was particularly heightened among patients whose index concussion had a longer clinical course (>30 vs 0-7 days, adjusted risk ratio 1.65 [1.01-2.69]) and greater symptom burden (>11 vs 0-2 symptoms, adjusted risk ratio 2.12 [1.12-3.72]). Conclusions We estimate that 1 in 6 youth diagnosed with a concussion are diagnosed with a subsequent concussion within 2 years and that several clinical characteristics of the index concussion increase this risk. Identifying factors associated with a repeat injury is essential to inform the clinical management of concussion and direct injury prevention efforts.	[Curry, Allison E.; Arbogast, Kristy B.; Metzger, Kristina B.; Kessler, Ronni S.; Master, Christina L.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, 2716 South St,13th Floor, Philadelphia, PA 19146 USA; [Curry, Allison E.; Arbogast, Kristy B.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Breiding, Matthew J.; Haarbauer-Krupa, Juliet; DePadilla, Lara; Greenspan, Arlene] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19146 USA		Curry, AE (corresponding author), Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, 2716 South St,13th Floor, Philadelphia, PA 19146 USA.	currya@email.chop.edu		Arbogast, Kristy/0000-0002-1694-4562; Master, Christina/0000-0002-6717-4270; Curry, Allison/0000-0001-7076-3538	US Department of Health and Human Services Centers for Disease Control and Prevention (CDC); Children's Hospital of Philadelphia	Supported by an intergovernmental personnel act agreement between the US Department of Health and Human Services Centers for Disease Control and Prevention (CDC) and Children's Hospital of Philadelphia. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. The authors declare no conflicts of interest.	Arbogast KB, 2017, CLIN PEDIAT PHILA, V56, P9; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Centers for Disease Control and Prevention, 2011, ICD 9 CM OFF GUID CO; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Currie DW, 2017, J HEAD TRAUMA REHAB, V32, P90, DOI 10.1097/HTR.0000000000000240; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; Gruschow SM, 2016, J ATTEN DISORD; Guerriero RM, 2018, J CHILD NEUROL, V33, P168, DOI 10.1177/0883073817749655; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Howell DR, 2018, CLIN J SPORT MED; Institute of Medicine & National Research Council, 2014, SPORTS RELATED CONCU; Iverson GL, 2016, J ATTEN DISORD; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Lapointe AP, 2017, BRIT J SPORT MED, V51, pA2; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Moser RS, 2017, DEV NEUROPSYCHOL, V42, P276, DOI 10.1080/87565641.2017.1334785; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Swenson DM, 2009, AM J SPORT MED, V37, P1586, DOI 10.1177/0363546509332500; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	36	8	8	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	JUL	2019	210						13	+		10.1016/j.jpeds.2019.04.001			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	IE6PH	WOS:000472497600005	31101406	Green Accepted, Bronze			2022-02-06	
J	Kerr, ZY; Campbell, KR; Fraser, MA; Currie, DW; Pierpoint, LA; Kaminski, TW; Mihalik, JP				Kerr, Zachary Y.; Campbell, Kody R.; Fraser, Melissa A.; Currie, Dustin W.; Pierpoint, Lauren A.; Kaminski, Thomas W.; Mihalik, Jason P.			Head Impact Locations in US High School Boys' and Girls' Soccer Concussions, 2012/13-2015/16	JOURNAL OF NEUROTRAUMA			English	Article						athletes; heading; sports; traumatic brain injury	VIDEO INCIDENT ANALYSIS; STATES HIGH-SCHOOL; UNITED-STATES; FOOTBALL; INJURIES; ACCELERATION; SEX; BIOMECHANICS; DIRECTION; SYMPTOMS	This study describes concussions and concussion-related outcomes sustained by high school soccer players by head impact location, sex, and injury mechanism. Data were obtained for the 2012/13-2015/16 school years from the National High School Sports-Related Injury Surveillance System, High School RIO (TM). This Internet-based sports injury surveillance system captures data reported by athletic trainers from an annual average of 162 U.S. high schools. Data were analyzed to describe circumstances of soccer concussion (e.g., symptomology, symptom resolution, and return-to-play time) by impact location (i.e., front-[face included], back-, side-, and top-of-the-head) and sex. Most concussions were from front-of-the-head impacts (boys, 30.5%; girls, 34.0%). Overall, 4.1 +/- 2.2 and 4.6 +/- 2.3 symptoms were reported in boys and girls, respectively. In boys, symptom frequency was not associated with head impact location (p = 0.66); an association was found in girls (p = 0.02), with the highest symptom frequency reported in top-of-the-head impacts (5.4 +/- 2.2). Head impact location was not associated with symptom resolution time (boys, p = 0.21; girls, p = 0.19) or return-to-play time (boys, p = 0.18; girls, p = 0.07). Heading was associated with 28.0% and 26.5% of concussions in boys and girls, respectively. Most player-player contact concussions during heading occurred from side-of-the-head impacts (boys, 49.4%; girls, 43.2%); most heading-related ball contact concussions occurred from front-of-the-head (boys, 41.4%; girls, 42.6%) and top-of-the-head (boys, 34.5%; girls, 36.9%) impacts. Head impact location was generally independent of symptom resolution time, return-to-play time, and recurrence among high school soccer concussions. However, impact location may be associated with reported symptom frequency. Further, many of these clinical concussion descriptors were associated with sex.	[Kerr, Zachary Y.; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Campbell, Kody R.; Mihalik, Jason P.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Campbell, Kody R.] Univ N Carolina, Human Movement Sci Curriculum, Chapel Hill, NC USA; [Fraser, Melissa A.] Texas State Univ, Dept Hlth & Human Performance, San Marcos, TX USA; [Currie, Dustin W.; Pierpoint, Lauren A.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Kaminski, Thomas W.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu		Fraser, Missy/0000-0002-5753-8798; Campbell, Kody/0000-0002-4534-5497	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Federation of State High School Associations; National Operating Committee on Standards for Athletic Equipment; DonJoy Orthotics; EyeBlack; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA	The content of this report representing data collection by the National High School Sports-Related Injury Surveillance Study (High School Reporting Information Online) was funded, in part, by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01. We also acknowledge the generous research funding contributions of the National Federation of State High School Associations, the National Operating Committee on Standards for Athletic Equipment, DonJoy Orthotics, and EyeBlack. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the Centers for Disease Control and Prevention or any of the other institutions that provided financial support for this research.	Aspen Institute, 2016, STAT PLAY 2016 TREND; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Dick R, 2007, J ATHL TRAINING, V42, P173; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Gennarelli TA, 1972, STAPP CAR CRASH J, V16, P296; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hanlon E, 2010, J APPL BIOMECH, V26, P424, DOI 10.1123/jab.26.4.424; Kerr ZY, 2014, PEDIATRICS, V134, P489, DOI 10.1542/peds.2014-0770; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Khodaee M, 2017, BRIT J SPORT MED, V51, P185, DOI 10.1136/bjsports-2015-095946; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; National Soccer Coaches Association of America, 2017, GET AHEAD SAF SOCC; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Smith NA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0346; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Wu JZ, 2017, P I MECH ENG H, V231, P58, DOI 10.1177/0954411916678017; Yard EE, 2009, J ATHL TRAINING, V44, P645, DOI 10.4085/1062-6050-44.6.645	39	8	8	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2019	36	13					2073	2082		10.1089/neu.2017.5319			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IF4KG	WOS:000473049600428	29092652				2022-02-06	
J	Kumar, RG; Olsen, J; Juengst, SB; Dams-O'Connor, K; O'Neil-Pirozzi, TM; Hammond, FM; Wagner, AK				Kumar, Raj G.; Olsen, Jennifer; Juengst, Shannon B.; Dams-O'Connor, Kristen; O'Neil-Pirozzi, Therese M.; Hammond, Flora M.; Wagner, Amy K.			Comorbid Conditions Among Adults 50 Years and Older With Traumatic Brain Injury: Examining Associations With Demographics, Healthcare Utilization, Institutionalization, and 1-Year Outcomes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aging; brain injuries; comorbidity; epidemiology	REHOSPITALIZATION; REHABILITATION; EPIDEMIOLOGY; MORTALITY; SYSTEM; RISK; TBI; AGE; SURVIVORS; PATTERNS	Objectives: To assess the relationship of acute complications, preexisting chronic diseases, and substance abuse with clinical and functional outcomes among adults 50 years and older with moderate-to-severe traumatic brain injury (TBI). Design: Prospective cohort study. Participants: Adults 50 years and older with moderate-to-severe TBI (n = 2134). Measures: Clusters of comorbid health conditions empirically derived from non-injury International Classification of Diseases, Ninth Revision codes, demographic/injury variables, and outcome (acute and rehabilitation length of stay [LOS], Functional Independence Measure efficiency, posttraumatic amnesia [PTA] duration, institutionalization, rehospitalization, and Glasgow Outcome Scale-Extended (GOS-E) at 1 year). Results: Individuals with greater acute hospital complication burden were more often middle-aged men, injured in motor vehicle accidents, and had longer LOS and PTA. These same individuals experienced higher rates of 1-year rehospitalization and greater odds of unfavorable GOS-E scores at 1 year. Those with greater chronic disease burden were more likely to be rehospitalized at 1 year. Individuals with more substance abuse burden were most often younger (eg, middle adulthood), black race, less educated, injured via motor vehicle accidents, and had an increased risk for institutionalization. Conclusion: Preexisting health conditions and acute complications contribute to TBI outcomes. This work provides a foundation to explore effects of comorbidity prevention and management on TBI recovery in older adults.	[Kumar, Raj G.; Olsen, Jennifer; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med Rehabil, 3471 Fifth Ave,Ste 202, Pittsburgh, PA 15213 USA; [Kumar, Raj G.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Wagner, Amy K.] Univ Pittsburgh, Clin & Translat Sci Inst, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Juengst, Shannon B.] UT Southwestern, Dept Phys Med & Rehabil, Dallas, TX USA; [Juengst, Shannon B.] UT Southwestern, Dept Rehabil Counseling, Dallas, TX USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, Boston, MA 02115 USA; [O'Neil-Pirozzi, Therese M.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med Rehabil, 3471 Fifth Ave,Ste 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [TL1 TR001858]; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDLRR) TBIMS (University of Pittsburgh) [90DP0041]; NIDLRR (University of Texas Southwestern Medical Center) [90DPTB0013]; NIDLRR TBIMS (Icahn School of Medicine at Mount Sinai) [90DP0038]; NIH National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD074651]; NIDLRR TBIMS [90DPTB0011, 90DP0039, H133A120085]; NIDILRR TBIMS (Indiana University School of Medicine) [90DP0036, 90DRTB0002]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD074651] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001858] Funding Source: NIH RePORTER	R.G.K.: National Institutes of Health (NIH) TL1 TR001858; R.G.K., A.K.W.: National Institute on Disability, Independent Living, and Rehabilitation Research (NIDLRR) TBIMS (University of Pittsburgh 90DP0041); S.B.J.: NIDLRR (University of Texas Southwestern Medical Center 90DPTB0013); K.D.-O.: NIDLRR TBIMS (Icahn School of Medicine at Mount Sinai 90DP0038); K.D.-O.: NIH National Institute of Child Health and Human Development (K01HD074651); T.M.O.-P.: NIDLRR TBIMS (Spaulding-Harvard 90DPTB0011, 90DP0039, and H133A120085); F.M.H.: NIDILRR TBIMS (Indiana University School of Medicine 90DP0036 and 90DRTB0002).	Agency for Healthcare Research and Quality, 2015, SAV LIV SAV MON HOSP; Bay E, 2017, PROF CASE MANAG, V22, P284, DOI 10.1097/NCM.0000000000000224; Calanzani N, 2017, TECHNICAL REPORT; Center for Disease Control and Prevention, 2013, STAT AG HLTH AM 2013; Centers for Disease Control and Prevention, 2017, TRAUM BRAIN INJ CONC; Centers for Disease Control and Prevention, CDC GRAND ROUNDS RED; Clark-Wilson J, 2015, NEUROREHABILITATION, V36, P289, DOI 10.3233/NRE-151217; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Dams-O'Connor K, 2017, J HEAD TRAUMA REHAB, V32, P147, DOI 10.1097/HTR.0000000000000263; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Davy C, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0854-8; ERABI, GALV OR AMN TEST; Eska K, 2013, DEMENT GER COGN D EX, V3, P426, DOI 10.1159/000355079; Eum RS, 2017, J HEAD TRAUMA REHAB, V32, P158, DOI 10.1097/HTR.0000000000000246; Eum RS, 2015, J NEUROTRAUM, V32, P280, DOI 10.1089/neu.2014.3351; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Finkelstein EA., 2007, J EPIDEMIOL COMMUNIT, V61, P926, DOI DOI 10.1136/JECH.2007.059717; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Goodwin JE, 2011, J HYPERTENS, V29, P1347, DOI [10.1097/HJH.0b013e328347da54, 10.1093/gerona/glr171]; Gorst-Rasmussen A, 2011, AM J EPIDEMIOL, V173, P1097, DOI 10.1093/aje/kwr060; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS330, DOI 10.1016/j.apmr.2014.09.041; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; Karpur A, 2013, A GUIDE TO THE TRAUM; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Kumar RG, 2016, BRAIN BEHAV IMMUN, V53, P183, DOI 10.1016/j.bbi.2015.12.008; Lecours A, 2012, J HEAD TRAUMA REHAB, V27, P379, DOI 10.1097/HTR.0b013e31823b2385; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Penna S, 2010, J HEAD TRAUMA REHAB, V25, P52, DOI 10.1097/HTR.0b013e3181c29952; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; SAS Institute Inc, 2017, SAS 9 4; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Tardif PA, 2017, INJURY, V48, P94, DOI 10.1016/j.injury.2016.10.042; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; The Center for Outcome Measurement in Brain Injury (COMBI), EXT GLASG OUTC SCAL; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Tuglus C, 2008, ANN APPL STAT, V2, P489, DOI 10.1214/08-AOAS137F; US Census Bureau, 65 PLUS US; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137	54	8	8	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2019	34	4					224	232		10.1097/HTR.0000000000000470			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IQ4XH	WOS:000480754400011	30829819				2022-02-06	
J	Mashima, P; Waldron-Perrine, B; Seagly, K; Milman, L; Ashman, T; Mudar, R; Paul, D				Mashima, Pauline; Waldron-Perrine, Brigid; Seagly, Katharine; Milman, Lisa; Ashman, Teresa; Mudar, Raksha; Paul, Diane			Looking Beyond Test Results Interprofessional Collaborative Management of Persistent Mild Traumatic Brain Injury Symptoms	TOPICS IN LANGUAGE DISORDERS			English	Article						cognitive rehabilitation; concussion; interprofessional collaboration; mild traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; SPEECH-LANGUAGE PATHOLOGISTS; MINOR HEAD-INJURY; POSTCONCUSSIONAL-SYNDROME; COGNIFORM CONDITION; PROPOSED DIAGNOSES; COGNITIVE RESERVE; CONCUSSION; REHABILITATION; PREDICTORS	Patients with cognitive concerns following mild traumatic brain injury (mTBI), often referred to as concussion, present with complex constellations of strengths and limitations. Increasing evidence indicates that psychosocial factors, as opposed to the injury itself, predict persistent symptoms. As an alternative to the traditional medical model, a person-centered model empowers the patient to move forward past the injury in order to optimize function and maximize quality of life. Patient-centered assessment and treatment by speech-language pathologists, neuropsychologists, and rehabilitation psychologists can engender change, reduce perceived limitations, and increase participation in meaningful activities and roles. This article outlines several collaborative, process-oriented approaches to managing cognitive concerns subsequent to mTBI. The emphasis is on maximizing patient participation to guide clinical decision making and build self-efficacy. The authors are members of the Joint Committee on Interprofessional Relations Between the American Psychological Association (APA) and the American Speech-Language-Hearing Association (ASHA).	[Mashima, Pauline] Univ Hawaii Manoa, John A Burns Sch Med, Dept Commun Sci & Disorders, Honolulu, HI 96822 USA; [Waldron-Perrine, Brigid] Detroit Med Ctr, Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, Detroit, MI USA; [Waldron-Perrine, Brigid] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Seagly, Katharine] Univ Michigan, Dept Phys Med & Rehabil, Div Rehabil Psychol & Neuropsychol, Michigan Med, Ann Arbor, MI 48109 USA; [Milman, Lisa] Utah State Univ, Dept Communicat Disorders & Deaf Educ, Language & Aphasia NeuroRehabil Lab, Logan, UT 84322 USA; [Mudar, Raksha] Univ Illinois, Dept Speech & Hearing Sci, Urbana, IL 61801 USA; [Paul, Diane] Amer Speech Language Hearing Assoc, Rockville, MD USA		Mashima, P (corresponding author), Univ Hawaii, Dept Commun Sci & Disorders, 677 Ala Moana Blvd,Ste 625, Honolulu, HI 96813 USA.	mashima@hawaii.edu					Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carone DA, 2017, APPL NEUROPSYCH-ADUL, V24, P160, DOI 10.1080/23279095.2015.1116074; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carson A, 2017, J NEUROL NEUROSUR PS, V88, P462, DOI 10.1136/jnnp-2016-315510; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Donders J, 2019, ARCH CLIN NEUROPSYCH, V34, P206, DOI 10.1093/arclin/acy035; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Fischer CT, 2000, J PERS ASSESS, V74, P2, DOI 10.1207/S15327752JPA740102; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Hanks RA, 2019, J NEUROTRAUM, V36, P554, DOI 10.1089/neu.2018.5873; Harris R., 2019, ACT MADE SIMPLE EASY; Hayes S.C., 2016, ACCEPTANCE COMMITMEN; Hettema J, 2005, ANNU REV CLIN PSYCHO, V1, P91, DOI 10.1146/annurev.clinpsy.1.102803.143833; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/316575; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P313, DOI 10.1097/HTR.0b013e3181d6f9bd; Joint Committee on Interprofessional Relations Between the American Speech Language Hearing Association and Division 40 (Clinical Neuropsychology) of the American Psychological Association, 1990, INT APPR BRAIN DAM P; Joint Committee on Interprofessional Relations Between the American Speech Language Hearing Association and Division 40 (Clinical Neuropsychology) of the American Psychological Association, 1989, INT APPR BRAIN DAM; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kennedy M. R. T., 2017, COACHING COLL STUDEN; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kennedy MRT, 2011, J HEAD TRAUMA REHAB, V26, P212, DOI 10.1097/HTR.0b013e318218dd0e; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P683, DOI 10.1016/j.acn.2007.07.007; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Laxe S, 2015, NEUROREHABILITATION, V36, P37, DOI 10.3233/NRE-141189; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; McCrea M., 2008, MILD TRAUMATIC BRAIN; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Paul-Brown D, 2003, TECHNICAL REPORT; Pavawalla SP, 2013, J INT NEUROPSYCH SOC, V19, P305, DOI 10.1017/S135561771200135X; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Powers MB, 2009, PSYCHOTHER PSYCHOSOM, V78, P73, DOI 10.1159/000190790; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rogers CR, 1951, CLIENT CTR THERAPY I; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rollnick S., 1995, BEHAV COGN PSYCHOTH, V23, P322, DOI [10.1017/S135246580001643X, 10.1017/S135246580001643X., DOI 10.1017/S135246580001643X]; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Ruiz F. J., 2012, INT J PSYCHOL, DOI DOI 10.1016/J.BETH.2011.07.004; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sander AM, 2008, J HEAD TRAUMA REHAB, V23, P271, DOI 10.1097/01.HTR.0000336839.68585.0f; Sander AM, 2009, CLIN NEUROPSYCHOL, V23, P1196, DOI 10.1080/13854040902845706; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; The CDC NIH DoD and VA Leadership Panel, 2013, C TRAUM BRAIN INJ US; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Turgoose D, 2018, OPEN ACCESS J NEUROL, V7, P555713, DOI DOI 10.19080/OAJNN.2018.07.555713; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vanderploeg RD, 2019, REHABIL PSYCHOL, V64, P1, DOI 10.1037/rep0000255; Vasterling JJ, 2012, PTSD MILD TRAUMATIC; Waldron-Perrine B., 2016, BRAIN INJURY PROFESS, V12, P22; Waldron-Perrine B, 2012, MIL MED, V177, P1293, DOI 10.7205/MILMED-D-12-00169; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wertheimer JC, 2008, J HEAD TRAUMA REHAB, V23, P273, DOI 10.1097/01.HTR.0000336840.76209.a1; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Working Group to Develop a Clinician's Guide to Cognitive Rehabilitation in mTBI, 2017, CLIN GUID COGN REH M; World Health Organization, 2007, INT CLASS FUNCT DIS; World Health Organization (WHO), 2010, FRAM ACT INT ED COLL; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172; Zwarentein M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000072.pub2	98	8	8	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-8294	1550-3259		TOP LANG DISORD	Top. Lang. Disord.	JUL-SEP	2019	39	3			SI		293	312		10.1097/TLD.0000000000000189			20	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	IM3IN	WOS:000477887000006					2022-02-06	
J	Tajali, S; Mehravar, M; Negahban, H; van Dieen, JH; Shaterzadeh-Yazdi, MJ; Mofateh, R				Tajali, Shirin; Mehravar, Mohammad; Negahban, Hossein; van Dieen, Jaap H.; Shaterzadeh-Yazdi, Mohammad-Jafar; Mofateh, Razieh			Impaired local dynamic stability during treadmill walking predicts future falls in patients with multiple sclerosis: A prospective cohort study	CLINICAL BIOMECHANICS			English	Article						Multiple sclerosis; Falling; Local dynamic stability; Risk factor	COGNITIVE-MOTOR INTERFERENCE; DUAL-TASK; KINEMATIC VARIABILITY; ACCIDENTAL FALLS; GAIT VARIABILITY; BALANCE; ADULTS; RISK; HISTORY; PEOPLE	Background: Falling is a significant problem in patients with multiple sclerosis (MS) and the majority of falls occur during dynamic activities. Recently, there have been evidences focusing on falls and local stability of walking based on dynamic system theory in the elderly as well as patients with cerebral concussion. However, in patient with MS, this relationship has not been fully investigated. The aim of this study was to investigate local stability of walking as a risk factor for falling in patients with MS. Methods: Seventy patients were assessed while walking at their preferred speed on a treadmill under single and dual task conditions. A cognitive task (backward counting) was used to assess the importance of dual tasking to fall risk. Trunk kinematics were collected using a cluster marker over the level of T-7 and a 7-camera motion capture system. To quantify local stability of walking, maximal finite-time Lyapunov exponent was calculated from a 12-dimensional state space reconstruction based on 3-dimensional trunk linear and angular velocity time series. Participants were classified as fallers (>= 1) and non-fallers based on their prospective fall occurrence. Findings: 30 (43%) participants recorded >= 1 falls and were classified as fallers. The results of multiple logistic regression analysis revealed that short-term local dynamic stability in the single task condition (P < 0.05, odds ratio = 2.214 (1.037-4.726)) was the significant fall predictor. Interpretation: The results may indicate that the assessment of local stability of walking can identify patients who would benefit from gait retraining and fall prevention programs.	[Tajali, Shirin; Mehravar, Mohammad; Shaterzadeh-Yazdi, Mohammad-Jafar; Mofateh, Razieh] Ahvaz Jundishapur Univ Med Sci, Musculoskeletal Rehabil Res Ctr, Ahvaz, Iran; [Negahban, Hossein] Mashhad Univ Med Sci, Sch Paramed Sci, Dept Phys Therapy, Mashhad, Razavi Khorasan, Iran; [Negahban, Hossein] Mashhad Univ Med Sci, Orthoped Res Ctr, Mashhad, Razavi Khorasan, Iran; [van Dieen, Jaap H.] Vrije Univ Amsterdam, Res Inst MOVE, Dept Human Movement Sci, Amsterdam, Netherlands		Mehravar, M (corresponding author), Ahvaz Jundishapur Univ Med Sci, Musculoskeletal Rehabil Res Ctr, Ahvaz, Iran.	mohammad.mehravar@gamil.com	Mehravar, Mohamad/L-8621-2017; yazdi, mohammad jafar shaterzadeh/M-4232-2017; Tajali, Shirin/AAC-9576-2020; Tajali, shirin/AAN-5113-2020; Mofateh, Razieh/AAY-7108-2020; van Dieen, Jaap/B-3937-2013	Mehravar, Mohamad/0000-0001-8834-6521; yazdi, mohammad jafar shaterzadeh/0000-0002-5707-302X; van Dieen, Jaap/0000-0002-7719-5585; Mofateh, Razieh/0000-0003-0902-1900	Ahvaz Jundishapur University of Medical Sciences	Authors wish to express their sincere thanks and gratitude to Professor Geetanjali Gera for his valuable and constructive comments in the revision of manuscript. Special thanks to Ahvaz Jundishapur University of Medical Sciences for financial support.	Bethoux Francois, 2011, Int J MS Care, V13, P4, DOI 10.7224/1537-2073-13.1.4; Bruijn SM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0999; Bruijn SM, 2010, J EXP BIOL, V213, P3945, DOI 10.1242/jeb.045112; Bruijn SM, 2009, J NEUROSCI METH, V178, P327, DOI 10.1016/j.jneumeth.2008.12.015; Cattaneo D, 2002, ARCH PHYS MED REHAB, V83, P864, DOI 10.1053/apmr.2002.32825; Comber L, 2017, GAIT POSTURE, V51, P25, DOI 10.1016/j.gaitpost.2016.09.026; Coote Susan, 2014, Int J MS Care, V16, P178, DOI 10.7224/1537-2073.2014-059; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; Dingwell JB, 2001, GAIT POSTURE, V14, P1, DOI 10.1016/S0966-6362(01)00101-1; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Etemadi Y, 2017, CLIN REHABIL, V31, P278, DOI 10.1177/0269215516637201; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Gianni C, 2014, CLIN REHABIL, V28, P704, DOI 10.1177/0269215513517575; Gunn H, 2015, ARCH PHYS MED REHAB, V96, P1898, DOI 10.1016/j.apmr.2015.05.018; Gunn H, 2013, MULT SCLER J, V19, P1913, DOI 10.1177/1352458513488233; Gunn HJ, 2013, PHYS THER, V93, P504, DOI 10.2522/ptj.20120231; Hilfiker Roger, 2013, BMC Res Notes, V6, P260, DOI 10.1186/1756-0500-6-260; Huisinga JM, 2013, ANN BIOMED ENG, V41, P1670, DOI 10.1007/s10439-012-0697-y; Kasser SL, 2011, ARCH PHYS MED REHAB, V92, P1840, DOI 10.1016/j.apmr.2011.06.004; Lamoth CJ, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-2; Learmonth YC, 2017, ARCH PHYS MED REHAB, V98, P1229, DOI 10.1016/j.apmr.2016.07.018; Lockhart T, 2008, ERGONOMICS, V51, P1860, DOI 10.1080/00140130802567079; Mofateh R, 2017, MULT SCLER RELAT DIS, V18, P8, DOI 10.1016/j.msard.2017.09.002; Nilsagard Y, 2009, CLIN REHABIL, V23, P259, DOI 10.1177/0269215508095087; Pai YC, 2014, J GERONTOL A-BIOL, V69, P1586, DOI 10.1093/gerona/glu087; Pai YC, 2014, AGE, V36, P1367, DOI 10.1007/s11357-014-9640-5; Peebles AT, 2017, J BIOMECH, V63, P158, DOI 10.1016/j.jbiomech.2017.08.023; Reynard F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100550; Riva F, 2014, COMPUT BIOL MED, V50, P9, DOI 10.1016/j.compbiomed.2014.04.001; Siciliano B., 2016, SPRINGER HDB ROBOTIC; Sosnoff JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028021; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Tajali S, 2017, MULT SCLER RELAT DIS, V17, P69, DOI 10.1016/j.msard.2017.06.014; Toebes MJP, 2012, GAIT POSTURE, V36, P527, DOI 10.1016/j.gaitpost.2012.05.016; van Schooten KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158623; Wajda DA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/720856	36	8	8	2	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	JUL	2019	67						197	201		10.1016/j.clinbiomech.2019.05.013			5	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Orthopedics; Sport Sciences	IU2NG	WOS:000483416500030	31234121	Green Published			2022-02-06	
J	Tiernan, S; Byrne, G; O'Sullivan, DM				Tiernan, Stephen; Byrne, Gary; O'Sullivan, David Michael			Evaluation of skin-mounted sensor for head impact measurement	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Article						xPatch; head impact sensor; head acceleration	ACCELERATION MEASUREMENT; FOOTBALL; INJURY; VALIDATION; CONCUSSION; PLAYERS; SYSTEM; EXPOSURE	The requirement to measure the number and severity of head impacts in sports has led to the development of many wearable sensors. The objective of this study was to determine the reliability and accuracy of a wearable head impact sensor: xPatch, X2Biosystems, Inc. The skin-mounted sensor, xPatch, was fixed onto a Hybrid III headform and dropped using an impact test rig. A total of 400 impacts were performed, ranging from 20g to 200g linear acceleration, and impact velocities of 1.2 - 3.9 m/s. During each impact, the peak linear acceleration, angular velocity and angular acceleration were recorded and compared to the reference calibrated data. Impacts were also recorded using a high-speed video camera. The results show that the linear acceleration recorded by the xPatch during frontal and side impacts had errors of up to 24% when compared to the referenced data. The angular velocity and angular acceleration had substantially larger errors of up to 47.5% and 57%, respectively. The location of the impact had a significant effect on the results: if the impact was to the side of the head, the device on that side may have an error of up to 71%, thus highlighting the importance of device location. All impacts were recorded using two separate xPatches and, in certain cases, the difference in angular velocity between the devices was 43%. In conclusion, the xPatch can be useful for identifying impacts and recording linear accelerations during front and side impacts, but the rotational velocity and acceleration data need to be interpreted with caution.	[Tiernan, Stephen; Byrne, Gary] Technol Univ Dublin, Dublin, Ireland; [O'Sullivan, David Michael] Pusan Natl Univ, Div Sport Sci, 2,Busandaehak Ro 63 Beon Gil, Busan 46241, South Korea		O'Sullivan, DM (corresponding author), Pusan Natl Univ, Div Sport Sci, 2,Busandaehak Ro 63 Beon Gil, Busan 46241, South Korea.	davidosullivan@pusan.ac.kr		Tiernan, Stephen/0000-0002-0658-7557	President's Award from the Institute of Technology Tallaght, Dublin	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was funded by the President's Award from the Institute of Technology Tallaght, Dublin.	Abel JM, 1978, 780886 SAE; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Crisco JJ, 2014, J BIOMECHANICAL ENG, V126, P849; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Elliott MR, 2015, J BIOMECH, V48, P3059, DOI 10.1016/j.jbiomech.2015.07.026; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanlon E, 2010, J APPL BIOMECH, V26, P424, DOI 10.1123/jab.26.4.424; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Higgins M, 2007, J ATHL TRAINING, V42, P5; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; King A. I., 2003, IRCOBI C LISB PORT; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; National Instruments LabVIEW, 2017, US FAST FOUR TRANSF; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Schussler E, 2017, INT J SPORTS PHYS TH, V12, P592; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Wood GW, 2010, SAE INT J MATER MANU, V3, P186, DOI 10.4271/2010-01-0383; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	36	8	8	2	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4119	2041-3033		P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.	JUL	2019	233	7					735	744		10.1177/0954411919850961			10	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	ID6FK	WOS:000471772300006	31122140	Green Published			2022-02-06	
J	Trapp, SK; Ertl, MM; Gonzalez-Arredondo, S; Rodriguez-Agudelo, Y; Arango-Lasprilla, JC				Trapp, Stephen K.; Ertl, Melissa M.; Gonzalez-Arredondo, Susana; Rodriguez-Agudelo, Yaneth; Carlos Arango-Lasprilla, Juan			Family cohesion, burden, and health-related quality of life among Parkinson's disease caregivers in Mexico	INTERNATIONAL PSYCHOGERIATRICS			English	Article						caregiver; health-related quality of life; Parkinson's disease; Mexico; family cohesion; burden	TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; SOCIAL SUPPORT; STRESS PROCESS; EXPERIENCES; DYNAMICS; PEOPLE; MODEL	Background: Informal caregivers of individuals with Parkinson's disease face a range of responsibilities that increase as the disease progresses. As a result of these stressors, caregivers are vulnerable to decreased health-related quality of life (HRQOL). Guided by the stress process model of caregiving, the present study examined the relations between family cohesion, perceived burden, and mental and physical HRQOL among Parkinson's disease caregivers in Mexico. It was hypothesized that perceived burden would mediate the relations of family cohesion and mental and physical HRQOL. Methods: Ninety-five family caregivers of individuals with Parkinson's disease in Mexico City, Mexico, participated in the study. Multiple regression was utilized to conduct mediation analyses. Results: Results indicated that burden fully mediated the relation between family cohesion and mental HRQOL, and family cohesion was not associated with physical HRQOL. Conclusions: Findings extend the stress process model cross-culturally and lend support for the importance of family cohesion and perceived burden in determining caregiver mental HRQOL. Clinical health promotion interventions should target perceived burden and family cohesion together to improve mental HRQOL among familial caregivers in Mexico.	[Trapp, Stephen K.] Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT USA; [Ertl, Melissa M.] SUNY Albany, Div Educ & Counseling Psychol, Albany, NY 12222 USA; [Gonzalez-Arredondo, Susana; Rodriguez-Agudelo, Yaneth] Natl Inst Neurol & Neurosurg, Dept Neuropsychol, Tlalpan, DF, Mexico; [Carlos Arango-Lasprilla, Juan] Basque Fdn Sci, Ikerbasque, Bilbao, Spain		Arango-Lasprilla, JC (corresponding author), Univ Deusto, Ikerbasque, Basque Fdn Sci, Avda Univ 24, Bilbao 48007, Spain.	jcalasprilla@gmail.com		Arango-Lasprilla, Juan Carlos/0000-0002-7184-8311; Ertl, Melissa/0000-0002-1022-1777			Anderson MI, 2009, BRAIN INJURY, V23, P931, DOI 10.3109/02699050903302336; Ankri J, 2005, INT J GERIATR PSYCH, V20, P254, DOI 10.1002/gps.1275; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Bachner YG, 2007, AGING MENT HEALTH, V11, P678, DOI 10.1080/13607860701529965; Bastawrous M, 2013, INT J NURS STUD, V50, P431, DOI 10.1016/j.ijnurstu.2012.10.005; Burchard EG, 2005, AM J PUBLIC HEALTH, V95, P2161, DOI 10.2105/AJPH.2005.068668; Carod-Artal FJ, 2013, PARKINSONISM RELAT D, V19, P943, DOI 10.1016/j.parkreldis.2013.06.005; Domaradzki J, 2015, PSYCHIATR POL, V49, P931, DOI 10.12740/PP/34496; Edwards Nancy E, 2002, J Neurosci Nurs, V34, P184; Folkman S., 1984, STRESS; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Grun D, 2016, J AM MED DIR ASSOC, V17, P626, DOI 10.1016/j.jamda.2016.03.004; Gulin SL, 2014, FAM SYST HEALTH, V32, P53, DOI 10.1037/a0032623; HALEY WE, 1987, PSYCHOL AGING, V2, P323, DOI 10.1037/0882-7974.2.4.323; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Ice GH, 2012, SOC SCI MED, V74, P2020, DOI 10.1016/j.socscimed.2012.02.018; KAPLAN RM, 1988, HEALTH SERV RES, V23, P203; Kaplan RM, 1996, QUAL LIFE RES, V5, P302, DOI 10.1007/BF00434752; Lucke KT, 2013, QUAL HEALTH RES, V23, P218, DOI 10.1177/1049732312468062; Martin-Carrasco M, 2010, AGING MENT HEALTH, V14, P705, DOI 10.1080/13607860903586094; Martinez-Martin P, 2005, QUAL LIFE RES, V14, P463, DOI 10.1007/s11136-004-6253-y; Martinez-Martin P, 2007, MOVEMENT DISORD, V22, P924, DOI 10.1002/mds.21355; McRae C, 1999, PARKINSONISM RELAT D, V5, P69, DOI 10.1016/S1353-8020(99)00012-7; Mendez-Luck CA, 2016, J MARRIAGE FAM, V78, P813, DOI 10.1111/jomf.12300; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Perrin PB, 2013, PM&R, V5, P839, DOI 10.1016/j.pmrj.2013.05.018; Rivero N, 2010, FAM J, V18, P288, DOI 10.1177/1066480710372084; Sarmento VP, 2017, BMJ SUPPORT PALLIAT, V7, P390, DOI 10.1136/bmjspcare-2016-001141; Sutter M, 2014, AM J ALZHEIMERS DIS, V29, P67, DOI 10.1177/1533317513505128; Tan SB, 2012, J CLIN NURS, V21, P2235, DOI 10.1111/j.1365-2702.2012.04146.x; Torossian CL, 1999, J CONTEMP PSYCHOTHER, V29, P127, DOI DOI 10.1023/A:1021956715387; Tramonti F, 2015, PSYCHOL HEALTH MED, V20, P933, DOI 10.1080/13548506.2015.1009380; Trapp SK, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/507196; Vroman K, 2011, INT J AGING HUM DEV, V72, P1, DOI 10.2190/AG.72.1.a; Ware J., 2000, SF 36 HLTH SURVEY MA; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; Yu DSF, 2018, INT J NURS STUD, V79, P1, DOI 10.1016/j.ijnurstu.2017.10.008; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	39	8	8	1	5	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1041-6102	1741-203X		INT PSYCHOGERIATR	Int. Psychogeriatr.	JUL	2019	31	7			SI		1039	1045	PII S1041610218001515	10.1017/S1041610218001515			7	Psychology, Clinical; Geriatrics & Gerontology; Gerontology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Geriatrics & Gerontology; Psychiatry	KM5DU	WOS:000514156700015	30318024				2022-02-06	
J	Warren, A; Dale, S; McCaig, S; Ranson, C				Warren, A.; Dale, S.; McCaig, S.; Ranson, C.			Injury profiles in elite women's T20 cricket	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Surveillance; Epidemiology; Sports medicine	INTERNATIONAL CRICKET; BOWLING WORKLOAD; RISK; SURVEILLANCE	Objectives: To Describe the injury incidence and prevalence during two years of a professional women's T20 cricket tournament. Design: Prospective cohort study. Methods: Injuries were recorded prospectively for 68 matches during a professional women's T20 tournament in 2016 and 2017. There were six teams of 15 players. Participants were female, aged between 16-38 years (mean 23.4 +/- 4.8). Time-loss and non time-loss incidence and prevalence were calculated for match days, region, skill group, mode and activity at time of injury. Results: The greatest incidence occurred in the shoulder (1.8 injuries per 100 match days), lower back (1.7 injuries per 100 match days) and knee (1.7 injuries per 100 match days). The highest time-loss prevalence occurred in hand (1.7%), head/face (0.8%) and thigh (0.6%). All head injuries were concussion. Catching related injuries caused the most time-loss (2.5% prevalence) and throwing related shoulder injury had the highest incidence (2.3 injuries per 100 match days). Gradual onset injuries had the highest overall incidence (7.9 injuries per 100 match days). Conclusions: In elite female T20 cricket, time-loss injuries, particularly impact/traumatic injuries are most likely to occur during fielding, suggesting pitch side support and trauma training is a priority. The high incidence of gradual onset injuries, particularly throwing related shoulder pain, indicates that managing workload and ensuring physical preparedness is vital. (C) 2019 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Warren, A.] Loughborough Univ, England & Wales Cricket Board, Natl Cricket Performance Ctr, Loughborough, Leics, England; [Dale, S.] England & Wales Cricket Board, Sci & Med Dept, London, England; [McCaig, S.; Ranson, C.] English Inst Sport, Sci & Med Dept, Manchester, Lancs, England		Warren, A (corresponding author), Loughborough Univ, England & Wales Cricket Board, Natl Cricket Performance Ctr, Loughborough, Leics, England.; Dale, S (corresponding author), England & Wales Cricket Board, Sci & Med Dept, London, England.	Anna.Warren@ecb.co.uk	Ranson, Craig/AAQ-5452-2020	Ranson, Craig/0000-0002-3783-0505			[Anonymous], 2017, GUARDIAN; Dennis R, 2003, J SCI MED SPORT, V6, P359, DOI 10.1016/S1440-2440(03)80031-2; England & Wales Cricket Board, 2018, ENGL WAL CRICK BOARD; Evans R, 2015, 5 WORLD C SCI MED CR; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Frost WL, 2014, BRIT J SPORT MED, V48, P1002, DOI 10.1136/bjsports-2012-091337; Giles K, 2008, PHYS THER SPORT, V9, P109, DOI 10.1016/j.ptsp.2008.03.002; Hulin BT, 2014, BRIT J SPORT MED, V48, P708, DOI 10.1136/bjsports-2013-092524; Mansingh A, 2006, BRIT J SPORT MED, V40, P119, DOI 10.1136/bjsm.2005.019414; Orchard J, 2002, BRIT J SPORT MED, V36, P270, DOI 10.1136/bjsm.36.4.270; Orchard JW, 2006, J SCI MED SPORT, V9, P459, DOI 10.1016/j.jsams.2006.05.001; Orchard JW, 2016, OPEN ACCESS J SPORTS, V7, P187, DOI 10.2147/OAJSM.S117497; Orchard JW, 2016, BRIT J SPORT MED, V50, P1245, DOI 10.1136/bjsports-2016-096125; Orchard JW, 2015, BRIT J SPORT MED, V49, P1064, DOI 10.1136/bjsports-2014-093683; Orchard JW, 2009, AM J SPORT MED, V37, P1186, DOI 10.1177/0363546509332430; Orchard JW, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.012732; Rae K, 2007, CLIN J SPORT MED, V17, P201, DOI 10.1097/JSM.0b013e318059b536; Ranson C, 2008, PHYS THER SPORT, V9, P34, DOI 10.1016/j.ptsp.2007.08.001; Ranson C, 2013, BRIT J SPORT MED, V47, P637, DOI 10.1136/bjsports-2012-091783; Saw R, 2011, BRIT J SPORT MED, V45, P805, DOI 10.1136/bjsm.2009.061309; Stretch R A, 2014, SA J. Sports Med., V26, P123, DOI [10.7196/SAJSM.543, 10.7196/sajsm.543]; Stretch RA, 2003, BRIT J SPORT MED, V37, P250, DOI 10.1136/bjsm.37.3.250; Stretch RA, 2001, S AFR MED J, V91, P336; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Warren A, 2018, J SCI MED SPORT, V21, P40, DOI 10.1016/j.jsams.2017.07.009	25	8	8	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	JUL	2019	22	7					775	779		10.1016/j.jsams.2019.01.018			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	IM1ZL	WOS:000477790300007	30827845				2022-02-06	
J	Zarshenas, S; Colantonio, A; Horn, SD; Jaglal, S; Cullen, N				Zarshenas, Sareh; Colantonio, Angela; Horn, Susan D.; Jaglal, Susan; Cullen, Nora			Cognitive and Motor Recovery and Predictors of Long-Term Outcome in Patients With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Outcome assessment; Rehabilitation	FUNCTIONAL INDEPENDENCE MEASURE; INPATIENT REHABILITATION; FOLLOW-UP; MODERATE; TBI; IMPROVE; ADULTS; CARE; TRAJECTORIES; ASSOCIATIONS	Objectives: To explore the patterns of cognitive and motor recovery at 4 time points from admission to 9 months after discharge from inpatient rehabilitation (IR) and to investigate the association of therapeutic factors and conditions before and after discharge with long-term outcomes. Design: Secondary analysis of traumatic brain injury (TBI) and practice-based evidence dataset. Setting: IR in Ontario, Canada. Participants: Patients with TBI consecutively admitted for IR between 2008 and 2011 who had data available from admission to 9 months after discharge (N = 85). Interventions: Not applicable. Main Outcome Measure: FIM-Rasch cognitive and motor scores at admission, discharge, 3 months after discharge, and 9 months after discharge. Results: Cognitive and motor recovery showed similar patterns of improvement with recovery up to 3 months but no significant change from 3 to 9 months. Having fewer postdischarge health conditions was associated with better long-term cognitive scores (95% confidence interval, -13.06 to -1.2) and added 9.9% to the explanatory power of the model. More therapy time in complex occupational therapy activities (95% confidence interval, .02 to .09) and fewer postdischarge health conditions (95% confidence interval, -19.5 to -3.8) were significant predictors of better long-term motor function and added 14.3% and 7.2% to the explanatory power of the model, respectively. Conclusion: Results of this study inform health care providers about the influence of the timing of IR on cognitive and motor recovery. In addition, it underlines the importance of making patients and families aware of residual health conditions following discharge from IR. Crown Copyright (C) 2019 Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Zarshenas, Sareh; Colantonio, Angela; Jaglal, Susan; Cullen, Nora] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Zarshenas, Sareh; Colantonio, Angela; Jaglal, Susan; Cullen, Nora] Univ Ctr, Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Occupat Sci & Occupat Therapy Dept, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Horn, Susan D.] Univ Utah, Sch Med, Dept Populat Hlth Sci, Salt Lake City, UT USA		Cullen, N (corresponding author), Univ Ctr Res, Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave, University, ON MSG 2A2, Canada.	nora.cullen@westpark.org		Cullen, Nora/0000-0001-6359-9418; Jaglal, Susan/0000-0002-2930-1443; Colantonio, Angela/0000-0003-2094-4765	National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01); the National Institute on Disability and Rehabilitation Research (grant no. H133A080023); and the Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525).	Agrawal M, 2014, BRAIN INJURY, V28, P292, DOI 10.3109/02699052.2013.865266; American Occupational Therapy Association-AOTA, 2014, AM J OCCUP THER, V68, ps01, DOI [10.5014/ajot.2014.682006, DOI 10.5014/AJOT.2014.682006]; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; Bond T. G., 2007, APPL RASCH MODEL FUN, V2; Brett CE, 2017, NEUROPSYCHOL REHABIL, V27, P959, DOI 10.1080/09602011.2015.1090459; Canadian Association of Occupational Therapists, 2012, PROF OCC THER PRACT; Chan V, 2016, ARCH PHYS MED REHAB, V97, P772, DOI 10.1016/j.apmr.2016.01.011; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cullen N, 2007, J HEAD TRAUMA REHAB, V22, P214, DOI 10.1097/01.HTR.0000281836.54602.6d; D'Arcy RCN, 2016, J HEAD TRAUMA REHAB, V31, pE50, DOI 10.1097/HTR.0000000000000185; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Department for Professional Employees, US HLTH CAR SYST INT; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dixit SK, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312118769211; Foley N, 2012, DISABIL REHABIL, V34, P2132, DOI 10.3109/09638288.2012.676145; Government of Canada, CAN HLTH ACT LINKS P; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hoofien D, 2001, BRAIN INJURY, V15, P189; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS304, DOI 10.1016/j.apmr.2014.11.030; Howrey BT, 2017, ARCH PHYS MED REHAB, V98, P1606, DOI 10.1016/j.apmr.2017.03.009; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Jourdan C, 2017, J HEAD TRAUMA REHAB, V32, pE26, DOI 10.1097/HTR.0000000000000276; Khan F, 2016, J REHABIL MED, V48, P442, DOI 10.2340/16501977-2084; Konigs M, 2018, ARCH PHYS MED REHAB, V99, P1149, DOI 10.1016/j.apmr.2018.01.013; Lecours A, 2012, J HEAD TRAUMA REHAB, V27, P379, DOI 10.1097/HTR.0b013e31823b2385; Li Wei, 2017, Alzheimers Dement (Amst), V6, P196, DOI 10.1016/j.dadm.2017.01.008; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Martin A, OUTCOMES INPATIENT R; Martin D, 2018, LANCET, V391, P1718, DOI 10.1016/S0140-6736(18)30181-8; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Moriarty H, 2015, J AM PSYCHIAT NURSES, V21, P195, DOI 10.1177/1078390315591879; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Patil M, 2017, J NEUROSCI RURAL PRA, V8, P357, DOI 10.4103/jnrp.jnrp_53_17; Rabinowitz AR, 2018, J INT NEUROPSYCH SOC, V24, P237, DOI 10.1017/S1355617717000996; Ridic Goran, 2012, Mater Sociomed, V24, P112, DOI 10.5455/msm.2012.24.112-120; RUFF RM, 1991, J NEUROSURG, V75, pS50, DOI 10.3171/sup.1991.75.1s.0s50; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; Sander AM, 2001, J HEAD TRAUMA REHAB, V16, P356, DOI 10.1097/00001199-200108000-00006; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Schultz R, 2013, BRAIN IMPAIR, V14, P450, DOI 10.1017/BrImp.2013.24; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS235, DOI 10.1016/j.apmr.2014.10.027; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Smith PM, 1996, ARCH PHYS MED REHAB, V77, P431, DOI 10.1016/S0003-9993(96)90029-5; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Terpstra AR, 2017, NEUROREHAB NEURAL RE, V31, P1063, DOI 10.1177/1545968317736817; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Turner-Stokes L, 2015, INT J THER REHABIL, V22, P210, DOI 10.12968/ijtr.2015.22.5.210; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	63	8	9	1	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2019	100	7					1274	1282		10.1016/j.apmr.2018.11.023			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	IJ2IG	WOS:000475720900009	30605639				2022-02-06	
J	Patel, BH; Okoroha, KR; Jildeh, TR; Lu, YN; Idarraga, AJ; Nwachukwu, BU; Shen, SA; Forsythe, B				Patel, Bhavik H.; Okoroha, Kelechi R.; Jildeh, Toufic R.; Lu, Yining; Idarraga, Alexander J.; Nwachukwu, Benedict U.; Shen, Sarek A.; Forsythe, Brian			Concussions in the National Basketball Association Analysis of Incidence, Return to Play, and Performance From 1999 to 2018	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; National Basketball Association; incidence; return to play	COLLATERAL LIGAMENT RECONSTRUCTION; EXTREMITY MUSCULOSKELETAL INJURY; LEAGUE BASEBALL PITCHERS; TOMMY JOHN SURGERY; EPIDEMIOLOGY; LONGEVITY; SYMPTOMS; HISTORY; RISK; TIME	Background: The effect of concussions on professional athletes has been investigated in many sports. However, few studies have evaluated concussions in National Basketball Association (NBA) players. Hypothesis: We hypothesized that concussion incidence has increased, yet the return-to-play (RTP) rate will remain high following the institution of the NBA concussion policy (NBACP). We also hypothesized that the incidence of repeat concussions will be similar to first occurrences and that player performance and game availability will not be significantly affected by sustaining a concussion. Study Design: Descriptive epidemiology study. Methods: Publicly available records were searched to identify all concussions from NBA seasons 1999-2000 to 2017-2018. Player demographics and information regarding career history were tabulated. Incidence of concussion and RTP timing were evaluated before and after institution of the NBACP (2011). Minutes per game and game score per minute were evaluated pre- versus postconcussion. Player availability and performance were also compared with an age-, body mass index-, position-, and experience-matched control group of players who did not sustain a concussion. Results: A total of 189 concussions were reported in the NBA from 1999 to 2018, with a mean +/- SD incidence of 9.7 +/- 7.3 concussions per season. Following implementation of the NBACP, incidence significantly increased from 5.7 +/- 2.8 to 16.7 +/- 7.5 concussions per season (P - .007). All players returned to play following first-time concussion after missing 7.7 +/- 8.6 days and 3.5 +/- 4.1 games. RTP time was not significantly different after implementation of the NBACP (games missed, P = .24; days missed, P = .27), and there was no difference in concussion-free time interval (P = .29). Game score per minute and minutes per game were not significantly affected by sustaining a concussion (both P > .05). Conclusion: Concussion incidence in NBA players is approximately 17 instances per season since the 2011 institution of a league-wide concussion policy. The number of reported concussions significantly increased following the policy, in line with trends seen in other professional sports leagues. Players have retained a high rate of RTP after 3 to 4 missed games. Player performance and availability are not affected by sustaining a concussion following successful RTP.	[Patel, Bhavik H.; Okoroha, Kelechi R.; Jildeh, Toufic R.; Lu, Yining; Idarraga, Alexander J.; Nwachukwu, Benedict U.; Shen, Sarek A.; Forsythe, Brian] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Patel, Bhavik H.; Okoroha, Kelechi R.; Lu, Yining; Idarraga, Alexander J.; Nwachukwu, Benedict U.; Forsythe, Brian] Rush Univ, Med Ctr, Midwest Orthopaed Rush, Chicago, IL 60612 USA; [Jildeh, Toufic R.] Henry Ford Hlth Syst, Dept Orthopaed Surg, Detroit, MI USA; [Jildeh, Toufic R.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA		Forsythe, B (corresponding author), 1611 W Harrison St,Suite 360, Chicago, IL 60621 USA.	brian.forsythe@rushortho.com	Forsythe, Brian/AAN-9501-2020	Shen, Sarek/0000-0001-6627-6139			Blake AL, 2019, SLEEP HEALTH, V5, P72, DOI 10.1016/j.sleh.2018.10.011; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Camp CL, 2018, AM J SPORT MED, V46, P1997, DOI 10.1177/0363546518773048; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Cochrane GD, 2017, PHYSICIAN SPORTSMED, V45, P178, DOI 10.1080/00913847.2017.1305875; Corti SJ, 2019, J CHILD NEUROL, V34, P262, DOI 10.1177/0883073818825031; Dai JB, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118815448; Drakos MC, 2010, SPORTS HEALTH, V2, P284, DOI 10.1177/1941738109357303; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Erickson BJ, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117745021; Erickson BJ, 2014, AM J SPORT MED, V42, P536, DOI 10.1177/0363546513510890; Feldman D., S CURRY POSTS WORST; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Hoffman B., 2016, K BRYANTS FINALE TRI; Hollinger J., BEST FINALS PERFORMA; Kardouni JR, 2018, J ORTHOP SPORT PHYS, V48, P533, DOI 10.2519/jospt.2018.8053; Keller RA, 2017, J SHOULDER ELB SURG, V26, P288, DOI 10.1016/j.jse.2016.11.008; Keller RA, 2014, J SHOULDER ELB SURG, V23, P1591, DOI 10.1016/j.jse.2014.06.033; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Kerr ZY, 2018, AM J SPORT MED, V46, P22, DOI 10.1177/0363546517728264; Kerr ZY, 2017, NEUROL CLIN, V35, P409, DOI 10.1016/j.ncl.2017.03.001; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kuhn AW, 2016, AM J SPORT MED, V44, P2152, DOI 10.1177/0363546516638327; Kuhn AW, 2015, CONCUSSION, V1; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Makhni EC, 2014, AM J SPORT MED, V42, P1323, DOI 10.1177/0363546514528864; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marshall NE, 2018, ARTHROSCOPY, V34, P1809, DOI 10.1016/j.arthro.2018.01.008; Marshall NE, 2018, ARTHROSCOPY, V34, P473, DOI 10.1016/j.arthro.2017.08.298; Marshall NE, 2015, AM J SPORT MED, V43, P1051, DOI 10.1177/0363546515579636; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; National Basketball Association, NBA CONC POL SUMM 20; National Football League, NFL HEAD NECK SPIN C; National Hockey League, NHL CONC MAN EV PROT; Ochs CP, 2019, J SPORT REHABIL, V28, P769, DOI 10.1123/jsr.2018-0168; Okoroha KR, 2018, J SHOULDER ELB SURG, V27, P17, DOI 10.1016/j.jse.2017.07.027; Okoroha KR, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117698788; Padaki AS, 2016, AM J SPORT MED, V44, P2263, DOI 10.1177/0363546516634679; Paine N., L JAMES IS STILL HIS; Pierpoint Lauren A, 2018, Inj Epidemiol, V5, P29, DOI 10.1186/s40621-018-0159-6; Ramkumar PN, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118814238; Reams N, 2017, INT J SPORT PHYSIOL, V12, P1100, DOI 10.1123/ijspp.2016-0508; Sabesan VJ, 2018, OPEN ACCESS J SPORTS, V9, P253, DOI 10.2147/OAJSM.S157433; Taylor ME, 2017, J SCH NURS, V33, P73, DOI 10.1177/1059840515619683; Veliz P, 2019, J ADOLESCENT HEALTH, V64, P272, DOI 10.1016/j.jadohealth.2018.08.023; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Yengo-Kahn AM, 2016, PHYSICIAN SPORTSMED, V44, P297, DOI 10.1080/00913847.2016.1200956; Zetterberg H, 2019, J INTERN MED, V285, P624, DOI 10.1111/joim.12863; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman SL, 2018, J SURG ORTHOP ADV, V27, P187	54	8	8	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	JUN 27	2019	7	6							2325967119854199	10.1177/2325967119854199			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	KK2VZ	WOS:000512607200001	31276004	Green Published, gold			2022-02-06	
J	Giguere, FL; Frasnelli, A; De Guise, E; Frasnelli, J				Giguere, Fanny Lecuyer; Frasnelli, Andreas; De Guise, Elaine; Frasnelli, Johannes			Olfactory, cognitive and affective dysfunction assessed 24 hours and one year after a mild Traumatic Brain Injury (mTBI)	BRAIN INJURY			English	Article						Mild traumatic brain injury; olfaction; anxiety; cognition; cross-sectional	ODOR IDENTIFICATION; NORMATIVE DATA; HEAD-INJURY; ANXIETY; AGE; DISCRIMINATION; PERFORMANCE; DEPRESSION; SEQUELAE; METAANALYSES	Objective: This cross-sectional study aimed to evaluate olfaction 24 h (baseline) and 1 year (follow-up) after a mild traumatic brain injury (TBI). We further evaluated the influence of the cognition and affective state on olfactory function. Method: At baseline, olfactory function, neuropsychological, and affective states were assessed in 42 patients (20 mild TBI; 22 orthopedic injury). At follow-up, 12 patients with mild TBI and 7 controls could be included, and we assessed olfactory function, affective states, and post-concussion symptoms. Results: At baseline, patients with mild TBI demonstrated significantly reduced olfactory function, compared to controls, with more than 55% of the patients presenting signs of hyposmia. One year later, no significant differences in olfactory scores between cases and controls were observed. However, patients with mild TBI who had exhibited hyposmia at baseline exhibited significantly higher anxiety levels and more post-concussion symptoms than patients with mild TBI with normal olfactory function at baseline. Conclusions: In the acute phase of mild TBI a majority of patients has impaired olfactory function. Further patients with olfactory dysfunction are more likely to exhibit post-concussion and anxious symptoms at follow-up. Olfactory testing in the acute phase may therefore serve as a screening tool for long-term outcome.	[Giguere, Fanny Lecuyer; De Guise, Elaine; Frasnelli, Johannes] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Giguere, Fanny Lecuyer; De Guise, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Giguere, Fanny Lecuyer; Frasnelli, Johannes] Hop Sacre Coeur Montreal, CEAMS, 5400 Boul Gouin O,Room E-0360, Montreal, PQ H4J 1C5, Canada; [Frasnelli, Andreas] Spitalzentrum Oberwallis, Emergency Dept, Visp, Switzerland; [De Guise, Elaine] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada; [Frasnelli, Johannes] UQTR, Dept Anat, Trois Rivieres, PQ, Canada		Giguere, FL (corresponding author), Hop Sacre Coeur Montreal, CEAMS, 5400 Boul Gouin O,Room E-0360, Montreal, PQ H4J 1C5, Canada.	fanny.lecuyer.giguere@umontreal.ca		Frasnelli, Johannes/0000-0002-8863-3982	Fonds de recherche Sante Quebec [173003]	This work was supported by the Fonds de recherche Sante Quebec [Chercheur Boursier (173003)].	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Barwood CHS, 2013, BRAIN INJURY, V27, P671, DOI 10.3109/02699052.2013.775500; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Buron E, 2013, PSYCHOPATHOLOGY, V46, P63, DOI 10.1159/000338717; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Charland-Verville V, 2012, AM J RHINOL ALLERGY, V26, P222, DOI 10.2500/ajra.2012.26.3769; Ciofalo A, 2018, BRAIN INJURY, V32, P550, DOI 10.1080/02699052.2018.1432074; de Guise E, 2015, BRAIN INJURY, V29, P730, DOI 10.3109/02699052.2015.1004748; de Guise E, 2012, ISNR REHABILITATION; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; De Monte VE, 2010, J CLIN EXP NEUROPSYC, V32, P28, DOI 10.1080/13803390902806519; Deary IJ, 2009, BRIT MED BULL, V92, P135, DOI 10.1093/bmb/ldp033; Delis DC., 2001, DELIS KAPLAN EXECUTI; Doty R.L., 2001, BRIEF SMELL IDENTIFI; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; Drummond M, 2017, NEUROREHABILITATION, V41, P241, DOI 10.3233/NRE-171477; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Frasnelli J, 2016, CLIN NEUROL NEUROSUR, V140, P68, DOI 10.1016/j.clineuro.2015.11.013; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Humphries T, 2018, BRAIN INJURY, V32, P557, DOI 10.1080/02699052.2018.1434237; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; Larsson M, 2004, CHEM SENSES, V29, P547, DOI 10.1093/chemse/bjh059; Liao KH, 2016, PSYCHIAT RES, V243, P349, DOI 10.1016/j.psychres.2016.07.001; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Murman Daniel L., 2015, Seminars in Hearing, V36, P111, DOI 10.1055/s-0035-1555115; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Preece MHW, 2007, BRAIN INJURY, V21, P951, DOI 10.1080/02699050701481647; Randolph C., 1998, REPEATABLE BATTERY A; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; SHERMAN AH, 1979, OTOLARYNG HEAD NECK, V87, P717, DOI 10.1177/019459987908700604; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Swann IJ, 2006, EMERG MED J, V23, P618, DOI 10.1136/emj.2005.029017; Takahashi T, 2015, PSYCHIAT CLIN NEUROS, V69, P431, DOI 10.1111/pcn.12277; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; Wechsler D., 2012, WECHSLER PRESCHOOL P; Wechsler D., 2008, WECHSLER ADULT INTEL; Wong MN, 2010, APHASIOLOGY, V24, P1155, DOI 10.1080/02687030903168212; Xydakis MS, 2015, NEUROLOGY, V84, P1559, DOI 10.1212/WNL.0000000000001475; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	55	8	8	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2019	33	9					1184	1193		10.1080/02699052.2019.1631486		JUN 2019	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IO0TH	WOS:000472454400001	31223039				2022-02-06	
J	Rose, SC; Yeates, KO; Nguyen, JT; McCarthy, MT; Ercole, PM; Pizzimenti, NM				Rose, Sean C.; Yeates, Keith Owen; Nguyen, Joseph T.; McCarthy, Matthew T.; Ercole, Patrick M.; Pizzimenti, Natalie M.			Neurocognitive Function and Head Impact Burden over Two Seasons of Youth Tackle Football	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; concussion; outcome measures; pediatrics; sub-concussive impact	HIGH-SCHOOL FOOTBALL; NEUROLOGIC FUNCTION; LATER-LIFE; PARTICIPATION; IMPAIRMENT; EXPOSURE; CONTACT	This prospective cohort study sought to determine the association of repetitive sub-concussive head impacts with neurocognitive outcomes in youth tackle football players. The study sample included 166 youth tackle football players over two seasons: 70 primary school players ages 9-12 and 96 high school players ages 15-18. Helmet-based sensors recorded head impacts during practices and games, and impacts were summed to provide a cumulative measure of impact for each season. Participants also were stratified by "high intensity" and "low intensity" groups based on whether they sustained high or low g-force impacts. Participants completed assessments on a variety of neurologic, cognitive, and behavioral outcomes before and after each football season. In the subgroup of 55 players who participated in both seasons, the average combined cumulative impact for primary school and high school players was 7127 (standard deviation [SD] 4670) and 6558 (SD 4438) g-forces, respectively. Neither cumulative impact nor impact intensity predicted change scores from pre-season 1 to post-season 2 on any outcome measures. Instead, younger age group and history of attention deficit hyperactivity disorder (ADHD) predicted worse change scores on several cognitive measures and an ADHD symptom reporting scale. In the full 166-player cohort, a computerized test of processing speed declined over time, while the remaining 22 outcome measures either did not change or improved over time. Minimal changes were observed in neurocognitive outcomes associated with participation in youth tackle football over the course of two seasons, and there was no correlation with the number and severity of head impacts sustained over that time. However, longer prospective follow-up times will be beneficial.	[Rose, Sean C.] Nationwide Childrens Hosp, Div Child Neurol, Columbus, OH 43205 USA; [Rose, Sean C.] Ohio State Univ, Columbus, OH 43205 USA; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Nguyen, Joseph T.; Ercole, Patrick M.] Sansom Consulting, San Antonio, TX USA; [McCarthy, Matthew T.] Summit Med Grp, Florham Pk, NJ USA; [Pizzimenti, Natalie M.] MORE Fdn, Phoenix, AZ USA		Rose, SC (corresponding author), Nationwide Childrens Hosp, 700 Childrens Dr, Columbus, OH 43205 USA.; Rose, SC (corresponding author), Ohio State Univ, Child Neurol, 700 Childrens Dr, Columbus, OH 43205 USA.	sean.rose@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020	Rose, Sean/0000-0001-5177-7715	Riddell and ElMindA	Funding was provided by Riddell and ElMindA for this investigator-initiated study.	Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2018, CLIN J SPORT MED, V28, P130, DOI 10.1097/JSM.0000000000000420; Calamia M, 2012, CLIN NEUROPSYCHOL, V26, P543, DOI 10.1080/13854046.2012.680913; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Jennings D, 2015, INT J SPORTS PHYS TH, V10, P667; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Rose SC, 2019, J HEAD TRAUMA REHAB, V34, P87, DOI 10.1097/HTR.0000000000000441; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; The Aspen Institute: Project Play, 2018, STAT PLAY 2018 TREND	19	8	8	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2019	36	19					2803	2809		10.1089/neu.2019.6519		JUN 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	JB8IG	WOS:000475153000001	31084394				2022-02-06	
J	Shadgan, B; Macnab, A; Fong, A; Manouchehri, N; So, K; Shortt, K; Streijger, F; Cripton, PA; Sayre, EC; Dumont, GA; Pagano, R; Kim, KT; Kwon, BK				Shadgan, Babak; Macnab, Andrew; Fong, Allan; Manouchehri, Neda; So, Kitty; Shortt, Katelyn; Streijger, Femke; Cripton, Peter A.; Sayre, Eric C.; Dumont, Guy A.; Pagano, Roberto; Kim, Kyoung-Tae; Kwon, Brian K.			Optical Assessment of Spinal Cord Tissue Oxygenation Using a Miniaturized Near Infrared Spectroscopy Sensor	JOURNAL OF NEUROTRAUMA			English	Article						animal model; hemodynamics; implantable sensor; NIRS; spinal cord	TRAUMATIC BRAIN-INJURY; METABOLISM; MANAGEMENT; ANATOMY	Despite advances in the treatment of acute spinal cord injury (SCI), measures to mitigate permanent neurological deficits in affected patients are limited. Immediate post-trauma hemodynamic management of patients, to maintain blood supply and improve oxygenation to the injured spinal cord, is currently one aspect of critical care which clinicians can utilize to improve neurological outcomes. However, without a way to monitor the response of spinal cord hemodynamics and oxygenation in real time, optimizing hemodynamic management is challenging and limited in scope. This study aims to investigate the feasibility and validity of using a miniaturized multi-wavelength near-infrared spectroscopy (NIRS) sensor for direct transdural monitoring of spinal cord oxygenation in an animal model of acute SCI. Nine Yorkshire pigs underwent a weight-drop T10 contusion-compression injury and received episodes of ventilatory hypoxia and alterations in mean arterial pressure (MAP). Spinal cord hemodynamics and oxygenation were monitored throughout by a non-invasive transdural NIRS sensor, as well as an invasive intraparenchymal sensor as a comparison. NIRS parameters of tissue oxygenation were highly correlated with intraparenchymal measures of tissue oxygenation. In particular, during periods of hypoxia and MAP alterations, changes of NIRS-derived spinal cord oxygenated hemoglobin and tissue oxygenation percentage corresponded well with the changes in spinal cord oxygen partial pressures measured by the intraparenchymal sensor. Our data confirm that during hypoxic episodes and as changes occur in the MAP, non-invasive NIRS can detect and measure real-time changes in spinal cord oxygenation with a high degree of sensitivity and specificity.	[Shadgan, Babak; Cripton, Peter A.; Kwon, Brian K.] Univ British Columbia, Dept Orthopaed, Fac Med, Vancouver, BC, Canada; [Shadgan, Babak; Fong, Allan; Manouchehri, Neda; So, Kitty; Shortt, Katelyn; Streijger, Femke; Kwon, Brian K.] Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Macnab, Andrew] Wallenberg Res Ctr, Stellenbosch Inst Adv Study, Stellenbosch, South Africa; [Cripton, Peter A.] Univ British Columbia, Orthopaed & Injury Biomech Grp, Dept Mech Engn, Vancouver, BC, Canada; [Cripton, Peter A.] Univ British Columbia, Orthopaed & Injury Biomech Grp, Dept Orthopaed, Vancouver, BC, Canada; [Cripton, Peter A.] Univ British Columbia, Sch Biomed Engn, Vancouver, BC, Canada; [Sayre, Eric C.] Arthrit Res Canada, Richmond, BC, Canada; [Dumont, Guy A.; Pagano, Roberto] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC, Canada; [Kim, Kyoung-Tae] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Neurosurg, Sch Med, Daegu, South Korea		Shadgan, B (corresponding author), Univ British Columbia, Int Collaborat Repair Discoveries, Fac Med, Dept Orthopaed,Blusson Spinal Cord Ctr, 5440 ICORD,818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada.	shadgan@mail.ubc.ca	Cripton, Peter Alec/AAC-8268-2020	Cripton, Peter Alec/0000-0002-5067-0833; Fong, Allan/0000-0003-2738-4991	Translational Research Award from the United States Department of Defense, Spinal Cord Injury Research Program; ICORD Seed Grant from the Blusson Integrated Cures Partnership; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research	This study was supported by a Translational Research Award from the United States Department of Defense, Spinal Cord Injury Research Program, and an ICORD Seed Grant from the Blusson Integrated Cures Partnership. The authors gratefully acknowledge technical expertise and contributions of Dr. Behnam Molavi in design and development of the NIRS prototypes. The authors also acknowledge expertise and collaborations of the team of veterinarians and animal care technicians at the UBC Center for Comparative Medicine (CCM). B.S. holds a Scholar Award from the Michael Smith Foundation for Health Research. B.K.K. is the Canada Research Chair in Spinal Cord Injury and the Dvorak Chair in Spine Trauma.	Boushel R, 2000, J APPL PHYSIOL, V89, P1868, DOI 10.1152/jappl.2000.89.5.1868; Casha S, 2011, J NEUROTRAUM, V28, P1479, DOI 10.1089/neu.2009.1156; Consortium Spinal Cord Med, 2008, J SPINAL CORD MED, V31, P403; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Etz CD, 2011, J THORAC CARDIOV SUR, V141, P1020, DOI 10.1016/j.jtcvs.2010.06.023; Ferrari M, 1997, PHILOS T R SOC B, V352, P677, DOI 10.1098/rstb.1997.0049; Ferrari M, 2011, PHILOS T R SOC A, V369, P4577, DOI 10.1098/rsta.2011.0230; Ferraris A, 2018, J CLIN MONIT COMPUT, V32, P253, DOI 10.1007/s10877-017-0025-z; Hagino K, 2005, J THORAC CARDIOV SUR, V130, P384, DOI 10.1016/j.jtcvs.2005.02.058; Hamaoka T, 2011, PHILOS T R SOC A, V369, P4591, DOI 10.1098/rsta.2011.0298; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Kong CY, 2013, SPINAL CORD, V51, P466, DOI 10.1038/sc.2013.32; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217; Lee J. H., 2012, JOVE-J VIS EXP, V65, P3313; Macnab AJ, 2003, SPECTROSC-INT J, V17, P483, DOI 10.1155/2003/607654; Macnab A, 2012, BIOMED SPECTROSC IMA, V1, P205, DOI 10.3233/BSI-2012-0018; MATCHER SJ, 1995, ANAL BIOCHEM, V227, P54, DOI 10.1006/abio.1995.1252; Nielsen HB, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00093; Okon EB, 2013, J NEUROTRAUM, V30, P1564, DOI 10.1089/neu.2013.2956; Pascual JL, 2011, J TRAUMA, V70, P535, DOI 10.1097/TA.0b013e31820b59de; Pollard V, 1996, ANESTH ANALG, V82, P269, DOI 10.1097/00000539-199602000-00010; Ryken TC, 2013, NEUROSURGERY, V72, P84, DOI 10.1227/NEU.0b013e318276ee16; Schenkman K. A., 2002, CRIT CARE MED, V30, P267; Shadgan B, 2011, RESP PHYSIOL NEUROBI, V178, P202, DOI 10.1016/j.resp.2011.06.001; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Strauch JT, 2007, ANN THORAC SURG, V83, P2130, DOI 10.1016/j.athoracsur.2007.01.060; Streijger F, 2017, J NEUROTRAUM, V34, P3336, DOI 10.1089/neu.2017.5034; Tachtsidis I, 2009, ADV EXP MED BIOL, V645, P315, DOI 10.1007/978-0-387-85998-9_47; Wyser D, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.4.041413	30	8	8	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 1	2019	36	21					3034	3043		10.1089/neu.2018.6208		JUN 2019	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JG5UW	WOS:000472107300001	31044642				2022-02-06	
J	Turgeon, AF; Dorrance, K; Archambault, P; Lauzier, F; Lamontagne, F; Zarychanski, R; Fowler, R; Moore, L; Lacroix, J; English, S; Boutin, A; Muscedere, J; Burns, KEA; Griesdale, D; McIntyre, LA; Scales, D; Bernard, F; Yamada, J; Squires, JE				Turgeon, Alexis F.; Dorrance, Kristin; Archambault, Patrick; Lauzier, Francois; Lamontagne, Francois; Zarychanski, Ryan; Fowler, Robert; Moore, Lynne; Lacroix, Jacques; English, Shane; Boutin, Amelie; Muscedere, John; Burns, Karen E. A.; Griesdale, Donald; McIntyre, Lauralyn A.; Scales, Damon; Bernard, Francis; Yamada, Janet; Squires, Janet E.		Canadian Traumatic Brain Injury; Canadian Critical Care Trials Grp	Factors influencing decisions by critical care physicians to withdraw life-sustaining treatments in critically ill adult patients with severe traumatic brain injury	CANADIAN MEDICAL ASSOCIATION JOURNAL			English	Article							BEHAVIOR-CHANGE; SUPPORT; DEATH; DOMAINS	BACKGROUND: Most deaths in critically ill patients with severe traumatic brain injury are associated with a decision to withdraw life-sustaining treatments. We aimed to identify the behavioural determinants that influence recommendations by critical care physicians to consider the withdrawal of life-sustaining treatments in this population. METHODS: We conducted a descriptive qualitative study based on the Theoretical Domains Framework of critical care physicians caring for patients with severe traumatic brain injury across Canada. We stratified critical care physicians by regions and used a purposive sampling strategy. We conducted semistructured phone interviews using a piloted and pretested interview guide. We transcribed the interviews verbatim and verified the content for accuracy. We performed the analysis using a 3-step approach: coding, generation of specific beliefs and generation of specific themes. RESULTS: We recruited 20 critical care physicians across 4 geographic regions. After reaching saturation, we identified 7 core themes across 4 Theoretical Domains Framework domains for factors relevant to the decision to withdraw life-sustaining treatments. Four factors (i.e., clinical triggers, social triggers, interaction with families and intentions with medical decisions) were identified before the decision is made and 3 were identified during the decision-making process (i.e., considerations, priorities and knowledge needs). We identified multiple themes reflecting internal (n = 18, 8 Theoretical Domains Framework domains) and external (n = 15, 6 Theoretical Domains Framework domains) influences on the decision to withdraw life-sustaining treatments. INTERPRETATION: We identified several core themes and domains considered by critical care physicians in Canada in the decision to withdraw life-sustaining treatments in critically ill patients with severe traumatic brain injury. Future research should aim at identifying the factors influencing surrogate decision-makers in the decision to withdraw life-sustaining treatments in these patients.	[Turgeon, Alexis F.; Archambault, Patrick; Lauzier, Francois; Moore, Lynne; Boutin, Amelie] Univ Laval, CHU Quebec, Res Ctr, Dept Anesthesiol & Crit Care Med,Fac Med, Quebec City, PQ, Canada; [Turgeon, Alexis F.; Archambault, Patrick; Lauzier, Francois] Univ Laval, Populat Hlth & Optimal Hlth Practices Res Unit, Trauma Emergency Crit Care Med, Dept Anesthesiol & Crit Care Med,Fac Med, Quebec City, PQ, Canada; [Turgeon, Alexis F.; Archambault, Patrick; Lauzier, Francois] Univ Laval, Div Crit Care Med, Dept Anesthesiol & Crit Care Med, Fac Med, Quebec City, PQ, Canada; [Dorrance, Kristin; English, Shane; McIntyre, Lauralyn A.; Squires, Janet E.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Archambault, Patrick] Univ Laval, Dept Family & Emergency Med, Fac Med, Quebec City, PQ, Canada; [Lauzier, Francois] Univ Laval, Dept Med, Fac Med, Quebec City, PQ, Canada; [Lamontagne, Francois] Univ Sherbrooke, Dept Med, Sherbrooke, PQ, Canada; [Lamontagne, Francois] Univ Sherbrooke, Ctr Rech, CHU Sherbrooke, Sherbrooke, PQ, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Internal Med, Sect Crit Care Med, Fac Med, Winnipeg, MB, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Internal Med, Sect Haematol, Fac Med, Winnipeg, MB, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Internal Med, Sect Med Oncol, Fac Med, Winnipeg, MB, Canada; [Fowler, Robert; Scales, Damon] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada; [Moore, Lynne] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada; [Lacroix, Jacques] Univ Montreal, CHU Ste Justine Res Ctr, Montreal, PQ, Canada; [Bernard, Francis] Univ Montreal, CHU Ste Justine, Montreal, PQ, Canada; [Bernard, Francis] Univ Montreal, Dept Med, Montreal, PQ, Canada; [English, Shane; McIntyre, Lauralyn A.] Univ Ottawa, Div Crit Care, Dept Med, Ottawa, ON, Canada; [Muscedere, John] Queens Univ, Dept Crit Care Med, Kingston, ON, Canada; Queens Univ, Kingston Hlth Sci Ctr, Kingston, ON, Canada; [Burns, Karen E. A.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Burns, Karen E. A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Griesdale, Donald] Univ British Columbia, Div Crit Care Med, Dept Med, Vancouver, BC, Canada; [Griesdale, Donald] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [Bernard, Francis] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Yamada, Janet] Ryerson Univ, Daphne Cockwell Sch Nursing, Toronto, ON, Canada; [Squires, Janet E.] Univ Ottawa, Sch Nursing, Ottawa, ON, Canada		Turgeon, AF (corresponding author), Univ Laval, CHU Quebec, Res Ctr, Dept Anesthesiol & Crit Care Med,Fac Med, Quebec City, PQ, Canada.; Turgeon, AF (corresponding author), Univ Laval, Populat Hlth & Optimal Hlth Practices Res Unit, Trauma Emergency Crit Care Med, Dept Anesthesiol & Crit Care Med,Fac Med, Quebec City, PQ, Canada.; Turgeon, AF (corresponding author), Univ Laval, Div Crit Care Med, Dept Anesthesiol & Crit Care Med, Fac Med, Quebec City, PQ, Canada.	alexis.turgeon@fmed.ulaval.ca	Zarychanski, Ryan/AAB-6369-2022; McIntyre, Lauralyn/AAR-7710-2021; English, Shane/P-9187-2019; Muscedere, John/AAH-9291-2021; Lauzier, Francois/B-9237-2015	McIntyre, Lauralyn/0000-0001-7421-1407; English, Shane/0000-0002-9477-6146; Lauzier, Francois/0000-0002-6530-5513; Boutin, Amelie/0000-0003-1907-2920	Fonds de la Recherche du Quebec -Sante (FRQS) [24792]; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [354039]; FRQS; CIHRCanadian Institutes of Health Research (CIHR); Traumatology Research Consortium (FRQS); Canadian Traumatic Brain Injury Research Consortium - CIHR	This research was supported by the Fonds de la Recherche du Quebec -Sante (FRQS; grant no. 24792) and by the Canadian Institutes of Health Research (CIHR; Foundation Scheme no. 354039). Alexis Turgeon holds the Canada Research Chair in Critical Neurology and Trauma. Francois Lauzier, Francois Lamontagne and Lynne Moore received research salary awards from the FRQS. Patrick Archambault received an embedded clinician researcher salary award from the CIHR. Amelie Boutin received a training award from the CIHR when this work was performed. Alexis Turgeon, Francois Lauzier and Lynne Moore are supported by the Traumatology Research Consortium (FRQS). The Canadian Critical Care Trials Group is funded by a Community Development Grant from CIHR, and the Canadian Traumatic Brain Injury Research Consortium is funded by a Team Grant from CIHR.	Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2000, MANAGEMENT PROGNOSIS, P153; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; Cuthbertson BH, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-117; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Francis JJ, 2009, BRIT J HEALTH PSYCH, V14, P625, DOI 10.1348/135910708X397025; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Heyland D, 2015, CRIT CARE MED, V43, P1352, DOI 10.1097/CCM.0000000000001024; Islam R, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-93; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; OCALLAHAN JG, 1995, CRIT CARE MED, V23, P1567, DOI 10.1097/00003246-199509000-00018; Sandelowski M, 2004, QUAL HEALTH RES, V14, P1366, DOI 10.1177/1049732304269672; Souter M, 2010, CRIT CARE MED, V38, pS502, DOI 10.1097/CCM.0b013e3181ec5354; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Wall SN, 1997, PEDIATRICS, V99, P64, DOI 10.1542/peds.99.1.64; WARME PE, 1991, ACTA NEUROCHIR, V110, P57, DOI 10.1007/BF01402049	23	8	8	0	1	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0820-3946	1488-2329		CAN MED ASSOC J	Can. Med. Assoc. J.	JUN 17	2019	191	24					E652	E663		10.1503/cmaj.190154			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ID7SV	WOS:000471883800002	31209132	Green Published, gold			2022-02-06	
J	Kim, GH; Kang, I; Jeong, H; Park, S; Hong, H; Kim, J; Kim, JY; Edden, RAE; Lyoo, IK; Yoon, S				Kim, Geon Ha; Kang, Ilhyang; Jeong, Hyeonseok; Park, Shinwon; Hong, Haejin; Kim, Jinsol; Kim, Jung Yoon; Edden, Richard A. E.; Lyoo, In Kyoon; Yoon, Sujung			Low Prefrontal GABA Levels Are Associated With Poor Cognitive Functions in Professional Boxers	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						GABA; professional boxers; prefrontal cortex; cognitive impairment; traumatic brain injury	TRAUMATIC BRAIN-INJURY; TEST BATTERY CANTAB; CONCUSSION; SPECTROSCOPY; DYSFUNCTION; IMPAIRMENT; BIOMARKERS; DECLINE; NEURONS	Cognitive dysfunction has long been recognized as a frequently observed symptom in individuals with repetitive mild traumatic brain injury (rmTBI) such as professional boxers. The exact neurobiological mechanisms underlying this cognitive deficit have not yet been identified, but it is agreed upon that the prefrontal cortex (PFC) is one of the most commonly affected brain regions in professional boxers. Noting the pivotal role of the two major brain metabolites in human cognitive functions, gamma-aminobutyric acid (GABA) and glutamate/glutamine (Glx), we hypothesized that alterations in levels of GABA and Glx in the PFC would be prominent and may correlate with cognitive deficits in professional boxers. Twenty male professional boxers (Boxers) and 14 age-matched healthy males who had never experienced any TBI (CON) were recruited. Using a 3T magnetic resonance imaging (MRI) scanner, single-voxel proton magnetic resonance spectroscopy with Mescher-Garwood point-resolved spectroscopy (MEGAPRESS) sequence was performed to evaluate the levels of GABA and Glx in the PFC. Cognitive function was assessed using the memory and attention domains from the Cambridge Neuropsychological Test Automated Battery. The Boxers showed lower GABA level in the PFC compared to the CON, while also showing lower performance in the attention and memory domains. There were no significant between-group differences in Glx levels. Furthermore, the GABA level correlated with memory performance in the Boxers, but not in attention performance. The current findings may suggest that alterations in GABA levels in the PFC may be a potential neurochemical correlate underlying memory dysfunction related to rmTBI.	[Kim, Geon Ha; Kang, Ilhyang; Park, Shinwon; Hong, Haejin; Kim, Jinsol; Kim, Jung Yoon; Lyoo, In Kyoon; Yoon, Sujung] Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea; [Kim, Geon Ha] Ewha Womans Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Kang, Ilhyang; Park, Shinwon; Hong, Haejin; Kim, Jinsol; Kim, Jung Yoon; Lyoo, In Kyoon; Yoon, Sujung] Ewha Womans Univ, Dept Brain & Cognit Sci, Seoul, South Korea; [Jeong, Hyeonseok] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea; [Edden, Richard A. E.] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Div Neuroradiol, Sch Med, Baltimore, MD USA; [Edden, Richard A. E.] Kennedy Krieger Inst, FM Kirby Ctr Funct Brain Imaging, Baltimore, MD USA; [Lyoo, In Kyoon] Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul, South Korea		Lyoo, IK; Yoon, S (corresponding author), Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea.; Lyoo, IK; Yoon, S (corresponding author), Ewha Womans Univ, Dept Brain & Cognit Sci, Seoul, South Korea.; Lyoo, IK (corresponding author), Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul, South Korea.	inkylyoo@ewha.ac.kr; sujungjyoon@ewha.ac.kr			National Research Foundation of Korea - Ministry of Science and ICT [2015M3C7A1028373, 2017M3C1B6071145]; Ministry of Trade, Industry and Energy (MOTIE, South Korea) [10063300]; ICT R&D program of Institute for Information and Communications Technology Promotion [B0132-15-1001]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 EB016089, P41 EB015909]	This work was supported through the National Research Foundation of Korea funded by the Ministry of Science and ICT (2015M3C7A1028373 to IL and 2017M3C1B6071145 to GK), by the Ministry of Trade, Industry and Energy (MOTIE, South Korea) under Industrial Technology Innovation Program (No. 10063300 to GK) and by the ICT R&D program of Institute for Information and Communications Technology Promotion (B0132-15-1001 to SY). This study applies tools developed under NIH R01 EB016089 and P41 EB015909; RE also receives salary support from these grants.	Bai X, 2015, J MAGN RESON IMAGING, V41, P1326, DOI 10.1002/jmri.24665; Banuelos C, 2014, J NEUROSCI, V34, P3457, DOI 10.1523/JNEUROSCI.5192-13.2014; Bernick C, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt177; Bhagwagar Z, 2007, BIOL PSYCHIAT, V61, P806, DOI 10.1016/j.biopsych.2006.08.048; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cazalis Fabienne, 2011, Front Neurol, V1, P158, DOI 10.3389/fneur.2010.00158; Chun MY, 2012, KOREAN J FAM MED, V33, P144, DOI 10.4082/kjfm.2012.33.3.144; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Edden RAE, 2014, J MAGN RESON IMAGING, V40, P1445, DOI 10.1002/jmri.24478; Fino E, 2013, NEUROSCIENTIST, V19, P228, DOI 10.1177/1073858412456743; Gao F, 2013, NEUROIMAGE, V78, P75, DOI 10.1016/j.neuroimage.2013.04.012; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Group N. Z. G, 2006, TRAUM BRAIN INJ DIAG; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Jordan BD, 1996, PHYSICIAN SPORTSMED, V24, P87, DOI 10.3810/psm.1996.05.1358; Junkkila J, 2012, DEMENT GERIATR COGN, V34, P83, DOI 10.1159/000342116; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lenehan ME, 2016, ASSESSMENT, V23, P163, DOI 10.1177/1073191115581474; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Li L, 2010, BRAIN RES, V1344, P173, DOI 10.1016/j.brainres.2010.05.016; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mishra VR, 2017, RADIOLOGY, V285, P555, DOI 10.1148/radiol.2017162403; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; Murray AJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16778; Nagahiro S, 2014, NEUROL MED-CHIR, V54, P878, DOI 10.2176/nmc.ra.2014-0224; Neidecker J, 2019, BRIT J SPORT MED, V53, P328, DOI 10.1136/bjsports-2017-098799; Ng TSC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt239; Northoff G, 2014, MOL PSYCHIATR, V19, P966, DOI 10.1038/mp.2014.68; Perez-Arredondo A, 2016, CLIN NEUROPHARMACOL, V39, P311, DOI 10.1097/WNF.0000000000000179; PETTY F, 1995, J AFFECT DISORDERS, V34, P275, DOI 10.1016/0165-0327(95)00025-I; Porges EC, 2017, BIOL PSYCHIAT-COGN N, V2, P38, DOI 10.1016/j.bpsc.2016.06.004; Rae CD, 2014, NEUROCHEM RES, V39, P1, DOI 10.1007/s11064-013-1199-5; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Rothman DL, 1997, MAGN RESON MED, V38, P924, DOI 10.1002/mrm.1910380611; Ruiz-Veguilla M, 2017, BRAIN STIMUL, V10, P459, DOI [10.1016/j.brs.2017.01.347, DOI 10.1016/J.BRS.2017.01.347]; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith PJ, 2013, J CLIN EXP NEUROPSYC, V35, P319, DOI 10.1080/13803395.2013.771618; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sun ZL, 2014, J NEURAL TRANSM, V121, P79, DOI 10.1007/s00702-013-1078-x; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Vascak M, 2018, CEREB CORTEX, V28, P1625, DOI 10.1093/cercor/bhx058; Westfall P.H., 1993, RESAMPLING BASED MUL; WESTFALL PH, 1993, BIOMETRICS, V49, P941, DOI 10.2307/2532216; Wilde EA, 2016, J NEUROTRAUM, V33, P672, DOI 10.1089/neu.2015.4035; Wilke S, 2017, J NEUROTRAUM, V34, P281, DOI 10.1089/neu.2016.4399; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Xia F, 2017, ELIFE, V6, DOI 10.7554/eLife.27868; Yoon JH, 2016, J NEUROSCI, V36, P11788, DOI 10.1523/JNEUROSCI.1970-16.2016; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	69	8	8	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	JUN 11	2019	13								193	10.3389/fnhum.2019.00193			9	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	ID3QJ	WOS:000471591700001	31244630	gold, Green Published			2022-02-06	
J	Ammann-Reiffer, C; Bastiaenen, CHG; Van Hegel, HJA				Ammann-Reiffer, Corinne; Bastiaenen, Caroline H. G.; Van Hegel, Hubertus J. A.			Measuring change in gait performance of children with motor disorders: assessing the Functional Mobility Scale and the Gillette Functional Assessment Questionnaire walking scale	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							CEREBRAL-PALSY; RELIABILITY; ABILITY; ADOLESCENTS; VALIDITY; OUTCOMES; QUALITY; COSMIN	Aim To examine the responsiveness and minimal important change (MIC) of two gait performance measures, the Functional Mobility Scale (FMS) and the Gillette Functional Assessment Questionnaire walking scale (FAQ), in a paediatric inpatient setting. Method Sixty-four children and adolescents with a motor disorder, including cerebral palsy, traumatic brain injury, or stroke (25 females, 39 males; mean age [SD] 12y 6mo [3y 2mo], range 6-18y 6mo), were recruited. Physiotherapists scored the FMS and FAQ at the start and end of active gait rehabilitation. Change scores were compared with changes in gait capacity tests, the walking item of the Functional Independence Measure for Children, and a global rating scale (GRS) on the physiotherapists' perceived change of the child's functional mobility. The GRS was also used to define the MIC. Results Change scores of the FMS and FAQ correlated between 0.35 and 0.49 with those of the capacity tests, 0.54 to 0.76 with the Functional Independence Measure for Children walking item change scores, and 0.57 to 0.76 with the GRS. The MIC values for the FMS and FAQ were 0.5 and 1.5 respectively. Interpretation FMS and FAQ can illustrate change in inpatient gait performance of children and adolescents with motor disorders. An improvement of one level in the FMS and two levels in the FAQ is considered as a clinically meaningful change.	[Ammann-Reiffer, Corinne; Van Hegel, Hubertus J. A.] Univ Childrens Hosp Zurich, Rehabil Ctr Children & Adolescents, Pediat Rehab Res Grp, Muhlebergstr 104, CH-8910 Affoltern Am Albis, Switzerland; [Ammann-Reiffer, Corinne; Bastiaenen, Caroline H. G.] Maastricht Univ, Dept Epidemiol Functioning & Rehabil, CAPHRI, Maastricht, Netherlands; [Ammann-Reiffer, Corinne; Van Hegel, Hubertus J. A.] Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland		Ammann-Reiffer, C (corresponding author), Univ Childrens Hosp Zurich, Rehabil Ctr Children & Adolescents, Pediat Rehab Res Grp, Muhlebergstr 104, CH-8910 Affoltern Am Albis, Switzerland.	Corinne.ammanna@kispi.uzh.ch	van Hedel, Hubertus/AAL-3818-2021	Ammann-Reiffer, Corinne/0000-0003-1766-7023; van Hedel, Hubertus/0000-0002-9577-5049	Maxi Foundation, Zurich, Switzerland	We thank all children, adolescents, and parents who participated in this research project. We thank Corina Kloti and the physiotherapists who helped collect the data. Further, we acknowledge funding by the Maxi Foundation, Zurich, Switzerland, for this project. We also acknowledge the Children's Research Center of the University Children's Hospital Zurich and the Neuroscience Center Zurich. The authors have stated that they had no interests that might be perceived as posing a conflict or bias.	Ammann-Reiffer C, 2019, PHYS OCCUP THER PEDI, V39, P181, DOI 10.1080/01942638.2017.1420003; Ammann-Reiffer C, 2017, DEV MED CHILD NEUROL, V59, P1158, DOI 10.1111/dmcn.13525; Ammann-Reiffer C, 2014, PHYS THER, V94, P1067, DOI 10.2522/ptj.20130299; Bartels B, 2013, PHYS THER, V93, P529, DOI 10.2522/ptj.20120210; Chung MK, 2007, ENCY MEASUREMENT STA; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; desVet HCW, 2011, MEASUREMENT MED PRAC; Graham HK, 2004, J PEDIATR ORTHOPED, V24, P514, DOI 10.1097/01241398-200409000-00011; Graser JV, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0538-y; Harvey A, 2008, DEV MED CHILD NEUROL, V50, P190, DOI 10.1111/j.1469-8749.2008.02027.x; Harvey A, 2007, DEV MED CHILD NEUROL, V49, P603, DOI 10.1111/j.1469-8749.2007.00603.x; Harvey A, 2010, DEV MED CHILD NEUROL, V52, P181, DOI 10.1111/j.1469-8749.2009.03354.x; Harvey AR, 2010, PHYS OCCUP THER PEDI, V30, P139, DOI 10.3109/01942630903454930; Himuro N, 2017, DISABIL REHABIL, V39, P957, DOI 10.1080/09638288.2016.1175036; Holsbeeke L, 2009, ARCH PHYS MED REHAB, V90, P849, DOI 10.1016/j.apmr.2008.11.015; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Novacheck TF, 2000, J PEDIATR ORTHOPED, V20, P75, DOI 10.1097/00004694-200001000-00017; Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898; Ottenbacher KJ, 1996, DEV MED CHILD NEUROL, V38, P907; Ruscio J, 2008, J MOD APPL STAT METH, V7, P416; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Stout JL, 2008, J BONE JOINT SURG AM, V90A, P2470, DOI 10.2106/JBJS.G.00327; Stout JL, 2012, DEV MED CHILD NEUROL, V54, P443, DOI 10.1111/j.1469-8749.2012.04231.x; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Trost JP, 2008, DEV MED CHILD NEUROL, V50, P765, DOI 10.1111/j.1469-8749.2008.03031.x; Watson MJ, 2002, PHYSIOTHERAPY, V88, P386, DOI [10.1016/S0031-9406(05)61264-3, DOI 10.1016/S0031-9406(05)61264-3, 10.1016/S0031_9406(05)61264_3]; Wilson NC, 2014, DEV MED CHILD NEUROL, V56, P808, DOI 10.1111/dmcn.12431; Ziviani Jenny, 2001, Physical and Occupational Therapy in Pediatrics, V21, P91; Zwicker JG, 2010, PEDIATR PHYS THER, V22, P361, DOI 10.1097/PEP.0b013e3181f92e54	30	8	10	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	JUN	2019	61	6					717	+		10.1111/dmcn.14071			9	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	HW6QI	WOS:000466814700023	30341775	hybrid, Green Published, Green Accepted			2022-02-06	
J	Chierto, E; Simon, A; Castoldi, F; Meffre, D; Cristinziano, G; Sapone, F; Carrete, A; Borderie, D; Etienne, F; Rannou, F; Morrison, B; Massaad, C; Jafarian-Tehrani, M				Chierto, Elena; Simon, Anne; Castoldi, Francesca; Meffre, Delphine; Cristinziano, Giulia; Sapone, Francesca; Carrete, Alex; Borderie, Didier; Etienne, Francois; Rannou, Francois; Morrison, Barclay, III; Massaad, Charbel; Jafarian-Tehrani, Mehrnaz			Mechanical Stretch of High Magnitude Provokes Axonal Injury, Elongation of Paranodal Junctions, and Signaling Alterations in Oligodendrocytes	MOLECULAR NEUROBIOLOGY			English	Article						Tensile strain; Stretch-induced injury; Myelin; Oligodendrocytes; Traumatic brain injury; Cerebellum; Mechanostimulation; White matter injury	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; IN-VITRO; ENDOTHELIAL-CELLS; MYELIN DAMAGE; PROTEIN; ACTIVATION; DEMYELINATION; MODEL; REMYELINATION	Increasing findings suggest that demyelination may play an important role in the pathophysiology of brain injury, but the exact mechanisms underlying such damage are not well known. Mechanical tensile strain of brain tissue occurs during traumatic brain injury. Several studies have investigated the cellular and molecular events following a static tensile strain of physiological magnitude on individual cells such as oligodendrocytes. However, the pathobiological impact of high-magnitude mechanical strain on oligodendrocytes and myelinated fibers remains under investigated. In this study, we reported that an applied mechanical tensile strain of 30% on mouse organotypic culture of cerebellar slices induced axonal injury and elongation of paranodal junctions, two hallmarks of brain trauma. It was also able to activate MAPK-ERK1/2 signaling, a stretch-induced responsive pathway. The same tensile strain applied to mouse oligodendrocytes in primary culture induced a profound damage to cell morphology, partial cell loss, and a decrease of myelin protein expression. The lower tensile strain of 20% also caused cell loss and the remaining oligodendrocytes appeared retracted with decreased myelin protein expression. Finally, high-magnitude tensile strain applied to 158N oligodendroglial cells altered myelin protein expression, dampened MAPK-ERK1/2 and MAPK-p38 signaling, and enhanced the production of reactive oxygen species. The latter was accompanied by increased protein oxidation and an alteration of anti-oxidant defense that was strain magnitude-dependent. In conclusion, mechanical stretch of high magnitude provokes axonal injury with significant alterations in oligodendrocyte biology that could initiate demyelination.	[Chierto, Elena; Simon, Anne; Castoldi, Francesca; Meffre, Delphine; Cristinziano, Giulia; Sapone, Francesca; Carrete, Alex; Borderie, Didier; Etienne, Francois; Rannou, Francois; Massaad, Charbel; Jafarian-Tehrani, Mehrnaz] Univ Paris 05, Fac Sci Fondamentales & Biomed, Sorbonne Paris Cite, INSERM,UMR S 1124, 45 Rue St Peres, F-75006 Paris, France; [Borderie, Didier] Grp Hosp Cochin, AP HP, Hop Univ Paris Ctr, Serv Diagnost Biol, 27 Rue Faubourg St Jacques, F-75679 Paris 14, France; [Etienne, Francois; Rannou, Francois] Univ Paris 05, Fac Sci Fondamentales & Biomed, Sorbonne Paris Cite, Plateforme Mecanobiol, 45 Rue St Peres, F-75006 Paris, France; [Rannou, Francois] Grp Hosp Cochin, AP HP, Hop Univ Paris Ctr, Serv Reeduc & Readaptat Appareil Locomoteur & Pat, 27 Rue Faubourg St Jacques, F-75679 Paris 14, France; [Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, 1210 Amsterdam Ave,351 Engn Terrace,MC8904, New York, NY 10027 USA		Jafarian-Tehrani, M (corresponding author), Univ Paris 05, Fac Sci Fondamentales & Biomed, Sorbonne Paris Cite, INSERM,UMR S 1124, 45 Rue St Peres, F-75006 Paris, France.	mehrnaz.jafarian@parisdescartes.fr	Cristinziano, Giulia/AAB-8776-2021; Ruiz, Rebeca Gallego/AAE-8590-2021; Morrison, Barclay/B-7132-2008	Cristinziano, Giulia/0000-0001-8016-2226; Ruiz, Rebeca Gallego/0000-0001-9154-5951; Morrison, Barclay/0000-0001-7676-0864; MEFFRE, Delphine/0000-0002-9204-2245	Fondation des Gueules Cassees; Paris Descartes University; INSERM (Institut National de la Sante Et de la Recherche Medicale)Institut National de la Sante et de la Recherche Medicale (Inserm); French Ministry of ResearchMinistry of Research, FranceEuropean Commission	This work was supported by the non-profit organization "Fondation des Gueules Cassees" (grants toMJT), Paris Descartes University, and INSERM (Institut National de la Sante Et de la Recherche Medicale). E.C. is a recipient of PhD fellowship from French Ministry of Research.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Arulmoli J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08499; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; BASS DA, 1983, J IMMUNOL, V130, P1910; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BELLOMO G, 2003, MICROSC RES TECHNIQ, V36, P243, DOI DOI 10.1002/(SICI)1097-0029(19970215)36:4; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; Caprariello AV, 2012, ANN NEUROL, V72, P395, DOI 10.1002/ana.23606; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cervellini I, 2018, J NEUROSCI, V38, P679, DOI 10.1523/JNEUROSCI.2255-17.2017; Chew LJ, 2010, J NEUROSCI, V30, P11011, DOI 10.1523/JNEUROSCI.2546-10.2010; Chung SH, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.119; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Cui YD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7333; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Ellis EF, 2007, J NEUROCHEM, V101, P1463, DOI 10.1111/j.1471-4159.2007.04515.x; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Espinosa-Diez C, 2015, REDOX BIOL, V6, P183, DOI 10.1016/j.redox.2015.07.008; Feutz AC, 2001, GLIA, V34, P241, DOI 10.1002/glia.1058; FEUTZ AC, 1995, J NEUROCYTOL, V24, P865, DOI 10.1007/BF01179985; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Flygt J, 2018, J NEUROTRAUM, V35, P2837, DOI 10.1089/neu.2018.5660; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; French HM, 2009, J NEUROSCI RES, V87, P3076, DOI 10.1002/jnr.22139; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Ghandour MS, 2002, GLIA, V40, P300, DOI 10.1002/glia.10122; Gladman SJ, 2010, NEUROSCIENCE, V171, P577, DOI 10.1016/j.neuroscience.2010.07.009; Gladman SJ, 2012, J NEUROSCI, V32, P563, DOI 10.1523/JNEUROSCI.3371-11.2012; Gonsalvez D, 2016, NEUROPHARMACOLOGY, V110, P586, DOI 10.1016/j.neuropharm.2015.04.024; Haines JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145843; Hernandez M, 2016, J NEUROSCI, V36, P806, DOI 10.1523/JNEUROSCI.2873-15.2016; Herrera JJ, 2017, J NEUROTRAUM, V34, P291, DOI 10.1089/neu.2016.4407; Hsu HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012470; Jackman N, 2009, PHYSIOLOGY, V24, P290, DOI 10.1152/physiol.00016.2009; Jagielska A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00093; Jagielska A, 2012, STEM CELLS DEV, V21, P2905, DOI 10.1089/scd.2012.0189; Jeffries MA, 2016, J NEUROSCI, V36, P9186, DOI 10.1523/JNEUROSCI.1444-16.2016; Kaunas R, 2006, CELL SIGNAL, V18, P1924, DOI 10.1016/j.cellsig.2006.02.008; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kito H, 2000, J APPL PHYSIOL, V89, P2391, DOI 10.1152/jappl.2000.89.6.2391; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Llufriu-Daben G, 2018, J NEUROSCIENCE METHO; Llufriu-Daben G, 2018, NEUROBIOL DIS, V109, P11, DOI 10.1016/j.nbd.2017.09.008; Lourenco T, 2016, SCI REP-UK, V6, DOI 10.1038/srep21563; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Martineau LC, 2001, J APPL PHYSIOL, V91, P693, DOI 10.1152/jappl.2001.91.2.693; MAXWELL WL, 2004, MICROSC RES TECHNIQ, V34, P522, DOI DOI 10.1002/(SICI)1097-0029(19960815)34:6; McDonald S, 2019, BRAIN IMAGING BEHAV, V13, P819, DOI 10.1007/s11682-018-9906-0; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Meffre D, 2015, NEUROSCIENCE, V284, P962, DOI 10.1016/j.neuroscience.2014.10.064; Meffre D, 2015, P NATL ACAD SCI USA, V112, P7587, DOI 10.1073/pnas.1424951112; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; O'Meara RW, 2011, JOVE-J VIS EXP, DOI 10.3791/3324; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Owens JA, 2018, BRAIN INJURY, V32, P776, DOI 10.1080/02699052.2018.1451656; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Rosenberg SS, 2008, P NATL ACAD SCI USA, V105, P14662, DOI 10.1073/pnas.0805640105; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sanz-Rodriguez M, 2018, J NEUROSCI, V38, P5096, DOI 10.1523/JNEUROSCI.3364-17.2018; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Shimizu T, 2017, GLIA, V65, P360, DOI 10.1002/glia.23096; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Simons M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020479; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Sultana R, 2013, FREE RADICAL BIO MED, V62, P157, DOI 10.1016/j.freeradbiomed.2012.09.027; Sun WJ, 2012, J NEUROTRAUM, V29, P611, DOI 10.1089/neu.2011.2086; Sun XJ, 2012, EXP NEUROL, V237, P304, DOI 10.1016/j.expneurol.2012.07.011; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; Tomaiuolo F, 2012, BRAIN RES BULL, V87, P373, DOI 10.1016/j.brainresbull.2012.01.008; Urbanski MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33751; Vande Geest Jonathan P, 2004, J Biomech, V37, P1923, DOI 10.1016/j.jbiomech.2004.02.022; Volman V, 2014, J COMPUT NEUROSCI, V37, P439, DOI 10.1007/s10827-014-0515-7; Wang LW, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-175; Wang ZQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151489; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003; Zhou H, 2011, NEUROCHEM RES, V36, P17, DOI 10.1007/s11064-010-0254-8	94	8	9	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2019	56	6					4231	4248		10.1007/s12035-018-1372-6			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HX6DJ	WOS:000467494000030	30298339	Green Published, hybrid			2022-02-06	
J	Fehily, B; Bartlett, CA; Lydiard, S; Archer, M; Milbourn, H; Majimbi, M; Hemmi, JM; Dunlop, SA; Yates, NJ; Fitzgerald, M				Fehily, Brooke; Bartlett, Carole A.; Lydiard, Stephen; Archer, Michael; Milbourn, Hannah; Majimbi, Maimuna; Hemmi, Jan M.; Dunlop, Sarah A.; Yates, Nathanael J.; Fitzgerald, Melinda			Differential responses to increasing numbers of mild traumatic brain injury in a rodent closed-head injury model	JOURNAL OF NEUROCHEMISTRY			English	Article						functional deficits; microglia; myelin abnormalities; oxidative stress; repeated mild traumatic brain injury; transmission electron microscopy	WHITE-MATTER; SECONDARY DEGENERATION; COGNITIVE IMPAIRMENT; AXONAL INJURY; WATER-MAZE; VULNERABILITY; CONCUSSION; PATHOLOGY; RATS; PATHOPHYSIOLOGY	Following mild traumatic brain injury (mTBI), further mild impacts can exacerbate negative outcomes. To compare chronic damage and deficits following increasing numbers of repeated mTBIs, a closed-head weight-drop model of repeated mTBI was used to deliver 1, 2 or 3 mTBIs to adult female rats at 24 h intervals. Outcomes were assessed at 3 months following the first mTBI. No gross motor, sensory or reflex deficits were identified (p > 0.05), consistent with current literature. Cognitive function assessed using a Morris water maze revealed chronic memory deficits following 1 and 2, but not 3 mTBI compared to shams (p <= 0.05). Oxidative damage to DNA was assessed immunohistochemically in the dentate hilus of the hippocampus and splenium of the corpus callosum; no changes were observed. IBA1-positive microglia were increased in size in the cortex following 1 mTBI and in the corpus callosum following 2 mTBI compared to shams (p <= 0.05); no changes were observed in the dentate hilus. Glial fibrillary acidic protein (GFAP)-positive astrocyte immunoreactivity was assessed in all three brain regions and no chronic changes were observed. Integrity of myelin ultrastructure in the corpus callosum was assessed using transmission electron microscopy. G ratio was decreased following 2 mTBIs compared to shams (p <= 0.05) at post hoc level only. The changing patterns of damage and deficits following increasing numbers of mTBI may reflect dynamic responses to small numbers of mTBIs or a conditioning effect such that increasing numbers of mTBIs do not necessarily result in worsening pathology. Open science badges This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at . Cover Image for this issue: doi: .	[Fehily, Brooke; Bartlett, Carole A.; Lydiard, Stephen; Archer, Michael; Milbourn, Hannah; Majimbi, Maimuna; Hemmi, Jan M.; Dunlop, Sarah A.; Fitzgerald, Melinda] Sch Biol Sci, Expt & Regenerat Neurosci, Crawley, WA, Australia; [Fehily, Brooke; Yates, Nathanael J.] Univ Western Australia, Sch Human Sci, Nedlands, WA, Australia; [Majimbi, Maimuna; Fitzgerald, Melinda] Fac Hlth Sci, Curtin Hlth Innovat Res Inst, Bentley, WA, Australia; [Fitzgerald, Melinda] Perron Inst Neurol & Translat Sci, Sarich Neurosci Res Inst Bldg, Nedlands, WA, Australia		Fitzgerald, M (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Sarich Neurosci Res Inst Bldg 8 Verdun St, Nedlands, WA 6009, Australia.; Fitzgerald, M (corresponding author), Perron Inst, Sarich Neurosci Res Inst Bldg 8 Verdun St, Nedlands, WA 6009, Australia.	lindy.fitzgerald@curtin.edu.au	Hemmi, Jan M/B-6458-2008; Fitzgerald, Melinda/C-4235-2011; Yates, Nathanael/K-8358-2018	Hemmi, Jan M/0000-0003-4629-9362; Fitzgerald, Melinda/0000-0002-4823-8179; Milbourn, Hannah/0000-0003-4479-8635; Dunlop, Sarah/0000-0002-1306-3962; Yates, Nathanael/0000-0003-2742-6952; Fehily, Brooke/0000-0002-8432-4621	NHMRC Career Development FellowshipNational Health and Medical Research Council of Australia [APP1087114]	MF is supported by an NHMRC Career Development Fellowship (APP1087114). We thank Dr Andrew Mehnert for providing guidance with creating photomontages for TEM image analysis, Assoc./Prof Caitlin Wyrwoll for her provision of behavioural analysis software, Emeritus Professor Alan Harvey and Dr Ryan O'Hare Doig for helpful discussions, and Terence McGonigle for technical assistance with image deconvolution. No competing financial interests exist. M. Fitzgerald is an editor for Journal of Neurochemistry.	Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Briggs DI, 2016, AM J PATHOL, V186, P2869, DOI 10.1016/j.ajpath.2016.07.013; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cheng MF, 2013, FRONT NEUROENDOCRIN, V34, P167, DOI 10.1016/j.yfrne.2013.05.001; CHO EYP, 1989, EXP BRAIN RES, V78, P567; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Government N. S. W, 2011, CHILDR INF AC MAN HE; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Holbourn AHS, 1943, LANCET, V2, P438; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Itzkovich M, 2007, DISABIL REHABIL, V29, P1926, DOI 10.1080/09638280601046302; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; KATO H, 1991, BRAIN RES, V553, P238, DOI 10.1016/0006-8993(91)90831-F; Kongsui R, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0182-7; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Macciocchi SN, 1998, CLIN SPORT MED, V17, P27, DOI 10.1016/S0278-5919(05)70058-2; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martini DN, 2018, INT J PSYCHOPHYSIOL, V132, P25, DOI 10.1016/j.ijpsycho.2017.09.019; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Metz G. A., 2009, JOVE-J VIS EXP, V170, P229; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Miron VE, 2014, J NEUROCHEM, V130, P165, DOI 10.1111/jnc.12705; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mountney A, 2017, J NEUROTRAUM, V34, P2768, DOI 10.1089/neu.2016.4679; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Paxinos G., 2014, RAT BRAIN STEREOTAXI; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Prasad KN, 2015, BRAIN RES, V1599, P103, DOI 10.1016/j.brainres.2014.12.038; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Selwyn RG, 2016, J NEUROTRAUM, V33, P1479, DOI 10.1089/neu.2015.4129; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Smith NM, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1227-0; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Thomsen GM, 2016, J TRAUMA ACUTE CARE, V81, P1070, DOI 10.1097/TA.0000000000001248; Turner RC, 2014, NEUROSURGERY, V74, P382, DOI 10.1227/NEU.0000000000000292; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Yates NJ, 2017, EXP BRAIN RES, V235, P2133, DOI 10.1007/s00221-017-4958-8; Zhang L, 2004, J COMP NEUROL, V478, P395, DOI 10.1002/cne.20297	78	8	8	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUN	2019	149	5					660	678		10.1111/jnc.14673			19	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	IC4AI	WOS:000470904700006	30702755				2022-02-06	
J	Jiang, LL; Li, RG; Tang, HL; Zhong, JJ; Sun, HP; Tang, WJ; Wang, HJ; Zhu, JH				Jiang, Lili; Li, Ronggang; Tang, Hailiang; Zhong, Junjie; Sun, Huaping; Tang, Weijun; Wang, Huijuan; Zhu, Jianhong			MRI Tracking of iPS Cells-Induced Neural Stem Cells in Traumatic Brain Injury Rats	CELL TRANSPLANTATION			English	Article						induced pluripotent stem cells; neural stem cells; traumatic brain injury; superparamagnetic iron oxide particles; manganese-enhanced MRI	MANGANESE-ENHANCED MRI; CENTRAL-NERVOUS-SYSTEM; IN-VIVO TRACKING; THERAPY; GENERATION; ACTIVATION; MOUSE; VITRO	Induced pluripotent stem cells (iPS cells) are promising cell source for stem cell replacement strategy applied to brain injury caused by traumatic brain injury (TBI) or stroke. Neural stem cell (NSCs) derived from iPS cells could aid the reconstruction of brain tissue and the restoration of brain function. However, tracing the fate of iPS cells in the host brain is still a challenge. In our study, iPS cells were derived from skin fibroblasts using the four classic factors Oct4, Sox2, Myc, and Klf4. These iPS cells were then induced to differentiate into NSCs, which were incubated with superparamagnetic iron oxides (SPIOs) in vitro. Next, 30 TBI rat models were prepared and divided into three groups (n = 10). One week after brain injury, group A&B rats received implantation of NSCs (labeled with SPIOs), while group C rats received implantation of non-labeled NSCs. After cell implantation, all rats underwent T2*-weighted magnetic resonance imaging (MRI) scan at day 1, and 1 week to 4 weeks, to track the distribution of NSCs in rats' brains. One month after cell implantation, manganese-enhanced MRI (ME-MRI) scan was performed for all rats. In group B, diltiazem was infused during the ME-MRI scan period. We found that (1) iPS cells were successfully derived from skin fibroblasts using the four classic factors Oct4, Sox2, Myc, and Klf4, expressing typical antigens including SSEA4, Oct4, Sox2, and Nanog; (2) iPS cells were induced to differentiate into NSCs, which could express Nestin and differentiate into neural cells and glial cells; (3) NSCs were incubated with SPIOs overnight, and Prussian blue staining showed intracellular particles; (4) after cell implantation, T2*-weighted MRI scan showed these implanted NSCs could migrate to the injury area in chronological order; (5) the subsequent ME-MRI scan detected NSCs function, which could be blocked by diltiazem. In conclusion, using an in vivo MRI tracking technique to trace the fate of iPS cells-induced NSCs in host brain is feasible.	[Jiang, Lili; Wang, Huijuan] Fudan Univ, Huashan Hosp, Dept Nursing, Shanghai 200040, Peoples R China; [Li, Ronggang; Tang, Hailiang; Zhong, Junjie; Zhu, Jianhong] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Sun, Huaping; Tang, Weijun] Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai, Peoples R China		Wang, HJ (corresponding author), Fudan Univ, Huashan Hosp, Dept Nursing, Shanghai 200040, Peoples R China.; Zhu, JH (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China.	2564812537@qq.com; jzhu@fudan.edu.cn			National Key R&D Program of China [2018YFA0107900]; National Nature Science FoundationNational Natural Science Foundation of China (NSFC) [81200936]; Shanghai Committee of Science and TechnologyShanghai Science & Technology Committee [134119a8500]	We are very grateful to Dr. Li Yin (from Siemens Corporation) for her kind assistance in MRI scan. This study was supported by grant (No. 2018YFA0107900) from National Key R&D Program of China; grant (No. 81200936) from the National Nature Science Foundation, and grant (No. 134119a8500) from Shanghai Committee of Science and Technology.	Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan KWY, 2013, NAT MATER, V12, P268, DOI [10.1038/NMAT3525, 10.1038/nmat3525]; Connell JJ, 2015, REGEN MED, V10, P757, DOI 10.2217/rme.15.36; De Vloo P, 2017, BEHAV BRAIN RES; Esnault P, 2017, J NEUROSURG, V127, P16, DOI 10.3171/2016.4.JNS152600; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Gera A, 2010, REGEN MED, V5, P73, DOI 10.2217/RME.09.79; Koretsky AP, 2012, NEUROIMAGE, V62, P1208, DOI 10.1016/j.neuroimage.2012.02.076; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Lu HB, 2007, P NATL ACAD SCI USA, V104, P2489, DOI 10.1073/pnas.0606983104; Malheiros JM, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00161; Neri M, 2008, STEM CELLS, V26, P505, DOI 10.1634/stemcells.2007-0251; Pumphrey AL, 2017, RADIOLOGY, V282, P131, DOI 10.1148/radiol.2016152766; Randtke EA, 2017, MAGN RESON MED, V78, P97, DOI 10.1002/mrm.26348; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Shapiro EM, 2006, NEUROIMAGE, V32, P1150, DOI 10.1016/j.neuroimage.2006.04.219; Shen WB, 2016, CELL TRANSPLANT, V25, P1085, DOI 10.3727/096368915X689550; Silva AC, 2012, NEUROIMAGE, V62, P1009, DOI 10.1016/j.neuroimage.2012.01.008; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang HL, 2011, CHINESE MED J-PEKING, V124, P1848, DOI 10.3760/cma.j.issn.0366-6999.2011.12.016; Tang HL, 2013, CELL REPROGRAM, V15, P435, DOI 10.1089/cell.2012.0081; Thomaidou D, 2014, METHODS MOL BIOL, V1210, P9, DOI 10.1007/978-1-4939-1435-7_2; Tso D, 2015, NEURAL REGEN RES, V10, P1356, DOI 10.4103/1673-5374.165209; Villa C, 2011, TISSUE ENG PART B-RE, V17, P1, DOI 10.1089/ten.TEB.2010.0362; Wang P, 2014, STEM CELLS DEV, V23, P16, DOI 10.1089/scd.2013.0131; Watts LT, 2015, J NEUROTRAUM, V32, P1001, DOI 10.1089/neu.2014.3737; Wu X, 2008, J NEUROSURG, V108, P320, DOI 10.3171/JNS/2008/108/2/0320; Yao L, 2016, AM J TRANSL RES, V8, P4982; Zhao HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129625; Zhu J, 2005, CURR DRUG TARGETS, V6, P97, DOI 10.2174/1389450053345055; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	36	8	8	1	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.	JUN	2019	28	6			SI		747	755		10.1177/0963689718819994			9	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	IO3EU	WOS:000479264200010	30574806	gold, Green Published			2022-02-06	
J	Krishnamoorthy, V; Hough, CL; Vayilala, MS; Komisarow, J; Chaikittisilpa, N; Lele, AV; Raghunathan, K; Creutzfeldt, CJ				Krishnamoorthy, Vijay; Hough, Catherine L.; Vayilala, Monica S.; Komisarow, Jordan; Chaikittisilpa, Nophanan; Lele, Abhijit, V; Raghunathan, Karthik; Creutzfeldt, Claire J.			Tracheostomy After Severe Acute Brain Injury: Trends and Variability in the USA	NEUROCRITICAL CARE			English	Article						Brain injury; Tracheostomy; Respiratory failure	UNITED-STATES; PALLIATIVE CARE; OUTCOMES; STROKE; PROGNOSTICATION; MULTICENTER; SURVIVAL	Background/ObjectiveSevere acute brain injury (SABI) is responsible for 12 million deaths annually, prolonged disability in survivors, and substantial resource utilization. Little guidance exists regarding indication or optimal timing of tracheostomy after SABI. Our aims were to determine national trends in tracheostomy utilization among mechanically ventilated patients with SABI in the USA, as well as to examine factors associated with tracheostomy utilization following SABI.MethodsWe conducted a population-based retrospective cohort study using the National Inpatient Sample from 2002 to 2011. We identified adult patients with SABI, defined as a primary diagnosis of stroke, traumatic brain injury or post-cardiac arrest who received mechanical ventilation for greater than 96h. We analyzed trends in tracheostomy utilization over time and used multilevel mixed-effects logistic regression to analyze factors associated with tracheostomy utilization.ResultsThere were 94,082 hospitalizations for SABI during the study period, with 30,455 (32%) resulting in tracheostomy utilization. The proportion of patients with SABI who received a tracheostomy increased during the study period, from 28.0% in 2002 to 32.1% in 2011 (p<0.001). Variation in tracheostomy utilization was noted based on patient and facility characteristics, including higher odds of tracheostomy in large hospitals (OR 1.34, 95% CI 1.18-1.53, p<0.001, compared to small hospitals), teaching hospitals (OR 1.15, 95% CI 1.06-1.25, p=0.001, compared to non-teaching hospitals), and urban hospitals (OR 1.60, 95% CI 1.33-1.92, p<0.001, compared to rural hospitals).ConclusionsTracheostomy utilization has increased in the USA among patients with SABI, with wide variation by patient and facility-level factors.	[Krishnamoorthy, Vijay; Raghunathan, Karthik] Duke Univ, Dept Anesthesiol, 2301 Erwin Rd, Durham, NC 27710 USA; [Hough, Catherine L.] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA USA; [Vayilala, Monica S.; Lele, Abhijit, V] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Krishnamoorthy, Vijay; Hough, Catherine L.; Vayilala, Monica S.; Chaikittisilpa, Nophanan; Lele, Abhijit, V] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Komisarow, Jordan] Duke Univ, Dept Neurosurg, Durham, NC USA; [Creutzfeldt, Claire J.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA		Krishnamoorthy, V (corresponding author), Duke Univ, Dept Anesthesiol, 2301 Erwin Rd, Durham, NC 27710 USA.	vijay.krishnamoorthy@duke.edu	Creutzfeldt, Claire/AAA-1282-2020	Komisarow, Jordan/0000-0003-3919-7931	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [L30 NS084420, K23 NS099421]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS099421] Funding Source: NIH RePORTER	NIH L30 NS084420 (Krishnamoorthy), K23 NS099421 (Creutzfeldt).	Cai SQ, 2017, INJURY, V48, P866, DOI 10.1016/j.injury.2017.02.023; Cox CE, 2004, CRIT CARE MED, V32, P2219, DOI 10.1097/01.CCM.0000145232.46143.40; Cox CE, 2009, CRIT CARE MED, V37, P2888, DOI 10.1097/CCM.0b013e3181ab86ed; Creutzfeldt CJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3904; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; de Roulet Amory, 2017, J Trauma Acute Care Surg, V82, P781, DOI [10.1097/TA.0000000000001358, 10.1097/ta.0000000000001358]; George BP, 2014, NEUROLOGY, V83, P874, DOI 10.1212/WNL.0000000000000764; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Horn J, 2014, CURR OPIN CRIT CARE, V20, P280, DOI 10.1097/MCC.0000000000000085; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Kahn JM, 2015, CRIT CARE MED, V43, P282, DOI 10.1097/CCM.0000000000000710; Kendall M, 2018, CAN MED ASSOC J, V190, pE238, DOI 10.1503/cmaj.170604; Lorenz Laura, 2015, Issue Brief (Mass Health Policy Forum), P1; Mehta AB, 2015, AM J RESP CRIT CARE, V192, P446, DOI 10.1164/rccm.201502-0239OC; NAM J, 1987, BIOMETRICS, V43, P701, DOI 10.2307/2532006; Nonoyama ML, 2018, THORAX, V73, P644, DOI 10.1136/thoraxjnl-2017-211138; Prabhakaran S, 2017, NEUROL-CLIN PRACT, V7, P194, DOI 10.1212/CPJ.0000000000000358; Quill TE, 2011, JAMA-J AM MED ASSOC, V306, P1483, DOI 10.1001/jama.2011.1413; Sandroni C, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2060-7; Sandroni C, 2015, CURR OPIN CRIT CARE, V21, P209, DOI 10.1097/MCC.0000000000000202; Scales DC, 2015, AM J RESP CRIT CARE, V192, P404, DOI 10.1164/rccm.201505-1007ED; Singh T, 2017, STROKE, V48, P2534, DOI 10.1161/STROKEAHA.117.016893; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Wallace DJ, 2015, AM J RESP CRIT CARE, V191, P410, DOI 10.1164/rccm.201409-1746OC; Xian Y, 2014, STROKE, V45, P3243, DOI 10.1161/STROKEAHA.114.005620	26	8	9	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2019	30	3					546	554		10.1007/s12028-019-00697-5			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HY2EM	WOS:000467930300007	30919303	Green Accepted, Bronze			2022-02-06	
J	Lee, JM; Jeong, SW; Kim, MY; Park, JB; Kim, MS				Lee, Jong Min; Jeong, Sung Woo; Kim, Myoung Young; Park, Jun Bum; Kim, Min Soo			The Effect of Vitamin D Supplementation in Patients with Acute Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Brain injuries; Cognition; Glasgow outcome scale; Traumatic; Vitamin D	COGNITIVE DECLINE; D INSUFFICIENCY; CALCIUM; PATHOPHYSIOLOGY; PREVENTION; GUIDELINES; DEMENTIA; SCALE; RISK	OBJECTIVE: To investigate the acute and long-term effects of vitamin D supplementation on the recovery of patients with traumatic brain injury (TBI). METHODS: A retrospective study was conducted involving 345 patients with TBI who visited a single trauma center. Vitamin D serum levels were measured without supplementation at admission, 1 month, and 3 months post-TBI (control group) from August to December 2016. From January 2017, vitamin D supplementation was provided to patients with TBI with low vitamin D serum levels at admission (supplement group). The outcomes were investigated by assessing performance function (Extended Glasgow Outcome Scale) and cognitive function (Mini-Mental Status Examination, and Clinical Dementia Rating) at 1 week and 3 months post-TBI. RESULTS: The mean vitamin D serum level in patients with TBI at admission was 13.62 +/- 9.01 ng/mL. The level significantly increased from 14.03 +/- 8.68 ng/mL at admission to 37.42 +/- 12.57 ng/mL at 3 months post TBI in the supplement group (P < 0.001). The cognitive outcomes (Mini-Mental Status Examination/Clinical Dementia Rating, P = 0.042/P = 0.044) and GOS-E score (total TBI, P = 0.003; mild-to-moderate TBI, P = 0.002) significantly improved from the first week to 3 months post TBI in the patients with vitamin D supplementation. CONCLUSIONS: Administration of vitamin D supplements in mild-to-moderate TBI patients with significant vitamin D deficiency during the acute phase of the injury may improve long-term performance and cognitive outcomes. Therefore, the treatment strategies should be individually planned for the patients with TBI based on their baseline vitamin D level.	[Lee, Jong Min; Jeong, Sung Woo; Park, Jun Bum; Kim, Min Soo] Univ Ulsan, Ulsan Univ Hosp, Dept Neurosurg, Coll Med, Ulsan, South Korea; [Kim, Myoung Young] Sungkyunkwan Univ, Samsung Changwon Hosp, Dept Thorac & Cardiovasc Surg, Sch Med, Chang Won, South Korea		Kim, MS (corresponding author), Univ Ulsan, Ulsan Univ Hosp, Dept Neurosurg, Coll Med, Ulsan, South Korea.	kist1817@gmail.com		Park, Jun Bum/0000-0001-6005-9221; Kim, Min Soo/0000-0002-8901-7241	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT [2017R1C1B5018173]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (grant number: 2017R1C1B5018173).	Annweiler C, 2016, J INTERN MED, V280, P300, DOI 10.1111/joim.12491; Armas LAG, 2004, J CLIN ENDOCR METAB, V89, P5387, DOI 10.1210/jc.2004-0360; Asad M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0928-6; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bikle DD, 2010, TRENDS ENDOCRIN MET, V21, P375, DOI 10.1016/j.tem.2010.01.003; Bischoff-Ferrari Heike A, 2014, Adv Exp Med Biol, V810, P500; Calvo MS, 2005, J NUTR, V135, P310, DOI 10.1093/jn/135.2.310; Cekic M, 2011, NEUROBIOL AGING, V32, P864, DOI 10.1016/j.neurobiolaging.2009.04.017; Choi HS, 2013, ENDOCRINOL METAB, V28, P12, DOI 10.3803/EnM.2013.28.1.12; Clelland JD, 2014, SCHIZOPHR RES, V156, P15, DOI 10.1016/j.schres.2014.03.017; Dahlquist DT, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0093-8; Fogli-Cawley JJ, 2006, J NUTR, V136, P2908, DOI 10.1093/jn/136.11.2908; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Hollis BW, 1996, CALCIFIED TISSUE INT, V58, P4, DOI 10.1007/BF02509538; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Kamen DL, 2010, J MOL MED, V88, P441, DOI 10.1007/s00109-010-0590-9; Landel V, 2016, J ALZHEIMERS DIS, V53, P419, DOI 10.3233/JAD-150943; Miller JW, 2015, JAMA NEUROL, V72, P1295, DOI 10.1001/jamaneurol.2015.2115; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; Pangman VC, 2000, APPL NURS RES, V13, P209, DOI 10.1053/apnr.2000.9231; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Ross AC, 2011, PUBLIC HEALTH NUTR, V14, P938, DOI 10.1017/S1368980011000565; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Toffanello ED, 2014, NEUROLOGY, V83, P2292, DOI 10.1212/WNL.0000000000001080; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wong MSK, 2014, CIRCULATION, V130, P976, DOI 10.1161/CIRCULATIONAHA.114.010650; Zold E, 2011, AUTOIMMUN REV, V10, P155, DOI 10.1016/j.autrev.2010.09.018	34	8	9	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2019	126						E1421	E1426		10.1016/j.wneu.2019.02.244			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IA0BU	WOS:000469222400179	30904798				2022-02-06	
J	Marincowitz, C; Lecky, F; Allgar, V; Sheldon, T				Marincowitz, Carl; Lecky, Fiona; Allgar, Victoria; Sheldon, Trevor			Evaluation of the impact of the NICE head injury guidelines on inpatient mortality from traumatic brain injury: an interrupted time series analysis	BMJ OPEN			English	Article							MANAGEMENT STRATEGIES; HOSPITAL ADMISSIONS; ENGLAND; TRENDS; OUTCOMES; ADULTS	Objective To evaluate the impact of National Institute for Health and Care Excellence (NICE) head injury guidelines on deaths and hospital admissions caused by traumatic brain injury (TBI). Setting All hospitals in England between 1998 and 2017. Participants Patients admitted to hospital or who died up to 30 days following hospital admission with International Classification of Diseases (ICD) coding indicating the reason for admission or death was TBI. Intervention An interrupted time series analysis was conducted with intervention points when each of the three guidelines was introduced. Analysis was stratified by guideline recommendation specific age groups (0-15, 16-64 and 65+). Outcome measures The monthly population mortality and admission rates for TBI. Study design An interrupted time series analysis using complete Office of National Statistics cause of death data linked to hospital episode statistics for inpatient admissions in England. Results The monthly TBI mortality and admission rates in the 65+ age group increased from 0.5 to 1.5 and 10 to 30 per 100 000 population, respectively. The increasing mortality rate was unaffected by the introduction of any of the guidelines. The introduction of the second NICE head injury guideline was associated with a significant reduction in the monthly TBI mortality rate in the 16-64 age group (-0.005; 95% CI: -0.002 to -0.007). In the 0-15 age group the TBI mortality rate fell from around 0.05 to 0.01 per 100 000 population and this trend was unaffected by any guideline. Conclusion The introduction of NICE head injury guidelines was associated with a reduced admitted TBI mortality rate after specialist care was recommended for severe TBI. The improvement was solely observed in patients aged 16-64 years. The cause of the observed increased admission and mortality rates in those 65+ and potential treatments for TBI in this age group require further investigation.	[Marincowitz, Carl] Univ Hull, Hull York Med Sch, Kingston Upon Hull, N Humberside, England; [Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Allgar, Victoria] York Univ, HYMS Hlth Sci, York, N Yorkshire, England; [Sheldon, Trevor] Univ York, Hlth Sci, York, N Yorkshire, England		Marincowitz, C (corresponding author), Univ Hull, Hull York Med Sch, Kingston Upon Hull, N Humberside, England.	Carl.Marincowitz@hyms.ac.uk	Sheldon, Trevor/AAK-7088-2021	Sheldon, Trevor/0000-0002-7479-5913; Allgar, Victoria/0000-0002-5228-2623; Marincowitz, Carl/0000-0003-3043-7564	National Institute for Health Research Doctoral Fellowship [DRF-2016-09-086]; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR)	CM is funded by a National Institute for Health Research Doctoral Fellowship (DRF-2016-09-086). This study presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.	[Anonymous], 2017, MAJOR TRAUMA OLDER P; Barratt H, 2010, EMERG MED J, V27, P173, DOI 10.1136/emj.2009.075382; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Bouamra O, 2015, EMERG MED J, V32, P933, DOI 10.1136/emermed-2015-205176; Campbell MJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1001; Castelli A, 2008, MEASURING NHS OUTPUT, P43; Cnossen MC, 2016, J NEUROTRAUM; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Foks KA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3527; Fountain DM, 2017, ANN SURG, V265, P590, DOI 10.1097/SLA.0000000000001682; Fuller G, 2011, BRIT J NEUROSURG, V25, P414, DOI 10.3109/02688697.2011.570882; Goodacre S, 2008, EMERG MED J, V25, P556, DOI 10.1136/emj.2007.055723; Hamilton I, 2014, INT J DRUG POLICY, V25, P151, DOI 10.1016/j.drugpo.2013.05.016; Hand DJ, 2018, J ROYAL STAT SOC A, P1; Hassan Z, 2005, EMERG MED J, V22, P845, DOI 10.1136/emj.2004.021717; HODGKINSON S, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G104; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Lee JC, 2015, INJURY, V46, P854, DOI 10.1016/j.injury.2014.12.023; Linden A, 2015, STATA J, V15, P480, DOI 10.1177/1536867X1501500208; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marincowitz C, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022279; Marlow R, 2015, ARCH DIS CHILD, V100, P1136, DOI 10.1136/archdischild-2015-308615; Murthy S, 2012, CRIT CARE, V16, DOI 10.1186/cc11140; NICE, 2014, CG 176 HEAD INJ TRIA; NICE. National Clinical Guidance Centre, 2003, CLIN GUID 4 HEAD INJ; NICE. National Clinical Guidance Centre, 2007, GUID CG56 HEAD INJ T; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Yiannoullou P, 2017, ANN ROY COLL SURG, V99, P63, DOI 10.1308/rcsann.2016.0325	30	8	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JUN	2019	9	6							e028912	10.1136/bmjopen-2019-028912			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IC7ZV	WOS:000471197000097	31167873	Green Published, Green Accepted, gold			2022-02-06	
J	Slowinski, A; Coetzer, R; Byrne, C				Slowinski, Anya; Coetzer, Rudi; Byrne, Christopher			Pharmacotherapy Effectiveness in Treating Depression After Traumatic Brain Injury: A Meta-Analysis	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							MAJOR DEPRESSION; HEAD-INJURY; SERTRALINE; DISORDERS; ANTIDEPRESSANTS; MOOD	Objective: Depression is a highly prevalent neuropsychiatric sequela among individuals who have experienced traumatic brain injury (TBI). Despite its high prevalence, there continues to be conflicting evidence surrounding the efficacy of medication for treating depression post-TBI and whether different treatments have distinct effects. The aim of this study was to systematically review and synthesize the available evidence for the effectiveness of pharmacotherapy for depression following a TBI. Methods: A meta-analysis was completed using several online databases (PubMed, National Institute of Health and Care Excellence, and Healthcare Databases Advanced Search) to search for clinical trials involving various pharmacological treatments for depression in patients with TBIs. Twelve studies met the inclusion criteria and were assessed using their sample size, treatment duration, treatment used, TBI severity, method of assessment, and medication response. Standardized mean difference effect sizes (Cohen's d) were calculated for each study using pre- and postintervention scores and pooled using a random effects model to produce a summary effect size. Results: Fourteen effect sizes were calculated, and a mild to moderate pooled effect size (Cohen's d=-0.49, 95% CI: -0.96, -0.02, p=0.02) was found. Ten studies demonstrated effect sizes that were statistically significant, and four were nonsignificant. The weighted pooled effect size was higher for single-group design studies (Cohen's d=-1.35, 95% CI: -2.14, -0.56, N=5) compared with independent-group designs (Cohen's d=0.001, CI: -0.59, 0.58; N=9). Conclusions: This meta-analysis tentatively supports the view that pharmacological treatment may be effective in reducing depressive symptoms in those with depression following TBI. However, evidence from randomized controlled trials alone demonstrated no beneficial effect. The limitations are also discussed.	[Coetzer, Rudi; Byrne, Christopher] Betsi Cadwaladr Univ Hlth Board NHS, North Wales Brain Injury Serv, Bodelwyddan, Wales; [Slowinski, Anya; Coetzer, Rudi; Byrne, Christopher] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales		Byrne, C (corresponding author), Betsi Cadwaladr Univ Hlth Board NHS, North Wales Brain Injury Serv, Bodelwyddan, Wales.; Byrne, C (corresponding author), Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales.	Christopher.Byrne@nhs.wales.uk		Byrne, Christopher/0000-0002-8229-5361			Ansari Ahmed, 2014, Asian J Neurosurg, V9, P182, DOI 10.4103/1793-5482.146597; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Barker-Collo S, 2013, BRAIN INJURY, V27, P1124, DOI 10.3109/02699052.2013.801513; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Cascade Elisa, 2008, Psychiatry (Edgmont), V5, P31; Cipriani A, 2018, LANCET, V391, P1357, DOI 10.1016/S0140-6736(17)32802-7; Cohen J., 2013, STAT POWER ANAL BEHA; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; Fann JR, 2017, J HEAD TRAUMA REHAB, V32, P332, DOI 10.1097/HTR.0000000000000322; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Gorlyn M, 2008, J NEURAL TRANSM, V115, P1213, DOI 10.1007/s00702-008-0084-x; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Higgins J., 2008, COCHRANE HDB SYSTEMA; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kanetani Kouichi, 2003, Journal of Nippon Medical School, V70, P313; Kant R, 1998, BRAIN INJURY, V12, P661, DOI 10.1080/026990598122223; Kreitzer N, 2019, J HEAD TRAUMA REHAB, V34, pE47, DOI 10.1097/HTR.0000000000000439; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Linde K, 2015, ANN FAM MED, V13, P69, DOI 10.1370/afm.1687; Lipsey M. W., 2001, APPL SOCIAL RES METH, V49; Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371; Price A, 2011, J NEUROL NEUROSUR PS, V82, P914, DOI 10.1136/jnnp.2010.230862; Rapoport MJ, 2008, J PSYCHOPHARMACOL, V22, P860, DOI 10.1177/0269881107083845; Salter KL, 2016, J HEAD TRAUMA REHAB, V31, pE21, DOI 10.1097/HTR.0000000000000193; SARAN A, 1988, INT J PSYCHIAT MED, V18, P75, DOI 10.2190/15AH-JB7Q-U94T-JEAF; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; Zhang WT, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006960	35	8	8	0	2	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2019	31	3					220	227		10.1176/appi.neuropsych.18070158			8	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	IK5IW	WOS:000476619900007	30636565	Bronze, Green Submitted			2022-02-06	
J	Wofford, KL; Cullen, DK; Spiller, KL				Wofford, Kathryn L.; Cullen, D. Kacy; Spiller, Kara L.			Modulation of macrophage phenotype via phagocytosis of drug-loaded microparticles	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A			English	Article						macrophage; intracellular particles; dexamethasone; gene expression; cell-microparticle interactions	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; DEXAMETHASONE; MONOCYTES; EXPRESSION; RESPONSES; VASCULARIZATION; GLUCOCORTICOIDS; IDENTIFICATION; POLARIZATION	Monocyte-derived macrophages play a critical role in directing wound pathology following injury. Depending on their phenotype, macrophages also promote tissue regeneration. However, the therapeutic administration of macrophages with a controlled phenotype is challenging because macrophages are highly plastic and quickly revert to a detrimental, inflammatory phenotype in response to the environment of a damaged tissue. To address this issue, we developed a novel strategy to modulate macrophage phenotype intracellularly through phagocytosis of drug-loaded microparticles. Poly(lactic-co-glycolic acid) microparticles loaded with the anti-inflammatory drug dexamethasone (Dex) were phagocytosed by monocytes and stored intracellularly for at least 5 days. After differentiation into macrophages, cell phenotype was characterized over time with high-throughput gene expression analysis via NanoString. We found that the microparticles modulated macrophage phenotype for up to 7 days after microparticle uptake, with decreases in inflammation-related genes at early timepoints and upregulation of homing- and phagocytosis-related genes at multiple timepoints in a manner similar to cells treated with continuous free Dex. These data suggest that intracellularly loading macrophages with Dex microparticles via phagocytosis could be a unique methodology to selectively modulate macrophage phenotype over time. This strategy would allow therapeutic administration of macrophages for the treatment of a number of inflammatory disease and disorders. (c) 2019 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 1213-1224, 2019.	[Wofford, Kathryn L.; Spiller, Kara L.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Wofford, Kathryn L.; Cullen, D. Kacy] CMC VA Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA USA; [Wofford, Kathryn L.; Cullen, D. Kacy] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Cullen, D. Kacy] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Spiller, KL (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	spiller@drexel.edu		Wofford, Kathryn/0000-0002-0391-2641	Department of Veteran's AffairsUS Department of Veterans Affairs [I01-RX001097]; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01-HL130037]; Department of Education GAANN iCARE Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL130037] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX001097] Funding Source: NIH RePORTER	Contract grant sponsor: Department of Veteran's Affairs; contract grant number: I01-RX001097; Contract grant sponsor: National Heart, Lung, and Blood Institute; contract grant number: R01-HL130037; Contract grant sponsor: Department of Education GAANN iCARE Fellowship	Advani S, 1997, BONE, V20, P41, DOI 10.1016/S8756-3282(96)00314-6; Akilbekova D, 2015, J BIOMED MATER RES A, V103, P262, DOI 10.1002/jbm.a.35169; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Caulfield J, 2002, IMMUNOLOGY, V105, P155, DOI 10.1046/j.0019-2805.2001.01359.x; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Das A, 2013, BIOMATERIALS, V34, P9853, DOI 10.1016/j.biomaterials.2013.08.015; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Duffy BA, 2014, NEUROBIOL DIS, V63, P229, DOI 10.1016/j.nbd.2013.12.001; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078; Giles AJ, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0371-5; Graney PL, 2018, ACS BIOMATER SCI ENG, V4, P1137, DOI 10.1021/acsbiomaterials.6b00747; Gratchev A, 2005, SCAND J IMMUNOL, V61, P10, DOI 10.1111/j.0300-9475.2005.01524.x; Herdrich BJ, 2010, EUR J CARDIO-THORAC, V38, P691, DOI 10.1016/j.ejcts.2010.03.049; Hoekstra K, 2017, J LEUKOCYTE BIOL, V67, P801; Jiang KY, 2017, BIOMATERIALS, V114, P71, DOI 10.1016/j.biomaterials.2016.11.004; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; KUBOTA Y, 1983, Journal of Toxicological Sciences, V8, P189; KUNICKA JE, 1993, CELL IMMUNOL, V149, P39, DOI 10.1006/cimm.1993.1134; Lee S, 2016, J CONTROL RELEASE, V240, P527, DOI 10.1016/j.jconrel.2016.07.018; Mitchell MJ, 2014, P NATL ACAD SCI USA, V111, P930, DOI 10.1073/pnas.1316312111; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nairz M, 2017, PFLUG ARCH EUR J PHY, V469, P397, DOI 10.1007/s00424-017-1944-8; Novak ML, 2013, AM J PATHOL, V183, P1352, DOI 10.1016/j.ajpath.2013.06.034; Pentecost AE, 2017, BIOMATER SCI-UK, V5, P2131, DOI 10.1039/c7bm00294g; Pentecost A. E., 2016, MICROSCALE TECHNOLOG, P291; Penton-Rol G, 1999, J IMMUNOL, V163, P3524; Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/NMAT3922, 10.1038/nmat3922]; San Emeterio CL, 2017, BIOMATERIALS, V117, P32, DOI 10.1016/j.biomaterials.2016.11.021; Schaer DJ, 2002, BRIT J HAEMATOL, V119, P239, DOI 10.1046/j.1365-2141.2002.03790.x; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Spiller KL, 2017, ADV DRUG DELIVER REV, V122, P74, DOI 10.1016/j.addr.2017.05.010; Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017; Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012; Vegas AJ, 2016, NAT BIOTECHNOL, V34, P345, DOI 10.1038/nbt.3462; Vettori A, 2017, P NATL ACAD SCI USA, V114, P9948, DOI 10.1073/pnas.1705338114; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang Y, 2017, BIOMATERIALS, V112, P153, DOI 10.1016/j.biomaterials.2016.09.034; Witherel CE, 2016, WOUND REPAIR REGEN, V24, P514, DOI 10.1111/wrr.12423; Wofford KL, 2017, EXP NEUROL, V290, P85, DOI 10.1016/j.expneurol.2017.01.004; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01; Xing KL, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0103-2; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yu SS, 2013, MOL PHARMACEUT, V10, P975, DOI 10.1021/mp300434e; Zhang XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10376; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	50	8	8	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1549-3296	1552-4965		J BIOMED MATER RES A	J. Biomed. Mater. Res. Part A	JUN	2019	107	6					1213	1224		10.1002/jbm.a.36617			12	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	HX5DS	WOS:000467421500010	30672109	Green Accepted			2022-02-06	
J	Zhong, ZX; Feng, SS; Chen, SZ; Chen, ZM; Chen, XW				Zhong, Ze-Xiang; Feng, Si-Si; Chen, Shao-Ze; Chen, Zhen-Ming; Chen, Xuan-Wei			Inhibition of MSK1 Promotes Inflammation and Apoptosis and Inhibits Functional Recovery After Spinal Cord Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						MSK1; Spinal cord injury; Inflammation; Apoptosis; Functional recovery	TRAUMATIC BRAIN; REDUCES INFLAMMATION; ACTIVATION; PHOSPHORYLATION; ROLES; MAPK; RAT; ASTROCYTES; EXPRESSION; PATHWAYS	Mitogen- and stress-activated kinase (MSK) 1 is a nuclear serine/threonine kinase. In the central nervous system, it plays an important role in regulating cell proliferation and neuronal survival; it is also involved in astrocyte inflammation and the inhibition of inflammatory cytokine production. However, its specific role in spinal cord injury is not clear. Here, we aimed to elucidate this role using an in vivo animal model. In this study, we found that MSK1 is gradually decreased, starting 1day after spinal cord injury and to its lowest level 3days post-injury, after which it gradually increased. To further investigate the possible function of MSK1 in spinal cord injury, we interfered with its expression by utilizing a small interfering RNA (siRNA)-encoding lentivirus, which was injected into the injured spinal cord to inhibit local expression. After MSK1 inhibition, we found that the expression of tumor necrosis factor (TNF)-, interleukin (IL)-6, and IL-1 were increased. Moreover, the expression of IL-10 was decreased. In addition, neuronal apoptotic cells were increased significantly and expression of the apoptosis-related protein caspase-3 was also increased. Ultrastructural analysis of nerve cells also revealed typical neuronal apoptosis and severe neuronal damage. Finally, we found that hindlimb motor function decreased significantly with MSK1 knockdown. Therefore, our findings suggest that the inhibition of this protein promotes inflammatory responses and apoptosis and suppresses functional recovery after spinal cord injury. MSK1 might thus play an important role in repair after spinal cord injury by regulating inflammation and apoptosis.	[Zhong, Ze-Xiang; Chen, Shao-Ze; Chen, Zhen-Ming; Chen, Xuan-Wei] Fujian Med Univ, Affiliated Hosp 1, Dept Spine Surg, Fuzhou, Fujian, Peoples R China; [Feng, Si-Si] Fujian Med Univ, Sch Basic Med Sci, Dept Pathol, Fuzhou, Fujian, Peoples R China; [Feng, Si-Si] Fujian Med Univ, Sch Basic Med Sci, Inst Oncol, Fuzhou, Fujian, Peoples R China		Chen, XW (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Spine Surg, Fuzhou, Fujian, Peoples R China.	fjcxw@126.com			Medical Innovation Project of Fujian Provincial Health and Family Planning Commission [2014-CX-22]; Natural Science Foundation of Fujian ProvinceNatural Science Foundation of Fujian Province [2015J01388]	This work was supported by grants from Medical Innovation Project of Fujian Provincial Health and Family Planning Commission (2014-CX-22) and Natural Science Foundation of Fujian Province (2015J01388).	Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Chen XH, 2019, NEUROTOX RES, V35, P139, DOI 10.1007/s12640-018-9938-7; Cheng PP, 2013, INT J DEV NEUROSCI, V31, P783, DOI 10.1016/j.ijdevneu.2013.09.008; Clark CJ, 2007, J NEUROCHEM, V102, P1024, DOI 10.1111/j.1471-4159.2007.04601.x; Cronin M, 2008, MOL CELL NEUROSCI, V39, P152, DOI 10.1016/j.mcn.2008.06.005; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; El Mchichi B, 2007, CELL DEATH DIFFER, V14, P1826, DOI 10.1038/sj.cdd.4402187; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Goldshmit Y, 2018, NEURAL DEV, V13, DOI 10.1186/s13064-018-0122-9; Gong PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081747; Gonzalez R, 2003, EXP NEUROL, V184, P456, DOI 10.1016/S0014-4886(03)00257-7; Graeber MB, 2011, FEBS LETT, V585, P3798, DOI 10.1016/j.febslet.2011.08.033; Hashemi M, 2019, J CELL BIOCHEM, V120, P7199, DOI 10.1002/jcb.27994; Hu JZ, 2016, NEUROSCIENCE, V328, P40, DOI 10.1016/j.neuroscience.2016.04.031; Huante-Mendoza A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00533; Kaiser M, 2007, EUR J IMMUNOL, V37, P2583, DOI 10.1002/eji.200636606; Keane RW, 2006, J NEUROTRAUM, V23, P335, DOI 10.1089/neu.2006.23.335; Kim HG, 2008, CANCER RES, V68, P2538, DOI 10.1158/0008-5472.CAN-07-6597; Lang E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17316; Li Z, 2013, NEUROCHEM RES, V38, P2581, DOI 10.1007/s11064-013-1174-1; Lin CW, 2016, NEUROSCI BULL, V32, P137, DOI 10.1007/s12264-016-0017-x; Liu X, 2016, ACTA BIOCH BIOPH SIN, V48, P342, DOI 10.1093/abbs/gmw011; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Mellidis K, 2014, CARDIOVASC RES, V103, DOI 10.1093/cvr/cvu082.30; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Ning B, 2017, ONCOL LETT, V14, P2940, DOI 10.3892/ol.2017.6496; Ning B, 2013, J MOL NEUROSCI, V49, P380, DOI 10.1007/s12031-012-9893-3; Olgun HB, 2018, HIGH TITER PRODUCTIO, P323; Ottenweller JE, 2000, BIOL REPROD, V63, P730, DOI 10.1095/biolreprod63.3.730; Pan XQ, 2017, MOL NEUROBIOL, V54, P4781, DOI 10.1007/s12035-016-0021-1; Qu WS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-178; Reyskens KMSE, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00056; Rouanet C, 2017, ARQ NEURO-PSIQUIAT, V75, P387, DOI [10.1590/0004-282X20170048, 10.1590/0004-282x20170048]; Saghazadeh A, 2017, BIOMED PHARMACOTHER, V92, P128, DOI 10.1016/j.biopha.2017.05.048; Samuel MA, 2007, J VIROL, V81, P2614, DOI 10.1128/JVI.02311-06; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Tan BT, 2017, CNS NEUROSCI THER, V23, P475, DOI 10.1111/cns.12694; Tian DS, 2009, J NEUROCHEM, V109, P1658, DOI 10.1111/j.1471-4159.2009.06077.x; Ueno Masaki, 2008, Biologics, V2, P253; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Wang HF, 2017, NEURAL REGEN RES, V12, P1724, DOI 10.4103/1673-5374.217354; Wang JS, 2016, EXP THER MED, V12, P3607, DOI 10.3892/etm.2016.3850; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Xu YZ, 2018, CELL MOL NEUROBIOL, V38, P929, DOI 10.1007/s10571-017-0567-0; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Zhong Zexiang, 2018, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V32, P941, DOI 10.7507/1002-1892.201801093; Zhu PP, 2014, MOL NEUROBIOL, V49, P1338, DOI 10.1007/s12035-013-8611-7	57	8	9	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	JUN	2019	68	2					191	203		10.1007/s12031-019-01298-9			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	HX8HZ	WOS:000467648300004	30919247	Green Published, hybrid			2022-02-06	
J	Pernici, CD; Kemp, BS; Murray, TA				Pernici, Chelsea D.; Kemp, Benjamin S.; Murray, Teresa A.			Time course images of cellular injury and recovery in murine brain with high-resolution GRIN lens system	SCIENTIFIC REPORTS			English	Article							TRAUMATIC AXONAL INJURY; MICROSCOPY; ACTIVATION; SEVERITY; CORTEX	Time course, in vivo imaging of brain cells is crucial to fully understand the progression of secondary cellular damage and recovery in murine models of injury. We have combined high-resolution gradient index lens technology with a model of diffuse axonal injury in rodents to enable repeated visualization of fine features of individual cells in three-dimensional space over several weeks. For example, we recorded changes in morphology in the same axons in the external capsule numerous times over 30 to 60 days, before and after induced traumatic brain injury. We observed the expansion of secondary injury and limited recovery of individual axons in this subcortical white matter tract over time. In another application, changes in microglial activation state were visualized in the penumbra region of mice before and after ischemia induced by middle carotid artery occlusion. The ability to collect a series of high-resolution images of cellular features of the same cells pre-and post-injury enables a unique opportunity to study the progression of damage, spontaneous healing, and effects of therapeutics in mouse models of neurodegenerative disease and brain injury.	[Pernici, Chelsea D.; Kemp, Benjamin S.; Murray, Teresa A.] Louisiana Tech Univ, Ctr Biomed Engn & Rehabil Sci, Ruston, LA 71270 USA		Murray, TA (corresponding author), Louisiana Tech Univ, Ctr Biomed Engn & Rehabil Sci, Ruston, LA 71270 USA.	tmurray@latech.edu	Murray, Teresa/AAV-3011-2020; Murray, Teresa/AAG-3531-2019	Murray, Teresa/0000-0002-8857-154X; Pernici, Chelsea/0000-0003-3531-7086	United States National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21HD075376, R21NS090131]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS090131] Funding Source: NIH RePORTER	This work was supported by the United States National Institutes of Health (grants R21HD075376 and R21NS090131 to T.A.M.). The authors thank Dr. Steven Jones of Louisiana Tech University for thoughtful suggestions on the manuscript. The authors thank Haley Alexander, Anassas Anderson, Angelica Andrews, Claire E Jones, Hunter Rasnic, and Amara Stokes of Louisiana Tech University for conducting blinded analysis of image data.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; Barretto RPJ, 2009, NAT METHODS, V6, P511, DOI 10.1038/nmeth.1339; Bocarsly ME, 2015, BIOMED OPT EXPRESS, V6, P4546, DOI 10.1364/BOE.6.004546; Brugg B, 2018, SCI REP, V8, P1; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Chen BY, 2018, BIOMED OPT EXPRESS, V9, P1992, DOI 10.1364/BOE.9.001992; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Eakin K, 2015, BRAIN NEUROTRAUMA MO, P259, DOI [10.1201/b18126-23, DOI 10.1201/B18126-23]; Engelbrecht CJ, 2008, OPT EXPRESS, V16, P5556, DOI 10.1364/OE.16.005556; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fisher M, 2004, STROKE, V35, P2657, DOI 10.1161/01.STR.0000143217.53892.18; Flusberg BA, 2005, OPT LETT, V30, P2272, DOI 10.1364/OL.30.002272; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gu YZ, 2017, J CELL BIOL, V216, P2179, DOI 10.1083/jcb.201606065; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Horton NG, 2013, NAT PHOTONICS, V7, P205, DOI [10.1038/NPHOTON.2012.336, 10.1038/nphoton.2012.336]; Hossain I, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00500; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Levene MJ, 2004, J NEUROPHYSIOL, V91, P1908, DOI 10.1152/jn.01007.2003; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Meng GH, 2019, ELIFE, V8, DOI 10.7554/eLife.40805; Min Y, 2017, FRONT NEUROSCI, V11, P1; Mistry AM, 2014, NEUROBIOL DIS, V65, P1, DOI 10.1016/j.nbd.2014.01.006; Mizrahi A, 2004, J NEUROSCI, V24, P3147, DOI 10.1523/JNEUROSCI.5218-03.2004; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Murray TA, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.021106; Ohayon S, 2018, BIOMED OPT EXPRESS, V9, P1492, DOI 10.1364/BOE.9.001492; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Rochow N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161030; Rowe RK, 2018, J NEUROSURG-PEDIATR, V22, P22, DOI 10.3171/2018.1.PEDS17449; Samson A. J, 2016, SCI REP, V6; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Stogios PJ, 2016, NAT COMMUN, V7, P1, DOI 10.1038/ncomms11343; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Vasquez-Lopez SA, 2018, LIGHT-SCI APPL, V7, DOI 10.1038/s41377-018-0111-0; Velasco MGM, 2014, BIOMED OPT EXPRESS, V5, P1700, DOI 10.1364/BOE.5.001700; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Vital S, 2016, J VIS EXP, V116; Voziyanov V, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00169; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Zakaria N, 2012, BRAIN RES, V1467, P81, DOI 10.1016/j.brainres.2012.05.046; Zhuang ZR, 2019, ACS CHEM NEUROSCI, V10, P649, DOI 10.1021/acschemneuro.8b00482; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247	65	8	8	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 28	2019	9								7946	10.1038/s41598-019-44174-7			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ9ZW	WOS:000469217400011	31138885	gold, Green Published			2022-02-06	
J	Algamal, M; Saltiel, N; Pearson, AJ; Ager, B; Burca, I; Mouzon, B; Diamond, DM; Mullan, M; Ojo, JO; Crawford, F				Algamal, Moustafa; Saltiel, Nicole; Pearson, Andrew J.; Ager, Bryan; Burca, Ioana; Mouzon, Benoit; Diamond, David M.; Mullan, Michael; Ojo, Joseph O.; Crawford, Fiona			Impact of Repetitive Mild Traumatic Brain Injury on Behavioral and Hippocampal Deficits in a Mouse Model of Chronic Stress	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; behavior; locomotor function; neuroplasticity; traumatic brain injury	DENDRITIC SPINES; NEUROTROPHIC FACTOR; CONDITIONED FEAR; DISORDER; VETERANS; MEMORY; BDNF; IRAQ; RAT; DISINHIBITION	Clinical studies examining the interaction between traumatic brain injury (TBI) and stress-related disorders (e.g., post-traumatic stress disorder) are often complicated by methodological constraints, such as heterogeneity in injury type and severity, time post-trauma, and predisposing risk factors. Developing relevant animal models whereby many variables can be efficiently controlled is thus essential to understanding this elusive relationship. Here, we use our repeated unpredictable stress (RUS) paradigm, in combination with our established mouse model of repetitive mild TBI (r-mTBI), to assess the impact of repeated exposures to these paradigms on behavioral and neurobiological measures. C57BL/6J male mice were exposed to RUS and r-mTBI at 3 and 6 months of age followed by batteries of behavioral testing. Mice were euthanized 10 days and 3 months post-exposure, with brain and plasma samples collected for molecular profiling. The RUS paradigm involved exposure to a predator odor (trimethylthiazoline; TMT) while under restraint, daily unstable social housing, five inescapable footshocks on separate days, and chronic social isolation. Animals receiving r-mTBI ( x 5) and stress were exposed to a single closed-head injury 1 h after each footshock. Stress-alone mice showed significant weight loss, recall of traumatic memories, and anxiety-like and passive stress-coping behavior when compared with control mice. However, in stress+r-mTBI animals, the changes in cued fear memory, anxiety, and stress-coping tests were diminished, possibly due to TBI-induced hyperactivity. We also report complex brain molecular and neuropathological findings. Stress and r-mTBI, either individually or comorbidly, were associated with a chronic reduction in dendritic spine GluN2A/GluN2B ratio in the hippocampus. While stress augmented the r-mTBI-dependent astrogliosis in the corpus callosum, it mitigated r-mTBI-induced increases in hippocampal pro-brain-derived neurotrophic factor. We anticipate that our model will be a good platform to untangle the complex comorbid pathophysiology in stress disorders and r-mTBI.	[Algamal, Moustafa; Saltiel, Nicole; Pearson, Andrew J.; Ager, Bryan; Burca, Ioana; Mouzon, Benoit; Mullan, Michael; Ojo, Joseph O.; Crawford, Fiona] Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA; [Algamal, Moustafa; Pearson, Andrew J.; Mullan, Michael; Ojo, Joseph O.; Crawford, Fiona] Open Univ, Milton Keynes, Bucks, England; [Saltiel, Nicole; Mouzon, Benoit; Ojo, Joseph O.; Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Diamond, David M.] Univ S Florida, Dept Psychol Mol Pharmacol & Physiol, Tampa, FL USA		Algamal, M (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	elgamal.mostafa@gmail.com		Algamal, Moustafa/0000-0002-6215-0122	Roskamp Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH109655-0]	This work was funded by The Roskamp Foundation. FC is a VA research career scientist. DD was supported by NIH grant R01 MH109655-0.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Algamal M, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00150; Ballachey EL, 1932, U CALIFORNIA PUBLICA, V6, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2017, NEUROLOGY, V88, P1490, DOI 10.1212/WNL.0000000000003852; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; CUI ZZ, 2013, SCI REP-UK, V3, DOI DOI 10.1038/SREP01036; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Frankfurt M, 2015, HORM BEHAV, V74, P28, DOI 10.1016/j.yhbeh.2015.05.004; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; GIL J, 2010, J TRAUMA STRESS, V21, P530; Gil-Bea FJ, 2007, BEHAV NEUROSCI, V121, P340, DOI 10.1037/0735-7044.121.2.340; Gill JM, 2009, PERSPECT PSYCHIATR C, V45, P262, DOI 10.1111/j.1744-6163.2009.00229.x; Gola H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-40; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hines LA, 2014, CAN J PSYCHIAT, V59, P468, DOI 10.1177/070674371405900903; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holdeman TC, 2009, PSYCHIAT SERV, V60, P273, DOI 10.1176/appi.ps.60.2.273; Ito H, 2010, NEUROPHARMACOLOGY, V58, P746, DOI 10.1016/j.neuropharm.2009.12.011; Jergovic M, 2014, PROG NEURO-PSYCHOPH, V54, P275, DOI 10.1016/j.pnpbp.2014.06.010; Kaidanovich-Beilin O, 2011, JOVE-J VIS EXP, DOI 10.3791/2473; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Kouro T, 2009, INT IMMUNOL, V21, P1303, DOI 10.1093/intimm/dxp102; Li CJ, 2004, P NATL ACAD SCI USA, V101, P2185, DOI 10.1073/pnas.0307313101; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Luine VN, 2011, CURR GERONTOL GERIAT, P1, DOI DOI 10.1016/J.NEUROIMAGE.2013.08.017; Mahmmoud RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139739; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; MOUZON B, 2018, BRAIN INJURY, P32, DOI DOI 10.1016/J.IJPSYCHO.2011.03.011; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Newcomer J W, 2000, Dialogues Clin Neurosci, V2, P219; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Prasad KN, 2015, BRAIN RES, V1599, P103, DOI 10.1016/j.brainres.2014.12.038; Qiao H, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8056370; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Sanz-Clemente A, 2013, NEUROSCIENTIST, V19, P62, DOI 10.1177/1073858411435129; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Shors TJ, 2004, EUR J NEUROSCI, V19, P145, DOI 10.1046/j.1460-9568.2003.03065.x; SIMONOVIC MM, 2011, EUROPEAN PSYCHIAT, V26, P1070; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Song YQ, 2007, NEUROIMMUNOMODULAT, V14, P248, DOI 10.1159/000112050; Sook-Kyung CK, 2011, FRONT NEUROL, V2, P1; Tzekov R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153608; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Baez MV, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/5093048; Vyas A, 2002, J NEUROSCI, V22, P6810; Wang Z, 2016, HUM IMMUNOL, V77, P652, DOI 10.1016/j.humimm.2016.05.018; WANG ZW, 2017, FRONT PSYCHIATRY, V8, DOI DOI 10.3389/FPSYT.2017.00222; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Wolf RC, 2016, NEUROPSYCHOPHARMACOL, V41, P822, DOI 10.1038/npp.2015.209	65	8	8	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2019	36	17					2590	2607		10.1089/neu.2018.6314		MAY 2019	18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	IW9BT	WOS:000470631800001	30963958	Green Published			2022-02-06	
J	Cao, R; Zhang, CC; Mitkin, VV; Lankford, MF; Li, J; Zuo, ZY; Meyer, CH; Goyne, CP; Ahlers, ST; Stone, JR; Hu, S				Cao, Rui; Zhang, Chenchu; Mitkin, Vladimir V.; Lankford, Miles F.; Li, Jun; Zuo, Zhiyi; Meyer, Craig H.; Goyne, Christopher P.; Ahlers, Stephen T.; Stone, James R.; Hu, Song			Comprehensive Characterization of Cerebrovascular Dysfunction in Blast Traumatic Brain Injury Using Photoacoustic Microscopy	JOURNAL OF NEUROTRAUMA			English	Article						blast traumatic brain injury; cerebrovascular reactivity; hemodynamics; oxygen metabolism; photoacoustic microscopy	CEREBRAL VASCULAR INJURY; BLOOD-FLOW; OXYGEN-SATURATION; LONG-TERM; REACTIVITY; INFLAMMATION; PRESSURE; ARTERY	Blast traumatic brain injury (bTBI) is a leading contributor to combat-related injuries and death. Although substantial emphasis has been placed on blast-induced neuronal and axonal injuries, co-existing dysfunctions in the cerebral vasculature, particularly the microvasculature, remain poorly understood. Here, we studied blast-induced cerebrovascular dysfunctions in a rat model of bTBI (blast overpressure: 187.8 +/- 18.3 kPa). Using photoacoustic microscopy (PAM), we quantified changes in cerebral hemodynamics and metabolism-including blood perfusion, oxygenation, flow, oxygen extraction fraction, and the metabolic rate of oxygen-4 h post-injury. Moreover, we assessed the effect of blast exposure on cerebrovascular reactivity (CVR) to vasodilatory stimulation. With vessel segmentation, we extracted these changes at the single-vessel level, revealing their dependence on vessel type (i.e., artery vs. vein) and diameter. We found that bTBI at this pressure level did not induce pronounced baseline changes in cerebrovascular diameter, blood perfusion, oxygenation, flow, oxygen extraction, and metabolism, except for a slight sO(2) increase in small veins (<45 mu m) and blood flow increase in large veins (>= 45 mu m). In contrast, this blast exposure almost abolished CVR, including arterial dilation, flow upregulation, and venous sO(2) increase. This study is the most comprehensive assessment of cerebrovascular structure and physiology in response to blast exposure to date. The observed impairment in CVR can potentially cause cognitive decline due to the mismatch between cognitive metabolic demands and vessel's ability to dynamically respond to meet the demands. Also, the impaired CVR can lead to increased vulnerability of the brain to metabolic insults, including hypoxia and ischemia.	[Cao, Rui; Zhang, Chenchu; Meyer, Craig H.; Hu, Song] Univ Virginia, Dept Biomed Engn, 415 Lane Rd,Room 2215, Charlottesville, VA 22908 USA; [Mitkin, Vladimir V.; Goyne, Christopher P.] Univ Virginia, Dept Mech & Aerosp Engn, Charlottesville, VA 22908 USA; [Lankford, Miles F.; Stone, James R.] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA 22908 USA; [Li, Jun; Zuo, Zhiyi] Univ Virginia, Dept Anesthesiol, Charlottesville, VA 22908 USA; [Ahlers, Stephen T.] Naval Med Res Ctr, Operat & Undersea Med Directorate, Silver Spring, MD USA		Hu, S (corresponding author), Univ Virginia, Dept Biomed Engn, 415 Lane Rd,Room 2215, Charlottesville, VA 22908 USA.	songhu@virginia.edu	Cao, Rui/B-1434-2016; Hu, Song/ABD-6256-2021	Cao, Rui/0000-0003-4444-7528; Hu, Song/0000-0002-5760-8012	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS099261]; Brain Institute at the University of Virginia (Transformative, Collaborative Neuroscience Pilot Grant);  [603115HP.3520.001.A1411]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS099261] Funding Source: NIH RePORTER	This work is supported in part by the National Institutes of Health (NS099261 to S.H.) and the Brain Institute at the University of Virginia (Transformative, Collaborative Neuroscience Pilot Grant to S.H. and C.M.). S.T. Ahlers: The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. Government. This work was supported/funded by work unit number 603115HP.3520.001.A1411. The study protocol was reviewed and approved by the Walter Reed Army Institute of Research/Naval Medical Research Center Institutional Animal Care and Use Committee in compliance with all applicable federal regulations governing the protection of animals in research. The experiments reported herein were conducted in compliance with the Animal Welfare Act and per the principles set forth in the Guide for Care and Use of Laboratory Animals, Institute of Laboratory Animals Resources, National Research Council, National Academy Press, 2011. Some of the authors are military service members (or employees of the U.S. Government). This work was prepared as part of their official duties. Title 17 U.S.C. 105 provides that "Copyright protection under this title is not available for any work of the United States Government." Title 17 U.S.C. 101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person's official duties.	Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; Bitner BR, 2012, ACS NANO, V6, P8007, DOI 10.1021/nn302615f; Buch S, 2017, J CEREBR BLOOD F MET, V37, P825, DOI 10.1177/0271678X16641129; Cao R., 2016, BIOMED OPT C, V150, P4; Cao R, 2017, NEUROIMAGE, V150, P77, DOI 10.1016/j.neuroimage.2017.01.049; Chan ST, 2009, BRAIN RES, V1291, P53, DOI 10.1016/j.brainres.2009.07.057; Chen SL, 2011, OPT LETT, V36, P4017, DOI 10.1364/OL.36.004017; Chen SL, 2010, OPT LETT, V35, P1200, DOI 10.1364/OL.35.001200; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Drew PJ, 2010, NAT METHODS, V7, P981, DOI [10.1038/nmeth.1530, 10.1038/NMETH.1530]; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Ellis Michael J, 2016, Front Neurol, V7, P61, DOI 10.3389/fneur.2016.00061; Esenaliev RO, 2018, J NEUROTRAUM, V35, P1510, DOI 10.1089/neu.2017.5249; Everds N., 2004, LAB MOUSE, P271, DOI DOI 10.1016/B978-012336425-8/50070-4; Goldey GJ, 2014, NAT PROTOC, V9, P2515, DOI 10.1038/nprot.2014.165; Govinahallisathyanarayana S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18860-3; HESTER RL, 1993, AM J PHYSIOL, V265, pH146; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Hu S., 2016, IEEE J SEL TOP QUANT, V22, P1, DOI DOI 10.HTTPS://D0I.0RG/10.1109/JSTQE.2015.2487890; Hu S., 2009, J BIOMED OPT, V14; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Markus H, 2001, BRAIN, V124, P457, DOI 10.1093/brain/124.3.457; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Ning B, 2015, SCI REP-UK, V5, DOI 10.1038/srep18775; Ning B, 2015, OPT LETT, V40, P910, DOI 10.1364/OL.40.000910; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; SAUNDERS NR, 2015, FRONT NEUROSCI SWITZ, V9; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Soetikno B, 2012, PROC SPIE, V8223, DOI 10.1117/12.911089; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Toklu HZ, 2015, J CEREBR BLOOD F MET, V35, P1950, DOI 10.1038/jcbfm.2015.151; Tully H, 2018, SCI TRANSL MED, V10; VORSTRUP S, 1984, J CLIN INVEST, V74, P1634, DOI 10.1172/JCI111579; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Xu Z, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3584847; Zhang HF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2435697; Zijlstra W.G., 2000, VISIBLE AND NEAR INF	56	8	8	4	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2019	36	10					1526	1534		10.1089/neu.2018.6062			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HX7CZ	WOS:000467562900004	30501547	Green Published			2022-02-06	
J	Hosomi, S; Koyama, Y; Watabe, T; Ohnishi, M; Ogura, H; Yamashita, T; Shimazu, T				Hosomi, Sanae; Koyama, Yoshihisa; Watabe, Tadashi; Ohnishi, Mitsuo; Ogura, Hiroshi; Yamashita, Toshihide; Shimazu, Takeshi			Myeloid-Derived Suppressor Cells Infiltrate the Brain and Suppress Neuroinflammation in a Mouse Model of Focal Traumatic Brain Injury	NEUROSCIENCE			English	Article						traumatic brain injury; inflammation; blood-brain barrier; myeloid-derived suppressor cells; microglia	INFLAMMATION; ADHESION; PET	Myeloid-derived suppressor cells (MDSCs) have strong immunosuppressive characteristics, which allow them to limit inflammation and facilitate wound healing and recovery. Although MDSCs are a newly-determined cell type that is gaining attention in the immunology field, their neuroimmunological characteristics remain unstudied. In this study, we explored the suppressive role of MDSCs in cerebral inflammatory reactions after focal traumatic brain injury (TBI) using in vivo imaging. Through morphological, functional, and phenotypic analyses we determined that CD11b(+)/Gr-1(+) cells infiltrating the contusion area are MDSCs. MDSCs are among the first responders to tissue injury, responding even prior to microglial activation. Positron emission tomography imaging of translocator protein results suggest that infiltrating MDSCs suppress neuronal inflammation and interact with resident immune cells, like microglia, following focal TBI. (C) 2019 IBRO. Published by Elsevier Ltd. All rights reserved.	[Hosomi, Sanae; Ohnishi, Mitsuo; Ogura, Hiroshi; Shimazu, Takeshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan; [Koyama, Yoshihisa; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka 5650871, Japan; [Watabe, Tadashi] Osaka Univ, Positron Emiss Tomog Mol Imaging Ctr, Grad Sch Med, Osaka 5650871, Japan; [Watabe, Tadashi] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Osaka 5650871, Japan		Hosomi, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.	s-hosomi@hp-emerg.med.osaka-u.ac.jp; koyama@anat2.med.osaka-u.ac.jp; watabe@tracer.med.osaka-u.ac.jp; mohnishi@hp-emerg.med.osaka-u.ac.jp; ogura@hp-emerg.med.osaka-u.ac.jp; yamashita@molneu.med.osaka-u.ac.jp; shimazu@hp-emerg.med.osaka-u.ac.jp	Hosomi, Sanae/M-1838-2019		Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [18 K08886]; General Insurance Association of Japan; ZENKYOREN (National Mutual Insurance Federation of Agricultural Cooperatives)	This work was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (18 K08886), a grant from the General Insurance Association of Japan, and a grant from ZENKYOREN (National Mutual Insurance Federation of Agricultural Cooperatives) to S. H.	Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Crook Kristen R, 2014, World J Immunol, V4, P26; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Dupont AC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040785; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hosomi S, 2018, NEUROIMAGE-CLIN, V20, P946, DOI 10.1016/j.nicl.2018.09.031; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kusmartsev S, 2002, CANCER IMMUNOL IMMUN, V51, P293, DOI 10.1007/s00262-002-0280-8; Lee Jae-Kyung, 2013, Methods Mol Biol, V1041, P17, DOI 10.1007/978-1-62703-520-0_3; Mira JC, 2017, CRIT CARE MED, V45, P253, DOI [10.1097/CCM.0000000000002074, 10.1097/ccm.0000000000002074]; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Pistoia V, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00167; Rinaldi SF, 2014, J IMMUNOL, V192, P2315, DOI 10.4049/jimmunol.1302891; Saiwai H, 2013, J NEUROCHEM, V125, P74, DOI 10.1111/jnc.12135; Sendo S, 2018, INFLAMM REGEN, V38, DOI 10.1186/s41232-018-0076-7; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Ueno M, 2012, BRAIN, V135, P1253, DOI 10.1093/brain/aws053; Ueno M, 2011, EXP NEUROL, V230, P280, DOI 10.1016/j.expneurol.2011.05.006; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zaffaroni M, 1999, EUR J NEUROL, V6, P579, DOI 10.1046/j.1468-1331.1999.650579.x; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	32	8	8	4	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 15	2019	406						457	466		10.1016/j.neuroscience.2019.03.015			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HX4RO	WOS:000467388000039	30880103				2022-02-06	
J	Chaaya, N; Jacques, A; Belmer, A; Beecher, K; Ali, SA; Chehrehasa, F; Battle, AR; Johnson, LR; Bartlett, SE				Chaaya, Nicholas; Jacques, Angela; Belmer, Arnauld; Beecher, Kate; Ali, Syed A.; Chehrehasa, Fatemeh; Battle, Andrew R.; Johnson, Luke R.; Bartlett, Selena E.			Contextual Fear Conditioning Alter Microglia Number and Morphology in the Rat Dorsal Hippocampus	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						contextual fear conditioning; microglia; BDNF; hippocampus and amygdala; dentate gyrus	ELEMENT-BINDING PROTEIN; BDNF GENE-TRANSCRIPTION; MEMORY CONSOLIDATION; MESSENGER-RNA; NEUROTROPHIC FACTOR; LATERAL NUCLEUS; DENTATE GYRUS; AMYGDALA; EXPRESSION; ACTIVATION	Contextual fear conditioning is a Pavlovian conditioning paradigm capable of rapidly creating fear memories to contexts, such as rooms or chambers. Contextual fear conditioning protocols have long been utilized to evaluate how fear memories are consolidated, maintained, expressed, recalled, and extinguished within the brain. These studies have identified the lateral portion of the amygdala and the dorsal portion of the hippocampus as essential for contextual fear memory consolidation. The current study was designed to evaluate how two different contextual fear memories alter amygdala and hippocampus microglia, brain derived neurotrophic factor (BDNF), and phosphorylated cyclic-AMP response element binding (pCREB). We find rats provided with standard contextual fear conditioning to have more microglia and more cells expressing BDNF in the dentate gyrus as compared to a context only control group. Additionally, standard contextual fear conditioning altered microglia morphology to become amoeboid in shape - a common response to central nervous system insult, such as traumatic brain injury, infection, ischemia, and more. The unpaired fear conditioning procedure (whereby non-reinforced and non-overlapping auditory tones were provided at random intervals during conditioning), despite producing equivalent levels of fear as the standard procedure, did not alter microglia, BDNF or pCREB number in any dorsal hippocampus or lateral amygdala brain regions. Despite this, the unpaired fear conditioning protocol produced some alterations in microglia morphology, but less compared to rats provided with standard contextual fear conditioning. Results from this study demonstrate that contextual fear conditioning is capable of producing large alterations to dentate gyrus plasticity and microglia, whereas unpaired fear conditioning only produces minor changes to microglia morphology. These data show, for the first time, that Pavlovian fear conditioning protocols can induce similar responses as trauma, infection or other insults within the central nervous system.	[Chaaya, Nicholas; Jacques, Angela; Belmer, Arnauld; Beecher, Kate; Ali, Syed A.; Bartlett, Selena E.] Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld, Australia; [Chaaya, Nicholas; Jacques, Angela; Belmer, Arnauld; Beecher, Kate; Ali, Syed A.; Chehrehasa, Fatemeh; Battle, Andrew R.; Johnson, Luke R.; Bartlett, Selena E.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Translat Res Inst, Brisbane, Qld, Australia; [Chehrehasa, Fatemeh; Battle, Andrew R.] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia; [Battle, Andrew R.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Johnson, Luke R.] Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld, Australia; [Johnson, Luke R.] Uniformed Serv Univ Hlth Sci, Sch Med, Dept Psychiat, Ctr Study Traumat Stress, Bethesda, MD USA		Bartlett, SE (corresponding author), Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld, Australia.; Bartlett, SE (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Translat Res Inst, Brisbane, Qld, Australia.	selena.bartlett@qut.edu.au	Matthews, Kate/AAX-9784-2021; Belmer, Arnauld/AAE-2554-2019	Matthews, Kate/0000-0001-7462-1158; Belmer, Arnauld/0000-0001-6640-5631; Johnson PhD, Luke R/0000-0002-5088-1788; Chehrehasa, Fatemeh/0000-0002-3702-9179; Jacques, Angela/0000-0002-2524-711X; Battle, Andrew/0000-0002-7447-3519	NHMRCNational Health and Medical Research Council of Australia [GNT1146417]	This research was funded by NHMRC project grant (GNT1146417).	Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Anderson MI, 2003, J NEUROSCI, V23, P8827; Antoine B, 2014, BRAIN STRUCT FUNCT, V219, P415, DOI 10.1007/s00429-013-0505-y; Barot SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006156; Barrientos RM, 2004, J NEUROIMMUNOL, V155, P119, DOI 10.1016/j.jneuroim.2004.06.009; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Bergstrom HC, 2014, NEUROBIOL LEARN MEM, V116, P1, DOI 10.1016/j.nlm.2014.07.008; Bergstrom HC, 2013, BRAIN STRUCT FUNCT, V218, P1569, DOI 10.1007/s00429-012-0478-2; Bergstrom HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015698; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; BOUTON ME, 1993, PSYCHOL BULL, V114, P80, DOI 10.1037/0033-2909.114.1.80; Calandreau L, 2005, LEARN MEMORY, V12, P383, DOI 10.1101/lm.92305; Calandreau L, 2006, J NEUROSCI, V26, P13556, DOI 10.1523/JNEUROSCI.3713-06.2006; Calcia MA, 2016, PSYCHOPHARMACOLOGY, V233, P1637, DOI 10.1007/s00213-016-4218-9; Caruana DA, 2012, LEARN MEMORY, V19, P391, DOI 10.1101/lm.025304.111; Chaaya N, 2019, NEUROSCIENCE, V398, P231, DOI 10.1016/j.neuroscience.2018.12.004; Chaaya N, 2018, NEUROSCI BIOBEHAV R, V92, P43, DOI 10.1016/j.neubiorev.2018.05.013; Cheng WJ, 2015, MOL MED REP, V11, P1132, DOI 10.3892/mmr.2014.2794; Choi M, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0253-z; Desmedt A, 1998, J NEUROSCI, V18, P480; Dwyer JB, 2016, BIOL PSYCHIAT, V80, pE47, DOI 10.1016/j.biopsych.2016.08.006; Fanselow MS, 2010, TRENDS COGN SCI, V14, P7, DOI 10.1016/j.tics.2009.10.008; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; FOA EB, 1992, PSYCHOL BULL, V112, P218, DOI 10.1037/0033-2909.112.2.218; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Greter M, 2013, GLIA, V61, P121, DOI 10.1002/glia.22408; Hagewoud R, 2011, J SLEEP RES, V20, P259, DOI 10.1111/j.1365-2869.2010.00895.x; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Hubbard DT, 2007, NEUROSCIENCE, V150, P818, DOI 10.1016/j.neuroscience.2007.10.001; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Ivashkina OI, 2016, B EXP BIOL MED+, V160, P729, DOI 10.1007/s10517-016-3296-3; Izumi T, 2008, PHARMACOL BIOCHEM BE, V90, P297, DOI 10.1016/j.pbb.2008.02.023; Jeffery KJ, 2003, HIPPOCAMPUS, V13, P175, DOI 10.1002/hipo.10047; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kudo K, 2004, BRAIN RES, V1024, P233, DOI 10.1016/j.brainres.2004.08.007; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LeDoux JE, 2014, P NATL ACAD SCI USA, V111, P2871, DOI 10.1073/pnas.1400335111; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; Lonergan ME, 2010, NEURAL PLAST, V2010, P1, DOI 10.1155/2010/139891; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Majak K, 2003, EUR J NEUROSCI, V18, P1652, DOI 10.1046/j.1460-9568.2003.02854.x; Malkani S, 2000, NEUROSCIENCE, V97, P693, DOI 10.1016/S0306-4522(00)00058-0; Mamiya N, 2009, J NEUROSCI, V29, P402, DOI 10.1523/JNEUROSCI.4639-08.2009; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 1997, NEUROBIOL LEARN MEM, V67, P142, DOI 10.1006/nlme.1996.3752; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Mizuno K, 2012, GENES BRAIN BEHAV, V11, P651, DOI 10.1111/j.1601-183X.2012.00805.x; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nair A, 2006, J NEUROIMMUNOL, V171, P72, DOI 10.1016/j.jneuroim.2005.09.012; National Health and Medical Research Council, 2013, AUSTR COD CAR US AN; Paxinos G, 2006, RAT BRAIN STEREOTAXI; Perez-Villalba A, 2008, PHYSIOL BEHAV, V93, P206, DOI 10.1016/j.physbeh.2007.08.017; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pierson JL, 2015, HIPPOCAMPUS, V25, P779, DOI 10.1002/hipo.22413; Pignataro A, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00156; Pillai AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038971; Posfai B, 2019, NEUROSCIENCE, V405, P103, DOI 10.1016/j.neuroscience.2018.04.046; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Quinn JJ, 2005, HIPPOCAMPUS, V15, P665, DOI 10.1002/hipo.20088; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Radley JJ, 2006, EUR J NEUROSCI, V24, P876, DOI 10.1111/j.1460-9568.2006.04962.x; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rasmusson AM, 2002, NEUROPSYCHOPHARMACOL, V27, P133, DOI 10.1016/S0893-133X(02)00286-5; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Reichelt AC, 2015, BRAIN BEHAV IMMUN, V43, P68, DOI 10.1016/j.bbi.2014.07.005; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rogers JL, 2006, NEUROBIOL LEARN MEM, V86, P72, DOI 10.1016/j.nlm.2006.01.002; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Sananbenesi F, 2002, MOL CELL NEUROSCI, V21, P463, DOI 10.1006/mcne.2002.1188; Schafe GE, 2000, J NEUROSCI, V20, P8177; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SHIROMANI PJ, 1995, MOL BRAIN RES, V29, P163, DOI 10.1016/0169-328X(94)00242-7; Smith DM, 2006, HIPPOCAMPUS, V16, P716, DOI 10.1002/hipo.20208; Stanciu M, 2001, MOL BRAIN RES, V94, P15, DOI 10.1016/S0169-328X(01)00174-7; Takei S, 2011, J PSYCHIATR RES, V45, P460, DOI 10.1016/j.jpsychires.2010.08.009; Trifilieff P, 2007, NEUROBIOL LEARN MEM, V88, P424, DOI 10.1016/j.nlm.2007.05.004; Trifilieff P, 2006, LEARN MEMORY, V13, P349, DOI 10.1101/lm.80206; Trogrlic L, 2011, LEARN MEMORY, V18, P678, DOI 10.1101/lm.2314311; Tynan RJ, 2010, BRAIN BEHAV IMMUN, V24, P1058, DOI 10.1016/j.bbi.2010.02.001; Vollmer LL, 2016, BIOL PSYCHIAT, V80, P541, DOI 10.1016/j.biopsych.2016.04.022; Walker FR, 2014, BRAIN BEHAV IMMUN, V37, P1, DOI 10.1016/j.bbi.2013.12.010; Wilson YM, 2009, LEARN MEMORY, V16, P357, DOI 10.1101/lm.1361509; Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907; Wohleb ES, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00544; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Zelikowsky M, 2014, J NEUROSCI, V34, P8462, DOI 10.1523/JNEUROSCI.3624-13.2014; Zheng J, 2015, BRAIN RES, V1627, P109, DOI 10.1016/j.brainres.2015.08.035; 2013, NEURAL PLAST, DOI DOI 10.1155/2013/429815	97	8	8	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	MAY 14	2019	13								214	10.3389/fncel.2019.00214			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HY3BV	WOS:000467998900002	31139053	Green Accepted, Green Published, gold			2022-02-06	
J	Skau, S; Bunketorp-Kall, L; Kuhn, HG; Johansson, B				Skau, Simon; Bunketorp-Kall, Lina; Kuhn, Hans Georg; Johansson, Birgitta			Mental Fatigue and Functional Near-Infrared Spectroscopy (fNIRS) - Based Assessment of Cognitive Performance After Mild Traumatic Brain Injury	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						mild TBI; fNIRS; mental fatigue; frontal cortex; conflict processing; processing speed	PREFRONTAL CORTEX; STROOP TASK; ATTENTION IMPAIRMENTS; CONTROL MECHANISMS; DIVIDED ATTENTION; SYMPTOMS; ACTIVATION; EXERCISE; NIRS; QUESTIONNAIRE	Pathological mental fatigue after mild traumatic brain injury (TBI-MF) is characterized by pronounced mental fatigue after cognitive activity. The neurological origin is unknown, and we aimed in the present study to investigate how prolonged mental activity affects cognitive performance and its neural correlates in individuals with TBI-MF. We recruited individuals with TBI-MF (n = 20) at least 5 months after injury, and age-matched healthy controls (n = 20). We used functional near-infrared spectroscopy (fNIPS) to assess hemodynamic changes in the frontal cortex. The self-assessed mental energy level was measured with a visual analog scale (VAS) before and after the experimental procedure. A battery of six neuropsychological tests including Stroop-Simon, Symbol Search, Digit Span, Parallel Serial Mental Operation (PaSMO), Sustained Attention and Working Memory test, and Digit Symbol Coding (DSC) were used. The sequence was repeated once after an 8 min sustained-attention test. The test procedure lasted 21/2 h. The experimental procedure resulted in a decrease in mental energy in the TBI-MF group, compared to controls (interaction, p < 0.001, eta(2)(p) = 0.331). The TBI-MF group performed at a similar level on both DSC tests, whereas the controls improved their performance in the second session (interaction, p < 0.01, eta(2)(p) = 0.268). During the Stroop-Simon test, the fNIRS event-related response showed no time effect. However, the TBI-MF group exhibited lower oxygenated hemoglobin (oxy-Hb) concentrations in the frontal polar area (FPA), ventrolateral motor cortex, and dorsolateral prefrontal cortex (DLPFC) from the beginning of the test session. A Stroop and Group interaction was found in the left ventrolateral prefrontal cortex showing that the TBI-MF group did have the same oxy-Hb concentration for both congruent and incongruent trials, whereas the controls had more oxy-Hb in the incongruent trial compared to the congruent trial (interaction, p < 0.01, eta(2)(p) = 0.227). In sum these results indicate that individuals with TBI-MF have a reduced ability to recruit the frontal cortex, which is correlated with self-reported mental fatigue. This may result both in deterioration of cognitive function and the experience of a mental fatigue after extended mental activity.	[Skau, Simon; Bunketorp-Kall, Lina; Kuhn, Hans Georg; Johansson, Birgitta] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Bunketorp-Kall, Lina] Sahlgrens Univ Hosp, Ctr Adv Reconstruct Extrem, Molndal, Sweden; [Kuhn, Hans Georg] Charite, Ctr Stroke Res, Dept Neurol, Berlin, Germany		Kuhn, HG (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden.; Kuhn, HG (corresponding author), Charite, Ctr Stroke Res, Dept Neurol, Berlin, Germany.		Kuhn, Hans-Georg/L-8127-2014; Bunketorp-Kall, Lina/AAI-1237-2020	Kuhn, Hans-Georg/0000-0003-4247-5613; Bunketorp Kall, lina/0000-0002-4571-0335; Skau, Simon/0000-0002-2669-5440	Local Research and Development Council Goteborg and Sodra Bohuslan; Swedish Research Council (Vetenskapsradet)Swedish Research Council [721-2014-2468, 521-2014-3224]; Swedish Childhood Cancer Foundation (Barncancerfonden) [MT2017-0013]; Swedish state under the ALF agreement [ALFGBG-726541]	The study was funded by grants from The Local Research and Development Council Goteborg and Sodra Bohuslan. HK was supported by the Swedish Research Council (Vetenskapsradet 721-2014-2468 and 521-2014-3224), Swedish Childhood Cancer Foundation (Barncancerfonden MT2017-0013) and by a grant from the Swedish state under the ALF agreement (ALFGBG-726541).	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; [Anonymous], 2014, MATLAB; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Balardin JB, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00258; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Berginstrom N, 2018, J HEAD TRAUMA REHAB, V33, P266, DOI 10.1097/HTR.0000000000000340; Borragan G, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00378; Brigadoi S, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.2.025005; Byun KH, 2014, NEUROIMAGE, V98, P336, DOI 10.1016/j.neuroimage.2014.04.067; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Egner T, 2008, TRENDS COGN SCI, V12, P374, DOI 10.1016/j.tics.2008.07.001; Egner T, 2007, NEUROIMAGE, V35, P940, DOI 10.1016/j.neuroimage.2006.11.061; Ehlis AC, 2014, NEUROIMAGE, V85, P478, DOI 10.1016/j.neuroimage.2013.03.067; Endo K, 2013, J PHYSIOL SCI, V63, P287, DOI 10.1007/s12576-013-0267-6; Everdell NL, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2038567; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Forster SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090281; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gagnon L, 2011, NEUROIMAGE, V56, P1362, DOI 10.1016/j.neuroimage.2011.03.001; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Helmich I, 2015, J NEUROPSYCH CLIN N, V27, P287, DOI 10.1176/appi.neuropsych.14100276; Hibino S, 2013, NEUROL MED-CHIR, V53, P299, DOI 10.2176/nmc.53.299; Hocke LM, 2018, J NEUROTRAUM, V35, P1224, DOI 10.1089/neu.2017.5365; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Hyodo K, 2012, NEUROBIOL AGING, V33, P2621, DOI 10.1016/j.neurobiolaging.2011.12.022; Irani F, 2007, CLIN NEUROPSYCHOL, V21, P9, DOI 10.1080/13854040600910018; Jobsis-vanderVliet FF, 1999, J BIOMED OPT, V4, P392, DOI 10.1117/1.429952; Johansson B., 2014, INT J PHYS MED REHAB, V2, P572, DOI [10.4172/2329-9096, DOI 10.4172/2329-9096]; Johansson B., 2014, TRAUMATIC BRAIN INJU; Johansson B, 2015, NEUROREHABILITATION, V36, P195, DOI 10.3233/NRE-151207; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Jonasson A, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1056; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Kontos AP, 2014, BRAIN IMAGING BEHAV, V8, P621, DOI 10.1007/s11682-014-9289-9; Kopton IM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00549; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Lague-Beauvais M, 2013, NEUROIMAGE, V64, P485, DOI 10.1016/j.neuroimage.2012.09.042; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Leon-Carrion J, 2008, BEHAV BRAIN RES, V193, P248, DOI 10.1016/j.bbr.2008.06.013; LINDQVIST G, 1993, ACTA PSYCHIAT SCAND, V88, P5, DOI 10.1111/j.1600-0447.1993.tb05611.x; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Merzagora AC, 2011, J INNOV OPT HEAL SCI, V4, P251, DOI 10.1142/S1793545811001551; Moller MC, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00496; Musz E, 2017, BRAIN LANG, V165, P21, DOI 10.1016/j.bandl.2016.11.002; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Obrig H, 2014, NEUROIMAGE, V85, P535, DOI 10.1016/j.neuroimage.2013.03.045; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Plenger P, 2016, BRAIN IMAGING BEHAV, V10, P357, DOI 10.1007/s11682-015-9401-9; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Reitan R, 1985, HALSTEAD REITAN NEUR; Roberts KL, 2008, J COGNITIVE NEUROSCI, V20, P1063, DOI 10.1162/jocn.2008.20074; Sato H, 2013, NEUROIMAGE, V83, P158, DOI 10.1016/j.neuroimage.2013.06.043; Sawamura D, 2014, BRAIN INJURY, V28, P1455, DOI 10.3109/02699052.2014.919531; Schroeter ML, 2004, NEUROIMAGE, V23, P1317, DOI 10.1016/j.neuroimage.2004.08.001; Schroeter ML, 2002, HUM BRAIN MAPP, V17, P61, DOI 10.1002/hbm.10052; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Uludag K, 2004, NEUROIMAGE, V22, P583, DOI 10.1016/j.neuroimage.2004.02.023; Vanderhasselt MA, 2009, PSYCHON B REV, V16, P609, DOI 10.3758/PBR.16.3.609; Wechsler D., 2010, WECHSLER ADUT INTELL; Wylie GR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08846-6; Yasumura A, 2014, BRAIN DEV-JPN, V36, P97, DOI 10.1016/j.braindev.2013.01.005; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383; 2014, BRAIN IMAGING BEHAV, V8, P446, DOI DOI 10.1007/S11682-013-9258-8	75	8	9	2	15	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	MAY 14	2019	13								145	10.3389/fnhum.2019.00145			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HY3BA	WOS:000467996800002	31139065	Green Published, Green Submitted, gold			2022-02-06	
J	Rezaii, PG; Grant, GA; Zeineh, MM; Richardson, KJ; Coburn, ML; Bet, AM; Weber, A; Jiang, B; Li, Y; Ubungen, K; Routh, G; Wheatcroft, AM; Paulino, AD; Hayes, RL; Steinberg, GK; Wintermark, M				Rezaii, Paymon Garakani; Grant, Gerald Arthur; Zeineh, Michael Maroun; Richardson, Kara Janice; Coburn, Maria Lynn; Bet, Anthony Marco; Weber, Art; Jiang, Bin; Li, Ying; Ubungen, Kristine; Routh, Gay; Wheatcroft, Alex Marie; Paulino, Amy Devine; Hayes, Ronald Lawrence; Steinberg, Gary Kenneth; Wintermark, Max			Stability of Blood Biomarkers of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; stability; traumatic brain injury	FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE; MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; INTRACRANIAL LESIONS; SERUM BIOMARKERS; S-100 PROTEIN; MILD; S100B; GFAP	Blood biomarker tests were recently approved for clinical diagnosis of traumatic brain injury (TBI), yet there are still fundamental questions that need attention. One such question is the stability of putative biomarkers in blood over the course of several days after injury if the sample is unable to be processed into serum or plasma and stored at low temperatures. Blood may not be able to be stored at ultra-low temperatures in austere combat or sports environments. In this prospective study of 20 adult patients with positive head computed tomography imaging findings, the stability of three biomarkers (glial fibrillary acidic protein [GFAP], ubiquitin C-terminal hydrolase-L1 [UCH-L1], and S100 calcium binding protein B [S100B]) in whole blood and in serum stored at 4-5 degrees C was evaluated over the course of 72 h after blood collection. The amount of time whole blood and serum were refrigerated had no significant effect on GFAP concentration in plasma obtained from whole blood and in serum (p = 0.6256 and p = 0.3687, respectively), UCH-L1 concentration in plasma obtained from whole blood and in serum (p = 0.0611 and p = 0.5189, respectively), and S100B concentration in serum (p = 0.4663). Concentration levels of GFAP, UCH-L1, and S100B in blood collected from patients with TBI were found to be stable at 4-5 degrees C for at least 3 days after blood draw. This study suggests that the levels of the three diagnostic markers above are still valid for diagnostic TBI tests if the sample is stored in 4-5 degrees C refrigerated conditions.	[Zeineh, Michael Maroun; Jiang, Bin; Li, Ying; Wintermark, Max] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Rezaii, Paymon Garakani; Grant, Gerald Arthur; Coburn, Maria Lynn; Bet, Anthony Marco; Steinberg, Gary Kenneth] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Ubungen, Kristine; Routh, Gay] Stanford Univ, Dept Anat Pathol, Stanford, CA 94305 USA; [Ubungen, Kristine; Routh, Gay] Stanford Univ, Clin Labs, Stanford, CA 94305 USA; [Weber, Art; Wheatcroft, Alex Marie; Paulino, Amy Devine; Hayes, Ronald Lawrence] Banyan Biomarkers Inc, San Diego, CA USA; [Richardson, Kara Janice] Sci 37, Los Angeles, CA USA		Wintermark, M (corresponding author), Stanford Med Ctr, Room S047,300 Pasteur Dr, Stanford, CA 94305 USA.	mwinterm@stanford.edu		Rezaii, Paymon/0000-0002-4803-0853			Banks RE, 2005, CLIN CHEM, V51, P1637, DOI 10.1373/clinchem.2005.051417; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Biancotto A, 2012, CYTOKINE, V60, P438, DOI 10.1016/j.cyto.2012.05.019; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bishop P, 2016, BIOCHEM J, V473, P2453, DOI 10.1042/BCJ20160082; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; BURGI W, 1967, KLIN WOCHENSCHR, V45, P83, DOI 10.1007/BF01747968; DAY IN, 2009, PROG NEUROBIOL, V90, P327, DOI DOI 10.1016/J.PNEUROBIO.2009.10.020; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Food and Drug Administration, 2018, FDA AUTH MARK 1 BLOO; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gong B, 2007, DRUG NEWS PERSPECT, V20, P365, DOI 10.1358/dnp.2007.20.6.1138160; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Heidari K, 2015, BRAIN INJURY, V29, P1146, DOI [10.3109/02699052.2014.948068, 10.3109/02699052.2015.1037349]; Hsieh SY, 2006, PROTEOMICS, V6, P3189, DOI 10.1002/pmic.200500535; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Li J, 2015, AM J EMERG MED, V33, P1191, DOI 10.1016/j.ajem.2015.05.023; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Luoto TM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00652; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Middleton PM, 2012, AUSTRALAS EMERG NURS, V15, P170, DOI 10.1016/j.aenj.2012.06.002; Mirvis S E, 1994, J Intensive Care Med, V9, P305; Missler U, 1999, CLIN CHEM, V45, P138; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; O'Neal WK, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-9; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Raabe A, 2003, CLIN CHEM LAB MED, V41, P700, DOI 10.1515/CCLM.2003.106; Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P42, DOI 10.1017/S0317167100006296; Sapsed-Byrne S, 1997, PERFUSION-UK, V12, P167, DOI 10.1177/026765919701200304; Shabihkhani M, 2014, CLIN BIOCHEM, V47, P258, DOI 10.1016/j.clinbiochem.2014.01.002; Shahjouei S, 2018, BRAIN INJURY, V32, P1, DOI 10.1080/02699052.2017.1382717; Stein DM, 2012, SHOCK, V37, P563, DOI 10.1097/SHK.0b013e3182534f93; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Tammen H, 2005, PROTEOMICS, V5, P3414, DOI 10.1002/pmic.200401219; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Tongaonkar P, 2000, MOL CELL BIOL, V20, P4691, DOI 10.1128/MCB.20.13.4691-4698.2000; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Welch RD, 2017, J NEUROTRAUM, V34, P1957, DOI 10.1089/neu.2016.4772; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Woertgen C, 2002, BRAIN INJURY, V16, P807, DOI 10.1080/02699050210128933; Xiong H, 2000, Sheng Li Ke Xue Jin Zhan, V31, P217; Yu ZY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015843, 10.1371/journal.pone.0017951]; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	65	8	8	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2019	36	16					2407	2416		10.1089/neu.2018.6053		MAY 2019	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IN3NH	WOS:000469288400001	30968744				2022-02-06	
J	Oeur, RA; Gilchrist, MD; Hoshizaki, TB				Oeur, R. Anna; Gilchrist, Michael D.; Hoshizaki, T. Blaine			Interaction of impact parameters for simulated falls in sport using three different sized Hybrid III headforms	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						Falls; head impact; sports-related concussion; Hybrid III	FINITE-ELEMENT SIMULATIONS; TRAUMATIC BRAIN-INJURIES; DIFFUSE AXONAL INJURY; HEAD IMPACT; BIOMECHANICAL DETERMINANTS; INTRACRANIAL-PRESSURE; ANGULAR ACCELERATION; DYNAMIC-RESPONSE; CONCUSSION; RECONSTRUCTION	This study describes the interaction of impact parameters on peak head acceleration and strain variables for test conditions represented in sport. The Hybrid III 6-year-old child, 5th percentile female, and 50th percentile adult male headforms were subject to parametric tests using a monorail drop tower at four impact velocities (1.5, 3.0, 4.5, and 6.0 m/s), three surfaces (unprotected, protected/helmeted, and well-padded/mat), and four impact locations (frontal, sagittal, combined-plane motions, and a rotationally dominant motion). Scaled finite-element models of the brain were used to obtain peak strains. Regression analyses revealed that compliance produced the greatest increases in head acceleration, while impact velocity was for strain. Smaller headforms were associated with higher responses. Non-uniform trends for impact location were noted and are likely a result of localised headform properties interacting with velocity and compliance. These findings support the need for size-appropriate parameters in the design and development of head protection.	[Oeur, R. Anna; Hoshizaki, T. Blaine] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Oeur, RA (corresponding author), Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada.	anna.oeur@uottawa.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC)	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) post-graduate research scholarship awarded to R. Anna Oeur.	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bak K., 1994, Scandinavian Journal of Medicine and Science in Sports, V4, P148; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Doorly MC, 2005, SOLID MECH APPL, V124, P431; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gennarelli T, 1987, P 31 STAPP CAR CRASH; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Gennarelli TA, 1982, AGARD C P; Gimbel GM, 2008, EUR J SPORT SCI, V8, P341, DOI 10.1080/17461390802438763; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; GURDJIAN E S, 1964, J Trauma, V4, P309; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Hajiaghamemar M, 2015, ANN BIOMED ENG, V43, P2143, DOI 10.1007/s10439-015-1255-1; Hardy W N, 2001, Stapp Car Crash J, V45, P337; HODGSON VR, 1983, 27 STAPP CAR CRASH C; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Hutchinson TP, 2014, EUR J SPORT SCI, V14, pS377, DOI 10.1080/17461391.2012.705334; Kamitani T, 2013, AM J SPORT MED, V41, P1915, DOI 10.1177/0363546513490662; Kang J, 2005, HYBRID 3 DUMMY NECK; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Laforest S, 2001, Inj Prev, V7, P35, DOI 10.1136/ip.7.1.35; Lee JS, 2005, J KOREAN MED SCI, V20, P483, DOI 10.3346/jkms.2005.20.3.483; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Love PF, 2009, J TRAUMA, V67, pS12, DOI 10.1097/TA.0b013e3181ac7f22; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Mertz H. J., 1971, P 15 STAPP CAR CRASH; Mertz HJ, 1989, INT C EXP MICH US; MOHAN D, 1979, J BIOMECH ENG-T ASME, V101, P250, DOI 10.1115/1.3426254; Nahum A, 1977, 21 STAPP CAR CRASH C; Newman J. A., 2002, ACCIDENTAL INJURY BI, P303; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; Oeur RA, 2016, EFFECT IMPACT COMPLI; OMMAYA A K, 1968, Journal of Biomechanics, V1, P127, DOI 10.1016/0021-9290(68)90015-8; OMMAYA AK, 1994, INT J IMPACT ENG, V15, P535, DOI 10.1016/0734-743X(94)80033-6; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patrick L., 1963, 7 STAPP CAR CRASH C, P470; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; ROCHE AF, 1987, PEDIATRICS, V79, P706; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Seidi M, 2015, INT J CRASHWORTHINES, V20, P134, DOI 10.1080/13588265.2014.983261; Spyrou E, 2000, SPORTS ENG, V3, P25; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Trosseille X, 1992, 36 STAPP CAR CRASH C; UNTERHARNSCHEIDT F J, 1972, Scandinavian Journal of Rehabilitation Medicine, V4, P24; Walsh ES, 2012, ASTM INT F08 S MECH; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C, 1995, P 39 STAPP CAR CRASH	78	8	9	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness	MAY 4	2019	24	3					326	335		10.1080/13588265.2018.1441617			10	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	HX2YX	WOS:000467259300007					2022-02-06	
J	Agimi, Y; Regasa, LE; Stout, KC				Agimi, Yll; Regasa, Lemma Ebssa; Stout, Katharine C.			Incidence of Traumatic Brain Injury in the US Military, 2010-2014	MILITARY MEDICINE			English	Article							LONG-TERM DISABILITY; UNITED-STATES; EPIDEMIOLOGY; ARMY; DEPLOYMENT; COMBAT; HEALTH; TRENDS	Introduction: Traumatic brain injury (TBI) is a significant health issue that affects U.S. military service members (SM) at home and in combat deployments. We estimated the TBI incidence rate in the deployed and non-deployed setting between 2010 and 2014 and identified subgroups with elevated rates for prevention efforts. Methods: Retrospective population-based study of all active duty U.S. military SM that sustained a first active duty TBI diagnosis between January 2010 and December 2014 collected and analyzed in 2017. Using Armed Forces Health Surveillance Branch data we calculated the Mantel-Haenszel (MH) standardized TBI incidence rate in the deployed and non-deployed setting, adjusting for service and demographic factors. Results: From 2010 to 2014, the MH standardized incidence rate for deployed SMs was 3,265 TBIs per 100 thousand p-yrs (95% CI: 3,222-3,307) and 1,705.2 (95% CI: 1,694.0-1,716.5) for non-deployed SMs. The youngest deployed male Army soldiers, those ages 17-24, especially White and Hispanic soldiers, had the highest TBI incidence rate (IR) of 5,748.7 (95% CI: 5,585.8-5,916.4) and 5,010.3 (95% CI: 4,647.5-5,401.4), respectively. The IR for all branches was 1,972.6 (95% CI: 1,959.5-1,985.7) and 724.0 (95% CI: 714.9-733.0) for Reserve/Guard Service members. Conclusions: Across all years, Marines and Army Soldiers experience the highest rates of injury with deployed SMs having elevated IRs of TBI. The TBI IR among deployed SMs was 91% higher than among those in the non-deployed setting, due to continued exposures to combat. Deployed Reserve/Guard component SMs seem to have an above average rate, a finding with implications for training and prevention.	[Agimi, Yll; Regasa, Lemma Ebssa; Stout, Katharine C.] DHA, DVBIC, 1335 East West HWY 4-214E, Silver Spring, MD 20910 USA; [Agimi, Yll] SalientCRGT Inc, 4000 Legato Rd Suite 600, Fairfax, VA 22033 USA; [Regasa, Lemma Ebssa] GDIT, 3211 Jermantown Rd, Fairfax, VA 22030 USA		Agimi, Y (corresponding author), DHA, DVBIC, 1335 East West HWY 4-214E, Silver Spring, MD 20910 USA.; Agimi, Y (corresponding author), SalientCRGT Inc, 4000 Legato Rd Suite 600, Fairfax, VA 22033 USA.		AGIMI, YLL/AAL-9337-2021		Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs	This material was supported by Defense and Veterans Brain Injury Center (DVBIC). This study was approved by the US Army Public Health Review Board (DV-15-04).	AFHSB, 2018, SURV CAS DEF TRAUM B; AFHSC, 2015, CAS DEF DAT AN HLTH; Agimi Y, 2018, AM J PUBLIC HEALTH, V108, P683, DOI 10.2105/AJPH.2018.304347; [Anonymous], 2018, ACT DUT SERV AG YEAR; [Anonymous], 2017, CONFL CAS; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; CDC, 2015, TRAUM BRAIN INJ US F; CDC, 2015, INJ PREV CONTR TRAUM; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, C TRAUM BRAIN INJ US; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Department of Defense, 09033 DTM DEP DEF; Dismuke CE, 2015, AM J PUBLIC HEALTH, V105, P1696, DOI 10.2105/AJPH.2014.302545; DMDC, 2013, CONT TRACK SYST DEPL; DVBIC. Defense and Veterans Brain Injury Center, 2018, DOD NUMB TRAUM BRAIN; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Gubata ME, 2013, MIL MED, V178, P708, DOI 10.7205/MILMED-D-12-00542; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ivins BJ, 2006, NEUROEPIDEMIOLOGY, V27, P154, DOI 10.1159/000096127; Office of the Surgeon General (Army) Fort Sam Houston TX, 2013, MENT HLTH ADV TEAM 9; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Regasa LE, 2016, J HEAD TRAUMA REHAB, V31, pE28, DOI 10.1097/HTR.0000000000000155; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shen Y-C, EFFECT OEF OIF DEPLO; The CDC NIH DoD and VA Leadership Panel, 2013, C TRAUM BRAIN INJ US; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	30	8	8	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY-JUN	2019	184	5-6					E233	E241		10.1093/milmed/usy313			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HY5SU	WOS:000468188900017	30517721	Bronze			2022-02-06	
J	Ayaz, H; Izzetoglu, M; Izzetoglu, K; Onaral, B; Ben Dor, B				Ayaz, Hasan; Izzetoglu, Meltem; Izzetoglu, Kurtulus; Onaral, Banu; Ben Dor, Baruch			Early diagnosis of traumatic intracranial hematomas	JOURNAL OF BIOMEDICAL OPTICS			English	Article						near-infrared spectroscopy; medical device; traumatic brain injury; epidural; subdural; hematoma	NEAR-INFRARED SPECTROSCOPY; COMA DATA-BANK; BRAIN-INJURY; INFRASCANNER; ACTIVATION; DEVICE; QUANTIFICATION; HEMODYNAMICS; HEMORRHAGE; DEPRESSION	Timing of the intervention for intracranial hematomas is critical for its success, specifically since expansion of the hemorrhage can result in debilitating and sometimes fatal outcomes. Led by Britton Chance, we and an extended team from University of Pennsylvania, Baylor and Drexel universities developed a handheld brain hematoma detector for early triage and diagnosis of head trauma victims. After obtaining de novo Food and Drug Administration clearance, over 200 systems are deployed in all Marine battalion aid stations around the world. Infrascanner, a handheld brain hematoma detection system, is based on the differential near-infrared light absorption of the injured versus the noninjured part of brain. About 12 independent studies have been conducted in the USA, Canada, Spain, Italy, the Netherlands, Germany, Russia, Poland, Afghanistan, India, China, and Turkey. Here, we outline the background and design of the device as well as clinical studies with a total of 1293 patients and 203 hematomas. Infrascanner demonstrates high sensitivity (adults: 92.5% and children: 93%) and specificity (adults: 82.9% and children: 86.5%) in detecting intracranial hematomas >3.5 mL in volume and <2.5 cm from the surface of the brain. Infrascanner is a clinically effective screening solution for head trauma patients in prehospital settings where timely triage is critical. (C) The Authors. Published by SPIE undera Creative Commons Attribution 4.0 Unported License.	[Ayaz, Hasan; Izzetoglu, Meltem; Izzetoglu, Kurtulus; Onaral, Banu] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Ayaz, Hasan] Univ Penn, Dept Family & Community Hlth, Philadelphia, PA 19104 USA; [Ayaz, Hasan] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Izzetoglu, Meltem] Villanova Univ, Elect & Comp Engn, Villanova, PA 19085 USA; [Ben Dor, Baruch] Infrascan Inc, Philadelphia, PA USA		Ayaz, H (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.; Ayaz, H (corresponding author), Univ Penn, Dept Family & Community Hlth, Philadelphia, PA 19104 USA.; Ayaz, H (corresponding author), Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA.	ayaz@drexel.edu	Izzetoglu, Kurtulus/AAB-6402-2020	Izzetoglu, Kurtulus/0000-0001-5304-7361; Ben Dor, Baruch/0000-0002-5531-8732; Ayaz, Hasan/0000-0001-5514-2741			Ayaz Hasan, 2011, Journal of Medical Devices, V5, DOI 10.1115/1.3591407; Ayaz H, 2011, JOVE-J VIS EXP, DOI 10.3791/3443; Ayaz H, 2012, NEUROIMAGE, V59, P36, DOI 10.1016/j.neuroimage.2011.06.023; Braun T, 2015, UNFALLCHIRURG, V118, P693, DOI 10.1007/s00113-013-2549-0; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Bressan S, 2014, CHILD NERV SYST, V30, P477, DOI [10.1007/s00381-014-2368-9, 10.1007/s00381-013-2314-2]; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chance B, 1998, OPT EXPRESS, V2, P411, DOI 10.1364/OE.2.000411; Cope M., 1991, DEV NEAR INFRARED SP; Coskun F, 2010, SCI RES ESSAYS, V5, P1911; Cowley R A, 1977, J Med Soc N J, V74, P979; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; ELWELL CE, 1994, J APPL PHYSIOL, V77, P2753, DOI 10.1152/jappl.1994.77.6.2753; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; GOPINATH SP, 1993, J NEUROSURG, V79, P43, DOI 10.3171/jns.1993.79.1.0043; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hoshi Y, 1997, NEUROIMAGE, V5, P292, DOI 10.1006/nimg.1997.0270; Izzetoglu K, 2011, J INNOV OPT HEAL SCI, V4, P239, DOI 10.1142/S1793545811001587; Izzetoglu M, 2005, IEEE T NEUR SYS REH, V13, P153, DOI 10.1109/TNSRE.2005.847377; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; Lewartowska-Nyga Dorota, 2017, Dev Period Med, V21, P51; Liang CY, 2018, MIL MED, V183, pE318, DOI 10.1093/milmed/usx088; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Melton JTK, 2007, ANN ROY COLL SURG, V89, P513, DOI 10.1308/003588407X202074; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Obrig H, 2000, INT J PSYCHOPHYSIOL, V35, P125, DOI 10.1016/S0167-8760(99)00048-3; Onaral B., 2011, ADV TECHNOL APPL COM; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Peters J, 2017, PREHOSP DISASTER MED, V32, P414, DOI 10.1017/S1049023X17006367; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; Robertson C S, 1997, J Biomed Opt, V2, P31, DOI 10.1117/12.261680; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Salonia R, 2012, J NEUROTRAUM, V29, P1047, DOI 10.1089/neu.2011.1890; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Semenova ZB, 2016, BRAIN INJURY, V30, P18, DOI 10.3109/02699052.2014.989401; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Skotnicka-Klonowicz G, 2014, STANDARDY MED PROBLE, V4, P42; STEIN SC, 1993, BRAIN INJURY, V7, P425, DOI 10.3109/02699059309029685; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Tyzo B, 2014, NEUROL PRAKTYCZNA, V2, P13; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; Walker P, 2018, CURR TRAUMA REP, V4, P149, DOI 10.1007/s40719-018-0133-3; WRAY S, 1988, BIOCHIM BIOPHYS ACTA, V933, P184, DOI 10.1016/0005-2728(88)90069-2; WYATT JS, 1986, LANCET, V2, P1063, DOI 10.1016/S0140-6736(86)90467-8; Xiong Y, 2001, HEAD TRAUMA, P257; Xu L, 2017, J CLIN NEUROSCI, V40, P136, DOI 10.1016/j.jocn.2017.02.056; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	55	8	9	1	2	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668	1560-2281		J BIOMED OPT	J. Biomed. Opt.	MAY	2019	24	5							051411	10.1117/1.JBO.24.5.051411			10	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	IS0ZB	WOS:000481880600011	30719879	Green Published, gold			2022-02-06	
J	Chan, JW; Hills, NK; Bakall, B; Fernandez, B				Chan, Jane W.; Hills, Nancy K.; Bakall, Benjamin; Fernandez, Brian			Indirect Traumatic Optic Neuropathy in Mild Chronic Traumatic Brain Injury	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						indirect traumatic optic neuropathy; traumatic brain injury; optical coherence tomography	RETINAL GANGLION-CELLS; NERVE-FIBER LAYER; CHOROIDAL THICKNESSES; AXONAL LOSS; BLAST; MELANOPSIN; COMPLEX; OVERPRESSURE; ASSOCIATION; DAMAGE	PURPOSE. To analyze the clinical presentation and optical coherence tomography (OCT) findings in indirect traumatic optic neuropathy (ITON) in veterans with chronic mild traumatic brain injury (mTBI). METHODS. This retrospective study is the first to describe the OCT pattern of subclinical to mild ITON in veterans with chronic mTBI. The thicknesses of the macular ganglion cell layer (mGCL), peripapillary retinal nerve fiber layer (pRNFL), and subfoveal choroidal layer were analyzed in young veterans who had mTBI of >6 months' duration and either blunt head injury or improvised explosive device (IED) concussions. RESULTS. Three major OCT findings were demonstrated: (1) temporal pRNFL thinning was associated with subclinical TON in the eyes of chronic mTBI patients compared with controls; within mTBI subjects, nasal mGCL thinning at the 3-mm modified Early Treatment Diabetic Retinopathy Study circle diameter distance from the fovea correlated with the corresponding temporal retinal nerve fiber layer thinning; (2) inner (1 mm) superior thinning was greater than that of the temporal mGCL in blunt head injury and could potentially distinguish it from IED concussive head trauma; and (3) subfoveal choroidal thinning was significantly worse in eyes of mTBI patients compared with those of controls. CONCLUSIONS. These OCT findings may contribute to the understanding of the spectrum of visual injuries resulting from head trauma.	[Chan, Jane W.; Bakall, Benjamin] Univ Arizona, Dept Ophthalmol, Coll Med, 4430 North 22nd St,Unit 8, Phoenix, AZ 85016 USA; [Chan, Jane W.] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ USA; [Hills, Nancy K.] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA USA; [Bakall, Benjamin] Associated Retinal Consultants, Phoenix, AZ USA; [Fernandez, Brian] Heidelberg Engn Inc, Franklin, MA USA		Chan, JW (corresponding author), Univ Arizona, Dept Ophthalmol, Coll Med, 4430 North 22nd St,Unit 8, Phoenix, AZ 85016 USA.	janechan098@gmail.com			Clinical and Translational Sciences Institute grant at University of California, San Francisco; Kuen Lau Research Foundation	Supported by the Clinical and Translational Sciences Institute grant at University of California, San Francisco, and the Kuen Lau Research Foundation.	Abdellatif MK, 2018, EUR J OPHTHALMOL, V28, P714, DOI 10.1177/1120672117750054; Allen RS, 2018, J NEUROTRAUM, V35, P2104, DOI 10.1089/neu.2017.5394; ANDERSON RL, 1982, OPHTHALMOLOGY, V89, P445; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Colak HN, 2016, ARQ BRAS OFTALMOL, V79, P78, DOI 10.5935/0004-2749.20160024; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; Cunha LP, 2009, ARQ BRAS OFTALMOL, V72, P622, DOI 10.1590/S0004-27492009000500004; Dadaci Z, 2014, BRIT J OPHTHALMOL, V98, P972, DOI 10.1136/bjophthalmol-2013-304711; Daniel S, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0069-y; Defense and Veterans Brain Injury Center, 2015, DOD NUMB TRAUM BRAIN; Dwyer B, 2018, SEMIN NEUROL, V38, P619, DOI 10.1055/s-0038-1673692; Ekinci M, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-75; Feng L, 2013, INVEST OPHTH VIS SCI, V54, P1106, DOI 10.1167/iovs.12-10791; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; GROSS CE, 1981, NEUROSURGERY, V9, P1; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Gunes A, 2018, CLIN EXP OPTOM, V101, P109, DOI 10.1111/cxo.12585; HOLLANDER H, 1985, EXP BRAIN RES, V59, P633; Kanamori A, 2012, ARCH OPHTHALMOL-CHIC, V130, P1067, DOI 10.1001/archophthalmol.2012.470; Keller J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097444; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Kohno T, 1998, AM J OPHTHALMOL, V126, P248, DOI 10.1016/S0002-9394(98)00153-6; La Morgia C, 2016, ANN NEUROL, V79, P90, DOI 10.1002/ana.24548; La Morgia C, 2011, VISION RES, V51, P296, DOI 10.1016/j.visres.2010.07.023; La Morgia C, 2010, BRAIN, V133, P2426, DOI 10.1093/brain/awq155; Lee JY, 2017, CURR EYE RES, V42, P1628, DOI 10.1080/02713683.2017.1358374; Lee JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157388; Lemke S, 2016, OPHTHALMOLOGY, V123, P415, DOI 10.1016/j.ophtha.2015.10.003; LINSENMEIER RA, 1992, J GEN PHYSIOL, V99, P177, DOI 10.1085/jgp.99.2.177; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Medeiros FA, 2003, AM J OPHTHALMOL, V135, P406, DOI 10.1016/S0002-9394(02)02049-4; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; Schmidt TM, 2014, NEURON, V82, P781, DOI 10.1016/j.neuron.2014.03.022; Shedd DE, 2018, INVEST OPHTH VIS SCI, V59, P349, DOI 10.1167/iovs.17-21530; Singman EL, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0069-2; Tunc A, 2017, ACTA NEUROL BELG, V117, P121, DOI 10.1007/s13760-016-0715-1; Tzekov R, 2016, BRAIN INJURY, V30, P1428, DOI 10.1080/02699052.2016.1219062; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Uzun S, 2016, ARQ BRAS OFTALMOL, V79, P352, DOI 10.5935/0004-2749.20160100; Vessani RM, 2007, BRIT J OPHTHALMOL, V91, P697, DOI 10.1136/bjo.2006.103598; VONBUSSMANN KA, 1993, NEUROREPORT, V4, P247, DOI 10.1097/00001756-199303000-00005; Xu LY, 2015, EXP NEUROL, V273, P168, DOI 10.1016/j.expneurol.2015.08.014; Yan Hong, 2002, Yan Ke Xue Bao, V18, P80; Yuhas PT, 2017, OPTOMETRY VISION SCI, V94, P108, DOI 10.1097/OPX.0000000000000934	50	8	8	0	0	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	MAY	2019	60	6					2005	2011		10.1167/iovs.18-26094			7	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	HZ6RS	WOS:000468980600023	31067321	Green Published, gold			2022-02-06	
J	Genrikhs, EE; Stelmashook, EV; Alexandrova, OP; Novikova, SV; Voronkov, DN; Glibka, YA; Skulachev, VP; Isaev, NK				Genrikhs, Elisaveta E.; Stelmashook, Elena V.; Alexandrova, Olga P.; Novikova, Svetlana V.; Voronkov, Dmitriy N.; Glibka, Yuliya A.; Skulachev, Vladimir P.; Isaev, Nickolay K.			The single intravenous administration of mitochondria-targeted antioxidant SkQR1 after traumatic brain injury attenuates neurological deficit in rats	BRAIN RESEARCH BULLETIN			English	Article						Traumatic brain injury; Neuroprotection; SkQR1; C12R1	LONG-TERM POTENTIATION; THERAPEUTIC STRATEGIES; CARDIOLIPIN OXIDATION; CEREBRAL-ISCHEMIA; DERIVATIVES; MECHANISMS	The protective effect of SkQR1, a mitochondria-targeted antioxidant, was investigated on the model of focal one-sided traumatic brain injury (TBI) of the sensorimotor cortex region from 1 to 7 days after the injury. TBI caused a reliable disruption of the functions of the limbs contralateral to injury focus. The intravenous single injection of SkQR1 (250 nmol/kg) but not C12R1 (a SkQR1 homologue devoid of the antioxidant group) 30 min after TBI reduced the impairment of the motor functions of the limbs. A statistically significant improvement in limb function in animals was shown using 3 different tests: limb-placing test, beam-walking test and grip strength test. A pronounced therapeutic effect appeared on the 1th day and lasted until the end of the experiment - the 7th day after TBI. Histopathological examination showed that in the group of animals that did not receive SkQR1 in the marginal layer of the lesion there was a marked increase in astroglial expression, infiltration with segmented neutrophils, and poor survivability of neurons compared with animals treated with SkQR1. The obtained results demonstrate that the single use of plastoquinone-containing mitochondria-targeted antioxidant SkQR1 at the early stages of development of traumatic brain damage can reduce TBI-related disruptions of limb functions, and that mechanisms of the brain damage after trauma are dependent on the production of mitochondrial reactive oxygen species.	[Genrikhs, Elisaveta E.; Stelmashook, Elena V.; Alexandrova, Olga P.; Novikova, Svetlana V.; Voronkov, Dmitriy N.; Glibka, Yuliya A.; Isaev, Nickolay K.] Res Ctr Neurol, Volokolamskoe Shosse 80, Moscow 125367, Russia; [Skulachev, Vladimir P.; Isaev, Nickolay K.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Isaev, Nickolay K.] Moscow MV Lomonosov State Univ, Biol Fac, Moscow 119234, Russia		Isaev, NK (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Biol Fac, Leninskiye Gory,1,B 40, Moscow 119991, Russia.	isaev@genebee.msu.ru	Genrikhs, Elizaveta E/C-3854-2012; Isaev, Nikolay K/B-4194-2012; Stelmashook, Elena V/B-4442-2012; Voronkov, Dmitry N/B-3910-2012; Alexandrova, Olga P./AAN-8475-2020	Voronkov, Dmitry N/0000-0001-5222-5322; Skulachev, Vladimir/0000-0001-5141-7517; Genrikhs, Elizaveta/0000-0002-3203-0250	Russian Science FoundationRussian Science Foundation (RSF) [16-15-10108]; Russian Science FoundationRussian Science Foundation (RSF) [19-15-13004] Funding Source: Russian Science Foundation	This work was supported by the Russian Science Foundation grant No. 16-15-10108.	Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Antonenko YN, 2008, J MEMBRANE BIOL, V222, P141, DOI 10.1007/s00232-008-9108-6; Bakeeva LE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1288, DOI 10.1134/S000629790812002X; Che W, 2017, BRAIN RES BULL, V131, P100, DOI 10.1016/j.brainresbull.2017.03.014; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chesnut R M, 1995, New Horiz, V3, P366; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Davis A E, 2000, Crit Care Nurs Q, V23, P1; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; Genrikhs EE, 2017, B EXP BIOL MED+, V164, P211, DOI 10.1007/s10517-017-3960-2; Genrikhs EE, 2018, BRAIN RES BULL, V140, P148, DOI 10.1016/j.brainresbull.2018.05.002; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; HICKS SP, 1977, EXP NEUROL, V56, P410, DOI 10.1016/0014-4886(77)90357-0; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Isaev NK, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1578, DOI 10.1134/S0006297915120056; Isaev NK, 2012, BIOCHEMISTRY-MOSCOW+, V77, P996, DOI 10.1134/S0006297912090052; Isaev NK, 2016, REV NEUROSCIENCE, V27, P849, DOI 10.1515/revneuro-2016-0036; Ji J, 2015, J CEREBR BLOOD F MET, V35, P319, DOI 10.1038/jcbfm.2014.204; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Kapay NA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1367, DOI 10.1134/S0006297911120108; Kapay NA, 2013, J ALZHEIMERS DIS, V36, P377, DOI 10.3233/JAD-122428; Kolosova NG, 2017, CURR ALZHEIMER RES, V14, P1283, DOI 10.2174/1567205014666170621111033; Li L, 2017, J NEUROTRAUM, V34, P182, DOI 10.1089/neu.2015.4315; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Saraiva ALL, 2012, BRAIN RES BULL, V87, P180, DOI 10.1016/j.brainresbull.2011.10.010; Ma T, 2011, J NEUROSCI, V31, P5589, DOI 10.1523/JNEUROSCI.6566-10.2011; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Madav Y, 2019, BRAIN RES BULL, V146, P171, DOI 10.1016/j.brainresbull.2019.01.004; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Niizuma K, 2010, BBA-MOL BASIS DIS, V1802, P92, DOI 10.1016/j.bbadis.2009.09.002; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Pierce JD, 2018, J NEUROSCI RES, V96, P1080, DOI 10.1002/jnr.24210; Pointer CB, 2017, CELL MOL NEUROBIOL, V37, P1161, DOI 10.1007/s10571-016-0458-9; Silachev DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051553; Skulachev VP, 2012, J ALZHEIMERS DIS, V28, P283, DOI 10.3233/JAD-2011-111391; Skulachev VP, 2010, BBA-BIOENERGETICS, V1797, P878, DOI 10.1016/j.bbabio.2010.03.015; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Stelmashook EV, 2015, BIOCHEMISTRY-MOSCOW+, V80, P592, DOI 10.1134/S0006297915050119; Szarka N, 2018, J NEUROTRAUM, V35, P930, DOI 10.1089/neu.2017.5056; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007; Zhou J, 2018, AM J TRANSL RES, V10, P1887; Zhu YH, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4783602; 2015, J DRUG TARGET, V23, P347, DOI DOI 10.3109/1061186X.2014.997736; 2017, B EXP BIOL MED, V162, P730, DOI DOI 10.1007/S10517-017-3699-9	50	8	9	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	MAY	2019	148						100	108		10.1016/j.brainresbull.2019.03.011			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HX8PD	WOS:000467666900012	30935979				2022-02-06	
J	Gibson, TJ; Oliveira, SEO; Dalla Costa, FA; Gregory, NG				Gibson, Troy John; Octavio Oliveira, Steffan Edward; Dalla Costa, Filipe Antonio; Gregory, Neville George			Electroencephalographic assessment of pneumatically powered penetrating and non-penetrating captive-bolt stunning of bulls	MEAT SCIENCE			English	Article						Bulls; Cattle; Electroencephalogram (EEG); Non-penetrating; Penetrating; Pneumatic captive bolt stunning	VENTRAL-NECK INCISION; CATTLE SHOT; SLAUGHTER; RESPONSES; CONCUSSION; EFFICIENCY; CALVES; SHEEP	The electroencephalographic (EEG) responses of 31 bulls (zebu crossbred cattle) stunned with either pneumatically powered Jarvis penetrating (PCB) or non-penetrating captive bolt (NPCB) was examined. Animals were organized into two treatment groups: PCB (n = 20); and NPCB (n = 11) stunning, both using airline pressures of 220 psi (1517 kPa). All bulls shot with PCB (n = 20/20) had patterns of EEG activity that were inconsistent with consciousness. Of the cattle shot with NPCB 82% (n = 9/11) showed waveforms suggesting complete unconsciousness. After stunning two NPCB bulls had periods of normal EEG activity and maintenance (Ptot, delta, theta, beta) or increased (alpha) spectral power compared to pre-treatment values, indicating incomplete concussion. The study showed that pneumatic PCB stunning was effective in rendering all bulls unconscious, while NPCB was less effective. This highlights the potential animal welfare risks associated with NPCB compared to PCB stunning of mature bulls in commercial abattoirs.	[Gibson, Troy John; Gregory, Neville George] Univ London, Royal Vet Coll, Dept Pathobiol & Populat Sci, London, England; [Octavio Oliveira, Steffan Edward; Dalla Costa, Filipe Antonio] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Programa Posgrad Zootecnia, BR-14884900 Jaboticabal, SP, Brazil; [Octavio Oliveira, Steffan Edward; Dalla Costa, Filipe Antonio] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Grp Estudos & Pesquisas Etol & Ecol Anim, Dept Zootecnia, BR-14884900 Jaboticabal, SP, Brazil		Gibson, TJ (corresponding author), Univ London, Royal Vet Coll, Dept Pathobiol & Populat Sci, London, England.	tgibson@rvc.ac.uk	Costa, Filipe Dalla/AAV-5252-2021; Gibson, Troy/AAA-8687-2019	Gibson, Troy/0000-0002-1242-2695; Dalla Costa, Filipe Antonio/0000-0002-6038-841X	CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/24.910-4]; Humane Slaughter Association Special Travel Award	The authors would like to thank the assistance of the JBS abattoir staff in making this project possible. Particular thanks go to TG Baraldi and S Ferreira for all the help with data collection. Special thanks go to M.J.R. Paranhos da Costa for helping to develop the study, identifying industry contacts and supporting the drafting of the manuscript. This project was partially funded by CNPq (scholarships to SE Octavio Oliveira and FA Dalla Costa) and by FAPESP (grant number 2016/24.910-4) for supporting NG Gregory as a visiting professor at FCAV-UNESP, Jaboticabal campus. Ti Gibson was supported by a Humane Slaughter Association Special Travel Award.	Atkinson S, 2013, ANIM WELFARE, V22, P473, DOI 10.7120/09627286.22.4.473; Atkinson S. R., 2016, THESIS; Bauer G., 2005, ELECTROENCEPHALOGREG, P471; Blackmore D.W., 1988, SLAUGHTER STOCK PRAC; BLACKMORE DK, 1979, VET REC, V105, P372, DOI 10.1136/vr.105.16.372; Cerri CC, 2016, J CLEAN PROD, V112, P2593, DOI 10.1016/j.jclepro.2015.10.072; DALY CC, 1988, VET REC, V122, P325, DOI 10.1136/vr.122.14.325; DALY CC, 1987, BRIT VET J, V143, P574, DOI 10.1016/0007-1935(87)90049-2; DENNIS MB, 1988, LAB ANIM SCI, V38, P459; Derscheid R. J, 2015, J AM VET MED ASSOC, V248, P96; EFSA, 2004, EFSA J, V45, P1, DOI [DOI 10.2903/J.EFSA.2004.45, 10.2903/j. efsa.2004.45]; FAOSTAT, 2014, CATTLE SLAUGHTERED, V2017; FRICKER C, 1981, FLEISCHWIRTSCHAFT, V61, P124; Gerritzen M. A, 2016, ANIMAL WELFARE SLAUG, P203; Gibson TJ, 2018, BRIT POULTRY SCI, V59, P13, DOI 10.1080/00071668.2017.1401215; Gibson TJ, 2012, ANIM WELFARE, V21, P35, DOI 10.7120/096272812X13353700593446; Gibson TJ, 2009, NEW ZEAL VET J, V57, P96, DOI 10.1080/00480169.2009.36885; Gibson TJ, 2009, NEW ZEAL VET J, V57, P77, DOI 10.1080/00480169.2009.36882; Gibson TJ, 2009, NEW ZEAL VET J, V57, P90, DOI 10.1080/00480169.2009.36884; Gibson TJ, 2015, MEAT SCI, V100, P227, DOI 10.1016/j.meatsci.2014.10.022; Gouveia KG, 2009, ANIM WELFARE, V18, P171; Gregory NG, 2009, MEAT SCI, V81, P178, DOI 10.1016/j.meatsci.2008.07.016; Gregory NG, 2007, MEAT SCI, V77, P499, DOI 10.1016/j.meatsci.2007.04.026; Grist A, 2018, ANIMALS, V8, DOI 10.3390/ani8040049; Groll R, 1979, ELEKTROENCEPHALOGRAP; LAMBOOY E, 1981, VET REC, V109, P359, DOI 10.1136/vr.109.16.359; LAMBOOY E, 1981, FLEISCHWIRTSCHAFT, V61, P128; LAMBOOY E, 1982, MEAT SCI, V7, P51, DOI 10.1016/0309-1740(82)90098-5; Murrell JC, 2006, J VET PHARMACOL THER, V29, P325, DOI 10.1111/j.1365-2885.2006.00758.x; Oliveira SEO, 2018, MEAT SCI, V145, P347, DOI 10.1016/j.meatsci.2018.07.016; Oliveira SEO, 2018, MEAT SCI, V140, P9, DOI 10.1016/j.meatsci.2018.02.010; Oliveira SEO, 2017, MEAT SCI, V130, P64, DOI 10.1016/j.meatsci.2017.04.007; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Verheul M, 2016, ANN RHEUM DIS, P1; von Wenzlawowicz M, 2012, ANIM WELFARE, V21, P51, DOI 10.7120/096272812X13353700593527; Williams D, 1941, BRAIN, V64, P223, DOI 10.1093/brain/64.4.223; Zulkifli I, 2014, ANIM PROD SCI, V54, P187, DOI 10.1071/AN12128	37	8	8	0	23	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0309-1740	1873-4138		MEAT SCI	Meat Sci.	MAY	2019	151						54	59		10.1016/j.meatsci.2019.01.006			6	Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Food Science & Technology	HO9EL	WOS:000461264100008	30685511	hybrid, Green Accepted			2022-02-06	
J	Iovine-Wong, PE; Nichols-Hadeed, C; Stone, JT; Gamble, S; Cross, W; Cerulli, C; Levandowski, BA				Iovine-Wong, Paige E.; Nichols-Hadeed, Corey; Stone, Jennifer Thompson; Gamble, Stephanie; Cross, Wendi; Cerulli, Catherine; Levandowski, Brooke A.			Intimate Partner Violence, Suicide, and Their Overlapping Risk in Women Veterans: A Review of the Literature	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; FEMALE VETERANS; MILITARY VETERANS; INTERPERSONAL VIOLENCE; SEEKING VETERANS; SOCIAL SUPPORT; SUBSTANCE USE; IDEATION	Introduction: Suicidal thoughts and behaviors (STB) and intimate partner violence (IPV) are both serious and prevalent problems in the Veteran population that often occur in tandem, particularly among women Veterans. Women Veterans, the fastest growing segment of the Veteran population, may have unique overlapping risks that are worth exploring. Although the intersection of IPV and STB is well documented in the civilian population, it has not been thoroughly explored in women Veterans. Materials and Methods: Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) framework, we conducted a systematic review of the STB and IPV literature specifically related to women Veterans. We only included articles that sampled women Veterans, rather than active duty/reservist/National Guard women; due to the small volume of STB research using samples of only women Veterans, we included studies that used mixed-gender samples. We extracted risk factors for STB and/or IPV involvement from 56 selected articles and placed them into tables for comparison to determine commonalities. Results: Common risk factors fell into three categories: socio-demographic risk factors (young age, unemployment, and sexual minority status) were significant across both bodies of literature; mental health risk factors (general psychopathology, post-traumatic stress disorder (PTSD), depression, sleep disturbance, and substance use/abuse) also had significant overlap; and military service-related risk factors (military sexual trauma (MST) and deployment factors) were also relevant across both bodies of literature. Mental health risk factors, particularly PTSD, were the most common. Conclusion: Frequently, the risk factors for IPV and STB are shared and it is important to consider how research, screening and intervention efforts for these serious problems might be integrated. Our exploration of the literature may be used as a basis for future research with women Veterans on the intersection of STB and IPV. Further, Veterans Health Administration clinicians should be aware of these intersecting risk factors to enhance care and improve screening for both issues in women Veteran clients.	[Iovine-Wong, Paige E.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Community Hlth & Hlth Behav, 401 Goodyear Rd, Buffalo, NY 14215 USA; [Nichols-Hadeed, Corey; Stone, Jennifer Thompson; Gamble, Stephanie; Cross, Wendi; Cerulli, Catherine] Univ Rochester, Med Ctr, Dept Psychiat, Lab Interpersonal Violence & Victimizat, 601 Elmwood Ave,Box 668, Rochester, NY 14642 USA; [Levandowski, Brooke A.] Univ Rochester, Med Ctr, Clin & Translat Sci Inst, Dept Obstet & Gynecol, 300 Crittenden Blvd, Rochester, NY 14642 USA; [Gamble, Stephanie; Cross, Wendi] Canandaigua VA Med Ctr, Ctr Excellence Suicide Prevent, 400 Ft Hill Ave, Canandaigua, NY 14424 USA		Iovine-Wong, PE (corresponding author), SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Community Hlth & Hlth Behav, 401 Goodyear Rd, Buffalo, NY 14215 USA.				Center of Excellence for Suicide Prevention, Hendershot funding, University of Rochester Medical Center Department of Psychiatry; Center of Excellence for Suicide Prevention, Hendershot funding, University of Rochester Medical Center Department of Obstetrics and Gynecology	Center of Excellence for Suicide Prevention, Hendershot funding, University of Rochester Medical Center Departments of Psychiatry and Obstetrics and Gynecology. The contents do not represent the views of the US Department of Veterans Affairs or the United States Government.	Benda BB, 2006, AM J ORTHOPSYCHIAT, V76, P70, DOI 10.1037/0002-9432.76.1.70; Benda BB, 2005, SUICIDE LIFE-THREAT, V35, P106, DOI 10.1521/suli.35.1.106.59262; Blosnich JR, 2016, ANN EPIDEMIOL, V26, P592, DOI 10.1016/j.annepidem.2016.06.009; Blosnich JR, 2012, AM J PUBLIC HEALTH, V102, pS44, DOI 10.2105/AJPH.2011.300565; Bradley C, 2007, J FAM VIOLENCE, V22, P197, DOI 10.1007/s10896-007-9072-4; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Britton PC, 2012, AM J PUBLIC HEALTH, V102, pS125, DOI 10.2105/AJPH.2011.300415; Campbell R, 2008, J CONSULT CLIN PSYCH, V76, P194, DOI 10.1037/0022-006X.76.2.194; Cavanaugh CE, 2011, SUICIDE LIFE-THREAT, V41, P372, DOI 10.1111/j.1943-278X.2011.00035.x; Centers for Disease Control and Prevention (CDC), INT PARTN VIOL DEF; Dardis CM, 2017, WOMEN HEALTH, V57, P775, DOI 10.1080/03630242.2016.1202884; Dardis CM, 2017, PSYCHOL TRAUMA-US, V9, P67, DOI 10.1037/tra0000171; DeBeer BB, 2014, PSYCHIAT RES, V216, P357, DOI 10.1016/j.psychres.2014.02.010; Dichter ME, 2015, MIL MED, V180, P1124, DOI 10.7205/MILMED-D-14-00582; Dichter ME, 2014, SOC WORK MENT HEALTH, V12, P411, DOI 10.1080/15332985.2013.870104; Dichter ME, 2011, WOMEN HEALTH ISS, V21, pS190, DOI 10.1016/j.whi.2011.04.008; Dutra L, 2012, PSYCHOL TRAUMA-US, V4, P323, DOI 10.1037/a0026849; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Gobin RL, 2015, SUBST USE MISUSE, V50, P1765, DOI 10.3109/10826084.2015.1037398; Gold JI, 2007, MIL PSYCHOL, V19, P71, DOI 10.1080/08995600701323368; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Gradus JL, 2013, SUICIDE LIFE-THREAT, V43, P574, DOI 10.1111/sltb.12040; Gutierrez PM, 2013, J CLIN PSYCHOL, V69, P923, DOI 10.1002/jclp.21997; Hamilton AB, 2011, WOMEN HEALTH ISS, V21, pS203, DOI 10.1016/j.whi.2011.04.005; Homaifar BY, 2016, MIL PSYCHOL, V28, P185, DOI 10.1037/mil0000111; Ilgen MA, 2010, ARCH GEN PSYCHIAT, V67, P1152, DOI 10.1001/archgenpsychiatry.2010.129; Iverson KM, 2015, J AM BOARD FAM MED, V28, P772, DOI 10.3122/jabfm.2015.06.150154; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Iverson KM, 2013, J TRAUMA STRESS, V26, P767, DOI 10.1002/jts.21867; Jakupcak M, 2011, J NERV MENT DIS, V199, P272, DOI 10.1097/NMD.0b013e3182124604; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Kaplan MS, 2009, J TRAUMA, V67, P503, DOI 10.1097/TA.0b013e3181b36521; Kelley ML, 2017, J FAM VIOLENCE, V32, P505, DOI 10.1007/s10896-016-9903-2; Kelly UA, 2011, RES NURS HEALTH, V34, P457, DOI 10.1002/nur.20453; Kimerling R, 2016, J GEN INTERN MED, V31, P888, DOI 10.1007/s11606-016-3701-7; Kirby AC, 2012, VIOLENCE VICTIMS, V27, P777, DOI 10.1891/0886-6708.27.5.777; Legarreta M, 2015, PSYCHOL TRAUMA-US, V7, P277, DOI 10.1037/tra0000026; Lemaire CM, 2011, J AFFECT DISORDERS, V130, P231, DOI 10.1016/j.jad.2010.10.021; Magruder KM, 2012, AM J PUBLIC HEALTH, V102, pS118, DOI 10.2105/AJPH.2011.300451; Marshall AD, 2005, CLIN PSYCHOL REV, V25, P862, DOI 10.1016/j.cpr.2005.05.009; McCarthy JF, 2009, AM J EPIDEMIOL, V169, P1033, DOI 10.1093/aje/kwp010; McFarland BH, 2010, PSYCHIAT SERV, V61, P1177, DOI 10.1176/ps.2010.61.12.1177; Mercado R, 2015, PSYCHOL SERV, V12, P348, DOI 10.1037/ser0000056; Merriam Webster Dictionary, 2018, DEF VET; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Office of Mental Health and Suicide Prevention U.S. Department of Veterans Affairs, 2017, FACTS SUIC WOM VET; Office of Suicide Prevention, 2016, SUIC VET OTH AM 2001; Owens GP, 2014, J INTERPERS VIOLENCE, V29, P1318, DOI 10.1177/0886260513506274; Pavao J, 2013, J GEN INTERN MED, V28, pS536, DOI 10.1007/s11606-013-2341-4; Pfeiffer PN, 2009, DEPRESS ANXIETY, V26, P752, DOI 10.1002/da.20583; Pietrzak RH, 2010, J AFFECT DISORDERS, V123, P102, DOI 10.1016/j.jad.2009.08.001; Pigeon WR, 2012, AM J PUBLIC HEALTH, V102, pS93, DOI 10.2105/AJPH.2011.300470; Ramchand R, 2016, WOMEN HEALTH ISS, V26, P667, DOI 10.1016/j.whi.2016.07.005; Ray-Sannerud B. N., 2015, PSYCHOL SEX ORIENTAT, V2, P130, DOI DOI 10.1037/SGD0000096; Sadler AG, 2000, OBSTET GYNECOL, V96, P473, DOI 10.1016/S0029-7844(00)00919-4; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Sher L, 2012, CLEV CLIN J MED, V79, P92, DOI 10.3949/ccjm.79a.11069; Sullivan CP, 2014, LAW HUMAN BEHAV, V38, P1, DOI 10.1037/lhb0000035; Suris A, 2011, J TRAUMA STRESS, V24, P605, DOI 10.1002/jts.20674; Taft CT, 2009, VIOLENCE VICTIMS, V24, P639, DOI 10.1891/0886-6708.24.5.639; Tiet QQ, 2006, ALCOHOL CLIN EXP RES, V30, P998, DOI 10.1111/j.1530-0277.2006.00114.x; Tripp JC, 2016, PSYCHOL TRAUMA-US, V8, P626, DOI 10.1037/tra0000085; Weiner J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-374; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Zinzow HM, 2007, TRAUMA VIOLENCE ABUS, V8, P384, DOI 10.1177/1524838007307295; Zivin K, 2007, AM J PUBLIC HEALTH, V97, P2193, DOI 10.2105/AJPH.2007.115477	67	8	8	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY-JUN	2019	184	5-6					E201	E210		10.1093/milmed/usy355			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HY5SU	WOS:000468188900013	30690471	Bronze			2022-02-06	
J	Li, H; Hua, TF; Wang, W; Wu, XB; Miao, CQ; Huang, WP; Xiao, Y; Yang, J; Bradley, JL; Peberdy, MA; Ornato, J; Dix, TA; Beck, T; Tang, WC				Li, Hao; Hua, Tianfeng; Wang, Wei; Wu, Xiaobo; Miao, Changqing; Huang, Weiping; Xiao, Yan; Yang, Jin; Bradley, Jennifer L.; Peberdy, Mary Ann; Ornato, Joseph; Dix, Thomas A.; Beck, Tyler; Tang, Wanchun			THE EFFECTS OF PHARMACOLOGICAL HYPOTHERMIA INDUCED BY NEUROTENSIN RECEPTOR AGONIST ABS 201 ON OUTCOMES OF CPR	SHOCK			English	Article						Cardiopulmonary resuscitation; myocardial-neurological dysfunction; neurotensin analogue; survival duration; therapeutic hypothermia	AMERICAN-HEART-ASSOCIATION; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; CARDIOPULMONARY-RESUSCITATION; PERFUSION-PRESSURE; 24-HOUR SURVIVAL; MODEL; WIN55	Neurotensin is an endogenous tridecapeptide that binds to neurotensin receptors in the brain, which induce hypothermia. The aim of this study was to investigate whether the receptor agonist ABS 201 could induce therapeutic hypothermia and improve postresuscitation outcomes in a ventricular fibrillation cardiac arrest (VFCA) rat model. VF was electrically induced in 12 rats. Defibrillation was achieved after 6 min of cardiopulmonary resuscitation. After successful resuscitation, animals were randomized to receive ABS 201 (8 mg/kg/h) or placebo. Postresuscitation myocardial function and neurological deficit scores (NDS) were assessed, and postresuscitation survival duration was observed for up to 72 h. After administration of ABS 201, blood temperature decreased significantly from 37 degrees C to 34 degrees C, and was maintained for 2.5 h. There was a significant improvement of postresuscitation myocardial dysfunction, NDS, and survival duration in animals treated with ABS 201. These results demonstrated that ABS 201 induces therapeutic hypothermia in a VFCA rat model, ameliorates postresuscitation myocardial-neurological dysfunction, and prolongs survival duration. ABS 201 may therefore be an alternative method to induce therapeutic hypothermia with current cooling methods and improve postresuscitation outcomes.	[Li, Hao; Hua, Tianfeng; Wang, Wei; Wu, Xiaobo; Miao, Changqing; Huang, Weiping; Xiao, Yan; Yang, Jin; Bradley, Jennifer L.; Peberdy, Mary Ann; Ornato, Joseph; Tang, Wanchun] Virginia Commonwealth Univ, Weil Inst Emergency & Crit Care Res, Richmond, VA 23298 USA; [Li, Hao] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Crit Care Med, Xian, Shaanxi, Peoples R China; [Peberdy, Mary Ann] Virginia Commonwealth Univ Hlth Syst, Dept Internal Med, Richmond, VA USA; [Ornato, Joseph; Tang, Wanchun] Virginia Commonwealth Univ Hlth Syst, Dept Emergency Med, Richmond, VA USA; [Dix, Thomas A.; Beck, Tyler] Med Univ South Carolina, Dept Drug Discovery Biomed Sci, Charleston, SC 29425 USA; [Dix, Thomas A.; Beck, Tyler] JT Pharmaceut Inc, Mt Pleasant, SC USA; [Tang, Wanchun] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China		Tang, WC (corresponding author), Virginia Commonwealth Univ, Weil Inst Emergency & Crit Care Res, Richmond, VA 23298 USA.	wanchun.tang@vcuhealth.org	Wu, Xiaobo/AAW-9060-2020	Beck, Tyler/0000-0002-1717-8943; Bradley, Jennifer/0000-0001-6430-9275	project of Leading Talents in Pearl River Talent Plan of Guangdong Province, China [81000-42020004]	This work was technically supported by Dr. Mario Dance, clinical veterinarian (Virginia Commonwealth University). This work was supported by the project of Leading Talents in Pearl River Talent Plan of Guangdong Province, China (No. 81000-42020004) and theWeil Family Foundation, California. The funding agencies had no role in study design, data collection, and analysis.	Boules M, 2003, BRAIN RES, V987, P39, DOI 10.1016/S0006-8993(03)03227-X; Byrnes JJ, 2012, J PSYCHOPHARMACOL, V26, P1348, DOI 10.1177/0269881112443745; CARRAWAY R, 1982, J PHYSIOL-LONDON, V323, P403, DOI 10.1113/jphysiol.1982.sp014080; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Hadden MK, 2005, NEUROPHARMACOLOGY, V49, P1149, DOI 10.1016/j.neuropharm.2005.06.010; HENDRICKX HHL, 1984, RESUSCITATION, V12, P97, DOI 10.1016/0300-9572(84)90062-5; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hosseini A, 2006, EXP EYE RES, V82, P753, DOI 10.1016/j.exer.2005.09.017; Hsu CY, 2009, SHOCK, V32, P210, DOI 10.1097/SHK.0b013e318196ee99; Hua W, 2009, J AM COLL CARDIOL, V54, P1110, DOI 10.1016/j.jacc.2009.06.016; Hughes FM, 2010, J MED CHEM, V53, P4623, DOI 10.1021/jm100092s; Kalafatakis K, 2011, REGUL PEPTIDES, V170, P7, DOI 10.1016/j.regpep.2011.04.005; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Katz LM, 2004, CRIT CARE MED, V32, P806, DOI 10.1097/01.CCM.0000114998.00860.FD; KERN KB, 1988, RESUSCITATION, V16, P241, DOI 10.1016/0300-9572(88)90111-6; Kleinman ME, 2018, CIRCULATION, V137, pE7, DOI 10.1161/CIR.0000000000000539; Kokko KP, 2005, NEUROPHARMACOLOGY, V48, P417, DOI 10.1016/j.neuropharm.2004.10.008; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Ma LH, 2014, CRIT CARE MED, V42, pE42, DOI 10.1097/CCM.0b013e31829a8753; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Naim MY, 2016, CRIT CARE MED, V44, pE1111, DOI 10.1097/CCM.0000000000001859; National Research Council (US), 1996, I LAB AN RES GUID CA; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Osadchii O, 2005, EUR J PHARMACOL, V520, P108, DOI 10.1016/j.ejphar.2005.07.014; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Sun SJ, 2010, CRIT CARE MED, V38, P2282, DOI 10.1097/CCM.0b013e3181f9f9e3; Sun SJ, 2004, AM J PHYSIOL-HEART C, V287, pH969, DOI 10.1152/ajpheart.01171.2003; Tei C, 1995, J CARDIOL, V26, P135; Vaagenes P, 1997, RESUSCITATION, V35, P41, DOI 10.1016/S0300-9572(97)01108-8; Wei S, 2013, NEUROSCIENCE, V252, P489, DOI 10.1016/j.neuroscience.2013.07.052; Weng YL, 2012, RESUSCITATION, V83, P1145, DOI 10.1016/j.resuscitation.2012.01.022	34	8	8	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	MAY	2019	51	5					667	673		10.1097/SHK.0000000000001178			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	IQ5JS	WOS:000480789100017	30986796	Bronze			2022-02-06	
J	Mollayeva, T; Amodio, V; Mollayeva, S; D'Souza, A; Colquhoun, H; Quilico, E; Haag, H; Colantonio, A				Mollayeva, Tatyana; Amodio, Vanessa; Mollayeva, Shirin; D'Souza, Andrea; Colquhoun, Heather; Quilico, Enrico; Haag, Halina (Lin); Colantonio, Angela			A gender-transformative approach to improve outcomes and equity among persons with traumatic brain injury	BMJ OPEN			English	Article							PATIENT; RIGOUR	Introduction The initiation and translation of sex-sensitive and gender-sensitive research programmes into clinically useful considerations for patients with traumatic brain injury (TBI) have been difficult. Clinical frameworks are currently not specific according to sex and gender, despite evidence that these constructs influence the incidence, course and outcome of patients with TBI. The present protocol outlines a strategy for a research programme, supported by the Canadian Institutes of Health Research (CIHR) Institute of Gender and Health, which explores sex and gender topics in the context of TBI, with the goal of building an infrastructure to facilitate the implementation of sex/gender-sensitive research findings into clinical considerations. Methods and analysis A comprehensive multistep research programme is proposed to support three research objectives: (1) documentation of important concepts and ideas for education on topics of sex and gender in the TBI context using a knowledge-user feedback framework, current scientific evidence and the research team's expertise; (2) development of educational materials for patients with TBI, significant others and clinicians providing care that account for sex/gender and (3) testing the application of these educational materials for feasibility and effectiveness. This programme supports the CIHR Institute's mission by facilitating partnership with knowledge users across clinical, research, academic and community sectors, through a range of platforms and activities. Ethics and dissemination The Research Ethics Board of the University Health Network has approved the programme. It is anticipated that this work will add significant value to the advancement of the field of sex, gender and health by serving as a model to foster the integration of these constructs across the spectrum of disorders. This will transform clinical practices and ensure that generated knowledge is translated into improved training programmes, policies and health services that are responsive to the diverse needs of men and women with TBI.	[Mollayeva, Tatyana; Colquhoun, Heather; Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Mollayeva, Tatyana; Amodio, Vanessa; Mollayeva, Shirin; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Res Dept, Toronto, ON, Canada; [D'Souza, Andrea; Colquhoun, Heather; Quilico, Enrico; Haag, Halina (Lin); Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Haag, Halina (Lin)] Wilfrid Laurier Univ, Lyle S Hallman Fac Social Work, Waterloo, ON, Canada		Mollayeva, T (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada.; Mollayeva, T (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Res Dept, Toronto, ON, Canada.	tatyana.mollayeva@utoronto.ca	, Mollayeva/A-4522-2018	Colantonio, Angela/0000-0003-2094-4765; Mollayeva, Shirin/0000-0001-9612-8655; Mollayeva, Tatyana/0000-0002-2787-1848	Canadian Institutes of Health Research (CIHR) Institutes of Gender and Health grantCanadian Institutes of Health Research (CIHR) [CGW-126580]; CIHR Grant-Institute for Gender and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]; Alzheimer's AssociationAlzheimer's Association [AARF-16-442937]	This research program is supported by the Canadian Institutes of Health Research (CIHR) Institutes of Gender and Health grant #CGW-126580. The study was peer-reviewed and funded by the CIHR Grant-Institute for Gender and Health (#CGW-126580). Ethics approval was granted by the Toronto Rehabilitation Institute-University Health Network and the University of Toronto Ethics Boards. During the work on this manuscript, the first author was supported by the postdoctoral research grant from the Alzheimer's Association (AARF-16-442937). The funders had no role in the study design, decision to publish or preparation of the manuscript. This research program was developed with endorsement by patient and public organizations (table 1). The critical need to address sex and gender in brain injury research and rehabilitation, to ensure appropriate, equitable interventions for all patients, was highly endorsed by the leadership of these organizations, which reviewed the research program prior its submission to the funding agency (CIHR). These organizations acted as a liaison between our research team, the patients and the public. Dr Richard Riopelle, a member of the Brain Injury Canada Board of Directors and a primary knowledge user on the grant, and all our other partners are committed to engaging in further knowledge transfer events, meetings and dialogues to expand, share and disseminate project results and educational tools.	[Anonymous], 2010, CONSOLIDATED STANDAR; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Bartholomew LK, 2001, INTERVENTION MAPPING; Biswas RK, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0211-y; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Brain Injury Association of Canada, NAT POP HLTH STUD NE; Canadian Institute of Healthcare Research, IMP GEND KNOWL TRANS; Canadian Institutes of Health Research, 2015, DEF SEX GEND; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Center for Disease Control and Prevention, BRAIN INJ BAS; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Hansen K, 2017, ROUT RES CREAT CULT, P41; Hedges L. V., 1982, J ED STAT, V7, P119, DOI [DOI 10.3102/10769986006002107, 10.3102/10769986006002107]; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; KUZEL AJ, 1992, RES METH PR, V3, P31; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Mollayeva T, 2018, SEX GENDER INTERSECT; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; National Institutes of Health, NOT OD 15 102 CONS S; Ocloo J, 2016, BMJ QUAL SAF, V25, P626, DOI 10.1136/bmjqs-2015-004839; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Polderman T, 2018, BEHAV GENET, V48, P95, DOI 10.1007/s10519-018-9889-z; Quaglio G, 2017, LANCET NEUROL, V16, P951, DOI 10.1016/S1474-4422(17)30370-8; Stergiou-Kita M, 2016, ARCH PHYS MED REHAB, V97, pS40, DOI 10.1016/j.apmr.2015.04.008; Tannenbaum C, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0247-7; Tran VT, 2017, J CLIN EPIDEMIOL, V82, P71, DOI 10.1016/j.jclinepi.2016.10.001; Wassertheil S, 2003, PSYCHOL METHODS, V8, P254; World Health Organization, GEND EQ HUM RIGHTS	31	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	MAY	2019	9	5							e024674	10.1136/bmjopen-2018-024674			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IC7YG	WOS:000471192800083	31110084	gold, Green Published			2022-02-06	
J	Ouvrard, C; Berr, C; Meillon, C; Ribet, C; Goldberg, M; Zins, M; Amieva, H				Ouvrard, C.; Berr, C.; Meillon, C.; Ribet, C.; Goldberg, M.; Zins, M.; Amieva, H.			Norms for standard neuropsychological tests from the French CONSTANCES cohort	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						neuropsychological tests; norms; older adults	TRAUMATIC BRAIN-INJURY; MINI-MENTAL-STATE; EDUCATION; AGE; VARIABILITY; DECLINE; ADULTS; TRAIL	Background and purpose Neuropsychological testing plays a key role in various clinical contexts. Even though a substantial number of adults suffer neurological disorders such as early-onset dementia, stroke, traumatic brain injury or multiple sclerosis, most normative data do not include persons below 65. The aim of this study was to produce updated norms for the Mini-Mental State Examination, the Free and Cued Selective Reminding Test, the Trail Making Test, verbal fluency tasks and the Digit Symbol Substitution Test for middle-aged and older adults. Methods The sample consisted of 51 879 participants aged 45-70 years from the CONSTANCES study. Norms are presented in percentiles stratified on age, education and gender. Results The results illustrated the effect of age in all tests considered. For tests involving speed processing, the impact of age was observed including in tight age range categories (5 years). The results also showed the well-known effect of education and an effect of gender in tests involving verbal memory and speed processing. Conclusions The norms provided allow the variability of the cognitive performances of middle-aged to older populations to be understood, with a high precision in age categories. The tests considered are broadly used in neuropsychological practice and should be helpful in a variety of clinical contexts.	[Ouvrard, C.; Meillon, C.; Amieva, H.] Univ Bordeaux, INSERM, Bordeaux Populat Hlth Res Ctr, UMR 1219, F-33000 Bordeaux, France; [Berr, C.] Univ Montpellier, Inserm U1061, Neuropsychiat Epidemiol & Clin Res, Montpellier, France; [Ribet, C.; Goldberg, M.; Zins, M.] UMS 011 Inserm UVSQ, Populat Based Epidemiol Cohorts Unit, Villejuif, France; [Goldberg, M.; Zins, M.] Paris Descartes Univ, Paris, France		Ouvrard, C (corresponding author), Univ Bordeaux, INSERM U1219, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	camille.ouvrard@u-bordeaux.fr	Ouvrard, Camille/T-3841-2019; Meillon, Celine/T-4487-2019; Berr, Claudine/AAD-8539-2020; berr, Claudine/D-5238-2014; Amieva, Helene/T-4170-2019	Ouvrard, Camille/0000-0002-5051-4232; Berr, Claudine/0000-0001-5254-7655; berr, Claudine/0000-0001-5254-7655; Amieva, Helene/0000-0002-0119-7242	ANRFrench National Research Agency (ANR) [ANR-11-INBS-0002]; MSD; AstraZenecaAstraZeneca; LundbeckLundbeck Corporation	CONSTANCES is an Infrastructure nationale en Biologie et Sante. It is supported by the Caisse nationale d'assurance maladie des travailleurs salaries, a grant from ANR (ANR-11-INBS-0002) and is also partly funded by MSD, AstraZeneca and Lundbeck.	Amieva H, 2007, REV NEUROL-FRANCE, V163, P205, DOI 10.1016/S0035-3787(07)90392-6; Amieva H, 2014, BRAIN, V137, P1167, DOI 10.1093/brain/awu035; Bang J, 2015, LANCET, V386, P1672, DOI 10.1016/S0140-6736(15)00461-4; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; GROBER E, 1988, NEUROLOGY, V38, P900, DOI 10.1212/WNL.38.6.900; Grober Ellen, 2018, Alzheimers Dement (Amst), V10, P161, DOI 10.1016/j.dadm.2017.12.004; Hall CB, 2007, NEUROLOGY, V69, P1657, DOI 10.1212/01.wnl.0000278163.82636.30; Hensel A, 2009, DEMENT GERIATR COGN, V27, P50, DOI 10.1159/000189267; Holtzer R, 2008, JAMA-J AM MED ASSOC, V300, P823, DOI 10.1001/jama.300.7.823; Lazar RM, 2008, J NEUROL NEUROSUR PS, V79, P530, DOI 10.1136/jnnp.2007.122457; Le Carret N, 2003, DEV NEUROPSYCHOL, V23, P317, DOI 10.1207/S15326942DN2303_1; Lechevallier-Michel N, 2004, REV NEUROL-FRANCE, V160, P1059, DOI 10.1016/S0035-3787(04)71143-1; Malek-Ahmadi M, 2015, AGING NEUROPSYCHOL C, V22, P755, DOI 10.1080/13825585.2015.1041449; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roivainen E, 2011, LEARN INDIVID DIFFER, V21, P145, DOI 10.1016/j.lindif.2010.11.021; Roos A, 2010, COMPR PSYCHIAT, V51, P207, DOI 10.1016/j.comppsych.2009.03.007; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Snaphaan L, 2007, STROKE, V38, P198, DOI 10.1161/01.STR.0000251842.34322.8f; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Trahan LH, 2014, PSYCHOL BULL, V140, P1332, DOI 10.1037/a0037173; Vieira Renata Teles, 2013, Clin Pract Epidemiol Ment Health, V9, P88, DOI 10.2174/1745017901309010088; Wechsler, 1997, WECHSLER ADULT INTEL; Wilson RS, 2002, PSYCHOL AGING, V17, P179, DOI 10.1037/0882-7974.17.2.179; Zimmermann N, 2017, TRENDS PSYCHIATR PSY, V39, P188, DOI 10.1590/2237-6089-2016-0082; Zins M, 2015, EUR J EPIDEMIOL, V30, P1317, DOI 10.1007/s10654-015-0096-4	29	8	8	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	MAY	2019	26	5					786	793		10.1111/ene.13890			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HW1JN	WOS:000466439300018	30575234	Green Submitted			2022-02-06	
J	Ramey, L; Osborne, C; Kasitinon, D; Juengst, S				Ramey, Lindsay; Osborne, Candice; Kasitinon, Donald; Juengst, Shannon			Apps and Mobile Health Technology in Rehabilitation The Good, the Bad, and the Unknown	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Mobile health (mHealth); Smartphone; Applications (apps); Technology; Rehabilitation	TRAUMATIC BRAIN-INJURY; SCHEDULED TELEPHONE INTERVENTION; CARDIOVASCULAR RISK-FACTORS; CARDIAC REHABILITATION; MYOCARDIAL-INFARCTION; SELF-MANAGEMENT; FEASIBILITY; ADHERENCE; EXERCISE; SYMPTOMS	Although there is disparity in access to mobile health (mHealth) services among people with disabilities, several smartphone and tablet-based mHealth applications are available that may affect the care of patients in rehabilitation medicine. This article reviews the current evidence for and breadth of application-based mHealth interventions in rehabilitation medicine, including comprehensive self-management mHealth services; weight management mHealth services; diagnosis-specific mHealth services for individuals with brain, spinal cord, musculoskeletal, or other injury types; and nonmedical services to improve community and social integration.	[Ramey, Lindsay; Osborne, Candice; Kasitinon, Donald; Juengst, Shannon] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, 5161 Harry Hines Blvd,Charles Sprague Bldg, Dallas, TX 75390 USA		Ramey, L (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, 5161 Harry Hines Blvd,Charles Sprague Bldg, Dallas, TX 75390 USA.	Lindsay.ramey@utsouthwestern.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X; Kasitinon, Donald/0000-0002-5505-1572			Adams K, 2004, THE 1ST ANNUAL CROSS, P57; Aitken M., 2015, PATIENT ADOPTION MHE; Anderson M, TECHNOLOGY USE SENIO; Anderson M., 2017, DISABLED AM ARE LESS; [Anonymous], 2018, ADULT OBESITY CAUSES; [Anonymous], 2018, I LIMB MOB APPS; [Anonymous], 2017, MOB FACT SHEET; Anthes E, 2016, NATURE, V532, P20, DOI 10.1038/532020a; Atreja Ashish, 2005, MedGenMed, V7, P4; Balducci S, 2010, ARCH INTERN MED, V170, P1794, DOI 10.1001/archinternmed.2010.380; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bell KR, 2017, J NEUROTRAUM, V34, P313, DOI 10.1089/neu.2016.4444; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Beratarrechea A, 2014, TELEMED E-HEALTH, V20, P75, DOI 10.1089/tmj.2012.0328; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Brown TM, 2009, J AM COLL CARDIOL, V54, P515, DOI 10.1016/j.jacc.2009.02.080; Case A., 2017, NEW MOBILE APP PROMO; Chau B., 2018, AMPUTEE GAIT ANAL MU; Cikajlo I, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.6849; de Jongh T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007459.pub2; Dean SG, 2005, DISABIL REHABIL, V27, P625, DOI 10.1080/0963820500030449; DeHoff BA, 2016, J MED INTERNET RES, V18, P192, DOI 10.2196/jmir.6722; Dicianno BE, 2016, AM J PHYS MED REHAB, V95, P425, DOI 10.1097/PHM.0000000000000400; Dicianno BE, 2015, PHYS THER, V95, P397, DOI 10.2522/ptj.20130534; Dicianno BE, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.7335; Donker T, 2013, J MED INTERNET RES, V15; Ernsting C, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6838; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Fox S., 2013, TRACKING FOR HLTH; Free C, 2013, PLOS MED, V10; Goel K, 2011, CIRCULATION, V123, P2344, DOI 10.1161/CIRCULATIONAHA.110.983536; Gold DT, 2006, AM J MED, V119, p32S, DOI 10.1016/j.amjmed.2005.12.021; Jamison RN, 2018, J TELEMED TELECARE, V24, P93, DOI 10.1177/1357633X16679049; Jamison RN, 2017, CLIN J PAIN, V33, P676, DOI 10.1097/AJP.0000000000000455; Johnston N, 2016, AM HEART J, V178, P85, DOI 10.1016/j.ahj.2016.05.005; Jones M, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030515; Juengst SB, CURRENT TOPICS PHYS; Juengst SB, 2015, BRAIN INJURY, V29, P1351, DOI 10.3109/02699052.2015.1045031; Kitsiou S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173160; Laing BY, 2014, ANN INTERN MED, V161, pS5, DOI 10.7326/M13-3005; Lambert TE, 2017, J PHYSIOTHER, V63, P161, DOI 10.1016/j.jphys.2017.05.015; Lee DJ, 2017, THE O P EDGE; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Matthew-Maich N, 2016, JMIR MHEALTH UHEALTH, V4, P164, DOI 10.2196/mhealth.5127; Milne Lauren R., 2014, INT TECHN PERS DIS C, P166; Morris J., 2017, J TECHNOL PERSONS DI, V5, P50; Morris J., 2016, J TECHNOL PERS DISAB, V4, P101; Mortenson WB, 2017, AM J PHYS MED REH S1, V96, pe138; Ng EMW, 2013, BRAIN INJURY, V27, P548, DOI 10.3109/02699052.2013.766927; Oh B, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.8719; Plackett R, 2017, DISABIL REHABIL-ASSI, V12, P236, DOI 10.3109/17483107.2015.1127436; Reynoldson C, 2014, PAIN MED, V15, P898, DOI 10.1111/pme.12327; Rivera J, 2016, JMIR MHEALTH UHEALTH, V4, DOI 10.2196/mhealth.5115; Rosser BA, 2011, J TELEMED TELECARE, V17, P308, DOI 10.1258/jtt.2011.101102; Scheenen ME, 2017, J NEUROTRAUM, V34, P2713, DOI 10.1089/neu.2016.4885; Scherer MJ, 2005, DISABIL REHABIL, V27, P731, DOI 10.1080/09638280400014816; SLUIJS EM, 1993, PHYS THER, V73, P786, DOI 10.1093/ptj/73.11.786; Spring B, 2013, JAMA INTERN MED, V173, P105, DOI 10.1001/jamainternmed.2013.1221; Suaya JA, 2007, CIRCULATION, V116, P1653, DOI 10.1161/CIRCULATIONAHA.107.701466; Sundararaman LV, 2017, REGION ANESTH PAIN M, V42, P488, DOI 10.1097/AAP.0000000000000621; van Mechelen DM, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2012-092136; Vargas BB, 2017, NEUROLOGY, V88, P1580, DOI 10.1212/WNL.0000000000003841; Vuletic S, 2016, J HEAD TRAUMA REHAB, V31, P147, DOI 10.1097/HTR.0000000000000221; Wang YF, 2017, ADV NUTR, V8, P449, DOI 10.3945/an.116.014100; Widmer RJ, 2015, J CARDIOVASC TRANSL, V8, P283, DOI 10.1007/s12265-015-9629-1; Wong D, 2017, DISABIL REHABIL, V39, P2387, DOI 10.1080/09638288.2016.1226434; WONG SJ, 2015, BMC SPORTS SCI MED R, V7; 2017, J PEDIAT PSYCHOL, V42, P962	69	8	8	4	17	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2019	30	2					485	+		10.1016/j.pmr.2018.12.001			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	HW6VZ	WOS:000466830100015	30954161				2022-02-06	
J	Rosenfeld, E; Lau, P; Zhang, W; Russell, RT; Shah, SR; Naik-Mathuria, B; Vogel, AM				Rosenfeld, Eric; Lau, Patricio; Zhang, Wei; Russell, Robert T.; Shah, Sohail R.; Naik-Mathuria, Bindi; Vogel, Adam M.			Defining massive transfusion in civilian pediatric trauma	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	50th Annual Meeting of the Canadian-Association-of-Pediatric-Surgeons (CAPS)	SEP 26-28, 2018	Toronto, CANADA	Canadian Assoc Pediat Surg		Massive transfusion; Pediatric trauma; Hemorrhagic shock	PROTOCOL; MORTALITY; RATIO; RESUSCITATION; COAGULOPATHY; SURVIVAL; OUTCOMES; PLASMA	Purpose: The purpose of this study was to identify an optimal definition of massive transfusion (MT) in civilian pediatric trauma. Methods: Severely injured children (age <= 18 years, injury severity score >= 25) in the Trauma Quality Improvement Program research datasets 2014-2015 that received blood products were identified. Children with traumatic brain injury and non-survivable injuries were excluded. Early mortality was defined as death within 24 h and delayed mortality as death after 24 h from hospital admission. Receiver operating curves and sensitivity and specificity analysis identified an MT threshold. Continuous variables are presented as median [IQR]. Results: Of the 270 included children, the overall mortality was 27% (N = 74). There were no differences in demographics or mechanism of injury between children that lived or died. Sensitivity and specificity for early mortality was optimized at a 4-h transfusion volume of 37 ml/kg. After controlling for other significant variables, a threshold of 37 ml/kg/4 h predicted the need for a hemorrhage control procedure (OR 8.60; 95% CI 4.25-17.42; p < 0.01) and early mortality (OR 4.24; 95% CI 1.96-9.16; p < 0.01). Conclusion: An MTP threshold of 37 mL/kg/4 h of transfused blood products predicted the need for hemorrhage control procedures and early mortality. This threshold may provide clinicians with a timely prognostic indicator, improve research methodology, and resource utilization. Type of Study: Diagnostic Test. (C) 2019 Elsevier Inc. All rights reserved.	[Rosenfeld, Eric; Lau, Patricio; Shah, Sohail R.; Naik-Mathuria, Bindi; Vogel, Adam M.] Texas Childrens Hosp, Dept Pediat Surg, 6701 Fannin St 1210, Houston, TX 77030 USA; [Rosenfeld, Eric; Lau, Patricio; Shah, Sohail R.; Naik-Mathuria, Bindi; Vogel, Adam M.] Baylor Coll Med, Houston, TX 77030 USA; [Zhang, Wei] Texas Childrens Hosp, Outcomes & Impact Serv, Houston, TX 77030 USA; [Russell, Robert T.] Childrens Hosp Alabama, Dept Pediat Surg, Birmingham, AL USA		Vogel, AM (corresponding author), Texas Childrens Hosp, Dept Pediat Surg, 6701 Fannin St 1210, Houston, TX 77030 USA.	amvogel@texaschildrens.org		Russell, Robert/0000-0002-8531-4249			Acker SN, 2017, EUR J PEDIATR SURG, V27, P32, DOI 10.1055/s-0036-1587587; Avarello JT, 2007, EMERG MED CLIN N AM, V25, P803, DOI 10.1016/j.emc.2007.06.013; Barcelona SL, 2005, PEDIATR ANESTH, V15, P716, DOI 10.1111/j.1460-9592.2005.01548.x; Borgman MA, 2011, VOX SANG, V101, P44, DOI 10.1111/j.1423-0410.2011.01466.x; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Centers for Disease Control and Prevention NCfHS, 2017, DAT TABL WEIGHT FOR; Chidester SJ, 2012, J TRAUMA ACUTE CARE, V73, P1273, DOI 10.1097/TA.0b013e318265d267; Cotton BA, 2008, J TRAUMA, V64, P1177, DOI 10.1097/TA.0b013e31816c5c80; Cotton BA, 2009, J TRAUMA, V66, P41, DOI 10.1097/TA.0b013e31819313bb; Dente CJ, 2009, J TRAUMA, V66, P1616, DOI 10.1097/TA.0b013e3181a59ad5; Diab YA, 2013, BRIT J HAEMATOL, V161, P15, DOI 10.1111/bjh.12247; Dressler AM, 2010, J PEDIATR SURG, V45, P1530, DOI 10.1016/j.jpedsurg.2010.03.023; Gunter OL, 2008, J TRAUMA, V65, P527, DOI 10.1097/TA.0b013e3181826ddf; Hendrickson JE, 2012, TRANSFUSION, V52, P1228, DOI 10.1111/j.1537-2995.2011.03458.x; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Horst J, 2016, TRANSFUSION MED, V26, P49, DOI 10.1111/tme.12277; National Center for Health Statistics (NCHS), 2015, NAT VIT STAT SYST; Neff LP, 2015, J TRAUMA ACUTE CARE, V78, P22, DOI 10.1097/TA.0000000000000488; NYSTRUP KB, SCAND J TRAUMA RESUS; O'Keeffe T, 2008, ARCH SURG-CHICAGO, V143, P90; O'Keeffe T, 2008, ARCH SURG-CHICAGO, V143, P686, DOI 10.1001/archsurg.143.7.686; Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d; Rubin D.B., 2004, MULTIPLE IMPUTATION; Sambasivan CN, 2009, AM J SURG, V197, P576, DOI 10.1016/j.amjsurg.2008.12.011; Schuster KM, 2010, TRANSFUSION, V50, P1545, DOI 10.1111/j.1537-2995.2010.02587.x; Sihler KC, 2010, CHEST, V137, P209, DOI 10.1378/chest.09-0252; Spinella PC, 2011, J TRAUMA, V71, pS343, DOI 10.1097/TA.0b013e318227ef2d; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Zink KA, 2009, AM J SURG, V197, P565, DOI 10.1016/j.amjsurg.2008.12.014	30	8	8	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	MAY	2019	54	5					975	979		10.1016/j.jpedsurg.2019.01.029			5	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pediatrics; Surgery	HX0LA	WOS:000467080000020	30765151				2022-02-06	
J	Shao, HF; Li, ZZ; Zheng, XF; Wang, HJ; Wang, YG; Ma, ZL; Liu, ZB; Han, QY				Shao, H-F; Li, Z-Z; Zheng, X-F; Wang, H-J; Wang, Y-G; Ma, Z-L; Liu, Z-B; Han, Q-Y			Research on the correlation of changes in plasma lncRNA MEG3 with change in inflammatory factors and prognosis in patients with traumatic brain injury	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Long non-coding RNA MEG3; Inflammatory cytokines; Traumatic brain injury; Prognosis	PROLIFERATION; CYTOKINES; CELLS	OBJECTIVE: To study the correlation between the plasma long non-coding RNA (lncRNA) maternally expressed gene 3 (MEG3) and the levels of inflammatory cytokines in patients with traumatic brain injury (TBI) and to evaluate its prognosis to screen new biological targets for the diagnosis and treatment of TBI. PATIENTS AND METHODS: 40 patients with TBI (TBI group) and 40 healthy people (control group) were collected and venous blood was drawn. The plasma MEG3 in subjects was quantitatively analyzed via quantitative Polymerase Chain Reaction (qPCR). Moreover, the levels of inflammatory cytokines [tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), IL-6, and IL8] in plasma in each group were detected via enzyme-linked immunosorbent assay (ELISA). Finally, the correlation analysis was performed for the MEG3 expression level and inflammatory cytokine levels in patients with TBI. Patients were divided into high-expression MEG3 group and low-expression MEG3 group, high-level inflammatory cytokine group and low-level inflammatory cytokine group according to the median, followed by prognosis evaluation. The MEG3 expression level in TBI group was significantly decreased compared to that in control group, and the levels of inflammatory cytokines in plasma, including TNF-alpha, IL-1 beta, IL-6, and IL-8, were significantly higher than in control group. RESULTS: The results of the correlation analysis showed that the expression level of plasma MEG3 had a significantly negative correlation with the level of each inflammatory cytokine. The prognostic analysis revealed that the prognosis of patients with high MEG3 expression level and low inflammatory cytokine levels was good, while it was poor in patients with low MEG3 expression level and high inflammatory cytokine levels; the difference was significant. In patients with TBI, the expression level of plasma MEG3 is de- creased, while the inflammatory cytokine levels are increased, and there is a significantly negative correlation between the two items. CONCLUSIONS: The prognosis of patients with high MEG3 expression level and low inflammatory cytokine levels is good so MEG3 and inflammatory cytokines can be used as biomarkers for diagnosis and treatment of TBI, improving the prognosis of patients.	[Shao, H-F; Li, Z-Z; Ma, Z-L; Liu, Z-B] Xingtai Peoples Hosp, Dept Neurosurg, Xingtai, Hebei, Peoples R China; [Zheng, X-F; Wang, H-J] Jinan Univ, Affiliated Hosp 1, Clin Coll 1, Dept Orthoped, Guangzhou, Guangdong, Peoples R China; [Wang, Y-G] Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Han, Q-Y] Xingtai Peoples Hosp, Dept Personnel Off, Xingtai, Hebei, Peoples R China		Li, ZZ (corresponding author), Xingtai Peoples Hosp, Dept Neurosurg, Xingtai, Hebei, Peoples R China.	gank4174@126.com					Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Meirelles CMJ, 2011, NUTR HOSP, V26, P1120, DOI [10.1590/S0212-16112011000500030, 10.3305/nh.2011.26.5.5133]; Kim CY, 2013, J VASC INTERV RADIOL, V24, P1845, DOI 10.1016/j.jvir.2013.08.012; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Luo G, 2015, CELL PHYSIOL BIOCHEM, V37, P2209, DOI 10.1159/000438577; Mantovani Alberto, 2000, Recenti Progressi in Medicina, V91, P422; Qin R, 2013, NEOPLASMA, V60, P486, DOI 10.4149/neo_2013_063; Ramos AD, 2013, CELL STEM CELL, V12, P616, DOI 10.1016/j.stem.2013.03.003; Rapicavoli NA, 2013, ELIFE, V2, DOI 10.7554/eLife.00762; Seekamp A, 2002, EUR J TRAUMA, V3, P183; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Stevens Jan, 2008, Kans Nurse, V83, P3; Sun CQ, 2016, INT J CLIN EXP PATHO, V9, P1975; Takaada K, 2012, BRAIN INJURY, V26, P428; ZHAO FY, 2015, SCI REP UK, V0005; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200; Zhu Tao, 2004, Chin J Traumatol, V7, P32	21	8	9	0	0	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	MAY	2019	23	10					4341	4347					7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	IC1EJ	WOS:000470701700035	31173307				2022-02-06	
J	Shetty, T; Cogsil, T; Dalal, A; Kim, E; Halvorsen, K; Cummings, K; Nguyen, JT				Shetty, Teena; Cogsil, Taylor; Dalal, Aashka; Kim, Esther; Halvorsen, Kristin; Cummings, Kelianne; Nguyen, Joseph T.			High-Sensitivity C-Reactive Protein: Retrospective Study of Potential Blood Biomarker of Inflammation in Acute Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acute care; blood biomarker panel; closed head injury; gender; Glasgow Coma Scale; high-sensitivity C-reactive protein; inflammation; mild traumatic brain injury	INTERNATIONAL-CONFERENCE; INTRACRANIAL LESIONS; CONSENSUS STATEMENT; CEREBROSPINAL-FLUID; SPORT HELD; DISEASE; SERUM; RISK; CONCUSSION; PREDICTORS	Objective: A panel of biomarkers is needed to definitively diagnose mild traumatic brain injury (mTBI). There is a clear role for the inclusion of an inflammatory biomarker. This study looked to find a relationship between high sensitivity C-reactive protein (hsCRP), an inflammatory biomarker, and mTBI. Setting: Neurology department of high-volume tertiary orthopedic hospital. Participants: Individuals diagnosed with mTBI (n = 311, age 21 +/- 12 years, 53% female). Design: Retrospective cohort study. Main Measures: hsCRP levels; postconcussive symptoms; demographics. Results: Continuous hsCRP levels were transformed into quartiles, as defined by less than 0.200 mg/L for quartile 1 (Q1); 0.200 to 0.415 mg/L for quartile 2 (Q2); 0.415 to 1.100 mg/L for quartile 3 (Q3); and greater than 1.100 mg/L for quartile 4 (Q4). Mean hsCRP was elevated in the cohort of individuals who presented within 1 week of injury and was found to significantly decrease between the first visit and 4 weeks postinjury (P = .016). Initial hsCRP level was positively correlated with age (r = 0.163, P = .004), and age significantly increased between quartiles (P = .013). Patients with increased age (odds ratio: 3.48) and those who endorsed headache (odds ratio: 3.48) or fatigue (odds ratio: 2.16) were significantly associated with increased risk of having an hsCRP level in Q4. Conclusion: hsCRP may be a viable addition to acute and longitudinal biomarker panels for diagnosis and prognosis of mTBI.	[Shetty, Teena; Cogsil, Taylor; Kim, Esther; Halvorsen, Kristin] Hosp Special Surg, Dept Neurol, 535 E 70th St, New York, NY 10021 USA; [Nguyen, Joseph T.] Hosp Special Surg, Biostat Core, New York, NY 10021 USA; [Dalal, Aashka] New York Med Coll, Valhalla, NY 10595 USA; [Cummings, Kelianne] SUNY Downstate Med Sch, Brooklyn, NY USA		Shetty, T (corresponding author), Hosp Special Surg, Dept Neurol, 535 E 70th St, New York, NY 10021 USA.	shettyt@hss.edu					[Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cervellin G, 2012, CLIN BIOCHEM, V45, P408, DOI 10.1016/j.clinbiochem.2012.01.006; Dessein PH, 2004, J RHEUMATOL, V31, P1095; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Faul M, 2010, TRAUMATIC BRAIN INJU; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Is M, 2007, J CLIN NEUROSCI, V14, P1163, DOI 10.1016/j.jocn.2006.05.020; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lachmann HJ, 2006, RHEUMATOLOGY, V45, P746, DOI 10.1093/rheumatology/kei279; Levy D, 2009, CURR PAIN HEADACHE R, V13, P237, DOI 10.1007/s11916-009-0040-y; Liu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093063; Liukkonen T, 2011, EUR PSYCHIAT, V26, P363, DOI 10.1016/j.eurpsy.2011.02.001; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Lugones M, 2018, NEUROSCI BIOBEHAV R, V87, P206, DOI 10.1016/j.neubiorev.2018.02.006; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Prasad K, 2006, CARDIOVASC DRUG REV, V24, P33, DOI 10.1111/j.1527-3466.2006.00033.x; Ray KK, 2009, ARTERIOSCL THROM VAS, V29, P424, DOI 10.1161/ATVBAHA.108.181735; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Sharma R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173798; Sogut O, 2010, J INT MED RES, V38, P1708, DOI 10.1177/147323001003800516; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang J, 2015, J HAINAN MED U, V9, P69	33	8	8	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2019	34	3			SI		E28	E36		10.1097/HTR.0000000000000450			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IH1KG	WOS:000474249100004	30499931				2022-02-06	
J	Tang, Y; Liu, HL; Min, LX; Yuan, HS; Guo, L; Han, PB; Lu, YX; Zhong, JF; Wang, DL				Tang, Ying; Liu, Hong-Liang; Min, Ling-Xia; Yuan, Hao-Shi; Guo, Lei; Han, Peng-Bo; Lu, Yu-Xin; Zhong, Jian-Feng; Wang, Dong-Lin			Serum and cerebrospinal fluid tau protein level as biomarkers for evaluating acute spinal cord injury severity and motor function outcome	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; spinal cord injury; tau; injury severity; outcome; cerebrospinal fluid; serum; biomarker; Basso; Beattie; Bresnahan locomotor rating scale; neural regeneration	NEURON-SPECIFIC ENOLASE; ALZHEIMERS-DISEASE; AMYLOID-BETA; BRAIN; EXPRESSION; INHIBITOR; MECHANISM; LOCOMOTOR; MICRORNAS; RECOVERY	Tau protein, a microtubule-associated protein, has a high specific expression in neurons and axons. Because traumatic spinal cord injury mainly affects neurons and axons, we speculated that tau protein may be a promising biomarker to reflect the degree of spinal cord injury and prognosis of motor function. In this study, 160 female Sprague-Dawley rats were randomly divided into a sham group, and mild, moderate, and severe spinal cord injury groups. A laminectomy was performed at the T8 level to expose the spinal cord in all groups. A contusion lesion was made with the NYU-MASCIS impactor by dropping a 10 g rod from heights of 12.5 mm (mild), 25 mm (moderate) and 50 mm (severe) upon the exposed dorsal surface of the spinal cord. Tau protein levels were measured in serum and cerebrospinal fluid samples at 1, 6, 12, 24 hours, 3, 7, 14 and 28 days after operation. Locomotor function of all rats was assessed using the Basso, Beattie and Bresnahan locomotor rating scale. Tau protein concentration in the three spinal cord injury groups (both in serum and cerebrospinal fluid) rapidly increased and peaked at 12 hours after spinal cord injury. Statistically significant positive linear correlations were found between tau protein level and spinal cord injury severity in the three spinal cord injury groups, and between the tau protein level and Basso, Beattie, and Bresnahan locomotor rating scale scores. The tau protein level at 12 hours in the three spinal cord injury groups was negatively correlated with Basso, Beattie, and Bresnahan locomotor rating scale scores at 28 days (serum: r = -0.94; cerebrospinal fluid: r = 0.95). Our data suggest that tau protein levels in serum and cerebrospinal fluid might be a promising biomarker for predicting the severity and functional outcome of traumatic spinal cord injury.	[Tang, Ying; Wang, Dong-Lin] Chongqing Univ, Key Lab Biorheol Sci & Technol, Minist Educ, Canc Hosp, Chongqing, Peoples R China; [Liu, Hong-Liang; Min, Ling-Xia] Third Mil Med Univ, Dept Rehabil, Southwest Hosp, Chongqing, Peoples R China; [Yuan, Hao-Shi; Han, Peng-Bo; Lu, Yu-Xin; Zhong, Jian-Feng] Xian Med Univ, Dept Spine Surg, Affiliated Hosp 2, Xian, Shanxi, Peoples R China; [Guo, Lei] Chinese PLA Beijing Army Gen Hosp, Dept Orthoped, Beijing, Peoples R China		Wang, DL (corresponding author), Chongqing Univ, Key Lab Biorheol Sci & Technol, Minist Educ, Canc Hosp, Chongqing, Peoples R China.; Zhong, JF (corresponding author), Xian Med Univ, Dept Spine Surg, Affiliated Hosp 2, Xian, Shanxi, Peoples R China.	jianfeng206@qq.com; xiaolianbei@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671211, 81672251]	This study was supported by the National Natural Science Foundation of China, No. 81671211, 81672251 (both to HLL).	Agrawal G, 2010, SPINE, V35, P1122, DOI 10.1097/BRS.0b013e3181be5fa7; Barbagallo M, 2017, J BIOL REG HOMEOS AG, V31, P195; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bitsch A, 2002, EUR NEUROL, V47, P45, DOI 10.1159/000047946; Brettschneider J, 2005, MULT SCLER J, V11, P261, DOI 10.1191/1352458505ms1159oa; Breuzard G, 2013, J CELL SCI, V126, P2810, DOI 10.1242/jcs.120832; Buongiorno M, 2011, J NEUROL SCI, V310, P25, DOI 10.1016/j.jns.2011.06.046; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Caprelli MT, 2019, NEUROSCIENTIST, V25, P8, DOI 10.1177/1073858417742125; Caprelli MT, 2018, J NEUROTRAUM, V35, P1929, DOI 10.1089/neu.2017.5495; Chen CX, 2017, NEUROSCIENCE, V356, P193, DOI 10.1016/j.neuroscience.2017.05.022; Cheran S, 2011, J NEUROTRAUM, V28, P1881, DOI 10.1089/neu.2010.1741; Cruz SA, 2018, NEURAL REGEN RES, V13, P252, DOI 10.4103/1673-5374.226394; Duan HQ, 2018, CNS NEUROSCI THER, V24, P429, DOI 10.1111/cns.12801; Fan YD, 2018, EUR REV MED PHARMACO, V22, P4063, DOI 10.26355/eurrev_201807_15394; Feng HL, 2016, INT J IMMUNOPATH PH, V29, P734, DOI 10.1177/0394632016659494; Fu HT, 2018, J NEUROTRAUM, V35, P2507, DOI 10.1089/neu.2017.5606; Gu MC, 2017, BRAIN RES, V1654, P43, DOI 10.1016/j.brainres.2016.10.023; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Guo YJ, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43035; Hachisuka S, 2014, SPINAL CORD, V52, P596, DOI 10.1038/sc.2014.86; Hulme CH, 2017, SPINAL CORD, V55, P114, DOI 10.1038/sc.2016.174; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Jazayeri SB, 2015, EUR SPINE J, V24, P905, DOI 10.1007/s00586-014-3424-6; Josephs KA, 2017, MAYO CLIN PROC, V92, P1291, DOI 10.1016/j.mayocp.2017.04.016; Ko WK, 2019, MOL NEUROBIOL, V56, P267, DOI 10.1007/s12035-018-0994-z; Krishna V, 2014, J NEUROTRAUM, V31, P215, DOI 10.1089/neu.2013.2982; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Lee BG, 2018, J NEUROTRAUM, V35, P2015, DOI 10.1089/neu.2017.5558; Lewczuk P, 2004, J MOL NEUROSCI, V23, P115, DOI 10.1385/JMN:23:1-2:115; Li Q, 2017, J BIOL REG HOMEOS AG, V31, P745; Liliang PC, 2010, RESUSCITATION, V81, P1205, DOI 10.1016/j.resuscitation.2010.05.016; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Mukaetova-Ladinska EB, 2018, CURR ALZHEIMER RES, V15, P800, DOI 10.2174/1567205015666180404165915; Pouw MH, 2014, SPINAL CORD, V52, P428, DOI 10.1038/sc.2014.26; Qi ZP, 2016, NEURAL REGEN RES, V11, P332, DOI 10.4103/1673-5374.177744; Rink S, 2018, EXP NEUROL, V309, P148, DOI 10.1016/j.expneurol.2018.08.003; Roerig A, 2013, VET J, V197, P253, DOI 10.1016/j.tvjl.2013.02.005; Rong W, 2017, NEURAL REGEN RES, V12, P470, DOI 10.4103/1673-5374.202923; Sabour H, 2017, J SPINAL CORD MED, V40, P329, DOI 10.1080/10790268.2016.1139771; SEGAL MB, 1993, J INHERIT METAB DIS, V16, P617, DOI 10.1007/BF00711896; Shapiro JS, 2012, J NEUROSCI METH, V205, P36, DOI 10.1016/j.jneumeth.2011.12.010; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Sotiropoulos I, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0489-6; Tatebe H, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0206-8; Tigchelaar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01299-x; Wang JW, 2016, EXP THER MED, V11, P1147, DOI 10.3892/etm.2016.3017; Wen T, 2016, SPINAL CORD, V54, P431, DOI 10.1038/sc.2015.171; Wu YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38718; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006; Xu M, 2016, INFLAMMATION, V39, P1594, DOI 10.1007/s10753-016-0395-2; Yahata K, 2016, J NEUROSURG-SPINE, V25, P745, DOI 10.3171/2016.4.SPINE15923; Ydens E, 2017, MOL NEUROBIOL, V54, P1482, DOI 10.1007/s12035-016-9757-x; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Zetterberg H, 2017, NEUROPATH APPL NEURO, V43, P194, DOI 10.1111/nan.12378; Zhang JH, 2016, TOXICOL RES-UK, V5, P651, DOI 10.1039/c5tx00393h; Zhang Y, 2018, ZHONGGUO ZUZHI GONGC, V22, P3824	58	8	10	4	26	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAY	2019	14	5					896	902		10.4103/1673-5374.249238			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	HI6ZY	WOS:000456605600023	30688276	Green Published, gold			2022-02-06	
J	Tator, C; Starkes, J; Dolansky, G; Quet, J; Michaud, J; Vassilyadi, M				Tator, Charles; Starkes, Jill; Dolansky, Gillian; Quet, Julie; Michaud, Jean; Vassilyadi, Michael			Fatal Second Impact Syndrome in Rowan Stringer, A 17-Year-Old Rugby Player	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Concussion; Adolescent athletes; Traumatic brain injury; Second impact syndrome	INJURY	Second impact syndrome (SIS) is associated with malignant brain swelling and usually occurs in young athletes with one or more prior, recent concussions. SIS is rare and some dispute its existence. We report a case of SIS in Rowan Stringer, age 17, a rugby player who sustained a fatal brain injury despite prompt medical therapy including decompression surgery. The cause of the massive brain swelling was initially unknown. An inquest revealed Rowan's text messages to friends describing symptoms from two prior, recent rugby brain injuries, likely concussions, within 5 days of the fatal blow and confirming the diagnosis of SIS. RESUME:Un cas de syndrome du second impact ayant entraine le deces d'un joueur de rugby age de 17 ans. Le syndrome du second impact (SIS) est associe a une forme maligne d'enflure du cerveau. Il se produit habituellement chez de jeunes athletes victimes d'une ou de plusieurs commotions cerebrales recentes. On estime qu'un tel syndrome est rare ; certains en contestent meme l'existence. Nous voulons rapporter ici un cas de SIS ayant affecte un joueur de rugby age de 17 ans : Rowan Stringer. Stringer est decede a la suite de lesions cerebrales, et ce, en depit de soins medicaux rapides lui ayant ete prodigues, notamment une chirurgie de decompression. La cause de l'enflure massive de son cerveau est demeuree initialement inconnue. Toutefois, une enquete a revele qu'il avait envoye des messages texte a ses amis cinq jours avant le coup mortel. Dans ces messages, il decrivait les symptomes de deux lesions cerebrales survenues recemment, probablement des commotions cerebrales. Le contenu de ces messages texte vient ainsi confirmer le diagnostic de SIS.	[Tator, Charles] Toronto Western Hosp, Canadian Concuss Ctr, Toronto, ON, Canada; [Starkes, Jill; Dolansky, Gillian; Quet, Julie; Michaud, Jean; Vassilyadi, Michael] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Starkes, Jill] Mem Univ Newfoundland, Fac Med, St John, NF, Canada; [Starkes, Jill] Dalhousie Univ, Fac Med, Halifax, NS, Canada; [Dolansky, Gillian; Quet, Julie; Michaud, Jean; Vassilyadi, Michael] Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON, Canada; [Dolansky, Gillian; Quet, Julie; Michaud, Jean; Vassilyadi, Michael] Childrens Hosp Eastern Ontario, Dept Emergency, Ottawa, ON, Canada; [Dolansky, Gillian; Quet, Julie; Michaud, Jean; Vassilyadi, Michael] Childrens Hosp Eastern Ontario, Dept Neuropathol, Ottawa, ON, Canada; [Dolansky, Gillian; Quet, Julie; Michaud, Jean; Vassilyadi, Michael] Childrens Hosp Eastern Ontario, Dept Neurosurg, Ottawa, ON, Canada		Tator, C (corresponding author), Toronto Western Hosp, 399 Bathurst St, Toronto, ON, Canada.	charles.tator@uhn.ca					Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McNaughton-Filion L., 2015, VERDICT CORONERS JUR; Su E, 2016, TRANSLATIONAL RES TR, P41; Tator CH, 2008, CATASTROPHIC INJURIE, DOI [10.3138/9781442687561, DOI 10.3138/9781442687561]; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020	9	8	8	0	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	2019	46	3					351	354		10.1017/cjn.2019.14			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ID5XJ	WOS:000471750300016	30945632	Green Published, hybrid			2022-02-06	
J	Ma, SQ; Xu, XX; He, ZZ; Li, XH; Luo, JM				Ma, Si-qing; Xu, Xue-xia; He, Zong-zhao; Li, Xin-hui; Luo, Jun-ming			Dynamic changes in peripheral blood-targeted miRNA expression profiles in patients with severe traumatic brain injury at high altitude	MILITARY MEDICAL RESEARCH			English	Article						Severe traumatic brain injury; miRNA expression profile; High altitude	SERUM	BackgroundThe aim of this work is to detect and compare the peripheral blood miRNA expression profiles in patients with severe traumatic brain injury (sTBI) 2, 12, 24, 48, and 72h after injury at high altitude and to predict the target genes of differential expressed miRNAs.MethodsTwenty sTBI patients from high-altitude areas were randomly selected according to the inclusion and exclusion criteria and were divided into five groups: the 2-h group, 12-h group, 24-h group, 48-h group, and 72-h group. Peripheral blood miRNA expression profiles were detected using real-time quantitative PCR (qRT-PCR).ResultsThe expression levels of miR-18a, miR-203, miR-146a, miR-149, miR-23b, and miR-let-7b in peripheral blood showed significant differences between the 2-h group and the 12-h group. The expression levels of miR-203, miR-146a, miR-149, miR-23b, and miR-let-7f in peripheral blood were up-regulated in the 24-h group. In the 48-h group, the expression levels of miR-181d, miR-29a, and miR-18b were upregulated. In the 72-h group, the expression levels of miR-203, miR-146a, miR-149, miR-23b, and miR-let-7f changed. The main target genes of the differentiation expressed miRNAs were genes that regulate inflammatory responses, apoptosis, and DNA damage/repair.ConclusionsmiRNAs may be involved in the pathogenesis of sTBI by dynamically regulating the target genes that regulate inflammatory responses, apoptosis, and DNA damage/repair pathways.	[Ma, Si-qing; Xu, Xue-xia; He, Zong-zhao; Li, Xin-hui] Qinghai Prov Peoples Hosp, Dept Intens Care Unit, Xining 810007, Qinghai, Peoples R China; [Luo, Jun-ming] Qinghai Prov Peoples Hosp, Dept Pathol, Xining 810007, Qinghai, Peoples R China		Ma, SQ (corresponding author), Qinghai Prov Peoples Hosp, Dept Intens Care Unit, Xining 810007, Qinghai, Peoples R China.	siqing177@sina.com			Qinghai Provincial Agricultural Science and Technology Achievements Transformation and Extension Project [2013-N-531]	This work was supported by the Qinghai Provincial Agricultural Science and Technology Achievements Transformation and Extension Project (2013-N-531).	Acharya SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa6593; Amantini A, 2008, EUR J ANAESTH, V25, P196, DOI 10.1017/S0265021507003183; Amantini A, 2012, MINERVA ANESTESIOL, V78, P1067; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Badiatia N, 2009, CURR OPIN CRIT CARE, V15, P79, DOI 10.1097/MCC.0b013e32832922e9; Bahloul Mabrouk, 2011, J Emerg Trauma Shock, V4, P29, DOI 10.4103/0974-2700.76831; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Ballesteros MA, 2007, INTENS CARE MED, V33, P58, DOI 10.1007/s00134-006-0361-9; Berardino M, 2004, ACTA NEUROCHIR, V146, P453, DOI 10.1007/s00701-003-0176-1; Bhalala OG, 2015, BRAIN NEUROTRAUMA MO, DOI DOI 10.1007/S12975-011-0137-6; Bryczkowski SB, 2014, J TRAUMA ACUTE CARE, V77, P944, DOI 10.1097/TA.0000000000000427; Bucy PC, 1987, SURG NEUROL, P80; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Dziurdzik P, 2004, INFLAMM RES, V53, P338, DOI 10.1007/s00011-004-1265-1; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Gim Jeong-An, 2014, Genomics & Informatics, V12, P261, DOI 10.5808/GI.2014.12.4.261; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Kumar M, 2015, CELL HOST MICROBE, V17, P345, DOI 10.1016/j.chom.2015.01.007; Marques-Rocha JL, 2018, J PHYSIOL BIOCHEM, V74, P579, DOI 10.1007/s13105-018-0629-x; Martinez B, 2017, NEURAL REGEN RES, V12, P1749, DOI 10.4103/1673-5374.219025; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Sun LQ, 2018, BEHAV BRAIN RES, V340, P126, DOI 10.1016/j.bbr.2016.09.020; Yang Z, 2015, MOL IMMUNOL, V65, P293, DOI 10.1016/j.molimm.2015.01.019	23	8	9	4	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2095-7467	2054-9369		MILITARY MED RES	MILITARY MED. RES.	APR 30	2019	6								12	10.1186/s40779-019-0203-z			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HW0NG	WOS:000466377300001	31036067	gold, Green Published			2022-02-06	
J	Wang, C; Iashchishyn, IA; Kara, J; Fodera, V; Vetri, V; Sancataldo, G; Marklund, N; Morozova-Roche, LA				Wang, Chao; Iashchishyn, Igor A.; Kara, John; Fodera, Vito; Vetri, Valeria; Sancataldo, Giuseppe; Marklund, Niklas; Morozova-Roche, Ludmilla A.			Proinflammatory and amyloidogenic S100A9 induced by traumatic brain injury in mouse model	NEUROSCIENCE LETTERS			English	Article						Alzheimer's disease; Amyloid; Neuroinflammation; Oligomerization; S100A9; Traumatic brain injury	NEUROPATHOLOGICAL SEQUELAE; EXPRESSION; DISEASE; IMPACT; RISK	Traumatic brain injury (TBI) represents a significant risk factor for development of neurodegenerative diseases such as Alzheimer's and Parkinson's. The S100A9-driven amyloid-neuroinflammatory cascade occurring during primary and secondary TBI events can serve as a mechanistic link between TBI and Alzheimer's as demonstrated recently in the human brain tissues. Here by using immunohistochemistry in the controlled cortical impact TBI mouse model we have found pro-inflammatory S100A9 in the brain tissues of all mice on the first and third post- TBI days, while 70% of mice did not show any S100A9 presence on seventh post-TBI day similar to controls. This indicates that defensive mechanisms effectively cleared S100A9 in these mouse brain tissues during post-TBI recovery. By using sequential immunohistochemistry we have shown that S100A9 was produced by both neuronal and microglial cells. However, A beta peptide deposits characteristic for Alzheimer's disease were not detected in any post-TBI animals. On the first and third post-TBI days S100A9 was found to aggregate intracellularly into amyloid oligomers, similar to what was previously observed in human TBI tissues. Complementary, by using Rayleigh scatting, intrinsic fluorescence and atomic force microscopy we demonstrated that in vitro S100A9 self- assembles into amyloid oligomers within minutes. Its amyloid aggregation is highly dependent on changes of environmental conditions such as variation of calcium levels, pH, temperature and reduction/oxidation, which might be relevant to perturbation of cellular and tissues homeostasis under TBI. Present results demonstrate that S100A9 induction mechanisms in TBI are similar in mice and humans, emphasizing that S100A9 is an important marker of brain injury and therefore can be a potential therapeutic target.	[Wang, Chao; Iashchishyn, Igor A.; Kara, John; Morozova-Roche, Ludmilla A.] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Fodera, Vito] Univ Copenhagen, Dept Pharm, DK-2100 Copenhagen, Denmark; [Vetri, Valeria; Sancataldo, Giuseppe] Univ Palermo, Dipartimento Fis & Chim, I-90128 Palermo, Italy; [Vetri, Valeria; Sancataldo, Giuseppe] Univ Palermo, Aten Ctr, I-90128 Palermo, Italy; [Marklund, Niklas] Uppsala Univ Hosp, Dept Neurosurg, S-75185 Uppsala, Sweden		Morozova-Roche, LA (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	ludmilla.morozova-roche@umu.se	Morozova-Roche, Ludmilla A./AAU-9044-2021; Iashchishyn, Igor/AAL-4677-2021; Sancataldo, Giuseppe/AAK-5326-2020; Vetri, Valeria/F-2314-2010; Fodera, Vito/AAZ-9925-2020; Fodera, Vito/F-9029-2010	Vetri, Valeria/0000-0002-2307-1165; Fodera, Vito/0000-0003-2855-0568; Fodera, Vito/0000-0003-2855-0568; sancataldo, giuseppe/0000-0002-8661-5895	Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [2014-3241]; Insamlingsstiftelsen [FS 2.1.12-1605-14]; Forskningsstrategiska medel, Umea University, Sweden	L.A.M.-R. thanks the Swedish Medical Research Council (grant 2014-3241), Insamlingsstiftelsen (grant FS 2.1.12-1605-14) and Forskningsstrategiska medel, Umea University, Sweden.	Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Eikelenboom P, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt118; ENEVOLDSEN EM, 1977, CLIN NEUROL NEUROSUR, V80, P213; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Ha TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008840; Horvath I, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1210-9; Horvath I, 2017, ACS CHEM NEUROSCI, V8, P1170, DOI 10.1021/acschemneuro.7b00063; Iashchishyn IA, 2018, ACS CHEM NEUROSCI, V9, P1338, DOI 10.1021/acschemneuro.7b00512; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Israelsson C, 2014, RESTOR NEUROL NEUROS, V32, P717, DOI 10.3233/RNN-140419; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lim S, 2016, BRAIN PATHOL, V26, P404, DOI 10.1111/bpa.12371; Ma LP, 2012, INT J CARDIOL, V155, P26, DOI 10.1016/j.ijcard.2011.01.082; Malisauskas M, 2010, J MOL BIOL, V396, P60, DOI 10.1016/j.jmb.2009.11.012; McIntosh TK, 1996, LAB INVEST, V74, P315; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Paradisi S, 2004, GLIA, V46, P252, DOI 10.1002/glia.20005; Patt S, 1999, EXP TOXICOL PATHOL, V51, P119, DOI 10.1016/S0940-2993(99)80084-0; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Postler E, 1997, GLIA, V19, P27, DOI 10.1002/(SICI)1098-1136(199701)19:1<27::AID-GLIA3>3.0.CO;2-7; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Sacho RH, 2008, BRIT J NEUROSURG, V22, P497, DOI 10.1080/02688690802245558; Schluesener HJ, 1998, ACTA NEUROPATHOL, V96, P575, DOI 10.1007/s004010050938; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Taha MM, 2015, INTERNET J NEUROSURG, V11, P1; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; Vogl T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5593; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893; Wang C-M, 2018, SCI REP, V8, P1; Wang C, 2014, ACTA NEUROPATHOL, V127, P507, DOI 10.1007/s00401-013-1208-4	38	8	8	0	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	APR 23	2019	699						199	205		10.1016/j.neulet.2019.02.012			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HU1TR	WOS:000465055200032	30753908				2022-02-06	
J	Pais, C; Ponsford, JL; Gould, KR; Wong, D				Pais, Celia; Ponsford, Jennie L.; Gould, Kate R.; Wong, Dana			Role of valued living and associations with functional outcome following traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; valued living; post-injury adjustment	QUALITY-OF-LIFE; SEVERE HEAD-INJURY; COMMITMENT THERAPY; PSYCHIATRIC-DISORDERS; ACCEPTANCE; ANXIETY; REHABILITATION; DEPRESSION; IMPACT	Valued living (VL) is associated with improved enjoyment and engagement with daily activities despite negative emotional state or ongoing pain. However, the role of VL in recovery following traumatic brain injury (TBI) has yet to be investigated. This study aimed to examine changes in VL over the course of recovery and variables associated with VL. Participants with moderate-to-severe TBI were recruited from a rehabilitation hospital in three cohorts: "Early" (n = 25), "Mid" (n = 9) and "Late" (n = 36) post-TBI. All participants were assessed at time of recruitment and 12 months later. The main measure was the Valued Living Questionnaire. Compared to pre-injury estimates, VL was significantly reduced at 12 months post-injury. Levels of VL remained reduced between 2 and 3 years and increased between 3 and 6 years post-injury. VL was strongly associated with improved functional and psychosocial outcomes. Changes in VL occur over at least 3-5 years post-injury, with 12 months post-TBI a suitable time for intervention given VL remains low over the next 24 to 36 months post injury. Targeted intervention to modify values and/or valued activities to be consistent with post-injury capacity could improve rates of return to pre-injury levels of VL.	[Pais, Celia; Ponsford, Jennie L.; Gould, Kate R.; Wong, Dana] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia; [Pais, Celia; Ponsford, Jennie L.; Gould, Kate R.; Wong, Dana] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Pais, Celia; Ponsford, Jennie L.; Gould, Kate R.; Wong, Dana] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Wong, D (corresponding author), Monash Univ Clayton Campus, Monash Inst Cognit & Clin Neurosci, Sch Psychol Sci, 18 Innovat Walk, Clayton, Vic 3800, Australia.	Dana.Wong@monash.edu	Wong, Dana/AAD-3410-2020; Gould, Kate Rachel/AAA-5511-2020	Gould, Kate Rachel/0000-0002-3564-7408; Wong, Dana/0000-0001-9619-1929	Institute for Safety Compensation and Recovery Research [D187 (N-M-12-034)]	This work was supported by the Institute for Safety Compensation and Recovery Research [grant number D187 (N-M-12-034)].	Arch JJ, 2008, CLIN PSYCHOL-SCI PR, V15, P263, DOI 10.1111/j.1468-2850.2008.00137.x; Blair H, 2010, BRAIN INJURY, V24, P833, DOI 10.3109/02699051003789203; Branstetter-Rost A, 2009, J PAIN, V10, P887, DOI 10.1016/j.jpain.2009.01.001; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Dalrymple KL, 2007, BEHAV MODIF, V31, P543, DOI 10.1177/0145445507302037; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Gould KR, 2015, BRAIN INJURY, V29, P283, DOI 10.3109/02699052.2014.974671; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hayes SA, 2010, BEHAV RES THER, V48, P238, DOI 10.1016/j.brat.2009.11.006; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Helps Y., 2008, HOSP SEPARATIONS DUE; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Joseph S, 2006, J LOSS TRAUMA, V11, P85, DOI 10.1080/15325020500358241; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCracken LM, 2006, PAIN, V123, P137, DOI 10.1016/j.pain.2006.02.021; McCracken LM, 2004, PAIN, V109, P4, DOI 10.1016/j.pain.2004.02.006; Michelson SE, 2011, DEPRESS ANXIETY, V28, P358, DOI 10.1002/da.20793; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ossman WA, 2006, INT J PSYCHOL THER, V6, P397; Ponsford J. L., 2012, BRAIN INJURY MED PRI, P1068; Schwartz SH, 2001, J CROSS CULT PSYCHOL, V32, P519, DOI 10.1177/0022022101032005001; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; Snaith R., 1994, HOSP ANXIETY DEPRESS; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Stotts AL, 2009, COGN BEHAV PRACT, V16, P205, DOI 10.1016/j.cbpra.2008.08.003; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; VanBuskirk K, 2012, COGNITIVE THER RES, V36, P796, DOI 10.1007/s10608-011-9405-8; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wilson KG, 2010, PSYCHOL REC, V60, P249, DOI 10.1007/BF03395706; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	8	8	1	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR 21	2019	29	4					625	637		10.1080/09602011.2017.1313745			13	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HL3ZN	WOS:000458654800006	28421872				2022-02-06	
J	Braaf, S; Ameratunga, S; Christie, N; Teague, W; Ponsford, J; Cameron, PA; Gabbe, BJ				Braaf, Sandra; Ameratunga, Shanthi; Christie, Nicola; Teague, Warwick; Ponsford, Jennie; Cameron, Peter A.; Gabbe, Belinda J.			Care coordination experiences of people with traumatic brain injury and their family members in the 4-years after injury: a qualitative analysis	BRAIN INJURY			English	Article						Traumatic brain injury; care coordination; health literacy; community; interviews; qualitative	HEALTH-CARE; SERVICE UTILIZATION; NEEDS; REHABILITATION; TBI; OUTCOMES; SUPPORT	Title: Care coordination experiences of people with traumatic brain injury and their family members 4-years after injury: A qualitative analysis. Aim: To explore experiences of care coordination in the first 4-years after severe traumatic brain injury (TBI). Methods: A qualitative study nested within a population-based longitudinal cohort study. Eighteen semi-structured telephone interviews were conducted 48-months post-injury with six adults living with severe TBI and the family members of 12 other adults living with severe TBI. Participants were identified through purposive sampling from the Victorian State Trauma Registry. A thematic analysis was undertaken. Results: No person with TBI or their family member reported a case manager or care coordinator were involved in assisting with all aspects of their care. Many people with severe TBI experienced ineffective care coordination resulting in difficulty accessing services, variable quality in the timing, efficiency and appropriateness of services, an absence of regular progress evaluations and collaboratively formulated long-term plans. Some family members attempted to fill gaps in care, often without success. In contrast, effective care coordination was reported by one family member who advocated for services, closely monitored their relative, and effectively facilitated communication between services providers. Conclusion: Given the high cost, complexity and long-term nature of TBI recovery, more effective care coordination is required to consistently meet the needs of people with severe TBI.	[Braaf, Sandra; Cameron, Peter A.; Gabbe, Belinda J.] Monash Univ, Dept Epidemiol & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand; [Christie, Nicola] UCL, Dept Civil Environm & Geomat Engn, London, England; [Teague, Warwick] Royal Childrens Hosp, Trauma Serv, Melbourne, Vic, Australia; [Teague, Warwick] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Teague, Warwick] Murdoch Childrens Res Inst, Surg Res Grp, Melbourne, Vic, Australia; [Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia; [Gabbe, Belinda J.] Swansea Univ, Farr Inst, Ctr Improvement Populat Hlth E Records Res CIPHER, Sch Med, Swansea, W Glam, Wales		Braaf, S (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia.	sandra.braaf@monash.edu	Teague, Warwick J/AAY-7260-2020; Ponsford, Jennie/H-8341-2014	Teague, Warwick J/0000-0003-4747-6025; Christie, Nicola/0000-0001-7152-5240; Ponsford, Jennie/0000-0003-0430-125X	Australian Government's National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [GNT1061786]; Department of Health, State Government of Victoria; Transport Accident Commission; Australian Research CouncilAustralian Research Council; NHMRC Practitioner FellowshipNational Health and Medical Research Council of Australia	This project was funded by the Australian Government's National Health and Medical Research Council [GNT1061786]. The Victorian State Trauma Registry (VSTR) is funded by the Department of Health, State Government of Victoria and Transport Accident Commission. BG was supported by a Future Fellowship from the Australian Research Council and PC by a NHMRC Practitioner Fellowship.	[Anonymous], 2018, WORK INC; Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL 2005; Australian Commission on Safety and Quality in Health Care [ACSQHC], 2014, HLTH LIT TAK ACT IMP; Australian Department of Health and Ageing, 2007, NAT EV 2 ROUND COORD; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Boon H, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-15; Cameron PA, 2005, J TRAUMA, V59, P1469, DOI 10.1097/01.ta.0000198350.15936.a1; Carayon P, 2012, WORK, V41, P4468, DOI 10.3233/WOR-2012-0746-4468; Chan J, 2014, IMPACT TRAUMATIC BRA, V8, P155; Creswell J.W ., 2007, QUAL INQ; Davies GP, 2008, MED J AUSTRALIA, V188, pS65; Gabbe BJ, 2015, INJURY PREV, V21, P348, DOI 10.1136/injuryprev-2014-041336; Goodridge D, 2015, DISABIL REHABIL, V37, P1401, DOI 10.3109/09638288.2014.972593; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Hocomb EM, 2012, ARCH PHYS MED REHAB, V93, P1338, DOI 10.1016/j.apmr.2012.04.029; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Jackson GL, 2013, ANN INTERN MED, V158, P169, DOI 10.7326/0003-4819-158-3-201302050-00579; Jaffee MS, 2009, J REHABIL RES DEV, V46, P655, DOI 10.1682/JRRD.2008.09.0114; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; Jones CD, 2015, J GEN INTERN MED, V30, P417, DOI 10.1007/s11606-014-3056-x; Jowsey T, 2016, SOCIOL HEALTH ILL, V38, P854, DOI 10.1111/1467-9566.12404; Kroll T, 2003, DISABIL REHABIL, V25, P1106, DOI 10.1080/0963828031000152002; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Liamputtong P., 2009, QUALITATIVE RES METH; Maeng DD, 2012, HEALTH SERV RES, V47, P1960, DOI 10.1111/j.1475-6773.2012.01405.x; McCluskey A, 2007, BRAIN IMPAIR, V8, P293, DOI DOI 10.1375/brim.8.3.293; McColl MA, 2015, INT J ENV RES PUB HE, V12, P4638, DOI 10.3390/ijerph120504638; McColl MA, 2009, ARCH PHYS MED REHAB, V90, P1523, DOI 10.1016/j.apmr.2009.03.017; Moore M, 2017, BRAIN INJURY, V31, P1876, DOI 10.1080/02699052.2017.1346291; Munce SEP, 2014, BRAIN INJURY, V28, P1042, DOI 10.3109/02699052.2014.890744; Murgatroyd D, 2015, BMC PUBLIC HEALTH, V15, P1; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; OWNSWORTH T, 2004, BRAIN IMPAIR, V5, P53, DOI DOI 10.1375/BRIM.5.1.53.35407; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Pope C, 2006, QUALITATIVE RES HLTH; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; Pressman Helaine Tobey, 2007, Phys Med Rehabil Clin N Am, V18, P165, DOI 10.1016/j.pmr.2006.11.006; Productivity Commission, 2011, DIS CAR SUPP; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Ritchie J., 2002, ANAL QUALITATIVE DAT, P305, DOI 10.4135/9781412986274; Schultz EM, 2017, BMC HEALTH SERV RES, V13, P119; Solovieva TI, 2014, J REHABIL, V80, P10; Ta'eed G, 2015, NEUROPSYCHOL REHABIL, V25, P841, DOI 10.1080/09602011.2014.990043; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; TEASDALE G, 1974, LANCET, V2, P81; Tongco M. D. C., 2007, Ethnobotany Research and Applications, V5, P147; Transport Accident Commission, 2017, PREP GO HOM MAJ INJ; Transport Accident Commission, 2018, WHAT WE CAN PAY; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Walsh JM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-42; Winter L, 2017, BRAIN INJURY, V31, P493, DOI 10.1080/02699052.2017.1283534; Wobma R, 2016, J REHABIL MED, V48, P837, DOI 10.2340/16501977-2160	54	8	8	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2019	33	5					574	583		10.1080/02699052.2019.1566835			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HR1NT	WOS:000462901200004	30669868	Green Submitted, Green Accepted			2022-02-06	
J	Schorr, E; Wade, SL; Taylor, HG; Stancin, T; Yeates, KO				Schorr, Emily; Wade, Shari L.; Taylor, H. Gerry; Stancin, Terry; Yeates, Keith Owen			Parenting styles as a predictor of long-term psychosocial outcomes after traumatic brain injury (TBI) in early childhood	DISABILITY AND REHABILITATION			English	Article						Behavior; social competence; executive functioning; youth; concussion; pediatric	RECOVERY; BEHAVIOR	Objective: This study sought to determine whether parenting styles predict long-term psychosocial outcomes after traumatic brain injury in young children. Methods: The study involved a concurrent cohort, prospective design, with longitudinal assessments up to early adolescence. Participants included 126 children with moderate to severe traumatic brain injury or orthopedic injury, ages 3 to 6 years 11 months, recruited between 2003 and 2006. Parents rated children's pre-injury behavioral adjustment, social competence, and executive functioning shortly after injury, and again 6.8 years post injury. Parents also rated their parenting styles (permissive, authoritarian, authoritative) at both occasions. Results: After controlling for pre-injury functioning, the groups differed significantly on all three outcomes (Delta R-2 0.07 to 0.13). Late but not early parenting styles predicted outcomes in all groups (Delta R-2 0.06 to 0.17): more permissive parenting predicted worse outcomes in all domains (beta= -0.18, 0.20, 0.27); and more authoritative parenting predicted better social competence and executive functioning (beta= -0.17, 0.46). Severe traumatic brain injury interacted with parenting style for several outcomes, with ineffective parenting exacerbating the negative sequelae. Conclusions: Parenting style predicts children's long-term psychosocial functioning after early childhood injury, and may moderate the effects of early traumatic brain injury.	[Schorr, Emily; Yeates, Keith Owen] Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Rehabil Med, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Cleveland Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Dept Psychiat, Div Child & Adolescent Psychiat & Psychol, Cleveland, OH 44106 USA; [Stancin, Terry] MetroHlth Med Ctr, Cleveland, OH USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada		Yeates, KO (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	kyeates@ucalgary.ca	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [RO1HD042729]; Ohio Emergency Medical Services program	The research was funded by the National Institute of Child Health and Human Development [RO1HD042729] and the Ohio Emergency Medical Services program.	Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Allen JP, 1994, J RES ADOLESCENCE, V4, P18; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VG, 2012, INT J DEV NEUROSCI, V30, P8; Anderson VG, 2012, PEDIATRICS, V129, P8; BAUMRIND D, 1971, DEV PSYCHOL, V4, P1, DOI 10.1037/h0030372; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Bradley RH, 2000, J RES ADOLESCENCE, V10, P42; Burke J, 2008, J ABNORM CHILD PSYCH, V36, P14; Caldwell B., 1984, HOME OBSERVATION MEA; Corp I, 2013, IBM SPSS STAT MAC VE; Durber C, 2017, NEUROPSYCHOLOGY, V31, P8; Durish C, 2017, J INT NEUROPSYCH SOC, V23, P10; Gioia G, 2000, CHILD NEUROPSYCHOL, V6, P8; Glascoe F, 2010, PEDIATRICS, V125, P7; Hipwell A, 2008, J ABNORM CHILD PSYCH, V36, P663, DOI 10.1007/s10802-007-9206-4; Humphreys I, 2013, CLINICOECON OUTCOMES, V5, P8; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; KUEHN B, 2018, JAMA-J AM MED ASSOC, V319, P1428, DOI DOI 10.1001/JAMA.2018.3167; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Lund J, 2001, J PSYCHOEDUC ASSESS, V19, P112, DOI 10.1177/073428290101900201; Luyckx KT, 2011, J CLIN CHILD ADOLESC, V40, P11; Mangeot S, 2010, CHILD NEUROPSYCHOL, V8, P14; Merrell K, 2001, PSYCHOL SCH, V38, P13; Merrell K, 1996, J EARLY INTERV, V20, P14; Merrell K. W., 2002, PRESCHOOL KINDERGART; Merrell KM., 2002, HOME COMMUNITY SOCIA; Micklewright J, 2012, J INT NEUROPSYCH SOC, V18, P8; Narad ME, 2019, DEV NEUROREHABIL, V22, P437, DOI 10.1080/17518423.2018.1518350; Narad ME, 2017, J HEAD TRAUMA REHAB, V32, P98, DOI 10.1097/HTR.0000000000000247; Pardini DA, 2008, J ABNORM CHILD PSYCH, V36, P16; Potter J, 2011, REHABIL PSYCHOL, V56, P8; Robinson C, 2001, HDB FAMILY MEASUREME, V3, P3; Robinson C, 1995, PSYCHOL REP, V77, P12; Roozeneek B, 2013, NAT REV NEUROSCI, V9, P6; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P14; Serbin LA, 2015, DEV PSYCHOPATHOL, V27, P969, DOI 10.1017/S0954579415000632; Shaffer A, 2013, J ABNORM CHILD PSYCH, V41, P199, DOI 10.1007/s10802-012-9670-3; Taylor H, 2001, J INT NEUROPSYCH SOC, V7, P13; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Wade S, 2017, J AM ACAD CHILD ADOL, V56, P10; Wade S, 2016, JAMA PEDIAT, V170, P7; Wade S, 2001, J CONSULT CLIN PSYCH, V69, P10; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Yeates K, 2017, J INS, V23, P12; Yeates K, 2010, NEUROPSYCHOLOGY, V24, P13; Yeates K, 1997, J INT NEUROPSYCH SOC, V3, P14; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P15	50	8	8	1	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	AUG 13	2020	42	17			SI		2437	2443		10.1080/09638288.2019.1602676		APR 2019	7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	NE7PD	WOS:000469622000001	31006276	Green Accepted			2022-02-06	
J	Silverberg, ND; Otamendi, T				Silverberg, Noah D.; Otamendi, Thalia			Advice to Rest for More Than 2 Days After Mild Traumatic Brain Injury Is Associated With Delayed Return to Productivity: A Case-Control Study	FRONTIERS IN NEUROLOGY			English	Article						brain concussion; craniocerebral trauma; rehabilitation; rest; return to work	CONCUSSION KNOWLEDGE; AGREEMENT STATEMENT; FAMILY PHYSICIANS; ACTIVITY LEVEL; SPORT; RECOMMENDATIONS; REHABILITATION; SYMPTOMS; DURATION; VALIDITY	Objectives: Recent expert agreement statements and evidence-based practice guidelines for mild traumatic brain injury (mTBI) management no longer support advising patients to "rest until asymptomatic," and instead recommend gradual return to activity after 1-2 days of rest. The present study aimed to: (i) document the current state of de-implementation of prolonged rest advice, (ii) identify patient characteristics associated with receiving this advice, and (iii) examine the relationship between exposure to this advice and clinical outcomes. Methods: In a case-control design, participants were prospectively recruited from two concussion clinics in Canada's public health care system. They completed self-report measures at clinic intake (Rivermead Post-concussion Symptom Questionnaire, Personal Health Questionnaire-9, and Generalized Anxiety Disorder-7) as well as a questionnaire with patient, injury, and recovery characteristics and the question: "Were you advised by at least one health professional to rest for more than 2 days after your injury?" Results: Of the eligible participants (N = 146), 82.9% reported being advised to rest for more than 2 days (exposure group). This advice was not associated with patient characteristics, including gender (95% CI odds ratio = 0.48-2.91), race (0.87-6.28) age (0.93-1.01), a history of prior mTBI(s) (0.21-1.20), or psychiatric problems (0.40-2.30), loss of consciousness (0.23-2.10), or access to financial compensation (0.50-2.92). In generalized linear modeling, exposure to prolonged rest advice predicted return to productivity status at intake (B = -1.06, chi-squared(1) = 5.28, p = 0.02; 64.5% in the exposure group vs. 40.0% in the control were on leave from work/school at the time of clinic intake, 19.8 vs. 24% had partially returned, and 11.6 vs. 24% had fully returned to work/school). The exposure group had marginally (non-significantly) higher post-concussion, depression, and anxiety symptoms. Conclusions: mTBI patients continue to be told to rest for longer than expert recommendations and practice guidelines. This study supports growing evidence that prolonged rest after mTBI is generally unhelpful, as patients in the exposure group were less likely to have resumed work/school at 1-2 months post-injury. We could not identify patient characteristics associated with getting prolonged rest advice. Further exploration of who gets told to rest and who delivers the advice could inform strategic de-implementation of this clinical practice.	[Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Rehabil Res Program, GF Strong Rehab Ctr, Vancouver, BC, Canada; [Otamendi, Thalia] Univ British Columbia, Sch Kinesiol, Sport & Exercise Psychol Lab, Vancouver, BC, Canada		Silverberg, ND (corresponding author), Univ British Columbia, Div Phys Med & Rehabil, Rehabil Res Program, GF Strong Rehab Ctr, Vancouver, BC, Canada.	noah.silverberg@vch.ca			VGH+UBC Hospital Foundation	The VGH+UBC Hospital Foundation provided funding for this study.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Craton N, 2014, CURR SPORT MED REP, V13, P201, DOI 10.1249/JSR.0000000000000072; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; Montini T, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0211-7; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Moser Rosemarie Scolaro, 2012, Front Neurol, V3, P171, DOI 10.3389/fneur.2012.00171; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Ontario Neurotrauma Foundation, 2013, GUID CONC MILD TRAUM; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williamson GM, 2000, HEALTH PSYCHOL, V19, P339, DOI 10.1037//0278-6133.19.4.339	32	8	8	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 12	2019	10								362	10.3389/fneur.2019.00362			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HT3AS	WOS:000464436500004	31037065	Green Published, gold			2022-02-06	
J	Lippa, SM; Yeh, PH; Gill, J; French, LM; Brickell, TA; Lange, RT				Lippa, Sara M.; Yeh, Ping-Hong; Gill, Jessica; French, Louis M.; Brickell, Tracey A.; Lange, Rael T.			Plasma Tau and Amyloid Are Not Reliably Related to Injury Characteristics, Neuropsychological Performance, or White Matter Integrity in Service Members with a History of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						amyloid; military; tau; traumatic brain injury; white matter integrity	NEUROFILAMENT LIGHT; ALZHEIMERS-DISEASE; EXOSOMAL TAU; VETERANS; BETA; PREDICTORS; BIOMARKERS; COGNITION; PROTEIN; ROBUST	The aim of this study was to examine the relationship between plasma tau and amyloid beta-42 (A beta 42), neuropsychological functioning, and white matter integrity in U.S. military service members with (n = 155) and without (n = 42) a history of uncomplicated mild (n = 83), complicated mild (n = 26), or moderate, severe, or penetrating (n = 46) traumatic brain injury (TBI). We hypothesized that higher levels of tau and A beta 42 would be related to reduced neurocognitive performance and white matter integrity. Participants were enrolled prospectively from Walter Reed National Military Medical Center. Participants completed a blood draw, neuropsychological assessment, and diffusion tensor imaging (General Electric 3T) of the whole brain. From 20 neuropsychological test scores, five cognitive domain scores were computed. Measures of fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD) were generated for 18 regions of interest (ROIs). There was no relationship found between the plasma biomarkers and neurocognitive performance in any of the three TBI groups (all ps >0.05; all R-2 changes <0.146). Although not reaching statistical significance after correction for multiple comparisons, higher tau and A beta 42 tended to be related to higher FA and lower MD, RD, and AD in patients with a history of moderate, severe, or penetrating TBI. There was no consistent relationship between either of the biomarkers and white matter integrity in the complicated and uncomplicated mild TBI groups. In addition, there was no significant relationship between the biomarkers and age, education, sex, race, bodily injury severity, time since injury, TBI severity, or number of TBIs (all ps >0.15). Future investigation in larger samples of moderate, severe, and penetrating TBI are needed. Other plasma biomarkers, including phosphorylated tau, exosomal tau, and interleukin-10, may be more promising measures to use in the diagnosis, management, and treatment of TBI.	[Lippa, Sara M.; French, Louis M.; Brickell, Tracey A.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Room 6003,Bldg 19,8901 Wisconsin Ave, Bethesda, MD 20814 USA; [Lippa, Sara M.; Yeh, Ping-Hong; French, Louis M.; Brickell, Tracey A.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20814 USA; [Lippa, Sara M.; Brickell, Tracey A.; Lange, Rael T.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Gill, Jessica] NINR, NIH, Bethesda, MD 20892 USA; [French, Louis M.; Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada		Lippa, SM (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Room 6003,Bldg 19,8901 Wisconsin Ave, Bethesda, MD 20814 USA.	sara.m.lippa.ctr@mail.mil	french, louis/AAB-2083-2020; Gill, Gill M/Q-2020-2017	french, louis/0000-0002-9451-0604			Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Ben-Porath Y. S., 2011, MMPI 2 RF MINNESOTA; Bendlin BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037720; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernick C, 2018, J NEUROTRAUM, V35, P2351, DOI 10.1089/neu.2017.5553; Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Conners K., 2002, CONNERS CONTINUOUS P; Dahm J, 2015, BRAIN INJURY, V29, P1539, DOI 10.3109/02699052.2015.1075141; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Defense and Veterans Brain Injury Center, 2019, DOD WORLDW NUMB TBI; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Di Battista AP, 2018, J NEUROIMMUNOL, V319, P1, DOI 10.1016/j.jneuroim.2018.03.002; Fan YT, 2019, AGING MENT HEALTH, V23, P831, DOI 10.1080/13607863.2018.1455804; Gardner RC, 2018, J NEUROTRAUM, V35, P2341, DOI 10.1089/neu.2018.5694; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Gold BT, 2014, NEUROBIOL AGING, V35, P2263, DOI 10.1016/j.neurobiolaging.2014.04.030; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Green P, 2004, GREENS MEDICAL SYMPT; Heaton R. K., 2004, REVISED COMPREHENSIV; Hedden T, 2013, NEUROLOGY, V80, P1341, DOI 10.1212/WNL.0b013e31828ab35d; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; Jbabdi S, 2007, NEUROIMAGE, V37, P116, DOI 10.1016/j.neuroimage.2007.04.039; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Kawata K, 2018, J NEUROTRAUM, V35, P260, DOI 10.1089/neu.2017.5376; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; Leyns CEG, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0192-x; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; Mielke MM, 2017, JAMA NEUROL, V74, P1073, DOI 10.1001/jamaneurol.2017.1359; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Pearson, 2009, ADV CLIN XOL US WAIS; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Racine AM, 2014, NEUROIMAGE-CLIN, V4, P604, DOI 10.1016/j.nicl.2014.02.001; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Vipin A., 2019, HUM BRAIN MAPP; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	71	8	9	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2019	36	14					2190	2199		10.1089/neu.2018.6269		APR 2019	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	IH1NO	WOS:000463875700001	30834814	Green Published			2022-02-06	
J	Bevilacqua, ZW; Huibregtse, ME; Kawata, K				Bevilacqua, Zachary W.; Huibregtse, Megan E.; Kawata, Keisuke			In Vivo Protocol of Controlled Subconcussive Head Impacts for the Validation of Field Study Data	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Behavior; Issue 146; Subconcussion; soccer heading; chronic traumatic encephalopathy; repeated measures; methodology; concussion	CHRONIC TRAUMATIC ENCEPHALOPATHY; SERUM NEUROFILAMENT LIGHT; BRAIN-INJURY; DIVISION-I; FOOTBALL; ASSOCIATION; CONCUSSION; PLAYERS	Subconcussive hits pose a threat to neuronal health as they have shown to induce neuronal structural damage and functional impairment without causing outward symptomology and appear to be a key contributor to an irreversible neurodegenerative disease, chronic traumatic encephalopathy (CTE). In addition, athletes can incur more than 1,000 of these hits per season. The subconcussive soccer heading model (SSHM) is a relevant, reproducible, and leading method of isolating and examining the effects of these subconcussive head impacts. By controlling variables such as ball traveling speed, the frequency of impacts, interval, ball placement to the head, as well as by measuring head impact magnitude, the SSHM provides the scientific community with a superior avenue of investigating the acute subconcussive effects on neuronal health. In this paper, we demonstrate the utility of SSHM in studying a time-course expression of neurofilament-light polypeptide (NF-L) in plasma in a repeated measures fashion. NF-L is an axonal injury marker that has previously been shown to be elevated in boxers and football players following subconcussive head trauma. Thirty-four adult aged soccer players were recruited and randomly assigned to either a soccer heading (n = 18) or kicking (n = 16) group. The heading group executed 10 headers with soccer balls projected at a velocity of 25 mph over 10 min. The kicking group followed the same protocol with 10 kicks. Plasma samples were obtained before and at 0 h, 2 h, and 24 h after heading/kicking and assessed for NF-L expressions. The heading group showed a gradual increase in plasma NF-L expression and peaked at 24 h after the heading protocol, whereas the kicking group remained consistent across the time points. These results confirmed the NF-L data from clinical field studies, encouraging the use of SSHM to validate clinical subconcussion data.	[Bevilacqua, Zachary W.; Huibregtse, Megan E.; Kawata, Keisuke] Indiana Univ, Dept Kinesiol, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA; [Kawata, Keisuke] Indiana Univ, Program Neurosci, Coll Arts & Sci, Bloomington, IN 47405 USA		Kawata, K (corresponding author), Indiana Univ, Dept Kinesiol, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA.; Kawata, K (corresponding author), Indiana Univ, Program Neurosci, Coll Arts & Sci, Bloomington, IN 47405 USA.	kkawata@indiana.edu					Alfonsi S, 2018, CBS NEWS; [Anonymous], 2007, FIFA BIG COUNT 2006; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Coon S, 2018, THESIS; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; NCAA, 2018, EST PROB COMP COLL A; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Reynolds B.B., 2015, J NEUROSURG, P1, DOI [10.3171/2015.5.JNS15573, DOI 10.3171/2015.5.JNS15573]; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Wallwork R, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012631; Ward J., 2017, NY TIMES; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Wirsching A, 2018, J NEUROTRAUMA	27	8	8	1	3	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	APR	2019		146							e59381	10.3791/59381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HW2GG	WOS:000466500600082	31058892	Green Published			2022-02-06	
J	Hu, E; Hu, W; Yang, AL; Zhou, HJ; Zhou, J; Luo, JK; Wang, Y; Tang, T; Cui, HJ				Hu, En; Hu, Wang; Yang, Ali; Zhou, Huajun; Zhou, Jun; Luo, Jiekun; Wang, Yang; Tang, Tao; Cui, Hanjin			Thrombin promotes pericyte coverage by Tie2 activation in a rat model of intracerebral hemorrhage	BRAIN RESEARCH			English	Article						Intracerebral hemorrhage; Pericyte coverage; Tie2 activation; Thrombin	TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; MESSENGER-RNA; MOUSE MODEL; ANGIOGENESIS; EXPRESSION; ANGIOPOIETIN-1; BARRIER; NEUROGENESIS; 3-KINASE/AKT	Pericyte coverage on the endothelial tubes leads to the formation of a mature and stable microvessel system, which is critical for brain repair after intracerebral hemorrhage (ICH). We report herein that thrombin promotes pericyte coverage by activating Tie2 and the downstream signaling pathway PI3K/Akt in a rat model of ICH. ICH was induced by injection of autologous blood with or without thrombin inhibitor hirudin. Rats were treated with thrombin alone or in combination with a Tie2 inhibitor. The expression of total- and phospho-Tie2, PI3K and phospho-Akt, blood perfusion, pericyte coverage, IgG extravasation, neuron survival and neurological deficits were evaluated by western blot, fluorescein-5-isothiocyanate-dextran staining, immunohistochemistry, Nissl staining and modified neurological severity scores respectively. Induction of ICH resulted in increased phosphorylation of Tie2 on endothelial cells and pericyte coverage, better formation of integral and functional microvessels, more surviving neurons and accelerated motor function recovery, all of which were significantly attenuated by hirudin at 7 and 14 days after ICH induction. Furthermore, thrombin increased phosphorylation of Tie2 and Akt, expression of PI3K, and pericyte coverage, which were however reversed by pharmacological inhibition of Tie2. Our results demonstrated that thrombin promotes pericyte coverage on microvessels following ICH by enhancing activation of Tie2, in which the downstream PI3K/Akt signaling pathway might be involved.	[Hu, En; Hu, Wang; Luo, Jiekun; Wang, Yang; Tang, Tao; Cui, Hanjin] Cent S Univ, Inst Integrat Med, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Yang, Ali] Cent S Univ, Inst Neurol, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Yang, Ali] Henan Prov Peoples Hosp, Dept Neurol, Zhengzhou 450003, Henan, Peoples R China; [Zhou, Huajun] China Three Gorges Univ, Inst Neurol, Coll Clin Med Sci 1, Yichang 443002, Hubei, Peoples R China; [Zhou, Jun] Cent S Univ, Inst Med Sci, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China		Cui, HJ (corresponding author), Cent S Univ, Inst Integrat Med, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China.	cuihanjin@csu.edu.cn		Cui, Hanjin/0000-0002-4041-473X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81473573, 81874425, 81774322, 81202625, 81673719, 81571382, 81603414]; Science Foundation for Young Scientists of Xiangya Hospital, Central South University [2016Q09]	This study was supported by grants from the National Natural Science Foundation of China [Grant Nos. 81473573, 81874425, 81774322, 81202625, 81673719, 81571382 and 81603414]; and the Science Foundation for Young Scientists of Xiangya Hospital, Central South University [Grant No. 2016Q09].	An SJ, 2017, J STROKE, V19, P3, DOI 10.5853/jos.2016.00864; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bae JS, 2010, J THROMB HAEMOST, V8, P1107, DOI 10.1111/j.1538-7836.2010.03812.x; Bae JS, 2009, J CELL PHYSIOL, V219, P744, DOI 10.1002/jcp.21718; Bao Xuhui, 2018, Cond Med, V1, P57; Cai J, 2008, INVEST OPHTH VIS SCI, V49, P2163, DOI 10.1167/iovs.07-1206; Caporali A, 2017, PHARMACOL THERAPEUT, V171, P56, DOI 10.1016/j.pharmthera.2016.10.001; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cui HJ, 2017, BRAIN INJURY, V31, P456, DOI 10.1080/02699052.2017.1279752; Cui HJ, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0605-8; Dalkara T, 2015, BRAIN RES, V1623, P3, DOI 10.1016/j.brainres.2015.03.047; Eklund L, 2017, CLIN SCI, V131, P87, DOI 10.1042/CS20160129; Griffin JH, 2018, BLOOD, V132, P159, DOI 10.1182/blood-2018-02-769026; Han X., 2018, J CEREB BLOOD FLOW M, V27; Han XN, 2016, J CEREBR BLOOD F MET, V36, P1059, DOI 10.1177/0271678X15606462; Haribalaganesh R, 2009, ANGIOGENESIS, V12, P381, DOI 10.1007/s10456-009-9159-z; Hu HT, 2011, ACTA NEUROCHIR SUPPL, V111, P259, DOI 10.1007/978-3-7091-0693-8_43; Hu SK, 2011, BRAIN RES, V1424, P60, DOI 10.1016/j.brainres.2011.09.062; Hua Y, 2009, STROKE, V40, pS88, DOI 10.1161/STROKEAHA.108.533281; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Koh GY, 2013, TRENDS MOL MED, V19, P31, DOI 10.1016/j.molmed.2012.10.010; Krenzlin H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010084; LEE KR, 1995, J NEUROSURG, V83, P1045, DOI 10.3171/jns.1995.83.6.1045; Lekas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043568; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Li Y, 2016, BEHAV BRAIN RES, V314, P165, DOI 10.1016/j.bbr.2016.08.015; Liebner S, 2018, ACTA NEUROPATHOL, V135, P311, DOI 10.1007/s00401-018-1815-1; Lin TN, 2000, J CEREBR BLOOD F MET, V20, P387, DOI 10.1097/00004647-200002000-00021; Liu CM, 2014, GENET MOL RES, V13, P4617, DOI 10.4238/2014.June.18.4; Machida T, 2015, NEUROSCI LETT, V599, P109, DOI 10.1016/j.neulet.2015.05.028; Mazzoni J, 2017, NEURON, V96, P1055, DOI 10.1016/j.neuron.2017.10.025; Qin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061831; Rabinstein AA, 2017, LANCET, V389, P575, DOI 10.1016/S0140-6736(17)30002-8; Rezaie AR, 2014, THROMB HAEMOSTASIS, V112, P876, DOI 10.1160/TH14-02-0167; Roy RV, 2016, BLOOD, V128, P1884, DOI 10.1182/blood-2016-06-720581; Ruan GX, 2013, J BIOL CHEM, V288, P21161, DOI 10.1074/jbc.M113.474619; Ruan LH, 2015, BRAIN RES, V1623, P166, DOI 10.1016/j.brainres.2015.02.042; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Tang T, 2007, BRAIN RES, V1175, P134, DOI 10.1016/j.brainres.2007.08.028; Teichert M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16106; Trenkwalder T, 2015, EXPERT OPIN BIOL TH, V15, pS175, DOI 10.1517/14712598.2015.1011122; Uebelhoer M, 2013, HUM MOL GENET, V22, P3438, DOI 10.1093/hmg/ddt198; VAUGHAN PJ, 1995, J NEUROSCI, V15, P5389; Wang J, 2005, NEUROCRIT CARE, V3, P77, DOI 10.1385/NCC:3:1:077; Wang JP, 2017, NEUROSCIENCE, V364, P202, DOI 10.1016/j.neuroscience.2017.09.025; White RR, 2008, ANGIOGENESIS, V11, P395, DOI 10.1007/s10456-008-9122-4; Wilkinson DA, 2018, NEUROPHARMACOLOGY, V134, P240, DOI 10.1016/j.neuropharm.2017.09.033; Winkler EA, 2018, J NEUROSURG, V129, P1464, DOI 10.3171/2017.6.JNS17860; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Wu H, 2010, BRAIN RES, V1342, P111, DOI 10.1016/j.brainres.2010.04.033; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Xiao M, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5819514; Yang AL, 2013, CHIN J INTEGR MED, V19, P815, DOI 10.1007/s11655-013-1342-1; Yang AL, 2012, J NEUROL SCI, V323, P141, DOI 10.1016/j.jns.2012.09.002; Yang SX, 2008, STROKE, V39, P2079, DOI 10.1161/STROKEAHA.107.508911; Yun JH, 2013, BIOCHEM BIOPH RES CO, V436, P691, DOI 10.1016/j.bbrc.2013.06.018; Zechariah A, 2013, STROKE, V44, P1690, DOI 10.1161/STROKEAHA.111.000240; Zhang YH, 2017, EXP CELL RES, V356, P28, DOI 10.1016/j.yexcr.2017.04.007; Zhang Z, 2017, MOL NEUROBIOL, V54, P1874, DOI 10.1007/s12035-016-9785-6; Zhang ZG, 2015, TRENDS MOL MED, V21, P543, DOI 10.1016/j.molmed.2015.07.005; Zhao B, 2017, THROMB HAEMOSTASIS, V117, P44, DOI 10.1160/TH16-05-0416; Zhao XR, 2015, J NEUROCHEM, V133, P144, DOI 10.1111/jnc.12974; Zhou HJ, 2012, J NEUROSURG, V117, P920, DOI 10.3171/2012.8.JNS112152; Zhou HJ, 2008, ACTA NEUROBIOL EXP, V68, P147; Zhou J, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0113-2	66	8	8	5	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	APR 1	2019	1708						58	68		10.1016/j.brainres.2018.12.003			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HO1ZX	WOS:000460712300007	30527680				2022-02-06	
J	Jones, JP; Drass, JM; Kaimal, G				Jones, Jacqueline P.; Drass, Jessica M.; Kaimal, Girija			Art therapy for military service members with post-traumatic stress and traumatic brain injury: Three case reports highlighting trajectories of treatment and recovery	ARTS IN PSYCHOTHERAPY			English	Article						Post-traumatic stress; Art therapy; Traumatic brain injury; Case reports; Long term; Military	COGNITIVE PROCESSING THERAPY; PTSD; VETERANS; DISORDER	Advances in both military and medical technology have led to decreased mortality rates among military service personnel in the United States, yet have led to an Increase in occurrences of traumatic brain injuries and post traumatic stress disorder in military service personnel, often resulting in prolonged unresolved symptoms. The purpose of this article is to illustrate the implementation and effects of an art therapy program on military service personnel attending an outpatient military treatment facility. To this end, we present case reports of three military service personnel diagnosed with comorbid traumatic brain injury and post-traumatic stress and describe their participation in the art therapy program at Intrepid Spirit One, the National Intrepid Center of Excellence satellite site at Fort Belvoir Community Hospital. Through discussion of the therapist's subjective observations, as well as the patients' visual art productions and their personal verbal and written reflections on their experiences in art therapy and, eventually, on community art programs, this article highlights how art therapy was used to treat military trauma as part of a comprehensive integrative treatment program. The cases highlight how participation in a long-term, stage-based, structured art therapy program (through both group and individual sessions), enabled military service personnel to identify and articulate the complexity of their lingering trauma symptoms, fostering improvement in their communication with other treatment providers and loved ones, which, in turn, led to improvements in their overall quality of life.	[Jones, Jacqueline P.] Ft Belvoir Community Hosp, Intrepid Spirit Ctr, Ft Belvoir, VA USA; [Jones, Jacqueline P.] Invisible Wounds Ctr, Eglin AFB, FL USA; [Drass, Jessica M.; Kaimal, Girija] Drexel Univ, Coll Nursing & Hlth Profess, Philadelphia, PA 19104 USA		Jones, JP (corresponding author), Invisible Wounds Ctr, AMDS SGPF 96MDG, 307 Boatner Rd, Eglin AFB, FL 32542 USA.	Jacqueline.P.Jones4.civ@mail.mil		Jones, Jacqueline/0000-0002-8484-2891; Drass, Jessica/0000-0001-9867-4019	Drexel University; Creative Forces(R): NEA Military Healing Arts Network which is an initiative of the National Endowment for the Arts (NEA); U.S. Departments of Defense and Veterans Affairs	This project was funded by a graduate research fellowship from Drexel University to Ms. Jessica Drass and by Creative Forces (R): NEA Military Healing Arts Network which is an initiative of the National Endowment for the Arts (NEA) in partnership with the U.S. Departments of Defense and Veterans Affairs and the state and local arts agencies. The Creative Forces.: NEA Military Healing Arts Network initiative serves the special needs of military patients and veterans with traumatic brain injury and psychological health conditions, as well as their families and caregivers. Administrative support for the initiative is provided by Americans for the Arts.	Aronson KR, 2018, MIL PSYCHOL, V30, P465, DOI 10.1080/08995605.2018.1478550; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Baker FA, 2018, PSYCHOL TRAUMA-US, V10, P643, DOI 10.1037/tra0000353; Banducci AN, 2018, PSYCHOL SERV, V15, P529, DOI 10.1037/ser0000204; Bowes MA, 2018, CLIN PSYCHOL PSYCHOT, V25, P583, DOI 10.1002/cpp.2182; Campbell M, 2016, ART THER, V33, P169, DOI 10.1080/07421656.2016.1226643; Clark IA, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00104; COHEN BM, 1988, ART PSYCHOTHER, V15, P11, DOI 10.1016/0197-4556(88)90048-2; Curran L, 2010, TRAUMA COMPETENCY CL; Decker KP, 2018, ART THER, V35, P184, DOI 10.1080/07421656.2018.1540822; DeLucia JM, 2016, ART THER, V33, P4, DOI 10.1080/07421656.2016.1127113; Foa EB, 2011, DEPRESS ANXIETY, V28, P1043, DOI 10.1002/da.20907; Gibson D, 2018, ART THER, V35, P99, DOI 10.1080/07421656.2018.1483166; Herman J.L., 1992, TRAUMA RECOVERY AFTE; Howell E., 2009, DISSOCIATION DISSOCI, P495; Hundt NE, 2018, PSYCHOL SERV, V15, P536, DOI 10.1037/ser0000212; Jansen D.J., 2013, POSTTRAUMATIC STRESS; JOHNSON DR, 1987, ART PSYCHOTHER, V14, P7, DOI 10.1016/0197-4556(87)90030-X; Kaimal, 2018, INT J ART THERAPY, V23, P70, DOI [10.1080/17454832.2017.1388263, DOI 10.1080/17454832.2017.1388263]; Kaimal G, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021448; Kaimal G, 2017, ART PSYCHOTHER, V55, P85, DOI 10.1016/j.aip.2017.05.004; Kaimal G, 2015, ART THER, V32, P89, DOI 10.1080/07421656.2015.1028310; King J., 2016, ART THERAPY TRAUMA N, P67; King JL, 2017, BIOMEDICAL J SCI TEC, DOI [DOI 10.26717/BJSTR.2017.01.000366, 10.26717/BJSTR.2017.01.000366]; Kline T, 2016, ART THER, V33, P67, DOI 10.1080/07421656.2016.1164002; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Lobban J, 2016, INT J ART THER, V21, P15, DOI DOI 10.1080/17454832.2015.1124899; Lobban J., 2014, INT J ART THER, V19, P3, DOI [https://doi.org/10.1080/17454832.2012.725547, DOI 10.1080/17454832.2012.725547]; McCann L, 1990, J TRAUMATIC STRESS, V3, P131, DOI DOI 10.1007/BF00975140; McGrath R.E., 2017, TECHNICAL REPORT VIA; Orkibi H, 2019, PSYCHOL AESTHET CREA, V13, P416, DOI 10.1037/aca0000193; Pearlman Laurie Anne, 1995, TRAUMA THERAPIST COU; Resick PA, 2014, COGNITIVE PROCESSING; Shapiro F., 2018, EYE MOVEMENT DESENSI; Smith A., 2016, INT J ART THERAP, V21, P66, DOI DOI 10.1080/17454832.2016.1170055; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Talwar S, 2007, ART PSYCHOTHER, V34, P22, DOI 10.1016/j.aip.2006.09.001; Tripp T, 2007, ART THER, V24, P176, DOI 10.1080/07421656.2007.10129476; van der Kolk B.A., 2014, BODY KEEPS SCORE BRA; Walker MS, 2017, INT J QUAL STUD HEAL, V12, DOI 10.1080/17482631.2016.1267317; Walker MS, 2016, ART PSYCHOTHER, V49, P10, DOI 10.1016/j.aip.2016.05.015; Wall PLH, 2012, J AM PSYCHIAT NURSES, V18, P278, DOI 10.1177/1078390312460578	42	8	8	2	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-4556	1873-5878		ART PSYCHOTHER	Arts Psychother.	APR	2019	63						18	30		10.1016/j.aip.2019.04.004			13	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	IK8OL	WOS:000476854300004		hybrid			2022-02-06	
J	Kosari-Nasab, M; Sadeghi, T; Bashiri, H; Shokouhi, G; Salari, AA				Kosari-Nasab, Morteza; Sadeghi, Tayebeh; Bashiri, Hamideh; Shokouhi, Ghaffar; Salari, Ali-Akbar			The blockade of corticotropin-releasing factor 1 receptor attenuates anxiety-related symptoms and hypothalamus-pituitary-adrenal axis reactivity in mice with mild traumatic brain injury	BEHAVIOURAL PHARMACOLOGY			English	Article						adrenocorticotropic hormone; corticosterone; corticotropin-releasing factor-1 receptor; hypothalamus-pituitary-adrenal axis; mouse; traumatic brain injury	DEPRESSION-LIKE BEHAVIORS; CRITICALLY-ILL PATIENTS; HPA-AXIS; FACTOR ANTAGONIST; ACUTE-PHASE; ENDOCRINE ABNORMALITIES; CORTISOL RESPONSE; DEPENDENT MANNER; HORMONE-LEVELS; CHRONIC STRESS	Recent studies have shown that mild traumatic brain injury (mTBI) is associated with higher risk for anxiety-related disorders. Dysregulation in the hypothalamus-pituitary-adrenal (HPA) axis following mTBI has been proposed to be involved in the development of neurobehavioral abnormalities; however, the underlying mechanisms are largely unknown. The aim of this study was to determine whether the corticotropin-releasing-factor-1 (CRF-1) receptor is involved in the regulation of anxiety-related symptoms in a mouse model of mTBI. Animals with or without mTBI received intracerebroventricular injections of a CRF-1 receptor agonist (CRF; 0.01nmol/mouse) or antagonist (antalarmin; 1 mu g/mouse) for 5 days, and then the animals were subjected to anxiety tests (light-dark box and zero maze). The levels of adrenocorticotropic hormone and corticosterone, the most important markers of HPA axis, were also measured after behavioral tests. Our results indicated that mTBI-induced anxiety-related symptoms in mice through increased levels of adrenocorticotropic hormone and corticosterone, showing HPA axis hyperactivity. Interestingly, activation of CRF receptor by a subthreshold dose of CRF resulted in significant increases in anxiety-like behaviors and HPA axis response to stress, whereas blockade of CRF receptors by a subthreshold dose of antalarmin decreased anxiety-related symptoms and HPA axis response to stress in mTBI-induced mice. Collectively, these findings suggest that the CRF-1 receptor plays an important role in the regulation of anxiety-related behaviors following mTBI induction in mice and support the hypothesis that blockade of the CRF-1 receptor may be a promising therapeutic target for anxiety-related disorders in patients with TBI.	[Kosari-Nasab, Morteza; Salari, Ali-Akbar] Tabriz Univ Med Sci, Drug Appl Res Ctr, POB 51656-65811, Tabriz, Iran; [Shokouhi, Ghaffar] Tabriz Univ Med Sci, Dept Neurosurg, Tabriz, Iran; [Shokouhi, Ghaffar] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran; [Sadeghi, Tayebeh] Islamic Azad Univ, Kerman Branch, Dept Biol, Kerman, Iran; [Bashiri, Hamideh] Kerman Univ Med Sci, Afzalipour Sch Med, Dept Physiol & Pharmacol, Kerman, Iran; [Salari, Ali-Akbar] SICBD, Alborz, Iran		Salari, AA (corresponding author), Tabriz Univ Med Sci, Drug Appl Res Ctr, POB 51656-65811, Tabriz, Iran.	aa.salari@yahoo.com	sadeghi, tayebeh/AAU-8832-2021; Bashiri, Hamideh/AAU-2552-2020; Salari, Ali-Akbar/I-7843-2013	Salari, Ali-Akbar/0000-0002-4970-0337; Kosari-Nasab, Morteza/0000-0001-8454-5873			Abelson JL, 2007, DEPRESS ANXIETY, V24, P66, DOI 10.1002/da.20220; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Amani M, 2013, NEUROPHARMACOLOGY, V73, P87, DOI 10.1016/j.neuropharm.2013.04.056; Traslavina GAA, 2011, BRAIN RES, V1421, P11, DOI 10.1016/j.brainres.2011.09.004; Ayatollahi AM, 2017, NEUROL RES, V39, P1056, DOI 10.1080/01616412.2017.1376789; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Bensalah M, 2018, CLIN ENDOCRINOL, V88, P627, DOI 10.1111/cen.13562; Bhutada P, 2010, PROG NEURO-PSYCHOPH, V34, P955, DOI 10.1016/j.pnpbp.2010.04.025; BIRO E, 1993, NEUROENDOCRINOLOGY, V57, P340, DOI 10.1159/000126377; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Cernak I, 1999, BRAIN INJURY, V13, P1005; CHIOLERO R, 1988, J TRAUMA, V28, P1368, DOI 10.1097/00005373-198809000-00011; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; de la Tremblaye PB, 2014, HORM BEHAV, V65, P273, DOI 10.1016/j.yhbeh.2014.01.003; Della Corte F, 1998, CRIT CARE MED, V26, P1419; Dieleman GC, 2015, PSYCHONEUROENDOCRINO, V51, P135, DOI 10.1016/j.psyneuen.2014.09.002; Dimopoulou I, 2005, INTENS CARE MED, V31, P1020, DOI 10.1007/s00134-005-2689-y; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Enayati M, 2012, BRAIN RES BULL, V87, P295, DOI 10.1016/j.brainresbull.2011.08.015; FEIBEL J, 1983, J CLIN ENDOCR METAB, V57, P1245, DOI 10.1210/jcem-57-6-1245; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Habib KE, 2000, P NATL ACAD SCI USA, V97, P6079, DOI 10.1073/pnas.97.11.6079; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; HEINRICHS SC, 1994, NEUROPSYCHOPHARMACOL, V11, P179, DOI 10.1038/sj.npp.1380104; HEINRICHS SC, 1992, BRAIN RES, V581, P190, DOI 10.1016/0006-8993(92)90708-H; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Hoen S, 2002, ANESTHESIOLOGY, V97, P807, DOI 10.1097/00000542-200210000-00010; Holsboer F, 2008, EUR J PHARMACOL, V583, P350, DOI 10.1016/j.ejphar.2007.12.032; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kask A, 1997, NEUROREPORT, V8, P3645, DOI 10.1097/00001756-199711100-00044; Keck ME, 2001, EUR J NEUROSCI, V13, P373, DOI 10.1046/j.0953-816X.2000.01383.x; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Kosari-Nasab M, 2018, TOXICOL APPL PHARM, V338, P159, DOI 10.1016/j.taap.2017.11.012; Majidi J, 2016, BRAIN RES BULL, V120, P1, DOI 10.1016/j.brainresbull.2015.10.009; MENZAGHI F, 1994, J PHARMACOL EXP THER, V269, P564; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Paxinos G., 2001, MOUSE BRAIN STEREOTA, P160; Pentelenyi T, 1992, Acta Neurochir Suppl (Wien), V55, P21; Roe SY, 1998, EUR J NEUROSCI, V10, P553, DOI 10.1046/j.1460-9568.1998.00064.x; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salari AA, 2015, EUR NEUROPSYCHOPHARM, V25, P1260, DOI 10.1016/j.euroneuro.2015.04.022; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Sartori SB, 2012, NEUROPHARMACOLOGY, V62, P304, DOI 10.1016/j.neuropharm.2011.07.027; Savaridas T, 2004, INTENS CARE MED, V30, P1479, DOI 10.1007/s00134-004-2306-5; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Spina MG, 2000, NEUROPSYCHOPHARMACOL, V22, P230, DOI 10.1016/S0893-133X(99)00108-6; STEINBOK P, 1979, NEUROSURGERY, V5, P559, DOI 10.1227/00006123-197911000-00003; STENZELPOORE MP, 1994, J NEUROSCI, V14, P2579; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2018, J NEUROTRAUM, V35, P630, DOI 10.1089/neu.2017.5238; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Webster EL, 2002, J RHEUMATOL, V29, P1252; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P917, DOI 10.1111/j.1530-0277.1990.tb01838.x; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209; Zorrilla EP, 2002, BRAIN RES, V952, P188, DOI 10.1016/S0006-8993(02)03189-X	62	8	9	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0955-8810	1473-5849		BEHAV PHARMACOL	Behav. Pharmacol.	APR	2019	30	2-3			SI		220	228		10.1097/FBP.0000000000000450			9	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	HR2SZ	WOS:000462988600011	30883392				2022-02-06	
J	McGuire, JL; DePasquale, EAK; Watanabe, M; Anwar, F; Ngwenya, LB; Atluri, G; Romick-Rosendale, LE; McCullumsmith, RE; Evanson, NK				McGuire, Jennifer L.; DePasquale, Erica A. K.; Watanabe, Miki; Anwar, Fatima; Ngwenya, Laura B.; Atluri, Gowtham; Romick-Rosendale, Lindsey E.; McCullumsmith, Robert E.; Evanson, Nathan K.			Chronic Dysregulation of Cortical and Subcortical Metabolism After Experimental Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article						NMR metabolomics; Chronic TBI; Lateral fluid percussion; Network structure; Correlations-based analysis	GLUTAMATERGIC NEUROTRANSMISSION; OXIDATIVE-METABOLISM; GLUCOSE-METABOLISM; MR SPECTROSCOPY; TAURINE UPTAKE; UNITED-STATES; C-13 MRS; IN-VIVO; ACETYLCHOLINE; METABOLOMICS	Traumatic brain injury (TBI) is a leading cause of death and long-term disability worldwide. Although chronic disability is common after TBI, effective treatments remain elusive and chronic TBI pathophysiology is not well understood. Early after TBI, brain metabolism is disrupted due to unregulated ion release, mitochondrial damage, and interruption of molecular trafficking. This metabolic disruption causes at least part of the TBI pathology. However, it is not clear how persistent or pervasive metabolic injury is at later stages of injury. Using untargeted H-1-NMR metabolomics, we examined ex vivo hippocampus, striatum, thalamus, frontal cortex, and brainstem tissue in a rat lateral fluid percussion model of chronic brain injury. We found altered tissue concentrations of metabolites in the hippocampus and thalamus consistent with dysregulation of energy metabolism and excitatory neurotransmission. Furthermore, differential correlation analysis provided additional evidence of metabolic dysregulation, most notably in brainstem and frontal cortex, suggesting that metabolic consequences of injury are persistent and widespread. Interestingly, the patterns of network changes were region-specific. The individual metabolic signatures after injury in different structures of the brain at rest may reflect different compensatory mechanisms engaged to meet variable metabolic demands across brain regions.	[McGuire, Jennifer L.; Anwar, Fatima; Ngwenya, Laura B.] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45267 USA; [DePasquale, Erica A. K.; Atluri, Gowtham] Univ Cincinnati, Grad Program Biomed Informat, Cincinnati, OH 45267 USA; [Watanabe, Miki; Romick-Rosendale, Lindsey E.] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA; [Ngwenya, Laura B.] Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH 45267 USA; [Atluri, Gowtham] Univ Cincinnati, Dept Elect Engn & Comp Sci, Cincinnati, OH 45267 USA; [McCullumsmith, Robert E.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45267 USA; [Evanson, Nathan K.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45267 USA; [Evanson, Nathan K.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, Cincinnati, OH 45229 USA		McGuire, JL (corresponding author), Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45267 USA.	jennifer.mcguire@uc.edu	Atluri, Gowtham/AAA-1814-2022	Ngwenya, Laura/0000-0001-7103-971X; McGuire, Jennifer/0000-0003-3058-5241; Romick-Rosendale, Lindsey/0000-0002-7252-1193	Cincinnati Children's Hospital Medical Center as a Shared Facilities Discovery Award; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH107916, R01MH107487] Funding Source: NIH RePORTER	These studies received financial support from Cincinnati Children's Hospital Medical Center as a Shared Facilities Discovery Award to NKE and JLM.	Aiello GL, 2000, J NEUROSCI METH, V103, P145, DOI 10.1016/S0165-0270(00)00308-3; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BALLEVRE O, 1991, AM J PHYSIOL, V260, pE662, DOI 10.1152/ajpendo.1991.260.4.E662; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bartnik-Olson Brenda L, 2013, Front Neuroenergetics, V5, P8, DOI 10.3389/fnene.2013.00008; Bartnik-Olson BL, 2010, J NEUROTRAUM, V27, P2191, DOI 10.1089/neu.2010.1508; BEANI L, 1983, BRIT J PHARMACOL, V79, P623, DOI 10.1111/j.1476-5381.1983.tb11038.x; Bryant AS, 2009, J NEUROPHYSIOL, V102, P2880, DOI 10.1152/jn.00476.2009; Calvetti Daniela, 2013, Front Endocrinol (Lausanne), V4, P137, DOI 10.3389/fendo.2013.00137; Camacho D, 2005, METABOLOMICS, V1, P53, DOI 10.1007/s11306-005-1107-3; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; CHEESEMAN AJ, 1988, J NEUROCHEM, V50, P1559, DOI 10.1111/j.1471-4159.1988.tb03044.x; Christensen CD, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0236-1; Curt MJC, 2015, BIOCHIMIE, V119, P146, DOI 10.1016/j.biochi.2015.10.022; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; del Olmo N, 2004, EUR J NEUROSCI, V19, P1875, DOI 10.1111/j.1460-9568.2004.03309.x; DOLEZAL V, 1981, J NEUROCHEM, V36, P1323, DOI 10.1111/j.1471-4159.1981.tb00569.x; Dorsett CR, 2017, J NEUROTRAUM, V34, P220, DOI 10.1089/neu.2015.4372; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; El Idrissi A, 2004, NEUROCHEM RES, V29, P189, DOI 10.1023/B:NERE.0000010448.17740.6e; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fridman EA, 2014, P NATL ACAD SCI USA, V111, P6473, DOI 10.1073/pnas.1320969111; Fukushima A, 2013, GENE, V518, P209, DOI 10.1016/j.gene.2012.11.028; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Granger AJ, 2017, CURR OPIN NEUROBIOL, V45, P85, DOI 10.1016/j.conb.2017.04.007; Gu T, 2008, NEUROL RES, V30, P229, DOI 10.1179/016164107X235473; GUHA SK, 1982, J BIOL CHEM, V257, P6634; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hertz L, 2017, FRONT INTEGR NEUROSC, V11, DOI 10.3389/fnint.2017.00018; Hovda D.A., 1996, NEUROTRAUMA, P1459; Ipata PL, 2011, INT J BIOCHEM CELL B, V43, P140, DOI 10.1016/j.biocel.2010.10.007; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Ito K, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3794029; Jaeger C, 2015, AM J PATHOL, V185, P1699, DOI 10.1016/j.ajpath.2015.02.016; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Katsu-Jimenez Y, 2017, EXP CELL RES, V360, P41, DOI 10.1016/j.yexcr.2017.03.002; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Kose F, 2001, BIOINFORMATICS, V17, P1198, DOI 10.1093/bioinformatics/17.12.1198; KSIEZAK HJ, 1981, J NEUROCHEM, V37, P88, DOI 10.1111/j.1471-4159.1981.tb05294.x; Ma Z, 2008, NEUROL SCI, V29, P337, DOI 10.1007/s10072-008-0991-5; Mader I, 2008, EUR J RADIOL, V67, P250, DOI 10.1016/j.ejrad.2008.02.033; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Mayeux J, 2017, J NEUROTRAUM, V34, P436, DOI 10.1089/neu.2016.4452; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Moffett John R, 2013, Front Neuroenergetics, V5, P11, DOI 10.3389/fnene.2013.00011; Morgenthal K, 2006, BIOSYSTEMS, V83, P108, DOI 10.1016/j.biosystems.2005.05.017; Palmada M., 1998, FRONT BIOSCI, V3, P701; Parsons HM, 2009, ANALYST, V134, P478, DOI 10.1039/b808986h; Patel AB, 2004, J CEREBR BLOOD F MET, V24, P972, DOI 10.1097/01.WCB.0000126234.16188.71; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; PELLERIN L, 1922, P NATL ACAD SCI USA, V91, P10625; Ragan DK, 2013, J CEREBR BLOOD F MET, V33, P48, DOI 10.1038/jcbfm.2012.130; Rothman DL, 2011, NMR BIOMED, V24, P943, DOI 10.1002/nbm.1772; Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170541; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; Shetty PK, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00043; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Sobieski C, 2017, J NEUROSCI, V37, P1888, DOI 10.1523/JNEUROSCI.2712-16.2017; Sonnay S, 2016, J CEREBR BLOOD F MET, V36, P928, DOI 10.1177/0271678X16629482; Stender J, 2016, CURR BIOL, V26, P1494, DOI 10.1016/j.cub.2016.04.024; Steuer R, 2003, BIOINFORMATICS, V19, P1019, DOI 10.1093/bioinformatics/btg120; Steuer R, 2006, BRIEF BIOINFORM, V7, P151, DOI 10.1093/bib/bbl009; Suarez LM, 2014, NEUROPHARMACOLOGY, V79, P101, DOI 10.1016/j.neuropharm.2013.10.035; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tani H, 2014, NEURON, V81, P888, DOI 10.1016/j.neuron.2013.12.026; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; von Schwarzenfeld I, 1975, Acta Biol Med Ger, V34, P1525; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Watanabe M, 2015, METABOLOMICS, V11, P1302, DOI 10.1007/s11306-015-0789-4; Weckwerth W, 2003, ANNU REV PLANT BIOL, V54, P669, DOI 10.1146/annurev.arplant.54.031902.135014; Wei T., 2017, R PACKAGE CORRPLOT V; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	82	8	8	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	APR	2019	56	4					2908	2921		10.1007/s12035-018-1276-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HU7XZ	WOS:000465498200049	30069831	Green Accepted			2022-02-06	
J	Niemeier, JP; Kreutzer, JS; Marwitz, JH; Sima, AP				Niemeier, Janet P.; Kreutzer, Jeffrey S.; Marwitz, Jennifer H.; Sima, Adam P.			A Randomized Controlled Pilot Study of a Manualized Intervention for Caregivers of Patients With Traumatic Brain Injury in Inpatient Rehabilitation	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Caregivers; Family; Rehabilitation; Traumatic brain injury	QUALITY-OF-LIFE; INTENSIVE-CARE-UNIT; COPING SKILLS GROUP; PERCEIVED BURDEN; FAMILY NEEDS; SUPPORT GROUP; INDIVIDUALS; PREDICTORS; DEPRESSION; VETERANS	Objective: Investigate effectiveness of a 5-session manualized intervention for addressing needs of caregivers of persons in acute traumatic brain injury (TBI) rehabilitation. Design: Prospective, pilot randomized controlled trial. Setting: Inpatient brain injury rehabilitation unit, level 1 trauma center. Participants: Patients (N=93) with moderate-to-severe TBI and their family members were enrolled in the study with 42 randomized to the treatment group, 51 to the control group. Intervention: Five-session manualized caregiver intervention with educational, stress and anxiety self-management, coping, and emotional support components. Main outcome measures: Family Needs Questionnaire-Revised, knowledge assessment, Zarit Family Burden Scale, and Brief Symptom Inventory-18 were collected at pretreatment, posttreatment, and 3-month follow-up. Results: Treatment group caregivers showed an increase in met needs for emotional, instrumental, and professional support, and brain injury knowledge from baseline to posttreatment, whereas controls did not. Between-group differences were significant for only emotional support needs. Treatment effects were not sustained at 3-month follow-up. Conclusions: Caregivers of persons undergoing acute TBI rehabilitation may benefit from interventions that target their unique needs. Caregivers may require additional and longer-term supports to sustain treatment benefits. (C) 2018 by the American Congress of Rehabilitation Medicine	[Niemeier, Janet P.; Kreutzer, Jeffrey S.; Marwitz, Jennifer H.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, POB 980542, Richmond, VA 23298 USA; [Sima, Adam P.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [Niemeier, Janet P.] Carolinas Med Ctr, Dept Phys Med & Rehabil, Charlotte, NC 28203 USA		Marwitz, JH (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, POB 980542, Richmond, VA 23298 USA.	Jennifer.Marwitz@vcuhealth.org		Sima, Adam/0000-0001-8426-9987	National Institute on Disability and Rehabilitation Research (NIDRR) of the US Department of Education [H133A070036]	Supported in part by a grant from the National Institute on Disability and Rehabilitation Research (NIDRR) of the US Department of Education (grant no. H133A070036). The contents of this article do not necessarily represent the policy of NIDRR and the Department of Education, and you should not assume endorsement by the Federal Government.	Bachner YG, 2007, AGING MENT HEALTH, V11, P678, DOI 10.1080/13607860701529965; Backhaus S, 2016, ARCH PHYS MED REHAB, V97, P281, DOI 10.1016/j.apmr.2015.10.097; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Baumhover NC, 2013, AACN ADV CRIT CARE, V24, P130, DOI 10.1097/NCI.0b013e318286489e; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boutron I, 2017, ANN INTERN MED, V167, P40, DOI 10.7326/M17-0046; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chronister J, 2016, REHABIL COUNS BULL, V59, P235, DOI 10.1177/0034355215601072; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Damianakis T, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000178; Davidson JE, 2007, CRIT CARE MED, V35, P605, DOI 10.1097/01.CCM.0000254067.14607.EB; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Derogatis L.R., 2000, BRIEF SYMPTOM INVENT; Elliott TR, 2001, J COUNS PSYCHOL, V48, P223, DOI 10.1037//0022-0167.48.2.223; Family Caregiver Alliance, CAR STAT DEM; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Katz S, 2005, BRAIN INJURY, V19, P59, DOI 10.1080/02699050410001719970; Kenward MG, 2009, COMPUT STAT DATA AN, V53, P2583, DOI 10.1016/j.csda.2008.12.013; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Kreutzer J. S., 1988, FAMILY NEEDS QUESTIO; Kreutzer JS, 2018, J HEAD TRAUMA REHAB, V33, P228, DOI 10.1097/HTR.0000000000000390; Kreutzer JS, 2016, J FAM THEOR REV, V8, P386, DOI 10.1111/jftr.12150; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Kreutzer JS, 2010, J HEAD TRAUMA REHAB, V25, P113, DOI 10.1097/HTR.0b013e3181cf0712; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Kreutzer JS, 1999, GETTING BETTER BETTE; Lehan T, 2012, NEUROREHABILITATION, V30, P87, DOI 10.3233/NRE-2011-0730; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Norup A, 2015, BRAIN INJURY, V29, P822, DOI 10.3109/02699052.2015.1016451; Norup A, 2015, NEUROREHABILITATION, V36, P203, DOI 10.3233/NRE-151208; Perlick DA, 2013, PSYCHIAT SERV, V64, P534, DOI 10.1176/appi.ps.001622012; Perrin PB, 2013, PM&R, V5, P839, DOI 10.1016/j.pmrj.2013.05.018; Powell JM, 2017, J HEAD TRAUMA REHAB, V32, pE33, DOI 10.1097/HTR.0000000000000219; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Rosenquist JN, 2011, MOL PSYCHIATR, V16, P273, DOI 10.1038/mp.2010.13; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Warren AM, 2016, REHABIL PSYCHOL, V61, P179, DOI 10.1037/rep0000080	48	8	8	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2019	100	4		1			S65	S75		10.1016/j.apmr.2018.07.422			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HR2FV	WOS:000462951900008	30075147				2022-02-06	
J	Pike, AM; Adams, WM; Huggins, RA; Mazerolle, SM; Casa, DJ				Pike, Alicia M.; Adams, William M.; Huggins, Robert A.; Mazerolle, Stephanie M.; Casa, Douglas J.			Analysis of States' Barriers to and Progress Toward Implementation of Health and Safety Policies for Secondary School Athletics	JOURNAL OF ATHLETIC TRAINING			English	Article						risk mitigation; emergency preparedness; emergency best practices; sudden death	ASSOCIATION POSITION STATEMENT; PREVENTING SUDDEN-DEATH; TRAINER SERVICES; CARDIAC-ARREST; TASK-FORCE; MANAGEMENT; PROGRAMS	Context: Implementation of health and safety best practices for the leading causes of sudden death and catastrophic injury has been shown to mitigate risk. However, to our knowledge, no authors have examined progress toward health and safety policy implementation at the state level. Objective: To investigate the progress made by state secondary school leaders in developing and implementing health and safety policies (ie, exertional heat stroke, sudden cardiac arrest, concussion, emergency action plans) and to explore perceived barriers to and strategies for implementation. Design: Mixed-methods study. Setting: State high school athletics associations and sports medicine advisory committees. Patients or Other Participants: Collaborative Solutions for Safety in Sport meeting attendees participated in this study. Thirty-five state leaders (current role experience = 8 +/- 6 years) completed the survey. Ten of the 35 participated in follow-up interviews. Data Collection and Analysis: A survey assessing progress on health and safety policy implementation was administered. Respondents indicated whether their state had implemented a policy, made progress without implementation, or made no progress. We conducted follow-up telephone interviews so they could expand on the survey responses. The data were analyzed using descriptive statistics and the general inductive approach. Results: A total of 89% of respondents reported their states made progress on or implemented health and safety policies during the 2015-2016 academic year. Barriers to policy implementation included cost, a lack of understanding regarding policies versus recommendations, the content and value of policy change, and a false sense of security. Strategies for implementation included varying approaches to change, education of all constituents, and collaborative relationships among key stakeholders. Conclusions: Although a majority of respondents reported progress in implementing health and safety policies in their states, perceived barriers pointed to the need for the continued education of state leaders in charge of developing and implementing health and safety policies. Despite these barriers, collaboration among key stakeholders is crucial to successful implementation of best-practice policies in secondary school athletics.	[Pike, Alicia M.; Huggins, Robert A.; Mazerolle, Stephanie M.; Casa, Douglas J.] Univ Connecticut, Korey Stringer Inst, Dept Kinesiol, 2095 Hillside Rd,Unit 1110, Storrs, CT 06269 USA; [Adams, William M.] Univ North Carolina Greensboro, Dept Kinesiol, Greensboro, NC USA		Pike, AM (corresponding author), Univ Connecticut, Korey Stringer Inst, Dept Kinesiol, 2095 Hillside Rd,Unit 1110, Storrs, CT 06269 USA.	alicia.pike@uconn.edu		Huggins, Robert/0000-0003-2174-8088	National Athletic Trainers' Association; American Medical Society for Sports Medicine	We thank the National Athletic Trainers' Association and American Medical Society for Sports Medicine for organizing and funding the 2015 Collaborative Solutions for Safety in Sport meeting.	Adams WM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117727262; Adams WM, 2016, J ATHL TRAINING, V51, P358, DOI 10.4085/1062-6050-51.4.14; Adams WM, 2016, J ATHL TRAIN S, V51, pS167; Andersen JC, 2002, J ATHL TRAINING, V37, P99; [Anonymous], NFHS RUL WRIT PROC; [Anonymous], PART STAT; [Anonymous], REPORTS; Attanasio SM, 2016, J ATHL TRAIN S6, V51, pS; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Casa DJ, 2015, J ATHL TRAINING, V50, P986, DOI 10.4085/1062-6050-50.9.07; Casa DJ, 2013, J ATHL TRAINING, V48, P546, DOI 10.4085/1062-6050-48.4.12; Casa DJ, 2012, J ATHL TRAINING, V47, P96; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; DIMAGGIO PJ, 1983, AM SOCIOL REV, V48, P147, DOI 10.2307/2095101; Drezner JA, 2007, J ATHL TRAINING, V42, P143; Drezner JA, 2013, BRIT J SPORT MED, V47, P1179, DOI 10.1136/bjsports-2013-092786; Grissom J.B., 2005, J EXERC PHYSL ONLINE, V8, P11, DOI DOI 10.5297/SER.1403.010; Jones-Palm DH, 2005, PHYS ACTIVITY ITS IM; Kritsonis A., 2005, INT J MANAGEMENT BUS, V8, P1; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MOORE LL, 1991, J PEDIATR-US, V118, P215, DOI 10.1016/S0022-3476(05)80485-8; Pagnotta KD, 2016, J ATHL TRAINING, V51, P291, DOI 10.4085/1062-6050-51.2.09; Pike A, 2016, J ATHL TRAINING, V51, P717, DOI 10.4085/1062-6050-51.11.04c; Pike AM, 2017, J ATHL TRAINING, V52, P5, DOI 10.4085/1062-6050-51.11.15; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Schneider K, 2017, RURAL REMOTE HEALTH, V17; Slack T., 2006, UNDERSTANDING SPORT, V2nd; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748	29	8	8	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	APR	2019	54	4					361	373		10.4085/1062-6050-28-18			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HY0LT	WOS:000467804100003	31017807	Green Published, gold			2022-02-06	
J	Posti, JP; Sankinen, M; Sipila, JOT; Ruuskanen, JO; Rinne, J; Rautava, P; Kyto, V				Posti, Jussi P.; Sankinen, Matti; Sipila, Jussi O. T.; Ruuskanen, Jori O.; Rinne, Jaakko; Rautava, Paivi; Kyto, Ville			Fatal traumatic brain injuries during 13 years of successive alcohol tax increases in Finland - a nationwide population-based registry study	SCIENTIFIC REPORTS			English	Article							MORTALITY; EPIDEMIOLOGY	We sought to investigate how increases in alcohol taxation and changes in alcohol consumption were associated with the incidence rate of fatal traumatic brain injuries (TBI) in Finland during the years 2004-2016. Nationwide, mandatory cause of death database covering all deaths in Finland was searched for all deaths related to TBIs (ICD-10: S06.X) in persons >= 16 years of age during 2004-2016. Study period included 28,657,870 person-years and 325,514 deaths of which 12,110 were TBI-related. Occurrence rates were standardized to European 2013 standard population. Data for alcohol consumption were obtained from the National Institute for Health and Welfare and for alcohol taxation from Ministry of Finance, Finland. Standardized incidence rate of TBI-related death was 22.0 (95%Cl 21.61-22.38) per 100,000 person-years. Overall alcohol consumption decreased on average by 1.2% annually. Concurrently, the overall incidence rate of fatal TBIs decreased by 4.1% annually (by 4.3% in men and 2.4% in women). There was an association between overall alcohol consumption and TBI-related mortality rate (p < 0.001). Tax-rate increases of all beverage types were associated with decreased incidence rate of TBI-related death in men (p < 0.001), in women (p < 0.036) and overall (p < 0.001). In this population-based study, we report that during 13 years of successive alcohol tax increases, overall alcohol consumption has decreased in parallel with a reduction in the incidence rate of fatal TBIs in Finland.	[Posti, Jussi P.; Sankinen, Matti; Rinne, Jaakko] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku, Finland; [Posti, Jussi P.] Turku Univ Hosp, Turku Brain Injury Ctr, Turku, Finland; [Posti, Jussi P.; Sankinen, Matti; Sipila, Jussi O. T.; Ruuskanen, Jori O.; Rinne, Jaakko; Rautava, Paivi] Univ Turku, Turku, Finland; [Sipila, Jussi O. T.; Ruuskanen, Jori O.] Turku Univ Hosp, Dept Neurol, Div Clin Neurosci, Turku, Finland; [Sipila, Jussi O. T.] North Karelia Cent Hosp, Dept Neurol, Siun Sote, Joensuu, Finland; [Rautava, Paivi] Turku Univ Hosp, Clin Res Ctr, Turku, Finland; [Kyto, Ville] Turku Univ Hosp, Heart Ctr, Turku, Finland; [Rautava, Paivi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Kyto, Ville] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland		Posti, JP (corresponding author), Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku, Finland.; Posti, JP (corresponding author), Turku Univ Hosp, Turku Brain Injury Ctr, Turku, Finland.; Posti, JP (corresponding author), Univ Turku, Turku, Finland.	jussi.posti@utu.fi	Posti, Jussi P./Y-2908-2019; Kyto, Ville/D-7971-2014; Sipila, Jussi/C-8585-2015	Posti, Jussi P./0000-0002-5925-5193; Kyto, Ville/0000-0002-4521-1093; Sipila, Jussi/0000-0003-0183-9054	Government's Special Financial Transfer tied to academic research in Health Sciences; Finnish Brain Foundation sr; Emil Aaltonen Foundation sr; Maire Taponen Foundation	Robert Paul, MD, PhD is acknowledged for the language content editing of the manuscript. This work was partially funded by Government's Special Financial Transfer tied to academic research in Health Sciences (Jussi P. Posti), a grant from Finnish Brain Foundation sr (Jussi P. Posti), a grant from Emil Aaltonen Foundation sr (Jussi P. Posti) and a grant from Maire Taponen Foundation (Jussi P. Posti).	Baldwin G, 2015, C TRAUM BRAIN INJ US; Cheever C, 2018, J NEUROSCI NURS, V50, P83, DOI 10.1097/JNN.0000000000000345; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Griswold MG, 2018, LANCET, V392, P1015, DOI [10.1016/S0140-6736(18)31310-2, 10.1016/s0140-6736(18)31310-2]; Kasper C. E, 2015, TRAUMATIC BRAIN INJU, V33; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Makela P, 2009, ADDICTION, V104, P554, DOI 10.1111/j.1360-0443.2009.02517.x; Naimi TS, 2018, JAMA INTERN MED, V178, P894, DOI 10.1001/jamainternmed.2018.1406; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Peeters W, 2017, NEUROEPIDEMIOLOGY, V48, P63, DOI 10.1159/000471877; Puljula J, 2013, SCAND J PUBLIC HEALT, V41, P524, DOI 10.1177/1403494813481644; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099	18	8	8	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	APR 1	2019	9								5419	10.1038/s41598-019-41913-8			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CC	WOS:000462864700025	30931989	Green Published, gold			2022-02-06	
J	Srivastava, NK; Mukherjee, S; Sharma, R; Das, J; Sharma, R; Kumar, V; Sinha, N; Sharma, D				Srivastava, Niraj Kumar; Mukherjee, Somnath; Sharma, Rajkumar; Das, Jharana; Sharma, Rohan; Kumar, Vikas; Sinha, Neeraj; Sharma, Deepak			Altered lipid metabolism in post-traumatic epileptic rat model: one proposed pathway	MOLECULAR BIOLOGY REPORTS			English	Article						Oxidative stress; Post-traumatic epilepsy; Phospholipids; Lipid extraction; Lipid components; Abnormal lipid metabolism; Metabolic pathway; Iron-induced epileptic rat; Neuronal membrane lipids; Cholesterol; Triglycerides	COLLAGEN-INDUCED ARTHRITIS; CHOLESTEROL-METABOLISM; ANTIEPILEPTIC ACTION; NMR-SPECTROSCOPY; IN-VITRO; BRAIN; IRON; SEIZURES; PEROXIDATION; INFLAMMATION	Post-traumatic epilepsy (PTE) is a common long-term risk associated with traumatic brain injury (TBI). PTE rat model, proposed by Willmore et al., is a well known model that mimics human PTE. The present study explored the lipid metabolism in this PTE rat model by using in vitro, high-resolution NMR (nuclear magnetic resonance) spectroscopy and lipid staining based investigations. The level of gene expression, cytokines and enzyme activity was estimated. Level of TG (triglycerides), PL (phospholipids) and CHOL (cholesterol) was found to increase in brain tissue of PTE rats. This is an indication of the altered lipid metabolism in PTE rats. Level of lipid peroxidation and cytokines was enhanced in the brain tissue of PTE rats. A positive correlation was also observed in cytokines vs. lipid peroxidation. These results make available the evidence of the oxidative stress induced damage or destruction of the lipid components and also the cause of the inflammatory events in PTE rats. Antioxidant enzyme activity and respective gene expression were found to increase in brain tissue of PTE rats. A positive correlation was also observed in antioxidant enzyme's activity vs. respective enzyme gene expression and lipid peroxidation vs. activity of antioxidant enzymes. Such outcomes reflect the oxidative stress induced lipid damage responsible for production enhancement of antioxidant enzymes, which further responsible for enhancing the activity of antioxidant enzymes. A positive correlation was observed in lipid peroxidation vs. lipid components (TG, PL and CHOL) and provides the confirmatory verification of alteration in the level of lipid components. A negative correlation was observed in the level of cytokines and the quantity of TG. This showed that TG is consumed in the production of cytokines. MUA (Motor unit activity) is highly correlated with the level of LP and indicated that oxidative stress is responsible for the event of epileptogenesis. Positive correlation of MUA with RA (rearing activity) and MWM (Morris-water maze) showed that epileptogenesis also influences the memory of PTE rats. Overall results based analyses clearly indicate that the inflammatory activity and oxidative stress in brain tissue of PTE rats, which are responsible to establish a significant change in the lipid metabolism. This can be visualized through a well constructed possible pathway of altered lipid metabolism. This study will improve our understanding and approach in the field of epilepsy that need to be considered for the development of new drugs or therapy for patients with PTE.Graphical abstractRepresentation of the proposed pathway of altered lipid metabolism in posttraumatic epileptic rats.	[Srivastava, Niraj Kumar; Mukherjee, Somnath; Das, Jharana; Sharma, Rohan; Kumar, Vikas; Sharma, Deepak] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Sharma, Rajkumar; Sinha, Neeraj] Sanjay Gandhi Postgrad Inst Med Sci Campus, Ctr Biomed Res CBMR, Lucknow 226014, Uttar Pradesh, India		Srivastava, NK (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	nirajsuprabhat@gmail.com	Sharma, Raj Kumar/AAQ-5288-2021; SRIVASTAVA, NIRAJ/AAS-6631-2021	Sharma, Raj Kumar/0000-0003-0623-3238; SRIVASTAVA, NIRAJ/0000-0002-5369-4195; Sinha, Neeraj/0000-0003-3235-6127; Das, Jharana/0000-0001-7212-9215	Council of Scientific & Industrial Research (CSIR), Government of IndiaCouncil of Scientific & Industrial Research (CSIR) - India [13 (8660-A) 2013-Pool]	This work was funded by a Grant from the Council of Scientific & Industrial Research (CSIR), Government of India, in the form of CSIR-SRA (Senior research associate) [No. 13 (8660-A) 2013-Pool].	Acharya MM, 2005, EXP NEUROL, V192, P79, DOI 10.1016/j.expneurol.2004.11.004; Adams CWM, 1969, ADV LIPID RES; Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Aynaci FM, 2001, J CHILD NEUROL, V16, P367; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Carrey N, 2000, J CHILD ADOL PSYCHOP, V10, P277, DOI 10.1089/cap.2000.10.277; Cesnik E, 2014, INT J NEUROREHABILIT, V1, P2; Cesnik E, 2013, J NEUROL NEUROPHYS S, V2, P9; Das J, 2016, NUTR NEUROSCI, V19, P1, DOI [DOI 10.1179/1476830515Y.0000000040, 10.1179/1476830515Y.0000000040]; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; El-Bahr SM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-368; Fantini J., 2015, BRAIN LIPIDS SYNAPTI; Fauvelle F, 2015, J PROTEOME RES, V14, P2177, DOI 10.1021/pr501309b; Hernandes MS, 2012, CURR NEUROPHARMACOL, V10, P321, DOI 10.2174/157015912804143540; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Jyoti A, 2009, EPILEPSY BEHAV, V14, P300, DOI 10.1016/j.yebeh.2008.11.011; Jyoti A, 2009, NEUROSCI LETT, V453, P86, DOI 10.1016/j.neulet.2009.01.082; Kinoshita Yoshimasa, 1993, Neurologia Medico-Chirurgica, V33, P350, DOI 10.2176/nmc.33.350; Kontny E, 2012, ANN RHEUM DIS, V71, P262, DOI 10.1136/annrheumdis-2011-200123; Lehnhardt FG, 2001, NMR BIOMED, V14, P307, DOI 10.1002/nbm.708; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Malaisse WJ, 2006, NEUROSCI LETT, V409, P75, DOI 10.1016/j.neulet.2006.09.023; Mangiola A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/736104; McKenna MC, 2015, NEUROCHEM RES, V40, P2527, DOI 10.1007/s11064-015-1600-7; MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5; Mishra M, 2013, EPILEPSY RES, V106, P83, DOI 10.1016/j.eplepsyres.2013.06.008; Mishra M, 2010, EPILEPSY BEHAV, V19, P264, DOI 10.1016/j.yebeh.2010.06.048; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Norska A, 2010, NEUROIMAG CLIN N AM, V20, P293, DOI 10.1016/j.nic.2010.04.003; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Patsoukis N, 2005, EPILEPSIA, V46, P1205, DOI 10.1111/j.1528-1167.2005.63704.x; Raphael R, 2011, RUBINS PATHOLOGY CLI; Rzanny R, 2003, EUR RADIOL, V13, P763, DOI 10.1007/s00330-002-1565-1; Schwaninger M, 2000, J NEUROL, V247, P687, DOI 10.1007/s004150070111; Sharma S, 2011, FOOD CHEM TOXICOL, V49, P3395, DOI 10.1016/j.fct.2011.08.013; Sharma V, 2007, SEIZURE-EUR J EPILEP, V16, P680, DOI 10.1016/j.seizure.2007.05.012; Singh R, 2012, INDIAN J EXP BIOL, V50, P101; Singh RP, 2000, MOL CELL BIOCHEM, V213, P99, DOI 10.1023/A:1007182913931; Sonmez FM, 2006, J CHILD NEUROL, V21, P70, DOI 10.2310/7010.2006.00015; Srivastava NK, 2008, NMR BIOMED, V21, P89, DOI 10.1002/nbm.1159; Srivastava NK, 2014, INDIAN J EXP BIOL, V52, P673; Srivastava NK, 2010, NMR BIOMED, V23, P13, DOI 10.1002/nbm.1419; Srivastava NK, 2006, ANAL LETT, V39, P297, DOI 10.1080/00032710500477001; Srivastava NK, 2015, INT J PHARM BIO SCI, V6, P315; Streit WJ, 2004, GLIA, V45, P208, DOI 10.1002/glia.10319; Sue W, 2006, AM J CLIN NUTR, V83, p470S; Tejada S, 2006, BRAIN RES BULL, V69, P587, DOI 10.1016/j.brainresbull.2006.03.002; Van Horn JD, 2017, TRENDS NEUROSCI, V40, P39, DOI 10.1016/j.tins.2016.10.007; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; WILLMORE LJ, 1978, SCIENCE, V200, P1501, DOI 10.1126/science.96527; Willmore LJ, 1998, NEUROLOGY, V51, pS34, DOI 10.1212/WNL.51.5_Suppl_4.S34; WILLMORE LJ, 1978, ANN NEUROL, V4, P329, DOI 10.1002/ana.410040408; ZEISEL SH, 1985, BIOCHIM BIOPHYS ACTA, V835, P331, DOI 10.1016/0005-2760(85)90289-9; Zhang J, 2015, PROTEIN CELL, V6, P254, DOI 10.1007/s13238-014-0131-3	56	8	8	0	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-4851	1573-4978		MOL BIOL REP	Mol. Biol. Rep.	APR	2019	46	2					1757	1773		10.1007/s11033-019-04626-9			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6QP	WOS:000463996700024	30706359				2022-02-06	
J	Whitney, SL; Sparto, PJ				Whitney, Susan L.; Sparto, Patrick J.			Eye Movements, Dizziness, and Mild Traumatic Brain Injury (mTBI): A Topical Review of Emerging Evidence and Screening Measures	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article; Proceedings Paper	Inaugural International Conference on Vestibular Rehabilitation (ICVR)	AUG 17-20, 2018	Chicago, IL			concussion; eye movement; mild head injury; vestibular rehabilitation	PAROXYSMAL POSITIONAL VERTIGO; SPORTS-RELATED CONCUSSION; SYMPTOMATIC CONVERGENCE INSUFFICIENCY; VESTIBULAR REHABILITATION; RISK-FACTORS; RECOVERY; RELIABILITY; PREDICTORS; DYSFUNCTION; VALIDITY	Background and Purpose: Eye movements may be adversely affected after mild traumatic brain injury (mTBI) and should be examined. The purpose of this topical review is to provide the clinician with the most up-to-date knowledge related to eye movement abnormalities, screening measures, and evidence related to exercise interventions that are designed to enhance outcomes in persons after mTBI. Summary of Key Points: Presence of eye misalignment such as tropias or phoria or symptoms with head/eye movements such as vestibulo-ocular reflex (VOR) x 1, saccades, or smooth pursuits may slow the person's recovery. Tools such as the Convergence Insufficiency Symptom Survey, the Vestibular/Ocular Motor Screening, the Pediatric Vestibular Symptom Questionnaire, and the Pediatric Visually Induced Dizziness questionnaire may aid in identifying visual concerns to target in the physical therapy intervention program. There is emerging evidence that vestibular rehabilitation enhances recovery in persons after mTBI. Recommendations for Clinical Practice: A thorough eye examination is highly recommended after mTBI to identify targeted areas for intervention.	[Whitney, Susan L.; Sparto, Patrick J.] Univ Pittsburgh, 100 Technol Dr, Pittsburgh, PA 15219 USA		Whitney, SL (corresponding author), Univ Pittsburgh, 100 Technol Dr, Pittsburgh, PA 15219 USA.	Whitney@pitt.edu					Ahn SK, 2011, J TRAUMA, V70, P442, DOI 10.1097/TA.0b013e3181d0c3d9; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, pS1, DOI 10.1177/0194599816689667; Brodsky JR, 2018, OTOL NEUROTOL, V39, P344, DOI 10.1097/MAO.0000000000001673; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Capo-Aponte JE, 2018, MIL MED, V183, P9, DOI 10.1093/milmed/usx166; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Carrick FR, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00414; Chan C, 2018, ARCH PHYS MED REHAB, V99, P242, DOI 10.1016/j.apmr.2017.09.108; Chorney SR, 2017, LARYNGOSCOPE, V127, P2850, DOI 10.1002/lary.26564; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Doble JE, 2010, PM&R, V2, P244, DOI 10.1016/j.pmrj.2010.01.011; Dobney DM, 2017, BRAIN INJURY, V31, P1753, DOI 10.1080/02699052.2017.1346294; Dobney DM, 2017, DISABIL REHABIL, P1; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gordon CR, 2004, ARCH NEUROL-CHICAGO, V61, P1590, DOI 10.1001/archneur.61.10.1590; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Hoffer ME, 2017, LARYNGOSCOPE INVEST, V2, P157, DOI 10.1002/lio2.74; Howell DR, 2020, CLIN J SPORT MED, V30, P444, DOI 10.1097/JSM.0000000000000630; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jang Jung Un, 2017, J Ophthalmic Vis Res, V12, P187, DOI 10.4103/jovr.jovr_249_15; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Klatt BN, 2015, PHYS MED REHABIL INT, V2, P4; Kleffelgaard I, 2019, CLIN REHABIL, V33, P74, DOI 10.1177/0269215518791274; Kleffelgaard I, 2016, PHYS THER, V96, P839, DOI 10.2522/ptj.20150095; Kontos AP, 2018, MIL MED, V183, P333, DOI 10.1093/milmed/usx172; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Liu HJ, 2012, ACTA OTO-LARYNGOL, V132, P803, DOI 10.3109/00016489.2012.657359; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Maruta J, 2017, MIL MED, V182, P120, DOI 10.7205/MILMED-D-16-00093; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Matuseviciene G, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018734; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Moran RN, 2018, SCAND J MED SCI SPOR, V28, P2686, DOI 10.1111/sms.13286; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Pavlou M, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00656; Pavlou M, 2016, J PEDIATR-US, V168, P171, DOI 10.1016/j.jpeds.2015.09.075; Pavlou M, 2015, J NEUROL PHYS THER, V39, P215, DOI 10.1097/NPT.0000000000000105; Prangley A, 2017, GAIT POSTURE, V58, P229, DOI 10.1016/j.gaitpost.2017.08.006; Reneker JC, 2018, MUSCULOSKEL SCI PRAC, V34, P8, DOI 10.1016/j.msksp.2017.11.012; Rogers DL, 2011, J AAPOS, V15, P511, DOI 10.1016/j.jaapos.2011.07.005; Rosner MS, 2016, BRAIN INJURY, V30, P311, DOI 10.3109/02699052.2015.1113564; Rouse M, 2009, OPTOMETRY VISION SCI, V86, P357, DOI 10.1097/OPX.0b013e3181989252; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Russell-Giller S, 2018, SPORTS HEALTH, V10, P334, DOI 10.1177/1941738118765450; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schneider KJ, 2018, J ORTHOP SPORT PHYS, V12, P1; Serna A, 2011, J AAPOS, V15, P140, DOI 10.1016/j.jaapos.2010.11.023; Storey EP, 2018, J NEUROL PHYS THER, V42, P134, DOI 10.1097/NPT.0000000000000228; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Tannen B, 2019, J OPTOM, V12, P64, DOI 10.1016/j.optom.2018.02.003; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750; Yang Y, 2017, J HEAD TRAUMA REHAB, V32, P168, DOI 10.1097/HTR.0000000000000257; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	78	8	8	3	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	APR	2019	43			2	SI		S31	S36		10.1097/NPT.0000000000000272			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Rehabilitation	HX9FW	WOS:000467713400007	30883491	Bronze			2022-02-06	
J	Wyss, T; Roos, L; Studer, F; Mader, U; Beuchat, C; Staub, K				Wyss, Thomas; Roos, Lilian; Studer, Fabian; Maeder, Urs; Beuchat, Christiane; Staub, Kaspar			Development of physical fitness performance in young Swiss men from 2006 to 2015	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						fitness; fitness development; physical activity behavior; physical fitness; population health	BODY-MASS INDEX; SECULAR TRENDS; CHILDREN; OBESITY; ADOLESCENTS; OVERWEIGHT; INJURIES; ARMY	From 1980 to 2000, physical fitness decreased and body mass index (BMI) increased in the population of many industrialized countries. Little is known about these trends after the year 2000. This study aimed to investigate physical fitness performance, physical activity (PA) behavior, and BMI of young, male Swiss adults between 2006 and 2015. For this purpose, results from the Swiss Armed Forces mandatory recruitment were used. A total of 306 746 male conscripts provided complete fitness test data, mean +/- SD (range from 5th to 95th percentile): 20 +/- 1 (18-21) years, 178 +/- 7 (168-189) cm; 74 +/- 13 (58-97) kg, predicted maximal oxygen consumption of 49.9 +/- 4.6 (41.8-56.9) mL/kg/min (Conconi test), 125 +/- 58 (43-232) seconds in trunk muscle strength test (prone bridge), 2.31 +/- 0.24 (1.90-2.66) m in standing long jump, 6.46 +/- 0.73 (5.30-7.70) m in seated shot put (2 kg medical-ball shot) and 45.6 +/- 12.2 (29.9-66.7) seconds in one-leg standing test (sum of both legs; eyes closed after 10 seconds and head tilted back after 20 seconds). In the investigated population, 73.8% fulfilled basic PA recommendations, 46.2% were classified as regularly vigorously active. Performances in aerobic endurance and muscle power did not show secular changes over time. However, core stability performance and PA behavior increased, while balance ability decreased over this 10-year period. Average BMI increased by 2.0% between 2006 and 2010 and did not change thereafter. Male Swiss adults are at least as physically fit as they were a decade ago. The secular trends of decreasing physical performances and increasing BMI have stopped, and self-reported sport participation and leisure time PA have been increased in the observed population over the last 10 years.	[Wyss, Thomas; Roos, Lilian; Studer, Fabian; Maeder, Urs; Beuchat, Christiane] SFISM, Magglingen, Switzerland; [Staub, Kaspar] Univ Zurich, IEM, Zurich, Switzerland		Wyss, T (corresponding author), SFISM, Magglingen, Switzerland.	Thomas.wyss@baspo.admin.ch		Staub, Kaspar/0000-0002-3951-1807			Bialoskorska M., 2016, SCI REV PHYS CULTURE, V6, P56; Borodulin K, 2016, SCAND J MED SCI SPOR, V26, P93, DOI 10.1111/sms.12401; Bourban P., 2001, SCHWEIZ Z SPORTMED S, V49, P73; Catley MJ, 2013, BRIT J SPORT MED, V47, P98, DOI 10.1136/bjsports-2011-090218; CONCONI F, 1982, J APPL PHYSIOL, V52, P869, DOI 10.1152/jappl.1982.52.4.869; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Dossegger A, 2017, EVALUATION, V16, P24; Dyrstad SM, 2016, SCAND J MED SCI SPOR, V26, P291, DOI 10.1111/sms.12425; Federal Office of Sport FOSPO  Federal Office of Public Health FOPH  Health Promotion Switzerland  bfu-Swiss Council for Accident Prevention  Swiss Accident Insurance Fund (Suva)  Health and Physical Activity Network Switzerland, 2013, HLTH PROM SWITZ BFU; Fischer, 2014, SPORT SCHWEIZ 2014 S; Jurimae Toivo, 2007, Med Sport Sci, V50, P129, DOI 10.1159/000101356; Lamprecht M, 2015, SERIES; Mader U, 2006, MED SCI SPORT EXER, V38, P1255, DOI 10.1249/01.mss.0000227310.18902.28; Martin Diener E, 2013, HEALTHEN HANCING PHY, P32; Matton L, 2007, AM J HUM BIOL, V19, P345, DOI 10.1002/ajhb.20592; MIYAMURA M, 1972, J APPL PHYSIOL, V32, P185, DOI 10.1152/jappl.1972.32.2.185; Nikolaidis PT, 2015, MLTJ-MUSCLE LIGAMENT, V5, P187, DOI 10.11138/mltj/2015.5.3.187; Panczak R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096721; Rasmussen F, 1999, ACTA PAEDIATR, V88, P431, DOI 10.1080/08035259950169837; Santtila M, 2006, MED SCI SPORT EXER, V38, P1990, DOI 10.1249/01.mss.0000232023.28984.78; Santtila M, 2018, MED SCI SPORT EXER, V50, P292, DOI 10.1249/MSS.0000000000001436; Sharp MA, 2002, MED SCI SPORT EXER, V34, P356, DOI 10.1097/00005768-200202000-00026; Sorensen HT, 1997, INT J OBESITY, V21, P712, DOI 10.1038/sj.ijo.0800461; Staub K, 2015, PRAXIS, V104, P8; Staub K, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018664; Staub K, 2016, OBESITY FACTS, V9, P259, DOI 10.1159/000446966; Stratton G, 2007, INT J OBESITY, V31, P1172, DOI 10.1038/sj.ijo.0803562; Swiss Federal Statistical Office, 2018, NOM; Tian Y, 2016, LANCET DIABETES ENDO, V4, P487, DOI 10.1016/S2213-8587(16)00081-4; Tomkinson GR, 2007, INT J SPORTS MED, V28, P314, DOI 10.1055/s-2006-924357; Tomkinson GR, 2018, BRIT J SPORT MED, V52, P1445, DOI 10.1136/bjsports-2017-098253; Tschopp M., 2001, SWISS J SPORTS MED S, V49, P67; Wunderlin S, 2015, J SPORT MED PHYS FIT, V55, P535; Wyss T, 2012, J SPORT MED PHYS FIT, V52, P513; Wyss T, 2012, ECSS 17 ANN C EUR CO; Wyss T., 2007, SWISS J SPORTS MED S, V55, P126; Wyss T, 2009, SWISS J SPORTS MED S, V57, P75	38	8	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	APR	2019	29	4					586	596		10.1111/sms.13376			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HO5NR	WOS:000460975000010	30586205	hybrid, Green Published			2022-02-06	
J	Yalcin, N; Chen, SP; Yu, ES; Liu, TT; Yen, JC; Atalay, YB; Qin, T; Celik, F; van den Maagdenberg, AMJM; Moskowitz, MA; Ayata, C; Eikermann-Haerter, K				Yalcin, Nilufer; Chen, Shih-Pin; Yu, Esther S.; Liu, Tzu-Ting; Yen, Jiin-Cherng; Atalay, Yahya B.; Qin, Tao; Celik, Furkan; van den Maagdenberg, Arn M. J. M.; Moskowitz, Michael A.; Ayata, Cenk; Eikermann-Haerter, Katharina			Caffeine does not affect susceptibility to cortical spreading depolarization in mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Caffeine; cortical spreading depolarization; migraine; withdrawal; headache	TRAUMATIC BRAIN-INJURY; DOUBLE-BLIND; ADENOSINE; DEPRESSION; MIGRAINE; HEADACHE; TRIGGERS; INHIBITION; ACTIVATION; EXPRESSION	Several factors that modulate migraine, a common primary headache disorder, also affect susceptibility to cortical spreading depolarization (CSD). CSD is a wave of neuronal and glial depolarization and thought to underlie the migraine aura and possibly headache. Here, we tested whether caffeine, known to alleviate or trigger headache after acute exposure or chronic use/withdrawal, respectively, modulates CSD. We injected C57BL/6J mice with caffeine (30, 60, or 120 mg/kg; i.p.) once (acute) or twice per day for one or two weeks (chronic). Susceptibility to CSD was evaluated by measuring the electrical CSD threshold and by assessing KCl-induced CSD. Simultaneous laser Doppler flowmetry was used to assess CSD-induced cortical blood flow changes. Recordings were performed 15 min after caffeine/vehicle administration, or 24 h after the last dose of chronic caffeine in the withdrawal group. The latter paradigm was also tested in mice carrying the familial hemiplegic migraine type 1 R192Q missense mutation, considered a valid migraine model. Neither acute/chronic administration nor withdrawal of caffeine affected CSD susceptibility or related cortical blood flow changes, either in WT or R192Q mice. Hence, adverse or beneficial effects of caffeine on headache seem unrelated to CSD pathophysiology, consistent with the non-migrainous clinical presentation of caffeine-related headache.	[Yalcin, Nilufer; Yu, Esther S.; Atalay, Yahya B.; Qin, Tao; Celik, Furkan; Moskowitz, Michael A.; Ayata, Cenk; Eikermann-Haerter, Katharina] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Neurovasc Res Lab, Charlestown, MA USA; [Chen, Shih-Pin] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Chen, Shih-Pin] Taipei Vet Gen Hosp, Dept Med Res, Div Translat Res, Taipei, Taiwan; [Chen, Shih-Pin] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Liu, Tzu-Ting; Yen, Jiin-Cherng] Natl Yang Ming Univ, Inst Pharmacol, Taipei, Taiwan; [van den Maagdenberg, Arn M. J. M.] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands; [van den Maagdenberg, Arn M. J. M.] Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands; [Ayata, Cenk] Harvard Med Sch, Dept Neurol, Stroke Serv, Boston, MA 02114 USA; [Ayata, Cenk] Massachusetts Gen Hosp, Neurosci Intens Care Unit, Boston, MA 02114 USA		Eikermann-Haerter, K (corresponding author), Massachusetts Gen Hosp, Dept Radiol, 55 Fruit St, Boston, MA 02114 USA.; Eikermann-Haerter, K (corresponding author), Harvard Med Sch, 55 Fruit St, Boston, MA 02114 USA.	khaerter@mgh.harvard.edu	Atalay, Yahya/AAW-7681-2021; van den Maagdenberg, Arn M.J.M./AAE-9052-2019		American Heart AssociationAmerican Heart Association [10SDG2610275]; Massachusetts General HospitalGeneral Electric; Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [MOST 104-2314-B-075 -006 - MY3]; Taipei Veterans General HospitalTaipei Veterans General Hospital [V104C-174]; Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program [102-V-A-001, 104-V-B-035]; Vivian W. Yen Neurological Foundation; Center for Medical Systems Biology (CMSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [050060-409]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the American Heart Association (10SDG2610275 to K.E.H.); the Massachusetts General Hospital (Claflin Distinguished Award to K.E.H.); the Ministry of Science and Technology of Taiwan (MOST 104-2314-B-075 -006 - MY3 to S.P.C), Taipei Veterans General Hospital (V104C-174 to S.P.C), Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program (No. 102-V-A-001 and No. 104-V-B-035 to S.P.C.); and the Vivian W. Yen Neurological Foundation (2013 research grant to S.P.C.) and by the Center for Medical Systems Biology (CMSB) established by the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (project No. 050060-409, A.M.J.M.v.d.M.).	Arendash GW, 2009, J ALZHEIMERS DIS, V17, P661, DOI 10.3233/JAD-2009-1087; Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Bauer A, 2003, NEUROIMAGE, V19, P1760, DOI 10.1016/S1053-8119(03)00241-6; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Burstein R, 2005, J COMP NEUROL, V493, P9, DOI 10.1002/cne.20688; Carruthers AM, 2001, MOL PHARMACOL, V59, P1533, DOI 10.1124/mol.59.6.1533; Chen SP, 2017, BRAIN, V140, P1643, DOI 10.1093/brain/awx085; Chen YF, 2009, NEUROIMAGE, V46, P577, DOI 10.1016/j.neuroimage.2009.03.012; Conlay LA, 1997, NATURE, V389, P136, DOI 10.1038/38160; Deboer T, 2013, SLEEP, V36, P127, DOI 10.5665/sleep.2316; Diener HC, 2005, CEPHALALGIA, V25, P776, DOI 10.1111/j.1468-2982.2005.00948.x; Diukova A, 2012, NEUROIMAGE, V62, P239, DOI 10.1016/j.neuroimage.2012.04.041; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; DURZO AD, 1990, J APPL PHYSIOL, V68, P322, DOI 10.1152/jappl.1990.68.1.322; Eikermann-Haerter K, 2009, ANN NEUROL, V66, P564, DOI 10.1002/ana.21779; Eikermann-Haerter K, 2009, J CLIN INVEST, V119, P99, DOI 10.1172/JCI36059; FRANK GB, 1970, BRIT J PHARMACOL, V39, P716, DOI 10.1111/j.1476-5381.1970.tb09897.x; Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027; Germe K, 2015, EPILEPSY RES, V110, P105, DOI 10.1016/j.eplepsyres.2014.11.022; Gilbert R M, 1984, Prog Clin Biol Res, V158, P185; GRIFFITHS RR, 1990, J PHARMACOL EXP THER, V255, P1123; Guieu R, 1998, CAN J NEUROL SCI, V25, P55, DOI 10.1017/S0317167100033497; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hagen K, 2009, J HEADACHE PAIN, V10, P153, DOI 10.1007/s10194-009-0114-6; HARTMANN M, 1980, Z ERNAHRUNGSWISS, V19, P215, DOI 10.1007/BF02018787; Hering-Hanit R, 2003, CEPHALALGIA, V23, P332, DOI 10.1046/j.1468-2982.2003.00576.x; Hohoff C, 2007, CEPHALALGIA, V27, P177, DOI 10.1111/j.1468-2982.2007.01254.x; KAKU T, 1994, BRAIN RES, V658, P39, DOI 10.1016/S0006-8993(09)90008-7; KAPLAN GB, 1990, BRIT J PHARMACOL, V100, P435, DOI 10.1111/j.1476-5381.1990.tb15824.x; KAPLAN GB, 1989, J PHARMACOL EXP THER, V248, P1078; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; KRNJEVIC K, 1966, J PHYSIOL-LONDON, V184, P78, DOI 10.1113/jphysiol.1966.sp007904; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Lindquist BE, 2012, NEUROSCIENCE, V223, P365, DOI 10.1016/j.neuroscience.2012.07.053; Lindquist BE, 2017, J CEREBR BLOOD F MET, V37, P1656, DOI 10.1177/0271678X16650696; MOSKOWITZ MA, 1993, J NEUROSCI, V13, P1167, DOI 10.1523/jneurosci.13-03-01167.1993; NIKODIJEVIC O, 1993, PHARMACOL BIOCHEM BE, V44, P199, DOI 10.1016/0091-3057(93)90299-9; Sachse KT, 2008, J CEREBR BLOOD F MET, V28, P395, DOI 10.1038/sj.jcbfm.9600539; Scher AI, 2004, NEUROLOGY, V63, P2022, DOI 10.1212/01.WNL.0000145760.37852.ED; SILVERMAN K, 1992, NEW ENGL J MED, V327, P1109, DOI 10.1056/NEJM199210153271601; Sjaastad O, 2004, CEPHALALGIA, V24, P241, DOI 10.1111/j.1468-2982.2003.00638.x; Tchekalarova JD, 2013, PHARMACOL REP, V65, P847, DOI 10.1016/S1734-1140(13)71065-X; Traversa Ugo, 1994, In Vivo (Attiki), V8, P1073; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; Volkow ND, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.46; WARD N, 1991, PAIN, V44, P151, DOI 10.1016/0304-3959(91)90129-L	48	8	8	1	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	APR	2019	39	4			SI		740	750		10.1177/0271678X18768955			11	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	HR3JI	WOS:000463032400013	29651899	Green Published, Bronze			2022-02-06	
J	Zhao, JL; Du, ZY; Yuan, Q; Yu, J; Sun, YR; Wu, X; Li, ZQ; Wu, XH; Hu, J				Zhao, Jian-Lan; Du, Zhuo-Ying; Yuan, Qiang; Yu, Jian; Sun, Yi-Rui; Wu, Xing; Li, Zhi-Qi; Wu, Xue-Hai; Hu, Jin			Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Predicting the 6-Month Outcome of Patients with Traumatic Brain Injury: A Retrospective Study	WORLD NEUROSURGERY			English	Article						6-Month outcome; Neutrophil-to-lymphocyte ratio; Prediction model; Traumatic brain injury	INFLAMMATION; MECHANISMS	BACKGROUND: Peripheral white blood cells are regularly analyzed on admission for patients with traumatic brain injury (TBI). The prognostic value of the neutrophil-to-lymphocyte ratio (NLR) in predicting the 6-month outcome of patients with TBI is unclear. METHODS: We designed a single-center retrospective cohort study. Patients admitted to Fudan University Huashan Hospital within 6 hours after TBI were identified between December 2004 and December 2017. The primary outcome was 6-month Glasgow Outcome Scale score. Independent predictors of 6-month outcome were assessed using uni- and multivariate analyses. Three models based on admission characteristics were built to evaluate the prognostic value of the NLR in predicting the outcome of patients with TBI. The discriminative ability of predictive models was evaluated by the area under the curve (AUC). RESULTS: A total of 1291 patients with TBI were included. Multivariate analysis showed age, Glasgow Coma Scale scores at admission, subdural hematoma, intraparenchymal hemorrhage, traumatic subarachnoid hemorrhage, NLR (P < 0.001), and coagulopathy (P = 0.028) were independent predictors of 6-month outcome. The model combining the NLR and standard variables (AUC = 0.936; 95% confidence interval [CI], 0.923-0.949) was more favorable in predicting 6-month outcome of patients with TBI than the model without the NLR (AUC = 0.901; 95% CI, 0.883-0.919) and the model based only on the NLR (AUC = 0.827; 95% CI, 0.802-0.852). CONCLUSIONS: NLR is an independent prognostic factor of predicting 6-month outcome of patients with TBI. A high NLR in patients with TBI is associated with poor outcome. The prognostic value of the NLR in predicting 6-month outcome of patients with TBI is favorable.	[Zhao, Jian-Lan; Du, Zhuo-Ying; Yuan, Qiang; Yu, Jian; Sun, Yi-Rui; Wu, Xing; Li, Zhi-Qi; Wu, Xue-Hai; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Yu, Jian] Shigatse Peoples Hosp, Dept Neurosurg, Shigatse, Tibet Autonomou, Peoples R China; [Sun, Yi-Rui] Fudan Univ, Zhongshan Hosp, Minhang Branch, Dept Neurosurg, Shanghai, Peoples R China		Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China.	286644104@qq.com		Zhao, Jian-Lan/0000-0001-6178-2470	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471241, 81271375, 81701206, 81671200, 81171133]; Shanghai Municipal Science and Technology Commission project [16411955300, 18441903300, 18695841300]; Shanghai Municipal Commission of Health and Family Planning project [201840063, 201801075]; Major and Develop Project of Chinese Ministry of Science and Technology [2017ZX09304005]; Public Medical Artificial Intelligence Training Platform [XX-RGZN-01-17-4684]; Shanghai Minhang Natural Science Foundation [2014MHZ001]	This work was supported by the National Natural Science Foundation of China (81471241, 81271375, 81701206, 81671200, and 81171133), Shanghai Municipal Science and Technology Commission project (16411955300, 18441903300, and 18695841300), Shanghai Municipal Commission of Health and Family Planning project (201840063 and 201801075), The Major and Develop Project of Chinese Ministry of Science and Technology (2017ZX09304005), the Public Medical Artificial Intelligence Training Platform (XX-RGZN-01-17-4684), and Shanghai Minhang Natural Science Foundation (2014MHZ001).	Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen WQ, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000320; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dewall Jeremy, 2010, JEMS, V35, P54, DOI 10.1016/S0197-2510(10)70095-4; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lattanzi S, 2016, STROKE, V47, P1654, DOI 10.1161/STROKEAHA.116.013627; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sun YM, 2017, AM J EMERG MED, V35, P429, DOI 10.1016/j.ajem.2016.11.037; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Wang F, 2018, NEUROTOX RES, V34, P347, DOI 10.1007/s12640-018-9890-6; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; West KL, 2011, J NEUROSURG, V114, P9, DOI 10.3171/2010.7.JNS091857; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0	28	8	8	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2019	124						E411	E416		10.1016/j.wneu.2018.12.107			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HR4BE	WOS:000463087800053	30610986				2022-02-06	
J	Purkayastha, S; Sorond, FA; Lyng, S; Frantz, J; Murphy, MN; Hynan, LS; Sabo, T; Bell, KR				Purkayastha, Sushmita; Sorond, Farzaneh A.; Lyng, Sydney; Frantz, Justin; Murphy, Megan N.; Hynan, Linda S.; Sabo, Tonia; Bell, Kathleen R.			Impaired Cerebral Vasoreactivity Despite Symptom Resolution in Sports-Related Concussion	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; cerebral reactivity; headache; return-to-play; traumatic brain injury	TRAUMATIC BRAIN-INJURY; BLOOD-FLOW; CEREBROVASCULAR REACTIVITY; CO2 REACTIVITY; NITRIC-OXIDE; RECOVERY; EXERCISE; ASSOCIATION; HEADACHE	Traumatic brain injury (TBI) is associated with increased risk of later-life neurodegeneration and dementia. However, the underpinning mechanisms are poorly understood, and secondary injury resulting from perturbed physiological processes plays a significant role. Cerebral vasoreactivity (CVR), a measure of hemodynamic reserve, is known to be impaired in TBI. However, the temporal course of this physiological perturbation is not established. We examined CVR and clinical symptoms on day 3 (T1), day 21 (T2), and day 90 (T3) after concussion in collegiate athletes and cross-sectionally in non-injured controls. Changes in middle cerebral artery blood flow velocity (MCAV; transcranial Doppler ultrasonography) were measured during changes in end-tidal CO2 (PetCO(2)) at normocapnia, hypercapnia (inspiring 8% CO2), and hypocapnia (hyperventilation). CVR was determined as the slope of the linear relationship and expressed as percent change in MCAV per mmHg change in PetCO(2). CVR was attenuated during the acute phase T1 (1.8 +/- 0.4U; p = 0.0001), subacute phases T2 (2.0 +/- 0.4U; p = 0.0017), and T3 (1.9 +/- 0.6U; p = 0.023) post-concussion compared to the controls (2.3 +/- 0.3U). Concussed athletes exhibited higher symptom number (2.5 +/- 3.0 vs. 12.1 +/- 7.0; p < 0.0001) and severity (4.2 +/- 6.0 vs. 29.5 +/- 23.0; p < 0.0001), higher Patient Health Questionnaire-9 score (2.2 +/- 2.0 vs. 9.1 +/- 6.0; p = 0.0003) at T1. However, by T2, symptoms had resolved. We show that CVR is impaired as early as 4 days and remains impaired up to 3 months post-injury despite symptom resolution. Persistent perturbations in CVR may therefore be involved in secondary injury. Future studies with a larger sample size and longer follow-up period are needed to validate this finding and delineate the duration of this vulnerable period.	[Purkayastha, Sushmita; Lyng, Sydney; Frantz, Justin; Murphy, Megan N.] Southern Methodist Univ, Dept Appl Physiol & Wellness, Simmons Sch Educ & Human Dev, 3101 Univ Blvd,Room 118A, Dallas, TX 75205 USA; [Sorond, Farzaneh A.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Hynan, Linda S.] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci & Psychiat, Dallas, TX 75390 USA; [Sabo, Tonia] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Div Pediat Neurol & Pain Management, Dallas, TX USA; [Purkayastha, Sushmita; Bell, Kathleen R.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA		Purkayastha, S (corresponding author), Southern Methodist Univ, Dept Appl Physiol & Wellness, Simmons Sch Educ & Human Dev, 3101 Univ Blvd,Room 118A, Dallas, TX 75205 USA.	spurkayastha@smu.edu	Purkaysastha, Sushmita/Y-8908-2019	Bell, Kathleen/0000-0002-0928-2046; Sabo, Tonia/0000-0002-7293-4764	University Research Council Grant, at SMU, Dallas, Texas; Texas Institute for Brain Injury & Repair at University of Texas Southwestern Medical Center, Dallas, Texas; Northwestern University [R01NS085002]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS085002] Funding Source: NIH RePORTER	This study was supported by funds from the University Research Council Grant, at SMU, Dallas, Texas (to S.P.), Pilot Grant 2016 from the Texas Institute for Brain Injury & Repair at University of Texas Southwestern Medical Center, Dallas, Texas (to K.R.B., S.P., and T.S.), and Northwestern University R01NS085002 (to F.A.S.).	Ainslie PN, 2009, AM J PHYSIOL-REG I, V296, pR1473, DOI 10.1152/ajpregu.91008.2008; Albalawi T, 2017, J NEUROTRAUM, V34, P2700, DOI 10.1089/neu.2017.5060; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fierstra J, 2013, J PHYSIOL-LONDON, V591, P5809, DOI 10.1113/jphysiol.2013.259150; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; JORGENSEN LG, 1992, J APPL PHYSIOL, V73, P1825, DOI 10.1152/jappl.1992.73.5.1825; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lavi S, 2003, CIRCULATION, V107, P1901, DOI 10.1161/01.CIR.0000057973.99140.5A; Lavi S, 2006, AM J PHYSIOL-HEART C, V291, pH1856, DOI 10.1152/ajpheart.00014.2006; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Mutch WAC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00107; NCAA Sport Science Institute, 2016, DIAGN MAN SPORT REL; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Purkayastha S, 2012, SEMIN NEUROL, V32, P411, DOI 10.1055/s-0032-1331812; Seifert TD, 2013, HEADACHE, V53, P726, DOI 10.1111/head.12087; Seifert T, 2011, PROG NEUROBIOL, V95, P406, DOI 10.1016/j.pneurobio.2011.09.008; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547; Wallasch TM, 2011, FUNCT NEUROL, V26, P223; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang PZ, 2011, J APPL PHYSIOL, V110, P352, DOI 10.1152/japplphysiol.00802.2010	34	8	8	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2019	36	16					2385	2390		10.1089/neu.2018.5861		MAR 2019	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IN3NH	WOS:000462760700001	30693827	Green Published			2022-02-06	
J	Sandsmark, DK; Bogoslovsky, T; Qu, BX; Haber, M; Cota, MR; Davis, C; Butman, JA; Latour, LL; Diaz-Arrastia, R				Sandsmark, Danielle K.; Bogoslovsky, Tanya; Qu, Bao-Xi; Haber, Margalit; Cota, Martin R.; Davis, Cora; Butman, John A.; Latour, Lawrence L.; Diaz-Arrastia, Ramon			Changes in Plasma von Willebrand Factor and Cellular Fibronectin in MRI-Defined Traumatic Microvascular Injury	FRONTIERS IN NEUROLOGY			English	Article						TBI; vascular; MRI; biomarkers; trauma	DIFFUSE AXONAL INJURY; BRAIN-INJURY; OUTCOME PREDICTION; THROMBOLYTIC THERAPY; HEAD-INJURY; NF-H; LESIONS; SERUM; BIOMARKERS; CHILDREN	The neuropathology of traumatic brain injury (TB) is diverse, including primary injury to neurons, axons, glial cells, vascular structures, and secondary processes, such as edema and inflammation that vary between individual patients. Traumatic microvascular injury is an important endophenotype of TBI-related injury. We studied patients who sustained a TBI requiring ER evaluation and had an MRI performed within 48 h of injury. We classified patients into 3 groups based on their MRI findings: (1) those that had evidence of traumatic microvascular injury on susceptibility or diffusion weighted MRI sequences without frank hemorrhage [Traumatic Vascular Injury (TVI) group; 20 subjects]. (2) those who had evidence of intraparenchymal, subdural, epidural, or subarachnoid hemorrhage [Traumatic Hemorrhage (TH) group; 26 subjects], and (3) those who had no traumatic injuries detected by MRI [MRI-negative group; 30 subjects]. We then measured plasma protein biomarkers of vascular injury [von Willebrand Factor (vWF) or cellular fibronectin (cFn)] and axonal injury (phosphorylated neurofilament heavy chain; pNF-H). We found that the TVI group was characterized by decreased expression of plasma vWF (p < 0.05 compared to MRI-negative group; p < 0.00001 compared to TH group) <= 48 h after injury. cFN was no different between groups <= 48 h after injury, but was increased in the TVI group compared to the MRI-negative (p < 0.00001) and TH (p < 0.00001) groups when measured <= 48 h from injury. pNF-H was increased in both the TH and TVI groups compared to the MRI-negative group <= 48 h from injury. When we used the MRI grouping and molecular biomarkers in a model to predict Glasgow Outcome Scale-Extended (GOS-E) score at 30-90 days, we found that inclusion of the imaging data and biomarkers substantially improved the ability to predict a good outcome over clinical information alone. These data indicate that there is a distinct, vascular-predominant endophenotype in a subset of patients who sustain a TBI and that these injuries are characterized by a specific biomarker profile. Further work to will be needed to determine whether these biomarkers can be useful as predictive and pharmacodynamic biomarkers for vascular-directed therapies after TBI.	[Sandsmark, Danielle K.; Haber, Margalit; Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Bogoslovsky, Tanya] Univ Turku, Turku Univ Hosp, Div Clin Neurosci, Turku, Finland; [Qu, Bao-Xi; Cota, Martin R.; Butman, John A.; Latour, Lawrence L.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Cota, Martin R.; Latour, Lawrence L.] NINDS, Acute Cerebrovasc Diagnost Unit, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Davis, Cora] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Butman, John A.] Natl Inst Hlth Radiol & Imaging Sci, Bethesda, MD USA		Sandsmark, DK (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	danielle.sandsmark@uphs.upenn.edu	Latour, Larry/AAH-5663-2021; Butman, John/J-2780-2013; Butman, John A/A-2694-2008	Latour, Larry/0000-0001-6160-5263; Butman, John/0000-0002-1547-9195; 	Intramural Research Program at NINDS; Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; National Institute of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS104239]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003120, K23NS104239] Funding Source: NIH RePORTER	This research was funded by the Intramural Research Program at NINDS and the Department of Defense in the Center for Neuroscience and Regenerative Medicine. DS is supported by the National Institute of Health/National Institute of Neurological Disorders and Stroke (K23 NS104239).	Amyot F, 2018, J NEUROTRAUM, V35, P1116, DOI 10.1089/neu.2017.5114; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Bruce ED, 2015, MOL CELL NEUROSCI, V66, P103, DOI 10.1016/j.mcn.2015.03.017; Castellanos M, 2004, STROKE, V35, P1671, DOI 10.1161/01.STR.0000131656.47979.39; Castellanos M, 2007, STROKE, V38, P1855, DOI 10.1161/STROKEAHA.106.481556; Copin JC, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-83; De Oliveira CO, 2007, J NEUROTRAUM, V24, P1331, DOI 10.1089/neu.2006.0159; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Haber M, 2018, J NEUROTRAUM, V35, P2250, DOI 10.1089/neu.2018.5684; Haghbayan H, 2017, CRIT CARE MED, V45, pe1280, DOI 10.1097/CCM.0000000000002731; Haqqani AS, 2007, J NEUROTRAUM, V24, P54, DOI 10.1089/neu.2006.0079; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Horvath Beata, 2004, Exp Clin Cardiol, V9, P31; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Izzy S, 2017, NEUROCRIT CARE, V27, P199, DOI 10.1007/s12028-017-0399-2; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kanaji S, 2012, J THROMB HAEMOST, V10, P1646, DOI 10.1111/j.1538-7836.2012.04797.x; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kraft P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099851; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Ricciardi MC, 2017, J NEUROTRAUM, V34, P23, DOI 10.1089/neu.2015.4338; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Rutten B, 2015, EUR HEART J-ACUTE CA, V4, P64, DOI 10.1177/2048872614534388; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; Yokota H, 2002, J NEUROTRAUM, V19, P1007, DOI 10.1089/089771502760341929; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zurek J, 2011, BRAIN INJURY, V25, P221, DOI 10.3109/02699052.2010.541895	48	8	9	2	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 26	2019	10								246	10.3389/fneur.2019.00246			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ6SV	WOS:000462549200001	30972003	Green Published, gold			2022-02-06	
J	Tomita, K; Nakada, T; Oshima, T; Motoshima, T; Kawaguchi, R; Oda, S				Tomita, Keisuke; Nakada, Taka-aki; Oshima, Taku; Motoshima, Takayuki; Kawaguchi, Rui; Oda, Shigeto			Tau protein as a diagnostic marker for diffuse axonal injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; HEAD-INJURY; MAGNETIC-RESONANCE; SERUM; CLASSIFICATION; DAMAGE; ANESTHETIST; BIOMARKERS; S100B	Background Diffuse axonal injury (DAI) is difficult to identify in the early phase of traumatic brain injury (TBI) using common diagnostic methods. Tau protein is localized specifically in nerve axons. We hypothesized that serum level of tau can be a useful biomarker to diagnose DAI in the early phase of TBI. Methods & results We measured serum tau levels in 40 TBI patients who were suspected of DAI within 6 hours after TBI to evaluate the accuracy of the tau level as a diagnostic marker for DAI. Diagnosis of DAI was confirmed according to magnetic resonance imaging (MRI) findings. The serum tau level in the DAI group (n = 13) was significantly higher than that in the non-DAI group (n = 27) (DAI vs. non-DAI, 25.3 [0 to 99.1] pg/mL vs. 0 [0 to 44.4] pg/mL, P = 0.03)). A receiver-operating characteristic curve to evaluate the diagnostic ability of serum tau level within 6 hours for DAI showed an area under the curve of 0.690 with 74.1% for sensitivity and 69.2% for specificity. Serum tau level was not significantly higher in unfavorable outcome group (Glasgow Outcome scale [GOS] score = 1-3 at hospital discharge) compared with favorable outcome group (GOS score = 4-5) (P = 0.19). Conclusions Tau protein may be a useful biomarker for diagnosis of DAI in the early phase of TBI.	[Tomita, Keisuke; Nakada, Taka-aki; Oshima, Taku; Motoshima, Takayuki; Kawaguchi, Rui; Oda, Shigeto] Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chiba, Japan		Nakada, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chiba, Japan.	taka.nakada@nifty.com	Oshima, Taku/AAX-1936-2021	Oshima, Taku/0000-0002-3868-8272; Nakada, Taka-aki/0000-0002-4480-556X	General Insurance Association of Japan [15-1-16]	This work was supported by The General Insurance Association of Japan (Grant Number 15-1-16). The funder had no role in the study design, experiments, collection, analysis, interpretation of data, writing of the manuscript, or decision to submit the manuscript for publication.	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; [Anonymous], 1993, CER CONC DIFF BRAIN, P137; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Chabok SY, 2012, J TRAUMA ACUTE CARE, V72, P1654, DOI 10.1097/TA.0b013e318246887e; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Liliang PC, 2010, RESUSCITATION, V81, P1205, DOI 10.1016/j.resuscitation.2010.05.016; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MENON DK, 1992, ANAESTHESIA, V47, P240, DOI 10.1111/j.1365-2044.1992.tb02130.x; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; PEDEN CJ, 1992, ANAESTHESIA, V47, P508, DOI 10.1111/j.1365-2044.1992.tb02278.x; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Wang JW, 2016, EXP THER MED, V11, P1147, DOI 10.3892/etm.2016.3017; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zurek J, 2011, BRAIN INJURY, V25, P221, DOI 10.3109/02699052.2010.541895	30	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214381	10.1371/journal.pone.0214381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	WOS:000462000400050	30901365	Green Submitted, Green Published, gold			2022-02-06	
J	Chen, CC; Hsieh, PC; Chen, CPC; Hsieh, YW; Chung, CY; Lin, KL				Chen, Chih-Chi; Hsieh, Po-Chuan; Chen, Carl P. C.; Hsieh, Yu-Wei; Chung, Chia-Ying; Lin, Kuang-Lin		Prevention Protection Child Abuse	Clinical Characteristics and Predictors of Poor Hospital Discharge Outcome for Young Children with Abusive Head Trauma	JOURNAL OF CLINICAL MEDICINE			English	Article						abusive head trauma; accidental head trauma; predictors; poor outcome; Glasgow Coma Scale	GLASGOW COMA SCALE; BRAIN-INJURY; RISK-FACTORS; SCORE; INFANTS; MORTALITY; SEIZURES; FEATURES	Children with abusive head trauma tend to have worse outcomes than children with accidental head trauma. However, current predictors of poor outcomes for children with abusive head trauma are still limited. We aim to use clinical data to identify early predictors of poor outcome at discharge in children with abusive head trauma. In the 10-year observational retrospective cohort study, children aged between zero and four years with abusive or accidental head trauma were recruited. Multivariate logistic regression models were applied to evaluate factors associated with poor prognosis in children with abusive head trauma. The primary outcome was mortality or a Glasgow Coma Scale (GCS) motor component score of less than 6 at discharge. A total of 292 head trauma children were included. Among them, 59 children had abusive head trauma. In comparison to children with accidental head trauma, children with abusive head trauma were younger, had more severe head injuries, and experienced a higher frequency of post-traumatic seizures. Their radiologic findings showed common presence of subdural hemorrhage, cerebral edema, and less epidural hemorrhage. They were more in need of neurosurgical intervention. In the multivariate analysis for predictors of poor outcome in children with abusive head trauma, initial GCS <= 5 (versus GCS > 5 with the adjusted odds ratio (OR) = 25.7, 95% confidence interval (CI) = 1.5-432.8, p = 0.024) and older age (per year with the adjusted OR = 3.3, 95% CI = 1.2-9.5, p = 0.024) were independently associated with poor outcome. These findings demonstrate the characteristic clinical differences between children with abusive and accidental head trauma. Initial GCS <= 5 and older age are predictive of poor outcome at discharge in children with abusive head trauma.	[Chen, Chih-Chi; Chen, Carl P. C.; Chung, Chia-Ying] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Phys Med & Rehabil, 5 Fuhsing St, Taoyuan 333, Taiwan; [Hsieh, Po-Chuan] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurosurg, 5 Fuhsing St, Taoyuan 333, Taiwan; [Hsieh, Yu-Wei] Chang Gung Univ, Coll Med, Dept Occupat Therapy, 259,Sec1,WenHua First Rd, Taoyuan 333, Taiwan; [Hsieh, Yu-Wei] Chang Gung Univ, Coll Med, Grad Inst Behav Sci, 259,Sec1,WenHua First Rd, Taoyuan 333, Taiwan; [Hsieh, Yu-Wei] Chang Gung Univ, Hlth Aging Res Ctr, 259,Sec1,WenHua First Rd, Taoyuan 333, Taiwan; [Lin, Kuang-Lin] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Div Pediat Neurol,Dept Pediat, 5 Fuhsing St, Taoyuan 333, Taiwan; [Lin, Kuang-Lin; Prevention Protection Child Abuse] Chang Gung Mem Hosp, Study Grp Prevent & Protect Child Abuse & Neglect, 5 Fuhsing St, Taoyuan 333, Taiwan		Chung, CY (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Phys Med & Rehabil, 5 Fuhsing St, Taoyuan 333, Taiwan.; Lin, KL (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Div Pediat Neurol,Dept Pediat, 5 Fuhsing St, Taoyuan 333, Taiwan.; Lin, KL (corresponding author), Chang Gung Mem Hosp, Study Grp Prevent & Protect Child Abuse & Neglect, 5 Fuhsing St, Taoyuan 333, Taiwan.	claudia5477@gmail.com; pochuan.hsieh@gmail.com; carlchendr@gmail.com; Ywhsieh@mail.cgu.edu.tw; chiaying928@yahoo.com; lincgh@cgmh.org.tw		Chung, Chia-Ying/0000-0002-2146-6040			Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Bahloul Mabrouk, 2011, J Emerg Trauma Shock, V4, P198, DOI 10.4103/0974-2700.82206; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Boop S, 2016, J NEUROSURG-PEDIATR, V18, P542, DOI 10.3171/2016.1.PEDS15583; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Camfield C, 2015, SEIZURE-EUR J EPILEP, V27, P80, DOI 10.1016/j.seizure.2015.02.031; Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; Cicero MX, 2013, PEDIATR EMERG CARE, V29, P43, DOI 10.1097/PEC.0b013e31827b52bf; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; Graupman P, 2006, J NEUROSURG, V104, P245, DOI 10.3171/ped.2006.104.4.245; Green SM, 2011, ANN EMERG MED, V58, P427, DOI 10.1016/j.annemergmed.2011.06.009; Heather NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082245; Hsieh KLC, 2015, AM J ROENTGENOL, V204, P944, DOI 10.2214/AJR.14.13228; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2015, ARCH DIS CHILD, V100, P1123, DOI 10.1136/archdischild-2014-306960; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; Lopes NRL, 2013, J PEDIAT-BRAZIL, V89, P426, DOI 10.1016/j.jped.2013.01.011; Maguire SA, 2011, PEDIATRICS, V128, pE550, DOI 10.1542/peds.2010-2949; Parks SE., 2012, PEDIAT ABUSIVE HEAD; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Shein SL, 2012, J PEDIATR-US, V161, P716, DOI 10.1016/j.jpeds.2012.03.046; Slovis JC, 2018, PEDIATR CRIT CARE ME, V19, P353, DOI 10.1097/PCC.0000000000001490; TEASDALE G, 1974, LANCET, V2, P81; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; WISSOW LS, 1995, NEW ENGL J MED, V332, P1425, DOI 10.1056/NEJM199505253322107	41	8	9	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2077-0383			J CLIN MED	J. Clin. Med.	MAR 20	2019	8	3							390	10.3390/jcm8030390			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HT2WX	WOS:000464425800004	30897787	Green Submitted, Green Published, gold			2022-02-06	
J	Dretsch, MN; Rangaprakash, D; Katz, JS; Daniel, TA; Goodman, AM; Denney, TS; Deshpande, G				Dretsch, Michael N.; Rangaprakash, D.; Katz, Jeffrey S.; Daniel, Thomas A.; Goodman, Adam M.; Denney, Thomas S.; Deshpande, Gopikrishna			Strength and Temporal Variance of the Default Mode Network to Investigate Chronic Mild Traumatic Brain Injury in Service Members with Psychological Trauma	JOURNAL OF EXPERIMENTAL NEUROSCIENCE			English	Article						Functional magnetic resonance imaging; functional connectivity; posttraumatic stress disorder; mild traumatic brain injury; default mode network; military	POSTTRAUMATIC-STRESS-DISORDER; SUPERIOR FRONTAL GYRUS; CONNECTIVITY; PRECUNEUS; SYMPTOMS; SOLDIERS; VARIABILITY; IMPAIRMENT; INSTRUMENT; IMPACT	BACKGROUND: There is a significant number of military personnel with a history of mild traumatic brain injury (mTBI) who suffer from comorbid posttraumatic stress symptoms (PTS). Although there is evidence of disruptions of the default mode network (DMN) associated with PTS and mTBI, previous studies have only studied static connectivity while ignoring temporal variability of connectivity. OBJECTIVE: To assess DMN disrupted or dysregulated neurocircuitry, cognitive functioning. and psychological health of active-duty military with mTBI and PTS. METHOD: U.S. Army soldiers with PTS (n = 14). mTBI + PTS (n =25), and healthy controls (n =21) voluntarily completed a cognitive and symptom battery. In addition, participants had magnetic resonance imaging (MRI) to assess both static functional connectivity (SFC) and variance of dynamic functional connectivity (vDFC) of the DMN. RESULTS: Both the PTS and mTBI l PTS groups had significant symptoms. but only the comorbid group had significant decrements in cognitive functioning. Both groups showed less stable and disrupted neural signatures of the DMN, mainly constituting the cingulate-frontal-temporal-parietal attention network. Specifically, the PTS group showed a combination of both reduced contralateral strength and reduced unilateral variability of frontal-cingulate-temporal connectivities, as well as increased variability of frontal-parietal connectivities. The mTBI + PTS group had fewer abnormal connectives than the PTS group, all of which included reduced strength of frontal-temporal regions and reduced variability frontal-cingulate-temporal regions. Greater SFC and vDFC connectivity of the left dorsolateral prefrontal cortex (dIPFC) <--> precuneus was associated with higher cognitive scores and lower symptom scores. CONCLUSIONS: Findings suggest that individuals with PTS and mTBI + PTS have a propensity for accentuated generation of thoughts, feelings. sensations. and/or images while in a resting state. Compared with controls. only the PTS group was associated with accentuated variability of the frontal-parietal attention network. While there were no significant differences in DMN connectivity strength between the mTBI + PTS and PTS groups. variability of connectivity was able to distinguish them.	[Dretsch, Michael N.] US Army, Aeromed Res Lab, Ft Rucker, AL USA; [Dretsch, Michael N.; Katz, Jeffrey S.; Daniel, Thomas A.; Goodman, Adam M.] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA; [Dretsch, Michael N.] US Army, Med Res Directorate West, Walter Reed Army Inst Res, Joint Base Lewis McChord, WA 98433 USA; [Rangaprakash, D.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Rangaprakash, D.; Katz, Jeffrey S.; Denney, Thomas S.; Deshpande, Gopikrishna] Auburn Univ, Dept Elect & Comp Engn, AU MRI Res Ctr, Auburn, AL 36849 USA; [Katz, Jeffrey S.; Goodman, Adam M.; Denney, Thomas S.; Deshpande, Gopikrishna] Auburn Univ, Alabama Adv Imaging Consortium, Auburn, AL 36849 USA; [Katz, Jeffrey S.; Goodman, Adam M.; Denney, Thomas S.; Deshpande, Gopikrishna] Univ Alabama Birmingham, Birmingham, AL USA		Dretsch, MN (corresponding author), US Army, Med Res Directorate West, 9933A W Johnson St, Joint Base Lewis McChord, WA 98433 USA.	michael.n.dretsch.mil@mail.mil	Goodman, Adam/AAI-3643-2021	Goodman, Adam/0000-0002-7550-679X; Dretsch, Michael/0000-0001-8773-6376	U.S. Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC); Military Operational Medicine Research Program; U.S. Department of EnergyUnited States Department of Energy (DOE); USAMRMCU.S. Army Medical Research & Materiel Command (USAMRMC)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was funded by the U.S. Army Medical Research and Materiel Command (USAMRMC) and Military Operational Medicine Research Program and was supported in part by an appointment to the Internship/Research Participation Program for the USAMRMC, administered by the Oak Ridge Institute for Science and Education (ORISE) through an agreement between the U.S. Department of Energy and the USAMRMC. Dr Dretsch was the principal investigator (PI) of the study who secured funding, developed the protocol, analyzed the psychological health data, and was the primary author of the manuscript.	Andrews-Hanna JR, 2012, NEUROSCIENTIST, V18, P251, DOI 10.1177/1073858411403316; Aupperle RL, 2012, ARCH GEN PSYCHIAT, V69, P360, DOI 10.1001/archgenpsychiatry.2011.1539; Boly M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125337; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chao-Gan Y, DATA PROCESSING ASSI; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen S., 1994, AM J HEMATOL, V47, P235; Dretsch M.N., 2013, TRAUMATOLOGY, V19, P118, DOI DOI 10.1177/1534765612455228; Dretsch M, 2016, J HEAD TRAUMA REHAB, V31, P23, DOI 10.1097/HTR.0000000000000109; Dretsch MN, 2019, APPL NEUROPSYCH-ADUL, V26, P76, DOI 10.1080/23279095.2017.1362406; Dretsch Michael N, 2016, Open Neuroimag J, V10, P111; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Dretsch MN, 2012, BRAIN BEHAV, V2, P357, DOI 10.1002/brb3.53; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Holdeman TC, 2009, PSYCHIAT SERV, V60, P273, DOI 10.1176/appi.ps.60.2.273; Jia H, 2014, BRAIN CONNECT, V4, P741, DOI 10.1089/brain.2014.0300; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Joseph AR, 2018, AM J EPIDEMIOL, V187, P7, DOI 10.1093/aje/kwx199; King D. W., 2003, MANUAL DEPLOYMENT RI; King NS, 2002, BRAIN INJURY, V16, P65, DOI 10.1080/02699050110088263; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Koch SBJ, 2016, DEPRESS ANXIETY, V33, P592, DOI 10.1002/da.22478; Lamichhane B, 2014, BRAIN CONNECT, V4, P619, DOI 10.1089/brain.2014.0243; Li W, 2013, NEUROIMAGE, V78, P46, DOI 10.1016/j.neuroimage.2013.04.011; Liang PP, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004222; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Miller DR, 2017, BIOL PSYCHIAT-COGN N, V2, P363, DOI 10.1016/j.bpsc.2016.12.006; Misaki M, 2018, NEUROIMAGE-CLIN, V17, P285, DOI 10.1016/j.nicl.2017.10.032; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Nagahama Y, 1999, NEUROIMAGE, V10, P193, DOI 10.1006/nimg.1999.0451; Nathan DE, 2017, BRAIN CONNECT, V7, P236, DOI 10.1089/brain.2016.0433; Penny W. D., 2011, STAT PARAMETRIC MAPP; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rangaprakash D, 2018, HUM BRAIN MAPP, V39, P264, DOI 10.1002/hbm.23841; Rangaprakash D, 2017, NEUROIMAGE-CLIN, V16, P409, DOI 10.1016/j.nicl.2017.07.016; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Rashid B, 2016, NEUROIMAGE, V134, P645, DOI 10.1016/j.neuroimage.2016.04.051; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Song XW, 2008, RESTING STATE FMRI D; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Thorp S.R., 2005, PTSD RES Q, V16, P1; TOMBAUGH TN, 2003, J FORENSIC NEUROPSYC, V2, P69, DOI DOI 10.1300/J151V02N03_04; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; Valdez CE, 2017, J CLIN PSYCHOL, V73, P707, DOI 10.1002/jclp.22371; Weathers FW., 2013, PTSD CHECKLIST DSM 5; Willems RM, 2009, NEUROIMAGE, V47, P1992, DOI 10.1016/j.neuroimage.2009.05.066; Wu GR, 2013, MED IMAGE ANAL, V17, P365, DOI 10.1016/j.media.2013.01.003; Zhang YY, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.912; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P164	53	8	8	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-0695			J EXP NEUROSCI	J. Exp. Neurosci.	MAR 18	2019	13								1179069619833966	10.1177/1179069619833966			14	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	HQ2IO	WOS:000462224200001	30911222				2022-02-06	
J	Siegkas, P; Sharp, DJ; Ghajari, M				Siegkas, Petros; Sharp, David J.; Ghajari, Mazdak			The traumatic brain injury mitigation effects of a new viscoelastic add-on liner	SCIENTIFIC REPORTS			English	Article							MOTORCYCLE HELMET; BODY; HEAD; EPIDEMIOLOGY; TOLERANCE; AXONS	Traumatic brain injury (TBI) affects millions of people worldwide with significant personal and social consequences. New materials and methods offer opportunities for improving designs of TBI prevention systems, such as helmets. We combined empirical impact tests and computational modelling to test the effectiveness of new viscoelastic add-on components in decreasing biomechanica I forces within the brain during helmeted head impacts. Motorcycle helmets with and without the viscoelastic components were fitted on a head/neck assembly and were tested under oblique impact to replicate realistic accident conditions. Translational and rotational accelerations were measured during the tests. The inclusion of components reduced peak accelerations, with a significant effect for frontal impacts and a marginal effect for side and rear impacts. The head accelerations were then applied on a computational model of TBI to predict strain and strain-rate across the brain. The presence of viscoelastic components in the helmet decreased strain and strain-rate for frontal impacts at low impact speeds. The effect was less pronounced for front impact at high speeds and for side and rear impacts. This work shows the potential of the viscoelastic add-on components as lightweight and cost-effective solutions for enhancing helmet protection and decreasing strain and strain-rate across the brain during head impacts.	[Siegkas, Petros; Ghajari, Mazdak] Imperial Coll London, Dyson Sch Design Engn, South Kensington Campus, London SW7 2AZ, England; [Sharp, David J.] Imperial Coll London, Div Brain Sci, Computat Cognit & Clin Neuroimaging Lab, London W12 0NN, England		Siegkas, P (corresponding author), Imperial Coll London, Dyson Sch Design Engn, South Kensington Campus, London SW7 2AZ, England.	petros.siegkas@ntu.ac.uk	Sharp, David J/A-2119-2013	Siegkas, Petros/0000-0001-9528-2247; Ghajari, Mazdak/0000-0001-5678-5124	Welsh Government for supporting this work through the Small Business Research Initiative (SBRI) grant; National Institute of Health Research Professorship [RP-011-048]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006] Funding Source: UKRI	The authors would like to thank Rheon Labs (Dr. Plant and Mr. Roseveare) for designing and manufacturing the components and technical support, the Welsh Government for supporting this work through the Small Business Research Initiative (SBRI) grant, and Dainese for providing the helmets. D.J.S. has a National Institute of Health Research Professorship - RP-011-048.	Aiello M, 2007, INT J CRASHWORTHINES, V12, P1, DOI 10.1533/ijcr.2006.0134; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Caserta GD, 2011, COMPOS STRUCT, V93, P2748, DOI 10.1016/j.compstruct.2011.05.029; Cernicchi A, 2008, INT J CRASHWORTHINES, V13, P451, DOI 10.1080/13588260802055460; Chinn B., 1999, SAE TECHNICAL PAPER; Chinn B., 2001, COST 327 MOTORCYCLE; Dowling N.E., 2012, MECH BEHAV MAT; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Ferguson J. R, 2012, United States patent, Patent No. [US 8,087, 101 B2, 8]; Fernandes FAO, 2013, ACCIDENT ANAL PREV, V56, P1, DOI 10.1016/j.aap.2013.03.011; Ghajari M., 2011, THESIS; Ghajari M., 2017, BRAIN; Ghajari M, 2013, ACCIDENT ANAL PREV, V50, P263, DOI 10.1016/j.aap.2012.04.016; Ghajari M, 2011, INT J CRASHWORTHINES, V16, P621, DOI 10.1080/13588265.2011.616078; Ghajari M, 2011, INT J CRASHWORTHINES, V16, P285, DOI 10.1080/13588265.2011.559798; Halldin P, 2001, INT J CRASHWORTHINES, V6, P53, DOI 10.1533/cras.2001.0162; Hallquist J.O., 2014, LS DYNA KEYWORD USER, P1265; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; King A. I., IRCOBI C LISB PORT, P1; Kleiven S., 2007, SAE TECHNICAL PAPER; Lin MR, 2008, ACCIDENT ANAL PREV, V40, P1653, DOI 10.1016/j.aap.2008.05.005; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Nicolle S., 2004, SAE TECHNICAL PAPER; Nightingale RW, 1996, J BIOMECH, V29, P307, DOI 10.1016/0021-9290(95)00056-9; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Plant D. J., 2009, United States patent, Patent No. [US 7. 608,314 B2, 7.]; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roseveare A. J., 2016, IRCOBI C 2016 SHORT; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P406, DOI 10.1016/S0924-0136(02)00048-1; Smith DH, 1999, J NEUROSCI, V19, P4263; Southgate D. F., 2016, SPORTS INNOVATION TE; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Umar R. R., 1998, MOTORCYCLE SAFETY PR; Venkatraman P., 2016, CRITICAL REV IMPACT; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	40	8	8	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 5	2019	9								3471	10.1038/s41598-019-39953-1			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7OV	WOS:000460381600044	30837536	Green Accepted, Green Published, gold			2022-02-06	
J	Meulenbroek, P; Ness, B; Lemoncello, R; Byom, L; MacDonald, S; O'Neil-Pirozzi, TM; Sohlberg, MM				Meulenbroek, Peter; Ness, Bryan; Lemoncello, Rik; Byom, Lindsey; MacDonald, Sheila; O'Neil-Pirozzi, Therese M.; Sohlberg, McKay Moore			Social communication following traumatic brain injury part 2: Identifying effective treatment ingredients	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						Social communication; pragmatics; traumatic brain injury; treatment; speech-language pathology	INCOG RECOMMENDATIONS; SELF-AWARENESS; REHABILITATION; INTERVENTION; COGNITION; DEFICITS; MANAGEMENT; IMPAIRMENTS; REMEDIATION; TYPOLOGY	Purpose: Social communication deficits are a severely debilitating aspect of traumatic brain injury (TBI), and there is strong clinical and research interest in how social communication interventions work for this population. Informed by a companion paper targeting assessment of social communication impairments post-TBI, this paper reviews relevant treatment theories and provides an inventory of social communication treatment components. Method: We completed a mapping review examining 17 articles from recent literature reviews and 4 updated articles from a literature search to identify treatment targets and ingredients using the Rehabilitation Treatment Specification System (RTSS). Result: Social communication interventions are primarily based on behavioural and cognitive treatment theories. Common social communication treatment targets include changing skilled behaviours and cognitive or affective representations. We offer a menu of therapeutic ingredients and treatment considerations which represent the current state of social communication interventions. Conclusion: By reviewing the social communication intervention literature through a theoretical lens, we identify which treatment targets are missing, which targets are being addressed, and which therapeutic ingredients (i.e. clinician activities) are recommended. A hypothetical case study is provided as a supplement to demonstrate how speech-language pathologists may integrate treatment theory, ingredients, and targets into clinical practice.	[Meulenbroek, Peter; Ness, Bryan; Lemoncello, Rik; Byom, Lindsey; MacDonald, Sheila; O'Neil-Pirozzi, Therese M.; Sohlberg, McKay Moore] Univ Kentucky, Acad Neurol Commun Disorders, Traumat Brain Injury Writing Comm, Lexington, KY USA; [Meulenbroek, Peter] Univ Kentucky, Dept Rehabil Sci, Div Commun Sci & Disorders, Lexington, KY USA; [Ness, Bryan] Calif Baptist Univ, Commun Sci & Disorders, Riverside, CA USA; [Lemoncello, Rik] Pacific Univ, Sch Commun Sci & Disorders, Forest Grove, OR USA; [Byom, Lindsey] Univ N Carolina, Dept Allied Hlth, Div Speech & Hearing Sci, Chapel Hill, NC 27515 USA; [MacDonald, Sheila] Univ Toronto, Sheila MacDonald Associates, Toronto, ON, Canada; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, Boston, MA 02115 USA; [O'Neil-Pirozzi, Therese M.] Spaulding Harvard Traumat Brain Injury Model Syst, Boston, MA USA; [Sohlberg, McKay Moore] Univ Oregon, Commun Disorders & Sci, Eugene, OR 97403 USA		O'Neil-Pirozzi, TM (corresponding author), Northeastern Univ, 360 Huntington Ave,70 Forsyth Bldg,Room 103, Boston, MA 02115 USA.	t.oneil-pirozzi@neu.edu	Byom, Lindsey/AAC-5095-2019	MacDonald, Sheila/0000-0002-0932-2060; Meulenbroek, Peter/0000-0003-4233-9910; Byom, Lindsey/0000-0002-2457-1735			[Anonymous], 2005, KNOWLEDGE, pA15; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; BRAUNLINGMCMORROW D, 1986, J REHABIL, V52, P39; BROTHERTON FA, 1988, ARCH PHYS MED REHAB, V69, P827; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Dijkers MP, 2014, ARCH PHYS MED REHAB, V95, pS45, DOI 10.1016/j.apmr.2013.05.033; Douglas JM, 2019, NEUROPSYCHOL REHABIL, V29, P73, DOI 10.1080/09602011.2016.1259114; Ehrlich J. S, 1985, COGNITIVE REHABILITA, P32; Finch E, 2017, BRAIN INJURY, V31, P1830, DOI 10.1080/02699052.2017.1346284; Finch E, 2016, ARCH PHYS MED REHAB, V97, P1352, DOI [10.1016/j.apmr.2015.11.005, 10.1016/j.apmr.20.15.11.005]; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; GAJAR A, 1984, J APPL BEHAV ANAL, V17, P353, DOI 10.1901/jaba.1984.17-353; Giles G M, 1988, Brain Inj, V2, P75, DOI 10.3109/02699058809150933; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Goldblum G, 2001, S Afr J Commun Disord, V48, P3; Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x; Hart T., 2017, MANUAL REHABILITATIO; Hart T, 2014, ARCH PHYS MED REHAB, V95, pS33, DOI 10.1016/j.apmr.2013.05.032; HELFFENSTEIN DA, 1982, INT J CLIN NEUROPSYC, V4, P139; Kendall PC, 1979, COGNITIVE BEHAV INTE; Kirsch NL, 2004, J HEAD TRAUMA REHAB, V19, P366, DOI 10.1097/00001199-200409000-00002; Krasny-Pacini A, 2016, ARCH PHYS MED REHAB, V97, P157, DOI 10.1016/j.apmr.2015.08.424; Ludemann A, 2017, AM J SPEECH-LANG PAT, V26, P443, DOI 10.1044/2016_AJSLP-16-0035; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Malec JF, 2009, NEUROPSYCHOL REHABIL, V19, P790, DOI 10.1080/09602010903031203; McDonald S, 2013, NEUROPSYCHOL REHABIL, V23, P267, DOI 10.1080/09602011.2012.751340; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; O'Reilly MF, 2000, J VOCAT REHABIL, V14, P187; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Rousseau DM, 2016, ANNU REV PSYCHOL, V67, P667, DOI 10.1146/annurev-psych-122414-033336; Ryan AM, 2017, NEW ENGL J MED, V376, P2358, DOI 10.1056/NEJMsa1613412; Samnani SS, 2017, JCPSP-J COLL PHYSICI, V27, P635, DOI 2724; SLADYK K, 1992, AM J OCCUP THER, V46, P267, DOI 10.5014/ajot.46.3.267; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg M.M., INT J SPEECH LANGUAG; Swift MC, 2017, INT J SPEECH-LANG PA, V19, P335, DOI 10.1080/17549507.2017.1309067; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Turkstra LS, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-15-0060; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Westerhof-Evers HJ, 2017, J HEAD TRAUMA REHAB, V32, P296, DOI 10.1097/HTR.0000000000000332; Whyte J., 2017, AM C REH MED LOS ANG; Whyte J., 2017, WORLD C BRAIN INJ NE; Whyte J, 2014, ARCH PHYS MED REHAB, V95, pS24, DOI 10.1016/j.apmr.2013.05.034; World Health Organization, 2002, B WORLD HEALTH ORGAN, V80, P983; World Health Organization, 2007, INT CLASS FUNCT DIS; Ylvisaker M, 2002, J MED SPEECH-LANG PA, V10, pXXV	51	8	8	1	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1754-9507	1754-9515		INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.	MAR 4	2019	21	2					128	142		10.1080/17549507.2019.1583281			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	HW0XE	WOS:000466404900002	30955383				2022-02-06	
J	Aguilar, JM; Cassedy, AE; Shultz, EL; Kirkwood, MW; Stancin, T; Yeates, KO; Taylor, HG; Wade, SL				Aguilar, Jessica M.; Cassedy, Amy E.; Shultz, Emily L.; Kirkwood, Michael W.; Stancin, Terry; Yeates, Keith Owen; Taylor, H. Gerry; Wade, Shari L.			A Comparison of 2 Online Parent Skills Training Interventions for Early Childhood Brain Injury: Improvements in Internalizing and Executive Function Behaviors	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						executive function behaviors; Internet; mental disorders; parenting; traumatic brain injury; videoconferencing	POSTTRAUMATIC-STRESS-DISORDER; SOCIOECONOMIC-STATUS; MATERNAL DEPRESSION; INTERACTION THERAPY; CHILDREN; PREDICTORS; SYMPTOMS; OUTCOMES; PROGRAM; METAANALYSIS	Objective: To examine the effectiveness of a web-based parenting intervention (Internet-Based Interacting Together Everyday: Recovery After Childhood TBI [I-InTERACT]) and an abbreviated version (Express) in reducing executive dysfunction and internalizing problems among young children following traumatic brain injury (TBI). Method: Parents of 113 children (ages 3-9 years) who had sustained a TBI were randomized to 1 of 3 treatment groups: I-InTERACT, Express, or an Internet Resource Comparison (IRC) group. Parents who participated in either I-InTERACT or Express completed self-guided web sessions and received live coaching of their parenting skills via videoconferencing with a therapist. I-InTERACT included additional psychoeducation, stress management, and family communication skills (eg, marriage, grief, pain, and sleep). Analyses of covariance were utilized to compare the groups on parent-reported executive function behaviors (ie, Behavior Rating Inventory of Executive Function) and internalizing symptoms (ie, Child Behavior Checklist) at baseline and 6 months. Results: Parents who participated in Express reported significantly lower levels of executive dysfunction than those in I-InTERACT, beta = -0.49; t(2, 73) = -2.47, P = .048, and significantly lower levels of withdrawal than those in the IRC group, beta = -0.44; t(2, 74) = -2.22, P = .03. The Express group did not significantly differ from the IRC group on executive function behaviors or the I-InTERACT group on internalizing problems, all P > .05. Children with more problems at baseline, families with lower education levels, and parents with more symptoms of depression benefited most. Conclusion: A brief, online parent training intervention may be efficacious in improving executive dysfunction and internalizing problems following early TBI, particularly among children of lower socioeconomic status or with existing behavioral concerns.	[Aguilar, Jessica M.; Shultz, Emily L.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Cassedy, Amy E.] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Shultz, Emily L.; Wade, Shari L.] Univ Cincinnati, Cincinnati, OH USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Denver, CO USA; [Stancin, Terry] Metrohlth Med Ctr, Cleveland, OH USA; [Stancin, Terry; Taylor, H. Gerry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Yeates, Keith Owen] Univ Calgary, Dept Pediat & Clin Neurosci, Toronto, ON, Canada; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA		Aguilar, JM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Jessica.Aguilar@cchmc.org	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133B090010]	This study was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research, formerly known as the National Institute on Disability and Rehabilitation Research (grant number: H133B090010).	Achenbach T.M, 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Albicini M, 2015, WIRELESS COMMUNICATI, P199; Alway Y, 2016, DEPRESS ANXIETY, V33, P19, DOI 10.1002/da.22396; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Brown FL, 2013, BRAIN IMPAIR, V14, P253, DOI 10.1017/BrImp.2013.18; Carpenter AL, 2014, CLIN CHILD FAM PSYCH, V17, P340, DOI 10.1007/s10567-014-0172-4; Cartwright-Hatton S, 2005, J CHILD ADOL PS NURS, V18, P45, DOI 10.1111/j.1744-6171.2005.00014.x; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Conger RD, 2007, ANNU REV PSYCHOL, V58, P175, DOI 10.1146/annurev.psych.58.110405.085551; Conger RD, 2010, J MARRIAGE FAM, V72, P685, DOI 10.1111/j.1741-3737.2010.00725.x; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eyberg S. M., 2005, MANUAL DYADIC PARENT; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Herman KC, 2011, SCHOOL PSYCHOL QUART, V26, P189, DOI 10.1037/a0025228; Isquith PK, 2005, MENT RETARD DEV D R, V11, P209, DOI 10.1002/mrdd.20075; Kaminski JW, 2008, J ABNORM CHILD PSYCH, V36, P567, DOI 10.1007/s10802-007-9201-9; Karreman A, 2006, INFANT CHILD DEV, V15, P561, DOI 10.1002/icd.478; Kurowski BG, 2013, ARCH PHYS MED REHAB, V94, P543, DOI 10.1016/j.apmr.2012.10.029; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Lundahl B, 2006, CLIN PSYCHOL REV, V26, P86, DOI 10.1016/j.cpr.2005.07.004; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; NARAD ME, 2017, HEALTH, V3, DOI DOI 10.1177/2055207617719423; Narad ME, 2017, J HEAD TRAUMA REHAB, V32, P98, DOI 10.1097/HTR.0000000000000247; Nixon RDV, 2003, J CONSULT CLIN PSYCH, V71, P251, DOI 10.1037/0022-006X.71.2.251; Patterson GR, 1985, CRIMINOLOGY, V23, P63, DOI 10.1111/j.1745-9125.1985.tb00326.x; Pincus, 1999, EYBERG CHILD BEHAV I; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raj SP, 2015, J HEAD TRAUMA REHAB, V30, P347, DOI 10.1097/HTR.0000000000000052; Reiss F, 2013, SOC SCI MED, V90, P24, DOI 10.1016/j.socscimed.2013.04.026; Rhine T, 2018, J HEAD TRAUMA REHAB, V33, P210, DOI 10.1097/HTR.0000000000000319; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Woods D, 2015, SOCIAL CARE NEURODIS, V5, P70, DOI [DOI 10.1108/SCN-01-2014-0001, 10.1108/SCN-01-2014-0001]; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	54	8	8	2	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2019	34	2			SI		65	76		10.1097/HTR.0000000000000443			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HU9CK	WOS:000465590400007	30499926				2022-02-06	
J	Burstein, R; Noseda, R; Fulton, AB				Burstein, Rami; Noseda, Rodrigo; Fulton, Anne B.			Neurobiology of Photophobia	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article							INDEPENDENT COMPONENT ANALYSIS; LIGHT SENSITIVITY; VISUAL-STIMULATION; NEURAL MECHANISM; MIGRAINE; COLOR; CORTEX; HEADACHE; ANATOMY; PATHOPHYSIOLOGY	Background: Photophobia is commonly associated with migraine, meningitis, concussion, and a variety of ocular diseases. Advances in our ability to trace multiple brain pathways through which light information is processed have paved the way to a better understanding of the neurobiology of photophobia and the complexity of the symptoms triggered by light. Purpose: The purpose of this review is to summarize recent anatomical and physiological studies on the neurobiology of photophobia with emphasis on migraine. Recent Findings: Observations made in blind and seeing migraine patients, and in a variety of animal models, have led to the discovery of a novel retino-thalamocortical pathway that carries photic signal from melanopsinergic and nonmelanopsinergic retinal ganglion cells (RGCs) to thalamic neurons. Activity of these neurons is driven by migraine and their axonal projections convey signals about headache and light to multiple cortical areas involved in the generation of common migraine symptoms. Novel projections of RGCs into previously unidentified hypothalamic neurons that regulate parasympathetic and sympathetic functions have also been discovered. Finally, recent work has led to a novel understanding of color preference in migrainetype photophobia and of the roles played by the retina, thalamus, and cortex. Summary: The findings provide a neural substrate for understanding the complexity of aversion to light in patients with migraine and neuro-ophthalmologic other disorders. (C) 2019 by North American Neuro-Ophthalmology Society Department of Anesthesia and Critical Care (RB, RN), Beth Israel	[Burstein, Rami; Noseda, Rodrigo] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia & Crit Care, CLS-649,330 Brookline Ave, Boston, MA 02215 USA; [Fulton, Anne B.] Childrens Hosp Boston, Dept Ophthalmol, Boston, MA USA		Burstein, R (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia & Crit Care, CLS-649,330 Brookline Ave, Boston, MA 02215 USA.	rburstei@bidmc.harvard.edu	Noseda, Rodrigo/AAN-1761-2020	Noseda, Rodrigo/0000-0002-9641-4691	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-051484, NS-035611, NS-104296]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094198, R01NS104296] Funding Source: NIH RePORTER	Supported by NIH Grants NS-051484 (RB), NS-035611 (RB) and NS-104296 (RN).	Adams WH, 2006, AM J OPHTHALMOL, V142, P82, DOI 10.1016/j.ajo.2006.02.020; Antal A, 2011, CEPHALALGIA, V31, P338, DOI 10.1177/0333102410379889; Aurora SK, 1999, HEADACHE, V39, P469, DOI 10.1046/j.1526-4610.1999.3907469.x; Blackburn MK, 2009, OPHTHALMOLOGY, V116, P997, DOI 10.1016/j.ophtha.2008.12.031; Boulloche N, 2010, J NEUROL NEUROSUR PS, V81, P978, DOI 10.1136/jnnp.2009.190223; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; Caywood MS, 2004, J NEUROPHYSIOL, V91, P2859, DOI 10.1152/jn.00775.2003; Conway BR, 2009, NEUROSCIENTIST, V15, P274, DOI 10.1177/1073858408331369; Danilova MV, 2006, VISION RES, V46, P823, DOI 10.1016/j.visres.2005.09.026; Datta R, 2013, CEPHALALGIA, V33, P365, DOI 10.1177/0333102412474503; Denuelle M, 2011, NEUROLOGY, V76, P213, DOI 10.1212/WNL.0b013e3182074a57; Doi E, 2003, NEURAL COMPUT, V15, P397, DOI 10.1162/089976603762552960; Donchin O, 1998, NATURE, V395, P274, DOI 10.1038/26220; FINE PG, 1995, J NEURO-OPHTHALMOL, V15, P90; GOOD PA, 1991, HEADACHE, V31, P533, DOI 10.1111/j.1526-4610.1991.hed3108533.x; Griebe M, 2014, HEADACHE, V54, P131, DOI 10.1111/head.12194; Hong SC, 2012, ACTA OTO-LARYNGOL, V132, pS27, DOI 10.3109/00016489.2012.659759; Hoyer PO, 2000, NETWORK-COMP NEURAL, V11, P191, DOI 10.1088/0954-898X/11/3/302; Huang J, 2011, CEPHALALGIA, V31, P925, DOI 10.1177/0333102411409076; HUBEL DH, 1987, J NEUROSCI, V7, P3378; Hurlbert AC, 2007, CURR BIOL, V17, pR623, DOI 10.1016/j.cub.2007.06.022; Kawasaki A, 2002, J NEURO-OPHTHALMOL, V22, P3, DOI 10.1097/00041327-200203000-00002; Kentridge RW, 2007, P NATL ACAD SCI USA, V104, P15129, DOI 10.1073/pnas.0706603104; LAMONTE M, 1995, HEADACHE, V35, P520, DOI 10.1111/j.1526-4610.1995.hed3509520.x; LEBENSOHN JE, 1951, AM J OPHTHALMOL, V34, P1294, DOI 10.1016/0002-9394(51)91866-1; LIVEING E, 1873, MEGRIM SICK HEADACHE; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; Main A, 2000, HEADACHE, V40, P194, DOI 10.1046/j.1526-4610.2000.00028.x; Maleki N, 2012, HUM BRAIN MAPP, V33, P75, DOI 10.1002/hbm.21194; Martin PR, 2006, HEADACHE, V46, P962, DOI 10.1111/j.1526-4610.2006.00468.x; MILLER NR, 1985, WALSH HOYTS CLIN NEU, V2, P1099; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Noseda R, 2017, P NATL ACAD SCI USA, V114, pE5683, DOI 10.1073/pnas.1708361114; Noseda R, 2016, BRAIN, V139, P1971, DOI 10.1093/brain/aww119; Noseda R, 2013, PAIN, V154, pS44, DOI 10.1016/j.pain.2013.07.021; Noseda R, 2011, J NEUROSCI, V31, P14204, DOI 10.1523/JNEUROSCI.3285-11.2011; Noseda R, 2011, CURR OPIN NEUROL, V24, P197, DOI 10.1097/WCO.0b013e3283466c8e; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Palmer SE, 2010, P NATL ACAD SCI USA, V107, P8877, DOI 10.1073/pnas.0906172107; Strauss ED, 2013, PSYCHON B REV, V20, P935, DOI 10.3758/s13423-013-0423-2; Tailor DR, 2000, VISION RES, V40, P2671, DOI 10.1016/S0042-6989(00)00105-X; TOOTELL RBH, 1988, J NEUROSCI, V8, P1569; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; Vincent M, 2003, CEPHALALGIA, V23, P860, DOI 10.1046/j.1468-2982.2003.00609.x; Wang W, 1996, NEUROLOGY, V46, P1404, DOI 10.1212/WNL.46.5.1404; WELTY TE, 1990, CLIN PHARMACY, V9, P35; WOLBERG FL, 1982, ARCH NEUROL-CHICAGO, V39, P382, DOI 10.1001/archneur.1982.00510180060017; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034	50	8	8	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1070-8022	1536-5166		J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	MAR	2019	39	1					94	102		10.1097/WNO.0000000000000766			9	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	IQ5DD	WOS:000480771000018	30762717	Green Accepted, Bronze			2022-02-06	
J	Genest, C; Neslehova, JG; Remillard, B; Murphy, OA				Genest, C.; Neslehova, J. G.; Remillard, B.; Murphy, O. A.			Testing for independence in arbitrary distributions	BIOMETRIKA			English	Article						Independence test; Mixed data; Multilinear copula; Sparse contingency table; Wild bootstrap	MULTIVARIATE NONPARAMETRIC TEST; MULTILINEAR COPULA PROCESS; LOCAL EFFICIENCY	Statistics are proposed for testing the hypothesis that arbitrary random variables are mutually independent. The tests are consistent and well behaved for any marginal distributions; they can be used, for example, for contingency tables which are sparse or whose dimension depends on the sample size, as well as for mixed data. No regularity conditions, data jittering, or binning mechanisms are required. The statistics are rank-based functionals of Cramer-von Mises type whose asymptotic behaviour derives from the empirical multilinear copula process. Approximate -values are computed using a wild bootstrap. The procedures are simple to implement and computationally efficient, and maintain their level well in moderate to large samples. Simulations suggest that the tests are robust with respect to the number of ties in the data, can easily detect a broad range of alternatives, and outperform existing procedures in many settings. Additional insight into their performance is provided through asymptotic local power calculations under contiguous alternatives. The procedures are illustrated on traumatic brain injury data.	[Genest, C.; Neslehova, J. G.; Murphy, O. A.] McGill Univ, Dept Math & Stat, 805 Rue Sherbrooke Ouest, Montreal, PQ H3A 0B9, Canada; [Remillard, B.] HEC Montreal, Dept Decis Sci, 3000 Chemin Cote St Catherine, Montreal, PQ H3T 2A4, Canada		Genest, C (corresponding author), McGill Univ, Dept Math & Stat, 805 Rue Sherbrooke Ouest, Montreal, PQ H3A 0B9, Canada.	christian.genest@mcgill.ca; johanna.neslehova@mcgill.ca; bruno.remillard@hec.ca; orla.murphy@mail.mcgill.ca		Remillard, Bruno/0000-0003-0254-6712	Canada Research Chairs ProgramCanada Research Chairs; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; Canadian Institute of Statistical Sciences; Fonds de recherche du Quebec-Nature et technologies	The authors thank Dr Elaine de Guise for permission to use the brain injury data and for insightful discussions. Thanks are also due to the editor, associate editor and referees for comments that have improved the manuscript. This work was partially supported by the Canada Research Chairs Program, the Natural Sciences and Engineering Research Council of Canada, the Canadian Institute of Statistical Sciences, and the Fonds de recherche du Quebec-Nature et technologies.	Agresti Alan., 2013, CATEGORICAL DATA ANA, V3rd ed; Bakirov NK, 2006, J MULTIVARIATE ANAL, V97, P1742, DOI 10.1016/j.jmva.2005.10.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLUM JR, 1961, ANN MATH STAT, V32, P485, DOI 10.1214/aoms/1177705055; Bucher A, 2010, STAT PROBABIL LETT, V80, P1925, DOI 10.1016/j.spl.2010.08.021; CLAYTON DG, 1978, BIOMETRIKA, V65, P141, DOI 10.2307/2335289; DEHEUVELS P, 1981, J MULTIVARIATE ANAL, V11, P102, DOI 10.1016/0047-259X(81)90136-6; DEHEUVELS P, 1980, LECT NOTES MATH, P95, DOI DOI 10.1007/BFB0097426; Fan YA, 2017, J MULTIVARIATE ANAL, V153, P189, DOI 10.1016/j.jmva.2016.09.014; FEUERVERGER A, 1993, INT STAT REV, V61, P419, DOI 10.2307/1403753; Gauthier S, 2018, J COMMUN DISORD, V73, P77, DOI 10.1016/j.jcomdis.2018.04.003; Genest C, 2006, J MULTIVARIATE ANAL, V97, P274, DOI 10.1016/j.jmva.2005.03.003; Genest C, 2004, TEST-SPAIN, V13, P335, DOI 10.1007/BF02595777; Genest C, 2007, ASTIN BULL, V37, P475, DOI 10.2143/AST.37.2.2024077; Genest C, 2007, ANN STAT, V35, P166, DOI 10.1214/009053606000000984; Genest C, 2017, J MULTIVARIATE ANAL, V159, P82, DOI 10.1016/j.jmva.2017.04.002; Genest C, 2014, BERNOULLI, V20, P1344, DOI 10.3150/13-BEJ524; Genest C, 2013, J MULTIVARIATE ANAL, V117, P214, DOI 10.1016/j.jmva.2013.02.007; Ghoudi K, 2001, J MULTIVARIATE ANAL, V79, P191, DOI 10.1006/jmva.2000.1967; Heller R, 2016, J MACH LEARN RES, V17; HOEFFDING W, 1948, ANN MATH STAT, V19, P546, DOI 10.1214/aoms/1177730150; LITTELL RC, 1973, J AM STAT ASSOC, V68, P193, DOI 10.2307/2284167; McNeil A.J., 2015, QUANTITATIVE RISK MA, VRevised edition; Meintanis SG, 2008, COMPUT STAT DATA AN, V52, P1884, DOI 10.1016/j.csda.2007.06.005; MOORE DS, 1975, ANN STAT, V3, P599, DOI 10.1214/aos/1176343125; Nelsen RB, 2006, INTRO COPULAS; Neslehova J, 2007, J MULTIVARIATE ANAL, V98, P544, DOI 10.1016/j.jmva.2005.11.007; R Development Core Team, 2019, R LANG ENV STAT COMP; REMILLARD B, 2011, INT ENCY STAT SCI, P1598; Remillard B, 2009, J MULTIVARIATE ANAL, V100, P377, DOI 10.1016/j.jmva.2008.05.004; SCHWEIZER B, 1974, STUD MATH, V52, P43; Shorack G.R., 1984, EMPIRICAL PROCESSES; SPITZER F. L, 1974, ECOLE DETE PROBABILI, P114; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; van der Vaart A., 1996, WEAK CONVERGENCE EMP, DOI [10.1007/978-1-4757-2545-2, DOI 10.1007/978-1-4757-2545-2]	35	8	8	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-3444	1464-3510		BIOMETRIKA	Biometrika	MAR	2019	106	1					47	68		10.1093/biomet/asy059			22	Biology; Mathematical & Computational Biology; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology; Mathematics	HO0SS	WOS:000460615100007		hybrid			2022-02-06	
J	Schumacher, DJ; Martini, A; Holmboe, E; Varadarajan, K; Busari, J; van der Vleuten, C; Carraccio, C				Schumacher, Daniel J.; Martini, Abigail; Holmboe, Eric; Varadarajan, Kartik; Busari, Jamiu; van der Vleuten, Cees; Carraccio, Carol			Developing Resident-Sensitive Quality Measures: Engaging Stakeholders to Inform Next Steps	ACADEMIC PEDIATRICS			English	Article						outcomes-based assessment; quality care; resident assessment	MEDICAL-EDUCATION; PATIENT OUTCOMES; PERSPECTIVE; PROGRAMS; ERRORS; FOCUS	OBJECTIVE: Despite the need for quality measures relevant to the work residents complete, few attempts have been made to address this gap. Resident-sensitive quality measures (RSQMs) can help fill this void. This study engaged resident and supervisor stakeholders to develop and inform next steps in creating such measures. METHODS: Two separate nominal group techniques (NGTs), one with residents and one with faculty and fellow supervisors, were used to generate RSQMs for 3 specific illnesses (asthma, bronchiolitis, and closed head injury) as well as general care for the pediatric emergency department. Two separate Delphi processes were then used to prioritize identified RSQMs. The measures produced by each group were compared side by side, illuminating similarities and differences that were explored through focus groups with residents and supervisors. These focus groups also probed future settings in which to develop RSQMs. RESULTS: In the NGT and Delphi groups, residents and supervisors placed considerable focus on measures in 3 areas across the illnesses of interest: 1) appropriate medication dosing, 2) documentation, and 3) information provided at patient discharge. Focus groups highlighted hospital medicine and general pediatrics as priority areas for developing future RSQMs but also noted contextual variables that influence the application of similar measures in different settings. Residents and supervisors had both similar as well as unique insights into developing RSQMs. CONCLUSIONS: This study continues to pave the path forward in developing future RSQMs by exploring specific settings, measures, and stakeholders to consider when undertaking this work.	[Schumacher, Daniel J.; Martini, Abigail] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, MLC 2008,3333 Burnet Ave, Cincinnati, OH 45226 USA; [Varadarajan, Kartik] UCHealth, Cincinnati, OH USA; [Holmboe, Eric] Accreditat Council Grad Med Educ, Chicago, IL USA; [Busari, Jamiu] Maastricht Univ, Sch Hlth Profess Educ, Maastricht, Netherlands; [van der Vleuten, Cees] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Educ Dev & Res, Maastricht, Netherlands; [van der Vleuten, Cees] Maastricht Univ, Sch Hlth Profess Educ SHE, Maastricht, Netherlands; [Carraccio, Carol] Amer Board Pediat Inc, Chapel Hill, NC USA		Schumacher, DJ (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, MLC 2008,3333 Burnet Ave, Cincinnati, OH 45226 USA.	daniel.schumacher@cchmc.org	Busari, Jamiu/C-9425-2018	Busari, Jamiu/0000-0002-8616-5564	Place Outcomes Research Award at Cincinnati Children's; Division of Emergency Medicine at Cincinnati Children's	This study was supported by a Place Outcomes Research Award at Cincinnati Children's as well as by the Division of Emergency Medicine at Cincinnati Children's.	[Anonymous], 2007, PRACT ASSESS RES EVA, DOI DOI 10.1576/T0AG.7.2.120.27071; [Anonymous], 2018, THE CTM 15 AND CTM 3; Asch DA, 2009, JAMA-J AM MED ASSOC, V302, P1277, DOI 10.1001/jama.2009.1356; Bansal N, 2016, JAMA SURG, V151, P111, DOI 10.1001/jamasurg.2015.3637; Butler JM, 2017, ACAD MED, V92, P984, DOI 10.1097/ACM.0000000000001474; Carraccio C, 2016, ACAD MED, V91, P199, DOI 10.1097/ACM.0000000000000985; Chen C, 2014, JAMA-J AM MED ASSOC, V312, P2385, DOI 10.1001/jama.2014.15973; Cook DA, 2013, ACAD MED, V88, P162, DOI 10.1097/ACM.0b013e31827c3d78; Cordasco K, 2009, WORKING PAPER; Creswell J. W., 2019, ED RES PLANNING COND; Gruppen L, 2017, MED TEACH, V39, P623, DOI 10.1080/0142159X.2017.1315065; Haan CK, 2008, ACAD MED, V83, P574, DOI 10.1097/ACM.0b013e318172318d; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Humphrey-Murto S, 2016, ACAD MED, V91, P11; Kalet AL, 2010, ACAD MED, V85, P844, DOI 10.1097/ACM.0b013e3181d734a5; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lewis PJ, 2009, DRUG SAFETY, V32, P379, DOI 10.2165/00002018-200932050-00002; Medicare Payment Advisory Commission, 2009, REP C IMPR INC MED P; MedPAC (Payment Advisory Commission), 2010, REP C AL INC MED, P103; Mittiga Matthew R, 2010, J Grad Med Educ, V2, P571, DOI 10.4300/JGME-D-10-00106.1; Moreau KA, 2015, MED TEACH, V37, P1060, DOI 10.3109/0142159X.2015.1060307; Navanandan N, 2017, ACAD PEDIATR, V17, P755, DOI 10.1016/j.acap.2017.02.003; Phillips RL, 2017, ANN FAM MED, V15, P140, DOI 10.1370/afm.2044; Schumacher DJ, 2018, ACAD MED, V93, P1071, DOI 10.1097/ACM.0000000000002093; Sirovich BE, 2014, JAMA INTERN MED, V174, P1640, DOI 10.1001/jamainternmed.2014.3337; Swing SR, 2007, ACAD EMERG MED, V14, P463, DOI 10.1197/j.aem.2006.12.011; Taylor BL, 2005, PEDIATR EMERG CARE, V21, P822, DOI 10.1097/01.pec.0000190239.04094.72; van der Leeuw RM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-65; Van Melle E, 2017, ACAD MED, V92, P752, DOI 10.1097/ACM.0000000000001479; Wiest FC, 2002, JAMA-J AM MED ASSOC, V288, P2609, DOI 10.1001/jama.288.20.2609; Yin HS, 2015, J GEN INTERN MED, V30, P1363, DOI 10.1007/s11606-015-3329-z	31	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1876-2859	1876-2867		ACAD PEDIATR	Acad. Pediatr.	MAR	2019	19	2					177	185		10.1016/j.acap.2018.09.013			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	HO9FM	WOS:000461267000010	30268426				2022-02-06	
J	Vesga-Jimenez, DJ; Hidalgo-Lanussa, O; Baez-Jurado, E; Echeverria, V; Ashraf, GM; Sahebkar, A; Barreto, GE				Vesga-Jimenez, Diego J.; Hidalgo-Lanussa, Oscar; Baez-Jurado, Eliana; Echeverria, Valentina; Ashraf, Ghulam Md; Sahebkar, Amirhossein; Barreto, George E.			Raloxifene attenuates oxidative stress and preserves mitochondrial function in astrocytic cells upon glucose deprivation	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article						astrocytes; glucose deprivation; mitochondria; neuroprotection; raloxifene	ESTROGEN-RECEPTOR MODULATORS; TRAUMATIC BRAIN-INJURY; INDUCED UP-REGULATION; GLUTAMATE TRANSPORTERS; GROWTH-FACTORS; 17-BETA-ESTRADIOL; METABOLISM; ASTROGLIA; MECHANISM; RAT	Oxidative stress and mitochondrial dysfunction induced by metabolic insults are both hallmarks of various neurological disorders, whereby neuronal cells are severely affected by decreased glucose supply to the brain. Likely injured, astrocytes are important for neuronal homeostasis and therapeutic strategies should be directed towards improving astrocytic functions to improve brain's outcome. In the present study, we aimed to assess the actions of raloxifene, a selective estrogen receptor modulator in astrocytic cells under glucose deprivation. Our findings indicated that pretreatment with 1 mu M raloxifene results in an increase in cell viability and attenuated nuclei fragmentation. Raloxifene's actions also rely on the reduction of oxidative stress and preservation of mitochondrial function in glucose-deprived astrocytic cells, suggesting the possible direct effects of this compound on mitochondria. In conclusion, our results demonstrate that raloxifene's protective actions might be mediated in part by astrocytes in the setting of a metabolic insult.	[Vesga-Jimenez, Diego J.; Hidalgo-Lanussa, Oscar; Baez-Jurado, Eliana; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Cra 7 40-62, Bogota, Colombia; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Concepcion, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev, Bay Pines, FL USA; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Cra 7 40-62, Bogota, Colombia.	gsampaio@javeriana.edu.co	Barreto, George E./AAD-7420-2020; Ashraf, Ghulam Md/H-9485-2012; Sahebkar, Amirhossein/B-5124-2018; Valentina Echeverria Moran, BCh/E-7765-2013	Barreto, George E./0000-0002-6644-1971; Ashraf, Ghulam Md/0000-0002-9820-2078; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Vesga Jimenez, Diego Julian/0000-0003-1531-3862; Hidalgo Lanussa, Oscar Alejandro/0000-0001-6028-922X			Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Arevalo MA, 2011, J MOL ENDOCRINOL, V46, pR1, DOI 10.1677/JME-10-0122; Avila MF, 2013, CELL BIOL INT, V37, P521, DOI 10.1002/cbin.10058; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Bourque M, 2014, NEUROBIOL AGING, V35, P2347, DOI 10.1016/j.neurobiolaging.2014.03.017; Cabezas R, 2016, MED CHEM, V12, P204, DOI 10.2174/1573406411666151019120444; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Dhandapani KM, 2007, EXP GERONTOL, V42, P70, DOI 10.1016/j.exger.2006.06.032; Dwyer D., 2002, GLUCOSE METABOLISM B; Giatti S., 2018, PROGR NEUROBIOLOGY; Karki P, 2014, MOL CELL ENDOCRINOL, V389, P58, DOI 10.1016/j.mce.2014.01.010; Karki P, 2014, GLIA, V62, P1270, DOI 10.1002/glia.22679; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Osmanova S, 2011, IRAN J REPROD MED, V9, P295; Paradies G, 2014, ANTIOXID REDOX SIGN, V20, P1925, DOI 10.1089/ars.2013.5280; Paradies G, 2009, CELL CALCIUM, V45, P643, DOI 10.1016/j.ceca.2009.03.012; Pottoo F. H., 2018, MOL NEUROBIOLOGY; Richardson TE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034600; Toro-Urrego N, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00152; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Vega-Vela NE, 2017, MOL NEUROBIOL, V54, P4996, DOI 10.1007/s12035-016-0045-6; Zhao LQ, 2005, BRAIN RES REV, V49, P472, DOI 10.1016/j.brainresrev.2005.01.009; Zhao TZ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.449	29	8	8	0	37	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	MAR	2019	234	3					2051	2057		10.1002/jcp.27481			7	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	HC2FU	WOS:000451618500011	30246411				2022-02-06	
J	Okigbo, AA; Helkowski, MS; Royes, BJ; Bleimeister, IH; Lam, TR; Bao, GC; Cheng, JP; Bondi, CO; Kline, AE				Okigbo, Adaora A.; Helkowski, Michael S.; Royes, Brittany J.; Bleimeister, Isabel H.; Lam, Tracey R.; Bao, Gina C.; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.			Dose-dependent neurorestorative effects of amantadine after cortical impact injury	NEUROSCIENCE LETTERS			English	Article						Amantadine; Beam-walk; Controlled cortical impact; Functional recovery; Learning and memory; Morris water maze; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; WATER MAZE PERFORMANCE; ENVIRONMENTAL ENRICHMENT; RECOVERY; EXPOSURE; SURVIVAL; BEHAVIOR; RATS	Numerous pharmacotherapies have been evaluated after experimental traumatic brain injury (TBI). While amantadine (AMT) has shown potential for clinical efficacy, the few studies on its effectiveness have been mixed. It is possible that suboptimal dosing, due to the evaluation of only one dose, may be causing the discrepancies in outcomes. Hence, the goal of the current study was to conduct a dose response of AMT after TBI to determine an optimal behavioral benefit. Anesthetized adult male rats received either a cortical impact of moderate severity or sham injury and then were randomly assigned to receive once daily intraperitoneally injections of AMT (10, 20, or 40 mg/kg) or saline vehicle (VEH, 1 mL/kg) commencing 24 h after injury for 19 days. Motor and cognitive function were assessed on post-operative days 1-5 and 14-19, respectively. There were no statistical differences among the sham groups treated with AMT or VEH so the data were pooled. AMT (20 mg/kg) facilitated beam-balance recovery and spatial learning relative to VEH-treated controls (p < 0.05). No other doses of AMT were effective. These results indicate that dosing should be carefully considered when assessing the effects of pharmacotherapies after TBI so that potential benefits are not inadvertently missed.	[Okigbo, Adaora A.; Helkowski, Michael S.; Royes, Brittany J.; Bleimeister, Isabel H.; Lam, Tracey R.; Bao, Gina C.; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Okigbo, Adaora A.; Helkowski, Michael S.; Royes, Brittany J.; Bleimeister, Isabel H.; Lam, Tracey R.; Bao, Gina C.; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA 15213 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA 15213 USA		Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Sch Med,Crit Care Med & Psychol, John G Rangos Res Ctr,Childrens Hosp Pittsburgh,P, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.	klineae@upmc.edu		Kline, PhD, Anthony E./0000-0002-7218-3454; Cheng, Jeffrey/0000-0001-8285-3207; Bleimeister, Isabel/0000-0003-1565-0017	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD069620, HD069620-S1, NS060005, NS084967, NS094950, NS099683]; University of Pittsburgh Physicians/UPMC Academic Foundation; UMPC Rehabilitation Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS094950, R21NS099674, R01NS084967, R21NS099683] Funding Source: NIH RePORTER	This work was supported, in part, by NIH grants HD069620, HD069620-S1, NS060005, NS084967 (AEK), NS094950, NS099683 (COB), the University of Pittsburgh Physicians/UPMC Academic Foundation, and the UMPC Rehabilitation Institute (COB).	Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Ghalaenovi H, 2018, BRAIN INJURY, V32, P1050, DOI 10.1080/02699052.2018.1476733; Ghate Prajakta Suresh, 2018, Asian J Neurosurg, V13, P647, DOI 10.4103/ajns.AJNS_272_16; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hammond FM, 2018, J NEUROTRAUM, V35, P2298, DOI 10.1089/neu.2018.5767; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Ossola B, 2011, NEUROPHARMACOLOGY, V61, P574, DOI 10.1016/j.neuropharm.2011.04.030; Radabaugh HL, 2017, EXP NEUROL, V294, P12, DOI 10.1016/j.expneurol.2017.04.013; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Spritzer SD, 2015, NEUROLOGIST, V19, P61, DOI 10.1097/NRL.0000000000000001; Stelmaschuk S, 2015, J TRAUMA NURS, V22, P194, DOI 10.1097/JTN.0000000000000138; Wang T, 2014, J NEUROTRAUM, V31, P370, DOI 10.1089/neu.2013.2917	27	8	8	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	FEB 16	2019	694						69	73		10.1016/j.neulet.2018.11.030			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HM7FS	WOS:000459643800012	30472358	Green Accepted			2022-02-06	
J	Aranda, ML; Fleitas, MFG; Dieguez, HH; Milne, GA; Devouassoux, JD; Sarmiento, MIK; Chianelli, M; Sande, PH; Dorfman, D; Rosenstein, RE				Aranda, Marcos L.; Gonzalez Fleitas, Maria F.; Dieguez, Hernan H.; Milne, Georgia A.; Devouassoux, Julian D.; Sarmiento, Maria I. Keller; Chianelli, Monica; Sande, Pablo H.; Dorfman, Damian; Rosenstein, Ruth E.			Therapeutic benefit of environmental enrichment on optic neuritis	NEUROPHARMACOLOGY			English	Article						Optic neuritis; Environmental enrichment; Neuroinflammation; Retinal ganglion cells	MEDIATED FUNCTIONAL IMPROVEMENT; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; LIPOPOLYSACCHARIDE; DEGENERATION; MODEL; STIMULATION; ACTIVATION; INCREASES; EXERCISE	Optic neuritis (ON) is an inflammatory, demyelinating, neurodegenerative, and presently untreatable condition of the optic nerve which might induce blindness. We analyzed the effect of environmental enrichment (EE) on visual pathway damage provoked by experimental ON induced by a microinjection of bacterial lipopolysaccharide (LPS) into the optic nerve. For this purpose, LPS was microinjected into the optic nerve from male Wistar rats. After injection, one group of animals was submitted to EE, and another group remained in standard environment (SE) for 21 days. EE prevented the decrease in pupil light reflex (PLR), visual evoked potentials, retinal anterograde transport, phosphorylated neurofilament immunoreactivity, myelination (luxol fast blue staining), and axon (toluidine blue staining) and retinal ganglion cell (Brn3a-immunoreactivity) number. EE also prevented microglial/macrophage reactivity (lba-1- and ED1-immunoreactivity), and astrocytosis (glial fibrillary acidic protein-immunostaining) induced by experimental ON. LPS-injected optic nerves displayed oxidative damage and increased inducible nitric oxide synthase, cyclooxygenase-2, and interleukin-1 beta and TNF alpha, mRNA levels which were prevented by EE. EE increased optic nerve brain-derived neurotrophic factor levels. When EE started at 4 (but not 7) days post-injection of LPS, a preservation of the PLR was observed at 21 days post-LPS, which was blocked by the daily administration of ANA-12 from day 4 to day 7 post-LPS. Moreover, EE from day 4 to day 7 post-LPS significantly preserved the PLR at 21 days post-injection. Taken together, our data suggest that EE preserved visual functions and reduced neuroinflammation of the optic nerve. This article is part of the Special Issue entitled "Neurobiology of Environmental Enrichment". (C) 2017 Elsevier Ltd. All rights reserved.	[Aranda, Marcos L.; Gonzalez Fleitas, Maria F.; Dieguez, Hernan H.; Milne, Georgia A.; Devouassoux, Julian D.; Sarmiento, Maria I. Keller; Chianelli, Monica; Sande, Pablo H.; Dorfman, Damian; Rosenstein, Ruth E.] Univ Buenos Aires, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med,CEFyBO,CONICET, Paraguay 2155,5th Floor, RA-1121 Buenos Aires, DF, Argentina		Rosenstein, RE (corresponding author), Univ Buenos Aires, Dept Bioquim Humana, Fac Med, CEFyBO,CONICET, Paraguay 2155,5 P, RA-1121 Buenos Aires, DF, Argentina.	ruthr@fmed.uba.ar		Gonzalez Fleitas, Maria Florencia/0000-0001-5795-8365; Ruth, Rosenstein/0000-0002-8804-4395; Aranda, Marcos/0000-0003-1891-3476	Agencia Nacional de Promotion Cientifica y Tecnologica [PICT 1563]; University of Buenos AiresUniversity of Buenos Aires [20020130100564]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, ArgentinaConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 0707]	This research was supported by grants from the Agencia Nacional de Promotion Cientifica y Tecnologica [PICT 1563]; The University of Buenos Aires [20020130100564]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 0707], Buenos Aires, Argentina. These funding sources have no involvement in study design, the collection, analysis and interpretation of data, the writing of the report, and in the decision to submit the article for publication.	Ambrogini P, 2013, BRAIN RES, V1534, P1, DOI 10.1016/j.brainres.2013.08.023; Aranda ML, 2016, J PINEAL RES, V60, P360, DOI 10.1111/jpi.12318; Aranda ML, 2015, EXP NEUROL, V266, P30, DOI 10.1016/j.expneurol.2015.01.010; Berardi N, 2015, DEV MED CHILD NEUROL, V57, P4, DOI 10.1111/dmcn.12691; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727; Campos AC, 2016, BEHAV BRAIN RES, V312, P186, DOI 10.1016/j.bbr.2016.06.027; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; Das A, 2013, J NEUROCHEM, V124, P133, DOI 10.1111/jnc.12064; de Sousa AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015597; Diem R, 2003, J NEUROSCI, V23, P6993, DOI 10.1523/JNEUROSCI.23-18-06993.2003; Dorfman D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136637; Dorfman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101829; Dorfman D, 2013, EXP NEUROL, V240, P146, DOI 10.1016/j.expneurol.2012.11.017; Eggenberger E R, 2001, Ophthalmol Clin North Am, V14, P73; Faherty CJ, 2003, DEV BRAIN RES, V141, P55, DOI 10.1016/S0165-3806(02)00642-9; Fan D, 2016, MOL NEUROBIOL, V53, P344, DOI 10.1007/s12035-014-9013-1; Fernandez DC, 2013, CHRONOBIOL INT, V30, P583, DOI 10.3109/07420528.2012.754453; Fonseca-Kelly Zoe, 2012, Front Neurol, V3, P84, DOI 10.3389/fneur.2012.00084; Frigui M, 2011, LUPUS, V20, P1214, DOI 10.1177/0961203311403344; Gal RL, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001430.pub4; Galetta SL, 2015, NEUROL NEUROIMMUNOL; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Guan ZW, 2006, BRAIN BEHAV IMMUN, V20, P64, DOI 10.1016/j.bbi.2005.04.005; Guy J, 2008, OPHTHAL RES, V40, P212, DOI 10.1159/000119879; Hanif AM, 2015, INVEST OPHTH VIS SCI, V56, P6839, DOI 10.1167/iovs.15-16792; Hannan AJ, 2014, NEUROPATH APPL NEURO, V40, P13, DOI 10.1111/nan.12102; Hickman SJ, 2002, LANCET, V360, P1953, DOI 10.1016/S0140-6736(02)11919-2; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Horstmann L, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-120; Horwitz H, 2014, J NEUROL, V261, P98, DOI 10.1007/s00415-013-7166-x; Jain V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062235; Jurgens HA, 2012, BRAIN BEHAV IMMUN, V26, P1006, DOI 10.1016/j.bbi.2012.05.015; Kallenbach K, 2008, ACTA OPHTHALMOL, V86, P459, DOI 10.1111/j.1600-0420.2007.01034.x; Khan RS, 2014, INVEST OPHTH VIS SCI, V55, P5744, DOI 10.1167/iovs.14-14672; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Landi S, 2007, FASEB J, V21, P130, DOI 10.1096/fj.06-6083com; Li KJ, 2014, MED HYPOTHESES, V82, P636, DOI 10.1016/j.mehy.2014.02.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maier K, 2006, AM J PATHOL, V169, P1353, DOI 10.2353/ajpath.2006.060159; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; McGuiness B, 2016, NEUROIMMUNOMODULAT, V23, P137, DOI 10.1159/000446370; Mitre M, 2017, CLIN SCI, V131, P13, DOI 10.1042/CS20160044; Naismith RT, 2009, NEUROLOGY, V73, P46, DOI 10.1212/WNL.0b013e3181aaea32; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; Nowacka-Chmielewska MM, 2017, PHARMACOL REP, V69, P520, DOI 10.1016/j.pharep.2017.01.004; Prusky GT, 2000, BEHAV BRAIN RES, V114, P11, DOI 10.1016/S0166-4328(00)00186-8; Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P681, DOI 10.1167/iovs.06-0553; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Rodriguez JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.194; Sale A, 2014, PHYSIOL REV, V94, P189, DOI 10.1152/physrev.00036.2012; Sattler MB, 2004, CELL DEATH DIFFER, V11, pS181, DOI 10.1038/sj.cdd.4401504; Shindler KS, 2012, EXP EYE RES, V100, P1, DOI 10.1016/j.exer.2012.04.005; Smith AW, 2016, J NEUROCHEM, V139, P270, DOI 10.1111/jnc.13770; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Szabadfi K, 2009, BRAIN RES, V1259, P107, DOI 10.1016/j.brainres.2009.01.004; Tanaka S, 2006, J NEUROSCI RES, V83, P557, DOI 10.1002/jnr.20752; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; Walter SD, 2012, OPHTHALMOLOGY, V119, P1250, DOI 10.1016/j.ophtha.2011.11.032; WEKERLE H, 1994, ANN NEUROL, V36, pS47, DOI 10.1002/ana.410360714; Yang S, 2013, NEUROSCIENCE, V234, P13, DOI 10.1016/j.neuroscience.2013.01.003; You YY, 2015, JOVE-J VIS EXP, DOI 10.3791/52934	63	8	8	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	FEB	2019	145		A		SI		87	98		10.1016/j.neuropharm.2017.12.017			12	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	HG4TG	WOS:000454967300009	29233635				2022-02-06	
J	Blake, AL; McVicar, CL; Retino, M; Hall, EE; Ketcham, CJ				Blake, Abby L.; McVicar, Casey L.; Retino, Mckenzie; Hall, Eric E.; Ketcham, Caroline J.			Concussion history influences sleep disturbances, symptoms, and quality of life in collegiate student-athletes	SLEEP HEALTH			English	Article						Concussion; Sleep; Sleep disturbances; Symptoms; Quality of life; Mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; PATIENT COMPLAINTS; HEAD-INJURY; DISORDERS; RECOVERY; TIME; QUESTIONNAIRE; PERFORMANCE; PREVALENCE; IMPACT	Objectives: Immediately after experiencing a concussion, many will report the presence of a variety of symptoms, which may include disturbances in sleep. It is possible that these symptoms and other resulting quality of life (QOL) disturbances may persist for some time following a concussion. The purpose of this study was to determine if a history of concussions was related to ongoing sleep disturbances, symptoms, and changes in QOL. Methods: Eighty-two student-athletes (club and varsity) completed an online survey to determine concussion history, sleep disturbances, concussion symptoms, and QOL dysfunctions. Separate analyses of variance were performed to determine if sleep disturbances, symptoms, and QOL dysfunctions were related and if they differed based on concussion history (0, 1-2, 3+). Results: Those with no concussion history reported fewer sleep disturbances (P = .028), symptoms (P = .029), symptom severity (P = .014), QOL dysfunctions (P = .003), and QOL severity (P = .011) than those who self-reported having had a previous concussion(s). Additionally, the number of sleep disturbances was found to positively correlate with symptoms (P < .001), symptom severity (P < .001), QOL dysfunctions (P = .001), and severity of QOL dysfunctions (P = .002). Conclusions: The results of the current study demonstrate that concussion history is related to persistent changes in sleep, ongoing symptoms, and QOL dysfunctions and should be considered in concussion management protocols even after return to play and academics has occurred. (c) 2018 National Sleep Foundation. Published by Elsevier Inc. All rights reserved.	[Blake, Abby L.; McVicar, Casey L.; Retino, Mckenzie; Hall, Eric E.; Ketcham, Caroline J.] Elon Univ, Dept Exercise Sci, Campus Box 2525, Elon, NC 27244 USA		Hall, EE (corresponding author), 2525 Campus Box, Elon, NC 27244 USA.	ehall@elon.edu		Ketcham, Caroline/0000-0002-6713-130X			[Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Chan LG, 2015, J HEAD TRAUMA REHAB, V30, pE67, DOI 10.1097/HTR.0000000000000119; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Demirel Havva, 2016, Clin Invest Med, V39, P27525; Fullagar HHK, 2015, SPORTS MED, V45, P161, DOI 10.1007/s40279-014-0260-0; Gaultney JF, 2010, J AM COLL HEALTH, V59, P91, DOI 10.1080/07448481.2010.483708; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gordon KE, 2018, BRAIN INJURY, V32, P843, DOI 10.1080/02699052.2018.1463105; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Grander M., 2014, MIND BODY SPORT UNDE, P51; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Kamdar BB, 2004, SLEEP MED, V5, P441, DOI 10.1016/j.sleep.2004.05.003; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Lin CH, 2014, J AFFECT DISORDERS, V166, P173, DOI 10.1016/j.jad.2014.03.039; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Tkachenko N, 2016, PEDIATR NEUROL, V57, P46, DOI 10.1016/j.pediatrneurol.2015.12.019; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8	32	8	8	1	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2352-7218	2352-7226		SLEEP HEALTH	Sleep Health	FEB	2019	5	1					72	77		10.1016/j.sleh.2018.10.011			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HI2BZ	WOS:000456250800012	30670170				2022-02-06	
J	Chen, P; Toglia, J				Chen, Peii; Toglia, Joan			Online and Offline Awareness Deficits: Anosognosia for Spatial Neglect	REHABILITATION PSYCHOLOGY			English	Article						hemispatial neglect; unilateral spatial neglect; self-awareness; awareness deficits; anosognosia	IMPAIRED SELF-AWARENESS; TRAUMATIC BRAIN-INJURY; UNILATERAL NEGLECT; METACOGNITIVE KNOWLEDGE; DISABILITY; DISORDERS; CONSEQUENCES; UNAWARENESS; DISCOVERY; ATTENTION	Purpose/Objective: Anosognosia for spatial neglect (ASN) can be offline or online. Offline ASN is general unawareness of having experienced spatial deficits. Online ASN is an awareness deficit of underestimating spatial difficulties that likely to occur in an upcoming task (anticipatory ASN) or have just occurred during the task (emergent ASN). We explored the relationships among spatial neglect, offline ASN, anticipatory ASN, and emergent ASN. Research Method/Design: Forty-four survivors of stroke answered questionnaires assessing offline and online self-awareness of spatial problems. The online questionnaire was asked immediately before and after each of 4 tests for spatial neglect, including shape cancellation, address and sentence copying, telephone dialing, and indented paragraph reading. Results: Participants were certain they had difficulties in daily spatial tasks (offline awareness), in the task they were about to perform (anticipatory awareness) and had just performed (emergent awareness). Nonetheless, they consistently overestimated their spatial abilities, indicating ASN. Offline and online ASN appeared independent. Online ASN improved after task execution. Neglect severity was not positively correlated with offline ASN. Greater neglect severity correlated with both greater anticipatory and emergent ASN. Regardless of neglect severity, we found task-specific differences in emergent ASN but not in anticipatory ASN. Conclusions/Implications: Individuals with spatial neglect acknowledge their spatial difficulty (certainty of error occurrence) but may not necessarily recognize the extent of their difficulty (accuracy of error estimation). Our findings suggest that offline and online ASN are independent. A potential implication from the study is that familiar and challenging tasks may facilitate emergence of self-awareness. Impact and Implications Consistent with previous studies in other clinical populations, the present study demonstrated the dissociation between offline and online self-awareness among individuals with spatial neglect after stroke. Adding to the existing literature of anosognosia for spatial neglect, the present study also showed that online awareness changes after task execution. Self-awareness of neglect symptoms can emerge to a greater extent within some tasks more than others. To assess metacognitive knowledge or offline self-awareness of spatial neglect, we suggest clinicians use questions that ask about certainty as well as frequency of difficulties. Because a reference point is not always readily available, a qualitative approach may be used by interviewing patients with follow-up questions to determine the presence and severity of offline anosognosia for spatial neglect (ASN). To assess online, situational self-awareness of spatial neglect, we suggest clinicians use similar questionnaires used in the present study before and after familiar but challenging tasks (such as paragraph reading). Those tasks tend to provide inherent feedback based on prior performance such that patients may use prior experience to direct spatial attention and improve self-awareness.	[Chen, Peii] Kessler Fdn, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA; [Chen, Peii] Rutgers State Univ, Dept Phys Med & Rehabil, New Brunswick, NJ USA; [Toglia, Joan] Weill Cornell Med Ctr, Mercy Coll, Sch Hlth & Nat Sci, New York, NY USA; [Toglia, Joan] Weill Cornell Med Ctr, New York Presbyterian, Dept Rehabil Med, New York, NY USA		Chen, P (corresponding author), Kessler Fdn, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	pchen@kesslerfoundation.org	Toglia, Joan/AAN-6674-2021	Toglia, Joan/0000-0002-6902-6853; Chen, Peii/0000-0002-6724-7046			Austin PC, 2015, J CLIN EPIDEMIOL, V68, P627, DOI 10.1016/j.jclinepi.2014.12.014; Azouvi P, 1996, NEUROPSYCHOL REHABIL, V6, P133, DOI 10.1080/713755501; Azouvi P, 2017, ANN PHYS REHABIL MED, V60, P186, DOI 10.1016/j.rehab.2015.12.005; Babinski J.F.F., 1914, REV NEUROL, DOI [DOI 10.1016/J.CORTEX.2014.04.019, 10.1016/j.cortex.2014.04.019]; Barrett AM, 2005, NEUROLOGY, V64, P693, DOI 10.1212/01.WNL.0000151959.64379.1B; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergego C., 1995, Annales de Readaptation et de Medecine Physique, V38, P183, DOI 10.1016/0168-6054(96)89317-2; Berti A, 1996, J Int Neuropsychol Soc, V2, P426; Buxbaum LJ, 2004, NEUROLOGY, V62, P749, DOI 10.1212/01.WNL.0000113730.73031.F4; CAPLAN B, 1987, J CLIN EXP NEUROPSYC, V9, P359, DOI 10.1080/01688638708405056; Chen P, 2017, TOP STROKE REHABIL, V24, P24, DOI 10.1080/10749357.2016.1186373; Chen P, 2016, NEUROREHAB NEURAL RE, V30, P451, DOI 10.1177/1545968315604397; Chen PI, 2015, ARCH PHYS MED REHAB, V96, P1458, DOI 10.1016/j.apmr.2015.03.019; Chen PI, 2015, ARCH PHYS MED REHAB, V96, P869, DOI 10.1016/j.apmr.2014.10.023; Chen P, 2012, TOP STROKE REHABIL, V19, P423, DOI 10.1310/tsr1905-423; Colquhoun D, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140216; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Friedman PJ., 1992, J CLIN REHABILITATIO, V6, P23; Gasquoine PG, 2016, NEUROPSYCHOL REHABIL, V26, P261, DOI 10.1080/09602011.2015.1011665; Goverover Y, 2014, NEUROREHABILITATION, V35, P315, DOI 10.3233/NRE-141113; Gutschalk Alexander, 2015, Handb Clin Neurol, V129, P557, DOI 10.1016/B978-0-444-62630-1.00031-7; Halligan P. W., 1991, NEUROPSYCHOL REHABIL, V1, P281; Harvey M, 2012, NEUROPSYCHOLOGIA, V50, P1018, DOI 10.1016/j.neuropsychologia.2011.09.030; HEILMAN KM, 1979, ANN NEUROL, V5, P166, DOI 10.1002/ana.410050210; HIBBARD MR, 1992, REHABIL PSYCHOL, V37, P103, DOI 10.1037/0090-5550.37.2.103; Jehkonen M, 2001, ACTA NEUROL SCAND, V104, P136, DOI 10.1034/j.1600-0404.2001.00025.x; Kerkhoff G, 2014, NEUROREHAB NEURAL RE, V28, P554, DOI 10.1177/1545968313517757; Langer KG, 2014, CORTEX, V61, P5, DOI 10.1016/j.cortex.2014.04.019; Leung DPK, 2011, INT J REHABIL RES, V34, P187, DOI 10.1097/MRR.0b013e3283487f31; Maguire AM, 2002, NEUROPSYCHOLOGIA, V40, P879, DOI 10.1016/S0028-3932(01)00169-5; Malouf T, 2014, BRAIN INJURY, V28, P1523, DOI 10.3109/02699052.2014.922700; Mattioli F, 2012, NEUROPSYCHOL REHABIL, V22, P501, DOI 10.1080/09602011.2012.662340; Mesulam M., 1985, PRINCIPLES BEHAV NEU; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Nijboer TCW, 2014, NEUROREPORT, V25, P1381, DOI 10.1097/WNR.0000000000000277; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Papagno C., 2003, CLASSIC CASES NEUROP, V2s, P171; Perennou D, 2006, RESTOR NEUROL NEUROS, V24, P319; Prigatano G.P., 2010, STUDY ANOSOGNOSIA; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; Cherney LR, 2006, TOP STROKE REHABIL, V13, P47, DOI 10.1310/2611-45K0-24R7-00N6; Robertson K, 2015, BRAIN INJURY, V29, P848, DOI 10.3109/02699052.2015.1005135; Ronchi R, 2014, CORTEX, V61, P167, DOI 10.1016/j.cortex.2014.10.004; Rousseaux M, 2015, NEUROPSYCHOLOGIA, V70, P64, DOI 10.1016/j.neuropsychologia.2015.02.011; Rousseaux M, 2013, CORTEX, V49, P2607, DOI 10.1016/j.cortex.2013.07.007; Salthouse TA, 2017, NEUROPSYCHOLOGY, V31, P11, DOI 10.1037/neu0000330; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Salvato G, 2014, NEUROPSYCHOLOGY, V28, P706, DOI 10.1037/neu0000062; STONE SP, 1993, AGE AGEING, V22, P46, DOI 10.1093/ageing/22.1.46; Ten Brink AF, 2017, J CLIN EXP NEUROPSYC, V39, P707, DOI 10.1080/13803395.2016.1262333; Tham K, 2001, AM J OCCUP THER, V55, P46, DOI 10.5014/ajot.55.1.46; Tham K, 2000, AM J OCCUP THER, V54, P398, DOI 10.5014/ajot.54.4.398; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia J, 2011, COGNITION OCCUPATION, P351; von Monakow C., 1885, ARCH PSYCHIAT NERVEN, V16, P151, DOI DOI 10.1007/BF02227304; Vossel S, 2013, CORTEX, V49, P1782, DOI 10.1016/j.cortex.2012.12.011; Vossel S, 2012, STROKE, V43, P1954, DOI 10.1161/STROKEAHA.112.657288; Wee JYM, 2008, AM J PHYS MED REHAB, V87, P910, DOI 10.1097/PHM.0b013e31818a58bd; Wilson B., 1999, BEHAVIOURAL INATTENT BEHAV INATTENTION TE	60	8	9	0	4	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2019	64	1					50	64		10.1037/rep0000207			15	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	HK5TA	WOS:000458029100005	29648845				2022-02-06	
J	Choi, S; Saxena, N; Dhammu, T; Khan, M; Singh, AK; Singh, I; Won, J				Choi, Seungho; Saxena, Nishant; Dhammu, Tajinder; Khan, Mushfiquddin; Singh, Avtar K.; Singh, Inderjit; Won, Jeseong			Regulation of endothelial barrier integrity by redox-dependent nitric oxide signaling: Implication in traumatic and inflammatory brain injuries	NITRIC OXIDE-BIOLOGY AND CHEMISTRY			English	Article						Brain endothelial barrier; Endothelial nitric oxide synthase (eNOS); Actin stress fiber; Peroxynitrite (ON00(-)); S-nitrosoglutathione (GSNO); Nitric oxide	APPARENT DIFFUSION-COEFFICIENT; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; S-NITROSYLATION; MULTIPLE-SCLEROSIS; PLATELET ACTIVATION; RAT MODEL; THROMBIN; PEROXYNITRITE; DISRUPTION	Nitric oxide (NO) synthesized by eNOS plays a key role in regulation of endothelial barrier integrity but underlying cell signaling pathway is not fully understood at present. Here, we report opposing roles of two different redox-dependent NO metabolites; peroxynitrite (ONOO-) vs. S-nitrosoglutathione (GSNO), in cell signaling pathways for endothelial barrier disruption. In cultured human brain microvessel endothelial cells (hBMVECs), thrombin induced F-actin stress fiber formation causes barrier disruption via activating eNOS. Thrombin induced eNOS activity participated in cell signaling (e.g. RhoA and calcium influx mediated phosphorylation of myosin light chain) for F-actin stress fiber formation by increasing ONOO- levels. On the other hand, thrombin had no effect on intracellular levels of S-nitrosoglutathione (GSNO), another cellular NO metabolite. However, exogenous GSNO treatment attenuated the thrombin-induced cell signaling pathways for endothelial barrier disruption, thus suggesting the role of a shift of NO metabolism (GSNO vs. ONOO-) toward ONOO- synthesis in cell signaling for endothelial barrier disruption. Consistent with these in vitro studies, in animal models of traumatic brain injury and experimental autoimmune encephalomyelitis (EAE), ONOO- scavenger treatment as well as GSNO treatment were effective for attenuation of BBB leakage, edema formation, and CNS infiltration of mononuclear cells. Taken together, these data document that eNOS-mediated NO production and following redox-dependent NO metabolites (ONOO- vs. GSNO) are potential therapeutic target for CNS microvascular disease (traumatic and inflammatory) pathologies.	[Choi, Seungho; Saxena, Nishant; Dhammu, Tajinder; Khan, Mushfiquddin; Singh, Inderjit] Med Univ South Carolina, Dept Pediat, Charleston, SC 29425 USA; [Singh, Avtar K.; Won, Jeseong] Med Univ South Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Singh, Avtar K.] Ralph H Johnson Vet Adm Med Ctr, Pathol & Lab Med Serv, Charleston, SC USA; [Singh, Inderjit] Ralph H Johnson Vet Adm Med Ctr, Res Serv, Charleston, SC USA		Singh, I (corresponding author), Med Univ South Carolina, 173 Ashley Ave,DCRI Rm 509, Charleston, SC 29425 USA.; Won, J (corresponding author), Med Univ South Carolina, 173 Ashley Ave,DCRI Rm 510, Charleston, SC 29425 USA.	singhi@musc.edu; wonj@musc.edu		Won, Jeseong/0000-0003-2408-0386; Khan, Mushfiquddin/0000-0001-7945-3237	U.S. Department of Veterans AffairsUS Department of Veterans Affairs [BX002829, BX003401]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS037766]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037766] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003401, I01BX002829] Funding Source: NIH RePORTER	This work was supported in part by U.S. Department of Veterans Affairs (BX002829 and BX003401) and National Institutes of Health (NS037766).	Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Arora D, 2016, FREE RADICAL RES, V50, P291, DOI 10.3109/10715762.2015.1118473; Bogatcheva NV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P75, DOI 10.1023/A:1013904231324; Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; Broniowska KA, 2013, BBA-GEN SUBJECTS, V1830, P3173, DOI 10.1016/j.bbagen.2013.02.004; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Cannon JR, 2007, BEHAV BRAIN RES, V183, P161, DOI 10.1016/j.bbr.2007.06.004; Chen B, 2010, STROKE, V41, P2348, DOI 10.1161/STROKEAHA.110.584920; Chen F, 2017, BIOCHEM PHARMACOL, V127, P34, DOI 10.1016/j.bcp.2016.12.014; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Cramer SP, 2014, NEUROIMAGE-CLIN, V4, P182, DOI 10.1016/j.nicl.2013.12.001; Crawley JTB, 2007, J THROMB HAEMOST, V5, P95, DOI 10.1111/j.1538-7836.2007.02500.x; Davalos D, 2014, ANN NEUROL, V75, P303, DOI 10.1002/ana.24078; De Bock M, 2013, PROG NEUROBIOL, V108, P1, DOI 10.1016/j.pneurobio.2013.06.001; Di Lorenzo A, 2013, J CELL SCI, V126, P5541, DOI 10.1242/jcs.115972; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Ortiz GG, 2014, ARCH MED RES, V45, P687, DOI 10.1016/j.arcmed.2014.11.013; GARCIA JGN, 1986, J CELL PHYSIOL, V128, P96, DOI 10.1002/jcp.1041280115; Gaston Benjamin M, 2003, Mol Interv, V3, P253, DOI 10.1124/mi.3.5.253; GERSZTEN RE, 1994, NATURE, V368, P648, DOI 10.1038/368648a0; Gordge MP, 1998, BRIT J PHARMACOL, V124, P141, DOI 10.1038/sj.bjp.0701821; Grammas P, 2014, J ALZHEIMERS DIS, V42, pS537, DOI 10.3233/JAD-141557; Haldar SM, 2013, J CLIN INVEST, V123, P101, DOI 10.1172/JCI62854; He WL, 2016, REDOX BIOL, V9, P1, DOI 10.1016/j.redox.2016.05.002; Hoda MN, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-21; Holland JA, 1998, ENDOTHELIUM-NEW YORK, V6, P113, DOI 10.3109/10623329809072198; Kaur J, 2009, INT J STROKE, V4, P159, DOI 10.1111/j.1747-4949.2009.00288.x; Khan M, 2018, BEHAV BRAIN RES, V340, P63, DOI 10.1016/j.bbr.2016.10.037; Khan M, 2016, BRAIN RES, V1630, P159, DOI 10.1016/j.brainres.2015.11.015; Khan M, 2012, J NEUROCHEM, V123, P86, DOI 10.1111/j.1471-4159.2012.07947.x; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kim J, 2014, ANTIOXID REDOX SIGN, V20, P2514, DOI 10.1089/ars.2013.5223; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kraehling JR, 2017, CIRC RES, V120, P1174, DOI 10.1161/CIRCRESAHA.117.303776; Lahteenvuo J, 2012, CIRC RES, V110, P1252, DOI 10.1161/CIRCRESAHA.111.246116; Langer HF, 2012, CIRC RES, V110, P1202, DOI 10.1161/CIRCRESAHA.111.256370; Li B, 2006, FEBS LETT, V580, P4252, DOI 10.1016/j.febslet.2006.06.056; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Majumdar M, 1999, J BIOL CHEM, V274, P26815, DOI 10.1074/jbc.274.38.26815; Nalli AD, 2014, CELL BIOCHEM BIOPHYS, V70, P867, DOI 10.1007/s12013-014-9992-6; Nath N, 2004, J IMMUNOL, V172, P1273, DOI 10.4049/jimmunol.172.2.1273; Nath N, 2010, J NEUROIMMUNE PHARM, V5, P240, DOI 10.1007/s11481-009-9187-x; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Nishikawa H, 2017, NEURAL REGEN RES, V12, P1982, DOI 10.4103/1673-5374.221150; NISHINO A, 1993, J NEUROTRAUM, V10, P167, DOI 10.1089/neu.1993.10.167; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Olah L, 2000, J CEREBR BLOOD F MET, V20, P1474, DOI 10.1097/00004647-200010000-00009; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pan BX, 2004, REDOX REP, V9, P49, DOI 10.1179/135100004225003914; Popovic M, 2012, MOL CELL BIOCHEM, V359, P301, DOI 10.1007/s11010-011-1024-x; Prasad R, 2007, GLIA, V55, P65, DOI 10.1002/glia.20436; Price L., 2016, TRANSLATIONAL RES TR; RADOMSKI MW, 1992, BRIT J PHARMACOL, V107, P745, DOI 10.1111/j.1476-5381.1992.tb14517.x; Rafikov R, 2014, J BIOL CHEM, V289, P4710, DOI 10.1074/jbc.M114.547596; Satpathy M, 2004, EXP EYE RES, V79, P477, DOI 10.1016/j.exer.2004.06.018; SHAPIRO PE, 1991, J AM ACAD DERMATOL, V24, P665, DOI 10.1016/S0190-9622(08)80178-8; Sheremata WA, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-27; Shi YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10523; Stolz L, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0926-2; STONE LA, 1995, NEUROLOGY, V45, P1122, DOI 10.1212/WNL.45.6.1122; Touyz RM, 2007, HYPERTENSION, V49, P429, DOI 10.1161/01.HYP.0000255955.75119.1a; van Hinsbergh VWM, 2002, J ANAT, V200, P549, DOI 10.1046/j.1469-7580.2002.00060.x; Wilcox JN, 1997, ARTERIOSCL THROM VAS, V17, P2479, DOI 10.1161/01.ATV.17.11.2479; Won JS, 2013, J ALZHEIMERS DIS, V34, P621, DOI 10.3233/JAD-121786; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x	72	8	8	1	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1089-8603	1089-8611		NITRIC OXIDE-BIOL CH	Nitric Oxide-Biol. Chem.	FEB 1	2019	83						51	64		10.1016/j.niox.2018.12.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HI7KW	WOS:000456636100007	30590116	Green Accepted			2022-02-06	
J	Donald, R; Howells, T; Piper, I; Enblad, P; Nilsson, P; Chambers, I; Gregson, B; Citerio, G; Kiening, K; Neumann, J; Ragauskas, A; Sahuquillo, J; Sinnott, R; Stell, A				Donald, Rob; Howells, Tim; Piper, Ian; Enblad, P.; Nilsson, P.; Chambers, I.; Gregson, B.; Citerio, G.; Kiening, K.; Neumann, J.; Ragauskas, A.; Sahuquillo, J.; Sinnott, R.; Stell, A.		BrainIT Grp	Forewarning of hypotensive events using a Bayesian artificial neural network in neurocritical care	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Traumatic brain injury; Neuro-intensive care; Bayesian prediction; Clinical study results	BIG DATA; PREDICTION	Traumatically brain injured (TBI) patients are at risk from secondary insults. Arterial hypotension, critically low blood pressure, is one of the most dangerous secondary insults and is related to poor outcome in patients. The overall aim of this study was to get proof of the concept that advanced statistical techniques (machine learning) are methods that are able to provide early warning of impending hypotensive events before they occur during neuro-critical care. A Bayesian artificial neural network (BANN) model predicting episodes of hypotension was developed using data from 104 patients selected from the BrainIT multi-center database. Arterial hypotension events were recorded and defined using the Edinburgh University Secondary Insult Grades (EUSIG) physiological adverse event scoring system. The BANN was trained on a random selection of 50% of the available patients (n = 52) and validated on the remaining cohort. A multi-center prospective pilot study (Phase 1, n = 30) was then conducted with the system running live in the clinical environment, followed by a second validation pilot study (Phase 2, n = 49). From these prospectively collected data, a final evaluation study was done on 69 of these patients with 10 patients excluded from the Phase 2 study because of insufficient or invalid data. Each data collection phase was a prospective non-interventional observational study conducted in a live clinical setting to test the data collection systems and the model performance. No prediction information was available to the clinical teams during a patient's stay in the ICU. The final cohort (n = 69), using a decision threshold of 0.4, and including false positive checks, gave a sensitivity of 39.3% (95% CI 32.9-46.1) and a specificity of 91.5% (95% CI 89.0-93.7). Using a decision threshold of 0.3, and false positive correction, gave a sensitivity of 46.6% (95% CI 40.1-53.2) and specificity of 85.6% (95% CI 82.3-88.8). With a decision threshold of 0.3, > 15min warning of patient instability can be achieved. We have shown, using advanced machine learning techniques running in a live neuro-critical care environment, that it would be possible to give neurointensive teams early warning of potential hypotensive events before they emerge, allowing closer monitoring and earlier clinical assessment in an attempt to prevent the onset of hypotension. The multi-centre clinical infrastructure developed to support the clinical studies provides a solid base for further collaborative research on data quality, false positive correction and the display of early warning data in a clinical setting.	[Donald, Rob] Stats Res Ltd, Dingwall, Scotland; [Howells, Tim] Uppsala Univ Hosp, Dept Neurosurg, Uppsala, Sweden; [Piper, Ian] Queen Elizabeth Univ Hosp, Inst Neurol Sci, Clin Phys, Glasgow, Lanark, Scotland; [Enblad, P.; Nilsson, P.] Uppsala Univ, Sect Neurosurg, Uppsala, Sweden; [Chambers, I.] James Cook Univ Hosp, Dept Med Phys, Middlesbrough, Cleveland, England; [Gregson, B.] Newcastle Univ, Neurosurg Trials Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Citerio, G.] Hosp San Gerardo, Neurorianimaz, Monza, Italy; [Kiening, K.; Neumann, J.] Ruprecht Karls Univ Hosp, Dept Neurosurg, Heidelberg, Germany; [Ragauskas, A.] Kaunas Univ Technol, Kaunas, Lithuania; [Sahuquillo, J.] Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Sinnott, R.] Univ Melbourne, Dept Informat Syst, Parkville, Vic, Australia; [Stell, A.] Univ Glasgow, Dept Clin Phys, Glasgow, Lanark, Scotland		Piper, I (corresponding author), Queen Elizabeth Univ Hosp, Inst Neurol Sci, Clin Phys, Glasgow, Lanark, Scotland.	rob@statsresearch.co.uk	Sahuquillo, Juan/B-3577-2008; Citerio, Giuseppe/B-1839-2015	Sahuquillo, Juan/0000-0003-0713-5875; Citerio, Giuseppe/0000-0002-5374-3161; Donald, Rob/0000-0001-5301-0219	European 2020 IST Programme [IST-2007-217049]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/R004498/1] Funding Source: UKRI	Funding: European 2020 IST Programme - IST-2007-217049; Investigators and participating centers: Barcelona, Spain: Prof. Sahuquillo; Cambridge, UK: Prof. Pickard; Edinburgh, UK: Prof. Whittle; Glasgow, UK: Mr. Dunn; Gothenburg, Sweden: Dr. Rydenhag; Heidelberg, Germany: Dr. Kiening; Iasi, Romania: Dr. Iencean; Kaunas, Lithuania: Prof. Pavalkis; Leipzig, Germany: Prof. Meixensberger; Leuven, Belgium: Prof. Goffin; Mannheim, Germany: Prof. Vajkoczy; Milano, Italy: Prof. Stocchetti; Monza, Italy: Dr. Citerio; Newcastle upon Tyne, UK: Dr. Chambers; Novara, Italy: Prof. Della Corte; Southampton, UK: Dr. Hell; Uppsala, Sweden: Prof. Enblad; Torino, Italy: Dr. Mascia; Vilnius, Lithuania: Prof. Jarzemaskas; Zurich, Switzerland: Prof. Stocker.	American College of Surgeons, 2011, ADV TRAUM LIF SUPP; AvertIT, 2008, FP7217049AVERTIT; Bijker JB, 2009, ANESTHESIOLOGY, V111, P1217, DOI 10.1097/ALN.0b013e3181c14930; Bishop C. M., 1995, NEURAL NETWORKS PATT; BrainIT, 2009, BRAIN IT CORE DATASE; BrainIT Consortium, 2007, BRAINIT CONSORTIUM; Celi LA, 2013, AM J RESP CRIT CARE, V187, P1157, DOI 10.1164/rccm.201212-2311ED; Chen X, 2009, COMPUT CARDIOL, V36, P545; Crawley M.J., 2012, R BOOK; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Docherty AB, 2015, CURR OPIN CRIT CARE, V21, P467, DOI 10.1097/MCC.0000000000000228; Donald Rob, 2012, Acta Neurochir Suppl, V114, P45, DOI 10.1007/978-3-7091-0956-4_9; Figini S, 2014, TECHNICAL REPORT; FUNAHASHI K, 1989, NEURAL NETWORKS, V2, P183, DOI 10.1016/0893-6080(89)90003-8; Gabutti L, 2004, NEPHROL DIAL TRANSPL, V19, P1204, DOI 10.1093/ndt/gfh084; Ghassemi M, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0801-4; Hand DJ, 2012, INT STAT REV, V80, P400, DOI 10.1111/j.1751-5823.2012.00183.x; Hanfelt JJ, 1999, CONTROL CLIN TRIALS, V20, P555, DOI 10.1016/S0197-2456(99)00028-8; Henriques JH, 2009, COMPUT CARDIOL, V36, P549; IBM InfoSphere, BIG DAT HELP TOR HOS; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lehman LH, 2008, COMPUTERS IN CARDIOLOGY 2008, VOLS 1 AND 2, P653, DOI 10.1109/CIC.2008.4749126; MACKAY DJC, 1995, NETWORK-COMP NEURAL, V6, P469, DOI 10.1088/0954-898X/6/3/011; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mneimneh MA, 2009, COMPUT CARDIOL, V36, P557; Moody GB, 2009, COMPUT CARDIOL, V36, P541; Neal R.M., 1996, BAYESIAN LEARNING NE, V118; Piper I, 2010, ACTA NEUROCHIR, V152, P1859, DOI 10.1007/s00701-010-0719-1; Reich DL, 2005, ANESTH ANALG, V101, P622, DOI 10.1213/01.ANE.0000175214.38450.91; Ripley B., 1996, PATTERN RECOGN; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Smiley R, 2005, ANESTHESIOLOGY, V102, P1079, DOI 10.1097/00000542-200506000-00002; Stell A, 2009, PHILOS T R SOC A, V367, P2679, DOI 10.1098/rsta.2009.0042; Williams CKI, 2016, MACHINE LEARNING HEA	35	8	9	0	13	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	FEB	2019	33	1					39	51		10.1007/s10877-018-0139-y			13	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	HG2UH	WOS:000454820400007	29799079				2022-02-06	
J	Killien, EY; Mills, B; Watson, RS; Vavilala, MS; Rivara, FP				Killien, Elizabeth Y.; Mills, Brianna; Watson, R. Scott; Vavilala, Monica S.; Rivara, Frederick P.			Morbidity and Mortality Among Critically Injured Children With Acute Respiratory Distress Syndrome	CRITICAL CARE MEDICINE			English	Article						acute respiratory distress syndrome; child; intensive care units; hospital mortality; outcome assessment; trauma centers	ACUTE LUNG INJURY; PEDIATRIC INTENSIVE-CARE; CONSENSUS CONFERENCE; RISK-FACTORS; TRAUMA; OUTCOMES; TRACHEOSTOMY; DEFINITION; COMPLICATIONS; EPIDEMIOLOGY	Objectives: To evaluate morbidity and mortality among critically injured children with acute respiratory distress syndrome. Design: Retrospective cohort study. Setting: Four-hundred sixty Level I/II adult or pediatric trauma centers contributing to the National Trauma Data Bank. Patients: One hundred forty-six thousand fifty-eight patients less than 18 years old admitted to an ICU with traumatic injury from 2007 to 2016. Interventions: None. Measurements and Main Results: We assessed in-hospital mortality and need for postdischarge care among patients with and without acute respiratory distress syndrome and hospital resource utilization and discharge disposition among survivors. Analyses were adjusted for underlying mortality risk (age, Injury Severity Score, serious brain or chest injury, and admission heart rate and hypotension) and year, transfer status, and facility trauma level designation. Acute respiratory distress syndrome occurred in 2,590 patients (1.8%). Mortality was 20.0% among acute respiratory distress syndrome patients versus 4.3% among nonacute respiratory distress syndrome patients, with an adjusted relative risk of 1.76 (95% CI, 1.52-2.04). Postdischarge care was required in an additional 44.8% of acute respiratory distress syndrome patients versus 16.0% of patients without acute respiratory distress syndrome (adjusted relative risk, 3.59; 2.87-4.49), with only 35.1% of acute respiratory distress syndrome patients discharging to home versus 79.8% of patients without acute respiratory distress syndrome. Acute respiratory distress syndrome mortality did not change over the 10-year study period (adjusted relative risk, 1.01/ yr; 0.96-1.06) nor did the proportion of acute respiratory distress syndrome patients requiring postdischarge care (adjusted relative risk, 1.04/yr; 0.97-1.11). Duration of ventilation, ICU stay, and hospital stay were all significantly longer among acute respiratory distress syndrome survivors. Tracheostomy placement occurred in 18.4% of acute respiratory distress syndrome survivors versus 2.1% of patients without acute respiratory distress syndrome (adjusted relative risk, 3.10; 2.59-3.70). Conclusions: Acute respiratory distress syndrome development following traumatic injury in children is associated with significantly increased risk of morbidity and mortality, even after adjustment for injury severity and hemodynamic abnormalities. Outcomes have not improved over the past decade, emphasizing the need for new therapeutic interventions, and prevention strategies for acute respiratory distress syndrome among severely injured children.	[Killien, Elizabeth Y.; Mills, Brianna; Vavilala, Monica S.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Killien, Elizabeth Y.; Watson, R. Scott] Univ Washington, Dept Pediat, Div Pediat Crit Care Med, Seattle, WA 98195 USA; [Watson, R. Scott; Rivara, Frederick P.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Div Gen Pediat, Seattle, WA 98195 USA		Killien, EY (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA.	elizabeth.killien@seattlechildrens.org	/AAD-2116-2020		National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5 T32 HD057822-08]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822] Funding Source: NIH RePORTER	Supported, in part, by National Institute of Child Health and Human Development grant 5 T32 HD057822-08.	Afshar M, 2016, J SURG RES, V201, P394, DOI 10.1016/j.jss.2015.11.050; American College of Surgeons, NAT TRAUM DAT BANK; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Calfee CS, 2007, CRIT CARE MED, V35, P2243, DOI 10.1097/01.CCM.0000280434.33451.87; Center for Disease Control, 10 LEAD CAUS DEATH A; Chang MC, 2016, AM COLL SURG NATL TR; Cheifetz IM, 2017, RESP CARE, V62, P718, DOI 10.4187/respcare.05591; Dahlem P, 2003, EUR RESPIR J, V22, P980, DOI 10.1183/09031936.03.00003303; De Luca D, 2013, INTENS CARE MED, V39, P2083, DOI 10.1007/s00134-013-3110-x; de Roulet A, 2018, J PEDIATR SURG; Dowell JC, 2018, CRIT CARE MED, V46, P1811, DOI [10.1097/CCM.0000000000003371, 10.1097/ccm.0000000000003371]; Eisner MD, 2001, AM J RESP CRIT CARE, V164, P231, DOI 10.1164/ajrccm.164.2.2011093; Erickson S, 2007, PEDIATR CRIT CARE ME, V8, P317, DOI 10.1097/01.PCC.0000269408.64179.FF; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Flori HR, 2005, AM J RESP CRIT CARE, V171, P995, DOI 10.1164/rccm.200404-544OC; Gupta S, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00093; Haider AH, 2015, SURGERY, V158, P96, DOI 10.1016/j.surg.2015.02.015; Haider AH, 2014, J TRAUMA ACUTE CARE, V76, P1061, DOI 10.1097/TA.0000000000000182; Holloway Adrian J, 2015, Pediatr Crit Care Med, V16, pe52, DOI 10.1097/PCC.0000000000000336; Holscher CM, 2014, J PEDIATR SURG, V49, P590, DOI 10.1016/j.jpedsurg.2013.09.002; Howard BM, 2015, J TRAUMA ACUTE CARE, V78, P735, DOI 10.1097/TA.0000000000000583; Ingraham AM, 2010, ANN SURG, V252, P358, DOI 10.1097/SLA.0b013e3181e623bf; Jouvet P, 2015, PEDIATR CRIT CARE ME, V16, P428, DOI 10.1097/PCC.0000000000000350; Khemani RG, 2015, PEDIATR CRIT CARE ME, V16, pS23, DOI 10.1097/PCC.0000000000000432; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Kneyber MCJ, 2008, INTENS CARE MED, V34, P751, DOI 10.1007/s00134-008-1029-4; Lopez-Fernandez Y, 2012, CRIT CARE MED, V40, P3238, DOI 10.1097/CCM.0b013e318260caa3; McLaughlin C, 2018, J PEDIATR SURG, V53, P344, DOI 10.1016/j.jpedsurg.2017.10.006; Parvathaneni K, 2017, PEDIATR CRIT CARE ME, V18, P17, DOI 10.1097/PCC.0000000000000945; Plurad D, 2007, J TRAUMA, V63, P1, DOI 10.1097/TA.0b013e318068b1ed; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Salim A, 2006, ARCH SURG-CHICAGO, V141, P655, DOI 10.1001/archsurg.141.7.655; Schouten LRA, 2016, CRIT CARE MED, V44, P819, DOI [10.1097/CCM.0000000000001388, 10.1097/CCM.0000000000002008]; Treggiari MM, 2004, CRIT CARE MED, V32, P327, DOI 10.1097/01.CCM.0000108870.09693.42; Wakeham MK, 2014, INTENS CARE MED, V40, P863, DOI 10.1007/s00134-014-3298-4; Watters KF, 2017, RESP CARE, V62, P799, DOI 10.4187/respcare.05366; Yehya N, 2015, CRIT CARE MED, V43, P937, DOI 10.1097/CCM.0000000000000867; Zimmerman JJ, 2009, PEDIATRICS, V124, P87, DOI 10.1542/peds.2007-2462	38	8	8	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	FEB	2019	47	2					E112	E119		10.1097/CCM.0000000000003525			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HN0RD	WOS:000459895200006	30379667	Green Accepted			2022-02-06	
J	Klima, D; Morgan, L; Baylor, M; Reilly, C; Gladmon, D; Davey, A				Klima, Dennis; Morgan, Lindsay; Baylor, Michelle; Reilly, Cordia; Gladmon, Daniel; Davey, Adam			Physical Performance and Fall Risk in Persons With Traumatic Brain Injury	PERCEPTUAL AND MOTOR SKILLS			English	Article						traumatic brain injury; gait; balance; falls; posturography	DUAL-TASK PERFORMANCE; 10-METER WALK TEST; BALANCE DEFICITS; GO TEST; OLDER-ADULTS; GAIT SPEED; REHABILITATION; ASSOCIATIONS; RELIABILITY; INDIVIDUALS	Injuries sustained from traumatic brain injury (TBI) culminate in both cognitive and neuromuscular deficits. Patients often progress to higher functioning on the Rancho continuum even while mobility deficits persist. Although prior studies have examined physical performance among persons with chronic symptoms of TBI, less is known about the relatively acute phase of TBI as patients prepare for rehabilitation discharge. The aims of this cross-sectional study were to (a) compare balance and gait performance in 20 ambulant persons with moderate to severe TBI who were nearing rehabilitation discharge with their age-matched controls and (b) describe performance with thresholds for fall risk and community navigation. During a designed task circuit, 40 participants (20 persons with TBI and 20 controls) performed the Timed Up and Go (TUG), gait velocity, and Walking and Remembering tests. Balance testing included the Fullerton Advanced Balance Scale (FABS) and instrumented Modified Clinical Test for Sensory Interaction in Balance (MCTSIB). Statistical analyses included analysis of covariance for group comparisons and a multivariate analysis of covariance for MCTSIB sway velocities with anthropometric controls. The TBI group (mean [M] age = 42, standard deviation [SD] =19.5 years; 70% males) performed significantly more poorly on all mobility tests (p < .05) and their scores reflected a potential fall risk. Gait velocity was significantly slower for the TBI versus control group (M = .96, SD = 2.6 vs. M = 1.5, SD = 2.2 m/s; p < .001), including TUG times (M = 13.5, SD = 4.9 vs. M = 7.7, SD = 1.4; p < .001). TBI participants also demonstrated significantly greater sway velocity on all MCTSIB conditions (p < .01) and lower performance on the FABS (p < .001). Performance indices indicate potential fall risk and community navigation compromise for individuals with moderate to severe TBI. Physical performance scores support the need for continued interventions to optimize functional mobility upon discharge.	[Klima, Dennis] Univ Maryland Eastern Shore, Dept Phys Therapy, Princess Anne, MD 21853 USA; [Morgan, Lindsay] Anne Arundel Med Ctr, Dept Rehabil, Annapolis, MD USA; [Baylor, Michelle; Gladmon, Daniel] Univ Maryland, Rehabil & Orthoped Inst, Rehabil Serv, Baltimore, MD 21201 USA; [Reilly, Cordia] Univ Maryland Shore Reg Hlth, Rehabil Serv, Easton, MD USA; [Davey, Adam] Univ Delaware, Dept Behav Hlth & Nutr, Newark, DE USA		Klima, D (corresponding author), Univ Maryland Eastern Shore, Dept Phys Therapy, Princess Anne, MD 21853 USA.	dwklima@umes.edu			NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA194178] Funding Source: Medline		Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Barry E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-14; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Beauchet O, 2011, J NUTR HEALTH AGING, V15, P933, DOI 10.1007/s12603-011-0062-0; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Bonnyaud C, 2016, GAIT POSTURE, V49, P258, DOI 10.1016/j.gaitpost.2016.06.023; Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; Buster TW, 2016, BRAIN INJURY, V30, P1249, DOI 10.1080/02699052.2016.1183822; Campbell CM., 2003, J NEUROL PHYS THER, V27, P2, DOI [DOI 10.1097/01253086-200327010-00002, 10.1097/01253086-200327010-00002]; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; Center for Disease Control and Prevention, 2018, TBI GET FACTS; Chainani V, 2016, INT J CARDIOL, V215, P487, DOI 10.1016/j.ijcard.2016.04.068; Cherry BJ, 2012, ARCH PHYS MED REHAB, V93, P62, DOI 10.1016/j.apmr.2011.08.006; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Drijkoningen D, 2015, HUM BRAIN MAPP, V36, P4897, DOI 10.1002/hbm.22958; Drijkoningen D, 2015, J NEUROTRAUM, V32, P1324, DOI 10.1089/neu.2014.3787; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Flannery J, 1995, J Nurs Meas, V3, P43; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; HAGEMAN PA, 1995, ARCH PHYS MED REHAB, V76, P961, DOI 10.1016/S0003-9993(95)80075-1; Hagen C, 1979, REHABILITATION HEAD; Hernandez D, 2008, ARCH PHYS MED REHAB, V89, P2309, DOI 10.1016/j.apmr.2008.05.020; Hirsch MA, 2014, BRAIN INJURY, V28, P1115, DOI 10.3109/02699052.2014.910701; Hwang HF, 2015, J HEAD TRAUMA REHAB, V30, pE9, DOI 10.1097/HTR.0000000000000093; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Johns JS, 1999, J HEAD TRAUMA REHAB, V14, P269, DOI 10.1097/00001199-199906000-00007; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Katz-Leurer M, 2011, NEUROREHABILITATION, V29, P45, DOI 10.3233/NRE-2011-0676; Katz-Leurer Michal, 2008, Pediatr Phys Ther, V20, P254, DOI 10.1097/PEP.0b013e3181820dd8; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Klein PJ, 2011, PHYSIOTHER CAN, V63, P115, DOI 10.3138/ptc.2009-51; Kojima G, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0039-7; Kolakowsky-Hayner SA, 2016, NEUROREHABILITATION, V39, P363, DOI 10.3233/NRE-161368; Labi MLC, 2003, BRAIN INJURY, V17, P265, DOI 10.1080/0269905021000038410; Lei-Rivera L, 2013, NEUROREHABILITATION, V32, P463, DOI 10.3233/NRE-130869; Majdan M, 2015, EUR J TRAUMA EMERG S, V41, P651, DOI 10.1007/s00068-014-0490-8; McCulloch K. L., 2006, J NEUROL PHYS THER, V31, P104; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; McCulloch KL, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932010-00002; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; McKechnie D, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000146; McKechnie D, 2015, DISABIL REHABIL, V37, P2291, DOI 10.3109/09638288.2014.1002578; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Montero-Odasso M, 2005, J GERONTOL A-BIOL, V60, P1304, DOI 10.1093/gerona/60.10.1304; Mossberg KA, 2010, J HEAD TRAUMA REHAB, V25, P173, DOI 10.1097/HTR.0b013e3181dc98ff; Navalon N, 2014, BRAIN INJURY, V28, P1417, DOI 10.3109/02699052.2014.917200; NEWTON RA, 1995, BRAIN INJURY, V9, P445, DOI 10.3109/02699059509008204; Pardasaney PK, 2012, PHYS THER, V92, P388, DOI 10.2522/ptj.20100398; Perry SB, 2014, J HEAD TRAUMA REHAB, V29, P117, DOI 10.1097/HTR.0b013e3182864f2f; Peters DM, 2013, J GERIATR PHYS THER, V36, P24, DOI 10.1519/JPT.0b013e318248e20d; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rose DJ, 2006, ARCH PHYS MED REHAB, V87, P1478, DOI 10.1016/j.apmr.2006.07.263; Rothman MD, 2008, J AM GERIATR SOC, V56, P2211, DOI 10.1111/j.1532-5415.2008.02008.x; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Salbach NM, 2014, ARCH PHYS MED REHAB, V95, P117, DOI 10.1016/j.apmr.2013.06.017; Salottolo K, 2017, J CRIT CARE, V38, P197, DOI 10.1016/j.jcrc.2016.11.034; Schlenstedt C, 2016, PHYS THER, V96, P494, DOI 10.2522/ptj.20150249; Schoene D, 2013, J AM GERIATR SOC, V61, P202, DOI 10.1111/jgs.12106; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Singer BJ, 2004, ARCH PHYS MED REHAB, V85, P1465, DOI 10.1016/j.apmr.2003.08.103; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Suttanon P, 2011, INT PSYCHOGERIATR, V23, P1152, DOI 10.1017/S1041610211000639; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Viccaro LJ, 2011, J AM GERIATR SOC, V59, P887, DOI 10.1111/j.1532-5415.2011.03336.x; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wampler MA, 2007, ARCH PHYS MED REHAB, V88, P1002, DOI 10.1016/j.apmr.2007.05.007; Watson MJ, 2004, PHYSIOTHERAPY, V90, P103; Williams G, 2017, BRAIN INJURY, V31, P193, DOI 10.1080/02699052.2016.1218548; Williams G, 2013, J HEAD TRAUMA REHAB, V28, P379, DOI 10.1097/HTR.0b013e3182575f80; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Williams GP, 2013, J HEAD TRAUMA REHAB, V28, P371, DOI 10.1097/HTR.0b013e31824a1d40; Williams GP, 2011, PHYSIOTHER CAN, V63, P58, DOI 10.3138/ptc.2009-53; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711	80	8	8	2	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0031-5125	1558-688X		PERCEPT MOTOR SKILL	Percept. Mot. Skills	FEB	2019	126	1					50	69		10.1177/0031512518809203			20	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	HI5QO	WOS:000456509200004	30458668	Green Accepted, Bronze			2022-02-06	
J	Liaudanskaya, V; Jgamadze, D; Berk, AN; Bischoff, DJ; Gu, BJ; Hawks-Mayer, H; Whalen, MJ; Chen, HI; Kaplan, DL				Liaudanskaya, Volha; Jgamadze, Dennis; Berk, Alexander N.; Bischoff, David J.; Gu, Ben J.; Hawks-Mayer, Hannah; Whalen, Michael J.; Chen, H. Isaac; Kaplan, David L.			Engineering advanced neural tissue constructs to mitigate acute cerebral inflammation after brain transplantation in rats	BIOMATERIALS			English	Article						Tissue engineering; Brain tissue; Brain damage; Transplantation; Neuroinflammation; Cortical tissue	HIGH-DOSE METHYLPREDNISOLONE; STEM-CELLS; REACTIVE ASTROCYTES; INJURY; MICROGLIA; NEUROINFLAMMATION; REGULATOR; SURVIVAL; NEURONS; ORIGIN	Stroke, traumatic brain injuries, and other similar conditions often lead to significant loss of functional brain tissue and associated disruption of neuronal signaling. A common strategy for replacing lost neurons is the injection of dissociated neural stem cells or differentiated neurons. However, this method is unlikely to be suitable for replacing large brain cavities, and the resulting distribution of neurons may lack the necessary architecture to support appropriate brain function. Engineered neural tissues may be a viable alternative. Cell death is a prominent concern in neuronal grafting studies, a problem that could be magnified with the transplantation of engineered neural tissues. Here, we examined the effect of one contributor to cell death, acute cerebral inflammation, on neuronal survival after the transplantation of bioengineered constructs based on silk scaffolds. We found evidence of a high degree of inflammation and poor neuronal survival after introducing engineered constructs into the motor cortex of rats. Integrating a corticosteroid (methylprednisolone) into the constructs resulted in significantly improved neuron survival during the acute phase of inflammation. The improved construct survival was associated with decreased markers of inflammation and an anti-inflammatory state of the immune system due to the steroid treatment.	[Liaudanskaya, Volha; Berk, Alexander N.; Bischoff, David J.; Hawks-Mayer, Hannah; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Jgamadze, Dennis; Gu, Ben J.; Chen, H. Isaac] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Chen, H. Isaac] Corposal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA USA; [Whalen, Michael J.] Massachusetts Gen Hosp, Neurosci Ctr, Charlestown, MA USA		Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.; Chen, HI (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.	Isaac.Chen@uphs.upenn.edu; david.kaplan@tufts.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS092847, R01NS094218, S10OD021624]; Department of Veterans AffairsUS Department of Veterans Affairs [IK2RX002013]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB021264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092847, R01NS094218] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD021624] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2RX002013] Funding Source: NIH RePORTER	We thank the NIH (R01NS092847, R01NS094218, S10OD021624 to DK) and the Department of Veterans Affairs (grant IK2RX002013 to HIC) for support of this work. Dr. Chuang Du for help with electrophysiology recordings and Dr. Mattia Bonzanni for help with electrophysiology data interpretation.	Agarwal J. R., 2014, METH MODEL INTECH, DOI [10.5772/57602, DOI 10.5772/57602]; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Banchereau R, 2016, CELL, V165, P551, DOI 10.1016/j.cell.2016.03.008; Bi PP, 2015, TRENDS ENDOCRIN MET, V26, P248, DOI 10.1016/j.tem.2015.02.006; Bible E, 2012, BIOMATERIALS, V33, P7435, DOI 10.1016/j.biomaterials.2012.06.085; Boche D, 2013, NEUROPATH APPL NEURO, V39, P1, DOI 10.1111/nan.12009; Bouyer C, 2016, ADV MATER, V28, P161, DOI 10.1002/adma.201503916; Carlson AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10862; Chen HI, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00001; Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Chwalek K, 2015, NAT PROTOC, V10, P1362, DOI 10.1038/nprot.2015.091; Dani C, 2007, J MATERN-FETAL NEO M, V20, P325, DOI 10.1080/14767050701227992; Deczkowska A, 2018, CELL, V173, P1073, DOI 10.1016/j.cell.2018.05.003; Falkner S, 2016, NATURE, V539, P248, DOI 10.1038/nature20113; Friedman BA, 2018, CELL REP, V22, P832, DOI 10.1016/j.celrep.2017.12.066; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Gao W, 2016, NEURAL REGEN RES, V11, P823, DOI 10.4103/1673-5374.182711; Ghosh M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0463-9; Gotz M, 2015, GLIA, V63, P1452, DOI 10.1002/glia.22850; Gutierrez H, 2011, TRENDS NEUROSCI, V34, P316, DOI 10.1016/j.tins.2011.03.001; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jgamadze D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030293; Ju YE, 2007, BIOMATERIALS, V28, P2097, DOI 10.1016/j.biomaterials.2007.01.008; Kirmse K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8750; Kyritsis N, 2014, TRENDS CELL BIOL, V24, P128, DOI 10.1016/j.tcb.2013.08.004; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Le Page E, 2015, LANCET, V386, P974, DOI 10.1016/S0140-6736(15)61137-0; Lee JH, 2017, INT J OBESITY, V41, P645, DOI 10.1038/ijo.2017.3; Li Y., 2016, SCI REP, V6, P1, DOI DOI 10.1038/srep22755; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lukovic D, 2015, STEM CELLS, V33, P1036, DOI 10.1002/stem.1959; Mothe AJ, 2013, INT J DEV NEUROSCI, V31, P701, DOI 10.1016/j.ijdevneu.2013.07.004; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Payne SL, 2018, TISSUE ENG PT A, V24, P351, DOI [10.1089/ten.tea.2016.0515, 10.1089/ten.TEA.2016.0515]; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Rummel C, 2010, MOL PSYCHIATR, V15, P523, DOI 10.1038/mp.2009.98; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Tamashiro TT, 2012, JOVE-J VIS EXP, DOI 10.3791/3814; Tang-Schomer MD, 2014, P NATL ACAD SCI USA, V111, P13811, DOI 10.1073/pnas.1324214111; Thompson LH, 2015, NEUROBIOL DIS, V79, P28, DOI 10.1016/j.nbd.2015.04.003; Wagner A. K., 2013, BRAIN INJURY MED; Walsh M, 2013, KIDNEY INT, V84, P397, DOI 10.1038/ki.2013.131; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Wong VS, 2016, NEUROSCI LETT, V625, P26, DOI 10.1016/j.neulet.2016.04.009; Yasuda H, 2010, J NEUROSURG, V112, P336, DOI 10.3171/2009.2.JNS08495; Zhang Y., 2013, NFKB SIGNALING DIREC; Zhao HH, 2016, Int J Nurs Sci, V3, P385, DOI 10.1016/j.ijnss.2016.11.001	51	8	8	1	33	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	FEB	2019	192						510	522		10.1016/j.biomaterials.2018.11.031			13	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	HJ1DL	WOS:000456902000041	30529870	Green Accepted			2022-02-06	
J	Sarmiento, K; Donnell, Z; Bell, E; Hoffman, R				Sarmiento, Kelly; Donnell, Zoe; Bell, Elizabeth; Hoffman, Rosanne			From the CDC: A qualitative study of middle and high school professionals' experiences and views on concussion: Identifying opportunities to support the return to school process	JOURNAL OF SAFETY RESEARCH			English	Article						Concussion; Traumatic brain injury; Children; School; Nurse	POSTCONCUSSION SYNDROME; CHILDREN; RECOMMENDATIONS; SYMPTOMS; STUDENT; INJURY	Introduction: Current research recommends that students returning to school after a concussion should receive a return to school plan that is tailored to their individual symptoms. School professionals play important roles in designing and implementing the supports outlined in return to school plans. Methods: This qualitative study explored middle and high school professionals' experiences with concussion, particularly their knowledge and perceptions of the injury and their experience with supporting students with concussion. Six focus groups were conducted with two to four school professionals per group, including two groups of teachers, two groups of school psychologists and counselors, and two groups of school nurses. Findings were coded into four categories: (a) challenges with identifying a concussion; (b) strategies for communicating with students about concussion; (c) barriers to implementing return to learn plans; and (d) establishing a collaborative school support team. Results: School professionals who participated in the focus groups were knowledgeable about concussion and the importance of helping their student recover. Participants also understood the importance of recognizing the signs and symptoms of concussion and communicating with students and parents about this injury. However, the study participants reported various challenges related to concussion identification and management, including the perceived validity of concussion symptom reporting by students. A team-based approach was mentioned across all groups as the preferred method for school-based concussion management for students. Conclusion: School professionals in this study were eager to address concussion in their schools, but desire guidance on how to overcome social norms around concussion identification and reporting. In addition, there is a need for consistent use of written instructions from healthcare providers to help guide return to learn (RTL) accommodations. Practical applications: The findings from this study can help inform the integration of concussion, and other health, management plans in schools. Published by Elsevier Ltd.	[Sarmiento, Kelly] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, 1600 Clifton Rd, Atlanta, GA 30329 USA; [Donnell, Zoe; Bell, Elizabeth; Hoffman, Rosanne] ICF, 530 Gaither Rd, Rockville, MD 20850 USA		Sarmiento, K (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, 1600 Clifton Rd, Atlanta, GA 30329 USA.	KSarmiento@cdc.gov			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [GS-23F-0115K]	This project was fund through Centers for Disease Control and Prevention contract GS-23F-0115K.	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Centers for Disease Control and Prevention, 2006, AC CONC EV CAR PLAN; Centers for Disease Control and Prevention, 2017, WHAT IS A CONC; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; De Maio VJ, 2014, PEDIATR EMERG CARE, V30, P20, DOI 10.1097/PEC.0000000000000058; Diaz Anne L, 2013, NASN Sch Nurse, V28, P110; Gioia GA, 2016, J HEAD TRAUMA REHAB, V31, P397, DOI 10.1097/HTR.0000000000000205; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Hossler P., 2014, PRINCIPALS RES REV, V9, P2; Kania K, 2016, J NEUROSURG-PEDIATR, V18, P224, DOI 10.3171/2016.1.PEDS15511; McNeal Lori, 2017, NASN Sch Nurse, V32, P310, DOI 10.1177/1942602X17698487; Peterson A., 2018, MMINR; Rose S. C., 2015, CONCUSSION, V1; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Thomas D. J., 2017, CLIN J SPORT MED, P1; Upchurch C., 2014, CLIN J SPORT MED; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Wing R, 2016, CLIN PEDIATR, V55, P228, DOI 10.1177/0009922815592879; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	28	8	8	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	FEB	2019	68						223	229		10.1016/j.jsr.2018.10.010			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	HR7BE	WOS:000463306100024	30876515	Green Accepted			2022-02-06	
J	Schmidt, SB; Kulig, W; Winter, R; Vasold, AS; Knoll, AE; Rollnik, JD				Schmidt, Simone B.; Kulig, Willibald; Winter, Ralph; Vasold, Antje S.; Knoll, Anette E.; Rollnik, Jens D.			The effect of a natural food based tube feeding in minimizing diarrhea in critically ill neurological patients	CLINICAL NUTRITION			English	Article						Diarrhea; Tube feeding; Natural food; Neurological patients	ENTERAL NUTRITION; DIETARY FIBER; STOOL; METAANALYSIS; MICROBIOTA	Background & aims: Diarrhea has negative consequences for patients, health care staff and health care costs when neurological patients are fed enterally over long periods. We examined the effect of tube feeding with natural foods in reducing the number of fluid stool evacuations and diarrhea in critically ill neurological patients. Methods: A multicenter, prospective, open-label and randomized controlled trial (RCT) was conducted at facilities in Germany specializing in early rehabilitation after neurological damage. Patients of the INTERVENTION group were fed by tube using a commercially available product based on real foods such as milk, meat, carrots, whereas CONTROL patients received a standard tube-feed made of powdered raw materials. All received enteral nutrition over a maximum of 30 days. The number of defecations and the consistency of each stool according to the Bristol Stool Chart (BSC) were monitored. In addition, daily calories, liquids and antibiotic-use were recorded. Results: 118 Patients who had suffered ischemic stroke, intracerebral hemorrhage, traumatic brain injury or hypoxic brain damage and requiring enteral nutrition were enrolled; 59 were randomized to receive the intervention and 59 control feed. There were no significant differences in clinical screening data, age, sex, observation period or days under enteral nutrition between the groups. Patients in both groups received equivalent amount of calories and fluids. In both groups antibiotics were frequently prescribed (69.5% in the INTERVENTION group and 75.7% in the CONTROL group) for 10-11 days on average. In comparison to the CONTROL group, patients in the INTERVENTION group had a significant reduction of the number of watery stool evacuations (type 7 BSC) (minus 61%, IRR = 0.39, p < 0.001). Further statistical evaluations using the following corrections: major diarrhea-associated confounders (number and duration of antibiotics); shorter observation period of 15 days; excluding patients with Clostridium difficile associated diarrhea (CDAD) and the Per Protocol Population, confirmed the primary hypothesis. The number of days with diarrhea was significantly lower in the INTERVENTION group (0.8 +/- 1.60 days versus 2.0 +/- 3.46 days). Conclusions: Tube feeding with natural based food was effective in reducing the number of watery defecations and diarrhea in long term tube-fed critically ill neurological patients, compared to those fed with standard tube feeding. (C) 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Schmidt, Simone B.; Rollnik, Jens D.] Hannover Med Sch, BDH Clin Hessisch Oldendorf, Inst Neurorehabil Res InFo, Hessisch Oldendorf, Germany; [Kulig, Willibald] HiPP GmbH & Co Vertrieb KG, Georg Hipp Str 7, D-85276 Pfaffenhofen, Germany; [Winter, Ralph] SRH Kurpfalzkrankenhaus Heidelberg gGmbH, Heidelberg, Germany; [Vasold, Antje S.] Med Einrichtung Bezirkes Oberpfalz KU, Klin Neurol Rehabil, Regensburg, Germany; [Knoll, Anette E.] AK Stat, Kreppe 2, D-85276 Pfaffenhofen, Germany		Schmidt, SB (corresponding author), Hannover Med Sch, BDH Clin Hessisch Oldendorf, Inst Neurorehabil Res InFo, Hessisch Oldendorf, Germany.	si.schmidt@nkho.de			HiPP GmbH Co.	This study was funded by HiPP GmbH & Co. Vertrieb KG.	[Anonymous], 1985, World Health Organ Tech Rep Ser, V724, P1; Arevalo-Manso JJ, 2014, INTERN MED J, V44, P1199, DOI 10.1111/imj.12586; Barbut F, 2002, BMJ-BRIT MED J, V324, P1345, DOI 10.1136/bmj.324.7350.1345; Bliss DZ, 1998, ANN INTERN MED, V129, P1012, DOI 10.7326/0003-4819-129-12-199812150-00004; Bruggeman J, 2003, GRUNDSATZSTELLUNGNAH, P39; Chang SJ, 2013, CURR OPIN CLIN NUTR, V16, P588, DOI 10.1097/MCO.0b013e328363bcaf; Dag GS, 2015, GASTROENTEROL NURS, V38, P218, DOI 10.1097/SGA.0000000000000114; Perez-Cobas AE, 2013, GUT, V62, P1591, DOI 10.1136/gutjnl-2012-303184; Elia M, 2008, ALIMENT PHARM THER, V27, P120, DOI 10.1111/j.1365-2036.2007.03544.x; Emery E A, 1997, Nutr Clin Pract, V12, P72, DOI 10.1177/011542659701200272; Frohmader TJ, 2010, AM J CRIT CARE, V19, pE1, DOI 10.4037/ajcc2010976; Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479; Green Ceri J, 2002, Nutr Hosp, V17 Suppl 2, P1; Guggenbichler J. P., 1997, Pharmaceutical and Pharmacological Letters, V7, P35; Halmos EP, 2013, J GASTROEN HEPATOL, V28, P25, DOI 10.1111/jgh.12272; Heine W, 1993, AKTUETLE ERNAHRUNGSM, V18, P380; Jack Leanne, 2010, Intensive Crit Care Nurs, V26, P327, DOI 10.1016/j.iccn.2010.08.001; Jacobs DR, 2007, NUTR REV, V65, P439, DOI 10.1301/nr.2007.oct.439-450; Kastner U, 2002, Wien Med Wochenschr, V152, P379, DOI 10.1046/j.1563-258X.2002.02057.x; Levy J, 2000, AM J GASTROENTEROL, V95, pS8, DOI 10.1016/S0002-9270(99)00808-4; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Lievin V, 2000, GUT, V47, P646, DOI 10.1136/gut.47.5.646; Majid HA, 2014, CLIN NUTR, V33, P966, DOI 10.1016/j.clnu.2013.11.008; MORO E, 1908, MUNCHEN MED WSCHR, V31, P1637; Nakao M, 2002, NUTRITION, V18, P35, DOI 10.1016/S0899-9007(01)00715-8; O'Keefe SJD, 2010, WORLD J GASTROENTERO, V16, P139, DOI 10.3748/wjg.v16.i2.139; Rollnik JD, 2011, REHABILITATION, V50, P408, DOI 10.1055/s-0031-1273728; Schneider SM, 2006, CLIN NUTR, V25, P82, DOI 10.1016/j.clnu.2005.09.006; Tamura Z., 1983, Bifidobacteria and Microflora, V2, P3; Thibault R, 2013, CRIT CARE, V17, DOI 10.1186/cc12832; Trabal J, 2008, NUTR HOSP, V23, P500; VOLLAARD EJ, 1994, ANTIMICROB AGENTS CH, V38, P409, DOI 10.1128/AAC.38.3.409; Whelan K, 2009, AM J CLIN NUTR, V89, P240, DOI 10.3945/ajcn.2008.26219; Wierdsma NJ, 2009, SCAND J GASTROENTERO, V44, P804, DOI 10.1080/00365520902839675; World Health Organization, DIARRH; Yang G, 2005, WORLD J GASTROENTERO, V11, P3935; Zaman MK, 2015, WORLD J GASTROENTERO, V21, P5372, DOI 10.3748/wjg.v21.i17.5372	37	8	8	3	5	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614	1532-1983		CLIN NUTR	Clin. Nutr.	FEB	2019	38	1					332	340		10.1016/j.clnu.2018.01.007			9	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	HR9EQ	WOS:000463462400036	29358002	hybrid			2022-02-06	
J	Sobrido-Camean, D; Robledo, D; Sanchez, L; Rodicio, MC; Barreiro-Iglesias, A				Sobrido-Camean, Daniel; Robledo, Diego; Sanchez, Laura; Rodicio, Maria Celina; Barreiro-Iglesias, Anton			Serotonin inhibits axonal regeneration of identifiable descending neurons after a complete spinal cord injury in lampreys	DISEASE MODELS & MECHANISMS			English	Article						5-HT; Serotonin receptor 1A; cAMP; Descending neurons; Fish; Axon regeneration; CNS	CENTRAL-NERVOUS-SYSTEM; BRAIN BARRIER SYSTEMS; IN-VITRO OUTGROWTH; CYCLIC-AMP; SEA LAMPREY; DIRECTIONAL SPECIFICITY; RETICULOSPINAL NEURONS; FUNCTIONAL RECOVERY; GOLDFISH RETINA; CDNA CLONING	Classical neurotransmitters are mainly known for their roles as neuromodulators, but they also play important roles in the control of developmental and regenerative processes. Here, we used the lamprey model of spinal cord injury to study the effect of serotonin in axon regeneration at the level of individually identifiable descending neurons. Pharmacological and genetic manipulations after a complete spinal cord injury showed that endogenous serotonin inhibits axonal regeneration in identifiable descending neurons through the activation of serotonin 1A receptors and a subsequent decrease in cyclic adenosine monophosphate (cAMP) levels. RNA sequencing revealed that changes in the expression of genes that control axonal guidance could be a key factor determining the serotonin effects during regeneration. This study provides new targets of interest for research in non-regenerating mammalian models of traumatic central nervous system injuries and extends the known roles of serotonin signalling during neuronal regeneration.	[Sobrido-Camean, Daniel; Rodicio, Maria Celina; Barreiro-Iglesias, Anton] Univ Santiago de Compostela, Fac Biol, CIBUS, Dept Funct Biol, Santiago De Compostela 15782, Spain; [Robledo, Diego] Univ Edinburgh, Roslin Inst, Roslin EH25 9RG, Midlothian, Scotland; [Robledo, Diego] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9RG, Midlothian, Scotland; [Sanchez, Laura] Univ Santiago de Compostela, Dept Genet, Campus Lugo, Lugo 27002, Spain		Barreiro-Iglesias, A (corresponding author), Univ Santiago de Compostela, Fac Biol, CIBUS, Dept Funct Biol, Santiago De Compostela 15782, Spain.	anton.barreiro@usc.es	Sanchez, Laura/L-2411-2014; Barreiro-Iglesias, Anton/G-5281-2010; Gomez, ACUIGEN/ABD-5337-2020; Camean, Daniel Sobrido/T-8395-2019; Rodicio, Maria Celina/K-1883-2014	Sanchez, Laura/0000-0001-7927-5303; Barreiro-Iglesias, Anton/0000-0002-7507-080X; Camean, Daniel Sobrido/0000-0001-8239-2965; Rodicio, Maria Celina/0000-0002-7267-3285; Robledo, Diego/0000-0002-9616-5912	Spanish Ministry of Economy and Competitiveness (Ministerio de Economia, Industria y Competitividad, Gobierno de Espana); European Regional Development Fund 2007-2013 [BFU2014-56300-P, BFU-2017-87079-P]; Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia [2016-PG008, GPC2014/030]; FECYT; Spanish Ministry of Economy and Competitiveness [2017-CP081]; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/D/10002071] Funding Source: UKRI	Grant sponsors: Spanish Ministry of Economy and Competitiveness (Ministerio de Economia, Industria y Competitividad, Gobierno de Espana) and the European Regional Development Fund 2007-2013 (grant numbers: BFU2014-56300-P and BFU-2017-87079-P); and Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia (grant number: GPC2014/030). A.B.-I. was supported by a grant from the Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia (grant number: 2016-PG008) and a grant from the crowdfunding platform Precipita (FECYT; Spanish Ministry of Economy and Competitiveness; grant number 2017-CP081). The authors would like to acknowledge the following individual donors of the crowdfunding campaign in Precipita: Blanca Fernandez, Emilio Rio, Guillermo Vivar, Pablo Perez, Jorge Fernandez, Ignacio Valino, Pago de los Centenarios, Eva Candal, Maria del Pilar Balsa, Jorge Faraldo, Isabel Rodriguez-Moldes, Jose Manuel Lopez, Juan Jose Pita, Maria E. Camean, Jesus Torres, Jose Pumares, Veronica Rodriguez, Sara Lopez, Tania Villares Balsa, Rocio Lizcano, Jose Garcia, Ana M. Cereijo, Maria Pardo, Nerea Santamaria, Carolina Hernandez, Jesus Lopez and Maria Maneiro.	Abalo XM, 2007, J CHEM NEUROANAT, V34, P29, DOI 10.1016/j.jchemneu.2007.03.010; Alam T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10388; Antri M, 2006, J COMP NEUROL, V495, P788, DOI 10.1002/cne.20910; Antri M, 2008, EUR J NEUROSCI, V28, P655, DOI 10.1111/j.1460-9568.2008.06368.x; Ayers J., 1989, CELLULAR NEURONAL OS, P349; Barreiro-Iglesias A, 2008, J CHEM NEUROANAT, V36, P77, DOI 10.1016/j.jchemneu.2008.06.001; Barreiro-Iglesias A, 2015, CELL REP, V13, P924, DOI 10.1016/j.celrep.2015.09.050; Barreiro-Iglesias A, 2015, NEURAL REGEN RES, V10, P25, DOI 10.4103/1673-5374.150642; Barreiro-Iglesias A, 2014, JOVE-J VIS EXP, DOI 10.3791/51494; Barreiro-Iglesias A, 2012, J COMP NEUROL, V520, P4141, DOI 10.1002/cne.23143; Barreiro-Iglesias A, 2012, BRAIN BEHAV EVOLUT, V79, P1, DOI 10.1159/000334187; Becker MI, 2015, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00148; Bhatt DH, 2004, SCIENCE, V305, P254, DOI 10.1126/science.1098439; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; BUNDGAARD M, 1982, BRAIN RES, V240, P55, DOI 10.1016/0006-8993(82)90643-6; BUNDGAARD M, 1982, BRAIN RES, V240, P65, DOI 10.1016/0006-8993(82)90644-8; Rodicio MC, 2012, REV NEUROLOGIA, V55, P157, DOI 10.33588/rn.5503.2012136; Chen JE, 2017, NEUROSCIENCE, V341, P95, DOI 10.1016/j.neuroscience.2016.11.020; COHEN AH, 1986, P NATL ACAD SCI USA, V83, P2763, DOI 10.1073/pnas.83.8.2763; DAVIS GR, 1994, EXP NEUROL, V127, P94, DOI 10.1006/exnr.1994.1083; Driessens MHE, 2002, FEBS LETT, V529, P168, DOI 10.1016/S0014-5793(02)03323-9; Cornide-Petronio ME, 2014, NEUROPHARMACOLOGY, V77, P369, DOI 10.1016/j.neuropharm.2013.10.017; Cornide-Petronio ME, 2013, BRAIN STRUCT FUNCT, V218, P1317, DOI 10.1007/s00429-012-0461-y; Cornide-Petronio ME, 2011, J NEUROTRAUM, V28, P2535, DOI 10.1089/neu.2011.1766; Fabbiani G, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00020; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fernandez-Lopez B, 2014, GLIA, V62, P1254, DOI 10.1002/glia.22678; Fogerson SM, 2016, EXP NEUROL, V278, P105, DOI 10.1016/j.expneurol.2016.02.004; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gregory R. W. B. B, 2016, GPLOTS VARIOUS R PRO, V3; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Hao Y, 2016, ELIFE, V5, DOI 10.7554/eLife.14048; Hoffman N, 2011, NEUROSCIENCE, V199, P563, DOI 10.1016/j.neuroscience.2011.09.021; Hu JL, 2017, NEUROBIOL DIS, V98, P25, DOI 10.1016/j.nbd.2016.11.006; Jacobs AJ, 1997, J NEUROSCI, V17, P5206; Jin LQ, 2009, J COMP NEUROL, V515, P295, DOI 10.1002/cne.22057; Koert CE, 2001, J NEUROSCI, V21, P5597, DOI 10.1523/JNEUROSCI.21-15-05597.2001; Lau BYB, 2013, EXP NEUROL, V250, P31, DOI 10.1016/j.expneurol.2013.09.004; Lau BYB, 2011, EXP NEUROL, V228, P283, DOI 10.1016/j.expneurol.2011.02.003; Lima L, 1996, NEUROCHEM RES, V21, P939, DOI 10.1007/BF02532344; LIMA L, 1994, J NEUROSCI RES, V38, P444, DOI 10.1002/jnr.490380410; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MACKLER SA, 1987, J PHYSIOL-LONDON, V388, P183, DOI 10.1113/jphysiol.1987.sp016609; MACKLER SA, 1986, J NEUROSCI, V6, P1814; MURRAIN M, 1990, J NEUROBIOL, V21, P611, DOI 10.1002/neu.480210408; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; Oliphint PA, 2010, J COMP NEUROL, V518, P2854, DOI 10.1002/cne.22368; Pale T, 2013, NEUROSCIENCE, V245, P74, DOI 10.1016/j.neuroscience.2013.04.016; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Romaus-Sanjurjo D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0704-9; Schmeer C, 2001, NEUROCHEM RES, V26, P213, DOI 10.1023/A:1010960332229; Shifman MI, 2000, NEUROREHAB NEURAL RE, V14, P49, DOI 10.1177/154596830001400106; Shifman MI, 2007, J COMP NEUROL, V501, P631, DOI 10.1002/cne.21283; Sobrido-Camean D., 2018, FRONT MOL NEUROSCI, V3, P11; Sobrido-Camean D, 2018, NEURAL REGEN RES, V13, P237, DOI 10.4103/1673-5374.226387; Suarez I, 2002, DEV NEUROSCI-BASEL, V24, P300, DOI 10.1159/000066744; Villar-Cervino V, 2006, J COMP NEUROL, V499, P810, DOI 10.1002/cne.21136; YIN HS, 1983, J NEUROSCI, V3, P1135; YIN HS, 1984, SCIENCE, V224, P894, DOI 10.1126/science.6719120; Zhang GX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137670; Zhang GX, 2014, J COMP NEUROL, V522, P1316, DOI 10.1002/cne.23485	64	8	8	1	5	COMPANY BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND	1754-8403	1754-8411		DIS MODEL MECH	Dis. Model. Mech.	FEB	2019	12	2							dmm037085	10.1242/dmm.037085			11	Cell Biology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Pathology	HN4CM	WOS:000460131800009	30709851	Green Submitted, Green Published, gold			2022-02-06	
J	Turner, NE; McDonald, AJ; Ialomiteanu, AR; Mann, RE; McCready, J; Millstone, D; Hamilton, H; Elton-Marshall, T; Rehm, J; Kurdyak, P; Ilie, G; Wickens, CM; Le, TL; van der Maas, M; Faregh, N; Cook, S; Bondy, S; Sanchez, S; Cusimano, MD				Turner, Nigel E.; McDonald, Andre J.; Ialomiteanu, Anca R.; Mann, Robert E.; McCready, John; Millstone, Dov; Hamilton, Hayley; Elton-Marshall, Tara; Rehm, Jurgen; Kurdyak, Paul; Ilie, Gabriela; Wickens, Christine M.; Thao Lan Le; van der Maas, Mark; Faregh, Neda; Cook, Steven; Bondy, Susan; Sanchez, Sherald; Cusimano, Michael D.			Moderate to severe gambling problems and traumatic brain injury: A population-based study	PSYCHIATRY RESEARCH			English	Article						Problem gambling; Traumatic brain injury; Population-based; Survey	CARE PATIENTS; ASSOCIATION; PREVALENCE; IMPULSIVITY; OLDER; AGGRESSION; DISORDER; HISTORY; SAMPLE; ADHD	Traumatic brain injury (TBI) is a common injury characterized by a change in brain function after an external blow to the head and is associated with substance abuse, psychological distress, risk-taking, and impulsivity. Convenience and clinical samples have also linked TBI to problem gambling, but have not ruled out confounding variables such as hazardous drinking and psychological distress. This study examines the relationship between TBI and moderate to severe problem gambling in a general population probability sample controlling for hazardous drinking and psychological distress. The data were obtained from a 2015-2016 cross-sectional general population telephone survey of adults ages 18 + from Ontario, Canada (N = 3809). Logistic regression was used to estimate the association as adjusted odds ratios (AOR). Moderate to severe problem gambling was independently associated with a history of TBI after adjusting for potential confounders (AOR: 2.80), and had a statistically significant relationship with psychological distress (AOR = 2.74), hazardous drinking (AOR = 2.69), and lower educational levels (AOR = 0.37). This study provides further data to suggest a link between TBI and moderate to severe problem gambling; however, more research is needed to determine if there is a causal relationship or the potential implications for prevention and treatment.	[Turner, Nigel E.; McDonald, Andre J.; Ialomiteanu, Anca R.; Mann, Robert E.; McCready, John; Millstone, Dov; Hamilton, Hayley; Elton-Marshall, Tara; Rehm, Jurgen; Kurdyak, Paul; Wickens, Christine M.; Thao Lan Le; van der Maas, Mark; Sanchez, Sherald] Ctr Addict & Mental Hlth, Inst Mental Hlth Policy Res, 33 Russell St, Toronto, ON M5S 2S1, Canada; [Turner, Nigel E.; McDonald, Andre J.; Mann, Robert E.; Hamilton, Hayley; Elton-Marshall, Tara; Rehm, Jurgen; Bondy, Susan; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [McCready, John] Healthy Horizons Consulting, Toronto, ON, Canada; [Elton-Marshall, Tara] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Rehm, Jurgen] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Rehm, Jurgen] Tech Univ Dresden, Dresden, Germany; [Ilie, Gabriela] Dalhousie Univ, Dept Community Hlth & Epidemiol, Fac Med, Halifax, NS, Canada; [Faregh, Neda] Jewish Gen Hosp, Lady Davis Inst Res, Montreal, PQ, Canada; [Cook, Steven] Cardiff Univ, Dept Social Sci, Cardiff, S Glam, Wales; [Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Dept Surg, Toronto, ON, Canada		Turner, NE (corresponding author), Ctr Addict & Mental Hlth, Inst Mental Hlth Policy Res, 33 Russell St, Toronto, ON M5S 2S1, Canada.	Nigel.Turner@camh.ca	Turner, Nigel E/ABC-8263-2020; Wickens, Christine M./Q-2014-2017; Elton-Marshall, Tara/AAF-9328-2020; McDonald, Andre/AAZ-9353-2021; Ilie, Gabriela/AAM-9122-2021; Faregh, Neda/R-5069-2019; Cusimano, Michael/X-4059-2019; van der Maas, Mark/AAL-5601-2020; Bondy, Susan/C-6737-2014; Ilie, Gabriela/J-6066-2014	Turner, Nigel E/0000-0002-1035-2064; Wickens, Christine M./0000-0002-9865-850X; Elton-Marshall, Tara/0000-0002-1674-8588; McDonald, Andre/0000-0003-1734-5067; van der Maas, Mark/0000-0001-9606-0187; Cook, Steven/0000-0002-6363-2940; Le, Thao Lan/0000-0003-3299-7450; Bondy, Susan/0000-0002-6516-4159; Sanchez, Sherald/0000-0001-5558-1007; Ilie, Gabriela/0000-0002-1602-6374; Kurdyak, Paul/0000-0001-8115-7437	Institute for Mental Health Policy Research; Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario [06703]; Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP 123371]; Ontario Neurotrauma Foundation	The ideas expressed are those of the authors and do not necessarily reflect those of the Centre for Addiction and Mental Health, the University of Toronto, or the Ministry of Health and Long Term Care. This study was supported by the Institute for Mental Health Policy Research. The study was funded by the Ministry of Health and Long Term Care as grant number 06703. In addition, this research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946, Canadian Institutes of Health Research MOP 123371 and the Ontario Neurotrauma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project was subject to ethics review by the Centre for Addiction and Mental Health (CAMH). The project was reviewed by the CAMH ethics review board and approved as Protocol #305/2009-06, 2015. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments including informed consent and confidentiality of all personal information.	Abbott M, 2018, ADDICTION, V113, P699, DOI 10.1111/add.14083; Adlaf E. M., 2005, CANADIAN ADDICTION S; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Babor TF, 2001, AUDIT ALCOHOL USE DI; Blaszczynski A, 2002, ADDICTION, V97, P487, DOI 10.1046/j.1360-0443.2002.00015.x; Blaszczynski A, 2010, ADDICT RES THEORY, V18, P681, DOI 10.3109/16066351003786752; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US E; Cook S, 2015, J GAMBL STUD, V31, P1121, DOI 10.1007/s10899-014-9483-0; Crockford D, 2008, J GAMBL STUD, V24, P411, DOI 10.1007/s10899-008-9099-3; Currie CL, 2013, J GAMBL STUD, V29, P393, DOI 10.1007/s10899-012-9323-z; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Ferris J. A., 2001, CANADIAN PROBLEM GAM; Galea S, 2007, ARCH GEN PSYCHIAT, V64, P1427, DOI 10.1001/archpsyc.64.12.1427; Grant JE, 2002, ALCOHOL RES HEALTH, V26, P143; Guercio JM, 2012, J APPL BEHAV ANAL, V45, P485, DOI 10.1901/jaba.2012.45-485; Hie G., 2015, J NEUROTRAUM, V32, P10; Hodgins DC, 2015, INT J MENT HEALTH AD, V13, P699, DOI 10.1007/s11469-015-9572-z; Hodgins DC, 2011, LANCET, V378, P1874, DOI 10.1016/S0140-6736(10)62185-X; Hodgins DC, 2010, PSYCHOL ADDICT BEHAV, V24, P548, DOI 10.1037/a0019946; Holdsworth L, 2012, INT GAMBL STUD, V12, P199, DOI 10.1080/14459795.2012.656317; Hope J, 2002, J AGING STUD, V16, P177, DOI 10.1016/S0890-4065(02)00043-9; Ilie G, 2017, PSYCHIAT RES, V258, P184, DOI 10.1016/j.psychres.2017.08.011; Ilie G, 2017, VIOLENCE VICTIMS, V32, P869, DOI 10.1891/0886-6708.VV-D-16-00027; Ilie G, 2015, J PSYCHIATR RES, V69, P174, DOI 10.1016/j.jpsychires.2015.08.004; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kerber Cindy Sullivan, 2008, Issues Ment Health Nurs, V29, P1018, DOI 10.1080/01612840802274933; Korman LM, 2008, J GAMBL STUD, V24, P13, DOI 10.1007/s10899-007-9077-1; Korn David A., 1999, J Gambl Stud, V15, P289, DOI 10.1023/A:1023005115932; lalomiteanu A., 2015, CAMH RES DOCUMENT SE, V45; Levens S, 2005, AM J GERIAT PSYCHIAT, V13, P69, DOI 10.1176/appi.ajgp.13.1.69; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Loxton NJ, 2008, PERS INDIV DIFFER, V45, P167, DOI 10.1016/j.paid.2008.03.017; Maccallum F, 2007, PERS INDIV DIFFER, V43, P1829, DOI 10.1016/j.paid.2007.06.002; MacPherson SE, 2009, CLIN NEUROPSYCHOL, V23, P510, DOI 10.1080/13854040802396586; McCready J, 2008, J GAMBL ISSUES, P174, DOI 10.4309/jgi.2008.22.3; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Parke A., 2005, INT J MENT HEALTH AD, V2, P50; Rennert L, 2014, EXP CLIN PSYCHOPHARM, V22, P50, DOI 10.1037/a0034518; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; StataCorp, 2013, STATA STAT SOFTW REL; Turner N.E., 2008, INT GAMBL STUD, V8, P281, DOI [DOI 10.1080/14459790802405905, https://doi.org/10.1080/14459790802405905]; Turner NE., 2006, INT GAMBL STUD, V6, P237, DOI [DOI 10.1080/14459790600928793, 10.1080/14459790600928793]; Turner NE, 2018, J GAMBL ISSUES, P85, DOI 10.4309/jgi.2018.39.4; Turner NE, 2011, J GAMBL ISSUES, P88, DOI 10.4309/jgi.2011.25.7; van der Maas M., 2018, J GAMBL; van der Maas M, 2017, ADDICTION, V112, P2217, DOI 10.1111/add.13914; Volberg R.A, 2013, GAMBLING PROBLEM GAM; Volberg R. A., 2003, J GAMBL; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Weatherly JN, 2007, ANAL GAMBLING BEHAV, V1, P4; Welte JW, 2004, SUBST USE MISUSE, V39, P1405, DOI 10.1081/JA-120039397; Whiting SW, 2016, J BEHAV ADDICT, V5, P213, DOI 10.1556/2006.5.2016.027; Williams RJ., 2012, POPULATION PREVALENC; Williams RJ, 2007, CAN PUBLIC POL, V33, P367, DOI 10.3138/cpp.33.3.367; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613	58	8	8	1	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	FEB	2019	272						692	697		10.1016/j.psychres.2018.12.170			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	HO5UW	WOS:000460994400099	30832188	Green Accepted, hybrid			2022-02-06	
J	Volovici, V; Ercole, A; Citerio, G; Stocchetti, N; Haitsma, LK; Huijben, JA; Dirven, CMF; van der Jagt, M; Steyerberg, EW; Nelson, D; Cnossen, MC; Maas, AIR; Polinder, S; Menon, DK; Lingsma, HF				Volovici, Victor; Ercole, Ari; Citerio, Giuseppe; Stocchetti, Nino; Haitsma, Lain K.; Huijben, Jilske A.; Dirven, Clemens M. F.; van der Jagt, Mathieu; Steyerberg, Ewout W.; Nelson, David; Cnossen, Maryse C.; Maas, Andrew I. R.; Polinder, Suzanne; Menon, David K.; Lingsma, Hester F.			Intensive care admission criteria for traumatic brain injury patients across Europe	JOURNAL OF CRITICAL CARE			English	Article						Intensive care admission; Moderate and Severe TBI; Intensive care occupancy; Cost-effectiveness; CENTER-TBI; European policy	BED NUMBERS	Within a prospective, observational, multi-center cohort study 68 hospitals (of which 66 responded), mostly academic (n = 60,91%) level I trauma centers (n = 44.67%) in 20 countries were asked to complete questionnaires regarding the "standard of care" for severe neurotrauma patients in their hospitals. From the questionnaire pertaining to ICU management, 12 questions related to admission criteria were selected for this analysis. The questionnaires were completed by 66 centers. The median number of TBI patients admitted to the ICU was 92 [interquartile range (IQR): 52-160] annually. Admission policy varied: in 45 (68%) centers, patients with a Glasgow Come Score (GCS) between 13 and 15 without CT abnormalities but with other risk factors would be admitted to the ICU while the rest indicated that they would not admit these patients routinely to the ICU. We found no association between ICU admission policy and the presence of a dedicated neuro ICU, the discipline in charge of rounds, the presence of step down beds or geographic location (North-Western Europe vs. South-Eastern Europe and Israel). Variation in admission policy, primarily of mild TBI patients to ICU exists, even among high-volume academic centers and seems to be largely independent of other center characteristics. The observed variation suggests a role for comparative effectiveness research to investigate the potential benefit and cost-effectiveness of a liberal versus more restrictive admission policies. (C) 2018 Elsevier Inc. All rights reserved.	[Volovici, Victor; Haitsma, Lain K.; Dirven, Clemens M. F.] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; [Volovici, Victor; Huijben, Jilske A.; Steyerberg, Ewout W.; Cnossen, Maryse C.; Polinder, Suzanne; Lingsma, Hester F.] Erasmus MC, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands; [Ercole, Ari; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Cambridge, England; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Citerio, Giuseppe] ASST Monza, Neurointens Care Unit, San Gerardo Hosp, Monza, Italy; [Stocchetti, Nino] Univ Milan, Dept Pathophysiolopy & Transplants, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda, Dept Anesthesia & Crit Care, Osped Maggiore Policlin, Neurosci Intens Care Unit, Milan, Italy; [van der Jagt, Mathieu] Erasmus MC, Dept Intens Care Adults, Rotterdam, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands; [Nelson, David] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium		Volovici, V (corresponding author), Erasmus MC Univ Med Ctr, Erasmus MC Stroke Ctr, Dept Neurosurg & Med Decis Making, Doctor Molenwaterpl 40, NL-3015 GD Rotterdam, Netherlands.	v.volovici@erasmusmc.nl	Ercole, Ari/B-6288-2009; Citerio, Giuseppe/B-1839-2015; Maas, Andrew IR/C-5584-2013; Volovici, Victor/AAZ-8901-2020; van der Jagt, Mathieu/G-1905-2017; Stocchetti, Nino/O-7444-2017	Ercole, Ari/0000-0001-8350-8093; Citerio, Giuseppe/0000-0002-5374-3161; Maas, Andrew IR/0000-0003-1612-1264; Volovici, Victor/0000-0002-5798-5360; Huijben, Jilske (Antonia)/0000-0002-2892-5406; van der Jagt, Mathieu/0000-0003-2566-8325; Stocchetti, Nino/0000-0003-3250-6834; Nelson, David/0000-0003-2530-8207			Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Chrusch CA, 2009, CRIT CARE MED, V37, P2753, DOI 10.1097/CCM.0b013e3181a57b0c; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Grieve R, 2016, BRIT J NEUROSURG, V30, P388, DOI 10.3109/02688697.2016.1161166; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Thattil R, 2012, ANAESTHESIST, V61, P56, DOI 10.1007/s00101-011-1969-x; Tuominen R, 2012, BRAIN INJURY, V26, P1697, DOI 10.3109/02699052.2012.722256; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	12	8	8	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2019	49						158	161		10.1016/j.jcrc.2018.11.002			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HC3UQ	WOS:000451728600026	30447560	Green Accepted, Green Submitted			2022-02-06	
J	Wasserman, EB; Sauers, EL; Register-Mihalik, JK; Pierpoint, LA; Currie, DW; Knowles, SB; Dompier, TP; Comstock, RD; Marshall, SW; Kerr, ZY				Wasserman, Erin B.; Sauers, Eric L.; Register-Mihalik, Johna K.; Pierpoint, Lauren A.; Currie, Dustin W.; Knowles, Sarah B.; Dompier, Thomas P.; Comstock, R. Dawn; Marshall, Stephen W.; Kerr, Zachary Y.			The First Decade of Web-Based Sports Injury Surveillance: Descriptive Epidemiology of Injuries in US High School Boys' Baseball (2005-2006 Through 2013-2014) and National Collegiate Athletic Association Men's Baseball (2004-2005 Through 2013-2014)	JOURNAL OF ATHLETIC TRAINING			English	Article						athletes; injury incidence; pitching; fielding	UNITED-STATES; RISK-FACTORS; PATTERNS; SERVICES; SPECIALIZATION; CONCUSSION; FATIGUE; SYSTEM; RATES	Context: The advent of Web-based sports injury surveillance via programs such as the High School Reporting Information Online system and the National Collegiate Athletic Association Injury Surveillance Program has aided the acquisition of boys' and men's baseball injury data. Objective: To describe the epidemiology of injuries sustained in high school boys' baseball in the 2005-2006 through 2013-2014 academic years and collegiate men's baseball in the 2004-2005 through 2013-2014 academic years using Web-based sports injury surveillance. Design: Descriptive epidemiology study. Setting: Online injury surveillance from baseball teams in high school boys (annual average = 100) and collegiate men (annual average = 34). Patients or Other Participants: Boys' or men's baseball players who participated in practices and competitions during the 2005-2006 through 2013-2014 academic years in high school or the 2004-2005 through 2013-2014 academic years in college, respectively. Main Outcome Measure(s): Athletic trainers collected time-loss injury and exposure data. Injury rates per 1000 athlete-exposures (AEs) were calculated. Injury rate ratios (IRRs) with 95% confidence intervals (Cis) compared injury rates by school size or division, time in season, event type, and competition level. Results: The High School Reporting Information Online system documented 1537 time-loss injuries during 1 573 257 AEs; the National Collegiate Athletic Association Injury Surveillance Program documented 2574 time-loss injuries during 804 737 AEs. The injury rate was higher in college than in high school (3.20 versus 0.98/1000 AEs; IRR = 3.27; 95% CI = 3.07, 3.49). The competition injury rate was higher than the practice injury rate in high school (IRR = 2.27; 95% CI = 2.05, 2.51) and college (IRR = 2.32; 95% CI = 2.15, 2.51). Baseball players at the high school and collegiate levels sustained a variety of injuries across the body, with the most common injuries reported to the upper extremity. Many injuries also occurred while fielding or pitching. Conclusions: Injury rates were greater in collegiate versus high school baseball and in competition versus practice. These findings highlight the need for injury-prevention interventions focused on reducing the incidence of upper extremity injuries and protecting batters from pitches and fielders from batted balls.	[Wasserman, Erin B.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Sauers, Eric L.] AT Still Univ, Arizona Sch Hlth Sci, Dept Interdisciplinary Hlth Sci, Athlet Training Program, Mesa, AZ USA; [Register-Mihalik, Johna K.; Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Register-Mihalik, Johna K.; Marshall, Stephen W.; Kerr, Zachary Y.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Pierpoint, Lauren A.; Currie, Dustin W.; Comstock, R. Dawn] Univ Colorado Anschutz, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Knowles, Sarah B.] Palo Alto Med Fdn Res Inst, Palo Alto, CA USA; [Dompier, Thomas P.] Lebanon Valley Coll, Annville, PA USA; [Comstock, R. Dawn] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA		Kerr, ZY (corresponding author), Univ N Carolina, Injury Prevent Res Ctr, Dept Exercise & Sport Sci, 313 Woollen Gym CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu		Wasserman, Erin/0000-0001-5957-5878	NCAA; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Center for Research Resources awardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025754]; National Federation of State High School Associations (Indianapolis, IN); National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); DonJoy Orthotics (Vista, CA); EyeBlack (Potomac, MD)	The NCAA-ISP data were provided by the Datalys Center for Sports Injury Research and Prevention. The ISP was funded by the NCAA. Funding for HS RIO was provided in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01 and the National Center for Research Resources award KL2 RR025754. The authors also acknowledge the research funding contributions of the National Federation of State High School Associations (Indianapolis, IN), the National Operating Committee on Standards for Athletic Equipment (Overland Park, KS), DonJoy Orthotics (Vista, CA), and EyeBlack (Potomac, MD). The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. We thank the many athletic trainers who have volunteered their time and efforts to submit data to HS RIO and the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of high school and collegiate student-athletes.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Bell DR, 2016, AM J SPORT MED, V44, P1469, DOI 10.1177/0363546516629943; Brenner JS, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2148; Collins CL, 2008, PEDIATRICS, V121, P1181, DOI 10.1542/peds.2007-2572; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Cooper JJ., HIGH SCH PITCH COUNT; Dick R, 2007, J ATHL TRAINING, V42, P183; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Drew MK, 2016, BRIT J SPORT MED, V50, P1423, DOI 10.1136/bjsports-2015-095543; Erickson BJ, 2016, ARTHROSCOPY, V32, P762, DOI 10.1016/j.arthro.2015.11.051; Erickson BJ, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114553916; Frollo J., SEE YOUR STATE STAND; Grantham WJ, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114537032; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kucera KL, 2011, J ATHL TRAINING, V46, P489; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; McFarland EG, 1998, CLIN J SPORT MED, V8, P10, DOI 10.1097/00042752-199801000-00003; Olsen SJ, 2006, AM J SPORT MED, V34, P905, DOI 10.1177/0363546505284188; Pike A, 2016, J ATHL TRAINING, V51, P717, DOI 10.4085/1062-6050-51.11.04c; Post EG, 2017, SPORTS HEALTH, V9, P148, DOI 10.1177/1941738116675455; Powell JW, 2004, J ATHL TRAINING, V39, P56; Powell JW, 1999, J ATHL TRAINING, V34, P277; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Shanley E, 2011, J ATHL TRAINING, V46, P648; Swenson DM, 2012, AM J SPORT MED, V40, P2078, DOI 10.1177/0363546512453304; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wang LH, 2016, J SPORT SCI, V34, P1182, DOI 10.1080/02640414.2015.1101481; Woodall B, STATES IMPLEMENT PIT; Yang JZ, 2014, AM J SPORT MED, V42, P1456, DOI 10.1177/0363546514524699	32	8	8	0	7	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	FEB	2019	54	2					198	211		10.4085/1062-6050-239-17			14	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HR9YS	WOS:000463518100012	30951387	Green Published, gold			2022-02-06	
J	Wasserman, EB; Register-Mihalik, JK; Sauers, EL; Currie, DW; Pierpoint, LA; Knowles, SB; Dompier, TP; Comstock, RD; Marshall, SW; Kerr, ZY				Wasserman, Erin B.; Register-Mihalik, Johna K.; Sauers, Eric L.; Currie, Dustin W.; Pierpoint, Lauren A.; Knowles, Sarah B.; Dompier, Thomas P.; Comstock, R. Dawn; Marshall, Stephen W.; Kerr, Zachary Y.			The First Decade of Web-Based Sports Injury Surveillance: Descriptive Epidemiology of Injuries in US High School Girls' Softball (2005-2006 Through 2013-2014) and National Collegiate Athletic Association Women's Softball (2004-2005 Through 2013-2014)	JOURNAL OF ATHLETIC TRAINING			English	Article						concussions; ankle sprains; musculoskeletal injuries; overuse injuries; injury prevention	SHOULDER PAIN; RISK; PATTERNS; SERVICES; ELBOW; SYSTEM; RATES	Context: The advent of Web-based sports injury surveillance via programs such as the High School Reporting Information Online system and the National Collegiate Athletic Association Injury Surveillance Program has aided the acquisition of girls' and women's softball injury data. Objective: To describe the epidemiology of injuries sustained in high school girls' softball in the 2005-2006 through 2013-2014 academic years and collegiate women's softball in the 2004-2005 through 2013-2014 academic years using Web-based sports injury surveillance. Design: Descriptive epidemiology study. Setting: Online injury surveillance from softball teams in high school girls (annual average = 100) and collegiate women (annual average = 41). Patients or Other Participants: Girls' or women's softball players who participated in practices and competitions during the 2005-2006 through 2013-2014 academic years in high school and the 2004-2005 through 2013-2014 academic years in college. Main Outcome Measure(s): Athletic trainers collected time-loss injury and exposure data. Injury rates per 1000 athlete-exposures (AEs) were calculated. Injury rate ratios (IRRs) with 95% confidence intervals (Cis) compared injury rates by competition level, school size or division, event type, and time in season. Results: The High School Reporting Information Online system documented 1357 time-loss injuries during 1 173 722 AEs; the National Collegiate Athletic Association Injury Surveillance Program documented 1848 time-loss injuries during 579 553 AEs. The injury rate was higher in college than in high school (3.19 versus 1.16/1000 AEs; IRR = 2.76; 95% CI = 2.57, 2.96). The competition injury rate was higher than the practice injury rate in high school (IRR = 2.02; 95% CI = 1.82, 2.25) and in college (IRR = 1.39; 95% CI = 1.27, 1.52). Softball players at both levels sustained a variety of injuries, with the most common being ankle sprains and concussions. Many injuries also occurred while fielding or running bases. Conclusions: Injury rates were greater in collegiate versus high school softball and in competitions versus practices. These findings highlight the need for injury-prevention interventions, including strength-training and prevention programs to reduce ankle sprains and provide protection for batters from pitches and fielders from batted balls.	[Wasserman, Erin B.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Register-Mihalik, Johna K.; Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Register-Mihalik, Johna K.; Marshall, Stephen W.; Kerr, Zachary Y.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Sauers, Eric L.] AT Still Univ, Arizona Sch Hlth Sci, Dept Interdisciplinary Hlth Sci, Athlet Training Program, Mesa, AZ USA; [Currie, Dustin W.; Pierpoint, Lauren A.; Comstock, R. Dawn] Univ Colorado Anschutz, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Knowles, Sarah B.] Palo Alto Med Fdn Res Inst, Palo Alto, CA USA; [Dompier, Thomas P.] Lebanon Valley Coll, Annville, PA USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA		Kerr, ZY (corresponding author), Univ N Carolina, Injury Prevent Res Ctr, Dept Exercise & Sport Sci, 313 Woollen Gym CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu		Wasserman, Erin/0000-0001-5957-5878	NCAA; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Center for Research Resources awardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025754]; NFHS; National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); DonJoy Orthotics (Vista, CA); EyeBlack (Potomac, MD)	The NCAA-ISP data were provided by the Datalys Center for Sports Injury Research and Prevention, Inc. The ISP was funded by the NCAA. Funding for HS RIO was provided in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01 and the National Center for Research Resources award KL2 RR025754. The authors also acknowledge the research funding contributions of the NFHS, National Operating Committee on Standards for Athletic Equipment (Overland Park, KS), DonJoy Orthotics (Vista, CA), and EyeBlack (Potomac, MD). The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. We thank the many ATs who have volunteered their time and efforts to submit data to HS RIO and the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of high school and collegiate student-athletes.	Birchak JC, 2013, AM J EMERG MED, V31, P900, DOI 10.1016/j.ajem.2013.02.039; Brenner JS, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2148; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Drew MK, 2016, BRIT J SPORT MED, V50, P1423, DOI 10.1136/bjsports-2015-095543; Fleisig GS, 2011, AM J SPORT MED, V39, P253, DOI 10.1177/0363546510384224; Frollo J, 2013, SEE YOUR STATE STAND; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kucera KL, 2011, J ATHL TRAINING, V46, P489; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lear A, 2016, CURR SPORT MED REP, V15, P336, DOI 10.1249/JSR.0000000000000293; Lyman S, 2002, AM J SPORT MED, V30, P463, DOI 10.1177/03635465020300040201; Lyman S, 2001, MED SCI SPORT EXER, V33, P1803, DOI 10.1097/00005768-200111000-00002; Marshall SW, 2007, J ATHL TRAINING, V42, P286; National Collegiate Athletic Association, 2010, 2011 SOFTB BAT COMPL; National Collegiate Athletic Association, 2015, STUD ATHL PART 1981; National Collegiate Athletic Association, 2015, 2016 2017 NCAA SOFTB; National Collegiate Athletic Association, 2017, NCAA APPR SOFTB BAT; National Federation of State High School Associations, 2016, PART STAT; Olsen SJ, 2006, AM J SPORT MED, V34, P905, DOI 10.1177/0363546505284188; Pike A, 2016, J ATHL TRAINING, V51, P717, DOI 10.4085/1062-6050-51.11.04c; Post EG, 2017, SPORTS HEALTH, V9, P148, DOI 10.1177/1941738116675455; Powell JW, 2004, J ATHL TRAINING, V39, P56; Powell JW, 1999, J ATHL TRAINING, V34, P277; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Roos KG, 2015, AM J SPORT MED, V43, P1790, DOI 10.1177/0363546515580790; Sauers EL, 2011, J SPORT REHABIL, V20, P100, DOI 10.1123/jsr.20.1.100; Shanley E, 2011, J ATHL TRAINING, V46, P648; Smith MV, 2015, SPORTS HEALTH, V7, P497, DOI 10.1177/1941738115606058; The National Collegiate Athletic Association, 2014, 2014 15 NCAA SPORTS, V25th; US Census Bureau, 2009, CENS REG US; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Yang JZ, 2014, AM J SPORT MED, V42, P1456, DOI 10.1177/0363546514524699	36	8	8	4	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	FEB	2019	54	2					212	225		10.4085/1062-6050-206-17			14	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HR9YS	WOS:000463518100013	30951383	gold, Green Published			2022-02-06	
J	Frenette, LC; Tinawi, S; Correa, JA; Alturki, AY; LeBlanc, J; Feyz, M; de Guise, E				Frenette, L. C.; Tinawi, S.; Correa, J. A.; Alturki, A. Y.; LeBlanc, J.; Feyz, M.; de Guise, E.			Early detection of cognitive impairments with the Montreal Cognitive Assessment in patients with uncomplicated and complicated mild traumatic brain injury	BRAIN INJURY			English	Article						Concussion; traumatic brain injury; sceening; MoCA	MENTAL-STATE-EXAMINATION; ASSOCIATION; PERFORMANCE; PREDICTION; RESERVE; LESIONS; RISK; TBI	Objectives: The Montreal Cognitive Assessement (MoCA) is a brief and standardized cognitive screening tool that has been used with several clinical populations. The aim of this study was to screen the early cognitive status of patients following mild traumatic brain injury (mTBI) with the MoCA. Methods: The MoCA was administered within the first 2 weeks post-injury to 42 patients with uncomplicated mTBI, 92 patients with complicated mTBI and 50 healthy controls. Results: Patients with complicated mTBI had a significantly lower performance (more impairments) on the total score of the MoCA than both the group with uncomplicated mTBI and the control group. Also, the group with uncomplicated mTBI had a significantly lower performance than controls. Moreover, age, education and TBI severity had a significant effect on the MoCA total score where younger, more educated and patients with less severe (higher GCS score) mTBI performed significantly better. Conclusions: The MoCA may be clinically useful to acutely screen cognition following mTBI.	[Frenette, L. C.; de Guise, E.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Frenette, L. C.; de Guise, E.] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Tinawi, S.; LeBlanc, J.; Feyz, M.] McGill Univ, Hlth Ctr, Traumat Brain Injury Program, Montreal, PQ, Canada; [Correa, J. A.] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Alturki, A. Y.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Alturki, A. Y.] Natl Neurosci Inst, Dept Neurosurg, Riyadh, Saudi Arabia; [de Guise, E.] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada		de Guise, E (corresponding author), Univ Montreal, Campus Laval,1700 Rue Jacques Tetreault,Bur 6230, Laval, PQ H7N 0B6, Canada.	elaine.de.guise@umontreal.ca	Frenette, Lucie C./C-9579-2017		Research Institute of the McGill University Health Center	We thank the Research Institute of the McGill University Health Center for their support.	AharonPeretz J, 1997, BRAIN INJURY, V11, P871; Allison PD, 2001, MISSING DATA; Althouse AD, 2016, ANN THORAC SURG, V101, P1644, DOI 10.1016/j.athoracsur.2015.11.024; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bryan RN, 1997, RADIOLOGY, V202, P47, DOI 10.1148/radiology.202.1.8988191; Caplain S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00666; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chabok SY, 2012, NEUROPSYCHOLOGIA, V50, P1444, DOI 10.1016/j.neuropsychologia.2012.02.029; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Copersino ML, 2009, EXP CLIN PSYCHOPHARM, V17, P337, DOI 10.1037/a0017260; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Freitas S, 2018, APPL NEUROPSYCH-ADUL, V25, P57, DOI 10.1080/23279095.2016.1243108; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; Hendershott TR, 2017, PARKINSONISM RELAT D, V38, P31, DOI 10.1016/j.parkreldis.2017.02.008; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kletzel SL, 2017, PARKINSONISM RELAT D, V37, P58, DOI 10.1016/j.parkreldis.2017.01.012; KOBAYASHI S, 1991, STROKE, V22, P1379, DOI 10.1161/01.STR.22.11.1379; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Larouche E, 2016, ARCH CLIN NEUROPSYCH, V31, P819, DOI 10.1093/arclin/acw076; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; LeBlanc J, 2014, INT J SPEECH-LANG PA, V16, P582, DOI 10.3109/17549507.2013.871335; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lim PA, 2016, BRAIN INJURY, V30, P29, DOI 10.3109/02699052.2015.1079732; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Neyens V, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00402; Ontario Neurotraumatology Fondation, 2013, GUID CONC MILD TRAUM; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Rigon A, 2016, J INT NEUROPSYCH SOC, V22, P705, DOI 10.1017/S1355617716000539; Roalf DR, 2017, ALZHEIMERS DEMENT, V13, P947, DOI 10.1016/j.jalz.2017.01.015; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Trzepacz PT, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0103-3; von Wild KRH, 2008, ACT NEUR S, V101, P55; Wilson RS, 2003, J CLIN EXP NEUROPSYC, V25, P634, DOI 10.1076/jcen.25.5.634.14572; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhang H, 2016, CHIN J TRAUMATOL, V19, P271, DOI 10.1016/j.cjtee.2015.03.007; Zuo LJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011310	55	8	9	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2019	33	2					189	197		10.1080/02699052.2018.1542506			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG9RL	WOS:000455346300009	30388898				2022-02-06	
J	Corne, R; Leconte, C; Ouradou, M; Fassina, V; Zhu, Y; Deou, E; Besson, V; Plotkine, M; Marchand-Leroux, C; Mongeau, R				Corne, R.; Leconte, C.; Ouradou, M.; Fassina, V; Zhu, Y.; Deou, E.; Besson, V; Plotkine, M.; Marchand-Leroux, C.; Mongeau, R.			Spontaneous resurgence of conditioned fear weeks after successful extinction in brain injured mice	PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY			English	Article						Brain derived neurotrophic factor; Fear conditioning; Myelin basic protein; Post-traumatic stress disorder; Risk-taking behaviors; Barnes maze	POSTTRAUMATIC-STRESS-DISORDER; CONTROLLED CORTICAL IMPACT; WHITE-MATTER INTEGRITY; FLUID PERCUSSION INJURY; NEUROTROPHIC FACTOR; RISK-TAKING; COGNITIVE FLEXIBILITY; MILD TBI; BDNF; VETERANS	Mild traumatic brain injury (TBI) is a major risk factor for post-traumatic stress disorder (PTSD), and both disorders share common symptoms and neurobiological defects. Relapse after successful treatment, known as long-term fear resurgence, is common in PTSD patients and a major therapeutic hurdle. We induced a mild focal TBI by controlled cortical impact (CCI) in male C57BL/6 J mice and used fear conditioning to assess PTSD-like behaviors and concomitant alterations in the fear circuitry. We found for the first time that mild TBI, and to a lesser extent sham (craniotomy), mice displayed a spontaneous resurgence of conditioned fear when tested for fear extinction memory recall, despite having effectively acquired and extinguished conditioned fear 6 weeks earlier in the same context. Other characteristic symptoms of PTSD are risk-taking behaviors and cognitive deficits. CCI mice displayed risk-taking behaviors, behavioral inflexibility and reductions in processing speed compared to naive mice. In conjunction with these changes there were alterations in amygdala morphology 3 months post-trauma, and decreased myelin basic protein density at the primary lesion site and in distant secondary sites such as the hippocampus, thalamus, and amygdala, compared to sham mice. Furthermore, activity-dependent brain-derived neurotrophic factor (BDNF) transcripts were decreased in the prefrontal cortex, a key region for fear extinction consolidation, following fear extinction training in both TBI and, to a lesser extent, sham mice. This study shows for the first time that a mild brain injury can generate a spontaneous resurgence of conditioned fear associated with defective BDNF signalling in the prefrontal cortex, PTSD-like behaviors, and have enduring effects on the brain.	[Corne, R.; Leconte, C.; Ouradou, M.; Fassina, V; Zhu, Y.; Deou, E.; Besson, V; Plotkine, M.; Marchand-Leroux, C.; Mongeau, R.] Univ Paris 05, Fac Pharm Paris, Pharmacol Circulat Cerebrale EA4475, Paris, France		Mongeau, R (corresponding author), UFR Sci Pharmaceut & Biol, Pharmacol Circulat Cerebrale EA4475, 4 Ave Observ, F-75006 Paris, France.	raymond.mongeau@parisdescartes.fr	BESSON, VALERIE/AAZ-9989-2020	BESSON, VALERIE/0000-0002-1491-2380	Fondation des Gueules Cassees	This study was partly funded by Fondation des Gueules Cassees (www.gueules-cassees.asso.fr/). The funders did not participate in study design, data collection and analysis, publishing decisions, or manuscript preparation.	Abrous DN, 1999, BRAIN RES, V826, P181, DOI 10.1016/S0006-8993(99)01259-7; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Andero R, 2011, AM J PSYCHIAT, V168, P163, DOI 10.1176/appi.ajp.2010.10030326; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Baker-Andresen D, 2013, LEARN MEMORY, V20, P237, DOI 10.1101/lm.029520.112; Berthier M L, 1998, Depress Anxiety, V8, P43, DOI 10.1002/(SICI)1520-6394(1998)8:1<43::AID-DA9>3.0.CO;2-6; Blechert J, 2007, BEHAV RES THER, V45, P2019, DOI 10.1016/j.brat.2007.02.012; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Boschen MJ, 2009, AUST NZ J PSYCHIAT, V43, P89, DOI 10.1080/00048670802607154; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Busse S, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00118; Cengiz P, 2011, DEV NEUROSCI-BASEL, V33, P270, DOI 10.1159/000328430; CENTER-TBI Project, 2018, CTR TBI PROJ; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; de Visser L, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00109, 10.3389/fnins.2011.00102]; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Eckart C, 2011, J PSYCHIATR NEUROSCI, V36, P176, DOI 10.1503/jpn.100010; Ekmark-Lewen S, 2010, J NEUROTRAUM, V27, P1643, DOI 10.1089/neu.2009.0953; Ellis TW, 2014, EXP NEUROL, V261, P434, DOI 10.1016/j.expneurol.2014.06.008; Ezaki J, 2016, NEUROL RES, V38, P994, DOI 10.1080/01616412.2016.1228746; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Friess SH, 2015, J NEUROTRAUM, V32, P791, DOI 10.1089/neu.2014.3564; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; George SA, 2015, BEHAV BRAIN RES, V286, P256, DOI 10.1016/j.bbr.2015.02.051; Gong Q, 2014, PSYCHOL MED, V44, P195, DOI 10.1017/S0033291713000561; Gourley SL, 2009, NEUROPSYCHOPHARMACOL, V34, P707, DOI 10.1038/npp.2008.123; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hauck S, 2010, PROG NEURO-PSYCHOPH, V34, P459, DOI 10.1016/j.pnpbp.2010.01.010; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Herrera JJ, 2017, J NEUROTRAUM, V34, P291, DOI 10.1089/neu.2016.4407; Howlett J. R., 2016, FRONTIERS NEUROSCIEN; Husson I, 2005, CEREB CORTEX, V15, P250, DOI 10.1093/cercor/bhh127; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; John EH, 2011, TXB MED PHYSL, P136, DOI [10.1176/appi.books.9781585624201.js04, DOI 10.1176/APPI.BOOKS.9781585624201.JS04]; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Keith J, 2015, J NERV MENT DIS, V203, P287, DOI 10.1097/NMD.0000000000000280; Klimek M, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/670480; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Lai SW, 2018, MOL NEUROBIOL, V55, P7487, DOI 10.1007/s12035-018-0933-z; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Linley SB, 2016, BRAIN RES, V1649, P110, DOI 10.1016/j.brainres.2016.08.022; Marek R, 2018, NAT NEUROSCI, V21, P384, DOI 10.1038/s41593-018-0073-9; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; Merkel SF, 2017, J NEUROTRAUM, V34, P165, DOI 10.1089/neu.2015.4275; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; OLESEN SP, 1987, ACTA PHYSIOL SCAND, V130, P63, DOI 10.1111/j.1748-1716.1987.tb08112.x; Ou LC, 2010, NEUROBIOL LEARN MEM, V93, P372, DOI 10.1016/j.nlm.2009.12.003; Palmer CP, 2016, EXP NEUROL, V277, P215, DOI 10.1016/j.expneurol.2016.01.004; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Pearson JM, 2011, TRENDS COGN SCI, V15, P143, DOI 10.1016/j.tics.2011.02.002; Prasad KN, 2015, BRAIN RES, V1599, P103, DOI 10.1016/j.brainres.2014.12.038; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rohleder N, 2010, NEUROSCI BIOBEHAV R, V35, P104, DOI 10.1016/j.neubiorev.2009.12.003; Rosas-Vidal LE, 2014, NEUROPSYCHOPHARMACOL, V39, P2161, DOI 10.1038/npp.2014.64; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Shucard JL, 2012, PSYCHIAT RES-NEUROIM, V204, P25, DOI 10.1016/j.pscychresns.2012.04.006; Sierra-Mercado D, 2015, BRAIN RES, V1606, P133, DOI 10.1016/j.brainres.2015.02.031; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Spring S, 2010, NEUROIMAGE, V50, P409, DOI 10.1016/j.neuroimage.2009.12.043; Svetlicky V, 2010, ISR J PSYCHIATR REL, V47, P276; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Takei S, 2011, J PSYCHIATR RES, V45, P460, DOI 10.1016/j.jpsychires.2010.08.009; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Wang XW, 2015, J SURG RES, V193, P308, DOI 10.1016/j.jss.2014.06.020; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Whiting DL, 2017, NEUROPSYCHOL REHABIL, V27, P263, DOI 10.1080/09602011.2015.1062115; Wurtz H, 2016, NEUROSCIENCE, V321, P222, DOI 10.1016/j.neuroscience.2015.06.012; Xiao JH, 2010, NEUROSIGNALS, V18, P186, DOI 10.1159/000323170; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Zhao J, 2018, J NEUROTRAUM, V35, P149, DOI 10.1089/neu.2016.4898	88	8	8	0	34	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-5846	1878-4216		PROG NEURO-PSYCHOPH	Prog. Neuro-Psychopharmacol. Biol. Psychiatry	JAN 10	2019	88						276	286		10.1016/j.pnpbp.2018.07.023			11	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	GU8ZY	WOS:000445634300029	30096331				2022-02-06	
J	Williams, C; Wood, RL; Howe, H				Williams, Claire; Wood, Rodger Llewellyn; Howe, Holly			Alexithymia is associated with aggressive tendencies following traumatic brain injury	BRAIN INJURY			English	Article						Alexithymia; emotional disturbances; behavior; prefrontal cortex; brain injuries; TBI	CLOSED-HEAD INJURY; BEHAVIOR; SCALE	Objective: Aggressive behavior is a frequent legacy of traumatic brain injury (TBI). This study explores the question of how alexithymia, which is associated with deficits in social cognition and empathy, may predispose individuals to aggressive tendencies after head trauma. Method: A total of 47 individuals referred for routine neuropsychological assessment and advice on the management of long-term neuropsychological sequelae after TBI and 72 demographically matched controls completed the 20-Item Toronto Alexithymia Scale (TAS-20) and Buss Perry Aggression Questionnaire (BPAQ; self and proxy). Results: The incidence of alexithymia and aggressive tendencies was significantly higher in the group with TBI. After controlling for covariates, alexithymia explained an additional 29% of variance in BPAQ total scores in the group with TBI and 11.1% in the control group. Of the three TAS-20 sub-scales, 'difficulty describing feelings' emerged as a consistent unique predictor of aggression scores. Conclusions: Higher levels of alexithymia are associated with greater aggressive tendencies post-TBI. The findings offer important theoretical and empirical insights into the prediction of aggression after TBI.	[Williams, Claire; Howe, Holly] Swansea Univ, Coll Human & Hlth Sci, Dept Psychol, Singleton Pk, Swansea SA2 8PP, W Glam, Wales; [Wood, Rodger Llewellyn] Swansea Univ, Med Sch, Swansea, W Glam, Wales; [Howe, Holly] Cardiff Univ, Neurodev Assessment Unit, Cardiff, S Glam, Wales		Williams, C (corresponding author), Swansea Univ, Coll Human & Hlth Sci, Dept Psychol, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	claire.williams@swansea.ac.uk		Williams, Claire/0000-0002-0791-744X			BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; Bowman M. L., 1997, IMPULSIVITY THEORY A, P116; Brooks D. N., 1987, J HEAD TRAUMA REHAB, V2, P1; Burba B, 2006, CAN J PSYCHIAT, V51, P468, DOI 10.1177/070674370605100709; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Buss AH, 2000, AGGRESSION QUESTIONN; Cohen J., 2013, STAT POWER ANAL BEHA; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Frewen PA, 2008, J ABNORM PSYCHOL, V117, P171, DOI 10.1037/0021-843X.117.1.171; Gauci A, 2012, J CRIM PSYCHOL, V2, P121, DOI 10.1108/20093821211264432; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Greve KW, 2001, BRAIN INJURY, V15, P255; Larsen JK, 2003, J PSYCHOSOM RES, V54, P533, DOI 10.1016/S0022-3999(02)00466-X; Lowry L, 2011, VASSARSTATS WEBSITE; Mathias CW, 2007, PSYCHIAT RES, V151, P231, DOI 10.1016/j.psychres.2006.11.001; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Motzkin JC, 2011, J NEUROSCI, V31, P17348, DOI 10.1523/JNEUROSCI.4215-11.2011; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P205, DOI 10.1097/HTR.0000000000000261; PASINI A, 1992, COMPR PSYCHIAT, V33, P42, DOI 10.1016/0010-440X(92)90078-5; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Stanford MS, 2003, ASSESSMENT, V10, P183, DOI 10.1177/1073191103010002009; Strickland J, 2017, AUST PSYCHOL, V52, P230, DOI 10.1111/ap.12187; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Taylor G. J., 1997, DISORDERS AFFECT REG; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Tremblay PF, 2005, PERS INDIV DIFFER, V38, P337, DOI 10.1016/j.paid.2004.04.012; WechslerD, 2001, WECHSLER TEST ADULT; Williams C, 2013, J HEAD TRAUMA REHAB, V28, pE21, DOI 10.1097/HTR.0b013e318267b0ab; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood R, 2009, BRAIN INJURY, V23, DOI [10.1080/02699050903196670, DOI 10.1080/02699050903196670]; Wood RL, 2001, BRAIN DAM B, P133; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Wood RLL, 2013, BRAIN INJURY, V27, P253, DOI 10.3109/02699052.2012.743181; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518; Wood RL, 2013, J HEAD TRAUMA REHAB, V28, P98, DOI 10.1097/HTR.0b013e3182426029	46	8	8	2	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2019	33	1			SI		69	77		10.1080/02699052.2018.1531302			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG2RW	WOS:000454812400009	30373401	Green Accepted			2022-02-06	
J	Bareham, CA; Allanson, J; Roberts, N; Hutchinson, PJA; Pickard, JD; Menon, DK; Chennu, S				Bareham, Corinne A.; Allanson, Judith; Roberts, Neil; Hutchinson, Peter J. A.; Pickard, John D.; Menon, David K.; Chennu, Srivas			Longitudinal assessments highlight long-term behavioural recovery in disorders of consciousness	BRAIN COMMUNICATIONS			English	Article						Coma Recovery Scale-Revised; disorders of consciousness; arousal; natural history; longitudinal	FOLLOW-UP; SCALE; STATE; DIAGNOSIS; ZOLPIDEM; OUTCOMES; INJURY; TRIAL; TDCS	Accurate diagnosis and prognosis of disorders of consciousness is complicated by the variability amongst patients' trajectories. However, the majority of research and scientific knowledge in this field is based on cross-sectional studies. The translational gap in applying this knowledge to inform clinical management can only be bridged by research that systematically examines follow-up. In this study, we present findings from a novel longitudinal study of the long-term recovery trajectory of 39 patients, repeatedly assessed using the Coma Recovery Scale-Revised once every 3 months for 2 years, generating 185 assessments. Despite the expected inter-patient variability, there was a statistically significant improvement in behaviour over time. Further, improvements began approximately 22 months after injury. Individual variation in the trajectory of recovery was influenced by initial diagnosis. Patients with an initial diagnosis of unresponsive wakefulness state, who progressed to the minimally conscious state, did so at a median of 485 days following onset-later than 12-month period after which current guidelines propose permanence. Although current guidelines are based on the expectation that patients with traumatic brain injury show potential for recovery over longer periods than those with non-traumatic injury, we did not observe any differences between trajectories in these two subgroups. However, age was a significant predictor, with younger patients showing more promising recovery. Also, progressive increases in arousal contributed exponentially to improvements in behavioural awareness, especially in minimally conscious patients. These findings highlight the importance of indexing arousal when measuring awareness, and the potential for interventions to regulate arousal to aid long-term behavioural recovery in disorders of consciousness.	[Bareham, Corinne A.; Hutchinson, Peter J. A.; Pickard, John D.; Chennu, Srivas] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 0QQ, England; [Allanson, Judith] Cambridge Univ Hosp NHS Fdn Trust, Cambridge CB2 0QQ, England; [Roberts, Neil] Jacobs & Gardens Neuro Ctr, Sawbridgeworth Med Serv, Sawbridgeworth CM21 0HH, England; [Menon, David K.] Univ Cambridge, Div Anaesthesia, Cambridge CB2 0QQ, England; [Chennu, Srivas] Univ Kent, Sch Comp, Chatham ME4 4AG, England		Bareham, CA (corresponding author), Dept Clin Neurosci, Cambridge Biomed Campus,Box 165, Cambridge CB2 0QQ, England.	corinne.bareham@gmail.com		Bareham, Corinne/0000-0003-1814-9527	Wellcome Trust Institutional Strategic Support FundWellcome Trust [ISSF/SCM/48]; Evelyn Trust [15/07]; UK Engineering and Physical Sciences Research CouncilUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/P033199/1]; UK National Institute for Health Research (NIHR) as part of the Acute Brain Injury and Repair Theme of the Cambridge Biomedical Research Centre; NIHR Research Professorship; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); NIHR Brain Injury Healthcare Technology Cooperative; James S. McDonnell Foundation; Alan Turing Institute (UK Engineering and Physical Sciences Research Council)UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N510129/1]; NIHR Senior Investigator award; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/P033199/1] Funding Source: UKRI	The authors also acknowledge the funders of the research; Wellcome Trust Institutional Strategic Support Fund [C.A.B., Ref: ISSF/SCM/48], Evelyn Trust [S.C., Ref: 15/07], UK Engineering and Physical Sciences Research Council [S.C., Ref: EP/P033199/1], the UK National Institute for Health Research (NIHR) as part of the Acute Brain Injury and Repair Theme of the Cambridge Biomedical Research Centre [P.J.A.H.], the NIHR Research Professorship [P.J.A.H.], the NIHR Cambridge Biomedical Research Centre [P.J.A.H. and D.K.M.], the NIHR Brain Injury Healthcare Technology Cooperative [J.D.P.], the NIHR Senior Investigator award [D.K.M.] and the James S. McDonnell Foundation [J.D.P.]. This research was undertaken with the support of the Alan Turing Institute (UK Engineering and Physical Sciences Research Council Grant Number EP/N510129/1).	ANDREWS K, 1993, BRIT MED J, V306, P1597, DOI 10.1136/bmj.306.6892.1597; Bagnato S, 2017, J NEUROTRAUM, V34, P535, DOI 10.1089/neu.2016.4418; Bodien YG, 2016, ARCH PHYS MED REHAB, V97, P490, DOI 10.1016/j.apmr.2015.08.422; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; Candelieri A, 2011, J NEUROTRAUM, V28, P2013, DOI 10.1089/neu.2011.1885; Childs NL, 1996, NEW ENGL J MED, V334, P24, DOI 10.1056/NEJM199601043340105; Cortese MD, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0455-5; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2014, ARCH PHYS MED REHAB, V95, P711, DOI 10.1016/j.apmr.2013.11.004; Faran S, 2006, J NEUROL NEUROSUR PS, V77, P998, DOI 10.1136/jnnp.2005.076554; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1699, DOI 10.1016/j.apmr.2018.07.001; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, NEUROREHABILITATION, V19, P293; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Jennett B, 2002, J NEUROL NEUROSUR PS, V73, P355, DOI 10.1136/jnnp.73.4.355; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kuehlmeyer K, 2013, BIOETHICA FORUM, V2013, P137; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Royal College of Physicians, 2013, PROL DIS CONSC NAT C; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Steppacher I, 2014, ANN CLIN TRANSL NEUR, V1, P401, DOI 10.1002/acn3.63; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; Thibaut A, 2015, PRINCIPLES PRACTICE, V1, P65; Thibaut A, 2017, BRAIN INJURY, V31, P466, DOI 10.1080/02699052.2016.1274776; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; Whyte J, 2014, AM J PHYS MED REHAB, V93, P101, DOI 10.1097/PHM.0000000000000069; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; Wilson SL, 1996, BRAIN INJURY, V10, P105, DOI 10.1080/026990596124593	37	8	8	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2019	1	1							17	10.1093/braincomms/fcz017			11	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	NW3RF	WOS:000574927100017	31886461	Green Published, gold, Green Accepted			2022-02-06	
J	Baxter, K; Hellewell, SC				Baxter, Kathleen; Hellewell, Sarah C.			Traumatic Brain Injury within Domestic Relationships: Complications, Consequences and Contributing Factors	JOURNAL OF AGGRESSION MALTREATMENT & TRAUMA			English	Article						Traumatic brain injury; domestic violence; intimate partner violence; battering; concussion; head injury; diffuse axonal injury; cognitive dysfunction	INTIMATE PARTNER-VIOLENCE; POSTTRAUMATIC-STRESS-DISORDER; FEMALE VICTIMS; REACTIVE ASTROCYTES; NERVE-FIBERS; OPTIC-NERVE; HEAD-INJURY; HEALTH; DEPRESSION; SYMPTOMS	Traumatic brain injury (TBI) resulting from episodes of domestic violence (DV) is a serious yet greatly underreported issue. Head injuries arising in these circumstances are often concussive or sub-concussive in nature, and are unlikely to be isolated incidents, with victims frequently suffering repetitive Ms over time. Although men may also be victims of DV, women and children are most at risk of DV via intimate partners and parents, respectively. Due to the complexities of these interpersonal relationships, victims of DV are not always able to receive appropriate clinical diagnoses, care or follow-up after TBI. TBI arising from DV is also likely to occur in a complex milieu of fear, anxiety and depression, the physical and psychological consequences of which may worsen or perpetuate the pathology of TBI. This review examines the complexities of TBI arising from DV from several perspectives, with focus on three pertinent and interrelated topics: 1) pathobiology and complications of single and repetitive TBI, encompassing direct neural consequences, inflammation and hormonal changes; 2) behavioral, cognitive and psychosocial consequences of TBI; and 3) contributing factors to TBI and complications, including strategies to increase clinician recognition of TBI in DV patients, and programs and policies in place in Australia and abroad to decrease rates of offending.	[Hellewell, Sarah C.] Univ Sydney, Sydney Translat Imaging Lab, Heart Res Inst, Charles Perkins Ctr, Sydney, NSW, Australia; [Hellewell, Sarah C.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia		Hellewell, SC (corresponding author), Charles Perkins Ctr, Heart Res Inst, Sydney Translat Imaging Lab, D17,John Hopkins Dr, Camperdown, NSW 2050, Australia.	sarah.hellewell@sydney.edu.au		Hellewell, Sarah/0000-0002-2179-2209			Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Anderson M. L., 2009, WATCH REPORT 2; Australian Institute of Health and Welfare, 2017, HOSP ASS INJ WOM GIR; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bays JA, 1998, PEDIATRICS, V101, P1091; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brain Injury Australia, 2018, PREV ACQ BRAIN INJ V; Breslau N, 2000, BIOL PSYCHIAT, V48, P902, DOI 10.1016/S0006-3223(00)00933-1; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Centers for Disease Control and Prevention (CDC), 2018, UND INT PARTN VIOL; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Choe MC, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0573-9; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Davis A, 2014, J TRAUMA NURS, V21, P300, DOI 10.1097/JTN.0000000000000086; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Gallyas F, 2006, ACTA NEUROPATHOL, V111, P229, DOI 10.1007/s00401-006-0034-3; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; GRAHAM DI, 1992, J CLIN PATHOL, V45, P840, DOI 10.1136/jcp.45.9.840; Griffin MG, 2005, AM J PSYCHIAT, V162, P1192, DOI 10.1176/appi.ajp.162.6.1192; Hamberger LK, 2015, J WOMENS HEALTH, V24, P86, DOI 10.1089/jwh.2014.4861; Hellewell SC, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/356494; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Juengst SB, 2017, PSYCHOL RES BEHAV MA, V10, P175, DOI 10.2147/PRBM.S113264; Kim HK, 2015, PSYCHONEUROENDOCRINO, V51, P35, DOI 10.1016/j.psyneuen.2014.09.013; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Llompart-Pou JA, 2008, NEUROCRIT CARE, V9, P230, DOI 10.1007/s12028-008-9115-6; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Lovestad S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4222-y; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Monahan K., 2018, J NEUROLOGY NEUROMED, V3, P3, DOI [10.29245/2572.942X/2018/3.1181, DOI 10.29245/2572.942X/2018/3.1181]; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pickard M., 1991, H128A00022 US DEP ED; Pico-Alfonso MA, 2006, J WOMENS HEALTH, V15, P599, DOI 10.1089/jwh.2006.15.599; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Portillo-Castro H., 2016, DOMESTIC FAMILY VIOL; Povlishock J. T., 1997, 7 LUB WORKSH NEUR BI; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Regehr C, 2008, J SOC SERV RES, V34, P5, DOI 10.1080/01488370802085890; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith DJ, 2001, J EMERG MED, V21, P323, DOI 10.1016/S0736-4679(01)00402-4; Snyder R. L., 2015, NEW YORKER; State Government of Victoria, 2018, INF SHAR RISK MAN; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; STRICH SJ, 1961, LANCET, V2, P443; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Training Institute on Strangulation Prevention, 2018, WHAT WE DO; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Victorian Government Department of Human Services, 2009, ENH ACC MENS BEH CHA; Voelker R, 2018, JAMA-J AM MED ASSOC, V320, P535, DOI 10.1001/jama.2018.9051; Waalen J, 2000, AM J PREV MED, V19, P230, DOI 10.1016/S0749-3797(00)00229-4; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Weaver TL, 2014, HEALTH CARE WOMEN IN, V35, P458, DOI 10.1080/07399332.2013.858162; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; World Health Organization/London School of Hygiene and Tropical Medicine, 2010, PREV INT PARTN SEX V, P1; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zheng P, 2014, NEUROL INDIA, V62, P280, DOI 10.4103/0028-3886.136922; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	90	8	8	2	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1092-6771	1545-083X		J AGGRESS MALTREAT T	J. Aggress. Maltreatment Trauma		2019	28	6			SI		660	676		10.1080/10926771.2019.1602089			17	Psychology, Clinical; Criminology & Penology; Family Studies; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology; Family Studies; Psychiatry	IM2YW	WOS:000477859700002					2022-02-06	
J	Cross, DJ; Meabon, JS; Cline, MM; Richards, TL; Stump, AJ; Cross, CG; Minoshima, S; Banks, WA; Cook, DG				Cross, Donna J.; Meabon, James S.; Cline, Marcella M.; Richards, Todd L.; Stump, Amanda J.; Cross, Chloe G.; Minoshima, Satoshi; Banks, William A.; Cook, David G.			Paclitaxel Reduces Brain Injury from Repeated Head Trauma in Mice	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Axonal injury; imaging; microtubule-stabilizing drug; repeat mild traumatic brain injury; synaptic preservation	INTRANASAL INSULIN; QUANTITATIVE-ANALYSIS; MICROTUBULE DYNAMICS; AXON REGENERATION; ENERGY-METABOLISM; RAT-BRAIN; MICROBLEEDS; MECHANISMS; DELIVERY; DISEASE	Repetitive mild traumatic brain injury (rmTBI) is known to disturb axonal integrity and may play an important role in the pathogenic cascades leading to neurodegeneration. One critical approach to reduce the future onset of neurodegeneration is to intervene in this process at an early stage following a brain injury. Previously we showed that direct application of the microtubule-stabilizing drug, paclitaxel, on the brain following controlled cortical impact improved motor function and reduced lesion size. Herein, we extended these findings to a model of mild brain injury induced by repeated closed-skull impacts. Paclitaxel was administered intranasally to circumvent its poor transport across the blood-brain barrier. Mice received five mild closed-skull impacts (one per day for five days). Intranasal paclitaxel was administered once only, immediately after the first impact. We found that paclitaxel prevented injury-induced deficits in a spatial memory task in a water tread maze. In vivo magnetic resonance imaging (MRI) and positron emission tomography with 18F-flurodeoxygluco se (FDG-PET) revealed that paclitaxel prevented structural injury and hypometabolism. On MRI, apparent, injury-induced microbleeds were observed in 100% of vehicle-treated rmTBI mice, but not in paclitaxel-treated subjects. FDG-PET revealed a 42% increase in whole brain glucose metabolism in paclitaxel-treated mice as compared to vehicle-treated rmTBI Immunohistochemistry found reduced evidence of axonal injury and synaptic loss. Our results indicate that intranasal paclitaxel administration imparts neuroprotection against brain injury and cognitive impairment in mice. The results from this study support the idea that microtubule-stabilization strategies hold therapeutic promise in mitigating traumatic brain injury.	[Cross, Donna J.; Stump, Amanda J.; Cross, Chloe G.; Minoshima, Satoshi] Univ Utah, Dept Radiol & Imaging Sci, 30 N 1900 E 1A71, Salt Lake City, UT 84132 USA; [Meabon, James S.] Mental Illness Res Educ & Clin Ctr, Seattle, WA USA; [Meabon, James S.; Cline, Marcella M.; Banks, William A.; Cook, David G.] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Cline, Marcella M.; Banks, William A.; Cook, David G.] Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Meabon, James S.] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Cline, Marcella M.] Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA; [Richards, Todd L.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Banks, William A.] Univ Washington, Dept Med, Seattle, WA USA; [Cook, David G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA		Cross, DJ (corresponding author), Univ Utah, Dept Radiol & Imaging Sci, 30 N 1900 E 1A71, Salt Lake City, UT 84132 USA.	d.cross@utah.edu	Banks, William A/K-1330-2017	Banks, William A/0000-0002-0496-3619; Minoshima, Satoshi/0000-0002-0043-3047; Cline, Marcella/0000-0002-9590-3725	Institute for Translational Health Sciences pilot grant [UL1TR000423]; University of Washington Center on Human Development and DisabilityUniversity of Washington [HD 083091]; Department of Veterans Affairs Office of Research and Development Medical Research Service RDIS [0005]; VA Puget Sound Health Care System Seed Grant; University of Washington Friends of Alzheimer's Research; University ofWashington Royalty Research Fund;  [R01AG046619]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD083091] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000423, UL1TR002319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG046619] Funding Source: NIH RePORTER	The authors would like to thank Greg Garwin and Bradley Neal for their assistance with the research in this study. Support for this research was provided by the Institute for Translational Health Sciences pilot grant UL1TR000423 (D.J.C.) and the University of Washington Center on Human Development and Disability small animal imaging and behavioral cores (HD 083091). These studies were supported by R01AG046619 (W.A.B.), Department of Veterans Affairs Office of Research and Development Medical Research Service RDIS#0005 (D.G.C.), VA Puget Sound Health Care System Seed Grant (J.S.M.) University of Washington Friends of Alzheimer's Research (D.G.C), University ofWashington Royalty Research Fund (D.G.C.).	Adlard PA, 2000, ACTA NEUROPATHOL, V100, P183, DOI 10.1007/s004019900160; Amin ML, 2013, DRUG TARGET INSIGHT, V7, P27, DOI 10.4137/DTI.S12519; Amos LA, 1999, CHEM BIOL, V6, pR65, DOI 10.1016/S1074-5521(99)89002-4; Ballatore C, 2017, ACS CHEM NEUROSCI, V8, P5, DOI 10.1021/acschemneuro.6b00384; Banks WA, 2009, J DRUG TARGET, V17, P91, DOI [10.1080/10611860802382777, 10.1080/10611860802382777 ]; Bleeker-Rovers CP, 2004, EUR J NUCL MED MOL I, V31, P29, DOI 10.1007/s00259-003-1338-3; Brabazon F, 2017, J CEREBR BLOOD F MET, V37, P3203, DOI 10.1177/0271678X16685106; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Brunden KR, 2017, NEUROBIOL DIS, V105, P328, DOI 10.1016/j.nbd.2016.12.021; Brunden KR, 2011, PHARMACOL RES, V63, P341, DOI 10.1016/j.phrs.2010.12.002; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buchsbaum MS, 2015, J NEUROTRAUM, V32, P1736, DOI 10.1089/neu.2014.3660; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Cline MM, 2017, JOVE-J VIS EXP, DOI 10.3791/55986; Cline MM, 2017, BRAIN RES, V1657, P140, DOI 10.1016/j.brainres.2016.11.027; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Cross DJ, 2004, NEUROIMAGE, V23, P1326, DOI 10.1016/j.neuroimage.2004.07.038; Cross DJ, 2015, BRAIN RES, V1618, P299, DOI 10.1016/j.brainres.2015.06.006; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Dent EW, 2017, MOL BIOL CELL, V28, P1, DOI 10.1091/mbc.E15-11-0769; Diaz JF, 2003, J BIOL CHEM, V278, P8407, DOI 10.1074/jbc.M211163200; Ducharme N, 2010, EUR J PHARMACOL, V641, P128, DOI 10.1016/j.ejphar.2010.05.033; Erez H, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00034; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Fernandez-Peralbo MA, 2014, J PHARMACEUT BIOMED, V91, P131, DOI 10.1016/j.jpba.2013.12.028; Field A., 2012, DISCOVERING STAT USI; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; GEISERT EE, 1990, P NATL ACAD SCI USA, V87, P3967, DOI 10.1073/pnas.87.10.3967; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Gornstein E, 2014, NEUROPHARMACOLOGY, V76, P175, DOI 10.1016/j.neuropharm.2013.08.016; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Henry LC, 2017, NEUROSCIENTIST, V23, P567, DOI 10.1177/1073858416651034; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kumar Hitesh, 2017, Pharmaceutical Nanotechnology, V5, P203, DOI 10.2174/2211738505666170515113936; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lawrence TP, 2017, NEUROSCI LETT, V655, P143, DOI 10.1016/j.neulet.2017.06.046; Lochhead JJ, 2015, J CEREBR BLOOD F MET, V35, P371, DOI 10.1038/jcbfm.2014.215; Lochhead JJ, 2012, ADV DRUG DELIVER REV, V64, P614, DOI 10.1016/j.addr.2011.11.002; Lou K, 2014, J MED CHEM, V57, P6116, DOI 10.1021/jm5005623; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Pettan-Brewer C, 2013, PATHOBIOL AGING AGE, V3, DOI 10.3402/pba.v3i0.20679; Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016; Semmler A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-38; Sengottuvel V, 2011, J NEUROSCI, V31, P2688, DOI 10.1523/JNEUROSCI.4885-10.2011; Shinoda J, 2017, NEUROL MED-CHIR, V57, P199, DOI 10.2176/nmc.ra.2016-0293; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; SOKOLOFF L, 1993, DEV NEUROSCI-BASEL, V15, P194, DOI 10.1159/000111335; Sundman MH, 2014, J ALZHEIMERS PARKINS, V4, P137; TAKAMIYA Y, 1988, DEV BRAIN RES, V38, P201, DOI 10.1016/0165-3806(88)90045-4; THORNE RG, 1995, BRAIN RES, V692, P278, DOI 10.1016/0006-8993(95)00637-6; Toth A, 2016, NEUROSCI LETT, V617, P207, DOI 10.1016/j.neulet.2016.02.028; Watanabe J, 2016, ACTA NEUROCHIR, V158, P1247, DOI 10.1007/s00701-016-2805-5; Winer B. J., 1991, STAT PRINCIPLES EXPT, V3rd	65	8	8	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2019	67	3					859	874		10.3233/JAD-180871			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HL1ZO	WOS:000458503200007	30664506	Green Accepted			2022-02-06	
J	Howell, DR; Wilson, JC; Kirkwood, MW; Grubenhoff, JA				Howell, David R.; Wilson, Julie C.; Kirkwood, Michael W.; Grubenhoff, Joseph A.			Quality of Life and Symptom Burden 1 Month After Concussion in Children and Adolescents	CLINICAL PEDIATRICS			English	Article						pediatric; Health and Behavior Index; mild traumatic brain injury; adolescent medicine; health-related quality of life	POSTCONCUSSIVE SYMPTOMS; SCHOOL; SPORTS; RETURN	We conducted a prospective study of children and adolescents (n = 176; mean age = 13.0 +/- 2.7 years; 38% female) assessed acutely post-concussion and again 30 days later. We investigated the association between symptom burden and quality of life (QOL) outcomes, as well as the effect of age on QOL. We assessed QOL using patient-reported Pediatric Quality of Life Inventory 4.0, and symptoms using the Health and Behavior Inventory (HBI). Acute (<2 days post-injury) HBI ratings demonstrated a low correlation (R-2 = 0.08) with physical health QOL and a moderate correlation with psychosocial health QOL (R-2 = 0.21) 30 days post-concussion. HBI ratings 30 days post-concussion demonstrated a moderately high correlation with physical health QOL (R-2 = 0.35) and psychosocial health QOL (R-2 = 0.57). Age was not significantly associated with physical or psychosocial QOL ratings. Impairments in QOL following concussion may identify children and adolescents who need additional referral to address persistent symptoms at this time.	[Howell, David R.; Wilson, Julie C.; Kirkwood, Michael W.; Grubenhoff, Joseph A.] Childrens Hosp Colorado, Aurora, CO USA; [Howell, David R.; Wilson, Julie C.; Kirkwood, Michael W.; Grubenhoff, Joseph A.] Univ Colorado, Sch Med, Aurora, CO USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Ctr Sports Med, 13123 East 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu	Grubenhoff, Joseph A/H-9994-2019	Grubenhoff, Joseph A/0000-0001-5072-4064; Howell, David/0000-0002-2955-0191	Colorado Department of Human Services Traumatic Brain Injury Program [4600]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding for this study was provided by Colorado Department of Human Services Traumatic Brain Injury Program Grant 4600 to Dr Grubenhoff. The study sponsor played no role in the study design, the collection, analysis, and interpretation of data, the writing of the report, or the decision to submit the article for publication.	Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Caplain S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00666; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Eiser C, 2001, Health Technol Assess, V5, P1; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Grubenhoff' JA, 2015, BRAIN INJURY, V29, P1186, DOI 10.3109/02699052.2015.1035325; Houston MN, 2016, BRAIN INJURY, V30, P891, DOI 10.3109/02699052.2016.1146960; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Hullmann SE, 2011, ARTHRIT CARE RES, V63, pS420, DOI 10.1002/acr.20637; Kim J, 2014, DISABIL HEALTH J, V7, P96, DOI 10.1016/j.dhjo.2013.08.007; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Matza LS, 2004, J DEV BEHAV PEDIATR, V25, P166, DOI 10.1097/00004703-200406000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117745033; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Pieper P, 2014, BRAIN INJURY, V28, P105, DOI 10.3109/02699052.2013.847208; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Raat H, 2006, CURR OPIN ALLERGY CL, V6, P180, DOI 10.1097/01.all.0000225157.67897.c2; Rivara FP, 2007, J TRAUMA, V63, pS155, DOI 10.1097/TA.0b013e31815acd92; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Steindel SJ, 2010, J AM MED INFORM ASSN, V17, P274, DOI 10.1136/jamia.2009.001230; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, PEDSQL SCORING ALGOR; Vassilyadi M, 2014, PEDIATR NEUROSURG, V50, P196, DOI 10.1159/000431232; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	33	8	8	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	JAN	2019	58	1					42	49		10.1177/0009922818806308			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	HD4NC	WOS:000452503500006	30311786	Bronze			2022-02-06	
J	King, R; Grohs, MN; Kirton, A; Lebel, C; Esser, MJ; Barlow, KM				King, Regan; Grohs, Melody N.; Kirton, Adam; Lebel, Catherine; Esser, Michael J.; Barlow, Karen M.			Microstructural neuroimaging of white matter tracts in persistent post-concussion syndrome: A prospective controlled cohort study	NEUROIMAGE-CLINICAL			English	Article						Diffusion tensor imaging; Mild traumatic brain injury; Pediatrics; Persistent post-concussive symptoms; Uncinate fasciculus	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; HEAD-INJURY; POSTCONCUSSION SYNDROME; UNCINATE FASCICULUS; CORPUS-CALLOSUM; OPTIC-NERVE; CHILDREN; INTEGRITY; OUTCOMES	Introduction: Children with mild traumatic brain injury (mTBI) typically recover quickly, however approximately 15% experience persistent post-concussive symptoms (PPCS) past 3 months. The microstructural pathology associated with underlying persistent symptoms is poorly understood but is suggested to involve axonal injury to white matter tracts. Diffusion tensor imaging (DTI) can be used to visualize and characterize damage to white matter microstructure of the brain. Objective: We aimed to investigate white matter microstructure in children with persistent concussive symptoms as compared to typically developing controls, alongside evaluating differences in white matter changes over time and how this relates to symptom recovery. Methods: The current study is a prospective, longitudinal, controlled cohort study of children with mTBI. 104 children aged 8 to 18 years with a mTBI (72 symptomatic; 32 asymptomatic) were recruited from the Alberta Children's Hospital and compared to 20 healthy controls. Microstructural evidence of white matter injury was evaluated using DTI one month post injury and repeated 4 to 6 weeks later. Primary outcomes included fractional anisotropy and mean diffusivity of the corticospinal tracts, uncinate fasciculi, and motor fibers of the corpus callosum. Post-concussive symptoms were also measured using the Post-Concussion Symptom Inventory (PCSI) taken at both time points. Results: Fractional anisotropy of the left uncinate fasciculi was lower in symptomatic children compared to controls (F(2,119) = 3.582, p = 0.031). No other significant differences were observed. Conclusions: Our findings provide evidence of microstructural injury following mTBI in children with ongoing post-concussive symptoms one month post injury. The changes were persistent 4-6 weeks later. Further longitudinal studies of white matter microstructure in PPCS will be helpful to clarify whether these white matter alterations resolve over time.	[King, Regan; Kirton, Adam; Barlow, Karen M.] Hotchkiss Brain Inst, Calgary, AB, Canada; [King, Regan; Grohs, Melody N.; Kirton, Adam; Lebel, Catherine; Esser, Michael J.; Barlow, Karen M.] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [King, Regan; Grohs, Melody N.; Kirton, Adam; Lebel, Catherine; Barlow, Karen M.] Dept Clin Neurosci, Calgary, AB, Canada; [Kirton, Adam; Lebel, Catherine; Esser, Michael J.; Barlow, Karen M.] Dept Pediat, Calgary, AB, Canada; [Kirton, Adam; Esser, Michael J.; Barlow, Karen M.] Univ Calgary, Cummings Sch Med, Calgary, AB, Canada		Barlow, KM (corresponding author), Univ Queensland, Lady Cilento Childrens Hosp, Fac Med, Child Hlth Res Ctr, Rm 610,Level 6,62 Graham St, South Brisbane, Qld 4010, Australia.	k.barlow@uq.edu.au	Barlow, Karen/I-6492-2019; Lebel, Catherine/B-4298-2015	Barlow, Karen/0000-0003-2612-8507; Lebel, Catherine/0000-0002-0344-4032	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [293375]; Faculty of Medicine, University of Calgary	This study was funded by the Canadian Institutes of Health Research (grant number: 293375); and the Faculty of Medicine, University of Calgary.	ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bhatia KD, 2018, J AFFECT DISORDERS, V235, P220, DOI 10.1016/j.jad.2018.04.055; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Centers for Disease Control and Prevention, 2010, HEADS FACTS PHYS MIL; Cernak I, 2010, DEV NEUROSCI-BASEL, V32, P442, DOI 10.1159/000320085; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Diehl B, 2008, EPILEPSIA, V49, P1409, DOI 10.1111/j.1528-1167.2008.01596.x; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Ewing-Cobbs L, 2006, AM J NEURORADIOL, V27, P879; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Garvey MA, 2001, CLIN NEUROPHYSIOL, V112, P1451, DOI 10.1016/S1388-2457(01)00581-8; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gosselin N, 2010, PHYSICIAN SPORTSMED, V38, P27, DOI 10.3810/psm.2010.10.1805; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Keihaninejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045996; Lai CH, 2013, J AFFECT DISORDERS, V150, P330, DOI 10.1016/j.jad.2013.04.014; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maxwell WL, 2015, J NEUROTRAUM, V32, P780, DOI 10.1089/neu.2014.3369; McCauley SR, 2011, J NEUROTRAUM, V28, P503, DOI 10.1089/neu.2010.1555; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moran LM, 2011, J HEAD TRAUMA REHAB, V26, P348, DOI 10.1097/HTR.0b013e3181f8d32e; Mori S, 2005, MRI ATLAS HUMAN WHIT; Neal EG, 2018, EPILEPSY BEHAV, V81, P25, DOI 10.1016/j.yebeh.2018.01.033; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Seeger TA, 2017, BRAIN STIMUL, V10, P305, DOI 10.1016/j.brs.2016.11.011; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tonks James, 2011, Clin Child Psychol Psychiatry, V16, P185, DOI 10.1177/1359104511403583; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Urban KJ, 2015, J NEUROTRAUM, V32, P833, DOI 10.1089/neu.2014.3577; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698	65	8	8	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2019	23								101842	10.1016/j.nicl.2019.101842			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IX6OV	WOS:000485804400051	31108457	Green Published, gold			2022-02-06	
J	Klimova, A; Korgaonkar, MS; Whitford, T; Bryant, RA				Klimova, Aleksandra; Korgaonkar, Mayuresh S.; Whitford, Thomas; Bryant, Richard A.			Diffusion Tensor Imaging Analysis of Mild Traumatic Brain Injury and Posttraumatic Stress Disorder	BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING			English	Article						Concussion; Diffusion tensor imaging; Mild traumatic brain injury; Postconcussive syndrome; Posttraumatic stress disorder; White matter integrity	WHITE-MATTER INTEGRITY; VOXEL-BASED METAANALYSIS; UNCINATE FASCICULUS; SYMPTOMS; ABNORMALITIES; VETERANS; PTSD; CONNECTIVITY; COMBAT; IRAQ	BACKGROUND: Debate exists over the extent to which dysfunctions arising from mild traumatic brain injury (mTBI) are distinct from posttraumatic stress disorder (PTSD). METHODS: This study investigated 1) the white matter integrity of participants with either mTBI or PTSD, and 2) the relationship between white matter integrity and postconcussive syndrome. The sample comprised 110 civilians (mTBI group = 40; PTSD group = 32; age- and sex-matched trauma-exposed control subjects = 38) recruited from community advertising. Indicators of white matter abnormalities were fractional anisotropy, mean diffusivity, axial diffusivity, and radial diffusivity. PTSD symptoms were indexed by the Clinician-Administered PTSD Scale, and postconcussive symptoms were assessed using the Somatic and Psychological Health Report measure. RESULTS: Fractional anisotropy was reduced in mTBI participants in the corpus callosum, tracts of the brainstem, projection fibers, association fibers, and limbic fibers compared with both PTSD and trauma-exposed control subjects. This decrease in fractional anisotropy was observed in the context of concurrent changes in radial diffusivity, axial diffusivity, and mean diffusivity. Postconcussive symptoms were largely explained by PTSD severity rather than by changes in brain white matter. mTBI appears to be characterized by distinct reductions in white matter integrity, and this cannot be attributed to PTSD. CONCLUSIONS: PTSD symptoms appear to be more strongly associated with postconcussive syndrome than with white matter compromise. These findings extend epidemiological evidence of the relative associations of PTSD and mTBI with postconcussive syndrome.	[Klimova, Aleksandra; Whitford, Thomas; Bryant, Richard A.] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Klimova, Aleksandra; Korgaonkar, Mayuresh S.; Bryant, Richard A.] Westmead Inst Med Res, Brain Dynam Ctr, Westmead, NSW, Australia		Bryant, RA (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	r.bryant@unsw.edu.au	Korgaonkar, Mayuresh/K-7447-2014	Korgaonkar, Mayuresh/0000-0002-1339-2221	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1073041]	This work was supported by National Health and Medical Research Council Program Grant No. 1073041 (to RAB).	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; Anderson AW, 2005, MAGN RESON MED, V54, P1194, DOI 10.1002/mrm.20667; [Anonymous], TBI DAT STAT; Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bolzenius JD, 2018, J HEAD TRAUMA REHAB, V33, P393, DOI 10.1097/HTR.0000000000000378; Brandstack N, 2011, CLIN NEURORADIOL, V21, P75, DOI 10.1007/s00062-011-0058-5; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Costanzo ME, 2016, NEUROSCI LETT, V618, P66, DOI 10.1016/j.neulet.2016.02.041; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jenkins LM, 2016, NEUROIMAGE-CLIN, V12, P1022, DOI 10.1016/j.nicl.2016.09.001; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kennis M, 2015, NEUROPSYCHOPHARMACOL, V40, P2434, DOI 10.1038/npp.2015.94; Koch SBJ, 2017, J PSYCHIATR NEUROSCI, V42, P331, DOI 10.1503/jpn.160129; Korgaonkar MS, 2011, HUM BRAIN MAPP, V32, P2161, DOI 10.1002/hbm.21178; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Li L, 2016, CHINESE MED J-PEKING, V129, P1091, DOI 10.4103/0366-6999.180518; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; McFarlane AC, 2008, J PSYCHOSOM RES, V65, P337, DOI 10.1016/j.jpsychores.2008.02.005; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; O'Doherty DCM, 2018, HUM BRAIN MAPP, V39, P1327, DOI 10.1002/hbm.23920; Olson EA, 2017, DEPRESS ANXIETY, V34, P437, DOI 10.1002/da.22615; Petrides M., 2002, PRINCIPLES FRONTAL L, V1, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rinne-Albers MAW, 2016, EUR CHILD ADOLES PSY, V25, P869, DOI 10.1007/s00787-015-0805-2; Ropper A, 2011, NEW ENGL J MED, V364, P2156, DOI 10.1056/NEJMe1102187; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Santhanam P, 2018, J NEUROTRAUMA; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Segev S, 2016, NEUROPSYCHOLOGY, V30, P800, DOI 10.1037/neu0000299; Sekiguchi A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/180468; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Siehl S, 2018, NEUROIMAGE-CLIN, V19, P581, DOI 10.1016/j.nicl.2018.05.013; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tromp DPM, 2012, ARCH GEN PSYCHIAT, V69, P925, DOI 10.1001/archgenpsychiatry.2011.2178; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	63	8	9	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2451-9022	2451-9030		BIOL PSYCHIAT-COGN N	Biol. Psychiat.-Cogn. Neurosci. Neuroimag.	JAN	2019	4	1					81	90		10.1016/j.bpsc.2018.10.004			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JJ7UV	WOS:000494360200010	30616750				2022-02-06	
J	Liu, JJ; Xiong, X; Sui, YT				Liu, Jingjing; Xiong, Xin; Sui, Yutong			Isoliquiritigenin Attenuates Neuroinflammation in Traumatic Brain Injury in Young Rats	NEUROIMMUNOMODULATION			English	Article						Traumatic brain injury; Isoliquiritigenin; Shear stress; Apoptosis; Inflammation	IMPAIRMENT; ACTIVATION; APOPTOSIS; AGE	Objectives: Inflammation and apoptosis play a critical role in the pathological progress of traumatic brain injury (TBI). Isoliquiritigenin is a bioactive component extracted from licorice roots, which possesses anti-inflammatory and antiapoptotic properties. This study aims to investigate the potential effects of isoliquiritigenin on neuroinflammation in a rat model of TBI. Methods: The SH-SY5Y cells were subjected to cell injury induced by shear stress and the effect of isoliquiritigenin on cell apoptosis was measured. Male rats received a controlled cortical impact to induce TBI and were then treated with isoliquiritigenin (20 mg/kg). Brain edema and contusion volume were measured to assess brain damage. Morris water maze, the beam-balance test, and the beam-walk test were performed to evaluate the cognitive and motor functions. Results: Levels of proinflammatory cytokines and apoptotic regulators were measured. Results showed that isoliquiritigenin reduced shear stress-induced cell apoptosis in vitro. In young rats subjected to TBI, treatment of isoliquiritigenin reduced brain damage and attenuated motor and cognitive impairments. Isoliquiritigenin also reduced the level of proinflammatory cytokines and Bax and increased Bcl-2 and Bcl-xL in TBI rats. Conclusions: These findings suggest that isoliquiritigenin possesses beneficial effects in TBI by inhibiting inflammation and apoptosis. (C) 2019 S. Karger AG, Basel	[Liu, Jingjing] Daqing Oilfields Gen Hosp, Dept Tradit Chinese Med, Daqing, Peoples R China; [Xiong, Xin] Daqing Oilfields Gen Hosp, Dept Pharm, Daqing, Peoples R China; [Sui, Yutong] Chinese Acad Med Sci, Canc Hosp, Natl Clin Res Ctr Canc, Natl Canc Ctr, Zhongkang St 9, Beijing 100021, Peoples R China; [Sui, Yutong] Peking Union Med Coll, Zhongkang St 9, Beijing 100021, Peoples R China		Sui, YT (corresponding author), Chinese Acad Med Sci, Canc Hosp, Natl Clin Res Ctr Canc, Natl Canc Ctr, Zhongkang St 9, Beijing 100021, Peoples R China.; Sui, YT (corresponding author), Peking Union Med Coll, Zhongkang St 9, Beijing 100021, Peoples R China.	hljzysyt123@126.com					Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Cheng WH, 2018, EXP NEUROL, V301, P26, DOI 10.1016/j.expneurol.2017.12.007; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Li W, 2014, ARCH PHARM RES, V37, P186, DOI 10.1007/s12272-013-0174-7; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Maneshi MM, 2014, THRESHOLD SHEAR FORC; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Peng F, 2015, PHYTOTHER RES, V29, P969, DOI 10.1002/ptr.5348; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Soares de Souza R, 2015, INT ARCH MED, V8, P73; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Triyoso DH, 1999, J PHYSIOL-LONDON, V515, P355, DOI 10.1111/j.1469-7793.1999.355ac.x; Wang B, 2019, ASAIO J, V65, P285, DOI 10.1097/MAT.0000000000000810; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Zeng J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0895-5; 2012, BIOCHEM BIOPH RES CO, V421, P658, DOI DOI 10.1016/J.BBRC.2012.04.053; 2017, CELL MOL NEUROBIOL, V37, P43, DOI DOI 10.1007/S10571-016-0341-8	25	8	8	1	6	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation		2019	26	2					102	109		10.1159/000495467			8	Endocrinology & Metabolism; Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	HY6WP	WOS:000468271500006	30783039				2022-02-06	
J	Mozayeni, BR; Duncan, W; Zant, E; Love, TL; Beckman, RL; Stoller, KP				Mozayeni, B. Robert; Duncan, William; Zant, Eddie; Love, Tommy L.; Beckman, Robert L.; Stoller, Kenneth P.			The National Brain Injury, Rescuc and Rehabilitation Study - a multicenter observational study of hyperbaric oxygen for mild traumatic brain injury with post-concussive symptoms	MEDICAL GAS RESEARCH			English	Article						hyperbaric oxygen; traumatic brain injury; post-concussion syndrome; post-traumatic stress disorder; 21st Century Cures Act; HBOT; mTBI; PTSD; concussion	NEUROPSYCHOLOGICAL ASSESSMENT METRICS; THERAPY; RELIABILITY; VALIDITY; BATTERY	The National Brain Injury Rescue and Rehabilitation Project was established as a preliminary study to test the safety and practicality of multi-center hyperbaric oxygen administration for the post-concussive symptoms of chronic mild traumatic brain injury as a precursor to a pivotal, independent, multi-center, controlled clinical trial. This report presents the results for 32 subjects who completed a preliminary trial of hyperbaric oxygen several years before the passage of the 21st Century Cures Act. This study anticipated the Act and its reassessment of clinical research. Subjects received 40-82 one-hour treatments at 1.5 atmospheres absolute 100% oxygen. Outcome measures included repeated self-assessment measures and automated neurocognitive tests. The subjects demonstrated improvement in 21 of 25 neurocognitive test measures observed. The objective neurocognitive test components showed improvement in 13 of 17 measures. Earlier administration of hyperbaric oxygen post injury, younger age at the time of injury and hyperbaric oxygen administration, military status, and increased number of hyperbaric oxygen administrations were characteristics associated with improved outcomes. There were no adverse events. Hyperbaric oxygen was found to be safe, inexpensive and worthy of clinical application in the 21st Century model of facile data collection provided by recent research regulatory shifts in medicine. The study was approved by the ethics review committee of the Western Institutional Review Board (WIRB (R) Protocol #20090761).	[Mozayeni, B. Robert; Beckman, Robert L.] Fdn Study Inflammatory Dis, Bethesda, MD 20852 USA; [Duncan, William] Patriot Clin, Oklahoma City, OK USA; [Zant, Eddie] Hyperbar Med Inc Florida, Destin, FL USA; [Love, Tommy L.] Concentra Med Ctr, Salt Lake City, UT USA; [Stoller, Kenneth P.] Amer Coll Hyperbar Med, Hyperbar Oxygen Therapy San Francisco, San Francisco, CA USA		Mozayeni, BR (corresponding author), Fdn Study Inflammatory Dis, Bethesda, MD 20852 USA.	nbirr01@nbirr.org			pro-bono clinical care	The study was funded through pro-bono clinical care provided by the investigators and involved clinics, augmented by philanthropic resources of the International Hyperbaric Medical Foundation and multiple community hyperbaric clinics.	Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; [Anonymous], 2012, C BUDG OFF PUB, V4097; [Anonymous], 2013, HYP OX THER DONT BE; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Clark J, 2009, HYPERBARIC OXYGEN TH; Collet JP, 2001, LANCET, V357, P582, DOI 10.1016/S0140-6736(00)04054-X; COUCH JR, 2012, HEADACHE, V52, P907; DUFF JH, 1967, CAN MED ASSOC J, V97, P510; Figueroa XA, 2016, NEUROLOGY, V87, P1400, DOI 10.1212/WNL.0000000000003146; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; Grammer GG, 2016, VA DOD CLIN PRACTICE; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Gualtieri C Thomas, 2008, Medscape J Med, V10, P90; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Harch PG, 2017, MED GAS RES, V7, P156, DOI 10.4103/2045-9912.215745; Harch PG, 2013, J NEUROTRAUM, V30, P1995, DOI 10.1089/neu.2012.2799; Hardy P, 2007, J NEUROL SCI, V253, P94, DOI 10.1016/j.jns.2006.12.005; Hart GB, 1971, STROKE, V2, P247; Hoge CW, 2014, JAMA INTERN MED, V175, P53; Institute of Medicine of the National Academies, 2014, TREATM POSTTR STRESS; Jain KK, 2009, TXB HYPERBARIC MED, pX; James Philip B, 2014, OXYGEN BRAIN JOURNEY; Johnson DR, 2008, ARCH CLIN NEUROPSYCH, V23, P73, DOI 10.1016/j.acn.2007.10.001; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Miller FG, 2009, PERSPECT BIOL MED, V52, P518, DOI 10.1353/pbm.0.0115; Miller RS, 2015, JAMA INTERN MED, V175, P43, DOI 10.1001/jamainternmed.2014.5479; Neubauer RA, 1998, NEUROL RES, V20, pS33; NEUBAUER RA, 1990, LANCET, V335, P542, DOI 10.1016/0140-6736(90)90777-3; NEUBAUER RA, 1993, J NEUROSURG, V78, P687; Paris John J, 2003, J Perinatol, V23, P250, DOI 10.1038/sj.jp.7210889; PARSONS HM, 1974, SCIENCE, V183, P922, DOI 10.1126/science.183.4128.922; Perrins DJD, 2002, UNDERSEA HYPERBAR M, V29, P236; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Samueli Institute, 2015, IS HYP OX THER EFF T; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; SLUIJTER ME, 1963, P ROY SOC MED, V56, P1002, DOI 10.1177/003591576305601129; SMITH G, 1960, LANCET, V2, P905; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Weaver LK, 2014, HYPERBARIC OXYGEN TH; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Worth Robert F., 2016, NY TIMES MAGAZINE; Wright JK, 2009, UNDERSEA HYPERBAR M, V36, P391	46	8	9	1	7	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2045-9912			MED GAS RES	Med. Gas Res.	JAN-MAR	2019	9	1					1	12		10.4103/2045-9912.254636			12	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	HR2KJ	WOS:000462964700001	30950414	Green Published			2022-02-06	
J	Pierpoint, LA; Lincoln, AE; Walker, N; Caswell, SV; Currie, DW; Knowles, SB; Wasserman, EB; Dompier, TP; Comstock, RD; Marshall, SW; Kerr, ZY				Pierpoint, Lauren A.; Lincoln, Andrew E.; Walker, Nina; Caswell, Shane, V; Currie, Dustin W.; Knowles, Sarah B.; Wasserman, Erin B.; Dompier, Thomas P.; Comstock, R. Dawn; Marshall, Stephen W.; Kerr, Zachary Y.			The First Decade of Web-Based Sports Injury Surveillance: Descriptive Epidemiology of Injuries in US High School Boys' Lacrosse (2008-2009 Through 2013-2014) and National Collegiate Athletic Association Men's Lacrosse (2004-2005 Through 2013-2014)	JOURNAL OF ATHLETIC TRAINING			English	Article						concussions; musculoskeletal injuries; muscle strains; injury prevention	STATES HIGH-SCHOOL; UNITED-STATES; CONCUSSION; SYSTEM; SOCCER; GIRLS; HEAD	Context: The advent of Web-based sports injury surveillance via programs such as the High School Reporting Information Online system and the National Collegiate Athletic Association Injury Surveillance Program has aided the acquisition of boys' and men's lacrosse injury data. Objective: To describe the epidemiology of injuries sustained in high school boys' lacrosse in the 2008-2009 through 2013-2014 academic years and collegiate men's lacrosse in the 2004-2005 through 2013-2014 academic years using Webbased sports injury surveillance. Design: Descriptive epidemiology study. Setting: Online injury surveillance from lacrosse teams of high school boys (annual average = 55) and collegiate men (annual average = 14). Patients or Other Participants: Boys' and men's lacrosse players who participated in practices and competitions during the 2008-2009 through 2013-2014 academic years in high school or the 2004-2005 through 2013-2014 academic years in college. Main Outcome Measure(s): Athletic trainers collected time-loss (>= 24 hours) injury and exposure data. Injury rates per 1000 athlete-exposures (AEs), injury rate ratios (IRRs) with 95% confidence intervals (CIs), and injury proportions by body site and diagnosis were calculated. Results: High School Reporting Information Online documented 1407 time-loss injuries during 662 960 AEs. The National Collegiate Athletic Association Injury Surveillance Program documented 1882 time-loss injuries during 390 029 AEs. The total injury rate from 2008-2009 through 2013-2014 was higher in college than in high school (3.77 versus 2.12/1000 AEs; IRR = 1.78; 95% CI = 1.63, 1.94). Most injuries occurred during competitions in high school (61.4%) and practices in college (61.4%). Injury rates were higher in competitions compared with practices in high school (IRR = 3.59; 95% CI = 3.23, 4.00) and college (IRR= 3.38; 95% CI = 3.08, 3.71). Lower limb injuries, muscle strains, and ligament sprains were common at both levels. Concussion was the most frequent competition diagnosis for all high school player positions. Conclusions: Rates of time-loss injury were higher in college versus high school and in competitions versus practices. Attention to preventing common lower leg injuries and concussions, especially at the high school level, is essential to decrease their incidence and severity.	[Pierpoint, Lauren A.; Currie, Dustin W.; Comstock, R. Dawn] Univ Colorado Anschutz, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Lincoln, Andrew E.] MedStar Sports Med Res Ctr, Baltimore, MD USA; [Walker, Nina] Univ N Carolina, Carolina Athlet, Chapel Hill, NC 27599 USA; [Walker, Nina] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Marshall, Stephen W.; Kerr, Zachary Y.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Caswell, Shane, V] George Mason Univ, Res & Testing SMART Lab, Sports Med Assessment, Manassas, VA USA; [Knowles, Sarah B.] Palo Alto Med Fdn Res Inst, Palo Alto, CA USA; [Wasserman, Erin B.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Annville, PA USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Injury Prevent Res Ctr, 313 Woollen Gym CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu		Wasserman, Erin/0000-0001-5957-5878	NCAA; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025754]; National Federation of State High School Associations (Indianapolis, IN); National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); DonJoy Orthotics (Vista, CA); EyeBlack (Potomac, MD)	The NCAA-ISP data were provided by the Datalys Center for Sports Injury Research and Prevention, Inc. The NCAA-ISP was funded by the NCAA. Funding for HS RIO was provided in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01 and the National Center for Research Resources award KL2 RR025754. The authors also acknowledge the research funding contributions of the National Federation of State High School Associations (Indianapolis, IN), National Operating Committee on Standards for Athletic Equipment (Overland Park, KS), DonJoy Orthotics (Vista, CA), and EyeBlack (Potomac, MD). The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. We thank the many ATs who have volunteered their time and efforts to submit data to HS RIO and the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of high school and collegiate student-athletes.	[Anonymous], 2013 14 NCAA SPORTS; Chappell JD, 2008, AM J SPORT MED, V36, P1081, DOI 10.1177/0363546508314425; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Comstock RD, 2014, CONVENIENCE SAMPLE S; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Dick R, 2007, J ATHL TRAINING, V42, P255; Gardner EC, 2016, AM J SPORT MED, V44, P2675, DOI 10.1177/0363546516644246; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCulloch PC, 2007, ORTHOPEDICS, V30, P29, DOI 10.3928/01477447-20070101-05; Mihata LCS, 2006, AM J SPORT MED, V34, P899, DOI 10.1177/0363546505285582; Myer GD, 2011, CURR SPORT MED REP, V10, P157, DOI 10.1249/JSR.0b013e31821b1442; National Collegiate Athletic Association, 2010, NCAA MENS LACR ANN M; National Collegiate Athletic Association, 2014, 2014 YEAR ROUND FOOT; National Federation of State High School Associations, 2014, 2013 14 HIGH SCH ATH; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Vincent HK, 2015, SPORTS HEALTH, V7, P448, DOI 10.1177/1941738114552990; Wasser JG, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116657535; Webb M, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114543444; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914; Yard EE, 2006, J ATHL TRAINING, V41, P441; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	37	8	8	0	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2019	54	1					30	41		10.4085/1062-6050-200-17			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HO1BA	WOS:000460639000005	30848953	gold, Green Published			2022-02-06	
S	Polich, G; Iaccarino, MA; Zafonte, R		Reus, VI; Lindqvist, D		Polich, Ginger; Iaccarino, Mary Alexis; Zafonte, Ross			Psychopharmacology of traumatic brain injury	PSYCHOPHARMACOLOGY OF NEUROLOGIC DISEASE	Handbook of Clinical Neurology		English	Article; Book Chapter							RANDOMIZED CONTROLLED-TRIAL; POSTTRAUMATIC-STRESS-DISORDER; TERM BENZODIAZEPINE USE; DOUBLE-BLIND; PSYCHIATRIC-DISORDERS; ATTENTION DEFICITS; MAJOR DEPRESSION; COGNITIVE PERFORMANCE; HEAD-INJURY; AXIS-I	The pathophysiology of traumatic brain injury (TBI) can be highly variable, involving functional and/or structural damage to multiple neuroanatomical networks and neurotransmitter systems. This wide-ranging potential for physiologic injury is reflected in the diversity of neurobehavioral and neurocognitive symptoms following TBI. Here, we aim to provide a succinct, clinically relevant, up-to-date review on psychopharmacology for the most common sequelae of TBI in the postacute to chronic period. Specifically, treatment for neurobehavioral symptoms (depression, mania, anxiety, agitation/irritability, psychosis, pseudobulbar affect, and apathy) and neurocognitive symptoms (processing speed, attention, memory, executive dysfunction) will be discussed. Treatment recommendations will reflect general clinical practice patterns and the research literature.	[Polich, Ginger; Iaccarino, Mary Alexis; Zafonte, Ross] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA		Zafonte, R (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil,Spaulding Rehabil Hosp, Boston, MA 02115 USA.	rzafonte@partners.org					Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Alway Y, 2016, J NEUROTRAUM, V33, P825, DOI 10.1089/neu.2015.3992; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arciniegas DB, 2003, INT REV PSYCHIATR, V15, P328, DOI 10.1080/09540260310001606719; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Barker MJ, 2004, ARCH CLIN NEUROPSYCH, V19, P437, DOI 10.1016/S0887-6177(03)00096-9; Barker MJ, 2004, CNS DRUGS, V18, P37, DOI 10.2165/00023210-200418010-00004; Bellus SB, 1996, BRAIN INJURY, V10, P849, DOI 10.1080/026990596123954; Bhatnagar S, 2016, BRAIN RES, V1640, P164, DOI 10.1016/j.brainres.2016.01.021; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Butler PV, 2000, AUST NZ J PSYCHIAT, V34, P684, DOI 10.1080/j.1440-1614.2000.00758.x; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CARDENAS DD, 1994, BRAIN INJURY, V8, P579, DOI 10.3109/02699059409151010; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Chahine LM, 2006, EPILEPSY BEHAV, V8, P610, DOI 10.1016/j.yebeh.2006.01.017; ChathamShowalter PE, 1996, J NEUROPSYCH CLIN N, V8, P96; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Daniels JP, 2008, J CLIN PSYCHIAT, V69, P497, DOI 10.4088/JCP.v69n0324a; Deb S, 1999, AM J PSYCHIAT, V156, P374; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; Drake DF, 2017, PHYS MED REH CLIN N, V28, P363, DOI 10.1016/j.pmr.2016.12.011; Drevets WC, 2000, PROG BRAIN RES, V126, P413; Dymowski AR, 2017, CLIN REHABIL, V31, P733, DOI 10.1177/0269215516655590; Dymowski AR, 2015, J CLIN EXP NEUROPSYC, V37, P1024, DOI 10.1080/13803395.2015.1074663; Engelman W, 2014, NEUROPSYCH DIS TREAT, V10, P1903, DOI 10.2147/NDT.S63304; Fann JR, 2017, J HEAD TRAUMA REHAB, V32, P332, DOI 10.1097/HTR.0000000000000322; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Fann JR., 2013, MANAG ADULTS TRAUMA, P195; Feeney DM, 2004, RESTOR NEUROL NEUROS, V22, P175; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Fujii DE, 2014, PSYCHIAT CLIN N AM, V37, P113, DOI 10.1016/j.psc.2013.11.006; Garcia-Baran D, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002886; GLENN MB, 1989, AM J PHYS MED REHAB, V68, P221, DOI 10.1097/00002060-198910000-00004; GOLDSTEIN LB, 1995, NEUROLOGY, V45, P865, DOI 10.1212/WNL.45.5.865; GOLDSTEIN LB, 1990, BRAIN RES, V508, P305, DOI 10.1016/0006-8993(90)90413-6; GREEN RL, 1987, AM J PSYCHIAT, V144, P442; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; GREENDYKE RM, 1986, J CLIN PSYCHIAT, V47, P423; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; HALE MS, 1982, J NERV MENT DIS, V170, P362, DOI 10.1097/00005053-198206000-00006; Hammond FM, 2017, J HEAD TRAUMA REHAB, V32, P308, DOI 10.1097/HTR.0000000000000342; Hammond FM, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0609-0; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Hedges D, 2003, DRUG TODAY, V39, P551, DOI 10.1358/dot.2003.39.7.799445; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; HOEHNSARIC R, 1990, J CLIN PSYCHOPHARM, V10, P343; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Horsfield SA, 2002, INT J PSYCHIAT MED, V32, P337, DOI 10.2190/KQ48-XT0L-2H14-5UMV; Hurley Robin A., 2002, Curr Treat Options Neurol, V4, P59, DOI 10.1007/s11940-002-0005-5; Jamall OA, 2016, CLIN ENDOCRINOL, V85, P636, DOI 10.1111/cen.13045; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; Jorge RE, 2016, JAMA PSYCHIAT, V73, P1041, DOI 10.1001/jamapsychiatry.2016.2189; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; Kanetani Kouichi, 2003, Journal of Nippon Medical School, V70, P313; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kant R, 1998, BRAIN INJURY, V12, P661, DOI 10.1080/026990598122223; Kaschka WP, 2001, PHARMACOPSYCHIATRY, V34, P254, DOI 10.1055/s-2001-18031; Khateb A, 2005, EUR NEUROL, V54, P39, DOI 10.1159/000087718; Kim E, 2002, J NEUROPSYCH CLIN N, V14, P202, DOI 10.1176/appi.neuropsych.14.2.202; Kim E, 2008, CURR OPIN PSYCHIATR, V21, P286, DOI 10.1097/YCO.0b013e3282fbcd21; Kim E, 2006, J NEUROPSYCH CLIN N, V18, P547, DOI 10.1176/appi.neuropsych.18.4.547; Kim J, 2012, PSYCHOPHARMACOLOGY, V222, P47, DOI 10.1007/s00213-011-2622-8; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Krieger D, 2003, NEUROREHABILITATION, V18, P205; Lawrence DW, 2016, BRAIN INJURY, V30, P960, DOI 10.3109/02699052.2016.1147081; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; LEVIN HS, 1991, J NEUROL SCI, V103, pS39; Levy R, 2012, REV NEUROL-FRANCE, V168, P585, DOI 10.1016/j.neurol.2012.05.003; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Maryniak O, 2001, BRAIN INJURY, V15, P167, DOI 10.1080/026990501458399; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McAllister TW, 2016, NEUROPSYCHOPHARMACOL, V41, P1191, DOI 10.1038/npp.2015.282; McAllister TW, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1034; McAllister Thomas W., 1994, P357; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDonald BC, 2017, NEUROPSYCHOPHARMACOL, V42, P1766, DOI 10.1038/npp.2016.261; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; Muller U, 1999, BRAIN INJURY, V13, P805, DOI 10.1080/026990599121197; Mysiw WJ, 2006, BRAIN INJURY, V20, P905, DOI 10.1080/02699050600743972; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; Nahas Z, 1998, J NEUROPSYCH CLIN N, V10, P453, DOI 10.1176/jnp.10.4.453; Newburn G, 1999, BRAIN INJURY, V13, P637; Noe E, 2007, BEHAV NEUROL, V18, P7, DOI 10.1155/2007/529076; Novack TA, 2009, J NEUROTRAUM, V26, P1921, DOI 10.1089/neu.2009.0895; Oster TJ, 2007, CNS SPECTRUMS, V12, P764, DOI 10.1017/S1092852900015455; Ozolins B, 2016, BRAIN INJURY, V30, P937, DOI 10.3109/02699052.2016.1147080; Pachet A, 2003, BRAIN INJURY, V17, P715, DOI 10.1080/0269905031000110445; Patel MB, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-177; Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Pioro EP, 2014, NEUROL THER, V3, P15, DOI 10.1007/s40120-014-0018-5; Plantier D, 2016, ANN PHYS REHABIL MED, V59, P42, DOI 10.1016/j.rehab.2015.10.003; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Polich G, 2018, J NEUROTRAUM, V35, P1205, DOI 10.1089/neu.2017.5506; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; Price A, 2011, J NEUROL NEUROSUR PS, V82, P914, DOI 10.1136/jnnp.2010.230862; Quinn M, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00008; Rabins PV, 2007, CNS SPECTRUMS, V12, P17, DOI 10.1017/S1092852900025979; Ramasubbu R, 2004, J CLIN PSYCHIAT, V65, P1642, DOI 10.4088/JCP.v65n1209; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Rapoport MJ, 2008, J PSYCHOPHARMACOL, V22, P860, DOI 10.1177/0269881107083845; Rapoport MJ, 2010, J CLIN PSYCHIAT, V71, P1125, DOI 10.4088/JCP.09m05086blu; Ripley DL, 2014, BRAIN INJURY, V28, P1514, DOI 10.3109/02699052.2014.919530; Roth Robert M, 2007, Curr Treat Options Neurol, V9, P363, DOI 10.1007/s11940-007-0022-5; Salter KL, 2016, J HEAD TRAUMA REHAB, V31, pE21, DOI 10.1097/HTR.0000000000000193; Samuel G S, 2013, Med J Malaysia, V68, P376; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; Schmitter-Edgecombe M, 2000, NEUROPSYCHOLOGY, V14, P559; Schneider WN, 1999, BRAIN INJURY, V13, P863; Scrimgeour AG, 2014, J NEUROTRAUM, V31, P989, DOI 10.1089/neu.2013.3234; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Seel RT, 2011, EUR NEUROL REV, V6, P25; Showalter PEC, 2000, J NEUROPSYCH CLIN N, V12, P395; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; Stanislav SW, 2000, BRAIN INJURY, V14, P261; STARKSTEIN SE, 1987, ARCH NEUROL-CHICAGO, V44, P1069, DOI 10.1001/archneur.1987.00520220065019; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; STEWART JT, 1988, J CLIN PSYCHIAT, V49, P74; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Taverni JP, 1998, BRAIN INJURY, V12, P77; Tenovuo O, 2009, BRAIN INJURY, V23, P548, DOI 10.1080/02699050902926275; Theadom A, 2013, EUR J NEUROL, V20, P1135, DOI 10.1111/ene.12099; Tramontana MG, 2014, BRAIN INJURY, V28, P1461, DOI 10.3109/02699052.2014.930179; Trovato M, 2006, BRAIN INJURY, V20, P339, DOI 10.1080/02699050500487811; Umene-Nakano W, 2013, GEN HOSP PSYCHIAT, V35, DOI 10.1016/j.genhosppsych.2012.05.002; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; Viana BD, 2010, PROG NEURO-PSYCHOPH, V34, P233, DOI 10.1016/j.pnpbp.2009.08.026; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Whyte J, 2008, AM J PHYS MED REHAB, V87, P85, DOI 10.1097/PHM.0b013e3181619609; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB; Work SS, 2011, ADV THER, V28, P586, DOI 10.1007/s12325-011-0031-3; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001; Wortzel HS, 2012, CURR TREAT OPTION NE, V14, P493, DOI 10.1007/s11940-012-0193-6; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; WROBLEWSKI BA, 1990, J CLIN PSYCHOPHARM, V10, P124, DOI 10.1097/00004714-199004000-00009; Wroblewski BA, 1997, BRAIN INJURY, V11, P37, DOI 10.1080/026990597123791; YASSA R, 1994, J GERIATR PSYCH NEUR, V7, P55, DOI 10.1177/089198879400700110; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	190	8	8	1	2	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-464013-0; 978-0-444-64012-3	HAND CLINIC			2019	165						253	267		10.1016/B978-0-444-64012-3.00015-0			15	Behavioral Sciences; Clinical Neurology; Pharmacology & Pharmacy; Psychiatry	Book Citation Index – Science (BKCI-S)	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	BP5NM	WOS:000557239100017	31727216				2022-02-06	
J	Riganello, F; Chatelle, C; Schnakers, C; Laureys, S				Riganello, Francesco; Chatelle, Camille; Schnakers, Caroline; Laureys, Steven			Heart Rate Variability as an Indicator of Nociceptive Pain in Disorders of Consciousness?	JOURNAL OF PAIN AND SYMPTOM MANAGEMENT			English	Article						Pain; heart rate; consciousness; nociception; unresponsive wakefulness syndrome; minimally conscious state	MULTISCALE ENTROPY ANALYSIS; TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; APPROXIMATE ENTROPY; COMPLEXITY; STIMULATION; INTEGRATION; PERCEPTION; MODULATION; ACTIVATION	Context. Heart rate variability is thought to reflect the affective and physiological aspects of pain and is emerging as a possible descriptor of the functional brain organization contributing to homeostasis. Objectives. To investigate whether the short-term Complexity Index (CIs), a measure of heart rate variability complexity is useful to discriminate responses to potentially noxious and nonnoxious stimulation in patients with different levels of consciousness. Methods. Twenty-two patients (11 minimally conscious state [MCS], 11 vegetative state/unresponsive wakefulness syndrome [VS/UWS]) and 14 healthy controls (HC) were enrolled. We recorded the electrocardiographic response and calculated the CIs before (baseline), during, and after nonnoxious and noxious stimulation. Mann-Whitney and Wilcoxon's tests were used to investigate differences in CIs according to the level of consciousness (i.e., HC vs. patients and VS/UWS vs. MCS) and the three conditions (i.e., baseline, nonnoxious, noxious). The correlation between the three conditions and the Coma Recovery Scale-Revised was investigated by Spearman's correlations. Results. We observed higher CIs values in HC as compared with patients during the baseline (P < 0.034) and after the noxious stimulation (P < 0.0001). We also found higher values in MCS versus VS/UWS patients after the noxious condition (P < 0.001) and lower values in the noxious versus nonnoxious condition solely for the VS/UWS group (P < 0.007). A correlation was found between CIs in noxious condition and Coma Recovery ScaleeRevised scores. Conclusion. Our results suggest a less complex autonomic response to noxious stimuli in VS/UWS patients. Such method may help to better understand sympathovagal response to potentially painful stimulation in brain-injured patients. (C) 2018 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.	[Riganello, Francesco; Chatelle, Camille; Laureys, Steven] Coma Sci Grp, GIGA Consciousness, Liege, Belgium; [Riganello, Francesco] S Anna Inst, RAN, Crotone, Italy; [Chatelle, Camille] Massachusetts Gen Hosp, Lab NeuroImaging Coma & Consciousness, Boston, MA 02114 USA; [Schnakers, Caroline] Univ Calif Los Angeles, Neurosurg Dept, Los Angeles, CA USA; [Laureys, Steven] Casa Colina Hosp & Ctr Healthcare, Res Inst, Pomona, CA USA		Riganello, F (corresponding author), Coma Sci Grp, GIGA Consciousness, RAN, GIGA Res B34, Ave Hop 11, B-4000 Liege, Belgium.	francescoriganello@gmail.com	Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021; Riganello, Francesco/AAC-3976-2020; Riganello, Francesco/N-2615-2014	Laureys, Steven/0000-0002-3096-3807; Riganello, Francesco/0000-0003-0678-9252; Riganello, Francesco/0000-0003-0678-9252; Chatelle, Camille/0000-0002-7526-2107	University Hospital of Liege; French Speaking Community Concerted Research Action [ARC 12-17/01]; Belgian National Funds for Scientific Research (FRS-FNRS)Fonds de la Recherche Scientifique - FNRS; German Research Society (DFG)German Research Foundation (DFG); James McDonnell Foundation; Mind Science Foundation; IAP research network P7/06 of the Belgian Government (Belgian Science Policy); European CommissionEuropean CommissionEuropean Commission Joint Research Centre; Public Utility Foundation "Universite Europeenne du Travail"; Fondazione Europea di Ricerca Biomedica; Human Brain ProjectUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [EU-H2020-fetflagship-hbp-sga1-ga720270]; Luminous project [EU-H2020-fetopen-ga686764]	The study was supported by the University and University Hospital of Liege, the French Speaking Community Concerted Research Action (ARC 12-17/01), the Belgian National Funds for Scientific Research (FRS-FNRS), the German Research Society (DFG), Human Brain Project (EU-H2020-fetflagship-hbp-sga1-ga720270), Luminous project (EU-H2020-fetopen-ga686764), the James McDonnell Foundation, Mind Science Foundation, IAP research network P7/06 of the Belgian Government (Belgian Science Policy), the European Commission, the Public Utility Foundation "Universite Europeenne du Travail,'' "Fondazione Europea di Ricerca Biomedica.'' Camille Chatelle is a Marie Sklodowska-Curie fellow (H2020-MSCA-IF-2016-ADOC-752686).	Aboy M, 2007, P ANN INT IEEE EMBS, P5943; Benarroch E.E., 2007, CONTIN LIFELONG LEAR, V13, P13, DOI [10.1212/01.CON.0000299964.20642.9a, DOI 10.1212/01.CON.0000299964.20642.9A]; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Boly M, 2008, LANCET NEUROL, V7, P1013, DOI 10.1016/S1474-4422(08)70219-9; Calabro RS, 2017, CLIN NEUROPHYSIOL, V128, P454, DOI 10.1016/j.clinph.2016.12.011; Camm AJ, 1996, EUR HEART J, V17, P354; Chatelle C, 2014, BRAIN INJURY, V28, P1202, DOI 10.3109/02699052.2014.920518; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; Chen CH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17552; Chen WT, 2009, MED ENG PHYS, V31, P61, DOI 10.1016/j.medengphy.2008.04.005; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cooper SJ, 2008, APPETITE, V51, P419, DOI 10.1016/j.appet.2008.06.005; Corrales M. M., 2012, HEALTH, V4, P720, DOI [10.4236/health.2012.47060, DOI 10.4236/HEALTH.2012.47060]; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, MULTISCALE ENTROPY A; Costa MD, 2015, ENTROPY-SWITZ, V17, P1197, DOI 10.3390/e17031197; Cowen R, 2015, ANAESTHESIA, V70, P828, DOI 10.1111/anae.13018; D'Addio G, 2004, COMPUT CARDIOL, V31, P457, DOI 10.1109/CIC.2004.1442973; Dolce G, 2008, J PSYCHOPHYSIOL, V22, P150, DOI 10.1027/0269-8803.22.3.150; Echeverria JC, 2003, CHAOS, V13, P467, DOI 10.1063/1.1562051; Field A, 2013, DISCOVERING STAT USI; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Fusheng Y., 2000, NONLINEAR BIOMED SIG, P72, DOI DOI 10.1002/9780470545379; Gelinas C, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.01.013; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Herr K, 2006, PAIN MANAG NURS, V7, P44, DOI 10.1016/j.pmn.2006.02.003; Ingvar M, 1999, PHILOS T R SOC B, V354, P1347, DOI 10.1098/rstb.1999.0483; Jeanne M, 2009, AUTON NEUROSCI-BASIC, V147, P91, DOI 10.1016/j.autneu.2009.01.005; Kalpakis Konstantinos, 2012, Machine Learning and Data Mining in Pattern Recognition. Proceedings 8th International Conference, MLDM 2012, P415, DOI 10.1007/978-3-642-31537-4_33; KAPLAN DT, 1991, BIOPHYS J, V59, P945, DOI 10.1016/S0006-3495(91)82309-8; Kassubek J, 2003, J NEUROL SCI, V212, P85, DOI 10.1016/S0022-510X(03)00106-0; Katz-Leurer M, 2010, BRAIN INJURY, V24, P110, DOI 10.3109/02699050903508234; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Kotchoubey B, 2013, J NEUROL, V260, P975, DOI 10.1007/s00415-012-6734-9; LARSON MD, 1993, ANESTH ANALG, V76, P1072; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lee YC, 2011, IEEE ENG MED BIO, P1701, DOI 10.1109/IEMBS.2011.6090488; Markl A, 2013, BRAIN BEHAV, V3, P95, DOI 10.1002/brb3.110; Miu AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030618; Mohd Razali N., 2011, J STAT MODEL ANAL, V2, P21; Monti MM, 2015, NEUROLOGY, V84, P167, DOI 10.1212/WNL.0000000000001123; Nakahara H, 2011, INT J PSYCHOPHYSIOL, V81, P152, DOI 10.1016/j.ijpsycho.2011.06.003; Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238; Norris PR, 2008, SHOCK, V30, P17, DOI 10.1097/SHK.0b013e318164e4d0; Owen AM, 2014, NAT REV NEUROL, V10, P370, DOI 10.1038/nrneurol.2014.102; Oztuna D., 2006, TURK J MED SCI, V36, P171; Raimondo F, 2017, ANN NEUROL, V82, P578, DOI 10.1002/ana.25045; Rainville P, 1999, PAIN, V82, P159, DOI 10.1016/S0304-3959(99)00048-2; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Riganello F, 2010, CLIN NEUROPHYSIOL, V121, P2024, DOI 10.1016/j.clinph.2010.05.010; Riganello F, 2015, BRAIN FUNCTION RESPO; Riganello F, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00461; Riganello F, 2012, J REHABIL MED, V44, P495, DOI 10.2340/16501977-0975; Riganello F, 2011, CLIN NEUROPHYSIOL, V122, P1061, DOI 10.1016/j.clinph.2010.09.006; Riordan WP, 2009, J SURG RES, V156, P283, DOI 10.1016/j.jss.2009.03.086; ROSENTHAL R, 1991, AM PSYCHOL, V46, P1086, DOI 10.1037/0003-066X.46.10.1086; Ryan ML, 2011, ANESTHESIOL RES PRAC, V2011, DOI 10.1155/2011/416590; Schnakers C, 2010, PAIN, V148, P215, DOI 10.1016/j.pain.2009.09.028; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Stephens CL, 2010, BIOL PSYCHOL, V84, P463, DOI 10.1016/j.biopsycho.2010.03.014; Tang SC, 2015, J NEUROL NEUROSUR PS, V86, P95, DOI 10.1136/jnnp-2014-308389; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Thayer JF, 2002, IEEE ENG MED BIOL, V21, P24, DOI 10.1109/MEMB.2002.1032635; Thayer JF., 2007, PSYCHOL TOPICS, V16, P241, DOI DOI 10.1016/J.IJCARD.2012.02.004; Thurber M. R., 2010, BIOFEEDBACK, V38, P28, DOI DOI 10.5298/1081-5937-38.1.28; Tobaldini E, 2018, CLIN NEUROPHYSIOL, V129, P1083, DOI 10.1016/j.clinph.2018.01.068; Tonhajzerova I, 2012, HEART RATE VARIABILI, P185; Umetani K, 1998, J AM COLL CARDIOL, V31, P593, DOI 10.1016/S0735-1097(97)00554-8; Vickhoff B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00334; Voss A, 2012, PHYSIOL MEAS, V33, P1289, DOI 10.1088/0967-3334/33/8/1289; Wieser M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-30; Wildemeersch Davina, 2018, Rom J Anaesth Intensive Care, V25, P19, DOI 10.21454/rjaic.7518.251.wil; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3; ZHANG YC, 1991, J PHYS I, V1, P971	76	8	9	2	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0885-3924	1873-6513		J PAIN SYMPTOM MANAG	J. Pain Symptom Manage.	JAN	2019	57	1					47	56		10.1016/j.jpainsymman.2018.09.016			10	Health Care Sciences & Services; Medicine, General & Internal; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; General & Internal Medicine; Neurosciences & Neurology	HF4ZK	WOS:000454242100016	30267843	Bronze, Green Submitted			2022-02-06	
J	St Ivany, A; Schminkey, D				St Ivany, Amanda; Schminkey, Donna			Rethinking Traumatic Brain Injury from Intimate Partner Violence: A Theoretical Model of the Cycle of Transmission	JOURNAL OF AGGRESSION MALTREATMENT & TRAUMA			English	Article						Community violence; family/domestic violence; intimate partner violence; offender/perpetrator; prevention; structural violence; health equity; traumatic brain injury	HEALTH; NEUROPLASTICITY; RECOMMENDATIONS; AGGRESSION; WOMEN	Despite growing evidence of the repeated nature of traumatic brain injury (TBI) in women experiencing intimate partner violence (IPV), there is no theoretical model depicting TBIs as a cyclical process throughout a lifetime. Situational analysis methodology was used on interviews with 10 women who self-reported passing out from being hit in the head during an episode of IPV to create a theoretical model depicting the cycle of transmission of TBI. We define the cycle of transmission of TBI as the way that women experience multiple TBIs over the course of their lifetime and how TBI can be perpetuated in a family or community. The cycle begins in childhood or adolescence, when women receive a TBI from abuse, sports, or motor vehicle accident. They enter into abusive relationships with men who are also described as living with a TBI and the women receive other TBIs during this relationship. With repeating head trauma, women described increasing TBI symptoms: problems with memory, cognition, executive functioning, depression, and concentration. If they do seek help, they must choose between healthcare and protective shelter. With either choice, the element of instability could be introduced and the cycle of transmission continues. This theoretical model shows that it is necessary to move beyond individual behaviors to think about how TBIs are transmitted through communities and how untreated symptoms can impact help-seeking behavior and perpetuate other risk factors for receiving a TBI.	[St Ivany, Amanda] Geisel Sch Med Dartmouth, Dept Community & Family Med, 46 Centerra Pkwy, Lebanon, NH 03766 USA; [Schminkey, Donna] James Madison Univ, Coll Hlth & Behav Studies, Sch Nursing, Harrisonburg, VA 22807 USA		St Ivany, A (corresponding author), Geisel Sch Med Dartmouth, Dept Community & Family Med, 46 Centerra Pkwy, Lebanon, NH 03766 USA.	Amanda.R.St.Ivany@dartmouth.edu	St Ivany, Amanda/AAC-6228-2019		Health Resources and Services AdministrationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [T32HP30036]	This work was supported by the Health Resources and Services Administration [T32HP30036].	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Befus DR, 2018, NURS RES, V67, P395, DOI 10.1097/NNR.0000000000000301; Berg MT, 2017, SOC SCI MED, V193, P130, DOI 10.1016/j.socscimed.2017.09.028; Bickerdike L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013384; Blaylock R. L., 2011, SURG NEUROLOGY INT, V2; Braveman P, 2014, PUBLIC HEALTH REP, V129, P5, DOI 10.1177/00333549141291S203; Browne AJ, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0271-y; Buckley L, 2017, AGGRESS VIOLENT BEH, V37, P26, DOI 10.1016/j.avb.2017.08.004; Centers for Disease Control and Prevention (CDC), 2015, REP C TRAUM BRAIN IN; Coan J., 2013, OXFORD HDB CLOSE REL, DOI 10.1093/oxfordhb/9780195398694.001.0001/oxfordhb-9780195398694-e-031; Collins PH, 2015, ANNU REV SOCIOL, V41, P1, DOI 10.1146/annurev-soc-073014-112142; Crenshaw K., 1991, STANFORD LAW REV, V43, P1241, DOI [DOI 10.2307/1229039, 10.2307/1229039]; Davis R, 2016, INJURY PREV, V22, pA223, DOI 10.1136/injuryprev-2016-042156.622; DeMaster D, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.832; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Fleming PJ, 2015, SOC SCI MED, V146, P249, DOI 10.1016/j.socscimed.2015.10.021; Flood R.L., 1990, SYST PRACTICE, V3, P7; Freeman R, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0549-3; GALTUNG J, 1969, J PEACE RES, P167; Han K, 2018, NEUROIMAGE-CLIN, V18, P262, DOI 10.1016/j.nicl.2018.01.030; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hunnicutt G, 2009, VIOLENCE AGAINST WOM, V15, P553, DOI 10.1177/1077801208331246; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Krieger N., 2017, EMBODYING INEQUALITY; Linton KF, 2014, BRAIN INJURY, V28, P1076, DOI 10.3109/02699052.2014.901558; Ma ZC, 2019, DISABIL REHABIL, V41, P1360, DOI 10.1080/09638288.2018.1424957; Marsh NV, 2006, BRAIN INJURY, V20, P61, DOI 10.1080/02699050500110645; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; McEwen BS, 2017, CHRONIC STRESS, V1, DOI [10.1177/2470547017692328, DOI 10.1177/2470547017692328]; Meadows D., 2008, THINKING SYSTEMS PRI; MIDGLEY G, 1992, SYST PRACTICE, V5, P5, DOI 10.1007/BF01060044; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; Pinderhughes H., 2013, URBAN NETWORKS INCRE, P1; Pinto LA, 2010, AGGRESS VIOLENT BEH, V15, P387, DOI 10.1016/j.avb.2010.07.001; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Robinette JW, 2016, HEALTH PLACE, V41, P110, DOI 10.1016/j.healthplace.2016.08.003; ROSENBAUM A, 1994, J CONSULT CLIN PSYCH, V62, P1187, DOI 10.1037/0022-006X.62.6.1187; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; St Ivany A, 2018, J FORENSIC NURS, V14, P198, DOI 10.1097/JFN.0000000000000220; St Ivany A, 2018, QUAL HEALTH RES, V28, P1708, DOI 10.1177/1049732318786705; Tharp AT, 2017, J AGGRESS MALTREAT T, V26, P445, DOI 10.1080/10926771.2017.1287145; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tomaszczyk JC, 2014, NEUROPSYCHOL REV, V24, P409, DOI 10.1007/s11065-014-9273-6; Washburn R., 2017, SITUATIONAL ANAL GRO	51	8	8	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1092-6771	1545-083X		J AGGRESS MALTREAT T	J. Aggress. Maltreatment Trauma		2019	28	7			SI		785	806		10.1080/10926771.2019.1632400			22	Psychology, Clinical; Criminology & Penology; Family Studies; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology; Family Studies; Psychiatry	IV7RC	WOS:000484463300001					2022-02-06	
J	Tripathy, A; Shade, A; Erskine, B; Bailey, K; Grande, A; deJong, JJ; Perry, G; Castellani, RJ				Tripathy, Arushi; Shade, Ashley; Erskine, Brittany; Bailey, Kristi; Grande, Abigail; deJong, Joyce J.; Perry, George; Castellani, Rudy J.			No Evidence of Increased Chronic Traumatic Encephalopathy Pathology or Neurodegenerative Proteinopathy in Former Military Service Members: A Preliminary Study	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; chronic traumatic encephalopathy; tauopathy; traumatic brain injury; veterans	BRAIN-INJURY; HEAD-INJURY; ALZHEIMERS-DISEASE; DEMENTIA; NEUROPATHOLOGY; RISK; TAU; ASSOCIATION	It is presently unknown whether military service members are at risk for chronic traumatic encephalopathy (CTE) or Alzheimer's disease (AD) pathology, due to traumatic brain injury (TBI). Studies with respect to AD have had mixed results with respect to mild TBI, although an increased risk of clinical AD with moderate and severe TBI is more consistently demonstrated. No studies to date have demonstrated a longitudinal progression from TBI to autopsy. We therefore initiated a cross-sectional survey of former military service members. 18 brain specimens have been examined to date, with a mean age of 68.9 +/- 16 years (range 32-94). Twelve had a history of psychiatric problems; 10 had a history of PTSD specifically. Five had neurological problems including stroke and seizures. One subject had early-onset AD. Two subjects had a history of TBI and two had a history of blast exposure. Age-related proteinopathy, ranging from AD neuropathologic change A0B1C0 to A3B3C3 by NIA-AA guidelines, was identified. None of the cases showed changes specific for CTE pathology. There was no relationship between p-tau in the amygdala and psychiatric signs. There was no significant difference in phosphorylated tau (p-tau) or amyloid-beta burden compared to age-matched controls. These preliminary data suggest that military service per se is not a risk factor for CTE pathology or neurodegenerative proteinopathy. More research is needed to study the relationship, if any, between TBI and neurodegenerative proteinopathy.	[Tripathy, Arushi; Shade, Ashley; Erskine, Brittany; Bailey, Kristi; Grande, Abigail; deJong, Joyce J.; Castellani, Rudy J.] Western Michigan Univ, Ctr Neuropathol, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA; [Perry, George] Univ Texas San Antonio, Coll Sci, San Antonio, TX USA; [Castellani, Rudy J.] West Virginia Univ, Sch Med, Rockefeller Neurosci Inst, Dept Pathol, Morgantown, WV USA; [Castellani, Rudy J.] West Virginia Univ, Sch Med, Rockefeller Neurosci Inst, Dept Neurosci, Morgantown, WV USA		Castellani, RJ (corresponding author), 64 Med Ctr Dr, Morgantown, WV 26506 USA.	Rudolph.castellani@hsc.wvu.edu	Perry, George/A-8611-2009	Perry, George/0000-0002-6547-0172			Agoston D, 2017, J NEUROTRAUM, V34, pS6, DOI 10.1089/neu.2017.5220; Armon C, 2012, AMYOTROPH LATERAL SC, V13, P351, DOI 10.3109/17482968.2012.660954; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Brandenburg W, 1954, VIRCHOWS ARCH, V325, pS680; Brayne C, 2009, J ALZHEIMERS DIS, V18, P645, DOI 10.3233/JAD-2009-1182; Castellani RJ, 2017, J ALZHEIMERS DIS, V60, P1209, DOI 10.3233/JAD-170669; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Crook R, 1998, NAT MED, V4, P452, DOI 10.1038/nm0498-452; DePalma RG, 2018, BEHAV BRAIN RES, V340, P102, DOI 10.1016/j.bbr.2016.08.036; Dickson DW, 2018, PARKINSONISM RELAT D, V46, pS30, DOI 10.1016/j.parkreldis.2017.07.033; Dickson D, 2011, J MOL NEUROSCI, V45, P384, DOI 10.1007/s12031-011-9589-0; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fournier CN, 2015, NEUROLOGY, V84, P1788, DOI 10.1212/WNL.0000000000001522; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Groot C, 2018, NEUROLOGY, V90, pE149, DOI 10.1212/WNL.0000000000004802; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Koga S, 2016, J NEUROPATH EXP NEUR, V75, P963, DOI 10.1093/jnen/nlw073; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mirra S, 1991, NEUROLOGY, V46, P142; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Peters TL, 2013, AMYOTROPH LAT SCL FR, V14, P267, DOI 10.3109/21678421.2012.754043; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Riedl L, 2014, NEUROPSYCH DIS TREAT, V10, P297, DOI 10.2147/NDT.S38706; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Turner MR, 2010, J NEUROL SCI, V288, P45, DOI 10.1016/j.jns.2009.10.010; Yamamoto S, 2018, MOLECULES, V23, DOI 10.3390/molecules23020245	41	8	8	1	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2019	67	4					1277	1289		10.3233/JAD-181039			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HN8HE	WOS:000460435000015	30741674				2022-02-06	
J	Yin, YQ; De Lima, S; Gilbert, HY; Hanovice, NJ; Peterson, SL; Sand, RM; Sergeeva, EG; Wong, KA; Xie, LL; Benowitz, LI				Yin, Yuqin; De Lima, Silmara; Gilbert, Hui-Ya; Hanovice, Nicholas J.; Peterson, Sheri L.; Sand, Rheanna M.; Sergeeva, Elena G.; Wong, Kimberly A.; Xie, Lili; Benowitz, Larry, I			Optic nerve regeneration: A long view	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Optic nerve; axon regeneration; inflammatory cells; retina; survival; zinc chelation; brain re-innervation; vision; oncomodulin	RETINAL GANGLION-CELLS; MYELIN-ASSOCIATED GLYCOPROTEIN; CILIARY NEUROTROPHIC FACTOR; PROMOTES AXON REGENERATION; LEUCINE-ZIPPER KINASE; NECROSIS-FACTOR-ALPHA; SPINAL-CORD LESION; MULLER GLIA; NEURITE GROWTH; NOGO-A	The optic nerve conveys information about the outside world from the retina to multiple subcortical relay centers. Until recently, the optic nerve was widely believed to be incapable of re-growing if injured, with dire consequences for victims of traumatic, ischemic, or neurodegenerative diseases of this pathway. Over the past 10-20 years, research from our lab and others has made considerable progress in defining factors that normally suppress axon regeneration and the ability of retinal ganglion cells, the projection neurons of the retina, to survive after nerve injury. Here we describe research from our lab on the role of inflammation-derived growth factors, suppression of inter-cellular signals among diverse retinal cell types, and combinatorial therapies, along with related studies from other labs, that enable animals with optic nerve injury to regenerate damaged retinal axons back to the brain. These studies raise the possibility that vision might one day be restored to people with optic nerve damage.	[Yin, Yuqin; De Lima, Silmara; Gilbert, Hui-Ya; Hanovice, Nicholas J.; Peterson, Sheri L.; Wong, Kimberly A.; Xie, Lili; Benowitz, Larry, I] Boston Childrens Hosp, Labs Neurosci Res Neurosurg, Boston, MA 02115 USA; [Yin, Yuqin; De Lima, Silmara; Gilbert, Hui-Ya; Hanovice, Nicholas J.; Peterson, Sheri L.; Wong, Kimberly A.; Xie, Lili; Benowitz, Larry, I] Boston Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Yin, Yuqin; De Lima, Silmara; Hanovice, Nicholas J.; Peterson, Sheri L.; Sand, Rheanna M.; Sergeeva, Elena G.; Wong, Kimberly A.; Xie, Lili; Benowitz, Larry, I] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Yin, Yuqin; De Lima, Silmara; Hanovice, Nicholas J.; Peterson, Sheri L.; Wong, Kimberly A.; Xie, Lili; Benowitz, Larry, I] Harvard Med Sch, Dept Neurosurg, Boston, MA 02115 USA; [Sand, Rheanna M.; Sergeeva, Elena G.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Sand, Rheanna M.; Sergeeva, Elena G.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Benowitz, Larry, I] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA		Yin, YQ; Benowitz, LI (corresponding author), Boston Childrens Hosp, Labs Neurosci Res Neurosurg, Boston, MA 02115 USA.; Yin, YQ; Benowitz, LI (corresponding author), Boston Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA.; Yin, YQ; Benowitz, LI (corresponding author), Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.; Yin, YQ; Benowitz, LI (corresponding author), Harvard Med Sch, Dept Neurosurg, Boston, MA 02115 USA.; Benowitz, LI (corresponding author), Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA.	yuqin.yin@childrens.harvard.edu; larry.benowitz@childrens.harvard.edu		Benowitz, Larry/0000-0002-0277-7222; Peterson, Sheri/0000-0003-0046-1184; Wong, Kimberly/0000-0003-3335-2849; Sand, Rheanna/0000-0002-8936-0234	Adelson Medical Research Foundation; NIH/NEIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY027881, NEI R01EY024481, 2T32EY007145-19]; NINDS IDDRC [HD018655]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY027881, R01EY024481] Funding Source: NIH RePORTER	We are grateful for the support of the Adelson Medical Research Foundation, NIH/NEI (R01EY027881, NEI R01EY024481, 2T32EY007145-19), and NINDS IDDRC HD018655.	Abdesselem H, 2009, J NEUROSCI, V29, P15489, DOI 10.1523/JNEUROSCI.3561-09.2009; AGUAYO AJ, 1991, PHILOS T R SOC B, V331, P337, DOI 10.1098/rstb.1991.0025; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Tran AP, 2018, PHYSIOL REV, V98, P881, DOI 10.1152/physrev.00017.2017; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Ankerhold R, 1998, GLIA, V23, P257, DOI 10.1002/(SICI)1098-1136(199807)23:3<257::AID-GLIA8>3.0.CO;2-1; Apara A, 2017, J NEUROSCI, V37, P9632, DOI 10.1523/JNEUROSCI.0643-16.2017; Apara A, 2014, NEURAL REGEN RES, V9, P1418, DOI 10.4103/1673-5374.139454; Aras MA, 2011, ANTIOXID REDOX SIGN, V15, P2249, DOI 10.1089/ars.2010.3607; Aravindakumar CT, 1999, BIOCHEM J, V344, P253, DOI 10.1042/0264-6021:3440253; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Baldwin KT, 2015, P NATL ACAD SCI USA, V112, P2581, DOI 10.1073/pnas.1423221112; Becker CG, 2002, J NEUROSCI, V22, P842, DOI 10.1523/JNEUROSCI.22-03-00842.2002; Becker T, 2014, CURR OPIN NEUROBIOL, V27, P186, DOI 10.1016/j.conb.2014.03.019; Bei FF, 2016, CELL, V164, P219, DOI 10.1016/j.cell.2015.11.036; Belin S, 2015, NEURON, V86, P1000, DOI 10.1016/j.neuron.2015.03.060; Belmadani A, 2005, J NEUROSCI, V25, P3995, DOI 10.1523/JNEUROSCI.4631-04.2005; BENOWITZ LI, 1983, J NEUROSCI, V3, P2153; BENOWITZ LI, 1983, SCIENCE, V222, P185, DOI 10.1126/science.6194562; BENOWITZ LI, 1981, J NEUROSCI, V1, P300; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bernhardt RR, 1996, J COMP NEUROL, V376, P253, DOI 10.1002/(SICI)1096-9861(19961209)376:2<253::AID-CNE7>3.0.CO;2-2; Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793; Bi FF, 2013, P NATL ACAD SCI USA, V110, P4069, DOI 10.1073/pnas.1218497110; Blackmore MG, 2012, P NATL ACAD SCI USA, V109, P7517, DOI 10.1073/pnas.1120684109; Blanco RE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209733; Boato F, 2010, J CELL SCI, V123, P1652, DOI 10.1242/jcs.066050; Bodrikov V, 2017, J COMP NEUROL, V525, P2991, DOI 10.1002/cne.24253; Boghdadi AG, 2018, MOL NEUROBIOL, V55, P1831, DOI 10.1007/s12035-017-0433-6; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Bosco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043602; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; BROWN JO, 1947, J COMP NEUROL, V87, P131, DOI 10.1002/cne.900870204; Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; CARONI P, 1988, PROG BRAIN RES, V78, P363; Cen LP, 2007, INVEST OPHTH VIS SCI, V48, P4257, DOI 10.1167/iovs.06-0791; Cenni MC, 1996, EUR J NEUROSCI, V8, P1735, DOI 10.1111/j.1460-9568.1996.tb01317.x; Chalasani SH, 2007, J NEUROSCI, V27, P973, DOI 10.1523/JNEUROSCI.4132-06.2007; Chan CCM, 2005, EXP NEUROL, V196, P352, DOI 10.1016/j.expneurol.2005.08.011; CHEN DF, 1995, P NATL ACAD SCI USA, V92, P7287, DOI 10.1073/pnas.92.16.7287; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; Chierzi S, 1999, J NEUROSCI, V19, P8367; Chindasub P, 2013, INVEST OPHTH VIS SCI, V54, P96, DOI 10.1167/iovs.12-10850; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; COHEN A, 1994, J NEUROBIOL, V25, P953, DOI 10.1002/neu.480250805; Cui Q, 2002, INVEST OPHTH VIS SCI, V43, P1954; Cui Q, 2000, NEUROREPORT, V11, P3999, DOI 10.1097/00001756-200012180-00019; Cui ZL, 2014, MOL CELLS, V37, P613, DOI 10.14348/molcells.2014.0155; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Dergham P, 2002, J NEUROSCI, V22, P6570; Di Polo A, 1998, P NATL ACAD SCI USA, V95, P3978, DOI 10.1073/pnas.95.7.3978; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Drummond ES, 2014, RESTOR NEUROL NEUROS, V32, P391, DOI 10.3233/RNN-130360; Duan X, 2015, NEURON, V85, P1244, DOI 10.1016/j.neuron.2015.02.017; Elsaeidi F, 2014, J NEUROSCI, V34, P2632, DOI 10.1523/JNEUROSCI.3898-13.2014; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fawcett JW, 2018, TRENDS NEUROSCI, V41, P239, DOI 10.1016/j.tins.2018.02.012; Fehlings MG, 2018, J NEUROTRAUM, V35, P1049, DOI 10.1089/neu.2017.5434; Fehlings MG, 2011, J NEUROTRAUM, V28, P787, DOI 10.1089/neu.2011.1765; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Fink KL, 2015, J NEUROSCI, V35, P15403, DOI 10.1523/JNEUROSCI.3165-15.2015; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fouad K, 2004, EUR J NEUROSCI, V20, P2479, DOI 10.1111/j.1460-9568.2004.03716.x; Freund P, 2007, J COMP NEUROL, V502, P644, DOI 10.1002/cne.21321; Fry EJ, 2010, GLIA, V58, P423, DOI 10.1002/glia.20934; Galvao J, 2018, INVEST OPHTH VIS SCI, V59, P2736, DOI 10.1167/iovs.17-23319; Garcia-Alias G, 2012, EXP NEUROL, V235, P26, DOI 10.1016/j.expneurol.2011.09.009; GARCIAVALENZUELA E, 1994, J NEUROBIOL, V25, P431, DOI 10.1002/neu.480250408; Gaub P, 2011, BRAIN, V134, P2134, DOI 10.1093/brain/awr142; Ghosh AS, 2011, J CELL BIOL, V194, P751, DOI 10.1083/jcb.201103153; Giger RJ, 2008, RESTOR NEUROL NEUROS, V26, P97; Goldberg JL, 2004, J NEUROSCI, V24, P4989, DOI 10.1523/JNEUROSCI.4390-03.2004; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; Goldstein BJ, 2002, AM J CARDIOL, V90, P3, DOI DOI 10.1016/S0002-9149(02)02553-5; Graeber MB, 2011, FEBS LETT, V585, P3798, DOI 10.1016/j.febslet.2011.08.033; GRANT S, 1992, EXP BRAIN RES, V89, P383; Hanovice N., 2018, ANN M SOC NEUR SAN D; Herzog C, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.174698; Heskamp A, 2013, NEUROBIOL DIS, V55, P76, DOI 10.1016/j.nbd.2013.04.001; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Hilla AM, 2017, J NEUROSCI, V37, P6113, DOI 10.1523/JNEUROSCI.0584-17.2017; HIRSCH S, 1995, J COMP NEUROL, V360, P599, DOI 10.1002/cne.903600405; Hollis ER, 2016, NEUROTHERAPEUTICS, V13, P360, DOI 10.1007/s13311-015-0416-0; Hu Y, 2010, INVEST OPHTH VIS SCI, V51, P1747, DOI 10.1167/iovs.09-4450; Huang HL, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1289-z; Isenmann S, 1997, EUR J NEUROSCI, V9, P1763, DOI 10.1111/j.1460-9568.1997.tb01534.x; Janssen KT, 2013, INVEST OPHTH VIS SCI, V54, P1805, DOI 10.1167/iovs.11-9310; Jorstad NL, 2017, NATURE, V548, P103, DOI 10.1038/nature23283; Kalinski AL, 2015, J NEUROSCI, V35, P10357, DOI 10.1523/JNEUROSCI.1249-15.2015; Kermer P, 2000, MOL BRAIN RES, V85, P144, DOI 10.1016/S0169-328X(00)00256-4; Kermer P, 1999, FEBS LETT, V453, P361, DOI 10.1016/S0014-5793(99)00747-4; Khan AB, 2018, J CLIN INVEST, V128, P2010, DOI 10.1172/JCI97454; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Kimura T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030336; Kochanczyk T, 2015, METALLOMICS, V7, P244, DOI 10.1039/c4mt00094c; Koeberle PD, 1998, VISION RES, V38, P1505, DOI 10.1016/S0042-6989(97)00364-7; Koeberle PD, 2002, NEUROSCIENCE, V110, P555, DOI 10.1016/S0306-4522(01)00557-7; Koriyama Y, 2014, J PHARMACOL SCI, V124, P112, DOI 10.1254/jphs.13171SC; Kucher K, 2018, NEUROREHAB NEURAL RE, V32, P578, DOI 10.1177/1545968318776371; Kurimoto T, 2013, J NEUROSCI, V33, P14816, DOI 10.1523/JNEUROSCI.5511-12.2013; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Kusik BW, 2010, DEV DYNAM, V239, P482, DOI 10.1002/dvdy.22190; Kwon MJ, 2013, J NEUROSCI, V33, P15095, DOI 10.1523/JNEUROSCI.0278-13.2013; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Langhe R, 2017, GLIA, V65, P1333, DOI 10.1002/glia.23165; Leaver SG, 2006, EUR J NEUROSCI, V24, P3323, DOI 10.1111/j.1460-9568.2006.05230.x; Lebrun-Julien F, 2009, J NEUROSCI, V29, P5536, DOI 10.1523/JNEUROSCI.0831-09.2009; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Lee S.M., 2011, J NEUROTRAUMA; Lee-Liu D, 2017, NEUROSCI LETT, V652, P82, DOI 10.1016/j.neulet.2016.09.054; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Li SS, 2015, NEUROBIOL DIS, V73, P366, DOI 10.1016/j.nbd.2014.09.019; Li Y, 2000, EXP EYE RES, V71, P209, DOI 10.1006/exer.2000.0873; Li Y, 1999, INVEST OPHTH VIS SCI, V40, P1004; Li Y., 2017, NEUROSCIENCE M PLANN; Li Y., 2016, M SOC NEUR SAN DIEG; Li YQ, 2017, P NATL ACAD SCI USA, V114, pE209, DOI 10.1073/pnas.1616811114; Li YM, 2003, J NEUROSCI, V23, P7830; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lieven CJ, 2006, INVEST OPHTH VIS SCI, V47, P1477, DOI 10.1167/iovs.05-0921; Lim JHA, 2016, NAT NEUROSCI, V19, P1073, DOI 10.1038/nn.4340; Lingor P, 2008, BRAIN, V131, P250, DOI 10.1093/brain/awm284; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Liu YY, 2012, J NEUROSCI, V32, P3563, DOI 10.1523/JNEUROSCI.5197-11.2012; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Marin MA, 2016, J NEUROSCI, V36, P9148, DOI 10.1523/JNEUROSCI.1747-16.2016; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; McAllister BB, 2017, NEUROSCI BIOBEHAV R, V80, P329, DOI 10.1016/j.neubiorev.2017.06.006; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; McKinnon SJ, 2009, EXP EYE RES, V88, P816, DOI 10.1016/j.exer.2008.12.002; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MISANTONE LJ, 1984, J NEUROCYTOL, V13, P449, DOI 10.1007/BF01148334; Monsul NT, 2004, EXP NEUROL, V186, P124, DOI 10.1016/S0014-4886(03)00311-X; Moore D.L., 2009, KEYST S AX CONN MOL; Moore DL, 2011, MOL CELL NEUROSCI, V47, P233, DOI 10.1016/j.mcn.2011.05.005; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Muller A, 2007, BRAIN, V130, P3308, DOI 10.1093/brain/awm257; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nakashima AS, 2009, BRAIN RES REV, V59, P347, DOI 10.1016/j.brainresrev.2008.10.003; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Nelson CM, 2013, J NEUROSCI, V33, P6524, DOI 10.1523/JNEUROSCI.3838-12.2013; Norris GT, 2018, J EXP MED, V215, P1789, DOI 10.1084/jem.20172244; Osborne A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1041-8; Pan EH, 2011, NEURON, V71, P1116, DOI 10.1016/j.neuron.2011.07.019; Park KK, 2009, MOL CELL NEUROSCI, V41, P313, DOI 10.1016/j.mcn.2009.04.002; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pearson CS, 2018, ELIFE, V7, DOI 10.7554/eLife.37139; Pelzel HR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-62; Pernet V, 2006, BRAIN, V129, P1014, DOI 10.1093/brain/awl015; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Priscilla R, 2019, BRAIN RES, V1704, P150, DOI 10.1016/j.brainres.2018.10.012; Qin S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3633; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Ramon y Cajal S., 1991, DEGENERATION REGENER, V5; Reaux-Le Goazigo A, 2013, PROG NEUROBIOL, V104, P67, DOI 10.1016/j.pneurobio.2013.02.001; REIER PJ, 1974, J NEUROCYTOL, V3, P591, DOI 10.1007/BF01097626; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Robak LA, 2009, J NEUROSCI, V29, P5768, DOI 10.1523/JNEUROSCI.4935-08.2009; Roh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040065; Rosenzweig E.S., 2019, NATURE NEUROSCIENCE; RUDGE JS, 1990, J NEUROSCI, V10, P3594; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Sapieha PS, 2003, MOL CELL NEUROSCI, V24, P656, DOI 10.1016/S1044-7431(03)00228-8; Schmitt HM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-39; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHWAB ME, 1990, TRENDS NEUROSCI, V13, P452, DOI 10.1016/0166-2236(90)90098-U; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; SCHWALB JM, 1995, J NEUROSCI, V15, P5514; Schwalb JM, 1996, NEUROSCIENCE, V72, P901, DOI 10.1016/0306-4522(95)00605-2; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Shen SL, 1999, NEURON, V23, P285, DOI 10.1016/S0896-6273(00)80780-1; Shigeoka T, 2016, CELL, V166, P181, DOI 10.1016/j.cell.2016.05.029; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; SKENE JHP, 1981, J CELL BIOL, V89, P86, DOI 10.1083/jcb.89.1.86; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; SO KF, 1985, BRAIN RES, V328, P349, DOI 10.1016/0006-8993(85)91047-9; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Spahl DU, 2003, P NATL ACAD SCI USA, V100, P13952, DOI 10.1073/pnas.2335190100; SPERRY RW, 1948, PHYSIOL ZOOL, V21, P351, DOI 10.1086/physzool.21.4.30152014; Steinmetz MP, 2005, J NEUROSCI, V25, P8066, DOI 10.1523/JNEUROSCI.2111-05.2005; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Tedeschi A, 2013, EMBO REP, V14, P605, DOI 10.1038/embor.2013.64; Terenzio M, 2018, SCIENCE, V359, P1416, DOI 10.1126/science.aan1053; Theisen CC, 2017, J NEUROTRAUM, V34, P1909, DOI 10.1089/neu.2016.4640; Thomas JL, 2016, EXP EYE RES, V143, P98, DOI 10.1016/j.exer.2015.09.017; Trakhtenberg EF, 2018, EXP NEUROL, V300, P22, DOI 10.1016/j.expneurol.2017.10.025; Ueki Y, 2015, P NATL ACAD SCI USA, V112, P13717, DOI 10.1073/pnas.1510595112; Veldmam MB, 2010, MOL CELL NEUROSCI, V43, P370, DOI 10.1016/j.mcn.2010.01.004; Veldman MB, 2007, DEV BIOL, V312, P596, DOI 10.1016/j.ydbio.2007.09.019; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; Vigneswara V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053473; Wan J, 2016, CURR OPIN GENET DEV, V40, P41, DOI 10.1016/j.gde.2016.05.009; Wan J, 2012, DEV CELL, V22, P334, DOI 10.1016/j.devcel.2011.11.020; Wang JT, 2007, J NEUROSCI, V27, P8593, DOI 10.1523/JNEUROSCI.4488-06.2007; Wang J, 2017, SCIENCE, V358, P111, DOI 10.1126/science.aam9690; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang XX, 2012, EXP NEUROL, V237, P55, DOI 10.1016/j.expneurol.2012.06.009; Wang XX, 2011, ANN NEUROL, V70, P805, DOI 10.1002/ana.22527; Wang XW, 2018, CELL REP, V24, P2540, DOI 10.1016/j.celrep.2018.07.105; Watkins TA, 2013, P NATL ACAD SCI USA, V110, P4039, DOI 10.1073/pnas.1211074110; Weise J, 2000, NEUROBIOL DIS, V7, P212, DOI 10.1006/nbdi.2000.0285; Welsbie DS, 2017, NEURON, V94, P1142, DOI 10.1016/j.neuron.2017.06.008; Welsbie DS, 2013, P NATL ACAD SCI USA, V110, P4045, DOI 10.1073/pnas.1211284110; Weng YL, 2018, NEURON, V97, P313, DOI 10.1016/j.neuron.2017.12.036; Williams PA, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-018-0303-3; Williams PA, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0091-6; Xie L., 2019, 2019 NEUR M PLANN; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yao K, 2018, NATURE, V560, P484, DOI 10.1038/s41586-018-0425-3; Yin Y., 2018, NEUROSCIENCE M PLANN; Yin Y., 2012, NEUROSCIENCE M PLANN; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Yin YQ, 2009, P NATL ACAD SCI USA, V106, P19587, DOI 10.1073/pnas.0907085106; Yungher BJ, 2017, INVEST OPHTH VIS SCI, V58, P1743, DOI 10.1167/iovs.16-19873; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang YL, 2019, NEURON, V103, P39, DOI 10.1016/j.neuron.2019.04.033; Zhang ZZ, 2012, NEUROSCIENCE, V224, P282, DOI 10.1016/j.neuroscience.2012.07.056; Zhao XF, 2014, CELL REP, V9, P272, DOI 10.1016/j.celrep.2014.08.047; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zou SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057280	242	8	9	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2019	37	6					525	544		10.3233/RNN-190960			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JW4DX	WOS:000503005000002	31609715	Green Accepted			2022-02-06	
J	Ellis, MJ; Leddy, J; Cordingley, D; Willer, B				Ellis, Michael J.; Leddy, John; Cordingley, Dean; Willer, Barry			A Physiological Approach to Assessment and Rehabilitation of Acute Concussion in Collegiate and Professional Athletes	FRONTIERS IN NEUROLOGY			English	Article						acute concussion; physiology; assessment; targeted rehabilitation; collegiate and professional athletes	SPORTS-RELATED CONCUSSION; CEREBRAL-BLOOD-FLOW; HEART-RATE-VARIABILITY; TRAUMATIC BRAIN-INJURY; GRADED-EXERCISE; VESTIBULAR REHABILITATION; INTERNATIONAL-CONFERENCE; POSTCONCUSSION SYNDROME; PHYSICAL-EXAMINATION; CONSENSUS STATEMENT	Sport-related concussion is an important condition that can affect collegiate and professional athletes. Expert consensus guidelines currently suggest that all athletes who sustain acute concussion be managed with a conservative approach consisting of relative rest and gradual resumption of school and sport activities with active intervention reserved for those with persistent post-concussion symptoms lasting >10-14 days for adults. Unfortunately, these recommendations place little emphasis on the rapid physical deconditioning that occurs in athletes within days of exercise cessation or the pathophysiological processes responsible for acute concussion symptoms that can be successfully targeted by evidence-based rehabilitation strategies. Based on our evolving approach to patients with persistent post-concussion symptoms, we now present an updated physiological approach to the initial medical assessment, rehabilitation, and multi-disciplinary management of collegiate and professional athletes with acute concussion. Utilizing the results of a careful clinical history, comprehensive physical examination and graded aerobic exercise testing, we outline how team physicians, and athletic training staff can partner with multi-disciplinary experts in traumatic brain injury to develop individually tailored rehabilitation programs that target the main physiological causes of acute concussion symptoms (autonomic nervous system dysfunction/exercise intolerance, vestibulo-ocular dysfunction, and cervical spine dysfunction) while maintaining the athlete's physical fitness during the recovery period. Considerations for multi-disciplinary medical clearance of collegiate and professional athletes as well as the application of this approach to non-elite athletes are also discussed.	[Ellis, Michael J.] Univ Manitoba, Childrens Hosp, Dept Surg Pediat & Child Hlth,Res Inst Manitoba, Sect Neurosurg,Canada North Concuss Network, Winnipeg, MB, Canada; [Ellis, Michael J.; Cordingley, Dean] Pan Concuss Program, Winnipeg, MB, Canada; [Leddy, John] UBMD, Dept Orthqoaed & Sports Med, Buffalo, NY USA; [Cordingley, Dean] Pan Clin Fdn, Winnipeg, MB, Canada; [Willer, Barry] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA		Ellis, MJ (corresponding author), Univ Manitoba, Childrens Hosp, Dept Surg Pediat & Child Hlth,Res Inst Manitoba, Sect Neurosurg,Canada North Concuss Network, Winnipeg, MB, Canada.; Ellis, MJ (corresponding author), Pan Concuss Program, Winnipeg, MB, Canada.	mellis3@panamclinic.com			University of Manitoba, Department of Surgery Thorlakson Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094444] Funding Source: NIH RePORTER	Financial support of this manuscript was provided by the University of Manitoba, Department of Surgery Thorlakson Fund.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Armijo-Olivo S, 2016, PHYS THER REHABIL J, V96, P9, DOI 10.2522/ptj.20140548; Aron M, 2015, OTOLARYNG HEAD NECK, V153, P721, DOI 10.1177/0194599815594384; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Becker WJ, 2010, HEADACHE, V50, P698, DOI 10.1111/j.1526-4610.2010.01648.x; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bhattacharyya N, 2008, OTOLARYNG HEAD NECK, V139, pS47, DOI 10.1016/j.otohns.2008.08.022; Bishop S, 2017, BRAIN INJURY, V31, P247, DOI 10.1080/02699052.2016.1226385; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P733, DOI 10.1111/cpf.12487; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P573, DOI 10.1111/cpf.12447; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; Bonow RH, 2017, J NEUROTRAUM, V34, P2706, DOI 10.1089/neu.2017.4970; Brodsky JR, 2018, OTOL NEUROTOL, V39, P344, DOI 10.1097/MAO.0000000000001673; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cantu RC, 2013, CURR SPORT MED REP, V12, P14, DOI 10.1249/JSR.0b013e31827dc1fb; CANTU RV, 1994, J NEUROSURG, V80, P592; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Chrisman SPD, 2017, NEUROREHABILITATION, V40, P493, DOI 10.3233/NRE-161436; Chung S, 2011, J TRAUMA, V70, P873, DOI 10.1097/TA.0b013e3182108823; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Cochrane GD, 2017, PHYSICIAN SPORTSMED, V45, P178, DOI 10.1080/00913847.2017.1305875; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Concannon LG, 2014, CURR SPORT MED REP, V13, P365, DOI 10.1249/JSR.0000000000000098; Conder RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00890; Convertino VA, 1997, MED SCI SPORT EXER, V29, P187, DOI 10.1097/00005768-199702000-00004; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Ellis Michael J, 2017, Concussion, V2, pCNC33, DOI 10.2217/cnc-2016-0027; Ellis MJ, 2019, J HEAD TRAUMA REHAB, V34, P103, DOI 10.1097/HTR.0000000000000411; Ellis MJ, 2017, CURR SPORT MED REP, V16, P14, DOI 10.1249/JSR.0000000000000323; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2017, CLIN J SPORT MED, V27, P179, DOI 10.1097/JSM.0000000000000305; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15600; Ellis MJ, 2016, CURR SPORT MED REP, V15, P27, DOI 10.1249/JSR.0000000000000223; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gardner A, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00141; Giza CC, 2001, J ATHL TRAINING, V36, P228; Glick ID, 2005, CLIN SPORT MED, V24, P771, DOI 10.1016/j.csm.2005.03.007; Glick ID, 2012, J CLIN PSYCHIAT, V73, P640, DOI 10.4088/JCP.11r07381; Gouttebarge V, 2017, INT J SPORTS MED, V38, P864, DOI 10.1055/s-0043-114010; Gouttebarge V, 2017, CLIN J SPORT MED, V27, P487, DOI 10.1097/JSM.0000000000000388; Grady MF, 2012, PEDIATR ANN, V41, P377, DOI 10.3928/00904481-20120827-12; Griesbach GS, 2014, J NEUROTRAUM, V31, P674, DOI 10.1089/neu.2013.3151; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; HAAS DC, 1988, J NEUROSURG, V68, P181, DOI 10.3171/jns.1988.68.2.0181; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Hall CD, 2016, J NEUROL PHYS THER, V40, P124, DOI 10.1097/NPT.0000000000000120; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hautala AJ, 2009, NEUROSCI BIOBEHAV R, V33, P107, DOI 10.1016/j.neubiorev.2008.04.009; Henry M, 2013, J NEUROSURG-PEDIATR, V12, P30, DOI 10.3171/2013.4.PEDS12477; Hillier SL, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005397.pub3; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Hinds A, 2016, J NEUROL NEUROPHYSIO, V7, P388, DOI DOI 10.4172/2155-9562.1000388; Hughson RL, 2015, AUTON NEUROSCI-BASIC, V188, P32, DOI 10.1016/j.autneu.2014.10.012; Iadecola C, 2002, NAT MED, V8, P110, DOI 10.1038/nm0202-110; Itoh T, 2011, J NEURAL TRANSM, V118, P193, DOI 10.1007/s00702-010-0495-3; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnson BD, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13694; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; Khan S, 2013, NEUROREHABILITATION, V32, P437, DOI 10.3233/NRE-130866; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; LAURITZEN M, 1984, BRAIN, V107, P447, DOI 10.1093/brain/107.2.447; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Leao A A, 1986, Funct Neurol, V1, P363; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Liu HJ, 2012, ACTA OTO-LARYNGOL, V132, P803, DOI 10.3109/00016489.2012.657359; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mujika I, 2000, SPORTS MED, V30, P79, DOI 10.2165/00007256-200030020-00002; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Mutch WAC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00107; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Page P, 2011, INT J SPORTS PHYS TH, V6, P254; Parachute, 2017, CAN GUID CONC SPORT; Reardon CL, 2010, SPORTS MED, V40, P961, DOI 10.2165/11536580-000000000-00000; Reimer K, 2020, CLIN J SPORT MED, V30, P412, DOI 10.1097/JSM.0000000000000617; Reneker JC, 2017, SCAND J MED SCI SPOR, V27, P2009, DOI 10.1111/sms.12827; Reneker JC, 2018, MUSCULOSKEL SCI PRAC, V34, P8, DOI 10.1016/j.msksp.2017.11.012; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Scheiman M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006768.pub2; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Seifert T, 2017, HEADACHE, V57, P877, DOI 10.1111/head.13104; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Simpson-Jones ME, 2019, DISABIL REHABIL, V41, P2206, DOI 10.1080/09638288.2018.1460407; Smorawinski J, 2001, J APPL PHYSIOL, V91, P249, DOI 10.1152/jappl.2001.91.1.249; Spiering BA, 2003, J STRENGTH COND RES, V17, P329; Sport Neuropsychology Society, 2018, CHRON TRAUM ENC A Q; Stanula A, 2014, J HUM KINET, V44, P211, DOI 10.2478/hukin-2014-0126; Starling AJ, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0521-0; Stiell IG, 2010, CAN MED ASSOC J, V182, P1173, DOI 10.1503/cmaj.091430; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Sufrinko AM, 2017, J PEDIATR-US, V185, P167, DOI 10.1016/j.jpeds.2017.02.072; Terry DP, 2019, J NEUROTRAUM, V36, P142, DOI 10.1089/neu.2017.5443; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Torg JS, 1997, CLIN J SPORT MED, V7, P273, DOI 10.1097/00042752-199710000-00005; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Willer BS, 2016, ACAD EMERG MED, V23, P495, DOI 10.1111/acem.12940; Wright AD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00196; Wright AD, 2018, ACTA NEUROCHIR SUPPL, V126, P303, DOI 10.1007/978-3-319-65798-1_59; Wright AD, 2017, J NEUROTRAUM, V34, P3097, DOI 10.1089/neu.2017.5020	143	8	8	1	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 20	2018	9								1115	10.3389/fneur.2018.01115			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HF0XG	WOS:000453887300002	30619068	Green Published, gold			2022-02-06	
J	Manskow, US; Arntzen, C; Damsgard, E; Braine, M; Sigurdardottir, S; Andelic, N; Roe, C; Anke, A				Manskow, Unn Sollid; Arntzen, Cathrine; Damsgard, Elin; Braine, Mary; Sigurdardottir, Solrun; Andelic, Nada; Roe, Cecilie; Anke, Audny			Family members' experience with in-hospital health care after severe traumatic brain injury: a national multicentre study	BMC HEALTH SERVICES RESEARCH			English	Article						Experience of care; Quality of care; Traumatic brain injury; Rehabilitation; Family	HEAD-INJURY; SATISFACTION; QUALITY; QUESTIONNAIRE; TRANSITION; NEEDS; LIFE; INDIVIDUALS; HOME; REHABILITATION	BackgroundFamily member's experience and satisfaction of health care in the acute care and in-patient rehabilitation are important indicators of the quality of health care services provided to patients with severe traumatic brain injury (TBI). The objective was to assess family members' experience of the health care provided in-hospital to patients with severe TBI, to relate experiences to family member and patient demographics, patients' function and rehabilitation pathways.MethodsProspective national multicentre study of 122 family members of patients with severe TBI. The family experience of care questionnaire in severe traumatic brain injury (FECQ-TBI) was applied. Independent sample t-tests or analysis of variance (ANOVA) were used to compare the means between 2 or more groups. Paired samples t-tests were used to investigate differences between experience in the acute and rehabilitation phases.ResultsBest family members` experience were found regarding information during the acute phase, poorest scores were related to discharge. A significantly better care experience was reported in the acute phase compared with the rehabilitation phase (p<0.05). Worst family members` experience was related to information about consequences of the injury. Patient's dependency level (p<0.05) and transferral to non-specialized rehabilitation were related to a worse family members` experience (p<0.01).ConclusionsThis study underscores the need of better information to family members of patients with severe TBI in the rehabilitation as well as the discharge phase. The results may be important to improve the services provided to family members and individuals with severe TBI.	[Manskow, Unn Sollid; Anke, Audny] Univ Hosp North Norway, Dept Rehabil, Tromso, Norway; [Manskow, Unn Sollid; Arntzen, Cathrine; Damsgard, Elin] Arctic Univ Norway, UiT, Fac Hlth Sci, Dept Hlth & Care Sci, Tromso, Norway; [Anke, Audny] Arctic Univ Norway, Fac Hlth Sci, Dept Clin Med, Tromso, Norway; [Braine, Mary] Univ Salford, Sch Hlth & Soc, Salford, Lancs, England; [Sigurdardottir, Solrun] Sunnaas Rehabil Hosp, Dept Res, Nesoddtangen, Norway; [Andelic, Nada; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Andelic, Nada; Roe, Cecilie] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway		Manskow, US (corresponding author), Univ Hosp North Norway, Dept Rehabil, Tromso, Norway.; Manskow, US (corresponding author), Arctic Univ Norway, UiT, Fac Hlth Sci, Dept Hlth & Care Sci, Tromso, Norway.	unn.manskow@gmail.com		Andelic, Nada/0000-0002-3719-4406; Anke, Audny/0000-0002-2491-2560; Arntzen, Cathrine/0000-0002-8194-0437	North Norwegian Health Authorities [8744/SFP1108-13]	This study was conducted with grants from the North Norwegian Health Authorities, grant number 8744/SFP1108-13. The North Norwegian Health Authorities had no role in designing of the study, collection of data, analysis, interpretation of data or in writing the manuscript.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; Anke A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1884-6; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; Arntzen C, 2015, DISABIL REHABIL, V37, P1626, DOI 10.3109/09638288.2014.972590; Association for the Advancement of Automotive Medicine (AAAM), 2008, ABBR INJ SCAL AIS 20; Bayen E, 2012, J HEAD TRAUMA REHABI; Bjertnaes O, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-73; Coco K, 2011, J NEUROSCI NURS, V43, P337, DOI 10.1097/JNN.0b013e318234ea0b; Crow R, 2002, Health Technol Assess, V6, P1; Dodek PM, 2012, CRIT CARE MED, V40, P1506, DOI 10.1097/CCM.0b013e318241e368; Dodek PM, 2004, CRIT CARE MED, V32, P1922, DOI 10.1097/01.CCM.0000139920.53790.61; Garratt AM, 2005, QUAL SAF HEALTH CARE, V14, P433, DOI 10.1136/qshc.2005.014423; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jenkinson C, 2002, QUAL SAF HEALTH CARE, V11, P335, DOI 10.1136/qhc.11.4.335; Jenkinson C, 2002, INT J QUAL HEALTH C, V14, P353, DOI 10.1093/intqhc/14.5.353; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Lee DS, 2008, CIRCULATION, V118, P1938, DOI 10.1161/CIRCULATIONAHA.108.792713; Mcilvoy L, 2001, J Neurosci Nurs, V33, P72; Nalder E, 2013, BRAIN INJURY, V27, P1294, DOI 10.3109/02699052.2013.823560; Nalder E, 2012, J HEAD TRAUMA REHAB, V27, P143, DOI 10.1097/HTR.0b013e3182168fb1; Norup A, 2015, NEUROREHABILITATION, V36, P203, DOI 10.3233/NRE-151208; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; O'Callaghan AM, 2011, INT J SPEECH-LANG PA, V13, P218, DOI 10.3109/17549507.2011.549240; Oyesanya T, 2017, BRAIN INJURY, V31, P151, DOI 10.1080/02699052.2016.1225987; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Singh R, 2013, ARCH TRAUMA RES, V2, P103, DOI 10.5812/atr.13665; Smith J E, 2000, Care Manag J, V2, P27; Solheim E, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-512; Sollid S, 2009, EMERG MED J, V26, P769, DOI 10.1136/emj.2008.061630; Stelfox HT, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-31; Sundstrom Terje, 2005, Tidsskr Nor Laegeforen, V125, P1310; Sveen U, 2016, EUR J PHYS REHABIL M; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2009, J NEUROSCI NURS, V41, P148, DOI 10.1097/JNN.0b013e3181a23eda; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	40	8	8	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6963			BMC HEALTH SERV RES	BMC Health Serv. Res.	DEC 7	2018	18								951	10.1186/s12913-018-3773-7			10	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	HD7LZ	WOS:000452735100002	30526574	Green Published, gold			2022-02-06	
J	Castor, N; El Massioui, F				Castor, Naomie; El Massioui, Farid			Traumatic brain injury and stroke: does recovery differ?	BRAIN INJURY			English	Article						Traumatic brain injury; stroke; brain damage; cognitive performances; cognitive recovery	EPIDEMIOLOGY; STATES; SCALE	Background: Traumatic brain injury and stroke often lead to cognitive, neurological and psychological disorders, which can result in many difficulties. Despite the existence of various disorders, improving cognitive capacities may be possible for these two pathologies. Objectives: The purpose of this study was to assess cognitive recovery in patients with traumatic brain injury and stroke and compare recovery between both groups. Participants and methods: Forty-nine adults who had suffered from mild to severe traumatic brain injury and 42 from stroke were assessed third with a minimum of 2 months between assessments. The French version of the Barrow Neurological Institute Scale was used to examine cognitive abilities and included six subscales on language, memory, guidance, visual spatial functions, affectivity and attention. Results: Cognitive performances were similar for the two groups at both assessments, with the exception of language performances, which were higher for participants with traumatic brain injury. An improvement was observed for several cognitive abilities, but no significant differences were found between traumatic brain injury and stroke groups. Conclusions: The findings of this study reveal the possibility of cognitive recovery after brain damage. No recovery differences were found for vascular and traumatic lesions.	[Castor, Naomie] Univ Paris 08, Dept Psychol, Paris, France; [El Massioui, Farid] Lab CHArt EA4004, St Denis Vincennes, France		Castor, N (corresponding author), Univ Paris 08, Dept Psychol, Paris, France.	castor.naomie@gmail.com					Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; BASSO A, 1990, CORTEX, V26, P501, DOI 10.1016/S0010-9452(13)80300-0; Bejot Y, 2016, REV NEUROL-FRANCE, V172, P59, DOI 10.1016/j.neurol.2015.07.013; Boyle PA, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00050; BROTT T, 1989, STROKE, V20, P871, DOI 10.1161/01.STR.20.7.871; Cambier J, 2012, NEUROLOGIE; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Crozier S, 2014, CAHIERS CTR G CANGUI, V6, P281, DOI [10.3917/ccgc.006.0281, DOI 10.3917/CCGC.006.0281]; De Peretti C, 2012, B EPIDEMIOLOGIQUE HE; Egon G, 2009, EXTRAIT CAMPUS NEURO; Fredrickson BL, 2000, MOTIV EMOTION, V24, P237, DOI 10.1023/A:1010796329158; Guillon B, 2001, REV MED INTERNE, V22, P830, DOI 10.1016/S0248-8663(01)00434-9; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hannay HJ, 2004, NEUROPSYCHOLOGICAL A, P718; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; JONGBLOED L, 1986, STROKE, V17, P765, DOI 10.1161/01.STR.17.4.765; LECOURS AR, 1988, NEUROPSYCHOLOGIA, V26, P575, DOI 10.1016/0028-3932(88)90114-5; Lucas J.A., 2006, CLIN NEUROPSYCHOLOGY, V2nd ed., P351; Marques P, 2000, TRAITE NEUROPSYCHOLO, VII, P17; Miller EL, 2010, STROKE, V41, P2402, DOI 10.1161/STR.0b013e3181e7512b; Ministere de la Sante et des sports, 2009, PREV PRIS CHARG ACC; Mock C, 2004, LIGNES DIRECTRICES S; Prigatano G., 1991, BNI Q, V7, P2; Rosenberg M., 1965, ACCEPTANCE COMMITMEN, V61, P52, DOI DOI 10.1037/T01038-000; Salthouse TA, 2010, J INT NEUROPSYCH SOC, V16, P754, DOI 10.1017/S1355617710000706; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Traumatic Brain Injury and concussions (TBI), 2005, INC DISTR; Truelsen T, 2006, EUR J NEUROL, V13, P581, DOI 10.1111/j.1468-1331.2006.01138.x; Zhang YN, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/436125	33	8	8	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1803	1810		10.1080/02699052.2018.1508748			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600025	30118616				2022-02-06	
J	Studlack, PE; Keledjian, K; Farooq, T; Akintola, T; Gerzanich, V; Simard, JM; Keller, A				Studlack, Paige E.; Keledjian, Kaspar; Farooq, Tayyiaba; Akintola, Titilola; Gerzanich, Volodymyr; Simard, J. Marc; Keller, Asaf			Blast-induced brain injury in rats leads to transient vestibulomotor deficits and persistent orofacial pain	BRAIN INJURY			English	Article						chronic pain; trauma; neurotrauma	POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH; POSTCONCUSSIVE SYMPTOMS; SPREADING DEPRESSION; FACIAL EXPRESSIONS; MILITARY PERSONNEL; FREEDOM VETERANS; GRIMACE SCALE; RODENT MODEL; US SOLDIERS	Blast-induced traumatic & brain injury (blast-TBI) is associated with vestibulomotor dysfunction, persistent post-traumatic headaches and post-traumatic stress disorder, requiring extensive treatments and reducing quality-of-life. Treatment and prevention of these devastating outcomes require an understanding of their underlying pathophysiology through studies that take advantage of animal models. Here, we report that cranium-directed blast-TBI in rats results in signs of pain that last at least 8 weeks after injury. These occur without significantly elevated behavioural markers of anxiety-like conditions and are not associated with glial up-regulation in sensory thalamic nuclei. These injuries also produce transient vestibulomotor abnormalities that resolve within 3 weeks of injury. Thus, blast-TBI in rats recapitulates aspects of the human condition.	[Studlack, Paige E.; Farooq, Tayyiaba; Akintola, Titilola; Keller, Asaf] Univ Maryland, Sch Med, Program Neurosci, 20 Penn St,HSFII S251, Baltimore, MD 21201 USA; [Studlack, Paige E.; Farooq, Tayyiaba; Akintola, Titilola; Keller, Asaf] Univ Maryland, Sch Med, Dept Anat & Neurobiol, 20 Penn St,HSFII S251, Baltimore, MD 21201 USA; [Keledjian, Kaspar; Gerzanich, Volodymyr; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA		Keller, A (corresponding author), Univ Maryland, Sch Med, Program Neurosci, 20 Penn St,HSFII S251, Baltimore, MD 21201 USA.; Keller, A (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, 20 Penn St,HSFII S251, Baltimore, MD 21201 USA.	akeller@som.umaryland.edu		Studlack, Paige/0000-0002-3626-1865	U.S. Department of Veterans AffairsUS Department of Veterans Affairs [5I01BX001629]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01NS099245]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01DE021735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS105633, R01NS099245, R01NS102589] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX001629] Funding Source: NIH RePORTER	This work was supported by the U.S. Department of Veterans Affairs [5I01BX001629] and National Institutes of Health [5R01NS099245].	Adams S, 2014, RESP PHYSIOL NEUROBI, V204, P112, DOI 10.1016/j.resp.2014.08.015; Akintola Titilola, 2017, Neurobiol Pain, V2, P13, DOI 10.1016/j.ynpai.2017.10.001; Alabwah Y, 2016, SOMATOSENS MOT RES, V33, P35, DOI 10.3109/08990220.2016.1163258; Awwad HO, 2018, BEHAV BRAIN RES, V340, P183, DOI 10.1016/j.bbr.2016.10.041; Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; BERMAN JM, 1978, J OTOLARYNGOL, V7, P237; Bigal ME, 2008, NEUROLOGY, V70, P1525, DOI 10.1212/01.wnl.0000310645.31020.b1; BOWEN IG, 1968, ANN NY ACAD SCI, V152, P122, DOI 10.1111/j.1749-6632.1968.tb11971.x; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Dalla Costa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092281; De Rantere D, 2016, EUR J PAIN, V20, P417, DOI 10.1002/ejp.742; DIXON WJ, 1965, J AM STAT ASSOC, V60, P967, DOI 10.2307/2283398; Edelmayer RM, 2012, METHODS MOL BIOL, V851, P109, DOI 10.1007/978-1-61779-561-9_7; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Harris HM, 2017, J NEUROSCI METH, V284, P63, DOI 10.1016/j.jneumeth.2017.04.010; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hubbard William Brad, 2014, Biomed Sci Instrum, V50, P92; Institute of Medicine, 2010, RET HOM IR AFGH PREL, DOI [10.17226/12812, DOI 10.17226/12812]; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004017; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Kim J, 2014, CLIN ORTHOP SURG, V6, P103, DOI 10.4055/cios.2014.6.1.103; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Leung A, 2016, MOL PAIN, V12, DOI 10.1177/1744806916662661; Levy D, 2016, CEPHALALGIA, V36, P915, DOI 10.1177/0333102415617412; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Likavcanova K, 2008, MAGN RESON MED, V59, P499, DOI 10.1002/mrm.21504; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Lipton RB, 2008, ANN NEUROL, V63, P148, DOI 10.1002/ana.21211; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Masri R, 2012, ADV EXP MED BIOL, V760, P74; Masri R, 2009, J NEUROPHYSIOL, V102, P181, DOI 10.1152/jn.00152.2009; Matsumiya LC, 2012, J AM ASSOC LAB ANIM, V51, P42; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; MELLOR SG, 1992, WORLD J SURG, V16, P893, DOI 10.1007/BF02066988; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Noseda R, 2013, PAIN, V154, pS44, DOI 10.1016/j.pain.2013.07.021; O'Neil ME, 2017, J CLIN EXP NEUROPSYC, V39, P449, DOI 10.1080/13803395.2016.1232699; Okimura Y, 1996, J NEUROTRAUM, V13, P385, DOI 10.1089/neu.1996.13.385; Okubo M, 2013, J NEUROSCI, V33, P5152, DOI 10.1523/JNEUROSCI.3390-12.2013; Oliver V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097882; Paxinos G., 2013, RAT BRAIN STEREOTAXI; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Petullo D, 1999, LIFE SCI, V64, P1099, DOI 10.1016/S0024-3205(99)00038-7; PRKACHIN KM, 1992, PAIN, V51, P297, DOI 10.1016/0304-3959(92)90213-U; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rasband W.S, 1997, IMAGEJ US; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Ren K, 1999, PHYSIOL BEHAV, V67, P711, DOI 10.1016/S0031-9384(99)00136-5; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; RosenbergEL P, 2005, WHAT FACE REVEALS BA; Ruff RL, 2012, J REHABIL RES DEV, V49, P1305, DOI 10.1682/JRRD.2011.12.0251; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Saab CY, 2014, CHRONIC PAIN BRAIN A, P95, DOI DOI 10.1016/B978-0-12-398389-3.00006-6; Saine L, 2016, J PAIN RES, V9, P1039, DOI 10.2147/JPR.S121415; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schneider LE, 2017, J NEUROTRAUM, V34, P2982, DOI 10.1089/neu.2016.4665; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Smith JE, 2011, PHILOS T R SOC B, V366, P291, DOI 10.1098/rstb.2010.0251; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; Stokum JA, 2017, BEHAV BRAIN RES, V333, P43, DOI 10.1016/j.bbr.2017.06.038; Stratton KJ, 2014, J REHABIL RES DEV, V51, P1189, DOI 10.1682/JRRD.2014.04.0111; Sufka KJ, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0624-y; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2008, HEADACHE, V48, P876, DOI 10.1111/j.1526-4610.2008.01159.x; THOMAS WE, 1992, BRAIN RES REV, V17, P61; Tietjen GE, 2009, HEADACHE, V49, P1333, DOI 10.1111/j.1526-4610.2009.01521.x; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Wang HX, 2016, J NEUROPATH EXP NEUR, V75, P183, DOI 10.1093/jnen/nlv019; Whittaker AL, 2016, LAB ANIM-UK, V50, P108, DOI 10.1177/0023677215595554; Wood GW, 2013, INJURY PREV, V19, P19, DOI 10.1136/injuryprev-2011-040277; Wu JF, 2013, NEUROTHERAPEUTICS, V10, P520, DOI 10.1007/s13311-013-0198-1; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zhuo JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136151; Zuckerman A, 2017, J NEUROTRAUM, V34, P145, DOI 10.1089/neu.2015.4310	108	8	8	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1866	1878		10.1080/02699052.2018.1536282			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600033	30346868	Green Accepted			2022-02-06	
J	Gibson, N; Chappell, A; Blackmore, AM; Morris, S; Williams, G; Bear, N; Allison, G				Gibson, Noula; Chappell, Annie; Blackmore, Amanda Marie; Morris, Susan; Williams, Gavin; Bear, Natasha; Allison, Garry			The effect of a running intervention on running ability and participation in children with cerebral palsy: a randomized controlled trial	DISABILITY AND REHABILITATION			English	Article						Rehabilitation; pediatric neurological injury; goal-directed training; goal attainment; high level mobility; motor skill	TRAUMATIC BRAIN-INJURY; PHYSICAL-ACTIVITY; ENVIRONMENT MEASURE; ADOLESCENTS; AGILITY; SKILLS; SPEED; YOUTH	Purpose: The purpose of this study is to evaluate effects of a running intervention on running ability and participation in children with cerebral palsy. Materials and method: Children with cerebral palsy (9-18 years) with Gross Motor Function Classification System levels I-III were randomly assigned to a 12-week running intervention or usual care. Primary outcomes included improvement in running ability (assessed by Goal Attainment Scaling, high level mobility (assessed by the High-Level Mobility Assessment Tool) and participation (assessed by the Participation and Environment Measure for Children and Youth). Secondary outcomes were aerobic and anaerobic fitness and agility. Blinded assessments took place at baseline and 12 weeks. Regression analysis adjusting for baseline differences was used to determine between group differences. Results: Forty-two participants (mean age 12.5 years, SD 2.8 years; 15 female) completed the study. Statistically significant group differences at 12-weeks were found for improvements in running ability (86% treatment group versus 0% control group achieved or exceeded their running goals, p < 0.001), and participation in the school environment (Participation and Environment Measure mean difference 1.18: 95%CI 1.00-1.39, p = 0.045). Conclusion: A 12-week individualized running training skills intervention results in achievement of running ability goals and participation in the school environment in children with cerebral palsy. Implications for Rehabilitation Children with cerebral palsy who can walk unaided demonstrate impairments in higher level mobility such as running. Running is a motor skill that can be trained in children with cerebral palsy. Individually tailored running skills intervention, delivered in a group context can improve goal-identified running ability and translate into a higher frequency of participation in school activities.	[Gibson, Noula; Bear, Natasha] Princess Margaret Hosp Children, Perth, WA, Australia; [Gibson, Noula; Chappell, Annie; Blackmore, Amanda Marie] Abil Ctr, Perth, WA, Australia; [Gibson, Noula; Chappell, Annie; Morris, Susan; Allison, Garry] Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia; [Williams, Gavin] Univ Melbourne, Sch Hlth Sci, Melbourne, Vic, Australia; [Bear, Natasha] Natasha Bear Stat, Perth, WA, Australia		Gibson, N (corresponding author), Princess Margaret Hosp, POB D184, Perth, WA 6840, Australia.	Noula.Gibson@health.wa.gov.au	Gibson, Noula/AAJ-6200-2021; Allison, Garry/F-6636-2011	Allison, Garry/0000-0002-2430-6376; Morris, Susan/0000-0002-5334-5809; Gibson, Noula/0000-0003-0183-9214; Blackmore, Marie/0000-0002-5824-9402	Princess Margaret Hospital Foundation; Non-Government Centre Support	The authors wish to acknowledge grant funding support from Non-Government Centre Support and the Princess Margaret Hospital Foundation.	Barnett LM, 2009, J ADOLESCENT HEALTH, V44, P252, DOI 10.1016/j.jadohealth.2008.07.004; Bartlett DJ, 2000, PHYS THER, V80, P598, DOI 10.1093/ptj/80.6.598; Carlon SL, 2013, DISABIL REHABIL, V35, P647, DOI 10.3109/09638288.2012.715721; Coster W, 2012, DISABIL REHABIL, V34, P238, DOI 10.3109/09638288.2011.603017; Coster W, 2011, DEV MED CHILD NEUROL, V53, P1030, DOI 10.1111/j.1469-8749.2011.04094.x; Cusick A, 2006, Pediatr Rehabil, V9, P149, DOI 10.1080/13638490500235581; Davids JR, 1998, DEV MED CHILD NEUROL, V40, P528; Hardy LL, 2013, MED SCI SPORT EXER, V45, P1965, DOI 10.1249/MSS.0b013e318295a9fc; Iosa M, 2013, NEUROPEDIATRICS, V44, P147, DOI 10.1055/s-0033-1336016; Johnson BA, 2014, PEDIATR PHYS THER, V26, P169, DOI 10.1097/PEP.0000000000000012; Kantomaa MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014554; Kenyon LK, 2010, PEDIATR PHYS THER, V22, P234, DOI 10.1097/PEP.0b013e3181dba5e5; Kiresuk TJ, 2014, GOAL ATTAINMENT SCAL; Kissane AL, 2015, BRAIN INJURY, V29, P1711, DOI 10.3109/02699052.2015.1075174; Moreau NG, 2016, PHYS THER REHABIL J, V96, P1938, DOI 10.2522/ptj.20150401; Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246; Ostensjo S, 2004, DEV MED CHILD NEUROL, V46, P580; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Schache AG, 2014, J ORTHOP SPORT PHYS, V44, P813, DOI 10.2519/jospt.2014.5433; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Steenbeek D, 2011, CLIN REHABIL, V25, P1128, DOI 10.1177/0269215511407220; Verschuren O, 2006, J PHYSIOTHER, V56, P136; Verschuren O, 2008, AM J PHYS MED REHAB, V87, P404, DOI 10.1097/PHM.0b013e31815b2675; Verschuren Olaf, 2007, Pediatr Phys Ther, V19, P108, DOI 10.1097/pep.0b013e318036bfce; Verschuren O, 2007, ARCH PEDIAT ADOL MED, V161, P1075, DOI 10.1001/archpedi.161.11.1075; Verschuren O, 2006, PHYS THER, V86, P1107, DOI 10.1093/ptj/86.8.1107; Verschuren O, 2012, J PEDIATR-US, V161, P488, DOI 10.1016/j.jpeds.2012.02.042; Verschuren O, 2010, DEV MED CHILD NEUROL, V52, pe222, DOI 10.1111/j.1469-8749.2010.03747.x; Williams G, 2010, BRAIN INJURY, V24, P1027, DOI 10.3109/02699052.2010.490517; Williams GP, 2010, J HEAD TRAUMA REHAB, V25, P164, DOI 10.1097/HTR.0b013e3181dc120b; Williams GP, 2009, BRAIN INJURY, V23, P307, DOI 10.1080/02699050902774170; World Health Organization, 2007, INT CLASS FUNCT DIS; Wrisberg, 2008, MOTOR LEARNING PERFO	33	8	9	1	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	DEC 4	2018	40	25					3041	3049		10.1080/09638288.2017.1367426			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	HB0EN	WOS:000450685100008	28826274				2022-02-06	
J	Hachem, LD; Mansouri, A; Scales, DC; Geerts, W; Pirouzmand, F				Hachem, Laureen D.; Mansouri, Alireza; Scales, Damon C.; Geerts, William; Pirouzmand, Farhad			Anticoagulant prophylaxis against venous thromboembolism following severe traumatic brain injury: A prospective observational study and systematic review of the literature	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Venous thromboembolism; Prophylaxis; Anticoagulation; Traumatic brain injury; Outcomes; Intracranial hemorrhage	MOLECULAR-WEIGHT HEPARIN; PHARMACOLOGICAL THROMBOPROPHYLAXIS; ENOXAPARIN PROPHYLAXIS; PULMONARY-EMBOLISM; SAFETY; THROMBOSIS; EFFICACY; LIFE	Objectives: Venous thromboembolism (VTE) is a serious complication following severe traumatic brain injury (TBI), however, anticoagulant prophylaxis remains controversial due to concerns of intracranial hemorrhage (ICH) progression. We examined anticoagulant prophylaxis practice patterns at a major trauma centre and determined risk estimates for VTE and ICH progression classified by timing of anticoagulant initiation. Patients and methods: A 1-year prospective analysis of consecutive patients with severe TBI admitted to a Level-I trauma centre was conducted. In addition, we systematically reviewed the literature to identify studies on VTE and anticoagulant prophylaxis after severe TBI. Results: 64 severe TBI patients were included. 83% of patients received anticoagulant prophylaxis, initiated >= 3d post-TBI in 67%. The in-hospital VTE incidence was 16% and there was no significant difference between patients who received early (< 3d) versus late (>= 3d) prophylaxis (10% vs. 16%). Rates of ICH progression (0% vs. 7%) were similar between groups. Our systematic review identified 5 studies with VTE rates ranging from 5 to 10% with prophylaxis, to 11-30% without prophylaxis. The effect of timing of anticoagulant prophylaxis initiation on ICH progression was not reported in any study. Conclusion: VTE is a common complication after severe TBI. Anticoagulant prophylaxis is often started late (>= 3d) post-injury. Randomized trials are justifiable and necessary to provide practice guidance with regards to optimal timing of anticoagulant prophylaxis.	[Hachem, Laureen D.; Mansouri, Alireza; Pirouzmand, Farhad] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Scales, Damon C.] Univ Toronto, Interdept Div Crit Care Med, Dept Crit Care Med, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Geerts, William] Univ Toronto, Dept Med, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Pirouzmand, Farhad] Sunnybrook Hlth Sci Ctr, Div Neurosurg, Toronto, ON, Canada		Pirouzmand, F (corresponding author), Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	Farhad.Pirouzmand@sunnybrook.ca		Mansouri, Alireza/0000-0002-7442-7539			Abdel-Aziz H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0814-z; Byrne JP, 2017, J TRAUMA ACUTE CARE, V82, P252, DOI 10.1097/TA.0000000000001321; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Calder KK, 2005, ANN EMERG MED, V45, P302, DOI 10.1016/j.annemergmed.2004.10.001; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cupitt JM, 2001, ANAESTHESIA, V56, P780; Dengler BA, 2016, NEUROCRIT CARE, V25, P215, DOI 10.1007/s12028-016-0280-8; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; GERSIN K, 1994, J TRAUMA, V37, P205, DOI 10.1097/00005373-199408000-00009; Haut ER, 2012, ARCH SURG-CHICAGO, V147, P901, DOI 10.1001/archsurg.2012.2024; Jamjoom AAB, 2013, J NEUROTRAUM, V30, P503, DOI 10.1089/neu.2012.2584; Kahn SR, 2008, J THROMB HAEMOST, V6, P1105, DOI 10.1111/j.1538-7836.2008.03002.x; Kahn SR, 2005, THROMB HAEMOSTASIS, V93, P499, DOI 10.1160/TH04-10-0640; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Margolick J, 2018, CAN J NEUROL SCI, V45, P432, DOI 10.1017/cjn.2017.275; Galan LAM, 2016, J TRAUMA ACUTE CARE, V81, P567, DOI 10.1097/TA.0000000000001134; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Praeger AJ, 2012, CRIT CARE RESUSC, V14, P10; Scales DC, 2010, CRIT CARE, V14, DOI 10.1186/cc8980; Scales DC, 2009, J CRIT CARE, V24, P176, DOI 10.1016/j.jcrc.2009.03.010; Van Gent JM, 2014, J TRAUMA ACUTE CARE, V77, P238, DOI 10.1097/TA.0000000000000294	29	8	8	2	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2018	175						68	73		10.1016/j.clineuro.2018.09.032			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HE7TB	WOS:000453641800012	30384119				2022-02-06	
J	Kroshus, E; Utter, AC; Pierpoint, LA; Currie, DW; Knowles, SB; Wasserman, EB; Dompier, TP; Marshall, SW; Comstock, RD; Kerr, ZY				Kroshus, Emily; Utter, Alan C.; Pierpoint, Lauren A.; Currie, Dustin W.; Knowles, Sarah B.; Wasserman, Erin B.; Dompier, Thomas P.; Marshall, Stephen W.; Comstock, R. Dawn; Kerr, Zachary Y.			The First Decade of Web-Based Sports Injury Surveillance: Descriptive Epidemiology of Injuries in US High School Boys' Wrestling (2005-2006 Through 2013-2014) and National Collegiate Athletic Association Men's Wrestling (2004-2005 Through 2013-2014)	JOURNAL OF ATHLETIC TRAINING			English	Article						concussions; musculoskeletal injuries; skin infections; injury prevention	CONCUSSION; SYSTEM	Context: The advent of Web-based sports injury surveillance via programs such as the High School Reporting Information Online system and the National Collegiate Athletic Association Injury Surveillance Program has aided the acquisition of wrestling injury data. Objective: To describe the epidemiology of injuries sustained in high school boys' wrestling in the 2005-2006 through 2013-2014 academic years and collegiate men's wrestling in the 2004-2005 through 2013-2014 academic years using Web-based sports injury surveillance. Design: Descriptive epidemiology study. Setting: Online injury surveillance from wrestling teams of high school boys (annual average = 100) and collegiate men (annual average = 11). Patients or Other Participants: Male wrestlers who participated in practices and competitions during the 2005-2006 through 2013-2014 academic years in high school or the 2004-2005 through 2013-2014 academic years in college. Main Outcome Measure(s): Athletic trainers collected time-loss (>= 24 hours) injuries and exposure data during this time period. Injury rates per 1000 athlete-exposures (AEs), injury rate ratios with 95% confidence intervals, and injury proportions by body site and diagnosis were calculated. Results: The High School Reporting Information Online documented 3376 time-loss injuries during 1 416 314 AEs; the National Collegiate Athletic Association Injury Surveillance Program documented 2387 time-loss injuries during 257 297 AEs. The total injury rate was higher in college than in high school (9.28 versus 2.38/1000 AEs; injury rate ratio= 3.89; 95% confidence interval = 3.69, 4.10). In high school, the most commonly injured body parts for both practices and competitions were the head/face (practices = 19.9%, competitions = 21.4%) and shoulder/clavicle (practices = 14.1%, competitions = 21.0%). In college, the most frequently injured body parts for both practices and competitions were the knee (practices = 16.7%, competitions = 30.4%) and head/face (practices = 12.1%, competitions = 14.6%). Conclusions: Injury rates were higher in collegiate than in high school players, and the types of injuries sustained most often differed. Based on these results, continued study of primary and secondary prevention of injury in wrestlers across levels of competition is warranted.	[Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Seattle, WA USA; [Kroshus, Emily] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Utter, Alan C.] Texas Womans Univ, Acad Affairs, Denton, TX 76204 USA; [Pierpoint, Lauren A.; Currie, Dustin W.; Comstock, R. Dawn] Univ Colorado Anschutz, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Knowles, Sarah B.] Palo Alto Med Fdn, Res Inst, Palo Alto, CA 94301 USA; [Wasserman, Erin B.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Annville, PA USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Marshall, Stephen W.; Kerr, Zachary Y.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Injury Prevent Res Ctr, 313 Woollen Gym CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu		Wasserman, Erin/0000-0001-5957-5878	NCAA; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Center for Research Resources awardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025754]; National Federation of State High School Associations (Indianapolis, IN); National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); DonJoy Orthotics (Vista, CA); EyeBlack (Potomac, MD)	The NCAA-ISP data were provided by the Datalys Center for Sports Injury Research and Prevention, Inc. The ISP was funded by the NCAA. Funding for HS RIO was provided in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01 and the National Center for Research Resources award KL2 RR025754. The authors also acknowledge the research funding contributions of the National Federation of State High School Associations (Indianapolis, IN), National Operating Committee on Standards for Athletic Equipment (Overland Park, KS), DonJoy Orthotics (Vista, CA), and EyeBlack (Potomac, MD). The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. We thank the many ATs who have volunteered their time and efforts to submit data to HS RIO and the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of high school and collegiate student-athletes.	Agel J, 2007, J ATHL TRAINING, V42, P303; [Anonymous], STUD ATHL PART; [Anonymous], 2013 14 HIGH SCH ATH; [Anonymous], 2014 15 NCAA SPORTS; [Anonymous], CONC DIAGN MAN BEST; [Anonymous], WRESTL 2013 14 2014; [Anonymous], PROP DIV 2 3 LEG IND; [Anonymous], PAN APPR WRESTL CONC; CARROLL ST, 1988, J SPORT HIST, V15, P121; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Emery CA, 2003, CLIN J SPORT MED, V13, P256, DOI 10.1097/00042752-200307000-00011; Guttmann A., 2002, OLYMPICS HIST MODERN; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2017, J ATHL TRAINING, V52, P1041, DOI 10.4085/1062-6050-52.11.17; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Kroshus E, 2017, HEALTH COMMUN, V32, P963, DOI 10.1080/10410236.2016.1196417; Kucera KL, 2011, J ATHL TRAINING, V46, P489; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Powell JW, 1999, J ATHL TRAINING, V34, P277; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Sports Medicine Advisory Committee, SPORTS REL SKIN INF; Sports Medicine Advisory Committee, GEN GUID SPORTS HYG; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507	30	8	8	0	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	DEC	2018	53	12					1143	1155		10.4085/1062-6050-154-17			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HK4AE	WOS:000457860600003	30721631	gold, Green Published			2022-02-06	
J	Mirzaie, M; Karimi, M; Fallah, H; Khaksari, M; Nazari-Robati, M				Mirzaie, Masoumeh; Karimi, Mehrnaz; Fallah, Hossein; Khaksari, Mohammad; Nazari-Robati, Mahdieh			Downregulation of Matrix Metalloproteinases 2 and 9 is Involved in the Protective Effect of Trehalose on Spinal Cord Injury	INTERNATIONAL JOURNAL OF MOLECULAR AND CELLULAR MEDICINE			English	Article						Spinal cord injury; trehalose; matrix metalloproteinases	TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; BARRIER DISRUPTION; INFLAMMATORY RESPONSE; FUNCTIONAL RECOVERY; CEREBRAL-ISCHEMIA; ENDOTHELIAL-CELLS; NEUROPATHIC PAIN; AP-1 ACTIVATION; RATS	Upregulation of matrix metalloproteinases (MMPs), in particular MMP-2 and MMP-9 contributes to secondary pathogenesis of spinal cord injury (SCI) via promoting inflammation. Recently, we have reported that trehalose suppresses inflammatory responses following SCI. Therefore, we investigated the effect of trehalose on MMP-2 and MMP-9 expression in SCI. A weight-drop contusion SCI was induced in male rats. Then, the animals received trehalose at three doses of 10 (T10), 100 (T100) and 1000 (T1000) mM intrathecally. MMP-2 and MMP-9 transcripts were then measured in damaged spinal cord at 1, 3 and 7 days after trauma, and compared with vehicle and sham groups. Additionally, behavioral analysis was conducted for 1 week using Basso-Beattie-Bresnahan (BBB) locomotor rating scale. Our data showed an early upregulation of MMP-9 at 1 day post-SCI. However, MMP-2 expression was increased at 3 days after trauma. Treatment with 10 mM trehalose significantly reduced MMP-2 expression in 3 and 7 days (P<0.01) and MMP-9 expression in 1, 3, and 7 days (P<0.05) post-damage compared with vehicle. Nonetheless, downregulation of both MMPs was not observed in T100 and T1000 groups. In addition, T10 group showed more rapid recovery of hind limb strength compared with T100 and T1000 groups. We propose that the neuroprotective effect of low dose trehalose is mediated by attenuation of MMP-2 and MMP-9 expression.	[Mirzaie, Masoumeh; Karimi, Mehrnaz; Fallah, Hossein; Nazari-Robati, Mahdieh] Kerman Univ Med Sci, Dept Clin Biochem, Afzalipour Sch Med, Kerman, Iran; [Mirzaie, Masoumeh; Nazari-Robati, Mahdieh] Kerman Univ Med Sci, Neurosci Res Ctr, Inst Neuropharmacol, Kerman, Iran; [Khaksari, Mohammad] Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran		Nazari-Robati, M (corresponding author), Kerman Univ Med Sci, Neurosci Res Ctr, Inst Neuropharmacol, Dept Clin Biochem,Afzalipour Sch Med, Kerman, Iran.	mnazari@kmu.ac.ir	Haddad, Mohammad Khaksari/AAB-9025-2019; Nazari-robati, Mahdieh/ABD-6666-2020; Fallah, Hossein/AAA-5135-2019	Haddad, Mohammad Khaksari/0000-0003-0770-4281; Fallah, Hossein/0000-0001-6196-0775	Kerman Neuroscience Research Center [96-3]	This study was financially supported by a grant (No. 96-3) from Kerman Neuroscience Research Center.	Ahmed MM, 2011, ANN NEUROSCI, V18, P162, DOI 10.5214/ans.0972.7531.1118413; Akbari M, 2017, IRAN J BASIC MED SCI, V20, P806, DOI 10.22038/IJBMS.2017.9016; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Choi EM, 2010, FOOD CHEM TOXICOL, V48, P2607, DOI 10.1016/j.fct.2010.06.029; Crowe JH, 2001, CRYOBIOLOGY, V43, P89, DOI 10.1006/cryo.2001.2353; Dang ABC, 2008, SPINE, V33, pE576, DOI 10.1097/BRS.0b013e31817ecc87; Echigo R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-80; Espinosa-Cueto P, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0102-3; Esposito E, 2008, J PINEAL RES, V45, P149, DOI 10.1111/j.1600-079X.2008.00569.x; Fang B, 2015, CELL PHYSIOL BIOCHEM, V36, P373, DOI 10.1159/000430107; Fujimoto M, 2008, J CEREBR BLOOD F MET, V28, P1674, DOI 10.1038/jcbfm.2008.59; Goussev S, 2003, J NEUROSURG, V99, P188, DOI 10.3171/spi.2003.99.2.0188; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; He Q, 2014, NEUROTOX RES, V26, P430, DOI 10.1007/s12640-014-9487-7; Higashiyama T, 2002, PURE APPL CHEM, V74, P1263, DOI 10.1351/pac200274071263; Hong J, 2015, NEUROSCI LETT, V597, P19, DOI 10.1016/j.neulet.2015.04.016; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Jang JW, 2011, J KOREAN NEUROSURG S, V50, P288, DOI 10.3340/jkns.2011.50.4.288; Lee JY, 2015, ENDOCRINOLOGY, V156, P1838, DOI 10.1210/en.2014-1832; Lee JY, 2012, BRAIN, V135, P2375, DOI 10.1093/brain/aws171; Lee JY, 2012, J NEUROCHEM, V121, P818, DOI 10.1111/j.1471-4159.2012.07731.x; Lee Jee Youn, 2010, Exp Neurobiol, V19, P146, DOI 10.5607/en.2010.19.3.146; Mao L, 2010, ANN CLIN LAB SCI, V40, P354; Minutoli L, 2008, EUR J PHARMACOL, V589, P272, DOI 10.1016/j.ejphar.2008.04.005; Minutoli L, 2007, SHOCK, V27, P91, DOI 10.1097/01.shk.0000235092.76292.bc; Mountain DJH, 2007, AM J PHYSIOL-CELL PH, V292, pC867, DOI 10.1152/ajpcell.00161.2006; Noble LJ, 2002, J NEUROSCI, V22, P7526; Portbury SD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183683; Qin WW, 2012, J ENDOCRINOL, V214, P145, DOI 10.1530/JOE-12-0147; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Schomberg D, 2012, ANN NEUROSCI, V19, P125, DOI 10.5214/ans.0972.7531.190309; Wells JEA, 2003, J NEUROSCI, V23, P10107, DOI 10.1523/jneurosci.23-31-10107.2003; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang DP, 2016, CELL PHYSIOL BIOCHEM, V39, P1152, DOI 10.1159/000447822; Zhang HQ, 2011, NEUROTHERAPEUTICS, V8, P206, DOI 10.1007/s13311-011-0038-0	38	8	10	1	42	CELLULAR & MOLECULAR BIOLOGY RESEARCH CENTER	BABOL	BABOL UNIV MEDICAL SCIENCES, GANJAFROUZ AVE, BABOL, 4717647745, IRAN	2251-9637	2251-9645		INT J MOL CELL MED	Int. J. Mol. Cell. Med.	WIN	2018	7	1					8	16		10.22088/IJMCM.BUMS.7.1.8			9	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	GM8BN	WOS:000438431100002	30234068				2022-02-06	
J	Sahbaie, P; Tajerian, M; Yang, P; Irvine, KA; Huang, TT; Luo, J; Wyss-Coray, T; Clark, JD				Sahbaie, Peyman; Tajerian, Maral; Yang, Phillip; Irvine, Karen Amanda; Huang, Ting-Ting; Luo, Jian; Wyss-Coray, Tony; Clark, J. David			Nociceptive and Cognitive Changes in a Murine Model of Polytrauma	JOURNAL OF PAIN			English	Article						Traumatic brain injury; fracture; pain; memory; descending inhibition	TRAUMATIC BRAIN-INJURY; CHRONIC PAIN; RAT MODEL; SEX-DIFFERENCES; NERVE INJURY; MOUSE MODEL; MODULATION; FRACTURE; HYPERSENSITIVITY; PREVALENCE	Polytrauma commonly involves concussion (mild traumatic brain injury [mTBI]) and peripheral trauma including limb fractures. Interactions between mTBI and peripheral injuries are poorly understood, both leading to chronic pain and neurobehavioral impairments. To elucidate these interactions, a murine polytrauma model was developed. mTBI alone resulted in similar increased mechanical allodynia in male and female mice. Female fracture and polytrauma groups displayed greater increases in hind paw tactile hypersensitivity for weeks after injury than did the respective male groups. Capsaicin-evoked spontaneous pain behaviors were greater in fracture and polytrauma female mice compared with male mice. The mTBI and polytrauma male mice displayed significant deficits in spatial working memory. All fracture, mTBI, or polytrauma groups had deficits in object recognition memory. Only male mTBI or polytrauma mice showed greater agitation and increased risk-taking behavior in open field testing as well as zero maze tests. Additionally, impaired diffuse noxious inhibitory control was observed in all mTBI and polytrauma mice. The model presented offers clinically relevant features useful for studying persistent pain as well as cognitive and other behavioral changes after TBI including polytrauma. A better understanding of nervous system dysfunction after TBI and polytrauma might help prevent or reduce persistent pain and disability in these patients. Perspective: The polytrauma model presented has relevant features of chronic pain and neurobehavioral impairments useful for studying mechanisms involved in their development. This model may have special value in understanding altered descending pain modulation after TB! and polytrauma. (C) 2018 by the American Pain Society	[Sahbaie, Peyman; Tajerian, Maral; Irvine, Karen Amanda; Clark, J. David] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA; [Sahbaie, Peyman; Tajerian, Maral; Irvine, Karen Amanda; Clark, J. David] Vet Affairs Palo Alto Hlth Care Syst, Anesthesiol Serv, Palo Alto, CA USA; [Yang, Phillip; Huang, Ting-Ting; Luo, Jian; Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Yang, Phillip; Huang, Ting-Ting] Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA USA; [Luo, Jian; Wyss-Coray, Tony] Vet Affairs Palo Alto Hlth Care Syst, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA USA		Sahbaie, P (corresponding author), VA Palo Alto HCS, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	psahbaie@stanford.edu	Wyss-Coray, Tony/AAF-3380-2019; Luo, Jian/B-8449-2014	Wyss-Coray, Tony/0000-0001-5893-0831; Yang, Phillip/0000-0001-8883-0276; Luo, Jian/0000-0002-2064-8467	VA Merit Review awardUS Department of Veterans Affairs [1I01RX001776]; Department of DefenseUnited States Department of Defense [MR130295]; Veterans AffairsUS Department of Veterans Affairs [I01RX001776] Funding Source: NIH RePORTER	Supported by the VA Merit Review award 1I01RX001776 and Department of Defense award MR130295 to J.D.C.	Albrecht JS, 2016, J TRAUMA ACUTE CARE, V81, P486, DOI 10.1097/TA.0000000000001118; Brickell TA, 2016, J NEUROTRAUMA; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chan V, 2016, ARCH PHYS MED REHAB, V97, P772, DOI 10.1016/j.apmr.2016.01.011; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Farace E, 2000, Neurosurg Focus, V8, pe6; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Guo TZ, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-85; Guo TZ, 2004, PAIN, V108, P95, DOI 10.1016/j.pain.2003.12.010; Guskiewicz Kevin M, 2015, Handb Clin Neurol, V127, P157, DOI 10.1016/B978-0-444-52892-6.00010-6; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Irvine KA, 2018, J NEUROTRAUM, V35, P1495, DOI 10.1089/neu.2017.5411; JANG SH, 2016, MEDICINE BALTIMORE, V95; Kimura M, 2015, ANESTHESIOLOGY, V123, P899, DOI 10.1097/ALN.0000000000000796; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; Maegele M, 2007, INFLAMM RES, V56, P318, DOI 10.1007/s00011-007-6141-3; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Mustafa G, 2016, NEUROPHARMACOLOGY, V107, P27, DOI 10.1016/j.neuropharm.2016.03.016; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453; Peters CM, 2015, ANESTHESIOLOGY, V122, P895, DOI 10.1097/ALN.0000000000000593; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Poree LR, 1998, ANESTH ANALG, V87, P941, DOI 10.1097/00000539-199810000-00037; Rashiq S, 2014, CAN J ANESTH, V61, P123, DOI 10.1007/s12630-013-0072-y; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; Sahbaie, 2016, J NEUROINFLAMM, V13, P90; Sahbaie P, 2014, ANESTH ANALG, V118, P1336, DOI 10.1213/ANE.0000000000000189; Shepherd AJ, 2018, NEUROPHARMACOLOGY, V130, P18, DOI 10.1016/j.neuropharm.2017.11.036; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Sorge R. E., 2016, J NEUROSCI RES; Staud R, 2012, EXPERT REV NEUROTHER, V12, P577, DOI [10.1586/ERN.12.41, 10.1586/ern.12.41]; Sun Y, 2013, ANESTHESIOLOGY, V119, P1198, DOI 10.1097/ALN.0b013e31829ce340; Tajerian M, 2015, NEUROBIOL LEARN MEM, V123, P100, DOI 10.1016/j.nlm.2015.06.004; Tajerian M, 2014, ANESTHESIOLOGY, V121, P852, DOI 10.1097/ALN.0000000000000403; Wang L, 2011, CHIN J TRAUMATOL, V14, P7, DOI 10.3760/cma.j.issn.1008-1275.2011.01.002; Yang F, 2014, NEUROSCI BULL, V30, P887, DOI 10.1007/s12264-014-1477-5; Yarnitsky D, 2010, CURR OPIN ANESTHESIO, V23, P611, DOI 10.1097/ACO.0b013e32833c348b; Zhang XD, 2016, ADV MATER, V28, P6872, DOI 10.1002/adma.201600706; Zou Y, EXTRACELLULAR SUPERO, P21522	51	8	8	0	6	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1526-5900			J PAIN	J. Pain	DEC	2018	19	12					1392	1405		10.1016/j.jpain.2018.06.004			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HG0XH	WOS:000454672100003	29964216				2022-02-06	
J	Sanz-Garcia, A; Perez-Romero, M; Pastor, J; Sola, RG; Vega-Zelaya, L; Monasterio, F; Torrecilla, C; Vega, G; Pulido, P; Ortega, GJ				Sanz-Garcia, Ancor; Perez-Romero, Miriam; Pastor, Jesus; Sola, Rafael G.; Vega-Zelaya, Lorena; Monasterio, Fernando; Torrecilla, Carmen; Vega, Gema; Pulido, Paloma; Ortega, Guillermo J.			Identifying causal relationships between EEG activity and intracranial pressure changes in neurocritical care patients	JOURNAL OF NEURAL ENGINEERING			English	Article						intracranial pressure; electroencephalography; Granger causality; traumatic brain injury; subarachnoid hemorrhage	BURST-SUPPRESSED PATIENTS; INTRA-CRANICAL PRESSURE; SEVERE HEAD-INJURY; MIDAZOLAM; TRAUMA; HYPERTENSION; ANESTHESIA; MANAGEMENT; INDUCTION; FENTANYL	Objective. To explore and assess the relationship between electroencephalography (EEG) activity and intracranial pressure (ICP) in patients suffering from traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH) during their stay in an intensive care unit. Approach. We performed an observational prospective cohort study of adult patients suffering from TBI or SAH. Continuous EEG-ECG was performed during ICP monitoring. In every patient, variables derived from the EEG were calculated and the Granger causality (GC) methodology was employed to assess whether, and in which direction, there is any relationship between EEG and ICP. Main results. One-thousand fifty-five hours of continuous multimodal monitoring were analyzed in 21 patients using the GC test. During 37.88% of the analyzed time, significant GC statistic was found in the direction from the EEG activity to the ICP, with typical lags of 25-50 s between them. When recordings were adjusted by sedation-perfusion and/or bolus-and handling, these percentages hardly changed. Significance. Long-lasting, continuous and simultaneous EEG and ICP recordings from TBI and SAH patients provide highly rich and useful information, which has allowed for uncovering a strong relationship between both signals. The use of this relationship could lead to developing a medical device to measure ICP in a non-invasive way.	[Pastor, Jesus; Vega-Zelaya, Lorena] Hosp Univ la Princesa, Clin Neurophysiol, Madrid, Spain; [Sola, Rafael G.; Pulido, Paloma; Ortega, Guillermo J.] Hosp Univ la Princesa, Neurosurg, Madrid, Spain; [Monasterio, Fernando; Torrecilla, Carmen; Vega, Gema] Hosp Univ la Princesa, Intens Care Unit, Madrid, Spain; [Sanz-Garcia, Ancor; Perez-Romero, Miriam; Pastor, Jesus; Sola, Rafael G.; Monasterio, Fernando; Torrecilla, Carmen; Vega, Gema; Pulido, Paloma; Ortega, Guillermo J.] HHosp Univ la Princesa, Inst Invest Sanitaria, Madrid, Spain; [Ortega, Guillermo J.] Consejo Nacl Invest Cient & Tecn, Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [Sanz-Garcia, Ancor] Hosp Univ La Princesa, Hosp la Princesa, Fdn Invest Biomed, C Diego de Leon 62, Madrid 28006, Spain		Sanz-Garcia, A (corresponding author), HHosp Univ la Princesa, Inst Invest Sanitaria, Madrid, Spain.; Sanz-Garcia, A (corresponding author), Hosp Univ La Princesa, Hosp la Princesa, Fdn Invest Biomed, C Diego de Leon 62, Madrid 28006, Spain.	ancor.sanz@gmail.com	Pastor, Jesus/AAH-9238-2020; Sanz-Garcia, Ancor/AAL-8043-2021; Vega-Zelaya, Lorena/AAV-5670-2021	Pastor, Jesus/0000-0001-6870-8409; Sanz-Garcia, Ancor/0000-0002-5024-5108; G. Sola, Rafael/0000-0002-0063-9301; Pulido Rivas, Paloma/0000-0002-5933-9274	Instituto de Salud Carlos III - Fondo Europeo de Desarrollo regional (F.E.D.E.R) [PI10/00160, PI12/02839]; Mutua Madrilena; Comunidad de MadridComunidad de Madrid	This work was funded by grants from Instituto de Salud Carlos III (PI10/00160 and PI12/02839), partially supported by Fondo Europeo de Desarrollo regional (F.E.D.E.R) and from Mutua Madrilena. AS-G is the recipient of a postdoctoral fellowship from Mutua Madrilena. MP-R is the recipient of an Ayudante de investigation fellowship from Comunidad de Madrid.	ALBRECHT RF, 1977, ANESTHESIOLOGY, V47, P252, DOI 10.1097/00000542-197709000-00004; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; BROWN CR, 1979, ANESTHESIOLOGY, V50, P467, DOI 10.1097/00000542-197905000-00017; Celi LA, 2013, AM J RESP CRIT CARE, V187, P1157, DOI 10.1164/rccm.201212-2311ED; Chen H, 2012, CAN J NEUROL SCI, V39, P483, DOI 10.1017/S0317167100013998; Colton K, 2014, J TRAUMA ACUTE CARE, V77, P47, DOI 10.1097/TA.0000000000000270; Connolly M, 2016, ACTA NEUROCHIR SUPPL, V122, P225, DOI 10.1007/978-3-319-22533-3_45; Connolly M, 2015, NEUROCRIT CARE, V22, P212, DOI 10.1007/s12028-014-0059-8; Franceschini MA, 2010, NEUROIMAGE, V51, P1367, DOI 10.1016/j.neuroimage.2010.03.060; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Huang ZC, 2002, CLIN NEUROPHYSIOL, V113, P446, DOI 10.1016/S1388-2457(02)00012-3; Kirkman M A, 2013, BRIT J ANAESTH, V112, P36; KISHORE PRS, 1981, AM J ROENTGENOL, V137, P829, DOI 10.2214/ajr.137.4.829; Kuizenga K, 2001, BRIT J ANAESTH, V86, P354, DOI 10.1093/bja/86.3.354; Lescot T, 2005, ACTA NEUROCHIR, V147, P125, DOI 10.1007/s00701-004-0355-8; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MUNARI C, 1981, ELECTROEN CLIN NEURO, V51, P170, DOI 10.1016/0013-4694(81)90006-7; PAPAZIAN L, 1993, BRIT J ANAESTH, V71, P267, DOI 10.1093/bja/71.2.267; Purdon PL, 2015, ANESTHESIOLOGY, V123, P937, DOI 10.1097/ALN.0000000000000841; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Sanz-Garcia A, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19020081; SEBEL PS, 1981, ANESTHESIOLOGY, V55, P203, DOI 10.1097/00000542-198109000-00004; SPERRY RJ, 1992, ANESTHESIOLOGY, V77, P416, DOI 10.1097/00000542-199209000-00002; TODA HY, 1995, J ECONOMETRICS, V66, P225, DOI 10.1016/0304-4076(94)01616-8; Wolfla CE, 1996, J NEUROSURG, V84, P642, DOI 10.3171/jns.1996.84.4.0642; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9	30	8	8	2	18	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1741-2560	1741-2552		J NEURAL ENG	J. Neural Eng.	DEC	2018	15	6							066029	10.1088/1741-2552/aadeea			10	Engineering, Biomedical; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	GY0CX	WOS:000448180000003	30181428				2022-02-06	
J	van Gijn, DR; D'Souza, J; King, W; Bater, M				van Gijn, Daniel Richard; D'Souza, Jacob; King, Wendy; Bater, Michael			Free Flap Head and Neck Reconstruction with an Emphasis on Postoperative Care	FACIAL PLASTIC SURGERY			English	Article						microvascular; free tissue transfer; perioperative care; surgical optimization; head and neck	FREE-TISSUE TRANSFER; MICROVASCULAR BREAST RECONSTRUCTION; SURGERY; EXPERIENCE; COMPLICATIONS; DOPPLER; SALVAGE; REEXPLORATION; DOBUTAMINE; MANAGEMENT	Microsurgical free tissue transfer represents the mainstay of care in both ablative locoregional management and the simultaneous reconstruction of a defect. Advances in microsurgical techniques have helped balance the restoration of both form and functiondecreasing the significant morbidity once associated with large ablative, traumatic, or congenital defectswhile providing immediate reconstruction enabling early aesthetic and functional rehabilitation. There are a multitude of perioperative measures and considerations that aim to maximize the success of free tissue transfer. These include nutritional support, tight glycemic control, acknowledgment of psychological and psychiatric factors, intraoperative surgical technique, and close postoperative monitoring of the patients' hemodynamic physiology. While the success rates of free tissue transfer in experienced hands are comparable to alternative options, the consequences of flap failure are catastrophicwith the potential for significant patient morbidity, prolonged hospital stay (and associated increased financial implications), and increasingly limited options for further reconstruction. Success is entirely dependent on a continuous arterial inflow and venous outflow until neovascularization occurs. Flap failure is multifactorial and represents a dynamic process from the potentially reversible failing flap to the necrotic irreversibly failed flapnecessitating debridement, prolonged wound care, and ultimately decisions concerned with future reconstruction. The overriding goal of free flap monitoring is therefore the detection of microvascular complications prior to permanent injury occurringidentifying and intervening within that critical period between the failing flap and the failed flapmaximizing the potential for salvage. With continued technique refinement, microvascular free flap reconstruction offers patients the chance for both reliable functional and aesthetic restoration in the face of significant ablative defects. The caveat to this optimism is the requirement for considered perioperative care and the optimization of those factors that may offer the difference between success and failure.	[van Gijn, Daniel Richard; D'Souza, Jacob; King, Wendy; Bater, Michael] Royal Surrey Cty Hosp NHS Fdn Trust, Dept Oral & Maxillofacial Surg, Egerton Rd, Guildford GU2 7XX, Surrey, England		van Gijn, DR (corresponding author), Royal Surrey Cty Hosp NHS Fdn Trust, Dept Oral & Maxillofacial Surg, Egerton Rd, Guildford GU2 7XX, Surrey, England.	danielvangijn@doctors.net.uk					Al-Dam A, 2014, J CRANIO MAXILL SURG, V42, P1178, DOI 10.1016/j.jcms.2014.02.005; Archer J, 2008, J ORAL PATHOL MED, V37, P255, DOI 10.1111/j.1600-0714.2008.00635.x; Ashjian P, 2007, ANN PLAS SURG, V59, P36, DOI 10.1097/01.sap.0000264837.15110.2f; Bater M, 2017, BRIT J ORAL MAX SURG, V55, P1024, DOI 10.1016/j.bjoms.2017.10.012; Bui DT, 2007, PLAST RECONSTR SURG, V119, P2092, DOI 10.1097/01.prs.0000260598.24376.e1; Cameron M, 2009, INT J ORAL MAX SURG, V38, P846, DOI 10.1016/j.ijom.2009.03.713; Care NCCfA, 2006, NUTR SUPP AD OR NUTR; Chen CM, 2008, PLAST RECONSTR SURG, V121, p49E, DOI 10.1097/01.prs.0000299267.84139.2a; Chen KT, 2007, PLAST RECONSTR SURG, V120, P187, DOI 10.1097/01.prs.0000264077.07779.50; Cheng NC, 2008, HEAD NECK-J SCI SPEC, V30, P829, DOI 10.1002/hed.20784; Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Disa JJ, 1999, PLAST RECONSTR SURG, V104, P97, DOI 10.1097/00006534-199907000-00014; Eley KA, 2012, PLAST RECONSTR SURG, V130, P564, DOI 10.1097/PRS.0b013e31825dbf73; Findlay GP, 2011, KNOWING RISK REV PER; Geis S, 2013, ULTRASCHALL MED, V34, P550, DOI 10.1055/s-0033-1355758; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Hanasono MM, 2014, J PLAST RECONSTR AES, V67, P1186, DOI 10.1016/j.bjps.2014.05.012; Hanasono MM, 2009, MICROSURG, V29, P1, DOI 10.1002/micr.20560; HIDALGO DA, 1989, PLAST RECONSTR SURG, V84, P71, DOI 10.1097/00006534-198907000-00014; Howard MA, 2005, PLAST RECONSTR SURG, V116, P1659, DOI 10.1097/01.prs.0000187135.49423.9f; Kelly DA, 2014, ANN PLAS SURG, V72, pS135, DOI 10.1097/SAP.0000000000000076; Lutz BS, 2005, CLIN PLAST SURG, V32, P421, DOI 10.1016/j.cps.2005.02.006; Marsh M, 2009, BRIT J ORAL MAX SURG, V47, P182, DOI 10.1016/j.bjoms.2008.06.004; Mehrara BJ, 2006, PLAST RECONSTR SURG, V118, P1100, DOI 10.1097/01.prs.0000236898.87398.d6; Miller RB, 2007, PLAST RECONSTR SURG, V119, P38, DOI 10.1097/01.prs.0000244745.21562.58; Padubidri AN, 2001, PLAST RECONSTR SURG, V107, P342, DOI 10.1097/00006534-200102000-00007; Poldermans D, 2010, EUR J ANAESTH, V27, P92, DOI 10.1097/EJA.0b013e328334c017; Quinlan J, 2006, ANAEST INTENS CARE M, V7, P31, DOI 10.1383/anes.2006.7.1.31; Rodby KA, 2014, J PLAST RECONSTR AES, V67, P1171, DOI 10.1016/j.bjps.2014.04.038; Rozen WM, 2010, MICROSURG, V30, P105, DOI 10.1002/micr.20706; Schmulder A, 2011, MICROSURG, V31, P1, DOI 10.1002/micr.20816; Scholz A, 2009, ANAESTHESIA, V64, P1089, DOI 10.1111/j.1365-2044.2009.06055.x; Serletti JM, 2000, PLAST RECONSTR SURG, V106, P66, DOI 10.1097/00006534-200007000-00012; Stavrianos SD, 2003, BRIT J PLAST SURG, V56, P140, DOI 10.1016/S0007-1226(03)00024-9; Swanson EW, 2016, J RECONSTR MICROSURG, V32, P87, DOI 10.1055/s-0035-1563381; SWARTZ WM, 1994, PLAST RECONSTR SURG, V93, P152, DOI 10.1097/00006534-199401000-00024; Szakmany T, 2006, BRIT J CANCER, V94, P647, DOI 10.1038/sj.bjc.6603013; Takamatsu A, 1996, J RECONSTR MICROSURG, V12, P499, DOI 10.1055/s-2007-1006622; Tan NC, 2014, MICROSURG, V34, P602, DOI 10.1002/micr.22270; TAYLOR GI, 1975, PLAST RECONSTR SURG, V55, P533, DOI 10.1097/00006534-197505000-00002; Tew GA, 2018, ANAESTHESIA, V73, P750, DOI 10.1111/anae.14177; Udesen A, 2000, J RECONSTR MICROSURG, V16, P101, DOI 10.1055/s-2000-9434; Weinzweig N, 1999, ANN PLAS SURG, V42, P320, DOI 10.1097/00000637-199903000-00015; Whitaker IS, 2010, J RECONSTR MICROSURG, V26, P409, DOI 10.1055/s-0030-1249607; WHITNEY TM, 1992, PLAST RECONSTR SURG, V90, P105, DOI 10.1097/00006534-199207000-00016; Wong CH, 2010, HEAD NECK-J SCI SPEC, V32, P1236, DOI 10.1002/hed.21284; Yang Q, 2014, INT J ORAL MAX SURG, V43, P1059, DOI 10.1016/j.ijom.2014.06.003; Yokoyama T, 2010, J RECONSTR MICROSURG, V26, P79, DOI 10.1055/s-0029-1243291	49	8	8	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0736-6825	1098-8793		FACIAL PLAST SURG	Facial Plast. Surg.	DEC	2018	34	6					597	604		10.1055/s-0038-1676076			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	HF8UH	WOS:000454517200007	30593075				2022-02-06	
J	Venkata, C; Kasal, J				Venkata, Chakradhar; Kasal, Jan			Cardiac Dysfunction in Adult Patients with Traumatic Brain Injury: A Prospective Cohort Study	CLINICAL MEDICINE & RESEARCH			English	Article						Cardiac dysfunction; Traumatic brain injury	TAKOTSUBO CARDIOMYOPATHY; ECHOCARDIOGRAPHY	Background: There are limited data regarding the development of myocardial dysfunction after a traumatic brain injury (TBI). We investigated incidence, risk factors, and prognostic importance of cardiac dysfunction in adult patients admitted to the intensive care unit (ICU) after a moderate to severe TBI. Methods: Prospective observational study of consecutive patients admitted to neuro-trauma ICU with moderate to severe TBI from August 2014 to June 2015. Results: A total of 46 patients were included. Patients' mean (+/- SD) age was 44.7 (+/- 20.7) years and mean Glasgow Coma Scale value was 5.6 (+/- 3). Motor vehicle accident was the most common mechanism of TBI, with subdural and subarachnoid hemorrhages as the most common pathologies. Cardiac dysfunction developed in 6 of 46 (13%) patients. Patients with cardiac dysfunction had higher prevalence of diabetes mellitus (50% vs. 10%, P = 0.03) and higher proportion of electrocardiogram abnormalities (83% vs. 27%, P = 0.02) compared to the patients without cardiac dysfunction. Mean Glasgow Coma Scale scores were not significantly different between patients who developed cardiac dysfunction from those who did not (5.5 vs. 5.6, P = 0.95). Requirement for vasopressor support (33.3% vs. 40%, P = 1.0) and median ventilator days (5.2 vs.4.7, P = 0.9) were similar between patients with and without cardiac dysfunction.There were no significant differences in hospital lengths of stay (12.3 vs. 13.8 days, P = 0.34) and hospital mortality (33% vs. 17.5%, P = 0.58) between the two groups. Conclusions: Cardiac dysfunction occurs in patients after moderate to severe TBI, with mild to moderate reduction in left ventricular ejection fraction. Patients who developed cardiac dysfunction after TBI had a higher prevalence of diabetes mellitus and higher proportion of abnormalities in electrocardiograms. Development of cardiac dysfunction was not associated with adverse clinical outcomes.	[Venkata, Chakradhar] St Louis Univ, Sch Med, Mercy Hosp, Dept Crit Care Med, St Louis, MO USA; [Venkata, Chakradhar] St Louis Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO USA; [Kasal, Jan] Washington Univ, Dept Anesthesia & Crit Care Med, St Louis, MO USA		Venkata, C (corresponding author), 62S S New Ballas Rd,Suite 7020, St Louis, MO 63141 USA.	chakradhar.venkata@gmail.com					Blanc C, 2015, EUR NEUROL, V74, P163, DOI 10.1159/000440717; Cheah CF, 2017, NEUROCRIT CARE, V26, P284, DOI 10.1007/s12028-016-0334-y; Chengode S, 2016, ANN CARD ANAESTH, V19, pS20, DOI 10.4103/0971-9784.192617; Cinotti R, 2016, INTENS CARE MED, V42, P173, DOI 10.1007/s00134-015-4106-5; Cuisinier A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0323-3; DIMANT J, 1977, STROKE, V8, P449, DOI 10.1161/01.STR.8.4.448; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Gudmundsson P, 2005, INT J CARDIOL, V101, P209, DOI 10.1016/j.ijcard.2004.03.027; Hasanin A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0246-z; Krishnamoorthy V, 2013, CASE REP ANAESTHESIO, V2013, P1; Krishnamoorthy V, 2017, CRIT CARE MED, V45, P1028, DOI 10.1097/CCM.0000000000002404; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Levitov A, 2016, CRIT CARE MED, V44, P1206, DOI 10.1097/CCM.0000000000001847; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Mayer SA, 1999, STROKE, V30, P780, DOI 10.1161/01.STR.30.4.780; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Sadaka Farid, 2015, J Clin Med Res, V7, P18, DOI 10.14740/jocmr1935w; Serri K, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0217-4; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016	22	8	8	0	4	MARSHFIELD CLINIC	MARSHFIELD	1000 N OAK AVE, MAILSTOP ML7, MARSHFIELD, WI 54449 USA	1539-4182	1554-6179		CLIN MED RES	Clin. Med. Res.	DEC 1	2018	16	3-4					57	65		10.3121/cmr.2018.1437			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HF6JN	WOS:000454342300001	30587559	Green Published, gold			2022-02-06	
J	Wade, SL; Kaizar, EE; Narad, M; Zang, HY; Kurowski, BG; Yeates, KO; Taylor, HG; Zhang, NH				Wade, Shari L.; Kaizar, Eloise E.; Narad, Megan; Zang, Huaiyu; Kurowski, Brad G.; Yeates, Keith Owen; Taylor, H. Gerry; Zhang, Nanhua			Online Family Problem-solving Treatment for Pediatric Traumatic Brain Injury	PEDIATRICS			English	Article							EXECUTIVE FUNCTION; RANDOMIZED-TRIAL; SELF-REGULATION; IMPROVING CHILD; SHORT-TERM; OUTCOMES; BEHAVIOR; TEEN; INTERVENTION; ADOLESCENTS	BACKGROUND AND OBJECTIVES: To determine whether online family problem-solving treatment (OFPST) is more effective in improving behavioral outcomes after pediatric traumatic brain injury with increasing time since injury. METHODS: This was an individual participant data meta-analysis of outcome data from 5 randomized controlled trials of OFPST conducted between 2003 and 2016. We included 359 children ages 5 to 18 years who were hospitalized for moderate-to-severe traumatic brain injury 1 to 24 months earlier. Outcomes, assessed pre-and posttreatment, included parentreported measures of externalizing, internalizing, and executive function behaviors and social competence. RESULTS: Participants included 231 boys and 128 girls with an average age at injury of 13.6 years. Time since injury and age at injury moderated OFPST efficacy. For earlier ages and short time since injury, control participants demonstrated better externalizing problem scores than those receiving OFPST (Cohen's d = 0.44; P =.008; n = 295), whereas at older ages and longer time since injury, children receiving OFPST had better scores (Cohen's d = -0.60; P =.002). Children receiving OFPST were rated as having better executive functioning relative to control participants at a later age at injury, with greater effects seen at longer (Cohen's d = -0.66; P =.009; n = 298) than shorter (Cohen's d = -0. 28; P =.028) time since injury. CONCLUSIONS: OFPST may be more beneficial for older children and when begun after the initial months postinjury. With these findings, we shed light on the optimal application of family problem-solving treatments within the first 2 years after injury.	[Wade, Shari L.; Narad, Megan; Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Dept Rehabil Med, Cincinnati, OH 45229 USA; [Zang, Huaiyu] Cincinnati Childrens Hosp Med Ctr, Dept Stat, Cincinnati, OH 45229 USA; [Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Dept Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Rehabil, Cincinnati, OH USA; [Wade, Shari L.; Zhang, Nanhua] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Zang, Huaiyu] Univ Cincinnati, Dept Math Sci, Cincinnati, OH USA; [Taylor, H. Gerry] Nationwide Childrens Hosp, Res Inst, Dept Pediat, Columbus, OH USA; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Kaizar, Eloise E.] Dept Stat, Columbus, OH USA; [Taylor, H. Gerry] Ohio State Univ, Columbus, OH 43210 USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Yeates, Keith/AAJ-4223-2020; Zang, Huaiyu/AAY-6603-2021	Yeates, Keith/0000-0001-7680-2892; Zhang, Nanhua/0000-0001-5796-3404	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21HD089076-01]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD089076] Funding Source: NIH RePORTER	Funded by grant 1R21HD089076-01 to Dr Wade from the National Institutes of Health. Funded by the National Institutes of Health (NIH).	Abo-Zaid G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-56; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Ahmed SP, 2015, DEV COGN NEUROS-NETH, V15, P11, DOI 10.1016/j.dcn.2015.07.006; Brown FL, 2014, J CHILD PSYCHOL PSYC, V55, P1172, DOI 10.1111/jcpp.12227; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Gilkey SL, 2009, FAM SOC, V90, P37, DOI 10.1606/1044-3894.3843; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Hackman DA, 2015, DEVELOPMENTAL SCI, V18, P686, DOI 10.1111/desc.12246; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Law EF, 2014, J PEDIATR PSYCHOL, V39, P866, DOI 10.1093/jpepsy/jsu032; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Mercier E, 2018, J NEUROTRAUM, V35, P609, DOI 10.1089/neu.2017.5013; Merrell KM., 2002, HOME COMMUNITY SOCIA; Narad ME, 2015, J DEV BEHAV PEDIATR, V36, P700, DOI 10.1097/DBP.0000000000000208; Nevitt SJ, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1390; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Olson SL, 2011, DEV PSYCHOPATHOL, V23, P253, DOI 10.1017/S0954579410000775; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; R Core Team, 2017, R COMP PROGR; Raj SP, 2018, J HEAD TRAUMA REHAB, V33, P158, DOI 10.1097/HTR.0000000000000331; Sanders MR, 2013, CLIN CHILD FAM PSYCH, V16, P1, DOI 10.1007/s10567-013-0129-z; Seid M, 2010, J PEDIATR PSYCHOL, V35, P1133, DOI 10.1093/jpepsy/jsp133; Simmonds M, 2015, CONTEMP CLIN TRIALS, V45, P76, DOI 10.1016/j.cct.2015.06.012; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor SJ, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015.00252, 10.3389/finbeh.2015.00252]; TEASDALE G, 1974, LANCET, V2, P81; Thompson A, 2009, EUR J EPIDEMIOL, V24, P727, DOI 10.1007/s10654-009-9412-1; Tonelli MR, 2017, JAMA-J AM MED ASSOC, V318, P1649, DOI 10.1001/jama.2017.11914; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2017, REHABIL PSYCHOL, V62, P290, DOI 10.1037/rep0000160; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2014, REHABIL PSYCHOL, V59, P1, DOI 10.1037/a0034911; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2017, J AM ACAD CHILD ADOL, V56; Wysocki T, 2006, J PEDIATR PSYCHOL, V31, P928, DOI 10.1093/jpepsy/jsj098; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	50	8	8	0	2	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	DEC	2018	142	6							e20180422	10.1542/peds.2018-0422			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	HB8WO	WOS:000451372200007	30413559	Green Published, Bronze			2022-02-06	
J	Zakharov, S; Hlusicka, J; Nurieva, O; Kotikova, K; Lischkova, L; Kacer, P; Kacerova, T; Urban, P; Vaneckova, M; Seidl, Z; Diblik, P; Kuthan, P; Heissigerova, J; Lesovsky, J; Rulisek, J; Vojtova, L; Hubacek, JA; Navratil, T				Zakharov, Sergey; Hlusicka, Jiri; Nurieva, Olga; Kotikova, Katerina; Lischkova, Lucie; Kacer, Petr; Kacerova, Tereza; Urban, Pavel; Vaneckova, Manuela; Seidl, Zdenek; Diblik, Pavel; Kuthan, Pavel; Heissigerova, Jarmila; Lesovsky, Jiri; Rulisek, Jan; Vojtova, Lucie; Hubacek, Jaroslav A.; Navratil, Tomas			Neuroinflammation markers and methyl alcohol induced toxic brain damage	TOXICOLOGY LETTERS			English	Article; Proceedings Paper	10th International Symposium on Biological Monitoring (ISBM)	OCT 02-04, 2017	Naples, ITALY	Univ Naples Federico II, Dept Publ Hlth, Sect Occupat Med		Neuroinflammation; Methyl alcohol poisoning; CNS damage; Interleukins; Lipoxins; Non-traumatic brain injury	MASS POISONING OUTBREAK; ACUTE OPTIC NEUROPATHY; CENTRAL-NERVOUS-SYSTEM; METHANOL INTOXICATION; REACTIVE ASTROCYTES; EXTRACORPOREAL TREATMENTS; CLINICAL-FEATURES; SERUM FORMATE; HEAD-INJURY; MICROGLIA	Methyl alcohol intoxication is a global problem with high mortality and long-term visual sequelae and severe brain damage in survivors. The role of neuroinflammation in the mechanisms of methyl alcohol-induced toxic brain damage has not been well studied. We measured the acute concentrations and dynamics of lipoxins LxA4 and LxB4 and the interleukins IL-4, IL-5, IL-9, IL-10, and IL-13 in the serum of patients treated with methyl alcohol poisoning and the follow-up concentrations in survivors two years after discharge from the hospital. A series of acute measurements was performed in 28 hospitalized patients (mean age 54.2 +/- 5.2 years, mean observation time 88 +/- 20 h) and the follow-up measurements were performed in 36 subjects who survived poisoning (including 12/28 survivors from the acute group). Visual evoked potentials (VEP) and magnetic resonance imaging of the brain (MRI) were performed to detect long-term visual and brain sequelae of intoxication. The acute concentrations of inflammatory mediators were higher than the follow-up concentrations: LxA4, 62.0 +/- 6.0 vs. 30.0 +/- 5.0 pg/mL; LxB4, 64.0 +/- 7.0 vs. 34.0 +/- 4.0 pg/mL; IL-4, 29.0 +/- 4.0 vs. 15.0 +/- 1.0 pg/mL; IL-5, 30.0 +/- 4.0 vs. 13.0 +/- 1.0 pg/mL; IL-9, 30.0 +/- 4.0 vs. 13.0 +/- 1.0 pg/mL; IL-10, 38.0 +/- 5.0 vs. 16.0 +/- 1.0 pg/mL; IL-13, 35.0 +/- 4.0 vs. 14.0 +/- 1.0 pg/mL (all p < 0.001). The patients with higher follow-up IL-5 concentration had prolonged latency P1 (r=0.413; p=0.033) and lower amplitude N1P1 (r=-0.498; p=0.010) of VEP. The higher follow-up IL-10 concentration was associated with MRI signs of brain necrotic damage (r=0.533; p=0.001) and brain hemorrhage (r=0.396; p=0.020). Our findings suggest that neuroinflammation plays an important role in the mechanisms of toxic brain damage in acute methyl alcohol intoxication.	[Zakharov, Sergey; Hlusicka, Jiri; Nurieva, Olga; Kotikova, Katerina; Lischkova, Lucie; Urban, Pavel] Charles Univ Prague, Dept Occupat Med, Fac Med 1, Bojisti 1, Prague 12000, Czech Republic; [Zakharov, Sergey; Hlusicka, Jiri; Lischkova, Lucie; Lesovsky, Jiri; Navratil, Tomas] Gen Univ Hosp, Toxicol Informat Ctr, Bojisti 1, Prague 12000, Czech Republic; [Kacer, Petr; Kacerova, Tereza] Charles Univ Prague, Biocev, Fac Med 1, Prumyslova 595, Vestec 25250, Czech Republic; [Urban, Pavel] Natl Inst Publ Hlth, Ctr Ind Hyg & Occupat Med, Srobarova 49-48, Prague 10000, Czech Republic; [Vaneckova, Manuela; Seidl, Zdenek; Diblik, Pavel; Kuthan, Pavel; Heissigerova, Jarmila; Rulisek, Jan] Charles Univ Prague, Fac Med 1, U Nemocnice 499-2, Prague 12808, Czech Republic; [Vaneckova, Manuela; Seidl, Zdenek] Gen Univ Hosp, Dept Radiol, U Nemocnice 499-2, Prague 12808, Czech Republic; [Diblik, Pavel; Kuthan, Pavel; Heissigerova, Jarmila] Gen Univ Hosp, Dept Ophthalmol, U Nemocnice 499-2, Prague 12808, Czech Republic; [Rulisek, Jan] Gen Univ Hosp, Clin Anesthesiol Resuscitat & Intens Med, U Nemocnice 499-2, Prague 12808, Czech Republic; [Vojtova, Lucie] Charles Univ Prague, Fac Med 1, Inst Clin Biochem & Lab Diagnost, Katerinska 32, Prague 12108, Czech Republic; [Vojtova, Lucie] Gen Univ Hosp, Katerinska 32, Prague 12108, Czech Republic; [Hubacek, Jaroslav A.] Inst Clin & Expt Med, Ctr Med Expt, Videnska 1958-9, Prague 14021, Czech Republic; [Navratil, Tomas] AS CR, Dept Biomimet Electrochem, J Heyrovsky Inst Phys Chem, Vvi, Dolejskova 2155-3, Prague 18200, Czech Republic		Zakharov, S (corresponding author), Dept Occupat Med, Bojisti 1, Prague 12000, Czech Republic.	sergey.zakharov@vfn.cz	Hubacek, Jaroslav Alois/AAN-6134-2021; Zakharov, Sergey/L-8511-2014; Zakharov, Sergey/O-2896-2019; Navratil, Tomas/F-4000-2012; Kacerova, Tereza/AAV-7242-2021; Hlusicka, Jiri/AAA-7425-2020; Heissigerova, Jarmila/D-7125-2013; Kacer, Petr/AAW-2355-2021	Hubacek, Jaroslav Alois/0000-0001-6537-1353; Zakharov, Sergey/0000-0001-9864-8304; Zakharov, Sergey/0000-0001-9864-8304; Navratil, Tomas/0000-0003-4633-2601; Kacerova, Tereza/0000-0002-9477-0182; Heissigerova, Jarmila/0000-0002-2614-4681; Kacer, Petr/0000-0002-5905-3516; Vaneckova, Manuela/0000-0002-8784-7997	AZV VES 2016 [16-27075A]; Project PROGRES Q25 of 1st Faculty of Medicine, Charles University in Prague; Ministry of Health of the Czech RepublicMinistry of Health, Czech Republic [44/18/D]; Project PROGRES Q29 of 1st Faculty of Medicine, Charles University in Prague	This work was supported by the Project 16-27075A of AZV VES 2016, the Project 44/18/D of the Ministry of Health of the Czech Republic, and the Projects PROGRES Q25 and Q29 of the 1st Faculty of Medicine, Charles University in Prague.	Barceloux DG, 2002, J TOXICOL-CLIN TOXIC, V40, P415; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Benveniste EN, 1998, CYTOKINE GROWTH F R, V9, P259, DOI 10.1016/S1359-6101(98)00015-X; Bezdicek O, 2017, ALCOHOL, V59, P27, DOI 10.1016/j.alcohol.2016.12.003; Bezdicek O, 2014, CESK SLOV NEUROL N, V77, P320; Blood A, 2015, J INVEST MED, V63, P124; Blug M., 2014, METHANOL BASIC CHEM; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Choi JH, 2017, J KOREAN MED SCI, V32, P371, DOI 10.3346/jkms.2017.32.2.371; Ciceri P, 2001, BRIT J PHARMACOL, V133, P1323, DOI 10.1038/sj.bjp.0704189; Corser-Jensen CE, 2014, EXP NEUROL, V256, P7, DOI 10.1016/j.expneurol.2014.03.008; Desai T, 2013, JAMA OPHTHALMOL, V131, P358, DOI 10.1001/jamaophthalmol.2013.1463; Dhillon HS, 1996, J NEUROTRAUM, V13, P781, DOI 10.1089/neu.1996.13.781; Dommergues MA, 2000, ANN NEUROL, V47, P54, DOI 10.1002/1531-8249(200001)47:1<54::AID-ANA10>3.0.CO;2-Y; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Elenkov IJ, 2005, NEUROIMMUNOMODULAT, V12, P255, DOI 10.1159/000087104; Farias SE, 2007, J NEUROCHEM, V103, P1310, DOI 10.1111/j.1471-4159.2007.04830.x; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fernandes A, 2014, CELL MOL LIFE SCI, V71, P3969, DOI 10.1007/s00018-014-1670-8; Gebicke-Haerter PJ, 2001, MICROSC RES TECHNIQ, V54, P47, DOI 10.1002/jemt.1120; Ghannoum M, 2014, SEMIN DIALYSIS, V27, P395, DOI 10.1111/sdi.12237; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hlusicka J, 2018, CLIN TOXICOL, V56, P893, DOI 10.1080/15563650.2018.1455980; Hovda KE, 2005, J ANAL TOXICOL, V29, P586, DOI 10.1093/jat/29.6.586; Hovda KE, 2005, J INTERN MED, V258, P181, DOI 10.1111/j.1365-2796.2005.01521.x; Hubacek JA, 2015, BASIC CLIN PHARMACOL, V116, P168, DOI 10.1111/bcpt.12310; Karayel F, 2010, AM J FOREN MED PATH, V31, P34, DOI 10.1097/PAF.0b013e3181c160d9; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kemsley J, 2007, CHEM ENG NEWS, V85, P55, DOI 10.1021/cen-v085n049.p055; Kochanek PM, 2009, J NEUROTRAUM, V26, P813, DOI 10.1089/neu.2008.0893; Kraut JA, 2010, CLIN J AM SOC NEPHRO, V3, P194; Kraut JA, 2016, AM J KIDNEY DIS, V68, P161, DOI 10.1053/j.ajkd.2016.02.058; Lagraoui M, 2012, FRONT NEUR, V3, P1; Liva SM, 2001, NEUROCHEM RES, V26, P629, DOI 10.1023/A:1010983119125; MCMARTIN KE, 1975, BIOCHEM MED METAB B, V13, P319, DOI 10.1016/0006-2944(75)90171-4; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Neprasova M, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/3650909; Nurieva O, 2016, MONATSH CHEM, V147, P239, DOI 10.1007/s00706-015-1580-y; Olah GA, 2005, ANGEW CHEM INT EDIT, V44, P2636, DOI 10.1002/anie.200462121; Paasma R, 2007, CLIN TOXICOL, V45, P152, DOI 10.1080/15563650600956329; Paasma Raido, 2009, BMC Clin Pharmacol, V9, P5, DOI 10.1186/1472-6904-9-5; Parthasarathy NJ, 2007, CELL BIOL TOXICOL, V23, P177, DOI 10.1007/s10565-006-0151-8; Peterova K, 2018, BASIC CLIN PHARMACOL, V122, P176, DOI 10.1111/bcpt.12853; PIKE CJ, 1995, EXP NEUROL, V132, P172, DOI 10.1016/0014-4886(95)90022-5; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Roberts DM, 2015, CRIT CARE MED, V43, P461, DOI 10.1097/CCM.0000000000000708; Rulisek J, 2017, J CRIT CARE, V39, P190, DOI 10.1016/j.jcrc.2017.03.001; Ryu J, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0153-9; Sanaei-Zadeh H, 2011, CLIN TOXICOL, V49, P102, DOI 10.3109/15563650.2011.556642; SAWADA M, 1993, NEUROSCI LETT, V155, P175, DOI 10.1016/0304-3940(93)90701-L; Schlosser G, 2007, APPL ENVIRON MICROB, V73, P6945, DOI 10.1128/AEM.01136-07; Schuhmann MU, 2003, NEUROL RES, V25, P481, DOI 10.1179/016164103101201896; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Soysal D, 2007, Acta Anaesthesiol Scand, V51, P779, DOI 10.1111/j.1399-6576.2007.01332.x; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Urban P, 2016, INT J OCCUP MED ENV, V29, P471, DOI 10.13075/ijomeh.1896.00452; Vaneckova M, 2014, CESK SLOV NEUROL N, V77, P235; Vaneckova M, 2015, NEUROENDOCRINOL LETT, V36, P737; Wang ML, 2006, BIOCHEM BIOPH RES CO, V350, P399, DOI 10.1016/j.bbrc.2006.09.057; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Zakaryan AV, 2011, BIOCHEM MOSC-SUPPL S, V5, P51, DOI 10.1134/S199075081101015X; Zakharov S, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0300-7; Zakharov S, 2017, CLIN TOXICOL, V55, P123, DOI 10.1080/15563650.2016.1250901; Zakharov S, 2017, MONATSH CHEM, V148, P409, DOI 10.1007/s00706-016-1846-z; Zakharov S, 2017, CLIN TOXICOL, V55, P249, DOI 10.1080/15563650.2017.1284332; Zakharov S, 2016, BASIC CLIN PHARMACOL, V119, P228, DOI 10.1111/bcpt.12559; Zakharov S, 2016, ANN EMERG MED, V68, P52, DOI 10.1016/j.annemergmed.2016.01.010; Zakharov S, 2016, MONATSH CHEM, V147, P251, DOI 10.1007/s00706-015-1581-x; Zakharov S, 2015, BIOMED PAP, V159, P666, DOI 10.5507/bp.2015.008; Zakharov S, 2015, CLIN TOXICOL, V53, P884, DOI 10.3109/15563650.2015.1086488; Zakharov S, 2015, CLIN TOXICOL, V53, P797, DOI 10.3109/15563650.2015.1059946; Zakharov S, 2015, MONATSH CHEM, V146, P787, DOI 10.1007/s00706-014-1374-7; Zakharov S, 2015, BASIC CLIN PHARMACOL, V116, P445, DOI 10.1111/bcpt.12338; Zakharov S, 2014, BIOMED PAP, V158, P641, DOI 10.5507/bp.2014.056; Zakharov S, 2014, CLIN TOXICOL, V52, P1013, DOI 10.3109/15563650.2014.974106; Zakharov S, 2014, J APPL BIOMED, V12, P309, DOI 10.1016/j.jab.2014.04.001; Zakharov S, 2014, KIDNEY INT, V86, P199, DOI 10.1038/ki.2014.60; Zhang G, 2015, APPL INCLUDE FOMEPIZ; Zhang WP, 2004, NEUROSCI LETT, V363, P247, DOI 10.1016/j.neulet.2004.03.088; Zhang XJ, 2006, NEUROL INDIA, V54, P402	82	8	8	0	16	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-4274	1879-3169		TOXICOL LETT	Toxicol. Lett.	DEC 1	2018	298				SI		60	69		10.1016/j.toxlet.2018.05.001			10	Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Toxicology	HA3AV	WOS:000450122200009	29733875				2022-02-06	
J	Chen, Q; Zheng, WM; Chen, X; Li, XJ; Wang, L; Qin, W; Li, KC; Chen, N				Chen, Qian; Zheng, Weimin; Chen, Xin; Li, Xuejing; Wang, Ling; Qin, Wen; Li, Kuncheng; Chen, Nan			Whether Visual-related Structural and Functional Changes Occur in Brain of Patients with Acute Incomplete Cervical Cord Injury: A Multimodal Based MRI Study	NEUROSCIENCE			English	Article						incomplete cervical cord injury; vision; change; multimodal MRI study; clinical variables	RESTING-STATE NETWORKS; NEUROPATHIC PAIN; MOTOR CORTEX; SENSORIMOTOR CORTEX; PREFRONTAL CORTEX; CONNECTIVITY; ACTIVATION; REPRESENTATIONS; REORGANIZATION; ORGANIZATION	Visual-related cortex plays an important role in the process of movement. It is of great importance to clarify whether traumatic spinal cord injury (SCI), which is a typical disease that results in sensorimotor dysfunction, leads to the alteration of visual-related brain structure and function area. To address this issue, multimodality MRI was applied on eleven patients with acute incomplete cervical cord injury (ICCI) and eleven healthy controls (HCs) to explore possible structural and functional changes of the brain. Voxel-based morphometry (VBM) analysis was performed to investigate the changes in brain structure of ICCI patients. The fractional amplitude of low-frequency fluctuations (fALFF) was used to characterize changes in regional neural activities, and independent component analysis (ICA) was carried out to explore alterations in the resting-state networks (RSNs) after ICU. We also investigated correlations among brain imaging metrics and between the metrics and clinical variables. Compared with HCs, ICCI patients exhibited significant gray matter atrophy in the left hippocampus and parahippocampal gyrus, right superior frontal gyrus (SFG), and middle frontal gyrus (MFG) and also a decrease in fALFF in the left orbitofrontal cortex (OFC). Moreover, ICCI patients exhibited decreased intranetwork functional connectivity (FC) in the medial vision network (mVN). The mean fALFF value was correlated with clinical motor scores of the left extremities and the total motor scores. Our findings proved that ICCI can not only cause structural changes in visual-related brain regions, but also result in visual-related brain functional alterations, revealing the possible mechanism of the effects of visual feedback training in motor function rehabilitation of SCI patients. (C) 2018 IBRO. Published by Elsevier Ltd. All rights reserved.	[Chen, Qian; Zheng, Weimin; Chen, Xin; Li, Xuejing; Wang, Ling; Li, Kuncheng; Chen, Nan] Capital Med Univ, Xuanwu Hosp, Dept Radiol, 45 Chang Chun St, Beijing, Peoples R China; [Chen, Qian; Zheng, Weimin; Chen, Xin; Li, Xuejing; Wang, Ling; Li, Kuncheng; Chen, Nan] Beijing Key Lab Magnet Resonance Imaging & Brain, 45 Chang Chun St, Beijing, Peoples R China; [Zheng, Weimin] Beijing Univ Chinese Med, Dongfang Hosp, Dept Radiol, 6 Star Pk 1 Dist, Beijing, Peoples R China; [Qin, Wen] Tianjin Med Univ, Gen Hosp, Dept Radiol, 154 Anshan Rd, Tianjin, Peoples R China		Chen, N (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing Key Lab Magnet Resonance Imaging & Brain, 45 Changchun St, Beijing, Peoples R China.	chenzen8057@sina.com	Chen, Qian/AAN-1922-2021; CHEN, NAN/L-1223-2019	Chen, Qian/0000-0001-5210-9647; 	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81871339, 81271556]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201609]; Beijing Municipal Natural Science FoundationBeijing Natural Science Foundation [7113155]; Science Foundation of Beijing Municipal Commission of Education [KM201210025013]	This study was supported by the National Natural Science Foundation of China (No. 81871339; No. 81271556), Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201609), Beijing Municipal Natural Science Foundation (No. 7113155), and Science Foundation of Beijing Municipal Commission of Education (No. KM201210025013).	Aguirre GK, 1997, J NEUROSCI, V17, P2512; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Arrigo A, 2017, RADIOLOGY, V285, P885, DOI 10.1148/radiol.2017161732; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baldassano C, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0178-16.2016; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bose P, 2005, EXP NEUROL, V191, P13, DOI 10.1016/j.expneurol.2004.08.028; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chen Q, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00211; Choe AS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00290; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Crawley AP, 2004, BRAIN RES, V1028, P19, DOI 10.1016/j.brainres.2004.08.060; Soler MD, 2010, BRAIN, V133, P2565, DOI 10.1093/brain/awq184; Donati ARC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30383; Du YH, 2015, NEUROIMAGE, V122, P272, DOI 10.1016/j.neuroimage.2015.07.054; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; GAFFAN D, 1994, J COGNITIVE NEUROSCI, V6, P305, DOI 10.1162/jocn.1994.6.4.305; Glickstein M, 2000, TRENDS NEUROSCI, V23, P613, DOI 10.1016/S0166-2236(00)01681-7; Glover S, 2004, BEHAV BRAIN SCI, V27, P3; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grabher P, 2015, ANN NEUROL, V78, P751, DOI 10.1002/ana.24508; Graves, 2003, J SPINAL CORD MED S1, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; Hawasli AH, 2018, J NEUROTRAUM, V35, P864, DOI 10.1089/neu.2017.5212; Hesse C, 2012, NEUROPSYCHOLOGIA, V50, P90, DOI 10.1016/j.neuropsychologia.2011.11.002; Himmelbach M, 2012, NEUROPSYCHOLOGIA, V50, P139, DOI 10.1016/j.neuropsychologia.2011.11.011; Hou JM, 2014, NEUROSCIENCE, V277, P446, DOI 10.1016/j.neuroscience.2014.07.045; Hou JM, 2016, HUM BRAIN MAPP, V37, P2195, DOI 10.1002/hbm.23163; Ilvesmaki T, 2017, HUM BRAIN MAPP; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jiang A, 2015, NEURAL PLAST, V2015, P1; Jurkiewicz MT, 2006, NEUROLOGY, V66, P762, DOI 10.1212/01.wnl.0000201276.28141.40; Jutzeler CR, 2016, SCI REP-UK, V6, DOI 10.1038/srep18534; Jutzeler CR, 2015, J PAIN, V16, P1256, DOI 10.1016/j.jpain.2015.08.008; Kalra L, 1997, STROKE, V28, P1386, DOI 10.1161/01.STR.28.7.1386; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Li W, 2013, NEUROIMAGE, V78, P46, DOI 10.1016/j.neuroimage.2013.04.011; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Ma Y, 2016, P NATL ACAD SCI USA, V113, pE8463, DOI 10.1073/pnas.1525369113; Maguire EA, 1996, P ROY SOC B-BIOL SCI, V263, P1745, DOI 10.1098/rspb.1996.0255; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 1997, J NEUROSCI, V17, P7103; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Marino RJ, 2008, J SPINAL CORD MED, V31, P166, DOI 10.1080/10790268.2008.11760707; Medendorp WP, 2018, CORTEX, V98, P194, DOI 10.1016/j.cortex.2016.11.013; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; MILNER AD, 1993, PROG BRAIN RES, V95, P317, DOI 10.1016/S0079-6123(08)60379-9; Min YS, 2015, J NEUROTRAUM, V32, P1422, DOI 10.1089/neu.2014.3661; Mole TB, 2014, NEUROIMAGE-CLIN, V5, P28, DOI 10.1016/j.nicl.2014.05.014; Parker RI, 2007, BEHAV THER, V38, P95, DOI 10.1016/j.beth.2006.05.002; Rao JS, 2015, MAGN RESON IMAGING, V33, P1156, DOI 10.1016/j.mri.2015.06.011; Rao JS, 2014, MAGN RESON IMAGING, V32, P482, DOI 10.1016/j.mri.2014.02.001; Rolls ET, 1997, EUR J NEUROSCI, V9, P1789, DOI 10.1111/j.1460-9568.1997.tb01538.x; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Sabbah P, 2002, J NEUROTRAUM, V19, P53, DOI 10.1089/089771502753460231; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Seitz RJ, 1999, RESTOR NEUROL NEUROS, V14, P25; Sharp KG, 2017, J NEUROTRAUM, V34, P623, DOI 10.1089/neu.2016.4503; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063727; Steeves JD, 2011, SPINAL CORD, V49, P257, DOI 10.1038/sc.2010.99; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Velanova K, 2003, J NEUROSCI, V23, P8460; Vigneau-Roy N, 2014, HUM BRAIN MAPP, V35, P1906, DOI 10.1002/hbm.22301; Villiger M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00254; Villiger M, 2013, NEUROREHAB NEURAL RE, V27, P675, DOI 10.1177/1545968313490999; Wang CH, 2014, J CEREBR BLOOD F MET, V34, P597, DOI 10.1038/jcbfm.2013.238; Wang DW, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/128236; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Yan CG, 2016, NEUROINFORMATICS, V14, P339, DOI 10.1007/s12021-016-9299-4; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Yoon EJ, 2013, BRAIN RES, V1540, P64, DOI 10.1016/j.brainres.2013.10.007; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zheng WM, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/4671607; Zhong JD, 2016, HUM BRAIN MAPP, V37, P4262, DOI 10.1002/hbm.23307; Zhu L, 2015, PLOS ONE, V10; Zimmerli L, 2013, ARCH PHYS MED REHAB, V94, P1737, DOI 10.1016/j.apmr.2013.01.029; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	87	8	9	4	25	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 21	2018	393						284	294		10.1016/j.neuroscience.2018.10.014			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HB1JE	WOS:000450777900023	30326291				2022-02-06	
J	Liu, SY; Xu, JF; Gao, YZ; Shen, P; Xia, SL; Li, ZL; Zhang, M				Liu, Shaoyun; Xu, Jiefeng; Gao, Yuzhi; Shen, Peng; Xia, Senlin; Li, Zilong; Zhang, Mao			Multi-organ protection of ulinastatin in traumatic cardiac arrest model	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Ulinastatin; Traumatic cardiac arrest; Organ protection; Cardiopulmonary resuscitation; Post-resuscitation; Ischemia-reperfusion injury	ISCHEMIA-REPERFUSION INJURY; URINARY TRYPSIN-INHIBITOR; BLOOD-BRAIN-BARRIER; CARDIOPULMONARY-RESUSCITATION; SUPEROXIDE-DISMUTASE; SEVERE SEPSIS; RATS; PERMEABILITY; EXPRESSION; GUIDELINES	Post-cardiac arrest syndrome, which has no specific curative treatment, contributes to the high mortality rate of victims who suffer traumatic cardiac arrest (TCA) and initially can be resuscitated. In the present study, we investigated the potential of ulinastatin to mitigate multiple organ injury after resuscitation in a swine TCA model. Twenty-one male pigs were subjected to hemodynamic shock (40% estimated blood loss in 20 min) followed by cardiac arrest (electrically induced ventricular fibrillation) and respiratory suspension for 5 min, and finally manual resuscitation. At 5 min after resuscitation, pigs were randomized to receive 80,000 U/kg ulinastatin (n = 7) or the same volume of saline (n = 9) in the TCA group. Pigs in the sham group (n = 5) were not exposed to bleeding or cardiac arrest. At baseline and at 1, 3, and 6 h after the return of spontaneous circulation, blood samples were collected and assayed for tumor necrosis factor-alpha, interleukin 6, and other indicators of organ injury. At 24 h after resuscitation, pigs were sacrificed and apoptosis levels were assessed in samples of heart, brain, kidney, and intestine. One pig died in the ulinastatin group and one pig died in the TCA group; the remaining animals were included in the final analysis. TCA and resuscitation caused significant increases in multiple organ function biomarkers in serum, increases in tumor necrosis factor-alpha, and interleukin 6 in serum and increases in the extent of apoptosis in key organs. All these increases were lower in the ulinastatin group. Ulinastatin may attenuate multiple organ injury after TCA, which should be explored in clinical studies.	[Liu, Shaoyun; Xu, Jiefeng; Gao, Yuzhi; Shen, Peng; Xia, Senlin; Zhang, Mao] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Emergency Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China; [Liu, Shaoyun; Xu, Jiefeng; Gao, Yuzhi; Shen, Peng; Xia, Senlin; Zhang, Mao] Zhejiang Univ, Inst Emergency Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China; [Xu, Jiefeng; Li, Zilong] Ningbo Univ, Sch Med, Yuyao Peoples Hosp, Dept Emergency Med, Yuyao 315400, Peoples R China; [Shen, Peng] Jiaxing Univ, Affiliated Hosp 1, Hosp Jiaxing 1, Dept Emergency Med, Jiaxing 314000, Peoples R China; [Xia, Senlin] Huzhou Cent Hosp, Dept Emergency Med, Huzhou 313000, Peoples R China		Zhang, M (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Emergency Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.; Zhang, M (corresponding author), Zhejiang Univ, Inst Emergency Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	21618158@zju.edu.cn; 11518266@zju.edu.cn; gyz2010@126.com; sunpong@163.com; 13735140036@163.com; lizilong55@vip.sina.com; z2jzk@zju.edu.cn			Welfare Scientific Research Project from the Chinese Ministry of Health [2015SQ00050]; Zhejiang Province; National Health and Family Planning Commission of China [2018271879]; Welfare Scientific Research Project of Zhejiang Province [LGF18H150003]	Mao Zhang is funded by the Welfare Scientific Research Project from the Chinese Ministry of Health (2015SQ00050), the Key Program Co-sponsored by Zhejiang Province and National Health and Family Planning Commission of China (2018271879), and the Welfare Scientific Research Project of Zhejiang Province (LGF18H150003). These agencies provided financial support but were not involved in any other aspect of the research.	BAKER GL, 1985, ANN SURG, V202, P628, DOI 10.1097/00000658-198511000-00016; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Chen HM, 2014, INT J CLIN EXP MED, V7, P1483; Cho YS, 2015, MOL MED REP, V12, P1796, DOI 10.3892/mmr.2015.3612; Feng ZS, 2016, J TRAUMA ACUTE CARE, V80, P335, DOI 10.1097/TA.0000000000000909; Guan LY, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1429835; Harris T, 2015, EUR J EMERG MED, V22, P72, DOI 10.1097/MEJ.0000000000000180; He QL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/630835; He WJ, 2015, INT J CLIN EXP PATHO, V8, P10792; Hopson LR, 2003, J AM COLL SURGEONS, V196, P106, DOI 10.1016/S1072-7515(02)01668-X; Inoue K, 2010, EXPERT OPIN INV DRUG, V19, P513, DOI 10.1517/13543781003649533; Karnad DR, 2014, INTENS CARE MED, V40, P830, DOI 10.1007/s00134-014-3278-8; KORTHUIS RJ, 1985, CIRC RES, V57, P599, DOI 10.1161/01.RES.57.4.599; Lee B, 2017, SURG ENDOSC, V31, P3728, DOI 10.1007/s00464-017-5608-8; Li XF, 2017, NEUROL RES, V39, P367, DOI 10.1080/01616412.2017.1286541; Lin B, 2015, INT J CLIN EXP PATHO, V8, P7685; Liu M, 2017, BIOMED PHARMACOTHER, V85, P412, DOI 10.1016/j.biopha.2016.11.044; Lockey D, 2006, ANN EMERG MED, V48, P240, DOI 10.1016/j.annemergmed.2006.03.015; Lv ZT, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2571080; Ma L, 2016, INT J NEUROSCI, V126, P463, DOI 10.3109/00207454.2015.1025394; Salvadori Maurizio, 2015, World J Transplant, V5, P52, DOI 10.5500/wjt.v5.i2.52; Smith JE, 2015, J ROY SOC MED, V108, P11, DOI 10.1177/0141076814560837; Wan X, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1207-7; WERNS SW, 1985, CIRC RES, V56, P895, DOI 10.1161/01.RES.56.6.895; Xiao J, 2014, MOL MED REP, V10, P1949, DOI 10.3892/mmr.2014.2450; Xu LL, 2013, NEUROSCI LETT, V541, P15, DOI 10.1016/j.neulet.2013.02.008	26	8	11	1	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	NOV 12	2018	13								51	10.1186/s13017-018-0212-3			8	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	HB5IY	WOS:000451094900001	30459824	Green Published, gold			2022-02-06	
J	Russell, AL; Handa, RJ; Wu, TJ				Russell, Ashley L.; Handa, Robert J.; Wu, T. John			Sex-Dependent Effects of Mild Blast-induced Traumatic Brain Injury on Corticotropin-releasing Factor Receptor Gene Expression: Potential Link to Anxiety-like Behaviors	NEUROSCIENCE			English	Article						anxiety; traumatic brain injury; corticotropin-releasing factor; receptor; sex differences	POSTTRAUMATIC-STRESS-DISORDER; ELEVATED PLUS-MAZE; PSYCHIATRIC-DISORDERS; TYPE-2 RECEPTORS; LATERAL SEPTUM; CRF RECEPTORS; BED NUCLEUS; AMYGDALA; HORMONE; MICE	Traumatic brain injury (TBI) affects 1.7 million people in the United States every year, resulting in increased risk of death and disabilities. A significant portion of TBIs experienced by military personnel are induced by explosive blast devices. Active duty military personnel are especially vulnerable to mild blast-induced (mb)TBI and the associated long-term effects, such as anxiety disorders. Additionally, females are at an increased risk of being diagnosed with anxiety-related disorders. The mechanism by which mbTBI results in anxiety disorders in males and females is unknown. The sexually dimorphic corticotropin-releasing factor (CRF) is a brain signaling system linked to anxiety. CRF and its family of related peptides modulate anxiety-related behaviors by binding to CRF receptor subtypes 1 and 2 (CRFR1, CRFR2, respectively). These receptors are distributed throughout limbic structures that control behaviors related to emotion, memory, and arousal. Therefore, the aim of this study was to understand the link between mbTBI and anxiety by examining the impact of mbTBI on the CRFR system in male and female mice. mbTBI increased anxiety-like behaviors in both males and females (p < 0.05). In the present study, mbTBI did not alter CRFR1 gene expression in males or females. However, mbTBI disrupted CRFR2 gene expression in different limbic structures in males and females. In males, mbTBI increased baseline CRFR2 gene expression in the ventral hippocampus (p < 0.05) and decreased restraint-induced expression in the anterior bed nucleus of the stria terminalis (aBNST) and amygdala (p < 0.05). In females, mbTBI decreased restraint-induced CRFR2 gene expression in the dorsal hippocampus (p < 0.05). The inherent sex differences and the mbTBI-induced decrease in restraint-induced CRFR2 gene expression may contribute to anxiety-like behaviors. The results of the present study show that the response to mbTBI within the limbic structures modulates anxiety in a sex-dependent manner. The studies further suggest that CRFR2 may serve as a potential target to mitigate mbTBI effects. Published by Elsevier Ltd on behalf of IBRO.	[Russell, Ashley L.; Wu, T. John] Uniformed Serv Univ Hlth Sci, Program Neurosci, Bethesda, MD 20814 USA; [Russell, Ashley L.; Wu, T. John] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Handa, Robert J.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Wu, T. John] Uniformed Serv Univ Hlth Sci, Dept Obstet & Gynecol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Wu, TJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Obstet & Gynecol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	twu@usuhs.edu	Wu, John/ABI-3578-2020	Russell, Ashley/0000-0003-1137-2769	Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [CNRM-85-3389]; CNRM Predoctoral Fellowship [308049-18.01-60855]	We would like to thank Dr. Yeonho Kim, Dr. Amanda Fu, Dr. Cara Olsen and Dr. Thomas Flagg for their extensive help with this project. This work was funded by the Department of Defense in the Center for Neuroscience and Regenerative Medicine (CNRM-85-3389 (TJW) and CNRM Predoctoral Fellowship, 308049-18.01-60855 (ALR)).	Alves SWE, 2016, BEHAV BRAIN RES, V305, P191, DOI 10.1016/j.bbr.2016.03.013; Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001; Arszovszki A, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00053; Bagosi Z, 2015, NEUROCHEM INT, V90, P67, DOI 10.1016/j.neuint.2015.07.015; Bagot RC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8062; Bakshi VP, 2002, J NEUROSCI, V22, P2926, DOI 10.1523/JNEUROSCI.22-07-02926.2002; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bale TL, 2002, INTEGR COMP BIOL, V42, P552, DOI 10.1093/icb/42.3.552; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bangasser DA, 2010, MOL PSYCHIATR, V15, P896, DOI 10.1038/mp.2010.66; Catalano RD, 2003, MOL ENDOCRINOL, V17, P395, DOI 10.1210/me.2002-0302; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Cipriano AC, 2016, HORM BEHAV, V81, P59, DOI 10.1016/j.yhbeh.2016.03.002; de Kloet CS, 2006, J PSYCHIATR RES, V40, P550, DOI 10.1016/j.jpsychires.2005.08.002; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; Dong HX, 2018, PSYCHONEUROENDOCRINO, V90, P92, DOI 10.1016/j.psyneuen.2018.02.013; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elharrar E, 2013, BIOL PSYCHIAT, V74, P827, DOI 10.1016/j.biopsych.2013.05.039; Eraslan E, 2015, NOISE HEALTH, V17, P141, DOI 10.4103/1463-1741.155838; Faul M, 2010, TRAUMATIC BRAIN INJU; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Henckens MJAG, 2017, MOL PSYCHIATR, V22, P1691, DOI 10.1038/mp.2016.133; Henckens MJAG, 2016, NAT REV NEUROSCI, V17, P636, DOI 10.1038/nrn.2016.94; Henry B, 2006, J NEUROSCI, V26, P9142, DOI 10.1523/JNEUROSCI.1494-06.2006; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ising M, 2007, EXP CLIN PSYCHOPHARM, V15, P519, DOI 10.1037/1064-1297.15.6.519; Kansagara D., 2013, COMPLICATIONS MILD T; Kash TL, 2015, MOL CELLS, V38, P1, DOI 10.14348/molcells.2015.2261; Kehne John H., 2007, CNS & Neurological Disorders-Drug Targets, V6, P163, DOI 10.2174/187152707780619344; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Lebow MA, 2016, MOL PSYCHIATR, V21, P450, DOI 10.1038/mp.2016.1; Lim MM, 2005, J COMP NEUROL, V487, P75, DOI 10.1002/cne.20532; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Nelson N. W., 2015, BRAIN NEUROTRAUMA MO; Neufeld-Cohen A, 2012, BIOL PSYCHIAT, V72, P437, DOI 10.1016/j.biopsych.2012.05.005; Nuss P, 2015, NEUROPSYCH DIS TREAT, V11, P165, DOI 10.2147/NDT.S58841; Padilla-Coreano N, 2016, NEURON, V89, P857, DOI 10.1016/j.neuron.2016.01.011; Radulovic J, 1999, J NEUROSCI, V19, P5016; Risbrough VB, 2006, HORM BEHAV, V50, P550, DOI 10.1016/j.yhbeh.2006.06.019; Rogers J, 2013, MOL PSYCHIATR, V18, P700, DOI 10.1038/mp.2012.152; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Russell AL, 2018, ENDOCRINOLOGY; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Todorovic C, 2007, EUR J NEUROSCI, V25, P3385, DOI 10.1111/j.1460-9568.2007.05592.x; Tsukahara S, 2009, J NEUROENDOCRINOL, V21, P370, DOI 10.1111/j.1365-2826.2009.01855.x; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Tucker LB, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00013; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Weiser MJ, 2008, EXP NEUROL, V214, P62, DOI 10.1016/j.expneurol.2008.07.013; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wolf EJ, 2013, DEPRESS ANXIETY, V30, P1161, DOI 10.1002/da.22176; Zhang WN, 2014, BEHAV BRAIN RES, V262, P47, DOI 10.1016/j.bbr.2013.10.044; Zhao Y, 2007, J PHARMACOL EXP THER, V323, P846, DOI 10.1124/jpet.107.123208	63	8	9	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 10	2018	392						1	12		10.1016/j.neuroscience.2018.09.014			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY0GY	WOS:000448194900001	30248435				2022-02-06	
J	Amaroli, A; Marcoli, M; Venturini, A; Passalacqua, M; Agnati, LF; Signore, A; Raffetto, M; Maura, G; Benedicenti, S; Cervetto, C				Amaroli, Andrea; Marcoli, Manuela; Venturini, Arianna; Passalacqua, Mario; Agnati, Luigi F.; Signore, Antonio; Raffetto, Mirco; Maura, Guido; Benedicenti, Stefano; Cervetto, Chiara			Near-infrared laser photons induce glutamate release from cerebrocortical nerve terminals	JOURNAL OF BIOPHOTONICS			English	Article						808-nm diode; astrocyte processes; glutamate release; laser light; mouse cerebral cortex; nerve terminals; slices	OPTICAL COMMUNICATION CHANNELS; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE; DIODE-LASER; PARAMECIUM-PRIMAURELIA; ISCHEMIC-STROKE; LIGHT THERAPY; PHOTOBIOMODULATION; EXOCYTOSIS; EXCITOTOXICITY	Although photons have been repeatedly shown to affect the functioning of the nervous system, their effects on neurotransmitter release have never been investigated. We exploited in vitro models that allow effects involving neuron-astrocyte network functioning to be detected (mouse cerebrocortical slices) and dissected these effects at cerebrocortical nerve endings and astrocyte processes. Infrared light proved able to induce glutamate release by stimulating glutamatergic nerve endings.	[Amaroli, Andrea; Signore, Antonio; Benedicenti, Stefano] Univ Genoa, Dept Surg & Diagnost Sci, Largo Rosanna Benzi 8, I-16132 Genoa, Italy; [Marcoli, Manuela; Venturini, Arianna; Maura, Guido; Cervetto, Chiara] Univ Genoa, Dept Pharm, Viale Cembrano 4, I-16148 Genoa, Italy; [Marcoli, Manuela] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy; [Passalacqua, Mario] Univ Genoa, Dept Expt Med, Genoa, Italy; [Agnati, Luigi F.] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy; [Agnati, Luigi F.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Raffetto, Mirco] Univ Genoa, Dept Elect Elect Telecommun Engn & Naval Architec, Genoa, Italy; [Venturini, Arianna] Telethon Inst Genet & Med, Pozzuoli, Italy		Benedicenti, S (corresponding author), Univ Genoa, Dept Surg & Diagnost Sci, Largo Rosanna Benzi 8, I-16132 Genoa, Italy.; Marcoli, M (corresponding author), Univ Genoa, Dept Pharm, Viale Cembrano 4, I-16148 Genoa, Italy.	marcoli@pharmatox.unige.it; benedicenti@unige.it	Amaroli, Andrea/AAB-1932-2021; Amaroli, Andrea/AAC-8693-2022; Cervetto, Chiara/G-6404-2010; Raffetto, Mirco/I-8902-2014; Passalacqua, Mario/W-1973-2019	Amaroli, Andrea/0000-0002-0494-7942; Amaroli, Andrea/0000-0002-0494-7942; Cervetto, Chiara/0000-0001-8290-3008; Passalacqua, Mario/0000-0003-2779-6259; Signore, Antonio/0000-0003-2957-8802; benedicenti, stefano/0000-0003-1302-3079; marcoli, manuela/0000-0003-3261-5264	Universita degli Studi di Genova [D31J1100003005, 020301002054, D31J1100161005, 100008-2015-FS-ALTRIPOSTL_006]	Universita degli Studi di Genova, Grant/Award Numbers: D31J1100003005, 020301002054, D31J1100161005, 100008-2015-FS-ALTRIPOSTL_006	Amaroli A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00123; Amaroli A, 2016, PHOTOCHEM PHOTOBIOL, V92, P854, DOI 10.1111/php.12644; Amaroli A, 2016, PHOTOMED LASER SURG, V34, P564, DOI 10.1089/pho.2015.4035; Amaroli A, 2016, LASER MED SCI, V31, P741, DOI 10.1007/s10103-016-1901-3; Amaroli A, 2015, PHOTOCHEM PHOTOBIOL, V91, P1150, DOI 10.1111/php.12486; Amaroli A, 2015, ATLA-ALTERN LAB ANIM, V43, P155, DOI 10.1177/026119291504300305; Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Auld DS, 2003, NEURON, V40, P389, DOI 10.1016/S0896-6273(03)00607-X; Barclay JW, 2005, CELL CALCIUM, V38, P343, DOI 10.1016/j.ceca.2005.06.012; Battilocchio C, 2013, ACS MED CHEM LETT, V4, P704, DOI 10.1021/ml400079h; Bergersen LH, 2009, NEUROSCIENCE, V158, P260, DOI 10.1016/j.neuroscience.2008.03.074; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Cervetto C, 2017, J NEUROCHEM, V140, P268, DOI 10.1111/jnc.13885; Cervetto C, 2016, NEUROMOL MED, V18, P50, DOI 10.1007/s12017-015-8377-3; Cervetto C, 2015, NEUROPHARMACOLOGY, V99, P396, DOI 10.1016/j.neuropharm.2015.08.011; Cervetto C, 2010, J PHARMACOL EXP THER, V332, P210, DOI 10.1124/jpet.109.154955; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Ghezali G, 2016, BRAIN STRUCT FUNCT, V221, P2427, DOI 10.1007/s00429-015-1070-3; Hadis MA, 2016, LASER MED SCI, V31, P789, DOI 10.1007/s10103-016-1914-y; Huang YY, 2014, J BIOPHOTONICS, V7, P656, DOI 10.1002/jbio.201300125; Huang YY, 2012, J BIOPHOTONICS, V5, P827, DOI 10.1002/jbio.201200077; Ivannikov MV, 2013, J MOL NEUROSCI, V49, P223, DOI 10.1007/s12031-012-9848-8; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Kumar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36508; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2010, ANN MED, V42, P576, DOI 10.3109/07853890.2010.532811; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; Liang HL, 2008, NEUROSCIENCE, V153, P963, DOI 10.1016/j.neuroscience.2008.03.042; Liu T, 2011, J NEUROSCI, V31, P10593, DOI 10.1523/JNEUROSCI.6401-10.2011; Marcoli M, 2006, NEUROCHEM INT, V49, P12, DOI 10.1016/j.neuint.2005.12.010; Michalikova S, 2008, NEUROBIOL LEARN MEM, V89, P480, DOI 10.1016/j.nlm.2007.07.014; Montana V, 2006, GLIA, V54, P700, DOI 10.1002/glia.20367; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Quirk BJ, 2012, PHOTOMED LASER SURG, V30, P523, DOI 10.1089/pho.2012.3261; Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042; Reichenbach A, 2010, BRAIN RES REV, V63, P11, DOI 10.1016/j.brainresrev.2010.02.003; Rochkind S, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E8; Tang RD, 2014, J PHOTOCH PHOTOBIO B, V139, P71, DOI 10.1016/j.jphotobiol.2013.12.008; Tang RD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085643; Wang Z, 2016, P NATL ACAD SCI USA, V113, P8753, DOI 10.1073/pnas.1604855113; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Wu XJ, 2009, LASER SURG MED, V41, P36, DOI 10.1002/lsm.20729; Zarkeshian P, 2018, FRONT BIOSCI-LANDMRK, V23, P1407, DOI 10.2741/4652	47	8	8	0	5	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1864-063X	1864-0648		J BIOPHOTONICS	J. Biophotonics	NOV	2018	11	11							e201800102	10.1002/jbio.201800102			6	Biochemical Research Methods; Biophysics; Optics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Optics	HD0ZM	WOS:000452238300013	29931754				2022-02-06	
J	Lasry, O; Dendukuri, N; Marcoux, J; Buckeridge, DL				Lasry, Oliver; Dendukuri, Nandini; Marcoux, Judith; Buckeridge, David L.			Accuracy of Administrative Health Data for Surveillance of Traumatic Brain Injury: A Bayesian Latent Class Analysis	EPIDEMIOLOGY			English	Article						administrative health data; latent class analysis; surveillance; traumatic brain injury	DIAGNOSTIC-TESTS; INTERNATIONAL-CLASSIFICATION; HEAD-INJURY; POPULATION; EPIDEMIOLOGY; MODEL; DISEASE; CODES	Background: Traumatic brain injury surveillance provides information for allocating resources to prevention efforts. Administrative data are widely available and inexpensive but may underestimate traumatic brain injury burden by misclassifying cases. Moreover, previous studies evaluating the accuracy of administrative data surveillance case definitions were at risk of bias by using imperfect diagnostic definitions as reference standards. We assessed the accuracy (sensitivity/specificity) of traumatic brain injury surveillance case definitions in administrative data, without using a reference standard, to estimate incidence accurately. Methods: We used administrative data from a 25% random sample of Montreal residents from 2000 to 2014. We used hierarchical Bayesian latent class models to estimate the accuracy of widely used traumatic brain injury case definitions based on the International Classification of Diseases, or on head radiologic examinations, covering the full injury spectrum in children, adults, and the elderly. We estimated measurement error-adjusted age- and severity-specific incidence. Results: The adjusted traumatic brain injury incidence was 76 (95% CrI = 68, 85) per 10,000 person-years (underestimated as 54 [95% CrI = 54, 55] per 10,000 without adjustment). The most sensitive case definitions were radiologic examination claims in adults/elderly (0.48; 95% CrI = 0.43, 0.55 and 0.66; 95% CrI = 0.54, 0.79) and emergency department claims in children (0.45; 95% CrI = 0.39, 0.52). The most specific case definitions were inpatient claims and discharge abstracts (0.99; 95% CrI = 0.99, 1.00). We noted strong secular trends in case definition accuracy. Conclusions: Administrative data remain a useful tool for conducting traumatic brain injury surveillance and epidemiologic research when measurement error is adjusted for.	[Lasry, Oliver; Dendukuri, Nandini; Buckeridge, David L.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Lasry, Oliver; Marcoux, Judith] McGill Univ, Ctr Hlth, Dept Neurol & Neurosurg, Montreal, PQ, Canada		Lasry, O (corresponding author), 1140 Pine Ave West, Montreal, PQ H3A 1A3, Canada.	oliver.lasry@mail.mcgill.ca			Canadian Institutes of Health Research (CIHR) Vanier Canada Graduate ScholarshipCanadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec - Sante (FRQS)Fonds de la Recherche en Sante du Quebec; CIHRCanadian Institutes of Health Research (CIHR)	O.L. reports having been supported by the Canadian Institutes of Health Research (CIHR) Vanier Canada Graduate Scholarship for his doctoral studies. N.D. reports having received a salary award from the Fonds de Recherche du Quebec - Sante (FRQS). D.L.B. reports having received a salary award from the CIHR.	Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Barker-Collo S, 2016, NEUROEPIDEMIOLOGY, V47, P46, DOI 10.1159/000448403; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P1, DOI 10.1159/000170084; Bernatsky S, 2007, RHEUMATOLOGY, V46, P1814, DOI 10.1093/rheumatology/kem233; Bernatsky S, 2005, STAT MED, V24, P2365, DOI 10.1002/sim.2116; Brazinova A, 2015, J NEUROTRAUM, V30, P1; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Centers for Disease Control and Prevention, 2010, TECHN GUID INT DIS S, P1; Chan V, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-97; Dendukuri N, 2009, STAT MED, V28, P441, DOI 10.1002/sim.3470; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Garrett ES, 2000, BIOMETRICS, V56, P1055, DOI 10.1111/j.0006-341X.2000.01055.x; Gelman A, 1996, STAT SINICA, V6, P733; Ghosh J, 2011, BIOMETRICS, V67, P917, DOI 10.1111/j.1541-0420.2010.01502.x; Izadi M., 2013, P 27 M AAAI, P35; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; Kostoulas P, 2017, STAT MED, V36, P3603, DOI 10.1002/sim.7316; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McCutcheon AL, 1987, LATENT CLASS ANAL; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Orientations ministerielles pour le traumatisme craniocerebral leger 2005-2010, OR MIN TRAUM CRAN LE; Qu YS, 1996, BIOMETRICS, V52, P797, DOI 10.2307/2533043; Richard YF, 2015, AM J EPIDEMIOL, V182, P177, DOI 10.1093/aje/kwv014; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363	32	8	8	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1044-3983	1531-5487		EPIDEMIOLOGY	Epidemiology	NOV	2018	29	6					876	884		10.1097/EDE.0000000000000888			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	GW1ZM	WOS:000446681600029	29994868				2022-02-06	
J	Orru', E; Huisman, TAGM; Izbudak, I				Orru', Emanuele; Huisman, Thierry A. G. . M.; Izbudak, Izlem			Prevalence, Patterns, and Clinical Relevance of Hypoxic-Ischemic Injuries in Children Exposed to Abusive Head Trauma	JOURNAL OF NEUROIMAGING			English	Article						Hypoxia-ischemia; hypoxic-ischemic; abusive; trauma; pediatric	IMAGING DTI FINDINGS; SHAKEN BABY SYNDROME; BRAIN-INJURY; YOUNG-CHILDREN; MRI; HEMORRHAGE; INFANTS; DAMAGE; COGNITION; OUTCOMES	BACKGROUND AND PURPOSE Hypoxic-ischemic injuries (HIIs) are a scarcely investigated but important cause of morbidity and mortality in children who suffered abusive head trauma (AHT). The purpose of this study is to determine: (a) prevalence, types, and clinical relevance of cytotoxic edema compatible with HII in nonpenetrating AHT, (b) their relationship to other classic neuroimaging findings of AHT, and (c) their correlation with clinical outcomes. METHODS RESULTS Diffusion-weighted imaging sequences of magnetic resonance imagings performed on children under 5 years diagnosed with AHT were reviewed to detect the most common patterns of acute parenchymal damage. Patterns of cytotoxic edema were described, and HII-compatible ones divided in subtypes. Correlation between HII, fractures, and subdural hemorrhages (SDHs) and with clinical outcomes was determined using imaging and available follow-up data. Out of 57 patients, 36.8% showed lesions compatible with HII. A predominantly asymmetric cortical distribution was observed in 66.7% of cases, while 33.3% had diffused both cortical and deep gray/white matter distribution injury. Traumatic axonal injuries and focal contusions were less common. There was no significant correlation between the presence of SDH (P = .6) or skull fractures (P = .53) and HII. HII was the most severe form of parenchymal damage in terms of in-hospital mortality and morbidity at follow-up. CONCLUSIONS HII is the most common type of parenchymal damage in children victim of AHT, being present in 1/3 of patients with this condition, and correlates with more severe outcomes. Its presence is independent from other classic traumatic findings such as SDH and fractures.	[Orru', Emanuele; Izbudak, Izlem] Johns Hopkins Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div Neuroradiol, Baltimore, MD USA; [Huisman, Thierry A. G. . M.] Johns Hopkins Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div Pediat Radiol & Pediat Neuroradiol, Baltimore, MD USA		Orru', E (corresponding author), Johns Hopkins Univ Hosp, Div Neuroradiol, 600 N Wolfe St JHOC Phipps B-100, Baltimore, MD 21287 USA.	surgeon.ema@gmail.com					Ashwal S, 2010, DEV NEUROSCI-BASEL, V32, P343, DOI 10.1159/000316801; Atkinson JLD, 1998, J TRAUMA, V45, P941, DOI 10.1097/00005373-199811000-00016; Babikian T, 2009, PEDIATR NEUROL, V41, P406, DOI 10.1016/j.pediatrneurol.2009.06.002; Byard RW, 2007, PEDIATR DEVEL PATHOL, V10, P348, DOI 10.2350/06-08-0154.1; Cohen MC, 2009, PEDIATR DEVEL PATHOL, V12, P169, DOI 10.2350/08-08-0509.1; Dijkhuizen RM, 1998, STROKE, V29, P695, DOI 10.1161/01.STR.29.3.695; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Flom L, 2016, PEDIATR RADIOL, V46, P519, DOI 10.1007/s00247-015-3500-z; Foerster BR, 2009, J PEDIATR-US, V154, P573, DOI 10.1016/j.jpeds.2008.09.051; Gabaeff SC, 2011, WEST J EMERG MED, V12, P144; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gencturk M, 2018, CLIN NEURORADIOL; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Huang BY, 2008, RADIOGRAPHICS, V28, P417, DOI 10.1148/rg.282075066; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Kadom N, 2014, PEDIATR RADIOL, V44, P839, DOI 10.1007/s00247-014-2874-7; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kralik SF, 2017, AM J NEURORADIOL, V38, P807, DOI 10.3174/ajnr.A5093; KRUGMAN RD, 1993, PEDIATRICS, V92, P872; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Matschke J, 2015, INT J LEGAL MED, V129, P105, DOI 10.1007/s00414-014-1060-7; McKinney AM, 2008, PEDIATR RADIOL, V38, P164, DOI 10.1007/s00247-007-0673-0; National center for injury prevention and control, 2018, RAT TBI REL DEATHS A; Parizel PM, 2003, PEDIATR RADIOL, V33, P868, DOI 10.1007/s00247-003-1025-3; Poussaint TY, 2002, NEUROIMAG CLIN N AM, V12, P271, DOI 10.1016/S1052-5149(02)00005-9; Punt J, 2004, Pediatr Rehabil, V7, P173, DOI 10.1080/13638490410001711515; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Roberts RM, 2016, DEV NEUROPSYCHOL, V41, P176, DOI 10.1080/87565641.2016.1186167; Ryan ME, 2014, J AM COLL RADIOL, V11, P939, DOI 10.1016/j.jacr.2014.07.017; Shannon P, 2001, LANCET, V358, P686, DOI 10.1016/S0140-6736(01)05849-4; Squier W, 2011, ACTA NEUROPATHOL, V122, P519, DOI 10.1007/s00401-011-0875-2; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Tanoue K, 2013, ACTA PAEDIATR, V102, P805, DOI 10.1111/apa.12281; von Kummer R, 2017, NEURORADIOLOGY, V59, P545, DOI 10.1007/s00234-017-1847-6; Wright JN, 2017, AM J ROENTGENOL, V208, P991, DOI 10.2214/AJR.16.17602; Zimmerman RA, 2007, J NEURORADIOLOGY, V34, P109, DOI 10.1016/j.neurad.2007.01.124	42	8	8	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	NOV-DEC	2018	28	6					608	614		10.1111/jon.12555			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	HA1QD	WOS:000449993400006	30125430				2022-02-06	
J	Phelan, SM; Bangerter, LR; Friedemann-Sanchez, G; Lackore, KA; Morris, MA; Van Houtven, CH; Carlson, KF; van Ryn, M; Harden, KJ; Griffin, JM				Phelan, Sean M.; Bangerter, Lauren R.; Friedemann-Sanchez, Greta; Lackore, Kandace A.; Morris, Megan A.; Van Houtven, Courtney H.; Carlson, Kathleen F.; van Ryn, Michelle; Harden, Kristin J.; Griffin, Joan M.			The Impact of Stigma on Community Reintegration of Veterans With Traumatic Brain Injury and the Well-Being of Their Caregivers	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Caregiving; Mental health prejudice; Rehabilitation; Stigma; Traumatic brain injury	ZARIT BURDEN INTERVIEW; MENTAL-ILLNESS; PARTICIPATION ASSESSMENT; ENACTED STIGMA; PEOPLE; HEALTH; STRAIN; INDIVIDUALS; RELATIVES; MILITARY	Objective: To assess the association between perceived stigma and discrimination and caregiver strain, caregiver well-being, and patient community reintegration. Design: A cross-sectional survey study of 564 informal caregivers of U.S. military service veterans of wars in Iraq and Afghanistan who experienced traumatic brain injuries or polytrauma (TBI/PT). Setting: Care settings of community-dwelling former inpatients of U.S. Department of Veterans Affairs Polytrauma Rehabilitation Centers. Participants: Caregivers of former inpatients (N = 564), identified through next-of-kin records and subsequent nominations. Interventions: Not applicable. Main Outcome Measures: Caregiver strain, depression, anxiety, loneliness, and self-esteem; as well as care recipient community reintegration, a key aspect of TBI/PT rehabilitation. Results: Family stigma was associated with strain, depression, anxiety, loneliness, lower self-esteem, and less community reintegration. Caregiver stigma-by-association was associated with strain, depression, anxiety, loneliness, and lower self-esteem. Care recipient stigma was associated with caregiver strain, depression, anxiety, loneliness, lower self-esteem, and less community reintegration. Conclusions: Perceived stigma may be a substantial source of stress for caregivers of U.S. military veterans with TBI/PT, and may contribute to poor outcomes for the health of caregivers and for the community reintegration of the veterans for whom they provide care. (C) 2018 by the American Congress of Rehabilitation Medicine.	[Phelan, Sean M.; Bangerter, Lauren R.; Harden, Kristin J.; Griffin, Joan M.] Mayo Clin, Coll Med, Robert D & Patricia E Kern Mayo Clin Ctr Sci Hlth, Rochester, MN USA; [Phelan, Sean M.; Lackore, Kandace A.; van Ryn, Michelle; Harden, Kristin J.; Griffin, Joan M.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA; [Friedemann-Sanchez, Greta] Univ Minnesota, Hubert H Humphrey Sch Publ Affairs, Minneapolis, MN USA; [Morris, Megan A.] Univ Colorado Aurora, Adult & Child Consortium Hlth Outcomes Res & Deli, Anschutz Med Campus, Aurora, CO USA; [Van Houtven, Courtney H.] Durham Vet Affairs Hlth Care Syst, Durham, NC USA; [Van Houtven, Courtney H.] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC USA; [Carlson, Kathleen F.] Vet Affairs Portland Hlth Care Syst, Portland, OR USA; [Carlson, Kathleen F.; van Ryn, Michelle] Oregon Hlth & Sci Univ, Portland, OR 97201 USA		Phelan, SM (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	phelan.sean@mayo.edu		Fischer, Kristin/0000-0001-8235-4942; Friedemann-Sanchez, Greta/0000-0002-0493-7218; Van Houtven, Courtney/0000-0002-0783-1611	Health Services Research and Development Service (U.S. Department of Veteran Affairs) [SDR-07-044]; U.S. Department of Veterans AffairsUS Department of Veterans Affairs	Supported by the U.S. Department of Veterans Affairs. Veterans Health Administration. Office of Research and Development, and a grant from the Health Services Research and Development Service (U.S. Department of Veteran Affairs) (grant no. SDR-07-044). The findings and conclusions presented in this manuscript are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs or the Health Services Research and Development Service. The sponsor was not involved in any aspect of the study's design and conduct; data collection, management, analysis, or interpretation of data; or preparation, review, or approval of the manuscript.	American Red Cross, MIL VET CAR NETW; Baronet AM, 1999, CLIN PSYCHOL REV, V19, P819, DOI 10.1016/S0272-7358(98)00076-2; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; BLUM NS, 1991, J CONTEMP ETHNOGR, V20, P263, DOI 10.1177/089124191020003002; Bogner J, 2013, J HEAD TRAUMA REHAB, V28, P337, DOI 10.1097/HTR.0b013e31829af969; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Brenner LA, 2015, REHABIL PSYCHOL, V60, P277, DOI 10.1037/rep0000048; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Corrigan P.W., 2004, J MENT HEALTH, V13, P537, DOI [DOI 10.1080/09638230400017004, 10.1080/09638230400017004]; Corrigan PW, 2006, J FAM PSYCHOL, V20, P239, DOI 10.1037/0893-3200.20.2.239; Doyle ME, 2005, PSYCHIAT QUART, V76, P361, DOI 10.1007/s11126-005-4972-z; Gray DE, 2002, SOCIOL HEALTH ILL, V24, P734, DOI 10.1111/1467-9566.00316; Green SE, 2007, SOC SCI MED, V64, P150, DOI 10.1016/j.socscimed.2006.08.025; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; JACOBY A, 1994, SOC SCI MED, V38, P269, DOI 10.1016/0277-9536(94)90396-4; Karlovits T, 1999, BRAIN INJURY, V13, P845; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kittikorn N, 2006, QUAL HEALTH RES, V16, P1286, DOI 10.1177/1049732306293992; Larson JE, 2008, ACAD PSYCHIATR, V32, P87, DOI 10.1176/appi.ap.32.2.87; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Link BG, 1997, J HEALTH SOC BEHAV, V38, P177, DOI 10.2307/2955424; Markowitz FE, 1998, J HEALTH SOC BEHAV, V39, P335, DOI 10.2307/2676342; McLellan T, 2010, J INT NEUROPSYCH SOC, V16, P705, DOI 10.1017/S1355617710000524; NEUBERG SL, 1994, PERS SOC PSYCHOL B, V20, P196, DOI 10.1177/0146167294202007; Perkins M, 2013, J GERONTOL B-PSYCHOL, V68, P504, DOI 10.1093/geronb/gbs084; Phelan JC, 1998, SCHIZOPHRENIA BULL, V24, P115, DOI 10.1093/oxfordjournals.schbul.a033304; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; Phelan SM, 2010, DISABIL HLTH J, V3, pe5; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Pryor JB, 2012, J PERS SOC PSYCHOL, V102, P224, DOI 10.1037/a0026270; Rosenberg M., 1979, CONCEIVING SELF; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Sayer NA, 2011, J TRAUMA STRESS, V24, P660, DOI 10.1002/jts.20706; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Siegert RJ, 2010, J REHABIL MED, V42, P302, DOI 10.2340/16501977-0511; SKAFF MM, 1992, GERONTOLOGIST, V32, P656, DOI 10.1093/geront/32.5.656; Struening FL, 2001, PSYCHIATR SERV, V52, P1633; Szmukler GI, 1996, SOC PSYCH PSYCH EPID, V31, P137, DOI 10.1007/BF00785760; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Trudel TM, 2007, J REHABIL RES DEV, V44, P1007, DOI 10.1682/JRRD.2006.12.0167; Van Houtven CH, 2012, INQUIRY-J HEALTH CAR, V49, P339, DOI 10.5034/inquiryjrnl_49.04.01; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P540, DOI 10.1016/j.apmr.2010.12.002; Williams DR, 2008, AM J PUBLIC HEALTH, V98, pS29, DOI 10.2105/AJPH.98.Supplement_1.S29; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	45	8	8	2	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2018	99	11					2222	2229		10.1016/j.apmr.2018.04.007			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HB8TD	WOS:000451362700012	29729228				2022-02-06	
J	Zeiler, FA; Czosnyka, M; Smielewski, P				Zeiler, Frederick A.; Czosnyka, Marek; Smielewski, Peter			Optimal cerebral perfusion pressure via transcranial Doppler in TBI: application of robotic technology	ACTA NEUROCHIRURGICA			English	Article						CPP optimum; Robotic transcranial Doppler; TCD; Traumatic brain injury; TBI	TRAUMATIC BRAIN-INJURY; AUTOREGULATION MEASUREMENT TECHNIQUES; REACTIVITY; SONOGRAPHY; GUIDELINES	Individualized cerebral perfusion pressure (CPP) targets may be derived via assessing the minimum of the parabolic relationship between an index of cerebrovascular reactivity and CPP. This minimum is termed the optimal CPP (CPPopt), and literature suggests that the further away CPP is from CPPopt, the worse is clinical outcome in adult traumatic brain injury (TBI). Typically, CPPopt estimation is based on intracranial pressure (ICP)-derived cerebrovascular reactivity indices, given ICP is commonly measured and provides continuous long duration data streams. The goal of this study is to describe for the first time the application of robotic transcranial Doppler (TCD) and the feasibility of determining CPPopt based on TCD autoregulation indices.	[Zeiler, Frederick A.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 0QQ, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada.	umzeiler@myumanitoba.ca; mc141@medschl.cam.ac.uk; ps10011@cam.ac.uk		Zeiler, Frederick/0000-0003-1737-0510; czosnyka, marek/0000-0003-2446-8006			Aries MJH, 2016, CRIT CARE MED, V44, pE996, DOI 10.1097/CCM.0000000000001816; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Blanco P, 2016, J ULTRAS MED, V35, P669, DOI 10.7863/ultra.15.12022; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; British Medical Ultrasound Society, 2012, BRIT MED ULTR SOC GU; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; Calviello LA, 2017, NEUROCRIT CARE, V27, P392, DOI 10.1007/s12028-017-0404-9; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Harris GR, 2016, ULTRASOUND MED BIOL, V42, P345, DOI 10.1016/j.ultrasmedbio.2015.09.016; Howells T, 2018, CRIT CARE MED, V46, pe235, DOI 10.1097/CCM.0000000000002930; Khan Marium Naveed, 2017, Surg Neurol Int, V8, P51, DOI 10.4103/sni.sni_403_16; Le Roux P, 2014, NEUROCRIT CARE, V21, P297, DOI 10.1007/s12028-014-0081-x; Liu XY, 2017, J NEUROTRAUM, V34, P3081, DOI 10.1089/neu.2017.5003; Mackinnon AD, 2004, STROKE, V35, P73, DOI 10.1161/01.STR.0000106915.83041.0A; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Postert T, 1998, J ULTRAS MED, V17, P91, DOI 10.7863/jum.1998.17.2.91; Robba C, 2018, J NEUROSCI RES, V96, P720, DOI 10.1002/jnr.24148; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; ter Haar G., 2012, SAFE USE ULTRASOUND, V3rd ed.; Thiara S, 2018, CAN J NEUROL SCI, P1; Varsos GV, 2015, J NEUROSURG, V123, P638, DOI 10.3171/2014.10.JNS14613; Varsos GV, 2014, NEUROCRIT CARE, V20, P142, DOI 10.1007/s12028-013-9868-4; Watt B., 2012, THESIS; Zeiler F, 2018, CAN J NEUROL SCI; Zeiler FA, 2018, CRIT ULTRASOUND J, V10, DOI 10.1186/s13089-018-0097-0; Zeiler FA, 2018, J NEUROTRAUM, V35, P314, DOI 10.1089/neu.2017.5364; Zeiler FA, 2018, J NEUROTRAUM, V35, P1559, DOI 10.1089/neu.2017.5596; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086; Zeiler FA, 2017, J NEUROTRAUM, V34, P3207, DOI 10.1089/neu.2017.5085	34	8	10	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2018	160	11					2149	2157		10.1007/s00701-018-3687-5			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GZ7PP	WOS:000449674300012	30267208	Green Published, hybrid			2022-02-06	
J	Nishijima, DK; VanBuren, J; Hewes, HA; Myers, SR; Stanley, RM; Adelson, PD; Barnhard, SE; Bobinski, M; Ghetti, S; Holmes, JF; Roberts, I; Schalick, WO; Tran, NK; Tzimenatos, LS; Dean, JM; Kuppermann, N				Nishijima, Daniel K.; VanBuren, John; Hewes, Hilary A.; Myers, Sage R.; Stanley, Rachel M.; Adelson, P. David; Barnhard, Sarah E.; Bobinski, Matthew; Ghetti, Simona; Holmes, James F.; Roberts, Ian; Schalick, Walton O., III; Tran, Nam K.; Tzimenatos, Leah S.; Dean, J. Michael; Kuppermann, Nathan		TIC-TOC Collaborators Pediat	Traumatic injury clinical trial evaluating tranexamic acid in children (TIC-TOC): study protocol for a pilot randomized controlled trial	TRIALS			English	Article						Children; Trauma; Tranexamic acid	THERAPEUTIC HYPOTHERMIA; ACUTE COAGULOPATHY; CARDIAC-SURGERY; BRAIN-INJURY; HYPERFIBRINOLYSIS; CHALLENGES; EXPERIENCE; BARRIERS; EFFICACY; ARREST	BackgroundTrauma is the leading cause of morbidity and mortality in children in the United States. The antifibrinolytic drug tranexamic acid (TXA) improves survival in adults with traumatic hemorrhage, however, the drug has not been evaluated in a clinical trial in severely injured children. We designed the Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children (TIC-TOC) trial to evaluate the feasibility of conducting a confirmatory clinical trial that evaluates the effects of TXA in children with severe trauma and hemorrhagic injuries.MethodsChildren with severe trauma and evidence of hemorrhagic torso or brain injuries will be randomized to one of three arms: (1) TXA dose A (15mg/kg bolus dose over 20min, followed by 2mg/kg/hr infusion over 8h), (2) TXA dose B (30mg/kg bolus dose over 20min, followed by 4mg/kg/hr infusion over 8h), or (3) placebo. We will use permuted-block randomization by injury type: hemorrhagic brain injury, hemorrhagic torso injury, and combined hemorrhagic brain and torso injury. The trial will be conducted at four pediatric Level I trauma centers. We will collect the following outcome measures: global functioning as measured by the Pediatric Quality of Life (PedsQL) and Pediatric Glasgow Outcome Scale Extended (GOS-E Peds), working memory (digit span test), total amount of blood products transfused in the initial 48h, intracranial hemorrhage progression at 24h, coagulation biomarkers, and adverse events (specifically thromboembolic events and seizures).DiscussionThis multicenter trial will provide important preliminary data and assess the feasibility of conducting a confirmatory clinical trial that evaluates the benefits of TXA in children with severe trauma and hemorrhagic injuries to the torso and/or brain.Trial registrationClinicalTrials.gov registration number: NCT02840097. Registered on 14 July 2016.	[Nishijima, Daniel K.; Holmes, James F.; Tzimenatos, Leah S.; Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, 4150 V St,PSSB 2100, Sacramento, CA 95817 USA; [VanBuren, John; Dean, J. Michael] Univ Utah, Sch Med, Dept Pediat, 295 Chipeta Way, Salt Lake City, UT 84108 USA; [Hewes, Hilary A.] Univ Utah, Sch Med, Dept Pediat, Div Pediat Emergency Med,Primary Childrens Hosp, 100 N Mario Capecchi Dr, Salt Lake City, UT 84113 USA; [Myers, Sage R.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat,Div Pediat Emergency Med, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Stanley, Rachel M.] Ohio State Univ, Sch Med, Dept Pediat, Div Pediat Emergency Med,Nationwide Childrens Hos, 700 Childrens Dr, Columbus, OH 43205 USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Dept Pediat, 1919 E Thomas Rd, Phoenix, AZ 85016 USA; [Barnhard, Sarah E.] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, 2315 Stockton Blvd, Sacramento, CA 95817 USA; [Bobinski, Matthew] Univ Calif Davis, Sch Med, Dept Radiol, 2315 Stockton Blvd, Sacramento, CA 95817 USA; [Ghetti, Simona] Univ Calif Davis, Dept Psychol, 102K Young Hall,1 Shields Ave, Davis, CA 95616 USA; [Roberts, Ian] London Sch Hyg & Trop Med, Dept Populat Hlth, Keppel St, London WC1E 7HT, England; [Schalick, Walton O., III] Univ Wisconsin, Dept Orthoped & Rehabil, 317 Knutson Dr, Madison, WI 53704 USA; [Tran, Nam K.] Univ Calif Davis, Dept Pathol & Lab Med, 3422 Tupper Hall, Davis, CA 95616 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, 4150 V St,PSSB 2100, Sacramento, CA 95817 USA		Nishijima, DK (corresponding author), Univ Calif Davis, Sch Med, Dept Emergency Med, 4150 V St,PSSB 2100, Sacramento, CA 95817 USA.	dnishijima@ucdavis.edu	Adelson, David/W-2083-2019	Tran, Nam/0000-0003-1565-0025	National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R34HL135214]; Utah Trial Innovation Center - National Center for Advancing Translational Sciences (NCATS) [U24TR001597]; Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB), Emergency Medical Services for Children (EMSC) Network Development Demonstration Program [U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, U03MC22685]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R34HL135214] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health under Award Number R34HL135214. Additional support has been provided by the Utah Trial Innovation Center funded by the National Center for Advancing Translational Sciences (NCATS) under cooperative agreement U24TR001597. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This project is also supported in part by the Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB), Emergency Medical Services for Children (EMSC) Network Development Demonstration Program under cooperative agreements U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, and U03MC22685. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, Health and Human Services (HHS) or the US Government. The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Aban IB, 2008, J NEUROIMMUNOL, V201, P80, DOI 10.1016/j.jneuroim.2008.05.031; [Anonymous], 2015, LEAD CAUS DEATH AG G; [Anonymous], TRANSEXAMIC ACID TRA; [Anonymous], MAJ TRAUM US TRAN AC; [Anonymous], INJ CIOL FACTS; Beca J, 2015, CRIT CARE MED, V43, P1458, DOI 10.1097/CCM.0000000000000947; Beno S, 2014, CRIT CARE, V18, DOI 10.1186/cc13965; Beslow LA, 2013, JAMA NEUROL, V70, P448, DOI 10.1001/jamaneurol.2013.1033; Beslow LA, 2010, STROKE, V41, P691, DOI 10.1161/STROKEAHA.109.566430; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Burman WJ, 2001, ANN INTERN MED, V134, P152, DOI 10.7326/0003-4819-134-2-200101160-00016; Califf RM, 2006, CLIN TRIALS, V3, P496, DOI 10.1177/1740774506073173; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Choi PM, 2014, CURR OPIN PEDIATR, V26, P343, DOI 10.1097/MOP.0000000000000086; Dilts DM, 2006, J CLIN ONCOL, V24, P4545, DOI 10.1200/JCO.2005.05.0104; Duley L, 2008, CLIN TRIALS, V5, P40, DOI 10.1177/1740774507087704; Faraoni D, 2014, ANESTH ANALG, V118, P628, DOI 10.1213/ANE.0000000000000080; Faraoni D, 2013, CURR OPIN ANESTHESIO, V26, P193, DOI 10.1097/ACO.0b013e32835e8e39; Faraoni D, 2012, EUR J CARDIO-THORAC, V42, P781, DOI 10.1093/ejcts/ezs127; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Hasegawa Tomomi, 2014, Asian Cardiovasc Thorac Ann, V22, P1039, DOI 10.1177/0218492314527991; Holmes JF, 2001, PEDIATR EMERG CARE, V17, P324, DOI 10.1097/00006565-200110000-00002; Kleinman JT, 2011, DEV MED CHILD NEUROL, V53, P281, DOI 10.1111/j.1469-8749.2010.03798.x; Koster A, 2015, ANESTHESIOLOGY, V123, P214, DOI 10.1097/ALN.0000000000000688; Levy JH, 2010, LANCET, V376, P3, DOI 10.1016/S0140-6736(10)60939-7; Liras IN, 2015, SURGERY, V158, P812, DOI 10.1016/j.surg.2015.05.004; Lyttle MD, 2014, ARCH DIS CHILD, V99, P602, DOI 10.1136/archdischild-2013-304998; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Nishijima DK, 2016, J EMERG MED, V50, P868, DOI 10.1016/j.jemermed.2016.02.004; Pasquali SK, 2012, PEDIATRICS, V130, pE1269, DOI 10.1542/peds.2011-3565; Pemberton VL, 2013, PEDIATR CRIT CARE ME, V14, P19, DOI 10.1097/PCC.0b013e31825b860b; Pusateri AE, 2013, SHOCK, V39, P121, DOI 10.1097/SHK.0b013e318280409a; Rivkin MJ, 2015, STROKE, V46, P880, DOI 10.1161/STROKEAHA.114.008210; Roberts I, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5839; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Schroen AT, 2010, CLIN TRIALS, V7, P312, DOI 10.1177/1740774510374973; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shimizu K, 2011, J ANESTH, V25, P823, DOI 10.1007/s00540-011-1235-z; Silbergleit R, 2012, ACAD EMERG MED, V19, P448, DOI 10.1111/j.1553-2712.2012.01328.x; Stanley RM, 2017, ACAD EMERG MED, V24, P31, DOI 10.1111/acem.13085; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Vogel AM, 2013, J PEDIATR SURG, V48, P1371, DOI 10.1016/j.jpedsurg.2013.03.036; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb	46	8	8	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	OCT 30	2018	19								593	10.1186/s13063-018-2974-z			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GY9ZJ	WOS:000449012700001	30376893	Green Published, Green Accepted, gold			2022-02-06	
J	Wright, AD; Smirl, JD; Bryk, K; Fraser, S; Jakovac, M; van Donkelaar, P				Wright, Alexander D.; Smirl, Jonathan D.; Bryk, Kelsey; Fraser, Sarah; Jakovac, Michael; van Donkelaar, Paul			Cerebral Autoregulation Is Disrupted Following a Season of Contact Sports Participation	FRONTIERS IN NEUROLOGY			English	Article						cerebral blood flow; autoregulation; blood pressure; transfer function analysis; repetitive subconcussive head impacts	TRANSCRANIAL DOPPLER ULTRASOUND; COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; HEAD IMPACT EXPOSURE; HIGH-SCHOOL FOOTBALL; ICE HOCKEY PLAYERS; SOCCER PLAYERS; BLOOD-PRESSURE; CONCUSSION; FLOW	Repetitive subconcussive head impacts across a season of contact sports participation are associated with a number of deficits in brain function. To date, no research has investigated the effect of such head impact exposure on dynamic cerebral autoregulation (dCA). To address this issue, 179 elite, junior-level (age 19.6 +/- 1.5 years) contact sport (ice hockey, American football) athletes were recruited for pre-season testing. Fifty-two non-concussed athletes returned for post-season testing. Fifteen non-contact sport athletes (age 20.4 +/- 2.2) also completed pre- and postseason testing. dCA was assessed via recordings of beat-by-beat mean arterial pressure (MAP) and middle cerebral artery blood velocity (MCAv) using finger photoplethysmography and transcranial Doppler ultrasound, respectively, during repetitive squat-stand maneuvers at 0.05 and 0.10 Hz. Transfer function analysis was used to determine Coherence (correlation), Gain (response amplitude), and Phase (response latency) of the MAP-MCAv relationship. Results showed that in contact sport athletes, Phase was reduced (p = 0.027) and Gain increased (p < 0.001) at post-season compared to pre-season during the 0.10 Hz squat-stand maneuvers, indicating cerebral autoregulatory impairment in both the latency and magnitude of the response. Changes in Phase were greater in athletes experiencing higher numbers and severity of head impacts. By contrast, no changes in dCA were observed in non-contact sport controls. Taken together, these results demonstrate that repetitive subconcussive head impacts occurring across a season of contact sports participation are associated with exposure-dependent impairments in the cerebrovascular pressure-buffering system capacity. It is unknown how long these deficits persist or if they accumulate year-over-year.	[Wright, Alexander D.] Univ British Columbia, MD PhD Program, Vancouver, BC, Canada; [Wright, Alexander D.; Fraser, Sarah; Jakovac, Michael] Univ British Columbia Okanagan, Reichwald Hlth Sci Ctr, Southern Med Program, Kelowna, BC, Canada; [Wright, Alexander D.] Univ British Columbia, Expt Med Program, Fac Med, Vancouver, BC, Canada; [Wright, Alexander D.; Smirl, Jonathan D.; Bryk, Kelsey; van Donkelaar, Paul] Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC, Canada; [Bryk, Kelsey] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA		van Donkelaar, P (corresponding author), Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC, Canada.	paul.vandonkelaar@ubc.ca		Smirl, Jonathan/0000-0003-1054-0038	CIHRCanadian Institutes of Health Research (CIHR) [183304]; CFICanada Foundation for Innovation [30979]; Vanier Canada Graduate Scholarships program; O'Brien Foundation Fellowship; Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship; Innovations in Wellness post-doctoral fellowship	This research was funded by grants from CIHR (183304) and CFI (30979) awarded to PvD. AW was supported by the Vanier Canada Graduate Scholarships program, the O'Brien Foundation Fellowship, and the Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship. JS was supported by the Innovations in Wellness post-doctoral fellowship.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Ainslie PN, 2008, BRAIN RES, V1230, P115, DOI 10.1016/j.brainres.2008.07.048; Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Claassen JAHR, 2016, J CEREBR BLOOD F MET, V36, P665, DOI 10.1177/0271678X15626425; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Edvinsson L, 1975, Acta Physiol Scand Suppl, V427, P1; Hoiland RL, 2016, J PHYSIOL-LONDON, V594, P4073, DOI 10.1113/JP271981; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Jeong SM, 2016, J APPL PHYSIOL, V120, P1434, DOI 10.1152/japplphysiol.00390.2015; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Macintyre I, 2014, J MED BIOGR, V22, P93, DOI 10.1177/0967772013479271; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reed N, 2017, J ATHL TRAINING, V52, P771, DOI 10.4085/1062-6050-52.5.04; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Schmidt JD, 2016, J ATHL TRAINING, V51, P366, DOI 10.4085/1062-6050-51.5.04; Siegmund GP, 2015, P 2015 INT IRCOBI C; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Smirl JD, 2015, J APPL PHYSIOL, V119, P487, DOI 10.1152/japplphysiol.00264.2015; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Tzeng YC, 2012, AM J PHYSIOL-HEART C, V303, pH658, DOI 10.1152/ajpheart.00328.2012; Wang X, 2005, BIOMED SCI INSTRUM, V41, P48; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Wright AD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00196; Wright AD, 2020, CLIN J SPORT MED, V30, pS53, DOI 10.1097/JSM.0000000000000578; Wright AD, 2017, J NEUROTRAUM, V34, P3097, DOI 10.1089/neu.2017.5020; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	49	8	8	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 22	2018	9								868	10.3389/fneur.2018.00868			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GX6KN	WOS:000447870000001	30405514	Green Published, gold			2022-02-06	
J	Aase, DM; Babione, JM; Proescher, E; Greenstein, JE; DiGangi, JA; Schroth, C; Kennedy, AE; Feeley, S; Tan, M; Cosio, D; Phan, KL				Aase, Darrin M.; Babione, Joseph M.; Proescher, Eric; Greenstein, Justin E.; DiGangi, Julia A.; Schroth, Christopher; Kennedy, Amy E.; Feeley, Stacey; Tan, Michelle; Cosio, David; Phan, K. Luan			Impact of PTSD on post-concussive symptoms, neuropsychological functioning, and pain in post-9/11 veterans with mild traumatic brain injury	PSYCHIATRY RESEARCH			English	Article						Veteran; PTSD; Traumatic brain injury; Pain; Post-concussive symptoms; Cognition	POSTTRAUMATIC-STRESS-DISORDER; COMORBID CHRONIC PAIN; COPING STRATEGIES; OEF/OIF VETERANS; SELF-REPORT; POSTCONCUSSIVE SYMPTOMS; BLAST EXPOSURE; MENTAL-HEALTH; IRAQI FREEDOM; DEPLOYMENT	Prior work suggested that post-traumatic stress disorder (PTSD) worsens post-concussive symptoms (PCS), neuropsychological functioning, and pain-related outcomes in post-9/11 veterans. However, the impact of PTSD in the context of mild traumatic brain injury (mTBI) is not entirely clear. We evaluated possible differences among veterans with deployment-related mTBI with and without PTSD, and a comparison group. We hypothesized that veterans with comorbid mTBI and PTSD would report more PCS, perform worse on neuropsychological tasks, and report greater pain intensity and maladaptive pain coping relative to those without PTSD. Ninety (15 female, 75 male) post-9/11 veterans completed measures of psychiatric functioning, PCS, deployment-related mTBI, pain intensity, pain coping, and a brief neuropsychological evaluation. Veterans with comorbid mTBI and PTSD reported significantly higher PCS across domains, and greater pain intensity and maladaptive coping. They also performed more poorly on measures of recall, but not on measures of attention, encoding, or executive functioning. Findings suggest that PTSD results in greater PCS in the context of mTBI, and is associated with greater pain catastrophizing, worse recall, greater pain intensity, and greater illness-focused coping than in mTBI alone. PCS symptoms, recall, and pain coping may be of clinical importance for post-9/11 veterans with the "polytrauma triad."	[Aase, Darrin M.; Babione, Joseph M.; Proescher, Eric; Greenstein, Justin E.; Schroth, Christopher; Kennedy, Amy E.; Feeley, Stacey; Tan, Michelle; Cosio, David; Phan, K. Luan] Jesse Brown VA Med Ctr, Mental Hlth Serv Line, 820 S Damen Ave, Chicago, IL 60612 USA; [Aase, Darrin M.] Governors State Univ, Coll Hlth & Human Serv, 1 Univ Pkwy, University Pk, IL 60484 USA; [Aase, Darrin M.; Proescher, Eric; Greenstein, Justin E.; DiGangi, Julia A.; Schroth, Christopher; Kennedy, Amy E.; Phan, K. Luan] Univ Illinois, Dept Psychiat, 1747 Roosevelt Rd, Chicago, IL 60608 USA		Aase, DM (corresponding author), Jesse Brown VA Med Ctr, Mental Hlth Serv Line, 820 S Damen Ave, Chicago, IL 60612 USA.; Aase, DM (corresponding author), Governors State Univ, Coll Hlth & Human Serv, 1 Univ Pkwy, University Pk, IL 60484 USA.; Aase, DM (corresponding author), Univ Illinois, Dept Psychiat, 1747 Roosevelt Rd, Chicago, IL 60608 USA.	daase@govst.edu			U.S. Department of Veterans AffairsUS Department of Veterans Affairs [I01CX000913]	This work was supported by the U.S. Department of Veterans Affairs [I01CX000913 to KLP].	Alschuler KN, 2012, EUR J PAIN, V16, P312, DOI 10.1016/j.ejpain.2011.06.010; Baldassarre M, 2015, PM&R, V7, P845, DOI 10.1016/j.pmrj.2015.03.003; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Benedict R., 1997, BRIEF VISUOSPATIAL M; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Conners C. K., 2000, CONNERS CONTINUOUS P; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Delis D.C., 2000, CALIFORNIA VERBAL LE; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Giordano NA, 2018, WORLDV EVID-BASED NU, V15, P113, DOI 10.1111/wvn.12274; Golden CJ., 2002, STROOP COLOR WORD TE; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Heaton R., 2000, WISCONSIN CARD SORTI; JENSEN MP, 1995, PAIN, V60, P203, DOI 10.1016/0304-3959(94)00118-X; Kansagara D., 2013, COMPLICATIONS MILD T; Lindquist L. K., 2017, J NEUROPSYCHIATRY CL, DOI [10.1176/appi.neuropsych, DOI 10.1176/APPI.NEUROPSYCH]; McCaffery M, 1993, PAIN CLIN MANUAL NUR; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Morasco BJ, 2013, PAIN, V154, P609, DOI 10.1016/j.pain.2013.01.001; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Outcalt SD, 2014, J REHABIL RES DEV, V51, P559, DOI 10.1682/JRRD.2013.06.0134; Randolph C., 1998, REPEATABLE BATTERY A; Romesser J, 2012, J REHABIL RES DEV, V49, P1127, DOI 10.1682/JRRD.2010.12.0238; ROSENSTIEL AK, 1983, PAIN, V17, P33, DOI 10.1016/0304-3959(83)90125-2; Runnals JJ, 2013, PAIN MED, V14, P1529, DOI 10.1111/pme.12208; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schwab KA, 2006, NEUROLOGY, V66, pA235; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Soble JR, 2013, J CLIN EXP NEUROPSYC, V35, P551, DOI 10.1080/13803395.2013.798398; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Tan G, 2009, PAIN MED, V10, P1237, DOI 10.1111/j.1526-4637.2009.00712.x; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Psychological Corporation, 2001, WECHSLER TEST ADULT; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Weathers F.W., 1993, 9 ANN C ISTSS; Wechsler D., 2008, WAIS IV WECHSLER ADU; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wrocklage KM, 2016, J INT NEUROPSYCH SOC, V22, P399, DOI 10.1017/S1355617716000059	51	8	8	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	OCT	2018	268						460	466		10.1016/j.psychres.2018.08.019			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	GV3JN	WOS:000445990300072	30138858				2022-02-06	
J	Bin Abdullah, MFIL; Ng, YP; Bin Sidi, H				Bin Abdullah, Mohammad Farris Iman Leong; Ng, Yin Ping; Bin Sidi, Hatta			Depression and anxiety among traumatic brain injury patients in Malaysia	ASIAN JOURNAL OF PSYCHIATRY			English	Article						Depressive disorders; Anxiety disorders; Comorbid depression and anxiety; Traumatic brain injury; Malaysia	PSYCHIATRIC-DISORDERS; AXIS-I; DISABILITY; SYMPTOMS; STRESS; RISK	Background: Depression and anxiety are common psychiatric sequelae of traumatic brain injury (TBI). However, there is lack of data on comorbid depression and anxiety, and depression and anxiety in TBI patients were often evaluated using non-validated diagnostic tools. This study aims to determine the rates, their comorbidity, and factors associated with depressive and anxiety disorders in TBI patients. Methods: In this cross-sectional study, 101 TBI patients were interviewed using the Structured Clinical Interview for DSM-IV Axis I Disorders to assess the rates of depressive and anxiety disorders after TBI. The association of socio-demographic and clinical factors with depressive and anxiety disorders were determined using Pearson's Chi-Square test. Results: A total of 25% of TBI patients (n = 25/101) were diagnosed with depressive disorders, of which 15% had major depressive disorder (n = 15/101) and 10% had minor depression (n = 10/101). Fourteen percent of TBI patients had anxiety disorders (n = 14/101), of which post-traumatic stress disorder (PTSD) was the commonest anxiety disorder (9%, n = 9/101). Seven percent of TBI patients (n = 7/101) had comorbid depressive and anxiety disorders. The only factor associated with depressive disorder was the duration of TBI ( >= 1 year) while the only factor associated with anxiety disorder was the mechanism of trauma (assault). Conclusion: Major depressive disorder, minor depression and PTSD are common psychiatric complications of TBI. Clinicians should screen for depressive and anxiety disorders in TBI patients, particularly those with >= 1 year of injury and had sustained TBI from assault.	[Bin Abdullah, Mohammad Farris Iman Leong] Univ Sains Malaysia, Adv Med & Dent Inst, Lifestyle Sci Cluster, Kepala Batas 13200, Pulau Pinang, Malaysia; [Ng, Yin Ping] RCSI & UCD Malaysia Campus, Dept Psychiat, 4 Jalan Sepoy Lines, George Town 10450, Pulau Pinang, Malaysia; [Bin Sidi, Hatta] Univ Kebangsaan Malaysia, Dept Psychiat, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia		Ng, YP (corresponding author), RCSI & UCD Malaysia Campus, Dept Psychiat, 4 Jalan Sepoy Lines, George Town 10450, Pulau Pinang, Malaysia.	farris@usm.my; ng.yp@rcsiucd.edu.my; hattasidi@hotmail.com	Bin Abdullah, Mohammad Farris Iman Leong/I-9583-2017	Bin Abdullah, Mohammad Farris Iman Leong/0000-0002-7762-4052			Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Greenberg M. S., 2010, HDB NEUROSURGERY; Guillamondegui OD, 2011, AHRQ PUBLICATION; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Mauri MC, 2014, ASIAN J PSYCHIATR, V12, P118, DOI 10.1016/j.ajp.2014.07.003; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Roy D, 2018, PSYCHOSOMATICS, V59, P47, DOI 10.1016/j.psym.2017.07.008; Roy D, 2015, ASIAN J PSYCHIATR, V13, P56, DOI 10.1016/j.ajp.2014.10.001; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Zaninotto AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00095	21	8	9	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1876-2018	1876-2026		ASIAN J PSYCHIATR	Asian J. Psychiatr.	OCT	2018	37						67	70		10.1016/j.ajp.2018.08.017			4	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	GY3RJ	WOS:000448471300015	30144779				2022-02-06	
J	Dierijck, JK; Wright, AD; Smirl, JD; Bryk, K; van Donkelaar, P				Dierijck, J. K.; Wright, A. D.; Smirl, J. D.; Bryk, K.; van Donkelaar, P.			Sub-concussive trauma, acute concussion, and history of multiple concussions: Effects on quiet stance postural control stability	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Sport concussion; Sub-concussive impacts; Concussion history; Postural control; Quiet stance	EXTREMITY MUSCULOSKELETAL INJURY; COLLEGIATE FOOTBALL PLAYERS; BRAIN-INJURY; BALANCE; SPORT; INCREASES; RECOVERY; IMPACT; RETURN; RISK	Although balance control has been studied extensively following acute concussion, little is known regarding repetitive sub-concussive head impacts or chronic exposure to multiple concussive events. Quiet stance postural control was characterized in contact sport athletes at pre-season (n = 135) and post-season (n = 48) to evaluate the effects of subconcussive trauma to the head. To determine the impact of acute concussion on postural control, athletes diagnosed with a concussion during the season (n = 12) were tested at 72-h, 2-weeks, and 1 month post-injury. Because only 4 of the concussed athletes completed baseline testing, control athletes (n = 12) matched for sport, age, body mass index (BMI), and previous concussion history served as a comparison group. Finally, the effects of previous concussion history on quiet stance postural control were determined by comparing pre-season data in contact sport athletes with either zero (Hx(0), n = 50) or three or more (Hx(3+), n = 25) previous concussions. A force plate was used to compare changes in centre-of-pressure root-mean-square displacement (RMSdisp) and mean-velocity (COPvel) in the anterior/posterior (AP) and medial/lateral (ML) directions. One-minute trials were performed with feet hip-width apart, hands-on-hips, and A) eyes-open and B) eyes-closed. Biomechanical head-impact exposure (impacts over 10 g) was indexed over the season using mastoid-fixed impact sensors. In acutely injured athletes, repeated-measures ANOVA revealed a significant effect of time for RMSdisp AP with increased displacement at 2 weeks compared to 72 h (p = 0.008, 95% CI:-0.180, -0.310 cm). No other COP variables were affected by acute concussion. Moreover, there was no effect of concussion history or repeated sub-concussive impacts on any quiet stance metric. Additionally, head-impact exposure metrics were not correlated with COP metrics. Taken together, the data suggests alterations in COP sway during quiet stance persist in the acute 2-week period after injury. These findings were not present with either a history of multiple concussions or exposure to sub-concussive head impacts indicating acute concussion does not have appear to have long term effects for these measures.	[Dierijck, J. K.; Wright, A. D.; Smirl, J. D.; Bryk, K.; van Donkelaar, P.] Univ British Columbia, Sch Hlth & Exercise Sci, ART 360 3333 Univ Way, Kelowna, BC V1V 1V7, Canada; [Wright, A. D.] Univ British Columbia, MD PhD Program, 2894 Detwiller Pavil,2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada; [Wright, A. D.] Univ British Columbia Okanagan, Reichwald Hlth Sci Ctr, Southern Med Program, 1088 Discovery Ave, Kelowna, BC V1V 1V7, Canada; [Wright, A. D.] Univ British Columbia, Fac Med, Expt Med Program, Vancouver, BC, Canada; [Bryk, K.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA		van Donkelaar, P (corresponding author), Univ British Columbia, Sch Hlth & Exercise Sci, ART 360 3333 Univ Way, Kelowna, BC V1V 1V7, Canada.	paul.vandonkelaar@ubc.ca		Smirl, Jonathan/0000-0003-1054-0038	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [290449]; Canadian Foundation for InnovationCanada Foundation for Innovation [30979]; MITACS [IT03862]; Canadian Traumatic Brain Injury Research Consortium [201510]	This work was funded by grants to Paul van Donkelaar from the Canadian Institutes of Health Research [grant number 290449; Canadian Foundation for Innovation [grant number 30979]; MITACS [grant number IT03862]; and by the Canadian Traumatic Brain Injury Research Consortium [grant number: 201510] trainee grant to Jillian Dierijck. The authors would like to thank the Okanagan Sun Junior Football Team, and West Kelowna Warriors Junior Hockey Team for their participation, as well as all of the members of the Sport Concussion Research Lab, University of British Columbia, Kelowna.	[Anonymous], 1995, GAIT POSTURE; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Boggild M, 2012, CAN J NEUROL SCI, V39, P361, DOI 10.1017/S0317167100013524; Broglio SP, 2004, BRIT J SPORT MED, V38, P561, DOI 10.1136/bjsm.2003.004887; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Degani AM, 2017, BRAIN INJURY, V31, P49, DOI 10.1080/02699052.2016.1225982; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Donaworth MA, 2016, PHYSICIAN SPORTSMED, V44, P1, DOI 10.1080/00913847.2016.1135039; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; EDWARDS AS, 1946, J EXP PSYCHOL, V36, P526, DOI 10.1037/h0059909; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Johnston W, 2017, QJM-INT J MED, V110, P779, DOI 10.1093/qjmed/hcw228; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; Ku PX, 2012, J BIOMECH, V45, P1638, DOI 10.1016/j.jbiomech.2012.03.029; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Lynall R, 2016, CLIN J SPORT MED, V1; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Merritt E, 2016, J SPORT REHABIL, P1; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Mulligan I, 2012, SPORTS HEALTH, V5, P22; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Reed-Jones RJ, 2014, SEMIN SPEECH LANG, V35, P186, DOI 10.1055/s-0034-1384680; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Ruhe A, 2014, SPORTS HEALTH, V6, P427, DOI 10.1177/1941738114541238; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537	48	8	8	1	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2018	132		A		SI		74	80		10.1016/j.ijpsycho.2018.03.005			7	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	GV7GC	WOS:000446289000010	29526776				2022-02-06	
J	Elbaih, AH; El-Sayed, DA; Abou-Zeid, AE; Elhadary, GK				Elbaih, Adel Hamed; El-Sayed, Doaa A.; Abou-Zeid, Ahmed E.; Elhadary, Ghada K.			Patterns of brain injuries associated with maxillofacial fractures and its fate in emergency Egyptian polytrauma patients	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Maxillofacial fractures; Brain injuries; Outcome		Purpose: Maxillofacial injuries are commonly encountered in the practice of emergency medicine. More than 50% of patients with these injuries have multisystem trauma that requires coordinated management between emergency physicians and surgical specialists in oral and maxillofacial surgery, otolaryngology, plastic surgery, ophthalmology, and trauma surgery. The aim of this study is to identify the patterns of brain injuries associated with maxillofacial trauma and its outcome. Methods: This descriptive study (cross-sectional) was carried out among 90 polytrauma patients with maxillofacial fractures attending the Emergency Department at Suez Canal university Hospital and fulfilling our inclusion and exclusion criteria. Results: This study demonstrates the relation between type of maxillofacial fracture and type of traumatic brain injuries in which the majority of patients with epidural hemorrhage presented with mid face fractures (60%), while the minority of them presented with upper and lower face fractures (20% for each of them). The majority of patients with subdural hemorrhage were associated with mid face fractures (75%), the majority of patients with brain contusions associated with mid face fractures (75%), and all of the patients presented by pneumocephalus were associated with mid face fractures (100%). Conclusion: The results of this study confirm the value of quick diagnosis and early intervention, which is fundamental to prevent morbidity as well as mortality especially with regards to prevention of traumatic brain injury as even a short duration of hypoxia and edema will lead to significant permanent neurological deficits. (C) 2018 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University. Production and hosting by Elsevier B.V.	[Elbaih, Adel Hamed; El-Sayed, Doaa A.; Abou-Zeid, Ahmed E.; Elhadary, Ghada K.] Suez Canal Univ, Fac Med, Dept Emergency Med, Ismailia, Egypt		Elbaih, AH (corresponding author), Suez Canal Univ, Fac Med, Dept Emergency Med, Ismailia, Egypt.	elbaihzico@yahoo.com	Elbaih, Adel Hamed/AAC-7876-2019	Elbaih, Adel Hamed/0000-0002-3347-5163			Elbaih A., 2016, NMJ, V5, P126, DOI [10.5455/nmj/00000111, DOI 10.5455/NMJ/00000111]; Hasnat A., 2017, UPDATE DENT COLL J, V7, P14, DOI [10.3329/updcj.v7i1.33304, DOI 10.3329/UPDCJ.V7I1.33304]; Hohlrieder M, 2004, INT J ORAL MAX SURG, V33, P389, DOI 10.1016/j.ijom.2003.10.011; Hung YC, 2004, J ORAL MAXIL SURG, V62, P938, DOI 10.1016/j.joms.2004.01.018; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Kloss F, 2008, J CRANIO MAXILL SURG, V36, P372, DOI 10.1016/j.jcms.2007.12.002; Latifi H, 2014, Glob J Health Sci, V6, P66, DOI 10.5539/gjhs.v6n7p66; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mabrouk A, 2014, CRANIOMAX TRAUM REC, V7, P214, DOI 10.1055/s-0034-1374061; Mahran Dalia G, 2013, Int J Crit Illn Inj Sci, V3, P235, DOI 10.4103/2229-5151.124108; Marianne Gausche-Hill, 2017, ROSENS EMERGENCY MED, P315; Rajandram RK, 2014, DENT TRAUMATOL, V30, P128, DOI 10.1111/edt.12052; Tintinalli JE, 2004, EMERGENCY MED COMPRE, P1583; Zandi M, 2013, ORAL MAXILLOFAC SURG, V17, P201, DOI 10.1007/s10006-012-0368-z	14	8	8	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	OCT	2018	21	5					287	292		10.1016/j.cjtee.2017.12.005			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	GZ9EU	WOS:000449800300009	30268680	Green Published, gold			2022-02-06	
J	Hoffman, H; Jalal, MS; Chin, LS				Hoffman, Haydn; Jalal, Muhammad S.; Chin, Lawrence S.			Effect of Hypernatremia on Outcomes After severe Traumatic Brain Injury: A Nationwide Inpatient Sample analysis	WORLD NEUROSURGERY			English	Article						Hypernatremia; Nationwide inpatient sample; Traumatic brain injury	INTENSIVE-CARE-UNIT; RENAL BLOOD-FLOW; INTRACRANIAL-PRESSURE; HYPERTONIC SALINE; DIABETES-INSIPIDUS; HEAD-INJURY; THERAPY; GUIDELINES; MANAGEMENT; CHLORIDE	OBJECTIVE: Induced hypernatremia is frequently used to reduce intracranial pressure in patients with severe traumatic brain injury (TBI). This technique is controversial, and some studies have independently associated hypernatremia with worse outcomes after TBI. We sought to investigate this potential association in a large healthcare database. METHODS: The Nationwide Inpatient Sample was used to obtain data on all adults who had been discharged from 2002 to 2011 with a primary diagnosis of TBI who required mechanical ventilation, intracranial pressure monitoring, or craniotomy/craniectomy. Patients with diabetes insipidus were excluded. The patients with hypernatremia were assigned to the hypernatremia group, and the rest were assigned to the control group. The primary outcome was in-hospital mortality, and the secondary outcomes included the length of stay, nonroutine hospital discharge, total hospital charges, tracheostomy, and gastrostomy placement. RESULTS: A total of 85,579 patients without a diagnosis of hypernatremia (control group) and 4542 patients with a diagnosis of hypernatremia (hypernatremia group) were identified. When controlling for age, comorbidities, gender, and cerebral edema, hypernatremia was associated with an increased rate of in-hospital mortality (odds ratio, 1.51; 95% confidence interval, 1.39-1.65), a longer mean length of stay (23.65 vs. 12.12 days; P < 0.001), an increased rate of nonroutine hospital discharge (odds ratio, 2.58; 95% confidence interval, 2.28-2.92), and greater mean total hospital cost ($227,112 vs. $112,507; P < 0.001). The patients with hypernatremia also had greater rates of tracheostomy and gastrostomy placement. CONCLUSIONS: Hypernatremia was associated with poorer outcomes in patients with severe TBI. This finding warrants further investigation in a prospective, randomized study.	[Hoffman, Haydn; Jalal, Muhammad S.; Chin, Lawrence S.] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA		Hoffman, H (corresponding author), SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA.	hoffmanh@upstate.edu		Hoffman, Haydn/0000-0002-2967-6528			Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Ayus JC, 1996, J PHYSIOL-LONDON, V492, P243, DOI 10.1113/jphysiol.1996.sp021305; Boughey JC, 2004, AM SURGEON, V70, P500; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; De Petris L, 2001, EUR J PEDIATR, V160, P71, DOI 10.1007/s004310000631; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; GENTLEMAN D, 1993, BRIT MED J, V307, P547, DOI 10.1136/bmj.307.6903.547; GERBER JG, 1979, AM J PHYSIOL, V237, pF441, DOI 10.1152/ajprenal.1979.237.6.F441; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Haddad S, 2011, ANAESTH INTENS CARE, V39, P1043, DOI 10.1177/0310057X1103900610; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Kahle KT, 2013, J CLIN NEUROSCI, V20, P30, DOI 10.1016/j.jocn.2012.10.004; Khajavikhan J, 2016, J CLIN DIAGN RES, V10, pPC16, DOI 10.7860/JCDR/2016/16390.7294; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kolmodin L, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-35; KOZENY GA, 1985, AM HEART J, V109, P290, DOI 10.1016/0002-8703(85)90596-4; Kugler JP, 2000, AM FAM PHYSICIAN, V61, P3623; KUNG AWC, 1991, POSTGRAD MED J, V67, P912, DOI 10.1136/pgmj.67.792.912; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Li M, 2013, INJURY, V44, P1213, DOI 10.1016/j.injury.2012.05.021; Lindner G, 2013, J CRIT CARE, V28, P214, DOI 10.1016/j.jcrc.2012.11.017; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; MUIZELAAR JP, 1986, STROKE, V17, P44, DOI 10.1161/01.STR.17.1.44; Murphy N, 2004, HEPATOLOGY, V39, P464, DOI 10.1002/hep.20056; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Shehata M, 2010, CRIT CARE, V14, P355; Tan SKR, 2016, CAN J ANESTH, V63, P664, DOI 10.1007/s12630-016-0633-y; Vedantam A, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17418; Waite MD, 2013, J CRIT CARE, V28, P405, DOI 10.1016/j.jcrc.2012.11.013; WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820	32	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2018	118						E880	E886		10.1016/j.wneu.2018.07.089			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GU1NY	WOS:000445032000115	30031178				2022-02-06	
J	Kerr, ZY; Gregory, AJ; Wosmek, J; Pierpoint, LA; Currie, DW; Knowles, SB; Wasserman, EB; Dompier, TP; Comstock, RD; Marshall, SW				Kerr, Zachary Y.; Gregory, Andrew J.; Wosmek, Jill; Pierpoint, Lauren A.; Currie, Dustin W.; Knowles, Sarah B.; Wasserman, Erin B.; Dompier, Thomas P.; Comstock, R. Dawn; Marshall, Stephen W.			The First Decade of Web-Based Sports Injury Surveillance: Descriptive Epidemiology of Injuries in US High School Girls ' Volleyball (2005-2006 Through 2013-2014) and National Collegiate Athletic Association Women's Volleyball (2004-2005 Through 2013-2014)	JOURNAL OF ATHLETIC TRAINING			English	Article						athletics; competition; females	PROSPECTIVE COHORT; MEDICAL COVERAGE; UNITED-STATES; PREVENTION; MECHANISMS; PATTERNS; FOOTBALL; SERVICES; SPRAINS; SYSTEM	Context: The advent of Web-based sports injury surveillance via programs such as the High School Reporting Information Online system and the National Collegiate Athletic Association Injury Surveillance Program has aided in the acquisition of girls' and women's volleyball injury data. Objective: To describe the epidemiology of injuries sustained in high school girls' volleyball in the 2005-2006 through 2013-2014 academic years and collegiate women's volleyball in the 2004-2005 through 2013-2014 academic years using Web-based sports injury surveillance. Design: Descriptive epidemiology study. Setting: Online injury surveillance from high school girls' (annual average= 100) and collegiate women's (annual average = 50) volleyball teams. Patients or Other Participants: Girls' and women's volleyball players who participated in practices and competitions during the 2005-2006 through 2013-2014 academic years in high school and the 2004-2005 through 2013-2014 academic years in college. Main Outcome Measure(s): Athletic trainers collected time-loss (>= 24 hours) injury and exposure data. Injury rates per 1000 athlete-exposures (AEs), injury rate ratios (IRRs) with 95% confidence intervals (Cis), and injury proportions by body site and diagnosis were calculated. Results: The High School Reporting Information Online system documented 1634 time-loss injuries during 1 471 872 AEs; the National Collegiate Athletic Association Injury Surveillance Program documented 2149 time-loss injuries during 563 845 AEs. The injury rate was higher in college than in high school (3.81/ 1000 versus 1.11/1000 AEs; IRR= 3.43; 95%CI=3.22, 3.66), and higher in high schools with <1000 students than in those with >1000 students (IRR= 1.35; 95% CI = 1.23, 1.49). Injury rates did not vary by collegiate division. The injury rate was higher during competitions than practices for high school (IRR = 1.23; 95% CI = 1.12, 1.36) but not for college (IRR = 1.01; 95% CI = 0.92, 1.10). Ankle sprains were common in both the high school and collegiate setting. However, liberos had a high incidence of concussion. Conclusions: Injury rates were higher among collegiate than high school players. However, injury rates differed by event type in high school, unlike college. Concussion injury patterns among liberos varied from those for other positions. These findings highlight the need for injury-prevention interventions specific to setting and position.	[Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym CB 8700, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Gregory, Andrew J.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Wosmek, Jill] Sports Acad, Newbury Pk, CA USA; [Pierpoint, Lauren A.; Currie, Dustin W.; Comstock, R. Dawn] Univ Colorado, Colorado Sch Publ Hlth, Dept Epidemiol, Anschutz Med Campus, Aurora, CO USA; [Knowles, Sarah B.] Palo Alto Med Fdn, Res Inst, Palo Alto, CA 94301 USA; [Wasserman, Erin B.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Annville, PA USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu		Wasserman, Erin/0000-0001-5957-5878	NCAA; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Center for Research Resources awardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025754]; National Federation of State High School Associations (Indianapolis, IN); National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); DonJoy Orthotics (Vista, CA); EyeBlack (Potomac, MD); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001172, R49CE000674] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR025754] Funding Source: NIH RePORTER	The NCAA-ISP data were provided by the Datalys Center for Sports Injury Research and Prevention. The ISP was funded by the NCAA. Funding for HS RIO was funded in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01 and the National Center for Research Resources award KL2 RR025754. We also acknowledge the research funding contributions of the National Federation of State High School Associations (Indianapolis, IN), National Operating Committee on Standards for Athletic Equipment (Overland Park, KS), DonJoy Orthotics (Vista, CA), and EyeBlack (Potomac, MD). The content of this report is solely our responsibility and does not necessarily represent the official views of the funding organizations. We thank the many ATs who have volunteered their time and efforts to submit data to HS RIO and the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of high school and collegiate student-athletes.	Aagaard H, 1997, INT J SPORTS MED, V18, P217, DOI 10.1055/s-2007-972623; Agel J, 2007, J ATHL TRAINING, V42, P295; [Anonymous], 2016, PART STAT 2016; Aukerman DF, 2006, SOUTH MED J, V99, P132, DOI 10.1097/01.smj.0000199749.22741.5e; Bahr R, 1997, SCAND J MED SCI SPOR, V7, P172, DOI 10.1111/j.1600-0838.1997.tb00135.x; Bahr R, 1997, SCAND J MED SCI SPOR, V7, P166, DOI 10.1111/j.1600-0838.1997.tb00134.x; BAHR R, 1994, AM J SPORT MED, V22, P595, DOI 10.1177/036354659402200505; Carek P J, 1999, J S C Med Assoc, V95, P420; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kreck C., STATES ADDRESS CONCU; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Pedowitz DI, 2008, AM J SPORT MED, V36, P324, DOI 10.1177/0363546507308358; Pollard KA, 2011, CLIN PEDIATR, V50, P844, DOI 10.1177/0009922811406262; Powell JW, 2004, J ATHL TRAINING, V39, P56; Powell JW, 1999, J ATHL TRAINING, V34, P277; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rutherford DS, 1999, CLIN J SPORT MED, V9, P209, DOI 10.1097/00042752-199910000-00005; Stasinopoulos D, 2004, BRIT J SPORT MED, V38, P182, DOI 10.1136/bjsm.2002.003947; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Verhagen EALM, 2004, BRIT J SPORT MED, V38, P477, DOI 10.1136/bjsm.2003.005785	26	8	8	1	11	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	OCT	2018	53	10					926	937		10.4085/1062-6050-162-17			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HB9TJ	WOS:000451435400002	30485148	Green Published, gold			2022-02-06	
J	Kersten, P; Cummins, C; Kayes, N; Babbage, D; Elder, H; Foster, A; Weatherall, M; Siegert, RJ; Smith, G; McPherson, K				Kersten, Paula; Cummins, Christine; Kayes, Nicola; Babbage, Duncan; Elder, Hinemoa; Foster, Allison; Weatherall, Mark; Siegert, Richard John; Smith, Greta; McPherson, Kathryn			Making sense of recovery after traumatic brain injury through a peer mentoring intervention: a qualitative exploration	BMJ OPEN			English	Article							PERSONAL SELF-ADVOCACY; SPINAL-CORD-INJURY; OF-LIFE; INDIVIDUALS; PEOPLE; REHABILITATION; SUPPORT; COMMUNITY; PROGRAM; MODERATE	Objective To explore the acceptability of peer mentoring for people with a traumatic brain injury (TBI) in New Zealand. Design This is a qualitative descriptive study exploring the experiences reported by mentees and mentors taking part in a feasibility study of peer mentoring. Interviews with five mentees and six mentors were carried out. Data were analysed using conventional content analysis. Setting The first mentoring session took place predischarge from the rehabilitation unit. The remaining five sessions took place in mentees' homes or community as preferred. Participants Twelve people with TBI took part: six mentees (with moderate to severe TBI; aged 18-46) paired with six mentors (moderate to severe TBI >12 months previously; aged 21-59). Pairing occurred before mentee discharge from postacute inpatient brain injury rehabilitation. Mentors had been discharged from rehabilitation following a TBI between 1 and 5 years previously. Intervention The peer mentoring programme consisted of up to six face-to-face sessions between a mentee and a mentor over a 6-month period. The sessions focused on building rapport, exploring hopes for and supporting participation after discharge through further meetings and supported community activities. Results Data were synthesised into one overarching theme: making sense of recovery. This occurred through the sharing of experiences and stories; was pivotal to the mentoring relationship; and appeared to benefit both mentees and mentors. Mentors were perceived as valued experts because of their personal experience of injury and recovery, and could provide support in ways that were different from that provided by clinicians or family members. Mentors required support to manage the uncertainties inherent in the role. Conclusions The insight mentors developed through their own lived experience established them as a trusted and credible source of hope and support for people re-engaging in the community post-TBI. These findings indicate the potential for mentoring to result in positive outcomes.	[Kersten, Paula] Univ Brighton, Sch Hlth Sci, Brighton, E Sussex, England; [Cummins, Christine; Kayes, Nicola; Babbage, Duncan; Siegert, Richard John; Smith, Greta; McPherson, Kathryn] Auckland Univ Technol, Ctr Person Ctr Res, Sch Clin Sci, Auckland, New Zealand; [Babbage, Duncan] Auckland Univ Technol, Sch Clin Sci, Ctr EHlth, Auckland, New Zealand; [Elder, Hinemoa] Whare Wananga Awanuiarangi, Auckland, New Zealand; [Foster, Allison] ABI Rehabil, Auckland, New Zealand; [Weatherall, Mark] Univ Otago, Rehabil Teaching & Res Unit, Wellington, New Zealand; [Siegert, Richard John] Auckland Univ Technol, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand; [McPherson, Kathryn] Hlth Res Council New Zealand, Auckland, New Zealand		Kersten, P (corresponding author), Univ Brighton, Sch Hlth Sci, Brighton, E Sussex, England.	p.kersten@brighton.ac.uk	Weatherall, Mark/Y-6824-2019	Weatherall, Mark/0000-0002-0051-9107; McPherson, Kath/0000-0003-0487-8497; Siegert, Richard/0000-0002-3074-0929	Health Research Council of New ZealandHealth Research Council of New Zealand [13/759]	This work was supported by the Health Research Council of New Zealand (grant number 13/759).	Accident Compensation Corporation, 2010, ACC INJ STAT 2008 20; Accident Compensation Corporation, 2012, 3 ACC; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; BANDURA A, 1991, ORGAN BEHAV HUM DEC, V50, P248, DOI 10.1016/0749-5978(91)90022-L; Bright FAS, 2011, TOP STROKE REHABIL, V18, P490, DOI 10.1310/tsr1805-490; Bright FAS, 2012, DISABIL REHABIL, V34, P997, DOI 10.3109/09638288.2011.629712; Brown AW, 2015, BRAIN INJURY, V29, P1530, DOI 10.3109/02699052.2015.1075173; Carlson PM, 2006, BRAIN INJURY, V20, P1111, DOI 10.1080/02699050600955337; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Disability Rights & Resources, ADV IND PEER MENT; Disability Rights UK, 2018, PEER SUPP MENT; Doser K, 2018, BRAIN INJURY, V32, P64, DOI 10.1080/02699052.2017.1363408; Douglas J, 2015, RETHINKING REHABILIT, DOI DOI 10.1201/B18118; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Ells C, 2011, INT J FEM APPROACHES, V4, P79; Fadyl JK, 2017, NEUROPSYCHOL REHABIL, P1; Fadyl JK, 2017, NURS INQ, V24, DOI 10.1111/nin.12170; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Foster A, 2011, 2011 NZ REH ASS BIEN; Foster G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005108.pub2; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Ginis KAM, 2013, TRANSL BEHAV MED, V3, P434, DOI 10.1007/s13142-013-0215-2; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Greenwood A, 2015, BRAIN INJURY, V29, P592, DOI 10.3109/02699052.2014.1002422; Haas BM, 2013, SPINAL CORD, V51, P295, DOI 10.1038/sc.2012.143; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Hawley L, 2017, BRAIN INJURY, V31, P290, DOI 10.1080/02699052.2016.1250952; Hawley LA, 2016, J SOC WORK DISABIL R, V15, P201, DOI 10.1080/1536710X.2016.1220885; Hibbard M, 2005, NEUROREHABILITATION, V19, P388; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hudson M, TE ARA TIKA GUIDELIN; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jacobson N, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-205; Kayes NM, 2011, DISABIL REHABIL, V33, P625, DOI 10.3109/09638288.2010.505992; Kessler D, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-256; Kolakowsky-Hayner SA, 2012, NEUROREHABILITATION, V31, P63, DOI 10.3233/NRE-2012-0775; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; MacNeil C, 2005, AM J EVAL, V26, P231, DOI 10.1177/1098214005275633; Malec JF, 2013, J HEAD TRAUMA REHAB, V28, P476, DOI 10.1097/HTR.0000000000000003; McPherson K, 2018, J HEAD TRAUMA REHAB, V33, pE44, DOI 10.1097/HTR.0000000000000321; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Mead H., 2003, TIKANGA MAORI LIVING; Medical Research Council, 2008, DEV EVALUATING COMPL; Moreci G, 1996, NEUROREHABILITATION, V7, P211, DOI 10.3233/NRE-1996-7307; Morris RPG, 2017, CLIN REHABIL, V31, P1030, DOI 10.1177/0269215516676303; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; Papadimitriou C, 2011, DISABIL REHABIL, V33, P2121, DOI 10.3109/09638288.2011.555597; Parry M, 2010, EUR J CARDIOVASC NUR, V9, P57, DOI 10.1016/j.ejcnurse.2009.10.002; Ryan RM, 2006, J PERS, V74, P1557, DOI 10.1111/j.1467-6494.2006.00420.x; Salas CE, 2018, NEUROPSYCHOL REHABIL, V28, P1161, DOI 10.1080/09602011.2016.1247730; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Sherman JE, 2004, REHABIL PSYCHOL, V49, P140, DOI 10.1037/0090-5550.49.2.140; Smith B, 2015, HEALTH PSYCHOL, V34, P303, DOI 10.1037/hea0000113; Statistics New Zealand, 2014, 2013 CENS QUICKSTATS; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; Struchen MA, 2006, MAKING CONNECTIONS B; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Sullivan-Bolyai S, 2005, NURS OUTLOOK, V53, P127, DOI 10.1016/j.outlook.2005.03.005; Veith EM, 2006, REHABIL PSYCHOL, V51, P289, DOI 10.1037/0090-5550.51.4.289; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002	67	8	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	OCT	2018	8	10							e020672	10.1136/bmjopen-2017-020672			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HG1SG	WOS:000454739500031	30309988	Green Published, gold			2022-02-06	
J	Liu, G; Geng, J				Liu, G.; Geng, J.			Glial fibrillary acidic protein as a prognostic marker of acute ischemic stroke	HUMAN & EXPERIMENTAL TOXICOLOGY			English	Article						Glial fibrillary acidic protein; acute ischemic stroke; prognosis; Chinese	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; SERUM-LEVELS; GFAP; EXPRESSION; PREDICTION; DIAGNOSIS; BIOMARKER	Background: We investigated the association between serum levels of glial fibrillary acidic protein (GFAP) and stroke functional outcomes in a cohort of 286 patients with acute ischemic stroke (AIS). Methods: We prospectively studied 286 patients with AIS who were admitted within 24 h after the onset of symptoms. Serum levels of GFAP and National Institutes of Health Stroke Scale (NIHSS) were measured at admission. The primary end point was stroke functional outcome among 1-year after stroke onset. We used logistic regression models to assess the relationship between GFAP levels and stroke outcomes. Results: The GFAP level was obtained with a median value of 0.18 (interquartile ranges (IQRs): 0.09-0.28) ng/ml. In multivariable models adjusted for age, gender, and other risk factors, GFAP levels were associated with an increased risk of a NIHSS>6 (odds ratio (OR) = 1.55; 95% confidence interval (CI): 1.16-1.89; p = 0.012). The poor outcome distribution across the GFAP quartiles ranged between 12.7% (first quartile) and 70.4% (fourth quartile). After adjusting for other established risk factors, in multivariate models comparing the Q3 and Q 4 quartiles against the Q1 of the GFAP, the levels of GFAP were associated with poor outcome, and the adjusted risk of poor outcome increased by 211% (3.11[1.80-5.05], p < 0.001) and 522% (6.22[2.98-11.83], p < 0.001), respectively. Interestingly, GFAP improved the ability of NIHSS score to diagnose poor outcomes (area under the curve [AUC] of the combined model 0.82; 95% CI: 0.77-0.88; p = 0.02). Conclusion: GFAP levels are a novel and complementary biomarker to predict functional outcome 1 year after AIS	[Liu, G.; Geng, J.] Kunming Med Univ, Affiliated Hosp 1, Dept Neurol, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China		Geng, J (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Neurol, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China.	basler777@163.com					BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Boutte AM, 2016, J NEUROTRAUM, V33, P147, DOI 10.1089/neu.2014.3672; Brunkhorst R, 2010, TRANSL STROKE RES, V1, P246, DOI 10.1007/s12975-010-0040-6; Clairembault T, 2014, J NEUROCHEM, V130, P805, DOI 10.1111/jnc.12742; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Foerch C, 2006, J NEUROL NEUROSUR PS, V77, P181, DOI 10.1136/jnnp.2005.074823; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Helwig K, 2017, NEUROCRIT CARE, V27, P68, DOI 10.1007/s12028-016-0371-6; Katsanos AH, 2017, STROKE, V48, P2586, DOI 10.1161/STROKEAHA.117.018409; Lamers KJB, 2003, BRAIN RES BULL, V61, P261, DOI 10.1016/S0361-9230(03)00089-3; Luger S, 2017, CLIN CHEM, V63, P377, DOI 10.1373/clinchem.2016.263335; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; Pang ZD, 2017, FASEB J, V31, P4053, DOI 10.1096/fj.201700110R; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Rozanski M, 2017, CEREBROVASC DIS, V43, P76, DOI 10.1159/000453460; Tichy J, 2016, J NEURO-ONCOL, V126, P361, DOI 10.1007/s11060-015-1978-8; Tobin MK, 2014, J CEREBR BLOOD F MET, V34, P1573, DOI 10.1038/jcbfm.2014.130; Tu WJ, 2017, NEUROLOGY, V88, P1899, DOI 10.1212/WNL.0000000000003937; Tykhomyrov AA, 2016, NEUROPHYSIOLOGY+, V48, P54, DOI 10.1007/s11062-016-9568-8; von Boyen GBT, 2004, GUT, V53, P222, DOI 10.1136/gut.2003.012625; Wang JW, 2017, INT J DEV NEUROSCI, V57, P41, DOI 10.1016/j.ijdevneu.2017.01.004; Wang WZ, 2017, CIRCULATION, V135, P759, DOI 10.1161/CIRCULATIONAHA.116.025250; Wunderlich MT, 2006, EUR J NEUROL, V13, P1118, DOI 10.1111/j.1468-1331.2006.01435.x; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Zhang YB, 2017, NEUROREPORT, V28, P598, DOI 10.1097/WNR.0000000000000806	26	8	8	0	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0960-3271	1477-0903		HUM EXP TOXICOL	Hum. Exp. Toxicol.	OCT	2018	37	10					1048	1053		10.1177/0960327117751236			6	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	GS6SO	WOS:000443829300005	29308673				2022-02-06	
J	Patel, SK; Gozal, YM; Krueger, BM; Bayley, JC; Moody, S; Andaluz, N; Falcone, RA; Bierbrauer, KS				Patel, Smruti K.; Gozal, Yair M.; Krueger, Bryan M.; Bayley, James C.; Moody, Suzanne; Andaluz, Norberto; Falcone, Richard A., Jr.; Bierbrauer, Karin S.			Routine surveillance imaging following mild traumatic brain injury with intracranial hemorrhage may not be necessary	JOURNAL OF PEDIATRIC SURGERY			English	Article						Mild traumatic brain injury; Pediatric; Repeat CT scan; Surveillance imaging; Intracranial hemorrhage	BLUNT HEAD TRAUMA; COMPUTED-TOMOGRAPHY; CHILDREN; UTILITY; CT; METAANALYSIS; PREVALENCE	Background: Mild traumatic brain injury (mTBI) comprises the majority of pediatric traumatic brain injury. Children with mTBI even with traumatic intracranial hemorrhage (tICH) rarely experience a clinically significant neurologic decline (CSND). The utility of routine surveillance imaging in the pediatric population also remains controversial, especially owing to concerns about the risks of radiation exposure at a young age. This study aims to identify demographic or injury-related characteristics that may facilitate recognition of children at risk of progression with mTBI. Methods: We performed a retrospective review of patients <16 years old with mTBI (GCS 13-15) and tICH admitted to a Level I pediatric trauma center between 2009 and 2014. Management of these patientswas directed by the Cincinnati Children's Hospital Medical Center Minor Head Injury Algorithm. We reviewed each chart with emphasis on patient demographics, injury specific data, and radiographic or clinical progression. Results: 154 patients met inclusion criteria with mean age of 4 [0-16]; 116 sustained an tICH and 38 patients had isolated skull fractures. Repeat neuroimaging was obtained in 68 patients (59%). Only 9 patients (13%) with tICH had radiographic progression, none of which resulted in CSND. In addition, 9 patients experienced CSND, leading to neurosurgical intervention in 6 patients. Notably, none of these patients had repeat imaging prior to their neurologic changes. Both CSND and need for intervention were significantly higher in patients with epidural hematomas than other types of tICH (19.2% vs. 1.1%, p = 0.002). Of 154 patients, 19 did not have documented follow-up, 135 were seen as outpatients and 65 (48%) had follow up neuroimaging. All patients who had surveillance imaging in the outpatient setting had stable or resolved tICH. Conclusion: Few childrenwithmTBI and tICH experience clinical decline. Importantly, all patients that required neurosurgical intervention were identified by clinical changes rather than via repeat imaging. Our study suggests that in the vast majority of cases, clinical monitoring alone is safe and sufficient in patients in order to avoid exposure to repeat radiographic imaging. (C) 2018 Published by Elsevier Inc.	[Patel, Smruti K.; Gozal, Yair M.; Krueger, Bryan M.; Bayley, James C.; Andaluz, Norberto] Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA; [Moody, Suzanne; Falcone, Richard A., Jr.] Cincinnati Childrens Hosp Med Ctr, Div Gen & Thorac Surg, Dept Surg, Cincinnati, OH 45229 USA; [Andaluz, Norberto] Mayfield Brain & Spine, Cincinnati, OH USA; [Bierbrauer, Karin S.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Neurosurg, Cincinnati, OH 45229 USA; [Moody, Suzanne; Falcone, Richard A., Jr.; Bierbrauer, Karin S.] Comprehens Childrens Injury Ctr, Cincinnati, OH USA		Patel, SK (corresponding author), Univ Cincinnati, Med Ctr, Dept Neurol Surg, POB 670515, Cincinnati, OH 45267 USA.	smruti.patel@uc.edu; ymgozal@gmail.com; bryan.krueger@my.rfums.org; james.c.bayley@gmail.com; Suzanne.moody@cchmc.org; andalun@ucmail.uc.edu; Richard.falcone@cchmc.org; Karin.bierbrauer@cchmc.org			Mayfield Education and Research Foundation	This work was supported by a grant from the Mayfield Education and Research Foundation awarded to the primary author, Smruti K. Patel, MD. The authors do not have any perceived conflicts of interest.	Alharthy Nesrin, 2015, J Emerg Trauma Shock, V8, P88, DOI 10.4103/0974-2700.155504; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Bata SC, 2014, ANZ J SURG, V84, P438, DOI 10.1111/ans.12582; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Chern JJ, 2014, J NEUROSURG-PEDIATR, V14, P306, DOI 10.3171/2014.6.PEDS13682; Cohen AR, 2015, AM J EMERG MED, V33, P887, DOI 10.1016/j.ajem.2015.03.052; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Faul M, 2010, TRAUMATIC BRAIN INJU; Ghizoni Enrico, 2013, Rev. Col. Bras. Cir., V40, P515; Goldberg J, 2011, J PEDIATR SURG, V46, P1777, DOI 10.1016/j.jpedsurg.2011.02.052; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Howe J, 2014, J TRAUMA ACUTE CARE, V76, P292, DOI 10.1097/TA.0000000000000119; Kim WH, 2015, J KOREAN NEUROSURG S, V58, P125, DOI 10.3340/jkns.2015.58.2.125; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mehta H, 2016, AM J NEURORADIOL, V37, P11, DOI 10.3174/ajnr.A4464; Mihindu E, 2014, AM SURGEON, V80, P841; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Sorantin E, 2013, EUR J PEDIATR SURG, V23, P444, DOI 10.1055/s-0033-1361924; Stein SC, 2008, PEDIATR NEUROSURG, V44, P448, DOI 10.1159/000172967; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	30	8	8	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	OCT	2018	53	10					2048	2054		10.1016/j.jpedsurg.2018.04.027			7	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	GU2PA	WOS:000445111000032	29784284				2022-02-06	
J	St Ivany, A; Kools, S; Sharps, P; Bullock, L				St Ivany, Amanda; Kools, Susan; Sharps, Phyllis; Bullock, Linda			Extreme Control and Instability: Insight Into Head Injury From Intimate Partner Violence	JOURNAL OF FORENSIC NURSING			English	Article						Extreme control; forced sex; head injury; intimate partner violence; syndemics; women's health	TRAUMATIC BRAIN-INJURY; ABUSED WOMEN; HEALTH; CONSEQUENCE; OUTCOMES; SEX	Aim: The aim of this study was to understand the social context of the lives of women who experienced a head injury from intimate partner violence. Background: Sixty percent to 92% of survivors of intimate partner violence receive head trauma during the abuse. Little research exists regarding the episodes of abuse when women receive a head injury, or the reasons women might not seek medical care for the head injury or the abuse. Method: Twenty-one interviews from nine women who self-reported passing out from being hit in the head were analyzed using thematic analysis. Findings: Themes of extreme control and manipulation from abusers emerged, and women described living with instability from cycles of incarceration, drug and alcohol use, and fear of losing their children. Women did not receive medical care for head injury because the abusers often used forced sex immediately after the head injury to instill fear and authorit	[St Ivany, Amanda; Kools, Susan; Bullock, Linda] Univ Virginia, Sch Nursing, Charlottesville, VA 22903 USA; [St Ivany, Amanda] Dartmouth Coll, Dept Community & Family Med, Hanover, NH 03755 USA; [Sharps, Phyllis] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA		St Ivany, A (corresponding author), Dartmouth Coll, Geisel Sch Med, Dept Community & Family Med, 46 Centerra Pkwy, Lebanon, NH 03766 USA.	Amanda.R.St.Ivany@dartmouth.edu	St Ivany, Amanda/AAC-6228-2019	Sharps, Phyllis/0000-0002-8508-5087	NIH/NINRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01009093]; HRSAUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [T32HP30036]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR009093] Funding Source: NIH RePORTER	This study was supported by NIH/NINR Grant R01009093 and HRSA T32HP30036.	Anderson JC, 2015, J EMERG NURS, V41, P36, DOI 10.1016/j.jen.2014.01.015; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Campbell JC, 2015, DANGER ASSESSMENT 5; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Ford-Gilboe M, 2011, FAMILY VIOLENCE NURS, P115; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Messing JT, 2014, HEALTH SOC WORK, V39, P181, DOI 10.1093/hsw/hlu026; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Picard M, 1991, HELPS BRAIN INJURY S; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Rich K, 2014, AFFILIA J WOM SOC WO, V29, P418, DOI 10.1177/0886109914522626; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sharps P, 2013, PEDIATRICS, V132, pS134, DOI 10.1542/peds.2013-1021L; Sharps PW, 2016, J WOMENS HEALTH, V25, P1129, DOI 10.1089/jwh.2015.5547; Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	28	8	8	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-3693	1939-3938		J FORENSIC NURS	J. Forensic Nurs.	OCT-DEC	2018	14	4					198	205		10.1097/JFN.0000000000000220			8	Criminology & Penology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Criminology & Penology; Nursing	HJ3IZ	WOS:000457065000004	30433908	Green Accepted			2022-02-06	
J	Yuan, XL; Zhao, YP; Huang, J; Liu, JC; Mao, WQ; Yin, J; Peng, BW; Liu, WH; Han, S; He, XH				Yuan, Xiao-Lu; Zhao, Yi-Peng; Huang, Jie; Liu, Jun-Chen; Mao, Wen-Qian; Yin, Jun; Peng, Bi-Wen; Liu, Wan-Hong; Han, Song; He, Xiao-Hua			A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						EAE; immunomodulation; Kv1; 3 channel; multiple sclerosis; neuroprotection	ACUTE AXONAL DAMAGE; OLIGODENDROCYTE PROGENITOR CELLS; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; THERAPEUTIC TARGET; POTASSIUM CHANNELS; WHITE-MATTER; K+ CHANNELS; DISEASE; MYELIN	AimMultiple sclerosis (MS) is a neurological autoimmune disorder characterized by mistaken attacks of inflammatory cells against the central nervous system (CNS), resulting in demyelination and axonal damage. Kv1.3 channel blockers can inhibit T-cell activation and have been designed for MS therapy. However, little is known about the effects of Kv1.3 blockers on protecting myelin sheaths/axons in MS. This study aimed at investigating the neuroprotection efficacy of a selective Kv1.3 channel blocker ImKTx88 (ImK) in MS animal model. MethodsExperimental autoimmune encephalomyelitis (EAE) rat model was established. The neuroprotective effect of ImK was assessed by immunohistochemistry and transmission electron microscopy (TEM). In addition, the antiinflammatory effect of ImK by suppressing T-cell activation was assessed by flow cytometry and ELISA in vitro. ResultsOur results demonstrated that ImK administration ameliorated EAE clinical severity. Moreover, ImK increased oligodendrocytes survival, preserved axons, and myelin integrity and reduced the infiltration of activated T cells into the CNS. This protective effect of the peptide may be related to its suppression of autoantigen-specific T-cell activation via calcium influx inhibition. ConclusionImK prevents neurological damage by suppressing T-cell activation, suggesting the applicability of this peptide in MS therapy.	[Yuan, Xiao-Lu; Zhao, Yi-Peng; Huang, Jie; Liu, Jun-Chen; Mao, Wen-Qian; Yin, Jun; Han, Song; He, Xiao-Hua] Wuhan Univ, Sch Basic Med Sci, Dept Pathophysiol, Wuhan, Hubei, Peoples R China; [Peng, Bi-Wen] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Dev Originated Dis, Wuhan, Hubei, Peoples R China; [Liu, Wan-Hong] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Allergy & Immunol, Wuhan, Hubei, Peoples R China		Han, S; He, XH (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Pathophysiol, Wuhan, Hubei, Peoples R China.	hansong@whu.edu.cn; hexiaohua@whu.edu.cn		Han, Song/0000-0003-4659-4388; Peng, Bi-wen/0000-0002-5599-6779	Natural Science Foundation of Hubei Province of ChinaNatural Science Foundation of Hubei Province [2017CFA017]; National Natural Sciences Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171127, 81371422, 81401230, 81401241]	Natural Science Foundation of Hubei Province of China, Grant/Award Number: 2017CFA017; National Natural Sciences Foundation of China, Grant/Award Number: 81171127, 81371422, 81401230 and 81401241	Baker D, 2011, MULT SCLER J, V17, P647, DOI 10.1177/1352458511398885; Beeton C, 2005, NEUROSCIENTIST, V11, P550, DOI 10.1177/1073858405278016; Beeton C, 2001, J IMMUNOL, V166, P936, DOI 10.4049/jimmunol.166.2.936; BEVER CT, 1994, ANN NEUROL, V36, pS118, DOI 10.1002/ana.410360728; Blight AR, 2014, ANN NY ACAD SCI, V1329, P33, DOI 10.1111/nyas.12512; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Chew LJ, 2005, GLIA, V52, P127, DOI 10.1002/glia.20232; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Chittajallu R, 2002, P NATL ACAD SCI USA, V99, P2350, DOI 10.1073/pnas.042698399; DAVIS FA, 1990, ANN NEUROL, V27, P186, DOI 10.1002/ana.410270215; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Feinstein A, 2015, LANCET NEUROL, V14, P194, DOI 10.1016/S1474-4422(14)70231-5; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Forrest AD, 2009, J NEUROSCI RES, V87, P3456, DOI 10.1002/jnr.22022; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Fyffe-Maricich SL, 2013, J NEUROSCI, V33, P18402, DOI 10.1523/JNEUROSCI.2381-13.2013; GALLO P, 1991, J NEUROL SCI, V101, P227, DOI 10.1016/0022-510X(91)90050-H; Gresle MM, 2008, J NEUROSCI RES, V86, P3548, DOI 10.1002/jnr.21803; Haghikia A, 2013, TRENDS MOL MED, V19, P309, DOI 10.1016/j.molmed.2013.03.004; Haile Y, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0376-7; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Han S, 2011, TOXICON, V57, P348, DOI 10.1016/j.toxicon.2010.12.015; Hedegaard CJ, 2008, IMMUNOLOGY, V125, P161, DOI 10.1111/j.1365-2567.2008.02837.x; Hemmer B, 2015, LANCET NEUROL, V14, P406, DOI 10.1016/S1474-4422(14)70305-9; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Hoflich KM, 2016, BRAIN RES, V1650, P125, DOI 10.1016/j.brainres.2016.08.048; Huang J, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0158-2; Koeberle PD, 2010, CELL DEATH DIFFER, V17, P134, DOI 10.1038/cdd.2009.113; Kotecha SA, 1999, J NEUROSCI, V19, P10680, DOI 10.1523/JNEUROSCI.19-24-10680.1999; Kuhle J, 2010, J NEUROIMMUNOL, V220, P114, DOI 10.1016/j.jneuroim.2010.01.004; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Maghzi AH, 2013, CNS DRUGS, V27, P799, DOI 10.1007/s40263-013-0093-7; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Ovsepian SV, 2016, PHARMACOL THERAPEUT, V159, P93, DOI 10.1016/j.pharmthera.2016.01.005; Peng Y, 2014, NEURO-ONCOLOGY, V16, P528, DOI 10.1093/neuonc/not221; Pfeifenbring S, 2015, ANN NEUROL, V77, P655, DOI 10.1002/ana.24364; Ponath G, 2017, BRAIN, V140, P399, DOI 10.1093/brain/aww298; Quintanar JL, 2001, CELL PHYSIOL BIOCHEM, V11, P27, DOI 10.1159/000047789; Rangaraju S, 2009, EXPERT OPIN THER TAR, V13, P909, DOI 10.1517/14728220903018957; Reeves TM, 2016, EXP NEUROL, V283, P188, DOI 10.1016/j.expneurol.2016.06.011; Ritter J, 2013, J NEUROSCI, V33, P8990, DOI 10.1523/JNEUROSCI.5528-12.2013; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; Schirmer L, 2013, BRAIN PATHOL, V23, P2, DOI 10.1111/j.1750-3639.2012.00608.x; Shirani A, 2012, JAMA-J AM MED ASSOC, V308, P247, DOI 10.1001/jama.2012.7625; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Sweeney E, 2008, BIOCHEM BIOPH RES CO, V374, P181, DOI 10.1016/j.bbrc.2008.06.127; Tegla CA, 2011, EXP MOL PATHOL, V91, P335, DOI 10.1016/j.yexmp.2011.04.006; Vautier F, 2004, GLIA, V48, P337, DOI 10.1002/glia.20088; Vazquez-Villoldo N, 2014, GLIA, V62, P171, DOI 10.1002/glia.22596; Wang ZC, 2017, MOL NEUROBIOL, V54, P7343, DOI 10.1007/s12035-016-0197-4; Wraith DC, 2009, P NATL ACAD SCI USA, V106, P15466, DOI 10.1073/pnas.0903360106; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Zhao N, 2015, SCI REP-UK, V5, DOI 10.1038/srep17381	56	8	8	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	OCT	2018	24	10					967	977		10.1111/cns.12848			11	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	GS9UU	WOS:000444073600012	29577640	Bronze, Green Published			2022-02-06	
J	Zeiler, FA; Smielewski, P; Stevens, A; Czosnyka, M; Menon, DK; Ercole, A				Zeiler, Frederick A.; Smielewski, Peter; Stevens, Andrew; Czosnyka, Marek; Menon, David K.; Ercole, Ari			Non-Invasive Pressure Reactivity Index Using Doppler Systolic Flow Parameters: A Pilot Analysis	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; brain injury; TBI; TCD; time series	CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; AUTOREGULATION MEASUREMENT TECHNIQUES	The goal was to predict pressure reactivity index (PRx) using non-invasive transcranial Doppler (TCD) based indices of cerebrovascular reactivity, systolic flow index (Sx_a), and mean flow index (Mx_a). Continuous extended duration time series recordings of middle cerebral artery cerebral blood flow velocity (CBFV) were obtained using robotic TCD in parallel with direct intracranial pressure (ICP). PRx, Sx_a, and Mx_a were derived from high frequency archived signals. Using time-series techniques, autoregressive integrative moving average (ARIMA) structure of PRx was determined and embedded in the following linear mixed effects (LME) models of PRx: PRx approximate to Sx_a and PRx approximate to Sx_a + Mx_a. Using 80% of the recorded patient data, the LME models were created and trained. Model superiority was assessed via Akaike information criterion (AIC), Bayesian information criterion (BIC), and log-likelihood (LL). The superior two models were then used to predict PRx using the remaining 20% of the signal data. Predicted and observed PRx were compared via Pearson correlation, linear models, and Bland-Altman (BA) analysis. Ten patients had 3-4h of continuous uninterrupted ICP and TCD data and were used for this pilot analysis. Optimal ARIMA structure for PRx was determined to be (2,0,2), and this was embedded in all LME models. The top two LME models of PRx were determined to be: PRx approximate to Sx_a and PRx approximate to Sx_a + Mx_a. Estimated and observed PRx values from both models were strongly correlated (r>0.9; p<0.0001 for both), with acceptable agreement on BA analysis. Predicted PRx using these two models was also moderately correlated with observed PRx, with acceptable agreement (r=0.797, p=0.006; r=0.763, p=0.011; respectively). With application of ARIMA and LME modeling, it is possible to predict PRx using non-invasive TCD measures. These are the first and as well as being preliminary attempts at doing so. Much further work is required.	[Zeiler, Frederick A.; Stevens, Andrew; Menon, David K.; Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Anaesthesia, Cambridge, England; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada.	umzeiler@myumanitoba.ca	Ercole, Ari/B-6288-2009	Ercole, Ari/0000-0001-8350-8093; Stevens, Andrew/0000-0002-3222-133X; czosnyka, marek/0000-0003-2446-8006; Zeiler, Frederick/0000-0003-1737-0510	Royal College of Surgeons of Canada - Harry S. Morton Travelling Fellowship in Surgery; University of Manitoba Clinician Investigator Program; National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre; NIHR Senior Investigator Award; European Union Framework Program 7 grant (CENTER-TBI) [602150]; Cambridge Commonwealth Trust Scholarship	This work was made possible through salary support through the Cambridge Commonwealth Trust Scholarship, the Royal College of Surgeons of Canada - Harry S. Morton Travelling Fellowship in Surgery, and the University of Manitoba Clinician Investigator Program. These studies were supported by National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre and an NIHR Senior Investigator Award to D.K.M. The authors were also supported by a European Union Framework Program 7 grant (CENTER-TBI, Grant Agreement No. 602150).	Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Howells T, 2018, CRIT CARE MED, V46, pe235, DOI 10.1097/CCM.0000000000002930; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Zeiler F.A., 2018, J NEUROTRAUM, V160, P1315; Zeiler FA, 2018, J NEUROTRAUM, V35, P314, DOI 10.1089/neu.2017.5364; Zeiler FA, 2018, J NEUROTRAUM, V35, P2812, DOI 10.1089/neu.2017.5604; Zeiler FA, 2018, J NEUROTRAUM, V35, P2803, DOI 10.1089/neu.2017.5603; Zeiler FA, 2018, J NEUROTRAUM, V35, P1559, DOI 10.1089/neu.2017.5596; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086; Zeiler FA, 2017, J NEUROTRAUM, V34, P3207, DOI 10.1089/neu.2017.5085; Zeiler FA, 2017, J NEUROTRAUM, V34, P3070, DOI 10.1089/neu.2017.5129	15	8	8	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2019	36	5					713	720		10.1089/neu.2018.5987		SEP 2018	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HR2BG	WOS:000445768900001	30091677	Green Submitted			2022-02-06	
J	Corwin, C; Nikolopoulou, A; Pan, AL; Nunez-Santos, M; Vallabhajosula, S; Serrano, P; Babich, J; Figueiredo-Pereira, ME				Corwin, Chuhyon; Nikolopoulou, Anastasia; Pan, Allen L.; Nunez-Santos, Mariela; Vallabhajosula, Shankar; Serrano, Peter; Babich, John; Figueiredo-Pereira, Maria E.			Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets	JOURNAL OF NEUROINFLAMMATION			English	Article						Neuroinflammation; Cyclooxygenase; Prostaglandins; L-PGDS; DP2; 15-PGDH; Parkinson's disease; PGD2/J2 signaling; Ibuprofen	TRAUMATIC BRAIN-INJURY; GLIAL-CELL MIGRATION; DOPAMINERGIC-NEURONS; ANIMAL-MODELS; D SYNTHASE; DISEASE; CYCLOOXYGENASE-2; INFLAMMATION; MICROGLIA; MORPHOLOGY	Background: Prostaglandins are products of the cyclooxygenase pathway, which is implicated in Parkinson's disease (PD). Limited knowledge is available on mechanisms by which prostaglandins contribute to PD neurodegeneration. To address this gap, we focused on the prostaglandin PGD2/J2 signaling pathway, because PGD2 is the most abundant prostaglandin in the brain, and the one that increases the most under pathological conditions. Moreover, PGJ2 is spontaneously derived from PGD2. Methods: In this study, we determined in rats the impact of unilateral nigral PGJ2-microinfusions on COX-2, lipocalin type PGD2 synthase (L-PGDS), PGD2/J2 receptor 2 (DP2), and 15 hydroxyprostaglandin dehydrogenase (15-PGDH). Nigral dopaminergic (DA) and microglial distribution and expression levels of these key factors of the prostaglandin D2/J2 pathway were evaluated by immunohistochemistry. PGJ2-induced motor deficits were assessed with the cylinder test. We also determined whether oral treatment with ibuprofen improved the PD-like pathology induced by PGJ2. Results: PGJ2 treatment induced progressive PD-like pathology in the rats. Concomitant with DA neuronal loss in the substantia nigra pars compacta (SNpc), PGJ2-treated rats exhibited microglia and astrocyte activation and motor deficits. In DA neurons, COX-2, L-PGDS, and 15-PGDH levels increased significantly in PGJ2-treated rats compared to controls, while DP2 receptor levels were unchanged. In microglia, DP2 receptors were basically non-detectable, while COX-2 and L-PGDS levels increased upon PGJ2-treatment, and 15-PGDH remained unchanged. 15-PGDH was also detected in oligodendrocytes. Notably, ibuprofen prevented most PGD2-induced PD-like pathology. Conclusions: The PGJ2-induced rat model develops progressive PD pathology, which is a hard-to-mimic aspect of this disorder. Moreover, prevention of most PGJ2-induced PD-like pathology with ibuprofen suggests a positive feedback mechanism between PGJ2 and COX-2 that could lead to chronic neuroinflammation. Notably, this is the first study that analyzes the nigral dopaminergic and microglial distribution and levels of factors of the PGD2/J2 signaling pathway in rodents. Our findings support the notions that upregulation of COX-2 and L-PGDS may be important in the PGJ2 evoked PD-like pathology, and that neuronal DP2 receptor antagonists and L-PGDS inhibitors may be novel pharmacotherapeutics to relieve neuroinflammation-mediated neurodegeneration in PD, circumventing the adverse side effects of cyclooxygenase inhibitors.	[Corwin, Chuhyon; Pan, Allen L.; Nunez-Santos, Mariela; Figueiredo-Pereira, Maria E.] CUNY Hunter Coll, Grad Ctr, Dept Biol Sci, Neurosci Collaborat Program, 695 Pk Ave, New York, NY 10065 USA; [Serrano, Peter] CUNY Hunter Coll, Dept Psychol, 695 Pk Ave, New York, NY 10021 USA; [Nikolopoulou, Anastasia; Vallabhajosula, Shankar; Babich, John] Weill Cornell Med, Dept Radiol, New York, NY USA		Figueiredo-Pereira, ME (corresponding author), CUNY Hunter Coll, Grad Ctr, Dept Biol Sci, Neurosci Collaborat Program, 695 Pk Ave, New York, NY 10065 USA.	pereira@genectr.hunter.cuny.edu	Babich, John/AAM-8940-2020	Figueiredo-Pereira, Maria/0000-0001-5131-4315	NIH [CTSC GRANT] [UL1-RR024996, GM060665]; NIMHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [MD007599]; NSFNational Science Foundation (NSF) [0965983]; Neuroscience Collaborative Program, Graduate Center, The City University of New York; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM060665] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [G12MD007599] Funding Source: NIH RePORTER	This work was supported by NIH [CTSC GRANT UL1-RR024996 (pilot award to JB & MEFP); GM060665 (RISE Training Program at Hunter College from NIGMS to MNS); MD007599 to Hunter College from NIMHD], NSF 0965983 (IGERT Training Program at Hunter College to CC), and the Neuroscience Collaborative Program, Graduate Center, The City University of New York.	Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Bartels AL, 2010, CURR NEUROPHARMACOL, V8, P62, DOI 10.2174/157015910790909485; Becker C, 2010, PARKINSONISM RELAT D, V16, P31, DOI 10.1016/j.parkreldis.2009.06.005; Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Blesa J, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00155; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Braune S, 2012, CLIN HEMORHEOL MICRO, V52, P349, DOI 10.3233/CH-2012-1610; Carlson NG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-25; Carta AR, 2015, EXPERT OPIN INV DRUG, V24, P219, DOI 10.1517/13543784.2015.963195; Cebrian C, 2015, CURR TOP BEHAV NEURO, V22, P237, DOI 10.1007/7854_2014_356; Czirr E, 2012, J CLIN INVEST, V122, P1156, DOI 10.1172/JCI58656; Deleidi M, 2013, CELL MOL LIFE SCI, V70, P4259, DOI 10.1007/s00018-013-1352-y; Dzamko N, 2015, NEUROSCIENCE, V302, P89, DOI 10.1016/j.neuroscience.2014.10.028; Ebrahimi-Fakhari D, 2012, ACTA NEUROPATHOL, V124, P153, DOI 10.1007/s00401-012-1004-6; Esposito E, 2007, EXP NEUROL, V205, P295, DOI 10.1016/j.expneurol.2007.02.008; FAHN S, 1971, J NEUROL SCI, V14, P427, DOI 10.1016/0022-510X(71)90178-X; Gao XA, 2011, NEUROLOGY, V76, P863, DOI 10.1212/WNL.0b013e31820f2d79; Gubellini P, 2015, REV NEUROL-FRANCE, V171, P750, DOI 10.1016/j.neurol.2015.07.011; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; Harrington MG, 2006, DIS MARKERS, V22, P73, DOI 10.1155/2006/241817; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; HERTTING G, 1989, ANN NY ACAD SCI, V559, P84; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hirsch Etienne C, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS210, DOI 10.1016/S1353-8020(11)70065-7; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Iannaccone PM, 2009, DIS MODEL MECH, V2, P206, DOI 10.1242/dmm.002733; Iravani MM, 2005, EUR J NEUROSCI, V22, P317, DOI 10.1111/j.1460-9568.2005.04220.x; Kanda H, 2013, GLIA, V61, P943, DOI 10.1002/glia.22487; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Lecanu L, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt171; Lee S, 2012, J BIOL CHEM, V287, P9414, DOI 10.1074/jbc.M111.330662; Li ZM, 2004, J NEUROSCI RES, V78, P824, DOI 10.1002/jnr.20346; Li ZM, 2004, BIOCHEM BIOPH RES CO, V319, P1171, DOI 10.1016/j.bbrc.2004.05.098; Liang X, 2007, J MOL NEUROSCI, V33, P94, DOI 10.1007/s12031-007-0058-8; Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x; Liu H, 2013, NEUROTOXICOLOGY, V39, P35, DOI 10.1016/j.neuro.2013.08.001; Liu M, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/327089; Ma J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24646; Maesaka John K, 2013, J Nephropathol, V2, P166, DOI 10.12860/JNP.2013.28; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Mercuri NB, 2005, TRENDS PHARMACOL SCI, V26, P341, DOI 10.1016/j.tips.2005.05.002; Meredith GE, 2006, MOVEMENT DISORD, V21, P1595, DOI 10.1002/mds.21010; Mohan Shekher, 2012, Front Neurol, V3, P145, DOI 10.3389/fneur.2012.00145; Molochnikov L, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00110; Monneret G, 2002, J IMMUNOL, V168, P3563, DOI 10.4049/jimmunol.168.7.3563; NARUMIYA S, 1986, J PHARMACOL EXP THER, V239, P500; Nelson EL, 1996, J COMP NEUROL, V369, P361, DOI 10.1002/(SICI)1096-9861(19960603)369:3<361::AID-CNE3>3.0.CO;2-3; OGOROCHI T, 1984, J NEUROCHEM, V43, P71, DOI 10.1111/j.1471-4159.1984.tb06680.x; Oueslati A, 2016, J PARKINSON DIS, V6, P39, DOI 10.3233/JPD-160779; Paxinos G., 2013, RAT BRAIN STEREOTAXI; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Phani Sudarshan, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS207, DOI 10.1016/S1353-8020(11)70064-5; Phillips J, 2013, CELL, P1; Pierre SR, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-18; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Rainsford KD, 2015, IBUPROFEN: DISCOVERY, DEVELOPMENT AND THERAPEUTICS, P547; Ramsey CP, 2014, EXP NEUROL, V256, P126, DOI 10.1016/j.expneurol.2013.05.014; Rees K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008454.pub2; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Richardson RL, 2002, BRAIN RES, V954, P1, DOI 10.1016/S0006-8993(02)03006-8; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Scher JU, 2005, CLIN IMMUNOL, V114, P100, DOI 10.1016/j.clim.2004.09.008; Shaik JSB, 2014, J CHROMATOGR B, V945, P207, DOI 10.1016/j.jchromb.2013.11.041; Shivers KY, 2014, BBA-MOL BASIS DIS, V1842, P1707, DOI 10.1016/j.bbadis.2014.06.020; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Suk K, 2012, CELL ADHES MIGR, V6, P160, DOI 10.4161/cam.20251; Surmeier DJ, 2013, PRION, V7, P85, DOI 10.4161/pri.23582; Tai HH, 2002, PROSTAG OTH LIPID M, V68-9, P483, DOI 10.1016/S0090-6980(02)00050-3; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Tillerson JL, 2001, J NEUROSCI, V21, P4427, DOI 10.1523/JNEUROSCI.21-12-04427.2001; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; Xu SY, 2000, BBA-PROTEIN STRUCT M, V1482, P298, DOI 10.1016/S0167-4838(00)00163-1	78	8	9	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	SEP 20	2018	15								272	10.1186/s12974-018-1305-3			18	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	GU4CB	WOS:000445227200001	30236122	gold, Green Published			2022-02-06	
J	Ni, SF; Cao, Y; Jiang, LY; Luo, ZX; Lu, HB; Hu, JZ; Wu, TD				Ni, Shuangfei; Cao, Yong; Jiang, Liyuan; Luo, Zixiang; Lu, Hongbin; Hu, Jianzhong; Wu, Tianding			Synchrotron Radiation Imaging Reveals the Role of Estrogen in Promoting Angiogenesis After Acute Spinal Cord Injury in Rats	SPINE			English	Article						acute spinal cord injury; angiogenesis; estrogen; synchrotron radiation	TRAUMATIC BRAIN-INJURY; FUNCTIONAL RECOVERY; ALZHEIMERS-DISEASE; EXPRESSION; TETRAMETHYLPYRAZINE; METHYLPREDNISOLONE; 17-BETA-ESTRADIOL; MICROVASCULATURE; NEUROPROTECTION; REGENERATION	Study Design. The efficacy of estrogen on vessel angiogenesis in acute spinal cord injury (SCI) in a rat model was evaluated by synchrotron radiation. Objective. Here, we investigate the change in injured spinal cord vessels and used the synchrotron radiation to investigate the effect of estrogen on vessel angiogenesis and functional recovery in a rat model of SCI. Summary of Background Data. The promotion of angiogenesis after SCI may be a therapeutic target in the treatment of SCI. Estrogen has been reported to improve locomotor recovery after SCI. However, how estrogen regulates angiogenesis in acute SCI and enhances neurological functional recovery has not been fully characterized. Methods. Synchrotron radiation imaging combined with histological methods was used to image angiogenesis in acute spinal cord treatment with estrogen in rats. Results. Synchrotron radiation imaging vividly demonstrated three-dimensional vessel changes in the spinal cord after injury. The imaging showed that vessel number, vessel volume fraction, and vessel connectivity value in the groups treated with estrogen after SCI were significantly increased compared to control groups (P<0.05). Vessel angiogenesis increased in groups treated with estrogen compared with control rats, which was confirmed with histological staining. Estrogen treatment also attenuated the injury-induced lesion area compared with control groups and improved locomotor functional recovery after SCI. Conclusion. The results indicated that synchrotron radiation is a powerful imaging tool for visualizing angiogenesis after acute SCI. Estrogen treatment exerted a neuroprotective effect on acute SCI treatment by promoting angiogenesis and reducing the injury-induced lesion area could be recommended as a potential preclinical treatment approach for acute SCI.	[Ni, Shuangfei; Cao, Yong; Jiang, Liyuan; Luo, Zixiang; Hu, Jianzhong; Wu, Tianding] Cent S Univ, Xiangya Hosp, Dept Spine Surg, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [Lu, Hongbin] Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha, Hunan, Peoples R China		Wu, TD (corresponding author), Cent S Univ, Xiangya Hosp, Dept Spine Surg, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	tiandingwu@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301522, 81371956, 81301542]; Fundamental Research Funds for the Central Universities of Central South University [2016zzts123]; Hunan Provincial Innovation Foundation For Postgraduate funds [CX2015B060]	The National Natural Science Foundation of China (Nos 81301522, 81371956, 81301542), the Fundamental Research Funds for the Central Universities of Central South University (2016zzts123), and Hunan Provincial Innovation Foundation For Postgraduate (No. CX2015B060) funds were received in support of this work.	Benton RL, 2008, J CEREBR BLOOD F MET, V28, P1771, DOI 10.1038/jcbfm.2008.76; Bosmia AN, 2015, CLIN ANAT, V28, P52, DOI 10.1002/ca.22281; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Cao Y, 2017, J NEUROTRAUM, V34, P1187, DOI 10.1089/neu.2016.4697; Cao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12643; Casella GTB, 2002, EXP NEUROL, V173, P63, DOI 10.1006/exnr.2001.7827; Chan WM, 2013, TRANSL STROKE RES, V4, P447, DOI 10.1007/s12975-012-0249-7; Del Gaizo DJ, 2013, SPINE J, V13, P439, DOI 10.1016/j.spinee.2012.11.024; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Engler-Chiurazzi EB, 2017, PROG NEUROBIOL, V157, P188, DOI 10.1016/j.pneurobio.2015.12.008; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Evaniew N, 2015, J NEUROTRAUM, V32, P1674, DOI 10.1089/neu.2015.3963; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; Fitzharris M, 2014, SPINAL CORD, V52, P117, DOI 10.1038/sc.2013.135; Harrop James S, 2014, Neurosurgery, V61 Suppl 1, P30, DOI 10.1227/NEU.0000000000000391; Henderson VW, 2000, NEUROLOGY, V54, P295, DOI 10.1212/WNL.54.2.295; Hu JZ, 2012, J NEUROSCI METH, V204, P150, DOI 10.1016/j.jneumeth.2011.10.018; Hu JZ, 2016, SPINE, V41, P1272, DOI 10.1097/BRS.0000000000001546; Hu JZ, 2014, MED PHYS, V41, DOI 10.1118/1.4894704; Huang JH, 2016, BRAIN RES, V1648, P35, DOI 10.1016/j.brainres.2016.07.023; Islamov RR, 2003, BRAIN RES, V966, P65, DOI 10.1016/S0006-8993(02)04191-4; Jing YL, 2017, J SPINAL CORD MED, V40, P222, DOI 10.1080/10790268.2016.1227912; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Lutton C, 2012, J NEUROTRAUM, V29, P957, DOI 10.1089/neu.2010.1423; Martirosyan NL, 2011, J NEUROSURG-SPINE, V15, P238, DOI 10.3171/2011.4.SPINE10543; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; Mehta S, 2016, ARCH PHYS MED REHAB, V97, P1381, DOI 10.1016/j.apmr.2015.12.023; Reinhardt JD, 2017, AM J PHYS MED REHAB, V96, pS61, DOI 10.1097/PHM.0000000000000680; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Samantaray S, 2016, J NEUROCHEM, V137, P604, DOI 10.1111/jnc.13610; Samantaray S, 2016, J NEUROCHEM, V136, P1064, DOI 10.1111/jnc.13464; Samantaray S, 2010, ANN NY ACAD SCI, V1199, P90, DOI 10.1111/j.1749-6632.2009.05357.x; Siddiqui AM, 2015, PROG BRAIN RES, V218, P15, DOI 10.1016/bs.pbr.2014.12.007; Sribnick EA, 2005, J NEUROSCI RES, V82, P283, DOI 10.1002/jnr.20622; Sribnick EA, 2010, J NEUROSCI RES, V88, P1738, DOI 10.1002/jnr.22337; Sribnick EA, 2006, J NEUROSCI RES, V84, P1064, DOI 10.1002/jnr.21016; Varma AK, 2013, NEUROCHEM RES, V38, P895, DOI 10.1007/s11064-013-0991-6; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Yue X, 2005, P NATL ACAD SCI USA, V102, P19198, DOI 10.1073/pnas.0505203102; Yune TY, 2008, J NEUROTRAUM, V25, P1121, DOI 10.1089/neu.2008.0544; Yune TY, 2004, J NEUROTRAUM, V21, P293, DOI 10.1089/089771504322972086	42	8	8	2	28	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	SEP 15	2018	43	18					1241	1249		10.1097/BRS.0000000000002629			9	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	HD0AE	WOS:000452169000011	29529001				2022-02-06	
J	Dubiel, R; Callender, L; Dunklin, C; Harper, C; Bennett, M; Kreber, L; Auchus, R; Diaz-Arrastia, R				Dubiel, Rosemary; Callender, Librada; Dunklin, Cynthia; Harper, Caryn; Bennett, Monica; Kreber, Lisa; Auchus, Richard; Diaz-Arrastia, Ramon			Phase 2 Randomized, Placebo-Controlled Clinical Trial of Recombinant Human Growth Hormone (rhGH) During Rehabilitation From Traumatic Brain Injury	FRONTIERS IN ENDOCRINOLOGY			English	Article						insulin-like growth factor I; glasgow outcome scale; disability rating scale; functional independence measure; short form 36	FACTOR-I LEVELS; QUALITY-OF-LIFE; IGF-I; PITUITARY DYSFUNCTION; REPLACEMENT THERAPY; ISCHEMIC-STROKE; GH TREATMENT; ADULT-RATS; DEFICIENCY; HYPOPITUITARISM	Traumatic brain injury (TBI) is a major cause of death and disability, but there are currently no therapies with proven efficacy for optimizing regeneration of repair during rehabilitation. Using standard stimulation tests, as many as 40-50% of survivors of severe TBI have deficiency of one or more pituitary hormones. Of these, the somatotropic axis is the most commonly affected, with Growth Hormone (GH) deficiency affecting similar to 20% of persons with severe TBI. Treatment with recombinant human Growth Hormone (rhGH) is generally effective in reversing the effects of acquired GH deficiency, but there is no evidence documenting functional or neurocognitive improvement after GH replacement in TBI patients. As a consequence, screening for GH deficiency and GH replacement when deficiency is found is not routinely performed as part of the rehabilitation of TBI survivors. Given that most of the recovery after TBI occurs within the first 6-12 months after injury and IGF-1 and GH are part of a coordinated restorative neurotrophic system, we hypothesized that patients will optimally benefit from GH therapy during the window of maximal neuroregenerative activity. We performed a Phase IIa, randomized, double-blind, placebo-controlled feasibility trial of recombinant human Growth Hormone (rhGH), starting at discharge from an inpatient rehabilitation unit, with follow up at 6 and 12 months. Our primary hypothesis was that treatment with rhGH in the subacute period would result in improved functional outcomes 6 months after injury. Our secondary hypothesis proposed that treatment with rhGH would increase IGF-1 levels and be well tolerated. Sixty-three subjects were randomized, and 40 completed the trial. At baseline, there was no correlation between IGF-1 levels and peak GH levels after L-arginine stimulation. IGF-1 levels increased after rhGH treatment, but it took longer than 1 month for levels to be higher than for placebo-treated patients. rhGH therapy was well-tolerated. The rhGH group was no different from placebo in the Disability Rating Scale, Glasgow Outcome Scale-Extended, or neuropsychological function. However, a trend toward greater improvement from baseline in Functional Independence Measure (FIM) was noted in the rhGH treated group. Future studies should include longer treatment periods, faster titration of rhGH, and larger sample sizes.	[Dubiel, Rosemary; Callender, Librada; Dunklin, Cynthia; Bennett, Monica] Baylor Inst Rehabil, Dept Phys Med & Rehabil, Dallas, TX USA; [Harper, Caryn] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Kreber, Lisa] Ctr Neuro Skills, Bakersfield, CA USA; [Auchus, Richard] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA		Diaz-Arrastia, R (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	ramon.diaz-arrastia@uphs.upenn.edu			National Institute of Disability, Independent Living, and Rehabilitation Research [H133A020526]; PfizerPfizer [GA62816O]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK020572] Funding Source: NIH RePORTER	National Institute of Disability, Independent Living, and Rehabilitation Research (Award H133A020526). Pfizer contributed rhGH and placebo preparations (Award GA62816O).	Aberg D, 2011, J CLIN ENDOCR METAB, V96, pE1055, DOI 10.1210/jc.2010-2802; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha A, 2007, CLIN ENDOCRINOL, V66, P72, DOI 10.1111/j.1365-2265.2006.02688.x; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Bianchi VE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112441; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2006, J CLIN ENDOCR METAB, V91, P3928, DOI 10.1210/jc.2006-1040; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; BURMAN P, 1995, J CLIN ENDOCR METAB, V80, P3585, DOI 10.1210/jc.80.12.3585; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Centers for Disease Control and Prevention, 2015, C TRAUM BRAIN INJ US; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; Devesa J, 2013, HORM BEHAV, V63, P331, DOI 10.1016/j.yhbeh.2012.02.022; Devesa P, 2011, BRAIN INJURY, V25, P503, DOI 10.3109/02699052.2011.559611; Feeney C, 2017, ANN NEUROL, V82, P30, DOI 10.1002/ana.24971; GUAN J, 1993, J CEREBR BLOOD F MET, V13, P609, DOI 10.1038/jcbfm.1993.79; Heredia M, 2013, BEHAV BRAIN RES, V247, P48, DOI 10.1016/j.bbr.2013.03.012; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Kazanis I, 2003, BRAIN RES, V991, P34, DOI 10.1016/S0006-8993(03)03525-X; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lopez-Lopez C, 2004, P NATL ACAD SCI USA, V101, P9833, DOI 10.1073/pnas.0400337101; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Ong LK, 2018, STROKE, V49, P1257, DOI 10.1161/STROKEAHA.117.020557; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Scheepens A, 2001, NEUROSCIENCE, V104, P677, DOI 10.1016/S0306-4522(01)00109-9; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; Walter HJ, 1997, ENDOCRINOLOGY, V138, P3024, DOI 10.1210/en.138.7.3024; Watanabe T, 2005, J AM GERIATR SOC, V53, P1748, DOI 10.1111/j.1532-5415.2005.53524.x; Zhang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108518	33	8	8	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2392			FRONT ENDOCRINOL	Front. Endocrinol.	SEP 10	2018	9								520	10.3389/fendo.2018.00520			11	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	GT0EH	WOS:000444101200001	30250451	Green Published, gold			2022-02-06	
J	Hanks, RA; Rapport, LJ; Seagly, K; Millis, SR; Scott, C; Pearson, C				Hanks, Robin A.; Rapport, Lisa J.; Seagly, Katharine; Millis, Scott R.; Scott, Carolyn; Pearson, Claire			Outcomes after Concussion Recovery Education: Effects of Litigation and Disability Status on Maintenance of Symptoms	JOURNAL OF NEUROTRAUMA			English	Article						concussion; disability; litigation; mild traumatic brain injury; outcome	COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; MONEY MATTERS; MILD; IMPACT	This study examined the hypothesis that people who receive concussion recovery education would have better outcomes than those who received usual discharge paperwork from the emergency department (ED) and tested whether participants who were in litigation or seeking disability compensation had more symptoms than individuals not engaged in these activities. Two hundred and fifty-five persons with a diagnosis of concussion were assigned randomly to a brief education group (one-page double-sided document), a longer education group (10-page document), and usual care (standard ED discharge instructions), and were these documents in the ED. A (non-concussion) trauma comparison group was enrolled to determine the symptom rate unrelated to brain injury. The Concussion Symptom Checklist (CSC) and litigation and disability status questions were completed by telephone at one week, three months, and six months. Neither long nor brief information handouts had a significant impact on symptoms over time; the standard form had an average decrease of 1.20 symptoms compared with the brief instructional intervention group (p=0.031). Litigation status and disability seeking status were significant predictors of symptoms on CSC over time: disability seeking (p=0.017) and litigation status (p=0.05). Persons seeking Social Security disability or legal compensation endorsed more symptoms over time than those who were not. Number of symptoms on the CSC for the trauma control group was the same as those who sustained concussion. Type of recovery material was not as important as noting that concussion symptoms resolve over time, and that remaining symptoms are not specific to brain injury. Litigation and disability seeking behavior accounted for maintained symptoms, rather than the concussion itself.	[Hanks, Robin A.; Millis, Scott R.] Wayne State Univ, Sch Med, Dept Phys Med, Detroit, MI USA; [Hanks, Robin A.; Millis, Scott R.] Wayne State Univ, Sch Med, Dept Rehabil, Detroit, MI USA; [Hanks, Robin A.; Rapport, Lisa J.] Wayne State Univ, Dept Psychol, Coll Liberal Arts & Sci, 71 W Warren Ave, Detroit, MI 48202 USA; [Seagly, Katharine] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Hanks, Robin A.; Millis, Scott R.; Pearson, Claire] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA; [Scott, Carolyn] Rainbow Rehabil, Livonia, MI USA		Hanks, RA (corresponding author), Rehabil Inst Michigan, Dept Phys Med & Rehabil, 261 Mack Blvd,Suite 555, Detroit, MI 48201 USA.	rhanks@wayne.edu		Rapport, Lisa/0000-0001-8014-9523	National Institute of Disability, Independent Living, and Rehabilitation Research through Health and Human Services [90IF0048]	This project was funded by the National Institute of Disability, Independent Living, and Rehabilitation Research, through Health and Human Services, grant # 90IF0048.	Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; FEE CRA, 1988, ARCH EMERG MED, V5, P12; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; GRONWALL D, 1986, J HEAD TRAUMA REHAB, V1, P53, DOI DOI 10.1097/00001199-198606000-00009; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Iverson G.L., 2006, BRAIN INJURY MED PRI, P333; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; LEVITT MA, 1994, AM J EMERG MED, V12, P172, DOI 10.1016/0735-6757(94)90240-2; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meares S, 2011, BRAIN INJURY, V25, P1198, DOI 10.3109/02699052.2011.608213; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; ROHLING ML, 1995, HEALTH PSYCHOL, V14, P537, DOI 10.1037/0278-6133.14.6.537; SAUNDERS CE, 1986, ANN EMERG MED, V15, P160, DOI 10.1016/S0196-0644(86)80012-9; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Scott C., 2010, ARCH PHYS MED REHAB, V91, pe33; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928	32	8	8	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2019	36	4					554	558		10.1089/neu.2018.5873		SEP 2018	5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HM4MQ	WOS:000444018600001	30117361				2022-02-06	
J	Wei, HL; Ma, SQ; Li, CX				Wei, Hao-Lan; Ma, Su-Qing; Li, Chun-Xia			Deficiency of unc-51 like kinase 1 (U1k1) protects against mice traumatic brain injury (TBI) by suppression of p38 and JNK pathway	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Traumatic brain injury (TBI); U1k1; Inflammation; Apoptosis and autophagy; p38/JNK	INFLAMMATORY RESPONSE; ULK1; APOPTOSIS; AUTOPHAGY; STRESS; CANCER; CELLS	Unc-51 like autophagy activating kinase 1 (U1k1) is a serine/threonine kinase that plays a key role in regulating autophagy processes. We attempted to investigate the effects of U1k1 on traumatic brain injury (TBI) progression by using wild type (WT) mice and U1k1-knockout (KO) mice suffered with or not TBI. The results were verified using LPS-treated primary astrocyte (AST). Here, U1k1 was over-expressed in hippocampus of WT mice after TBI, as well as in lipopolysaccharide (LPS)-stimulated AST. U1k1 deletion improved cognitive ability and hippocampus histological changes in TBI mice. Nissl and neuronal nuclei (NeuN) staining indicated that U1k1-deletion increased the number of surviving neurons in hippocampus of TBI mice. U1k1-ablation alleviated neuroinflammation, as evidenced by the reduced expression of hippocampus pro-inflammatory cytokines in TBI mice. TBI-induced apoptosis was also ameliorated by U1k1-ablation, as proved by the reduced number of TUNEL-staining cells, and cleaved Caspase-3 and poly (ADP-ribose) polymerase (PARP) expressions. Moreover, U1k1-knockout suppressed TBI-stimulated activation of astrocytes and microglia cells. Additionally, hippocampus autophagy induced by TBI was attenuated by U1k1-knockout. Further, TBI-activated p38/c-Jun N-terminal Kinase (JNK) pathway was repressed by U1k1-deletion in hippocampus of mice. The findings above were confirmed in LPS-stimulated AST with or without U1k1 siRNA transfection. Intriguingly, pre-treatment of p38 or JNK activator markedly abolished the anti-inflammation, anti-apoptosis and anti-autophagy effects of U1k1-knockdown on LPS-incubated AST. In conclusion, our results demonstrated that U1k1 might be a potential target for developing therapeutic strategy against TBI in future. (C) 2018 Published by Elsevier Inc.	[Wei, Hao-Lan; Li, Chun-Xia] Liaocheng Peoples Hosp, Dept Pediat, Liaocheng 252000, Shandong, Peoples R China; [Ma, Su-Qing] Shandong Shenxian Second Peoples Hosp, Dept Pediat, Liaocheng 252423, Shandong, Peoples R China		Li, CX (corresponding author), Liaocheng Peoples Hosp, Dept Pediat, Liaocheng 252000, Shandong, Peoples R China.	lcyiyuan@126.com					Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Chang ZQ, 2014, TUMOR BIOL, V35, P753, DOI 10.1007/s13277-013-1102-7; Chen MB, 2017, ONCOTARGET, V8, P33704, DOI 10.18632/oncotarget.16734; Chen ML, 2013, AUTOPHAGY, V9, P2033, DOI 10.4161/auto.26336; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Feng Y, 2017, CELL MOL NEUROBIOL, V37, P155, DOI 10.1007/s10571-016-0356-1; Galluzzi L, 2016, NAT REV NEUROSCI, V17, P467, DOI 10.1038/nrn.2016.51; Gao Y, 2015, J NEUROCHEM, V134, P340, DOI 10.1111/jnc.13123; Gong QH, 2010, PHARMACOL BIOCHEM BE, V96, P52, DOI 10.1016/j.pbb.2010.04.006; He Y., 2017, J CELL BIOL; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; Kaneko Y, 2012, CELL MED, V4, P55, DOI 10.3727/215517912X639306; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Lee JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015394; Mao JM, 2016, TOXICOL APPL PHARM, V303, P79, DOI 10.1016/j.taap.2016.05.003; Morgan A. R., 2012, GASTROENTEROL RES PR, V2012; Mukhopadhyay S, 2015, FREE RADICAL BIO MED, V89, P311, DOI 10.1016/j.freeradbiomed.2015.07.159; Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446; Ravizza T, 2005, EPILEPSIA, V46, P113, DOI 10.1111/j.1528-1167.2005.01006.x; Roach PJ, 2011, MOL CELL BIOL, V31, P3082, DOI 10.1128/MCB.05565-11; Shen X, 2013, ANESTHESIOLOGY, V118, P502, DOI 10.1097/ALN.0b013e3182834d77; Sun Y., 2017, HEPATOLOGY; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Wang R. C., 2012, SCIENCE; Wang W, 2015, FREE RADICAL BIO MED, V83, P214, DOI 10.1016/j.freeradbiomed.2015.02.029; White H., 2016, TRAUMATIC BRAIN INJU, P210; Xu LM, 2016, TUMOR BIOL, V37, P8721, DOI 10.1007/s13277-015-4737-8; Zhang C., 2018, HEPATOLOGY; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhu YG, 2013, PROTEIN CELL, V4, P711, DOI 10.1007/s13238-013-3910-3	30	8	9	1	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	SEP 5	2018	503	2					467	473		10.1016/j.bbrc.2018.04.154			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	GR5VY	WOS:000442711200011	29680658				2022-02-06	
J	Chao, HL; Liu, YL; Lin, C; Xu, XP; Li, Z; Bao, ZY; Fan, L; Tao, C; Zhao, L; Liu, Y; Wang, XM; You, YP; Liu, N; Ji, J				Chao, Honglu; Liu, Yinlong; Lin, Chao; Xu, Xiupeng; Li, Zheng; Bao, Zhongyuan; Fan, Liang; Tao, Chao; Zhao, Lin; Liu, Yan; Wang, Xiaoming; You, Yongping; Liu, Ning; Ji, Jing			Activation of bradykinin B2 receptor induced the inflammatory responses of cytosolic phospholipase A(2) after the early traumatic brain injury	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Bradykinin B2 receptor; Cytosolic phospholipase A(2); Protein kinase C delta; Traumatic brain injury; Arachidonic acid; Inflammation	PROTEIN-KINASE-C; NF-KAPPA-B; ARACHIDONIC-ACID RELEASE; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; FREE FATTY-ACIDS; B-2 RECEPTORS; SIGNALING PATHWAYS; MEDIATOR RELEASE; EDEMA FORMATION	Phospholipase A(2) is a known aggravator of inflammation and deteriorates neurological outcomes after traumatic brain injury (TBI), however the exact inflammatory mechanisms remain unknown. This study investigated the role of bradykinin and its receptor, which are known initial mediators within inflammation activation, as well as the mechanisms of the cytosolic phospholipase A(2) (cPLA(2))-related inflammatory responses after TBI. We found that cPLA(2) and bradykinin B2 receptor were upregulated after a TBI. Rats treated with the bradykinin B2 receptor inhibitor LF 16-0687 exhibited significantly less cPLA(2) expression and related inflammatory responses in the brain cortex after sustaining a controlled cortical impact (CCI) injury. Both the cPLA(2) inhibitor and the LF16-0687 improved CCI rat outcomes by decreasing neuron death and reducing brain edema. The following TBI model utilized both primary astrocytes and primary neurons in order to gain further understanding of the inflammation mechanisms of the B2 bradykinin receptor and the cPLA(2) in the central nervous system. There was a stronger reaction from the astrocytes as well as a protective effect of LF16-0687 after the stretch injury and bradykinin treatment. The protein kinase C pathway was thought to be involved in the B2 bradykinin receptor as well as the cPLA(2)-related inflammatory responses. Rottlerin, a Protein Kinase C (PKC) delta inhibitor, decreased the activity of the cPLA(2) activity post-injury, and LF16-0687 suppressed both the PKC pathway and the cPLA(2) activity within the astrocytes. These results indicated that the bradykinin B2 receptor-mediated pathway is involved in the cPLA(2)-related inflammatory response from the PKC pathway.	[Chao, Honglu; Liu, Yinlong; Lin, Chao; Xu, Xiupeng; Li, Zheng; Bao, Zhongyuan; Fan, Liang; Tao, Chao; Zhao, Lin; You, Yongping; Liu, Ning; Ji, Jing] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Liu, Yan] Nanjing Med Univ, Sch Pharm, Inst Stem Cell & Neural Regenerat, Nanjing, Jiangsu, Peoples R China; [Wang, Xiaoming] Nanjing Med Univ, Dept Immunol, Nanjing, Jiangsu, Peoples R China		Ji, J (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	yanliu@njmu.edu.cn; xmwang@njmu.edu.cn; yypl9@njmu.edu.cn; jijing@njmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81300998, 81471269]; National Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20131022, BK20160047]; Jiangsu Province's Key Discipline of Medicine [XK201117]; Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Specially Appointed Professor Foundation of Jiangsu Province [ky216r201307]	This work was supported by the National Natural Science Foundation of China (81300998 and 81471269), National Natural Science Foundation of Jiangsu Province (BK20131022 and BK20160047), Jiangsu Province's Key Discipline of Medicine (XK201117), Jiangsu Province and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and the Specially Appointed Professor Foundation of Jiangsu Province (ky216r201307).	Adeagbo ASO, 1998, J VASC RES, V35, P27, DOI 10.1159/000025562; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Akiba S, 2004, BIOL PHARM BULL, V27, P1174, DOI 10.1248/bpb.27.1174; Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; ALBERTWEISSENBERGE, 2014, FRONT CELL NEUROSCI, V8, DOI DOI 10.3389/FNCEL.2014.00345; Anthonymuthu TS, 2017, BBA-MOL BASIS DIS, V1863, P2601, DOI 10.1016/j.bbadis.2017.03.015; Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Bhattacharjee A, 2016, INFECT IMMUN, V84, P2954, DOI 10.1128/IAI.00528-16; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Chen WW, 2016, MOL MED REP, V13, P3391, DOI 10.3892/mmr.2016.4948; Chesnut R M, 1995, New Horiz, V3, P366; Clasadonte J, 2011, P NATL ACAD SCI USA, V108, P16104, DOI 10.1073/pnas.1107533108; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Dave KA, 2010, NEURON GLIA BIOL, V6, P201, DOI 10.1017/S1740925X10000244; DEMEDIUK P, 1985, P NATL ACAD SCI USA, V82, P7071, DOI 10.1073/pnas.82.20.7071; Dhillon HS, 1997, EXP NEUROL, V146, P240, DOI 10.1006/exnr.1997.6524; GIMPL G, 1992, NEUROSCI LETT, V144, P139, DOI 10.1016/0304-3940(92)90735-P; Greco S, 2004, J CELL PHYSIOL, V201, P84, DOI 10.1002/jcp.20052; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; Han HJ, 2007, AM J PHYSIOL-RENAL, V292, pF373, DOI 10.1152/ajprenal.00104.2006; Hsieh HL, 2006, J CELL PHYSIOL, V206, P246, DOI 10.1002/jcp.20457; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Ji J, 2012, J NEUROTRAUM, V29, P776, DOI 10.1089/neu.2010.1602; Kalyvas A, 2004, NEURON, V41, P323, DOI 10.1016/S0896-6273(04)00003-0; Kramer RM, 1996, J LIPID MEDIAT CELL, V14, P3, DOI 10.1016/0929-7855(96)01501-5; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Leslie CC, 2015, J LIPID RES, V56, P1386, DOI 10.1194/jlr.R057588; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li DZ, 2003, BRIT J PHARMACOL, V139, P1539, DOI 10.1038/sj.bjp.0705385; Liebmann C, 1996, BIOCHEM J, V313, P109, DOI 10.1042/bj3130109; Lin WW, 1998, BRIT J PHARMACOL, V125, P1601, DOI 10.1038/sj.bjp.0702219; Liu HT, 2009, J PHYSIOL-LONDON, V587, P2197, DOI 10.1113/jphysiol.2008.165084; Liu NK, 2014, ANN NEUROL, V75, P644, DOI 10.1002/ana.24134; Loiola RA, 2011, PEPTIDES, V32, P1700, DOI 10.1016/j.peptides.2011.06.010; Longhurst HJ, 2010, VASC HEALTH RISK MAN, V6, P795, DOI 10.2147/VHRM.S4332; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Marshall J, 2000, J IMMUNOL, V164, P2084, DOI 10.4049/jimmunol.164.4.2084; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nasseri S, 2015, CRIT CARE MED, V43, pE499, DOI 10.1097/CCM.0000000000001268; Negraes PD, 2015, CELL TRANSPLANT, V24, P613, DOI 10.3727/096368915X687778; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Ferreira APO, 2014, PSYCHOPHARMACOLOGY, V231, P1935, DOI 10.1007/s00213-013-3336-x; PELC LR, 1991, CIRCULATION, V83, P2048, DOI 10.1161/01.CIR.83.6.2048; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Plesnila N, 2001, J NEUROTRAUM, V18, P1049, DOI 10.1089/08977150152693746; RAUD J, 1990, BRIT J PHARMACOL, V99, P449, DOI 10.1111/j.1476-5381.1990.tb12948.x; Regoli D, 2016, BIOL CHEM, V397, P297, DOI 10.1515/hsz-2015-0240; Rehbock J, 1996, IMMUNOPHARMACOLOGY, V33, P164, DOI 10.1016/0162-3109(96)00034-3; Resnick D K, 2001, Spine J, V1, P432, DOI 10.1016/S1529-9430(01)00130-9; RIENDEAU D, 1994, J BIOL CHEM, V269, P15619; Rizzi A, 1997, N-S ARCH PHARMACOL, V356, P662, DOI 10.1007/PL00005103; Schulz J, 2000, ACT NEUR S, V76, P137; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Souza DG, 2004, J IMMUNOL, V172, P2542, DOI 10.4049/jimmunol.172.4.2542; STEPHENSON DT, 1994, BRAIN RES, V637, P97, DOI 10.1016/0006-8993(94)91221-1; Stephenson DT, 1996, NEUROBIOL DIS, V3, P51, DOI 10.1006/nbdi.1996.0005; Sun GY, 2014, MOL NEUROBIOL, V50, P6, DOI 10.1007/s12035-014-8662-4; Sun GY, 2010, NEUROMOL MED, V12, P133, DOI 10.1007/s12017-009-8092-z; Terzuoli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084358; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; WALKER K, 1995, NEUROCHEM INT, V26, P1, DOI 10.1016/0197-0186(94)00114-A; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xanthos DN, 2014, NAT REV NEUROSCI, V15, P43, DOI 10.1038/nrn3617; Xing MZ, 1997, J CLIN INVEST, V99, P805, DOI 10.1172/JCI119227; Xu JF, 2002, J NEUROCHEM, V83, P259, DOI 10.1046/j.1471-4159.2002.01145.x; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287; Zausinger S, 2002, BRAIN RES, V950, P268, DOI 10.1016/S0006-8993(02)03053-6; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]	70	8	8	1	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	SEP	2018	1864	9	B				2957	2971		10.1016/j.bbadis.2018.06.006			15	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	GQ8ZR	WOS:000442056200019	29894755				2022-02-06	
J	Daigle, LE; Harris, MN				Daigle, Leah E.; Harris, Michelle N.			Recurring victimization: What role does head injury play?	JOURNAL OF CRIMINAL JUSTICE			English	Article						Head injury; victimization; recurring victimization	TRAUMATIC BRAIN-INJURY; VICTIM-OFFENDER OVERLAP; SUBSTANCE USE DISORDERS; SEVERE MENTAL-ILLNESS; RISKY LIFE-STYLES; OF-THE-LITERATURE; REPEAT VICTIMIZATION; CRIMINAL VICTIMIZATION; VIOLENT VICTIMIZATION; SELF-CONTROL	Purpose: There is little understanding of why some victims experience multiple victimization events while others are victimized once or not at all. One possible distinguishing characteristic is having a prior head injury, given the strong linkage between prior head injuries and aggression/violence and their connection to victimization. It is plausible that prior head injuries may also lead to recurring victimization. Methods: To examine the possibility that head injury and serious head injury may distinguish between people who are non-victims, single-wave victims, or recurring-victims, we use data from multiple waves of the Pathways to Desistance study. Multinomial regression analyses were utilized to examine prior head injury's (and serious head injury's) effects on being a recurring victim compared to a single-wave victim or non-victim, holding constant demographic controls and other related correlates that may be related to head injury and victimization status. Results: We find that having a prior head injury and serious head injury are able to distinguish between nonvictims, single-wave victims, and recurring-victims. Conclusions: Head injury increases the odds of being a recurring victim compared to a non-victim, and serious head injury increases the odds of being a recurring victim compared to a non-victim and a single-wave victim. Future research, theoretical implications, and policy implications are discussed.	[Daigle, Leah E.; Harris, Michelle N.] Georgia State Univ, Dept Criminol & Criminal Justice, POB 3992, Atlanta, GA 30302 USA		Daigle, LE (corresponding author), Georgia State Univ, Dept Criminol & Criminal Justice, POB 3992, Atlanta, GA 30302 USA.	ldaigle@gsu.edu; Mharris78@student.gsu.edu					Agnew R, 2002, JUSTICE Q, V19, P603, DOI 10.1080/07418820200095371; Agnew R, 2011, J CRIM JUST, V39, P169, DOI 10.1016/j.jcrimjus.2011.01.005; Averdijk M, 2011, J QUANT CRIMINOL, V27, P125, DOI 10.1007/s10940-010-9106-6; Beaver KM, 2007, INT J OFFENDER THER, V51, P620, DOI 10.1177/0306624X07304157; Berg MT, 2012, CRIMINOLOGY, V50, P359, DOI 10.1111/j.1745-9125.2011.00265.x; Bonta J., 2007, 20070 PUBL SAF, V6, P1; Bramsen RH, 2013, AM J ORTHOPSYCHIAT, V83, P47, DOI 10.1111/ajop.12011; Broidy LM, 2006, HOMICIDE STUD, V10, P155, DOI 10.1177/1088767906288577; Clay-Warner J, 2016, CRIM JUSTICE BEHAV, V43, P1406, DOI 10.1177/0093854816636415; COHEN LE, 1979, AM SOCIOL REV, V44, P588, DOI 10.2307/2094589; Cuevas CA, 2010, CHILD ABUSE NEGLECT, V34, P235, DOI 10.1016/j.chiabu.2009.07.004; Daigle Leah, 2016, HDB MEASUREMENT ISSU, P249; Daigle LE, 2008, J INTERPERS VIOLENCE, V23, P1296, DOI 10.1177/0886260508314293; Daigle LE, 2018, CRIM JUSTICE BEHAV, V45, P693, DOI 10.1177/0093854818760966; Daigle LE, 2010, BIODEMOGR SOC BIOL, V56, P137, DOI 10.1080/19485565.2010.524095; DeLisi M, 2014, CRIME DELINQUENCY, V60, P85, DOI 10.1177/0011128709354036; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Fagan AA, 2011, CRIME DELINQUENCY, V57, P732, DOI 10.1177/0011128708321322; Fanti KA, 2012, J RES ADOLESCENCE, V22, P617, DOI 10.1111/j.1532-7795.2012.00809.x; Farrell C, 2017, J CRIM JUST, V53, P25, DOI 10.1016/j.jcrimjus.2017.09.004; FARRELL G, 1995, BRIT J CRIMINOL, V35, P384, DOI 10.1093/oxfordjournals.bjc.a048523; Farrell G., 1995, CRIME JUSTICE, V19, P469, DOI [10.1086/449236, DOI 10.1086/449236]; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Finkelhor D, 2007, CHILD ABUSE NEGLECT, V31, P479, DOI 10.1016/j.chiabu.2006.03.012; Fishbein D, 2016, INT J OFFENDER THER, V60, P575, DOI 10.1177/0306624X14554778; Fisher BS, 2010, JUSTICE Q, V27, P102, DOI 10.1080/07418820902763061; Ford JD, 2010, J ADOLESCENT HEALTH, V46, P545, DOI 10.1016/j.jadohealth.2009.11.212; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gabor T., 2004, INT REV VICT, V10, P193, DOI DOI 10.1177/026975800401000301; Gidycz CA, 2006, AGGRESS VIOLENT BEH, V11, P441, DOI 10.1016/j.avb.2006.01.004; GOTTFREDSON MR, 1981, J CRIM LAW CRIM, V72, P714, DOI 10.2307/1143011; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Herman, 2013, VICTIMS CRIME, P371; Hiday VA, 1999, PSYCHIATR SERV, V50, P62, DOI 10.1176/ps.50.1.62; Hiday VA, 2002, AM J PSYCHIAT, V159, P1403, DOI 10.1176/appi.ajp.159.8.1403; Hindelang M. J., 1978, VICTIMS PERSONAL CRI; Hughes T, 2010, ADDICTION, V105, P2130, DOI 10.1111/j.1360-0443.2010.03088.x; JANOFFBULMAN R, 1979, J PERS SOC PSYCHOL, V37, P1798, DOI 10.1037/0022-3514.37.10.1798; Jennings WG, 2012, AGGRESS VIOLENT BEH, V17, P16, DOI 10.1016/j.avb.2011.09.003; Jennings WG, 2010, J INTERPERS VIOLENCE, V25, P2147, DOI 10.1177/0886260509354888; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kaasa S., 2016, RECURRING VICTIMIZAT; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kira IA, 2014, J AGGRESS MALTREAT T, V23, P431, DOI 10.1080/10926771.2014.904463; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LASLEY JR, 1988, SOCIOL SOC RES, V73, P47; Lauritsen J. L., 2007, CRIME PREVENTION STU, V22, P55; LAURITSEN JL, 1995, J QUANT CRIMINOL, V11, P143, DOI 10.1007/BF02221121; Manasse ME, 2009, J CRIM JUST, V37, P371, DOI 10.1016/j.jcrimjus.2009.06.004; Meijers J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00043; Mukherjee S., 1998, RES PUBLIC POLICY AN, V15, P1; Mulvey E. P, 2014, 2008IJCX0023 NAT I J; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Oudekerk Barbara A., 2017, REPEAT VIOLENT VICTI; Outlaw Maureen, 2002, Violence Vict, V17, P187, DOI 10.1891/vivi.17.2.187.33648; Perreault S, 2004, MULTIPLE VICTIMIZATI; Perron B. E, 2015, ROUTLEDGE INT HDB BI; Policastro C, 2016, J QUANT CRIMINOL, V32, P675, DOI 10.1007/s10940-015-9271-8; Pratt TC, 2000, CRIMINOLOGY, V38, P931, DOI 10.1111/j.1745-9125.2000.tb00911.x; Pratt TC, 2016, VICTIMS OFFENDERS, V11, P335, DOI 10.1080/15564886.2015.1057351; Pyrooz DC, 2014, J RES CRIME DELINQ, V51, P315, DOI 10.1177/0022427813516128; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Ray B, 2017, CRIM JUSTICE BEHAV, V44, P472, DOI 10.1177/0093854816686631; Rozee PD, 2001, PSYCHOL WOMEN QUART, V25, P295, DOI 10.1111/1471-6402.00030; Sagovsky A, 2007, AUST NZ J CRIMINOL, V40, P1, DOI 10.1375/acri.40.1.1; SAMPSON RJ, 1990, J RES CRIME DELINQ, V27, P110, DOI 10.1177/0022427890027002002; Sariaslan A, 2016, JAMA PSYCHIAT, V73, P796, DOI 10.1001/jamapsychiatry.2016.1349; Schreck C. J., 1999, JUSTICE Q, V16, P633, DOI [DOI 10.1080/07418829900094291, 10.1080/07418829900094291]; Schreck CJ, 2006, J QUANT CRIMINOL, V22, P319, DOI 10.1007/s10940-006-9014-y; Schreck CJ, 2008, CRIMINOLOGY, V46, P871, DOI 10.1111/j.1745-9125.2008.00127.x; Schwartz JA, 2017, J RES CRIME DELINQ, V54, P869, DOI 10.1177/0022427817710287; Selner-O'Hagan MB, 1998, J CHILD PSYCHOL PSYC, V39, P215, DOI 10.1017/S002196309700187X; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Silver E, 2005, AM J PUBLIC HEALTH, V95, P2015, DOI 10.2105/AJPH.2003.021436; Silver E, 2002, CRIMINOLOGY, V40, P191, DOI 10.1111/j.1745-9125.2002.tb00954.x; Silver E, 2011, LAW HUMAN BEHAV, V35, P49, DOI 10.1007/s10979-009-9206-8; Soler-Baillo JM, 2005, BEHAV RES THER, V43, P169, DOI 10.1016/j.brat.2004.01.004; Teasdale B, 2014, J INTERPERS VIOLENCE, V29, P987, DOI 10.1177/0886260513506054; Teasdale B, 2009, CRIM JUSTICE BEHAV, V36, P513, DOI 10.1177/0093854809331793; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tseloni A, 2003, BRIT J CRIMINOL, V43, P196, DOI 10.1093/bjc/43.1.196; Tseloni A, 2000, J QUANT CRIMINOL, V16, P415, DOI 10.1023/A:1007547115344; Turanovic JJ, 2014, J QUANT CRIMINOL, V30, P29, DOI 10.1007/s10940-012-9188-4; Turner HA, 2010, AM J PREV MED, V38, P323, DOI 10.1016/j.amepre.2009.11.012; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilson AE, 1999, J CONSULT CLIN PSYCH, V67, P705, DOI 10.1037/0022-006X.67.5.705; Yancey JR, 2013, J CRIM JUST, V41, P309, DOI 10.1016/j.jcrimjus.2013.06.002; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012	90	8	8	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0047-2352	1873-6203		J CRIM JUST	J. Crim. Justice	SEP-OCT	2018	58						78	86		10.1016/j.jcrimjus.2018.07.005			9	Criminology & Penology	Social Science Citation Index (SSCI)	Criminology & Penology	GW1NW	WOS:000446647300008					2022-02-06	
J	Miles, A; McFarlane, M; Scott, S; Hunting, A				Miles, Anna; McFarlane, Mary; Scott, Samantha; Hunting, Alexandra			Cough response to aspiration in thin and thick fluids during FEES in hospitalized inpatients	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						dysphagia; cough; endoscopy; diet modification; aspiration; viscosity	FIBEROPTIC ENDOSCOPIC EVALUATION; PENETRATION-ASPIRATION; SWALLOWING FUNCTION; RELATIVE RISK; REFLEX	Background: The modifications of fluid viscosity and/or volume are common strategies in dysphagia management, with increased viscosity or reduced volume intended to reduce aspiration. Little attention has been given to whether cough response to aspiration varies across different viscosities and volumes. Aims: This prospective observational study investigated aspiration prevalence and cough response to aspiration in thin and thick fluids of two different volumes in patients referred for flexible endoscopic evaluation of swallowing (FEES) in an acute hospital setting. Methods & Procedures: Consecutive inpatients (N=180) referred for FEES were recruited: stroke 51 (28%); other neurological condition (traumatic brain injury, progressive neurological) 33 (18%); cardiovascular critical care 51 (28%); respiratory illness/condition 23 (13%); spinal injury 9 (5%); and other 13 (7%). A standardized protocol was completed on 268 FEES (180 first FEES, 88 repeat FEES). Penetration-aspiration scale (PAS) scores were obtained for thin and mildly thick fluids at two volumes: 5 ml teaspoon and 50 ml continuous drinking. Outcomes & Results: The incidence of aspiration (PAS > 5) was 32% for thin fluids and 18% for thick fluids. There was a significant association between cough response to aspiration and viscosity (p < .001) and volume (p < .001). There was a higher prevalence of silent aspiration in thick fluids than thin fluids. Some patients demonstrated variable cough responsiveness to aspiration across different viscosities and volumes. With 5 ml volumes, 20 patients coughed when they aspirated thin fluids but silently aspirated thick fluids. In comparison, discrepancies in the 50 ml volume were fewer, with three patients coughing when they aspirated thin fluids but silently aspirating thick fluids. Conclusions & Implications: Cough response to aspiration differs across bolus volumes and viscosities. The finding of inconsistent cough response to aspiration in some patients strongly encourages the use of instrumental assessment to guide decisions regarding diet modifications.	[Miles, Anna; McFarlane, Mary; Hunting, Alexandra] Univ Auckland, Auckland, New Zealand; [McFarlane, Mary] Counties Manukau Dist Hlth Board, Auckland, New Zealand; [Scott, Samantha] Auckland Dist Hlth Board, Auckland, New Zealand		Miles, A (corresponding author), Univ Auckland, Sch Psychol, Speech Sci, Tamaki Campus,Private Bag, Auckland 92019, New Zealand.	a.miles@auckland.ac.nz		Miles, Anna/0000-0003-3260-5824			Canning BJ, 2006, CHEST, V129, p33S, DOI 10.1378/chest.129.1_suppl.33S; Cichero JA, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-54; Clave P, 2006, ALIMENT PHARM THER, V24, P1385, DOI 10.1111/j.1365-2036.2006.03118.x; Colodny N, 2002, DYSPHAGIA, V17, P308, DOI 10.1007/s00455-002-0073-4; Davenport PW, 2002, EUR RESPIR REV, V12, P249; Donzelli J, 2003, ANN OTO RHINOL LARYN, V112, P469, DOI 10.1177/000348940311200515; Gescheider GA, 2005, SOMATOSENS MOT RES, V22, P255, DOI 10.1080/08990220500420236; Hafner G, 2008, EUR ARCH OTO-RHINO-L, V265, P441, DOI 10.1007/s00405-007-0507-6; HOLAS MA, 1994, ARCH NEUROL-CHICAGO, V51, P1051, DOI 10.1001/archneur.1994.00540220099020; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leder S., 2010, DYSPHAGIA, V26, P304; Leder SB, 1998, DYSPHAGIA, V13, P208, DOI 10.1007/PL00009573; Logemanin JA, 2008, J SPEECH LANG HEAR R, V51, P173, DOI 10.1044/1092-4388(2008/013); Logemann JA, 1998, EVALUATION TREATMENT; Miles A, 2013, PHYSIOL BEHAV, V118, P25, DOI 10.1016/j.physbeh.2013.05.004; Mills R., 2008, ASHA LEADER; Molfenter SM, 2014, DYSPHAGIA, V29, P269, DOI 10.1007/s00455-013-9506-5; Nativ-Zeltzer N, 2018, LARYNGOSCOPE, V128, P327, DOI 10.1002/lary.26698; Pikus L, 2003, AM J ROENTGENOL, V180, P1613, DOI 10.2214/ajr.180.6.1801613; Pisegna JM, 2016, DYSPHAGIA, V31, P462, DOI 10.1007/s00455-016-9700-3; Robbins J, 2008, ANN INTERN MED, V148, P509, DOI 10.7326/0003-4819-148-7-200804010-00007; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Rumbach A, 2018, DYSPHAGIA, V33, P216, DOI 10.1007/s00455-017-9849-4; Sasaki H, 1997, INTERNAL MED, V36, P851, DOI 10.2169/internalmedicine.36.851; Schmidt John, 1994, Dysphagia, V9, P7; Steele CM, 2017, DYSPHAGIA, V32, P601, DOI 10.1007/s00455-017-9809-z; Takahashi N, 2012, J ORAL REHABIL, V39, P429, DOI 10.1111/j.1365-2842.2011.02286.x	27	8	9	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	SEP-OCT	2018	53	5					909	918		10.1111/1460-6984.12401			10	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	GS3XT	WOS:000443561900001	29845700				2022-02-06	
J	Nevins, D; Hildenbrand, K; Kensrud, J; Vasavada, A; Smith, L				Nevins, Derek; Hildenbrand, Kasee; Kensrud, Jeff; Vasavada, Anita; Smith, Lloyd			Laboratory and field evaluation of a small form factor head impact sensor in un-helmeted play	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Head acceleration; concussion; mild traumatic brain injury; angular acceleration; linear acceleration; soccer	COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; CONCUSSION; ACCELERATIONS; KINEMATICS; EXPOSURE; HOCKEY; BALL	Head impact sensors are increasingly used to quantify the frequency and magnitude of head impacts in sports. A dearth of information exists regarding head impact in un-helmeted sport, despite the substantial number of concussions experienced in these sports. This study evaluated the performance of one small form factor head impact sensor in both laboratory and field environments. In laboratory tests, sensor performance was assessed using a Hybrid III headform and neck. The headform assembly was mounted on a low-friction sled and impacted with three sports balls over a range of velocities (10-31m/s) at two locations and from three directions. Measures of linear and angular acceleration obtained from the small form factor wireless sensor were compared to measures of linear and angular acceleration obtained by wired sensors mounted at the headform center of mass. Accuracy of the sensor varied inversely with impact magnitude, with relative differences across test conditions ranging from 0.1% to 266.0% for peak linear acceleration and 4.7% to 94.6% for peak angular acceleration when compared to a wired reference system. In the field evaluation, eight male high school soccer players were instrumented with the head impact sensor in seven games. Video of the games was synchronized with sensor data and reviewed to determine the number of false positive and false negative head acceleration event classifications. Of the 98 events classified as valid by the sensor, 20.5% (20 impacts) did not result from contact with the ball, another player, the ground or player motion and were therefore considered false positives. Video review of events classified as invalid or spurious by the sensor found 77.8% (14 of 18 impacts) to be due to contact with the ball, another player or player motion and were considered false negatives.	[Nevins, Derek; Kensrud, Jeff; Smith, Lloyd] Washington State Univ, Sch Mech & Mat Engn, 201 Sloan,Spokane St, Pullman, WA 99163 USA; [Hildenbrand, Kasee] Washington State Univ, Coll Educ, Athlet Training & Educ Program, Pullman, WA 99164 USA; [Vasavada, Anita] Washington State Univ, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA		Nevins, D (corresponding author), Washington State Univ, Sch Mech & Mat Engn, 201 Sloan,Spokane St, Pullman, WA 99163 USA.	dnevins@wsu.edu	Nevins, Derek/AAE-8209-2020	Nevins, Derek/0000-0001-9055-2121			Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; BURKHARD MD, 1975, J ACOUST SOC AM, V58, P214, DOI 10.1121/1.380648; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Chartrand R., 2011, APPL MATH, V2011; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2009, J APPL BIOMECH, V25, P184, DOI 10.1123/jab.25.2.184; De Lench B, 2013, SMARTEST TEAM MAKING; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Funk JR, 2006, INT BIOM RES P 34 IN, P1; Gardiner B., 2013, WIRED; Goldsmith S., 2015, UPSTART BUS J; Johnson RC., 2012, EE TIMES; Kellis E, 2007, J SPORT SCI MED, V6, P154; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King DA, 2016, J NEUROSURG-PEDIATR, V18, P65, DOI 10.3171/2015.12.PEDS15605; Kunz M., 2007, FIFA MAGAZINE, V7, P11, DOI DOI 10.1080/13673882.2007.9680857; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Mihalik JP, 2008, P I MECH ENG P-J SPO, V222, P45, DOI 10.1243/17543371JSET4; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; National Federation of State High School Associations, 2015, 2014 15 HIGH SCH ATH; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; Nevins D, 2016, PROCEDIA ENGINEER, V147, P186, DOI 10.1016/j.proeng.2016.06.211; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; NOCSAE, 2012, 02111M12 NOCSAE ND; NOCSAE, 2013, 00111M13 NOCSAE ND, P081; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Smith L, 2014, SPORTS ENG, V17, P75, DOI 10.1007/s12283-013-0126-y; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; The National Collegiate Athletic Association (NCAA), 2014, STUD ATHL PART 2013; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	49	8	8	0	8	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	SEP	2018	232	3					242	254		10.1177/1754337117739458			13	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	GR9EZ	WOS:000443051400007					2022-02-06	
J	Satoh, Y; Araki, Y; Kashitani, M; Nishii, K; Kobayashi, Y; Fujita, M; Suzuki, S; Morimoto, Y; Tokuno, S; Tsumatori, G; Yamamoto, T; Saitoh, D; Ishizuka, T				Satoh, Yasushi; Araki, Yoshiyuki; Kashitani, Masashi; Nishii, Kiyomasa; Kobayashi, Yasushi; Fujita, Masanori; Suzuki, Shinya; Morimoto, Yuji; Tokuno, Shinichi; Tsumatori, Gentaro; Yamamoto, Tetsuo; Saitoh, Daizoh; Ishizuka, Toshiaki			Molecular Hydrogen Prevents Social Deficits and Depression Like Behaviors Induced by Low-Intensity Blast in Mice	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Blast wave; Depression; Hydrogen; Social behavior; Traumatic brain injury	OXIDATIVE STRESS; TERM-MEMORY; MOUSE MODEL; RAT MODEL; EXPOSURE; INJURY; ADULT; BRAIN; ANTIOXIDANT; EXPRESSION	Detonation of explosive devices creates blast waves, which can injure brains even in the absence of external injuries. Among these, blast-induced mild traumatic brain injury (bmTBI) is increasing in military populations, such as in the wars in Afghanistan, Iraq, and Syria. Although the clinical presentation of bmTBI is not precisely defined, it is frequently associated with psycho-neurological deficits and usually manifests in the form of poly-trauma including psychiatric morbidity and cognitive disruption. Although the underlying mechanisms of bmTBI are largely unknown, some studies suggested that bmTBI is associated with blood-brain barrier disruption, oxidative stress, and edema in the brain. The present study investigated the effects of novel antioxidant, molecular hydrogen gas, on bmTBI using a laboratory-scale shock tube model in mice. Hydrogen gas has a strong prospect for clinical use due to easy preparation, lowcost, and no side effects. The administration of hydrogen gas significantly attenuated the behavioral deficits observed in our bmTBI model, suggesting that hydrogen application might be a strong therapeutic method for treatment of hinTBI.	[Satoh, Yasushi; Ishizuka, Toshiaki] Natl Def Med Coll, Dept Dept Pharmacol, Tokorozawa, Saitama, Japan; [Araki, Yoshiyuki; Tokuno, Shinichi; Tsumatori, Gentaro] Natl Def Med Coll, Dept Def Med, Tokorozawa, Saitama, Japan; [Kashitani, Masashi] Natl Def Acad Japan, Dept Aerosp Engn, Yokosuka, Kanagawa, Japan; [Nishii, Kiyomasa; Kobayashi, Yasushi] Natl Def Med Coll, Dept Anat & Neurobiol, Tokorozawa, Saitama, Japan; [Fujita, Masanori] Natl Def Med Coll, Div Environm Med, Res Inst, Tokorozawa, Saitama, Japan; [Morimoto, Yuji] Natl Def Med Coll, Dept Integrated Physiol Bionano Med, Tokorozawa, Saitama, Japan; [Suzuki, Shinya] Kameda Med Ctr, Emergency & Trauma Ctr, Chiba, Japan; [Yamamoto, Tetsuo] Japan Ground Sell Def Force, Mil Med Res Unit, Test & Evaluat Command, Setagaya Ku, Tokyo, Japan; [Saitoh, Daizoh] Natl Def Med Coll, Div Traumatol, Res Inst, Tokorozawa, Saitama, Japan		Satoh, Y (corresponding author), Natl Def Med Coll, Dept Pharmaceut Sci, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	wndlt3@gmail.com	Tokuno, Shinichi/L-1117-2019; MORIMOTO, YUJI/F-2912-2019	Tokuno, Shinichi/0000-0002-2691-6979; Kobayashi, Yasushi/0000-0001-5072-5040; MORIMOTO, YUJI/0000-0001-6494-413X	Ministry of Defense, Japan; Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [15H04970]	This study was in part carried out with support from the Ministry of Defense, Japan (YS, DS, ST, YK, YM, GT) and from the Japan Society for the Promotion of Science (YS; 15H04970).	Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chase RP, 2015, SOC SCI MED, V147, P309, DOI 10.1016/j.socscimed.2015.11.015; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Elsayed NM, 1997, TOXICOLOGY, V121, P81, DOI 10.1016/S0300-483X(97)03657-3; Fu Y, 2009, NEUROSCI LETT, V453, P81, DOI 10.1016/j.neulet.2009.02.016; Gu M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2075463; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ichihara M, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0035-1; Jones M. W., 2002, Current Molecular Medicine (Hilversum), V2, P639, DOI 10.2174/1566524023361989; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kaur C, 1996, ARCH HISTOL CYTOL, V59, P239, DOI 10.1679/aohc.59.239; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Kikkawa YS, 2009, NEUROREPORT, V20, P689, DOI 10.1097/WNR.0b013e32832a5c68; Knudsen SK, 2003, NEUROSCI RES, V46, P377, DOI 10.1016/S0168-0102(03)00101-9; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Lindley TE, 2009, AM J PHYSIOL-REG I, V296, pR1, DOI 10.1152/ajpregu.00078.2008; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Murcia CL, 2005, INT J DEV NEUROSCI, V23, P265, DOI 10.1016/j.ijdevneu.2004.07.001; Nakashima-Kamimura N, 2009, CANCER CHEMOTH PHARM, V64, P753, DOI 10.1007/s00280-008-0924-2; Ning YL, 2015, CHIN J TRAUMATOL, V18, P187, DOI 10.1016/j.cjtee.2015.04.005; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohsawa I, 2008, BIOCHEM BIOPH RES CO, V377, P1195, DOI 10.1016/j.bbrc.2008.10.156; Ohta S, 2012, BBA-GEN SUBJECTS, V1820, P586, DOI 10.1016/j.bbagen.2011.05.006; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2010, J NEUROTRAUM, V27, P383, DOI 10.1089/neu.2009.1053; Satoh Y, 2007, J NEUROSCI, V27, P10765, DOI 10.1523/JNEUROSCI.0117-07.2007; Satoh Y, 2011, J NEUROSCI, V31, P11953, DOI 10.1523/JNEUROSCI.2349-11.2011; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, P1; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Yufune S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10252	36	8	8	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	SEP	2018	77	9					827	836		10.1093/jnen/nly060			10	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	GS3TJ	WOS:000443544600008	30053086	Bronze			2022-02-06	
J	Koyama, Y; Mukuda, T; Hamasaki, S; Nakane, H; Kaidoh, T				Koyama, Yuka; Mukuda, Takao; Hamasaki, Sawako; Nakane, Hironobu; Kaidoh, Toshiyuki			Short-term Heat Exposure Promotes Hippocampal Neurogenesis via Activation of Angiotensin II Type 1 Receptor in Adult Rats	NEUROSCIENCE			English	Article						neurogenesis; hippocampus; short-term heat exposure; angiotensin II type 1 receptor; candesartan; vascular endothelial growth factor	ENDOTHELIAL GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; GENE-EXPRESSION; EXERCISE; MEMORY; MICE; NEUROPROTECTION; POTENTIATION	Angiotensin II (Ang II) synthesized in response to body fluid loss caused by actions such as sweating and breathing is today considered as one of the essential factors for promoting hippocampal neurogenesis. Because heat stimuli, along with exercise, increase systemic levels of Ang II, the effects of short-term heat exposure on hippocampal neurogenesis were examined in adult male rats. When rats were exposed daily to a 1-h heat treatment (36.0 +/- 0.1 degrees C) during a 7-d experimental period, the number of doublecortin-immunoreactive newborn cells in the hippocampal dentate gyrus was increased approximately 1.4-fold compared with that in controls that were exposed to a normothermic environment (25.0 +/- 0.8 degrees C). No significant change was observed in the number of Ki-67-immunoreactive stem cells. Western blot and immunohistochemical analyses revealed an enhancement of vascular endothelial growth factor (VEGF) expression in hippocampal astrocytes following short-term heat exposure. These beneficial effects of short-term heat exposure were prevented when an antagonist for Ang II type 1 receptor (AT1R), candesartan, was given orally. These results indicate that short-term heat exposure enhances adult neurogenesis via activation of AT1R in the hippocampal dentate gyrus, in which VEGF may participate by promoting cell proliferation and/or newborn neuron survival. (C) 2018 IBRO. Published by Elsevier Ltd. All rights reserved.	[Koyama, Yuka; Mukuda, Takao; Hamasaki, Sawako; Nakane, Hironobu; Kaidoh, Toshiyuki] Tottori Univ, Fac Med, Dept Anat, 86 Nishi Cho, Yonago, Tottori 6838503, Japan		Mukuda, T (corresponding author), Tottori Univ, Fac Med, Dept Anat, 86 Nishi Cho, Yonago, Tottori 6838503, Japan.	mtakao@tottori-u.ac.jp	中根, 裕信/V-9816-2019	Mukuda, Takao/0000-0002-4764-7296	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [15K0161]	This work was supported by the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research (C) #15K0161).	Akhavan MM, 2008, BRAIN RES, V1232, P132, DOI 10.1016/j.brainres.2008.07.042; Armando I, 2001, ENDOCRINOLOGY, V142, P3880, DOI 10.1210/en.142.9.3880; Armstrong DL, 1996, PEPTIDES, V17, P689, DOI 10.1016/0196-9781(96)00030-7; Atlas SA, 2007, J MANAGE CARE PHARM, V13, pS9, DOI 10.18553/jmcp.2007.13.s8-b.9; Barney CC, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12642; Beazley-Long N, 2013, AM J PATHOL, V183, P918, DOI 10.1016/j.ajpath.2013.05.031; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Chao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063488; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Fitzsimons JT, 1998, PHYSIOL REV, V78, P583, DOI 10.1152/physrev.1998.78.3.583; Fuchtbauer L, 2011, BRAIN BEHAV IMMUN, V25, P897, DOI 10.1016/j.bbi.2010.09.015; Gohlke P, 2002, J HYPERTENS, V20, P909, DOI 10.1097/00004872-200205000-00026; Guimond MO, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/351758; Huber G, 2017, PHARMACOL RES, V125, P72, DOI 10.1016/j.phrs.2017.06.016; Kang YS, 2006, J MOL ENDOCRINOL, V36, P377, DOI 10.1677/jme.1.02033; Kim MS, 2017, STEM CELL TRANSL MED, V6, P1491, DOI 10.1002/sctm.16-0382; Matsuzaki K, 2015, J COMP NEUROL, V523, P1190, DOI 10.1002/cne.23732; Meier M, 2001, HYPERTENSION, V38, P1260, DOI 10.1161/hy1201.096573; Mukuda T, 2007, NEUROSCI RES, V58, P140, DOI 10.1016/j.neures.2007.02.005; Mukuda T, 2014, BRAIN RES, V1588, P92, DOI 10.1016/j.brainres.2014.09.019; Pan PX, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-36; Paxinos G, 2009, RAT BRAIN STEREOTAXI; RYDZEWSKI B, 1992, ENDOCRINOLOGY, V130, P1255, DOI 10.1210/en.130.3.1255; Saavedra JM, 2017, PHARMACOL RES, V125, P91, DOI 10.1016/j.phrs.2017.06.017; Schricker K, 1997, PFLUG ARCH EUR J PHY, V434, P166, DOI 10.1007/s004240050379; Sharp FR, 2013, TRANSL STROKE RES, V4, P685, DOI 10.1007/s12975-013-0271-4; Soeda S, 2008, THROMB HAEMOSTASIS, V100, P1014, DOI 10.1160/TH08-04-0259; Speisman RB, 2013, BRAIN BEHAV IMMUN, V28, P25, DOI 10.1016/j.bbi.2012.09.013; STORNETTA RL, 1988, SCIENCE, V242, P1444, DOI 10.1126/science.3201232; Udo H, 2008, J NEUROSCI, V28, P14522, DOI 10.1523/JNEUROSCI.3673-08.2008; UENO M, 1994, ACTA NEUROL SCAND, V90, P400; Ueno M, 2000, ACTA NEUROPATHOL, V99, P385, DOI 10.1007/s004010051140; Umschweif G, 2014, NEUROTHERAPEUTICS, V11, P665, DOI 10.1007/s13311-014-0286-x; Umschweif G, 2014, J CEREBR BLOOD F MET, V34, P1381, DOI 10.1038/jcbfm.2014.93; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Thiel BS, 2017, HYPERTENSION, V69, P1136, DOI 10.1161/HYPERTENSIONAHA.116.08922; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Wang XW, 2015, HEART VESSELS, V30, P396, DOI 10.1007/s00380-014-0523-6; WAYNER MJ, 1993, PHARMACOL BIOCHEM BE, V45, P455, DOI 10.1016/0091-3057(93)90265-U	41	8	8	0	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 10	2018	385						121	132		10.1016/j.neuroscience.2018.05.045			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM6VW	WOS:000438316600011	29902505	Green Published, Green Submitted			2022-02-06	
J	Weber, AM; Pukropski, A; Kames, C; Jarrett, M; Dadachanji, S; Taunton, J; Li, DKB; Rauscher, A				Weber, Alexander M.; Pukropski, Anna; Kames, Christian; Jarrett, Michael; Dadachanji, Shiroy; Taunton, Jack; Li, David K. B.; Rauscher, Alexander			Pathological Insights From Quantitative Susceptibility Mapping and Diffusion Tensor Imaging in Ice Hockey Players Pre and Post-concussion	FRONTIERS IN NEUROLOGY			English	Article						concussion; quantitative susceptibility mapping; diffusion tensor imaging; axial diffusivity; radial diffusivity; myelin; white matter; magnetic resonance imaging	TRAUMATIC BRAIN-INJURY; MYELIN WATER FRACTION; MULTIPLE-SCLEROSIS; DEGENERATION; AXON; DEMYELINATION; DECOMPACTION; MECHANISMS; BIOLOGY; DAMAGE	Myelin sensitive MRI techniques, such as diffusion tensor imaging and myelin water imaging, have previously been used to reveal changes in myelin after sports-related concussions. What is not clear from these studies, however, is how myelin is affected: whether it becomes degraded and possibly removed, or whether the myelin sheath loosens and becomes "decompacted". Previously, our team revealed myelin specific changes in ice hockey players 2 weeks post-concussion using myelin water imaging. In that study, 45 subjects underwent a pre-season baseline scan, 11 of which sustained a concussion during play and received follow-up scans: eight were scanned within 3 days, 10 were scanned at 14 days, and nine were scanned at 60 days. In the current retrospective analysis, we used quantitative susceptibility mapping, along with the diffusion tensor imaging measures axial diffusivity and radial diffusivity, to investigate this myelin disruption. If sports-related concussive hits lead to myelin fragmentation in regions of lowered MWF, this should result in a measurable increase in magnetic susceptibility, due to the anisotropic myelin fragmenting into isotropic myelin debris, and the diamagnetic myelin tissue being removed, while no such changes should be expected if the myelin sheath simply loosens and becomes decompacted. An increase in radial diffusivity would likewise reveal myelin fragmentation, as myelin sheaths block water diffusion out of the axon, with little to no changes expected for myelin sheath loosening. Statistical analysis of the same voxels-of-interest that were found to have reduced myelin water fraction 2 weeks post-concussion, revealed no statistically significant changes in magnetic susceptibility, axial diffusivity, or radial diffusivity at any time-point post-concussion. This suggests that myelin water fraction changes are likely due to a loosening of the myelin sheath structure, as opposed to fragmentation and removal of myelin debris.	[Weber, Alexander M.; Jarrett, Michael; Rauscher, Alexander] Univ British Columbia, Dept Pediat, Div Neurol, Vancouver, BC, Canada; [Weber, Alexander M.; Kames, Christian; Jarrett, Michael; Li, David K. B.; Rauscher, Alexander] Univ British Columbia, UBC MRI Res Ctr, Vancouver, BC, Canada; [Pukropski, Anna] Univ Osnabrueck, Program Cognit Sci, Osnabruck, Germany; [Kames, Christian] Univ British Columbia, Dept Phys & Astron, Vancouver, BC, Canada; [Dadachanji, Shiroy; Taunton, Jack] Univ British Columbia, Fac Med, Div Sports Med, Vancouver, BC, Canada; [Li, David K. B.; Rauscher, Alexander] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Li, David K. B.] Univ British Columbia, MS MRI Res Grp, Vancouver, BC, Canada		Weber, AM (corresponding author), Univ British Columbia, Dept Pediat, Div Neurol, Vancouver, BC, Canada.; Weber, AM (corresponding author), Univ British Columbia, UBC MRI Res Ctr, Vancouver, BC, Canada.	alex.weber@ubc.ca		Weber, Alexander/0000-0001-7295-0775	London Drugs Award; BC Sport Medicine Educational Development Fund; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [201109MSH-261306-183304]; Canada Research ChairNatural Resources CanadaCanadian Forest ServiceCanada Research Chairs; German Academic Exchange Service (DAAD) Research Internship (RISE); British Columbia Children's Hospital Research Institute - M.I.N.D. Postdoctoral Fellowship	This research was funded by a London Drugs Award for Research Excellence in Radiology (no grant number) and by the BC Sport Medicine Educational Development Fund. AR was supported by a New Investigator Award from the Canadian Institutes of Health Research (CIHR, grant # 201109MSH-261306-183304) and is now supported through a Canada Research Chair. AP was sponsored by the German Academic Exchange Service (DAAD) Research Internship (RISE). AW is supported by a British Columbia Children's Hospital Research Institute - M.I.N.D. Postdoctoral Fellowship.	Baayen R. H., 2013, LANGUAGER DATA SETS; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Borja MJ, 2018, NEUROIMAG CLIN N AM, V28, P117, DOI 10.1016/j.nic.2017.09.009; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; CAHILL GM, 1989, BRAIN RES, V479, P65, DOI 10.1016/0006-8993(89)91336-X; Chiang CW, 2014, NEUROIMAGE, V101, P310, DOI 10.1016/j.neuroimage.2014.06.064; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Faul M, 2010, TRAUMATIC BRAIN INJU; FOSTER RE, 1982, DEV BRAIN RES, V3, P371, DOI 10.1016/0165-3806(82)90005-0; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; GUTIERREZ R, 1995, NEUROSCI LETT, V195, P93, DOI 10.1016/0304-3940(94)11789-L; Harrison DM, 2016, AM J NEURORADIOL, V37, P1447, DOI 10.3174/ajnr.A4726; He X, 2009, P NATL ACAD SCI USA, V106, P13558, DOI 10.1073/pnas.0904899106; Ibrahim JG, 2009, TEST-SPAIN, V18, P1, DOI 10.1007/s11749-009-0138-x; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kames C, 2018, NEUROIMAGE, V167, P276, DOI 10.1016/j.neuroimage.2017.11.018; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Kirov II, 2018, NEUROIMAG CLIN N AM, V28, P91, DOI 10.1016/j.nic.2017.09.007; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Langkammer C, 2018, MAGN RESON MED, V79, P1661, DOI 10.1002/mrm.26830; Laule C, 2004, J NEUROL, V251, P284, DOI 10.1007/s00415-004-0306-6; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Li XR, 2016, J NEUROSCI METH, V264, P47, DOI 10.1016/j.jneumeth.2016.03.001; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; MacKay Alex L, 2016, Brain Plast, V2, P71, DOI 10.3233/BPL-160033; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Prasloski T, 2012, NEUROIMAGE, V63, P533, DOI 10.1016/j.neuroimage.2012.06.064; R Core Team, 2016, R LANG ENV STAT COMP; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Schofield MA, 2003, OPT LETT, V28, P1194, DOI 10.1364/OL.28.001194; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Vavasour IM, 2009, J NEUROL SCI, V276, P49, DOI 10.1016/j.jns.2008.08.022; Wiggermann V, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3727; Wiggermann V, 2013, NEUROLOGY, V81, P211, DOI 10.1212/WNL.0b013e31829bfd63; Wisnieff C, 2015, MAGN RESON MED, V74, P564, DOI 10.1002/mrm.25420; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215	50	8	8	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 6	2018	9								575	10.3389/fneur.2018.00575			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GP4EB	WOS:000440809800001	30131752	Green Published, gold			2022-02-06	
J	Amiri, S; Naserkhaki, S; Parnianpour, M				Amiri, Sorosh; Naserkhaki, Sadegh; Parnianpour, Mohamad			Modeling and validation of a detailed FE viscoelastic lumbar spine model for vehicle occupant dummies	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Finite element (FE) model; Lumbar spine; Viscoelastic discs; Modified HYBRID III dummy; Vehicle accident	FINITE-ELEMENT MODEL; INTRADISCAL PRESSURE; MOTION SEGMENT; INTERVERTEBRAL DISC; FLEXION; LOAD; BIOMECHANICS; COMPRESSION; HEIGHT	The dummies currently used for predicting vehicle occupant response during frontal crashes or whole-body vibration provide insufficient information about spinal loads. Although they aptly approximate upper-body rotations in different loading scenarios, they overlook spinal loads, which are crucial to injury assessment. This paper aims to develop a modified dummy finite element (FE) model with a detailed viscoelastic lumbar spine. This model has been developed and validated against in-vitro and in-silico data under different loading conditions, and its predicted ranges of motion (RoM) and intradiscal pressure (IDP) maintain close correspondence with the in-vitro data. The dominant frequency of the model was f = 8.92 Hz, which was close to previous results. In the relaxation test, a force reduction of up to 21% was obtained, showing high agreement in force relaxation during the in-vitro test. The FE lumbar spine model was placed in the HYBIUD III test dummy and aligned in a seated position based on available MRI data. Under two impulsive acceleration loadings in flexion and lateral directions with a peak acceleration of 60 m/s(2), flexion responses of the modified and original dummies were close (RoMs of 29.1 degrees and 29.6 degrees, respectively), though not in lateral bending (RoMs of 34.1 and 15.6, respectively), where the modified dummy was more flexible than the original. By reconstructing a real frontal crash, it was found that the modified dummy provided a 10% reduction in the Head Injury Criterion (HIC). Other than the more realistic behavior of this modified dummy, its capability of approximating lumbar loads and risk of lumbar spine injuries in vehicle crashes or whole-body vibration is of great importance.	[Amiri, Sorosh; Parnianpour, Mohamad] Sharif Univ Technol, Dept Mech Engn, Tehran, Iran; [Naserkhaki, Sadegh] Islamic Azad Univ, Dept Med Sci & Technol, Sci & Res Branch, Tehran, Iran		Amiri, S (corresponding author), Sharif Univ Technol, Dept Mech Engn, Tehran, Iran.	s_amiri@mech.sharif.ir; snkhaki@gmail.com; parnianpour@sharif.ir					Argoubi M, 1996, J BIOMECH, V29, P1331, DOI 10.1016/0021-9290(96)00035-8; Ayturk UM, 2011, COMPUT METHOD BIOMEC, V14, P695, DOI 10.1080/10255842.2010.493517; Backaitis S.H., 1993, HYBRID 3 1 HUMAN LIK, P830; Begeman P., 1994, 01487191 SAE; BRINCKMANN P, 1991, SPINE, V16, P641, DOI 10.1097/00007632-199106000-00008; Danelson KA, 2015, ACCIDENT ANAL PREV, V85, P125, DOI 10.1016/j.aap.2015.09.010; Davis K G, 2003, Technol Health Care, V11, P183; Demetropoulos C.K., 1998, 01487191 SAE; Dreischarf M, 2014, J BIOMECH, V47, P1757, DOI 10.1016/j.jbiomech.2014.04.002; Dreischarf M, 2013, MED ENG PHYS, V35, P1385, DOI 10.1016/j.medengphy.2013.03.007; European new car Assessment Programme (Euro NCAP), 2017, FULL WIDTH FRONT IMP; Fan W, 2017, COMPUT BIOL MED, V86, P75, DOI 10.1016/j.compbiomed.2017.05.004; Freutel M, 2014, CLIN BIOMECH, V29, P363, DOI 10.1016/j.clinbiomech.2014.01.006; Fung Y.C., 2013, BIOMECHANICS MECH PR; Guo LX, 2016, ACTA BIOENG BIOMECH, V18, P19, DOI 10.5277/ABB-00406-2015-02; Guo LX, 2005, P I MECH ENG H, V219, P277, DOI 10.1243/095441105X34275; Ivancic PC, 2013, ACCIDENT ANAL PREV, V59, P185, DOI 10.1016/j.aap.2013.05.024; Karakida O, 2003, CLIN RADIOL, V58, P389, DOI 10.1016/S0009-9260(02)00583-4; Kiapour A, 2012, SPINE, V37, pE581, DOI 10.1097/BRS.0b013e3182463775; Naserkhaki S, 2018, J BIOMECH, V70, P33, DOI 10.1016/j.jbiomech.2017.05.003; Naserkhaki S, 2017, COMPUT METHOD BIOMEC, V20, P550, DOI 10.1080/10255842.2016.1257707; Naserkhaki S, 2016, J BIOMECH, V49, P2909, DOI 10.1016/j.jbiomech.2016.06.032; Naserkhaki S, 2016, J BIOMECH, V49, P974, DOI 10.1016/j.jbiomech.2015.09.050; NHTSA, 2011, TRAFF SAF FACTS COMP; Niemeyer F, 2012, J BIOMECH, V45, P1414, DOI 10.1016/j.jbiomech.2012.02.021; Noureddine A, 2002, MATH COMPUT MODEL, V35, P885, DOI 10.1016/S0895-7177(02)00057-2; Radebold A, 2000, SPINE, V25, P947, DOI 10.1097/00007632-200004150-00009; Rao RD, 2014, SPINE J, V14, P2355, DOI 10.1016/j.spinee.2014.01.038; Rohlmann A, 2006, J BIOMECH, V39, P981, DOI 10.1016/j.jbiomech.2005.02.019; Sato F, 2016, IJAET, V7, P29; Schmidt H, 2007, SPINE, V32, P748, DOI 10.1097/01.brs.0000259059.90430.c2; Wang JL, 1997, THEOR APPL FRACT MEC, V28, P81, DOI 10.1016/S0167-8442(97)00032-3; Wang JL, 2000, SPINE, V25, P310, DOI 10.1097/00007632-200002010-00009; Xu M, 2017, COMPUT BIOL MED, V84, P53, DOI 10.1016/j.compbiomed.2017.03.018; Zhou SH, 2000, EUR SPINE J, V9, P242, DOI 10.1007/s005860000140	35	8	9	2	36	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	AUG 1	2018	99						191	200		10.1016/j.compbiomed.2018.06.013			10	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	GR8MT	WOS:000442978700018	29945043				2022-02-06	
J	Antona-Makoshi, J; Mikami, K; Lindkvist, M; Davidsson, J; Schick, S				Antona-Makoshi, Jacobo; Mikami, Koji; Lindkvist, Mats; Davidsson, Johan; Schick, Sylvia			Accident analysis to support the development of strategies for the prevention of brain injuries in car crashes	ACCIDENT ANALYSIS AND PREVENTION			English	Article						NASS-CDS; Traumatic brain injuries; Concussion; Subdural haemorrhage; Sex; Age	MOTOR-VEHICLE CRASHES; UNITED-STATES; NECK; CONCUSSION; IMPACT; HEAD; FEMALE; POPULATION; VOLUNTEERS; SEVERITY	This study estimated the frequency and risk of Moderate-to-Maximal traumatic brain injuries sustained by occupants in motor vehicle crashes in the US. National Automotive Sampling System - Crashworthiness Data System crashes that occurred in years 2001-2015 with light vehicles produced 2001 or later were incorporated in the study. Crash type, crash severity, car model year, belt usage and occupant age and sex were controlled for in the analysis. The results showed that Moderate concussions account for 79% of all MAIS(brain)2 + injuries. Belted occupants were at lower risks than unbelted occupants for most brain injury categories, including concussions. After controlling for the effects of age and crash severity, belted female occupants involved in frontal crashes were estimated to be 1.5 times more likely to sustain a concussion than male occupants in similar conditions. Belted elderly occupants were found to be at 10.5 and 8 times higher risks for sub-dural haemorrhages than nonelderly belted occupants in frontal and side crashes, respectively. Adopted occupant protection strategies appear to be insufficient to achieve significant decreases in risk of both life-threatening brain injuries and concussions for all car occupants. Further effort to develop occupant and injury specific strategies for the prevention of brain injuries are needed. This study suggests that these strategies may consider prioritization of life-threatening brain vasculature injuries, particularly in elderly occupants, and concussion injuries, particularly in female occupants.	[Antona-Makoshi, Jacobo; Mikami, Koji] Japan Automobile Res Inst, 2530 Karima, Tsukuba, Ibaraki 3050822, Japan; [Lindkvist, Mats] Umea Univ, SE-90187 Umea, Sweden; [Davidsson, Johan] Charles Univ Prague, SE-41296 Gothenburg, Sweden; [Schick, Sylvia] LMU, Munich, Germany		Antona-Makoshi, J (corresponding author), Japan Automobile Res Inst, 2530 Karima, Tsukuba, Ibaraki 3050822, Japan.	ajacobo@jari.or.jp; kmikami@jari.or.jp; mats.lindkvist@umu.se; johan.davidsson@chalmers.se; sylvia.schick@med.uni-muenchen.de	Davidsson, Johan/A-3229-2016	Davidsson, Johan/0000-0002-1717-1514	Chalmers Area of Advance in Transport; Japan Automobile Research Institute	Funding for this research was provided by Chalmers Area of Advance in Transport and by the Japan Automobile Research Institute. David Viano and Chantal Parenteau are acknowledged for providing guidance and expertise before the initiation of this study. The members of the Impact Biomechanics Experts Committee of the Society of Automotive Engineers of Japan (JSAE) are acknowledged for providing feedback at intermediate steps of this study.	Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Bose D, 2011, AM J PUBLIC HEALTH, V101, P2368, DOI 10.2105/AJPH.2011.300275; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carlsson A, 2012, TRAFFIC INJ PREV, V13, P378, DOI 10.1080/15389588.2012.659362; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Eigen A. M, 2005, 19 ESV C; Elkin BS, 2016, J ORTHOP SPORT PHYS, V46, P874, DOI 10.2519/jospt.2016.7049; Finan JD, 2017, ACTA BIOMATER, V55, P333, DOI 10.1016/j.actbio.2017.03.037; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Griffin R, 2012, J TRAUMA ACUTE CARE, V73, P914, DOI 10.1097/TA.0b013e31825a7636; Kahane C. J, 2012, 811 665 DOT HS NHTSA; Kitagawa Y, 2015, IRCOBI C P; Klier W, 2016, AIRB 2016 13 INT S S; Kullgren A, 2010, IRCOBI C P; Lindera A, 2013, ACCIDENT ANAL PREV, V60, P334, DOI 10.1016/j.aap.2013.02.043; Mallory A, 2011, 22 ESV C; Mallory A., 2010, ANN ADV AUTOMOT MED, V54; Organization W. H., 2013, WHO GLOB STAT REP RO; Osth J, 2017, IRCOBI C P; Pickrell T. M, 2017, 812 417 DOT HS NHTSA; Pintar F, 2000, AAAM C; Ridella S. A, 2012, IRCOBI C P; Rowson S, 2016, SPORTS MED ARTHROSC, V24, P100, DOI 10.1097/JSA.0000000000000121; Sato F, 2016, IRCOBI C; Sato F, 2010, IRCOBI C P; Sato F, 2017, TRAFFIC INJ PREV, V18, P199, DOI 10.1080/15389588.2016.1227072; Schick S, 2010, ESAR C; Siegmund GP, 2003, J BIOMECH, V36, P473, DOI 10.1016/S0021-9290(02)00458-X; Stemper BD, 2008, SPINE, V33, pE44, DOI 10.1097/BRS.0b013e318160462a; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Sunnevang C, 2015, TRAFFIC INJ PREV, V16, pS117, DOI 10.1080/15389588.2015.1022895; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Talmor D, 2006, ACCIDENT ANAL PREV, V38, P767, DOI 10.1016/j.aap.2006.01.008; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; Viano DC, 2015, TRAFFIC INJ PREV, V16, P747, DOI 10.1080/15389588.2015.1013188; Yoganandan N, 2007, ACCIDENT ANAL PREV, V39, P22, DOI 10.1016/j.aap.2006.05.014; Zaloshnja E, 2004, ACCIDENT ANAL PREV, V36, P415, DOI 10.1016/S0001-4575(03)00035-6; Zhang F., 2013, NASS CDS SAMPLE DESI; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	40	8	8	0	48	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	AUG	2018	117						98	105		10.1016/j.aap.2018.04.009			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	GL1SI	WOS:000436888400010	29679852				2022-02-06	
J	Caprelli, MT; Mothe, AJ; Tator, CH				Caprelli, Mitchell T.; Mothe, Andrea J.; Tator, Charles H.			Hyperphosphorylated Tau as a Novel Biomarker for Traumatic Axonal Injury in the Spinal Cord	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; biomarker; hyperphosphorylation; spinal cord injury; tau	BRAIN-INJURY; CEREBROSPINAL-FLUID; HEAD-INJURY; STRUCTURAL BIOMARKERS; ALZHEIMER-DISEASE; NEURODEGENERATION; RATS; PHOSPHORYLATION; TAUOPATHY; SEVERITY	Current biomarker research in spinal cord injury (SCI) and traumatic brain injury has focused on a number of structural protein candidates, including the microtubule-associated protein tau. Evidence from models of traumatic brain injury has demonstrated that hyperphosphorylation of tau (p-tau) occurs in injured axons and demonstrates its utility as a biomarker for brain injury; however, the potential of p-tau as a biomarker for SCI is not yet known. Therefore, the present study determined whether tau is hyperphosphorylated in injured spinal cord axons, and then examined cerebrospinal fluid (CSF) and serum concentrations of p-tau and total-tau protein after a clinically relevant severe impact-compression SCI in rats. We found that severe SCI at T8 showed the presence of p-tau in damaged axons with a similar time course and distribution pattern to beta-APP, a biomarker of axonal injury. The presence of p-tau and /3-APP positive axons extended no farther than 5000 m rostral and caudal to the injury epicenter, and was at its maximum at one day post-SCI. CSF levels of p-tau and total-tau significantly increased at one day post-SCI; however, only serum p-tau levels were significantly elevated in rats with SCI compared with na ve rats. These results suggest that CSF and serum p-tau may be a useful biomarker for severe traumatic SCI.	[Caprelli, Mitchell T.; Tator, Charles H.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Caprelli, Mitchell T.; Mothe, Andrea J.; Tator, Charles H.] Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Tator, Charles H.] Toronto Western Hosp, Div Neurosurg, Toronto, ON, Canada		Tator, CH (corresponding author), Krembil Neurosci Ctr, 7KDT-406 60 Leonard Ave, Toronto, ON M5T 2R1, Canada.	Charles.tator@uhn.ca					ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Caprelli M.T., 2017, NEUROSCIENTIST; Chen LJ, 2010, J NEUROTRAUM, V27, P1657, DOI 10.1089/neu.2010.1308; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; Genis L, 2000, J NEUROSCI RES, V60, P559, DOI 10.1002/(SICI)1097-4547(20000515)60:4<559::AID-JNR15>3.0.CO;2-K; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Hulme CH, 2017, SPINAL CORD, V55, P114, DOI 10.1038/sc.2016.174; Hung KS, 2005, J NEUROPATH EXP NEUR, V64, P15, DOI 10.1093/jnen/64.1.15; Hung KS, 2007, J NEUROSURG-SPINE, V6, P35, DOI 10.3171/spi.2007.6.1.7; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kwon BK, 2017, J NEUROTRAUM, V34, P567, DOI 10.1089/neu.2016.4435; Kwon BK, 2011, CLIN CHEM LAB MED, V49, P425, DOI 10.1515/CCLM.2011.068; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu MC, 2011, ASN NEURO, V3, P25, DOI 10.1042/AN20100012; Lv QS, 2014, J NEUROL SCI, V345, P48, DOI 10.1016/j.jns.2014.06.037; McAdoo DJ, 1999, EXP NEUROL, V159, P538, DOI 10.1006/exnr.1999.7166; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mothe AJ, 2011, SPINAL CORD, V49, P967, DOI 10.1038/sc.2011.46; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pouw MH, 2014, SPINAL CORD, V52, P428, DOI 10.1038/sc.2014.26; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Roerig A, 2013, VET J, V197, P253, DOI 10.1016/j.tvjl.2013.02.005; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; SEGAL MB, 1993, J INHERIT METAB DIS, V16, P617, DOI 10.1007/BF00711896; Seif GI, 2007, J NEUROTRAUM, V24, P1513, DOI 10.1089/neu.2007.0323; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Springer JE, 1997, J NEUROCHEM, V69, P1592, DOI 10.1046/j.1471-4159.1997.69041592.x; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Wang JZ, 2014, NEUROSCI BULL, V30, P359, DOI 10.1007/s12264-013-1415-y; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; Wang YX, 2015, NEUROBIOL AGING, V36, P188, DOI 10.1016/j.neurobiolaging.2014.07.035; Wen Y, 2007, BBA-MOL BASIS DIS, V1772, P473, DOI 10.1016/j.bbadis.2006.10.011; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yang WJ, 2017, ACTA NEUROL SCAND, V135, P622, DOI 10.1111/ane.12644; Ydens E, 2017, MOL NEUROBIOL, V54, P1482, DOI 10.1007/s12035-016-9757-x; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Zhang SX, 2000, J NEUROPATH EXP NEUR, V59, P287, DOI 10.1093/jnen/59.4.287	50	8	9	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2018	35	16					1929	1941		10.1089/neu.2017.5495			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GQ2YY	WOS:000441527400011	29644915				2022-02-06	
J	Faried, A; Satriawan, FC; Arifin, MZ				Faried, Ahmad; Satriawan, Ferry C.; Arifin, Muhammad Z.			Feasibility of Online Traumatic Brain Injury Prognostic Corticosteroids Randomisation After Significant Head Injury (CRASH) Model as a Predictor of Mortality	WORLD NEUROSURGERY			English	Article						Online CRASH calculator; Prognostic model; Traumatic brain injury		BACKGROUND: Traumatic brain injury (TBI) is a major cause of mortality in many countries. According to the World Health Organization, traffic crashes are a leading cause of death, with 1.25 million deaths worldwide in 2013. A 2013 global road safety report listed 68 low-to-middle income countries that had an increased mortality rate owing to traffic accidents. The aim of this study was to analyze feasibility of use of an online prognostic model from the Medical Research Council Corticosteroids Randomization After Significant Head Injury (CRASH) trial collaborators in our center. METHODS: This is a cross-sectional retrospective study of 229 patients with TBI who were admitted to the Neurosurgery Unit at Dr. Hasan Sadikin Hospital, Bandung, from July to December 2016. RESULTS: During the study period, 495 patients with TBI were admitted; 229 patients were included in the study. Several variables were analyzed using independent statistical methods before being included in the online CRASH calculator, including Glasgow Coma Scale score (P = 0.000), pupillary reaction to light (P = 0.000), major extracranial injury (P = 0.002), and interval following incidence (P = 0.000). Statistical analysis showed that the online CRASH prognostic model reliably predicted 14-day mortality rate (P = 0.000) with 91.6% sensitivity and 95.1% specificity. CONCLUSIONS: The online CRASH model is a good prognostic model that can be used for patients with TBI in many developing countries.	[Faried, Ahmad; Satriawan, Ferry C.; Arifin, Muhammad Z.] Univ Padjadjaran, Dr Hasan Sadikin Hosp, Fac Med, Dept Neurosurg, Bandung, West Java, Indonesia		Faried, A (corresponding author), Univ Padjadjaran, Dr Hasan Sadikin Hosp, Fac Med, Dept Neurosurg, Bandung, West Java, Indonesia.	faried.fkup@gmail.com			Ministry of Research, Technology and Higher Education of the Republic of Indonesia [30/E/KPT/2017]	This study was supported by the Grants-in-Aid from the Ministry of Research, Technology and Higher Education of the Republic of Indonesia No. 30/E/KPT/2017 (PUPT) to A.F.	Faried A, 2017, WORLD NEUROSURG, V100, P195, DOI 10.1016/j.wneu.2016.12.133; Goodman JC., 2017, YOUMANS WINN NEUROLO, P9287; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Miller JD, 1996, NEUROTRAUMA, P61; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Tjahjadi M, 2013, INDIAN J NEUROTRAUM, V10, P3, DOI 10.1016/j.ijnt.2013.04.007; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640	9	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2018	116						E239	E245		10.1016/j.wneu.2018.04.180			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GN9GM	WOS:000439498500031	29730104				2022-02-06	
J	Gebregziabher, M; Ward, RC; Taber, DJ; Walker, RJ; Ozieh, M; Dismuke, CE; Axon, RN; Egede, LE				Gebregziabher, Mulugeta; Ward, Ralph C.; Taber, David J.; Walker, Rebekah J.; Ozieh, Mukoso; Dismuke, Clara E.; Axon, Robert N.; Egede, Leonard E.			Ethnic and geographic variations in multimorbidty: Evidence from three large cohorts	SOCIAL SCIENCE & MEDICINE			English	Article						Elixhauser; Insular-island; Multimorbidity; Racial disparities; Walraven-elixhauser	TRAUMATIC BRAIN-INJURY; CHRONIC KIDNEY-DISEASE; ADMINISTRATIVE DATA; HEALTH-CARE; COMORBIDITY; OUTCOMES; ASSOCIATION; MORBIDITY; EPIDEMIOLOGY; PREVALENCE	A common characteristic of patients seen at the Veterans Health Administration (VHA) is a high number of concurrent comorbidities (i.e. multimorbidity). This study (i) examines the magnitude and patterns of multi morbidity by race/ethnicity and geography; (ii) compares the level of variation explained by these factors in three multimorbidity measures across three large cohorts. We created three national cohorts for Veterans with chronic kidney disease (CKD:n = 2,190,564), traumatic brain injury (TBI:n = 167,954) and diabetes-mellitus (DM:n = 1,263,906). Multimorbidity was measured by Charlson-Deyo, Elixhauser and Walraven-Elixhauser scores. Multimorbidity differences by race/ethnicity and geography were compared using generalized linear models (GLM). Latent class analysis (LCA) was used to identify groups of conditions that are highly associated with race/ethnic groups. Differences in age (CKD,74.5, TBI,49.7, DM, 66.9 years), race (CKD,80.9%, TBI,76.4%, DM, 63.8% NHW) and geography (CKD,64.4%, TBI,70%, DM, 70.9% urban) were observed among the three cohorts. Accounting for these differences, GLM results showed that risk of multimorbidity in non-Hispanic blacks (NHB) with CKD were 1.16 times higher in urban areas and 1.10 times higher in rural areas compared to non Hispanic whites (NHW) with CKD. DM and TBI showed similar results with risk for NHB, 1.05 higher in urban areas and 0.97 lower in rural areas for both diseases. Overall, our results show that (i) multimorbidity risk was higher for NHB in urban areas compared to rural areas in all three cohorts; (ii) multimorbidity risk was higher for Hispanics in urban areas compared to rural areas in the DM and CKD cohorts; and (iii) the highest overall multimorbidity risk of any race group or location exists for Hispanics in insular islands for all three disease cohorts. These findings are consistent among the three multimorbidity measures. In fact, our LCA also showed that a three class LC model based on Elixhauser or Charlson provides good discrimination by type and extent of multimorbidity.	[Gebregziabher, Mulugeta; Ward, Ralph C.; Taber, David J.; Dismuke, Clara E.; Axon, Robert N.] Ralph H Johnson VA Med Ctr, Charleston Hlth Equ & Rural Outreach Innovat Ctr, Charleston, SC USA; [Gebregziabher, Mulugeta; Ward, Ralph C.] Med Univ South Carolina, Dept Publ Hlth Sci, 135 Cannon St,MSC 835, Charleston, SC 29425 USA; [Walker, Rebekah J.; Ozieh, Mukoso; Egede, Leonard E.] Med Coll Wisconsin, Div Gen Internal Med, Milwakee, WI USA; [Taber, David J.] Med Univ South Carolina, Div Transplant Surg, Charleston, SC 29425 USA		Gebregziabher, M (corresponding author), Med Univ South Carolina, Dept Publ Hlth Sci, 135 Cannon St,MSC 835, Charleston, SC 29425 USA.	gebregz@musc.edu	Osakwe, Ozieh, Mukoso N./AAX-1369-2021	Gebregziabher, Mulugeta/0000-0002-4826-481X; Walker, Rebekah/0000-0002-7773-557X; Egede, Leonard/0000-0003-1546-1515	VHSRD [HX001229]	This study was supported VHSR&D (HX001229) funded grant (PI: Leonard Egede) and was undertaken at the Ralph H. Johnson VAMC.	Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chu YT, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-140; Donohue JT, 2007, J TRAUMA, V62, P419, DOI 10.1097/01.ta.0000219286.88179.18; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fraser SD, 2016, CURR OPIN NEPHROL HY, V25, P465, DOI 10.1097/MNH.0000000000000270; Fraser SDS, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0189-z; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Gamble JM, 2011, CIRC-HEART FAIL, V4, P317, DOI 10.1161/CIRCHEARTFAILURE.110.959262; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Gardizi E, 2014, ARCH PHYS MED REHAB, V95, P2396, DOI 10.1016/j.apmr.2014.06.004; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363; Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Mathur R, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572454; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; NIMHD, 2018, NIMHD RES FRAM; Okazaki T, 2016, WORLD NEUROSURG, V93, P336, DOI 10.1016/j.wneu.2016.06.070; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Salisbury C, 2012, LANCET, V380, P7, DOI 10.1016/S0140-6736(12)60482-6; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Sharabiani MTA, 2012, MED CARE, V50, P1109, DOI 10.1097/MLR.0b013e31825f64d0; Sinnige J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079641; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Tonelli M, 2015, KIDNEY INT, V88, P859, DOI 10.1038/ki.2015.228; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979	32	8	8	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	AUG	2018	211						198	206		10.1016/j.socscimed.2018.06.020			9	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	GQ2LH	WOS:000441486000024	29960171				2022-02-06	
J	Guys, NP; Mir, A; Svider, PF; Sheyn, A				Guys, Nicholas P.; Mir, Ahsan; Svider, Peter F.; Sheyn, Anthony			Wet and wounded: Pediatric facial trauma from swimming and diving	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						Facial trauma; Pediatrics; Swimming; Diving; Swimming pools; Diving boards	EMERGENCY-DEPARTMENT VISITS; SPINAL-CORD INJURIES; UNITED-STATES; PSYCHOLOGICAL SEQUELAE; RETROSPECTIVE ANALYSIS; EPIDEMIOLOGY; CONCUSSION; PREVENTION; FRACTURES; PATTERNS	Objectives: Swimming has been reported as the most common recreational activity among American youths, while diving remains a popular youth activity as well. We characterize the most common facial injuries occurring during these activities and evaluate facial fracture mechanisms and demographic trends, as this information may be helpful in preventative counseling as well as diagnosis. Methods: The National Electronic Injury Surveillance System was assessed for swimming- and diving-related facial injuries in children from 2007 to 2016. Estimates of national injury incidence were recorded, and patient diagnoses, demographics, and injury mechanisms were evaluated. Results: In the 10-year period assessed, 789 NEISS entries extrapolated to an estimated 27,709 patients nationwide were analyzed. The yearly incidence fluctuated but steadily rose from 2013 to 2016. Males comprised a majority of injuries (58%), and laceration was the most common diagnosis (65%), followed by abrasion/contusion (22%) and fracture (9%). Facial fractures were most likely to involve the nasal bones (87%). Swimming injuries were more numerous overall (74%), but a greater proportion of diving injuries resulted in fracture (12% vs. 7%). Teenagers were also more likely to suffer fractures than were younger children involved in the same activities. Conclusion: Most analyses of swimming and diving injuries have focused on spinal and orthopedic trauma. Nevertheless, the nature of headfirst diving and swim strokes suggest facial trauma is an underappreciated concern for clinicians. These findings reinforce the need for safer swimming and diving practices and serve as a useful resource for physicians managing pediatric facial injuries.	[Guys, Nicholas P.; Mir, Ahsan; Svider, Peter F.] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 4102 St Antoine,5E UHC, Detroit, MI 48201 USA; [Sheyn, Anthony] Univ Tennessee, Dept Otolaryngol, Hlth Sci Ctr, Memphis, TN USA; [Sheyn, Anthony] LeBonheur Childrens Hosp, Dept Pediat Otolaryngol, Memphis, TN USA		Guys, NP (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 4102 St Antoine,5E UHC, Detroit, MI 48201 USA.	nguys@med.wayne.edu					Amorim EC, 2011, SPINAL CORD, V49, P206, DOI 10.1038/sc.2010.79; Badman Brian L, 2004, Spine J, V4, P584, DOI 10.1016/j.spinee.2004.03.002; Bagga H. S., 2015, UROLOGY, V85; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bandte A, 2018, WORLD NEUROSURG, V111, pE434, DOI 10.1016/j.wneu.2017.12.094; Baugh TP, 2016, OTOLARYNG HEAD NECK, V154, P645, DOI 10.1177/0194599815627794; Bisson JI, 1997, J TRAUMA, V43, P496, DOI 10.1097/00005373-199709000-00018; Blanksby BA, 1997, SPORTS MED, V23, P228, DOI 10.2165/00007256-199723040-00003; Bobian MR, 2016, ANN OTO RHINOL LARYN, V125, P992, DOI 10.1177/0003489416668195; Boden Barry P, 2005, Curr Sports Med Rep, V4, P45; Boyette JR, 2014, OTOLARYNG CLIN N AM, V47, P747, DOI 10.1016/j.otc.2014.06.008; Braun TL, 2017, SEMIN PLAST SURG, V31, P118, DOI 10.1055/s-0037-1601380; CARTER RL, 1986, CLIN SPORT MED, V5, P185; Chalmers DJ, 2003, SPORTS MED, V33, P745, DOI 10.2165/00007256-200333100-00003; Chen X, 2006, INT J PEDIATR OTORHI, V70, P325, DOI 10.1016/j.ijporl.2005.07.010; Conforte JJ, 2016, INT J ORAL MAX SURG, V45, P575, DOI 10.1016/j.ijom.2015.11.022; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cusimano MD, 2008, J TRAUMA, V65, P1180, DOI 10.1097/TA.0b013e3181826e09; Day C, 2008, PEDIATRICS, V122, pE388, DOI 10.1542/peds.2008-0024; DeVivo MJ, 1997, SPINAL CORD, V35, P509, DOI 10.1038/sj.sc.3100430; Ellis M., 2018, J NEUROSURG PEDIAT, P1; Erdmann D, 2008, ANN PLAS SURG, V60, P398, DOI 10.1097/SAP.0b013e318133a87b; Ferreira PC, 2016, ANN PLAS SURG, V77, P54, DOI 10.1097/SAP.0000000000000346; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Ghosh R, 2018, J CRANIOFAC SURG, V29, pE334, DOI 10.1097/SCS.0000000000004269; Glynn SM, 2010, ORAL MAXIL SURG CLIN, V22, P217, DOI 10.1016/j.coms.2010.01.008; Hardt J., 2011, J SCI MED SPORT, P14; Herman J M, 1991, Crit Care Nurs Clin North Am, V3, P331; Hostetler SG, 2005, AM J SPORT MED, V33, P1065, DOI 10.1177/0363546504271748; Iida S, 2001, INT J ORAL MAX SURG, V30, P286, DOI 10.1054/ijom.2001.0056; Jacobson NA, 2012, J TRAUMA ACUTE CARE, V72, P521, DOI 10.1097/TA.0b013e31823f5fe3; Kerr ZY, 2015, BRIT J SPORT MED, V49, P465, DOI 10.1136/bjsports-2014-094423; KEWALRAMANI LS, 1977, WESTERN J MED, V126, P353; KLUGER Y, 1994, J TRAUMA, V36, P349, DOI 10.1097/00005373-199403000-00011; Korres Demetrios S, 2006, Spine J, V6, P44, DOI 10.1016/j.spinee.2005.06.013; Lawrence LA, 2015, LARYNGOSCOPE, V125, P589, DOI 10.1002/lary.24893; Loder RT, 2008, J TRAUMA, V65, P447, DOI 10.1097/TA.0b013e31817dac43; Lowell G, 2016, J TRAUMA ACUTE CARE, V81, pS20, DOI 10.1097/TA.0000000000001050; Luckstead EF, 2002, PEDIATR CLIN N AM, V49, P581, DOI 10.1016/S0031-3955(02)00006-8; McMaster WC, 1999, CLIN SPORT MED, V18, P349, DOI 10.1016/S0278-5919(05)70150-2; Pollard KA, 2013, AM J EMERG MED, V31, P803, DOI 10.1016/j.ajem.2013.01.028; Randazzo C, 2010, PEDIATRICS, V126, P727, DOI 10.1542/peds.2009-2497; Rubin BD, 1999, CLIN SPORT MED, V18, P293, DOI 10.1016/S0278-5919(05)70145-9; Shah Neil S, 2015, Hand (N Y), V10, P266, DOI 10.1007/s11552-014-9710-2; Svider PF, 2016, INT J PEDIATR OTORHI, V87, P78, DOI 10.1016/j.ijporl.2016.05.025; Svider PF, 2015, LARYNGOSCOPE, V125, P709, DOI 10.1002/lary.24935; Svider PF, 2014, LARYNGOSCOPE, V124, P2257, DOI 10.1002/lary.24686; Umstattd LA, 2016, OTOLARYNG HEAD NECK, V155, P94, DOI 10.1177/0194599816640477; US Bureau of the Census, 2012, STAT ABSTR US; van den Bergh B, 2012, J CRANIO MAXILL SURG, V40, pE165, DOI 10.1016/j.jcms.2011.08.006; Wolf BR, 2009, AM J SPORT MED, V37, P2037, DOI 10.1177/0363546509339364; Wong FK, 2016, J CRANIOFAC SURG, V27, P128, DOI 10.1097/SCS.0000000000002185; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	53	8	8	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-5876	1872-8464		INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	AUG	2018	111						153	157		10.1016/j.ijporl.2018.06.009			5	Otorhinolaryngology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Pediatrics	GM8LH	WOS:000438479600029	29958600				2022-02-06	
J	Hanninen, T; Parkkari, J; Tuominen, M; Ohman, J; Howell, DR; Iverson, GL; Luoto, TM				Hanninen, Timo; Parkkari, Jari; Tuominen, Markku; Ohman, Juha; Howell, David R.; Iverson, Grant L.; Luoto, Teemu M.			Sport Concussion Assessment Tool: Interpreting day-of-injury scores in professional ice hockey players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain injuries; Concussion; Head injuries; Baseline testing; Ice hockey; Sports injury	SELF-REPORTED SYMPTOMS; HIGH-SCHOOL; SCAT3; RECOVERY; PROGRAM; BALANCE; GAMES	Objectives: To characterize the clinical utility of Sport Concussion Assessment Tool 3 (SCAT3) baseline and normative reference values for the assessment of acute concussion; and to identify the sensitivity of each SCAT3 subcomponent to the acute effects of concussion. Design: Prospective cohort. Methods: The day-of-concussion SCAT3 results (n=27) of professional male ice hockey players (mean age=27, SD=4) were compared to athlete's individual baseline and to the league's normative reference values. Normative cutoffs corresponding to 10th percentile and natural distribution change cutoffs corresponding to 90th percentile cumulative frequency were considered uncommon. Results: The percentages of the players with uncommon day-of-injury performance, when post-injury scores were compared to individual baseline versus (vs.) normative values, were as follows: symptoms: 96% vs. 100% (post-injury score: M=12, Md=12, SD=4; severity M=26, Md=23, SD=13); Standardized Assessment of Concussion (SAC): 33% vs. 27% (post-injury M=25, Md=26, SD=3); modified-BESS (M-BESS): 46% vs. 46% (post-injury M=7, Md=5, SD=7); Tandem Gait: 18% vs. 31% (post-injury M=11, Md=12, SD=4); coordination: both 8%. The number and severity of post-injury symptoms were significantly greater, with extremely large effect sizes (Cohen's d=2.44-3.92), than normative values and individual baseline scores. The post-injury SAC score was significantly lower relative to both baseline (d=0.68) and normative values (d=0.88). The post-injury M-BESS performance was significantly worse when compared to both individual baseline (d=1.06) and league normative values (d=1.46). No significant day-of-injury Tandem Gait deficits were observed using either comparison method. Conclusions: SCAT3 league normative values were as sensitive as individual baseline scores during day-of-injury assessments. Symptoms were the most sensitive post-concussion component of the SCAT3. (C) 2017 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Hanninen, Timo; Parkkari, Jari] UKK Inst Hlth Promot Res, Tampere Res Ctr Sports Med, Tampere, Finland; [Tuominen, Markku] Medisport Inc, Liiga Finnish Ice Hockey Assoc, IIHF Med Comm, Tampere, Finland; [Ohman, Juha] Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere, Finland; [Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Boulder, CO 80309 USA; [Iverson, Grant L.] Harvard Med Sch, Massachusetts Gen Hosp, Sport Concuss Program, Spaulding Rehabil Hosp,Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Home Base, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Luoto, Teemu M.] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland		Hanninen, T (corresponding author), UKK Inst Hlth Promot Res, Tampere Res Ctr Sports Med, Tampere, Finland.	timo.hanninen@fimnet.fi	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284; Iverson, Grant/0000-0001-7348-9570	Finnish Ministry of Education and Culture; Finnish Medical Foundation; Maire Taponen Foundation; Finnish Hockey League; Finnish Ice Hockey Association; Finnish Hockey Player Association (FHPA)	This study was financially supported by the Finnish Ministry of Education and Culture, the Finnish Medical Foundation, the Maire Taponen Foundation, and the Finnish Hockey League. There was no involvement with any commercial sponsor for this study regarding the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the paper for publication.; We greatly appreciate the cooperation of all the team physicians and physiotherapists who volunteered their time to collect the data for this project. We sincerely thank Mr. Kari Tokola, M.Sc. for statistical advice, Ms. Birgitta Jarvinen, M.Sc for help in conducting literature searches, and research assistant Anne Simi for her contribution to data collection. We would like to thank the Finnish Hockey League, Finnish Ice Hockey Association, and Finnish Hockey Player Association (FHPA) for their support.	Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hanninen T, 2017, J SCI MED SPORT, V20, P424, DOI 10.1016/j.jsams.2016.09.009; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Sabin MJ, 2011, CLIN J SPORT MED, V21, P411, DOI 10.1097/JSM.0b013e318223f3a4; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Tuominen M, 2017, BRIT J SPORT MED, V51, P244, DOI 10.1136/bjsports-2016-097119; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40	25	8	8	0	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	AUG	2018	21	8					794	799		10.1016/j.jsams.2017.12.001			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GN9PN	WOS:000439536500008	29254676				2022-02-06	
J	McDonald, WS; Jones, EE; Wojciak, JM; Drake, RR; Sabbadini, RA; Harris, NG				McDonald, Whitney S.; Jones, Elizabeth E.; Wojciak, Jonathan M.; Drake, Richard R.; Sabbadini, Roger A.; Harris, Neil G.			Matrix-Assisted Laser Desorption Ionization Mapping of Lysophosphatidic Acid Changes after Traumatic Brain Injury and the Relationship to Cellular Pathology	AMERICAN JOURNAL OF PATHOLOGY			English	Article							IMAGING MASS-SPECTROMETRY; CONTROLLED CORTICAL IMPACT; SMOOTH-MUSCLE-CELLS; PHOSPHOLIPASE A(2); NEUROPATHIC PAIN; THERAPEUTIC TARGET; RECEPTOR; RAT; LPA; PROLIFERATION	Lysophosphatidic acid (LPA) levels increase in the cerebrospinal fluid and blood within 24 hours after traumatic brain injury (TBI), indicating it may be a biomarker for subsequent cellular pathology. However, no data exist that document this association after TBI. We, therefore, acquired matrix assisted laser desorption ionization imaging mass spectrometry data of LPA, major LPA metabolites, and hemoglobin from adult rat brains at 1 and 3 hours after controlled cortical impact injury. Data were semiquantitatively assessed by signal intensity analysis normalized to naive rat brains acquired concurrently. Gray and white matter pathology was assessed on adjacent sections using immunohistochemistry for cell death, axonal injury, and intracellular LPA, to determine the spatiotemporal patterning of LPA corresponding to pathology. The results revealed significant increases in LPA and LPA precursors at 1 hour after injury and robust enhancement in LPA diffusively throughout the brain at 3 hours after injury. Voxel-wise analysis of LPA by matrix-assisted laser desorption ionization and beta-amyloid precursor protein by immunohistochemistry in adjacent sections showed significant association, raising the possibility that LPA is linked to secondary axonal injury. Total LPA and metabolites were also present in remotely injured areas, including cerebellum and brain stem, and in particular thalamus, where intracellular LPA is associated with cell death. LPA may be a useful biomarker of cellular pathology after TBI.	[McDonald, Whitney S.; Harris, Neil G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Jones, Elizabeth E.; Drake, Richard R.] Med Univ South Carolina, Prote Ctr, Charleston, SC 29425 USA; [Wojciak, Jonathan M.; Sabbadini, Roger A.] Lpath Inc, San Diego, CA USA		Harris, NG (corresponding author), UCLA, David Geffen Sch Med, Dept Neurosurg, 300 Stein Plaza,Ste 535,Box 956901, Los Angeles, CA 90095 USA.	ngharris@ucla.edu		Harris, Neil/0000-0002-1965-6750	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R44 NS87641, R01 NS091222]; UCLA Brain Injury Research Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091222] Funding Source: NIH RePORTER	Supported by NIH grants R44 NS87641 (R.A.S., N.G.H.) and R01 NS091222 (N.G.H.) and the UCLA Brain Injury Research Center.	Adibhatla RM, 2007, FUTURE LIPIDOL, V2, P403, DOI 10.2217/17460875.2.4.403; Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Aichler M, 2015, LAB INVEST, V95, P422, DOI 10.1038/labinvest.2014.156; Anliker B, 2004, SEMIN CELL DEV BIOL, V15, P457, DOI 10.1016/j.semcdb.2004.05.005; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Birgbauer E, 2006, CELL MOL LIFE SCI, V63, P2695, DOI 10.1007/s00018-006-6155-y; Bolen AL, 2011, J LIPID RES, V52, P958, DOI 10.1194/jlr.M013326; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Crack PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-37; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Farooqui AA, 1997, J NEUROCHEM, V69, P889; Fernandis AZ, 2007, CURR OPIN LIPIDOL, V18, P121, DOI 10.1097/MOL.0b013e328082e4d5; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; Fink KL, 2017, CELL REP, V18, P2687, DOI 10.1016/j.celrep.2017.02.058; Frisca F, 2013, J LIPID RES, V54, P1192, DOI 10.1194/jlr.M032284; Frugier T, 2011, CELL MOL NEUROBIOL, V31, P569, DOI 10.1007/s10571-011-9650-0; Furui T, 1999, CLIN CANCER RES, V5, P4308; Gessel M, 2015, J MASS SPECTROM, V50, P1288, DOI 10.1002/jms.3696; Gessel MM, 2014, J PROTEOMICS, V107, P71, DOI 10.1016/j.jprot.2014.03.021; Gierse J, 2010, J PHARMACOL EXP THER, V334, P310, DOI 10.1124/jpet.110.165845; Goetzl EJ, 1999, J IMMUNOL, V162, P2049; Goldshmit Y, 2012, AM J PATHOL, V181, P978, DOI 10.1016/j.ajpath.2012.06.007; Goldshmit Y, 2010, CELL TISSUE RES, V341, P23, DOI 10.1007/s00441-010-0977-5; Hasegawa Y, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0353-1_8; Hayashi K, 2001, CIRC RES, V89, P251, DOI 10.1161/hh1501.094265; Hildebrandt JP, 1997, GLIA, V19, P67, DOI 10.1002/(SICI)1098-1136(199701)19:1<67::AID-GLIA7>3.0.CO;2-7; Holschneider DP, 2013, J NEUROTRAUM, V30, P907, DOI 10.1089/neu.2012.2657; Holtsberg FW, 1998, J NEUROCHEM, V70, P66; Holtsberg FW, 1997, J NEUROCHEM, V69, P68; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Im DS, 2000, MOL PHARMACOL, V57, P753, DOI 10.1124/mol.57.4.753; Inoue M, 2008, NEUROSCIENCE, V152, P296, DOI 10.1016/j.neuroscience.2007.12.041; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; JALINK K, 1995, BIOCHEM J, V307, P609, DOI 10.1042/bj3070609; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jones EE, 2014, ANAL CHEM, V86, P8303, DOI 10.1021/ac501937d; Kadl A, 2004, ANTIOXID REDOX SIGN, V6, P311, DOI 10.1089/152308604322899378; Kagan VE, 2002, PHOSPHOLIPID METABOL; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Lai JM, 2001, BIOCHEM J, V359, P227, DOI 10.1042/0264-6021:3590227; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Ma L, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-29; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moller T, 2001, J BIOL CHEM, V276, P25946, DOI 10.1074/jbc.M102691200; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Nagai J, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-78; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; On NH, 2013, J CEREB BLOOD FLOW M, V33, P1; Ostrowski RP, 2006, NEUROL RES, V28, P399, DOI 10.1179/016164106X115008; Pages C, 2001, PROSTAG OTH LIPID M, V64, P1, DOI 10.1016/S0090-6980(01)00110-1; Pages C, 2000, ANN NY ACAD SCI, V905, P159; Pasvogel AE, 2010, BIOL RES NURS, V11, P325, DOI 10.1177/1099800409346056; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Santos-Nogueira E, 2015, J NEUROSCI, V35, P10224, DOI 10.1523/JNEUROSCI.4703-14.2015; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shano S, 2008, NEUROCHEM INT, V52, P216, DOI 10.1016/j.neuint.2007.07.004; Shanta SR, 2011, ANAL CHEM, V83, P1252, DOI 10.1021/ac1029659; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Spraggins JM, 2015, J AM SOC MASS SPECTR, V26, P974, DOI 10.1007/s13361-015-1147-5; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Steiner MR, 2002, BBA-MOL CELL BIOL L, V1582, P154, DOI 10.1016/S1388-1981(02)00150-6; Tabuchi S, 2000, NEUROCHEM RES, V25, P573, DOI 10.1023/A:1007542532395; Thomsen GM, 2014, STEM CELL RES, V13, P48, DOI 10.1016/j.scr.2014.04.013; Tigyi G, 1996, J NEUROCHEM, V66, P537; Titsworth WL, 2008, CNS NEUROL DISORD-DR, V7, P254, DOI 10.2174/187152708784936671; TOKUMURA A, 1994, AM J PHYSIOL, V267, pC204, DOI 10.1152/ajpcell.1994.267.1.C204; Underwood KW, 1998, J BIOL CHEM, V273, P21926, DOI 10.1074/jbc.273.34.21926; Vereyken EJF, 2009, GLIA, V57, P1326, DOI 10.1002/glia.20852; Wang HYJ, 2012, ANAL BIOANAL CHEM, V404, P113, DOI 10.1007/s00216-012-6077-5; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yalcin EB, 2015, J HISTOCHEM CYTOCHEM, V63, P762, DOI 10.1369/0022155415596202; Yano R, 2013, CELL MOL NEUROBIOL, V33, P1033, DOI 10.1007/s10571-013-9970-3; Ye XQ, 2002, BBA-MOL CELL BIOL L, V1585, P108, DOI 10.1016/S1388-1981(02)00330-X; Yoshida K, 2003, CIRCULATION, V108, P1746, DOI 10.1161/01.CIR.0000089374.35455.F3	82	8	8	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	AUG	2018	188	8					1779	1793		10.1016/j.ajpath.2018.05.005			15	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	GP3SI	WOS:000440773100006	30037420	Bronze, Green Published			2022-02-06	
J	Reisner, A; Chern, JJ; Walson, K; Tillman, N; Petrillo-Albarano, T; Sribnick, EA; Blackwell, LS; Suskin, ZD; Kuan, CY; Vats, A				Reisner, Andrew; Chern, Joshua J.; Walson, Karen; Tillman, Natalie; Petrillo-Albarano, Toni; Sribnick, Eric A.; Blackwell, Laura S.; Suskin, Zaev D.; Kuan, Chia-Yi; Vats, Atul			Introduction of severe traumatic brain injury care protocol is associated with reduction in mortality for pediatric patients: a case study of Children's Healthcare of Atlanta's neurotrauma program	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; intracranial pressure monitoring; intensive care unit; practice guidelines; trauma	INTRACRANIAL-PRESSURE; NEUROCRITICAL CARE; OUTCOMES; MANAGEMENT; GUIDELINES; DISCHARGE	OBJECTIVE Evidence shows mixed efficacy of applying guidelines for the treatment of traumatic brain injury (TBI) in children. A multidisciplinary team at a children's health system standardized intensive care unit-based TBI care using guidelines and best practices. The authors sought to investigate the impact of guideline implementation on outcomes. METHODS A multidisciplinary group developed a TBI care protocol based on published TBI treatment guidelines and consensus, which was implemented in March 2011. The authors retrospectively compared preimplementation outcomes (May 2009 to March 2011) and postimplementation outcomes (April 2011 to March 2014) among patients < 18 years of age admitted with severe TBI (Glasgow Coma Scale score <= 8) and potential survivability who underwent intracranial pressure (ICP) monitoring. Measures included mortality, hospital length of stay (LOS), ventilator LOS, critical ICP elevation time (percentage or total time that ICP was > 40 mm Hg), and survivor functionality at discharge (measured by the WeeFIM score). Data were analyzed using Student t-tests. RESULTS A total of 71 and 121 patients were included pre- and postimplementation, respectively. Mortality (32% vs 19%; p <0.001) and length of critical ICP elevation (> 20 mm Hg; 26.3% vs 15%; p = 0.001) decreased after protocol implementation. WeeFIM discharge scores were not statistically different (57.6 vs 58.9; p = 0.9). Hospital LOS (median 19.6 days; p = 0.68) and ventilator LOS (median 10 days; p = 0.24) were unchanged. CONCLUSIONS A multidisciplinary effort to develop, disseminate, and implement an evidence-based TBI treatment protocol at a children's hospital was associated with improved outcomes, including survival and reduced time of ICP elevation. This type of ICP-based protocol can serve as a guide for other institutions looking to reduce practice disparity in the treatment of severe TBI.	[Reisner, Andrew; Chern, Joshua J.; Petrillo-Albarano, Toni; Blackwell, Laura S.; Vats, Atul] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Reisner, Andrew; Chern, Joshua J.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA; [Reisner, Andrew; Chern, Joshua J.; Walson, Karen; Tillman, Natalie; Blackwell, Laura S.] Childrens Healthcare Atlanta, Atlanta, GA 30329 USA; [Sribnick, Eric A.] Nationwide Childrens Hosp, Dept Surg, Columbus, OH USA; [Suskin, Zaev D.] Georgetown Univ, Sch Med, Washington, DC USA; [Kuan, Chia-Yi] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA		Reisner, A (corresponding author), Childrens Healthcare Atlanta, Atlanta, GA 30329 USA.	andrew.reisner@choa.org	Sribnick, Eric/AAH-6693-2020				Agrawal Shruti, 2016, World J Crit Care Med, V5, P36, DOI 10.5492/wjccm.v5.i1.36; Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Centers for Disease Control and Prevention, 2001, RAT TBI REL EM DEP V; Cuschieri J, 2012, ANN SURG, V255, P993, DOI 10.1097/SLA.0b013e31824f1ebc; Dinsmore J, 2013, BJA EDUC, V13, P189, DOI 10.1093/bjaceaccp/mkt010; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Kannan Nithya, 2014, Int J Crit Illn Inj Sci, V4, P131, DOI 10.4103/2229-5151.134152; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Larsen GY, 2016, NEUROCRIT CARE, V24, P353, DOI 10.1007/s12028-015-0218-6; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; McCabe M A, 1990, Appl Nurs Res, V3, P120, DOI 10.1016/S0897-1897(05)80128-4; O'Lynnger TM, 2016, J NEUROSURG-PEDIATR, V17, P19, DOI 10.3171/2015.5.PEDS1544; Peterson ED, 2008, J CARDIOVASC NURS, V23, P50, DOI 10.1097/01.JCN.0000305058.03872.f1; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Roumeliotis N, 2015, CHILD NERV SYST, V31, P2011, DOI 10.1007/s00381-015-2837-9; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Schwentner L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-487; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Visser BC, 2012, HPB, V14, P539, DOI 10.1111/j.1477-2574.2012.00496.x; Wainwright MS, 2016, CURR OPIN CRIT CARE, V22, P106, DOI 10.1097/MCC.0000000000000288; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Yue JK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15612	28	8	9	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	AUG	2018	22	2					165	172		10.3171/2018.2.PEDS17562			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	GP2DS	WOS:000440632500008	29799350	Bronze			2022-02-06	
J	Reznik, ME; Mahta, A; Schmidt, JM; Frey, HP; Park, S; Roh, DJ; Agarwal, S; Claassen, J				Reznik, Michael E.; Mahta, Ali; Schmidt, J. Michael; Frey, Hans-Peter; Park, Soojin; Roh, David J.; Agarwal, Sachin; Claassen, Jan			Duration of Agitation, Fluctuations of Consciousness, and Associations with Outcome in Patients with Subarachnoid Hemorrhage	NEUROCRITICAL CARE			English	Article						Agitation; Consciousness; Delirium; Subarachnoid hemorrhage; Stroke; Brain injury	TRAUMATIC BRAIN-INJURY; SEDATION SCALE; CORTEX INJURY; DELIRIUM; COMPLICATIONS; RELIABILITY; HALOPERIDOL; RECOVERY; VALIDITY; STROKE	Agitation is common after subarachnoid hemorrhage (SAH) and may be independently associated with outcomes. We sought to determine whether the duration of agitation and fluctuating consciousness were also associated with outcomes in patients with SAH. We identified all patients with positive Richmond Agitation Sedation Scale (RASS) scores from a prospective observational cohort of patients with SAH from 2011 to 2015. Total duration of agitation was extrapolated for each patient using available RASS scores, and 24-h mean and standard deviation (SD) of RASS scores were calculated for each patient. We also calculated each patient's duration of substantial fluctuation of consciousness, defined as the number of days with 24-h RASS SD > 1. Patients were stratified by 3-month outcome using the modified Rankin scale, and associations with outcome were assessed via logistic regression. There were 98 patients with at least one positive RASS score, with median total duration of agitation 8 h (interquartile range [IQR] 4-18), and median duration of substantially fluctuating consciousness 2 days (IQR 1-3). Unfavorable 3-month outcome was significantly associated with a longer duration of fluctuating consciousness (odds ratio [OR] per day, 1.51; 95% confidence interval [CI], 1.04-2.20; p = 0.031), but a briefer duration of agitation (OR per hour, 0.94; 95% CI, 0.89-0.99; p = 0.031). Though a longer duration of fluctuating consciousness was associated with worse outcomes in our cohort, total duration of agitation was not, and may have had the opposite effect. Our findings should therefore challenge the intensity with which agitation is often treated in SAH patients.	[Reznik, Michael E.; Mahta, Ali] Brown Univ, Warren Alpert Med Sch, Dept Neurol, Providence, RI 02912 USA; [Schmidt, J. Michael; Frey, Hans-Peter; Park, Soojin; Roh, David J.; Agarwal, Sachin; Claassen, Jan] Columbia Univ, Med Ctr, Dept Neurol, 177 Ft Washington Ave,Milstein Hosp Bldg, New York, NY 10032 USA		Claassen, J (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, 177 Ft Washington Ave,Milstein Hosp Bldg, New York, NY 10032 USA.	jc1439@cumc.columbia.edu	Mahta, Ali/ABA-7340-2021; Reznik, Michael/AAY-6848-2020; Claassen, Jan/AAA-5451-2020		DANA foundation; NLM of the NIH [R01 LM011826]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01 ES026833]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K01ES026833] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM011826] Funding Source: NIH RePORTER	This publication was supported by the DANA foundation (JC, JMS), the NLM of the NIH under Award Number R01 LM011826 (JC), and NIH Grant K01 ES026833 (SP).	Ali Shahid, 2011, Innov Clin Neurosci, V8, P25; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Bogner J, 2015, ARCH PHYS MED REHAB, V96, pS274, DOI 10.1016/j.apmr.2015.04.020; Caeiro L, 2004, J NEUROL, V251, P171, DOI 10.1007/s00415-004-0294-6; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; DEHAAN R, 1995, STROKE, V26, P2027, DOI 10.1161/01.STR.26.11.2027; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Goldstein Larry B, 2006, NeuroRx, V3, P451, DOI 10.1016/j.nurx.2006.07.010; Goldstein LB, 2002, NEUROREHAB NEURAL RE, V16, P321, DOI 10.1177/154596830201600402; Hshieh TT, 2008, J GERONTOL A-BIOL, V63, P764, DOI 10.1093/gerona/63.7.764; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Maldonado JR, 2008, CRIT CARE CLIN, V24, P789, DOI 10.1016/j.ccc.2008.06.004; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Oldenbeuving AW, 2011, NEUROLOGY, V76, P993, DOI 10.1212/WNL.0b013e318210411f; Reznik ME, 2017, NEUROCRIT CARE, V26, P428, DOI 10.1007/s12028-016-0331-1; Riker RR, 2014, NEUROCRIT CARE, V21, P27, DOI 10.1007/s12028-014-0025-5; Robinson TN, 2008, AM J SURG, V196, P670, DOI 10.1016/j.amjsurg.2008.07.007; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Singh R, 2014, BRAIN INJURY, V28, P336, DOI 10.3109/02699052.2013.873142; van der Mast R C, 2000, Semin Clin Neuropsychiatry, V5, P125; Wartenberg KE, 2005, STROKE, V36, P521	26	8	8	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2018	29	1					33	39		10.1007/s12028-017-0491-7			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GO6JM	WOS:000440146900006	29313314	Green Accepted			2022-02-06	
J	Sangobowale, M; Nikulina, E; Bergold, PJ				Sangobowale, Michael; Nikulina, Elena; Bergold, Peter J.			Minocycline plus N-acetylcysteine protect oligodendrocytes when first dosed 12 hours after closed head injury in mice	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; corpus callosum; glia; therapeutic time window	INFLAMMATION; REMYELINATION; INHIBITION; EXPRESSION	The mouse closed head injury (CHI) model of traumatic brain injury (TBI) produces widespread demyelination. Myelin content is restored by minocycline (MINO) plus n-acetylcysteine (NAC) or MINO alone when first dosed at 12 h after CHI. In a rat controlled cortical impact model of TB1, a first dose of MINO plus NAC one h after injury protects resident oligodendrocytes that induce remyelination. In contrast, MINO less effectively protects oligodendrocytes and remyelination is mediated by oligodendrocyte precursor cell proliferation and differentiation. MINO plus NAC or MINO alone is hypothesized to work similarly in the CHI model as in the controlled cortical impact model even when first dosed at 12-h post - CHI. We tested this hypothesis by examining the time course of the changes in the oligodendrocyte antigenic markers CC1, 2',3'-Cyclic-nucleotide 3'-phosphodiesterase and phospholipid protein between 2 and 14 days post - CHI in mice treated with saline, NAC, MINO or MINO plus NAC. CHI produced a long-lasting loss of these markers that was not altered by NAC treatment. In contrast, oligodendrocyte marker expression was maintained by MINO plus NAC between 2 and 14 days post injury. MINO alone did not prevent the early loss of oligodendrocyte markers, but marker expression significantly increased by 14-days post-injury. These data suggest that MINO plus NAC or MINO alone when first dosed 12 h after CHI increase myelin content using similar mechanisms seen when first dosed 1 h after closed head injury. These data also suggest that drugs protect oligodendrocytes with a clinically useful therapeutic time window.	[Sangobowale, Michael; Bergold, Peter J.] Suny Downstate Med Ctr, Sch Grad Studies, Brooklyn, NY 11203 USA; [Sangobowale, Michael; Nikulina, Elena] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Sangobowale, Michael] Penn Presbyterian Med Ctr, Med Off Bldg,51 N 39th St,Suite 205, Philadelphia, PA 19104 USA		Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA.	pbergold@downstate.edu			 [RO1070512]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS076693] Funding Source: NIH RePORTER	This work was supported by a grant (RO1070512) to P.J.B.	Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bhat RV, 1996, GLIA, V17, P169; Brakeman JSF, 1999, NEUROSCIENCE, V91, P661, DOI 10.1016/S0306-4522(98)00605-8; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen XH, 2012, EUR J PHARMACOL, V686, P124, DOI 10.1016/j.ejphar.2012.04.043; Foote AK, 2005, BRAIN, V128, P528, DOI 10.1093/brain/awh417; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Grin'kina NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161053; Haber M., 2018, J CEREB BLOOD FLOW M; Inman CF, 2005, J IMMUNOL METHODS, V302, P156, DOI 10.1016/j.jim.2005.05.005; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lang J, 2013, J NEUROSCI, V33, P3113, DOI 10.1523/JNEUROSCI.3467-12.2013; Li WW, 2005, J NEUROIMMUNOL, V158, P58, DOI 10.1016/j.jneuroim.2004.08.011; Paxinos G., 2013, MOUSE BRAIN STEREOTA, VFourth; Popovic N, 2002, ANN NEUROL, V51, P215, DOI 10.1002/ana.10092; Raasakka A, 2014, NEUROSCI BULL, V30, P956, DOI 10.1007/s12264-013-1437-5; Sangobowale MA, 2018, J NEUROTRAUM, V35, P907, DOI 10.1089/neu.2017.5348; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Skripuletz T, 2010, NEUROCHEM RES, V35, P1422, DOI 10.1007/s11064-010-0202-7; Tanaka T, 2013, J NEUROCHEM, V127, P259, DOI 10.1111/jnc.12289; Watzlawik J, 2010, EXPERT REV NEUROTHER, V10, P441, DOI 10.1586/ERN.10.13; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	25	8	8	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	AUG	2018	682						16	20		10.1016/j.neulet.2018.06.010			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GS6GU	WOS:000443787700003	29885452				2022-02-06	
J	Suto, Y; Nagata, K; Ahmed, SM; Jacovides, C; Browne, KD; Cognetti, J; Weber, MT; Johnson, VE; Leone, R; Kaplan, LJ; Smith, DH; Pascual, JL				Suto, Yujin; Nagata, Katsuhiro; Ahmed, Syed M.; Jacovides, Christina; Browne, Kevin D.; Cognetti, John; Weber, Maura T.; Johnson, Victoria E.; Leone, Ryan; Kaplan, Lewis J.; Smith, Douglas H.; Pascual, Jose L.			A concomitant bone fracture delays cognitive recovery from traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	31st Annual Scientific Meeting of the Eastern-Association-for-Surgery-of-Trauma (EAST)	JAN 09-13, 2018	Lake Buena Vista, FL	Eastern Assoc Surg Trauma		Traumatic brain injury; polytrauma; tibial fracture; enoxaparin; Morris Water Maze	MORRIS WATER MAZE; LONG-TERM POTENTIATION; IN-VIVO; SPATIAL MEMORY; RATS; MODEL; INFLAMMATION; PERFORMANCE; ENOXAPARIN; HEPARIN	BACKGROUND: Brain injury progression after severe traumatic brain injury (TBI) is associated with worsening cerebral inflammation but it is unknown how a concomitant bone fracture (BF) affects this progression. Enoxaparin (ENX) decreases penumbral leukocyte mobilization after TBI and improves neurologic recovery. We hypothesized that a concomitant BF worsens learning/memory recovery weeks after TBI and that ENX improves this recovery. METHODS: CD1 male mice underwent controlled cortical impact or sham craniotomy with or without tibial fracture, receiving either daily ENX (0.8 mg/kg) or saline for 14 days after injury. Randomization defined four groups (Sham, TBI only, TBI + Fx, TBI + Fx + ENX, n = 5/each). Body weight loss and neurologic recovery (Garcia Neurologic Test, max score = 18) were assessed each day. Mouse learning (swimming time [s] and total distance [m] to reach the submerged platform Days 14 to 17 after TBI) and memory (swimming time [s] in platform quadrant after platform removed [probe]) was assessed by the Morris water maze. Ly-6G (cerebral neutrophil sequestration) and glial fibrillary acidic protein were evaluated by immunohistochemistry in brain tissue post mortem. Analysis of variance with Tukey's post hoc test determined significance (p < 0.05). RESULTS: A concurrent BF worsened Garcia Neurologic Test scores post-TBI Days 2 to 4 (p < 0.01) as compared with TBI only, and ENX reversed this worsening on Day 4 (p < 0.01). Learning was significantly slower (greater swimming time and distance) in TBI + Fx versus TBI only on Day 17 (p < 0.01). This was despite similar swimming velocities in both groups, indicating intact extremity motor function. Memory was similar in isolated TBI and Sham which was significantly better than in TBI + Fx animals (p < 0.05). Glial fibrillary acidic protein-positive cells in penumbral cortex were most prevalent in TBI + Fx animals, significantly greater than in Sham (p < 0.05). CONCLUSION: A long BF accompanying TBI worsens early neurologic recovery and subsequent learning/memory. Enoxaparin may partially counter this and improve neurologic recovery. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.	[Suto, Yujin; Ahmed, Syed M.; Jacovides, Christina; Leone, Ryan; Kaplan, Lewis J.; Pascual, Jose L.] Univ Penn, Perelman Sch Med, Div Traumatol Surg Clin Care & Emergency Surg, Rm 108,1st Floor Suite 120,Med Off Bldg, Philadelphia, PA 19104 USA; [Suto, Yujin; Ahmed, Syed M.; Jacovides, Christina; Browne, Kevin D.; Cognetti, John; Weber, Maura T.; Johnson, Victoria E.; Smith, Douglas H.; Pascual, Jose L.] Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA; [Nagata, Katsuhiro] Tokyo Med Univ, Hachioji Med Ctr, Dept Emergency & Crit Care Med, Tokyo, Japan		Pascual, JL (corresponding author), Univ Penn, Perelman Sch Med, Div Traumatol Surg Clin Care & Emergency Surg, Rm 108,1st Floor Suite 120,Med Off Bldg, Philadelphia, PA 19104 USA.	jose.pascual@uphs.upenn.edu		Leone, Ryan/0000-0003-0549-9990; Ahmed, Syed Moiz/0000-0003-3922-5525	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS094003, R01 NS092398] Funding Source: Medline		ADAMS J, 1986, HDB BEHAV TERATOLOGY, P67; Borsig L, 2010, THROMB RES, V125, pS66, DOI 10.1016/S0049-3848(10)70017-7; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Clausen F, 2005, NEUROSURGERY, V57, P154, DOI 10.1227/01.NEU.0000163412.07546.57; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Degos V, 2013, ANESTHESIOLOGY, V118, P1362, DOI 10.1097/ALN.0b013e31828c23f8; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; JEFFERY KJ, 1993, HIPPOCAMPUS, V3, P133, DOI 10.1002/hipo.450030205; Kessels RPC, 2001, BRAIN RES REV, V35, P295, DOI 10.1016/S0165-0173(01)00058-3; Kubes P, 2000, BRAIN PATHOL, V10, P127; Kumasaka K, 2014, AM J SURG, V208, P961, DOI 10.1016/j.amjsurg.2014.08.004; Lecky FE, 2010, DAMAGE CONTROL MANAGEMENT IN THE POLYTRAUMA PATIENT, P13, DOI 10.1007/978-0-387-89508-6_2; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; MacGregor AJ, 2012, INJURY, V43, P1551, DOI 10.1016/j.injury.2011.04.017; Maei HR, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.033.2009; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Nagata K, 2017, J TRAUMA ACUTE CARE, V83, P406, DOI 10.1097/TA.0000000000001590; Nagata K, 2016, J TRAUMA ACUTE CARE, V81, P1088, DOI 10.1097/TA.0000000000001215; Pascual JL, 2003, J TRAUMA, V54, pS133, DOI 10.1097/01.TA.0000064526.33647.63; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Rao SV, 2010, CIRCULATION, V121, P1713, DOI 10.1161/CIRCULATIONAHA.109.913277; Robert AP, 2013, VHA HDB; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Sen O, 2011, TURK NEUROSURG, V21, P203, DOI 10.5137/1019-5149.JTN.3646-10.1; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Singh S, 2016, BEHAV BRAIN RES, V299, P141, DOI 10.1016/j.bbr.2015.11.023; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stutzmann JM, 2002, CNS DRUG REV, V8, P1; Suto Y, 2017, ANN SCI SESS W SURG, P40; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Weckbach S, 2013, J TRAUMA ACUTE CARE, V74, P489, DOI 10.1097/TA.0b013e31827d5f1b; Yang L, 2016, SCAND J IMMUNOL, V83, P26, DOI 10.1111/sji.12393; Yukata K, 2014, BONE, V62, P79, DOI 10.1016/j.bone.2014.02.002; Zhai PP, 2015, NEUROPHARMACOLOGY, V95, P1, DOI 10.1016/j.neuropharm.2015.02.026; Zhang YL, 2017, J NEUROSURG, V126, P782, DOI 10.3171/2016.3.JNS152699	47	8	9	2	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2018	85	2					275	284		10.1097/TA.0000000000001957			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	GR7AB	WOS:000442836600005	29787539				2022-02-06	
J	Schmidt, JD; Lynall, RC; Lempke, LB; Weber, ML; Devos, H				Schmidt, Julianne D.; Lynall, Robert C.; Lempke, Landon B.; Weber, Michelle L.; Devos, Hannes			Post-Concussion Driving Behaviors and Opinions: A Survey of Collegiate Student-Athletes	JOURNAL OF NEUROTRAUMA			English	Article						driving safety; fitness to drive; mild traumatic brain injury; post-concussion	TRAUMATIC BRAIN-INJURY; DRIVERS; SYMPTOMS; PERFORMANCE; PARKINSONS; CESSATION; FITNESS; ABILITY; ADVICE	Post-concussion driving restrictions are eminent, but we lack understanding of current behaviors and opinions about driving following concussion among populations at risk of concussion. We aimed to describe post-concussion driving behaviors and opinions among collegiate student-athletes. Student-athletes completed a survey (response rate=45.3%, 223/492) regarding their post-concussion driving behaviors and opinions. Response frequencies and percentages are presented. Student-athletes self-reported a total of 169 lifetime concussions (0.76 +/- 1.02 each). Of the 169 concussions, 52.1% (88/169) were diagnosed and 52.7% (89/169) occurred while the student-athlete possessed a valid driver's license. Student-athletes refrained from driving following 43.8% (39/89) of the concussive events. Student-athletes who refrained most commonly did so for only 24-48h (20.5%, 8/39) and because a health care provider advised them to (33.3%, 13/39). Student-athletes most commonly reported that they would feel very unsafe driving a car immediately following injury (38.4%, 84/219). When asked whether driving restrictions would influence their decision to report the injury to a health care provider, 7.9% reported that it definitely would (17/214), 26.6% probably would (57/214), 17.8% neutral (38/214), 24.8% probably would not (53/214), and 22.9% definitely would not (49/214). Despite generally believing that driving immediately following a concussion is unsafe, a majority of student-athletes did not refrain from driving at any point following their previous concussions. Post-concussion driving restrictions may have some influence on student-athletes' decisions to report the injury to a health care provider. Health care providers play a critical role in post-concussion driving restriction, but lack standardized recommendations to guide their care.	[Schmidt, Julianne D.; Lynall, Robert C.; Lempke, Landon B.; Weber, Michelle L.] Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA; [Devos, Hannes] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66103 USA		Schmidt, JD (corresponding author), Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA.	schmidtj@uga.edu	Lempke, Landon/C-4800-2018; Devos, Hannes/I-6852-2019; Lynall, Robert/M-2888-2014	Lempke, Landon/0000-0003-0007-1362; Devos, Hannes/0000-0002-8853-6840; Lynall, Robert/0000-0002-0785-6640	National Collegiate Athletic Association-Department of Defense Research Grand Challenge: Changing Attitudes about Concussions in Young and Emerging Adults	This study was partially supported by the National Collegiate Athletic Association-Department of Defense Research Grand Challenge: Changing Attitudes about Concussions in Young and Emerging Adults.	[Anonymous], 2017, ASS FITN DRIV 2016; Baker A., 2015, ACCIDENT ANAL PREV, P7950; Baker A, 2015, BRIT J OCCUP THER, V78, P73, DOI 10.1177/0308022614562405; Baker A, 2015, AUST OCCUP THER J, V62, P50, DOI 10.1111/1440-1630.12172; Barrash J, 2010, J INT NEUROPSYCH SOC, V16, P679, DOI 10.1017/S1355617710000470; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Canadian Council of Motor Transport Administrators, 2015, DET DRIV FITN CAN; Devos H, 2012, PHYSIOTHER RES INT, V17, DOI 10.1002/pri.1535; Devos H, 2013, MOVEMENT DISORD, V28, P1949, DOI 10.1002/mds.25701; Devos H, 2013, DISABIL REHABIL, V35, P1387, DOI 10.3109/09638288.2012.731468; Fisk GD, 1998, BRAIN INJURY, V12, P683; Grace J, 2005, J INT NEUROPSYCH SOC, V11, P766, DOI 10.1017/S135561770505848; Horswill MS, 2004, J APPL SOC PSYCHOL, V34, P177, DOI 10.1111/j.1559-1816.2004.tb02543.x; Klein TA, 2017, J PEDIATR HEALTH CAR, V31, P441, DOI 10.1016/j.pedhc.2016.11.004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Logan PA, 2004, CLIN REHABIL, V18, P703, DOI 10.1191/0269215504cr742oa; MacDonald J, 2018, J PEDIATR-US, V194, P177, DOI 10.1016/j.jpeds.2017.10.032; Marottoli RA, 2000, J GERONTOL B-PSYCHOL, V55, pS334, DOI 10.1093/geronb/55.6.S334; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Owens Katherine, 2009, P43, DOI 10.1007/978-3-7643-9923-8_3; Preece MHW, 2016, BRAIN INJURY, V30, P1096, DOI 10.3109/02699052.2016.1165868; Preece MHW, 2013, BRAIN INJURY, V27, P83, DOI 10.3109/02699052.2012.722260; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Reger MA, 2004, NEUROPSYCHOLOGY, V18, P85, DOI 10.1037/0894-4105.18.1.85; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Schmidt JD, 2017, J NEUROTRAUM, V34, P1571, DOI 10.1089/neu.2016.4668; Schneider JJ, 2005, APPL NEUROPSYCHOL, V12, P138, DOI 10.1207/S15324826AN1203_3; Scott-Parker B, 2009, TRANSPORT RES F-TRAF, V12, P470, DOI 10.1016/j.trf.2009.08.003; SVENSON O, 1981, ACTA PSYCHOL, V47, P143, DOI 10.1016/0001-6918(81)90005-6; The Driver and Vehicle Licensing Agency, 2018, ASS FITN DRIV GUID M; Uc EY, 2009, NEUROLOGY, V73, P2112, DOI 10.1212/WNL.0b013e3181c67b77; Windsor TD, 2007, GERONTOLOGIST, V47, P215, DOI 10.1093/geront/47.2.215; World Health Organization, 2013, GLOB STAT REP ROAD S	34	8	8	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2418	2424		10.1089/neu.2018.5707		JUL 2018	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000438238600001	29737227				2022-02-06	
J	Si, B; Dumkrieger, G; Wu, T; Zafonte, R; Valadka, AB; Okonkwo, DO; Manley, GT; Wang, LJ; Dodick, DW; Schwedt, TJ; Li, J				Si, Bing; Dumkrieger, Gina; Wu, Teresa; Zafonte, Ross; Valadka, Alex B.; Okonkwo, David O.; Manley, Geoffrey T.; Wang, Lujia; Dodick, David W.; Schwedt, Todd J.; Li, Jing			Sub-classifying patients with mild traumatic brain injury: A clustering approach based on baseline clinical characteristics and 90-day and 180-day outcomes	PLOS ONE			English	Article							POST-CONCUSSION SYMPTOMS; HEAD-INJURY; PREDICTION; POLYMORPHISM; SELECTION; SCALE	Background The current classification of traumatic brain injury (TBI) into "mild", "moderate", or "severe" does not adequately account for the patient heterogeneity that still exists within each of these categories. The objective of this study was to identify "sub-groups" of mild TBI (mTBI) patients based on data available at the time of the initial post-TBI patient evaluation and to determine if the sub-grouping correlates with patient outcomes at 90 and 180 days post-TBI. Methods Data from patients in the TRACK-TBI Pilot dataset who had a Glasgow Coma Scale (GCS) score of 13 to 15 at arrival to the Emergency Department and a closed head injury were included. Considering 53 clinical variables that are typically available during the initial evaluation of the patient with mild TBI, sparse heirarchial clustering with cluster quality assessment was used to identify the optimal number of patient sub-groups. Patient sub-groups were then compared for ten outcomes measured at 90 or 180 days post-TBI. Results Amongst the 485 patients with mTBI, optimal clustering was based on the inclusion of 12 clinical variables that divided the patients into 5 mild TBI sub-groups. Clinical variables driving the sub-clustering included: gender, employment status, marital status, TBI due to falling, brain CT scan result, systolic blood pressure, diastolic blood pressure, administration of IV fluids in the Emergency Department, alcohol use, tobacco use, history of neurologic disease, and history of psychiatric disease. These 5 mild TBI sub-groups differed in their 90 day and 180 day outcomes within several domains including global outcomes, persistence of TBI-related symptoms, and neuropsychological impairment. Conclusions Sub-groups of patients with mTBI can be identified according to clinical variables that are relatively easy to obtain at the time of initial patient evaluation. A patient's sub-group assignment is associated with multidimensional patient outcomes at 90 and 180 days. These findings support the notion that there are clinically meaningful subgroups of patients amongst those currently classified as having mTBI.	[Si, Bing; Dumkrieger, Gina; Wu, Teresa; Wang, Lujia; Li, Jing] Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Tempe, AZ 85287 USA; [Dumkrieger, Gina; Dodick, David W.; Schwedt, Todd J.] Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA; [Zafonte, Ross] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Massachusetts Gen Hosp,Brigham & Womens Hosp, Boston, MA USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA		Li, J (corresponding author), Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Tempe, AZ 85287 USA.; Schwedt, TJ (corresponding author), Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA.	schwedt.todd@mayo.edu; jing.li.8@asu.edu		Dumkrieger, Gina/0000-0001-9519-5370; Schwedt, Todd/0000-0002-7780-7086	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [NIHR21HD089035, NIH R21HD089035]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD089035] Funding Source: NIH RePORTER	TJS JL, DWD, TW, and RZ received funding for this research from NIHR21HD089035 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NIH R21HD089035 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cnossen MC, 2017, J NEUROTRAUMA; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39; HAMILITON BB, 1994, PHYS THER, V74, P494, DOI 10.1093/ptj/74.5.494; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Kapp AV, 2007, BIOSTATISTICS, V8, P9, DOI 10.1093/biostatistics/kxj029; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Mitrishina MB, 2005, HDB NORMATIVE DATA N; Nelson L.D., 2017, J NEUROTRAUM, V34; Reitan R, 1986, TRAIL MAKING TEST MA; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; TEASDALE G, 1974, LANCET, V2, P81; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winkler EA, 2017, J CLIN NEUROSCI, V35, P109, DOI 10.1016/j.jocn.2016.09.017; Witten DM, 2010, J AM STAT ASSOC, V105, P713, DOI 10.1198/jasa.2010.tm09415; Wolfson, 1993, HALSTEAD REITAN NEUR; Yue JK, 2017, NEUROGENETICS, V18, P29, DOI 10.1007/s10048-016-0500-6; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zabora J, 2001, PSYCHOSOMATICS, V42, P241, DOI 10.1176/appi.psy.42.3.241	32	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0198741	10.1371/journal.pone.0198741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	WOS:000438388800012	29995912	gold, Green Submitted, Green Published			2022-02-06	
J	van Eijck, M; van der Naalt, J; de Jongh, M; Schoonman, G; Oldenbeuving, A; Peluso, J; de Vries, J; Roks, G				van Eijck, Marleen; van der Naalt, Joukje; de Jongh, Mariska; Schoonman, Guus; Oldenbeuving, Annemarie; Peluso, Jo; de Vries, Jolanda; Roks, Gerwin			Patients with Diffuse Axonal Injury Can Recover to a Favorable Long-Term Functional and Quality of Life Outcome	JOURNAL OF NEUROTRAUMA			English	Article						DAI; GOSE; HRQL; QOLIBRI; TBI	TRAUMATIC BRAIN-INJURY; LONGITUDINAL MRI; CORPUS-CALLOSUM; LESIONS; PROGNOSIS; MODERATE; PREDICTION; SCALE	Functional outcome and quality of life are difficult to predict in patients with diffuse axonal injury (DAI) after traumatic brain injury (TBI). The primary aim of this cross-sectional cohort study was to assess the long-term functional outcome in patients with DAI and to identify prognostic factors. Second, health-related quality of life (HRQL) at long-term follow-up was assessed. Patients >= 16 years of age with TBI and DAI (admitted 2008-2014) were included. Clinical and imaging data were collected. The primary outcome parameter was the Glasgow Outcome Scale Extended (GOSE) at long-term follow-up. Second, the HRQL was assessed with the Quality Of Life after Brain Injury (QOLIBRI) questionnaire. DAI was diagnosed in 185 patients. Long-term functional outcome was obtained in 134 patients (72%), median follow-up was 54 months (range 14-100); and 51% had a favorable outcome (GOSE 6-8). Independent prognostic factors were age, pupillary reaction, Hb, DAI grading, and return of consciousness <= 7 days. Sixty-two percent had a good HRQL, after a median follow-up of 57 months (range 14-100) with age as an independent prognostic factor. More than half of patients with DAI had a favorable functional outcome and a good HRQL at long-term follow-up. Also in patients with a DAI grade 3, a favorable outcome was seen. HRQL is a clinically relevant outcome measure because it reflects perceived outcome by patients. Independent prognostic variables for functional outcome were factors obtained in the acute phase after injury, whereas age was an independent prognostic factor for HRQL.	[van Eijck, Marleen; de Jongh, Mariska; Schoonman, Guus; de Vries, Jolanda; Roks, Gerwin] Elisabeth Tweesteden Hosp, Trauma TopCare, Tilburg, Netherlands; [van Eijck, Marleen; Schoonman, Guus; Roks, Gerwin] Elisabeth Tweesteden Hosp, Dept Neurol, Hilvarenbeekseweg 60, NL-5022 GC Tilburg, Netherlands; [Oldenbeuving, Annemarie] Elisabeth Tweesteden Hosp, Dept Intens Care, Tilburg, Netherlands; [Peluso, Jo] Elisabeth Tweesteden Hosp, Dept Radiol, Tilburg, Netherlands; [de Vries, Jolanda] Elisabeth Tweesteden Hosp, Dept Med Psychol, Tilburg, Netherlands; [van der Naalt, Joukje] Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [de Jongh, Mariska] Brabant Trauma Registry, Network Emergency Care Brabant, Tilburg, Netherlands; [de Vries, Jolanda] Tilburg Univ, CoRPS, Dept Med & Clin Psychol, Tilburg, Netherlands		van Eijck, M (corresponding author), Elisabeth Tweesteden Hosp, Dept Neurol, Hilvarenbeekseweg 60, NL-5022 GC Tilburg, Netherlands.; van Eijck, M (corresponding author), Elisabeth Tweesteden Ziekenhuis, Dept Trauma TopCare, Hilvarenbeekseweg 60, NL-5022 GC Tilburg, Netherlands.	m.vaneijck@etz.nl		van der Naalt, Joukje/0000-0001-9873-2418	Dutch organization for health research and care innovation (ZonMW) section TopCare projects [842004002]	We thank Joyce Brust, research assistant, for her help with contacting patients and gathering long-term follow-up data. Also, we thank Leonie de Munter for her practical assistance in the use of the statistical analyses. This work was supported by a grant of the Dutch organization for health research and care innovation (ZonMW) section TopCare projects, grant number 842004002. The funding source had no role in the design, collection, analysis, interpretation, or publication of the data.	Baruch Y, 1999, HUM RELAT, V52, P421, DOI 10.1177/001872679905200401; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; Chung SW, 2012, J KOREAN NEUROSURG S, V52, P377, DOI 10.3340/jkns.2012.52.4.377; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gu L, 2013, J TRAUMA ACUTE CARE, V74, P242, DOI 10.1097/TA.0b013e3182684fe8; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lin YN, 2016, J NEUROTRAUM, V33, P1363, DOI 10.1089/neu.2015.4094; Luccichenti G, 2010, FUNCT NEUROL, V25, P109; Matsukawa H, 2011, J NEUROSURG, V115, P1019, DOI 10.3171/2011.6.JNS11513; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Rosa CM, 2011, J TRAUMA, V70, P447, DOI 10.1097/TA.0b013e3182095e14; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Steyerberg EW, 2009, CLIN PREDICTION MODE, P113; Twisk J., 2014, INLEIDING TOEGEPASTE; van Eijck M.M., BRAIN INJURY, V32, P385; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; Yanagawa Y, 2009, J TRAUMA, V66, P162, DOI 10.1097/TA.0b013e3181469857; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501	37	8	8	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2357	2364		10.1089/neu.2018.5650		JUL 2018	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000437231300001	29774826	Green Submitted			2022-02-06	
J	Bell, ED; Converse, M; Mao, HJ; Unnikrishnan, G; Reifman, J; Monson, KL				Bell, E. David; Converse, Matthew; Mao, Haojie; Unnikrishnan, Ginu; Reifman, Jaques; Monson, Kenneth L.			Material Properties of Rat Middle Cerebral Arteries at High Strain Rates	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						traumatic brain injury; blast injury; blood vessel mechanical properties; high strain rate testing	TRAUMATIC BRAIN-INJURY; FAILURE PROPERTIES; SUBFAILURE; HEAD	Traumatic brain injury (TBI), resulting from either impact-or nonimpact blast-related mechanisms, is a devastating cause of death and disability. The cerebral blood vessels, which provide critical support for brain tissue in both health and disease, are commonly injured in TBI. However, little is known about how vessels respond to traumatic loading, particularly at rates relevant to blast. To better understand vessel responses to trauma, the objective of this project was to characterize the high-rate response of passive cerebral arteries. Rat middle cerebral arteries (MCAs) were isolated and subjected to high-rate deformation in the axial direction. Vessels were perfused at physiological pressures and stretched to failure at strain rates ranging from approximately 100 to 1300 s(-1). Although both in vivo stiffness and failure stress increased significantly with strain rate, failure stretch did not depend on rate.	[Bell, E. David; Monson, Kenneth L.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Converse, Matthew; Monson, Kenneth L.] Univ Utah, Dept Mech Engn, 1495 E 100 S,MEK 1550, Salt Lake City, UT 84112 USA; [Mao, Haojie; Unnikrishnan, Ginu; Reifman, Jaques] US Army Med Res & Mat Command, Telemed & Adv Technol Res Ctr, Dept Def, Biotechnol High Performance Comp Software Applica, Frederick, MD 21702 USA		Monson, KL (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.; Monson, KL (corresponding author), Univ Utah, Dept Mech Engn, 1495 E 100 S,MEK 1550, Salt Lake City, UT 84112 USA.	ken.monson@utah.edu	Mao, Haojie/Q-7514-2018	Mao, Haojie/0000-0002-7563-9234	Henry M. Jackson Foundation [W81XWH-14-2-0134]	Henry M. Jackson Foundation (Award No. W81XWH-14-2-0134).	Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Bastien H, 2014, SOFT TISSUE STRAIN R; Bell ED, 2017, J MECH BEHAV BIOMED, V65, P627, DOI 10.1016/j.jmbbm.2016.09.028; Bell ED, 2013, J BIOMECH, V46, P91, DOI 10.1016/j.jbiomech.2012.10.015; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chalupnik J. D., 1971, MAT PROPERTIES CEREB; Coupland RM, 1999, BRIT MED J, V319, P407, DOI 10.1136/bmj.319.7207.407; Cullis I G, 2001, J R Army Med Corps, V147, P16; Delye Hans, 2006, Stapp Car Crash J, V50, P625; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Graham D.I., 1996, NEUROTRAUMA, P43; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; LOWENHIELM P, 1978, J BIOENG, V2, P509; LOWENHIELM P, 1974, Z RECHTSMED, V74, P55, DOI 10.1007/BF01869185; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Meaney D.F., 1990, P 1990 INT IRCOBI C, P215; MOHAN D, 1982, J BIOMECH, V15, P887, DOI 10.1016/0021-9290(82)90055-0; Monea AG, 2014, J MECH BEHAV BIOMED, V32, P155, DOI 10.1016/j.jmbbm.2013.12.007; Monson KL, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002935; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; SAE, 1995, SAE HDB, P384; Stemper BD, 2007, J BIOMECH, V40, P1806, DOI 10.1016/j.jbiomech.2006.07.005; VANLOON P, 1977, BIORHEOLOGY, V14, P181; Zhang Jiangyue, 2008, Biomed Sci Instrum, V44, P129; Zhang JY, 2009, STAPP CAR CRASH JO, V53, P215; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088; Zhang Liying, 2002, Stapp Car Crash J, V46, P145	36	8	8	0	1	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	JUL	2018	140	7							071004	10.1115/1.4039625			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	HQ4DR	WOS:000462360600004	29560495				2022-02-06	
J	Lee, MH; Mitra, B; Pui, JK; Fitzgerald, M				Lee, Matthew Hao; Mitra, Biswadev; Pui, Jiun Kae; Fitzgerald, Mark			The use and uptake of pupillometers in the Intensive Care Unit	AUSTRALIAN CRITICAL CARE			English	Article						Critical care; Critical care nursing; Intensive care units; Pupillometer; Pupil; Neurological Pupil index; Neurosurgery; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; INFRARED PUPILLOMETRY; HEAD-INJURY; LESION; SIZE	Background: Traumatic brain injury (TBI) is a significant public health issue. Assessing pupil reactivity is a crucial aspect of its management and the pupillometer has been shown to be a more objective tool compared to the standard penlight. Its use, however, is not widespread. Objective: To investigate the paucity in uptake, we examined the frequency of use of pupillometers (NeurOptics (R) NPi-100 (TM)) amongst Intensive Care Unit (ICU) doctors and nurses, evaluated its user-friendliness and explored barriers to its use. Design: An online cross-sectional survey. Methods: Surveys were distributed five months after the introduction of pupillometers (in May 2015) to ICU doctors and nurses working in a quaternary referral centre providing state services for trauma. The survey included sections on: questions on demographics and experience, methods of conventional pupillary assessment in patients with TBI, experience of using the pupillometer, and questions on barriers to its use. Responses were collated as discrete variables and summarised using counts and proportions. Comparisons among proportions were undertaken using the chi-squared test and reported with 95% confidence intervals. Results: A total of 79 responses were recorded, predominantly 94.9% (n = 75) from nursing staff. A total of 50 (63.3%) responders were using the pupillometers, with a mean frequency-of-use rating of 4.67 out of 10 and a mean user-friendliness rating of 6.28 out of 10. There was no association between frequency of use and user-friendliness (p = 0.36). The main identified barriers to its use included a lack of education with regards to its use, a perceived lack of clinical significance, a lack of standardisation of documenting findings, and difficulties with access to disposable patient shields (Smartguards). Conclusions: There was good adoption of the technology in the early phases of ICU implementation with user-friendliness rated favourably. In this paper we identify barriers to use and discuss possible solutions to increase clinical utility. (C) 2017 Australian College of Critical Care Nurses Ltd. Published by Elsevier Ltd. All rights reserved.	[Lee, Matthew Hao; Mitra, Biswadev; Pui, Jiun Kae; Fitzgerald, Mark] Alfred Hlth, 55 Commercial Rd, Melbourne, Vic, Australia; [Mitra, Biswadev; Fitzgerald, Mark] Natl Trauma Res Inst, 85-89 Commercial Rd, Melbourne, Vic, Australia		Lee, MH (corresponding author), Alfred Hlth, 55 Commercial Rd, Melbourne, Vic, Australia.	matthewhaolee@gmail.com; biswadev.mitra@monash.edu; jkpui1@gmail.com; m.fitzgerald@alfred.org.au	Mitra, Biswadev/AAC-3724-2019	Mitra, Biswadev/0000-0002-0508-2450; Fitzgerald, Mark/0000-0003-0183-7761			Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; CHESNUT RM, 1994, NEUROSURGERY, V34, P840, DOI 10.1227/00006123-199405000-00008; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; de Veer AJE, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-67; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Kerr RG, 2016, AM J CRIT CARE, V25, P213, DOI 10.4037/ajcc2016554; Larson MD, 2015, ANESTH ANALG, V120, P1242, DOI 10.1213/ANE.0000000000000314; Litvan I, 2000, NEUROLOGY, V54, P530, DOI 10.1212/WNL.54.2.530; Manley GT, 2002, J NEUROSURG ANESTH, V14, P223, DOI 10.1097/00008506-200207000-00009; Martinez-Ricarte F, 2013, NEUROLOGIA, V28, P41, DOI 10.1016/j.nrl.2010.07.028; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; NeurOptics, PUP FREQ ASK QUEST; Olson DM, 2016, NEUROCRIT CARE, V24, P251, DOI 10.1007/s12028-015-0182-1; Olson DM, 2016, CRIT CARE NURS CLIN, V28, P101, DOI 10.1016/j.cnc.2015.09.003; Park JG, 2015, J KOREAN NEUROSURG S, V58, P363, DOI 10.3340/jkns.2015.58.4.363; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; Zhao W, 2015, INTERRATER RELIABILI	19	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1036-7314	1878-1721		AUST CRIT CARE	Aust. Crit. Care	JUL	2018	31	4					199	203		10.1016/j.aucc.2017.06.003			5	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	GK8OA	WOS:000436484500003	28728875				2022-02-06	
J	Martin, JV; Liberati, DM; Diebel, LN				Martin, Jonathan V.; Liberati, David M.; Diebel, Lawrence N.			Excess sodium is deleterious on endothelial and glycocalyx barrier function: A microfluidic study	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	31st Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma (EAST)	JAN 09-13, 2018	Lake Buena Vista, FL	Eastern Assoc Surg Trauma		Hypernatremia; glycocalyx degradation; human umbilical vein endothelial cell; microfluidics; endotheliopathy	TRAUMATIC BRAIN-INJURY; HYPERTONIC SALINE; ACQUIRED HYPERNATREMIA; FLUID RESUSCITATION; HEMORRHAGIC-SHOCK; COAGULATION; MORTALITY; RATS; ENAC	BACKGROUND Hypernatremia is a common problem affecting critically ill patients, whether due to underlying pathology or the subsequent result of hypertonic fluid resuscitation. Numerous studies have been published, suggesting that hypernatremia may adversely affect the vascular endothelial glycocalyx. Our study aimed to evaluate if high sodium concentration would impair the endothelial and glycocalyx barrier function and if stress conditions that simulate the shock microenvironment would exacerbate any observed adverse effects of hypernatremia. METHODS Human umbilical vein endothelial cells (HUVEC) were cultured in microfluidic channels subjected to flow conditions overnight to stimulate glycocalyx growth. Cells were then subjected to sodium (Na+) concentrations of either 150 mEq/L or 160 mEq/L, with Hepes solution applied to media to maintain physiologic pH. Subsets of HUVEC were also exposed to hypoxia/reoxygenation and epinephrine (HR + Epi) to simulate shock insult, then followed by Na+ treatment. Perfusate was then collected 60 minutes and 120 minutes following treatments. Relevant biomarkers were then evaluated and HUVEC underwent fluorescent staining followed by microscopy. RESULTS Glycocalyx degradation as indexed by hyaluronic acid and syndecan-1 was elevated in all subgroups, particularly those subjected to HR + Epi with Na+ 160 mEq/L. Thickness of the glycocalyx as evaluated by fluorescent microscopy was reduced to half of baseline with Na+ 160 mEq/L and to one third of baseline with additional insult of HR + Epi. Endothelial activation/injury as indexed by soluble thrombomodulin was elevated in all subgroups. A profibrinolytic coagulopathy phenotype was demonstrated in all subgroups with increased tissue plasminogen activator levels and decreased plasminogen activator inhibitor-1 levels. CONCLUSION Our data suggest that hypernatremia results in degradation of the endothelial glycocalyx with further exacerbation by shock conditions. A clinical study using clinical measurements of the endothelial glycocalyx in critically ill or injured patients with acquired hypernatremia would be warranted.	[Martin, Jonathan V.; Liberati, David M.; Diebel, Lawrence N.] Wayne State Univ, Sch Med, Michael & Marian Ilitch Dept Surg, Detroit, MI USA		Diebel, LN (corresponding author), Univ Hlth Ctr, Michael & Marian Ilitch Dept Surg, 6C,4201 St Antoine, Detroit, MI 48201 USA.	ldiebel@med.wayne.edu					Alansari MA, 2016, SAUDI J ANAESTH, V10, P409, DOI 10.4103/1658-354X.177327; Basile-Filho Anibal, 2016, J Clin Med Res, V8, P141, DOI 10.14740/jocmr2425w; Blanchard IE, 2017, BMC EMERG MED, V17, DOI 10.1186/s12873-017-0146-1; Ciesla DJ, 2000, J TRAUMA, V48, P388, DOI 10.1097/00005373-200003000-00004; de Crescenzo C, 2017, J TRAUMA ACUTE CARE, V82, P956, DOI 10.1097/TA.0000000000001409; Dekker SE, 2014, SURGERY, V156, P556, DOI 10.1016/j.surg.2014.04.016; Delano MJ, 2015, SHOCK, V44, P25, DOI 10.1097/SHK.0000000000000368; Diebel LN, 2017, J TRAUMA ACUTE CARE; Donati A, 2013, MICROVASC RES, V90, P86, DOI 10.1016/j.mvr.2013.08.007; Funk GC, 2010, INTENS CARE MED, V36, P304, DOI 10.1007/s00134-009-1692-0; Gucyetmez B, 2014, MINERVA ANESTESIOL, V80, P1096; Johansson P, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1605-5; Korte S, 2014, FASEB J, V28, P4015, DOI 10.1096/fj.14-250282; Korte S, 2012, PFLUG ARCH EUR J PHY, V463, P269, DOI 10.1007/s00424-011-1038-y; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Kusche-Vihrog K, 2014, PFLUG ARCH EUR J PHY, V466, P851, DOI 10.1007/s00424-013-1356-3; Lansink-Hartgring AO, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0124-x; Liao JM, 2013, J SURG RES, V183, P546, DOI 10.1016/j.jss.2012.05.057; Lindner G, 2013, J CRIT CARE, V28, P216; Madsen CM, 2016, OSTEOPOROSIS INT, V27, P397, DOI 10.1007/s00198-015-3423-4; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; McDonald KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167576; Namdar T, 2010, GER MED SCI, V8; Naumann DN, 2018, J TRAUMA ACUTE CARE, V84, P81, DOI 10.1097/TA.0000000000001695; Nicolini EA, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006182; Oberleithner H, 2007, P NATL ACAD SCI USA, V104, P16281, DOI 10.1073/pnas.0707791104; Oberleithner H, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00188; Oberleithner H, 2012, ANN MED, V44, pS143, DOI 10.3109/07853890.2011.653397; Oberleithner H, 2011, PFLUG ARCH EUR J PHY, V462, P519, DOI 10.1007/s00424-011-0999-1; Petroni RC, 2015, SHOCK, V44, P609, DOI 10.1097/SHK.0000000000000461; Potter DR, 2008, CIRC RES, V102, P770, DOI 10.1161/CIRCRESAHA.107.160226; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Sen A, 2017, CRIT CARE MED, V45, pE146, DOI 10.1097/CCM.0000000000002063; Shah SK, 2011, J SURG RES, V166, P120, DOI 10.1016/j.jss.2009.09.010; Torres LN, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1745-7; Toung TJ, 2008, CRIT CARE MED, V36, P256, DOI 10.1097/01.CCM.0000295306.52783.1E; Tsvirkun D, 2017, SCI REP-UK, V7, DOI 10.1038/srep45036; Tuma M, 2016, SHOCK, V46, P352, DOI 10.1097/SHK.0000000000000635; Vedantam A, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17418; Waite MD, 2013, J CRIT CARE, V28, P405, DOI 10.1016/j.jcrc.2012.11.013; Wang HF, 2017, AM J EMERG MED, V35, P1404, DOI 10.1016/j.ajem.2017.04.020	41	8	9	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2018	85	1					128	134		10.1097/TA.0000000000001892			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	GL8GZ	WOS:000437457000019	29538236				2022-02-06	
J	Palm, NM; McKinzie, B; Ferguson, PL; Chapman, E; Dorlon, M; Eriksson, EA; Jewett, B; Leon, SM; Privette, AR; Fakhry, SM				Palm, Nicole M.; McKinzie, Brian; Ferguson, Pamela L.; Chapman, Emily; Dorlon, Margaret; Eriksson, Evert A.; Jewett, Brent; Leon, Stuart M.; Privette, Alicia R.; Fakhry, Samir M.			Pharmacologic Stress Gastropathy Prophylaxis May Not Be Necessary in At-Risk Surgical Trauma ICU Patients Tolerating Enteral Nutrition	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						trauma; ICU outcomes; enteral nutrition; stress ulcer prophylaxis; histamine receptor antagonists	INTENSIVE-CARE-UNIT; ULCER PROPHYLAXIS; CRITICALLY-ILL	Objective: Stress gastropathy is a rare complication of the intensive care unit stay with high morbidity and mortality. There are data that support the concept that patients tolerating enteral nutrition have sufficient gut blood flow to obviate the need for prophylaxis; however, no robust studies exist. This study assesses the incidence of clinically significant gastrointestinal bleeding in surgical trauma intensive care unit (STICU) patients at risk of stress gastropathy secondary to mechanical ventilation receiving enteral nutrition without pharmacologic prophylaxis. Design: A retrospective cohort study of records from 2008 to 2013. Setting: Adult patients in a single-center STICU were included. Patients: Patients were included if they received full enteral nutrition while on mechanical ventilation. Exclusion criteria were coagulopathy, glucocorticoid use, prior-to-admission acid-suppressive therapy use, direct trauma or surgery to the stomach, failure to tolerate goal enteral nutrition, orders to allow natural death, and deviation from the intervention. Intervention: Pharmacologic stress ulcer prophylaxis was discontinued once enteral nutrition was providing full caloric requirements for patients requiring mechanical ventilation. Measurements and Main Results: A total of 200 patients were included. The median age was 42 years, 83.0% were male, and 96.0% were trauma patients. The incidence of clinically significant gastrointestinal bleeding was 0.50%, with a subset analysis of traumatic brain injury patients yielding an incidence of 0.68%. Rates of ventilator-associated pneumonia and Clostridium difficile infection were low at 1.0 case/1000 ventilator days and 0.2 events/1000 patient days, respectively. Hospital all-cause mortality was 2.0%. Cost savings of US$121/patient stay were realized. Conclusion: Stress gastropathy is rare in this population. Surgical and trauma patients at risk for stress gastropathy did not benefit from continued pharmacologic prophylaxis once they tolerated enteral nutrition. Pharmacologic prophylaxis may safely be discontinued in this patient population. Further investigation is warranted to determine whether continued prophylaxis after attaining enteral feeding goals is detrimental.	[Palm, Nicole M.] Cleveland Clin, Dept Pharm, 9500 Euclid Ave Hb 105, Cleveland, OH 44195 USA; [McKinzie, Brian] Med Univ South Carolina, Dept Pharm, Charleston, SC USA; [Ferguson, Pamela L.; Dorlon, Margaret; Eriksson, Evert A.; Jewett, Brent; Leon, Stuart M.; Privette, Alicia R.; Fakhry, Samir M.] Med Univ South Carolina, Dept Surg, Charleston, SC USA; [Chapman, Emily] Med Univ South Carolina, Hlth Nutr Serv, Charleston, SC USA		Palm, NM (corresponding author), Cleveland Clin, Dept Pharm, 9500 Euclid Ave Hb 105, Cleveland, OH 44195 USA.	palmn@ccf.org		Palm, Nicole/0000-0002-1668-1061			ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis, 1999, AM J HLTH SYST PHARM, V56, P347, DOI DOI 10.1093/AJHP/56.4.347; COOK DJ, 1994, NEW ENGL J MED, V330, P377, DOI 10.1056/NEJM199402103300601; COOK DJ, 1991, AM J MED, V91, P519, DOI 10.1016/0002-9343(91)90189-5; EPHGRAVE KS, 1990, CRIT CARE MED, V18, P621, DOI 10.1097/00003246-199006000-00009; Hurt RT, 2012, JPEN-PARENTER ENTER, V36, P721, DOI 10.1177/0148607112436978; Kantorova I, 2004, HEPATO-GASTROENTEROL, V51, P757; Krag M, 2013, ACTA ANAESTH SCAND, V57, P835, DOI 10.1111/aas.12099; Marik PE, 2010, CRIT CARE MED, V38, P2222, DOI 10.1097/CCM.0b013e3181f17adf; Michetti CP, 2012, J TRAUMA ACUTE CARE, V72, P1165, DOI 10.1097/TA.0b013e31824d10fa; Stollman N, 2005, J CRIT CARE, V20, P35, DOI 10.1016/j.jcrc.2004.10.003	10	8	8	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	JUL	2018	33	7					424	429		10.1177/0885066616678385			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI4CJ	WOS:000434318300006	27837045				2022-02-06	
J	Sander, AM; Lequerica, AH; Ketchum, JM; Hammond, FM; Gary, KW; Pappadis, MR; Felix, ER; Johnson-Greene, D; Bushnik, T				Sander, Angelle M.; Lequerica, Anthony H.; Ketchum, Jessica M.; Hammond, Flora M.; Gary, Kelli Williams; Pappadis, Monique R.; Felix, Elizabeth R.; Johnson-Greene, Douglas; Bushnik, Tamara			Race/Ethnicity and Retention in Traumatic Brain Injury Outcomes Research: A Traumatic Brain Injury Model Systems National Database Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cultural competency; follow-up studies; traumatic brain injury	FUNCTIONAL INDEPENDENCE MEASURE; POSTTRAUMATIC AMNESIA DURATION; COMMUNITY INTEGRATION; FOLLOW-UP; REHABILITATION RESEARCH; PHYSICAL-ACTIVITY; PRIMARY-CARE; RECRUITMENT; HEALTH; STRATEGIES	Objective: To investigate the contribution of race/ethnicity to retention in traumatic brain injury (TBI) research at 1 to 2 years postinjury. Setting: Community. Participants: With dates of injury between October 1, 2002, and March 31, 2013, 5548 whites, 1347 blacks, and 790 Hispanics enrolled in the Traumatic Brain Injury Model Systems National Database. Design: Retrospective database analysis. Main Measure: Retention, defined as completion of at least 1 question on the follow-up interview by the person with TBI or a proxy. Results: Retention rates 1 to 2 years post-TBI were significantly lower for Hispanic (85.2%) than for white (91.8%) or black participants (90.5%) and depended significantly on history of problem drug or alcohol use. Other variables associated with low retention included older age, lower education, violent cause of injury, and discharge to an institution versus private residence. Conclusions: The findings emphasize the importance of investigating retention rates separately for blacks and Hispanics rather than combining them or grouping either with other races or ethnicities. The results also suggest the need for implementing procedures to increase retention of Hispanics in longitudinal TBI research.	[Sander, Angelle M.] Baylor Coll Med, Harris Hlth Syst & Brain Injury Res Ctr, TIRR Mem Hermann, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Baylor Coll Med, Harris Hlth Syst & Brain Injury Res Ctr, TIRR Mem Hermann, Dept Psychiat, Houston, TX 77030 USA; [Lequerica, Anthony H.] Kessler Fdn, W Orange, NJ USA; [Lequerica, Anthony H.] Rutgers New Jersey Med Sch, W Orange, NJ USA; [Ketchum, Jessica M.] Craig Hosp, Englewood, CO USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Gary, Kelli Williams] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23284 USA; [Gary, Kelli Williams] Virginia Commonwealth Univ, Dept Neuropsychol & Occupat Therapy, Richmond, VA 23284 USA; [Pappadis, Monique R.] Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX 77555 USA; [Pappadis, Monique R.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Felix, Elizabeth R.; Johnson-Greene, Douglas] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Bushnik, Tamara] NYU, Langone Sch Med, Rusk Rehabil, New York, NY USA		Sander, AM (corresponding author), TIRR Mem Hermann Res Ctr, 1333 Moursund St, Houston, TX 77030 USA.	asander@bcm.edu	Ketchum, Jessica/AAE-8200-2020; Felix, Elizabeth/AAD-6356-2021	Felix, Elizabeth/0000-0002-6239-715X; Bushnik, Tamara/0000-0003-3328-257X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DPTB0016, 90DP0028, 90DP0060, 90RT5007, 90DP0032, 90DP0034, 90DP0084, 90DP0036, 90DP0046, 90DP0047, 90DP0033]; Agency for Healthcare Research and Quality (AHRQ)United States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R24HS022134]; UTMB Claude D. Pepper Older Americans Independence Center - National Institute on Aging (NIA) [5P30-AG024832]; UTMB Institute for Translational Sciences - National Institutes of Health (NIH) Clinical and Translational Science Award [UL1RR029876]; National Institute on Minority Health and Health Disparities (NIMHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [L60 MD009326]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R24HS022134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG024832] Funding Source: NIH RePORTER	The contents of this publication were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant numbers 90DPTB0016, 90DP0028, 90DP0060, and 90RT5007 [TIRR], 90DP0032 [Kessler], 90DP0034 and 90DP0084 [Craig], 90DP0036 [Indiana], 90DP0046 [Miami], 90DP0047 [New York], and 90DP0033 [Virginia]); the Agency for Healthcare Research and Quality (AHRQ grant number R24HS022134); UTMB Claude D. Pepper Older Americans Independence Center funded by the National Institute on Aging (NIA grant number 5P30-AG024832); the UTMB Institute for Translational Sciences supported by a National Institutes of Health (NIH) Clinical and Translational Science Award (UL1RR029876), and the National Institute on Minority Health and Health Disparities (NIMHD) contract number L60 MD009326 [Dr Pappadis]. NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy or official views of NIDILRR, ACL, AHRQ, NIA, NIH, or HHS, and you should not assume endorsement by the Federal Government.	Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Arango-Lasprilla JC, 2001, PM&R, V3, P1083; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Bell KR, 2008, AM J PHYS MED REHAB, V87, P330, DOI 10.1097/PHM.0b013e318168d092; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bhamra S, 2008, QUAL AGEING OLDER AD, V9, P27, DOI 10.1108/14717794200800025; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Carroll JK, 2011, TRANSL BEHAV MED, V1, P234, DOI 10.1007/s13142-011-0034-2; Centers for Disease Control and Prevention, 1998, BEH RISK FACT SURV S; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dismuke CE, 2016, GLOB J HLTH SCI, V8, P260; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Eakin EG, 2007, HEALTH EDUC RES, V22, P361, DOI [10.1093/her/cyl095, 10.1093/het/cyl095]; Ejiogu N, 2011, GERONTOLOGIST, V51, pS33, DOI 10.1093/geront/gnr027; Fleming J, 2014, J HEAD TRAUMA REHAB, V29, P125, DOI 10.1097/HTR.0b013e318286545d; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Haack LM, 2014, J CHILD FAM STUD, V23, P410, DOI 10.1007/s10826-012-9689-7; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jamison L, 2012, BRAIN INJURY, V26, P805, DOI 10.3109/02699052.2012.655367; Jourdan C, 2016, J HEAD TRAUMA REHAB, V31, pE42, DOI 10.1097/HTR.0000000000000147; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Ketchum JM, 2012, NEUROREHABILITATION, V30, P13, DOI 10.3233/NRE-2011-0723; Krellman JW, 2014, ARCH PHYS MED REHAB, V95, P633, DOI 10.1016/j.apmr.2013.10.016; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Martinez CR, 2012, PREV SCI, V13, P15, DOI 10.1007/s11121-011-0239-0; Mascialino G, 2009, NEUROREHABILITATION, V24, P29, DOI 10.3233/NRE-2009-0451; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Ojeda L, 2011, HISPANIC J BEHAV SCI, V33, P184, DOI 10.1177/0739986311402626; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Paskett ED, 2008, CONTEMP CLIN TRIALS, V29, P847, DOI 10.1016/j.cct.2008.07.006; Radler BT, 2010, J AGING HEALTH, V22, P307, DOI 10.1177/0898264309358617; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Sankare IC, 2015, CTS-CLIN TRANSL SCI, V8, P412, DOI 10.1111/cts.12273; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; *SUBST AB MENT HLT, 1998, NAT HOUS SURV DRUG A; Traumatic Brain Injury Model Systems National Data and Statistical Center, 2017, TRAUM BRAIN INJ MOD; Traumatic Brain Injury Model Systems National Data and Statistical Center, 2016, H133A110006 TRAUM BR; US Census Bureau, 2016, ANN EST RES POP SEX; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570	48	8	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2018	33	4					219	227		10.1097/HTR.0000000000000395			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GR6GT	WOS:000442745900008	29863614	Green Accepted, Green Submitted			2022-02-06	
J	Velt, KB; Cnossen, M; Rood, PPM; Steyerberg, EW; Polinder, S; Lingsma, HF				Velt, Kimberley Bernadette; Cnossen, Maryse; Rood, Pleunie P. M.; Steyerberg, Ewout W.; Polinder, Suzanne; Lingsma, Hester F.		CENTER-TBI Investigators	Emergency department overcrowding: a survey among European neurotrauma centres	EMERGENCY MEDICINE JOURNAL			English	Article						emergency department; quality; crowding		BackgroundED overcrowding is an increasing problem worldwide that may negatively affect quality of care and patient outcomes. We aimed to study ED overcrowding across European centres.MethodsQuestionnaires on structure and process of care, including crowding, were distributed to 68 centres participating in a large European study on traumatic brain injury (Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury).ResultsOf the 65 centres included in the analysis, 32 (49%) indicated that overcrowding was a frequent problem and 28 (43%) reported that patients were placed in hallways multiple times a day'; 27 (41%) stated that multiple times a day, there was no bed available when a patient needed to be admitted. Ambulance diversion rarely occurred in the participating centres.ConclusionSimilar to reports from other parts of the world, ED crowding appears to be a considerable problem in Europe. More research is needed to determine effective ways to reduce overcrowding.	[Velt, Kimberley Bernadette; Cnossen, Maryse; Steyerberg, Ewout W.; Polinder, Suzanne; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, NL-3015 CN Rotterdam, Netherlands; [Rood, Pleunie P. M.] Erasmus MC, Dept Emergency Med, Rotterdam, Netherlands		Velt, KB (corresponding author), Erasmus MC, Dept Publ Hlth, NL-3015 CN Rotterdam, Netherlands.	m.c.cnossen@erasmusmc.nl			European Commission 7th Framework ProgrammeEuropean Commission [602150]	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Commission 7th Framework Programme (602150).	Australasian College for Emergency Medicine, 2002, Emerg Med (Fremantle), V14, P337; Bernstein SL, 2009, ACAD EMERG MED, V16, P1, DOI 10.1111/j.1553-2712.2008.00295.x; Bond Kenneth, 2007, Healthc Q, V10, P32; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Derlet RW, 2001, ACAD EMERG MED, V8, P151, DOI 10.1111/j.1553-2712.2001.tb01280.x; Hwang U, 2004, ACAD EMERG MED, V11, P1097, DOI 10.1197/j.aem.2004.07.004; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Richardson DB, 2009, MED J AUSTRALIA, V190, P369, DOI 10.5694/j.1326-5377.2009.tb02451.x	8	8	9	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JUL	2018	35	7					447	448		10.1136/emermed-2017-206796			2	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GO2XS	WOS:000439844900009	29563151	Green Submitted			2022-02-06	
J	Yin, G; Du, MJ; Li, R; Li, K; Huang, XM; Duan, DB; Ai, XL; Yao, F; Zhang, LL; Hu, ZY; Wu, BY				Yin, Guo; Du, Mingjun; Li, Rong; Li, Ke; Huang, Xiaomin; Duan, Dongbei; Ai, Xiaolan; Yao, Fang; Zhang, Lanlan; Hu, Ziyou; Wu, Bingyi			Glia maturation factor beta is required for reactive gliosis after traumatic brain injury in zebrafish	EXPERIMENTAL NEUROLOGY			English	Article						Glia maturation factor beta; Reactive gliosis; Traumatic brain injury; Radial glial cells; Microglia	FIBRILLARY ACIDIC PROTEIN; REGENERATIVE RESPONSE; ADULT NEUROGENESIS; EXPRESSION; PROLIFERATION; CELLS; GMF; INFLAMMATION; INDUCTION; REGULATOR	Gliosis is a hallmark of neural pathology that occurs after most forms of central nervous system (CNS) injuries including traumatic brain injury (TBI). Identification of genes that control gliosis may provide novel treatment targets for patients with diverse CNS injuries. Glia maturation factor beta (GMFB) is crucial in brain development and stress response. In the present study, GMFB was found to be widely expressed in adult zebrafish telencephalon. A gmfb mutant zebrafish was created using CRISPR/cas9. In the uninjured zebrafish telencephalon, glial fibrillary acidic protein (GFAP) fibers in gmfb mutants were disorganized and shorter than wild type zebrafish. After TBI, transformation of quiescent type I radial glial cells (RGC) to proliferative type II RGCs was significantly suppressed in the gmfb mutant. RGC proliferation and hypertrophy post-TBI was reduced in gmfb mutants, indicating that reactive gliosis was attenuated. TBI-induced acute inflammation was also found to be alleviated in the gmfb mutant. Morphological changes also suggest attenuation of microglial reactive gliosis. In a mouse model of TBI, GMFB expression was increased around the injury site. These GMFB + cells were identified as astrocytes and microglia. Taken together, the data suggests that GMFB is not only required for normal development of GFAP fibers in the zebrafish telencephalon, but also promotes reactive gliosis after TBI. Our findings provide novel information to help better understand the reactive gliosis process following TBI.	[Yin, Guo; Du, Mingjun; Li, Ke; Huang, Xiaomin; Duan, Dongbei; Ai, Xiaolan; Yao, Fang; Zhang, Lanlan; Hu, Ziyou; Wu, Bingyi] Southern Med Univ, Nanfang Hosp, Res Ctr Clin Med, Guangzhou 510515, Guangdong, Peoples R China; [Li, Rong] Guangzhou Med Univ, Affiliated Canc Hosp, Dept Radiat Oncol, 78 Hengzhigang Rd, Guangzhou 510095, Guangdong, Peoples R China		Wu, BY (corresponding author), Southern Med Univ, Nanfang Hosp, Res Ctr Clin Med, Guangzhou 510515, Guangdong, Peoples R China.	wubingyi66@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771340]; President Foundation of Nanfang Hospital [2015C003]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2017M622666]	This study was funded by National Natural Science Foundation of China (Grant number: 81771340), the President Foundation of Nanfang Hospital (No. 2015C003) and the China Postdoctoral Science Foundation (2017M622666).	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Bahary N, 2004, METHOD CELL BIOL, V77, P305; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; BOSCH EP, 1984, BRAIN RES, V304, P311, DOI 10.1016/0006-8993(84)90335-4; BOSCH EP, 1989, J NEUROSCI, V9, P3690; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Chen Y, 2008, IEEE T MULTIMEDIA, V10, P2, DOI 10.1109/TMM.2007.911223; Dined G. C., 2017, J INT MED RES, P1, DOI [10.1177/0300060517700320, DOI 10.1177/0300060517700320]; Gandhi M, 2010, CURR BIOL, V20, P861, DOI 10.1016/j.cub.2010.03.026; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Grupp L, 2010, J COMP NEUROL, V518, P4277, DOI 10.1002/cne.22481; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hotta N, 2005, MOL BRAIN RES, V133, P71, DOI 10.1016/j.molbrainres.2004.09.027; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; ITO JI, 1990, NEUROCHEM INT, V16, P133, DOI 10.1016/0197-0186(90)90080-D; ITO JI, 1986, BRAIN RES, V374, P335, DOI 10.1016/0006-8993(86)90427-0; KELES GE, 1992, ONCOL RES, V4, P431; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; LIM R, 1989, P NATL ACAD SCI USA, V86, P3901, DOI 10.1073/pnas.86.10.3901; LIM RM, 1990, FASEB J, V4, P3360, DOI 10.1096/fasebj.4.15.2253851; Lindsey BW, 2012, J COMP NEUROL, V520, P2275, DOI 10.1002/cne.23065; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; McNeill RS, 2014, JOVE-J VIS EXP, DOI [10.3791/51753, 10.3791/51763]; Nakano K, 2010, CYTOSKELETON, V67, P373, DOI 10.1002/cm.20451; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Schmidt R, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-3; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; WANG BR, 1992, BRAIN RES, V591, P1, DOI 10.1016/0006-8993(92)90971-B; Westerfield M., 2000, GUIDE LAB USE ZEBRAF; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; YAMAKAWA Y, 1982, BRAIN RES, V251, P291, DOI 10.1016/0006-8993(82)90746-6; Ydenberg CA, 2013, CURR BIOL, V23, P1037, DOI 10.1016/j.cub.2013.04.058; Zaheer A, 2007, BRAIN RES, V1144, P239, DOI 10.1016/j.brainres.2007.01.075; Zaheer S, 2011, NEUROSCIENCE, V194, P227, DOI 10.1016/j.neuroscience.2011.07.069; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zupanc GKH, 2008, J PHYSIOL-PARIS, V102, P357, DOI 10.1016/j.jphysparis.2008.10.007	47	8	10	2	26	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2018	305						129	138		10.1016/j.expneurol.2018.04.008			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH4TN	WOS:000433397500013	29655639				2022-02-06	
J	Fan, YY; Nan, F; Guo, BL; Liao, Y; Zhang, MS; Guo, J; Niu, BL; Liang, YQ; Yang, CH; Zhang, Y; Zhang, XP; Pang, XF				Fan, Yan-Ying; Nan, Fang; Guo, Bao-Lu; Liao, Yan; Zhang, Ming-Sheng; Guo, Jie; Niu, Bao-Long; Liang, Yue-Qin; Yang, Cai-Hong; Zhang, Yi; Zhang, Xuan-Ping; Pang, Xue-Fen			Effects of long-term rapamycin treatment on glial scar formation after cryogenic traumatic brain injury in mice	NEUROSCIENCE LETTERS			English	Article						Rapamycin; Traumatic brain injury; Astrocyte reactivation; Glial scar	REACTIVE ASTROCYTES; MAMMALIAN TARGET; AXONAL REGENERATION; CHONDROITIN SULFATE; CEREBRAL-ISCHEMIA; MTOR PATHWAY; INHIBITION; MODULATION; ROLES; PROLIFERATION	Glial scar impedes axon regeneration and functional recovery following traumatic brain injury (TBI). Although it has been shown that rapamycin (a specific inhibitor of mammalian target of rapamycin) can reduce astrocyte reactivation in the early stage of TBI, its effect on glial scar formation has not been characterized in TBI and other acute brain injury models. To test this, ICR mice received daily administration of rapamycin (0.5 or 1.5 mg/kg, i.p.) beginning at 1 h after cryogenic TBI (cTBI). The results showed that at 3 d post-injury, 1.5 mg/kg rapamycin increased cTBI-induced motor functional deficits and infarct size, and attenuated astrocyte reactivation in the ipsilateral cortex, while 0.5 mg/kg rapamycin did not worsen brain damage and only slightly attenuated astrocyte reactivation. Furthermore, at 7 and 14 d after cTBI, 0.5 mg/kg rapamycin group showed a better motor functional performance than cTBI group. At 14 d post-injury, 0.5 mg/kg rapamycin significantly reduced the area and thickness of glial scar and chondroitin sulfate proteoglycan expression, accompanied by decreased expression of p-S6 and enhanced expression of growth associated protein 43 (an axon regeneration marker) in the region of glial scar. Our data suggest that long-term treatment with rapamycin can inhibit glial scar formation after cTBI, which may be involved in the mechanisms of increased axon regeneration and improved neurological functional recovery, and low-dose rapamycin may be more beneficial for such a therapy.	[Fan, Yan-Ying; Nan, Fang; Guo, Bao-Lu; Liao, Yan; Zhang, Ming-Sheng; Guo, Jie; Liang, Yue-Qin; Yang, Cai-Hong; Zhang, Yi; Zhang, Xuan-Ping] Shanxi Med Univ, Dept Pharmacol, Taiyuan 030001, Shanxi, Peoples R China; [Niu, Bao-Long] Taiyuan Univ Technol, Dept Phys & Chem, Taiyuan 030024, Shanxi, Peoples R China; [Pang, Xue-Fen] Shanxi Med Univ, Dept Physiol, Taiyuan 030001, Shanxi, Peoples R China		Fan, YY (corresponding author), Shanxi Med Univ, Dept Pharmacol, Taiyuan 030001, Shanxi, Peoples R China.	fyanying6@hotmail.com			Shanxi Province Natural Science FoundationNatural Science Foundation of Shanxi Province [2014021038-1, 2014011040-2]; Fund for Shanxi Key Subjects Construction (FSKSC); National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81202520]	This work was sponsored by the Shanxi Province Natural Science Foundation (2014021038-1, 2014011040-2), the Fund for Shanxi Key Subjects Construction (FSKSC) and the National Natural Science Foundation of China (81202520). We thank the Key Laboratory of Cellular Physiology (Shanxi Medical University), China Ministry of Education for technical support.	Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Chen CH, 2016, EXP NEUROL, V278, P27, DOI 10.1016/j.expneurol.2016.01.023; Chi OZ, 2016, NEUROSCI LETT, V620, P132, DOI 10.1016/j.neulet.2016.03.053; Chiba S, 2004, J NEUROL SCI, V219, P107, DOI 10.1016/j.jns.2004.01.006; Codeluppi S, 2009, J NEUROSCI, V29, P1093, DOI 10.1523/JNEUROSCI.4103-08.2009; Crino PB, 2016, NAT REV NEUROL, V12, P379, DOI 10.1038/nrneurol.2016.81; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Goldshmit Y, 2015, MOL CELL NEUROSCI, V68, P82, DOI 10.1016/j.mcn.2015.04.006; Jahan N, 2015, EXP NEUROL, V263, P372, DOI 10.1016/j.expneurol.2014.10.023; Kuo JR, 2010, J TRAUMA, V69, P1467, DOI 10.1097/TA.0b013e3181f31b06; Lee DH, 2014, J NEUROSCI, V34, P15347, DOI 10.1523/JNEUROSCI.1935-14.2014; Li CY, 2015, NEUROCHEM INT, V83-84, P9, DOI 10.1016/j.neuint.2015.03.001; Li HP, 2013, J NEUROTRAUM, V30, P413, DOI 10.1089/neu.2012.2513; Liao RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15356; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nikolaeva I, 2016, J NEUROTRAUM, V33, P183, DOI 10.1089/neu.2015.3899; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Rozas NS, 2015, J NEUROTRAUM, V32, P149, DOI 10.1089/neu.2014.3469; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Shao AW, 2016, MOL NEUROBIOL, V53, P18, DOI 10.1007/s12035-014-8986-0; Shen LH, 2008, GLIA, V56, P1747, DOI 10.1002/glia.20722; Shinozaki Y, 2017, CELL REP, V19, P1151, DOI 10.1016/j.celrep.2017.04.047; Song Q, 2015, MOL MED REP, V12, P7203, DOI 10.3892/mmr.2015.4407; Sun ZG, 2013, NEURAL REGEN RES, V8, P101, DOI 10.3969/j.issn.1673-5374.2013.02.001; Wu HT, 2012, BRAIN RES, V1486, P121, DOI 10.1016/j.brainres.2012.09.039; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113; Zhu YM, 2017, NEUROSCIENCE, V356, P125, DOI 10.1016/j.neuroscience.2017.05.004	31	8	8	1	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 21	2018	678						68	75		10.1016/j.neulet.2018.05.002			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GI9ZE	WOS:000434903300011	29727731				2022-02-06	
J	Merritt, VC; Clark, AL; Sorg, SF; Evangelista, ND; Werhane, M; Bondi, MW; Schiehser, DM; Delano-Wood, L				Merritt, Victoria C.; Clark, Alexandra L.; Sorg, Scott F.; Evangelista, Nicole D.; Werhane, Madeleine; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa			Apolipoprotein E epsilon 4 Genotype Is Associated with Elevated Psychiatric Distress in Veterans with a History of Mild to Moderate Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						APOE gene; genetics; military veterans; psychiatric distress; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; BECK ANXIETY INVENTORY; PSYCHOMETRIC PROPERTIES; PTSD CHECKLIST; APOE GENOTYPE; COMBAT EXPOSURE; GENETIC-FACTORS; HEAD-INJURY; MILITARY	As few studies have examined the relationship between the apolipoprotein E (APOE) gene and clinical outcomes after military-related traumatic brain injury (TBI), we aimed to determine whether the epsilon 4 allele of the APOE gene influences neuropsychiatric symptoms in veterans with a history of mild-to-moderate TBI. Participants included 133 veterans (TBI=79; military controls [MC]=54) who underwent APOE genotyping and were divided into epsilon 4(+) (TBI=18; MC=15) and epsilon 4(-) (TBI=61; MC=39) groups. All participants underwent evaluation of psychological distress using the Beck Depression Inventory-II, Beck Anxiety Inventory, and PTSD Checklist-Military Version. Two-way analyses of variance were conducted to examine the effect of group (TBI vs. MC) and APOE-is an element of 4 status (epsilon 4(+) vs. epsilon 4(-)) across symptom measures. There was a significant main effect of group across all symptom measures (TBI > MC; all p values <0.001), no main effect of epsilon 4 genotype (p=0.152-0.222), and a significant interaction of group by epsilon 4 genotype across all measures (p=0.027-0.047). Specifically, for TBI participants, epsilon 4(+) veterans demonstrated significantly higher symptom scores across all measures when compared to epsilon 4(-) veterans (p=0.007-0.015). For MC participants, epsilon 4 status had no effect on the severity of psychiatric symptom scores (p=0.585-0.708). Our results demonstrate that, in our well-characterized sample of veterans with history of neurotrauma, possession of the epsilon 4 allele conveys risk for increased symptomatology (i.e., depression, anxiety, and post-traumatic stress disorder), even well outside of the acute phase of injury. Findings suggest a meaningful relationship between APOE genotype and psychiatric distress post-TBI, and they suggest that there is a brain basis for the complex neuropsychiatric presentation often observed in this vulnerable population. Future longitudinal studies are needed in order to further our understanding of how genetic factors influence response to TBI.	[Merritt, Victoria C.; Sorg, Scott F.; Evangelista, Nicole D.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa] VA San Diego Healthcare Syst VASDHS, San Diego, CA USA; [Clark, Alexandra L.; Werhane, Madeleine] Univ Calif San Diego, San Diego State Univ, Joint Doctoral Program Clin Psychol, San Diego, CA 92103 USA; [Sorg, Scott F.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa] Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA USA; [Schiehser, Dawn M.; Delano-Wood, Lisa] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA		Delano-Wood, L (corresponding author), VA San Diego Healthcare Syst 151B, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ldelano@ucsd.edu		Merritt, Victoria/0000-0001-5683-4168	Veterans Affairs grants [829-MR-NB-25860, CDA-2-065-10S, CDA-2-CX001508]; Department of DefenseUnited States Department of Defense [W81XWH-10-2-0169]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS09870]	This work was supported by Veterans Affairs grants awarded to Drs. Delano-Wood (829-MR-NB-25860), Schiehser (CDA-2-065-10S), and Sorg (CDA-2-CX001508). This work was further supported by grants awarded by the Department of Defense (W81XWH-10-2-0169) to Dr. Delano-Wood and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (F31NS09870) to Ms. Clark.	American Psychatric Association, 2000, DIAGN STAT MAN MENT; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; BECK AT, 1991, J ANXIETY DISORD, V5, P213, DOI 10.1016/0887-6185(91)90002-B; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Dardiotis E., 2010, NEUROSURGERY FOCUS, V28, P1; Delis D.C., 2000, CALIFORNIA VERBAL LE; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Dretsch MN, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.392; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; FYDRICH T, 1992, J ANXIETY DISORD, V6, P55, DOI 10.1016/0887-6185(92)90026-4; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hodgkinson A, 2009, BRAIN IMPAIR, V10, P162, DOI 10.1375/brim.10.2.162; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horsburgh K, 1997, BRAIN RES, V763, P103, DOI 10.1016/S0006-8993(97)00411-3; Iverson GL., 2012, PTSD MILD TRAUMATIC; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; Kennedy JE, 2015, ARCH CLIN NEUROPSYCH, V30, P236, DOI 10.1093/arclin/acv014; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kimbrel NA, 2015, DEPRESS ANXIETY, V32, P307, DOI 10.1002/da.22348; Koponen S, 2004, NEUROLOGY, V63, P749, DOI 10.1212/01.WNL.0000134603.57107.2F; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Leyfer OT, 2006, J ANXIETY DISORD, V20, P444, DOI 10.1016/j.janxdis.2005.05.004; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Luukinen H, 2008, ACTA NEUROL SCAND, V118, P153, DOI 10.1111/j.1600-0404.2008.00994.x; Lyons MJ, 2013, AM J MED GENET B, V162, P762, DOI 10.1002/ajmg.b.32154; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mahley RW, 1996, ANN NY ACAD SCI, V777, P139, DOI 10.1111/j.1749-6632.1996.tb34412.x; McAllister T. W., 2011, TXB TRAUMATIC BRAIN, P37; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nicoll JAR, 1996, ANN NY ACAD SCI, V777, P271, DOI 10.1111/j.1749-6632.1996.tb34431.x; Panza F, 2012, AGEING RES REV, V11, P87, DOI 10.1016/j.arr.2011.06.005; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sela-Kaufman M, 2013, J CLIN EXP NEUROPSYC, V35, P584, DOI 10.1080/13803395.2013.799123; Storch EA, 2004, DEPRESS ANXIETY, V19, P187, DOI 10.1002/da.20002; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Weathers F. W., 1991, PCL M FOR DSM 4; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wilson M, 2007, BRIT J ANAESTH, V99, P43, DOI 10.1093/bja/aem142; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	81	8	8	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	19					2272	2282		10.1089/neu.2017.5372		JUN 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GV3OA	WOS:000434858200001	29463164	Green Published			2022-02-06	
J	De Vloo, P; Nijs, S; Verelst, S; van Loon, J; Depreitere, B				De Vloo, Philippe; Nijs, Stefaan; Verelst, Sandra; van Loon, Johannes; Depreitere, Bart			Prehospital and Intrahospital Temporal Intervals in Patients Requiring Emergent Trauma Craniotomy. A 6-Year Observational Study in a Level 1 Trauma Center	WORLD NEUROSURGERY			English	Article						Delay in treatment; Epidural hematoma; Subdural hematoma; Trauma craniotomy; Traumatic brain injury	ACUTE SUBDURAL-HEMATOMA; ACUTE ISCHEMIC-STROKE; SEVERE HEAD-INJURY; TISSUE-PLASMINOGEN ACTIVATOR; EXTRADURAL HEMATOMA; PROGNOSTIC FEATURES; EPIDURAL HEMATOMA; BRAIN-INJURY; 25 MINUTES; THROMBOLYSIS	OBJECTIVE: According to level 2 evidence, earlier evacuation of acute subdural or epidural hematomas necessitating surgery is associated with better outcome. Hence, guidelines recommend performing these procedures immediately. Literature on the extent and causes of prehospital and intrahospital intervals in patients with trauma requiring emergent craniotomies is almost completely lacking. Studies delineating and refining the interval before thrombolytic agent administration in ischemic stroke have dramatically reduced the door-to-needle time. A similar exercise for trauma-to-decompression time might result in comparable reductions. We aim to map intervals in emergent trauma craniotomies in our level 1 trauma center, screen for associated factors, and propose possible ways to reduce these intervals. METHODS: We analyzed patients who were primarily referred (1R; n = 45) and secondarily referred (after computed tomography imaging in a community hospital [2R; n = 22]) to our emergency department (ED) and underwent emergent trauma craniotomies between 2010 and 2016. METHODS: We analyzed patients who were primarily referred (1R; n = 45) and secondarily referred (after computed tomography imaging in a community hospital [2R; n = 22]) to our emergency department (ED) and underwent emergent trauma craniotomies between 2010 and 2016. RESULTS: Median prehospital interval (between emergency call and arrival at the ED) was 42 minutes for 1R patients. Median intrahospital interval (between initial ED arrival and skin incision [SI]) was 140 minutes and 268 minutes for 1R and 2R patients, respectively. In 1R patients, ED- SI interval was positively correlated with Glasgow Coma Scale score (rho = .49; P < 0.001), but not with age, time of ED arrival, or extended Glasgow Outcome Scale score at 6 months. Based on outlier analysis, we propose prehospital and intrahospital measures to improve performance. CONCLUSIONS: This is the first report on emergency call-SI interval in emergent trauma craniotomy, with a median of 174 minutes and >297 minutes for 1R and 2R patients, respectively, in our center.	[De Vloo, Philippe; van Loon, Johannes; Depreitere, Bart] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium; [Nijs, Stefaan] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Traumatol, Leuven, Belgium; [Verelst, Sandra] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Emergency Med, Leuven, Belgium		De Vloo, P (corresponding author), Katholieke Univ Leuven, Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium.	philippe.devloo@uzleuven.be	Depreitere, Bart/AAA-9846-2020	Depreitere, Bart/0000-0002-7458-0648; Nijs, Stefaan/0000-0002-1119-4918	Research Funde Flanders (FWO)FWO [G0A5513N]	PDV was supported by Research Funde Flanders (FWO) (grant number G0A5513N). This funding source had no involvement in the study design, in the collection, analysis and interpretation of data, in the writing of the report, or in the decision to submit the article for publication.	Aubuchon MMF, 2013, EUR J TRAUMA EMERG S, V39, P35, DOI 10.1007/s00068-012-0218-6; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fuller G, 2011, J NEUROSURG ANESTH, V23, P198, DOI 10.1097/ANA.0b013e3182161816; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Gennarelli TA., 2008, ABBREVIATED INJURY S; GUTTERMAN P, 1970, J NEUROSURG, V32, P330, DOI 10.3171/jns.1970.32.3.0330; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; Jin PHPFK, 2008, J NEUROTRAUM, V25, P1003, DOI 10.1089/neu.2007.0463; Kuhne CA, 2013, UNFALLCHIRURG, V116, P39, DOI 10.1007/s00113-011-2042-6; Lindsberg PJ, 2006, NEUROLOGY, V67, P334, DOI 10.1212/01.wnl.0000224759.44743.7d; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marcoux J, 2016, J NEUROSURG, V125, P642, DOI 10.3171/2015.6.JNS15175; Marion DW, 2006, NEUROSURGERY, V58, P655; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; Meretoja A, 2013, NEUROLOGY, V81, P1071, DOI 10.1212/WNL.0b013e3182a4a4d2; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Mikulik R, 2012, STROKE, V43, P1578, DOI 10.1161/STROKEAHA.111.644120; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; POON WS, 1991, INJURY, V22, P323, DOI 10.1016/0020-1383(91)90016-8; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Smith RM, 2009, INJURY, V40, pS23, DOI 10.1016/j.injury.2009.10.033; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Van Schaik SM, 2014, J STROKE CEREBROVASC, V23, P2900, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.025; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Willeit J, 2015, LANCET NEUROL, V14, P48, DOI 10.1016/S1474-4422(14)70286-8; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wright KD, 1996, INJURY, V27, P719, DOI 10.1016/S0020-1383(96)00119-2; Wuerz RC, 2000, ACAD EMERG MED, V7, P236, DOI 10.1111/j.1553-2712.2000.tb01066.x	44	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2018	114						E546	E558		10.1016/j.wneu.2018.03.032			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8PI	WOS:000432959600062	29548947	Green Published			2022-02-06	
J	Iashchishyn, IA; Gruden, MA; Moskalenko, RA; Davydova, TV; Wang, C; Sewell, RDE; Morozova-Roche, LA				Iashchishyn, Igor A.; Gruden, Marina A.; Moskalenko, Roman A.; Davydova, Tatiana, V; Wang, Chao; Sewell, Robert D. E.; Morozova-Roche, Ludmilla A.			Intranasally Administered S100A9 Amyloids Induced Cellular Stress, Amyloid Seeding, and Behavioral Impairment in Aged Mice	ACS CHEMICAL NEUROSCIENCE			English	Article						Aged mice; amyloid; apoptosis; BAX; activated caspase-3; cellular stress; learning and memory; neuroinflammation; S100A9	TRANSGENIC MOUSE MODELS; PRO-INFLAMMATORY S100A9; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; COGNITIVE IMPAIRMENT; BETA-PEPTIDE; PROTEIN; EXPRESSION; MRP14	Amyloid formation and neuroinflammation are major features of Alzheimer's disease pathology. Proinflammatory mediator S100A9 was shown to act as a link between the amyloid and neuroinflammatory cascades in Alzheimer's disease, leading together with A ss to plaque formation, neuronal loss and memory impairment. In order to examine if S100A9 alone in its native and amyloid states can induce neuronal stress and memory impairment, we have administered S100A9 species intranasally to aged mice. Single and sequential immunohistochemistry and passive avoidance behavioral test were conducted to evaluate the consequences. Administered S100A9 species induced widespread cellular stress responses in cerebral structures, including frontal lobe, hippocampus and cerebellum. These were manifested by increased levels of S100A9, Box, and to a lesser extent activated caspase-3 immunopositive cells. Upon administration of S100A9 fibrils, the amyloid oligomerization was observed in the brain tissues, which can further exacerbate cellular stress. The cellular stress responses correlated with significantly increased training and decreased retention latencies measured in the passive avoidance test for the SI00A9 treated animal groups. Remarkably, the effect size in the behavioral tests was moderate already in the group treated with native S100A9, while the effect sizes were large in the groups administered S100A9 amyloid oligomers or fibrils. The findings demonstrate the brain susceptibility to neurotoxic damage of S100A9 species leading to behavioral and memory impairments. Intranasal administration of S100A9 species proved to be an effective method to study amyloid induced brain dysfunctions, and 5100A9 itself may be postulated as a target to allay early stage neurodegenerative and neuroinflammatory processes.	[Iashchishyn, Igor A.; Moskalenko, Roman A.; Wang, Chao; Morozova-Roche, Ludmilla A.] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Gruden, Marina A.] PK Anokhin Res Inst Normal Physiol, Dept Funct Neurochem, Moscow 125315, Russia; [Moskalenko, Roman A.] Sumy State Univ, Dept Pathol, UA-40007 Sumy, Ukraine; [Davydova, Tatiana, V] Res Inst Gen Pathol & Pathophysiol, Dept Neuroimmunopathol, Moscow 125315, Russia; [Sewell, Robert D. E.] Cardiff Univ, Cardiff Sch Pharm & Pharmaceut Sci, Cardiff CF10 3NB, S Glam, Wales; [Iashchishyn, Igor A.] Sumy State Univ, Dept Gen Chem, UA-40007 Sumy, Ukraine		Morozova-Roche, LA (corresponding author), Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden.	ludmilla.morozova-roche@umu.se	Davydova, Tatiana V./K-2012-2018; Iashchishyn, Igor/AAL-4677-2021; Morozova-Roche, Ludmilla A./AAU-9044-2021; Morozova-Roche, Ludmilla/AAV-9983-2021; Moskalenko, Roman/I-3208-2017; Sewell, Robert/M-9881-2014	Davydova, Tatiana V./0000-0002-3176-1035; Morozova-Roche, Ludmilla/0000-0001-5886-2023; Moskalenko, Roman/0000-0002-2342-0337; Sewell, Robert/0000-0003-1702-5100	ALF Vasterbotten Lans Landsting [ALFVLL-369861]; Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [2014-3241]; Marie Curie Action "Nano-Guard" [269138]; Insamlingsstiftelsen [FS 2.1.12-1605-14]	This study was funded by ALF Vasterbotten Lans Landsting (ALFVLL-369861 to L.A.M.-R http://fou.nu/info/index.php/vll/Om_oss), Swedish Medical Research Council (2014-3241 to L.A.M.-R, https://vr.se), FP-7 Marie Curie Action "Nano-Guard" (269138 to I.A.I. and L.A.M.-R), and Insamlingsstiftelsen (FS 2.1.12-1605-14 to L.A.M.-R, http://www.medfak.umu.se/forskning/insamlingsstiftelsen/).	Akar F, 2014, MED SCI MONIT BASIC, V20, P27, DOI 10.12659/MSMBR.890438; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Botelho HM, 2012, J BIOL CHEM, V287, P42233, DOI 10.1074/jbc.M112.396416; Bryan KJ, 2009, FRONT NEUROSCI, P1; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Carvalho SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076629; Chitnis T, 2017, J CLIN INVEST, V127, P3577, DOI 10.1172/JCI90609; CLIFF N, 1993, PSYCHOL BULL, V114, P494, DOI 10.1037/0033-2909.114.3.494; Cohen J., 2013, STAT POWER ANAL BEHA; Cole GM, 2010, CNS NEUROL DISORD-DR, V9, P140, DOI 10.2174/187152710791011991; DiCiccio TJ, 1996, STAT SCI, V11, P189; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Efron B., 1993, INTRO BOOTSTRAP; Elder GA, 2010, MT SINAI J MED, V77, P69, DOI 10.1002/msj.20159; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Eremenko E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058218; Fritz G, 2010, FEBS J, V277, P4578, DOI 10.1111/j.1742-4658.2010.07887.x; Fung J, 2004, J NEUROCHEM, V91, P1398, DOI 10.1111/j.1471-4159.2004.02828.x; Gandy S, 2013, NEURON, V78, P575, DOI 10.1016/j.neuron.2013.05.007; Glass G, 2009, J HISTOCHEM CYTOCHEM, V57, P899, DOI 10.1369/jhc.2009.953612; Goldberg EL, 2017, CELL REP, V18, P2077, DOI 10.1016/j.celrep.2017.02.004; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Gruden MA, 2016, BEHAV BRAIN RES, V306, P106, DOI 10.1016/j.bbr.2016.03.016; Gruden MA, 2015, BEHAV BRAIN RES, V279, P191, DOI 10.1016/j.bbr.2014.11.001; Gruden MA, 2014, BEHAV BRAIN RES, V263, P158, DOI 10.1016/j.bbr.2014.01.017; Ha TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008840; Haupt C, 2011, J MOL BIOL, V408, P529, DOI 10.1016/j.jmb.2011.02.032; Horvath I, 2016, ACS CHEM NEUROSCI, V7, P34, DOI 10.1021/acschemneuro.5b00265; Iashchishyn IA, 2017, ACS CHEM NEUROSCI, V8, P2152, DOI 10.1021/acschemneuro.7b00251; Illum L, 2004, J PHARM PHARMACOL, V56, P3, DOI 10.1211/0022357022539; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kim H. Y., 2016, JOVE-J VIS EXP, V109, DOI DOI 10.3791/53308; Kim HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088924; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kummer MP, 2012, J NEUROSCI, V32, P17824, DOI 10.1523/JNEUROSCI.1504-12.2012; Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200; Lodeiro M, 2017, J GERONTOL A-BIOL, V72, P319, DOI 10.1093/gerona/glw073; Ma L, 2017, INT J MOL MED, V40, P31, DOI 10.3892/ijmm.2017.2987; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; Michaels TCT, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4927655; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Narumi K, 2015, J IMMUNOL, V194, P5539, DOI 10.4049/jimmunol.1402301; Park KM, 2008, J BIOL CHEM, V283, P33069, DOI 10.1074/jbc.M802209200; Pirici D, 2009, J HISTOCHEM CYTOCHEM, V57, P567, DOI 10.1369/jhc.2009.953240; Postler E, 1997, GLIA, V19, P27, DOI 10.1002/(SICI)1098-1136(199701)19:1<27::AID-GLIA3>3.0.CO;2-7; Rogers J, 2001, NEUROCHEM INT, V39, P333, DOI 10.1016/S0197-0186(01)00040-7; Schluesener HJ, 1998, ACTA NEUROPATHOL, V96, P575, DOI 10.1007/s004010050938; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; Shepherd CE, 2006, NEUROBIOL AGING, V27, P1554, DOI 10.1016/j.neurobiolaging.2005.09.033; Sipos E, 2010, CELL MOL NEUROBIOL, V30, P405, DOI 10.1007/s10571-009-9463-6; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Swindell WR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01215; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Van Dam D, 2011, BRIT J PHARMACOL, V164, P1285, DOI 10.1111/j.1476-5381.2011.01299.x; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang C, 2014, ACTA NEUROPATHOL, V127, P507, DOI 10.1007/s00401-013-1208-4; Westermark P, 2013, PROTEOPATHIC SEEDS N, P47; Xiong HQ, 2011, NEUROSCI BULL, V27, P221, DOI 10.1007/s12264-011-1015-7; Yamada K, 2003, PHYSIOL BEHAV, V78, P303, DOI 10.1016/S0031-9384(02)00979-4; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yanamandra K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005562; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	66	8	9	4	15	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	JUN	2018	9	6					1338	1348		10.1021/acschemneuro.7b00512			21	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	GK5JQ	WOS:000436211800016	29618200	Green Accepted			2022-02-06	
J	Khaksari, M; Rajizadeh, MA; Bejeshk, MA; Soltani, Z; Motamedi, S; Moramdi, F; Islami, M; Shafa, S; Khosravi, S				Khaksari, Mohammad; Rajizadeh, Mohammad Amin; Bejeshk, Mohammad Abbas; Soltani, Zahra; Motamedi, Sina; Moramdi, Fatemeh; Islami, Masoud; Shafa, Shahriyar; Khosravi, Sepehr			Does inhibition of angiotensin function cause neuroprotection in diffuse traumatic brain injury?	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Angiotensin II receptor; Blood-brain barrier; Brain edema; Brain injury; Candesartan; Intracranial pressure; Lipid peroxidation	FOCAL CEREBRAL-ISCHEMIA; SEX STEROID-HORMONES; HYPERTENSIVE-RATS; HEAD-INJURY; INTRACRANIAL-PRESSURE; NEUROLOGIC OUTCOMES; RECEPTOR BLOCKER; OXIDATIVE STRESS; CANDESARTAN; STROKE	Objective(s): Neuroprotection is created following the inhibition of angiotensin II type 1 receptor (AT1R). Therefore, the purpose of this research was examining AT1R blockage by candesartan in diffuse traumatic brain injury (TBI). Materials and Methods: Male rats were assigned into sham, TBI, vehicle, and candesartan groups. Candesartan (0.3 mg/kg) or vehicle was administered IP, 30 min post-TBI. Brain water and Evans blue contents were determined, 24 and 5 hr after TBI, respectively. Intracranial pressure (ICP) and neurologic outcome were evaluated at -1, 1, 4 and 24 hr after TBI. Oxidant index [malondialdehyde (MDA)] was determined 24 hr after TBI. Results: Brain water and Evans blue contents, and MDA and ICP levels increased in TBI and vehicle groups in comparison with the sham group. Candesartan attenuated the TBI-induced brain water and Evans blue contents, and ICP and MDA enhancement. The neurologic score enhanced following candesartan administration, 24 hr after TBI. Conclusion: The blockage of AT1R may be neuroprotective by decreasing ICP associated with the reduction of lipid peroxidation, brain edema, and blood-brain barrier (BBB) permeability, which led to the improvement of neurologic outcome.	[Khaksari, Mohammad] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran; [Rajizadeh, Mohammad Amin; Soltani, Zahra; Motamedi, Sina; Islami, Masoud; Shafa, Shahriyar; Khosravi, Sepehr] Kerman Univ Med Sci, Inst Neuropharmacol, Neurosci Res Ctr, Kerman, Iran; [Bejeshk, Mohammad Abbas] Kerman Univ Med Sci, Inst Neuropharmacol, Afzalipour Fac Med Sci, Physiol Res Ctr, Kerman, Iran; [Moramdi, Fatemeh] Kerman Univ Med Sci, Inst Neuropharmacol, Pharmaceut Res Ctr, Kerman, Iran		Soltani, Z (corresponding author), Kerman Univ Med Sci, Inst Neuropharmacol, Neurosci Res Ctr, Kerman, Iran.	soltaniy@yahoo.com	Bejeshk, Mohammad Abbas/Q-3299-2017; Soltani, Zahra/AAC-1350-2019; Haddad, Mohammad Khaksari/AAB-9025-2019	Soltani, Zahra/0000-0002-8423-6189; Haddad, Mohammad Khaksari/0000-0003-0770-4281			Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Baranov D, 2003, ANESTHESIOLOGY, V99, P1118, DOI 10.1097/00000542-200311000-00018; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Bennai F, 1999, J AM SOC NEPHROL, V10, pS104; Blume A, 1999, J MOL MED, V77, P339, DOI 10.1007/s001090050360; Culman J, 2002, J HUM HYPERTENS, V16, pS64, DOI 10.1038/sj.jhh.1001442; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Faul M, 2010, TRAUMATIC BRAIN INJU; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Fouda AY, 2016, CLIN SCI, V130, P221, DOI 10.1042/CS20150350; Gasche Y, 2001, J CEREBR BLOOD F MET, V21, P1393, DOI 10.1097/00004647-200112000-00003; Gohlke P, 2002, N-S ARCH PHARMACOL, V365, P477, DOI 10.1007/s00210-002-0545-y; Groth W, 2003, J HYPERTENS, V21, P2175, DOI 10.1097/00004872-200311000-00028; Ishrat T, 2015, MOL NEUROBIOL, V51, P1542, DOI 10.1007/s12035-014-8830-6; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Jung KH, 2007, J PHARMACOL EXP THER, V322, P1051, DOI 10.1124/jpet.107.120097; Khaksari M, 2013, IRAN J BASIC MED SCI, V16, P858; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Kozak W, 2008, J PHARMACOL EXP THER, V326, P773, DOI 10.1124/jpet.108.139618; Kusaka I, 2004, AM J PHYSIOL-HEART C, V286, pH2442, DOI 10.1152/ajpheart.01169.2003; Liu H, 2008, J HYPERTENS, V26, P1435, DOI 10.1097/HJH.0b013e3283013b6e; Maeda A, 2009, INT IMMUNOPHARMACOL, V9, P1183, DOI 10.1016/j.intimp.2009.06.006; Marmarou A., 2007, NEUROSURG FOCUS, V22, P1; Nishimura Y, 2000, STROKE, V31, P2478, DOI 10.1161/01.STR.31.10.2478; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Panahpour H, 2013, NEUROPHYSIOLOGY+, V45, P441, DOI 10.1007/s11062-013-9391-4; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Pelisch N, 2011, AM J HYPERTENS, V24, P362, DOI 10.1038/ajh.2010.241; SAAVEDRA JM, 1992, ENDOCR REV, V13, P329, DOI 10.1210/er.13.2.329; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; SCHUIER FJ, 1980, STROKE, V11, P593, DOI 10.1161/01.STR.11.6.593; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Soltani Z., 2009, Iranian Journal of Endocrinology and Metabolism, V10, P629; Soltani Z, 2016, J PHYSIOL BIOCHEM, V72, P33, DOI 10.1007/s13105-015-0453-5; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Soustiel JF, 2010, NEUROTHERAPEUTICS, V7, P13, DOI 10.1016/j.nurt.2009.11.001; Stahel PF, 2000, J NEUROIMMUNOL, V109, P164, DOI 10.1016/S0165-5728(00)00304-0; Sugawara T, 2005, NEUROREPORT, V16, P325, DOI 10.1097/00001756-200503150-00004; TEASDALE G, 1974, LANCET, V2, P81; Thone-Reineke C, 2006, J HYPERTENS, V24, pS115; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Wright JW, 2011, PROG NEUROBIOL, V95, P49, DOI 10.1016/j.pneurobio.2011.07.001; Xu M, 2010, CHIN J TRAUMATOL, V13, P103, DOI 10.3760/cma.j.issn.1008-1275.2010.02.009; Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5	49	8	9	0	0	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	JUN	2018	21	6					615	620		10.22038/IJBMS.2018.26586.6512			6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	GJ9CY	WOS:000435692000009	29942452				2022-02-06	
J	Khor, D; Wu, JL; Hong, QQ; Benjamin, E; Xiao, SM; Inaba, K; Demetriades, D				Khor, Desmond; Wu, Jinglan; Hong, Quanqiu; Benjamin, Elizabeth; Xiao, Shuiming; Inaba, Kenji; Demetriades, Demetrios			Early Seizure Prophylaxis in Traumatic Brain Injuries Revisited: A Prospective Observational Study	WORLD JOURNAL OF SURGERY			English	Article							POSTTRAUMATIC SEIZURES; LEVETIRACETAM PROPHYLAXIS; PHENYTOIN; GUIDELINES; MANAGEMENT; TRIAL	Pharmacological prophylaxis for early seizures following traumatic brain injury (TBI) is a recommendation in the Brain Trauma Foundation Guidelines. However, several studies have challenged the efficacy and safety of this practice, resulting in varied practice across centers around the world. The purpose of the present study was to compare the incidence of early clinical seizures following TBI, between two large centers, a US Center that practises routine seizure prophylaxis and a Chinese Center that does not use seizure prophylaxis following TBI. This was a prospective observational study including an urban level I trauma center in the USA and a large hospital in Shenzhen, China. At the US Center, all patients received seizure prophylaxis with levetiracetam. At the Chinese Center, no seizure prophylaxis was given. All patients with blunt TBI and positive computed tomography findings for epidural hematoma, subdural hematoma, subarachnoid hemorrhage, intracerebral hemorrhage or diffuse axonal injury were included. Patients who died within 24 h of admission were excluded. The study population was monitored daily for clinical seizures for the first 7 post-injury days. Data collected included demographics, mechanism of injury, vital signs upon arrival, injury severity and emergency interventions. Primary outcome was the incidence of early seizures, defined as those occurring within 7 days of injury. A total of 522 patients were included in the analysis: 272 patients at the US Center who received seizure prophylaxis and 250 patients at the Chinese Center who did not receive prophylaxis. Overall, 3.7% of patients who received seizure prophylaxis developed early seizures, compared to 2.8% of patients who did not receive any prophylaxis (p = 0.573). Decompressive craniectomy was associated with the highest incidence of early seizure (9.2%). In this subgroup, the seizure rate was 10.4% in the prophylaxis group and 7.1% in the no-prophylaxis group (p = 0.738). Patients with admission GCS < 9 had an overall early seizure incidence of 7.0%: 4.3% in the prophylaxis group and 14.3% in the no-prophylaxis group (p = 0.062). Analysis of the subgroup with isolated blunt TBI showed an incidence of early seizures of 3.4% in the prophylaxis group versus 2.4% in the no-prophylaxis group (p = 0.593). Further analyses of outcomes according to head AIS 3, 4 and 5 showed no significant difference in the seizure rate between the two groups: head AIS 3: 6.1% in the prophylaxis group versus 2.6% in the no-prophylaxis group, p = 0.329; head AIS 4: 0 versus 2.7%, p = 0.302; head AIS 5: 8.7 versus 4.0%, p = 0.601. The present study failed to show any benefit of routine early seizure prophylaxis following blunt TBI. This practice should be reexamined in a large randomized clinical study.	[Khor, Desmond; Benjamin, Elizabeth; Inaba, Kenji; Demetriades, Demetrios] Los Angeles Cty Univ Southern Calif LAC USC Med C, 2051 Marengo St,Inpatient Tower C,Rm C5L100, Los Angeles, CA 90033 USA; [Wu, Jinglan; Hong, Quanqiu; Xiao, Shuiming] Shenzhen Nanshan Dist Peoples Hosp, Shenzhen, Guangdong, Peoples R China		Demetriades, D (corresponding author), Los Angeles Cty Univ Southern Calif LAC USC Med C, 2051 Marengo St,Inpatient Tower C,Rm C5L100, Los Angeles, CA 90033 USA.	demetria@usc.edu	INABA, KENJI/AAC-8532-2020; Benjamin, Elizabeth/AAD-2457-2020				Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chung MG, 2016, PEDIATR CRIT CARE ME, V17, P150, DOI 10.1097/PCC.0000000000000588; Cranley MR, 2016, J ROY ARMY MED CORPS, V162, P109, DOI 10.1136/jramc-2014-000392; Dauch WA, 1996, ZBL NEUROCHIR, V57, P190; Debenham S, 2011, CAN J NEUROL SCI, V38, P896, DOI 10.1017/S031716710001249X; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gennarelli T.A., 2005, ASS ADVANCEMENT AUTO; Hung C, 2012, CURR TREAT OPTION NE, V14, P293, DOI 10.1007/s11940-012-0178-5; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Jacka MJ, 2007, CAN J NEUROL SCI, V34, P307, DOI 10.1017/S0317167100006727; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Ritter AC, 2016, EPILEPSIA, V57, P1503, DOI 10.1111/epi.13470; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Won SY, 2017, SEIZURE-EUR J EPILEP, V45, P28, DOI 10.1016/j.seizure.2016.11.017; Yang Y, 2016, CNS DRUGS, V30, P677, DOI 10.1007/s40263-016-0365-0; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231; Zangbar B, 2016, WORLD J SURG, V40, P2667, DOI 10.1007/s00268-016-3606-y	23	8	8	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	JUN	2018	42	6					1727	1732		10.1007/s00268-017-4373-0			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GE7PM	WOS:000431425300020	29159600				2022-02-06	
J	Park, YK; Yi, HJ; Choi, KS; Lee, YJ; Chun, HJ; Kwon, SM				Park, Yung Ki; Yi, Hyeong-Joong; Choi, Kyu-Sun; Lee, Young-Jun; Chun, Hyoung-Joon; Kwon, Sae Min			Predictive Factors of Fever After Aneurysmal Subarachnoid Hemorrhage and Its Impact on Delayed Cerebral Ischemia and Clinical Outcomes	WORLD NEUROSURGERY			English	Article						Anterior communicating artery aneurysm; Brain ischemia; Fever; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; INDUCED NORMOTHERMIA; BODY-TEMPERATURE; RISK-FACTORS; VASOSPASM; STROKE; BLOOD; DEFINITION; PROGNOSIS; DIAGNOSIS	OBJECTIVE: Fever is relatively common and worsens neurologic injury after aneurysmal subarachnoid hemor-rhage (SAH). The aim of this study was to display the time course of body temperature, identify predictive factors of fever after SAH, and evaluate its impact on delayed cerebral ischemia (DCI) and clinical outcomes. METHODS: Four hundred twelve patients with SAH and ruptured aneurysms who were treated at our institution between January 2007 and December 2016 were analyzed retrospectively. The febrile group was defined as patients having a maximal temperature >= 38.0 degrees C for 2 consecutive days or for more than 3 days within 2 weeks after SAH, and the remaining patients comprised the afebrile group. The impact of fever on DCI and clinical outcomes was assessed. RESULTS: Anterior communicating artery aneurysm, Hunt and Hess grade, SAH sum score, intraventricular hemorrhage sum score, and body mass index were independent predictive factors for fever after SAH. A larger SAH and fever were independent risk factors for DCI. A worse Hunt and Hess grade, concomitant intracerebral hemorrhage, DCI, old age, and fever were independent risk factors for unfavorable outcomes. CONCLUSIONS: Predictors of fever after SAH were a worse clinical status at admission, larger SAH and intraventricular hemorrhage, anterior communicating artery aneurysm, and greater body mass index. Fever itself was an independent risk factor for DCI and unfavorable outcomes after aneurysmal SAH.	[Park, Yung Ki; Yi, Hyeong-Joong; Choi, Kyu-Sun; Chun, Hyoung-Joon; Kwon, Sae Min] Hanyang Univ, Med Ctr, Dept Neurosurg, Seoul, South Korea; [Lee, Young-Jun] Hanyang Univ, Med Ctr, Dept Radiol, Seoul, South Korea		Yi, HJ (corresponding author), Hanyang Univ, Med Ctr, Dept Neurosurg, Seoul, South Korea.	hjyi8499@hanyang.ac.kr	Yi, Hyeong-Joong/AAR-2685-2020; Park, Yung Ki/X-9121-2019	Park, Yung Ki/0000-0002-4925-5333			Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Badjatia N, 2010, NEUROSURGERY, V66, P696, DOI 10.1227/01.NEU.0000367618.42794.AA; BARR AN, 1978, NEUROLOGY, V28, P1196, DOI 10.1212/WNL.28.11.1196; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CROMPTON MR, 1963, BRAIN, V86, P301, DOI 10.1093/brain/86.2.301; Dhar R, 2008, NEUROCRIT CARE, V8, P253, DOI 10.1007/s12028-007-9020-4; Douds GL, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/479865; Fernandez A, 2007, NEUROLOGY, V68, P1013, DOI 10.1212/01.wnl.0000258543.45879.f5; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Frosini M, 1999, EXP BRAIN RES, V126, P252, DOI 10.1007/s002210050734; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; HIJDRA A, 1990, STROKE, V21, P1156, DOI 10.1161/01.STR.21.8.1156; Hocker SE, 2013, JAMA NEUROL, V70, P1499, DOI 10.1001/jamaneurol.2013.4354; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Juvela S, 2005, J NEUROSURG, V102, P998, DOI 10.3171/jns.2005.102.6.0998; Mees SMD, 2008, STROKE, V39, P2141, DOI 10.1161/STROKEAHA.107.509851; Naidech AM, 2008, NEUROSURGERY, V63, P212, DOI 10.1227/01.NEU.0000320453.61270.0F; Oddo M, 2009, STROKE, V40, P1913, DOI 10.1161/STROKEAHA.108.534115; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Rello J, 2001, CHEST, V120, P955, DOI 10.1378/chest.120.3.955; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; SAPER CB, 1994, NEW ENGL J MED, V330, P1880; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Suehiro E, 2016, J STROKE CEREBROVASC, V25, P1482, DOI 10.1016/j.jstrokecerebrovasdis.2016.01.053; van Dijk BJ, 2016, BBA-MOL BASIS DIS, V1862, P492, DOI 10.1016/j.bbadis.2015.10.013; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; WEIR B, 1989, NEUROSURGERY, V25, P161, DOI 10.1227/00006123-198908000-00002; Yoshimoto Y, 2001, STROKE, V32, P1989, DOI 10.1161/hs0901.095646	35	8	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2018	114						E524	E531		10.1016/j.wneu.2018.03.030			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8PI	WOS:000432959600060	29548963				2022-02-06	
J	Terry, DP; Iverson, GL; Panenka, W; Colantonio, A; Silverberg, ND				Terry, Douglas P.; Iverson, Grant L.; Panenka, William; Colantonio, Angela; Silverberg, Noah D.			Workplace and non-workplace mild traumatic brain injuries in an outpatient clinic sample: A case-control study	PLOS ONE			English	Article							SYMPTOM VALIDITY TEST; MOTOR-VEHICLE ACCIDENTS; POSTTRAUMATIC-STRESS; HEAD-INJURY; RECOVERY EXPECTATIONS; WHIPLASH-INJURY; WORK; DISABILITY; RETURN; DISORDER	Individuals who are injured in the workplace typically have a greater risk of delayed return to work (RTW) and other poor health outcomes compared to those not injured at work. It is not known whether these differences hold true for mild traumatic brain injuries (MTBI). The present study examined differences associated with workplace and non-workplace MTBI upon intake to a specialty MTBI clinic, their outcomes, and risk factors that influence RTW. Slow-to- recover participants were recruited from consecutive referrals to four outpatient MTBI clinics from March 2015 to February 2017. Two clinics treat Worker's Compensation claimants and two clinics serve patients with non-work related injuries in the publically funded health care system. Of 273 eligible patients, 102 completed an initial study assessment (M age = 41.2 years, SD age = 11.7; 54% women) at an average of 2-3 months post injury. Participants were interviewed about their MTBI and completed a battery of standardized questionnaires and performance validity testing. Outcomes, including RTW, were assessed via telephone follow-up 4-5 months later. Workplace injuries comprised 45.1% of the sample. The workplace MTBI group had a greater proportion of men and lower education levels compared to the non-workplace MTBI group. The two groups had a comparable post-concussion symptom burden and performance validity test failure rate. Workplace MTBI was associated with greater post-traumatic stress symptoms. Fifteen patients (14.7%) were lost to follow-up. There were no workplace/non-workplace MTBI differences in RTW outcome at 6-7 months post injury. Of the entire sample, 42.5% of patients had full RTW, 18.4% had partial RTW, and 39.1% had no RTW. Greater post-concussion symptom burden was most predictive of no RTW at follow-up. There was no evidence that the workplace and non-workplace MTBI groups had different risk factors associated with prolonged work absence. Despite systemic differences in compensation and health care access, the workplace and non-workplace MTBI groups were similar at clinic intake and indistinguishable at follow-up, 6-7 months post injury.	[Terry, Douglas P.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Terry, Douglas P.; Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Terry, Douglas P.; Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Terry, Douglas P.; Iverson, Grant L.] Home Base, Boston, MA USA; [Panenka, William] British Columbia Neuropsychiat Program, Vancouver, BC, Canada; [Panenka, William] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada		Silverberg, ND (corresponding author), Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada.; Silverberg, ND (corresponding author), Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada.	noah.silverberg@vch.ca		Colantonio, Angela/0000-0003-2094-4765; Panenka, William/0000-0001-7143-6512; Iverson, Grant/0000-0001-7348-9570	WorkSafeBC [RS2014-SP03]; Vancouver Coastal Health Research Institute; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; Heinz Family Foundation	Funding for this study was provided by WorkSafeBC, through a Specific Priorities Research Grant (#RS2014-SP03). The funder had no role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript. NDS received salary support from a Clinician-Scientist Career Development Award from the Vancouver Coastal Health Research Institute and a Health Professional Investigator Award from the Michael Smith Foundation for Health Research. The authors acknowledge unrestricted philanthropic support from the Heinz Family Foundation.	Axelrod BN, 2011, APPL NEUROPSYCHOL, V18, P27, DOI 10.1080/09084282.2010.523369; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; Badley E, 2000, WORLD HLTH ORG DISAB; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bush SS, 2012, NEUROPSYCHOLOGICAL A; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Chang VH, 2011, PM&R, V3, pS387, DOI 10.1016/j.pmrj.2011.08.007; Colangelo A, 2016, ARCH PHYS MED REHAB, V97, P714, DOI 10.1016/j.apmr.2015.12.019; Colantonio A, 2012, WORK, V43, P195, DOI 10.3233/WOR-2012-1377; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Cole DC, 2002, CAN MED ASSOC J, V166, P749; Derrett S, 2011, INJURY PREV, V17, P415, DOI 10.1136/injuryprev-2011-040044; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Gross N, 2015, J RURAL HEALTH, V31, P401, DOI 10.1111/jrh.12121; Guerriero EN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151462; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kennedy L, 2013, JOURNAL OF OCCUPATIO, P1; Kim H, 2006, NEUROREHABILITATION, V21, P269; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Kristman VL, 2008, BRAIN INJURY, V22, P51, DOI 10.1080/02699050701849991; Kristman VL, 2016, J HEAD TRAUMA REHAB, V31, pE33, DOI 10.1097/HTR.0000000000000226; Kristman VL, 2010, OPEN OCCUP HLTH SAF, V2, P1, DOI [10.2174/1876216601002010001, DOI 10.2174/1876216601002010001]; Lam RW, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-78; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lilley R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-995; MacDonald HA, 2003, J OCCUP REHABIL, V13, P63, DOI 10.1023/A:1022563930482; Mansfield E, 2015, BRAIN INJURY, V29, P1362, DOI 10.3109/02699052.2015.1053524; Martin C.W., 2003, MILD TRAUMATIC BRAIN; Mason S, 2002, J TRAUMA, V53, P98, DOI 10.1097/00005373-200207000-00019; Mollayeva T, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0432-z; Paniak C, 2000, J MUSCULOSKELET PAIN, V8, P193, DOI 10.1300/J094v08n01_16; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Posl M, 2007, QUAL LIFE RES, V16, P1521, DOI 10.1007/s11136-007-9259-4; Rabinowitz AR, 2014, ANNU REV PSYCHOL, V65, P301, DOI 10.1146/annurev-psych-010213-115103; Reid MW, 2015, MOL CELL NEUROSCI, V66, P123, DOI 10.1016/j.mcn.2015.03.014; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; Schultz IZ, 2004, PAIN, V107, P77, DOI 10.1016/j.pain.2003.09.019; Scott W, 2013, J OCCUP REHABIL, V23, P557, DOI 10.1007/s10926-013-9417-1; Scuderi Gaetano J, 2005, Spine J, V5, P639, DOI 10.1016/j.spinee.2005.04.007; Silverberg ND, 2014, UNDER REV; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Snell DL, 2017, J NEUROTRAUMA; Stergiou-Kita M, 2016, ARCH PHYS MED REHAB, V97, pS40, DOI 10.1016/j.apmr.2015.04.008; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Sullivan MJL, 2012, CLIN J PAIN, V28, P484, DOI 10.1097/AJP.0b013e3182527d13; Sullivan MJL, 2011, SPINE, V36, pS244, DOI 10.1097/BRS.0b013e3182387fed; Sullivan MJL, 2009, PAIN, V145, P325, DOI 10.1016/j.pain.2009.06.031; Sullivan MJL, 2008, ROLE PERCEIVED INJUS, DOI [10.1007/s10926-008-9140-5, DOI 10.1007/S10926-008-9140-5]; Svestkova O, 2010, DISABIL REHABIL, V32, pS68, DOI 10.3109/09638288.2010.511690; Turner JA, 2006, SPINE, V31, P682, DOI 10.1097/01.brs.0000202762.88787.af; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Vikane E, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8026414; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Webb JW, 2012, CLIN NEUROPSYCHOL, V26, P1377, DOI 10.1080/13854046.2012.728248; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Wortmann JH, 2016, PSYCHOL ASSESSMENT, V28, P1392, DOI 10.1037/pas0000260; Xiong C, 2016, DISABIL HEALTH J, V9, P439, DOI 10.1016/j.dhjo.2015.12.002	71	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198128	10.1371/journal.pone.0198128			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	WOS:000433900800074	29856799	Green Published, gold, Green Submitted			2022-02-06	
J	Tverdal, CB; Howe, EI; Roe, C; Helseth, E; Lu, J; Tenovuo, O; Andelic, N				Tverdal, Cathrine Buaas; Howe, Emilie Isager; Roe, Cecilie; Helseth, Eirik; Lu, Juan; Tenovuo, Olli; Andelic, Nada			TRAUMATIC BRAIN INJURY: PATIENT EXPERIENCE AND SATISFACTION WITH DISCHARGE FROM TRAUMA HOSPITAL	JOURNAL OF REHABILITATION MEDICINE			English	Article						patient transfer; patient discharge; brain injury; craniocerebral trauma	COMPLEX CARE NEEDS; TRANSITIONAL CARE; CONTINUOUS CHAIN; SEVERITY SCORE; QUALITY; REHABILITATION; PARTICIPATION; OPPORTUNITIES; RELIABILITY; CHALLENGES	Objectives: To describe the discharge process for patients with traumatic brain injury from a trauma hospital, and patient experience and satisfaction with care transition. Furthermore, to evaluate associations between discharge process and patient satisfaction and quality of care transition. Design: Prospective-retrospective observational study. Subjects/patients: Seventy-four patients admitted to ward or intensive care unit at a trauma referral hospital within 24 h of traumatic brain injury. Methods: Baseline characteristics and discharge process variables were extracted from medical records. Patients were interviewed 6-months post-injury about their experience and satisfaction with care transition, using a visual analogue scale (VAS) and the Care Transition Measurement (CTM-3 (R)) as outcome measures. Regression analyses were performed to investigate associations between discharge process and outcome. Results: One-third of patients were not involved in the discharge process, and information in discharge summaries was often inadequate. Patients' involvement in care transition and co-ordination of care were significantly associated with overall satisfaction (VAS, p = 0.002 and p = 0.001, respectively) and quality of care transition (CTM-3 (R), p =0.003 and p = 0.007, respectively). Patients with more severe injuries reported lower satisfaction and quality of care transition. Conclusion: Patient's involvement in healthcare decision-making and co-ordination of care is important for self-reported satisfaction with transition and quality of care transition.	[Howe, Emilie Isager; Roe, Cecilie; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, POB 4950 Nydalen, NO-0424 Oslo, Norway; [Tverdal, Cathrine Buaas; Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Tverdal, Cathrine Buaas; Roe, Cecilie; Lu, Juan; Andelic, Nada] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Howe, Emilie Isager; Roe, Cecilie; Helseth, Eirik] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Lu, Juan] Virginia Commonwealth Univ, Dept Family Med & Populat Hlth, Div Epidemiol, Richmond, VA USA; [Tenovuo, Olli] Turku Univ Hosp, Dept Rehabil & Brain Trauma, Div Clin Neurosci, Turku, Finland; [Tenovuo, Olli] Univ Turku, Dept Neurol, Turku, Finland		Tverdal, CB (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, POB 4950 Nydalen, NO-0424 Oslo, Norway.	cathrinebt@gmail.com	Helseth, Eirik/AAH-2466-2020	Tverdal, Cathrine/0000-0002-1094-3825; Andelic, Nada/0000-0002-3719-4406; Lu, Juan/0000-0002-5389-7603	European Union FP 7th Framework Program [602150]	The authors would like to thank all participants. The study was supported by The European Union FP 7th Framework Program (grant 602150).	Aase K., 2017, RES QUALITY CARE TRA, P3, DOI [10.1007/978-3-319-62346-7_1, DOI 10.1007/978-3-319-62346-7_1]; Almborg AH, 2009, J CLIN NURS, V18, P199, DOI 10.1111/j.1365-2702.2008.02321.x; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Care Transition Programs, 2016, DIV HLTH CAR POL RES; Cnossen MC, 2017, J REHABIL MED, V49, P395, DOI 10.2340/16501977-2216; Coleman EA, 2003, J AM GERIATR SOC, V51, P556, DOI 10.1046/j.1532-5415.2003.51186.x; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Coleman Eric A, 2002, Int J Integr Care, V2, pe02; Coulter A., 2008, ARE PATIENTS DECISIO; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dyrstad DN, 2015, COGN TECHNOL WORK, V17, P15, DOI 10.1007/s10111-014-0300-4; Ekdahl AW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-002027; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Foss C, 2011, PATIENT EDUC COUNS, V85, P68, DOI 10.1016/j.pec.2010.08.025; Goncalves-Bradley DC, 2016, COCHRANE DB SYST REV; Greenwald JL., 2007, J PATIENT SAF, V3, P97, DOI DOI 10.1097/01.JPS.0000236916.94696.12; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maduz R, 2017, INJURY, V48, P885, DOI 10.1016/j.injury.2017.02.015; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McDonald KM, 2014, AHRQ PUBLICATION; McLeod J, 2014, MUSCULOSKELET CARE, V12, P13, DOI 10.1002/msc.1043; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Parry C, 2008, MED CARE, V46, P317, DOI 10.1097/MLR.0b013e3181589bdc; Paterson B, 2001, Rehabil Nurs, V26, P48; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perry MAC, 2011, J REHABIL MED, V43, P916, DOI 10.2340/16501977-0874; Reddy D, 2014, NEUROSURGERY, V75, P646; Stenberg M, 2013, J REHABIL MED, V45, P792, DOI 10.2340/16501977-1200; Storm M, 2017, RES QUALITY CARE TRA, P143; Tardif PA, 2017, INJURY, V48, P94, DOI 10.1016/j.injury.2016.10.042; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; [World Health Organization http://www.who.int/patientsafety/education/mp_curriculum_guide/en/], 2011, PAT SAF CURR GUID PR	39	8	8	1	4	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	JUN	2018	50	6					505	513		10.2340/16501977-2332			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GL5HE	WOS:000437194300004	29620136	Green Submitted, gold, Green Published			2022-02-06	
J	Pagkalos, I; Rogers, ML; Boutelle, MG; Drakakis, EM				Pagkalos, Ilias; Rogers, Michelle L.; Boutelle, Martyn G.; Drakakis, Emmanuel M.			A High-Performance Application Specific Integrated Circuit for Electrical and Neurochemical Traumatic Brain Injury Monitoring	CHEMPHYSCHEM			English	Article							SPREADING DEPOLARIZATIONS; ONLINE MICRODIALYSIS; DEPRESSION; GLUCOSE; LACTATE	This paper presents the first application specific integrated chip (ASIC) for the monitoring of patients who have suffered a Traumatic Brain Injury (TBI). By monitoring the neurophysiological (ECoG) and neurochemical (glucose, lactate and potassium) signals of the injured human brain tissue, it is possible to detect spreading depolarisations, which have been shown to be associated with poor TBI patient outcome. This paper describes the testing of a new 7.5mm(2) ASIC fabricated in the commercially available AMS 0.35m CMOS technology. The ASIC has been designed to meet the demands of processing the injured brain tissue's ECoG signals, recorded by means of depth or brain surface electrodes, and neurochemical signals, recorded using microdialysis coupled to microfluidics-based electrochemical biosensors. The potentiostats use switchedcapacitor charge integration to record currents with 100fA resolution, and allow automatic gain changing to track the falling sensitivity of a biosensor. This work supports the idea of a behind the ear wireless microplatform modality, which could enable the monitoring of currently non-monitored mobile TBI patients for the onset of secondary brain injury.	[Pagkalos, Ilias; Rogers, Michelle L.; Boutelle, Martyn G.; Drakakis, Emmanuel M.] Imperial Coll London, Dept Bioengn, London, England		Boutelle, MG; Drakakis, EM (corresponding author), Imperial Coll London, Dept Bioengn, London, England.	m.boutelle@imperial.ac.uk; e.drakakis@imperial.ac.uk		Rogers, Michelle/0000-0002-1434-2322	A.G. Leventis Foundation; Wellcome Trust/UK Department of Health Healthcare Innovation Challenge Fund [HICF-0510-080]	This work was supported by The A.G. Leventis Foundation and the Wellcome Trust/UK Department of Health Healthcare Innovation Challenge Fund (HICF-0510-080). We also thank Mr. Momen Kamal Tageldeen for his help with part of measured data processing.	[Anonymous], 2012, LANCET NEUROL, V11, P651, DOI 10.1016/S1474-4422(12)70166-7; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Bah E, 2017, IEEE INT SYM MED MEA, P123, DOI 10.1109/MeMeA.2017.7985861; Balasubramanian V, 2012, IEEE INT SYMP CIRC S, P2215, DOI 10.1109/ISCAS.2012.6271731; Bledsoe JM, 2009, J NEUROSURG, V111, P712, DOI 10.3171/2009.3.JNS081348; Crescentini M, 2014, IEEE T BIOMED CIRC S, V8, P278, DOI 10.1109/TBCAS.2013.2262998; Dawodu S. T., 2017, MEDSCAPE; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Enz CC, 1996, P IEEE, V84, P1584, DOI 10.1109/5.542410; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Friis H.T., 1944, Proceedings of the Institute of Radio Engineers, V32, P419, DOI 10.1109/JRPROC.1944.232049; Graeme J. G., 1996, GAIN TECHNOLOGY; Griessenauer CJ, 2010, J NEUROSURG, V113, P656, DOI 10.3171/2010.3.JNS091627; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jeffcote T, 2014, NEUROCRIT CARE, V20, P21, DOI 10.1007/s12028-013-9938-7; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Lee KH, 2017, SCI REP-UK, V7, DOI 10.1038/srep46675; Li CY, 2016, BIOSENS BIOELECTRON, V77, P62, DOI 10.1016/j.bios.2015.09.021; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; Pagkalos I., 2016, J MEAS, V102, P249; Pagkalos I., 2016, THESIS; Papadimitriou KI, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00212; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Patel BA, 2011, BIOSENS BIOELECTRON, V26, P2890, DOI 10.1016/j.bios.2010.11.033; Rogers M, 2011, PHYS CHEM CHEM PHYS, V13, P5298, DOI 10.1039/c0cp02810j; Rogers ML, 2017, J CEREBR BLOOD F MET, V37, P1883, DOI 10.1177/0271678X16674486; Rogers ML, 2013, ACS CHEM NEUROSCI, V4, P799, DOI 10.1021/cn400047x; Sansen W.M.C., 2006, ANALOG DESIGN ESSENT; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Tang YY, 2013, IEEE SENS J, V13, P2984, DOI 10.1109/JSEN.2013.2264806; Temes G., 1986, ANALOG MOS INTEGRATE; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Vasylieva N, 2011, BIOSENS BIOELECTRON, V26, P3993, DOI 10.1016/j.bios.2011.03.012; Vidgeon S. D., 2011, J INTENSIVE CARE SOC, V12, P126, DOI DOI 10.1177/175114371101200208; Whitfield PC, 2009, HEAD INJURY: A MULTIDISCIPLINARY APPROACH, P1, DOI 10.1017/CBO9780511576515; Zhang M, 2008, IEEE INT SYMP CIRC S, P2094, DOI 10.1109/ISCAS.2008.4541862	42	8	8	1	10	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1439-4235	1439-7641		CHEMPHYSCHEM	ChemPhysChem	MAY 22	2018	19	10			SI		1215	1225		10.1002/cphc.201701119			11	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Physics	GI0RT	WOS:000434077800011	29388305	hybrid, Green Published			2022-02-06	
J	Ramirez-Lamelas, DT; Benlloch-Navarro, S; Lopez-Pedrajas, R; Gimeno-Hernandez, R; Olivar, T; Silvestre, D; Miranda, M				Ramirez-Lamelas, Dolores T.; Benlloch-Navarro, Soledad; Lopez-Pedrajas, Rosa; Gimeno-Hernandez, Roberto; Olivar, Teresa; Silvestre, Dolores; Miranda, Maria			Lipoic Acid and Progesterone Alone or in Combination Ameliorate Retinal Degeneration in an Experimental Model of Hereditary Retinal Degeneration	FRONTIERS IN PHARMACOLOGY			English	Article						retinitis pigmentosa; lipoic acid; progesterone; gliosis; glutathione	TRAUMATIC BRAIN-INJURY; PHOTORECEPTOR CELL-DEATH; KAPPA-B ACTIVATION; RETINITIS-PIGMENTOSA; HEPATIC GLUTATHIONE; MOUSE RETINA; RATS; NEUROPROTECTION; EXPRESSION; MICE	Retinitis pigmentosa (RP) is a group of inherited retinopathies characterized by photoreceptors death. Our group has shown the positive progesterone (P4) actions on cell death progression in an experimental model of RP. In an effort to enhance the beneficial effects of P4, the aim of this study was to combine P4 treatment with an antioxidant [lipoic acid (LA)] in the rd1 mice. rd1 and control mice were treated with 100 mg/kg body weight of P4, LA, or a combination of both on postnatal day 7 (PN7), 9, and 11, and were sacrificed at PN11. The administration of LA and/or P4 diminishes cell death in rd1 retinas. The effect obtained after the combined administration of LA and P4 is higher than the one obtained with LA or P4 alone. The three treatments decreased GFAP staining, however, in the far peripheral retina, and the two treatments that offered better results were LA and LA plus P4. LA or LA plus P4 increased retinal glutathione (GSH) concentration in the rd1 mice. Although LA and P4 are able to protect photoreceptors from death in rd1 mice retinas, a better effectiveness is achieved when administering LA and P4 at the same time.	[Ramirez-Lamelas, Dolores T.; Benlloch-Navarro, Soledad; Lopez-Pedrajas, Rosa; Gimeno-Hernandez, Roberto; Olivar, Teresa; Miranda, Maria] CEU Univ, Univ CEU Cardenal Herrera, Dept Ciencias Biomed, Valencia, Spain; [Lopez-Pedrajas, Rosa; Miranda, Maria] CEU Univ, Univ CEU Cardenal Herrera, Inst Ciencias Biomed, Valencia, Spain; [Silvestre, Dolores] CEU Univ, Univ CEU Cardenal Herrera, Dept Farm, Valencia, Spain		Miranda, M (corresponding author), CEU Univ, Univ CEU Cardenal Herrera, Dept Ciencias Biomed, Valencia, Spain.; Miranda, M (corresponding author), CEU Univ, Univ CEU Cardenal Herrera, Inst Ciencias Biomed, Valencia, Spain.	mmiranda@uchceu.es	Olivar, Teresa/G-1093-2016; Lopez-Pedrajas, Rosa/L-2734-2014; Miranda, Maria/L-3471-2014; Miranda, Maria/ABG-5343-2020	Lopez-Pedrajas, Rosa/0000-0003-4845-6544; Miranda, Maria/0000-0002-3738-367X; Miranda, Maria/0000-0002-3738-367X; Silvestre, Dolores/0000-0003-2101-050X	Cardenal Herrera University; Banco de Santander (Precompetitivo-Santander FUSPBS-PPC) [33/201]; Banco de Santander (Proyectos en Consolidacion CEU-UCH Banco Santander)	This work was supported by grants from Cardenal Herrera University and Banco de Santander (Precompetitivo-Santander FUSPBS-PPC 33/201 and Proyectos en Consolidacion CEU-UCH Banco Santander 2017-2018).	Allen RS, 2015, INVEST OPHTH VIS SCI, V56, P2880, DOI 10.1167/iovs.14-16070; Andrade AS, 2014, EXP EYE RES, V120, P1, DOI 10.1016/j.exer.2013.12.014; Atif F, 2013, NEUROPHARMACOLOGY, V67, P78, DOI 10.1016/j.neuropharm.2012.10.004; Baulieu EE, 1996, CELL MOL NEUROBIOL, V16, P143, DOI 10.1007/BF02088173; BAYES M, 1995, HUM MUTAT, V5, P228, DOI 10.1002/humu.1380050307; Bian QN, 2012, FREE RADICAL BIO MED, V53, P1298, DOI 10.1016/j.freeradbiomed.2012.06.024; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Brufani Mario, 2014, Acta Biomed, V85, P108; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Dalazen GR, 2014, METAB BRAIN DIS, V29, P175, DOI 10.1007/s11011-013-9466-3; Dalton TP, 2000, BIOCHEM BIOPH RES CO, V279, P324, DOI 10.1006/bbrc.2000.3930; Doonan F, 2012, EXPERT OPIN INV DRUG, V21, P579, DOI 10.1517/13543784.2012.667400; Doonan F, 2011, J NEUROCHEM, V118, P915, DOI 10.1111/j.1471-4159.2011.07354.x; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; Farrar GJ, 2002, EMBO J, V21, P857, DOI 10.1093/emboj/21.5.857; Freitas RM, 2009, NEUROSCI LETT, V455, P140, DOI 10.1016/j.neulet.2009.03.065; Ganea E, 2006, CURR EYE RES, V31, P1, DOI 10.1080/02713680500477347; Golbidi S, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00069; Gomes MB, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-80; Guarneri P, 2003, ANN NY ACAD SCI, V1007, P117, DOI 10.1196/annals.1286.012; Hippert C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120415; Inman DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065389; Irwin MH, 2016, DRUG DEVELOP RES, V77, P109, DOI 10.1002/ddr.21294; Ji D, 2013, BIOL PHARM BULL, V36, P1060, DOI 10.1248/bpb.b12-00941; Johnsen-Soriano S, 2008, FREE RADICAL RES, V42, P613, DOI 10.1080/10715760802206791; Jones BW, 2016, EXP EYE RES, V150, P149, DOI 10.1016/j.exer.2016.03.018; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pa.25.040185.003435; Keeler CE, 1924, P NATL ACAD SCI USA, V10, P329, DOI 10.1073/pnas.10.7.329; Kowluru RA, 2004, DIABETES, V53, P3233, DOI 10.2337/diabetes.53.12.3233; Kubota S, 2009, INVEST OPHTH VIS SCI, V50, P3512, DOI 10.1167/iovs.08-2666; Lopez AMR, 2017, EUR J NEUROSCI, V46, P1663, DOI 10.1111/ejn.13604; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Luna G, 2010, MOL VIS, V16, P2511; MAXSON WS, 1985, FERTIL STERIL, V44, P622; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Miranda M, 2010, FREE RADICAL BIO MED, V48, P216, DOI 10.1016/j.freeradbiomed.2009.10.042; MOORADIAN AD, 1993, J STEROID BIOCHEM, V45, P509, DOI 10.1016/0960-0760(93)90166-T; Moosmann B, 1999, P NATL ACAD SCI USA, V96, P8867, DOI 10.1073/pnas.96.16.8867; Noailles A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0186-3; Packer L, 1997, FREE RADICAL BIO MED, V22, P359, DOI 10.1016/S0891-5849(96)00269-9; Paradells-Navarro S, 2017, ACS CHEM NEUROSCI, V8, P569, DOI 10.1021/acschemneuro.6b00306; Pescosolido N, 2016, INT J OPHTHALMOL-CHI, V9, P1506, DOI 10.18240/ijo.2016.10.23; Petiz LL, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040353; Pierce EA, 2001, BIOESSAYS, V23, P605, DOI 10.1002/bies.1086; Punzo C, 2007, INVEST OPHTH VIS SCI, V48, P849, DOI 10.1167/iovs.05-1555; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; Sanchez-Vallejo V, 2015, PHARMACOL RES, V99, P276, DOI 10.1016/j.phrs.2015.06.019; Sanchez-Vallejo V, 2016, FREE RADICAL BIO MED, V96, P245, DOI 10.1016/j.freeradbiomed.2016.04.195; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; Sanz MM, 2007, NEUROSCIENCE, V145, P1120, DOI 10.1016/j.neuroscience.2006.12.034; Sarezky D, 2016, CLIN OPHTHALMOL, V10, P1899, DOI 10.2147/OPTH.S115900; Schweizer M, 1996, BIOCHEM PHARMACOL, V52, P1815, DOI 10.1016/S0006-2952(96)00459-5; Seifar F, 2019, NUTR NEUROSCI, V22, P306, DOI 10.1080/1028415X.2017.1386755; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; SUZUKI YJ, 1992, BIOCHEM BIOPH RES CO, V189, P1709, DOI 10.1016/0006-291X(92)90275-P; Swiatek-De Lange M, 2007, GLIA, V55, P1061, DOI 10.1002/glia.20523; Tian YF, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/349280; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Tuzcu M, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0524-1; Wang K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07601; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Zhao LL, 2014, INVEST OPHTH VIS SCI, V55, P5979, DOI 10.1167/iovs.14-15025	65	8	8	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	MAY 9	2018	9								469	10.3389/fphar.2018.00469			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	GF2KO	WOS:000431768300001	29867476	Green Published, gold			2022-02-06	
J	Zhao, S; Wang, XT; Gao, X; Chen, JH				Zhao, Shu; Wang, Xiaoting; Gao, Xiang; Chen, Jinhui			Delayed and progressive damages to juvenile mice after moderate traumatic brain injury	SCIENTIFIC REPORTS			English	Article							INFLICTED HEAD-INJURY; APOPTOTIC NEURODEGENERATION; IMMATURE RAT; TOTAL NUMBER; NEURONS; CHILDREN; DEATH; NEUROPATHOLOGY; CHILDHOOD; VULNERABILITY	Symptoms are commonly more severe in pediatric traumatic brain injury (TBI) patients than in young adult TBI patients. To understand the mechanism, juvenile mice received a controlled cortical impact (CCI) injury at moderate level. Tissue lesion and cell death were measured and compared to our previous reports on brain injury in the young adult mice that received same level of impact using same injury device. Tissue lesion and cell death in the cortex was much less in the juvenile mouse brain in the first few hours after injury. However, once the injury occurred, it developed more rapidly, lasted much longer, and eventually led to exaggerated cell death and a 32.7% larger tissue lesion cavity in the cortex of juvenile mouse brain than of young adult mouse brain. Moreover, we found significant cell death in the thalamus of juvenile brains at 72 h, which was not commonly seen in the young adult mice. In summary, cell death in juvenile mice was delayed, lasted longer, and finally resulted in more severe brain injury than in the young adult mice. The results suggest that pediatric TBI patients may have a longer therapeutic window, but they also need longer intensive clinical care after injury.	[Zhao, Shu; Wang, Xiaoting; Gao, Xiang; Chen, Jinhui] Indiana Univ, Dept Neurosurg, Stark Neurosci Res Inst, Spinal Cord & Brain Injury Res Grp, 320W 15th St, Indianapolis, IN 46202 USA		Chen, JH (corresponding author), Indiana Univ, Dept Neurosurg, Stark Neurosci Res Inst, Spinal Cord & Brain Injury Res Grp, 320W 15th St, Indianapolis, IN 46202 USA.	chen204@iupui.edu			Indiana Spinal Cord and Brain Injury Research Grants; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RR025761, 1R21NS072631, R21NS075733]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001108, TL1TR001107] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS075733, R21NS072631] Funding Source: NIH RePORTER	This work was supported by funding from Indiana Spinal Cord and Brain Injury Research Grants, and NIH grants RR025761, 1R21NS072631, and R21NS075733 to J. Chen.	Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Bayly PV, 2006, BRAIN RES, V1107, P70, DOI 10.1016/j.brainres.2006.05.102; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Chen L, 2015, J NEUROPATH EXP NEUR, V74, P557, DOI 10.1097/NEN.0000000000000199; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cudeiro J, 2006, TRENDS NEUROSCI, V29, P298, DOI 10.1016/j.tins.2006.05.002; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; DePompei R, 2008, J HEAD TRAUMA REHAB, V23, P191, DOI 10.1097/01.HTR.0000327251.16010.3b; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Gao X., 2009, J NEUROTRAUMA; Gao X, 2008, J NEUROTRAUM, V25, P985, DOI 10.1089/neu.2008.0460; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giza CC, 2006, INDIAN J NEUROTRAUM, V3, P19; Gobbel GT, 2007, CHILD NERV SYST, V23, P1171, DOI 10.1007/s00381-007-0345-2; HEDNER J, 1986, BIOL NEONATE, V49, P190; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; Huh JW, 2006, DEV NEUROSCI-BASEL, V28, P466, DOI 10.1159/000094172; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Kaldoja ML, 2012, BRAIN INJURY, V26, P1005, DOI 10.3109/02699052.2012.660516; Keshavan MS, 2002, LIFE SCI, V70, P1909, DOI 10.1016/S0024-3205(02)01492-3; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; NOWAKOWSKI RS, 1987, CHILD DEV, V58, P568, DOI 10.2307/1130199; Nowakowski RS, 1999, DEV PSYCHOPATHOL, V11, P395, DOI 10.1017/S0954579499002126; Parulekar MV, 2002, BRAIN, V125, P676, DOI 10.1093/brain/awf076; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; SUMI SM, 1968, ACTA NEUROPATHOL, V10, P324, DOI 10.1007/BF00690707; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Wang XX, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0270-16.2016; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1; Zhao S, 2016, MOL NEUROBIOL, V53, P1884, DOI 10.1007/s12035-015-9128-z; Zhao S, 2016, J NEUROTRAUM, V33, P2055, DOI 10.1089/neu.2015.4036; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078	64	8	8	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 9	2018	8								7339	10.1038/s41598-018-25475-9			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1ZX	WOS:000431737300025	29743575	Green Published, gold			2022-02-06	
J	Barden, C; Stokes, K				Barden, Craig; Stokes, Keith			Epidemiology of Injury in Elite English Schoolboy Rugby Union: A 3-Year Study Comparing Different Competitions	JOURNAL OF ATHLETIC TRAINING			English	Article						adolescents; injuries; youths; sport; upper limb; concussion	SHOULDER INJURIES; SPORTS INJURY; YOUTH RUGBY; CONCUSSION; FOOTBALL; CHILDREN; LEAGUE; RISKS	Context: Injury risks in professional and community rugby union have been extensively described; however, less is known about injury epidemiology at the schoolboy level. Objective: To investigate the injury risk in English schoolboy rugby union matches, comparing an elite competition (Achieving Academic and Sporting Excellence [AASE]) with subelite matches (non-AASE). Design: Retrospective cohort study. Setting: Rugby union academy, consisting of 16- to 19-year-old males, based at an elite sports college in England. Patients or Other Participants: A total of 132 participants (mean age = 17.5 years) were included in the study; 64 athletes experienced a total of 103 time-loss injuries over a 3-season period (2012-2015). All injuries were assessed and recorded by the team therapist using consensus statement definitions. Main Outcome Measure(s): Injury characteristics were recorded and compared between groups. Primary outcome measures were injury incidence (per 1000 h match exposure) and injury burden (days absent/1000 h), and rate ratios and 95% confidence intervals are presented throughout. Results: A total of 131 matches were played (34 AASE, 97 non-AASE) and a total of 103 injuries were recorded (47 AASE, 56 non-AASE). The injury incidence in AASE matches (77/1000 h) was greater than in non-AASE matches (34/1000 h). The concussion incidence in AASE matches (20/1000 h) was 5 times that of non-AASE matches (4/1000 h). The head/face had the highest injury incidence for a specific location, followed by the shoulder region (AASE = 19/1000 h, non-AASE = 5/1000 h), which had the greatest injury burden (553/1000 h and 105/1000 h, respectively) for any specific body location. More than 50% of all injuries were associated with tackles. Conclusions: A much greater incidence of all injuries occurred at the highest level of competition, and the concussion incidence was greater than that reported in any previously published study of youth rugby. Given the high incidence and burden of concussions and shoulder injuries, prevention and management deserve specific focus.	[Barden, Craig] South Gloucestershire & Stroud Coll, Physiotherapy Dept, Bristol BS34 8LP, Avon, England; [Barden, Craig; Stokes, Keith] Univ Bath, Bath, Avon, England		Barden, C (corresponding author), South Gloucestershire & Stroud Coll, Physiotherapy Dept, Bristol BS34 8LP, Avon, England.	Craig.Barden@sgscol.ac.uk	; Stokes, Keith/C-2605-2009	Barden, Craig/0000-0001-5504-2548; Stokes, Keith/0000-0002-5049-2838			Abernethy L, 2003, BRIT J SPORT MED, V37, P354, DOI 10.1136/bjsm.37.4.354; Archbold HAP, 2017, BRIT J SPORT MED, V51, P600, DOI 10.1136/bjsports-2015-095491; Bahr R, 2014, BRIT J SPORT MED, V48, P1265, DOI 10.1136/bjsports-2014-093832; Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Boufous S, 2004, AUST NZ J PUBL HEAL, V28, P482, DOI 10.1111/j.1467-842X.2004.tb00032.x; Burger N, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005556; Carter M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h26; Cumps E, 2008, BRIT J SPORT MED, V42, P767, DOI 10.1136/bjsm.2007.037937; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2011, CLIN J SPORT MED, V21, P356, DOI 10.1097/JSM.0b013e31821f5085; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Gabb N, 2015, THE SCI OF RUGBY, P219; Hagglund M, 2013, BRIT J SPORT MED, V47, P738, DOI 10.1136/bjsports-2013-092215; Haseler CM, 2010, BRIT J SPORT MED, V44, P1093, DOI 10.1136/bjsm.2010.074021; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; Maffulli N, 2010, BRIT J SPORT MED, V44, P21, DOI 10.1136/bjsm.2009.069526; Mathema P, 2016, CLIN J SPORT MED, V26, P320, DOI 10.1097/JSM.0000000000000256; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; Nutton RW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001149; Palmer-Green DS, 2013, AM J SPORT MED, V41, P749, DOI 10.1177/0363546512473818; Paul D, 2014, ASPETAR SPORTS MED J, V3, P578; Rae K, 2007, CLIN J SPORT MED, V17, P201, DOI 10.1097/JSM.0b013e318059b536; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Roberts SP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003998; Singh VR, 2016, INT J SPORTS MED, V37, P659, DOI 10.1055/s-0042-104414; Usman J, 2015, J SCI MED SPORT, V18, P529, DOI 10.1016/j.jsams.2014.07.020; Williams S, 2016, BRIT J SPORT MED, V50, P651, DOI 10.1136/bjsports-2015-094798; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1	30	8	8	0	13	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY	2018	53	5					514	520		10.4085/1062-6050-311-16			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GL5QN	WOS:000437223700010	29878844	gold, Green Published			2022-02-06	
J	Dabrowski, W; Schlegel, TT; Wosko, J; Rola, R; Rzecki, Z; Malbrain, MLNG; Jaroszynski, A				Dabrowski, Wojciech; Schlegel, Todd T.; Wosko, Jaroslaw; Rola, Radoslaw; Rzecki, Ziemowit; Malbrain, Manu L. N. G.; Jaroszynski, Andrzej			Changes in spatial QRS-T angle and QTc interval in patients with traumatic brain injury with or without intra-abdominal hypertension	JOURNAL OF ELECTROCARDIOLOGY			English	Article						Vectorcardiography; Intra-abdominal pressure; Brain-heart interaction; ST segment	CEREBROGENIC CARDIAC-ARRHYTHMIAS; ABDOMINAL COMPARTMENT SYNDROME; CORONARY-HEART-DISEASE; ELECTROCARDIOGRAPHIC ABNORMALITIES; SUBARACHNOID HEMORRHAGE; INTRACRANIAL-PRESSURE; ATHEROSCLEROSIS RISK; PERFUSION-PRESSURE; CLINICAL-PRACTICE; HEALTHY-SUBJECTS	Introduction: Traumatic brain injury (TBI) affects cardiac electrical function, and several extra-cerebral factors, including intra-abdominal pressure (IAP), might further modulate this brain-heart interaction. The purpose of this study was to investigate the impact of TBI, and of increased IAP during TBI, on cardiac electrical function as measured by vectorcardiographic (VCG) variables. Methods: Survival, IAP and changes in VCG variables including spatial QRS-T angle and QTc interval were measured in consecutive adult patients with either isolated TBI (iTBI), or with TBI accompanied by polytrauma to the abdomen and/or limbs (pTBI). For all patients, observations were performed just after the admission to the ICU (baseline) and at 24, 48, 72 and 96 h after admission. Results: 74 patients aged 45 18 were studied. 44 were treated for iTBI and 30 for pTBI. In all patients, spatial QRS-T angle and QTc interval increased after TBI (p < 0.001), relatively more so in patients with pTBI. Compared to survivors, non-survivors also ultimately had greater widening of the spatial QRS-T angle (p < 0.001), most notably just before foraminal herniation. Wider spatial QRS-T angle and longer QTc interval were also noted in patients with IAP > 12 mmHg (p < 0.001), and with right compared to left hemispheric injury (p < 0.001). ST segment level at the J point decreased 24 and 48 h after TBI in leads 1,11,111, aVR, aVF, V-1, V-2, V-3 and V-6, and increased in lead V-1, especially in non-survivors. Conclusions: Spatial QRS-T angle and QTc interval increase after TBI. If foraminal herniation complicates TBI, further widening of the spatial QRS-T angle typically precedes it, followed by notable narrowing thereafter. Increased IAP also intensifies TBI-associated increases in spatial QRS-T angle and QTc interval. (C) 2017 Elsevier Inc. All rights reserved.	[Dabrowski, Wojciech; Wosko, Jaroslaw; Rzecki, Ziemowit] Med Univ Lublin, Dept Anaesthesiol & Intens Therapy, Jaczewskiego 8, PL-20954 Lublin, Poland; [Schlegel, Todd T.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Schlegel, Todd T.] Nicollier Schlegel SARL, Trelex, Switzerland; [Rola, Radoslaw] Med Univ Lublin, Dept Neurosurg & Paediat Neurosurg, Lublin, Poland; [Malbrain, Manu L. N. G.] ZNA Stuivenberg, Ziekenhuis Netwerk Antwerp, Intens Care Unit, Antwerp, Belgium; [Malbrain, Manu L. N. G.] ZNA Stuivenberg, Ziekenhuis Netwerk Antwerp, High Care Burn Unit, Antwerp, Belgium; [Malbrain, Manu L. N. G.] Univ Hosp Brussels UZB, Intens Care Unit, Jette, Belgium; [Malbrain, Manu L. N. G.] Free Univ Brussels VUB, Fac Med, Brussels, Belgium; [Jaroszynski, Andrzej] Jan Kochanowski Univ Humanities & Sci, Inst Med Sci, Dept Nephrol, Kielce, Poland		Dabrowski, W (corresponding author), Med Univ Lublin, Dept Anaesthesiol & Intens Therapy, Jaczewskiego 8, PL-20954 Lublin, Poland.	w.dabrowski5@yahoo.com	Dabrowski, Wojciech/AAN-8425-2020; Malbrain, Manu LNG/B-3680-2017; Rola, Radoslaw/V-6749-2018; Rola, Radoslaw/AAQ-5587-2021	Dabrowski, Wojciech/0000-0003-0449-2375; Malbrain, Manu LNG/0000-0002-1816-5255; Rola, Radoslaw/0000-0003-0613-6593; Rola, Radoslaw/0000-0003-0613-6593; Jaroszynski, Andrzej/0000-0001-8194-1723			Abrich VA, 2017, INT J CARDIOL, V232, P243, DOI 10.1016/j.ijcard.2017.01.011; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Borleffs CJW, 2009, CIRC-ARRHYTHMIA ELEC, V2, P548, DOI 10.1161/CIRCEP.109.859108; Citerio G, 2001, CRIT CARE MED, V29, P1466, DOI 10.1097/00003246-200107000-00027; Coghlan LA, 2009, STROKE, V40, P412, DOI 10.1161/STROKEAHA.108.528778; Cortez DL, 2010, J ELECTROCARDIOL, V43, P302, DOI 10.1016/j.jelectrocard.2010.03.010; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2005, BRAIN, V128, P75, DOI 10.1093/brain/awh324; Dabrowski W, 2007, MED SCI MONITOR, V13, pCR548; Dabrowski W, 2017, J ELECTROCARDIOL, V50, P214, DOI 10.1016/j.jelectrocard.2016.10.002; Dabrowski W, 2009, EXP CLIN CARDIOL, V14, pE84; Daniele Ornella, 2002, J Stroke Cerebrovasc Dis, V11, P28, DOI 10.1053/jscd.2002.123972; Deeren DH, 2005, INTENS CARE MED, V31, P1577, DOI 10.1007/s00134-005-2802-2; EDENBRANDT L, 1988, J ELECTROCARDIOL, V21, P361, DOI 10.1016/0022-0736(88)90113-6; Egawa H, 2002, CAN J ANAESTH, V49, P805, DOI 10.1007/BF03017412; Ha YW, 2016, METAL IONS LIFE SCI, V16, P585, DOI 10.1007/978-3-319-21756-7_16; Hashemian Amir Masoud, 2015, Med J Islam Repub Iran, V29, P306; He MJ, 2015, INTERNAL MED, V54, P295, DOI 10.2169/internalmedicine.54.2297; Iyer D, 2014, ACTA ANAESTH SCAND, V58, P1267, DOI 10.1111/aas.12409; Jarosz B, 2012, MAGNESIUM RES, V25, P89, DOI 10.1684/mrh.2012.0310; Jaroszynski A, 2010, NEPHROL DIAL TRANSPL, V25, P3723, DOI 10.1093/ndt/gfq247; Kardys I, 2003, EUR HEART J, V24, P1357, DOI 10.1016/S0195-668X(03)00203-3; Katsanos AH, 2013, INT J CARDIOL, V167, P328, DOI 10.1016/j.ijcard.2012.06.107; Kirkpatrick AW, 2013, INTENS CARE MED, V39, P1190, DOI 10.1007/s00134-013-2906-z; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Lauerman MH, 2014, CURR OPIN ANESTHESIO, V27, P219, DOI 10.1097/ACO.0000000000000044; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Macmillan CSA, 2003, EUR J ANAESTH, V20, P537, DOI 10.1097/00003643-200307000-00004; Mahjoub Y, 2012, BRIT J ANAESTH, V108, P211, DOI 10.1093/bja/aer382; Malbrain MLNG, 2005, CRIT CARE MED, V33, P315, DOI 10.1097/01.CCM.0000153408.09806.1B; Moussouttas M, 2012, NEUROCRIT CARE, V16, P381, DOI 10.1007/s12028-012-9673-5; Oehler A, 2014, ANN NONINVAS ELECTRO, V19, P534, DOI 10.1111/anec.12206; Oji M, 2013, J CLIN MONIT COMPUT, V27, P243, DOI 10.1007/s10877-012-9420-7; Oppenheimer S, 2006, CLIN AUTON RES, V16, P6, DOI 10.1007/s10286-006-0276-0; OPPENHEIMER SM, 1990, ARCH NEUROL-CHICAGO, V47, P513, DOI 10.1001/archneur.1990.00530050029008; Owczuk R, 2012, MINERVA ANESTESIOL, V78, P483; Ozdemir O, 2008, J NEUROL SCI, V268, P6, DOI 10.1016/j.jns.2007.11.009; Rautaharju PM, 2007, AM J CARDIOL, V100, P1437, DOI 10.1016/j.amjcard.2007.06.036; REINTAM BA, 2012, INTENS CARE MED, V38, P384, DOI DOI 10.1007/S00134-011-2459-Y; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Shaheen Aisha W, 2016, J Emerg Trauma Shock, V9, P53, DOI 10.4103/0974-2700.179452; SHANLIN RJ, 1988, J AM COLL CARDIOL, V12, P727, DOI 10.1016/S0735-1097(88)80065-2; Shi SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101734; Silvani A, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0181; Staikou C, 2014, BRIT J ANAESTH, V112, P217, DOI 10.1093/bja/aet412; Stead LG, 2009, J STROKE CEREBROVASC, V18, P469, DOI 10.1016/j.jstrokecerebrovasdis.2009.02.006; Takala P, 2001, ANN BIOMED ENG, V29, P501, DOI 10.1114/1.1376388; Voulgari C, 2013, CURR CARDIOL REV, V9, P197, DOI 10.2174/1573403X113099990031; Xie Q, 2017, WORLD NEUROSURG, V100, P118, DOI 10.1016/j.wneu.2016.12.097; Yamazaki T, 2005, HEART RHYTHM, V2, P73, DOI 10.1016/j.hrthm.2004.10.040; Zhang XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136174; Zhang ZM, 2007, AM J CARDIOL, V100, P844, DOI 10.1016/j.amjcard.2007.03.104; Zhang ZM, 2015, J ELECTROCARDIOL, V48, P672, DOI 10.1016/j.jelectrocard.2015.04.014; Zipes DP, 2006, HEART RHYTHM, V3, P108, DOI 10.1016/j.hrthm.2005.09.021	54	8	8	2	3	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0022-0736	1532-8430		J ELECTROCARDIOL	J. Electrocardiol.	MAY-JUN	2018	51	3					499	507		10.1016/j.jelectrocard.2017.12.038			9	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	GI1BR	WOS:000434104700034	29310923				2022-02-06	
J	Garcia, M; Daugherty, C; Ben Khallouq, B; Maugans, T				Garcia, Michael; Daugherty, Christopher; Ben Khallouq, Bertha; Maugans, Todd			Critical assessment of pediatric neurosurgery patient/ parent educational information obtained via the Internet	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						Internet; pediatric; educational information	HEALTH INFORMATION; RESPONSE CATEGORIES; MEDICAL INFORMATION; QUALITY; RELIABILITY; NUMBER; SCALE; READABILITY; INSTRUMENT; WEBSITES	OBJECTIVE The Internet is used frequently by patients and family members to acquire information about pediatric neurosurgical conditions. The sources, nature, accuracy, and usefulness of this information have not been examined recently. The authors analyzed the results from searches of 10 common pediatric neurosurgical terms using a novel scoring test to assess the value of the educational information obtained. METHODS Google and Bing searches were performed for 10 common pediatric neurosurgical topics (concussion, craniosynostosis, hydrocephalus, pediatric brain tumor, pediatric Chiari malformation, pediatric epilepsy surgery, pediatric neurosurgery, plagiocephaly, spina bifida, and tethered spinal cord). The first 10 "hits" obtained with each search engine were analyzed using the Currency, Relevance, Authority, Accuracy, and Purpose (CRAAP) test, which assigns a numerical score in each of 5 domains. Agreement between results was assessed for 1) concurrent searches with Google and Bing; 2) Google searches over time (6 months apart); 3) Google searches using mobile and PC platforms concurrently; and 4) searches using privacy settings Readability was assessed with an online analytical tool. RESULTS Google and Bing searches yielded information with similar CRAAP scores (mean 72% and 75%, respectively), but with frequently differing results (58% concordance/matching results). There was a high level of agreement (72% concordance) over time for Google searches and also between searches using general and privacy settings (92% concordance). Government sources scored the best in both CRAAP score and readability. Hospitals and universities were the most prevalent sources, but these sources had the lowest CRAAP scores, due in part to an abundance of self-marketing. The CRAAP scores for mobile and desktop platforms did not differ significantly (p = 0.49). CONCLUSIONS Google and Bing searches yielded useful educational information, using either mobile or PC platforms. Most information was relevant and accurate; however, the depth and breadth of information was variable. Search results over a 6-month period were moderately stable. Pediatric neurosurgery practices and neurosurgical professional organization websites were inferior (less current, less accurate, less authoritative, and less purposeful) to governmental and encyclopedia-type resources such as Wikipedia. This presents an opportunity for pediatric neurosurgeons to participate in the creation of better online patient/parent educational material.	[Garcia, Michael; Ben Khallouq, Bertha; Maugans, Todd] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA; [Daugherty, Christopher; Maugans, Todd] Nemours Childrens Hosp, Div Pediat Neurosurg, Orlando, FL USA		Maugans, T (corresponding author), Nemours Childrens Hosp, Orlando, FL 32827 USA.	tmaugans@nemours.org					Alamoudi U, 2015, INT J PEDIATR OTORHI, V79, P151, DOI 10.1016/j.ijporl.2014.11.027; Azer SA, 2017, J CANC ED; Cerminara C, 2014, EPILEPSY BEHAV, V41, P119, DOI 10.1016/j.yebeh.2014.09.053; Charnock D, 1999, J EPIDEMIOL COMMUN H, V53, P105, DOI 10.1136/jech.53.2.105; Charvet-Berard AI, 2008, PATIENT EDUC COUNS, V70, P407, DOI 10.1016/j.pec.2007.11.018; Chi E, 2017, INT J PEDIATR OTORHI, V98, P1, DOI 10.1016/j.ijporl.2017.04.031; Clark David D., 1997, BRIEF HIST INTERNET; Coiera E, 1996, BMJ-BRIT MED J, V312, P3, DOI 10.1136/bmj.312.7022.3; Davis KS, 2017, INT J PEDIATR OTORHI, V93, P63, DOI 10.1016/j.ijporl.2016.12.004; Eysenbach G, 1998, BRIT MED J, V317, P1496, DOI 10.1136/bmj.317.7171.1496; Faden RR, 1986, HIST THEORY INFORM C; Fetto J, 2016, MOBILE SEARCH TOPICS; Fox S, 2013, HLTH ONLINE 2013; HALPIN G, 1994, PERCEPT MOTOR SKILL, V79, P928, DOI 10.2466/pms.1994.79.2.928; John ES, 2016, INT J COLORECTAL DIS, V31, P1817, DOI 10.1007/s00384-016-2652-0; KOMORITA SS, 1965, EDUC PSYCHOL MEAS, V25, P987, DOI 10.1177/001316446502500404; Lella A, 2016, COMSCORE RELEASES FE; MASTERS JR, 1974, J EDUC MEAS, V11, P49; MATELL MS, 1971, EDUC PSYCHOL MEAS, V31, P657, DOI 10.1177/001316447103100307; Maugans TA, 1998, PEDIATR NEUROSURG, V28, P186, DOI 10.1159/000028647; McCool ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139895; McKearney TC, 2013, INT J PEDIATR OTORHI, V77, P894, DOI 10.1016/j.ijporl.2013.03.021; MEREDITH P, 1995, BRIT MED J, V311, P4, DOI 10.1136/bmj.311.6996.4; Minervation, 2007, LIDA INSTR MIN VAL I; Moult B, 2004, HEALTH EXPECT, V7, P165, DOI 10.1111/j.1369-7625.2004.00273.x; Muhandiramge J, 2016, J MINIM ACCESS SURG, V12, P321, DOI 10.4103/0972-9941.186691; Nghiem AZ, 2016, BREAST, V25, P34, DOI 10.1016/j.breast.2015.10.001; Schairer WW, 2017, J ARTHROPLASTY, V32, P3616, DOI 10.1016/j.arth.2017.06.031; Silberg WM, 1997, JAMA-J AM MED ASSOC, V277, P1244, DOI 10.1001/jama.277.15.1244; Tang HW, 2006, BRIT MED J, V333, P1143, DOI 10.1136/bmj.39003.640567.AE; U.S. Department of Health and Human Services, 2015, QUICK GUID HLTH LIT; Weng LJ, 2004, EDUC PSYCHOL MEAS, V64, P956, DOI 10.1177/0013164404268674; Winker MA, 2000, JAMA-J AM MED ASSOC, V283, P1600, DOI 10.1001/jama.283.12.1600	33	8	9	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAY	2018	21	5					535	541		10.3171/2017.10.PEDS17177			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	GG9UP	WOS:000433046900016	29451451				2022-02-06	
J	Keret, A; Shweiki, M; Bennett-Back, O; Abed-Fteiha, F; Matoth, I; Shoshan, Y; Benifla, M				Keret, Amit; Shweiki, Moatasim; Bennett-Back, Odeya; Abed-Fteiha, Fadia; Matoth, Israel; Shoshan, Yigal; Benifla, Mony			The clinical characteristics of posttraumatic epilepsy following moderate-to-severe traumatic brain injury in children	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Children; Traumatic brain injury; Post-traumatic epilepsy; Paediatric neurosurgery	POPULATION-BASED COHORT; HEAD-INJURY; PARENT PERCEPTIONS; SEIZURES; RISK; EPILEPTOGENESIS; EPIDEMIOLOGY; METAANALYSIS; ENCOUNTERS; BIOMARKERS	Purpose: Children with traumatic brain injury (TBI) are at increased risk of posttraumatic epilepsy (PTE); the risk increases according to TBI severity. We examined the long-term incidence and risk factors for developing PTE in a cohort of children hospitalised at one medical centre with moderate or severe TBI. Methods: Moderate brain injury was classified as Glasgow Coma Score on Arrival (GCSOA) of 9-13, and severe brain injury as GCSOA <= 8. We collected demographics and clinical data from medical records and interviewed patients and parents at 5-11 years following the TBI event. Results: During a median follow-up period of 7.3 years, 9 (9%) of 95 children with moderate-to-severe TBI developed PTE; 4 developed intractable epilepsy. The odds for developing PTE was 2.9 in patients with severe compared to moderate TBI. CT findings showed fractures in 7/9 (78%) of patients with PTE, compared to 40/86 (47%) of those without PTE (p=0.09). Of the patients with fractures, all those with PTE had additional features on CT (such as haemorrhage, contusion and mass effect), compared to 29/40 (73%) of those without PTE. One of nine (11%) PTE patients and 10 of 86 (12%) patients without PTE had immediate seizures. Two (22%) children with PTE had their first seizure more than 2 years after the TBI. Conclusion: Among children with moderate or severe TBI, the presence of additional CT findings, other than skull fractures, seem to increase the risk of PTE. In our cohort, the occurrence of an early seizure did not confer an increased risk of PTE. (C) 2018 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Keret, Amit; Shweiki, Moatasim; Abed-Fteiha, Fadia] Hadassah Ein Kerem Med Ctr, Paediat Neurosurg Unit, Jerusalem, Israel; [Shweiki, Moatasim; Shoshan, Yigal] Hadassah Ein Kerem Med Ctr, Neurosurg Dept, Jerusalem, Israel; [Bennett-Back, Odeya; Matoth, Israel] Hadassah Ein Kerem Med Ctr, Paediat Neurol Dept, Jerusalem, Israel; [Benifla, Mony] Rambam Hlth Care Campus, Pediat Neurosurg Unit, Haifa, Israel		Benifla, M (corresponding author), Rambam Hlth Care Campus, Paediat Neurosurg Div, Haifa, Israel.	amit.keret@health.qld.gov.au; DRMOTASIMSS@hadassah.org.il; Hodaya.b@meuhedet.co.il; Fadia@hadassah.org.il; Matoth@hadassah.org.il; Yigal@hadassah.org.il; M_Benifla@rmc.gov.il		Keret, Amit/0000-0002-2242-3632			Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Allen KA, 2016, J NEUROSCI NURS, V48, P15, DOI 10.1097/JNN.0000000000000176; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Appleton RE, 2002, J NEUROL NEUROSUR PS, V72, P669, DOI 10.1136/jnnp.72.5.669; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bennett KS, 2017, PEDIATR CRIT CARE ME, V18, P54, DOI 10.1097/PCC.0000000000000948; Chen C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040414; Christensen J, 2015, SEMIN NEUROL, V35, P218, DOI 10.1055/s-0035-1552923; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Dennis EL, 2017, NEUROLOGY, V88, P1392, DOI 10.1212/WNL.0000000000003808; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; Huguenard AL, 2016, J NEUROSURG-PEDIATR, V17, P476, DOI 10.3171/2015.7.PEDS14723; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Immonen R, 2013, J NEUROTRAUM, V30, P1305, DOI 10.1089/neu.2012.2815; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; Keret A, 2017, J NEUROSURG, P1; Kieslich M, 2001, DISABIL REHABIL, V23, P665; Lee ST, 1997, CAN J NEUROL SCI, V24, P40, DOI 10.1017/S0317167100021077; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Matsumoto JH, 2013, EPILEPSY BEHAV, V27, P233, DOI 10.1016/j.yebeh.2013.01.024; Petridis AK, 2012, CLIN PRACTICE, V2; Piatt JH, 2012, J NEUROSURG-PEDIATR, V10, P257, DOI 10.3171/2012.7.PEDS11532; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Reuter-Rice K, 2015, ANNU REV NURS RES-SE, V33, P185, DOI 10.1891/0739-6686.33.185; Ritter AC, 2016, EPILEPSIA, V57, P984, DOI 10.1111/epi.13397; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Roscigno CI, 2016, J NEUROSCI NURS, V48, pE2, DOI 10.1097/JNN.0000000000000192; Roscigno CI, 2015, DISABIL REHABIL, V37, P523, DOI 10.3109/09638288.2014.933896; Roscigno CI, 2013, BRAIN INJURY, V27, P1536, DOI 10.3109/02699052.2013.831122; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schoderboeck L, 2009, NEUROBIOL DIS, V35, P368, DOI 10.1016/j.nbd.2009.05.026; Thapa A, 2010, SEIZURE-EUR J EPILEP, V19, P211, DOI 10.1016/j.seizure.2010.02.004; Thompson K, 2015, PHARM TREATMENTS PRE, DOI [10.1002/14651858CD009900.pub2, DOI 10.1002/14651858_CD009900.PUB2]; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Vaewpanich J, 2016, EPILEPSY BEHAV, V62, P225, DOI 10.1016/j.yebeh.2016.07.012; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547	44	8	9	0	5	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	MAY	2018	58						29	34		10.1016/j.seizure.2018.03.018			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GL1RM	WOS:000436884500007	29609147	Bronze			2022-02-06	
J	Lin, GQ; He, XF; Liang, FY; Guo, Y; Sunnassee, G; Chen, J; Cao, XM; Chen, YY; Pan, GJ; Pei, Z; Tan, S				Lin, Gui-qing; He, Xiao-fei; Liang, Feng-yin; Guo, Yang; Sunnassee, Gavin; Chen, Jian; Cao, Xiao-min; Chen, Yi-yi; Pan, Guang-jin; Pei, Zhong; Tan, Sheng			Transplanted human neural precursor cells integrate into the host neural circuit and ameliorate neurological deficits in a mouse model of traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Human neural progenitor cell transplantation; Cell therapy; Integration; Calcium imaging	EMBRYONIC STEM-CELLS; IN-VIVO; NEURONAL DIFFERENTIATION; NEUROGENESIS; RATS	Traumatic brain injury (TBI) is to date one of the major critical conditions causing death and disability worldwide. Exogenous neural stem/precursor cells (NSCs/NPCs) hold great promise for improving neurological dysfunction, but their functional properties in vivo remain unknown. Human neural precursor cells (hNPCs) carrying one fluorescent reporter gene (DsRed) can be observed directly in vivo using two-photon laser-scanning microscope. Therefore, we evaluated the neural integration and potential therapeutic effect of hNPCs on mice with TBI. Behavioral tests were performed by rotarod task and Morris Water Maze task. Neural integration was detected by fluorometric Ca2+ imaging and nerve tracing. We found that motor and cognition functions were significantly improved in mice with hNPCs injection compared to mice with vehicle treatment, and hNPCs integrated into the host circuit and differentiated toward neuronal lineage. Our study provided reliable evidence for further hNPCs transplantation in clinical practice.	[Lin, Gui-qing; Guo, Yang; Sunnassee, Gavin; Chen, Jian; Cao, Xiao-min; Chen, Yi-yi; Tan, Sheng] Southern Med Univ, Zhujiang Hosp, Dept Neurol, Ind Ave 253, Guangzhou 510282, Guangdong, Peoples R China; [He, Xiao-fei; Liang, Feng-yin; Pei, Zhong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China; [Lin, Gui-qing] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Neurol, Cadre Ward, Nanning, Guangxi, Peoples R China; [Pan, Guang-jin] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China		Tan, S (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Neurol, Ind Ave 253, Guangzhou 510282, Guangdong, Peoples R China.; Pei, Z (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	peizhong@mail.sysu.edu.cn; tansheng18@126.com		Gui-qing, Lin/0000-0001-9324-2858	Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases [2014B030301035]; Southern China International Cooperation Base for Early Intervention and Functional Rehabilitation of Neurological Diseases [2015B050501003]; Guangzhou Clinical Research and Translational Center for Major Neurological Diseases [201604020010]; Guangdong Provincial Engineering Center for Major Neurological Disease Treatment; National Key Research and Development Program of China, Stem Cell and Translational Research [2017YFA0105104]; Guangdong provincial science and technology plan project [2017A020215087, 20168030230002, 20148040404053, 2017A040406007]	This work was supported by the grants from: Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases (grant number: 2014B030301035); The Southern China International Cooperation Base for Early Intervention and Functional Rehabilitation of Neurological Diseases (grant number: 2015B050501003); Guangzhou Clinical Research and Translational Center for Major Neurological Diseases (grant number: 201604020010); Guangdong Provincial Engineering Center for Major Neurological Disease Treatment; The National Key Research and Development Program of China, Stem Cell and Translational Research (grant number: 2017YFA0105104); Guangdong provincial science and technology plan project (grant numbers: 2017A020215087,20168030230002, 20148040404053, 2017A040406007).	Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Ge XL, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.100; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Guillaume DJ, 2006, J NEUROSCI RES, V84, P1165, DOI 10.1002/jnr.21022; He XF, 2015, PHYSIOL BEHAV, V151, P502, DOI 10.1016/j.physbeh.2015.08.026; Hefferan MP, 2011, CELL TRANSPLANT, V20, P1153, DOI 10.3727/096368910X564553; Hendriks WT, 2016, CELL STEM CELL, V18, P53, DOI 10.1016/j.stem.2015.12.002; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Spurlock MS, 2017, J NEUROTRAUM, V34, P1981, DOI 10.1089/neu.2016.4602; Steward O, 2017, EXP NEUROL, V287, P374, DOI 10.1016/j.expneurol.2016.06.029; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tennstaedt A, 2015, BIOMATERIALS, V44, P143, DOI 10.1016/j.biomaterials.2014.12.038; Wang JY, 2013, CNS NEUROL DISORD-DR, V12, P413, DOI 10.2174/1871527311312030014; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097	22	8	9	0	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 1	2018	674						11	17		10.1016/j.neulet.2018.02.064			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GE0FJ	WOS:000430889200002	29501684				2022-02-06	
J	Mangat, HS; Scholler, K; Budohoski, KP; Ngerageza, JG; Qureshi, M; Santos, MM; Shabani, HK; Zubkov, MR; Hartl, R; Stieg, PE				Mangat, Halinder S.; Schoeller, Karsten; Budohoski, Karol P.; Ngerageza, Japhet G.; Qureshi, Mahmood; Santos, Maria M.; Shabani, Hamisi K.; Zubkov, Micaella R.; Hartl, Roger; Stieg, Philip E.			Neurosurgery in East Africa: Foundations	WORLD NEUROSURGERY			English	Article						Disease burden; East Africa; Low-middle income countries; Neurosurgery	SUB-SAHARAN AFRICA; ENDOSCOPIC 3RD VENTRICULOSTOMY; TRAUMATIC BRAIN-INJURY; CHOROID-PLEXUS CAUTERIZATION; CLINICAL ARTICLE; CONSECUTIVE CHILDREN; MEDICAL-CENTER; HYDROCEPHALUS; TANZANIA; UGANDA	This article is the first in a series of 3 articles that seek to provide readers with an understanding of the development of neurosurgery in East Africa (Foundations), the challenges that arise in providing neurosurgical care in developing countries (Challenges), and an overview of traditional and novel approaches to overcoming these challenges to improve healthcare in the region (Innovations). We review the history and evolution of neurosurgery as a clinical specialty in East Africa. We also review Kenya, Uganda, and Tanzania in some detail and highlight contributions of individuals and local and regional organizations that helped to develop and shape neurosurgical care in East Africa. Neurosurgery has developed steadily as advanced techniques have been adopted by local surgeons who trained abroad, and foreign surgeons who have dedicated part of their careers in local hospitals. New medical schools and surgical training programs have been established through regional and international partnerships, and the era of regional specialty surgical training has just begun. As more surgical specialists complete training, a comprehensive estimation of disease burden facing the neurosurgical field is important. We present an overview with specific reference to neurotrauma and neural tube defects, both of which are of epidemiologic importance as they gain not only greater recognition, but increased diagnoses and demands for treatment. Neurosurgery in East Africa is poised to blossom as it seeks to address the growing needs of a growing subspecialty.	[Mangat, Halinder S.] Weill Cornell Med, Div Stroke & Crit Care, Dept Neurol, New York, NY 10065 USA; [Schoeller, Karsten] Justus Liebig Univ Giessen, Dept Neurosurg, Giessen, Germany; [Budohoski, Karol P.] Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Cambridge, England; [Budohoski, Karol P.] Univ Cambridge, Natl Inst Healthcare Res, Global Hlth Res Grp Neurotrauma, Cambridge, England; [Ngerageza, Japhet G.; Shabani, Hamisi K.] Muhimbili Orthoped Neurosurg Inst, Dept Neurosurg, Dar Es Salaam, Tanzania; [Qureshi, Mahmood] Aga Khan Univ Hosp, Dept Neurosurg, Nairobi, Kenya; [Santos, Maria M.] Weill Cornell Med, Ctr Global Hlth, New York, NY USA; [Santos, Maria M.; Zubkov, Micaella R.; Hartl, Roger; Stieg, Philip E.] New York Presbyterian Hosp, Weill Cornell Med, Weill Cornell Brain & Spine Ctr, Dept Neurol Surg, New York, NY USA		Mangat, HS (corresponding author), Weill Cornell Med, Div Stroke & Crit Care, Dept Neurol, New York, NY 10065 USA.	hsm9001@med.cornell.edu	Mangat, HALINDER/AAN-9153-2020	Mangat, HALINDER/0000-0003-3426-2001			Adeloye A, 1997, J NATL MED ASSOC, V89, P62; [Anonymous], 2013, MIDTERM ANAL REV PER, P118; Attebery JE, 2010, WORLD NEUROSURG, V73, P290, DOI 10.1016/j.wneu.2010.02.008; Biluts Hagos, 2015, Ethiop Med J, V53, P75; Biluts Hagos, 2014, Ethiop Med J, V52, P67; Biluts Hagos, 2012, Ethiop Med J, V50, P57; Biluts Hagos, 2009, Ethiop Med J, V47, P135; Budohoski KP, 2018, WORLD NEURO IN PRESS; Byass P, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001477; Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001006; Cadotte DW, 2010, WORLD NEUROSURG, V73, P270, DOI 10.1016/j.wneu.2010.02.017; Chalya Phillipo L, 2012, J Trauma Manag Outcomes, V6, P1, DOI 10.1186/1752-2897-6-1; Coburger J, 2014, WORLD NEUROSURG, V82, pE1, DOI 10.1016/j.wneu.2012.09.019; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; FURNAS DW, 1985, ANN PLAS SURG, V15, P538, DOI 10.1097/00000637-198512000-00014; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gathura E, 2010, J NEUROSURG-PEDIATR, V6, P329, DOI 10.3171/2010.7.PEDS09543; Kiboi JG, 2011, WORLD NEUROSURG, V75, P586, DOI 10.1016/j.wneu.2010.05.041; Kinasha A, 2012, WORLD NEUROSURG, V78, DOI [10.1016/J.WNEU.2011.06.008, 10.1016/j.wneu.2011.06.008]; KIRYABWIRE JWM, 1987, NEUROSURGERY, V20, P664, DOI 10.1227/00006123-198704000-00029; Kodwavwala Y., 2009, MONOGRAPH COSECSA 10; Kulkarni AV, 2010, CHILD NERV SYST, V26, P1711, DOI 10.1007/s00381-010-1195-x; Lane JD, 2014, J NEUROSURG-PEDIATR, V13, P140, DOI 10.3171/2013.11.PEDS13394; Lehre MA, 2015, J NEUROSURG-SPINE, V23, P772, DOI 10.3171/2015.3.SPINE141282; Loefler IJP, 1998, E CENTRAL AFR J SURG, V5, P55; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Maier D, 2010, WIEN KLIN WOCHENSCHR, V122, P40, DOI 10.1007/s00508-010-1436-8; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; MCLARTY DG, 1982, LANCET, V2, P810; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; MLAY SM, 1993, E AFR MED J, V70, P291; Mwachaka PM, 2010, PEDIATR NEUROSURG, V46, P1, DOI 10.1159/000314050; Nkusi AE, 2016, WORLD NEUROSURG, V87, P269, DOI 10.1016/j.wneu.2015.11.092; Ochieng' N, 2015, J NEUROSURG-PEDIATR, V15, P150, DOI 10.3171/2014.10.PEDS14178; Qureshi MM, 2010, WORLD NEUROSURG, V73, P261, DOI 10.1016/j.wneu.2010.02.014; Rose J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089693; Shrime MG, 2015, LANCET GLOB HEALTH, V3, pS8, DOI 10.1016/S2214-109X(14)70384-5; Stagno V, 2014, CHILD NERV SYST, V30, P137, DOI 10.1007/s00381-013-2297-z; TEASDALE G, 1974, LANCET, V2, P81; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Wanyoike P K, 2004, East Afr Med J, V81, P258; Warf BC, 2005, J NEUROSURG, V102, P1, DOI 10.3171/ped.2005.102.1.0001; Warf BC, 2005, J NEUROSURG, V103, P475, DOI 10.3171/ped.2005.103.6.0475; Warf BC, 2008, J NEUROSURG-PEDIATR, V2, P310, DOI 10.3171/PED.2008.2.11.310; Warf BC, 2011, J NEUROSURG-PEDIATR, V7, P88, DOI 10.3171/2010.9.PEDS10326; Warf BC, 2012, J NEUROSURG-PEDIATR, V10, P463, DOI 10.3171/2012.9.PEDS1236; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P502, DOI 10.3171/2011.8.PEDS11221; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P509, DOI 10.3171/2011.8.PEDS11163; Warf BC, 2011, CHILD NERV SYST, V27, P1589, DOI 10.1007/s00381-011-1484-z; Warf BC, 2011, J NEUROSURG-PEDIATR, V7, P127, DOI 10.3171/2010.11.PEDS10428; Warf BC, 2010, WORLD NEUROSURG, V73, P296, DOI 10.1016/j.wneu.2010.02.009; Wilson DA, 2012, WORLD NEUROSURG, V77, P32, DOI 10.1016/j.wneu.2011.03.013; Winkler AS, 2010, WORLD NEUROSURG, V73, P264, DOI 10.1016/j.wneu.2010.03.037; Wong JC, 2016, EUR J NEUROL, V23, P382, DOI 10.1111/ene.12877; World Health Organization, NEUROSURGEONS WHO; Zellner H, 2010, WIEN KLIN WOCHENSCHR, V122, P47, DOI 10.1007/s00508-010-1437-7	56	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2018	113						411	424		10.1016/j.wneu.2018.01.086			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8JD	WOS:000432942700181	29702965				2022-02-06	
J	Nagata, K; Suto, Y; Cognetti, J; Browne, KD; Kumasaka, K; Johnson, VE; Kaplan, L; Marks, J; Smith, DH; Pascual, JL				Nagata, Katsuhiro; Suto, Yujin; Cognetti, John; Browne, Kevin D.; Kumasaka, Kenichiro; Johnson, Victoria E.; Kaplan, Lewis; Marks, Joshua; Smith, Douglas H.; Pascual, Jose L.			Early low-anticoagulant desulfated heparin after traumatic brain injury: Reduced brain edema and leukocyte mobilization is associated with improved watermaze learning ability weeks after injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						ODSH; TBI; leukocyte; Morris Water Maze; heparin	CEREBRAL ISCHEMIA/REPERFUSION INJURY; NEUROGENIC PULMONARY-EDEMA; MOLECULAR-WEIGHT HEPARIN; ACUTE LUNG INJURY; IN-VIVO; NONANTICOAGULANT HEPARIN; NEUROLOGIC RECOVERY; NEURONAL NECROSIS; HEMORRHAGIC-SHOCK; ARTERY OCCLUSION	BACKGROUND Unfractionated heparin administered immediately after traumatic brain injury (TBI) reduces brain leukocyte (LEU) accumulation, and enhances early cognitive recovery, but may increase bleeding after injury. It is unknown how non-anticoagulant heparins, such as 2,3-O desulfated heparin (ODSH), impact post-TBI cerebral inflammation and long-term recovery. We hypothesized that ODSH after TBI reduces LEU-mediated brain inflammation and improves long-term neurologic recovery. METHODS CD1 male mice (n = 66) underwent either TBI (controlled cortical impact [CCI]) or sham craniotomy. 2,3-O desulfated heparin (25 mg/kg [25ODSH] or 50 mg/kg [50ODSH]) or saline was administered for 48 hours after TBI in 46 animals. At 48 hours, intravital microscopy visualized rolling LEUs and fluorescent albumin leakage in the pial circulation, and the Garcia Neurologic Test assessed neurologic function. Brain edema (wet/dry ratio) was evaluated post mortem. In a separate group of animals (n = 20), learning/memory ability (% time swimming in the Probe platform quadrant) was assessed by the Morris Water Maze 17 days after TBI. Analysis of variance with Bonferroni correction determined significance (p < 0.05). RESULTS Compared with CCI (LEU rolling: 32.3 13.7 LEUs/100 m per minute, cerebrovascular albumin leakage: 57.4 +/- 5.6%), both ODSH doses reduced post-TBI pial LEU rolling (25ODSH: 18.5 +/- 9.2 LEUs/100 m per minute, p = 0.036; 50ODSH: 7.8 +/- 3.9 LEUs/100 m per minute, p < 0.001) and cerebrovascular albumin leakage (25ODSH: 37.9 +/- 11.7%, p = 0.001, 50ODSH: 32.3 +/- 8.7%, p < 0.001). 50ODSH also reduced injured cerebral hemisphere edema (77.7 +/- 0.4%) vs. CCI (78.7 +/- 0.4 %, p = 0.003). Compared with CCI, both ODSH doses improved Garcia Neurologic Test at 48 hours. Learning/memory ability (% time swimming in target quadrant) was lowest in CCI (5.9 +/- 6.4%) and significantly improved in the 25ODSH group (27.5 +/- 8.2%, p = 0.025). CONCLUSION 2,3-O desulfated heparin after TBI reduces cerebral LEU recruitment, microvascular permeability and edema. 2,3-O desulfated heparin may also improve acute neurologic recovery leading to improved learning/memory ability weeks after injury.	[Nagata, Katsuhiro; Suto, Yujin; Kaplan, Lewis; Pascual, Jose L.] Univ Penn, Perelman Sch Med, Div Traumatol Surg Crit Care & Emergency Surg, Room 108,1st Floor,Suite 120,Med Off Bldg,51N 39t, Philadelphia, PA 19104 USA; [Nagata, Katsuhiro; Suto, Yujin; Cognetti, John; Browne, Kevin D.; Johnson, Victoria E.; Smith, Douglas H.; Pascual, Jose L.] Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA; [Nagata, Katsuhiro; Kumasaka, Kenichiro] Tokyo Med Univ, Hachioji Med Ctr, Dept Emergency & Crit Care Med, Tokyo, Japan; [Marks, Joshua] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA		Pascual, JL (corresponding author), Univ Penn, Perelman Sch Med, Div Traumatol Surg Crit Care & Emergency Surg, Room 108,1st Floor,Suite 120,Med Off Bldg,51N 39t, Philadelphia, PA 19104 USA.	jose.pascual@uphs.upenn.edu	Pascual, Jose/ABI-2291-2020	Pascual, Jose/0000-0002-1613-7912			Barry William H, 2011, Recent Pat Cardiovasc Drug Discov, V6, P148; Barry WH, 2010, AM J PHYSIOL-HEART C, V298, pH102, DOI 10.1152/ajpheart.00316.2009; Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; Borsig L, 2010, PROG MOL BIOL TRANSL, V93, P335, DOI 10.1016/S1877-1173(10)93014-7; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Fryer A, 1997, J PHARMACOL EXP THER, V282, P208; Gajic O, 2007, CRIT CARE MED, V35, P1979, DOI 10.1097/01.CCM.0000277254.12230.7D; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; GARCIA JH, 1995, STROKE, V26, P636, DOI 10.1161/01.STR.26.4.636; Gonzales JN, 2014, VASC PHARMACOL, V62, P63, DOI 10.1016/j.vph.2014.01.005; Griffin KL, 2014, AM J RESP CELL MOL, V50, P684, DOI 10.1165/rcmb.2013-0338RC; Joglekar MV, 2012, THROMB HAEMOSTASIS, V107, P717, DOI 10.1160/TH11-11-0795; Kerr Zachary Y, 2014, N C Med J, V75, P8; Kumasaka K, 2014, AM J SURG, V208, P961, DOI 10.1016/j.amjsurg.2014.08.004; Lever R, 2000, BRIT J PHARMACOL, V129, P533, DOI 10.1038/sj.bjp.0703099; Li SJ, 2016, J TRAUMA ACUTE CARE, V80, P381, DOI 10.1097/TA.0000000000000935; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Li S, 2011, CRIT CARE MED, V39, P1493, DOI 10.1097/CCM.0b013e31821201d3; Liu L, 2011, LEUKEMIA, V25, P23, DOI 10.1038/leu.2010.225; Liu R, 2009, ACTA MED OKAYAMA, V63, P203; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lukaszewicz AC, 2011, CURR OPIN ANESTHESIO, V24, P138, DOI 10.1097/ACO.0b013e32834458af; Manaenko A, 2011, ACTA NEUROCHIR SUPPL, V111, P179, DOI 10.1007/978-3-7091-0693-8_30; Mocco J, 2007, NEUROSURGERY, V61, P1297, DOI 10.1227/01.neu.0000306109.55174.e6; Nagata K, 2017, J TRAUMA ACUTE CARE, V83, P406, DOI 10.1097/TA.0000000000001590; Nagata K, 2016, J TRAUMA ACUTE CARE, V81, P1088, DOI 10.1097/TA.0000000000001215; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; RANA MW, 1992, J TRAUMA, V32, P420, DOI 10.1097/00005373-199204000-00003; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Sharma L, 2014, J IMMUNOTOXICOL, V11, P260, DOI 10.3109/1547691X.2013.839587; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stutzmann JM, 2002, CNS DRUG REV, V8, P1; Wang P, 1996, AM J PHYSIOL-HEART C, V270, pH1294, DOI 10.1152/ajpheart.1996.270.4.H1294; WANG P, 1990, AM J PHYSIOL, V259, pR645, DOI 10.1152/ajpregu.1990.259.3.R645; WANG P, 1993, J SURG RES, V54, P499, DOI 10.1006/jsre.1993.1077; Weber JR, 1997, J CEREBR BLOOD F MET, V17, P1221, DOI 10.1097/00004647-199711000-00011; Yanaka K, 1996, J NEUROSURG, V85, P1102, DOI 10.3171/jns.1996.85.6.1102; Yanaka K, 1996, STROKE, V27, P2146; Zhang ZG, 2013, INT J MOL SCI, V14, P1932, DOI 10.3390/ijms14011932	45	8	10	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2018	84	5					727	735		10.1097/TA.0000000000001819			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	GE7LT	WOS:000431415300006	29373460				2022-02-06	
J	Phillips, B; Turco, L; McDonald, D; Mause, E; Walters, RW				Phillips, Bradley; Turco, Lauren; McDonald, Dan; Mause, Elizabeth; Walters, Ryan W.			A subgroup analysis of penetrating injuries to the pancreas: 777 patients from the National Trauma Data Bank, 2010-2014	JOURNAL OF SURGICAL RESEARCH			English	Article						Pancreatic trauma; Penetrating trauma; Tiger Country; Organ injury scales; National trauma data bank	COMBINED PANCREATICODUODENAL INJURIES; SURGICAL-MANAGEMENT; SEVERITY SCORE; EXPERIENCE; OUTCOMES; MORBIDITY; MORTALITY; DUODENUM	Background: This study is the first to analyze penetrating injuries to the pancreas within subgroups of severe traumatic brain injury (TBI), early deaths, and potential survivors. Our objectives were to identify national patterns of injury, predictors of mortality, and to validate the American Association for Surgery of Trauma Organ Injury Scale (AAST-OIS) pancreas injury grades by mortality. Secondary outcomes included hospital and intensive care unit length of stay and days on mechanical ventilation. Methods: Using the Abbreviated Injury Scale 2005 and ICD-9-CM E-codes, we identified 777 penetrating pancreatic trauma patients from the National Trauma Data Bank that occurred between 2010 and 2014. Severe TBI was identified by ICD-9-CM diagnosis codes and Glasgow Coma Score (GCS; n = 7), early deaths were those that occurred within 24 h of admission (n = 82), and potential survivors included patients without severe TBI who survived longer than 24 h following admission (n = 690). We estimated multivariable generalized linear mixed models to predict mortality to account for the nesting of potential survivors within trauma centers. Results: Our results indicated that overall mortality decreased from 16.9% to 6.8% after excluding severe TBI and early deaths. Approximately, 11% of patients died within 24 h of admission, of whom 78% died in the first 6 h. Associated injuries to the stomach, liver, and major vasculature occurred in approximately 50% of patients; rates of associated injuries were highest in patients who died within 6 h of admission. In potential survivors, mortality increased by AAST-OIS grade: 3.5% I/II; 8.3% III; 9.6% IV; and 13.8% V. Predictors of mortality with significantly increased odds of death were patients with increasing age, lower admission GCS, higher admission pulse rate, and more severe injuries as indicated by Organ Injury Scale grade. Conclusions: From 777 patients, we identified national patterns of injury, predictors of outcome, and mortality by AAST-OIS grade within the subgroups of severe TBI, early deaths, and potential survivors. Because AAST-OIS is not a reported element in the National Trauma Data Bank, we correlated Abbreviated Injury Scale 2005 codes to injury grade and identified an increase in mortality. After controlling for covariance, we found that greater age, lower GCS in stab wounds, higher pulse, and presence of a grade V pancreatic injury independently predicted the likelihood of death in patients surviving beyond 24 h following penetrating injuries to the pancreas. (C) 2018 Elsevier Inc. All rights reserved.	[Phillips, Bradley] Trauma Response & Transfer LLC, Denver, CO 80227 USA; [Turco, Lauren] Univ Kansas, Med Ctr, Dept Surg, Kansas City, KS 66103 USA; [McDonald, Dan] Univ Nebraska Med Ctr, Dept Anesthesiol, Omaha, NE USA; [Mause, Elizabeth] Creighton Univ, Sch Med, Dept Surg, Omaha, NE 68178 USA; [Walters, Ryan W.] Creighton Univ, Sch Med, Dept Med, Omaha, NE USA		Phillips, B (corresponding author), Trauma Response & Transfer LLC, Denver, CO 80227 USA.	bjpmd02@gmail.com	Turco, Lauren M/P-3444-2017	Turco, Lauren M/0000-0002-8897-8630; Walters, Ryan/0000-0002-8801-9886			Ahmad I, 2008, SCAND J SURG, V97, P243, DOI 10.1177/145749690809700307; Akhrass R, 1997, AM SURGEON, V63, P598; American College of Surgeons, 2015, NTDB RES DAT SET US; [Anonymous], 2016, NATL TRAUMA DATA STA; Asensio JA, 2003, J AM COLL SURGEONS, V197, P937, DOI 10.1016/j.jamcollsurg.2003.07.019; Bozdag Z, 2016, EUR J TRAUMA EMERG S, V42, P231, DOI 10.1007/s00068-015-0526-8; CLEVELAND WS, 1988, J ECONOMETRICS, V37, P87, DOI 10.1016/0304-4076(88)90077-2; Gennarelli TA., 2008, ABBREVIATED INJURY S; Gulla A, 2014, J SURG RES, V186, P1, DOI 10.1016/j.jss.2013.07.057; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Krige JEJ, 2017, EUR J TRAUMA EMERG S, V43, P411, DOI 10.1007/s00068-016-0657-6; Krige JEJ, 2015, INJURY, V46, P830, DOI 10.1016/j.injury.2015.01.032; Krige JE, 2016, J AM COLL SURGEONS, V222, P737, DOI 10.1016/j.jamcollsurg.2016.02.005; Mattox K, 2012, TRAUMA; MOORE EE, 1990, J TRAUMA, V30, P1427, DOI 10.1097/00005373-199011000-00035; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Phillips B, 2017, J TRAUMA ACUTE CARE, V83, P810, DOI 10.1097/TA.0000000000001604; Pritchard E, 1998, AM SURGEON, V64, P843; Recinos G, 2009, INJURY, V40, P516, DOI 10.1016/j.injury.2008.06.026; Rickard MJFX, 2005, ANZ J SURG, V75, P581, DOI 10.1111/j.1445-2197.2005.03351.x; Rutledge R, 1997, J TRAUMA, V42, P477, DOI 10.1097/00005373-199703000-00016; Seamon MJ, 2007, J TRAUMA, V62, P829, DOI 10.1097/TA.0b013e318033a790; Siboni S, 2016, J TRAUMA ACUTE CARE, V81, P855, DOI 10.1097/TA.0000000000001224; Stroup WW., 2013, GEN LINEAR MIXED MOD; Tyburski JG, 2001, AM SURGEON, V67, P227; van der Wilden GM, 2014, WORLD J SURG, V38, P335, DOI 10.1007/s00268-013-2257-5; Vasquez JC, 2001, INJURY, V32, P753, DOI 10.1016/S0020-1383(01)00099-7; Vertrees A, 2014, MIL MED, V179, P315, DOI 10.7205/MILMED-D-13-00375; Young PR, 1998, AM SURGEON, V64, P838	29	8	8	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAY	2018	225						131	141		10.1016/j.jss.2018.01.014			11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GB8WG	WOS:000429355400018	29605023	Bronze			2022-02-06	
J	Pucks-Faes, E; Hitzenberger, G; Matzak, H; Fava, E; Verrienti, G; Laimer, I; Fritz, J; Saltuari, L				Pucks-Faes, Elke; Hitzenberger, Gabriel; Matzak, Heinrich; Fava, Elena; Verrienti, Giulio; Laimer, Ilse; Fritz, Josef; Saltuari, Leopold			Eleven years' experience with Intrathecal Baclofen - Complications, risk factors	BRAIN AND BEHAVIOR			English	Article						autonomic nervous system diseases; baclofen; brain injuries; sympathetic nervous system; traumatic	TRAUMATIC BRAIN-INJURY; SUPRASPINAL SPASTICITY; CEREBRAL ORIGIN; INTRACTABLE SPASTICITY; DRUG INFUSION; HYPERTONIA; PUMP; CHILDREN; CATHETER; THERAPY	Objective: Treatment with intrathecal baclofen (ITB) is commonly used in patients with severe spasticity. However, complications may occur after implantation of the ITB-device, albeit mainly procedure- and device-related problems. The aim of the study was to assess surgical- as well as catheter- and pump-related complications and define their risk factors. Methods: We retrospectively evaluated all patients with an implanted ITB-device who were treated at the Department of Neurology, Hochzirl Hospital, Zirl, Austria, between 2006 and 2016. Results: Twenty-nine of 116 (25%) patients experienced 32 complications: 5 procedure- and 27 device-related (4 pump- and 23 catheter-associated) problems occurred. Risk factors for sustaining any complication were a spinal localization of lesion (odds ratio [OR] OR 2.71, p = .021), other catheter types than an Ascenda((R)) catheter (OR 3.87, p = .041), a lower modified Rankin Scale (median 4 vs. 5; OR 2.86, p = .015) and a higher Barthel Index (median 53 vs. 0; OR 2.84, p = .006). The median time from the last ITB-related surgery to the first complication was 18 (IQR 1-57) months. Overall, 47% complications occurred within the first year after any surgical procedure regarding the ITB-device, thereof 25% within the first month. Conclusions: Procedure- and device-related complications are frequent after implantation of an ITB-device with catheter-associated complications as the most frequently encountered problems. Patients with a spinal origin of spasticity, a lower modified Rankin Scale and a higher Barthel Index have a higher risk to sustain a complication.	[Pucks-Faes, Elke; Hitzenberger, Gabriel; Matzak, Heinrich; Fava, Elena; Verrienti, Giulio; Saltuari, Leopold] Hochzirl Hosp, Dept Neurol, Zirl, Austria; [Laimer, Ilse] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria; [Fritz, Josef] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, Innsbruck, Austria; [Saltuari, Leopold] Res Unit Neurorehabil, South Tyrol, Italy		Pucks-Faes, E (corresponding author), Hochzirl Hosp, Dept Neurol, Zirl, Austria.	elke.pucks-faes@tirol-kliniken.at		Fritz, Josef/0000-0003-1342-3435			ALBRIGHT AL, 1991, JAMA-J AM MED ASSOC, V265, P1418, DOI 10.1001/jama.265.11.1418; ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; Armstrong RW, 1997, J NEUROSURG, V87, P409, DOI 10.3171/jns.1997.87.3.0409; Awaad Y, 2012, ISRN NEUROL, V2012, DOI DOI 10.5402/2012/575168; Becker R, 1999, J NEUROL NEUROSUR PS, V66, P114, DOI 10.1136/jnnp.66.1.114; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; Borrini L, 2014, ARCH PHYS MED REHAB, V95, P1032, DOI 10.1016/j.apmr.2013.12.019; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; Coffey RJ, 2002, NEUROSURGERY, V50, P78, DOI 10.1097/00006123-200201000-00014; Dario A, 2002, ACTA NEUROL SCAND, V105, P83, DOI 10.1034/j.1600-0404.2002.1o042.x; Guillaume D, 2005, ARCH PHYS MED REHAB, V86, P2165, DOI 10.1016/j.apmr.2005.05.018; Kolaski K, 2007, NEUROREHABILITATION, V22, P383; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P461, DOI 10.1016/S0003-9993(96)90034-9; Motta F, 2007, J NEUROSURG, V107, P32, DOI 10.3171/PED-07/07/032; Motta F, 2016, J NEUROSURG-PEDIATR, V18, P493, DOI 10.3171/2016.4.PEDS15646; Motta F, 2014, J NEUROSURG-PEDIATR, V13, P301, DOI 10.3171/2013.11.PEDS13253; Paskhin D L, 2017, Zh Vopr Neirokhir Im N N Burdenko, V81, P63, DOI 10.17116/neiro201780763-69; PENN RD, 1985, LANCET, V2, P125; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; Rawicki B, 1999, J NEUROSURG, V91, P733, DOI 10.3171/jns.1999.91.5.0733; Rawlins Patrice Korth, 2004, J Neurosci Nurs, V36, P322; Rifici C, 1994, Funct Neurol, V9, P29; Stetkarova I, 2010, NEUROREHAB NEURAL RE, V24, P609, DOI 10.1177/1545968310363585; Turner JA, 2007, CLIN J PAIN, V23, P180, DOI 10.1097/01.ajp.0000210955.93878.44; Veizi IE, 2016, NEUROMODULATION, V19, P760, DOI 10.1111/ner.12481; Yaksh TL, 2002, PAIN MED, V3, P300, DOI 10.1046/j.1526-4637.2002.02048.x	28	8	8	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	MAY	2018	8	5							e00965	10.1002/brb3.965			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	GF4YN	WOS:000431970500016	29761017	gold, Green Published			2022-02-06	
J	Raj, SP; Zhang, NH; Kirkwood, MW; Taylor, HG; Stancin, T; Brown, TM; Wade, SL				Raj, Stacey P.; Zhang, Nanhua; Kirkwood, Michael W.; Taylor, H. Gerry; Stancin, Terry; Brown, Tanya M.; Wade, Shari L.			Online Family Problem Solving for Pediatric Traumatic Brain Injury: Influences of Parental Marital Status and Participation on Adolescent Outcomes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescent outcomes; closed head injury; parent-child relations; pediatric traumatic brain injury; pediatrics; treatment outcomes	BEHAVIOR PROBLEMS; LONG-TERM; PSYCHIATRIC-DISORDERS; COMPLICATED MILD; SKILLS PROGRAM; CHILDREN; PREDICTORS; CHILDHOOD; INTERVENTIONS; TBI	Objective: To examine the moderating effects of parent marital status and participation on efficacy of an online family problem-solving intervention for pediatric traumatic brain injury (TBI). Methods: Participants were 132 adolescents (12-17 years) who had sustained a recent (<6 months) TBI and their parents. Participants were randomly assigned to the intervention (Counselor-Assisted Problem Solving, CAPS) or an Internet resource comparison (IRC) condition. CAPS was designed to support families in the initial phase following TBI, by teaching problem-solving skills and addressing common challenges. To examine the moderating effect of parent marital status, participants were divided into 4 groups (ie, CAPS married household, CAPS unmarried household, IRC married household, and IRC unmarried household). Family income and caregiver education were controlled in analyses. Results: Parent marital status moderated treatment effects on adolescent externalizing behavior problems. Adolescents from married households in CAPS displayed fewer behavior problems at 6 and 18 months postbaseline compared with adolescents from unmarried households in CAPS. Among married CAPS families, there were no differences in outcomes among families where 1 or 2 parents actively participated. Conclusions: Web-based interventions for pediatric TBI, such as CAPS, are a viable option for some although not all families. Further research is needed to investigate factors that influence efficacy to match families to the most beneficial treatments.	[Raj, Stacey P.; Zhang, Nanhua; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,ML 4009, Cincinnati, OH 45229 USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Aurora, CO USA; [Kirkwood, Michael W.] Colorado Sch Med, Aurora, CO USA; [Taylor, H. Gerry; Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Stancin, Terry] MetroHlth Med Ctr, Cleveland, OH USA; [Brown, Tanya M.] Mayo Clin, Rochester, MN USA; [Brown, Tanya M.] Mayo Clin & Mayo Grad Sch Med, Rochester, MN USA; [Zhang, Nanhua; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Raj, SP (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,ML 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Stancin, Terry/L-7993-2019	Zhang, Nanhua/0000-0001-5796-3404	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH073764]; National Institute of Disability and Rehabilitation Research [H133G050239]; Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	This work was supported by grant R01-MH073764 from the National Institute of Mental Health, grant H133G050239 from the National Institute of Disability and Rehabilitation Research, and the Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Brier MJ, 2015, HEALTH PSYCHOL, V34, P130, DOI 10.1037/hea0000119; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Brown SL, 2004, J MARRIAGE FAM, V66, P351, DOI 10.1111/j.1741-3737.2004.00025.x; Carlson MJ, 2001, J MARRIAGE FAM, V63, P779, DOI 10.1111/j.1741-3737.2001.00779.x; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; D'Zurilla T. J., 2006, HDB COGNITIVE BEHAV, P211; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hodges K., 2003, CAFAS MANUAL TRAININ; Karver CL, 2014, ARCH PHYS MED REHAB, V95, P1556, DOI 10.1016/j.apmr.2014.03.030; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Linden M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011020.pub2; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Osborne C, 2007, J MARRIAGE FAM, V69, P1345, DOI 10.1111/j.1741-3737.2007.00451.x; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Petranovich CL, 2015, J PEDIATR PSYCHOL, V40, P680, DOI 10.1093/jpepsy/jsv001; Pew Research Center, 2013, BREADW MOMS; Pew Research Center, 2013, RIS SINGL FATH NIN I; Pew Research Centre, 2016, SMARTPH OWN INT US C; Raj SP, 2015, J HEAD TRAUMA REHAB, V30, P347, DOI 10.1097/HTR.0000000000000052; Reyno SM, 2006, J CHILD PSYCHOL PSYC, V47, P99, DOI 10.1111/j.1469-7610.2005.01544.x; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Woods D., 2014, SOCIAL CARE NEURODIS, V5, P51, DOI [10.1108/SCN-01-2013-0002, DOI 10.1108/SCN-01-2013-0002]	34	8	8	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2018	33	3					158	166		10.1097/HTR.0000000000000331			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ7HA	WOS:000435555500120	28731871	Green Accepted			2022-02-06	
J	Wewiorski, NJ; Gorman, JA; Scoglio, AAJ; Fukuda, S; Reilly, E; Mueller, L; O'Connor, M; Penk, WE; Drebing, CE				Wewiorski, Nancy J.; Gorman, Jay A.; Scoglio, Arielle A. J.; Fukuda, Seiya; Reilly, Erin; Mueller, Lisa; O'Connor, Maureen; Penk, Walter E.; Drebing, Charles E.			Promising Practices in Vocational Services for the Community Reintegration of Returning Veterans: The Individual Placement and Support Model and Beyond	PSYCHOLOGICAL SERVICES			English	Article						vocational services; supported employment; veteran reintegration; work; employment	RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; SEVERE MENTAL-ILLNESS; POSTTRAUMATIC-STRESS-DISORDER; POST 9/11 VETERANS; PSYCHIATRIC DISABILITIES; COGNITIVE REMEDIATION; HEALTH-STATUS; WORK THERAPY; EMPLOYMENT	Supporting returning veterans' job-seeking, hiring, and retention issues has become an essential goal for effective community reintegration. Given both the particular strengths and challenges associated with veterans transitioning from military to civilian life, multiple models for supported employment have become integrated into Veterans Affairs health care facilities across the nation. In this article, we review the state of vocational rehabilitation for veterans, with a particular focus on individual placement and support-supported employment (IPS-SE), the current vocational services model that is considered the gold standard of vocational rehabilitation. Various modifications to the IPS-SE model are presented, including additions such as cognitive rehabilitation, contingency management, motivational interviewing, supported self-employment, and transitional work. Finally, recommendations are made about future directions and strategies to expand access to IPS-SE-based programs and to effectively meet the needs of returning veterans for employment in jobs of their choice.	[Wewiorski, Nancy J.; Gorman, Jay A.; Scoglio, Arielle A. J.; Fukuda, Seiya; Reilly, Erin; Mueller, Lisa; O'Connor, Maureen; Penk, Walter E.; Drebing, Charles E.] Bedford Vet Affairs Med Ctr, Social & Community Reintegrat Res Program, Bedford, MA USA		Scoglio, AAJ (corresponding author), 200 Springs Rd,116A, Bedford, MA 01730 USA.	arielle.scoglio@va.gov	Scoglio, Arielle Ana Jackson/I-4160-2019; Fukuda, Seiya/D-6577-2017	Scoglio, Arielle Ana Jackson/0000-0002-3680-9405; Gorman, Jay/0000-0001-7302-1900; O'Connor, Maureen/0000-0002-2466-0367; Fukuda, Seiya/0000-0001-5904-4073			Ahern J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128599; Ali M, 2011, J OCCUP REHABIL, V21, P199, DOI 10.1007/s10926-010-9266-0; Areberg C, 2013, SCAND J CARING SCI, V27, P589, DOI 10.1111/j.1471-6712.2012.01056.x; Becker D.R., 2003, WORKING LIFE PEOPLE, DOI [10.1093/acprof:oso/9780195131215.001.0001, DOI 10.1093/ACPROF:OSO/9780195131215.001.0001]; Bell MD, 2014, PSYCHIAT SERV, V65, P469, DOI 10.1176/appi.ps.201200505; Ben-Shalom Y, 2016, DISABIL HEALTH J, V9, P449, DOI 10.1016/j.dhjo.2015.12.008; Blow F. C, 2001, COMPREHENSIVE NATL E; Boardman J, 2013, BRIT J PSYCHIAT, V203, P247, DOI 10.1192/bjp.bp.112.121962; Bond GR, 2015, EPIDEMIOL PSYCH SCI, V24, P446, DOI 10.1017/S2045796014000419; Bond GR, 2008, PSYCHIATR REHABIL J, V31, P280, DOI 10.2975/31.4.2008.280.290; Bond GR, 2014, ADM POLICY MENT HLTH, V41, P69, DOI 10.1007/s10488-012-0444-6; Bond GR, 2012, WORLD PSYCHIATRY, V11, P32, DOI 10.1016/j.wpsyc.2012.01.005; Bond GR, 1997, REHABIL COUNS BULL, V40, P265; BOND GR, 1995, REHABIL PSYCHOL, V40, P75; Bond GR, 2004, PSYCHIATR REHABIL J, V27, P345, DOI 10.2975/27.2004.345.359; Burgess J, 2011, PSYCHIAT PRAX, V38, DOI 10.1055/s-0031-1277807; Burns T, 2015, BRIT J PSYCHIAT, V207, P351, DOI 10.1192/bjp.bp.114.152082; Chung C, 2013, STROKE, V44, pE77, DOI 10.1161/STROKEAHA.113.002049; Davis LL, 2012, PSYCHIAT SERV, V63, P464, DOI 10.1176/appi.ps.201100340; del Vecchio P, 2012, SAMHSAS WORKING DEFI; Drake RE, 1996, J CONSULT CLIN PSYCH, V64, P391, DOI 10.1037/0022-006X.64.2.391; Drebing C. E., 2016, MOV TRAD MENT HLTH S; Drebing CE, 2005, J APPL BEHAV ANAL, V38, P359, DOI 10.1901/jaba.2005.100-03; Drebing CE, 2004, REHABIL COUNS BULL, V47, P162, DOI 10.1177/00343552040470030501; Drebing CE, 2012, J REHABIL RES DEV, V49, P101, DOI 10.1682/JRRD.2010.06.0105; Dunn EC, 2008, PSYCHIATR REHABIL J, V32, P59, DOI 10.2975/32.1.2008.59.62; Eisen SV, 2012, AM J PUBLIC HEALTH, V102, pS66, DOI 10.2105/AJPH.2011.300609; Gao N, 2016, PSYCHIATR REHABIL J, V39, P191, DOI 10.1037/prj0000196; Griffin C, 2008, J VOCAT REHABIL, V28, P135; Hampson ME, 2015, AM J PSYCHIATR REHAB, V18, P265, DOI 10.1080/15487768.2014.954158; Hoffmann H, 2014, AM J PSYCHIAT, V171, P1183, DOI 10.1176/appi.ajp.2014.13070857; Kang HK, 2015, ANN EPIDEMIOL, V25, P96, DOI 10.1016/j.annepidem.2014.11.020; Karakus M., 2011, FEDERAL FINANCING SU; Kashner TM, 2002, ARCH GEN PSYCHIAT, V59, P938, DOI 10.1001/archpsyc.59.10.938; Kinn LG, 2014, J OCCUP REHABIL, V24, P125, DOI 10.1007/s10926-013-9445-x; Kleylamp M, 2013, SOC SCI RES, V42, P836, DOI 10.1016/j.ssresearch.2012.12.017; Kukla M, 2015, J VOCAT REHABIL, V43, P51, DOI 10.3233/JVR-150754; Leddy M, 2014, J REHABIL RES DEV, V51, P161, DOI 10.1682/JRRD.2013.01.0011; LePage JP, 2016, PSYCHIAT SERV, V67, P735, DOI 10.1176/appi.ps.201500058; Lilienfeld SO, 2013, CLIN PSYCHOL REV, V33, P883, DOI 10.1016/j.cpr.2012.09.008; Marshall T, 2014, PSYCHIAT SERV, V65, P16, DOI 10.1176/appi.ps.201300262; McGurk SR, 2003, PSYCHIAT SERV, V54, P1129, DOI 10.1176/appi.ps.54.8.1129; McGurk SR, 2007, AM J PSYCHIAT, V164, P437, DOI 10.1176/appi.ajp.164.3.437; McGurk SR, 2016, SCHIZOPHR RES, V175, P48, DOI 10.1016/j.schres.2016.04.045; McKay C., ADM POLICY MENTAL HL; Mueller L., 2016, UNPUB; Mueller L., 2016, PSYCH REH ASS ANN C; Mueser KT, 2016, CURR OPIN PSYCHIATR, V29, P196, DOI 10.1097/YCO.0000000000000247; Mueser KT, 2015, PSYCHIAT SERV, V66, P680, DOI 10.1176/appi.ps.201400413; O'Connor MK, 2016, J REHABIL RES DEV, V53, P307, DOI 10.1682/JRRD.2014.10.0231; O'Connor MK, 2011, J REHABIL RES DEV, V48, P597, DOI 10.1682/JRRD.2010.06.0117; Ottomanelli L, 2014, PSYCHIATR REHABIL J, V37, P110, DOI 10.1037/prj0000079; Ottomanelli L, 2012, ARCH PHYS MED REHAB, V93, P740, DOI 10.1016/j.apmr.2012.01.002; Penk W, 2009, PSYCHIATR REHABIL J, V33, P297, DOI 10.2975/33.4.2010.297.307; Petry NM, 2002, J SUBST ABUSE TREAT, V23, P81, DOI 10.1016/S0740-5472(02)00251-9; Ramchand R, 2008, INVISIBLE WOUNDS WAR, P35; Resnick EM, 2012, J WOMENS HEALTH, V21, P895, DOI 10.1089/jwh.2012.3644; Resnick SG, 2009, PSYCHIAT SERV, V60, P682, DOI 10.1176/appi.ps.60.5.682; Rollnick S., 1995, BEHAV COGN PSYCHOTH, V23, P322, DOI [10.1017/S135246580001643X, 10.1017/S135246580001643X., DOI 10.1017/S135246580001643X]; Rosenheck R, 2000, HEALTH SERV RES, V35, P133; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Stern L, 2017, ADV DEV HUM RESOUR, V19, P66, DOI 10.1177/1523422316682928; Substance Abuse and Mental Health Services Administration, 2015, REC REC SUPP; Teachman J, 2007, SOCIOL EDUC, V80, P359, DOI 10.1177/003804070708000404; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; U. S. Department of Labor Bureau of Labor Statistics, 2017, EMPL STAT CIV POP 18; U. S. Department of Labor Bureau of Labor Statistics, 2016, EMPL SIT VET SUMM; U. S. Department of Labor Office of Disability Employment Policy, 2016, WHAT IS CUST EMPL; U. S. Department of Veterans Affairs, 2014, FISC YEAR 1998 REP; U.S. Department of Veterans Affairs, 2011, VHA HDB; US Department of Veterans Affairs, 2015, 2015 VET EC OPP REP; Wewiorski N., 2016, 2016 REC WORKF SUMM; Zivin K, 2011, PSYCHIAT SERV, V62, P35, DOI 10.1176/ps.62.1.pss6201_0035	73	8	8	3	12	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	MAY	2018	15	2			SI		191	199		10.1037/ser0000177			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GP4OP	WOS:000440847300008	29723021				2022-02-06	
J	Irvine, KA; Sahbaie, P; Liang, DY; Clark, JD				Irvine, Karen-Amanda; Sahbaie, Peyman; Liang, De-Yong; Clark, J. David			Traumatic Brain Injury Disrupts Pain Signaling in the Brainstem and Spinal Cord	JOURNAL OF NEUROTRAUMA			English	Article						axonal degeneration; chronic brain injury; neuroinflammation; pain	NOXIOUS INHIBITORY CONTROLS; FACTOR-KAPPA-B; C-FOS; NERVE INJURY; RAT HIPPOCAMPUS; NOCICEPTIVE SENSITIZATION; NEUROPATHIC PAIN; ANACARDIC ACID; AXONAL INJURY; EXPRESSION	Chronic pain is a common consequence of traumatic brain injury (TBI) that can increase the suffering of a patient and pose a significant challenge to rehabilitative efforts. Unfortunately, the mechanisms linking TBI to pain are poorly understood, and specific treatments for TBI-related pain are still lacking. Our laboratory has shown that TBI causes pain sensitization in areas distant to the site of primary injury, and that changes in spinal gene expression may underlie this sensitization. The aim of this study was to examine the roles that pain modulatory pathways descending from the brainstem play in pain after TBI. Deficiencies in one type of descending inhibition, diffuse noxious inhibitory control (DNIC), have been suggested to be responsible for the development of chronic pain by allowing excess and uncontrolled afferent nociceptive inputs. Here we expand our knowledge of pain after TBI in two ways: (1) by outlining the neuropathology in pain-related centers of the brain and spinal cord involved in DNIC using the rat lateral fluid percussion (LFP) model of TBI, and (2) by evaluating the effects of a potent histone acetyl transferase inhibitor, anacardic acid (AA), on LFP-induced pain behaviors and neuropathology when administered for several days after TBI. The results revealed that TBI induces transient mechanical allodynia and a chronic persistent loss of DNIC. Further, while short-term AA treatment can block acute nociceptive sensitization and some early neuropathological changes, this treatment neither prevented the loss of DNIC nor did it alter long-term neuropathological changes in the brain or spinal cord.	[Irvine, Karen-Amanda; Sahbaie, Peyman; Liang, De-Yong; Clark, J. David] Vet Affairs Palo Alto Hlth Care Syst, Dept Anesthesiol, Palo Alto, CA USA; [Irvine, Karen-Amanda; Sahbaie, Peyman; Liang, De-Yong; Clark, J. David] Stanford Univ, Dept Anesthesia Perioperat Med & Pain, Stanford, CA 94305 USA		Irvine, KA (corresponding author), VAPAHCS, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	Kairvine@stanford.edu			U.S. Dept. of DefenseUnited States Department of Defense [MR130295]; Dept. of Veterans AffairsUS Department of Veterans Affairs [RX001776]; Veterans AffairsUS Department of Veterans Affairs [I01RX001776] Funding Source: NIH RePORTER	This work was supported by grants from the U.S. Dept. of Defense (MR130295) and the Dept. of Veterans Affairs (RX001776). We thank Adam R. Ferguson (UCSF) for advice with the preparation of this article.	Abu-Judeh H H, 2000, Nucl Med Rev Cent East Eur, V3, P5; Ahmad Asma Hayati, 2002, Malays J Med Sci, V9, P3; Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bose P, 2013, J NEUROTRAUM, V30, P1177, DOI 10.1089/neu.2012.2740; BOUHASSIRA D, 1993, EUR J PHARMACOL, V232, P207, DOI 10.1016/0014-2999(93)90775-D; BOUHASSIRA D, 1992, BRAIN RES, V595, P353, DOI 10.1016/0006-8993(92)91071-L; BOUHASSIRA D, 1992, BRAIN RES, V571, P140, DOI 10.1016/0006-8993(92)90520-J; Boyer N, 2014, PAIN, V155, P1196, DOI 10.1016/j.pain.2014.03.001; Camandola S, 2007, EXPERT OPIN THER TAR, V11, P123, DOI 10.1517/14728222.11.2.123; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Cui JK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-21; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; DRAGUNOW M, 1987, NATURE, V329, P441, DOI 10.1038/329441a0; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; DRAGUNOW M, 1990, NEUROSCI LETT, V113, P144, DOI 10.1016/0304-3940(90)90294-J; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Grundy PL, 2001, BRAIN RES, V892, P386, DOI 10.1016/S0006-8993(00)03258-3; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Guo TZ, 2004, PAIN, V108, P95, DOI 10.1016/j.pain.2003.12.010; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; Hemshekhar M, 2012, BASIC CLIN PHARMACOL, V110, P122, DOI 10.1111/j.1742-7843.2011.00833.x; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Irvine K.A., 2017, PAIN MED, pprint; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; JORGENSEN MB, 1989, BRAIN RES, V484, P393, DOI 10.1016/0006-8993(89)90388-0; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kennedy DL, 2016, PAIN, V157, P2410, DOI 10.1097/j.pain.0000000000000689; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Kimura M, 2015, ANESTHESIOLOGY, V123, P899, DOI 10.1097/ALN.0000000000000796; Kuner R, 2017, NAT REV NEUROSCI, V18, P20, DOI 10.1038/nrn.2016.162; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Lautenbacher S, 1997, CLIN J PAIN, V13, P189, DOI 10.1097/00002508-199709000-00003; LEBARS D, 1979, PAIN, V6, P305, DOI 10.1016/0304-3959(79)90050-2; Leong ML, 2016, NEUROSCI LETT, V617, P82, DOI 10.1016/j.neulet.2016.02.006; Leong ML, 2011, J NEUROSCI, V31, P17028, DOI 10.1523/JNEUROSCI.1268-11.2011; Leung A, 2016, MOL PAIN, V12, DOI 10.1177/1744806916662661; Li CQ, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-27; Liang DY, 2017, IBRO REP, V2, P14, DOI 10.1016/j.ibror.2016.12.001; Liang DY, 2017, MOL PAIN, V13, DOI 10.1177/1744806917730212; Liang DY, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-59; Lin MS, 2011, J SURG RES, V166, P280, DOI 10.1016/j.jss.2009.07.001; Ling G.S., 2004, CURR PROTOC NEUROSCI, V9, pUnit; Lyman M, 2014, NEUROSCI RES, V79, P1, DOI 10.1016/j.neures.2013.10.004; Masuoka N, 2004, BBA-MOL BASIS DIS, V1688, P245, DOI 10.1016/j.bbadis.2003.12.010; Mateen BA, 2017, J NEUROTRAUM, V34, P2379, DOI 10.1089/neu.2017.5007; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McMahon CG, 2010, J TRAUMA, V69, P1169, DOI 10.1097/TA.0b013e3181cc8889; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Motohashi K, 2001, COGNITIVE BRAIN RES, V11, P39, DOI 10.1016/S0926-6410(00)00062-8; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nichols JN, 2017, J NEUROTRAUM, V34, P2481, DOI 10.1089/neu.2017.4998; Oono Y, 2008, PAIN, V136, P356, DOI 10.1016/j.pain.2007.07.016; Pan DS, 2007, BIOMED ENVIRON SCI, V20, P432; Peters CM, 2015, ANESTHESIOLOGY, V122, P895, DOI 10.1097/ALN.0000000000000593; Poree LR, 1998, ANESTH ANALG, V87, P941, DOI 10.1097/00000539-199810000-00037; PRICE DD, 1988, PAIN, V34, P245, DOI 10.1016/0304-3959(88)90119-4; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; SHARP JW, 1990, EXP NEUROL, V109, P323, DOI 10.1016/S0014-4886(05)80023-8; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sood RR, 2008, J CEREBR BLOOD F MET, V28, P431, DOI 10.1038/sj.jcbfm.9600534; Strigo IA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.116; Sun Y, 2013, ANESTHESIOLOGY, V119, P1198, DOI 10.1097/ALN.0b013e31829ce340; Sung B, 2008, BLOOD, V111, P4880, DOI 10.1182/blood-2007-10-117994; Tai YT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/980657; Thomas TC, 2015, BRAIN NEUROTRAUMA MO; Tracey I, 2004, GUT, V53, P1553, DOI 10.1136/gut.2004.046110; Trevisan MTS, 2006, FOOD CHEM TOXICOL, V44, P188, DOI 10.1016/j.fct.2005.06.012; VILLANUEVA L, 1986, J NEUROPHYSIOL, V56, P1185, DOI 10.1152/jn.1986.56.4.1185; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; Wang DD, 1998, J NAT PROD, V61, P1352, DOI 10.1021/np980117p; Watanabe S, 1996, J NEUROL SCI, V135, P68, DOI 10.1016/0022-510X(95)00253-X; Wen YR, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-19; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang JT, 2005, EXP NEUROL, V192, P437, DOI 10.1016/j.expneurol.2004.12.023; Yarnitsky D, 2012, PAIN, V153, P1193, DOI 10.1016/j.pain.2012.02.021; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; Zhang S, 2016, NEUROCHEM INT, V96, P46, DOI 10.1016/j.neuint.2016.02.013; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061	102	8	8	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	13					1495	1509		10.1089/neu.2017.5411		APR 2018	15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GJ4CQ	WOS:000431102300001	29373948				2022-02-06	
J	Uhde, AK; Ciurkiewicz, M; Herder, V; Khan, MA; Hensel, N; Claus, P; Beckstette, M; Teich, R; Floess, S; Baumgartner, W; Jung, K; Huehn, J; Beineke, A				Uhde, Ann-Kathrin; Ciurkiewicz, Malgorzata; Herder, Vanessa; Khan, Muhammad Akram; Hensel, Niko; Claus, Peter; Beckstette, Michael; Teich, Rene; Floess, Stefan; Baumgaertner, Wolfgang; Jung, Klaus; Huehn, Jochen; Beineke, Andreas			Intact interleukin-10 receptor signaling protects from hippocampal damage elicited by experimental neurotropic virus infection of SJL mice	SCIENTIFIC REPORTS			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRAUMATIC BRAIN-INJURY; REGULATORY T-CELLS; SPINAL-CORD; TH17 CELLS; IL-10; EXPRESSION; MODEL; APOPTOSIS	Theiler's murine encephalomyelitis virus (TMEV) infection represents an experimental mouse model to study hippocampal damage induced by neurotropic viruses. IL-10 is a pleiotropic cytokine with profound anti-inflammatory properties, which critically controls immune homeostasis. In order to analyze IL-10R signaling following virus-induced polioencephalitis, SJL mice were intracerebrally infected with TMEV. RNA-based next generation sequencing revealed an up-regulation of Il10, Il10r alpha and further genes involved in IL-10 downstream signaling, including Jak1, Socs3 and Stat3 in the brain upon infection. Subsequent antibody-mediated blockade of IL-10R signaling led to enhanced hippocampal damage with neuronal loss and increased recruitment of CD3(+) T cells, CD45R(+) B cells and an up-regulation of Il1 alpha mRNA. Increased expression of Tgf beta and Foxp3 as well as accumulation of Foxp3(+) regulatory T cells and arginase-1(+) macrophages/microglia was detected in the hippocampus, representing a potential compensatory mechanism following disturbed IL-10R signaling. Additionally, an increased peripheral Chi3l3 expression was found in spleens of infected mice, which may embody reactive regulatory mechanisms for prevention of excessive immunopathology. The present study highlights the importance of IL-10R signaling for immune regulation and its neuroprotective properties in the context of an acute neurotropic virus infection.	[Uhde, Ann-Kathrin; Ciurkiewicz, Malgorzata; Herder, Vanessa; Khan, Muhammad Akram; Baumgaertner, Wolfgang; Beineke, Andreas] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Ciurkiewicz, Malgorzata; Herder, Vanessa; Khan, Muhammad Akram; Claus, Peter; Baumgaertner, Wolfgang; Beineke, Andreas] Ctr Syst Neurosci, Hannover, Germany; [Khan, Muhammad Akram] PMAS Arid Agr Univ, Fac Vet & Anim Sci, Dept Pathobiol, Rawalpindi, Pakistan; [Hensel, Niko; Claus, Peter] Hannover Med Sch, Inst Neuroanat & Cell Biol, Hannover, Germany; [Claus, Peter; Baumgaertner, Wolfgang] Niedersachsen Res Network Neuroinfectiol N RENNT, Hannover, Germany; [Beckstette, Michael; Teich, Rene; Floess, Stefan; Huehn, Jochen] Helmholtz Ctr Infect Res, Expt Immunol, Braunschweig, Germany; [Jung, Klaus] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany		Beineke, A (corresponding author), Univ Vet Med Hannover, Dept Pathol, Hannover, Germany.; Beineke, A (corresponding author), Ctr Syst Neurosci, Hannover, Germany.	Andreas.Beineke@tiho-hannover.de	Claus, Peter/A-7978-2008; Herder, Vanessa/AAG-6647-2020	Claus, Peter/0000-0003-3824-9445; Herder, Vanessa/0000-0003-4814-1382; Jung, Klaus/0000-0001-9955-748X; Khan, Muhammad Akram/0000-0003-2137-9614; Ciurkiewicz, Malgorzata/0000-0001-6277-7366	Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [BE 4200/1-2, HU 1300/5-2]; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG); University of Veterinary Medicine Hannover	The authors thank Bettina Buck, Petra Grunig, Kerstin Schone, Caroline Schutz, Danuta Waschke, Kirsten Lohr and Beate Pietzsch for excellent technical support. The BeAn-strain of TMEV was a generous gift of Prof. Dr. H. L. Lipton (Department of Microbiology-Immunology, University of Illinois, Chicago, IL, USA). The study was supported by the Deutsche Forschungsgemeinschaft (DFG, BE 4200/1-2; HU 1300/5-2) and in part by the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony. This publication was supported by the Deutsche Forschungsgemeinschaft (DFG) and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing.	Abraham KE, 2004, NEUROSCIENCE, V124, P945, DOI 10.1016/j.neuroscience.2004.01.004; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Avdic S, 2013, J VIROL, V87, P10273, DOI 10.1128/JVI.00912-13; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; Belz GT, 2009, IMMUNOL CELL BIOL, V87, P364, DOI 10.1038/icb.2009.22; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Broer S, 2017, NEUROBIOL DIS, V99, P121, DOI 10.1016/j.nbd.2016.12.020; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Buenz EJ, 2006, TRENDS MICROBIOL, V14, P28, DOI 10.1016/j.tim.2005.11.003; Buenz EJ, 2006, NEUROBIOL DIS, V24, P266, DOI 10.1016/j.nbd.2006.07.003; Buenz EJ, 2009, AM J PATHOL, V175, P668, DOI 10.2353/ajpath.2009.081126; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; Cekanaviciute E, 2014, J IMMUNOL, V193, P139, DOI 10.4049/jimmunol.1303284; Chen HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep30459; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Ciurkiewicz M, 2018, BRAIN PATHOL, V28, P349, DOI 10.1111/bpa.12518; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Cusick MF, 2013, J VIROL, V87, P1849, DOI 10.1128/JVI.02747-12; Ding YZ, 2003, J IMMUNOL, V170, P1383, DOI 10.4049/jimmunol.170.3.1383; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Fujii S, 2001, BLOOD, V98, P2143, DOI 10.1182/blood.V98.7.2143; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Gerhauser I, 2005, INT J DEV NEUROSCI, V23, P637, DOI 10.1016/j.ijdevneu.2005.06.004; Getts MT, 2010, VIROLOGY, V402, P102, DOI 10.1016/j.virol.2010.02.031; Groux H, 1998, J IMMUNOL, V160, P3188; Hansenne I, 2009, NEUROIMMUNOMODULAT, V16, P35, DOI 10.1159/000179665; Hensel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031202; Herder V, 2015, BRAIN PATHOL, V25, P712, DOI 10.1111/bpa.12238; Herder V, 2012, J NEUROIMMUNOL, V249, P27, DOI 10.1016/j.jneuroim.2012.04.010; Herder V, 2012, J NEUROIMMUNOL, V244, P84, DOI 10.1016/j.jneuroim.2012.01.010; Hou WQ, 2014, J VIROL, V88, P8479, DOI 10.1128/JVI.00724-14; Howe CL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00545; Howe CL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-50; Hutchins AP, 2013, BRIEF FUNCT GENOMICS, V12, P489, DOI 10.1093/bfgp/elt028; Jung K, 2011, BIOINFORMATICS, V27, P1377, DOI 10.1093/bioinformatics/btr152; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Konig HG, 2005, J CELL BIOL, V168, P1077, DOI 10.1083/jcb.200407027; Kulcsar KA, 2014, P NATL ACAD SCI USA, V111, P16053, DOI 10.1073/pnas.1418966111; Kummerfeld M, 2012, INTERVIROLOGY, V55, P401, DOI 10.1159/000336563; Kummerfeld M, 2009, J VIROL METHODS, V160, P185, DOI 10.1016/j.jviromet.2009.04.030; Ledeboer A, 2002, EUR J NEUROSCI, V16, P1175, DOI 10.1046/j.1460-9568.2002.02200.x; Lee PW, 2015, BRAIN BEHAV IMMUN, V46, P44, DOI 10.1016/j.bbi.2014.12.007; Libbey JE, 2008, EPILEPSIA, V49, P1066, DOI 10.1111/j.1528-1167.2008.01535.x; Libbey JE, 2011, FUTURE VIROL, V6, P1339, DOI 10.2217/FVL.11.107; Libbey JE, 2011, J VIROL, V85, P6913, DOI 10.1128/JVI.00458-11; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lin MT, 1998, VIROLOGY, V245, P270, DOI 10.1006/viro.1998.9170; Liu Z, 2016, BRAIN BEHAV IMMUN, V51, P131, DOI 10.1016/j.bbi.2015.08.006; Martinez NE, 2014, BRAIN PATHOL, V24, P436, DOI 10.1111/bpa.12119; McDole JR, 2010, AM J PATHOL, V177, P1823, DOI 10.2353/ajpath.2010.100231; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nizzoli G, 2016, EUR J IMMUNOL, V46, P1622, DOI 10.1002/eji.201546136; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Oleszak EL, 2004, CLIN MICROBIOL REV, V17, P174, DOI 10.1128/CMR.17.1.174-207.2004; Perlman S, 2017, J NEUROIMMUNOL, V308, P6, DOI 10.1016/j.jneuroim.2017.01.001; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Pierson W, 2010, IMMUNOL CELL BIOL, V88, P769, DOI 10.1038/icb.2010.105; Pringproa K, 2008, INT J DEV NEUROSCI, V26, P283, DOI 10.1016/j.ijdevneu.2008.01.008; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Reichard RR, 2003, J NEUROPATH EXP NEUR, V62, P237, DOI 10.1093/jnen/62.3.237; Richards MH, 2011, J AUTOIMMUN, V36, P142, DOI 10.1016/j.jaut.2010.12.005; Richter K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003735; Rojas JM, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/6104054; Rubio N, 2010, CELL COMMUN ADHES, V17, P57, DOI 10.3109/15419061.2010.507827; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Santin AD, 2000, J VIROL, V74, P4729, DOI 10.1128/JVI.74.10.4729-4737.2000; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sergerie Y, 2007, J INFECT DIS, V196, P853, DOI 10.1086/520094; Smeal RM, 2012, J NEUROVIROL, V18, P30, DOI 10.1007/s13365-012-0082-5; Souza-Moreira L, 2013, BRAIN BEHAV IMMUN, V30, P54, DOI 10.1016/j.bbi.2013.01.080; Stewart KAA, 2010, J NEUROPATH EXP NEUR, V69, P1210, DOI 10.1097/NEN.0b013e3181ffc420; Stewart KAA, 2010, EPILEPSIA, V51, P1418, DOI 10.1111/j.1528-1167.2009.02405.x; Tsai TT, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-40; Tsunoda I, 1997, VIROLOGY, V228, P388, DOI 10.1006/viro.1996.8382; Tsunoda I, 2007, J NEUROIMMUNOL, V190, P80, DOI 10.1016/j.jneuroim.2007.07.026; Uhde AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161883; Ulrich R, 2005, DEV NEUROSCI-BASEL, V27, P408, DOI 10.1159/000088455; Ulrich R, 2006, J NEUROPATH EXP NEUR, V65, P783, DOI 10.1097/01.jnen.0000229990.32795.0d; Umpierre AD, 2014, NEUROBIOL DIS, V64, P98, DOI 10.1016/j.nbd.2013.12.015; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verma R, 2016, J CELL COMMUN SIGNAL, V10, P61, DOI 10.1007/s12079-015-0302-x; Williams LM, 2004, IMMUNOLOGY, V113, P281, DOI 10.1111/j.1365-2567.2004.01988.x; Wilson MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002171; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263; Zhang F, 2016, ONCOTARGET, V7, P52294, DOI 10.18632/oncotarget.10561; Zhang XM, 2004, INT IMMUNOL, V16, P249, DOI 10.1093/intimm/dxh029; Zhu Y, 2015, INT J MOL SCI, V17	94	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 17	2018	8								6106	10.1038/s41598-018-24378-z			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD0GB	WOS:000430177800006	29666403	Green Published, gold			2022-02-06	
J	Mufson, EJ; He, B; Ginsberg, SD; Carper, BA; Bieler, GS; Crawford, F; Alvarez, VE; Huber, BR; Stein, TD; McKee, AC; Perez, SE				Mufson, Elliott J.; He, Bin; Ginsberg, Stephen D.; Carper, Benjamin A.; Bieler, Gayle S.; Crawford, Fiona; Alvarez, Victor E.; Huber, Bertrand R.; Stein, Thor D.; McKee, Ann C.; Perez, Sylvia E.			Gene Profiling of Nucleus Basalis Tau Containing Neurons in Chronic Traumatic Encephalopathy: A Chronic Effects of Neurotrauma Consortium Study	JOURNAL OF NEUROTRAUMA			English	Article						basal forebrain; brain trauma; CTE; expression profiling; genes; TBI	HYDROXYLASE-IMMUNOREACTIVE NEURONS; MILD COGNITIVE IMPAIRMENT; BRAIN-INJURY; TYROSINE-HYDROXYLASE; FOREBRAIN NEURONS; UP-REGULATION; ALZHEIMERS-DISEASE; RNA AMPLIFICATION; EXPRESSION; CALPAIN	Military personnel and athletes exposed to traumatic brain injury may develop chronic traumatic encephalopathy (CTE). Brain pathology in CTE includes intracellular accumulation of abnormally phosphorylated tau proteins (p-tau), the main constituent of neurofibrillary tangles (NFTs). Recently, we found that cholinergic basal forebrain (CBF) neurons within the nucleus basalis of Meynert (nbM), which provide the major cholinergic innervation to the cortex, display an increased number of NFTs across the pathological stages of CTE. However, molecular mechanisms underlying nbM neurodegeneration in the context of CTE pathology remain unknown. Here, we assessed the genetic signature of nbM neurons containing the p-tau pretangle maker pS422 from CTE subjects who came to autopsy and received a neuropathological CTE staging assessment (Stages II, III, and IV) using laser capture microdissection and custom-designed microarray analysis. Quantitative analysis revealed dysregulation of key genes in several gene ontology groups between CTE stages. Specifically, downregulation of the nicotinic cholinergic receptor subunit -2 gene (CHRNB2), monoaminergic enzymes catechol-O-methyltransferase (COMT) and dopa decarboxylase (DDC), chloride channels CLCN4 and CLCN5, scaffolding protein caveolin 1 (CAV1), cortical development/cytoskeleton element lissencephaly 1 (LIS1), and intracellular signaling cascade member adenylate cyclase 3 (ADCY3) was observed in pS422-immunreactive nbM neurons in CTE patients. By contrast, upregulation of calpain 2 (CAPN2) and microtubule-associated protein 2 (MAP2) transcript levels was found in Stage IV CTE patients. These single-population data in vulnerable neurons indicate alterations in gene expression associated with neurotransmission, signal transduction, the cytoskeleton, cell survival/death signaling, and microtubule dynamics, suggesting novel molecular pathways to target for drug discovery in CTE.	[Mufson, Elliott J.; He, Bin; Perez, Sylvia E.] Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA; [Ginsberg, Stephen D.] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY USA; [Ginsberg, Stephen D.] NYU, Med Ctr, New York, NY 10016 USA; [Carper, Benjamin A.; Bieler, Gayle S.] RTI Int, Res Triangle Pk, NC USA; [Crawford, Fiona] Rosekamp Inst, Sarasota, FL USA; [Alvarez, Victor E.; Huber, Bertrand R.; Stein, Thor D.; McKee, Ann C.] Boston Univ, Sch Med, VA Boston HealthCare Syst, Boston, MA 02118 USA; [Alvarez, Victor E.; Huber, Bertrand R.; Stein, Thor D.; McKee, Ann C.] Boston Univ, Sch Med, Alzheimer Dis Ctr, Boston, MA 02118 USA; [Alvarez, Victor E.; Huber, Bertrand R.; Stein, Thor D.; McKee, Ann C.] Boston Univ, Sch Med, CTE Ctr Program, Boston, MA 02118 USA; [Alvarez, Victor E.; Huber, Bertrand R.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Stein, Thor D.; McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA		Mufson, EJ (corresponding author), Barrow Neurol Inst, Alzheimers Dis & Brain Trauma Res Lab, 350 W Thomas St, Phoenix, AZ 85013 USA.	elliott.mufson@dignityhealth.org	Carper, Benjamin A/L-3433-2017; , SDG/AAB-3329-2022	Carper, Benjamin A/0000-0001-5882-2232; Stein, Thor/0000-0001-6954-4477; Ginsberg, Stephen/0000-0002-1797-4288	United States Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-2-0095]; United States Department of Veterans Affairs (Chronic Effects of Neurotrauma Consortium)US Department of Veterans Affairs [W81XWH-13-2-0095]; United States Army Medical Research Acquisition Activity, Fort Detrick MD; Department of Veterans AffairsUS Department of Veterans Affairs [I01 RX001774]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U01NS086659-01]; National Institute of Aging Boston University AD Center [P30AG13846, 0572063345-5]; Veterans Affairs Biorepository [CSP 501]; National Operating Committee on Standards for Athletic Equipment; Concussion Legacy Foundation; Andlinger Foundation; World Wrestling Entertainment; National Football League; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846, P01AG014449] Funding Source: NIH RePORTER	This material is based on work supported by the United States Army Medical Research and Material Command and from the United States Department of Veterans Affairs (Chronic Effects of Neurotrauma Consortium) under Award No. W81XWH-13-2-0095. The United States Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the United States government, or the United States Department of Veterans Affairs, and no official endorsement should be inferred. An award from the Department of Veterans Affairs (No. I01 RX001774), National Institute of Neurological Disorders and Stroke, National Institute of Biomedical Imaging and Bioengineering (U01NS086659-01), National Institute of Aging Boston University AD Center (P30AG13846, supplement 0572063345-5), the Veterans Affairs Biorepository (CSP 501), the National Operating Committee on Standards for Athletic Equipment, the Concussion Legacy Foundation, the Andlinger Foundation and the World Wrestling Entertainment and the National Football League supported this work.. The authors gratefully acknowledge the use of the resources and facilities at the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, MA) and Barrow Neurological Institute Department of Neuropathology (Phoenix, AZ).	Alldred MJ, 2009, J NEUROSCI METH, V177, P381, DOI 10.1016/j.jneumeth.2008.10.027; [Anonymous], 2003, J NEUROPSYCH CLIN N, V15, P383, DOI 10.1176/appi.neuropsych.15.3.383; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Badaut J, 2015, NEUROSCIENCE, V285, P215, DOI 10.1016/j.neuroscience.2014.10.035; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; Block F, 2001, NEUROSCI LETT, V298, P103, DOI 10.1016/S0304-3940(00)01729-8; Bralic M, 2012, COLLEGIUM ANTROPOL, V36, P1319; Che SL, 2004, LAB INVEST, V84, P131, DOI 10.1038/labinvest.3700005; Cook LJ, 2004, NEUROSCI LETT, V358, P142, DOI 10.1016/j.neulet.2004.01.016; Counts SE, 2007, ARCH NEUROL-CHICAGO, V64, P1771, DOI 10.1001/archneur.64.12.1771; De Luca V, 2006, EXP BRAIN RES, V174, P292, DOI 10.1007/s00221-006-0458-y; DeKosky ST, 2002, ANN NEUROL, V51, P145, DOI 10.1002/ana.10069; Donat CK, 2010, NEUROPATH APPL NEURO, V36, P225, DOI 10.1111/j.1365-2990.2009.01050.x; Galvin JE, 2004, ALZ DIS ASSOC DIS, V18, P264; Ginsberg SD, 2004, LAB INVEST, V84, P952, DOI 10.1038/labinvest.3700110; Ginsberg SD, 2004, NEUROCHEM RES, V29, P1053, DOI 10.1023/B:NERE.0000023593.77052.f7; Ginsberg SD, 2006, J NEUROCHEM, V97, P475, DOI 10.1111/j.1471-4159.2006.03764.x; Ginsberg SD, 2011, J CHEM NEUROANAT, V42, P102, DOI 10.1016/j.jchemneu.2011.05.012; Ginsberg SD, 2010, BIOL PSYCHIAT, V68, P885, DOI 10.1016/j.biopsych.2010.05.030; Ginsberg Stephen D., 2008, V439, P147, DOI 10.1007/978-1-59745-188-8_10; Gioiosa L, 2008, BEHAV BRAIN RES, V188, P255, DOI 10.1016/j.bbr.2007.11.002; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GOURAS GK, 1992, BRAIN RES, V584, P287, DOI 10.1016/0006-8993(92)90907-Q; Guillozet-Bongaarts AL, 2006, J NEUROCHEM, V97, P1005, DOI 10.1111/j.1471-4159.2006.03784.x; Huh JW, 2003, J NEUROTRAUM, V20, P975, DOI 10.1089/089771503770195821; Ikemoto K, 1998, NEUROSCI LETT, V243, P129, DOI 10.1016/S0304-3940(98)00103-7; Imanishi T, 1997, EUR J PHARMACOL, V321, P273, DOI 10.1016/S0014-2999(96)00969-7; Jasmin JF, 2007, CIRC RES, V100, P721, DOI 10.1161/01.RES.0000260180.42709.29; Jentsch TJ, 2016, NAT REV MOL CELL BIO, V17, P293, DOI 10.1038/nrm.2016.29; Jimenez-Mateos EM, 2005, BIOCHEM J, V389, P333, DOI 10.1042/BJ20050244; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; KATO H, 1995, EUR J PHARMACOL, V272, P107, DOI 10.1016/0014-2999(94)00694-3; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; MANGANIELLO VC, 1995, ARCH BIOCHEM BIOPHYS, V322, P1, DOI 10.1006/abbi.1995.1429; Marciano PG, 2002, NEUROCHEM RES, V27, P1147, DOI 10.1023/A:1020973308941; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MESULAM MM, 1983, J COMP NEUROL, V214, P170, DOI 10.1002/cne.902140206; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Mufson EJ, 2015, NEUROSCIENCE, V309, P51, DOI 10.1016/j.neuroscience.2015.03.006; MUFSON EJ, 1989, J COMP NEUROL, V285, P196, DOI 10.1002/cne.902850204; Mufson EJ, 2002, NEUROCHEM RES, V27, P1035, DOI 10.1023/A:1020952704398; Mufson EJ, 2006, PROG BRAIN RES, V158, P197, DOI 10.1016/S0079-6123(06)58010-0; Mufson EJ, 2016, BRAIN INJURY, V30, P1399, DOI 10.1080/02699052.2016.1219058; Mufson EJ, 2016, BEHAV BRAIN RES, V311, P54, DOI 10.1016/j.bbr.2016.05.030; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Myeku N, 2016, NAT MED, V22, P46, DOI 10.1038/nm.4011; Nag S, 2009, NEUROPATH APPL NEURO, V35, P417, DOI 10.1111/j.1365-2990.2008.01009.x; Nag S, 2007, ACTA NEUROPATHOL, V114, P459, DOI 10.1007/s00401-007-0274-x; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Niesman IR, 2013, MOL CELL NEUROSCI, V56, P283, DOI 10.1016/j.mcn.2013.07.002; Okkenhaug H, 2006, FASEB J, V20, P2390, DOI 10.1096/fj.05-5588fje; Perez SE, 2012, AM J PATHOL, V180, P526, DOI 10.1016/j.ajpath.2011.10.027; Pike BR, 1997, PHARMACOL BIOCHEM BE, V57, P785, DOI 10.1016/S0091-3057(96)00453-4; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reiner O, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/393975; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Shin T, 2007, BRAIN RES, V1141, P228, DOI 10.1016/j.brainres.2007.01.009; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Steinlein OK, 1999, NEUROREPORT, V10, P2919, DOI 10.1097/00001756-199909290-00008; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Tiernan CT, 2016, NEUROBIOL AGING, V42, P80, DOI 10.1016/j.neurobiolaging.2016.02.031; TORRES EM, 1993, NEUROSCI LETT, V150, P29, DOI 10.1016/0304-3940(93)90100-Y; Vana L, 2011, AM J PATHOL, V179, P2533, DOI 10.1016/j.ajpath.2011.07.044; Walker W, 2004, BRAIN INJURY, V18, P739, DOI 10.1080/02699050310001646224; Wang JQ, 2006, J NEUROCHEM, V96, P825, DOI 10.1111/j.1471-4159.2005.03615.x; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203; WISNIOWSKI L, 1992, J COMP NEUROL, V325, P379, DOI 10.1002/cne.903250305; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Yamada KH, 2012, J BIOL CHEM, V287, P13182, DOI 10.1074/jbc.M111.302612; Yin YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep27283	87	8	8	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2018	35	11					1260	1271		10.1089/neu.2017.5368		APR 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GG7EW	WOS:000429334200001	29338612	Green Published, Bronze			2022-02-06	
J	Lithgow, K; Chin, A; Debert, CT; Kline, GA				Lithgow, Kirstie; Chin, Alex; Debert, Chantel T.; Kline, Gregory A.			Utility of serum IGF-1 for diagnosis of growth hormone deficiency following traumatic brain injury and sport-related concussion	BMC ENDOCRINE DISORDERS			English	Article							STIMULATION TEST; FACTOR-I; IMMUNOASSAYS; MASS; GH	Background: Growth hormone deficiency (GHD) is a potential consequence of traumatic brain injury (TBI), including sport-related concussion (SRC). GH stimulation testing is required for definitive diagnosis; however, this is resource intensive and can be associated with adverse symptoms or risks. Measurement of serum IGF-1 is more practical and accessible, and pituitary tumour patients with hypopituitarism and low serum IGF-1 have been shown to have a high probability of GHD. We aimed to evaluate IGF-1 measurement for diagnosing GHD in our local TBI population. Methods: We conducted a retrospective chart review of patients evaluated for GHD at the TBI clinic and referred for GH stimulation testing with insulin tolerance test (ITT) or glucagon stimulation test (GST) since December 2013. We obtained demographics, TBI severity, IGF-1, data pertaining to pituitary function, and GH stimulation results. IGF-1 values were used to calculate z-scores per age and gender specific reference ranges. Receiver operator curve analysis was performed to evaluate diagnostic threshold of IGF-1 z-score for determining GHD by GST or ITT. Results: Sixty four patient charts were reviewed. 48 patients had mild, six had moderate, eight had severe TBI, and two had non-traumatic brain injuries. 47 patients underwent ITT or GST. 27 were confirmed to have GHD (peak hGH < 5 mu g/L). IGF-1 level was within the age and gender specific reference range for all patients with confirmed GHD following GH stimulation testing. Only one patient had a baseline IGF-1 level below the age and gender specific reference range; this patient had a normal response to GH stimulation testing. ROC analysis showed IGF-1 z-score AUC f, confirming lack of diagnostic utility. Conclusion: Baseline IGF-1 is not a useful predictor of GHD in our local TBI population, and therefore has no value as a screening tool. TBI patients undergoing pituitary evaluation will require a dynamic test of GH reserve.	[Lithgow, Kirstie; Kline, Gregory A.] Univ Calgary, Cumming Sch Med, Dept Med, Div Endocrinol, 1820 Richmond Rd SW, Calgary, AB T2T 5C7, Canada; [Chin, Alex] Univ Calgary, Cumming Sch Med, Calgary Lab Serv, Clin Biochem, 9,3535 Res Rd NW, Calgary, AB T2L 2K8, Canada; [Chin, Alex] Univ Calgary, Cumming Sch Med, Dept Pathol & Lab Med, 9,3535 Res Rd NW, Calgary, AB T2L 2K8, Canada; [Debert, Chantel T.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Div Phys Med & Rehabil, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada		Lithgow, K (corresponding author), Univ Calgary, Cumming Sch Med, Dept Med, Div Endocrinol, 1820 Richmond Rd SW, Calgary, AB T2T 5C7, Canada.	kclithgo@ucalgary.ca		Debert, Chantel/0000-0002-2704-0438			Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Berg C, 2010, EUR J ENDOCRINOL, V162, P477, DOI 10.1530/EJE-09-0824; Bidlingmaier M, 2014, J CLIN ENDOCR METAB, V99, P1712, DOI 10.1210/jc.2013-3059; Brod Meryl, 2014, BMC Res Notes, V7, P813, DOI 10.1186/1756-0500-7-813; Chanson P, 2016, J CLIN ENDOCR METAB, V101, P3450, DOI 10.1210/jc.2016-1257; Cox HD, 2014, CLIN CHEM, V60, P541, DOI 10.1373/clinchem.2013.208538; Dubourg J, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11182; Glynn N, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/972617; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Hines J, 2015, CLIN CHEM, V61, P990, DOI 10.1373/clinchem.2014.234799; IBM Corp, IBM SPSS STAT WIND V; Langelier DM, 2017, CLIN J SPORT MED, P27; Lissett CA, 2003, CLIN ENDOCRINOL, V59, P773, DOI 10.1046/j.1365-2265.2003.01884.x; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Pokrajac A, 2007, CLIN ENDOCRINOL, V67, P65, DOI 10.1111/j.1365-2265.2007.02836.x; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Ranke MB, 2003, CLIN CHEM LAB MED, V41, P1329, DOI 10.1515/CCLM.2003.203; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814; Zgaljardic DJ, 2011, CLIN ENDOCRINOL, V74, P365, DOI 10.1111/j.1365-2265.2010.03935.x	20	8	8	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1472-6823			BMC ENDOCR DISORD	BMC Endocr. Disord.	APR 2	2018	18								20	10.1186/s12902-018-0247-1			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	GB3GR	WOS:000428944800001	29609574	Green Published, gold			2022-02-06	
J	Chauhan, K; Tiwari, AK; Chadha, N; Kaul, A; Singh, AK; Datta, A				Chauhan, Kanchan; Tiwari, Anjani K.; Chadha, Nidhi; Kaul, Ankur; Singh, Ajai Kumar; Datta, Anupama			Chalcone Based Homodimeric PET Agent, C-11-(Chal)(2)DEA-Me, for Beta Amyloid Imaging: Synthesis and Bioevaluation	MOLECULAR PHARMACEUTICS			English	Article						amyloid beta 42; bivalent ligand; chalcone; PET; carbon-11	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; F-18 FDG; A-BETA; PLAQUES; PROBES; ACCUMULATION; DEPOSITION; COMPLEXES; PROTEINS	Homodimeric chalcone based C-11-PET radiotracer, C-11-(Chal)(2)DEA-Me, was synthesized, and binding affinity toward beta amyloid (A beta) was evaluated. The computational studies revealed multiple binding of the tracer at the recognition sites of A beta fibrils. The bivalent ligand C-11-(Chal)(2)DEA-Me displayed higher binding affinity compared to the corresponding monomer, C-11-Chal-Me, and classical A beta agents. The radiolabeling yield with carbon-11 was 40-55% (decay corrected) with specific activity of 65-90 GBqh/mu mol. A significant (p<0.0001) improvement in the binding affinity of C-11-(Chal)(2)DEA-Me with synthetic A beta 42 aggregates over the monomer, C-11-Chal-Me, demonstrates the utility of the bivalent approach. The PET imaging and biodistribution data displayed suitable brain pharmacokinetics of both ligands with higher brain uptake in the case of the bivalent ligand. Metabolite analysis of healthy ddY mouse brain homogenates exhibited high stability of the radiotracers in the brain with >93% intact tracer at 30 min post injection. Both chalcone derivatives were fluorescent in nature and demonstrated significant changes in the emission properties after binding with A beta 42. The preliminary analysis indicates high potential of C-11-(Chal)(2)DEA-Me as in vivo A beta 42 imaging tracer and highlights the significance of the bivalent approach to achieve a higher biological response for detection of early stages of amyloidosis.	[Chauhan, Kanchan; Tiwari, Anjani K.; Chadha, Nidhi; Kaul, Ankur; Datta, Anupama] DRDO, Inst Nucl Med & Allied Sci, Div Cyclotron & Radiopharmaceut Sci, Brig SK Mazumdar Marg, Delhi 110054, India; [Chauhan, Kanchan] Univ Nacl Autonoma Mexico, Ctr Nanociencias & Nanotecnol, Dept Bionanotecnol, Km 107 Carratera Tijuana Ensenada, Ensenada 22860, Baja California, Mexico; [Tiwari, Anjani K.] Babasaheb Bhimrao Ambedkar Univ, Dept Appl Chem, Lucknow, Uttar Pradesh, India; [Singh, Ajai Kumar] Indian Inst Technol, Dept Chem, Delhi 110016, India		Datta, A (corresponding author), DRDO, Inst Nucl Med & Allied Sci, Div Cyclotron & Radiopharmaceut Sci, Brig SK Mazumdar Marg, Delhi 110054, India.	anupama@inmas.drdo.in	TIWARI, ANJANI KUMAR/AAG-6558-2019; Chauhan, Kanchan/P-1853-2018	TIWARI, ANJANI KUMAR/0000-0001-6271-3055; Chauhan, Kanchan/0000-0002-5021-3392; KAUL, ANKUR/0000-0002-1935-6133	Defence Research and Development Organization, Ministry of DefenceDefence Research & Development Organisation (DRDO) [TD-16-17/INM-321]	We thank Dr. Anil K Mishra, Scientist G, Additional Director, Head DCRS, and Dr. A. K Singh, Scientist H, Director, Institute of Nuclear Medicine and Allied Sciences, Delhi, for providing necessary facilities. This work was supported by Defence Research and Development Organization, Ministry of Defence, under Project TD-16-17/INM-321. The authors also acknowledge Dr. M. IL Zhang, NIRS, Japan, and his team for the technical support provided in optimization of radio biochemical studies.	[Anonymous], 2014, PROT PREP WIZ LIG PR; Becker GA, 2013, J NUCL MED, V54, P723, DOI 10.2967/jnumed.112.107185; Bird SM, 2016, NEUROSCI BIOBEHAV R, V64, P215, DOI 10.1016/j.neubiorev.2016.01.004; Chauhan K, 2016, BIOCONJUGATE CHEM, V27, P961, DOI 10.1021/acs.bioconjchem.6b00024; Chauhan K, 2014, ORG BIOMOL CHEM, V12, P7328, DOI 10.1039/c4ob00941j; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fissers J, 2016, MOL IMAGING BIOL, V18, P598, DOI 10.1007/s11307-016-0935-z; Glabe C, 2000, NAT MED, V6, P133, DOI 10.1038/72215; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Haviv H, 2007, CURR TOP MED CHEM, V7, P375, DOI 10.2174/156802607779941215; Holm NK, 2007, BBA-PROTEINS PROTEOM, V1774, P1128, DOI 10.1016/j.bbapap.2007.06.008; Iikuni S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25990; Iikuni S, 2014, MOL PHARMACEUT, V11, P1132, DOI 10.1021/mp400499y; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kikuchi T, 2013, J LABELLED COMPD RAD, V56, P672, DOI 10.1002/jlcr.3092; Kimura H, 2014, BIOORGAN MED CHEM, V22, P285, DOI 10.1016/j.bmc.2013.11.026; Klohs J, 2011, NEUROSCIENTIST, V17, P539, DOI 10.1177/1073858410383433; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Koole M, 2009, J NUCL MED, V50, P818, DOI 10.2967/jnumed.108.060756; Krall N, 2014, CHEM SCI, V5, P3640, DOI 10.1039/c4sc00685b; Li ZJ, 2013, J MED CHEM, V56, P471, DOI 10.1021/jm3014184; Liu K, 2012, ACS CHEM NEUROSCI, V3, P141, DOI 10.1021/cn200122j; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; Mestre-Fusco A, 2012, CLIN NUCL MED, V37, pE33, DOI 10.1097/RLU.0b013e3182335f33; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Ono M., 2011, INT J MOL IMAGING, V2011, DOI DOI 10.1155/2011/543267; Ono M, 2007, BIOORGAN MED CHEM, V15, P6802, DOI 10.1016/j.bmc.2007.07.052; Ono M, 2010, ACS CHEM NEUROSCI, V1, P598, DOI 10.1021/cn100042d; Park YD, 2012, BIOORG MED CHEM LETT, V22, P4106, DOI 10.1016/j.bmcl.2012.04.068; Pike VW, 2009, TRENDS PHARMACOL SCI, V30, P431, DOI 10.1016/j.tips.2009.05.005; Pontecorvo MJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt70; Rook Y, 2010, J MED CHEM, V53, P3611, DOI 10.1021/jm1000024; Rowe CC, 2008, LANCET NEUROL, V7, P129, DOI 10.1016/S1474-4422(08)70001-2; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; Thal DR, 2015, ACTA NEUROPATHOL, V129, P167, DOI 10.1007/s00401-014-1375-y; Tiwari AK, 2014, J NEUROCHEM, V129, P712, DOI 10.1111/jnc.12670; Tripathi M, 2012, CLIN NUCL MED, V37, P158, DOI 10.1097/RLU.0b013e318238f51a; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Yang LC, 2012, NEW ENGL J MED, V367, P885, DOI 10.1056/NEJMp1208061; Zha ZH, 2016, J NUCL MED, V57; Zha ZH, 2011, J MED CHEM, V54, P8085, DOI 10.1021/jm2009106	46	8	8	0	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	APR	2018	15	4					1515	1525		10.1021/acs.molpharmaceut.7b01070			11	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	GB7VN	WOS:000429283300014	29522675				2022-02-06	
J	Halaweish, I; Riebe-Rodgers, J; Randall, A; Ehrlich, PF				Halaweish, Ihab; Riebe-Rodgers, Jane; Randall, Amy; Ehrlich, Peter F.			Compliance with evidence-based guidelines for computed tomography of children with head and abdominal trauma	JOURNAL OF PEDIATRIC SURGERY			English	Article						CT; Computed tomography; Guidelines; Head; Abdominal; Trauma	EMERGENCY-DEPARTMENT; CT; RISK	Introduction: Recently, two large prospective clinical trials developed and validated prediction rules for children at very low risk for clinically important traumatic brain injuries (ciTBI) or abdominal injury for whom CT is unnecessary. Specific criteria/guidelines were identified which if met would obviate the need for CT scanning. The purpose of this study was to assess compliance at a level one pediatric center with these guidelines as a tool for quality improvement. Methods: Records of children admitted to our pediatric trauma center one year before and two years after publication of head (Kuppermann '09) and abdominal trauma (Holmes '13) CT imaging guidelines were reviewed. Data collected included demographics, Glasgow coma score, (GCS), injury severity score (ISS), mechanism of injury, and indication for imaging based on criteria/guidelines from the prediction rule including history, symptoms, and physical exam findings. Results: There were 296 total patients identified. Demographic data, GCS, ISS, and mechanism of injury were similar between both groups before and after guideline publication. Prior to publication of head trauma imaging guidelines, 20.7% of head trauma patients had no indication for head CT prior compared with 19.5% after publication of imaging guideline (p = 0.85). Prior to publication of abdominal trauma imaging guidelines, 28.9% of patients had no indication for abdominal CT compared with 31.5% after publication of imaging guidelines (0.76). The rate of ciTBI requiring intervention was 4.6% before and 1.1% after guideline publication (p = 0.4). The rate of abdominal injury requiring intervention was 7.9% before and 1.8% post guideline publication (p = 0.2). None of the children at very low risk for ciTBI or abdominal injury required surgical intervention. Conclusion: At our institution compliance with evidence-based guidelines for CT of children with head and abdominal trauma is poor with a significant number of patients undergoing unnecessary imaging. This provides an opportunity for quality improvement with evidence based methods to reduce unnecessary imaging for trauma. Type of study: Clinical Research Paper (c) 2017 Elsevier Inc. All rights reserved.	[Halaweish, Ihab; Riebe-Rodgers, Jane; Randall, Amy; Ehrlich, Peter F.] Univ Michigan, Dept Surg, Sect Pediat Surg, Ann Arbor, MI 48109 USA		Halaweish, I (corresponding author), Univ Michigan, CS Mott Childrens Hosp, 1540 E Hosp Dr,SPC 4211, Ann Arbor, MI 48109 USA.	ihalawe@med.umich.edu					Dunne RM, 2015, RADIOLOGY, V276, P167, DOI 10.1148/radiol.15141208; Holmes JF, 2013, ANN EMERG MED, V62, P107, DOI 10.1016/j.annemergmed.2012.11.009; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; National Center for Injury Prevention and Control, 2016, LEAD CAUS DEATH INJ; Raja AS, 2015, AM J ROENTGENOL, V205, P936, DOI 10.2214/AJR.15.14677	7	8	8	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	APR	2018	53	4					748	751		10.1016/j.jpedsurg.2017.07.008			4	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	GB8CF	WOS:000429301400032	28774508				2022-02-06	
J	Khan, MW; Muehlschlegel, S				Khan, Muhammad Waqas; Muehlschlegel, Susanne			Shared Decision Making in Neurocritical Care	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Shared decision making; Decision aid; Patient-centered care; Intensive care unit; Neurocritical care	TRAUMATIC BRAIN-INJURY; WITHDRAWAL; SURROGATES; LIFE; AIDS	Shared decision making (SDM) is a collaborative decision-making process between health care providers and patients or their surrogates, taking into account the best scientific evidence available while considering the patient's values, goals, and preferences. Decision aids are tools enabling SDM. This article discusses SDM in general and in the intensive care unit in particular and facilitators and barriers for the creation and implementation of International Patient Decision Aids Standards Collaboration-compliant decision aids for the intensive care unit and neuro-intensive care unit.	[Khan, Muhammad Waqas; Muehlschlegel, Susanne] Univ Massachusetts, Med Sch, Dept Neurol, 55 Lake Ave North,S-5, Worcester, MA 01655 USA; [Muehlschlegel, Susanne] Univ Massachusetts, Med Sch, Dept Surg, 55 Lake Ave North, Worcester, MA 01655 USA; [Muehlschlegel, Susanne] Univ Massachusetts, Med Sch, Dept Anesthesiol Crit Care, 55 Lake Ave North, Worcester, MA 01655 USA		Muehlschlegel, S (corresponding author), Univ Massachusetts, Med Sch, Dept Neurol, 55 Lake Ave North,S-5, Worcester, MA 01655 USA.	Susanne.Muehlschlegel@umassmemorial.org			NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K23HD080971, 889577]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD080971] Funding Source: NIH RePORTER	Dr S. Muehlschlegel is funded by NIH/NICHD grant 5K23HD080971 (NIHMS-ID: 889577).	Agency for Healthcare Research and Quality, 2014, SHARE APPR 5 ESS STE; [Anonymous], 2009, UND OPT PLANN CAR CR; [Anonymous], 2015, UND OPT PLANN CAR CR; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Col N., 2011, SHAR DEC MAK COMM RI; Cox CE, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0045-0; Cox CE, 2012, CRIT CARE MED, V40, P2327, DOI 10.1097/CCM.0b013e3182536a63; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; Gerteis M, 1993, PATIENTS EYES UNDERS, V1st; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Informed Medical Decisions Foundation, 2016, WHAT IS SHAR DEC MAK; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Kehl KL, 2015, JAMA ONCOL, V1, P50, DOI 10.1001/jamaoncol.2014.112; Kon AA, 2016, CRIT CARE MED, V44, P188, DOI 10.1097/CCM.0000000000001396; Muehlschlegel S, 2015, NEUROCRIT CARE, V23, P127, DOI 10.1007/s12028-014-0097-2; Ottawa Hospital Research Institute, DEC DEV TOOLK; Otttawa Hospital Research Institute, 2015, A Z DEC INV; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1982, MAK HLTH CAR DEC ETH; Quinn T, 2017, NEUROCRIT CARE; Scheunemann LP, 2015, CRIT CARE MED, V43, P757, DOI 10.1097/CCM.0000000000000772; Slover J, 2012, CLIN ORTHOP RELAT R, V470, P1046, DOI 10.1007/s11999-011-2156-8; Stacey D, 2017, COCHRANE DATABASE SY, V12; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; U. S. Department of Health and Human Services, 2010, HLTH PEOPL 2020 OV H; White DB, 2007, ARCH INTERN MED, V167, P461, DOI 10.1001/archinte.167.5.461; White DB, 2016, JAMA-J AM MED ASSOC, V315, P2086, DOI 10.1001/jama.2016.5351	30	8	9	2	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	APR	2018	29	2					315	+		10.1016/j.nec.2017.11.009			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GB6MJ	WOS:000429183000011	29502720	Green Accepted			2022-02-06	
J	Truong, JQ; Joshi, NR; Ciuffreda, KJ				Truong, James Q.; Joshi, Nabin R.; Ciuffreda, Kenneth J.			Influence of refractive error on pupillary dynamics in the normal and mild traumatic brain injury (mTBI) populations	JOURNAL OF OPTOMETRY			English	Article						Pupil light reflex (PLR); Refractive error; Myopia; Mild traumatic brain injury (mTBI); Infrared pupillometry		Purpose: There have been several studies investigating static, baseline pupil diameter in visually-normal individuals across refractive error. However, none have assessed the dynamic pupillary light reflex (PLR). In the present study, both static and dynamic pupillary parameters of the PLR were assessed in both the visually-normal (VN) and the mild traumatic brain injury (mTBI) populations and compared as a function of refractive error. Methods: The VN population comprised 40 adults (22-56 years of age), while the mTBI population comprised 32 adults (21-60 years of age) over a range of refractive errors (-9.00 D to +1.25 D). Seven pupillary parameters (baseline static diameter, latency, amplitude, and peak and average constriction and dilation velocities) were assessed and compared under four white-light stimulus conditions (dim pulse, dim step, bright pulse, and bright step). The Neuroptics, infrared, DP-2000 binocular pupillometer (30 Hz sampling rate; 0.05 mm resolution) was used in the monocular (right eye) stimulation mode. Results: For the majority of pupillary parameters and stimulus conditions, a Gaussian distribution best fit the data, with the apex centered in the low myopic range (-2.3 to -4.9D). Responsivity was reduced to either side of the apex. Conclusions: Over a range of dynamic and static pupillary parameters, the PLR was influenced by refractive error in both populations. In cases of high refractive error, the PLR parameters may need to be compensated for this factor for proper categorization and diagnosis. (C) 2017 Spanish General Council of Optometry. Published by Elsevier Espana, S.L.U.	[Truong, James Q.; Joshi, Nabin R.; Ciuffreda, Kenneth J.] SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA		Joshi, NR (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	njoshi@sunyopt.edu		joshi, nabin/0000-0002-7513-6952	US Army Aeromedical Research Laboratories	We thank Dr. Bernard Gilmartin for his insightful conversations, and the US Army Aeromedical Research Laboratories for their support and loan of the binocular pupillometer.	Birch D., 2003, ADLERS PHYSL EYE, P586; Cakmak HB, 2010, CURR EYE RES, V35, P130, DOI 10.3109/02713680903447892; Cap?-Aponte JE., 2013, SPINE, V4, P1; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Duke-Elder S, 1970, SYSTEM OPHTHALMOLOGY, P300; ELLIS CJK, 1981, BRIT J OPHTHALMOL, V65, P754, DOI 10.1136/bjo.65.11.754; Gilmartin B, 1998, MYOPIA NEARWORK, P117; Gilmartin B, 2013, INVEST OPHTH VIS SCI, V54, P7240, DOI 10.1167/iovs.13-12920; Gracitelli CPB, 2014, INVEST OPHTH VIS SCI, V55, P7997, DOI 10.1167/iovs.14-15146; Guillon M, 2016, OPTOMETRY VISION SCI, V93, P1; Kankipati L, 2011, INVEST OPHTH VIS SCI, V52, P2287, DOI 10.1167/iovs.10-6023; Law CL, 2015, OPTOMETRY VISION SCI, V92, P551, DOI 10.1097/OPX.0000000000000576; Loewenfeld I. E., 1993, PUPIL ANATOMY PHYSL; MCBRIEN NA, 1986, INVEST OPHTH VIS SCI, V27, P1187; MIEGE C, 1988, OPHTHAL PHYSL OPT, V8, P165, DOI 10.1111/j.1475-1313.1988.tb01032.x; Mordi JA, 2004, VISION RES, V44, P591, DOI 10.1016/j.visres.2003.07.014; Orr JB, 2015, OPTOMETRY VISION SCI, V92, P834, DOI 10.1097/OPX.0000000000000627; Osaiyuwu AB, 2014, NIGER J GEN PRACT, V12, P24; Park JC, 2011, INVEST OPHTH VIS SCI, V52, P6624, DOI 10.1167/iovs.11-7586; Richdale K, 2016, OPTOMETRY VISION SCI, V93, P3, DOI 10.1097/OPX.0000000000000757; Thiagarajan P, 2015, BRAIN INJURY, V29, P1420, DOI 10.3109/02699052.2015.1045029; Truong JQ, 2016, BRAIN INJURY, V30, P1378, DOI 10.1080/02699052.2016.1195922; Truong JQ, 2016, THESIS; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132; Zinn KM, 1972, THE PUPIL	26	8	9	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1888-4296	1989-1342		J OPTOM	J. Optom.	APR-JUN	2018	11	2					93	102		10.1016/j.optom.2016.12.005			10	Ophthalmology	Emerging Sources Citation Index (ESCI)	Ophthalmology	VJ1QG	WOS:000540844800005	28262507	Green Published, gold			2022-02-06	
J	Wolahan, SM; Mao, HC; Real, C; Vespa, PM; Glenn, TC				Wolahan, Stephanie M.; Mao, Howard C.; Real, Courtney; Vespa, Paul M.; Glenn, Thomas C.			Lactate supplementation in severe traumatic brain injured adults by primed constant infusion of sodium L-lactate	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; lactate infusion; metabolism	CEREBRAL-BLOOD-FLOW; HEAD-INJURY; METABOLISM; GLUCOSE; HUMANS; OXYGEN; FUEL	Carbohydrate fuel augmentation following traumatic brain injury may be a viable treatment to improve recovery when cerebral oxidative metabolism of glucose is depressed. We performed a primed constant sodium L-lactate infusion in 11 moderate to severely brain injured adults. Blood was collected before and periodically during the infusion study. We quantified global cerebral uptake of glucose and lactate and other systemic metabolites associated with energy metabolism. Our hypothesis was that cerebral lactate uptake, as measured by the arteriovenous difference of lactate (AVDlac), would increase in severely injured TBI patients in the neurocritical care unit. Infusion of sodium L-lactate changed net cerebral lactate release, where the arteriovenous difference of lactate is negative, to net cerebral lactate uptake. Results from a mixed effects model of AVDlac with the fixed effects of infusion time, arterial lactate concentration, arterial glucose concentration and arteriovenous difference of glucose shows that doubling arterial lactate concentration (from .92 to 1.84mM) results in an increase in AVDlac from -.078mM to .090mM. We did not detect changes in systemic glucose during the course of the infusion study and observed significant changes in alanine (30% [20 39]), glutamine (34% [24 43]), acetate (87% [60 113]), valine (40% [28 51]), and leucine (24% [16 32]) from baseline levels. Further studies are required to establish the impact of lactate supplementation on cerebral and systemic flux of lactate, on gluconeogenesis, and on the impact on cerebral energetics following injury. (C) 2017 Wiley Periodicals, Inc.	Univ Calif Los Angeles, Brain Injury Res Ctr, Los Angeles, CA USA; [Wolahan, Stephanie M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, POB 956901, Los Angeles, CA 90095 USA		Wolahan, SM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, POB 956901, Los Angeles, CA 90095 USA.	swolahan@mednet.ucla.edu			National Institute of Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS055902, NS057252, NS30308, NS058489]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS093136, P01NS058489, R21NS057252, R21NS055902, P50NS030308] Funding Source: NIH RePORTER	National Institute of Neurological Diseases and Stroke, grant/award numbers: NS055902, NS057252, NS30308, NS058489.	Anderson D.R., 2002, MODEL SELECTION MULT, Vsecond, DOI 10.1007/b97636; Barton, 2013, MUMIN MULTIMODEL INF; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; BRODERSEN P, 1974, J NEUROL NEUROSUR PS, V37, P384, DOI 10.1136/jnnp.37.4.384; Fernstrom JD, 2013, AMINO ACIDS, V45, P419, DOI 10.1007/s00726-012-1330-y; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Glenn TC, 2015, J NEUROTRAUM, V32, P811, DOI 10.1089/neu.2014.3482; Gowda GAN, 2010, ANAL CHEM, V82, P8983, DOI 10.1021/ac101938w; Herzog RI, 2013, J CLIN INVEST, V123, P1988, DOI 10.1172/JCI65105; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Leverve XM, 2001, CURR OPIN CLIN NUTR, V4, P137, DOI 10.1097/00075197-200103000-00010; Lewis IA, 2009, MAGN RESON CHEM, V47, pS123, DOI 10.1002/mrc.2526; Mason S, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00043; Mosienko V, 2015, J CEREBR BLOOD F MET, V35, P1069, DOI 10.1038/jcbfm.2015.77; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Pinheiro J. C., 2000, MIXED EFFECTS MODELS; Pinheiro JC, 2020, nlme: Linear and Nonlinear Mixed Effects Models_. R package version 31-151; Proia P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091450; Quintard H, 2016, J NEUROTRAUM, V33, P681, DOI 10.1089/neu.2015.4057; R Development Core Team, 2012, R LANG ENV STAT COMP; ROBERTSON CS, 1988, J TRAUMA, V28, P1523, DOI 10.1097/00005373-198811000-00002; Scrimgeour AG, 2014, J NEUROTRAUM, V31, P989, DOI 10.1089/neu.2013.3234; Smith D, 2003, J CEREBR BLOOD F MET, V23, P658, DOI 10.1097/01.WCB.0000063991.19746.11; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; Wilcox R., 1997, INTRO ROBUST ESTIMAT; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001; Wolahan SM, 2017, NEUROCRIT CARE, V26, P239, DOI 10.1007/s12028-016-0313-3; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	34	8	8	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2018	96	4			SI		688	695		10.1002/jnr.24085			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV2DK	WOS:000424374300018	28543565	Green Accepted			2022-02-06	
J	Deepika, A; Devi, BI; Shukla, D; Sathyaprabha, TN; Christopher, R; Ramesh, SS				Deepika, Akhil; Devi, Bhagavatula Indira; Shukla, Dhaval; Sathyaprabha, Talakad N.; Christopher, Rita; Ramesh, Shruthi S.			Neuroimmunology of Traumatic Brain Injury: A Longitudinal Study of Interdependency of Inflammatory Markers and Heart Rate Variability in Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						autonomic dysfunction; cytokines; heart rate variability; inflammatory markers; traumatic brain injury	TUMOR-NECROSIS-FACTOR; CEREBROSPINAL-FLUID; INTRACRANIAL HYPERTENSION; BAROREFLEX SENSITIVITY; PRESSURE VARIABILITY; SPECTRAL-ANALYSIS; SERUM IL-6; INTERLEUKIN-10; CYTOKINE; PATHOPHYSIOLOGY	The aim of the present study is to evaluate the interdependency between heart rate variability (HRV) and inflammatory markers in patients with severe traumatic brain injury (TBI). A prospective exploratory study was done with a sample size of 89 patients. HRV of these patients was recorded using a telemetric device. The recordings were made on day 1 of the patients' admission into the intensive care unit followed by serial recordings on day 3 and day 10. Serum samples of the patients were also collected on these days for analysis of interleukin (IL)-1, IL-6, IL-10, and tumor necrosis factor alpha levels using enzyme-linked immunosorbent assay kits. The outcome assessment was done using the Disability Rating Scale at discharge and Glasgow Outcome Scale-Extended at 6 months post-trauma. The data were analyzed by grouping the patients on based on mortality and outcome. In the present study, there was significant subclinical autonomic dysfunction in patients with severe TBI. Among the serum cytokines, levels of IL-10 had a significant impact on outcome. An increase in IL-10 levels correlated with the unfavorable outcome. This study highlights the association between the HRV parameters and immune response. The timely management of both autonomic and immune dysfunction in patients with severe TBI may have an impact in preventing the secondary injury process.	[Deepika, Akhil] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Clin Neurosci, Bangalore, Karnataka, India; [Devi, Bhagavatula Indira; Shukla, Dhaval] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Dr MH Marigowda Rd, Bangalore, Karnataka, India; [Sathyaprabha, Talakad N.] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurophysiol, Bangalore, Karnataka, India; [Christopher, Rita; Ramesh, Shruthi S.] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurochem, Bangalore, Karnataka, India		Shukla, D (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Dr MH Marigowda Rd, Bangalore, Karnataka, India.	neurodhaval@rediffmail.com			Indian Society of Neuroanesthesiology and Critical Care; Indian Council of Medical ResearchIndian Council of Medical Research (ICMR)	The authors acknowledge the Indian Society of Neuroanesthesiology and Critical Care for partial financial support and the Indian Council of Medical Research for supporting the PhD program.	Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baillard C, 2002, CRIT CARE MED, V30, P306, DOI 10.1097/00003246-200202000-00007; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Dziurdzik P, 2004, INFLAMM RES, V53, P338, DOI 10.1007/s00011-004-1265-1; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; ELIAS JA, 1989, J IMMUNOL, V142, P509; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Fradelizi D., 1989, LYMPHOKINE RECEPTOR; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; GRUBER MF, 1994, J IMMUNOL, V152, P1354; Haji-Michael PG, 2000, CRIT CARE MED, V28, P2578, DOI 10.1097/00003246-200007000-00066; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Henden PL, 2014, J NEUROSURG ANESTH, V26, P50, DOI 10.1097/ANA.0b013e3182a47b62; Hensler T, 2000, INFLAMM RES, V49, P524, DOI 10.1007/s000110050626; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Kahraman S, 2010, J NEUROSURG ANESTH, V22, P296, DOI 10.1097/ANA.0b013e3181e25fc3; Kalabalikis P, 1999, INTENS CARE MED, V25, P288, DOI 10.1007/s001340050837; KISHIMOTO T, 1988, ANNU REV IMMUNOL, V6, P485, DOI 10.1146/annurev.iy.06.040188.002413; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kox M, 2012, J NEUROTRAUM, V29, P747, DOI 10.1089/neu.2011.2035; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lo TYM, 2010, J NEUROTRAUM, V27, P2139, DOI 10.1089/neu.2010.1387; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; MALEFYT RD, 1991, J EXP MED, V174, P1209; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Papaioannou V, 2008, J CRIT CARE, V23, P380, DOI 10.1016/j.jcrc.2007.04.006; REICHLIN S, 1993, NEW ENGL J MED, V329, P1246; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Shimonkevitz R, 1999, SHOCK, V12, P10, DOI 10.1097/00024382-199907000-00002; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Tasci A, 2003, NEUROL RES, V25, P871, DOI 10.1179/016164103771953998; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; von Kanel R, 2011, CLIN RES CARDIOL, V100, P241, DOI 10.1007/s00392-010-0236-5; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018	46	8	9	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2018	35	10					1124	1131		10.1089/neu.2017.5151		MAR 2018	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GF8DL	WOS:000428434400001	29304719				2022-02-06	
J	Gilmore, CS; Marquardt, CA; Kang, SS; Sponheim, SR				Gilmore, Casey S.; Marquardt, Craig A.; Kang, Seung Suk; Sponheim, Scott R.			Reduced P3b brain response during sustained visual attention is associated with remote blast mTBI and current PTSD in US military veterans	BEHAVIOURAL BRAIN RESEARCH			English	Article						Mild TBI; PTSD; Degraded stimulus-continuous; performance task; P3b; Blast; Attention	POSTTRAUMATIC-STRESS-DISORDER; INDEPENDENT COMPONENT ANALYSIS; EVENT-RELATED POTENTIALS; MENTAL-HEALTH PROBLEMS; AFGHANISTAN VETERANS; COGNITIVE FUNCTION; WAR VETERANS; GULF-WAR; INJURY; IRAQ	Approximately 275,000 American service members deployed to Iraq or Afghanistan have sustained a mild traumatic brain injury (mTBI), with 75% of these incidents involving an explosive blast. Combat-related mTBI is frequently associated with comorbid mental health disorders, especially posttraumatic stress disorder (PTSD). Attention problems, including sustained attention, are common cognitive complaints of veterans with TBI and PTSD. The present study sought to examine neural correlates of sustained attention in veterans with blast mTBI and/or current PTSD. In 124 veterans of Operations Enduring and Iraqi Freedom (OEF/OIF), we examined event-related potentials (ERPs) elicited by targets and non-targets during performance of a degraded-stimulus continuous performance task (DS-CPT). Four groups, consisting of veterans with blast-related mTBI only, current PTSD only, both blast mTBI and PTSD, and a control group, were studied. Compared to all other groups, blast mTBI only participants were more likely to respond regardless of stimulus type during the DS-CPT. During target detection, the three mTBI/PTSD groups showed reduced amplitude of the P3b (i.e., P300) ERP at Pz compared to the control group. P3b of the three affected groups did not differ from each other. These results suggest that parietal P3b amplitude reduction during target detection in the DS-CPT task may be an index of brain pathology after combat trauma, yet the diminished brain response fails to differentiate independent effects of blast-related mTBI or severity of PTSD symptomatology. (C) 2016 Elsevier B.V. All rights reserved.	[Gilmore, Casey S.] Def & Vet Brain Injury Ctr, 1 Vet Dr, Minneapolis, MN 55417 USA; [Gilmore, Casey S.; Marquardt, Craig A.; Kang, Seung Suk; Sponheim, Scott R.] Minneapolis Vet Affairs Hlth Care Syst, 1 Vet Dr, Minneapolis, MN 55417 USA; [Marquardt, Craig A.; Kang, Seung Suk] Univ Minnesota Twin Cities, Dept Psychol, 75 E River Rd, Minneapolis, MN 55455 USA; [Sponheim, Scott R.] Univ Minnesota Twin Cities, Dept Psychiat, 2450 Riverside Ave, Minneapolis, MN 55455 USA		Gilmore, CS (corresponding author), Minneapolis Vet Affairs Hlth Care Syst, Def & Vet Brain Injury Ctr, 1 Vet Way, Minneapolis, MN 55417 USA.	casey.gilmore2@va.gov	Kang, Seung/AAO-7849-2020	Marquardt, Craig/0000-0003-2714-6168	Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0038]; Minnesota Veterans Research Institute (MVRI); Rehabilitation Research and Development Service of the VA Office of Research and Development [1I01RX000622]; National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF) [00039202]; Veterans AffairsUS Department of Veterans Affairs [I01RX000622] Funding Source: NIH RePORTER	This work was supported by grants to Scott R. Sponheim from the Congressionally Directed Medical Research Program (W81XWH-08-2-0038), the Minnesota Veterans Research Institute (MVRI), and the Rehabilitation Research and Development Service of the VA Office of Research and Development (Award Number 1I01RX000622). This work was also supported by the National Science Foundation Graduate Research Fellowship to Craig A. Marquardt (Grant Number 00039202). Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the Department of Defense, the Department Of Veterans Affairs, or the National Science Foundation. The authors wish to thank the U.S. military veterans whose participation made this work possible.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Barlow-Ogden K, 2012, J REHABIL RES DEV, V49, P1101, DOI 10.1682/JRRD.2010.09.0188; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Catena RD, 2009, EXP BRAIN RES, V194, P67, DOI 10.1007/s00221-008-1669-1; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Doi R, 2007, AM J PHYS MED REHAB, V86, P641, DOI 10.1097/PHM.0b013e318115aca9; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; First M. B., 2002, WILLIAMS STRUCTURED; Gilmore CS, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.454; Hart J, 2008, J NEUROPSYCH CLIN N, V20, P309, DOI 10.1176/appi.neuropsych.20.3.309; HAUTUS MJ, 1995, BEHAV RES METH INS C, V27, P46, DOI 10.3758/BF03203619; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jacobs U, 2001, PROF PSYCHOL-RES PR, V32, P458, DOI 10.1037/0735-7028.32.5.458; Kang MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127592; King LA, 2008, J REHABIL RES DEV, V45, P395, DOI 10.1682/JRRD.2007.06.0081; Lew HL, 2007, J CLIN NEUROPHYSIOL, V24, P398, DOI 10.1097/WNP.0b013e318150694b; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Maguen S, 2012, J REHABIL RES DEV, V49, P1115, DOI 10.1682/JRRD.2011.02.0015; McMenamin BW, 2010, NEUROIMAGE, V49, P2416, DOI 10.1016/j.neuroimage.2009.10.010; Navalta CP, 2006, J NEUROPSYCH CLIN N, V18, P45, DOI 10.1176/appi.neuropsych.18.1.45; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Palmieri PA, 2007, J ABNORM PSYCHOL, V116, P329, DOI 10.1037/0021-843X.116.2.329; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ramchurn A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00557; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rousseff R T, 2006, Electromyogr Clin Neurophysiol, V46, P275; Ruff RM, 1999, STUD NEUROPSYCHOL DE, P315; Sarac-Hadzihalilovic A., 2010, SUSTAINED ATTENTION; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Simms LJ, 2002, J ABNORM PSYCHOL, V111, P637, DOI 10.1037//0021-843X.111.4.637; SKRANDIES W, 1990, Brain Topography, V3, P137, DOI 10.1007/BF01128870; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Sponheim SR, 2006, BIOL PSYCHIAT, V60, P242, DOI 10.1016/j.biopsych.2005.11.017; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Vasterling JJ, 2004, J INT NEUROPSYCH SOC, V10, P709, DOI 10.1017/S1355617704105031; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Whyte J, 2006, NEUROPSYCHOLOGIA, V44, P2007, DOI 10.1016/j.neuropsychologia.2006.02.012; Yufik T, 2010, J ABNORM PSYCHOL, V119, P764, DOI 10.1037/a0020981	62	8	8	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		174	182		10.1016/j.bbr.2016.12.002			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400021	27931783				2022-02-06	
J	Horcajo, CB; Castillo, MZ; Crespo, JV				Bonilla Horcajo, Celia; Zurita Castillo, Mercedes; Vaquero Crespo, Jesus			Platelet-rich plasma-derived scaffolds increase the benefit of delayed mesenchymal stromal cell therapy after severe traumatic brain injury	CYTOTHERAPY			English	Article						brain injury; mesenchymal stromal cells; platelet-rich plasma scaffolds; transplantation	QUALITY-OF-LIFE; CHRONIC PARAPLEGIC RATS; STEM-CELLS; FUNCTIONAL RECOVERY; MARROW; TRANSPLANTATION; REPAIR; IMPACT; DIFFERENTIATION; SURVIVAL	Background. Cell therapy using mesenchymal stromal cells (MSCs) offers new perspectives in the treatment of traumatic brain injury (TBI). The aim of the present study was to assess the impact of platelet-rich plasma scaffolds (PRPS) as support of MSCs in a delayed phase after severe TBI in rats. Methods. TBI was produced by weight-drop impact to the right cerebral hemisphere. Two months after TBI, four experimental groups were established; saline, PRPS, MSCs in saline, or MSCs in PRPS was transplanted into the area of brain lesion through a small hole. All groups were evaluated in the course of the following 12 months after therapy and the animals were then humanely killed. Results. Our results showed that a greater functional improvement was obtained after the administration of MSCs in PRPS compared with the other experimental groups. Discussion. PRPS enhanced the benefit of cell therapy with MSCs to treat chronic brain damage in rats that suffered a severe TBI. The present findings suggest that the use of intralesional MSCs supported in PRPS may be a strategy of tissue engineering for patients with established neurological severe dysfunction after a TBI.	[Bonilla Horcajo, Celia] Puerta Hierro Hosp, Neurosci Res Unit, Joaquin Rodrigo 2, Madrid 28222, Spain; Puerta Hierro Hosp, Serv Neurosurg, Madrid, Spain		Horcajo, CB (corresponding author), Puerta Hierro Hosp, Neurosci Res Unit, Joaquin Rodrigo 2, Madrid 28222, Spain.	cbonilla@idiphim.org			Mapfre Foundation; Rafael del Pino Foundation	We thank the institutions supporting the development of our cell therapy program, in particular, Mapfre Foundation and Rafael del Pino Foundation.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bonilla C, 2014, CYTOTHERAPY, V16, P1501, DOI 10.1016/j.jcyt.2014.07.007; Bonilla C, 2012, J TRAUMA ACUTE CARE, V72, P1203, DOI 10.1097/TA.0b013e318248bdcf; Bonilla C, 2012, J NEUROTRAUM, V29, P394, DOI 10.1089/neu.2011.2101; Bonilla C, 2009, BRAIN INJURY, V23, P760, DOI 10.1080/02699050903133970; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Forraz N, 2013, J TISSUE ENG REGEN M, V7, P523, DOI 10.1002/term.552; HARRISON P, 1993, BLOOD REV, V7, P52, DOI 10.1016/0268-960X(93)90024-X; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Momin EN, 2010, CURR STEM CELL RES T, V5, P326; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Samadikuchaksaraei A, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-15; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sarnowska A, 2013, CELL TRANSPLANT, V22, pS67, DOI 10.3727/096368913X672172; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Sykova E, 2006, CELL MOL NEUROBIOL, V26, P1113, DOI 10.1007/s10571-006-9007-2; Van Den Dolder J, 2006, TISSUE ENG, V12, P3067, DOI 10.1089/ten.2006.12.3067; Vaquero J, 2006, NEUROSCI LETT, V398, P129, DOI 10.1016/j.neulet.2005.12.072; Vaquero J, 2013, CYTOTHERAPY, V15, P33, DOI 10.1016/j.jcyt.2012.10.005; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zhao TF, 2013, CYTOTHERAPY, V15, P792, DOI 10.1016/j.jcyt.2013.04.004; Zurita M, 2004, NEUROREPORT, V15, P1105, DOI 10.1097/00001756-200405190-00004; Zurita M, 2008, TRANSPLANTATION, V86, P845, DOI 10.1097/TP.0b013e318186198f; Zurita M, 2006, NEUROSCI LETT, V402, P51, DOI 10.1016/j.neulet.2006.03.069; Zurita M, 2013, CYTOTHERAPY, V15, P1218, DOI 10.1016/j.jcyt.2013.05.012; Zurita M, 2010, CYTOTHERAPY, V12, P522, DOI 10.3109/14653241003615164	38	8	8	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	MAR	2018	20	3					314	321		10.1016/j.jcyt.2017.11.012			8	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	FZ4IB	WOS:000427554800005	29306567				2022-02-06	
J	Broglio, SP; Williams, R; Rettmann, A; Moore, B; Eckner, JT; Meehan, S				Broglio, Steven P.; Williams, Richelle; Rettmann, Ashley; Moore, Brandon; Eckner, James T.; Meehan, Sean			No Seasonal Changes in Cognitive Functioning Among High School Football Athletes: Implementation of a Novel Electrophysiological Measure and Standard Clinical Measures	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						repeated head impacts; concussion; cognitive decline	CHRONIC TRAUMATIC ENCEPHALOPATHY; BRAIN NETWORK ACTIVATION; SPORT-RELATED CONCUSSION; WHITE-MATTER INTEGRITY; MEMORY PERFORMANCE; AEROBIC FITNESS; LIFE SCALE; IMPACT; SYMPTOMS; NEURODEGENERATION	Objective: To evaluate neuroelectric and cognitive function relative to a season of football participation. Cognitive and neuroelectric function declines are hypothesized to he present in football athletes. Design: Observational. Setting: Athletic fields and research laboratory. Patients (or Participants): Seventy-seven high school athletes (15.9 + 0.9 years. 178.6 + 7.2 cm. 74.4 + 14.7 kg, and 0.8 + 0.8 self-reported concussions) participating in football (n - 46) and noncontact sports (n - 31). Interventions (or Assessment of Risk Factors): All athletes completed preseason, midseason, and postseason assessments of cognitive and neuroelectric function, self-reported symptoms, and quality of life. All athletes participated in their respective sports without intervention, while head impact exposure in football athletes was tracked using the Head Impact Telemetry System. Main Outcome Measures: Cognitive performance was based on Cogstate computerized cognitive assessment tool processing speed, attention, learning, working memory speed, and working memory accuracy scores. ElMindA brain network activation amplitude, synchronization, timing and connectivity brain network activation scores demarcated neuroelectric performance. Quality of life was assessed on the Health Behavior Inventory and Satisfaction with Life Scale and symptoms on the SCAT3 inventory. Results: Football and control sport athletes did not show declines in cognitive or neuroelectric function, quality-of-life measures, or symptom reports across a season of sport participation. Conclusions: These findings refute the notion that routine football participation places athletes at risk for acute cognitive declines. The lack of impairment may be associated with no association with head impacts and cognitive function, increased physical activity offsetting any declines, and/or test sensitivity. How these findings are associated with long-term cognitive function is unknown.	[Broglio, Steven P.] Univ Michigan, Injury Ctr, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Williams, Richelle; Rettmann, Ashley] Univ Michigan, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Moore, Brandon] Univ Michigan, Michigan NeuroSport, Ann Arbor, MI 48109 USA; [Eckner, James T.] Univ Michigan, Michigan NeuroSport, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Meehan, Sean] Univ Michigan, Human Sensorimotor Lab, Ann Arbor, MI 48109 USA		Broglio, SP (corresponding author), NeuroTrauma Res Lab, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA.	broglio@umich.edu	Meehan, Sean K/N-6237-2018	Meehan, Sean K/0000-0002-9848-8803; Williams, Richelle/0000-0003-4728-7443	National Institutes of Health: National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R15NS081691-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS081691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG024824] Funding Source: NIH RePORTER	This investigation was funded by the National Institutes of Health: National Institute of Neurological Disorders and Stroke (1R15NS081691-01) and BNA calculations were provided by ElmindA, LTD.	Alsalaheen B, SPORTS HLTH MULTIDIS; Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub2, 10.1002/14651858.CD005381.pub3]; Anthony IC, 2010, BRAIN, V133, P3685, DOI 10.1093/brain/awq263; ARRINDELL WA, 1991, PERS INDIV DIFFER, V12, P117, DOI 10.1016/0191-8869(91)90094-R; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Berchicci M, 2015, NEUROSCIENCE, V298, P211, DOI 10.1016/j.neuroscience.2015.04.028; BottariC, 2015, NEUROPSYCHOL REHABIL, P1, DOI [DOI 10.1080/09602011.2015.1110528., 10.1080/09602011.2015.1110528]; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2016, INT J SPORTS MED, V37, P714, DOI 10.1055/s-0042-107250; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Buckley J, 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/Mhum.2014.00747, 10.3389/fnhum.2014.00747, 10.3389/fnhum.2014.00584]; Castellani RJ, 2015, J NEUROPATH EXP NEUR, V74, P493, DOI 10.1097/NEN.0000000000000193; Chaddock L, 2010, BRAIN RES, V1358, P172, DOI 10.1016/j.brainres.2010.08.049; Chaddock L, 2010, DEV NEUROSCI-BASEL, V32, P249, DOI 10.1159/000316648; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; 'Connor KL, J ATHL TRAIN; Cox EP, 2016, J SCI MED SPORT, V19, P616, DOI 10.1016/j.jsams.2015.09.003; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Davis GA, 2015, NEUROSURGERY, V76, P643, DOI 10.1227/NEU.0000000000000722; Drollette ES, 2012, MED SCI SPORT EXER, V44, P2017, DOI 10.1249/MSS.0b013e318258bcd5; Eckner JT, 2016, BRAIN INJURY, V30, P1075, DOI 10.3109/02699052.2016.1160152; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Hillman CH, 2014, PEDIATRICS, V134, pE1063, DOI 10.1542/peds.2013-3219; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Karantzoulis S, 2013, NEUROPSYCHOL REV, V23, P350, DOI 10.1007/s11065-013-9243-4; Kiefer AW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00243; Kontos AP, 2016, BRAIN IMAGING BEHAV, V10, P594, DOI 10.1007/s11682-015-9412-6; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Reches A, 2014, NEUROIMAGE, V88, P228, DOI 10.1016/j.neuroimage.2013.11.020; Reches A., 2013, FUNCT NEUROL REHABIL, V3, P295; Reches A, 2014, J MOL NEUROSCI, V54, P59, DOI 10.1007/s12031-014-0250-6; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schaeffer DJ, 2014, PSYCHOPHYSIOLOGY, V51, P728, DOI 10.1111/psyp.12227; Shahaf G, 2012, CLIN NEUROPHYSIOL, V123, P1568, DOI 10.1016/j.clinph.2011.12.010; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Sonnen JA, 2010, NEUROLOGY, V75, P1203, DOI 10.1212/WNL.0b013e3181f52db1; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Vasquez T, 2014, NFL CONCUSSION LIABI; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008	64	8	8	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2018	28	2					130	138		10.1097/JSM.0000000000000420			9	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	GP1HC	WOS:000440564900008	28727640	Green Accepted			2022-02-06	
J	Cheshire, EC; Malcomson, RDG; Sun, P; Mirkes, EM; Amoroso, JM; Rutty, GN				Cheshire, Emma C.; Malcomson, Roger D. G.; Sun, Peng; Mirkes, Evgeny M.; Amoroso, Jasmin M.; Rutty, Guy N.			A systematic autopsy survey of human infant bridging veins	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Bridging vein; Head injury; Child; Abuse; Subdural haemorrhage; Post-mortem	SUPERIOR SAGITTAL SINUS; SHAKEN BABY SYNDROME; ABUSIVE HEAD TRAUMA; MICROSURGICAL ANATOMY; SUBDURAL HEMORRHAGE; DURAL ENTRANCE; CHILDREN; HEMATOMA; INJURY; BRAIN	In the first years of life, subdural haemorrhage (SDH) within the cranial cavity can occur through accidental and non-accidental mechanisms as well as from birth-related injury. This type of bleeding is the most common finding in victims of abusive head trauma (AHT). Historically, the most frequent cause of SDHs in infancy is suggested to be traumatic damage to bridging veins traversing from the brain to the dural membrane. However, several alternative hypotheses have been suggested for the cause and origin of subdural bleeding. It has also been suggested by some that bridging veins are too large to rupture through the forces associated with AHT. To date, there have been no systematic anatomical studies on infant bridging veins. During 43 neonatal, infant and young child post-mortem examinations, we have mapped the locations and numbers of bridging veins onto a 3D model of the surface of a representative infant brain. We have also recorded the in situ diameter of 79 bridging veins from two neonatal, one infant and two young children at post-mortem examination. Large numbers of veins, both distant from and directly entering the dural venous sinuses, were discovered travelling between the brain and dural membrane, with the mean number of veins per brain being 54.1 and the largest number recorded as 94. The mean diameter of the bridging veins was 0.93 mm, with measurements ranging from 0.05 to 3.07 mm. These data demonstrate that some veins are extremely small and subjectively, and they appear to be delicate. Characterisation of infant bridging veins will contribute to the current understanding of potential vascular sources of subdural bleeding and could also be used to further develop computational models of infant head injury.	[Cheshire, Emma C.; Amoroso, Jasmin M.; Rutty, Guy N.] Univ Leicester, Leicester Royal Infirm, East Midlands Forens Pathol Unit, Robert Kilpatrick Bldg,Level 3, Leicester LE2 7LX, Leics, England; [Malcomson, Roger D. G.] Leicester Royal Infirm, Dept Histopathol, Leicester LE1 5WW, Leics, England; [Sun, Peng; Mirkes, Evgeny M.] Univ Leicester, Dept Math, Univ Rd, Leicester LE1 7RH, Leics, England		Cheshire, EC (corresponding author), Univ Leicester, Leicester Royal Infirm, East Midlands Forens Pathol Unit, Robert Kilpatrick Bldg,Level 3, Leicester LE2 7LX, Leics, England.	ecc25@le.ac.uk	Mirkes, Evgeny/Y-9614-2018	Mirkes, Evgeny/0000-0003-1474-1734	Home Office Forensic Pathology Unit	This article presents independent research funded by the Home Office Forensic Pathology Unit. The views expressed in this publication are those of the author(s) and not necessarily those of the Home Office. We thank Leicester Hospital's Little Lives, Big Journeys, for their donation towards the research project. We thank Dr. Tim Jaspan, Department of Neuroradiology, University Hospital, Nottingham, for his part in conceiving the idea behind the PhD study from which this study is derived. We thank all the parents who consented for their deceased infants to participate in this study. We thank Jeremy Levesley and Ivan Tyukin, Department of Mathematics, University of Leicester, for their support and advice and we thank the Radiology Department, University Hospitals of Leicester for undertaking brain MRI.	ANDREWS BT, 1989, NEUROSURGERY, V24, P514, DOI 10.1227/00006123-198904000-00005; Bradford R, 2013, J NEUROSURG-PEDIATR, V12, P110, DOI 10.3171/2013.4.PEDS12596; Brockmann C, 2012, CLIN IMAG, V36, P85, DOI 10.1016/j.clinimag.2011.05.003; Browder J, 1976, CEREBRAL DURAL SINUS, P49; Cabot RC, 1940, NEW ENGL J MED, V223, P1030; Cheshire EC, 2015, FORENSIC SCI MED PAT, V11, P395, DOI 10.1007/s12024-015-9691-7; Cheshire EC, 2015, INT J LEGAL MED, V129, P307, DOI 10.1007/s00414-014-1110-1; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Ehrlich E., 2003, LEGAL MED-TOKYO, V5, P225, DOI [DOI 10.1016/S1344-6223(02)00118-9, 10.1016/S1344-6223(02)00118-9]; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Gu SX, 2011, CLIN NEUROL NEUROSUR, V113, P889, DOI 10.1016/j.clineuro.2011.06.008; Han H, 2008, NEUROSURGERY, V62, P289, DOI 10.1227/01.NEU.0000310772.04153.58; Han H, 2007, NEURORADIOLOGY, V49, P169, DOI 10.1007/s00234-006-0175-z; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; Hoskote A, 2002, CHILD NERV SYST, V18, P311, DOI 10.1007/s00381-002-0616-x; Jaspan T, 2008, PEDIATR RADIOL, V38, pS378, DOI 10.1007/s00247-008-0896-8; Kubota M, 2001, ACTA NEUROCHIR, V143, P321, DOI 10.1007/s007010170085; Leary T, 1934, J AMER MED ASSOC, V103, P0897, DOI 10.1001/jama.1934.02750380017004; Mack J, 2009, PEDIATR RADIOL, V39, P200, DOI 10.1007/s00247-008-1084-6; MATSUSHIMA T, 1989, NEUROSURGERY, V24, P890, DOI 10.1227/00006123-198906000-00016; Matsushima T, 2015, MICROSURGICAL ANATOM, P41; Maxeiner H, 1997, FORENSIC SCI INT, V89, P103, DOI 10.1016/S0379-0738(97)00124-2; Miabi Z, 2004, AM J NEURORADIOL, V25, P1181; Morison CN, 2002, THESIS; NABESHIMA S, 1975, J COMP NEUROL, V164, P127, DOI 10.1002/cne.901640202; PADGET DH, 1956, AM J ANAT, V98, P307, DOI 10.1002/aja.1000980302; Park J, 2004, ACTA NEUROCHIR, V146, P973, DOI 10.1007/s00701-004-0304-6; PERESE DM, 1960, J NEUROSURG, V17, P402, DOI 10.3171/jns.1960.17.3.0402; Rambaud C, 2015, PEDIATR RADIOL, V45, P1126, DOI 10.1007/s00247-015-3285-0; Rhoton AL, 2002, NEUROSURGERY, V51, pS159, DOI 10.1227/01.NEU.0000028228.51706.2D; Rooks VJ, 2008, AM J NEURORADIOL, V29, P1082, DOI 10.3174/ajnr.A1004; Sakata K, 2000, NEUROSURGERY, V47, P153, DOI 10.1097/00006123-200007000-00032; Sampei T, 1996, NEUROSURGERY, V38, P971, DOI 10.1097/00006123-199605000-00024; Savardekar AR, 2014, ACTA NEUROCHIR, V156, P671, DOI 10.1007/s00701-014-2028-6; SCHACHENMAYR W, 1978, AM J PATHOL, V92, P53; Scheimberg I, 2013, PEDIATR DEVEL PATHOL, V16, P149, DOI 10.2350/12-08-1232-OA.1; Squier W, 2011, ACTA NEUROPATHOL, V122, P519, DOI 10.1007/s00401-011-0875-2; Squier W, 2009, FORENSIC SCI INT, V187, P6, DOI 10.1016/j.forsciint.2009.02.005; Suzuki Y, 2003, NEUROL MED-CHIR, V43, P550, DOI 10.2176/nmc.43.550; Trotter W, 1914, BRIT J SURG, V2, P271, DOI 10.1002/bjs.1800020608; Tzioumi D, 1998, CHILD ABUSE NEGLECT, V22, P1105, DOI 10.1016/S0145-2134(98)00093-3; Ueyama T, 1998, NEUROSURGERY, V43, P1137, DOI 10.1097/00006123-199811000-00068; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	46	8	8	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	MAR	2018	132	2					449	461		10.1007/s00414-017-1714-3			13	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	FV5WK	WOS:000424652900014	29075919	hybrid, Green Published			2022-02-06	
J	Cochrane, GD; Sundman, MH; Hall, EE; Kostek, MC; Patel, K; Barnes, KP; Ketcham, CJ				Cochrane, Graham D.; Sundman, Mark H.; Hall, Eric E.; Kostek, Matthew C.; Patel, Kirtida; Barnes, Kenneth P.; Ketcham, Caroline J.			Genetics Influence Neurocognitive Performance at Baseline but Not Concussion History in Collegiate Student-Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussions; mild traumatic brain injury; genetics; neurocognitive performance; cognitive function	TRAUMATIC BRAIN-INJURY; RECEPTOR GENE; ASSOCIATION; GENOTYPE; RISK; APOE; POLYMORPHISMS; EPSILON-4; ALLELE; IMPACT	Objective: This study investigates 4 single-nucleotide polymorphisms [Apolipoprotein E (APOE), APOE promoter, catechol-O-methyl transferase (COMT), and dopamine D2 receptor) that have been implicated in concussion susceptibility and/or cognitive ability in collegiate student-athletes. Design: Cross-sectional study. Setting: Neuroscience laboratory at Elan University. Participants: Two hundred fifty division I collegiate student-athletes (66 women, 184 men) from various sports. Intervention: All participants completed Immediate Postconcussion Assessment and Cognitive Testing (ImPACT) testing at baseline concussion testing and had a buccal swab taken for DNA for genotyping. Main Outcome Measures: Self-reported history of concussions and neurocognitive performance were taken from ImPACT. Results: Individuals carrying an epsilon 4 allele in their APOE gene had a significantly slower reaction time (P = 0.001). Individuals homozygous for the Val allele of the COMT gene showed significantly worse impulse control scores (P = 0.014). None of the genotypes were able to predict self-reported concussion history in collegiate student athletes. Conclusions: These results indicate that certain genotypes may influence performance on cognitive testing at baseline and that the APOE genotypes may not influence concussion susceptibility as suggested by past studies.	[Cochrane, Graham D.; Hall, Eric E.; Barnes, Kenneth P.; Ketcham, Caroline J.] Elon Univ, Dept Exercise Sci, 2525 Campus Box, Elon, NC 27244 USA; [Sundman, Mark H.] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; [Kostek, Matthew C.] Duquense Univ, Dept Phys Therapy, Pittsburgh, PA USA; [Patel, Kirtida] Elon Univ, Dept Athlet, Elon, NC USA; [Barnes, Kenneth P.] Greensboro Orthopaed, Greensboro, NC USA		Hall, EE (corresponding author), Elon Univ, Dept Exercise Sci, 2525 Campus Box, Elon, NC 27244 USA.	ehall@elon.edu		Ketcham, Caroline/0000-0002-6713-130X; Cochrane, Graham/0000-0003-1548-9382	American Medical Society for Sports Medicine	This study was partially funded by foundation grants from the American Medical Society for Sports Medicine to authors K. P. Barnes and E. E. Hall.	Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; ImPACT Applications Inc, TECHN MAN ONL IMPACT; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kuller LH, 1998, STROKE, V29, P388, DOI 10.1161/01.STR.29.2.388; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; LUCOTTE G, 1994, AM J MED GENET, V54, P286, DOI 10.1002/ajmg.1320540319; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McDevitt J, 2017, CONCUSSION; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; National Collegiate Athletics Association, 2014, 2014 2015 NCAA SPORT; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Terrell Thomas, 2013, BRIT J SPORT MED, V47, pE1, DOI DOI 10.1136/BJSPORTS-2012-092101.31; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Tierney RT, 2010, CLIN J SPORT MED, V20, P464, DOI 10.1097/JSM.0b013e3181fc0a81; Weinshilboum RM, 1999, ANNU REV PHARMACOL, V39, P19, DOI 10.1146/annurev.pharmtox.39.1.19; Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003	27	8	8	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2018	28	2					125	129		10.1097/JSM.0000000000000443			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	GP1HC	WOS:000440564900007	28708709				2022-02-06	
J	Davis, LL; Kyriakides, TC; Suris, A; Ottomanelli, L; Drake, RE; Parker, PE; Mueller, L; Resnick, SG; Toscano, R; Blansett, CM; McCall, KP; Huang, GD				Davis, Lori L.; Kyriakides, Tassos C.; Suris, Alina; Ottomanelli, Lisa; Drake, Robert E.; Parker, Pamela E.; Mueller, Lisa; Resnick, Sandra G.; Toscano, Richard; Blansett, Catherine M.; McCall, Kimberly P.; Huang, Grant D.			Veterans Individual Placement and Support Towards Advancing Recovery: Methods and Baseline Clinical Characteristics of a Multisite Study	PSYCHIATRIC REHABILITATION JOURNAL			English	Article						individual placement and support; posttraumatic stress disorder; supported employment; transitional work; unemployment	POSTTRAUMATIC-STRESS-DISORDER; SEVERE MENTAL-ILLNESS; TBI IDENTIFICATION METHOD; TRAUMATIC BRAIN-INJURY; HEALTH-SERVICE USE; TERM-FOLLOW-UP; NONVOCATIONAL OUTCOMES; DEPRESSIVE SYMPTOMS; EMPLOYMENT STATUS; ENDURING FREEDOM	Objective: This article describes the methodology and the baseline characteristics of veterans with posttraumatic stress disorder (PTSD) enrolled in a multisite trial comparing supported employment individual placement and support (IPS) to a stepwise vocational transitional work program (TWP). Method: The Veterans Affairs Cooperative Studies Program randomized 541 veterans with PTSD across 12 Veterans Affairs Medical Centers to either IPS or TWP. Demographic and clinical characteristics were evaluated at baseline. Results: Participants averaged 42 (SD +/- 11) years of age and had PTSD for 13 (SD +/- 11) years. The group was comprised of 18% female, 42% African Americans, and 16% Latino participants. Approximately 60% of participants served in the military since 2001, 89% were receiving or applying for service-connected disability, 60% had PTSD from nonsexual combat-related trauma, and 17% had PTSD from military sexual trauma. One third had not held a competitive job in the past 3 years; the average length of unemployment was 2.8 (SD +/- 4) years. Unique study features included the focus on veterans with PTSD, a comparison of a promising practice with a usual-care practice, and the outcome criterion of achieving steady competitive employment. Conclusions and Implication for Practice: This study is the first large-scale randomized trial of IPS in a PTSD population. These baseline findings illustrate the characteristics of the study sample, which are representative of a veteran population in need of vocational rehabilitation services and can be used to help guide the implementation of tailored veteran-centered programs.	[Davis, Lori L.] Tuscaloosa VA Med Ctr, 3701 Loop Rd East 151, Tuscaloosa, AL 35404 USA; [Davis, Lori L.] Univ Alabama, Sch Med, Dept Psychiat & Behav Neurol, Tuscaloosa, AL 35487 USA; [Kyriakides, Tassos C.] VA Connecticut Healthcare Syst, VA Cooperat Studies Program, Coordinating Ctr, West Haven, CT USA; [Suris, Alina] VA North Texas Hlth Care Syst, Dallas, TX USA; [Suris, Alina] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Ottomanelli, Lisa] James A Haley Vet Hosp, HS & RD Ctr Innovat Disabil & Rehabil Res, Tampa, FL 33612 USA; [Ottomanelli, Lisa] Univ S Florida, Dept Rehabil & Mental Hlth Counseling, Tampa, FL 33620 USA; [Drake, Robert E.] Westat Corp, Lebanon, NH USA; [Parker, Pamela E.] VA Med Ctr, Mental Hlth Serv Birmingham, Birmingham, AL USA; [Mueller, Lisa; Resnick, Sandra G.] VISN 1 Mental Illness Res Educ & Clin Ctr, West Haven, CT USA; [Resnick, Sandra G.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Toscano, Richard; Blansett, Catherine M.; McCall, Kimberly P.] Tuscaloosa VA Med Ctr, Res & Dev Serv, Tuscaloosa, AL USA; [Huang, Grant D.] Cent Office, Cooperat Studies Program, Washington, DC USA		Davis, LL (corresponding author), Tuscaloosa VA Med Ctr, 3701 Loop Rd East 151, Tuscaloosa, AL 35404 USA.	lori.davis@va.gov	Kyriakides, Tassos/E-4980-2013; Resnick, Sandra G/F-3883-2014; Drake, Robert/AAS-3310-2020	Kyriakides, Tassos/0000-0001-8913-108X; Resnick, Sandra G/0000-0001-6373-1482; 	Cooperative Studies Program, Department of Veterans Affairs Office of Research and Development (CSP) [589]; CSP Coordinating Center at the West Haven VA Medical Center [589]; CSP Study Chairs Office at the Tuscaloosa VA Medical Center [589]	This work was supported by Cooperative Studies Program, Department of Veterans Affairs Office of Research and Development (CSP#589). Opinions herein are those of the individual authors and the contents do not represent the views of the Department of Veterans Affairs or the United States Government.; We acknowledge the following participating investigators for their hard work and dedication to the successful completion of this study: Jose Canive, and Gerardo Villareal, Raymond G. Murphy VAMC, Albuquerque, New Mexico; Pamela Parker, Birmingham VAMC, Birmingham, Alabama; Noelle Berger, and Rachel Yehuda, James J. Peters VAMC, Bronx, New York; Ron Acierno, Ralph H. Johnson VAMC, Charleston, South Carolina; Alina Suris, and Geetha Shivakumar, VA North Texas Healthcare System, Dallas, Texas; Michael Hertzberg, and Loretta Braxton, Durham VAMC, Durham, North Carolina; Kelly Maieritsch, and Kenneth Weber, Edward Hines Jr. VA Hospital, Hines, Illinois; Anthony Kerrigan, and Karen Thompson, Michael E. DeBakey VAMC, Houston, Texas; Michael Messina, and Angel Zambrano, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin; Garry Kutcher, and Julie Malphurs, VA Miami Healthcare System, Miami, Florida; Thad Strom, and Christopher Erbes, VA Minneapolis Health Care System, Minneapolis, Minnesota; and, William Wolfe, San Francisco VAMC, San Francisco, California. We acknowledge the support of the Research and Development Services at all of the participating medical centers, as well as the CSP#589 Coordinating Center at the West Haven VA Medical Center and the CSP#589 Study Chairs Office at the Tuscaloosa VA Medical Center.	Abraham KM, 2014, J REHABIL RES DEV, V51, P401, DOI 10.1682/JRRD.2013.05.0114; Adler DA, 2011, PSYCHIAT SERV, V62, P39, DOI 10.1176/ps.62.1.pss6201_0039; Becker D, 2007, PSYCHIAT SERV, V58, P922, DOI 10.1176/appi.ps.58.7.922; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bond GR, 1997, REHABIL COUNS BULL, V40, P265; Bond GR, 2001, J CONSULT CLIN PSYCH, V69, P489, DOI 10.1037//0022-006X.69.3.489; Bond GR, 1998, PSYCHIATR REHABIL J, V22, P11, DOI 10.1037/h0095271; BROMBERGER JT, 1994, AM J PUBLIC HEALTH, V84, P202, DOI 10.2105/AJPH.84.2.202; Burns T, 2009, SCHIZOPHRENIA BULL, V35, P949, DOI 10.1093/schbul/sbn024; Bush PW, 2009, PSYCHIAT SERV, V60, P1024, DOI 10.1176/appi.ps.60.8.1024; CAPLAN RD, 1989, J APPL PSYCHOL, V74, P759, DOI 10.1037/0021-9010.74.5.759; Comino EJ, 2000, AUST NZ J PSYCHIAT, V34, P107, DOI 10.1046/j.1440-1614.2000.00645.x; Coric Vladimir, 2009, Psychiatry (Edgmont), V6, P26; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Davis LL, 2012, PSYCHIAT SERV, V63, P464, DOI 10.1176/appi.ps.201100340; Desai R., 2010, LONG JOURNEY HOME 18; Drake RE, 2003, CURR OPIN PSYCHIATR, V16, P451, DOI 10.1097/01.yco.0000079209.36371.84; Drake RE, 2016, HEALTH AFFAIR, V35, P1098, DOI 10.1377/hlthaff.2016.0001; Erbes CR, 2011, J REHABIL RES DEV, V48, P1159, DOI 10.1682/JRRD.2010.11.0212; Ferrie JE, 2001, J ROY SOC MED, V94, P71, DOI 10.1177/014107680109400206; Frisch M.B., 1994, QOLI QUALITY LIFE IN; Hoff R., 2011, LONG JOURNEY HOME 20; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Kimerling R, 2009, J INTERPERS VIOLENCE, V24, P450, DOI 10.1177/0886260508317191; Kleylamp M, 2013, SOC SCI RES, V42, P836, DOI 10.1016/j.ssresearch.2012.12.017; Korpi T, 2001, EUR SOCIOL REV, V17, P255, DOI 10.1093/esr/17.3.255; Kukla M, 2012, J NERV MENT DIS, V200, P214, DOI 10.1097/NMD.0b013e318247cb29; Leon LC, 2010, J REHABIL, V76, P41; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Martikainen PT, 1996, LANCET, V348, P909, DOI 10.1016/S0140-6736(96)03291-6; McCaslin SE, 2016, J PSYCHIATR RES, V72, P104, DOI 10.1016/j.jpsychires.2015.10.016; Montgomery SM, 1999, INT J EPIDEMIOL, V28, P95, DOI 10.1093/ije/28.1.95; Mueser KT, 2016, CURR OPIN PSYCHIATR, V29, P196, DOI 10.1097/YCO.0000000000000247; Murdoch M, 2005, MIL MED, V170, P137; PAYNE RL, 1987, J OCCUP BEHAV, V8, P351, DOI 10.1002/job.4030080407; Penk W, 2009, PSYCHIATR REHABIL J, V33, P297, DOI 10.2975/33.4.2010.297.307; Resnick SG, 2008, J REHABIL RES DEV, V45, P427, DOI 10.1682/JRRD.2007.06.0093; Resnick SG, 2007, J REHABIL RES DEV, V44, P867, DOI 10.1682/JRRD.2007.02.0043; Resnick SG, 2009, PSYCHIAT SERV, V60, P682, DOI 10.1176/appi.ps.60.5.682; Riviere LA, 2011, BRIT J PSYCHIAT, V198, P136, DOI 10.1192/bjp.bp.110.084863; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Rosenheck R, 2000, HEALTH SERV RES, V35, P133; Salyers MP, 2004, PSYCHIAT SERV, V55, P302, DOI 10.1176/appi.ps.55.3.302; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schnurr PR, 2011, WOMEN HEALTH ISS, V21, pS169, DOI 10.1016/j.whi.2011.04.013; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; STUDNICKA M, 1991, SOC PSYCH PSYCH EPID, V26, P86, DOI 10.1007/BF00791533; Substance Abuse and Mental Health Services Administration, 2003, PRES NEW FREED COMM; Swanson S.J., 2013, IPS SUPPORTED EMPLOY; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; U.S. Department of Labor, 2013, EMPL SIT VET 2013; VINOKUR AD, 1991, J APPL PSYCHOL, V76, P213, DOI 10.1037/0021-9010.76.2.213; Whitley R, 2010, PSYCHIAT SERV, V61, P1248, DOI 10.1176/ps.2010.61.12.1248; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270; Yur'yev A, 2012, INT J SOC PSYCHIATR, V58, P62, DOI 10.1177/0020764010387059	59	8	8	0	2	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1095-158X	1559-3126		PSYCHIATR REHABIL J	Psychiatr. Rehabil. J.	MAR	2018	41	1					55	66		10.1037/prj0000250			12	Psychiatry; Rehabilitation	Social Science Citation Index (SSCI)	Psychiatry; Rehabilitation	GN6AP	WOS:000439153200007	28358525	Bronze			2022-02-06	
J	Gantner, DC; Bailey, M; Presneill, J; French, CJ; Nichol, A; Little, L; Bellomo, R				Gantner, Dashiell C.; Bailey, Michael; Presneill, Jeffrey; French, Craig J.; Nichol, Alistair; Little, Lorraine; Bellomo, Rinaldo		EPO-TBI Investigators ANZICS Clini	Erythropoietin to Reduce Mortality in Traumatic Brain Injury A Post-hoc Dose-effect Analysis	ANNALS OF SURGERY			English	Article						dose-response relationship; erythropoietin; mortality; traumatic brain injury	CRITICALLY-ILL PATIENTS; RECOMBINANT-HUMAN-ERYTHROPOIETIN; RANDOMIZED CONTROLLED-TRIAL; GLASGOW OUTCOME SCALE; EPOETIN-ALPHA; HUMAN ERYTHROPOLETIN; IMPROVED SURVIVAL; DOUBLE-BLIND; PHARMACOKINETICS; PHARMACODYNAMICS	Objective: We aimed to assess whether the dosing regimen of erythropoietin shows a relationship to mortality in critically ill patients with traumatic brain injury (TBI). Background: Erythropoietin may decrease mortality in patients with TBI; however, the optimal dosing regimen remains uncertain. Methods: We conducted a post-hoc analysis of a multicenter, randomized trial of weekly erythropoietin versus placebo in patients with moderate and severe TBI admitted to intensive care. We assessed whether the cumulative dosage of erythropoietin was differentially associated with all-cause patient mortality evaluated at 6 months after injury. Results: There was a nonlinear relationship between dose and mortality (P = 0.008) that remained after adjustment for site and severity of illness (P = 0.01). Six-month mortality was lower in randomized patients who received 1 [adjusted hazard ratio (HR) 0.58, 95% confidence interval (CI) 0.33-1.01; P = 0.06] or 2 doses of erythropoietin (HR 0.31, 95% CI 0.12-0.80; P = 0.02) compared with those who received no doses. No benefit was seen with 3 doses (HR 1.55, 95% CI 0.66-3.62; P = 0.33). There was no differential effect of dose on functional neurological outcomes. Results across subgroups and secondary intention to treat analyses were consistent with primary findings. Conclusions: This post-hoc, hypothesis-generating analysis found potential reductions in mortality following 1 or 2 weekly doses of 40,000 IU of erythropoietin in intensive care unit patients with moderate or severe TBI, but not with 3 doses. These findings will inform the design of future trials of erythropoietin in critically ill patients with TBI and trauma.	[Gantner, Dashiell C.; Bailey, Michael; Presneill, Jeffrey; Nichol, Alistair; Little, Lorraine] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia; [Gantner, Dashiell C.; Nichol, Alistair] Alfred, Dept Intens Care & Hyperbar Med, 55 Commercial Rd, Melbourne, Vic 3004, Australia; [Presneill, Jeffrey] Royal Melbourne Hosp, Dept Intens Care, Melbourne, Vic, Australia; [Presneill, Jeffrey; French, Craig J.] Univ Melbourne, Melbourne, Vic, Australia; [French, Craig J.] Western Hlth, Dept Intens Care, Melbourne, Vic, Australia; [Nichol, Alistair] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland; [Bellomo, Rinaldo] Austin Hlth, Dept Intens Care, Melbourne, Vic, Australia		Gantner, DC (corresponding author), Alfred, Dept Intens Care & Hyperbar Med, 55 Commercial Rd, Melbourne, Vic 3004, Australia.	dashiell.gantner@monash.edu	Bailey, Michael J/A-4499-2012; French, Craig/ABF-5087-2020	Bailey, Michael J/0000-0002-5551-1401; French, Craig/0000-0003-1363-9711; Bellomo, Rinaldo/0000-0002-1650-8939	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Transport Accident Commission	The EPO-TBI trial was supported by the National Health and Medical Research Council and the Transport Accident Commission.	Abrishamkar S, 2012, J RES MED SCI, V17, P51; Arroliga AC, 2009, CRIT CARE MED, V37, P1299, DOI 10.1097/CCM.0b013e31819cec94; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P136, DOI 10.1016/j.jclinepi.2009.05.009; Caucio L, 2008, J TRAUMA, V65, P297; Corwin HL, 2002, JAMA-J AM MED ASSOC, V288, P2827, DOI 10.1001/jama.288.22.2827; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; French CJ, 2017, ANN SURG, V265, P54, DOI 10.1097/SLA.0000000000001746; Gabrilove JL, 2001, J CLIN ONCOL, V19, P2875, DOI 10.1200/JCO.2001.19.11.2875; [Герасимов Лев Владимирович Gerasimov L.V.], 2012, [Общая реаниматология, Obshchaya reanimatologiya], VVIII, P11; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Kawakami M, 2000, BIOCHEM BIOPH RES CO, V279, P293, DOI 10.1006/bbrc.2000.3926; Liao ZB, 2008, EUR J NEUROL, V15, P140, DOI 10.1111/j.1468-1331.2007.02013.x; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Napolitano LM, 2008, J TRAUMA, V65, P285, DOI 10.1097/TA.0b013e31817f2c6e; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nichol A, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0528-6; Nirula R, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/209848; Patel NSA, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-40; Ponce Lucido L, 2013, Pathophysiology, V20, P31, DOI 10.1016/j.pathophys.2012.02.005; Presneill Jeffrey, 2014, Trials, V15, P501, DOI 10.1186/1745-6215-15-501; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Sobrino Justin, 2013, Proc (Bayl Univ Med Cent), V26, P120; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Vincent JL, 2006, CRIT CARE MED, V34, P1661, DOI 10.1097/01.CCM.0000217919.22155.85; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu Y, 2007, EUR J PHARMACOL, V564, P47, DOI 10.1016/j.ejphar.2007.02.020	27	8	9	3	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	MAR	2018	267	3					585	589		10.1097/SLA.0000000000002142			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GB5KR	WOS:000429103500054	28151802				2022-02-06	
J	Kamalabai, RP; Nagar, M; Chandran, R; Suharanbeevi, SMH; Prabhakar, RB; Peethambaran, A; Dhanapalan, SM; Jain, S; Sharma, S				Kamalabai, Rosebist Pathrose; Nagar, Milesh; Chandran, Raj; Suharanbeevi, Sharmad Mohammed Haneefa; Prabhakar, Rajmohan Bhanu; Peethambaran, Anil; Dhanapalan, Sreejith Mallika; Jain, Sourabh; Sharma, Saurabh			Rationale Behind the Use of Double-Layer Polypropylene Patch (G-patch) Dural Substitute During Decompressive Craniectomy as an Adhesion Preventive Material for Subsequent Cranioplasty with Special Reference to Flap Elevation Time	WORLD NEUROSURGERY			English	Article						Cranioplasty; Decompressive craniectomy; Double-layer dural substitute; G-patch; Polypropylene patch	CREUTZFELDT-JAKOB-DISEASE; SEVERE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; TECHNICAL NOTE; BOVINE PERICARDIUM; TEMPORAL MUSCLE; COLLAGEN MATRIX; POLYTETRAFLUOROETHYLENE; DURAPLASTY; SAFETY	OBJECTIVE: Dural substitutes are used in decompressive craniectomy (DC) to prevent adhesions during subsequent cranioplasty. Current literature attributes them to reduced blood loss and reduction in operative time of cranioplasty. The use of double-layer substitute has rarely been documented. We studied the use of double-layer G-patch as a dural substitute in DC and evaluated its outcome during subsequent cranioplasty with special focus on flap elevation time and blood loss during cranioplasty. METHODS: We performed emergency frontotemporoparietal decompressive craniectomy using a double layer of G-patch as dural substitute. Subsequent cranioplasty was done in these 35 patients. The development of adhesion formation between the tissue layers, amount of blood loss, and flap elevation time were recorded. RESULTS: During the cranioplasty, a clear and smooth plane of dissection was found between the 2 layers of G-patch in all cases. Average flap elevation time was 21.8 minutes, and average time taken for cranioplasty was 124.12 minutes. Average blood loss was 83 mL. None of the patients required re-exploration for infection of bone flap or postoperative bleed. CONCLUSIONS: While evaluating the use of dural substitute during DC as an adhesion preventive material for subsequent cranioplasty, flap elevation time and blood loss should be taken into account rather than operative time. Double-layer G-patch during DC facilitates subsequent cranioplasty by preventing adhesions between the layers, resulting in easier dissection and reduced blood loss.	[Kamalabai, Rosebist Pathrose; Nagar, Milesh; Chandran, Raj; Suharanbeevi, Sharmad Mohammed Haneefa; Prabhakar, Rajmohan Bhanu; Peethambaran, Anil; Dhanapalan, Sreejith Mallika; Jain, Sourabh; Sharma, Saurabh] Govt Med Coll, Dept Neurosurg, Trivandrum, Kerala, India		Nagar, M (corresponding author), Govt Med Coll, Dept Neurosurg, Trivandrum, Kerala, India.	millesh.kem@gmail.com		Sharma, Saurabh/0000-0003-3523-2947			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Anson JA, 1996, NEUROSURGERY, V39, P764, DOI 10.1097/00006123-199610000-00025; Bejjani GK, 2007, J NEUROSURG, V106, P1028, DOI 10.3171/jns.2007.106.6.1028; Bulters D, 2010, BRIT J NEUROSURG, V24, P75, DOI 10.3109/02688690903506135; Centonze Roberto, 2016, Asian J Neurosurg, V11, P201, DOI 10.4103/1793-5482.179645; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Cho Yong Jun, 2017, Korean J Neurotrauma, V13, P9, DOI 10.13004/kjnt.2017.13.1.9; Chun HJ, 2011, J CRANIOFAC SURG, V22, P203, DOI 10.1097/SCS.0b013e3181f753bd; Coda A, 2012, HERNIA, V16, P9, DOI 10.1007/s10029-011-0868-z; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Di Rienzo A, 2013, NEUROL MED-CHIR, V53, P590; Dufrane D, 2003, J NEUROSURG, V98, P1198, DOI 10.3171/jns.2003.98.6.1198; Filippi R, 2001, NEUROSURG REV, V24, P103, DOI 10.1007/PL00012392; Grigoryuk AA, 2014, B EXP BIOL MED+, V156, P530, DOI 10.1007/s10517-014-2391-6; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Huang YH, 2011, J TRAUMA, V71, P533, DOI 10.1097/TA.0b013e318203208a; Ishida C, 2005, J NEUROL NEUROSUR PS, V76, P325, DOI 10.1136/jnnp.2003.035154; Kawaguchi T, 2003, NEUROL MED-CHIR, V43, P320, DOI 10.2176/nmc.43.320; Khalili Hosseinali, 2016, Bull Emerg Trauma, V4, P24; Lam FC, 2012, NEUROSURGERY, V71, P302, DOI 10.1227/NEU.0b013e31826a8ab0; Lee CH, 2007, CLIN NEUROL NEUROSUR, V109, P667, DOI 10.1016/j.clineuro.2007.05.015; Malliti M, 2004, NEUROSURGERY, V54, P599, DOI 10.1227/01.NEU.0000108640.45371.1A; Missori P, 2008, SURG NEUROL, V70, P437, DOI 10.1016/j.surneu.2007.03.029; Missori P, 2013, ACTA NEUROCHIR, V155, P1335, DOI 10.1007/s00701-013-1695-z; Miyake S, 2006, NEUROL MED-CHIR, V46, P104, DOI 10.2176/nmc.46.104; Muller-Stich BP, 2014, HERNIA, V18, P873, DOI 10.1007/s10029-014-1305-x; Mumert ML, 2012, J CLIN NEUROSCI, V19, P455, DOI 10.1016/j.jocn.2011.09.004; Nakagawa S, 2003, NEUROL MED-CHIR, V43, P120, DOI 10.2176/nmc.43.120; Norrby E, 2011, J INTERN MED, V270, P1, DOI 10.1111/j.1365-2796.2011.02387.x; Oladunjoye AO, 2013, J NEUROSURG, V118, P776, DOI 10.3171/2013.1.JNS121475; Ostendorf AP, 2013, J NEUROSURG-PEDIATR, V12, P357, DOI 10.3171/2013.7.PEDS13130; Papacchini Maddalena, 2003, Med Lav, V94, P271; Parizek J, 1997, ACTA NEUROCHIR, V139, P827, DOI 10.1007/BF01411400; Parizek J, 1996, J NEUROSURG, V84, P508, DOI 10.3171/jns.1996.84.3.0508; Pereira-lucena CG, 2014, HERNIA, V18, P563, DOI 10.1007/s10029-013-1206-4; Pierson M, 2016, WORLD NEUROSURG, V86, P153, DOI 10.1016/j.wneu.2015.09.078; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; Raul JS, 2003, NEUROCHIRURGIE, V49, P83; Rutala WA, 2001, CLIN INFECT DIS, V32, P1348, DOI 10.1086/319997; Sabatino G, 2014, CLIN NEUROL NEUROSUR, V116, P20, DOI 10.1016/j.clineuro.2013.11.010; Sekhar LN, 2013, WORLD NEUROSURG, V79, P440, DOI 10.1016/j.wneu.2011.12.062; Senapati SB, 2012, INDIAN J NEUROTRAUM, V9, P136, DOI 10.1016/j.ijnt.2012.10.006; Shimada Y, 2006, J ORTHOP SCI, V11, P454, DOI 10.1007/s00776-006-1044-7; Stendel R, 2008, J NEUROSURG, V109, P215, DOI 10.3171/JNS/2008/109/8/0215; Tanaka S, 2010, NEUROEPIDEMIOLOGY, V34, P232, DOI 10.1159/000297747; Tasiou A, 2014, INTERDISCIP NEUROSUR, V1, P107, DOI 10.1016/j.inat.2014.06.005; Tokoro K, 1989, Neurol Med Chir (Tokyo), V29, P196, DOI 10.2176/nmc.29.196; Topsakal C, 2004, J NEUROSURG, V101, P295, DOI 10.3171/jns.2004.101.2.0295; Vakis A, 2006, CLIN NEUROL NEUROSUR, V108, P798, DOI 10.1016/j.clineuro.2005.11.026; Wang F, 2015, INDIAN J SURG, V77, pS1008, DOI 10.1007/s12262-014-1111-9; Wood AJ, 2013, J MATER SCI-MATER M, V24, P1113, DOI 10.1007/s10856-013-4872-y; Yamagata Sen, 1993, Neurologia Medico-Chirurgica, V33, P582, DOI 10.2176/nmc.33.582; Yu FB, 2013, FRONT BIOSCI-LANDMRK, V18, P1336, DOI 10.2741/4182; Zerris VA, 2007, J BIOMED MATER RES B, V83B, P580, DOI 10.1002/jbm.b.30831; Zhang GL, 2010, CHIN J TRAUMATOL, V13, P259, DOI 10.3760/cma.j.issn.1008-1275.2010.05.001	55	8	8	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2018	111						E105	E112		10.1016/j.wneu.2017.12.005			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG7WI	WOS:000432908700015	29233748				2022-02-06	
J	Kerr, ZY; Lincoln, AE; Caswell, SV; Klossner, DA; Walker, N; Dompier, TP				Kerr, Zachary Y.; Lincoln, Andrew E.; Caswell, Shane V.; Klossner, David A.; Walker, Nina; Dompier, Thomas P.			Epidemiology of National Collegiate Athletic Association Women's Lacrosse Injuries, 2009-10 Through 2014-15	JOURNAL OF SPORT REHABILITATION			English	Article						sports injuries; epidemiology; injury prevention; college sports	SURVEILLANCE SYSTEM; EYE INJURIES; SPORTS; CONCUSSION; REDUCTION; GIRLS; HEAD	Context: Participation in collegiate women's lacrosse has increased dramatically, but little recent epidemiological data exists regarding injuries. Objective: Describe the epidemiology of National Collegiate Athletic Association (NCAA) women's lacrosse injuries during the 2009-10 through 2014-15 academic years. Setting: Aggregate injury and exposure data collected from 40 women's lacrosse programs providing 83 team-seasons of data. Patients or Other Participants: Collegiate women's lacrosse student-athletes. Intervention: Women's lacrosse data from the NCAA Injury Surveillance Program were analyzed. Main Outcome Measures: Injury rates; injury rate ratios; and injury proportions by body site, diagnosis, and injury mechanism were reported with 95% confidence intervals (CI). Time loss (TL) injuries resulted in participation restriction time of at least 24 hours. Nontime loss (NTL) injuries resulted in participation restriction time under 24 hours. Results: There were 705 TL and NTL women's lacrosse injuries, resulting in an injury rate of 4.93/1000 athlete-exposures (AEs; 95% CI: 4.57-5.30). The TL and NTL injury rates were 2.18/1000 AE (95% CI: 1.93-2.42) and 2.64/1000 AE (95% CI: 2.37-2.90), respectively. Most injuries were to the lower extremity (competition: 64.4%; practice: 71.2%). Most injuries in competition were sprains (26.0%), contusions (19.6%), and strains (19.2%); most injuries in practice were strains (21.4%), sprains (18.1%), and inflammatory conditions (15.8%). Concussions comprised the highest proportion of head/face injuries (competition: 82.1%; practice: 54.5%). No eye injuries were reported. The highest proportion of injuries were player contact (27.4%) in competitions and noncontact (32.1%) in practices. Contact with the ball and stick comprised 21.5% of competition and 14.0% of practice injuries. Conclusions: This study is the most robust assessment of collegiate women's lacrosse injuries to date, utilizing surveillance data that includes both TL and NTL injuries. Over half of all injuries were NTL; inclusion of such injuries further highlights the breadth of injuries managed by team medical staff.	[Kerr, Zachary Y.; Walker, Nina] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Lincoln, Andrew E.] MedStar Sports Med Res Ctr, Baltimore, MD USA; [Caswell, Shane V.] George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, Manassas, VA USA; [Klossner, David A.] Univ Maryland, Maryland Athlet, College Pk, MD 20742 USA; [Dompier, Thomas P.] Datalys Ctr Sports Injury Res & Prevent Inc, Indianapolis, IN USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu			NCAA	The NCAA-ISP data were provided by the Datalys Center for Sports Injury Research and Prevention and funded by the NCAA. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NCAA. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate student-athletes. The authors have no conflicts of interest to disclose.	ASTM International, 2015, STAND SPEC HEADG US; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Dick R, 2007, J ATHL TRAINING, V42, P262; Dick R, 2007, J ATHL TRAINING, V42, P173; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Klossner D., 2009, NEW DIRECTIONS I RES, V2009, P53, DOI DOI 10.1002/IR.313; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; National Collegiate Athletic Association, 2015, STUD ATHL PART 1981; Noyes FR, 2012, SPORTS HEALTH, V4, P36, DOI 10.1177/1941738111430203; Putukian M, 2014, CURR SPORT MED REP, V13, P334, DOI 10.1249/JSR.0000000000000092; US Lacrosse, 2015, WOM LACR RUL; US Lacrosse, 2012, STAND PERF SPEC NEWL; US Lacrosse, 2013, NOCSAE BALL MAND; US Lacrosse, 2015, WOM LACR HEADG FAQ; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	22	8	8	1	3	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	MAR	2018	27	2					118	125		10.1123/jsr.2016-0124			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	GB5MX	WOS:000429110100005	28095142				2022-02-06	
J	Liu, ZN; Sheng, JT; Peng, GY; Yang, JH; Chen, WQ; Li, KS				Liu, Zhenning; Sheng, Jiangtao; Peng, Guoyi; Yang, Jinhua; Chen, Weiqiang; Li, Kangsheng			TGF-beta 1 Regulation of P-JNK and L-Type Calcium Channel Cav1.2 in Cortical Neurons	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Cortical neurons; Jun NH2-terminal kinase 1/2; L-type calcium channels; Transforming growth factor-beta1; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; IN-VITRO; ALZHEIMERS-DISEASE; TRANSFORMING GROWTH-FACTOR-BETA-1; SUBARACHNOID HEMORRHAGE; CEREBROSPINAL-FLUID; TGF-BETA; MITOCHONDRIAL CALCIUM; MAPK ACTIVATION; P38 MAPK	Central nervous system (CNS) diseases can cause a series of neuronal lesions, which may be improved by the anti-apoptotic neuroprotection of transforming growth factor-beta 1 (TGF-beta 1). In neurons, L-type Ca2+ channels (LTCC) are mainly composed of Cav1.2 subunits. Given the implication of TGF-beta 1 in numerous CNS diseases, we examined the neuroprotective effects of TGF-beta 1 on the Cav1.2 channel in the CNS. To simulate acute mechanical traumatic brain injury (TBI), we used a needle to create parallel scratches across plates, which were cultured for 9 h. Meanwhile, Fluo4-AM-loaded laser scanning confocal microscopy with a dual wavelength of 488 nm/530 nm was employed to determine intracellular calcium concentrations ([Ca2+](i)). We found that MAPK inhibitors impede TGF-beta 1-induced cell viability and that TGF-beta 1 recovered from the trauma-induced cell viability in neurons. Cav1.2 production was significantly decreased in the TGF-beta 1-treated (10 ng/mL) neurons. At this TGF-beta 1 concentration, Cav1.2 was significantly down-regulated in a time-dependent manner after 12 h. Moreover, TGF-beta 1 partially recovered the protein levels of Cav1.2 that were reduced by TBI. TGF-beta 1 significantly inhibited the fluorescence intensity of [Ca2+](i) increased by KCl and delayed the time of the peak [Ca2+](i). The observed effects of TGF-beta 1 on Cav1.2 were regulated by MAPK inhibitors. The observed effects of TGF-beta 1 on P-JNK were also impeded by pre-incubation with the LTCC inhibitor (10 mu M) nimodipine in trauma-injured neurons. Altogether, TGF-beta 1 regulated LTCCs through a mechanism dependent on MEK, JNK1/2 and p38 MAPK signal pathways in cortical neurons. Thus, we suggest the involvement of this mechanism in cell viability.	[Liu, Zhenning; Sheng, Jiangtao; Chen, Weiqiang; Li, Kangsheng] Shantou Univ, Dept Microbiol & Immunol, Key Immunopathol Lab Guangdong Prov, Coll Med, 22 Xinling Rd, Shantou 515041, Guangdong, Peoples R China; [Peng, Guoyi; Yang, Jinhua; Chen, Weiqiang] Shantou Univ, Affiliated Hosp 1, Dept Neurosurg, Coll Med, 57 Changping Rd, Shantou 515041, Guangdong, Peoples R China		Chen, WQ; Li, KS (corresponding author), Shantou Univ, Dept Microbiol & Immunol, Key Immunopathol Lab Guangdong Prov, Coll Med, 22 Xinling Rd, Shantou 515041, Guangdong, Peoples R China.; Chen, WQ (corresponding author), Shantou Univ, Affiliated Hosp 1, Dept Neurosurg, Coll Med, 57 Changping Rd, Shantou 515041, Guangdong, Peoples R China.	wqchen@stu.edu.cn; ksli@stu.edu.cn		Li, Kangsheng/0000-0002-6981-9263	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31170852, 31300761, 81001322, 81001340, 81172795, 81374040, 81471622]; Guangdong Natural Science FoundationNational Natural Science Foundation of Guangdong Province [S2012040007470]; Medical Scientific Research Foundation of Guangdong Province, China [A2015211]; Foundation for Distinguished Young Teachers in Higher Education of Guangdong [Yq2013077, Yq2013079]; Department of Education, Guangdong Government [2015026]	This project was supported by the National Natural Science Foundation of China (31170852, 31300761, 81001322, 81001340, 81172795, 81374040 and 81471622), Guangdong Natural Science Foundation (S2012040007470), the Medical Scientific Research Foundation of Guangdong Province, China (A2015211), the Foundation for Distinguished Young Teachers in Higher Education of Guangdong (Yq2013077 and Yq2013079) and the Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases (2015026). The funding bodies did not participate in the study design; data collection, analysis and interpretation; and manuscript writing.	Almilaji A, 2016, CELL PHYSIOL BIOCHEM, V39, P693, DOI 10.1159/000445660; Avila G, 2007, AM J PHYSIOL-HEART C, V292, pH622, DOI 10.1152/ajpheart.00781.2006; Berliocchi L, 2005, PHILOS T R SOC B, V360, P2255, DOI 10.1098/rstb.2005.1765; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen WQ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0349-x; Davare MA, 2003, P NATL ACAD SCI USA, V100, P16018, DOI 10.1073/pnas.2236970100; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Douglas MR, 2009, J NEUROL NEUROSUR PS, V80, P545, DOI 10.1136/jnnp.2008.155671; Flanders KC, 1998, PROG NEUROBIOL, V54, P71, DOI 10.1016/S0301-0082(97)00066-X; Goldberg PL, 2002, AM J PHYSIOL-LUNG C, V282, pL146, DOI 10.1152/ajplung.2002.282.1.L146; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Green K. N., 2007, V45, P507; Gurkoff GG, 2012, EPILEPSIA, V53, P53, DOI 10.1111/j.1528-1167.2012.03475.x; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; HenrichNoack P, 1996, STROKE, V27, P1609, DOI 10.1161/01.STR.27.9.1609; Hu SX, 1999, J LEUKOCYTE BIOL, V65, P815, DOI 10.1002/jlb.65.6.815; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; Jaskova K, 2014, NEUROREPORT, V25, P340, DOI 10.1097/WNR.0000000000000106; Katano H, 1999, NEUROREPORT, V10, P2439, DOI 10.1097/00001756-199908200-00002; Li XF, 2007, NEUROSCI LETT, V413, P141, DOI 10.1016/j.neulet.2006.11.039; Liu XY, 2015, CELL PHYSIOL BIOCHEM, V37, P1903, DOI 10.1159/000438551; Lu SG, 2010, PAIN, V151, P633, DOI 10.1016/j.pain.2010.08.030; Ma H, 2013, BIOSCIENCE REP, V33, P97, DOI 10.1042/BSR20120099; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; Mathov I, 2001, J BONE MINER RES, V16, P2050, DOI 10.1359/jbmr.2001.16.11.2050; Meng Y, 2016, INT J MOL MED, V37, P258, DOI 10.3892/ijmm.2015.2419; Min DY, 2013, NEUROSCI LETT, V538, P60, DOI 10.1016/j.neulet.2013.02.001; MOGI M, 1995, NEUROSCI LETT, V193, P129, DOI 10.1016/0304-3940(95)11686-Q; Ortner NJ, 2016, CHANNELS, V10, P7, DOI 10.1080/19336950.2015.1048936; PREHN JHM, 1993, J CEREBR BLOOD F MET, V13, P521, DOI 10.1038/jcbfm.1993.67; PREHN JHM, 1993, J NEUROCHEM, V60, P1665, DOI 10.1111/j.1471-4159.1993.tb13389.x; Rodriguez-Barbero A, 2006, CELL PHYSIOL BIOCHEM, V18, P135, DOI 10.1159/000095181; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Rota E, 2006, NEUROL SCI, V27, P33, DOI 10.1007/s10072-006-0562-6; Sanchez AB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0724-2; Santos SF, 2010, REV NEUROSCIENCE, V21, P153; Scheff NN, 2015, J NEUROSCI, V35, P8423, DOI 10.1523/JNEUROSCI.3597-14.2015; Schlick B, 2010, NEUROSCIENCE, V167, P786, DOI 10.1016/j.neuroscience.2010.02.037; Scorziello A, 1997, J NEUROSCI RES, V49, P600, DOI 10.1002/(SICI)1097-4547(19970901)49:5&lt;600::AID-JNR10&gt;3.0.CO;2-Z; Shahlaie K, 2010, J NEUROTRAUM, V27, P175, DOI 10.1089/neu.2009.1003; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Takizawa T, 2001, NEUROL RES, V23, P724, DOI 10.1179/016164101101199243; VANDERWAL EA, 1993, NEUROREPORT, V4, P69, DOI 10.1097/00001756-199301000-00018; Walshe TE, 2011, NEUROSCIENCE, V189, P123, DOI 10.1016/j.neuroscience.2011.05.020; Wang XY, 2015, NEUROCHEM RES, V40, P1671, DOI 10.1007/s11064-015-1634-x; Yan HY, 2015, MOL NEUROBIOL, V52, P1637, DOI 10.1007/s12035-014-8942-z; Zhang JG, 2016, EURASIP J WIREL COMM, DOI 10.1186/s13638-016-0630-4; Zhang ZB, 2012, NEUROCHEM RES, V37, P948, DOI 10.1007/s11064-011-0687-8; Zheng Mingzhe, 2013, Acta Neurochir Suppl, V118, P169, DOI 10.1007/978-3-7091-1434-6_31; Zhu Y, 2001, NEUROCHEM INT, V38, P227, DOI 10.1016/S0197-0186(00)00084-X	52	8	8	4	16	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAR	2018	64	3					374	384		10.1007/s12031-018-1033-2			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GA8HD	WOS:000428579400006	29423686				2022-02-06	
J	Rao, DP; McFaull, S; Thompson, W; Jayaraman, GC				Rao, Deepa P.; McFaull, Steven; Thompson, Wendy; Jayaraman, Gayatri C.			Traumatic brain injury management in Canada: changing patterns of care	HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION IN CANADA-RESEARCH POLICY AND PRACTICE			English	Article						traumatic brain injury; concussion; surveillance	CONCUSSION; SPORTS; TRENDS	Introduction: With growing awareness about traumatic brain injuries (TBI), there is limited information about population level patterns of TBI care in Canada. Methods: We examined data from the Canadian Community Health Survey (years 2004, 2009, and 2014) among all respondents ages 12 years and older. TBI management characteristics examined included access to care within 48 hours of injury, point of care, hospital admission, and follow-up. Results: We observed that many Canadians sought care within 48 hours of their injury, with no changes over time. We found a significant decline in the proportion of Canadians opting to visit an emergency department (p = 0.03, all ages), and a significant increase in youth opting to visit a doctor's office (p < 0.01). Conclusion: TBIs are an important and growing health concern in Canada. Care for such injuries appears to have shifted towards the use of health care professionals outside the hospital environment, including primary care doctors.	[Rao, Deepa P.; McFaull, Steven; Thompson, Wendy; Jayaraman, Gayatri C.] Publ Hlth Agcy Canada, 785 Carling Ave,Off 707B1, Ottawa, ON K1A 0K9, Canada		Rao, DP (corresponding author), Publ Hlth Agcy Canada, 785 Carling Ave,Off 707B1, Ottawa, ON K1A 0K9, Canada.	deepa.rao@canada.ca					Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Beland Yves, 2002, Health Rep, V13, P9; Bey T, 2009, WEST J EMERG MED, V10, P6; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Faul M, 2010, TRAUMATIC BRAIN INJU; Feinstein A, 2000, CAN J PUBLIC HEALTH, V91, P325, DOI 10.1007/BF03404799; Gabbe BJ, 2003, BRIT J SPORT MED, V37, P545, DOI 10.1136/bjsm.37.6.545; Guskiewicz KM, 2011, PHYS MED REH CLIN N, V22, P603, DOI 10.1016/j.pmr.2011.08.003; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Parachute, 2017, CAN GUID CONC SPORT; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Taylor AE, 2015, J PEDIATR-US, V167, P1041, DOI 10.1016/j.jpeds.2015.05.011; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	17	8	8	1	1	PUBLIC HEALTH AGENCY CANADA	OTTAWA	130 COLONNADE RD, ADDRESS LOCATOR 6501G, OTTAWA, ONTARIO K1A 0K9, CANADA	2368-738X			HEALTH PROMOT CHRON	Health Promot. Chronic Dis. Prev. Can.-Res. Policy Pract.	MAR	2018	38	3					147	150		10.24095/hpcdp.38.3.05			4	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	FZ2RJ	WOS:000427428600005	29537772	gold, Green Published			2022-02-06	
J	Smedfors, G; Olson, L; Karlsson, TE				Smedfors, Gabriella; Olson, Lars; Karlsson, Tobias E.			A Nogo-Like Signaling Perspective from Birth to Adulthood and in Old Age: Brain Expression Patterns of Ligands, Receptors and Modulators	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						development; Nogo-A; NgR1; Lingo-1; Troy; OMgp; Olfactomedin; hippocampus	MYELIN-ASSOCIATED GLYCOPROTEIN; CENTRAL-NERVOUS-SYSTEM; NEURITE OUTGROWTH; MESSENGER-RNA; AXONAL REGENERATION; MULTIPLE-SCLEROSIS; GROWTH-INHIBITION; A EXPRESSION; BASOLATERAL AMYGDALA; FUNCTIONAL RECOVERY	An appropriate strength of Nogo-like signaling is important to maintain synaptic homeostasis in the CNS. Disturbances have been associated with schizophrenia, MS and other diseases. Blocking Nogo-like signaling may improve recovery after spinal cord injury, stroke and traumatic brain injury. To understand the interacting roles of an increasing number of ligands, receptors and modulators engaged in Nogo-like signaling, the transcriptional activity of these genes in the same brain areas from birth to old age in the normal brain is needed. Thus, we have quantitatively mapped the innate expression of 11 important genes engaged in Nogo-like signaling. Using in situ hybridization, we located and measured the amount of mRNA encoding Nogo-A, OMgp, NgR1, NgR2, NgR3, Lingo-1, Troy, Olfactomedin, LgI1, ADAM22, and MAG, in 18 different brain areas at six different ages (P0, 1, 2, 4, 14, and 104 weeks). We show gene-and area-specific activities and how the genes undergo dynamic regulation during postnatal development and become stable during adulthood. Hippocampal areas underwent the largest changes over time. We only found differences between individual cortical areas in Troy and MAG. Subcortical areas presented the largest inter-regional differences; lateral and basolateral amygdala had markedly higher expression than other subcortical areas. The widespread differences and unique expression patterns of the different genes involved in Nogo-like signaling suggest that the functional complexes could look vastly different in different areas.	[Smedfors, Gabriella; Olson, Lars; Karlsson, Tobias E.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden		Smedfors, G (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	gabriella.smedfors@ki.se			ERCEuropean Research Council (ERC)European Commission [322744]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [K2012-62x-03185-42-4]; StratNeuro, Karolinska Institutet Research Foundations; Swedish Brain Foundation; Karolinska DPAKarolinska Institutet; Clinical scientist training programme Karolinska Institutet; Research program for young medical doctors Karolinska Institutet	Supported by an ERC Advanced Investigator grant (322744; LO), the Swedish Research Council (K2012-62x-03185-42-4; LO), StratNeuro, Karolinska Institutet Research Foundations (LO), the Swedish Brain Foundation (LO), the Karolinska DPA (LO), the Clinical scientist training programme Karolinska Institutet (GS) and Research program for young medical doctors Karolinska Institutet (GS). We thank Katrin Wellfelt and Margareta Widing for skillful technical assistance.	Ahmed Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061878; Akbik FV, 2013, NEURON, V77, P859, DOI 10.1016/j.neuron.2012.12.027; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Barrette B, 2007, MOL CELL NEUROSCI, V34, P519, DOI 10.1016/j.mcn.2006.12.004; Borrie SC, 2012, CELL TISSUE RES, V349, P105, DOI 10.1007/s00441-012-1332-9; Boskovic Z, 2014, J NEUROSCI, V34, P13033, DOI 10.1523/JNEUROSCI.2364-14.2014; Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Cheatwood JL, 2008, STROKE, V39, P2091, DOI 10.1161/STROKEAHA.107.507426; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; ChenKinon, 2017, EXP NEUROL, V292, P135, DOI 10.1016/j.expneurol.2017.03.012; DAGERLIND A, 1992, HISTOCHEMISTRY, V98, P39, DOI 10.1007/BF00716936; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Erlich JC, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00016; Eslamboli A, 2006, NEUROSCI LETT, V408, P89, DOI 10.1016/j.neulet.2006.08.056; Fontoura P, 2006, J NEUROL SCI, V245, P201, DOI 10.1016/j.jns.2005.07.020; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Funahashi S, 2008, J COMP NEUROL, V506, P141, DOI 10.1002/cne.21541; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Giger RJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001867; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Habib AA, 1998, J NEUROCHEM, V70, P1704; Haybaeck J, 2012, DEV NEUROSCI-BASEL, V34, P402, DOI 10.1159/000343143; Hisaoka T, 2006, BRAIN RES, V1110, P81, DOI 10.1016/j.brainres.2006.06.068; Huber AB, 2002, J NEUROSCI, V22, P3553; INUZUKA T, 1991, BRAIN RES, V562, P173, DOI 10.1016/0006-8993(91)91204-E; Josephson A, 2001, EXP NEUROL, V169, P319, DOI 10.1006/exnr.2001.7659; Josephson A, 2003, CELL TISSUE RES, V311, P333, DOI 10.1007/s00441-002-0695-8; Josephson A, 2002, J COMP NEUROL, V453, P292, DOI 10.1002/cne.10408; Jung TY, 2011, NEUROPATHOLOGY, V31, P11, DOI 10.1111/j.1440-1789.2010.01118.x; Karlsson TE, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00094; Karlsson TE, 2016, CEREB CORTEX, V26, P1804, DOI 10.1093/cercor/bhw007; Kempf A, 2017, DEV CELL, V43, P24, DOI 10.1016/j.devcel.2017.08.014; Kempf A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001763; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Kim J, 2016, NAT NEUROSCI, V19, P1636, DOI 10.1038/nn.4414; Kumari A, 2014, CELL MOL NEUROBIOL, V34, P1131, DOI 10.1007/s10571-014-0088-z; Kurihara Y, 2014, MOL CELL NEUROSCI, V61, P211, DOI 10.1016/j.mcn.2014.07.001; Lauren J, 2003, MOL CELL NEUROSCI, V24, P581, DOI 10.1016/S1044-7431(03)00199-4; Lee JY, 2013, NEUROSCIENTIST, V19, P394, DOI 10.1177/1073858413477207; Lee X, 2007, J NEUROSCI, V27, P220, DOI 10.1523/JNEUROSCI.4175-06.2007; Lindau NT, 2014, BRAIN, V137, P739, DOI 10.1093/brain/awt336; Liu GX, 2015, BRAIN RES, V1627, P41, DOI 10.1016/j.brainres.2015.09.006; Llorens F, 2008, DEV NEUROBIOL, V68, P521, DOI 10.1002/dneu.20607; Lovero KL, 2015, P NATL ACAD SCI USA, V112, pE4129, DOI 10.1073/pnas.1511910112; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Meur AML, 2007, CEREB CORTEX, V17, P2375, DOI 10.1093/cercor/bhl146; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mingorance A, 2004, MOL CELL NEUROSCI, V26, P34, DOI 10.1016/j.mcn.2004.01.001; Mironova YA, 2013, TRENDS NEUROSCI, V36, P363, DOI 10.1016/j.tins.2013.04.003; Nakaya N, 2012, J BIOL CHEM, V287, P37171, DOI 10.1074/jbc.M112.389916; Niederost B, 2002, J NEUROSCI, V22, P10368; Nordgren M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078778; Okafuji T, 2005, GENE EXPR PATTERNS, V6, P57, DOI 10.1016/j.modgep.2005.04.016; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Paxinos G., 2007, MOUSE BRAIN STEREOTA; Pernet V, 2017, BBA-MOL BASIS DIS, V1863, P1300, DOI 10.1016/j.bbadis.2017.04.008; Richard M, 2005, EUR J NEUROSCI, V22, P2145, DOI 10.1111/j.1460-9568.2005.04418.x; Rodriguez L., 2017, 2017 NEUR M PLANN; Saha N, 2014, NEUROSCI RES, V87, P1, DOI 10.1016/j.neures.2014.06.003; Sato Y, 2011, SCIENCE, V333, P769, DOI 10.1126/science.1204144; Satoh JI, 2005, J NEUROPATH EXP NEUR, V64, P129, DOI 10.1093/jnen/64.2.129; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Seiler S, 2016, BIOCHEM PHARMACOL, V100, P28, DOI 10.1016/j.bcp.2015.08.113; Sozmen EG, 2016, P NATL ACAD SCI USA, V113, pE8453, DOI 10.1073/pnas.1615322113; Starkey HDV, 2013, CELL MOL NEUROBIOL, V33, P483, DOI 10.1007/s10571-013-9929-4; Sui YP, 2015, NEUROCHEM RES, V40, P1767, DOI 10.1007/s11064-015-1671-5; Thomas R, 2010, J NEUROSCI, V30, P6607, DOI 10.1523/JNEUROSCI.5147-09.2010; Tozaki H, 2002, MOL BRAIN RES, V104, P111, DOI 10.1016/S0169-328X(02)00172-9; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Vourc'h P, 2003, DEV BRAIN RES, V144, P159, DOI 10.1016/S0165-3806(03)00167-6; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Willi R, 2013, NEUROBIOL DIS, V54, P150, DOI 10.1016/j.nbd.2013.01.011; Xiong NX, 2012, MOL BIOL REP, V39, P2625, DOI 10.1007/s11033-011-1015-8; Zagrebelsky M, 2017, NEUROBIOL LEARN MEM, V138, P154, DOI 10.1016/j.nlm.2016.06.022; Zemmar A, 2014, J NEUROSCI, V34, P8685, DOI 10.1523/JNEUROSCI.3817-13.2014; Zhang L, 2009, J NEUROSCI, V29, P6348, DOI 10.1523/JNEUROSCI.5040-08.2009; Zhou XD, 2011, FASEB J, V25, P3146, DOI 10.1096/fj.11-184325	81	8	9	0	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	FEB 19	2018	11								42	10.3389/fnmol.2018.00042			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FW6PW	WOS:000425441600001	29520216	Green Published, gold			2022-02-06	
J	Hohl, A; Zanela, FA; Ghisi, G; Ronsoni, MF; Diaz, AP; Schwarzbold, ML; Dafre, AL; Reddi, B; Lin, K; Dal Pizzol, F; Walz, R				Hohl, Alexandre; Zanela, Fernando Areas; Ghisi, Gabriela; Ronsoni, Marcelo Fernando; Diaz, Alexandre Paim; Schwarzbold, Marcelo Liborio; Dafre, Alcir Luiz; Reddi, Benjamin; Lin, Katia; Dal Pizzol, Felipe; Walz, Roger			Luteinizing Hormone and Testosterone Levels during Acute Phase of Severe Traumatic Brain Injury: Prognostic Implications for Adult Male Patients	FRONTIERS IN ENDOCRINOLOGY			English	Article						traumatic brain injury; gonadotrophic axis; luteinizing hormone; testosterone; prognosis	SUBSTANCE-P; MORTALITY; PLASMA	Traumatic brain injury (TBI) is a worldwide core public health problem affecting mostly young male subjects. An alarming increase in incidence has turned TBI into a leading cause of morbidity and mortality in young adults as well as a tremendous resource burden on the health and welfare sector. Hormone dysfunction is highly prevalent during the acute phase of severe TBI. In particular, investigation of the luteinizing hormone (LH) and testosterone levels during the acute phase of severe TBI in male has identified a high incidence of low testosterone levels in male patients (36.5-100%) but the prognostic significance of which remains controversial. Two independent studies showed that normal or elevated levels of LH levels earlier during hospitalization are significantly associated with higher mortality/morbidity. The association between LH levels and prognosis was independent of other predictive variables such as neuroimaging, admission Glasgow coma scale, and pupillary reaction. The possible mechanisms underlying this association and further research directions in this field are discussed. Overall, current data suggest that LH levels during the acute phase of TBI might contribute to accurate prognostication and further prospective multicentric studies are required to develop more sophisticated predictive models incorporating biomarkers such as LH in the quest for accurate outcome prediction following TBI. Moreover, the potential therapeutic benefits of modulating LH during the acute phase of TBI warrant investigation.	[Hohl, Alexandre; Zanela, Fernando Areas; Ronsoni, Marcelo Fernando; Diaz, Alexandre Paim; Schwarzbold, Marcelo Liborio; Dafre, Alcir Luiz; Lin, Katia; Dal Pizzol, Felipe; Walz, Roger] Univ Fed Santa Catarina, HU, Ctr Neurociencias Aplicadas CeNAp, Florianopolis, SC, Brazil; [Hohl, Alexandre; Ghisi, Gabriela; Ronsoni, Marcelo Fernando] Univ Fed Santa Catarina, HU, Dept Clin Med, Serv Endocrinol & Metabol, Florianopolis, SC, Brazil; [Diaz, Alexandre Paim; Schwarzbold, Marcelo Liborio] Univ Fed Santa Catarina, HU, Dept Clin Med, Serv Psiquiatria, Florianopolis, SC, Brazil; [Dafre, Alcir Luiz] Univ Fed Santa Catarina, Dept Bioquim, Florianopolis, SC, Brazil; [Reddi, Benjamin] Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA, Australia; [Reddi, Benjamin] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Lin, Katia; Walz, Roger] Univ Fed Santa Catarina, HU, Dept Clin Med, Serv Neurol, Florianopolis, SC, Brazil; [Dal Pizzol, Felipe] Univ Extremo Sul Catarinense UNESC, Lab Fisiopatol Expt, Criciuma, Brazil		Walz, R (corresponding author), Univ Fed Santa Catarina, HU, Ctr Neurociencias Aplicadas CeNAp, Florianopolis, SC, Brazil.; Walz, R (corresponding author), Univ Fed Santa Catarina, HU, Dept Clin Med, Serv Neurol, Florianopolis, SC, Brazil.	rogerwalz@hotmail.com	Diaz, Alexandre Paim/AAD-8323-2019; Dafre, Alcir/AAE-7738-2019; Diaz, Alexandre Paim/J-9042-2014; Lin, Katia/G-4891-2012; Hohl, Alexandre/R-9269-2019; Walz, Roger/K-9096-2013	Diaz, Alexandre Paim/0000-0002-6591-6648; Dafre, Alcir/0000-0001-8097-4611; Lin, Katia/0000-0002-5401-7524; Hohl, Alexandre/0000-0002-8073-5837; Walz, Roger/0000-0002-9875-6687	PRONEX Program (NENASC) [56802/2010]; PPSUS Program of FAPESC-CNPq-MS, Santa Catarina Brazil [TO 201302248]; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)	This work was supported by PRONEX Program (NENASC Project process 56802/2010) and PPSUS Program (TO 201302248) of FAPESC-CNPq-MS, Santa Catarina Brazil. RW, ALD, KL, and FP are Researchers Fellows from CNPq (Brazilian Council for Scientific and Technologic Development, Brazil). FZ received a fellowship for his Ph.D. degree study from Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM).	Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Cernak I, 1999, BRAIN INJURY, V13, P1005; COIRO V, 1992, METABOLISM, V41, P689, DOI 10.1016/0026-0495(92)90305-T; Dalwadi Pradip P, 2017, Indian J Endocrinol Metab, V21, P80, DOI 10.4103/2230-8210.196018; Thais MERD, 2012, CNS NEUROSCI THER, V18, P606, DOI 10.1111/j.1755-5949.2012.00346.x; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; de Souza RL, 2015, ACTA ANAESTH SCAND, V59, P392, DOI 10.1111/aas.12447; Diaz AP, 2014, REV BRAS PSIQUIATR, V36, P213, DOI 10.1590/1516-4446-2013-1303; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dudas B, 2002, J CLIN ENDOCR METAB, V87, P2946, DOI 10.1210/jc.87.6.2946; Garrahy A, 2017, EUR J ENDOCRINOL, V176, pR217, DOI 10.1530/EJE-16-0962; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; Hari Kumar K V S, 2016, Indian J Endocrinol Metab, V20, P772; Hohl A., 2014, THESIS U FEDERAL SAN, P1; Hohl A, 2014, BRAIN INJURY, V28, P1262, DOI 10.3109/02699052.2014.915986; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Hohl A, 2009, ARQ BRAS ENDOCRINOL, V53, P1012, DOI 10.1590/S0004-27302009000800016; Hohl A, 2009, ARQ BRAS ENDOCRINOL, V53, P908, DOI 10.1590/S0004-27302009000800003; Kleindienst A, 2009, J NEUROTRAUM, V26, P1435, DOI 10.1089/neu.2008.0601; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lorente L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0911-z; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Olivecrona Z, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-33; Thais MERD, 2014, J NEUROPSYCHOL, V8, P125, DOI 10.1111/jnp.12000; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Vink R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00304; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	36	8	8	0	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2392			FRONT ENDOCRINOL	Front. Endocrinol.	FEB 13	2018	9								29	10.3389/fendo.2018.00029			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	FV9GM	WOS:000424895700001	29487565	Green Published, gold			2022-02-06	
J	Steed, TC; Treiber, JM; Brandel, MG; Patel, KS; Dale, AM; Carter, BS; Chen, CC				Steed, Tyler C.; Treiber, Jeffrey M.; Brandel, Michael G.; Patel, Kunal S.; Dale, Anders M.; Carter, Bob S.; Chen, Clark C.			Quantification of glioblastoma mass effect by lateral ventricle displacement	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; SURVIVAL; PROGRESSION; MULTIFORME; IMAGES; MRI; REGISTRATION; HEMORRHAGE; PREDICTION; CRITERIA	Mass effect has demonstrated prognostic significance for glioblastoma, but is poorly quantified. Here we define and characterize a novel neuroimaging parameter, lateral ventricle displacement (LVd), which quantifies mass effect in glioblastoma patients. LVd is defined as the magnitude of displacement from the center of mass of the lateral ventricle volume in glioblastoma patients relative to that a normal reference brain. Pre-operative MR images from 214 glioblastoma patients from The Cancer Imaging Archive (TCIA) were segmented using iterative probabilistic voxel labeling (IPVL). LVd, contrast enhancing volumes (CEV) and FLAIR hyper-intensity volumes (FHV) were determined. Associations with patient survival and tumor genomics were investigated using data from The Cancer Genome Atlas (TCGA). Glioblastoma patients had significantly higher LVd relative to patients without brain tumors. The variance of LVd was not explained by tumor volume, as defined by CEV or FLAIR. LVd was robustly associated with glioblastoma survival in Cox models which accounted for both age and Karnofsky's Performance Scale (KPS) (p = 0.006). Glioblastomas with higher LVd demonstrated increased expression of genes associated with tumor proliferation and decreased expression of genes associated with tumor invasion. Our results suggest LVd is a quantitative measure of glioblastoma mass effect and a prognostic imaging biomarker.	[Steed, Tyler C.] Emory Univ, Dept Neurosurg, Atlanta, GA 30322 USA; [Treiber, Jeffrey M.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Brandel, Michael G.] Univ Calif San Diego, Dept Neurosurg, La Jolla, CA 92093 USA; [Patel, Kunal S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Dale, Anders M.] Univ Calif San Diego, Multimodal Imaging Lab, La Jolla, CA 92093 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Carter, Bob S.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Chen, Clark C.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA		Chen, CC (corresponding author), Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA.	ccchen@umn.edu	Carter, Bob/AAB-4868-2021	Carter, Bob/0000-0002-3586-1324	Doris Duke Charitable Foundation Clinical Scientist Development AwardAmerican Heart AssociationDoris Duke Charitable Foundation (DDCF); Sontag Foundation Distinguished Scientist Award; Kimmel Scholar Award; BWF [1006774.01];  [1RO1NS097649-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS097649] Funding Source: NIH RePORTER	We thank Danielle Steed, PhD for her review and thorough editing of this manuscript. This work was supported by 1RO1NS097649-01, the Doris Duke Charitable Foundation Clinical Scientist Development Award, The Sontag Foundation Distinguished Scientist Award, the Kimmel Scholar Award, and BWF 1006774.01 awarded to CCC.	Abraham A, 2017, NEUROIMAGE, V147, P736, DOI 10.1016/j.neuroimage.2016.10.045; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avants BB, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00044; Chaddad A, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160575; Da Fonseca CO, 2013, ANTICANCER RES, V33, P5625; Gamburg ES, 2000, INT J RADIAT ONCOL, V48, P1359, DOI 10.1016/S0360-3016(00)01410-3; Gonda David D, 2013, Surg Neurol Int, V4, P110, DOI 10.4103/2152-7806.117173; Grossman R, 2017, ANN SURG ONCOL, V24, P794, DOI 10.1245/s10434-016-5635-z; Hatzikirou H, 2012, MATH MED BIOL, V29, P49, DOI 10.1093/imammb/dqq011; Howells T, 2012, INTENS CARE MED, V38, P1061, DOI 10.1007/s00134-012-2571-7; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Li GZ, 2006, COMPUT BIOL MED, V36, P313, DOI 10.1016/j.compbiomed.2004.11.003; Li Wen-bin, 2012, Cancer Biology Medicine, V9, P120, DOI 10.3969/j.issn.2095-3941.2012.02.007; Maass A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6547; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Mariano GL F. M., 2014, PRINCIPLES CRITICAL; Marion DW, 2006, NEUROSURGERY, V58, P655; McKenna A, 2012, BRIT J NEUROSURG, V26, P310, DOI 10.3109/02688697.2012.654835; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI 10.1093/neuonc/nov189; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; Schlichting ML, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9151; Shiroishi MS, 2013, MAGN RESON IMAGING C, V21, P241, DOI 10.1016/j.mric.2013.02.004; Steed TC, 2015, AM J NEURORADIOL, V36, P678, DOI 10.3174/ajnr.A4171; Steed TC, 2016, ONCOTARGET; Tain RW, 2009, IEEE T BIO-MED ENG, V56, P544, DOI 10.1109/TBME.2008.2006010; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Zacharaki EI, 2009, NEUROIMAGE, V46, P762, DOI 10.1016/j.neuroimage.2009.01.051; Zazulia AR, 1999, STROKE, V30, P1167, DOI 10.1161/01.STR.30.6.1167; Zhang Z, 2014, J NEURO-ONCOL, V119, P207, DOI 10.1007/s11060-014-1478-2	34	8	8	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	FEB 12	2018	8								2827	10.1038/s41598-018-21147-w			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV7DP	WOS:000424743500043	29434275	gold, Green Published			2022-02-06	
J	Wu, MY; Chou, PL; Wu, TI; Lin, PJ				Wu, Meng-Yu; Chou, Pin-Li; Wu, Tzu-I; Lin, Pyng-Jing			Predictors of hospital mortality in adult trauma patients receiving extracorporeal membrane oxygenation for advanced life support: a retrospective cohort study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Extracorporeal life support; Post-traumatic acute respiratory distress syndrome; Post-traumatic cardiac arrest; Bleeding shock	RESPIRATORY-DISTRESS-SYNDROME; BRAIN-INJURY; RESUSCITATION; SERIES; SHOCK; ECMO	Background: Using extracorporeal membrane oxygenation (ECMO) to provide advanced life support in adult trauma patients remains a controversial issue now. The study was aimed at identifying the independent predictors of hospital mortality in adult trauma patients receiving ECMO for advanced cardiopulmonary dysfunctions. Methods: This retrospective study enrolled 36 adult trauma patients receiving ECMO due to advanced shock or respiratory failure in a level I trauma center between August 2006 and October 2014. Variables collected for analysis were demographics, serum biomarkers, characteristics of trauma, injury severity score (ISS), damage-control interventions, indications of ECMO, and associated complications. The outcomes were hospital mortality and hemorrhage on ECMO. The multivariate logistic regression method was used to identify the independent prognostic predictors for the outcomes. Results: The medians of age and ISS were 36 (27-49) years and 29 (19-45). Twenty-three patients received damage-control interventions before ECMO. Among the 36 trauma patients, 14 received ECMO due to shock and 22 for respiratory failure. The complications of ECMO are major hemorrhages (n = 12), acute renal failure requiring hemodialysis (n = 10), and major brain events (n = 7). There were 15 patients died in hospital, and 9 of them were in the shock group. Conclusions: The severity of trauma and the type of cardiopulmonary dysfunction significantly affected the outcomes of ECMO used for sustaining patients with post-traumatic cardiopulmonary dysfunction. Hemorrhage on ECMO remained a concern while the device was required soon after trauma, although a heparin-minimized protocol was adopted.	[Wu, Meng-Yu; Lin, Pyng-Jing] Chang Gung Mem Hosp, Dept Cardiothorac Surg, Taoyuan, Taiwan; [Wu, Meng-Yu; Chou, Pin-Li; Lin, Pyng-Jing] Chang Gung Univ, Taoyuan, Taiwan; [Chou, Pin-Li] Chang Gung Mem Hosp, Dept Surg, Taoyuan, Taiwan; [Wu, Tzu-I] Taipei Med Univ, Wan Fang Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Wu, Tzu-I] Taipei Med Univ, Sch Med, Coll Med, Dept Obstet & Gynecol, Taipei, Taiwan; [Wu, Meng-Yu] Chang Gung Univ, Sch Tradit Chinese Med, Taoyuan, Taiwan		Wu, MY (corresponding author), Chang Gung Mem Hosp, Dept Cardiothorac Surg, Taoyuan, Taiwan.; Wu, MY (corresponding author), Chang Gung Univ, Taoyuan, Taiwan.; Wu, MY (corresponding author), Chang Gung Univ, Sch Tradit Chinese Med, Taoyuan, Taiwan.	david3627@gmail.com					Aberegg SK, 2008, CARDIOPULMONARY BYPA, P632; Arlt M, 2010, RESUSCITATION, V81, P804, DOI 10.1016/j.resuscitation.2010.02.020; Bedeir K, 2017, J TRAUMA ACUTE CARE, V82, P400, DOI 10.1097/TA.0000000000001292; Biscotti M, 2015, PERFUSION-UK, V30, P407, DOI 10.1177/0267659114554327; Bonacchi M, 2013, J THORAC CARDIOV SUR, V145, P1617, DOI 10.1016/j.jtcvs.2012.08.046; Cheng YT, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004380; Cordell-Smith JA, 2006, INJURY, V37, P29, DOI 10.1016/j.injury.2005.03.027; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; Gonzalez E, 2016, ANN SURG, V263, P1051, DOI 10.1097/SLA.0000000000001608; Huang YK, 2009, RESUSCITATION, V80, P535, DOI 10.1016/j.resuscitation.2009.02.016; Johansson PI, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-47; Lockey DJ, 2013, RESUSCITATION, V84, P738, DOI 10.1016/j.resuscitation.2012.12.003; Messing JA, 2014, ASAIO J, V60, P597, DOI 10.1097/MAT.0000000000000103; Muellenbach RM, 2012, J TRAUMA ACUTE CARE, V72, P1444, DOI 10.1097/TA.0b013e31824d68e3; Munoz-Bendix C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1088-1; Reynolds HN, 1999, PERFUSION-UK, V14, P489, DOI 10.1177/026765919901400612; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Ried M, 2013, CRIT CARE, V17, DOI 10.1186/cc12782; Robba C, 2017, J TRAUMA ACUTE CARE, V82, P165, DOI 10.1097/TA.0000000000001276; Shere-Wolfe RF, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-68; Thiagarajan RR, 2017, ASAIO J, V63, P60, DOI 10.1097/MAT.0000000000000475; Tseng YH, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-12; Wu MY, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0056-0; Wu MY, 2010, RESUSCITATION, V81, P1111, DOI 10.1016/j.resuscitation.2010.04.031; Yen TS, 2008, CLIN NEUROL NEUROSUR, V110, P295, DOI 10.1016/j.clineuro.2007.10.017; Zhou R, 2015, PERFUSION-UK, V30, P403, DOI 10.1177/0267659114554326	26	8	11	1	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	FEB 8	2018	26								14	10.1186/s13049-018-0481-6			12	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FV6OB	WOS:000424699800001	29422067	gold, Green Published			2022-02-06	
J	Zlotnik, S; Toglia, J				Zlotnik, Sharon; Toglia, Joan			Measuring Adolescent Self-Awareness and Accuracy Using a Performance-Based Assessment and Parental Report	FRONTIERS IN PUBLIC HEALTH			English	Article						adolescents; self -awareness; executive functions; weekly calendar planning activity; behavior rating inventory of executive function	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; GENDER-DIFFERENCES; RATING INVENTORY; STRATEGIES; CHILDREN; DEFICITS; ABILITY	Aim: The aim of this study was to assess awareness of performance and performance accuracy for a task that requires executive functions (EF), among healthy adolescents and to compare their performance to their parent's ratings. Method: Participants: 109 healthy adolescents (mean age 15.2 +/- 1.86 years) completed the Weekly Calendar Planning Activity NCPA). The discrepancy between self-estimated and actual performance was used to measure the level of awareness. The participants were divided into high and low accuracy groups according to the WCPA accuracy median score. The participants were also divided into high and low awareness groups. A comparison was conducted between groups using WCPA performance and parent ratings on the Behavior Rating Inventory of Executive Function (BRIEF). Results: Higher awareness was associated with better EF performance. Participants with high accuracy scores were more likely to show high awareness of performance as compared to participants with low accuracy scores. The high accuracy group had better parental ratings of EF, higher efficiency, followed more rules, and were more aware of their WCPA performance. Conclusion: Our results highlight the important contribution that self-awareness of performance may have on the individual's function. Assessing the level of awareness and providing metacognitive training techniques for those adolescents who are less aware, could support their performance.	[Zlotnik, Sharon] Univ Haifa, Dept Occupat Therapy, Lab Innovat Rehabil Technol, Israel Ctr Res Excellence LINKS Learning Networke, Haifa, Israel; [Toglia, Joan] Mercy Coll, Sch Hlth & Nat Sci, Dobbs Ferry, NY 10522 USA		Zlotnik, S (corresponding author), Univ Haifa, Dept Occupat Therapy, Lab Innovat Rehabil Technol, Israel Ctr Res Excellence LINKS Learning Networke, Haifa, Israel.	sharonzlotnik5@gmail.com	Toglia, Joan/AAN-6674-2021	Toglia, Joan/0000-0002-6902-6853			Allen JB, 1998, J SPORT EXERCISE PSY, V20, P280; Beauchemin J, 2008, J EVID-BASED INTEGR, V13, P34, DOI 10.1177/1533210107311624; Beyer S, 1997, PERS SOC PSYCHOL B, V23, P157, DOI 10.1177/0146167297232005; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Farrington CA, 2012, CONSORTIUM CHICAGO S; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Hart D, 1988, EARLY CHILD DEV CARE, V40, P5, DOI DOI 10.1080/0300443880400102; Harter S., 2012, HDB SELF IDENTITY, P680; Hewitt MP, 2005, J RES MUSIC EDUC, V53, P148, DOI 10.2307/3345515; JENSEN PS, 1988, J AM ACAD CHILD PSY, V27, P442, DOI 10.1097/00004583-198807000-00012; Katz Noomi, 2002, Can J Occup Ther, V69, P281; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Lahav O, 2018, J ATTEN DISORD, V22, P368, DOI 10.1177/1087054714564621; Lahav O, 2014, BRIT J OCCUP THER, V77, P614, DOI 10.4276/030802214X14176260335309; Lilienthal L, 2015, MEM COGNITION, V43, P357, DOI 10.3758/s13421-014-0465-3; Linder N, 2010, CHILD NEUROPSYCHOL, V16, P494, DOI 10.1080/09297041003781884; Lloyd O, 2015, J HEAD TRAUMA REHAB, V30, P311, DOI 10.1097/HTR.0000000000000113; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; MONTAGUE M, 1986, J LEARN DISABIL, V19, P26, DOI 10.1177/002221948601900107; NICHOLLS JG, 1984, PSYCHOL REV, V91, P328, DOI 10.1037/0033-295X.91.3.328; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Rasmussen C., 2007, J FAS INT, V5, P1; Rith-Najarian LR, 2014, STRESS, V17, P193, DOI 10.3109/10253890.2014.891102; Roebers CM, 2017, DEV REV, V45, P31, DOI 10.1016/j.dr.2017.04.001; Schoo LA, 2013, APPL NEUROPSYCH-ADUL, V20, P95, DOI 10.1080/09084282.2012.670144; Steward KA, 2017, J ATTEN DISORD, V21, P316, DOI 10.1177/1087054714530782; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia J, 2015, WEEKLY CALENDAR PLAN; Toglia J, 2017, AM J OCCUP THER, V71, DOI 10.5014/ajot.2016.020073; Toglia J, 2013, AM J OCCUP THER, V67, P515, DOI 10.5014/ajot.2013.008482; Toglia JP, 2012, CAN J OCCUP THER, V79, P225, DOI 10.2182/cjot.2012.79.4.4; Unsworth N, 2016, J EXP PSYCHOL LEARN, V42, P50, DOI 10.1037/xlm0000148; Unsworth N, 2013, MEM COGNITION, V41, P242, DOI 10.3758/s13421-012-0261-x; van der Veen-Mulders L, 2017, EUR CHILD ADOLES PSY, V26, P365, DOI 10.1007/s00787-016-0897-3; Winsler A, 2003, CHILD DEV, V74, P659, DOI 10.1111/1467-8624.00561	39	8	9	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-2565		FRONT PUBLIC HEALTH	Front. Public Health	FEB 2	2018	6								15	10.3389/fpubh.2018.00015			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FU9BQ	WOS:000424151400001	29456993	Green Published, gold			2022-02-06	
J	Abrahams, S; McFie, S; Patricios, J; Suter, J; Posthumus, M; September, AV				Abrahams, Shameemah; McFie, Sarah; Patricios, Jon; Suter, Jason; Posthumus, Michael; September, Alison V.			An association between polymorphisms within the APOE gene and concussion aetiology in rugby union players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Apolipoprotein E; Brain injuries; Genetic association studies; Promoter region; Genetic polymorphism; Apoptosis	TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; PROMOTER; RISK; METAANALYSIS; EXPRESSION; MANAGEMENT; STATEMENT; SEVERITY	Objectives: Concussion refers to changes in neurological function due to biomechanical forces transmitted to the head. The APOE epsilon 4 allele is associated with brain injury severity. The objective was to determine if APOE gene variants are associated with concussion history and severity in rugby players. Design: In total, 128 non-concussed controls and 160 previously concussed participants (all cases N = 160; diagnosed N = 139) were recruited from high school (junior, N = 121), club (N = 116) and professional rugby teams (N = 51). Methods: Participants were genotyped for rs405509 (G > T), rs429358 (T > C) and rs7412 (C > T) APOE variants. Statistical analyses were performed using the R environment. Results: The rs405509 TT genotype was over-represented in controls compared to all cases (P = 0.043; control: 29%, all cases: 18%; odds ratio: 0.55, 95% confidence interval 0.31-0.98). The APOE-c isoform frequencies were not significantly different between groups (P > 0.05). Additionally, the inferred APOE (rs405509-epsilon 2/epsilon 3/epsilon 4) T-epsilon 3 haplotype was over-represented in controls (41%) compared to diagnosed (32%, P = 0.042). The G-epsilon 3 haplotype was under-represented in controls (36%) compared to all cases (44%, P = 0.019) and diagnosed (44%, P = 0.021). The TT genotype was significantly associated with rapid recovery (P = 0.048, <1 week: 51%, N= 70, >= 1 week: 36%, N = 29; odds ratio: 0.55, 95% confidence interval 0.30-1.01). Conclusions: These findings support the further elucidation of the APOE gene or closely-related genes in concussion aetiology. Although similar preliminary results were found when juniors were separately analysed, the under-powered sample size for junior subgroup requires future investigation in larger cohorts of junior-level athletes. (C) 2017 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Abrahams, Shameemah; McFie, Sarah; Posthumus, Michael; September, Alison V.] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Div Exercise Sci & Sports Med, Cape Town, South Africa; [Patricios, Jon] Morningside Sports Med Clin, Morningside, South Africa; [Patricios, Jon] Univ Pretoria, Sect Sports Med, Pretoria, South Africa; [Patricios, Jon] Univ Witwatersrand, Dept Emergency Med, Johannesburg, South Africa; [Suter, Jason] Sports Sci & Exercise Med Clin, Johannesburg, South Africa		September, AV (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Div Exercise Sci & Sports Med, Cape Town, South Africa.	alison.september@uct.ac.za		September, Alison V/0000-0003-0950-286X; Abrahams, Shameemah/0000-0002-1120-678X; Patricios, Jon/0000-0002-6829-4098	National Research Foundation [90942, 93416, 85534]; National Research Foundation of South AfricaNational Research Foundation - South Africa; Deutscher Akademischer Austausch Dienst (DAAD)Deutscher Akademischer Austausch Dienst (DAAD); University of Cape Town	We would like to thank all the participants and respective authorities from the high schools, clubs, professional teams and medical practices for their time, effort and participation in our study. All authors declare no conflict of interest. This study was funded by the National Research Foundation (A.V.S., grant number 90942), (M.P., grant numbers 93416:2015, 85534:2015). The National Research Foundation of South Africa, the Deutscher Akademischer Austausch Dienst (DAAD) and the University of Cape Town funded S.A. and S.M.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Artiga MJ, 1998, FEBS LETT, V421, P105, DOI 10.1016/S0014-5793(97)01543-3; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; GUILMETTE TJ, 1995, NEUROPSYCHOLOGY, V9, P338, DOI 10.1037/0894-4105.9.3.338; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Lambert JC, 2005, J NEUROL NEUROSUR PS, V76, P928, DOI 10.1136/jnnp.2004.048983; Lendon CL, 2003, NEUROLOGY, V61, P683, DOI 10.1212/01.WNL.0000078033.81925.80; Little J, 2009, GENET EPIDEMIOL, V33, P581, DOI 10.1002/gepi.20410; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McMichael Gai L, 2009, J Biomol Tech, V20, P232; Mokone GG, 2005, AM J SPORT MED, V33, P1016, DOI 10.1177/0363546504271986; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Namboori PKK, 2011, FUNCT INTEGR GENOMIC, V11, P519, DOI 10.1007/s10142-011-0238-z; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; R Core Team, 2013, R LANG ENV STAT COMP; Seripa D, 2009, AGEING RES REV, V8, P214, DOI 10.1016/j.arr.2008.12.003; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Terrell TR, 2014, BIOM SCI ENG CENT C, P1; Tierney RT, 2010, CLIN J SPORT MED, V20, P464, DOI 10.1097/JSM.0b013e3181fc0a81; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Xin XY, 2010, J ALZHEIMERS DIS, V19, P1283, DOI 10.3233/JAD-2010-1329; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; ZANNIS VI, 1981, AM J HUM GENET, V33, P11	32	8	8	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	FEB	2018	21	2					117	122		10.1016/j.jsams.2017.06.004			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FX5TZ	WOS:000426144600004	28645497	Green Submitted			2022-02-06	
J	Chapple, LA; Chapman, M; Shalit, N; Udy, A; Deane, A; Williams, L				Chapple, Lee-anne; Chapman, Marianne; Shalit, Natalie; Udy, Andrew; Deane, Adam; Williams, Lauren			Barriers to Nutrition Intervention for Patients With a Traumatic Brain Injury: Views and Attitudes of Medical and Nursing Practitioners in the Acute Care Setting	JOURNAL OF PARENTERAL AND ENTERAL NUTRITION			English	Article						nutrition; traumatic brain injury; critical care; research and diseases; qualitative research	ENTERAL NUTRITION; SUPPORT; DYSPHAGIA; DELIVERY; OUTCOMES	Background: Nutrition delivered to patients with a traumatic brain injury (TBI) is typically below prescribed amounts. While the dietitian plays an important role in the assessment and provision of nutrition needs, they are part of a multidisciplinary team. The views and attitudes of medical and nursing practitioners are likely to be crucial to implementation of nutrition to patients with TBI, but there is limited information describing these. Methods: A qualitative exploratory approach was used to explore the views and attitudes of medical and nursing practitioners on nutrition for patients with TBI. Participants at 2 major neurotrauma hospitals in Australia completed individual semi-structured interviews with a set of questions and a case study. Interviews were transcribed and coded for themes. Results: Thirty-four health practitioners participated: 18 nurses and 16 physicians. Three major themes emerged: (1) nutrition practices over the hospital admission reflect the recovery course, (2) there are competing priorities when caring for patients with TBI, and (3) the implementation of nutrition therapy is influenced by practitioner roles and expectations. Conclusion: Use of qualitative inquiry in the study of attitudes toward nutrition provision to patients with TBI provided detailed insights into the challenges of operationalizing nutrition therapy. These insights can be used to clarify communication between health practitioners working with patients with TBI across the continuum of care.	[Chapple, Lee-anne; Chapman, Marianne; Deane, Adam] Univ Adelaide, Discipline Acute Care Med, North Terrace, Adelaide, SA 5000, Australia; [Chapple, Lee-anne; Chapman, Marianne; Deane, Adam] Natl Hlth & Med Res Council Ctr Clin Res Excellen, Adelaide, SA, Australia; [Chapman, Marianne; Deane, Adam] Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA, Australia; [Shalit, Natalie] Australian Ctr Hlth Innovat, Melbourne, Vic, Australia; [Udy, Andrew] Alfred Hlth, Dept Intens Care & Hyperbar Med, Melbourne, Vic, Australia; [Udy, Andrew] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Udy, Andrew] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia; [Williams, Lauren] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld, Australia		Chapple, LA (corresponding author), Univ Adelaide, Discipline Acute Care Med, North Terrace, Adelaide, SA 5000, Australia.	lee-anne.costello@adelaide.edu.au	Deane, Adam/AAF-7370-2020; Chapple, Lee-anne/AAN-7751-2021; Williams, Lauren T./G-6301-2013	Deane, Adam/0000-0002-7620-5577; Williams, Lauren T./0000-0002-7860-0319; Chapple, Lee-anne S/0000-0002-9818-2484			Adam S, 1997, INTENS CARE MED, V23, P261, DOI 10.1007/s001340050326; Alhashemi HH, 2010, NEUROSCIENCES, V15, P231; Bankhead Robin, 2009, JPEN J Parenter Enteral Nutr, V33, P122, DOI 10.1177/0148607108330314; Chapple LAS, 2016, CLIN NUTR, V35, P1315, DOI 10.1016/j.clnu.2016.02.009; Chapple LAS, 2016, CRIT CARE, V20, DOI 10.1186/s13054-015-1177-1; Charmaz K., 2006, CONSTRUCTING GROUNDE; Costello LAS, 2014, INJURY, V45, P1834, DOI 10.1016/j.injury.2014.06.004; Crary Michael A, 2006, Nutr Clin Pract, V21, P576, DOI 10.1177/0115426506021006576; DiGirolamo AM, 2003, BIRTH-ISS PERINAT C, V30, P94, DOI 10.1046/j.1523-536X.2003.00227.x; Frankenfield David, 2006, Nutr Clin Pract, V21, P430, DOI 10.1177/0115426506021005430; Gurgueira GL, 2005, JPEN-PARENTER ENTER, V29, P176, DOI 10.1177/0148607105029003176; Halvorsen L, 2010, MIDWIFERY, V26, P45, DOI 10.1016/j.midw.2008.04.011; Heyland DK, 2010, JPEN-PARENTER ENTER, V34, P675, DOI 10.1177/0148607110364843; Lane C, 2014, J HUM NUTR DIET, V27, P339, DOI 10.1111/jhn.12152; Laws RA, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-66; Lemke Denise M, 2004, J Neurosci Nurs, V36, P4; Marshall Andrea, 2004, Aust Crit Care, V17, P6, DOI 10.1016/S1036-7314(05)80045-1; Marshall Andrea P, 2006, Intensive Crit Care Nurs, V22, P95, DOI 10.1016/j.iccn.2005.09.004; Martin CM, 2009, CRIT CARE MED, V37, P81, DOI 10.1097/CCM.0b013e31819285f0; Nedfors K, 2015, NORDIC J NURS RES, V36, P122; Ros C, 2009, J CLIN NURS, V18, P2406, DOI 10.1111/j.1365-2702.2008.02765.x; Schneider Philip J, 2006, Nutr Clin Pract, V21, P62, DOI 10.1177/011542650602100162; Suter E, 2009, J INTERPROF CARE, V23, P41, DOI 10.1080/13561820802338579; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; WINSTEIN CJ, 1983, PHYS THER, V63, P1992, DOI 10.1093/ptj/63.12.1992	25	8	8	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-6071	1941-2444		JPEN-PARENTER ENTER	J. Parenter. Enter. Nutr.	FEB	2018	42	2					318	326		10.1177/0148607116687498			9	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nutrition & Dietetics	FW1XU	WOS:000425094500007	29443400				2022-02-06	
J	Douglas, DB; Chaudhari, R; Zhao, JM; Gullo, J; Kirkland, J; Douglas, PK; Wolin, E; Walroth, J; Wintermark, M				Douglas, David B.; Chaudhari, Ruchir; Zhao, Jason M.; Gullo, James; Kirkland, Jared; Douglas, Pamela K.; Wolin, Ely; Walroth, James; Wintermark, Max			Perfusion Imaging in Acute Traumatic Brain Injury	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article						Concussion; Traumatic brain injury; TBI; Perfusion	CEREBRAL-BLOOD-FLOW; ROUTINE CLINICAL-PRACTICE; CONTROLLED CORTICAL IMPACT; SUPPORT VECTOR MACHINES; COMPUTED-TOMOGRAPHY; ACUTE STROKE; XENON CT; NEUROPROTECTION; ADMISSION; TIME	Traumatic brain injury (TBI) is a significant problem worldwide, and neuroimaging plays a critical role in diagnosis and management. Perfusion neuroimaging techniques have been explored in TBI to determine and characterize potential perfusion neuroimaging biomarkers to aid in the diagnosis, treatment, and prognosis. In this article, computed tomography (CT) bolus perfusion, MR imaging bolus perfusion, MR imaging arterial spin labeling perfusion, and xenon CT are reviewed, with a focus on their applications in acute TBI. Future research directions are also discussed.	[Douglas, David B.; Chaudhari, Ruchir; Wintermark, Max] Stanford Univ, Med Ctr, Dept Neuroradiol, 300 Pasteur Dr,Room s047, Stanford, CA 94305 USA; [Douglas, David B.; Zhao, Jason M.; Gullo, James; Kirkland, Jared; Wolin, Ely; Walroth, James] David Grant Med Ctr, Dept Radiol, 101 Bodin Circle, Travis AFB, CA 94535 USA; [Douglas, Pamela K.] Univ Cent Florida, Inst Simulat & Training, 3100 Technol Pkwy, Orlando, FL 32826 USA		Wintermark, M (corresponding author), Stanford Univ, Med Ctr, Dept Neuroradiol, 300 Pasteur Dr,Room s047, Stanford, CA 94305 USA.	mwinterm@stanford.edu		Douglas, PK/0000-0002-3506-6857	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01MH110645] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01 MH110645] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS086872] Funding Source: Medline		Andre Jalal B, 2015, Top Magn Reson Imaging, V24, P275, DOI 10.1097/RMR.0000000000000065; AXEL L, 1983, INVEST RADIOL, V18, P94, DOI 10.1097/00004424-198301000-00018; AXEL L, 1980, RADIOLOGY, V137, P679, DOI 10.1148/radiology.137.3.7003648; Axel L, 1981, Adv Neurol, V30, P67; Bass E, 2012, VET HLTH ADM TREATME; Bendinelli C, 2013, INJURY, V44, P1208, DOI 10.1016/j.injury.2013.03.039; Bivard A, 2013, RADIOLOGY, V267, P543, DOI 10.1148/radiol.12120971; Bokkers RPH, 2010, J CEREBR BLOOD F MET, V30, P222, DOI 10.1038/jcbfm.2009.204; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Celli P, 1997, Minerva Chir, V52, P1467; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Coles Jonathan P, 2004, Curr Opin Crit Care, V10, P120, DOI 10.1097/00075198-200404000-00008; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Deibler AR, 2008, AM J NEURORADIOL, V29, P1428, DOI 10.3174/ajnr.A1034; Deibler AR, 2008, AM J NEURORADIOL, V29, P1228, DOI 10.3174/ajnr.A1030; Deibler AR, 2008, AM J NEURORADIOL, V29, P1235, DOI 10.3174/ajnr.A1033; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Douglas DB, 2015, PILOT STUDY MOL NEUR; Duyn JH, 2001, MAGNET RESON MED, V46, P88, DOI 10.1002/mrm.1163; Faul M, 2002, TRAUMATIC BRAIN INJU; Friston KJ, 2009, SCIENCE, V326, P399, DOI 10.1126/science.1174521; Garnett MR, 2001, J NEUROTRAUM, V18, P585, DOI 10.1089/089771501750291828; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gevers S, 2011, J CEREBR BLOOD F MET, V31, P1706, DOI 10.1038/jcbfm.2011.10; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; Honda M, 2016, NEUROL MED-CHIR, V56, P501, DOI 10.2176/nmc.oa.2015-0341; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Johnson NA, 2005, RADIOLOGY, V234, P851, DOI 10.1148/radiol.2343040197; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Lapalme-Remis Samuel, 2016, Continuum (Minneap Minn), V22, P1451; Latchaw RE, 2003, STROKE, V34, P1084, DOI 10.1161/01.STR.0000064840.99271.9E; Lev MH, 2001, STROKE, V32, P2021, DOI 10.1161/hs0901.095680; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McGehee BE, 2012, J MAGN RESON IMAGING, V36, P1257, DOI 10.1002/jmri.23645; Menon DK, 2006, CURR OPIN CRIT CARE, V12, P85, DOI 10.1097/01.ccx.0000216572.19062.8f; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Petcharunpaisan S, 2010, WORLD J RADIOL, V2, P384, DOI 10.4329/wjr.v2.i10.384; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Shetty VS, 2016, J AM COLL RADIOL, V13, P668, DOI 10.1016/j.jacr.2016.02.023; Soustiel JF, 2008, NEURORADIOLOGY, V50, P189, DOI 10.1007/s00234-007-0337-7; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wintermark M, 2000, AM J NEURORADIOL, V21, P1881; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Wintermark M, 2002, ANN NEUROL, V51, P417, DOI 10.1002/ana.10136; Wintermark M, 2002, STROKE, V33, P2025, DOI 10.1161/01.STR.0000023579.61630.AC; Wintermark M, 2001, AM J NEURORADIOL, V22, P905; Wintermark M, 2001, EUR RADIOL, V11, P1220, DOI 10.1007/s003300000707; Wong EC, 2006, MAGN RESON MED, V55, P1334, DOI 10.1002/mrm.20906; YONAS H, 1991, J CEREBR BLOOD F MET, V11, P716, DOI 10.1038/jcbfm.1991.128; Zaharchuk G, 2011, STROKE, V42, P2485, DOI 10.1161/STROKEAHA.111.616466; Zeineh M, 2015, AM SOC NEUR ANN C CH	66	8	8	2	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	FEB	2018	28	1					55	+		10.1016/j.nic.2017.09.002			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FR3UA	WOS:000418990900007	29157853	Green Accepted			2022-02-06	
J	Gincberg, G; Shohami, E; Trembovler, V; Alexandrovich, AG; Lazarovici, P; Elchalal, U				Gincberg, Galit; Shohami, Esther; Trembovler, Victoria; Alexandrovich, Alexander G.; Lazarovici, Philip; Elchalal, Uriel			Nerve growth factor plays a role in the neurotherapeutic effect of a CD45(+) pan-hematopoietic subpopulation derived from human umbilical cord blood in a traumatic brain injury model	CYTOTHERAPY			English	Article						CD45(+) pan-hematopoietic subpopulation; cord blood; nerve growth factor; neuroinflammation; neurotherapeutic effect; TBI; TrkA receptor	STEM-CELLS; ALPHA-9-BETA-1 INTEGRIN; NEURAL PROGENITORS; UP-REGULATION; EXPRESSION; NGF; NEUROPROTECTION; TRANSPLANTATION; DIFFERENTIATION; NEUROTROPHINS	Background aims. Human umbilical cord blood (HUCB) is an important source of stem cells for therapy of hematopoietic disorders and is a potential therapy for various neurological disorders, including traumatic brain injury (TBI). The expression of nerve growth factor (NGF) and its receptors TrkA, p75(NTR) and alpha 9 beta 1 integrin on an HUCB CD45(+) pan-hematopoietic subpopulation was investigated in the context of its neurotherapeutic potential after TBI. Methods. NGF and its receptors were detected on CD45(+) cells by reverse transcriptase polymerase chain reaction, flow cytometry analysis and confocal microscopy. CD45(+) cells were stimulated by TBI brain extracts, and NGF levels were measured by enzyme-linked immunosorbent assay. TBI mice were divided into six groups for xenogeneic intravenous transplantation, 1 day post-trauma, with 1 x 10(6) CD45(+) cells untreated or treated with the anti-NGF neutralizing antibody K252a, aTrkA antagonist; VLO5, an alpha 9 beta 1 disintegrin; or negative (vehicle) and positive (NGF) controls. Results. The HUCB CD45(+) subpopulation constitutively expresses NGF and its receptors, mainly TrkA and p75NTR and minor levels of alpha 9 beta 1. In vitro experiments provided evidence that trauma-related mediators from brain extracts of TBI mice induced release of NGF from HUCB CD45(+) cell cultures. HUCB CD45(+) cells induced a neurotherapeutic effect in TBI mice, abrogated by cell treatment with either anti-NGF antibody or K252a, but not VLO5. Conclusions. These findings strengthen the role of NGF and its TrkA receptor in the HUCB CD45(+) subpopulation's neurotherapeutic effect. The presence of neurotrophin receptors in the HUCB CD45(+) pan-hematopoietic subpopulation may explain the neuroprotective effect of cord blood in therapy of a variety of neurological disorders.	[Gincberg, Galit; Shohami, Esther; Trembovler, Victoria; Alexandrovich, Alexander G.; Lazarovici, Philip] Hebrew Univ Jerusalem, Fac Med, Inst Drug Res, Sch Pharm, Jerusalem, Israel; [Elchalal, Uriel] Hadassah Hebrew Univ, Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel		Lazarovici, P (corresponding author), Hebrew Univ Jerusalem, Fac Med, Inst Drug Res, Sch Pharm, Jerusalem, Israel.	philipl@ekmd.huji.ac.il	Lazarovici, Philip/S-5261-2018	Lazarovici, Philip/0000-0003-3650-4721	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; David R. Bloom Center for Pharmacy; Dr. Adolf and Klara Bretler Center for Research in Molecular Pharmacology and Therapeutics at the Hebrew University of Jerusalem, Israel	The authors thank the maternity ward staff members of the Department of Obstetrics and Gynecology at Hadassah-Hebrew University Medical Center for their cooperation during the project and their help in collecting the cord blood units. The authors appreciate the support with reagents and cells by Alomone Labs, Fermentek, Jerusalem, Israel, and Prof. C. Marcinkiewicz, Temple University, Pennsylvania, USA. ES was partially supported by a grant from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. PL holds the Jacob Gitlin Chair in Physiology and is affiliated with and supported by the David R. Bloom Center for Pharmacy and the Dr. Adolf and Klara Bretler Center for Research in Molecular Pharmacology and Therapeutics at the Hebrew University of Jerusalem, Israel. The funding sources had no involvement in the conduction, data collection and analysis and preparation of the article.	Arien-Zakay H, 2009, LEUKEMIA, V23, P1790, DOI 10.1038/leu.2009.106; Arien-Zakay H, 2014, J NEUROTRAUM, V31, P1405, DOI 10.1089/neu.2013.3270; Arien-Zakay H, 2010, INT J MOL SCI, V11, P3513, DOI 10.3390/ijms11093513; Arien-Zakay H, 2009, EXP NEUROL, V216, P83, DOI 10.1016/j.expneurol.2008.11.006; Ballen KK, 2015, BONE MARROW TRANSPL, V50, P1271, DOI 10.1038/bmt.2015.124; Ballen KK, 2013, BLOOD, V122, P491, DOI 10.1182/blood-2013-02-453175; Boltze J, 2012, CELL TRANSPLANT, V21, P723, DOI 10.3727/096368911X586783; Bracci-Laudiero L, 2003, J NEUROIMMUNOL, V136, P130, DOI 10.1016/S0165-5728(03)00007-9; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Brodie C, 1996, FEBS LETT, V394, P117, DOI 10.1016/0014-5793(96)00911-8; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Cheppudira BP, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0242-x; CHEVALIER S, 1994, BLOOD, V83, P1479; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; Divya MS, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt148; Drago D, 2013, BIOCHIMIE, V95, P2271, DOI 10.1016/j.biochi.2013.06.020; Ettinger K, 2012, CELL SIGNAL, V24, P2378, DOI 10.1016/j.cellsig.2012.08.008; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao JL, 2016, CELL TRANSPLANT, V25, P1863, DOI 10.3727/096368916X691150; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Geron M, 2017, BBA-GEN SUBJECTS, V1861, P615, DOI 10.1016/j.bbagen.2017.01.004; Gincberg G, 2018, J MOL NEUROSCI, V64, P185, DOI 10.1007/s12031-017-1008-8; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hordyjewska A, 2015, CYTOTECHNOLOGY, V67, P387, DOI 10.1007/s10616-014-9796-y; Hu De-zhi, 2005, Chin J Traumatol, V8, P23; Iafolla MAJ, 2014, BIOL BLOOD MARROW TR, V20, P20, DOI 10.1016/j.bbmt.2013.09.010; Jones E, 2008, RHEUMATOLOGY, V47, P126, DOI 10.1093/rheumatology/kem206; Kelamangalath Lakshmi, 2013, Front Biol (Beijing), V8, P486; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Koshinaga M, 2007, HISTOL HISTOPATHOL, V22, P129, DOI 10.14670/HH-22.129; Kraemer B R, 2014, Handb Exp Pharmacol, V220, P121, DOI 10.1007/978-3-642-45106-5_6; Labouyrie E, 1999, AM J PATHOL, V154, P405, DOI 10.1016/S0002-9440(10)65287-X; Lazarovici P, 2006, CURR PHARM DESIGN, V12, P2609, DOI 10.2174/138161206777698738; Lee S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0544-4; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Li N, 2007, BIOCHEM BIOPH RES CO, V356, P561, DOI 10.1016/j.bbrc.2007.03.013; Lin Y, 2015, BIOMATERIALS, V69, P148, DOI 10.1016/j.biomaterials.2015.08.010; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lv QS, 2013, BRAIN RES, V1493, P80, DOI 10.1016/j.brainres.2012.11.028; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; McGuckin CP, 2005, CELL PROLIFERAT, V38, P245, DOI 10.1111/j.1365-2184.2005.00346.x; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Munoz J, 2014, STEM CELL TRANSL MED, V3, P1435, DOI 10.5966/sctm.2014-0151; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Pimentel-Coelho PM, 2012, PEDIATR RES, V71, P464, DOI 10.1038/pr.2011.59; Rasouli J, 2011, Einstein J Biol Med, V27, P74; Samah B, 2008, CLIN EXP IMMUNOL, V151, P476, DOI 10.1111/j.1365-2249.2007.03578.x; Scardigli R, 2014, STEM CELLS, V32, P2516, DOI 10.1002/stem.1744; Schreiber TD, 2009, HAEMATOL-HEMATOL J, V94, P1493, DOI 10.3324/haematol.2009.006072; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Skaper SD, 2017, IMMUNOLOGY, V151, P1, DOI 10.1111/imm.12717; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Staniszewska I, 2008, J CELL SCI, V121, P504, DOI 10.1242/jcs.000232; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Sun JM, 2015, CYTOTHERAPY, V17, P775, DOI 10.1016/j.jcyt.2015.03.004; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; Ventresca EM, 2015, CELL SIGNAL, V27, P1225, DOI 10.1016/j.cellsig.2015.02.029; Zelentsova K, 2017, STEM CELLS, V35, P679, DOI 10.1002/stem.2522; Zhou Zheng, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P217; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	72	8	8	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	FEB	2018	20	2					245	261		10.1016/j.jcyt.2017.11.008			17	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	FR7CC	WOS:000419222900008	29274773				2022-02-06	
J	Jayakumar, AR; Taherian, M; Panickar, KS; Shamaladevi, N; Rodriguez, ME; Price, BG; Norenberg, MD				Jayakumar, A. R.; Taherian, M.; Panickar, K. S.; Shamaladevi, N.; Rodriguez, M. E.; Price, B. G.; Norenberg, M. D.			Differential Response of Neural Cells to Trauma-Induced Swelling In Vitro	NEUROCHEMICAL RESEARCH			English	Article						Cell swelling; Astrocytes; Microglia; Neurons; Cytokines; Glutamate; Traumatic brain injury	FLUID-PERCUSSION INJURY; FREE-RADICAL PRODUCTION; BRAIN-INJURY; GLUTAMATE TRANSPORTER; CULTURED ASTROCYTES; ENDOTHELIAL-CELLS; EDEMA; RAT; MICROGLIA; NEURONS	Brain edema and the associated increase in intracranial pressure are major consequences of traumatic brain injury (TBI) that accounts for most early deaths after TBI. We recently showed that acute severe trauma to cultured astrocytes results in cell swelling. We further examined whether trauma induces cell swelling in neurons and microglia. We found that severe trauma also caused cell swelling in cultured neurons, whereas no swelling was observed in microglia. While severe trauma caused cell swelling in both astrocytes and neurons, mild trauma to astrocytes, neurons, and microglia failed to cell swelling. Since extracellular levels of glutamate are increased in brain post-TBI and microglia are known to release cytokine, and direct exposure of astrocytes to these molecules are known to stimulate cell swelling, we examined whether glutamate or cytokines have any additive effect on trauma-induced cell swelling. Exposure of cultured astrocytes to trauma caused cell swelling, and such swelling was potentiated by the exposure of traumatized astrocytes to glutamate and cytokines. Conditioned medium (CM) from traumatized astrocytes had no effect on neuronal swelling post-trauma, while CM from traumatized neurons and microglia potentiated the effect of trauma on astrocyte swelling. Further, trauma significantly increased the Na-K-Cl co-transporter (NKCC) activity in neurons, and that inhibition of NKCC activity diminished the trauma-induced neuronal swelling. Our results indicate that a differential sensitivity to trauma-induced cell swelling exists in neural cells and that neurons and microglia are likely to be involved in the potentiation of the astrocyte swelling post-trauma.	[Jayakumar, A. R.; Taherian, M.; Panickar, K. S.; Rodriguez, M. E.; Price, B. G.; Norenberg, M. D.] Vet Affairs Med Ctr, Neuropathol Lab, Miami, FL 33125 USA; [Jayakumar, A. R.] South Florida Fdn Res & Educ Inc, Miami VA Healthcare Syst, Miami, FL 33125 USA; [Taherian, M.; Panickar, K. S.; Norenberg, M. D.] Univ Miami, Sch Med, Dept Pathol, Miami, FL USA; [Shamaladevi, N.] Univ Miami, Sch Med, Dept Urol, Miami, FL USA; [Norenberg, M. D.] Univ Miami, Dept Biochem & Mol Biol, Sch Med, Miami, FL 33101 USA; [Norenberg, M. D.] Univ Miami, Dept Neurol & Neurol Surg, Sch Med, Miami, FL USA		Jayakumar, AR (corresponding author), Vet Affairs Med Ctr, Neuropathol Lab, Miami, FL 33125 USA.; Jayakumar, AR (corresponding author), South Florida Fdn Res & Educ Inc, Miami VA Healthcare Syst, Miami, FL 33125 USA.	avrj_2000@yahoo.com			Merit Review from the US Department of Veterans Affairs; Stanley J. Glaser grant	This work was supported by a Merit Review from the US Department of Veterans Affairs (MDN) and a Stanley J. Glaser grant (ARJ). The authors thank Alina Fernandez-Revuelta for the preparation of cell cultures and Xiaoying Tong for technical assistance.	Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Dorsett CR, 2017, J NEUROTRAUM, V34, P220, DOI 10.1089/neu.2015.4372; DUCIS I, 1989, BRAIN RES, V493, P362, DOI 10.1016/0006-8993(89)91171-2; Flanary BE, 2004, GLIA, V45, P75, DOI 10.1002/glia.10301; Fontana ACK, 2016, J NEUROTRAUM, V33, P1073, DOI 10.1089/neu.2015.4079; GEHRMANN J, 1995, NEUROPATH APPL NEURO, V21, P277, DOI 10.1111/j.1365-2990.1995.tb01062.x; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Hirrlinger J, 2000, DEV NEUROSCI-BASEL, V22, P384, DOI 10.1159/000017464; Hu SX, 1996, CLIN IMMUNOL IMMUNOP, V78, P93, DOI 10.1006/clin.1996.0015; Jayakumar AR, 2016, NEUROCHEM RES, V41, P307, DOI 10.1007/s11064-015-1801-0; Jayakumar AR, 2012, NEUROSCIENCE, V218, P305, DOI 10.1016/j.neuroscience.2012.05.006; Jayakumar AR, 2006, J NEUROSCI, V26, P4774, DOI 10.1523/JNEUROSCI.0120-06.2006; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Jayakumar AR, 2017, J NEUROCHEM, V140, P645, DOI 10.1111/jnc.13867; JUURLINK BHJ, 1985, DEV NEUROSCI-BASEL, V7, P263, DOI 10.1159/000112295; KIMELBERG HK, 1987, J PHYSIOL-PARIS, V82, P294; KLETZIEN RF, 1975, ANAL BIOCHEM, V68, P537, DOI 10.1016/0003-2697(75)90649-1; Marmarou A, 2003, ACT NEUR S, V86, P7; Maxwell WL, 1994, ACTA NEUROCHIRURGICA, V60; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; NORENBERG MD, 1991, NEUROCHEM RES, V16, P833, DOI 10.1007/BF00965694; Panickar KS, 2002, NEUROCHEM RES, V27, P161, DOI 10.1023/A:1014875210852; Rao KVR, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-66; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Schousboe A., 1989, DISSECTION TISSUE CU, P183; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Sun DD, 1999, J NEUROPHYSIOL, V81, P1939, DOI 10.1152/jn.1999.81.4.1939; Unterberg AW, 1997, ACT NEUR S, V70, P106; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yi JH, 2005, GLIA, V49, P121, DOI 10.1002/glia.20099; Zhang JR, 1996, J NEUROCHEM, V66, P355	38	8	8	1	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	FEB	2018	43	2					397	406		10.1007/s11064-017-2434-2			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FV1EG	WOS:000424303200015	29150743				2022-02-06	
J	Kriegel, J; Papadopoulos, Z; McKee, AC				Kriegel, Joshua; Papadopoulos, Zachary; McKee, Ann C.			Chronic Traumatic Encephalopathy: Is Latency in Symptom Onset Explained by Tau Propagation?	COLD SPRING HARBOR PERSPECTIVES IN MEDICINE			English	Article							REPETITIVE HEAD-INJURY; BRAIN-INJURY; NEURODEGENERATIVE DISEASES; MICROGLIAL CELLS; IN-VIVO; MICE; PATHOLOGY; PROTEIN; CNS; NEUROPATHOLOGY	Chronic traumatic encephalopathy (CTE) is a neurodegenerative tauopathy associated with repetitive mild brain trauma. CTE, previously termed "dementia pugilistica," has been identified in American football, ice hockey, baseball, rugby and soccer players, boxers, wrestlers, and military personnel exposed to blast and other traumatic brain injuries. There is often a long latency period between an individual's exposure to repetitive brain trauma and the clinical symptoms of CTE. The pathology of CTE is characterized by a progression from isolated focal perivascular hyperphosphorylated tau lesions in the cerebral cortex to a widespread tauopathy that involves diffuse cortical and medial temporal lobe regions. We hypothesize that the spread of tau from focal perivascular lesions to a widespread tauopathy occurs as a result of intraneuronal and intrasynaptic prion-like protein templating, as well as tau secretion and propagation along glymphatic and cerebrospinal fluid pathways.	[Kriegel, Joshua; Papadopoulos, Zachary; McKee, Ann C.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Kriegel, Joshua; Papadopoulos, Zachary; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [McKee, Ann C.] US Dept Vet Affairs, VA Boston Healthcare Syst, Jamaica Plain, MA 02130 USA; [McKee, Ann C.] Dept Vet Affairs Med Ctr, Bedford, MA 01730 USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA		McKee, AC (corresponding author), Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA.; McKee, AC (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.; McKee, AC (corresponding author), US Dept Vet Affairs, VA Boston Healthcare Syst, Jamaica Plain, MA 02130 USA.; McKee, AC (corresponding author), Dept Vet Affairs Med Ctr, Bedford, MA 01730 USA.; McKee, AC (corresponding author), Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA.	amckee@bu.edu		Papadopoulos, Zachary/0000-0001-5681-1388			Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Brockhaus J, 1996, GLIA, V16, P81, DOI 10.1002/(SICI)1098-1136(199601)16:1<81::AID-GLIA9>3.0.CO;2-E; Clavaguera F, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024372; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fazio V, 2004, ANN THORAC SURG, V78, P46, DOI 10.1016/j.athoracsur.2003.11.042; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Frank MG, 2006, NEUROBIOL AGING, V27, P717, DOI 10.1016/j.neurobiolaging.2005.03.013; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Hall GF, 2012, PRION, V6, P223, DOI 10.4161/pri.19912; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Holmes BB, 2017, COLD SPRING HARB PER; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kanaan NM, 2016, J NEUROPATH EXP NEUR, V75, P19, DOI 10.1093/jnen/nlv001; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Le Meghan N, 2012, Am J Neurodegener Dis, V1, P316; Lewis J, 2016, ACTA NEUROPATHOL, V131, P27, DOI 10.1007/s00401-015-1507-z; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; NEUBUERGER KT, 1959, ARCH NEURO PSYCHIATR, V81, P403, DOI 10.1001/archneurpsyc.1959.02340160001001; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Rauch JN, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024034; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Stancu IC, 2015, ACTA NEUROPATHOL, V129, P875, DOI 10.1007/s00401-015-1413-4; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Toft-Hansen H, 2006, J IMMUNOL, V177, P7242, DOI 10.4049/jimmunol.177.10.7242; Van der Jeugd A, 2012, ACTA NEUROPATHOL, V123, P787, DOI 10.1007/s00401-012-0987-3; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Vincent A, 2011, LANCET NEUROL, V10, P759, DOI 10.1016/S1474-4422(11)70096-5; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	79	8	8	0	13	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	2157-1422			CSH PERSPECT MED	Cold Spring Harb. Perspect. Med.	FEB	2018	8	2							a024059	10.1101/cshperspect.a024059			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GB5YJ	WOS:000429143800001	28096246	Green Published, Bronze			2022-02-06	
J	Williams, C; Weston, R; Feinglass, J; Crandall, M				Williams, Chelsea; Weston, Raquel; Feinglass, Joe; Crandall, Marie			Pediatric bicycle helmet legislation and crash-related traumatic brain injury in Illinois, 1999-2009	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	Association-for-Academic-Surgery/Society-of-University-Surgeons 12th Annual Meeting of the Academic-Surgical-Congress (ASC)	FEB 07-09, 2017	Las Vegas, NV	Acad Surg Congress, Assoc Acad Surg, Soc Univ Surg		Bicycle helmets; Pediatric injury; Legislation		Background: Bicycling is one of the most popular forms of play and exercise for children in the US. However, over 200,000 children per year are injured in bicycle crashes, and an estimated 22,000 pediatric bicycle-related traumatic brain injuries (TBIs) occur annually. Bicycle helmets are known to decrease the risk of head injury, but efficacy and magnitude of the effect of helmet legislation have not been fully elucidated. Methods: This was a retrospective, observational study of children aged < 18, who presented after a bicycle crash in Illinois from 1999 to 2009. Demographic information, injury types, injury severity, helmet usage, and location of injury data were collected. Multiple logistic regression analysis was used to quantify the independent effects of helmet usage on TBI. Data were compared between communities with and without helmet legislation. Results: A total of 3080 pediatric bicycle-related crashes were identified. Children wearing helmets were less likely to sustain a TBI, odds ratio[OR] = 0.56 (95% confidenceinterval [CI] 0.37-0.84, P < 0.001). Overall 5.0% of patients were noted as wearing helmets. Black and Hispanic children were less likely to wear helmets, OR = 0.24 (95% CI 0.09-0.68, P < 0.001) and OR = 0.10 (95% CI 0.02-0.42, P < 0.001), respectively. There was no significant change in helmet usage between before and after legislation in helmet legislation areas or over time in non-helmet legislation areas. Discussion: Helmet use was protective against TBI, but socioeconomic and racial disparities exist in usage. Local legislation did not appear to impact helmet usage or admissions for bicycle-related TBIs in these areas.(C) 2017 Elsevier Inc. All rights reserved.	[Williams, Chelsea] Washington Univ, Sch Med, St Louis Dept Emergency Med, St Louis, MO USA; [Weston, Raquel; Crandall, Marie] Univ Florida, Coll Med Jacksonville, Dept Surg, Jacksonville, FL USA; [Feinglass, Joe] Northwestern Univ, Fienberg Sch Med, Dept Med, Chicago, IL 60611 USA		Crandall, M (corresponding author), Univ Florida, Coll Med Jacksonville, Surg, 655 W 8th St, Jacksonville, FL 32209 USA.; Crandall, M (corresponding author), Univ Florida, Coll Med Jacksonville, Res, 655 W 8th St, Jacksonville, FL 32209 USA.	Marie.crandall@jax.ufl.edu	Crandall, Marie/L-9066-2019	Crandall, Marie/0000-0002-6536-3123			Centers for Disease Control and Prevention (CDC), 2015, UN PED CYCL NONF INJ; Chevignard M, 2016, ANN PHYS REHABIL MED, V59, pe133; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Grant D, 2004, J POLICY ANAL MANAG, V23, P595, DOI 10.1002/pam.20029; Kennedy E, 2017, J HEAD TRAUMA REHAB, V32, P425, DOI 10.1097/HTR.0000000000000289; Lee BHY, 2005, ACCIDENT ANAL PREV, V37, P93, DOI 10.1016/j.aap.2004.07.001; National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention, 2000, TRAUM BRAIN INJ US A; Rivara FP, 2015, INJURY PREV, V21, P47, DOI 10.1136/injprev-00002-0038rep; Sacks J J, 1996, Inj Prev, V2, P258, DOI 10.1136/ip.2.4.258; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Thompson D C, 2000, Cochrane Database Syst Rev, pCD001855	11	8	8	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	FEB	2018	222						231	237		10.1016/j.jss.2017.11.006			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	FQ8CU	WOS:000418591300032	29229283				2022-02-06	
J	Mercier, E; Tardif, PA; Cameron, PA; Kuimi, BLB; Emond, M; Moore, L; Mitra, B; Frenette, J; De Guise, E; Ouellet, MC; Bordeleau, M; Le Sage, N				Mercier, Eric; Tardif, Pier-Alexandre; Cameron, Peter A.; Kuimi, Brice Lionel Batomen; Emond, Marcel; Moore, Lynne; Mitra, Biswadev; Frenette, Jerome; De Guise, Elaine; Ouellet, Marie-Christine; Bordeleau, Martine; Le Sage, Natalie			Prognostic Value of S-100 beta Protein for Prediction of Post-Concussion Symptoms after a Mild Traumatic Brain Injury: Systematic Review and Meta-Analysis	JOURNAL OF NEUROTRAUMA			English	Article						post-concussion symptoms; post-concussion syndrome; S-100 beta protein; systematic review; traumatic brain injury	INDIVIDUAL PARTICIPANT DATA; NEURON-SPECIFIC-ENOLASE; OPTIMAL SEARCH STRATEGIES; SERUM S-100B PROTEIN; MINOR HEAD-INJURY; QUALITY-OF-LIFE; S100B PROTEIN; FOLLOW-UP; BIOMARKERS; MODERATE	This systematic review and meta-analysis aimed to determine the prognostic value of S-100 beta protein to identify patients with post-concussion symptoms after a mild traumatic brain injury (mTBI). A search strategy was submitted to seven databases from their inception to October 2016. Individual patient data were requested. Cohort studies evaluating the association between S-100 beta protein level and post-concussion symptoms assessed at least seven days after the mTBI were considered. Outcomes were dichotomized as persistent (3 months) or early (>= 7 days <3 months). Our search strategy yielded 23,298 citations of which 29 studies including between seven and 223 patients (n = 2505) were included. Post-concussion syndrome (PCS) (16 studies) and neuropsychological symptoms (9 studies) were the most frequently assessed outcomes. The odds of having persistent PCS (odds ratio [OR] 0.62, 95% confidence interval [CI]: 0.34-1.12, p = 0.11, I-2 0% [n = five studies]) in patients with an elevated S-100 beta protein serum level were not significantly different from those of patients with normal values while the odds of having early PCS (OR 1.67, 95% CI: 0.98-2.85, p=0.06, I-2 38% [n = five studies]) were close to statistical significance. Similarly, having an elevated S-100 protein serum level was not associated with the odds of returning to work at six months (OR 2.31, 95% CI: 0.50-10.64, p = 0.28, I-2 22% [n = two studies]). Overall risk of bias was considered moderate. Results suggest that the prognostic biomarker S-100 beta protein has a low clinical value to identify patients at risk of persistent post-concussion symptoms. Variability in injury to S-100 beta protein sample time, mTBI populations, and outcomes assessed could potentially explain the lack of association and needs further evaluation.	[Mercier, Eric; Emond, Marcel; Le Sage, Natalie] Univ Laval, Fac Med, Dept Med Familiale & Med Urgence, Quebec City, PQ, Canada; [Tardif, Pier-Alexandre; Kuimi, Brice Lionel Batomen; Moore, Lynne; Ouellet, Marie-Christine; Bordeleau, Martine; Le Sage, Natalie] Univ Laval, Ctr Rech, Unite Rech Traumatol Urgence Soins Intensifs, CHU Quebec,Axe Sante Populat Prat Optimales Sante, Quebec City, PQ, Canada; [Cameron, Peter A.; Mitra, Biswadev] Alfred Hosp, Emergency & Trauma Ctr, Alfred Hlth, Melbourne, Vic, Australia; [Mercier, Eric] Monash Univ, Sch Publ Hlth & Prevent Med, Clayton, Vic, Australia; [Cameron, Peter A.; Mitra, Biswadev] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Emond, Marcel; Moore, Lynne] Univ Laval, Ctr Rech, Unite Rech Vieillissement, CHU Quebec,Axe Sante Populat Prat Optimales Sante, Quebec City, PQ, Canada; [Moore, Lynne] Univ Laval, Fac Med, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Frenette, Jerome; Ouellet, Marie-Christine] Ctr Rech & CHU Quebec, Quebec City, PQ, Canada; [De Guise, Elaine] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada; [De Guise, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada		Le Sage, N (corresponding author), Univ Laval, Ctr Rech, Unite Rech Traumatol Urgence Soins Intensifs, CHU Quebec,Axe Sante Populat Prat Optimales Sante, Quebec City, PQ, Canada.; Le Sage, N (corresponding author), CHU Quebec, Ctr Rech, CSPQ, 1401,18E Rue, Quebec City, PQ G1J 1Z4, Canada.	natalie.lesage@fmed.ulaval.ca	Kuimi, Brice Lionel Batomen/AAF-3970-2020; Emond, Marcel/G-5804-2014; Le Sage, Natalie/G-7063-2016; Mitra, Biswadev/AAC-3724-2019	Kuimi, Brice Lionel Batomen/0000-0002-5772-120X; Emond, Marcel/0000-0001-7158-8110; Le Sage, Natalie/0000-0003-4762-8156; Mitra, Biswadev/0000-0002-0508-2450; Cameron, Peter/0000-0002-1443-557X; Tardif, Pier-Alexandre/0000-0003-3003-2399	Fonds de Recherche en Sante du Quebec (FRQS)Fonds de la Recherche en Sante du Quebec [32058]; FRQS [30598]	Eric Mercier was supported by a grant from the Fonds de Recherche en Sante du Quebec (FRQS) for his fellowship and this project (Grant 32058). Natalie Le Sage was supported by a grant from the FRQS (Grant 30598).	Abbasi Mohsen, 2014, Turk J Emerg Med, V14, P147, DOI 10.5505/1304.7361.2014.74317; Abo-Zaid G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-56; Adams SD, 2012, J TRAUMA ACUTE CARE, V72, P112, DOI 10.1097/TA.0b013e318241f073; Ahmed I, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7762; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; [Anonymous], 2016, BEST BIOM ENDP OTH T; Asadollahi S, 2016, BRAIN INJURY, V30, P172, DOI 10.3109/02699052.2015.1091504; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Bazarian JJ, 2006, RESTOR NEUROL NEUROS, V24, P163; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Brousseau AA, 2017, CAN J EMERG MED, V19, P329, DOI 10.1017/cem.2016.368; Lima DPD, 2008, INJURY, V39, P604, DOI 10.1016/j.injury.2007.11.008; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dey S, 2017, NEUROL INDIA, V65, P761, DOI 10.4103/neuroindia.NI_884_15; Eady AM, 2008, J CLIN EPIDEMIOL, V61, P34, DOI 10.1016/j.jclinepi.2006.09.016; Ercole A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0614-3; Erickson JA, 2011, CLIN CHIM ACTA, V412, P2122, DOI 10.1016/j.cca.2011.07.020; Fitzpatrick Roberta Bronson, 2008, Journal of Electronic Resources in Medical Libraries, V5, P171, DOI 10.1080/15424060802064428; Hayden JA, 2013, ANN INTERN MED, V158, P280, DOI 10.7326/0003-4819-158-4-201302190-00009; Heidari K, 2015, BRAIN INJURY, V29, P1146, DOI [10.3109/02699052.2014.948068, 10.3109/02699052.2015.1037349]; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; INGEBRIGTSEN T, 2000, BRAIN, V1, P1047; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Kleinert K, 2010, ZBL CHIR, V135, P277, DOI 10.1055/s-0028-1098766; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Lee SJ, 2010, EMERG MED J, V27, P209, DOI 10.1136/emj.2008.063743; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mercier E, 2016, INJURY, V47, P985, DOI 10.1016/j.injury.2016.04.001; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Naeimi ZS, 2006, BRAIN INJURY, V20, P463, DOI 10.1080/02699050600664418; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Peng QL, 2017, INT J NEUROSCI, V127, P1, DOI 10.3109/00207454.2015.1135334; Plog BA, 2015, EXPERT REV NEUROTHER, V15, P465, DOI 10.1586/14737175.2015.1031112; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P431, DOI 10.1016/j.jclinepi.2006.09.009; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Ryb GE, 2014, BRAIN INJURY, V28, P1430, DOI 10.3109/02699052.2014.919525; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Schulte S, 2014, J ATHL TRAINING, V49, P830, DOI 10.4085/1062-6050-49.3.33; Schutze M, 2008, Versicherungsmedizin, V60, P78; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Shinozaki K, 2009, CRIT CARE, V13, DOI 10.1186/cc7973; Simmonds M, 2015, CONTEMP CLIN TRIALS, V45, P76, DOI 10.1016/j.cct.2015.06.012; Sirois MJ, 2013, J AM GERIATR SOC, V61, P1661, DOI 10.1111/jgs.12482; Sojka P, 2006, BRAIN INJURY, V20, P613, DOI 10.1080/02699050600676982; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Stapert S, 2005, EUR NEUROL, V53, P22, DOI 10.1159/000083678; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Stewart LA, 2015, JAMA-J AM MED ASSOC, V313, P1657, DOI 10.1001/jama.2015.3656; Stranjalis G, 2007, ACTA NEUROCHIR, V149, P231, DOI 10.1007/s00701-006-1106-9; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Townend W.J., J NEUROL NEUROSURG P, V73, P542; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Wang N., 2010, NE SAS US GROUP P SE; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; Wilczynski NL, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-23; Wilczynski NL, 2005, J AM MED INFORM ASSN, V12, P481, DOI 10.1197/jamia.M1752	95	8	8	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2018	35	4					609	622		10.1089/neu.2017.5013		JAN 2018	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FV3OH	WOS:000422998400001	28969486				2022-02-06	
J	Paniccia, M; Verweel, L; Thomas, S; Taha, T; Keightley, M; Wilson, KE; Reed, N				Paniccia, Melissa; Verweel, Lee; Thomas, Scott; Taha, Tim; Keightley, Michelle; Wilson, Katherine E.; Reed, Nick			Heart Rate Variability in Healthy Non-Concussed Youth Athletes: Exploring the Effect of Age, Sex, and Concussion-Like Symptoms	FRONTIERS IN NEUROLOGY			English	Article						youth athlete; healthy; non-injured; heart rate variability; concussion; symptoms	CARDIOVASCULAR AUTONOMIC FUNCTION; POWER SPECTRAL-ANALYSIS; PHYSICAL-ACTIVITY; PUBERTAL DEVELOPMENT; NORMAL RANGES; BASE-LINE; CHILDREN; ADOLESCENTS; MODULATION; STANDARDS	Background: Heart rate variability (HRV) is a non-invasive neurophysiological measure of autonomic nervous system regulation emerging in concussion research. To date, most concussion studies have focused on the university-aged athlete with no research examining healthy active youths. Corroborating changes in HRV alongside traditional subjective self-report measures (concussion symptoms) in the non-concussed state provides a foundation for interpreting change following concussion. The objectives were to (1) explore the influence of age and sex on HRV and (2) examine the relationship between HRV and baseline/pre-injury concussion symptom domains (physical, cognitive, emotional, and fatigue) in healthy youth athletes. Method: Healthy, youth athletes 13-18 years of age [N = 294, female = 166 (56.5%), male = 128 (43.5%)] participated in this cross-sectional study. Age, sex, and concussion-like symptoms were collected as part of a baseline/pre-injury assessment. The Post-Concussion Symptom Inventory-SR13 (PCSI-SR13) was used to collect domain scores for physical, cognitive, emotional, and fatigue symptoms. HRV was collected for 24 h. HRV measures included time (SDNN, RMSSD, and pNN50) and frequency (HF, HFnu, LF, LFnu, and total power) domain HRV measures. Variables were logarithmically transformed to increase robustness of linear regression models. Results: Older youth participants displayed significantly higher HRV compared to younger participants (p < 0.05). Females displayed significantly lower HRV compared to males (p < 0.05). A significant interaction effect between concussion-like symptoms and HRV indicated differential patterns as a function of sex (p < 0.05). Youth athletes who reported more cognitive symptoms had lower HRV (p < 0.05). Conclusion: HRV was found to have a significant relationship with a traditional clinical measure (subjective self-report of concussion-like symptoms) utilized in concussion assessment and management. Baseline/pre-concussion trends in HRV were significantly associated with age and sex, highlighting the value in understanding key demographic factors within the context of concussion-like symptoms.	[Paniccia, Melissa] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Paniccia, Melissa; Verweel, Lee; Wilson, Katherine E.; Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Concuss Ctr, Toronto, ON, Canada; [Thomas, Scott; Taha, Tim] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Thomas, Scott; Keightley, Michelle; Reed, Nick] Univ Toronto, Fac Med, Rehabil Sci Inst, Toronto, ON, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Keightley, Michelle; Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Paniccia, M (corresponding author), Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada.; Paniccia, M (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Concuss Ctr, Toronto, ON, Canada.	melissa.paniccia@utoronto.ca	Thomas, Scott G/G-4522-2012	Thomas, Scott G/0000-0002-5564-4271	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [127048]; Ontario Neurotrauma Foundation; Ontario Brain Institute; Ontario government; Rehabilitations Sciences Institute at the University of Toronto	This work was funded by the Canadian Institutes of Health Research (#127048), the Ontario Neurotrauma Foundation and the Ontario Brain Institute. The Ontario Brain Institute is an independent non-profit corporation, funded partially by the Ontario government. The opinions, results, and conclusions are those of the authors and no endorsement by the Ontario Brain Institute is intended or should be inferred. This work was originally featured within the first author's doctoral thesis, as part of a larger body of work on neurophysiological variation (77). The authors thank the Rehabilitations Sciences Institute at the University of Toronto for their support throughout the doctoral program. We would also like to acknowledge the efforts of the members of the CIHR "NeuroCare" Team and the members of the Concussion Centre (Bloorview Research Institute), specifically Talia Dick, James Murphy, and Katherine Mah. We are grateful to the youth and families for their participation in this research. Special thanks to Christopher Gupta for his work on collating background literature. Jordan Collins is also thanked for his work and expertise in statistical analysis.	Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; Balasundaram AP, 2016, BRAIN INJURY, V30, P1599, DOI 10.1080/02699052.2016.1199902; Balle M, 2013, INT J PSYCHOL, V48, P964, DOI 10.1080/00207594.2012.723804; BERNTSON GG, 1993, PSYCHOL BULL, V114, P296, DOI 10.1037/0033-2909.114.2.296; BILLMAN GE, 2013, FRONT PHYSIOL, V4; Blom EH, 2009, EUR J APPL PHYSIOL, V106, P877, DOI 10.1007/s00421-009-1089-3; Bornas X, 2015, INT J PSYCHOPHYSIOL, V98, P112, DOI 10.1016/j.ijpsycho.2015.07.007; Boullosa DA, 2013, MED SCI SPORT EXER, V45, P1223, DOI 10.1249/MSS.0b013e3182880359; Boullosa DA, 2012, EUR J APPL PHYSIOL, V112, P2233, DOI 10.1007/s00421-011-2202-y; Buchheit M, 2007, INT J SPORTS MED, V28, P204, DOI 10.1055/s-2006-924296; Camm AJ, 1996, CIRCULATION, V93, P1043; Castaldo R, 2015, BIOMED SIGNAL PROCES, V18, P370, DOI 10.1016/j.bspc.2015.02.012; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Chen SR, 2012, J SCH NURS, V28, P284, DOI 10.1177/1059840511435248; Covassin T, 2003, J ATHL TRAINING, V38, P238; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Cysarz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019400; da Silva VP, 2015, ANN NONINVAS ELECTRO, V20, P108, DOI 10.1111/anec.12237; DAVIGNON A, 1980, PEDIATR CARDIOL, V1, P123, DOI 10.1007/BF02083144; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DIXON EM, 1992, CARDIOVASC RES, V26, P713, DOI 10.1093/cvr/26.7.713; ECKBERG DL, 1991, J CLIN PHARMACOL, V31, P951, DOI 10.1002/j.1552-4604.1991.tb03655.x; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Faulkner MS, 2003, HEART LUNG, V32, P10, DOI 10.1067/mhl.2003.6; FINLEY JP, 1995, J AUTONOM NERV SYST, V51, P103, DOI 10.1016/0165-1838(94)00117-3; FINLEY JP, 1987, CAN J PHYSIOL PHARM, V65, P2048, DOI 10.1139/y87-320; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Fukuba Yoshiyuki, 2009, Journal of Physiological Anthropology, V28, P269, DOI 10.2114/jpa2.28.269; Garcia CA, 2013, HEART RATE VARIABILI; Gavrilova E. A., 2016, Human Physiology, V42, P571, DOI 10.1134/S036211971605008X; GOLDSMITH RL, 1992, J AM COLL CARDIOL, V20, P552, DOI 10.1016/0735-1097(92)90007-A; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Goto M, 1997, J PEDIATR-US, V130, P725, DOI 10.1016/S0022-3476(97)80013-3; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Gutin B, 2005, MED SCI SPORT EXER, V37, P1856, DOI 10.1249/01.mss.0000175867.98628.27; Hernando D, 2018, J STRENGTH COND RES, V32, P716, DOI 10.1519/JSC.0000000000001662; Higa KT, 2002, AM J PHYSIOL-REG I, V282, pR537, DOI 10.1152/ajpregu.00806.2000; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jarrin DC, 2015, PEDIATR CARDIOL, V36, P41, DOI 10.1007/s00246-014-0962-y; KAMATH MV, 1993, CRIT REV BIOMED ENG, V21, P245; Kim Hun-Sung, 2014, J Diabetes Sci Technol, V8, P431; Koenig J, 2016, NEUROSCI BIOBEHAV R, V64, P288, DOI 10.1016/j.neubiorev.2016.03.007; Lenard Z, 2004, CIRCULATION, V110, P2307, DOI 10.1161/01.CIR.0000145157.07881.A3; Lovell M. R., 2002, Medicine & Science in Sports & Exercise, V34, pS298, DOI 10.1097/00005768-200205001-01680; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; MALPAS SC, 1990, CARDIOVASC RES, V24, P210, DOI 10.1093/cvr/24.3.210; Massin M, 1997, PEDIATR CARDIOL, V18, P297, DOI 10.1007/s002469900178; Massin MM, 2000, ARCH DIS CHILD, V83, P179, DOI 10.1136/adc.83.2.179; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nagai N, 2004, INT J OBESITY, V28, P27, DOI 10.1038/sj.ijo.0802470; Oliveira-Silva I, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00648; Paniccia M, 2017, THESIS; Paniccia M, 2017, AUTON NEUROSCI-BASIC, V208, P1, DOI 10.1016/j.autneu.2017.08.008; Pittman-Polletta BR, 2013, BIOL REV, V88, P873, DOI 10.1111/brv.12032; PUIG J, 1993, J SPORT MED PHYS FIT, V33, P44; Reed KE, 2006, APPL PHYSIOL NUTR ME, V31, P277, DOI 10.1139/H05-015; Reed N, 2014, JOVE-J VIS EXP, DOI 10.3791/51892; Rogol AD, 2000, AM J CLIN NUTR, V72, p521S, DOI 10.1093/ajcn/72.2.521S; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Saeki Y, 1997, J AUTONOM NERV SYST, V66, P69, DOI 10.1016/S0165-1838(97)00067-2; SATO N, 1995, PSYCHOSOM MED, V57, P331, DOI 10.1097/00006842-199507000-00004; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Seifert G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091036; Sharma Vivek Kumar, 2015, J Clin Diagn Res, V9, pCC08, DOI 10.7860/JCDR/2015/15373.6662; Shin K, 1997, MED SCI SPORT EXER, V29, P1482, DOI 10.1097/00005768-199711000-00015; Silvetti MS, 2001, INT J CARDIOL, V81, P169, DOI 10.1016/S0167-5273(01)00537-X; Stein PK, 1997, AM J CARDIOL, V80, P302, DOI 10.1016/S0002-9149(97)00350-0; Tanaka H, 2000, J PEDIATR-US, V137, P63, DOI 10.1067/mpd.2000.108098; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Thayer JF, 2006, ANN NY ACAD SCI, V1088, P361, DOI 10.1196/annals.1366.014; Tsuji H, 1996, J AM COLL CARDIOL, V28, P1539, DOI 10.1016/S0735-1097(96)00342-7; Turton S, 2005, J APPL BIOBEHAV RES, V10, P209; Uckuyu A, 2013, GYNECOL OBSTET, V3, P172, DOI DOI 10.4172/2161-0932.1000172; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	77	8	8	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 18	2018	8								753	10.3389/fneur.2017.00753			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FS9WD	WOS:000422768900001	29403426	gold, Green Published			2022-02-06	
J	Samanamalee, S; Sigera, PC; De Silva, AP; Thilakasiri, K; Rashan, A; Wadanambi, S; Jayasinghe, KSA; Dondorp, AM; Haniffa, R				Samanamalee, Samitha; Sigera, Ponsuge Chathurani; Pubudu De Silva, Ambepitiyawaduge; Thilakasiri, Kaushila; Rashan, Aasiyah; Wadanambi, Saman; Amarasiri Jayasinghe, Kosala Saroj; Dondorp, Arjen M.; Haniffa, Rashan			Traumatic brain injury (TBI) outcomes in an LMIC tertiary care centre and performance of trauma scores	BMC ANESTHESIOLOGY			English	Article						Traumatic brain injury; Low middle income country; Economic outcome; Social outcome; Functional outcome; ICU mortality	HEAD-INJURY; SEVERITY SCORE; PROSPECTIVE COHORT; YOUNG-PEOPLE; MAJOR TRAUMA; FOLLOW-UP; SCALE; DISABILITY; PREDICTION; MULTICENTER	Background: This study evaluates post-ICU outcomes of patients admitted with moderate and severe Traumatic Brain Injury (TBI) in a tertiary neurocritical care unit in an low middle income country and the performance of trauma scores: A Severity Characterization of Trauma, Trauma and Injury Severity Score, Injury Severity Score and Revised Trauma Score in this setting. Methods: Adult patients directly admitted to the neurosurgical intensive care units of the National Hospital of Sri Lanka between 21st July 2014 and 1st October 2014 with moderate or severe TBI were recruited. A telephone administered questionnaire based on the Glasgow Outcome Scale Extended (GOSE) was used to assess functional outcome of patients at 3 and 6 months after injury. The economic impact of the injury was assessed before injury, and at 3 and 6 months after injury. Results: One hundred and one patients were included in the study. Survival at ICU discharge, 3 and 6 months after injury was 68.3%, 49.5% and 45.5% respectively. Of the survivors at 3 months after injury, 43 (86%) were living at home. Only 19 (38%) patients had a good recovery (as defined by GOSE 7 and 8). Three months and six months after injury, respectively 25 (50%) and 14 (30.4%) patients had become "economically dependent". Selected trauma scores had poor discriminatory ability in predicting mortality. Conclusions: This observational study of patients sustaining moderate or severe TBI in Sri Lanka (a LMIC) reveals only 46% of patients were alive at 6 months after ICU discharge and only 20% overall attained a good (GOSE 7 or 8) recovery. The social and economic consequences of TBI were long lasting in this setting. Injury Severity Score, Revised Trauma Score, A Severity Characterization of Trauma and Trauma and Injury Severity Score, all performed poorly in predicting mortality in this setting and illustrate the need for setting adapted tools.	[Samanamalee, Samitha] Hlth Educ Bureaue, 2 Kynsey Rd, Colombo 08, Sri Lanka; [Sigera, Ponsuge Chathurani; Pubudu De Silva, Ambepitiyawaduge; Thilakasiri, Kaushila; Rashan, Aasiyah; Haniffa, Rashan] Network Improving Crit Care Syst & Training, 2nd Floor,YMBA Bldg, Colombo 08, Sri Lanka; [Sigera, Ponsuge Chathurani; Pubudu De Silva, Ambepitiyawaduge; Haniffa, Rashan] Castle St Hosp Women, Natl Intens Care Surveillance, Qual Secretariat Bldg, Colombo 08, Sri Lanka; [Pubudu De Silva, Ambepitiyawaduge] Intens Care Natl Audit & Res Ctr, 24 High Holborn, London WC1V 6AZ, England; [Wadanambi, Saman] Natl Hosp Sri Lanka, Colombo 10, Sri Lanka; [Amarasiri Jayasinghe, Kosala Saroj] Univ Colombo, Fac Med, 25 Kynsey Rd, Colombo 08, Sri Lanka; [Dondorp, Arjen M.; Haniffa, Rashan] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, 3-F,60th Anniversary Chalermprakiat Bldg, Bangkok 10400, Thailand		Haniffa, R (corresponding author), Network Improving Crit Care Syst & Training, 2nd Floor,YMBA Bldg, Colombo 08, Sri Lanka.; Haniffa, R (corresponding author), Castle St Hosp Women, Natl Intens Care Surveillance, Qual Secretariat Bldg, Colombo 08, Sri Lanka.; Haniffa, R (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, 3-F,60th Anniversary Chalermprakiat Bldg, Bangkok 10400, Thailand.	rashan@nicslk.com		Haniffa, Rashan/0000-0002-8288-449X	Network for Improving Critical care Systems and Training (NICST); Mahidol Oxford Tropical Medicine Research Unit (MORU), Thailand	The study was supported by the Network for Improving Critical care Systems and Training (NICST) and the Mahidol Oxford Tropical Medicine Research Unit (MORU), Thailand.	Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bouamra O, 2015, EMERG MED J, V32, P933, DOI 10.1136/emermed-2015-205176; CHAMPION HR, 1990, J TRAUMA, V30, P539, DOI 10.1097/00005373-199005000-00003; Champion HR, 1996, J TRAUMA, V40, P42, DOI 10.1097/00005373-199601000-00009; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deepika A, 2017, NEUROL INDIA, V65, P83, DOI 10.4103/0028-3886.198228; Dhandapani S S, 2012, Asian J Neurosurg, V7, P17, DOI 10.4103/1793-5482.95690; Fuller Anthony, 2016, eNeurologicalSci, V3, P1, DOI 10.1016/j.ensci.2015.10.003; Gunaratne A, 2009, SRI LANKAN J ANAESTH, V17, P51; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Haniffa, 2017, J CRIT CARE IN PRESS; Haniffa R, J CRITICAL IN PRESS; Hosmer DW, 2004, APPL LOGISTIC REGRES, V392; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Majdan M, 2017, J NEUROSCI RURAL PRA, V8, P20, DOI 10.4103/0976-3147.193543; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nwomeh Benedict C, 2006, World J Emerg Surg, V1, P32; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Rabbani A, 2007, ARCH IRAN MED, V10, P383; Rahuman MBF, 2016, CEYLON MED J, V61, P26, DOI 10.4038/cmj.v61i1.8258; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; StataCorp, 2017, STAT DAT AN STAT SOF; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Vassar MJ, 1999, J TRAUMA, V47, P324, DOI 10.1097/00005373-199908000-00017; Veerasingam EQ, 2005, SRI LANKAN J ANAESTH, V13, P30; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Williams TA, 2011, AUST CRIT CARE, V24, P175, DOI 10.1016/j.aucc.2011.03.001; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; YATES DW, 1990, BRIT MED J, V301, P1090, DOI 10.1136/bmj.301.6760.1090; Zhu PF, 1998, CHINESE MED J-PEKING, V111, P169	35	8	9	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2253			BMC ANESTHESIOL	BMC Anesthesiol.	JAN 8	2018	18								4	10.1186/s12871-017-0463-7			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	FS2QH	WOS:000419622800001	29310574	Green Published, gold			2022-02-06	
J	Bosak, V; Murata, K; Bludau, O; Brand, M				Bosak, Viktoria; Murata, Kei; Bludau, Oliver; Brand, Michael			Role of the immune response in initiating central nervous system regeneration in vertebrates: learning from the fish	INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY			English	Article						neuro-inflammation; injury; lipid mediator; cytokine; immune cell	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; ADULT ZEBRAFISH BRAIN; MULLER GLIA; T-CELLS; INFLAMMATORY RESPONSE; RADIAL GLIA; HIPPOCAMPAL NEUROGENESIS; NEURONAL DIFFERENTIATION	The mammalian central nervous system is not able to regenerate neurons lost upon injury. In contrast, anamniote vertebrates show a remarkable regenerative capacity and are able to replace damaged cells and restore function. Recent studies have shown that in naturally regenerating vertebrates, such as zebrafish, inflammation is a key processes required for the initiation of regeneration. These findings are in contrast to many studies in mammals, where the central nervous system has long been viewed as an immune-privileged organ with inflammation considered one of the key negative factors causing lack of neuronal regeneration. In this review, we discuss similarities and differences between naturally regenerating vertebrates, and those with very limited to non-existing regenerative capacity. We will introduce neural stem and progenitor cells in different species and explain how they differ in their reaction to acute injury of the central nervous system. Next, we illustrate how different organisms respond to injuries by activation of their immune system. Important immune cell types will be discussed in relation to their effects on neural stem cell behavior. Finally, we will give an overview on key inflammatory mediators secreted upon injury that have been linked to activation of neural stem cells and regeneration. Overall, understanding how species with regenerative potential couple inflammation and successful regeneration will help to identify potential targets to stimulate proliferation of neural stem cells and subsequent neurogenesis in mammals and may provide targets for therapeutic intervention strategies for neurodegenerative diseases.	[Bosak, Viktoria; Murata, Kei; Bludau, Oliver; Brand, Michael] Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden CRTD, CMCB, Fetscherstr 105, D-01307 Dresden, Germany		Brand, M (corresponding author), Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden CRTD, CMCB, Fetscherstr 105, D-01307 Dresden, Germany.	michael.brand@tu-dresden.de	Brand, Michael/A-5509-2010	Brand, Michael/0000-0001-5711-6512	European Union (ERC-AdG-Zf-BrainReg); Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BR 1746/6-1]; German Excellence Initiative (CRTD seed grant)	The authors thank Stefan Hans and Veronika Kuscha for comments on an earlier version of this review, and members of the Brand lab for lively discussions. We are also grateful for grant support to our lab from the European Union (ERC-AdG-Zf-BrainReg), the Deutsche Forschungsgemeinschaft (BR 1746/6-1), and the German Excellence Initiative (CRTD seed grant).	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alunni A, 2016, DEVELOPMENT, V143, P741, DOI 10.1242/dev.122796; Aurora AB, 2014, CELL STEM CELL, V15, P15, DOI 10.1016/j.stem.2014.06.009; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Ayari B, 2010, J NEUROTRAUM, V27, P959, DOI 10.1089/neu.2009.0972; Baldwin KT, 2015, P NATL ACAD SCI USA, V112, P2581, DOI 10.1073/pnas.1423221112; Barbosa JS, 2015, SCIENCE, V348, P789, DOI 10.1126/science.aaa2729; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; BAZAN N. G., 2006, ARACHIDONIC ACID SIG, DOI [10.1038/npg.els.0004045, DOI 10.1038/NPG.ELS.0004045]; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Bazan NG, 2001, NAT MED, V7, P414, DOI 10.1038/86477; Bazan NG, 2014, MOL NEUROBIOL, V50, P1, DOI 10.1007/s12035-014-8897-0; Bazzoni F, 2010, EUR J IMMUNOL, V40, P2360, DOI 10.1002/eji.200940294; Beck BH, 2010, BREAST CANCER RES TR, V122, P135, DOI 10.1007/s10549-009-0527-6; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Berg DA, 2010, DEVELOPMENT, V137, P4127, DOI 10.1242/dev.055541; BERNINGER B, 2016, COLD SPRING HARB PER, V8, P5; Bhattarai P, 2016, CELL REP, V17, P941, DOI 10.1016/j.celrep.2016.09.075; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Camara-Lemarroy CR, 2008, J BRACHIAL PLEX PERI, V3, DOI 10.1186/1749-7221-3-25; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Chen AT, 2009, J CELL BIOCHEM, V108, P35, DOI 10.1002/jcb.22251; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corser-Jensen CE, 2014, EXP NEUROL, V256, P7, DOI 10.1016/j.expneurol.2014.03.008; Cortina MS, 2013, INVEST OPHTH VIS SCI, V54, P4109, DOI 10.1167/iovs.13-12075; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; de Oliveira S, 2016, NAT REV IMMUNOL, V16, P378, DOI 10.1038/nri.2016.49; de Oliveira S, 2013, J IMMUNOL, V190, P4349, DOI 10.4049/jimmunol.1203266; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; Dey A, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00683; Dinkel K, 2004, P NATL ACAD SCI USA, V101, P331, DOI 10.1073/pnas.0303510101; Diotel N, 2010, J COMP NEUROL, V518, P4855, DOI 10.1002/cne.22492; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Ekstrom P, 2001, J COMP NEUROL, V436, P92, DOI 10.1002/cne.1056; Ellwardt E, 2016, TRENDS IMMUNOL, V37, P154, DOI 10.1016/j.it.2015.12.008; Elsaeidi F, 2014, J NEUROSCI, V34, P2632, DOI 10.1523/JNEUROSCI.3898-13.2014; Than-Trong E, 2015, GLIA, V63, P1406, DOI 10.1002/glia.22856; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Erlandsson A, 2011, EXP NEUROL, V230, P48, DOI 10.1016/j.expneurol.2010.05.018; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Farias S, 2009, J NEUROTRAUM, V26, P1977, DOI 10.1089/neu.2009.0877; Farooqui AA, 2000, NEUROSCIENTIST, V6, P169, DOI 10.1177/107385840000600308; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gabel S, 2016, MOL NEUROBIOL, V53, P5041, DOI 10.1007/s12035-015-9428-3; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Gallina D, 2014, DEVELOPMENT, V141, P3340, DOI 10.1242/dev.109835; Ganz J, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019018; Garg SK, 2009, J NEUROCHEM, V108, P1155, DOI 10.1111/j.1471-4159.2009.05872.x; Garthe A, 2016, HIPPOCAMPUS, V26, P261, DOI 10.1002/hipo.22520; Gascon S, 2017, CELL STEM CELL, V21, P18, DOI 10.1016/j.stem.2017.06.011; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Geurtzen K, 2017, J BONE MINER RES, V32, P2476, DOI 10.1002/jbmr.3231; Ghasemlou N, 2010, BRAIN, V133, P126, DOI 10.1093/brain/awp304; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Grandel H, 2013, DEV GENES EVOL, V223, P131, DOI 10.1007/s00427-012-0425-5; Grosser T, 2002, P NATL ACAD SCI USA, V99, P8418, DOI 10.1073/pnas.112217799; Gruol DL, 2015, NEUROPHARMACOLOGY, V96, P42, DOI 10.1016/j.neuropharm.2014.10.023; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; Hamon A, 2016, DEV DYNAM, V245, P727, DOI [10.1002/DVDY.24375, 10.1002/dvdy.24375]; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Howe CL, 2007, J NEUROIMMUNOL, V188, P13, DOI 10.1016/j.jneuroim.2007.04.005; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Huber C, 2011, CELL PHYSIOL BIOCHEM, V28, P793, DOI 10.1159/000335793; Hurley SD, 2002, J NEUROTRAUM, V19, P1, DOI 10.1089/089771502753460196; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Ishikawa T, 2007, BIOCHEM BIOPH RES CO, V352, P181, DOI 10.1016/j.bbrc.2006.11.007; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kaslin J, 2017, DEVELOPMENT, V144, P1462, DOI 10.1242/dev.144907; Keightley MC, 2014, INT J BIOCHEM CELL B, V56, P92, DOI 10.1016/j.biocel.2014.07.010; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G., 2016, COLD SPRING HARB PER, V8; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim CC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0581-z; Kirkham M, 2011, NEUROSCI LETT, V497, P11, DOI 10.1016/j.neulet.2011.04.007; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-27; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kurimoto T, 2013, J NEUROSCI, V33, P14816, DOI 10.1523/JNEUROSCI.5511-12.2013; Kuscha V, 2012, J COMP NEUROL, V520, P3604, DOI 10.1002/cne.23115; Kuscha V, 2012, J COMP NEUROL, V520, P933, DOI 10.1002/cne.22739; Kwon MJ, 2016, NEURAL REGEN RES, V11, P1368, DOI 10.4103/1673-5374.191194; Kwon MJ, 2013, J NEUROSCI, V33, P15095, DOI 10.1523/JNEUROSCI.0278-13.2013; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Langenau DM, 2005, NAT REV IMMUNOL, V5, P307, DOI 10.1038/nri1590; Langenau DM, 2004, P NATL ACAD SCI USA, V101, P7369, DOI 10.1073/pnas.0402248101; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.126; Leiter O, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1681590; Lenkowski JR, 2014, PROG RETIN EYE RES, V40, P94, DOI 10.1016/j.preteyeres.2013.12.007; Lenkowski JR, 2013, GLIA, V61, P1687, DOI 10.1002/glia.22549; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Lindsey BW, 2006, PROG NEUROBIOL, V80, P281, DOI 10.1016/j.pneurobio.2006.11.007; LINDVALL O, 2015, COLD SPRING HARB PER, V7, P1; LLORENS-BOBADILLA E, 2015, CELL STEM CELL, V17, P1; London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034; Luo CL, 2013, BRAIN RES, V1502, P1, DOI 10.1016/j.brainres.2013.01.037; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Marschallinger J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9466; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Mathieu P, 2010, J NEUROCHEM, V112, P1368, DOI 10.1111/j.1471-4159.2009.06548.x; Mazaheri F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5046; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meireles AM, 2014, CELL REP, V8, P1659, DOI 10.1016/j.celrep.2014.08.018; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Moalem G, 1999, FASEB J, V13, P1207, DOI 10.1096/fasebj.13.10.1207; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; MOORE JC, 2016, MOL CELL BIOL; Moritz C, 2015, NEUROSCI LETT, V591, P13, DOI 10.1016/j.neulet.2015.02.004; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Nagashima M, 2013, DEVELOPMENT, V140, P4510, DOI 10.1242/dev.090738; Neirinckx V, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0150-2; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nelson CM, 2013, J NEUROSCI, V33, P6524, DOI 10.1523/JNEUROSCI.3838-12.2013; Nguyen-Chi M, 2015, ELIFE, V4, DOI 10.7554/eLife.07288; Niemi JP, 2016, EXP NEUROL, V275, P25, DOI 10.1016/j.expneurol.2015.09.018; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Oehlers SHB, 2010, DEV COMP IMMUNOL, V34, P352, DOI 10.1016/j.dci.2009.11.007; Ohnmacht J, 2016, DEVELOPMENT, V143, P1464, DOI 10.1242/dev.129155; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Parish CL, 2007, DEVELOPMENT, V134, P2881, DOI 10.1242/dev.002329; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Perez-Asensio FJ, 2013, J CELL SCI, V126, P4208, DOI 10.1242/jcs.127803; Peron S, 2015, CURR OPIN GENET DEV, V34, P46, DOI 10.1016/j.gde.2015.07.004; Petrie TA, 2014, DEVELOPMENT, V141, P2581, DOI 10.1242/dev.098459; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Popovich PG, 1996, J NEUROSCI RES, V45, P349, DOI 10.1002/(SICI)1097-4547(19960815)45:4<349::AID-JNR4>3.0.CO;2-9; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; Raposo C, 2014, GLIA, V62, P1895, DOI 10.1002/glia.22676; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Renshaw SA, 2012, DIS MODEL MECH, V5, P38, DOI 10.1242/dmm.007138; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rosenberg AF, 2012, J NEUROSCI, V32, P3898, DOI 10.1523/JNEUROSCI.5225-11.2012; ROSSI F, 2015, CELL REP, P1; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Satoh J, 2016, NEUROPATHOLOGY, V36, P39, DOI 10.1111/neup.12235; Savan R, 2006, COMP BIOCHEM PHYS D, V1, P89, DOI 10.1016/j.cbd.2005.08.005; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schwartz M, 2014, EMBO J, V33, P7, DOI 10.1002/embj.201386609; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shinomiya S, 2001, BIOCHEM PHARMACOL, V61, P1153, DOI 10.1016/S0006-2952(01)00586-X; Shrestha R, 2014, NEUROPHARMACOLOGY, V76, P184, DOI 10.1016/j.neuropharm.2013.06.025; Sieger D, 2012, DEV CELL, V22, P1138, DOI 10.1016/j.devcel.2012.04.012; Sifuentes CJ, 2016, INVEST OPHTH VIS SCI, V57, P5148, DOI 10.1167/iovs.16-19973; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Starnes Taylor W, 2012, Adv Hematol, V2012, P398640, DOI 10.1155/2012/398640; Stirling DP, 2008, J NEUROSCI RES, V86, P1944, DOI 10.1002/jnr.21659; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Stout RD, 2010, J LEUKOCYTE BIOL, V87, P19, DOI 10.1189/jlb.0509311; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Tappeiner C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167073; Tauzin S, 2014, J CELL BIOL, V207, P589, DOI 10.1083/jcb.201408090; van Ham TJ, 2014, DIS MODEL MECH, V7, P857, DOI 10.1242/dmm.014886; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Walsh JT, 2014, IMMUNOLOGY, V141, P340, DOI 10.1111/imm.12187; Wan J, 2016, CURR OPIN GENET DEV, V40, P41, DOI 10.1016/j.gde.2016.05.009; Wang XF, 2007, MOL CELL NEUROSCI, V36, P343, DOI 10.1016/j.mcn.2007.07.005; Wolf SA, 2009, FASEB J, V23, P3121, DOI 10.1096/fj.08-113944; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu J, 2015, DEV CELL, V34, P632, DOI 10.1016/j.devcel.2015.08.018; Yang P, 2012, EXP NEUROL, V236, P19, DOI 10.1016/j.expneurol.2012.03.019; Zendedel A, 2012, BRAIN RES, V1473, P214, DOI 10.1016/j.brainres.2012.07.037; Zhang YY, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2340; Zhao XF, 2014, CELL REP, V9, P272, DOI 10.1016/j.celrep.2014.08.047; Zheng ZK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081000; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Zupanc GKH, 1996, J COMP NEUROL, V370, P443; Zupanc GKH, 2005, J COMP NEUROL, V488, P290, DOI 10.1002/cne.20571	218	8	8	0	9	UNIV BASQUE COUNTRY UPV-EHU PRESS	BILBAO	PO BOX 1397, BILBAO, BIZKAIA E-48080, SPAIN	0214-6282	1696-3547		INT J DEV BIOL	Int. J. Dev. Biol.		2018	62	6-8					403	417		10.1387/ijdb.180033vb			15	Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology	HC3GZ	WOS:000451691600009	29938753	Bronze, Green Published			2022-02-06	
J	Bratt, M; Skandsen, T; Hummel, T; Moen, KG; Vik, A; Nordgard, S; Helvik, AS				Bratt, Mette; Skandsen, Toril; Hummel, Thomas; Moen, Kent G.; Vik, Anne; Nordgard, Stale; Helvik, Anne-S.			Frequency and prognostic factors of olfactory dysfunction after traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; olfactory dysfunction; ANOSMIA; CT scan	SMELL IDENTIFICATION TEST; HEAD-INJURY; SNIFFIN-STICKS; ODOR IDENTIFICATION; OLDER-ADULTS; TESTS; PERFORMANCE; DIAGNOSIS; ANOSMIA; DISCRIMINATION	Objective: To assess the frequency and factors associated with posttraumatic olfactory dysfunction, including anosmia, in a follow-up of patients with moderate and severe traumatic brain injury (TBI).Methods: The setting was a cross-sectional study of patients that were consecutively included in the Trondheim TBI database, comprising injury-related variables. Eligible participants 18-65 years were contacted 9-104 months post trauma and asked olfactory-related questions. Those reporting possible posttraumatic change of olfaction were invited to further examination using the Sniffin' Sticks panel.Results: Of 211 eligible participants, 182 (86.3%) took part in telephone interviews and 25(13.7%) were diagnosed with olfactory dysfunction. 60% of these, or 8.2% of all participants, had anosmia. In age-adjusted logistic regression analyses, fall (OR 2.5, 95% CI 1.0-6.2), skull base fracture (OR 2.9, 95% CI 1.2-7.1) and cortical contusion(s) (OR 6.0, 95% CI 2.1-17.3) were associated with olfactory dysfunction. In an analysis of anosmia, fall (OR 3.4, 95% CI 1.1-10.6) and cortical contusion(s) (OR 19.7, 95% CI 2.5-156.0) were associated with the outcome.Conclusion: Of the study participants 13.7% had olfactory dysfunction and 8.2% had anosmia. Higher age, trauma caused by fall and CT displaying skull base fracture and cortical contusion(s) were related to olfactory dysfunction.	[Bratt, Mette; Nordgard, Stale; Helvik, Anne-S.] St Olavs Univ Hosp, Dept Otorhinolaryngol, Trondheim, Norway; [Skandsen, Toril] St Olavs Univ Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Hummel, Thomas] Smell & Taste Clin, Dept Otorhinolaryngol, Dresden, Germany; [Moen, Kent G.] St Olavs Univ Hosp, Clin Radiol & Nucl Med, Trondheim, Norway; [Vik, Anne] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway; [Bratt, Mette; Skandsen, Toril; Moen, Kent G.; Vik, Anne; Nordgard, Stale] Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci MH, Dept Neuromed & Movement Sci, Trondheim, Norway; [Helvik, Anne-S.] NTNU, Fac MH, Dept Publ Hlth & Nursing, Trondheim, Norway		Bratt, M (corresponding author), St Olavs Univ Hosp, ENT Dept, Postboks 3250 Torgarden, NO-7006 Trondheim, Norway.	mette.bratt@stolav.no			Norwegian University of Science and Technology	This study was possible due to funding and support from the Norwegian University of Science and Technology.	Boesveldt S, 2011, RHINOLOGY, V49, P324, DOI 10.4193/Rhino10.155; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Ciofalo A, 2006, RHINOLOGY, V44, P78; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; Deems D. A., 1991, ARCH OTOLARYNGOL NEC, DOI [10.1001/archotol.1991.01870170065015, DOI 10.1001/ARCHOTOL.1991.01870170065015]; DOTY RL, 1989, ANN NY ACAD SCI, V561, P76, DOI 10.1111/j.1749-6632.1989.tb20971.x; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hummel C, 2012, EUR ARCH OTO-RHINO-L, V269, P871, DOI 10.1007/s00405-011-1770-0; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 2017, RHINOLOGY; Katotomichelakis M, 2007, LARYNGOSCOPE, V117, P114, DOI 10.1097/01.mlg.0000246518.79894.7e; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; Landis BN, 2005, J OTOLARYNGOL, V34, P86, DOI 10.2310/7070.2005.00086; Landis BN, 2003, CHEM SENSES, V28, P691, DOI 10.1093/chemse/bjg061; Lotsch J, 2015, RHINOLOGY, V53, P365, DOI 10.4193/Rhino15.010; Lund VJ, 2011, RHINOLOGY, V49, P497; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mullol J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001256; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Ogawa T, 1999, ACTA OTO-LARYNGOL, P50; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reden J, 2016, EUR ARCH OTO-RHINO-L, V273, P927, DOI 10.1007/s00405-015-3682-x; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Schopf V, 2015, HNO, V63, P511, DOI 10.1007/s00106-015-0017-6; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Seiden AM, 2001, LARYNGOSCOPE, V111, P9, DOI 10.1097/00005537-200101000-00002; Sigurdardottir S, 2016, NEUROPSYCHOLOGY, V30, P98, DOI 10.1037/neu0000206; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Steinbach S, 2008, Laryngorhinootologie, V87, P657, DOI 10.1055/s-2008-1077547; Stuck BA, 2015, J ALLERGY CLIN IMMUN, V136, P1460, DOI 10.1016/j.jaci.2015.08.003; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Swann IJ, 2006, EMERG MED J, V23, P618, DOI 10.1136/emj.2005.029017; TEASDALE G, 1974, LANCET, V2, P81; WYSOCKI CJ, 1989, ANN NY ACAD SCI, V561, P12, DOI 10.1111/j.1749-6632.1989.tb20966.x; Yang Jingpu, 2016, Curr Otorhinolaryngol Rep, V4, P130, DOI 10.1007/s40136-016-0120-6; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171	46	8	8	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	8			SI		1021	1027		10.1080/02699052.2018.1469043			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ2QK	WOS:000435116400009	29741969				2022-02-06	
J	Caine, DJ; Provance, AJ				Caine, Dennis J.; Provance, Aaron J.			Pediatric and adolescent injury in adventure and extreme sports	RESEARCH IN SPORTS MEDICINE			English	Article							UNITED-STATES; RISK-FACTORS; HELMET USE; CHILDREN; OSTEOARTHRITIS; SNOWBOARDERS; CONCUSSION; ILLNESSES; RATES; YOUNG		[Caine, Dennis J.] Univ North Dakota, Dept Kinesiol & Publ Hlth Educ, Grand Forks, ND 58201 USA; [Provance, Aaron J.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA		Caine, DJ (corresponding author), Univ North Dakota, Dept Kinesiol & Publ Hlth Educ, Grand Forks, ND 58201 USA.	dennis.caine@und.edu					American Academy of Orthopedic Surgeons, 2014, SCI DAILY; [Anonymous], 2017, VALLEY NEWS LIV 0902; Becker J, 2013, BRIT J SPORT MED, V47, P458, DOI 10.1136/bjsports-2012-091755; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Butterwick DJ, 2011, CLIN J SPORT MED, V21, P243, DOI 10.1097/JSM.0b013e318218acdd; Caine CG, 1996, EPIDEMIOLOGY SPORTS, P1; Caine D, 2005, CLIN J SPORT MED, V15, P287, DOI 10.1097/01.jsm.0000181467.36774.fd; Caine D., 2016, INJURY PEDIAT ADOLES, P69; Caine D, 2016, INJURY PEDIAT ADOLES, P191; Caine D, 2006, CLIN J SPORT MED, V16, P500, DOI 10.1097/01.jsm.0000251181.36582.a0; Caine DJ, 2018, RES SPORTS MED, V26, P71, DOI 10.1080/15438627.2018.1438284; Caine DJ, 2011, BRIT J SPORT MED, V45, P298, DOI 10.1136/bjsm.2010.081984; Caine DJ, 2016, INJURY PEDIAT ADOLES, P3; Carbone A, 2017, J ORTHOP RES, V35, P397, DOI 10.1002/jor.23341; Daniels DJ, 2015, J NEUROSURG-PEDIATR, V15, P261, DOI 10.3171/2014.9.PEDS14149; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Denning GM, 2018, RES SPORTS MED, V26, P38, DOI 10.1080/15438627.2018.1438279; Dodwell ER, 2010, AM J SPORT MED, V38, P1647, DOI 10.1177/0363546510365532; Emery C., 2016, INJURY PEDIAT ADOLES, P205; Emery CA, 2018, RES SPORTS MED, V26, P199, DOI 10.1080/15438627.2018.1452239; Emery CA, 2015, BRIT J SPORT MED, V49, P865, DOI 10.1136/bjsports-2015-094639; EWERT AW, 1997, INT J WILDERNESS, V3, P21; Feletti F, 2018, RES SPORTS MED, V26, P129, DOI 10.1080/15438627.2018.1438285; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Heggie TW, 2012, MED SPORT SCI, V58, P130, DOI 10.1159/000338721; Heggie TW, 2009, TRAVEL MED INFECT DI, V7, P19, DOI 10.1016/j.tmaid.2008.12.002; Heggie TW, 2008, J TRAVEL MED, V15, P404, DOI 10.1111/j.1708-8305.2008.00235.x; Helmkamp JC, 2009, PUBLIC HEALTH REP, V124, P409, DOI 10.1177/003335490912400310; Hootman J., 2010, SPORTS INJURY RES, P55; Hopkins WG, 2007, CLIN J SPORT MED, V17, P208, DOI 10.1097/JSM.0b013e3180592a68; Huelke DF, 1998, P ANN C ASS, P93; KABC News, 2014, KABC NEWS       0104; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Kucera KL, 2015, CATASTROPHIC SPORTS; Lackman J., 2015, NY TIMES; Larson AN, 2009, J PEDIATR ORTHOPED, V29, P847, DOI 10.1097/BPO.0b013e3181c1e2fa; Laver L, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0560-9; Maffulli N, 2010, BRIT J SPORT MED, V44, P21, DOI 10.1136/bjsm.2009.069526; Malina R. M., 2004, GROWTH MATURATION PH, P270; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McKenzie Lara B, 2016, Inj Epidemiol, V3, P10; Meeuwisse WH., 1994, CLIN J SPORT MED, V4, P166, DOI [10.1097/00042752-199407000-00004, DOI 10.1097/00042752-199407000-00004]; Mei-Dan O., 2013, EPIDEMIOLOGY TREATME; Milan M, 2017, J PEDIATR SURG, V52, P349, DOI 10.1016/j.jpedsurg.2016.11.001; *NAT CTR INJ PREV, 2009, CDC INJ RES AG 2009; Nelson NG, 2011, AM J SPORT MED, V39, P404, DOI 10.1177/0363546510383478; Outlook Foundation, 2017, OUTD PART REP; Phit America, 2018, AM 15 FAST GROW SPOR; Ruedl G, 2016, BRIT J SPORT MED, V50, P631, DOI 10.1136/bjsports-2015-095665; Ruedl G, 2012, BRIT J SPORT MED, V46, P1030, DOI 10.1136/bjsports-2012-091534; Russell K, 2014, BRIT J SPORT MED, V48, P23, DOI 10.1136/bjsports-2012-091912; Schoffl V, 2018, RES SPORTS MED, V26, P91, DOI 10.1080/15438627.2018.1438278; Schoffl V, 2004, AM J SPORT MED, V32, P1688, DOI 10.1177/0363546503262805; Sharma VK, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967114564358; Short S. S., 2017, J PEDIATR SURG, DOI [10.1016/j.pedsurg.2017.03.043, DOI 10.1016/J.PEDSURG.2017.03.043]; Shults RA, 2015, INJURY PREV, V21, P10, DOI 10.1136/injuryprev-2013-041138; Shults RA, 2013, PEDIATRICS, V132, P282, DOI 10.1542/peds.2013-0751; Steffen K, 2017, BRIT J SPORT MED, V51, P29, DOI 10.1136/bjsports-2016-096977; Tator CH, 2008, CATASTROPHIC INJURIE; *US DEP HHS, 2008, PHYS ACT ADV COMM RE; Vaca F, 2007, CLIN MED RES, V5, P149, DOI 10.3121/cmr.2007.761; Westin M, 2012, KNEE SURG SPORT TR A, V20, P1175, DOI 10.1007/s00167-012-1921-x; Zemper E. D., 2016, INJURY PEDIAT ADOLES	65	8	8	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.		2018	26			1	SI		5	19		10.1080/15438627.2018.1434041			15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GD9XM	WOS:000430866300002	30431358	Bronze			2022-02-06	
J	Cho, SM; Kim, HG; Yoon, SH; Chang, KH; Park, MS; Park, YH; Choi, MS				Cho, Sung Min; Kim, Hyun Gi; Yoon, Soo Han; Chang, Ki Hong; Park, Moon Sung; Park, Yul-Hyun; Choi, Mi Sun			Reappraisal of Neonatal Greenstick Skull Fractures Caused by Birth Injuries: Comparison of 3-Dimensional Reconstructed Computed Tomography and Simple Skull Radiographs	WORLD NEUROSURGERY			English	Article						3-Dimensional reconstruction; Birth injury; Computed tomogram; Neonate; Skull fracture	TRAUMATIC BRAIN-INJURY; PEDIATRIC SKULL; UNIQUE FEATURES; CHILDREN; HEAD; COMPLICATIONS; MECHANISMS; DIAGNOSIS; PATTERNS; INFANTS	OBJECTIVE: The most common birth-associated head injuries during vaginal delivery are cephalhematomas and subgaleal hematomas. Cranial injuries are rarely encountered. The neonate cranium is soft and pliable, and greenstick skull fractures (GSFs) are expected to be more frequent than linear or depressed fractures, but they are extremely difficult to detect with simple skull radiography. As a result, no reports have been issued on this topic to date. Recent reports suggest that technological advances in 3-dimensional (3D) computed tomography (CT) have successfully enhanced the diagnostic accuracy for cranial fractures. The authors researched the types and characteristics of GSFs and the diagnostic accuracy of 3D CT for cranial fractures in neonates. METHODS: The simple skull radiographs and 3D CT images of 101 neonates were retrospectively evaluated and compared with respect to diagnosis of cranial fractures, and skull GSFs were classified on the basis of 3D CT findings into 5 types depending on multiplicity and location. RESULTS: 3D CT detected 88 cases of cranial fractures, that is, 89 GSFs, 4 combined GSFs and linear fractures, and 3 combined GSFs and depressed fractures. The diagnostic rate of 3DCT was 91% and this was significantly higher than the 13% rate of simple skull radiographs (P < 0.001). CONCLUSIONS: GSFs rather than linear fractures were found to account for most cranial injuries among neonates. The diagnostic accuracy of 3D CT was considerably superior than simple skull radiography, but the high radiation exposure levels of 3D CT warrant the need for development of a modality with lower radiation exposure.	[Cho, Sung Min] Yonsei Univ, Wonju Severance Christian Hosp, Wonju Coll Med, Dept Neurosurg, Wonju, South Korea; [Kim, Hyun Gi] Ajou Univ, Sch Med, Dept Radiol, Suwon, South Korea; [Yoon, Soo Han; Choi, Mi Sun] Ajou Univ, Sch Med, Dept Neurosurg, Suwon, South Korea; [Chang, Ki Hong] Ajou Univ, Sch Med, Dept Gynecol & Obstet, Suwon, South Korea; [Park, Moon Sung] Ajou Univ, Sch Med, Dept Pediat, Suwon, South Korea; [Park, Yul-Hyun] Ajou Univ, Sch Med, Dept Phys Med & Rehabil, Suwon, South Korea		Yoon, SH (corresponding author), Ajou Univ, Sch Med, Dept Neurosurg, Suwon, South Korea.	ee802000@yahoo.co.kr		Park, Moonsung/0000-0002-9101-3581			Baskett TF, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.065; Berteau JP, 2015, BONE, V79, P190, DOI 10.1016/j.bone.2015.05.045; Bhat B. Vishnu, 1994, Indian Journal of Pediatrics, V61, P401, DOI 10.1007/BF02751901; Boice J. D. Jr., 2015, Annals of the ICRP, V44, P236, DOI 10.1177/0146645315575877; Bowen TR, 2006, J ORTHOP TRAUMA, V20, P147, DOI 10.1097/01.bot.0000174707.10980.f4; Bowman R, 2009, NEUROLOGICAL SURG, P3481; CHASLER CN, 1967, AMER J ROENTGENOL RA, V100, P92, DOI 10.2214/ajr.100.1.92; Elhassan Y, 2013, BMJ CASE REP, V22, P2013; Grobman WA, 2016, OBSTET GYNECOL, V127, P667, DOI 10.1097/AOG.0000000000001354; Harpold TL, 1998, NEUROSURG CLIN N AM, V9, P141; HARWOODNASH DC, 1971, RADIOLOGY, V101, P151, DOI 10.1148/101.1.151; Hovind KH, 1985, HEAD INJURIES NEWBOR, P87; Hughes CA, 1999, ARCH OTOLARYNGOL, V125, P193, DOI 10.1001/archotol.125.2.193; Kalia V, 2008, J Indian Soc Pedod Prev Dent, V26, P32; Kim YI, 2012, J KOREAN NEUROSURG S, V52, P528, DOI 10.3340/jkns.2012.52.6.528; Merhar SL, 2016, J PERINATOL, V36, P640, DOI 10.1038/jp.2016.53; Mulroy MH, 2012, FORENSIC SCI INT, V214, P167, DOI 10.1016/j.forsciint.2011.07.050; Nakahara K, 2011, NEUROL MED-CHIR, V51, P272, DOI 10.2176/nmc.51.272; NATELSON SE, 1973, PEDIATRICS, V51, P169; Noonan K J, 1998, J Am Acad Orthop Surg, V6, P146; Orman G, 2015, J NEUROSURG-PEDIATR, V16, P426, DOI 10.3171/2015.3.PEDS1553; Partan G, 2003, EUR J RADIOL, V48, P103, DOI 10.1016/S0720-048X(03)00199-2; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; PIATT JH, 1992, J NEUROSURG, V77, P799, DOI 10.3171/jns.1992.77.5.0799; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Pollina J, 2001, PEDIATR NEUROSURG, V35, P113, DOI 10.1159/000050403; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Sim SY, 2012, J KOREAN NEUROSURG S, V51, P31, DOI 10.3340/jkns.2012.51.1.31; Towner D, 1999, NEW ENGL J MED, V341, P1709, DOI 10.1056/NEJM199912023412301; White PM, 2001, RADIOLOGY, V219, P739, DOI 10.1148/radiology.219.3.r01ma16739; Yoshiiwa T, 2014, ASIAN SPINE J, V8, P339, DOI 10.4184/asj.2014.8.3.339; ZELSON C, 1974, J PEDIATR-US, V85, P371, DOI 10.1016/S0022-3476(74)80118-6	33	8	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2018	109						E305	E312		10.1016/j.wneu.2017.09.168			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FR4DD	WOS:000419015000040	28989045				2022-02-06	
J	Ciofalo, A; De Vincentiis, M; Iannella, G; Zambetti, G; Giacomello, P; Altissimi, G; Greco, A; Fusconi, M; Pasquariello, B; Magliulo, G				Ciofalo, Andrea; De Vincentiis, Marco; Iannella, Giannicola; Zambetti, Giampietro; Giacomello, Paola; Altissimi, Giancarlo; Greco, Antonio; Fusconi, Massimo; Pasquariello, Benedetta; Magliulo, Giuseppe			Mild traumatic brain injury: evaluation of olfactory dysfunction and clinical-neurological characteristics	BRAIN INJURY			English	Article						Head trauma; olfactory dysfunction; Glasgow coma scale; Sniffin' Sticks	HEAD-INJURY; TASTE; DISORDERS; DIAGNOSIS; ANOSMIA; TESTS; SMELL; DISCRIMINATION; PREDICTORS; COMPLAINTS	Objective: To evaluate olfactory function and clinical-neurological characteristics in a group of patients with mild head trauma.Methods: A total of 352 patients with MTBI underwent olfactory function evaluation. The site of head trauma, loss of consciousness <20min, memory loss, subjective presence or absence of olfaction and other clinical, neurological and radiological aspects were evaluated and compared with the olfactory dysfunction.Results: A total of 33.5% patients enrolled in the study had an olfactory dysfunction. Eighty-seven percent of the patients had a diagnosis of anosmia whereas 13% had a diagnosis of hyposmia. Statistical analysis did not show a correlation between radiologically detected head lesions and different types of olfactory dysfunction (p>0.05). Besides, no difference between head lesion site and different olfactory dysfunction was reported (p=0.5). Regarding olfactory sub-tests a low detection threshold was present in these patients.Conclusion: The possibility of olfactory dysfunction should be considered in any case of MTBI appears differently than expected, a minor head injury causes anosmia much more frequently than hyposmia.	[Ciofalo, Andrea; De Vincentiis, Marco; Iannella, Giannicola; Zambetti, Giampietro; Giacomello, Paola; Altissimi, Giancarlo; Greco, Antonio; Fusconi, Massimo; Pasquariello, Benedetta; Magliulo, Giuseppe] Univ Sapienza, Dept Organi Senso, Rome, Italy; [Ciofalo, Andrea; De Vincentiis, Marco; Iannella, Giannicola; Zambetti, Giampietro; Giacomello, Paola; Altissimi, Giancarlo; Greco, Antonio; Fusconi, Massimo; Pasquariello, Benedetta; Magliulo, Giuseppe] Univ Sapienza, Dept Social Sci & Econ, Rome, Italy		Magliulo, G (corresponding author), Via Gregorio 7 80, I-00165 Rome, Italy.	giuseppemagliuloorl@yahoo.com	Iannella, Giannicola/AAL-1553-2020	Iannella, giannicola/0000-0003-1781-2809; MAGLIULO, GIUSEPPE/0000-0003-3052-1969			Bakker K, 2016, BRAIN INJURY, V30, P191, DOI 10.3109/02699052.2015.1089597; Bonanno L, 2017, BRAIN INJURY, V31, P1964, DOI 10.1080/02699052.2017.1346293; Brain Injury Association of America, CAUS BRAIN INJ; Ciofalo A, 2006, RHINOLOGY, V44, P78; Ciofalo A, 2017, EUR ARCH OTO-RHINO-L, V274, P803, DOI 10.1007/s00405-016-4277-x; Ciofalo A, 2015, ANN OTO RHINOL LARYN, V124, P312, DOI 10.1177/0003489414555900; Coelho DH, 2016, AURIS NASUS LARYNX, V43, P137, DOI 10.1016/j.anl.2015.08.006; COSTANZO RM, 1987, ANN NY ACAD SCI, V510, P242; Costanzo RM, 1991, SMELL TASTE HLTH DIS, P711; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Doty RL, 2001, ANNU REV PSYCHOL, V52, P423, DOI 10.1146/annurev.psych.52.1.423; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Fan LY, 2015, J CHIN MED ASSOC, V78, P299, DOI 10.1016/j.jcma.2014.11.009; Ferrier D, 1876, FUNCTIONS BRAIN, P181; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Frasnelli J, 2016, CLIN NEUROL NEUROSUR, V140, P68, DOI 10.1016/j.clineuro.2015.11.013; Frasnelli J, 2004, EUR ARCH OTO-RHINO-L, V261, P411, DOI 10.1007/s00405-003-0703-y; Fujii M, 2002, AURIS NASUS LARYNX, V29, P35, DOI 10.1016/S0385-8146(01)00118-3; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Hummel C, 2012, EUR ARCH OTO-RHINO-L, V269, P871, DOI 10.1007/s00405-011-1770-0; Kim SW, 2014, CLIN EXP OTORHINOLAR, V7, P188, DOI 10.3342/ceo.2014.7.3.188; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Kuhn M, 2016, HNO, V64, P517, DOI 10.1007/s00106-016-0175-1; Kuo CL, 2015, J LARYNGOL OTOL, V129, P1201, DOI 10.1017/S0022215115002911; LEGG JW, 1873, LANCET, V2, P659, DOI DOI 10.1016/S0140-6736(02)66313-5; London B, 2008, ANN NEUROL, V63, P159, DOI 10.1002/ana.21293; MOTT AE, 1991, MED CLIN N AM, V75, P1321, DOI 10.1016/S0025-7125(16)30391-1; Nordin S, 2008, CURR OPIN ALLERGY CL, V8, P10, DOI 10.1097/ACI.0b013e3282f3f473; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Proskynitopoulos P. J., 2016, SURG NEUROLOGY INT, V7, P263; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Schriever VA, 2014, CHEM SENSES, V39, P343, DOI 10.1093/chemse/bju005; Skorpil M, 2011, MAGN RESON IMAGING, V29, P289, DOI 10.1016/j.mri.2010.07.004; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	43	8	8	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	5					550	556		10.1080/02699052.2018.1432074			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WL	WOS:000427074200004	29446651				2022-02-06	
J	Cortese, BM; Schumann, AY; Howell, AN; McConnell, PA; Yang, QX; Uhde, TW				Cortese, Bernadette M.; Schumann, Aicko Y.; Howell, Ashley N.; McConnell, Patrick A.; Yang, Qing X.; Uhde, Thomas W.			Preliminary evidence for differential olfactory and trigeminal processing in combat veterans with and without PTSD	NEUROIMAGE-CLINICAL			English	Article						PTSD; Olfaction; Odor-threat; Trigeminal; fMRI	POSTTRAUMATIC-STRESS-DISORDER; OBSESSIVE-COMPULSIVE DISORDER; MULTIPLE CHEMICAL-SENSITIVITY; TRAUMATIC BRAIN-INJURY; PANIC DISORDER; PSYCHIATRIC-DISORDERS; ODOR PLEASANTNESS; IDENTIFICATION; ANXIETY; HUMANS	Structural and functional changes in the olfactory system are increasingly implicated in the expression of PTSD. Still, very little is known about the neurobiological networks of trauma-related odor sensitivity or how they relate to other objective and subjective measures of olfaction and PTSD. The purpose of this study was to replicate prior findings and further characterize olfactory function in trauma-exposed combat veterans with and without PTSD. We also sought to extend this area of research by exploring the effects of time since the combat-related index trauma (TST) on post-trauma olfactory function, as well as by correlating odor-elicited brain activity to general olfactory ability and odor-elicited PTSD symptoms. Participants included combat veterans with PTSD (CV+PTSD; n = 21) or without any psychiatric disorder (CV-PTSD; n= 27). TST was coded as greater (n = 24) or less (n = 24) than 5 years. There were main effects and/ or interaction for PTSD-status and TST across several parameters of olfactory function: odor detection, odor identification, ratings for trauma-related odor intensity and triggered PTSD symptoms, and trauma odor-elicited brain activation. Overall, results suggest olfactory impairment in chronic PTSD, but not necessarily in the earlier stages of the disorder, although some early-stage olfactory findings may be predictive of later olfactory impairment. Results also suggest that trauma-exposed individuals who never develop PTSD may demonstrate olfactory resiliency. Finally, results highlight a potentially unique role of trigeminal odor properties in the olfactory-PTSD relationship.	[Cortese, Bernadette M.; Schumann, Aicko Y.; Howell, Ashley N.; Uhde, Thomas W.] MUSC, Dept Psychiat & Behav Sci, 67 President St,MSC 861, Charleston, SC 29425 USA; [McConnell, Patrick A.] MUSC, Dept Neurosci, Charleston, SC 29425 USA; [Yang, Qing X.] Penn State Hershey Med Ctr, Dept Radiol, Hershey, PA USA		Cortese, BM (corresponding author), MUSC, Dept Psychiat & Behav Sci, 67 President St,MSC 861, Charleston, SC 29425 USA.	corteseb@musc.edu	McConnell, Patrick A./AAE-8342-2020; McConnell, Patrick A./P-9391-2019	McConnell, Patrick A./0000-0002-6367-7065	NIMH Grant [K01 MH090548]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01MH090548] Funding Source: NIH RePORTER	Funding for this study was provided by NIMH Grant K01 MH090548 (BMC). The study sponsor had no role in the study design, collection, analysis and interpretation of data, in the writing of the report, and in the decision to submit the article for publication.	Ahs F, 2013, BIOL PSYCHOL, V92, P135, DOI 10.1016/j.biopsycho.2012.11.004; Albrecht J, 2010, BRAIN RES REV, V62, P183, DOI 10.1016/j.brainresrev.2009.11.001; Atanasova B, 2008, NEUROSCI BIOBEHAV R, V32, P1315, DOI 10.1016/j.neubiorev.2008.05.003; Azuma K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168006; BELL IR, 1995, J CLIN PSYCHIAT, V56, P151; Bensafi M, 2007, CLIN NEUROPHYSIOL, V118, P696, DOI 10.1016/j.clinph.2006.10.022; Berlin HA, 2017, PSYCHIAT RES-NEUROIM, V262, P15, DOI 10.1016/j.pscychresns.2017.01.012; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bornschein S, 2002, PSYCHOL MED, V32, P1387, DOI 10.1017/S0033291702006554; Buron E, 2015, J AFFECT DISORDERS, V175, P292, DOI 10.1016/j.jad.2015.01.049; CAIN WS, 1976, SENS PROCESS, V1, P57; Chu S, 2002, MEM COGNITION, V30, P511, DOI 10.3758/BF03194952; Cortese BM, 2015, J PSYCHIATR RES, V70, P58, DOI 10.1016/j.jpsychires.2015.08.015; Cortese BM, 2015, J AFFECT DISORDERS, V179, P23, DOI 10.1016/j.jad.2015.03.026; Croy I, 2010, INT J PSYCHOPHYSIOL, V75, P326, DOI 10.1016/j.ijpsycho.2010.01.003; Dileo JF, 2008, PSYCHOL MED, V38, P523, DOI 10.1017/S0033291707001456; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; DOTY RL, 1994, TOXICOL IND HEALTH, V10, P359; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Doty RL, 2009, SMELL THRESHOLD TEST; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fenger MM, 2005, NORD J PSYCHIAT, V59, P39, DOI 10.1080/08039480510018814; Frasnelli J, 2016, CLIN NEUROL NEUROSUR, V140, P68, DOI 10.1016/j.clineuro.2015.11.013; GOLDBERG ED, 1991, AM J PSYCHIAT, V148, P1757; Hermesh H, 1999, EUR NEUROPSYCHOPHARM, V9, P415, DOI 10.1016/S0924-977X(99)00018-8; Hinton DE, 2004, GEN HOSP PSYCHIAT, V26, P390, DOI 10.1016/j.genhosppsych.2004.04.007; HUMMEL T, 1992, ELECTROEN CLIN NEURO, V84, P192, DOI 10.1016/0168-5597(92)90025-7; Hummel T, 1996, REGUL TOXICOL PHARM, V24, pS79, DOI 10.1006/rtph.1996.0082; Hummel T, 2002, INT ARCH OCC ENV HEA, V75, P305, DOI 10.1007/s00420-002-0315-7; Jacquot L, 2004, CR BIOL, V327, P305, DOI 10.1016/j.crvi.2004.02.004; Jones SV, 2008, J NEUROSCI, V28, P13106, DOI 10.1523/JNEUROSCI.4465-08.2008; Kass MD, 2013, SCIENCE, V342, P1389, DOI 10.1126/science.1244916; Katerndahl DA, 2012, ANN FAM MED, V10, P357, DOI 10.1370/afm.1346; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; KLINE NA, 1985, J CLIN PSYCHIAT, V46, P383; KOBAL G, 1988, ELECTROEN CLIN NEURO, V71, P241, DOI 10.1016/0168-5597(88)90023-8; Kobal G., 1992, FRAGRANCE PSYCHOL BI; Kopala LC, 1996, J PSYCHIATR NEUROSCI, V21, P340; Krusemark EA, 2012, CHEMOSENS PERCEPT, V5, P37, DOI 10.1007/s12078-011-9111-7; La Buissonniere-Ariza V, 2013, CHEM SENSES, V38, P577, DOI 10.1093/chemse/bjt028; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Locatelli M, 1996, BIOL PSYCHIAT, V39, P326, DOI 10.1016/0006-3223(95)00172-7; Martzke JS, 1997, BIOL PSYCHIAT, V42, P721, DOI 10.1016/S0006-3223(96)00442-8; McTeague LM, 2012, DEPRESS ANXIETY, V29, P264, DOI 10.1002/da.21891; McTeague LM, 2011, BIOL PSYCHIAT, V70, P415, DOI 10.1016/j.biopsych.2011.03.005; McTeague LM, 2010, BIOL PSYCHIAT, V67, P346, DOI 10.1016/j.biopsych.2009.08.023; Moessnang C, 2013, NEUROIMAGE, V77, P93, DOI 10.1016/j.neuroimage.2013.03.049; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; NICKELL PV, 1994, ANXIETY, V1, P161; Pause BM, 2009, INT J PSYCHOPHYSIOL, V74, P88, DOI 10.1016/j.ijpsycho.2009.07.008; Price J.L., 1990, HUMAN NERVOUS SYSTEM, P979; Resnick H. S., 1996, STRESSFUL LIFE EVENT, P231; Savic I, 2002, CURR OPIN NEUROBIOL, V12, P455, DOI 10.1016/S0959-4388(02)00346-X; Schecklmann M, 2013, J NEURAL TRANSM, V120, P121, DOI 10.1007/s00702-012-0855-2; Segalas C, 2011, DEPRESS ANXIETY, V28, P932, DOI 10.1002/da.20836; Seubert J, 2013, NEUROIMAGE, V66, P333, DOI 10.1016/j.neuroimage.2012.10.030; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Takahashi T, 2015, PSYCHIAT CLIN NEUROS, V69, P431, DOI 10.1111/pcn.12277; Tobia MJ, 2016, NEUROREPORT, V27, P527, DOI 10.1097/WNR.0000000000000579; Vasterling JJ, 2000, J TRAUMA STRESS, V13, P241, DOI 10.1023/A:1007754611030; Vermetten E, 2003, J CLIN PSYCHIAT, V64, P202, DOI 10.4088/JCP.v64n0214; Vermetten E, 2007, PSYCHOPHARMACOL BULL, V40, P8; Wintermann GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074655; Xydakis MS, 2015, NEUROLOGY, V84, P1559, DOI 10.1212/WNL.0000000000001475; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; Zatorre RJ, 2000, NEUROREPORT, V11, P2711, DOI 10.1097/00001756-200008210-00021	67	8	8	1	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	17						378	387		10.1016/j.nicl.2017.09.018			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FX6GA	WOS:000426180300041	29159050	Green Published, gold			2022-02-06	
J	Cuevas, AMC; Ispierto, L; Vilas, D; Planas, A; Planas, A; Isern, I; Sanchez, J; De Haro, J; Alvarez, R				Crespo Cuevas, Ane Miren; Ispierto, Lourdes; Vilas, Dolores; Planas, Anna; Planas, Albert; Isern, Irina; Sanchez, Josep; De Haro, Josep; Alvarez, Ramiro			Distinctive Olfactory Pattern in Parkinson's Disease and Non-Neurodegenerative Causes of Hyposmia	NEURODEGENERATIVE DISEASES			English	Article						Parkinson's disease; Olfaction; Hyposmia	MILD COGNITIVE IMPAIRMENT; DE-NOVO; DYSFUNCTION; DIAGNOSIS; PATHOLOGY; INJURY	Background: Olfactory dysfunction is common in Parkinson's disease (PD). The characteristics of the hyposmia in PD have not been well defined. Objective: To characterize the pattern of the olfactory deficit in PD and in other non-neurodegenerative aetiologies of hyposmia. Methods: We evaluated 36 PD patients, 20 patients with hyposmia secondary to acute respiratory infection (ARI), and 19 patients with hyposmia secondary to traumatic brain injury (TBI). For comparison purposes, we included a group of 15 controls age and sex matched with PD patients. PD patients were classified based on disease duration and severity in de novo PD, and PD with and without chronic levodopa-related complications. The Barcelona Smell Identification Test was applied to all participants. Results: For the first cranial nerve odours, PD patients scored lower than controls on smell detection (85.28 vs. 97.67%, p = 0.006), definition (79.58 vs. 93.33%, p = 0.007), recognition (63.33 vs. 81%, p = 0.020), and forced choice (58.06 vs. 82%, p < 0.001). Compared with ARI, forced choice was significantly better in PD patients (p < 0.001), but no differences were found regarding other olfactory characteristics. TBI patients showed significantly lower scores than the other study groups in all the olfaction items. For the fifth cranial nerve odours, recognition (p = 0.003) and identification (p = 0.019) were lower in the TBI group than in the others. No differences werefound among PD subgroups regarding any olfactory characteristic. Conclusions: A differential pattern of hyposmia was observed in PD patients compared to other non-neurodegenerative aetiologies. Further studies with larger samples should replicate our results. (C) 2018 S. Karger AG, Basel	[Crespo Cuevas, Ane Miren; Ispierto, Lourdes; Vilas, Dolores; Planas, Anna; Alvarez, Ramiro] Hosp Badalona Germans Trias & Pujol, Movement Disorders Unit, Neurol Serv, Badalona, Spain; [Planas, Albert] Hosp Municipal Badalona, Neurol Serv, Badalona, Spain; [Sanchez, Josep] Hosp Municipal Badalona, Otorhinolaryngol Serv, Badalona, Spain; [Isern, Irina] Hosp Espirit St, Neurol Serv, Barcelona, Spain		Cuevas, AMC (corresponding author), Hosp Badalona Germans Trias & Pujol, Neurol Serv, Carretera Canyet S-N, ES-08916 Badalona, Barcelona, Spain.	anecrespocuevas@gmail.com	Vilas, Dolores/AAB-7244-2019	Crespo Cuevas, Ane Miren/0000-0003-1400-5809			ANSARI KA, 1975, J CHRON DIS, V28, P493, DOI 10.1016/0021-9681(75)90058-2; Bohnen NI, 2007, J NEUROL, V254, P84, DOI 10.1007/s00415-006-0284-y; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Buck LB, 2000, PRINCIPLES NEURAL SC, P712; Cardesin A, 2006, RHINOLOGY, V44, P83; DOTY RL, 1992, J NEUROL NEUROSUR PS, V55, P138, DOI 10.1136/jnnp.55.2.138; Fonteyn S, 2014, EUR ANN OTORHINOLARY, V131, P87, DOI 10.1016/j.anorl.2013.03.006; Gaig C, 2009, MOVEMENT DISORD, V24, pS656, DOI 10.1002/mds.22672; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hawkes CH, 1997, J NEUROL NEUROSUR PS, V62, P436, DOI 10.1136/jnnp.62.5.436; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hoyles K, 2013, J NEUROL, V260, P2951, DOI 10.1007/s00415-013-6848-8; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kalbe E, 2016, J NEUROL NEUROSUR PS, V87, P1099, DOI 10.1136/jnnp-2016-313838; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; Lundstrom JN, 2011, ACS CHEM NEUROSCI, V2, P5, DOI 10.1021/cn1000843; Moller JC, 2005, J NEUROL, V252, P926, DOI 10.1007/s00415-005-0784-1; Muller A, 2002, J NEURAL TRANSM, V109, P805, DOI 10.1007/s007020200067; Potagas C, 1998, MOVEMENT DISORD, V13, P394, DOI 10.1002/mds.870130304; Price SE, 2010, J INT NEUROPSYCH SOC, V16, P342, DOI 10.1017/S1355617709991391; QUINN NP, 1987, J NEUROL NEUROSUR PS, V50, P88, DOI 10.1136/jnnp.50.1.88; Saito Y, 2016, MOVEMENT DISORD, V31, P135, DOI 10.1002/mds.26463; Shulman LM, 2002, PARKINSONISM RELAT D, V8, P193, DOI 10.1016/S1353-8020(01)00015-3; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Tissingh G, 2001, MOVEMENT DISORD, V16, P41, DOI 10.1002/1531-8257(200101)16:1<41::AID-MDS1017>3.0.CO;2-M; WARD CD, 1983, NEUROLOGY, V33, P943, DOI 10.1212/WNL.33.7.943; Whitcroft KL, 2017, LARYNGOSCOPE, V127, P291, DOI 10.1002/lary.26229; Witt M, 2009, MOVEMENT DISORD, V24, P906, DOI 10.1002/mds.22464	30	8	8	0	8	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1660-2854	1660-2862		NEURODEGENER DIS	Neurodegener. Dis.		2018	18	2-3					143	149		10.1159/000488680			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GR4TI	WOS:000442610700011	29940577				2022-02-06	
J	Dismuke-Greer, CE; Nolen, TL; Nowak, K; Hirsch, S; Pogoda, TK; Agyemang, AA; Carlson, KF; Belanger, HG; Kenney, K; Troyanskaya, M; Walker, WC				Dismuke-Greer, Clara Elizabeth; Nolen, Tracy L.; Nowak, Kayla; Hirsch, Shawn; Pogoda, Terri K.; Agyemang, Amma A.; Carlson, Kathleen F.; Belanger, Heather G.; Kenney, Kimbra; Troyanskaya, Maya; Walker, William C.			Understanding the impact of mild traumatic brain injury on veteran service-connected disability: results from Chronic Effects of Neurotrauma Consortium	BRAIN INJURY			English	Article						Concussion; traumatic brain injury; military veterans; disability evaluation; veterans disability claims	POSTTRAUMATIC-STRESS-DISORDER; US VETERANS; HEALTH; VALIDITY; COMPENSATION; VALIDATION; INTERVIEW; MEMBERS; BURDEN; SCALE	Objectives: Disability evaluation is complex. The association between mild traumatic brain injury (mTBI) history and VA service-connected disability (SCD) ratings can have implications for disability processes in the civilian population. We examined the association of VA SCD ratings with lifetime mTBI exposure in three models: any mTBI, total mTBI number, and blast-related mTBI.Methods: Participants were 492 Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn veterans from four US VA Medical Centers enrolled in the Chronic Effects of Neurotrauma Consortium study between January 2015 and August 2016. Analyses entailed standard covariate-adjusted linear regression models, accounting for demographic, military, and health-related confounders and covariates.Results: Unadjusted and adjusted results indicated lifetime mTBI was significantly associated with increased SCD, with the largest effect observed for blast-related mTBI. Every unit increase in mTBI was associated with an increase in 3.6 points of percent SCD. However, hazardous alcohol use was associated with lower SCD.Conclusions: mTBI, especially blast related, is associated with higher VA SCD ratings, with each additional mTBI increasing percent SCD. The association of hazardous alcohol use with SCD should be investigated as it may impact veteran health services access and health outcomes. These findings have implications for civilian disability processes.	[Dismuke-Greer, Clara Elizabeth] Med Univ South Carolina, Ralph H Johnson VA Med Ctr, Hlth Equity & Rural Outreach Innovat Ctr, Charleston, SC 29425 USA; [Dismuke-Greer, Clara Elizabeth] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA; [Dismuke-Greer, Clara Elizabeth] Ralph H Johnson VAMC, Res Serv, Charleston, SC USA; [Nolen, Tracy L.; Nowak, Kayla; Hirsch, Shawn] RTI Int, Res Triangle Pk, NC USA; [Pogoda, Terri K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Pogoda, Terri K.] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Agyemang, Amma A.; Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Carlson, Kathleen F.] OHSU, HSR&D Ctr Innovat, VA Portland Hlth Care Syst, Portland, OR USA; [Carlson, Kathleen F.] OHSU, PSU Sch Publ Hlth, Portland, OR USA; [Belanger, Heather G.] Univ S Florida, James A Haley Vet Hosp VH, HSR&D Ctr Innovat Disabil & Rehabil Res CINDRR, Tampa, FL USA; [Belanger, Heather G.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL USA; [Kenney, Kimbra] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Troyanskaya, Maya] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Troyanskaya, Maya] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Walker, William C.] Hunter Holmes McGuire VA Med Ctr, Richmond, VA USA		Dismuke-Greer, CE (corresponding author), Ralph H Johnson VA Med Ctr, Res Serv, 109 Bee St, Charleston, SC 29401 USA.	dismuke@musc.edu	Pogoda, Terri/F-6243-2012	Pogoda, Terri/0000-0003-1397-8780; Hirsch, Shawn/0000-0001-6280-9559; Nolen, Tracy/0000-0003-2512-343X	Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC)	This material is based upon work supported with resources and the use of facilities at: Hunter Holmes McGuire Veterans Affairs Medical Center (VAMC) in Richmond, VA; James A. Haley Veterans Hospital (VH), Tampa, FL; Audie L. Murphy Memorial VH, San Antonio, TX; and Michael E. DeBakey VA Medical Center, Houston, TX and is based upon work supported in part by the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC).	[Anonymous], 2013, FED REG; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brix KA, 2017, J NEUROTRAUM, V34, pS18, DOI 10.1089/neu.2017.5222; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Centers for Disease Control & Prevention, COD PROP DOD VA COMM; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Denning JH, 2019, APPL NEUROPSYCH-ADUL, V26, P1, DOI 10.1080/23279095.2017.1350684; Department of Veterans Affairs, 2008, OFF RES DEV PROGR AN; Fried DA, 2015, MIL MED, V180, P1034, DOI 10.7205/MILMED-D-14-00435; Grubaugh AL, 2009, MIL MED, V174, P1241, DOI 10.7205/MILMED-D-09-00070; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, JAMA-J AM MED ASSOC, V312, P1685, DOI 10.1001/jama.2014.6670; Iverson GL, 2005, BRAIN INJURY, V19, P11, DOI 10.1080/02699050410001720068; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Maciejewski ML, 2012, HEALTH ECON, V21, P902, DOI 10.1002/hec.1759; Maynard C, 2017, MED CARE, V55, P965, DOI 10.1097/MLR.0000000000000806; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Murdoch M, 2011, ARCH GEN PSYCHIAT, V68, P1072, DOI 10.1001/archgenpsychiatry.2011.105; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Silva A, 2016, MIL MED, V181, P469, DOI 10.7205/MILMED-D-15-00094; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Spoont MR, 2007, MIL MED, V172, P572, DOI 10.7205/MILMED.172.6.572; Taniellian T., 2008, INVISIBLE WOUNDS WAR; Traumatic Brain Injury (TBI), EX COMPR VERS; US Department of Veterans Affairs, ANN BEN REP FISC YEA; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Worthen MD, 2011, PSYCHOL INJ LAW, V4, P187, DOI 10.1007/s12207-011-9115-2; Zasler ND, 2003, NEUROPSYCHOL REHABIL, V13, P31, DOI 10.1080/09602010	39	8	8	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	10			SI		1178	1187		10.1080/02699052.2018.1482428			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GS6YO	WOS:000443846200004	29889561				2022-02-06	
J	Dorociak, KE; Schulze, ET; Piper, LE; Molokie, RE; Janecek, JK				Dorociak, Katherine E.; Schulze, Evan T.; Piper, Lauren E.; Molokie, Robert E.; Janecek, Julie K.			Performance validity testing in a clinical sample of adults with sickle cell disease	CLINICAL NEUROPSYCHOLOGIST			English	Article						Test of Memory Malingering; performance validity testing; Neuropsychological Assessment; reliable digit span; sickle cell disease	MEMORY MALINGERING TOMM; TRAUMATIC BRAIN-INJURY; ALBANY CONSISTENCY INDEX; RELIABLE DIGIT SPAN; SYMPTOM VALIDITY; DIAGNOSTIC-TESTS; TRIAL 1; NEUROPSYCHOLOGICAL ASSESSMENT; CLASSIFICATION ACCURACY; SCREENING MEASURE	Objective: Neuropsychologists utilize performance validity tests (PVTs) as objective means for drawing inferences about performance validity. The Test of Memory Malingering (TOMM) is a well-validated, stand-alone PVT and the Reliable Digit Span (RDS) and Reliable Digit Span-Revised (RDS-R) from the Digit Span subtest of the WAIS-IV are commonly employed, embedded PVTs. While research has demonstrated the utility of these PVTs with various clinical samples, no research has investigated their use in adults with sickle cell disease (SCD), a condition associated with multiple neurological, physical, and psychiatric symptoms. Thus, the purpose of this study was to explore PVT performance in adults with SCD. Method: Fifty-four adults with SCD (M-age = 40.61, SD = 12.35) were consecutively referred by their hematologist for a routine clinical outpatient neuropsychological evaluation. During the evaluation, participants were administered the TOMM (Trials 1 and 2), neuropsychological measures including the WAIS-IV Digit Span subtest, and mood and behavioral questionnaires. Results: The average score on the TOMM was 47.70 (SD = 3.47, range = 34-50) for Trial 1 and 49.69 (SD = 1.66, range = 38-50) for Trial 2. Only one participant failed Trial 2 of the TOMM, yielding a 98.1% pass rate for the sample. Pass rates at various RDS and RDS-R values were calculated with TOMM Trial 2 performance as an external criterion. Conclusions: Results support the use of the TOMM as a measure of performance validity for individuals with SCD, while RDS and RDS-R should be interpreted with caution in this population.	[Dorociak, Katherine E.; Schulze, Evan T.; Piper, Lauren E.; Janecek, Julie K.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Molokie, Robert E.] Univ Illinois, Dept Med, Chicago, IL USA		Dorociak, KE (corresponding author), Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA.	katiedorociak@gmail.com	Dorociak, Katherine/W-4017-2019				Akobeng AK, 2007, ACTA PAEDIATR, V96, P338, DOI 10.1111/j.1651-2227.2006.00180.x; Anie KA, 2005, BRIT J HAEMATOL, V129, P723, DOI 10.1111/j.1365-2141.2005.05500.x; Armistead-Jehle P, 2011, APPL NEUROPSYCHOL, V18, P284, DOI 10.1080/09084282.2011.595455; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Ballas SK, 2010, AM J HEMATOL, V85, P6, DOI 10.1002/ajh.21550; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Berkelhammer LD, 2007, CHILD NEUROPSYCHOL, V13, P120, DOI 10.1080/09297040600800956; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Binder LM, 2014, CLIN NEUROPSYCHOL, V28, P1366, DOI 10.1080/13854046.2014.978383; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone K.B., 2007, ASSESSMENT FEIGNED C; Booth C, 2010, INT J INFECT DIS, V14, pE2, DOI 10.1016/j.ijid.2009.03.010; Brandt J., 1991, HOPKINS VERBAL LEARN; Buddin WH, 2014, CLIN NEUROPSYCHOL, V28, P525, DOI 10.1080/13854046.2014.906658; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chafetz MD, 2010, CLIN NEUROPSYCHOL, V24, P1045, DOI 10.1080/13854046.2010.481637; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Crawford JR, 2009, CLIN NEUROPSYCHOL, V23, P624, DOI 10.1080/13854040802524229; Davis JJ, 2012, ARCH CLIN NEUROPSYCH, V27, P706, DOI 10.1093/arclin/acs078; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Duncan A, 2005, ASSESSMENT, V12, P123, DOI 10.1177/1073191105275512; Etherton JL, 2005, ARCH CLIN NEUROPSYCH, V20, P375, DOI 10.1016/j.acn.2004.09.007; Fazio R. L., 2016, CLIN NEUROPSYCHOL, V31, P1; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; Gunner JH, 2012, ARCH CLIN NEUROPSYCH, V27, P1, DOI 10.1093/arclin/acr089; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Horner MD, 2006, INT J NEUROSCI, V116, P1181, DOI 10.1080/00207450500514029; Iverson GL, 2007, CLIN NEUROPSYCHOL, V21, P532, DOI 10.1080/13854040600611392; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Labarge AS, 2003, ARCH CLIN NEUROPSYCH, V18, P165, DOI 10.1016/S0887-6177(01)00193-7; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; National Institutes of Health, 2017, SICKL CELL DIS GEN H; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; O'Bryant SE, 2007, CLIN NEUROPSYCHOL, V21, P511, DOI 10.1080/13854040600611368; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; Ploetz DM, 2016, CHILD NEUROPSYCHOL, V22, P133, DOI 10.1080/09297049.2014.986446; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Schatz J, 2002, J PEDIATR PSYCHOL, V27, P739, DOI 10.1093/jpepsy/27.8.739; Schatz J, 2001, NEUROLOGY, V56, P1109, DOI 10.1212/WNL.56.8.1109; Schroeder RW, 2013, ARCH CLIN NEUROPSYCH, V28, P21, DOI 10.1093/arclin/acs094; Schroeder RW, 2016, CLIN NEUROPSYCHOL, V30, P515, DOI 10.1080/13854046.2016.1177118; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Sharpe M, 2010, PSYCHOL MED, V40, P689, DOI 10.1017/S0033291709990717; Simon MJ, 2007, J CLIN PSYCHOL, V63, P339, DOI 10.1002/jclp.20351; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spencer R. J., 2010, 8 ANN M AM AC CLIN N; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vichinsky EP, 2010, JAMA-J AM MED ASSOC, V303, P1823, DOI 10.1001/jama.2010.562; Walter J, 2014, CLIN NEUROPSYCHOL, V28, P1197, DOI 10.1080/13854046.2014.960454; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilkie DJ, 2010, J NATL MED ASSOC, V102, P18, DOI 10.1016/S0027-9684(15)30471-5; Wilkinson G.S., 2006, WRAT 4 WIDE RANGE AC; Yanez YT, 2006, ARCH CLIN NEUROPSYCH, V21, P161, DOI 10.1016/j.acn.2005.07.009; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083	73	8	8	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2018	32	1					81	97		10.1080/13854046.2017.1339830			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GD3XB	WOS:000430436000007	28632024				2022-02-06	
J	Golos, A; Bedell, G				Golos, Anat; Bedell, Gary			Responsiveness and discriminant validity of the Child and Adolescent Scale of Participation across three years for children and youth with traumatic brain injury	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Activity participation; disability; measurement; pediatric; youth	INPATIENT REHABILITATION; POSTCONCUSSIVE SYMPTOMS; PSYCHOMETRIC PROPERTIES; SHORT-TERM; OUTCOMES; SCHOOL; PREDICTORS; CASP; CONCEPTUALIZATION; DISABILITIES	Purpose: To examine responsiveness and discriminant validity of the Child and Adolescent Scale of Participation (CASP) across three years. Methods: Examined longitudinal data on 515 children and youth with TBI and arm injuries. Repeated measures analyses of variance were used to examine CASP scores (pre-injury; 3, 12, 24, 36 months post-injury). Results: Scores decreased from pre-injury to 3 months, but significantly only for moderate and severe TBI groups. Scores gradually increased post-injury for all groups except severe TBI. Scores were consistently lowest for severe TBI, followed by moderate TBI, mild TBI, and arm injury across time. Severe TBI scores were significantly lower than scores for mild TBI and arm injury, but not moderate TBI. Conclusions: CASP scores were responsive to change over time at most measurements and differentiated between groups, particularly severe TBI. Further research is needed with a larger sample of children with moderate/severe TBI as they were underrepresented in this study.	[Golos, Anat] Sch Occupat Therapy Hadassah, POB 24026, IL-91240 Jerusalem, Israel; [Golos, Anat] Hebrew Univ Jerusalem, POB 24026, IL-91240 Jerusalem, Israel; [Bedell, Gary] Tufts Univ, Dept Occupat Therapy, Medford, MA 02155 USA		Golos, A (corresponding author), Sch Occupat Therapy Hadassah, POB 24026, IL-91240 Jerusalem, Israel.; Golos, A (corresponding author), Hebrew Univ Jerusalem, POB 24026, IL-91240 Jerusalem, Israel.	anat.golos@mail.huji.ac.il		Bedell, Gary/0000-0002-9555-8861	CDC grant [R49 CE 001021]	We thank Fred P. Rivara, MD, MPH, Department of Pediatrics, University of Washington, who provided selected de-identified data to us to examine the psychometric properties of the CASP from his prior longitudinal study (CDC grant R49 CE 001021). We also thank Mrs. Haya Fogel-Grinvald, School of Occupational Therapy of Hadassah and the Hebrew University, Jerusalem, Israel, who provided statistical consultation.	Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Bedell G., 2012, DEV SOCIAL NEUROSCIE; Bedell G, 2011, CHILD ADOLESCENT SCA; Bedell G, 2008, J HEAD TRAUMA REHAB, V23, P220, DOI 10.1097/01.HTR.0000327254.61751.e7; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2008, BRAIN INJURY, V22, P313, DOI 10.1080/02699050801978948; Bedell GM, 2004, NEUROREHABILITATION, V19, P191; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; de Kloet AJ, 2015, BRAIN INJURY, V29, P1135, DOI 10.3109/02699052.2015.1034178; de Kloet AJ, 2015, DEV NEUROREHABIL, V18, P357, DOI 10.3109/17518423.2013.850749; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Field DA, 2016, ARCH PHYS MED REHAB, V97, P462, DOI 10.1016/j.apmr.2015.08.428; Fougeyrollas P., 2014, OPEN J THERAPY REHAB, V2, DOI [10.4236/ojtr.2014.24021, DOI 10.4236/OJTR.2014.24021]; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Golos A, 2016, NEUROREHABILITATION, V38, P311, DOI 10.3233/NRE-161322; Granlund M, 2013, CHILD CARE HLTH DEV, V39, P470, DOI 10.1111/cch.12080; Hwang AW, 2013, INT J REHABILITATION, P1; Khan F, 2013, MED J AUSTRALIA, V178, P290; King G, 2013, CHILD CARE HLTH DEV, V39, P466, DOI 10.1111/cch.12083; King Gillian, 2003, Physical & Occupational Therapy in Pediatrics, V23, P63, DOI 10.1300/J006v23n01_05; Law M, 2015, AUST OCCUP THER J, V62, P105, DOI [10.1111/1440-1630.12177, 10.1111/1440-1630.12188]; Law M, 2011, BRAIN INJURY, V25, P587, DOI 10.3109/02699052.2011.572945; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McDougall J, 2013, CHILD CARE HLTH DEV, V39, P512, DOI 10.1111/cch.12050; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Simeonsson RJ, 2001, DISABIL REHABIL, V23, P49; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Thompson H, 2012, J NEUROTRAUM, V29, pA189; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; World Health Organization, 2007, INT CLASS FUNCT DIS; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ziviani J, 2010, BRAIN IMPAIR, V11, P93, DOI 10.1375/brim.11.2.93	45	8	8	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2018	21	7			SI		431	438		10.1080/17518423.2017.1342711			8	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	GR1HR	WOS:000442284100002	28692352				2022-02-06	
J	Gordon, KE; Kuhle, S				Gordon, Kevin E.; Kuhle, Stefan			Validation of 'reported concussion' within a national health survey	BRAIN INJURY			English	Article						Brain concussion; brain injury; population-based; validity	TRAUMATIC BRAIN-INJURY; UNITED-STATES; EPIDEMIOLOGY; MILD; HISTORY; IMPACT; TRENDS; RISK	Setting: The Canadian Community Health Survey (CCHS) is a national cross-sectional health survey, which has collected information on injuries serious enough to limit normal activity. Objective: To assess the construct and discriminant validity of reporting 'concussion or other brain injury' in the CCHS as the respondents' most serious injury. Methods: Construct validity was assessed by describing the injury profile. Discriminant validity was assessed by examining differences between those reporting concussion or other brain injury, and either: respondents not reporting brain injury (population control); or respondents reporting orthopaedic injuries (orthopaedic control). Results: In total, 1,852 of the 682,455 eligible CCHS respondents (>= 12 years) reported a concussion or other brain injury within the prior year, a population annual incidence of 0.29%. Those reporting concussion or other brain injury were younger and male (p < 0.001), with an injury acquired by falling (p < 0.001) or sport or physical exercise (p < 0.001). Most (78.4%) who reported concussions or other brain injuries received medical attention from a health professional within 48 hours of their injury. The reported injury profiles appear to differ from the population controls and those reporting orthopaedic injuries. Conclusions: The report of 'concussion or other brain injury' in the CCHS may be a valid source of population-based traumatic brain injury epidemiological data.	[Gordon, Kevin E.] Dalhousie Univ, Dept Pediat, Div Pediat Neurol, Halifax, NS, Canada; [Kuhle, Stefan] Dalhousie Univ, Dept Pediat, Perinatal Epidemiol Res Unit, Halifax, NS, Canada; [Kuhle, Stefan] Dalhousie Univ, Dept Obstet & Gynaecol, Halifax, NS, Canada		Gordon, KE (corresponding author), IWK Hlth Ctr, Dept Pediat, Div Pediat Neurol, 5850 Univ Ave, Halifax, NS B3K 6R8, Canada.	kegor@dal.ca	Kuhle, Stefan/X-5815-2019	Kuhle, Stefan/0000-0001-9417-3727	Social Sciences and Humanities Research Council of Canada RDC Access Granting Committee [14-SSHDAL-3854]	The authors would like to acknowledge the support of the Social Sciences and Humanities Research Council of Canada RDC Access Granting Committee (grant number 14-SSHDAL-3854) and the assistance of the staff at the Atlantic Research Data Centre, Dalhousie University, Halifax, NS, Canada.	ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; [Anonymous], SURV STAT PROGR; [Anonymous], SPEC TOP TRAUM BRAIN; [Anonymous], TBI GET FACTS CONC T; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P1, DOI 10.1159/000170084; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Comstock RD, 2012, MILD TRAUMATIC BRAIN, P22; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Engberg A, 1998, EUR J EPIDEMIOL, V14, P165, DOI 10.1023/A:1007492025190; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; FIFE D, 1987, AM J PUBLIC HEALTH, V77, P810, DOI 10.2105/AJPH.77.7.810; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Gioia G, 2006, ACUTE CONCUSSION EVA; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LINDER CW, 1981, AM J SPORT MED, V9, P187, DOI 10.1177/036354658100900311; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2004, CLIN J SPORT MED, V14, P139, DOI 10.1097/00042752-200405000-00006; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mirabelli MH, 2015, AM FAM PHYSICIAN, V92, P371; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Norman, 1995, HLTH MEASUREMENT SCA; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Selassie A., 2003, NAT CTR INJ PREV CON; Sosin DM, 1996, BRAIN INJURY, V10, P47; Statistics Canada, 2014, CCHS 2014 2013 2014; Thomas Steven, 2009, Health Rep, V20, P53; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	43	8	8	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	1					41	48		10.1080/02699052.2017.1403046			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7VS	WOS:000427072300004	29172812				2022-02-06	
J	Gupta, S; Klaric, K; Sam, N; Din, V; Juschkewitz, T; Iv, V; Shrime, MG; Park, KB				Gupta, Saksham; Klaric, Katherine; Sam, Nang; Din, Vuthy; Juschkewitz, Tina; Iv, Vycheth; Shrime, Mark G.; Park, Kee B.			Impact of helmet use on traumatic brain injury from road traffic accidents in Cambodia	TRAFFIC INJURY PREVENTION			English	Article						Traumatic brain injury; helmet usage; Cambodia; road traffic accidents	MIDDLE-INCOME COUNTRIES; ADJUSTED LIFE-YEARS; MOTORCYCLE HELMET; CANADIAN ADULTS; PRACTICAL SCALE; EPIDEMIOLOGY; COMA; ASSOCIATION; DISABILITY; ATTITUDES	Objective: Rapid urbanization and motorization without corresponding increases in helmet usage have made traumatic brain injury due to road traffic accidents a major public health crisis in Cambodia. This analysis was conducted to quantify the impact of helmets on severity of injury, neurosurgical indication, and functional outcomes at discharge for motorcycle operators who required hospitalization for a traumatic brain injury following a road traffic accident in Cambodia.Methods: The medical records of 491 motorcycle operators who presented to a major tertiary care center in Cambodia with traumatic brain injury were retrospectively analyzed using multivariate logistic regression.Results: The most common injuries at presentation were contusions (47.0%), epidural hematomas (30.1%), subdural hematomas (27.9%), subarachnoid hemorrhages (12.4%), skull fractures (21.4%), and facial fractures (18.5%). Moderate-to-severe loss of consciousness was present in 36.3% of patients. Not wearing a helmet was associated with an odds ratio of 2.20 (95% confidence interval [CI], 1.15-4.22) for presenting with moderate to severe loss of consciousness compared to helmeted patients. Craniotomy or craniectomy was indicated for evacuation of hematoma in 20.0% of cases, and nonhelmeted patients had 3.21-fold higher odds of requiring neurosurgical intervention (95% CI, 1.25-8.27). Furthermore, lack of helmet usage was associated with 2.72-fold higher odds of discharge with functional deficits (95% CI, 1.14-6.49). In total, 30.1% of patients were discharged with severe functional deficits.Conclusions: Helmets demonstrate a protective effect and may be an effective public health intervention to significantly reduce the burden of traumatic brain injury in Cambodia and other developing countries with increasing rates of motorization across the world.	[Gupta, Saksham] Harvard Med Sch, Boston, MA USA; [Klaric, Katherine] Asia Injury Prevent Fdn, Chamkar Mon Dist, Phnom Penh, Cambodia; [Sam, Nang; Din, Vuthy; Iv, Vycheth; Park, Kee B.] Preah Kossamak Hosp, Dept Neurosurg, Phnom Penh, Cambodia; [Juschkewitz, Tina] Asklepios Klinikum Heidberg Nord, Dept Neurol, Hamburg, Germany; [Shrime, Mark G.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA; [Shrime, Mark G.; Park, Kee B.] Harvard Med Sch, Program Global Surg & Social Change, 641 Huntington Ave, Boston, MA 02115 USA		Park, KB (corresponding author), Harvard Med Sch, Program Global Surg & Social Change, 641 Huntington Ave, Boston, MA 02115 USA.	keebpark@gmail.com			Korean American Medical Foundation; Foundation of the World Federation of Neurosurgical Societies	This study received financial support from the Korean American Medical Foundation and the Foundation of the World Federation of Neurosurgical Societies.	Ackaah W, 2013, INJURY PREV, V19, P158, DOI 10.1136/injuryprev-2012-040348; Bachani AM, 2013, INJURY, V44, pS31, DOI [10.1016/S0020-1383(13)70210-9, 10.1016/S0020-1383(13)70209-2]; Bilgin S, 2012, NEURAL REGEN RES, V7, P1978, DOI 10.3969/j.issn.1673-5374.2012.25.009; Brewer BL, 2013, J TRAUMA ACUTE CARE, V75, P88, DOI 10.1097/TA.0b013e3182988b59; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chalya Phillipo L, 2014, Tanzan J Health Res, V16, P280; Cohen B, 2006, TECHNOL SOC, V28, P63, DOI 10.1016/j.techsoc.2005.10.005; Crandon Ivor W, 2009, BMC Res Notes, V2, P172, DOI 10.1186/1756-0500-2-172; Crompton JG, 2012, ARCH SURG-CHICAGO, V147, P674, DOI 10.1001/archsurg.2012.894; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Forjuoh Samuel N, 2003, Inj Control Saf Promot, V10, P109, DOI 10.1076/icsp.10.1.109.14115; Georgoff P, 2010, WORLD NEUROSURG, V74, P331, DOI 10.1016/j.wneu.2010.03.025; Haqverdi MQ, 2015, ACCIDENT ANAL PREV, V85, P102, DOI 10.1016/j.aap.2015.09.007; Hooten Kristopher G, 2012, Clin Neurosurg, V59, P126; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, ASIA-PAC J PUBLIC HE, V19, P16, DOI 10.1177/10105395070190020401; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Ilie G, 2015, ACCIDENT ANAL PREV, V81, P1, DOI 10.1016/j.aap.2015.04.021; JENNETT B, 1975, LANCET, V1, P480; Kauvar DS, 2005, CRIT CARE, V9, P1, DOI 10.1186/cc3779; Kim CY, 2015, TRAFFIC INJ PREV, V16, P732, DOI 10.1080/15389588.2015.1005207; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee HY, 2010, AM J PUBLIC HEALTH, V100, P165, DOI 10.2105/AJPH.2008.159004; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Naumann Rebecca B, 2015, N C Med J, V76, P70; Norvell DC, 2002, AM J EPIDEMIOL, V156, P483, DOI 10.1093/aje/kwf081; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Roehler DR, 2015, INT J INJ CONTROL SA, V22, P165, DOI 10.1080/17457300.2013.876050; Roehler DR, 2013, INT J INJ CONTROL SA, V20, P179, DOI 10.1080/17457300.2012.759594; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sone JY, 2017, J NEUROSURG, V126, P768, DOI 10.3171/2016.2.JNS151972; System Road Crash & Victim Information, 2010, CAMB ROAD CRASH VICT; TEASDALE G, 1974, LANCET, V2, P81; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Wiznia DH, 2016, TRAFFIC INJ PREV, V17, P633, DOI 10.1080/15389588.2015.1136059; World Health Organization and Ministry of Health,, 2012, CAMB CAMB HLTH SERV; Zhang Q, 2013, TRAFFIC INJ PREV, V14, P867, DOI 10.1080/15389588.2013.775432	40	8	9	2	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2018	19	1					66	70		10.1080/15389588.2017.1342821			5	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	FN0UP	WOS:000415696600011	28699848				2022-02-06	
J	Heiden, SM; Caldwell, BS				Heiden, Siobhan M.; Caldwell, Barrett S.			Considerations for developing chronic care system for traumatic brain injury based on comparisons of cancer survivorship and diabetes management care	ERGONOMICS			English	Article; Proceedings Paper	Triennial Congress of the International-Ergonomics-Association (IEA)	2015	Melbourne, AUSTRALIA	Intl Ergon Assoc		Health care systems engineering; traumatic brain injury; Chronic Care Model; chronic care; disease management	SELF-MANAGEMENT; SUICIDAL IDEATION; HEALTH LITERACY; DEMENTIA CARE; MODEL; DISEASE; MILD; OUTCOMES; RISK; RECOMMENDATIONS	Experts in traumatic brain injury (TBI) rehabilitation recently proposed the framing of TBI as a chronic disease rather than a discrete event. Within the framework of the Chronic Care Model (CCM), a systematic comparison of three diseases - cancer survivorship, diabetes management and TBI chronic care - was conducted regarding chronic needs and the management of those needs. In addition, comparisons of these conditions require comparative evaluations of disease management characteristics and the survivor concept. The analysis found diabetes is more established within the CCM, where care is integrated across specialists and primary care providers. No single comparison provides a full analogue for understanding the chronic care health delivery system for TBI, indicating the need for a separate model to address needs and resources for TBI survivors. The findings from this research can provide practitioners with a context to develop a robust continued care health system for TBI.Practitioner Summary: We examine development of a chronic care system for traumatic brain injury. We conducted a systematic comparison of Chronic Care Model elements of decision and information support. Development of capabilities using a benchmark of diabetes care, with additional insights from cancer care, provides insights for implementing TBI chronic care systems.	[Heiden, Siobhan M.; Caldwell, Barrett S.] Purdue Univ, Sch Ind Engn, W Lafayette, IN 47907 USA		Heiden, SM (corresponding author), Purdue Univ, Sch Ind Engn, W Lafayette, IN 47907 USA.	sheiden@purdue.edu			Purdue Graduate School; School of Industrial Engineering	The authors thank the Purdue Graduate School and the School of Industrial Engineering for their support of this work through the Purdue Doctoral Fellowship.	ADA, 2016, STAND MED CAR DIAB; Ahles TA, 2001, CANCER INVEST, V19, P812, DOI 10.1081/CNV-100107743; Anderson TM, 2010, J CLIN EXP NEUROPSYC, V32, P1074, DOI 10.1080/13803391003733560; ARC, 2012, AM RED CROSS SCI ADV; Austrom MG, 2004, GERONTOLOGIST, V44, P548, DOI 10.1093/geront/44.4.548; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Bandura A., 1997, SELF EFFICACY EXERCI; Battersby M, 2010, JT COMM J QUAL PATIE, V36, P561, DOI 10.1016/S1553-7250(10)36084-3; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Boustani MA, 2011, AGING MENT HEALTH, V15, P13, DOI 10.1080/13607863.2010.496445; Boykoff N, 2009, J CANCER SURVIV, V3, P223, DOI 10.1007/s11764-009-0098-x; Butler D., 2009, SYSTEMS ENG IMPROVE, V1; Caldwell BS, 2010, J HEALTHC ENG, V1, P255, DOI 10.1260/2040-2295.1.2.255; Callahan CM, 2011, AGING MENT HEALTH, V15, P5, DOI 10.1080/13607861003801052; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; Carney N., 2016, GUIDELINES MANAGEMEN, V4th; CDC, 2003, REP C MILD TRAUM BRA; Centers for Disease Control and Prevention (CDC), 2015, TRAUM BRAIN INJ US E; Chambers J, 1996, J TRAUMA, V41, P976, DOI 10.1097/00005373-199612000-00006; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Cozzarelli Tara A, 2010, J Spec Oper Med, V10, P39; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Degeneffe C. E., 2008, J APPL REHABILITATIO, V39, P45; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Douglas SE, 2011, INT J IND ERGONOM, V41, P352, DOI 10.1016/j.ergon.2011.02.004; Faul M, 2010, TRAUMATIC BRAIN INJU; Fonseca Vivian A., 2008, HYPOGLYCEMIA; Frame A., 2013, EGEMS, V1; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; GHRI, 2016, CHRON CAR MOD; Grady PA, 2014, AM J PUBLIC HEALTH, V104, pE25, DOI 10.2105/AJPH.2014.302041; Greenwald Brian, 2015, Arch Phys Med Rehabil, V96, P1189, DOI 10.1016/j.apmr.2013.07.014; Haas L, 2014, DIABETES CARE, V37, pS144, DOI 10.2337/dc14-S144; Hayes Sue, 2012, TRANSITION TOOLKIT S; Hebdon Megan, 2015, J Adv Pract Oncol, V6, P334; Hebdon M, 2015, J ADV NURS, V71, P1774, DOI 10.1111/jan.12646; Hebdon M, 2014, ONCOL NURS FORUM, V41, P615, DOI 10.1188/14.ONF.615-625; Heiden S. M., 2014, P 2014 IND SYST ENG; Heiden S.M., 2015, HUM FACT ERG SOC 201; Hewitt M., 2005, CANC PATIENT CANC SU; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Holman GT, 2016, J AM MED INFORM ASSN, V23, P29, DOI 10.1093/jamia/ocv107; Huff SM, 1998, J AM MED INFORM ASSN, V5, P276, DOI 10.1136/jamia.1998.0050276; Institute of Medicine, 2014, CAPT SOC BEH DOM MEA; IOM (Institute of Medicine), 2012, LIV WELL CHRON ILLN; Jaglal SB, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-409; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Lequerica AH, 2017, NEUROPSYCHOL REHABIL, V27, P1019, DOI 10.1080/09602011.2016.1231120; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Lucas S, 2016, HEADACHE, V56, P323, DOI 10.1111/head.12762; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Madden JM, 2016, J AM MED INFORM ASSN, V23, P1143, DOI 10.1093/jamia/ocw021; Malec JF, 2013, J HEAD TRAUMA REHAB, V28, P476, DOI 10.1097/HTR.0000000000000003; Marquart S M, 2001, Crit Care Nurs Clin North Am, V13, P349; Masel B, 2009, CONCEPTUALIZING BRAI; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mashima P. A., 2010, ASHA LEADER; McCulloch D K, 1998, Eff Clin Pract, V1, P12; McDonald CJ, 2003, CLIN CHEM, V49, P624, DOI 10.1373/49.4.624; Mishel M H, 1988, Image J Nurs Sch, V20, P225, DOI 10.1111/j.1547-5069.1988.tb00082.x; Monahan PO, 2012, CLIN INTERV AGING, V7, P143, DOI 10.2147/CIA.S30663; Nagelkerk J, 2006, J ADV NURS, V54, P151, DOI 10.1111/j.1365-2648.2006.03799.x; National Comprehensive Cancer Network (NCCN), 2016, NCCN GUID; NCAA, 2014, CONC GUID; NCCS, 2016, CANC SURV TOOLB; NCCS, 2016, PLANN ACT CANC TREAT; NERENZ DR, 1992, MED CARE, V30, pMS112, DOI 10.1097/00005650-199205001-00010; NNLM (National Network of Libraries of Medicine), 2013, PREV LOW HLTH LIT; Osborn CY, 2011, J HEALTH COMMUN, V16, P268, DOI 10.1080/10810730.2011.604388; Peck S, 2008, NURS FORUM, V43, P91, DOI 10.1111/j.1744-6198.2008.00100.x; Peters E, 2006, PSYCHOL SCI, V17, P407, DOI 10.1111/j.1467-9280.2006.01720.x; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Siminerio L, 2004, CLIN DIABETES, V22, P54, DOI DOI 10.2337/DIACLIN.22.2.54]; Siminerio LM, 2005, DIABETES EDUCATOR, V31, P225, DOI 10.1177/0145721705275325; Sperl-Hillen JoAnn M, 2004, Jt Comm J Qual Saf, V30, P303; Stuckey HL., 2011, DIABETES MANAGEMENT, V1, P37, DOI 10.2217/dmt.10.9; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Surwit RS, 2002, DIABETES CARE, V25, P30, DOI 10.2337/diacare.25.1.30; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; US Congress, 2009, PUBL L; USDHHS, 2010, MULT CHRON COND A ST; Vargas RB, 2007, J GEN INTERN MED, V22, P215, DOI 10.1007/s11606-006-0072-5; Wagner EH, 2002, J NURS CARE QUAL, V16, P67, DOI 10.1097/00001786-200201000-00008; WAGNER EH, 1998, EFFECTIVE CLIN PRACT, V0001, P00001; Warshaw G, 2006, GENERATIONS, V30, P5; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Williams MV, 2002, FAM MED, V34, P383	98	8	8	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0014-0139	1366-5847		ERGONOMICS	Ergonomics		2018	61	1			SI		134	147		10.1080/00140139.2017.1349932			14	Engineering, Industrial; Ergonomics; Psychology, Applied; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Engineering; Psychology	FR0GC	WOS:000418738400011	28679345				2022-02-06	
J	Hinson, HE; Rowell, S; Morris, C; Lin, AL; Schreiber, MA				Hinson, Holly E.; Rowell, Susan; Morris, Cynthia; Lin, Amber L.; Schreiber, Martin A.			Early fever after trauma: Does it matter?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	30th Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma (EAST)	JAN 09-14, 2017	Hollywood, FL	Eastern Assoc Surg Trauma		Traumatic brain injury; fever; multiple injuries; inflammation	CRITICALLY-ILL PATIENTS; BRAIN-INJURY; INTRACRANIAL-PRESSURE; NERVOUS-SYSTEM; RISK-FACTORS; SERUM IL-6; HYPERTHERMIA; CYTOKINES; SEVERITY; ACCURACY	BACKGROUND Fever is strongly associated with poor outcome after traumatic brain injury (TBI). We hypothesized that early fever is a direct result of brain injury and thus would be more common in TBI than in patients without brain injury and associated with inflammation. METHODS We prospectively enrolled patients with major trauma with and without TBI from a busy Level I trauma center intensive care unit (ICU). Patients were assigned to one of four groups based on their presenting Head Abbreviated Injury Severity Scale scores: multiple injuries: head Abbreviated Injury Scale (AIS) score greater than 2, one other region greater than 2; isolated head: head AIS score greater than 2, all other regions less than 3; isolated body: one region greater than 2, excluding head/face; minor injury: no region with AIS greater than 2. Early fever was defined as at least one recorded temperature greater than 38.3 degrees C in the first 48 hours after admission. Outcome measures included neurologic deterioration, length of stay in the ICU, hospital mortality, discharge Glasgow Outcome Scale-Extended, and plasma levels of seven key cytokines at admission and 24 hours (exploratory). RESULTS Two hundred sixty-eight patients were enrolled, including subjects with multiple injuries (n = 59), isolated head (n = 97), isolated body (n = 100), and minor trauma (n = 12). The incidence of fever was similar in all groups irrespective of injury (11-24%). In all groups, there was a significant association between the presence of early fever and death in the hospital (6-18% vs. 0-3%), as well as longer median ICU stays (3-7 days vs. 2-3 days). Fever was significantly associated with elevated IL-6 at admission (50.7 pg/dL vs. 16.9 pg/dL, p = 0.0067) and at 24 hours (83.1 pg/dL vs. 17.1 pg/dL, p = 0.0025) in the isolated head injury group. CONCLUSION Contrary to our hypothesis, early fever was not more common in patients with brain injury, though fever was associated with longer ICU stays and death in all groups. Additionally, fever was associated with elevated IL-6 levels in isolated head injury. LEVEL OF EVIDENCE Prognostic and Epidemiological study, level III.	[Hinson, Holly E.] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,CR 127, Portland, OR 97239 USA; [Hinson, Holly E.; Lin, Amber L.] Oregon Hlth & Sci Univ, Dept Emergency Med, 3181 SW Sam Jackson Pk Rd,CR 127, Portland, OR 97239 USA; [Rowell, Susan; Schreiber, Martin A.] Oregon Hlth & Sci Univ, Dept Trauma Crit Care & Acute Surg, 3181 SW Sam Jackson Pk Rd,CR 127, Portland, OR 97239 USA; [Morris, Cynthia] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, 3181 SW Sam Jackson Pk Rd,CR 127, Portland, OR 97239 USA		Hinson, HE (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,CR 127, Portland, OR 97239 USA.; Hinson, HE (corresponding author), Oregon Hlth & Sci Univ, Dept Emergency Med, 3181 SW Sam Jackson Pk Rd,CR 127, Portland, OR 97239 USA.	hinson@ohsu.edu	Hinson, Holly/Q-2268-2019; Rowell, Susan/S-7480-2019	Hinson, Holly/0000-0003-1598-9782; 	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5K12HL108974-03]; Oregon Clinical and Translational Research Institute (OCTRI) from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000128]; OHSU Foundation; Remedy Pharmaceuticals; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL108974] Funding Source: NIH RePORTER	The project described was supported in part by Award Number 5K12HL108974-03 from the National Heart, Lung, and Blood Institute. This publication was supported by Oregon Clinical and Translational Research Institute (OCTRI), grant number (UL1TR000128) from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health. Dr. Hinson has consulted for Remedy Pharmaceuticals about a clinical study (CHARM), which Remedy funds. Payment for this consulting is made directly to the OHSU Foundation. Dr. Hinson may benefit from these funds by using them to fund her OHSU research.	ABRAHAM E, 1985, ARCH SURG-CHICAGO, V120, P1341; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Bao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090956; Bengualid V, 2015, AM J CRIT CARE, V24, pE1, DOI 10.4037/ajcc2015856; Broessner G, 2009, STROKE, V40, pE657, DOI 10.1161/STROKEAHA.109.557652; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Dietrich WD, 2007, PROG BRAIN RES, V162, P201, DOI 10.1016/S0079-6123(06)62011-6; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Jefferies S, 2011, CRIT CARE RESUSC, V13, P194; Kalabalikis P, 1999, INTENS CARE MED, V25, P288, DOI 10.1007/s001340050837; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Meier K, 2016, J INTENSIVE CARE MED; Mizushima Y, 2009, J TRAUMA, V67, P1062, DOI 10.1097/TA.0b013e3181b848fc; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Netea MG, 2000, CLIN INFECT DIS, V31, pS178, DOI 10.1086/317513; Niven Daniel J, 2012, J Intensive Care Med, V27, P290, DOI 10.1177/0885066611402463; Nonose Y, 2012, ANAESTH INTENS CARE, V40, P820, DOI 10.1177/0310057X1204000510; O'Grady NP, 2008, CRIT CARE MED, V36, P1330, DOI 10.1097/CCM.0b013e318169eda9; Oh HS, 2012, INT J NURS PRACT, V18, P295, DOI 10.1111/j.1440-172X.2012.02039.x; Rabinstein AA, 2007, J NEUROL NEUROSUR PS, V78, P1278, DOI 10.1136/jnnp.2006.112730; Rincon F, 2015, J INTENSIVE CARE MED, V30, P107, DOI 10.1177/0885066613508266; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Thompson HJ, 2003, J NEUROL NEUROSUR PS, V74, P614, DOI 10.1136/jnnp.74.5.614; Venetsanou K, 2007, EUR CYTOKINE NETW, V18, P206, DOI 10.1684/ecn.2007.0112; Woiciechowsky C, 2005, ACT NEUR S, V95, P373; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021	29	8	8	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2018	84	1					19	24		10.1097/TA.0000000000001627			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	FS0JG	WOS:000419459600003	28640776	Green Accepted			2022-02-06	
J	Howard, BM; Kornblith, LZ; Redick, BJ; Conroy, AS; Nelson, MF; Calfee, CS; Callcut, RA; Cohen, MJ				Howard, Benjamin Michael; Kornblith, Lucy Z.; Redick, Brittney J.; Conroy, Amanda S.; Nelson, Mary F.; Calfee, Carolyn S.; Callcut, Rachael A.; Cohen, Mitchell Jay			Exposing the bidirectional effects of alcohol on coagulation in trauma: Impaired clot formation and decreased fibrinolysis in rotational thromboelastometry	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	100th Annual Clinical Congress of the American-College-of-Surgeons (ACS)	OCT 26-30, 2014	San Francisco, CA	Amer Coll Surg		Alcohol; ethanol; coagulation disorders; acute traumatic coagulopathy; ROTEM; rotational thromboelastometry; trauma	WHOLE-BLOOD; ETHANOL INTOXICATION; PLATELET-AGGREGATION; EARLY COAGULOPATHY; ORGAN FAILURE; BRAIN-INJURY; PROTEIN-C; CONSUMPTION; THROMBELASTOGRAPHY; SEVERITY	BACKGROUND Alcohol has been associated with altered viscoelastic testing in trauma, indicative of impaired coagulation. Such alterations, however, show no correlation to coagulopathy-related outcomes. Other data suggest that alcohol may inhibit fibrinolysis. We sought to clarify these mechanisms after traumatic injury using thromboelastometry (ROTEM), hypothesizing that alcohol-related clot formation impairment may be counter-balanced by inhibited fibrinolysis. METHODS Laboratory, demographic, clinical, and outcome data were prospectively collected from 406 critically injured trauma patients at a Level I trauma center. ROTEM and standard coagulation measures were conducted in parallel. Univariate comparisons were performed by alcohol level (EtOH), with subsequent regression analysis. RESULTS Among 274 (58%) patients with detectable EtOH, median EtOH was 229 mg/dL. These patients were primarily bluntly injured and had lower GCS (p < 0.05) than EtOH-negative patients, but had similar admission pH and injury severity (p = NS). EtOH-positive patients had prolonged ROTEM clotting time and rate of clot formation time (CFT/); they also had decreased fibrinolysis (max lysis %; all p < 0.05). In linear regression, for every 100 mg/dL increase in EtOH, clotting time increased by 13 seconds and fibrinolysis decreased by 1.5% (both p < 0.05). However, EtOH was not an independent predictor of transfusion requirements or mortality. In high-EtOH patients with coagulopathic ROTEM tracings, transfusion rates were significantly lower than expected, relative to EtOH-negative patients with similar ROTEM findings. CONCLUSION As assayed by ROTEM, alcohol appears to have a bidirectional effect on coagulation in trauma, both impairing initial clot formation and inhibiting fibrinolysis. This balancing of mechanisms may explain lack of correlation between altered ROTEM and coagulopathy-related outcomes. Viscoelastic testing should be used with caution in intoxicated trauma patients. Level of Evidence Epidemiological study, level III.	[Howard, Benjamin Michael; Kornblith, Lucy Z.; Redick, Brittney J.; Conroy, Amanda S.; Nelson, Mary F.; Callcut, Rachael A.] San Francisco Gen Hosp, Dept Surg, Room 3C-38,1001 Potrero Ave, San Francisco, CA 94110 USA; [Calfee, Carolyn S.] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA USA; [Calfee, Carolyn S.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA USA; [Cohen, Mitchell Jay] Univ Colorado, Sch Med, Denver Hlth Med Ctr, Denver, CO USA		Howard, BM (corresponding author), San Francisco Gen Hosp, Dept Surg, Ward 3A, Room 3C-38,1001 Potrero Ave, San Francisco, CA 94110 USA.	benjamin.howard@ucsf.edu	Callcut, Rachael/ABE-1484-2021		NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K01ES026834] Funding Source: NIH RePORTER; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K01 ES026834] Funding Source: Medline		Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; DUARTE APT, 1995, THROMB RES, V78, P107, DOI 10.1016/0049-3848(95)00039-9; Engstrom M, 2006, BLOOD COAGUL FIBRIN, V17, P661, DOI 10.1097/MBC.0b013e32801010b7; Gentilello LM, 2013, TRAUMA, P850; Harr JN, 2011, J SURG RES, V170, P319, DOI 10.1016/j.jss.2011.03.047; HAUT MJ, 1974, AM J MED, V56, P22, DOI 10.1016/0002-9343(74)90747-5; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Howard BM, 2015, J TRAUMA ACUTE CARE, V78, P735, DOI 10.1097/TA.0000000000000583; Howard BM, 2014, J TRAUMA ACUTE CARE, V77, P865, DOI 10.1097/TA.0000000000000357; Howard BM, 2014, J TRAUMA ACUTE CARE, V77, P71; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P87, DOI 10.1097/TA.0b013e3182598c70; Li GH, 1997, J TRAUMA, V42, P562, DOI 10.1097/00005373-199703000-00032; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Mukamal KJ, 2001, CIRCULATION, V104, P1367, DOI 10.1161/hc3701.096067; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Phelan H, 2002, J TRAUMA, V52, P675, DOI 10.1097/00005373-200204000-00010; Pieters M, 2010, THROMB HAEMOSTASIS, V104, P724, DOI 10.1160/TH10-01-0048; Plurad D, 2010, J EMERG MED, V38, P12, DOI 10.1016/j.jemermed.2007.09.048; Raza I, 2013, J THROMB HAEMOST, V11, P307, DOI 10.1111/jth.12078; Salem RO, 2005, AM J CLIN PATHOL, V123, pS9; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Sauaia A, 2009, SHOCK, V31, P438, DOI 10.1097/SHK.0b013e31818ba4c6; Sierksma A, 2002, EUR J CLIN NUTR, V56, P1130, DOI 10.1038/sj.ejcn.1601459; Spoerke N, 2010, J TRAUMA, V68, P1106, DOI 10.1097/TA.0b013e3181d86860; van de Wiel A, 2001, EUR J CLIN INVEST, V31, P164, DOI 10.1046/j.1365-2362.2001.00773.x; van Golde PM, 2003, ALCOHOL, V29, P183, DOI 10.1016/S0741-8329(03)00016-8; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; Wang ZQ, 1999, ALCOHOL CLIN EXP RES, V23, P1927, DOI 10.1111/j.1530-0277.1999.tb04093.x; WOOLF PD, 1991, J TRAUMA, V31, P1271, DOI 10.1097/00005373-199109000-00012; Woolf PD, 1997, J TRAUMA, V42, P5; Zhang QH, 2000, ALCOHOL CLIN EXP RES, V24, P528	35	8	8	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2018	84	1					97	103		10.1097/TA.0000000000001716			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	FS0JG	WOS:000419459600014	29267182	Green Accepted			2022-02-06	
S	Jak, AJ; Crocker, LD; Aupperle, RL; Clausen, A; Bomyea, J		Vermetten, E; Baker, DG; Risbrough, VB		Jak, Amy J.; Crocker, Laura D.; Aupperle, Robin L.; Clausen, Ashley; Bomyea, Jessica			Neurocognition in PTSD: Treatment Insights and Implications	BEHAVIORAL NEUROBIOLOGY OF PTSD	Current Topics in Behavioral Neurosciences		English	Article; Book Chapter						Neuroimaging; Neuropsychology; PTSD; Treatment	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE PROCESSING THERAPY; SMALLER HIPPOCAMPAL VOLUME; TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; PREFRONTAL CORTEX; DECLARATIVE MEMORY; ANTERIOR CINGULATE; TREATMENT RESPONSE; EXECUTIVE FUNCTION	Post-traumatic stress disorder (PTSD) is classified as a traumatic stress-related condition and is most often discussed in terms of emotional dysfunction. However, given that cognitive and emotional processes are intricately intertwined, implemented by overlapping brain networks, and effectively integrated in at least some of the same regions (e.g., prefrontal cortex, for a review, see Crocker et al. 2013), an abundance of literature now highlights the key role that cognitive functioning plays in both the development and maintenance (or exacerbation) of PTSD symptoms (Aupperle et al. 2012a; Verfaellie et al. 2012). Findings from this body of work detail objective impairment in neuropsychological function in those with PTSD (Brandes et al. 2002; Hayes et al. 2012a; Koenen et al. 2001). Yet despite the impact of neurocognition on PTSD treatment engagement and success (e.g., Haaland et al. 2016; Nijdam et al. 2015) and conversely, the role of PTSD treatment in normalizing cognitive dysfunction, a much smaller literature exists on neurocognitive changes following treatment for PTSD. Even aside from its role in treatment, cognitive functioning in PTSD has significant implications for daily functioning for individuals with this disorder, as cognition is predictive of school achievement, obtaining and maintaining employment, job advancement, maintaining relationships, greater wealth, and better health and quality of life (e.g., Diamond and Ling 2016).	[Jak, Amy J.; Crocker, Laura D.; Bomyea, Jessica] VA San Diego Healthcare Syst, San Diego, CA 92161 USA; [Jak, Amy J.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Aupperle, Robin L.; Clausen, Ashley] Laureate Inst Brain Res, Tulsa, OK USA; [Aupperle, Robin L.; Clausen, Ashley] Univ Tulsa, Tulsa, OK 74104 USA		Jak, AJ (corresponding author), VA San Diego Healthcare Syst, San Diego, CA 92161 USA.; Jak, AJ (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	ajak@ucsd.edu; laura.crocker@va.gov; raupperle@laureateinstitute.org; aclausen@laureateinstitute.org; jessica.bomyea@va.gov	Aupperle, Robin/AAU-8550-2020; Clausen, Ashley N/W-5627-2019	Clausen, Ashley N/0000-0002-1773-7733			Amir N, 2009, J ABNORM PSYCHOL, V118, P28, DOI 10.1037/a0012589; Anderson MC, 2009, CURR DIR PSYCHOL SCI, V18, P189, DOI 10.1111/j.1467-8721.2009.01634.x; Apfel BA, 2011, BIOL PSYCHIAT, V69, P541, DOI 10.1016/j.biopsych.2010.09.044; Aupperle R, 2014, NEUROPSYCHOPHARMACOL, V39, pS498; Aupperle RL, 2016, J TRAUMA STRESS, V29, P33, DOI 10.1002/jts.22068; Aupperle RL, 2013, PSYCHIAT RES-NEUROIM, V214, P48, DOI 10.1016/j.pscychresns.2013.05.001; Aupperle RL, 2012, ARCH GEN PSYCHIAT, V69, P360, DOI 10.1001/archgenpsychiatry.2011.1539; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Badura-Brack AS, 2015, AM J PSYCHIAT, V172, P1233, DOI 10.1176/appi.ajp.2015.14121578; Bailey CR, 2013, CNS DRUGS, V27, P221, DOI 10.1007/s40263-013-0051-4; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bomyea J, 2015, CURR PSYCHIATRY REV, V11, P160, DOI 10.2174/1573400511666150528212418; Bomyea J, 2015, J ANXIETY DISORD, V34, P33, DOI 10.1016/j.janxdis.2015.05.010; Bomyea J, 2012, CLIN PSYCHOL REV, V32, P630, DOI 10.1016/j.cpr.2012.06.008; Bomyea J, 2011, COGNITIVE THER RES, V35, P529, DOI 10.1007/s10608-011-9369-8; Bossini L, 2007, J CLIN PSYCHOPHARM, V27, P233, DOI 10.1097/01.jcp.0000264979.09862.a8; Boyd B, 2016, COGN BEHAV PRACT, V23, P173, DOI 10.1016/j.cbpra.2015.10.001; Brady K, 2000, JAMA-J AM MED ASSOC, V283, P1837, DOI 10.1001/jama.283.14.1837; Brandes D, 2002, PSYCHIAT RES, V110, P231, DOI 10.1016/S0165-1781(02)00125-7; Bremner JD, 2004, ANN NY ACAD SCI, V1032, P154, DOI 10.1196/annals.1314.012; Bremner JD, 2005, J PSYCHOPHARMACOL, V19, P159, DOI 10.1177/0269881105048996; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Brewin CR, 2011, ANNU REV CLIN PSYCHO, V7, P203, DOI 10.1146/annurev-clinpsy-032210-104544; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bryant RA, 2005, BIOL PSYCHIAT, V58, P111, DOI 10.1016/j.biopsych.2005.03.021; Buckley TC, 2000, CLIN PSYCHOL REV, V20, P1041, DOI 10.1016/S0272-7358(99)00030-6; Buschkuehl M, 2008, PSYCHOL AGING, V23, P743, DOI 10.1037/a0014342; Callinan S, 2015, COGNITIVE THER RES, V39, P4, DOI 10.1007/s10608-014-9634-8; CONSTANS JI, 2005, NEUROPSYCHOLOGY PTSD, P00105; Crocker LD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00261; Crocker LD, 2015, ANN M ANX DEPR ASS A; Cusack K, 2016, CLIN PSYCHOL REV, V43, P128, DOI 10.1016/j.cpr.2015.10.003; Den Hartog HM, 2003, PSYCHOL MED, V33, P1443, DOI 10.1017/S003329170300833X; Diamond A, 2016, DEV COGN NEUROS-NETH, V18, P34, DOI 10.1016/j.dcn.2015.11.005; Dickinson D, 2010, AM J PSYCHIAT, V167, P170, DOI 10.1176/appi.ajp.2009.09020264; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin Amit, 2013, Dialogues Clin Neurosci, V15, P419; Falconer E, 2008, J PSYCHIATR NEUROSCI, V33, P413; Fani N, 2011, NEUROSCI LETT, V491, P196, DOI 10.1016/j.neulet.2011.01.037; Farrow TFD, 2005, PSYCHIAT RES-NEUROIM, V140, P45, DOI 10.1016/j.pscychresns.2005.05.012; Felmingham K, 2007, PSYCHOL SCI, V18, P127, DOI 10.1111/j.1467-9280.2007.01860.x; Foa E.B., 2008, EFFECTIVE TREATMENTS; GAGE PW, 1980, BRIT J PHARMACOL, V69, P119, DOI 10.1111/j.1476-5381.1980.tb10890.x; Garfinkel SN, 2009, PSYCHIAT ANN, V39, P370, DOI 10.3928/00485713-20090527-01; Geuze E, 2008, J PSYCHIATR RES, V42, P659, DOI 10.1016/j.jpsychires.2007.06.007; Grohman K, 2006, BRAIN COGNITION, V60, P203; Haaland KY, 2016, J INT NEUROPSYCH SOC, V22, P643, DOI 10.1017/S1355617716000424; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Hayes JP, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00089; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jak AJ, 2015, CONTEMP CLIN TRIALS, V45, P210, DOI 10.1016/j.cct.2015.10.009; Jenkins MA, 2000, CLIN NEUROPSYCHOL, V14, P7, DOI 10.1076/1385-4046(200002)14:1;1-8;FT007; Joormann J., 2010, EMOTION REGULATION P, P174; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Kent M, 2011, J TRAUMA STRESS, V24, P591, DOI 10.1002/jts.20685; Keshavan MS, 2014, AM J PSYCHIAT, V171, P510, DOI 10.1176/appi.ajp.2013.13081075; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Koenen KC, 2001, BRAIN COGNITION, V45, P64, DOI 10.1006/brcg.2000.1256; Kuckertz JM, 2014, BEHAV RES THER, V63, P25, DOI 10.1016/j.brat.2014.09.002; LaGarde G, 2010, PSYCHIAT RES, V177, P144, DOI 10.1016/j.psychres.2009.02.002; Lee HJ, 2001, MOL PSYCHIATR, V6, P725, DOI 10.1038/sj.mp.4000947; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Levy-Gigi E, 2013, BIOL PSYCHIAT, V74, P793, DOI 10.1016/j.biopsych.2013.05.017; Lindauer RJL, 2006, BIOL PSYCHIAT, V59, P171, DOI 10.1016/j.biopsych.2005.06.033; Lindauer RJL, 2005, PSYCHOL MED, V35, P1421, DOI 10.1017/S0033291705005246; Marazziti D, 2010, EUR J PHARMACOL, V626, P83, DOI 10.1016/j.ejphar.2009.08.046; Mathews A, 2002, COGNITION EMOTION, V16, P331, DOI 10.1080/02699930143000518; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McNally RJ, 2007, CLIN PSYCHOL REV, V27, P750, DOI 10.1016/j.cpr.2007.01.003; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Merzenich MM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00385; Moores KA, 2008, PSYCHIAT RES-NEUROIM, V163, P156, DOI 10.1016/j.pscychresns.2007.08.011; Morey RA, 2009, J PSYCHIATR RES, V43, P809, DOI 10.1016/j.jpsychires.2008.10.014; Nassif Y, 2014, J CLIN PSYCHOL, V70, P510, DOI 10.1002/jclp.22047; Neylan TC, 2004, J TRAUMA STRESS, V17, P41, DOI 10.1023/B:JOTS.0000014675.75686.ee; Nijdam MJ, 2015, J CLIN PSYCHIAT, V76, pE1023, DOI 10.4088/JCP.14m09438; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Parslow RA, 2007, AM J PSYCHIAT, V164, P509, DOI 10.1176/appi.ajp.164.3.509; Peres JFP, 2011, J PSYCHIATR RES, V45, P727, DOI 10.1016/j.jpsychires.2010.11.004; Pineles SL, 2007, BEHAV RES THER, V45, P1903, DOI 10.1016/j.brat.2006.08.021; Pineles SL, 2009, BEHAV RES THER, V47, P1050, DOI 10.1016/j.brat.2009.08.001; Polak AR, 2012, J AFFECT DISORDERS, V141, P11, DOI 10.1016/j.jad.2012.01.001; Puetz TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126529; Ravindran LN, 2009, BRAIN RES, V1293, P24, DOI 10.1016/j.brainres.2009.03.037; Resick PA, 2008, J CONSULT CLIN PSYCH, V76, P243, DOI 10.1037/0022-006X.76.2.243; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Riemann BC, 2013, DEPRESS ANXIETY, V30, P822, DOI 10.1002/da.22127; Roy MJ, 2010, ANN NY ACAD SCI, V1208, P142, DOI 10.1111/j.1749-6632.2010.05689.x; Sailer U, 2008, NEUROPSYCHOLOGIA, V46, P2836, DOI 10.1016/j.neuropsychologia.2008.05.022; Salminen T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00166; Samuelson KW, 2006, NEUROPSYCHOLOGY, V20, P716, DOI 10.1037/0894-4105.20.6.716; Samuelson Kristin W, 2011, Dialogues Clin Neurosci, V13, P346; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schoorl M, 2013, PSYCHOTHER PSYCHOSOM, V82, P99, DOI 10.1159/000341920; Schweizer S, 2013, J NEUROSCI, V33, P5301, DOI 10.1523/JNEUROSCI.2593-12.2013; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Seedat S, 2004, J AFFECT DISORDERS, V80, P45, DOI 10.1016/S0165-0327(03)00047-8; Shin LM, 2004, HIPPOCAMPUS, V14, P292, DOI 10.1002/hipo.10183; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Shucard JL, 2008, BIOL PSYCHOL, V79, P223, DOI 10.1016/j.biopsycho.2008.05.005; Siegle GJ, 2007, COGNITIVE THER RES, V31, P235, DOI 10.1007/s10608-006-9118-6; Simmons AN, 2013, PSYCHOTHER PSYCHOSOM, V82, P382, DOI 10.1159/000348867; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Steckler T, 2012, NEUROPHARMACOLOGY, V62, P617, DOI 10.1016/j.neuropharm.2011.06.012; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Stillman A. N., 2015, NEUROANATOMICAL CORR; Takeuchi H, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00200; Thomaes K, 2012, PSYCHOL MED, V42, P2337, DOI 10.1017/S0033291712000499; Thomaes K, 2014, J PSYCHIATR RES, V50, P1, DOI 10.1016/j.jpsychires.2013.11.002; Tsourtos G, 2002, PSYCHOL MED, V32, P259, DOI 10.1017/S0033291701005001; Tucker P, 2001, J CLIN PSYCHIAT, V62, P860, DOI 10.4088/JCP.v62n1105; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Usui N, 2009, NEUROSCI LETT, V463, P1, DOI 10.1016/j.neulet.2009.07.048; van Rooij SJH, 2015, PSYCHOL MED, V45, P2737, DOI 10.1017/S0033291715000707; van Rooij SJH, 2016, NEUROPSYCHOPHARMACOL, V41, P1156, DOI 10.1038/npp.2015.257; van Rooij SJH, 2015, NEUROPSYCHOPHARMACOL, V40, P667, DOI 10.1038/npp.2014.220; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Verfaellie M, 2012, PTSD MILD TRAUMATIC, P82; Vermetten E, 2003, BIOL PSYCHIAT, V54, P693, DOI 10.1016/S0006-3223(03)00634-6; Verwoerd J, 2009, J BEHAV THER EXP PSY, V40, P189, DOI 10.1016/j.jbtep.2008.08.002; Vinogradov S, 2012, NEUROPSYCHOPHARMACOL, V37, P43, DOI 10.1038/npp.2011.251; Vythilingam M, 2005, PSYCHIAT RES-NEUROIM, V139, P89, DOI 10.1016/j.pscychresns.2005.04.003; Walter KH, 2010, J TRAUMA STRESS, V23, P292, DOI 10.1002/jts.20506; WATANABE Y, 1992, HIPPOCAMPUS, V2, P431, DOI 10.1002/hipo.450020410; Wild J, 2008, BRIT J PSYCHIAT, V193, P254, DOI 10.1192/bjp.bp.107.045922; Wilson EJ, 2006, J ABNORM PSYCHOL, V115, P103, DOI 10.1037/0021-843X.115.1.103; Woodward SH, 2009, J INT NEUROPSYCH SOC, V15, P830, DOI 10.1017/S1355617709990476; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016; Wu JH, 2010, NEUROSCI LETT, V486, P117, DOI 10.1016/j.neulet.2010.07.040; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; Zantvoord JB, 2013, PSYCHOTHER PSYCHOSOM, V82, P142, DOI 10.1159/000343258	136	8	8	2	5	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	1866-3370		978-3-319-94824-9; 978-3-319-94823-2	CURR TOP BEHAV NEURO	Cur. Top. Behav. Neurosci.		2018	38						93	116		10.1007/7854_2016_62	10.1007/978-3-319-94824-9		24	Psychology, Biological; Behavioral Sciences; Neurosciences; Psychiatry	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Behavioral Sciences; Neurosciences & Neurology; Psychiatry	BN6WM	WOS:000486443500006	28025811	hybrid			2022-02-06	
J	Jurick, SM; Hoffman, SN; Sorg, S; Keller, AV; Evangelista, ND; DeFord, NE; Sanderson-Cimino, M; Bangen, KJ; Delano-Wood, L; Deoni, S; Jak, AJ				Jurick, Sarah M.; Hoffman, Samantha N.; Sorg, Scott; Keller, Amber V.; Evangelista, Nicole D.; DeFord, Nicole E.; Sanderson-Cimino, Mark; Bangen, Katherine J.; Delano-Wood, Lisa; Deoni, Sean; Jak, Amy J.			Pilot investigation of a novel white matter imaging technique in Veterans with and without history of mild traumatic brain injury	BRAIN INJURY			English	Article						Concussion; myelin; cognition; processing speed	AMYLOID PRECURSOR PROTEIN; CLOSED-HEAD-INJURY; AXONAL INJURY; MULTIPLE-SCLEROSIS; PROCESSING SPEED; TRACK-TBI; DAMAGE; RATS; METAANALYSIS; CONCUSSION	Objective: The objective of this study is to assess utility of in vivo myelin imaging in combat Veterans with and without history of mild traumatic brain injury (mTBI). We hypothesized that those with history of mTBI would have lower myelin water fraction (MWF), a marker of myelin integrity and content, than those without, and lower MWF would be associated with worse speeded attention/processing speed.Research design: Combat Veterans (N=70) with (n=42) and without history of mTBI (n=28) underwent neuroimaging including a novel myelin-sensitive magnetic resonance imaging technique (multicomponent-driven equilibrium single-pulse observation of T1/T2; mcDESPOT) and comprehensive neuropsychological assessment.Results: There were no group differences in MWF using a region-of-interest approach. An exploratory analysis applying limited spatial constraints, however, revealed significantly more potholes' (clusters of low MWF) in Veterans with history of mTBI compared to those without. Lower MWF across several ROIs was associated with worse performance on a speeded attention task across groups.Conclusion: Veterans in the post-acute period following mTBI showed limited and spatially heterogeneous MWF changes and myelin integrity was significantly related to processing speed. This preliminary evidence for usefulness of mcDESPOT in combat Veterans with history of mTBI warrants future research to determine mcDESPOT's relative utility compared to techniques such as diffusion tensor imaging.	[Jurick, Sarah M.; Sanderson-Cimino, Mark] San Diego State Univ Univ Calif San Diego Joint D, San Diego, CA 92120 USA; [Hoffman, Samantha N.; Sorg, Scott; Keller, Amber V.; Evangelista, Nicole D.; DeFord, Nicole E.; Bangen, Katherine J.; Delano-Wood, Lisa; Jak, Amy J.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Sorg, Scott; Bangen, Katherine J.; Delano-Wood, Lisa; Jak, Amy J.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Deoni, Sean] Brown Univ, Dept Psychiat, Providence, RI 02912 USA		Jurick, SM (corresponding author), San Diego State Univ Univ Calif San Diego Joint D, San Diego, CA 92120 USA.	smjurick@gmail.com		Keller, Amber/0000-0002-2972-784X; Hoffman, Samantha/0000-0002-2792-8576; Sanderson-Cimino, Mark/0000-0002-5872-3186	RRD VA [I01 RX002076] Funding Source: Medline; Veterans AffairsUS Department of Veterans Affairs [I01RX002076] Funding Source: NIH RePORTER		Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Benarroch EE, 2009, NEUROLOGY, V72, P1779, DOI 10.1212/WNL.0b013e3181a6b123; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chopra S, 2018, NEUROIMAGE, V171, P332, DOI 10.1016/j.neuroimage.2017.12.069; Crawford MA, 2007, J INT NEUROPSYCH SOC, V13, P178, DOI 10.1017/S135561770707021X; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dean DC, 2015, BRAIN STRUCT FUNCT, V220, P1921, DOI 10.1007/s00429-014-0763-3; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Delis D.C., 2000, CALIFORNIA VERBAL LE; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; Deoni SCL, 2013, NEUROIMAGE, V82, P77, DOI 10.1016/j.neuroimage.2013.05.090; Deoni SCL, 2011, MAGN RESON MED, V65, P1021, DOI 10.1002/mrm.22685; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Isaac L, 2015, BIOL PSYCHOL, V105, P20, DOI 10.1016/j.biopsycho.2014.12.011; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Karr JE, 2014, J CLIN EXP NEUROPSYC, V36, P15, DOI 10.1080/13803395.2013.863833; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kitzler HH, 2012, NEUROIMAGE, V59, P2670, DOI 10.1016/j.neuroimage.2011.08.052; Kolind S, 2013, AMYOTROPH LAT SCL FR, V14, P562, DOI 10.3109/21678421.2013.794843; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Lu PH, 2013, BRAIN COGNITION, V81, P131, DOI 10.1016/j.bandc.2012.09.006; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Norton WT, 1984, MYELIN, V2nd, P147; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Riccitelli G.C., 2017, MULTIPLE SCLEROSIS J; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sheehan DV., 2014, MINI INT NEUROPSYCHI; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sojkova J, 2015, ALTERATIONS MYELIN C, V11, pP87; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Spader HS, PROSPECTIVE STUDY MY; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Taber Katherine H, 2013, J Neuropsychiatry Clin Neurosci, V25, P1, DOI 10.1176/appi.neuropsych.12120401; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tong LL, 2015, NEUROREPORT, V26, P429, DOI 10.1097/WNR.0000000000000366; Tsunoda I, 2002, SPRINGER SEMIN IMMUN, V24, P105, DOI 10.1007/s00281-002-0105-z; VA/DoD, 2016, VA DOD CLIN PRACT GU; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Weathers F., 2013, CLINICIAN ADMINISTER; Wechsler, 2008, WAIS 4 ADM SCORING M; White T, 2009, PSYCHIAT RES-NEUROIM, V174, P110, DOI 10.1016/j.pscychresns.2009.04.014; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	81	8	8	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	10			SI		1256	1265		10.1080/02699052.2018.1493225			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GS6YO	WOS:000443846200012	30169992				2022-02-06	
S	Kawata, K; Tierney, R; Langford, D		Hainline, B; Stern, RA		Kawata, Keisuke; Tierney, Ryan; Langford, Dianne			Blood and cerebrospinal fluid biomarkers	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE-L1; DIFFUSE AXONAL INJURY; TAU-PROTEIN; NEUROFILAMENT LIGHT; S100B PROTEIN; NEUROCHEMICAL AFTERMATH; COMPUTED-TOMOGRAPHY; ALZHEIMERS-DISEASE	Sports-related traumatic brain injuries (TBIs) range in severity from severe to subconcussive. Although technologies exist for clinical diagnosis of more severe injuries, methods for diagnosis of milder forms of brain injury are limited. Developing objective measures to indicate pathogenic processes after a suspected mild TBI is challenging for multiple reasons. The field of biomarker discovery for diagnosing TBI continues to expand, with newly identified candidate biomarkers being reported regularly. Brain-specific biomarkers include proteins derived from neurons and glia, and are often measured to assess neural injury and repair, and to predict outcomes. Ideally, changes in biomarker levels should indicate pathologic events and answer critical questions for accurate diagnosis and prognosis. For example, does the presence or a change in the biomarker level suggest greater vulnerability for sustaining a second concussion or show that the window of increased vulnerability has passed? Likewise, do changes in biomarker levels predict postconcussion syndrome or recovery/repair? Although there are numerous promising candidates for fluid biomarkers that may diagnose mild TBI or concussion, none has reached the clinic to date. In this chapter, we will define biomarkers, discuss the importance of understanding their normal and pathologic functions, and outline some considerations for interpreting detection assay results in TBI. We will then review five proposed blood and cerebrospinal fluid biomarkers (tau, neurofilament, ubiquitin carboxyl-terminal hydrolase L1, S100 beta, and glial fibrillary acidic protein) used currently to address TBI. Lastly, we will discuss a future trajectory for developing new, clinically useful fluid biomarkers.	[Kawata, Keisuke] Indiana Univ, Dept Kinesiol, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA; [Tierney, Ryan] Temple Univ, Coll Publ Hlth, Dept Kinesiol, Philadelphia, PA 19122 USA; [Langford, Dianne] Temple Univ, Lewis Katz Sch Med, Dept Neurosci, MERB 750,3500 North Broad St, Philadelphia, PA 19140 USA		Langford, D (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Neurosci, MERB 750,3500 North Broad St, Philadelphia, PA 19140 USA.	tdl@temple.edu					Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; BAUDIER J, 1988, J BIOL CHEM, V263, P5876; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; BAUDIER J, 1987, BIOCHEMISTRY-US, V26, P2886, DOI 10.1021/bi00384a033; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Carpenter KLH, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00026; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Chesser AS, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00122; Cserr H F, 1988, Ann N Y Acad Sci, V529, P9, DOI 10.1111/j.1749-6632.1988.tb51415.x; da Silva DR, 2008, RENAL FAILURE, V30, P175, DOI 10.1080/08860220701810307; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Di Pietro V, 2015, NEUROCHEM RES, V40, P991, DOI 10.1007/s11064-015-1554-9; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Diaz-Romero J, 2014, J CELL PHYSIOL, V229, P1106, DOI 10.1002/jcp.24547; Dietrich MO, 2003, CAN J APPL PHYSIOL, V28, P710, DOI 10.1139/h03-054; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; DORAN JF, 1983, J NEUROCHEM, V40, P1542, DOI 10.1111/j.1471-4159.1983.tb08124.x; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Ellis EF, 2007, J NEUROCHEM, V101, P1463, DOI 10.1111/j.1471-4159.2007.04515.x; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Esposito G, 2008, J CELL MOL MED, V12, P914, DOI 10.1111/j.1582-4934.2008.00159.x; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; FUJII T, 1986, CHEM PHARM BULL, V34, P5040; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; GhersiEgea JF, 1996, NEUROSCIENCE, V75, P1271, DOI 10.1016/0306-4522(96)00281-3; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Gisslen M, 2007, J NEUROIMMUNE PHARM, V2, P112, DOI 10.1007/s11481-006-9035-1; GOEDERT M, 1992, P NATL ACAD SCI USA, V89, P1983, DOI 10.1073/pnas.89.5.1983; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goldstein L.E., 2012, SCI TRANSL MED, V4; Goncalves C.A., 2010, CARDIOVASC PSYCHIAT, V2010, DOI [DOI 10.1155/2010/790431, 10.1155/2010/790431]; Gong B, 2007, DRUG NEWS PERSPECT, V20, P365, DOI 10.1358/dnp.2007.20.6.1138160; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Gu YJ, 1996, J NEUROCHEM, V67, P1235; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Hearst SM, 2011, NEUROSCIENCE, V197, P369, DOI 10.1016/j.neuroscience.2011.09.025; Heye AK, 2014, NEUROIMAGE-CLIN, V6, P262, DOI 10.1016/j.nicl.2014.09.002; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kawata K, 2018, J NEUROTRAUM, V35, P260, DOI 10.1089/neu.2017.5376; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Lin J, 2004, J BIOL CHEM, V279, P34071, DOI 10.1074/jbc.M405419200; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; LUBKE U, 1994, AM J PATHOL, V145, P175; Lucke-Wold BP, 2015, NEUROSCI BIOBEHAV R, V55, P68, DOI 10.1016/j.neubiorev.2015.04.010; Ma M, 2008, AM J EMERG MED, V26, P763, DOI 10.1016/j.ajem.2007.10.029; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; Mercier E, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017848; Missler U, 1999, CLIN CHEM, V45, P138; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mrak RE, 1996, J NEUROPATH EXP NEUR, V55, P273, DOI 10.1097/00005072-199603000-00002; Myzithras M, 2016, BIOANALYSIS, V8, P511, DOI 10.4155/bio.16.17; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Oliver JM, 2017, J NEUROTRAUM, V34, P3295, DOI 10.1089/neu.2017.5064; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Patel AV, 2007, J ATHL TRAINING, V42, P66; Peskind ER, 2015, JAMA NEUROL, V72, P1103, DOI 10.1001/jamaneurol.2015.1789; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Proescholdt MG, 2000, NEUROSCIENCE, V95, P577; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Rennels M L, 1990, Adv Neurol, V52, P431; Rhine T, 2016, BRAIN INJURY, V30, P1231, DOI 10.1080/02699052.2016.1178396; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Sharma R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173798; SHENG JG, 1994, J NEUROSCI RES, V39, P398, DOI 10.1002/jnr.490390406; Sheng JG, 2000, J NEUROCHEM, V74, P295, DOI 10.1046/j.1471-4159.2000.0740295.x; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Terwel D, 2002, NEUROMOL MED, V2, P151, DOI 10.1385/NMM:2:2:151; Tongaonkar P, 2000, MOL CELL BIOL, V20, P4691, DOI 10.1128/MCB.20.13.4691-4698.2000; Tortelli R, 2012, EUR J NEUROL, V19, P1561, DOI 10.1111/j.1468-1331.2012.03777.x; Tyler CJ, 2010, EUR J APPL PHYSIOL, V110, P1063, DOI 10.1007/s00421-010-1567-7; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; VANELDIK LJ, 1994, BBA-MOL CELL RES, V1223, P398, DOI 10.1016/0167-4889(94)90101-5; Vella LJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020173; Volman V, 2013, NEURAL COMPUT, V25, P2646, DOI 10.1162/NECO_a_00491; Wang YP, 2010, BIOCHEM SOC T, V38, P955, DOI 10.1042/BST0380955; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Welch RD, 2017, J NEUROTRAUM, V34, P1957, DOI 10.1089/neu.2016.4772; Whitaker-Azmitia PM., 2010, CARDIOVASC PSYCHIAT, V2010; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Winter C, 2015, NEUROL RES, V37, P599, DOI 10.1179/1743132815Y.0000000018; Wu DL, 2015, ANALYST, V140, P6277, DOI 10.1039/c5an01238d; Xiao TT, 2017, TRANSL NEURODEGENER, V6, DOI [10.1186/s40035-017-0072-x, 10.1186/s40035-017-0081-9]; Yu WH, 2001, J NEUROSCI, V21, P2240, DOI 10.1523/JNEUROSCI.21-07-02240.2001; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	153	8	8	0	1	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						217	233		10.1016/B978-0-444-63954-7.00022-7			17	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100024	30482350				2022-02-06	
J	Laffey, M; Darby, AJ; Cline, MG; Teng, E; Mendez, MF				Laffey, Megan; Darby, Adam J.; Cline, Michael G.; Teng, Edmond; Mendez, Mario F.			The utility of clinical criteria in patients with chronic traumatic encephalopathy	NEUROREHABILITATION			English	Article						Chronic traumatic encephalopathy; traumatic brain injury; dementia	BRAIN-INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; DEMENTIA; TAUOPATHY; ONSET; RISK; NEUROPATHOLOGY; CONCUSSION; DIAGNOSIS	BACKGROUND: Repetitive traumatic brain injury (TBI) is associated with chronic traumatic encephalopathy (CTE), a progressive neurodegenerative disorder characterized by Alzheimer-like changes in the brain. CTE has been defined through neuropathological findings among deceased athletes and others exposed to repetitive TBI, but to date there are no definitive clinical criteria for CTE. OBJECTIVE: To evaluate the utility of currently proposed clinical criteria for CTE and suggest improvements. METHODS: We describe two well-characterized patients referred for evaluation of CTE and apply the four major proposed criteria for CTE. These criteria were further assessed in a cohort of patients referred to a neurobehavior clinic with or without a history of TBI. RESULTS: Without a CTE biomarker, the current criteria were of limited utility when applied to the two patient and the Neurobehavior cohort. Six items were extracted as potentially improving the clinical diagnosis of CTE: length of exposure to head impacts, a progressive course, specific psychiatric symptoms, frontal-executive dysfunction, parkinsonism and tremors, and targeted findings on neuroimaging. CONCLUSIONS: The prevention and neurorehabilitation of CTE depends on clinical diagnosis, but, without a biomarker, the clinical diagnosis of CTE remains difficult. This report suggests that clinical criteria for CTE may be greatly improved with emphasis on several critical historical and clinical correlates of CTE.	[Darby, Adam J.; Cline, Michael G.; Mendez, Mario F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Laffey, Megan; Mendez, Mario F.] VA Greater Angeles Healthcare Syst, Neurobehav Unit, Los Angeles, CA USA; [Teng, Edmond] Stanford Univ, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA		Mendez, MF (corresponding author), VA Greater Angeles Hlth Care Ctr, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	mmendez@ucla.edu			NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG050967]	NIA R01AG050967.	Affairs Department of Veterans, 2013, PROJ PREV INC DEM IN; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; BOGDANOFF B, 1989, NEUROLOGY, V39, P991, DOI 10.1212/WNL.39.7.991; Cabanis E A, 1986, Acta Radiol Suppl, V369, P365; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dickstein DL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.175; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gardner RC, 2014, ANN NEUROL, V75, P339, DOI 10.1002/ana.24121; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; KASTE M, 1982, LANCET, V2, P1186; Lakis N, 2013, NEUROL RES, V35, P290, DOI 10.1179/1743132813Y.0000000177; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; LEVIN HS, 1987, J NEUROSURG, V67, P657, DOI 10.3171/jns.1987.67.5.0657; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; MACPHERSON P, 1988, NEURORADIOLOGY, V30, P506, DOI 10.1007/BF00339691; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	48	8	8	1	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	43	4					431	441		10.3233/NRE-182452			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HM5XL	WOS:000459548500008	30412511				2022-02-06	
J	Liu, H; He, JC; Zhong, JJ; Zhang, HR; Zhang, ZS; Liu, L; Huang, ZJ; Wu, Y; Jiang, L; Guo, ZD; Xu, R; Chai, WN; Huo, G; Sun, XC; Cheng, CJ				Liu, Han; He, Junchi; Zhong, Jianjun; Zhang, Hongrong; Zhang, Zhaosi; Liu, Liu; Huang, Zhijian; Wu, Yue; Jiang, Li; Guo, Zongduo; Xu, Rui; Chai, Weina; Huo, Gang; Sun, Xiaochuan; Cheng, Chongjie			Clinical and Basic Evaluation of the Prognostic Value of Uric Acid in Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MEDICAL SCIENCES			English	Article						UA (uric acid); oxidative stress; inflammation; traumatic brain injury	ACUTE ISCHEMIC-STROKE; OXIDATIVE STRESS; NEURONAL MAINTENANCE; CEREBROVASCULAR-DISEASE; FUNCTIONAL RECOVERY; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; RAT MODEL; IN-VIVO; IMPROVES	Background: As a major antioxidant in serum, uric acid (UA) was once considered only as the leading cause of gout; however, recent studies have validated its neuroprotective role in ischemic stroke. Because the potential protective effects of UA in traumatic brain injury (TBI) remain largely unknown, this study investigated the role of UA in TBI in both clinical patients and experimental animals. Methods: In TBI patients, serum UA concentrations were measured within 3 days after injury. Clinical outcomes at discharge were classified according to the Glasgow Outcome Scale: good outcome (4-5) and poor outcome (1-3). Risk factors for good outcome were identified via backward logistic regression analysis. For the animal study, a controlled cortical impact (CCI) injury model was established in mice. These mice were given UA at different doses intraperitoneally, and subsequent UA concentrations in mouse serum and brain tissue were determined. Neurological function, oxidative stress, inflammatory response, neuronal maintenance, cerebral blood flow, and lesion size were also assessed. Results: The serum UA level was significantly lower in TBI patients who had a good outcome (P<0.01), and low serum UA was an independent predictor of good outcome after TBI (P<0.01; odds ratio, 0.023; 95% confidence interval, 0.006-0.082). Consistently, decreased levels of serum UA were observed in both TBI patients and CCI animals (P<0.05), whereas the UA concentration was increased in CCI brain tissue (P<0.05). Administration of UA further increased the UA level in brain tissue as compared to that in control animals (P<0.05). Among the different doses administered, 16 mg/10.05). Conclusions: UA acted to attenuate neuronal loss, cerebral perfusion impairment and neurological deficits in TBI mice through suppression of neuronal and vascular oxidative stress. Following TBI, active antioxidant defense in the brain may result in consumption of UA in the serum, and thus, a decreased serum UA level could be predictive of good clinical recovery.	[Liu, Han; He, Junchi; Zhong, Jianjun; Zhang, Hongrong; Zhang, Zhaosi; Liu, Liu; Huang, Zhijian; Wu, Yue; Jiang, Li; Guo, Zongduo; Xu, Rui; Chai, Weina; Huo, Gang; Sun, Xiaochuan; Cheng, Chongjie] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China		Sun, XC; Cheng, CJ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China.	sunxch1445@qq.com; 358187887@qq.com	He, Junchi/AAD-8482-2019	Zhang, Zhaosi/0000-0002-4988-501X; Huang, Zhijian/0000-0002-8241-0761; sun, xiao chuan/0000-0001-6992-332X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571159]; National Natural Science Foundation for Youth of ChinaNational Natural Science Foundation of China (NSFC) [81601072, 81701226]; National Construction Project for Clinical Key Specialty [(2011)170]	This work was supported by the National Natural Science Foundation of China (No. 81571159), National Natural Science Foundation for Youth of China (No. 81601072 and No. 81701226), and National Construction Project for Clinical Key Specialty (No. (2011)170). The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. In addition, we'd like to thank Rami M. Z. Darwazeh for English proofreading.	Ali YO, 2013, TRENDS NEUROSCI, V36, P632, DOI 10.1016/j.tins.2013.07.002; Amaro S, 2015, ANN NEUROL, V77, P775, DOI 10.1002/ana.24378; Chamorro A, 2002, STROKE, V33, P1048, DOI 10.1161/hs0402.105927; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Chamorro A, 2014, LANCET NEUROL, V13, P453, DOI 10.1016/S1474-4422(14)70054-7; Chen XQ, 2013, P NATL ACAD SCI USA, V110, P300, DOI 10.1073/pnas.1217296110; Chrissobolis S, 2011, FRONT BIOSCI-LANDMRK, V16, P1733, DOI 10.2741/3816; Chrissobolis S, 2008, TRENDS MOL MED, V14, P495, DOI 10.1016/j.molmed.2008.09.003; Dachir S, 2014, BRAIN RES, V1555, P78, DOI 10.1016/j.brainres.2014.01.044; Delbary-Gossart S, 2016, BRAIN, V139, P1762, DOI 10.1093/brain/aww074; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Guerreiro S, 2009, J NEUROCHEM, V109, P1118, DOI 10.1111/j.1471-4159.2009.06040.x; Hoda Md Nasrul, 2014, Exp Transl Stroke Med, V6, P10, DOI 10.1186/2040-7378-6-10; Hoffmeister C, 2011, PAIN, V152, P1777, DOI 10.1016/j.pain.2011.03.025; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; Huang ZJ, 2016, J NEUROCHEM, V136, P1017, DOI 10.1111/jnc.13491; Jiang Y, 2012, J NEUROTRAUM, V29, P2332, DOI 10.1089/neu.2012.2362; Jin M, 2012, FRONT BIOSCI-LANDMRK, V17, P656, DOI 10.2741/3950; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Johnson RJ, 2009, J COMP PHYSIOL B, V179, P67, DOI 10.1007/s00360-008-0291-7; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kim D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081948; Kolz M, 2009, PLOS GENET, V5; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Llull L, 2015, STROKE, V46, P2162, DOI 10.1161/STROKEAHA.115.009960; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lu WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12144; Mao LL, 2017, BRAIN, V140, P1914, DOI 10.1093/brain/awx111; Milionis HJ, 2005, J INTERN MED, V258, P435, DOI 10.1111/j.1365-2796.2005.01565.x; Mills EJ, 2015, CONTEMP CLIN TRIALS, V45, P2, DOI 10.1016/j.cct.2015.07.019; Moor E, 2006, EXP GERONTOL, V41, P303, DOI 10.1016/j.exger.2005.12.006; Onetti Y, 2015, AM J PHYSIOL-HEART C, V308, pH862, DOI 10.1152/ajpheart.00001.2015; Park L, 2011, P NATL ACAD SCI USA, V108, P5063, DOI 10.1073/pnas.1015413108; Park MH, 2016, PHARMACOL THERAPEUT, V163, P1, DOI 10.1016/j.pharmthera.2016.03.018; Park UJ, 2011, ACTA NEUROPATHOL, V121, P459, DOI 10.1007/s00401-010-0785-8; Petkus V, 2017, J CRIT CARE, V41, P49, DOI 10.1016/j.jcrc.2017.04.029; Rock KL, 2013, NAT REV RHEUMATOL, V9, P13, DOI 10.1038/nrrheum.2012.143; Romanos E, 2007, J CEREBR BLOOD F MET, V27, P14, DOI 10.1038/sj.jcbfm.9600312; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Sochocka M, 2013, CNS NEUROL DISORD-DR, V12, P870, DOI 10.2174/18715273113129990072; Spasic MR, 2008, J NEUROSCI, V28, P6419, DOI 10.1523/JNEUROSCI.1646-08.2008; Spitsin SV, 2002, FREE RADICAL BIO MED, V33, P1363, DOI 10.1016/S0891-5849(02)01048-1; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Toda N, 2016, J PHARMACOL SCI, V131, P223, DOI 10.1016/j.jphs.2016.07.001; Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278; Wang D, 2013, CELL MOL LIFE SCI, V70, P2919, DOI 10.1007/s00018-012-1201-4; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wu HL, 2014, J STROKE CEREBROVASC, V23, P469, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.007; Yang SG, 2012, J NEUROTRAUM, V29, P2696, DOI 10.1089/neu.2012.2442; Yin Y, 2013, FRONT BIOSCI-LANDMRK, V18, P638, DOI 10.2741/4127; Yu ZF, 1998, J NEUROSCI RES, V53, P613, DOI 10.1002/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1; Zemmar A, 2014, J NEUROSCI, V34, P8685, DOI 10.1523/JNEUROSCI.3817-13.2014; Zhao ZR, 2013, J CEREBR BLOOD F MET, V33, P1897, DOI 10.1038/jcbfm.2013.144; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhou Y, 2010, AM J PHYSIOL-RENAL, V299, pF336, DOI 10.1152/ajprenal.00053.2010; Zhuang JL, 2015, GENE, V555, P150, DOI 10.1016/j.gene.2014.10.056; Zuo W, 2014, EUR J NEUROSCI, V39, P2107, DOI 10.1111/ejn.12551	57	8	9	1	4	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1449-1907			INT J MED SCI	Int. J. Med. Sci.		2018	15	10					1072	1082		10.7150/ijms.25799			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM6IO	WOS:000438269500014	30013449	Green Published, Green Submitted, gold			2022-02-06	
J	Lloyd, O; Ownsworth, T; Fleming, J; Zimmer-Gembeck, MJ				Lloyd, Owen; Ownsworth, Tamara; Fleming, Jennifer; Zimmer-Gembeck, Melanie J.			Development and preliminary validation of the Paediatric Awareness Questionnaire for children and adolescents with traumatic brain injury	CHILD NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; awareness; cognition; metacognition; children; adolescents	QUALITY-OF-LIFE; SELF-AWARENESS; IMPAIRED AWARENESS; DEFICITS; OUTCOMES; REHABILITATION; CHILDHOOD; TERM; PREDICTORS; KNOWLEDGE	There is a lack of validated measures for assessing self-awareness of deficits after pediatric traumatic brain injury (TBI). The current study aimed to develop and examine the psychometric properties of the Paediatric Awareness Questionnaire (PAQ), and investigate factors related to self-awareness. The PAQ was administered to 32 children aged 8-16years with mild to severe TBI (72% male, M age=11.75, SD=2.9), their parents, and treating clinicians, and to 32 age- and gender-matched typically developing controls and their parents. Children with TBI and their parents also completed the Knowledge of Injury Checklist (KIC), and parents completed the Depression Anxiety and Stress Scale 21. The PAQ was found to have fair to excellent (=.79-.97) internal consistency for all versions across both groups and good concordance between parent and clinician total scores (ICC=.78). There was also evidence of convergent validity between the PAQ and KIC for both child (r=-.45, p<.05) and parent ratings (r=-.66, p<.001). Poorer self-awareness was significantly related to younger age at injury for the TBI group and lower parental education for the total sample. ANCOVA identified that children with TBI demonstrated significantly poorer awareness than controls after controlling for parental education. Children with TBI typically overestimated their functioning compared to their parents, whereas typically developing children tended to rate their functioning lower than their parents. These findings provide preliminary support for the reliability and validity of the PAQ for assessing self-awareness after pediatric TBI.	[Lloyd, Owen; Ownsworth, Tamara] Griffith Univ, Sch Appl Psychol, Brisbane, Qld, Australia; [Lloyd, Owen; Ownsworth, Tamara] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia; [Lloyd, Owen] Childrens Hlth Queensland, Lady Cilento Childrens Hosp, Queensland Paediat Rehabil Serv, Brisbane, Qld, Australia; [Lloyd, Owen] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld, Australia; [Zimmer-Gembeck, Melanie J.] Griffith Univ, Sch Appl Psychol, Southport, Qld, Australia; [Zimmer-Gembeck, Melanie J.] Griffith Univ, Menzies Hlth Inst Queensland, Southport, Qld, Australia		Lloyd, O (corresponding author), Childrens Hlth Queensland, Queensland Paediat Rehabil Serv, Lady Cilento Childrens Hosp, Stanley St, South Brisbane, Qld 4101, Australia.	owen.lloyd@griffithuni.edu.au	Ownsworth, Tamara/ABB-6961-2021; Zimmer-Gembeck, Melanie/H-3031-2015	Ownsworth, Tamara/0000-0003-1835-7094; Zimmer-Gembeck, Melanie/0000-0001-9100-010X; Fleming, Jennifer/0000-0002-5603-2410			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Anderson VA, 2014, DEV MED CHILD NEUROL, V56, P329, DOI 10.1111/dmcn.12387; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Cohen J., 2013, STAT POWER ANAL BEHA; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Damon W, 1988, SELF UNDERSTANDING C; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; Geurten M, 2016, CLIN NEUROPSYCHOL, V30, P558, DOI 10.1080/13854046.2016.1178331; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Harter S., 2012, HDB SELF IDENTITY, P680; Hufford BJ, 2005, J CLIN EXP NEUROPSYC, V27, P255, DOI 10.1080/13803390490515478; Katz Noomi, 2002, Can J Occup Ther, V69, P281; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Kincaid J. P., 1975, DERIVATION NEW READA, P8; Krasny-Pacini A, 2015, DISABIL REHABIL, V37, P2092, DOI 10.3109/09638288.2014.998783; Laird RD, 2013, J ABNORM CHILD PSYCH, V41, P1, DOI 10.1007/s10802-012-9659-y; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lloyd O, 2015, J HEAD TRAUMA REHAB, V30, P311, DOI 10.1097/HTR.0000000000000113; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Malouf T, 2014, BRAIN INJURY, V28, P1523, DOI 10.3109/02699052.2014.922700; Markova IS, 2006, NEUROPSYCHOL REHABIL, V16, P439, DOI 10.1080/09602010500373396; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; Potter D, 2013, SOC SCI RES, V42, P446, DOI 10.1016/j.ssresearch.2012.09.009; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Richardson C, 2015, J HEAD TRAUMA REHAB, V30, pE43, DOI 10.1097/HTR.0000000000000048; Richardson C, 2014, BRAIN INJURY, V28, P1711, DOI 10.3109/02699052.2014.954270; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; SIMPSON D, 1982, LANCET, V2, P450; Tabachnick B.G., 2013, USING MULTIVARIATE S; Tate RL, 2010, COMPENDIUM TESTS SCA; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wales L, 2013, BRIT J OCCUP THER, V76, P325, DOI 10.4276/030802213X13729279115013; Weiss L. G., 2016, WISC 5 ASSESSMENT IN; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Wolfe KR, 2015, J PEDIATR PSYCHOL, V40, P272, DOI 10.1093/jpepsy/jsu060; Yeates K. O., 2009, PEDIAT NEUROPSYCHOLO, P112; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	69	8	8	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2018	24	5					702	722		10.1080/09297049.2017.1332173			21	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GE9CN	WOS:000431527600008	28532235				2022-02-06	
J	Martin, S; Armstrong, E; Thomson, E; Vargiu, E; Sola, M; Dauwalder, S; Miralles, F; Lynn, JD				Martin, Suzanne; Armstrong, Elaine; Thomson, Eileen; Vargiu, Eloisa; Sola, Marc; Dauwalder, Stefan; Miralles, Felip; Lynn, Jean Daly			A qualitative study adopting a user-centered approach to design and validate a brain computer interface for cognitive rehabilitation for people with brain injury	ASSISTIVE TECHNOLOGY			English	Article						Cognitive impairment; computer access; information technology and telecommunications; neurorehabilitation and brain computer interfaces; service delivery	WORKING-MEMORY; IMPACT	Cognitive rehabilitation is established as a core intervention within rehabilitation programs following a traumatic brain injury (TBI). Digitally enabled assistive technologies offer opportunities for clinicians to increase remote access to rehabilitation supporting transition into home. Brain Computer Interface (BCI) systems can harness the residual abilities of individuals with limited function to gain control over computers through their brain waves. This paper presents an online cognitive rehabilitation application developed with therapists, to work remotely with people who have TBI, who will use BCI at home to engage in the therapy. A qualitative research study was completed with people who are community dwellers post brain injury (end users), and a cohort of therapists involved in cognitive rehabilitation. A user-centered approach over three phases in the development, design and feasibility testing of this cognitive rehabilitation application included two tasks (Find-a-Category and a Memory Card task). The therapist could remotely prescribe activity with different levels of difficulty. The service user had a home interface which would present the therapy activities. This novel work was achieved by an international consortium of academics, business partners and service users.	[Martin, Suzanne] Ulster Univ, Fac Life & Hlth Sci, Jordanstown, North Ireland; [Armstrong, Elaine; Thomson, Eileen; Lynn, Jean Daly] Cedar Fdn, Belfast, Antrim, North Ireland; [Vargiu, Eloisa; Sola, Marc; Dauwalder, Stefan; Miralles, Felip] EURECAT, eHlth Dept, Barcelona, Spain		Martin, S (corresponding author), Fac Life & Hlth Sci, Sch Hlth Sci, Room 1B114,Jordanstown Campus,Shore Rd, Newtownabbey BT37 0QB, Antrim, North Ireland.	s.martin@ulster.ac.uk		Miralles, Felip/0000-0002-6917-6691; Armstrong, Elaine/0000-0001-7035-8989	European CommunityEuropean Commission [288566]	The research leading to these results received funding from the European Community's Seventh Framework Programme FP7/2007-2013, BackHome project grant agreement no 288566.	[Anonymous], 2012, LANCET NEUROL, V11, P651, DOI 10.1016/S1474-4422(12)70166-7; Bamdad M, 2015, DISABIL REHABIL-ASSI, V10, P355, DOI 10.3109/17483107.2014.961569; Braddock D., 2004, Journal of Special Education Technology, V19, P49; Bragge P, 2014, J HEAD TRAUMA REHAB, V29, P277, DOI 10.1097/HTR.0000000000000066; Brunner C, 2015, BRAIN-COMPUT INTERFA, V2, P1, DOI 10.1080/2326263X.2015.1008956; Hernandez RC, 2012, IFMBE PROC, V37, P838; Chen SHA, 1997, BRAIN INJURY, V11, P197; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Daly J., 2015, INT J RECENT INNOV T, V3, P4019; Dou ZL, 2006, BRAIN INJURY, V20, P219, DOI 10.1080/02699050500488215; Guger C, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00060; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johansson B, 2012, SCAND J OCCUP THER, V19, P176, DOI 10.3109/11038128.2011.603352; Kang SH, 2009, CLIN REHABIL, V23, P434, DOI 10.1177/0269215508101732; KATZ DI, 2006, COGNITIVE REHABILITA; Kubler A, 2001, PSYCHOL BULL, V127, P358, DOI 10.1037//0033-2909.127.3.358; Kujala S, 2003, BEHAV INFORM TECHNOL, V22, P1, DOI 10.1080/0144929021000055530; Lee TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079419; Lim CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039139; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; MIRALLES F, 2015, FRONT, P25, DOI DOI 10.3389/FICT.2015.00025; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Rego P., 2010, INF SYST TECHN CISTI, P1; Scherer M. J., 2012, ASSISTIVE TECHNOLOGI; Schreuder M, 2013, ARTIF INTELL MED, V59, P71, DOI 10.1016/j.artmed.2013.07.005; Smith E, 2005, BMJ-BRIT MED J, V330, P406, DOI 10.1136/bmj.330.7488.406; Tai K, 2008, ASSIST TECHNOL, V20, P204, DOI 10.1080/10400435.2008.10131947; Tam SF, 2004, BRAIN INJURY, V18, P461, DOI 10.1080/02699050310001646099; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; Tyerman A, 2004, VOCATIONAL ASSESSMEN; Zickefoose S, 2013, BRAIN INJURY, V27, P707, DOI 10.3109/02699052.2013.775484; [No title captured]; [No title captured]; [No title captured]	37	8	9	1	7	R E S N A PRESS	ARLINGTON	1700 MOORE ST, STE 1540, ARLINGTON, VA 22209-1903 USA	1040-0435	1949-3614		ASSIST TECHNOL	Assist. Technol.		2018	30	5					233	241		10.1080/10400435.2017.1317675			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	HC0HN	WOS:000451478800003	28708963	Green Published			2022-02-06	
J	McCuddy, WT; Espana, LY; Nelson, LD; Birn, RM; Mayer, AR; Meier, TB				McCuddy, William T.; Espana, Lezlie Y.; Nelson, Lindsay D.; Birn, Rasmus M.; Mayer, Andrew R.; Meier, Timothy B.			Association of acute depressive symptoms and functional connectivity of emotional processing regions following sport-related concussion	NEUROIMAGE-CLINICAL			English	Article						Resting state fMRI; Concussion; Mild traumatic brain injury (mTBI); Depression; Connectivity	TRAUMATIC BRAIN-INJURY; DEFAULT-MODE NETWORK; RESTING-STATE FMRI; HIGH-SCHOOL; INDIVIDUALS; PERFORMANCE	Acute mood disturbance following sport-related concussion is common and is known to adversely affect post-concussion symptoms and recovery. The physiological underpinnings of depressive symptoms following concussion, however, are relatively understudied. We hypothesized that functional connectivity of the emotional processing network would be altered in concussed athletes and associated with the severity of depressive symptoms following concussion. Forty-three concussed collegiate athletes were assessed at approximately one day (N=34), one week (N=34), and one month post-concussion (N=30). Fifty-one healthy contact-sport athletes served as controls and completed a single visit. The Hamilton Rating Scale for Depression (HAM-D) was used to measure depressive symptoms. Resting state fMRI data was collected on a 3 T scanner (TR=2s) and functional connectivity was calculated in a meta-analytically derived network of regions associated with emotional processing. Concussed athletes had elevated depressive symptoms across the first month post-concussion relative to control athletes, but showed partial recovery by one month relative to more acute visits (ps < 0.05). Concussed athletes had significantly different connectivity in regions associated with emotional processing at one month post-concussion relative to one day post-concussion (p=0.002) and relative to controls (p=0.003), with higher connectivity between default mode and attention regions being common across analyses. Additionally, depressive symptoms in concussed athletes at one day (p=0.003) and one week post-concussion (p=7x10(-8)) were inversely correlated with connectivity between attention (e.g., right anterior insula) and default mode regions (e.g., medial prefrontal cortex). Finally, the relationships with HAM-D scores were not driven by a general increase in somatic complaints captured by the HAM-D, but were strongly associated with mood-specific HAM-D items. These results suggest that connectivity of emotional processing regions is associated with acute mood disturbance following sport-related concussion. Increased connectivity between attention and default mode regions may reflect compensatory mechanisms.	[McCuddy, William T.; Espana, Lezlie Y.; Nelson, Lindsay D.; Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Birn, Rasmus M.] Univ Wisconsin, Dept Psychiat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Birn, Rasmus M.] Univ Wisconsin, Dept Med Phys, Sch Med & Publ Hlth, 1530 Med Sci Ctr, Madison, WI 53706 USA; [Mayer, Andrew R.] Lovelace Biomed & Environm Res Inst, Mind Res Network, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Neurol Dept, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Laureate Inst Brain Res, Tulsa, OK USA		Meier, TB (corresponding author), Med Coll Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	tmeier@mcw.edu		Espana, Lezlie/0000-0002-6466-4653	Laureate Institute for Brain Research; William K. Warren Foundation; Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin	This research was conducted using internal funds from the Laureate Institute for Brain Research, which is supported by The William K. Warren Foundation. Dr. Meier received support for this work through a project funded through the Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin. The sponsors had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The authors thank the psychiatric assessment team and MRI technicians at the Laureate Institute for Brain Research, Dr. Rashmi Singh and Dr. Patrick Bellgowan for their assistance with data collection and Christopher Nerio, David Polanski, Dr. Thomas Allen, and Dr. Lamont Cavanagh for athlete referral and injury oversight.	Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Birn RM, 2013, NEUROIMAGE, V83, P550, DOI 10.1016/j.neuroimage.2013.05.099; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chen G, 2014, NEUROIMAGE, V99, P571, DOI 10.1016/j.neuroimage.2014.06.027; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hamilton JP, 2015, BIOL PSYCHIAT, V78, P224, DOI 10.1016/j.biopsych.2015.02.020; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Sliz D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00323; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Taylor PA, 2016, BRAIN CONNECT, V6, P109, DOI 10.1089/brain.2015.0363; Taylor PA, 2013, BRAIN CONNECT, V3, P523, DOI 10.1089/brain.2013.0154; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	40	8	8	1	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	19						434	442		10.1016/j.nicl.2018.05.011			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GQ7PL	WOS:000441936300046	29984152	Green Published, gold			2022-02-06	
J	Mohammadifard, M; Ghaemi, K; Hanif, H; Sharifzadeh, G; Haghparast, M				Mohammadifard, Mahyar; Ghaemi, Kazem; Hanif, Hamed; Sharifzadeh, Gholamreza; Haghparast, Marzieh			Marshall and Rotterdam Computed Tomography scores in predicting early deaths after brain trauma	EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY			English	Article						Marshall scores; Rotterdam scores; brain CT scan; head trauma	SCORING SYSTEM; CT SCORES; INJURY; CLASSIFICATION; MANAGEMENT; MORTALITY	Trauma is one of the most important issues of most healthcare systems accompanying with head trauma in the most cases. We sought to determine the scoring system and initial Computed Tomography (CT) findings predicting the death at hospital discharge (early death) in patients with traumatic brain injury based on Marshall and Rotterdam CT scores. This is a cross sectional study on traumatic neurosurgical patients with mild-to-severe traumatic brain injury admitted to the emergency department of Emam Rem Hospital, Birjand University of Medical Sciences. Patients >= 18 years old with TBI during last 24 hours with GCS <= 13 were included and exclusion criteria were multiple trauma, penetrating injuries, previous history of anticoagulant therapy, pregnancy, not willingness for participation. Their initial CT and status at hospital discharge, one and three months (dead or alive) were reviewed, and both CT scores were calculated. We examined whether each score is related to death using SPS S11 by The Mann-Whitney U at the level of p <= 0.05. Overall, 98 patients were included. Mean age was 43.52 +/- 21.29. Most patients were male (63.3%). Mean Marshall and Rotterdam CT scores were 3.2 +/- 1.3 and 2.5 +/- 1. The mortality at two weeks, one moth and three months were 19.4%, 20.4%, and 20.4%. Rotterdam CT score was significantly different based on type of hematoma. Median GCS score in alive and dead patients on 2 weeks were 10 and 4 (p=0.0001), at one month were 10 and 4 (p=0.0001), and at three months were 10 and 4 (p=0.0001). The median Marshall CT score on 2 weeks were 2 and 4 (p=0.0001), at one month were 2 and 4 (p=0.0001), and at three months were 2 and 4 (p=0.0001). The median Rotterdam CT score on 2 weeks were 2 and 4 (p=0.0001), at one month were 2 and 3 (p=0.001), and at three months were 2 and 3 (p=0.001). The Rotterdam CT score was significantly correlated with mortality at two weeks, one month and three months (p=0.004, p=0.001, and p=0.001, respectively). The Marshall CT score was not significantly correlated with mortality at any time. The Rotterdam CT score was more accurate for prediction of mortality on 2 weeks (ROC80.9), at one month (ROC80.7), and at three months were (ROC80.7) than The Rotterdam CT score (ROC 76, 74.1, and 74.1, respectively). This study concluded that The Marshall CT score was more accurate for prediction of mortality on 2 weeks, at one month, and at three months were than The Marshall CT score with higher ROC. The correlation of the Rotterdam CT score with mortality was significant.	[Mohammadifard, Mahyar] Birjand Univ Med Sci, Imam Reza Hosp, Dept Radiol, Birjand, Iran; [Ghaemi, Kazem] Birjand Univ Med Sci, Dept Neurosurg, Tehran, Iran; [Hanif, Hamed] Tehran Univ Med Sci, Sina Hosp, Dept Neurosurg, Tehran, Iran; [Sharifzadeh, Gholamreza] Birjand Univ Med Sci, Epidemiol, Birjand Infect Dis Res Ctr, Birjand, Iran; [Haghparast, Marzieh] Birjand Univ Med Sci, Dept Radiol, Birjand, Iran		Haghparast, M (corresponding author), Birjand Univ Med Sci, Dept Radiol, Birjand, Iran.	Mahyarmohammadifard@yahoo.com; Ghaemi@bums.ac.ir; dr.hamed.hanif@gmail.com; rezamood@yahoo.com; Haghparast65m@yahoo.com	amiri, omolbanin/G-4425-2017	amiri, omolbanin/0000-0002-3815-5716; Sharifzadeh, Gholamreza/0000-0003-4812-0223			Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Deepika A, 2015, ACTA NEUROCHIR, V157, P2033, DOI 10.1007/s00701-015-2575-5; Faez DCdS, 2016, ANALISE RETIRADA VEN; Hemmati H., 2009, Acta Medica Iranica, V47, P403; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Karbakhsh M, 2009, East Mediterr Health J, V15, P57; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Fajardo PL, 2009, EMERGENCIAS, V21, P433; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Mehrjardi MZ, 2017, INT UROL NEPHROL, V49, P937, DOI 10.1007/s11255-017-1550-x; Munakomi S, 2016, CHIN J TRAUMATOL, V19, P25, DOI 10.1016/j.cjtee.2015.12.005; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Talari HR, 2016, WORLD NEUROSURG, V87, P195, DOI 10.1016/j.wneu.2015.11.055; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368	19	8	8	0	0	PAGEPRESS PUBL	PAVIA	MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY	2037-7452	2037-7460		EUR J TRANSL MYOL	Eur. J. Transl. Myol.		2018	28	3					265	273		10.4081/ejtm.2018.7542			9	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	HH4SG	WOS:000455715200005	30344974	gold, Green Published			2022-02-06	
J	Najafi, Z; Zakeri, H; Mirhaghi, A				Najafi, Zohre; Zakeri, Hossien; Mirhaghi, Amir			The accuracy of acuity scoring tools to predict 24-h mortality in traumatic brain injury patients: A guide to triage criteria	INTERNATIONAL EMERGENCY NURSING			English	Article						Traumatic brain injury; Triage; Prehospital; Emergency	GLASGOW COMA SCALE; SEVERE HEAD-INJURY; SEVERITY; COHORT; PERFORMANCE; MODERATE; SYSTEM; SCORES; TRISS; NEWS	Background and aim: Prompt identification of traumatic brain injury (TBI) is vital for patients in critical condition; however, it is not clear which acuity scoring tools are associated with short-term mortality. The aim of this study was to determine the accuracy of acuity scoring tools and 24-h mortality among TBI patients in both prehospital and hospital settings. Methods: This study was an observational, prospective cohort, in which patients with TBI were followed from the accident scene to the hospital. Vital signs and acuity scoring tools, including the Revised Trauma Score (RTS), Injury Severity Score (ISS), National Early Warning Score (NEWS), Shock Index (SI), Modified Shock Index (MSI) and Trauma and Injury Severity Score (TRISS), were collected both on the scene as well as at the hospital. A logistic regression was performed to ascertain the effects of clinical parameters on the likelihood of survival of patients with TBI regarding 24-h mortality. Results:: A total of 185 patients were included in this study. The mortality rate was 14% (25/185). The logistic regression model was statistically significant at chi(2) = 60.8, p = 0.001. A hierarchical forward stepwise logistic regression analysis showed that age, hospital RTS and prehospital NEWS significantly improved mortality predictions. The model explained the 51.2% variance in survival of patients with TBI. Conclusions: The NEWS and the RTS may be used to triage TBI patients for prehospital and hospital emergency care, respectively. Therefore, because traditional vital signs criteria may be of limited use for the triage of TBI patients, it is recommended that acuity scoring tools be used in such cases.	[Najafi, Zohre] Torbat Heydariyeh Univ Med Sci, Dept Med Surg Nursing, Razi St, Torbat Heydariyeh 9516915169, Razavi Khorasan, Iran; [Zakeri, Hossien] Mashhad Univ Med Sci, Sch Med, Hasheminejad Hosp, Emergency Med, Mashhad, Iran; [Mirhaghi, Amir] Mashhad Univ Med Sci, Sch Nursing & Midwifery, Dept Med Surg Nursing, Evidence Based Caring Res Ctr, Mashhad, Iran; [Zakeri, Hossien] Hasheminejad Hosp, Sch Med, Dept Emergency Med, Azadi Sq, Mashhad 9177948564, Razavi Khorasan, Iran		Mirhaghi, A (corresponding author), Sch Nursing & Midwifery, Dept Med Surg Nursing, Mashhad 9137913199, Razavi Khorasan, Iran.	najafiz1@thums.ac.ir; zakerih@mums.ac.ir; mirhaghia@mums.ac.ir	Smith, Gary B/A-8235-2013; Mirhaghi, Amir/A-1483-2014	najafi, zohre/0000-0002-6628-9834; Mirhaghi, Amir/0000-0002-4482-1156			Abbott TEF, 2015, RESUSCITATION, V92, P89, DOI 10.1016/j.resuscitation.2015.04.020; Alam N, 2015, RESUSCITATION, V90, P111, DOI 10.1016/j.resuscitation.2015.02.011; Baez AA, 2007, PREHOSP DISASTER MED, V22, P230, DOI 10.1017/S1049023X00004726; Baltas I, 1998, J Neurosurg Sci, V42, P85; Barmparas G, 2014, J TRAUMA ACUTE CARE, V77, P592, DOI 10.1097/TA.0000000000000382; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2; Fitzgerald M, 2011, ARCH SURG-CHICAGO, V146, P218, DOI 10.1001/archsurg.2010.333; Gomez PA, 2014, J NEUROSURG, V121, P1314, DOI 10.3171/2014.7.JNS131874; Heydari-Khayat N, 2014, ZAHEDAN J RES MED SC, V16, P33; Hodgson L, 2016, THORAX, V71, P208; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; Kamal VK, 2016, J NEUROSCI RURAL PRA, V7, P515, DOI 10.4103/0976-3147.188637; Kamal VK, 2016, BRAIN INJURY, P1; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Lichtveld RA, 2008, INT J EMERG MED, V1, P21, DOI 10.1007/s12245-008-0013-7; Liu YC, 2012, WORLD J EMERG MED, V3, P114, DOI [10.5847/wjem.j.1920-8642.2012.02.006, 10.5847/wjem.j.issn.1920-8642.2012.02.006]; Majdan M, 2017, J NEUROSCI RURAL PRA, V8, P20, DOI 10.4103/0976-3147.193543; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Majidi S, 2013, AM J EMERG MED, V31, P1215, DOI 10.1016/j.ajem.2013.05.026; Malekzadeh J, 2015, INT J EVID-BASED HEA, V13, P87, DOI 10.1097/XEB.0000000000000046; Mazandarani PD, 2016, EMERGENCY, V4, P88; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Mirhaghi A, 2016, EURASIAN J EMERG MED, V15, P144, DOI 10.5152/eajem.2016.80299; Moazzez Lesko MJT, 2012, J NEUROTRAUM, P1; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12851; Rau CS, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070683; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; VASSAR MJ, 1992, J TRAUMA, V32, P490, DOI 10.1097/00005373-199204000-00014; Weber KT, 2016, ARQ NEURO-PSIQUIAT, V74, P409, DOI 10.1590/0004-282X20160053; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P456, DOI 10.1097/00002060-199611000-00011	35	8	8	1	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1755-599X	1878-013X		INT EMERG NURS	Int. Emerg. Nurs.	JAN	2018	36						27	33		10.1016/j.ienj.2017.08.003			7	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	FX5WK	WOS:000426153100005	28965751				2022-02-06	
J	O'Rourke, C; Linden, MA; Lohan, M				O'Rourke, Conall; Linden, Mark A.; Lohan, Maria			Misconceptions about traumatic brain injury among probation services	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; offenders; prisoners; probation services; misconceptions	PREVALENCE; PROFESSIONALS; POPULATION; AWARENESS; METAANALYSIS; ASSOCIATION; DISORDERS; PRISONERS; RECOVERY; SAMPLE	Purpose: The prevalence of traumatic brain injury (TBI) among offender populations is significantly higher than among the general population. Despite this, no study has yet assessed the knowledge of members of the probation service surrounding TBI. Method: Knowledge was assessed among members of the Probation Board for Northern Ireland (PBNI) using a cross-sectional online version of the Common Misconceptions about TBI (CM-TBI) questionnaire. Mean total misconception scores, along with scores on four subdomains (recovery, sequelae, insight, and hidden injury) were calculated. Analysis of variance was used to explore differences in misconceptions based on the collected demographic information. Results: The overall mean percentage of misconceptions for the group was 22.37%. The subdomain with the highest rate of misconceptions (38.21%) was insight into injury which covered misconceptions around offenders' self-awareness of injuries. Those who knew someone with a brain injury scored significantly higher in the CM-TBI total score, F(1,63) = 6.639, p = 0.012, the recovery subdomain, F(1,63) = 10.080, p = 0.002, and the insight subdomain, F(1,63) = 5.834, p = 0.019. Additionally, significant training deficits around TBI were observed among the probation service. Conclusions: This study is the first of its kind to examine the level of understanding around TBI within probation services. The findings reflect potential barriers to identification and rehabilitation of TBI for offenders coming into contact with the criminal justice system. A lack of identification coupled with misconceptions about TBI could lead to inaccurate court reporting with a subsequent impact on sentencing. IMPLICATIONS FOR REHABILITATION Despite being one of the first points of contact for offenders entering the criminal justice system, members of the probation service reported having no formal training on traumatic brain injury (TBI). The subdomain with the highest rate of misconceptions (insight into injury) revealed an over-reliance on survivors of brain injury to identify, understand, and communicate the extent and severity of their injuries. Probation service personnel require training on TBI to improve awareness of the potential outcomes of the condition, ensuring injuries are identified and referred to the appropriate care pathways.	[O'Rourke, Conall; Linden, Mark A.; Lohan, Maria] Queens Univ Belfast, Sch Nursing & Midwifery, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland		O'Rourke, C (corresponding author), Queens Univ Belfast, Sch Nursing & Midwifery, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	corourke916@qub.ac.uk	Linden, Mark/L-7754-2019	Linden, Mark/0000-0002-3832-4102; Lohan, Maria/0000-0003-3525-1283	Department of Education and Learning, Northern Ireland	This research was supported by the Department of Education and Learning, Northern Ireland.	Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Centers for disease control and prevention, 2014, INJ PREV CONTR TRAUM; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; House of Commons Justice Committee, 2010, 8 REP SESS, V12, P1; Hughes N, 2015, J HEAD TRAUMA REHAB, V30, P94, DOI 10.1097/HTR.0000000000000124; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Linden MA, 2007, ARCH CLIN NEUROPSYCH, V22, P665, DOI 10.1016/j.acn.2007.04.009; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; National Prisoner Healthcare Network, 2015, BRAIN INJ OFF; O'Jile JR., 1997, INT J REHABILITATION, V3, P61, DOI [10.1007/BF02766798, DOI 10.1007/BF02766798]; O'Rourke C, 2016, BRAIN INJURY, V30, P839, DOI 10.3109/02699052.2016.1146967; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; Probation Board for Northern Ireland, 2013, PRES REP COURT; Probation Board for Northern Ireland, 2015, PBNI APR 2015 UNPUB; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Shivaji T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-2; Springer JA, 1997, J HEAD TRAUMA REHAB, V12, P41, DOI 10.1097/00001199-199706000-00005; Stuss DT, 2012, PRINCIPLES FRONTAL L, P616; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; The British Psychological Society, 2015, CHILDR YOUNG PEOPL N; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Williams WH, 2015, J HEAD TRAUMA REHAB, V30, P69, DOI 10.1097/HTR.0000000000000134; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Yuhasz JE, 2013, J CORRECT HEALTH CAR, V19, P135, DOI 10.1177/1078345812474644	39	8	8	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2018	40	10					1119	1126		10.1080/09638288.2017.1288274			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FW9WP	WOS:000425689100002	28637141	Green Published			2022-02-06	
J	Olczak, M; Kwiatkowska, M; Niderla-Bielinska, J; Chutoranski, D; Tarka, S; Wierzba-Bobrowicz, T				Olczak, Mieszko; Kwiatkowska, Magdalena; Niderla-Bielinska, Justyna; Chutoranski, Dominik; Tarka, Sylwia; Wierzba-Bobrowicz, Teresa			Brain-originated peptides as possible biochemical markers of traumatic brain injury in cerebrospinal fluid post-mortem examination	FOLIA NEUROPATHOLOGICA			English	Article						TBI markers; post-mortem examination; neurofilaments; glial fibrillary acidic protein; myelin basic protein	AXONAL INJURY; HEAD TRAUMA; BIOMARKERS; PROTEIN; DEMYELINATION; DIAGNOSIS; DISEASE; PLASMA; ADULTS; BLOOD	The release of brain-originated peptides such as tau protein (MAPT), S-100 beta, neurofilament light chain (NFL), and glial fibrillary acidic protein (GFAP) into the cerebrospinal fluid (CSF) has been positively correlated with head injuries in clinical and basic research. In this study, we wanted to examine if selected CSF biomarkers (GFAP, NFL, and myelin basic protein - MBP) of head injury may be useful in post-mortem examination and diagnosis of forensic cases. The study was carried out using cases of head injury and cases of sudden death (cardiopulmonary failure, no injuries of the head as control group) provided by forensic pathologists at the Department of Forensic Medicine, Medical University of Warsaw. Cerebrospinal fluid was collected within 24 h after death using suboccipital puncture. The concentration of these peptides was compared using an enzyme-linked immunosorbent assay (ELISA). Brain specimens (frontal cortex) were collected during forensic autopsies. Sections were stained immunohistochemically against GFAP, MBP, NF, and amyloid-beta precursor protein (APP). As a result we documented that elevated levels of CSF, GFAP, MBP, and NFL should be considered a marker for severe and moderate traumatic brain injury. Elevated levels of those peptides combined with a negative APP staining point to their role as markers of head trauma with a shorter time span than APP (manner of minutes).	[Olczak, Mieszko; Kwiatkowska, Magdalena; Tarka, Sylwia] Med Univ Warsaw, Dept Forens Med, 1 Oczki St, PL-02007 Warsaw, Poland; [Niderla-Bielinska, Justyna] Med Univ Warsaw, Dept Histol & Embriol, Warsaw, Poland; [Chutoranski, Dominik; Tarka, Sylwia; Wierzba-Bobrowicz, Teresa] Inst Psychiat & Neurol, Dept Neuropathol, Warsaw, Poland		Olczak, M (corresponding author), Med Univ Warsaw, Dept Forens Med, 1 Oczki St, PL-02007 Warsaw, Poland.	mieszkothe1st@hotmail.com		Wierzba-Bobrowicz, Teresa/0000-0003-2518-8321; , Dominik/0000-0001-5060-7423			Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Benarroch EE, 2009, NEUROLOGY, V72, P1779, DOI 10.1212/WNL.0b013e3181a6b123; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Clarner T, 2012, GLIA, V60, P1468, DOI 10.1002/glia.22367; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; HESSELINK JR, 1988, AM J ROENTGENOL, V150, P1133; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Morrison C, 2008, NEUROPATH APPL NEURO, V34, P124, DOI 10.1111/j.1365-2990.2007.00876.x; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Olczak M, 2017, FORENSIC SCI INT, V280, P1, DOI 10.1016/j.forsciint.2017.09.008; Papa L, 2016, BENCH BEDSIDE TRAUMA; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tsitsopoulos PP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00599; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	33	8	9	1	4	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1641-4640	1509-572X		FOLIA NEUROPATHOL	Folia Neuropathol.		2018	56	2					97	103		10.5114/fn.2018.76613			7	Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	GL2WN	WOS:000436986900003	30509029	Green Submitted, gold			2022-02-06	
J	Olsson, A; Persson, AC; Bartfai, A; Boman, IL				Olsson, Anna; Persson, Ann-Christine; Bartfai, Aniko; Boman, Inga-Lill			Sensor technology more than a support	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						ADL; aging in place; assistive technology; brain injury; dementia; cognitive rehabilitation; smart home technology; significant others; quality of life	TRAUMATIC BRAIN-INJURY; ASSISTIVE TECHNOLOGY; TRAINING APARTMENT; ELECTRONIC-AIDS; PERFORMANCE; EXPERIENCES; COGNITION; DEVICES; PEOPLE; HEALTH	Background: This interview study is a part of a project that evaluated sensor technology as a support in everyday activities for patients with memory impairment. Aim: To explore patients with memory impairment and their partners' experiences of using sensor technology in their homes. Methods and material: Five patients with memory impairment after stroke and three partners were interviewed. Individual semi-structured interviews were analyzed with qualitative content analysis. Results: Installing sensor technology with individually prerecorded voice reminders as memory support in the home had a broad impact on patients' and their families' lives. These effects were both positive and negative. The sensor technology not only supported activities but also influenced the patients by changing behavior, providing a sense of security, independence and increased self-confidence. For the partners, the sensor technology eased daily life, but also gave increased responsibility for maintenance. Technical problems led to frustration and stress for the patients. Conclusion: The results indicate that sensor technology has potential to increase opportunities for persons with memory impairment to perform and participate in activities and to unburden their partners. The results may promote an understanding of how sensor technology can be used to support persons with memory impairment in their homes.	[Olsson, Anna; Persson, Ann-Christine; Bartfai, Aniko; Boman, Inga-Lill] Danderyd Hosp, Div Rehabil Med, Stockholm, Sweden; [Bartfai, Aniko; Boman, Inga-Lill] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, S-18288 Stockholm, Sweden		Boman, IL (corresponding author), Karolinska Inst, Danderyd Hosp, Dept Clin Sci, S-18288 Stockholm, Sweden.	inga-lill.boman@ki.se		Persson, Ann-Christine/0000-0003-1143-6777	Karolinska Institutet Centre for Health Sciences; Promobilia Foundation	We would like to thank the patients with memory impairment and their partners in the study who openly shared their thoughts and experience. The study has been supported by the Karolinska Institutet Centre for Health Sciences, and the Promobilia Foundation.	Agree EM, 2014, DISABIL HEALTH J, V7, pS33, DOI 10.1016/j.dhjo.2013.09.004; Bartfai A., 2014, TECHNOL DISABIL, V26, P11, DOI 10.3233/TAD-140400; Boman IL, 2010, DISABIL REHABIL-ASSI, V5, P339, DOI 10.3109/17483100903131777; Boman IL, 2007, DISABIL REHABIL-ASSI, V2, P23, DOI 10.1080/17483100600856213; Boman IL, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0238-x; Boman IL, 2010, SCAND J OCCUP THER, V17, P140, DOI 10.3109/11038120902875144; Connell B., 1997, PRINCIPLES UNIVERSAL; Corbin J., 2014, BASICS QUALITATIVE R; Demiris G, 2010, YB MED INFORM, V6, P51; Ding D, 2011, MATURITAS, V69, P131, DOI 10.1016/j.maturitas.2011.03.016; Edwards B, 2009, MED J AUSTRALIA, V190, pS61; Erikson A, 2004, AM J OCCUP THER, V58, P261, DOI 10.5014/ajot.58.3.261; Evald L, 2015, NEUROPSYCHOL REHABIL, V25, P283, DOI 10.1080/09602011.2014.970557; Govercin M, 2016, INFORM HEALTH SOC CA, V41, P430, DOI 10.3109/17538157.2015.1064425; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Haggblom-Kronlof G, 2007, DISABIL REHABIL-ASSI, V2, P335, DOI 10.1080/17483100701701672; Ivanoff Synneve Dahlin, 2006, Can J Occup Ther, V73, P109; Jamieson M, 2014, NEUROPSYCHOL REHABIL, V24, P419, DOI 10.1080/09602011.2013.825632; Kielhofner G., 2007, MODEL HUMAN OCCUPATI; Lee ML, 2008, P 10 INT C UB COMP; Lenker JA, 2013, DISABIL REHABIL-ASSI, V8, P373, DOI 10.3109/17483107.2012.749429; Leopold A, 2015, NEUROREHABILITATION, V37, P359, DOI 10.3233/NRE-151267; Lindqvist E, 2010, TECHNOLOGY DISABILIT, V22, P89, DOI DOI 10.3233/TAD20100294; Lindqvist E, 2015, NEUROREHABILITATION, V36, P135, DOI 10.3233/NRE-141201; Lindqvist E, 2013, SCAND J OCCUP THER, V20, P386, DOI 10.3109/11038128.2013.766761; Liu LL, 2016, INT J MED INFORM, V91, P44, DOI 10.1016/j.ijmedinf.2016.04.007; Lund ML, 2011, DISABIL REHABIL-ASSI, V6, P402, DOI 10.3109/17483107.2011.574309; Lund ML, 2003, OTJR-OCCUP PART HEAL, V23, P67, DOI 10.1177/153944920302300204; McCreadie C, 2005, AGEING SOC, V25, P91, DOI 10.1017/S0144686X0400248X; Scherer MJ, 2014, DISABIL REHABIL-ASSI, V9, P1, DOI 10.3109/17483107.2013.870239; Scherer MJ, 2005, DISABIL REHABIL, V27, P731, DOI 10.1080/09638280400014816; Schroeter C, 2013, ROB AUT ICRA 2013 IE; Svoboda E, 2010, NEUROPSYCHOL REHABIL, V20, P562, DOI 10.1080/09602011003669918; Wang J, 2016, MIL MED, V181, P560, DOI 10.7205/MILMED-D-14-00704; Wilson B., 2008, RIVERMEAD BEHAV MEMO, VThird	35	8	8	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1103-8128	1651-2014		SCAND J OCCUP THER	Scand. J. Occup. Ther.		2018	25	2					79	87		10.1080/11038128.2017.1293155			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GC0HL	WOS:000429458100001	28276963				2022-02-06	
J	Osborn, AJ; Mathias, JL; Fairweather-Schmidt, AK; Anstey, KJ				Osborn, A. J.; Mathias, J. L.; Fairweather-Schmidt, A. K.; Anstey, K. J.			Traumatic Brain Injury and Depression in a Community-Based Sample: A Cohort Study Across the Adult Life Span	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						community; depression; longitudinal; multivariate; population; traumatic brain injury	ACUTE ALCOHOL-INTOXICATION; RISK-FACTORS; PSYCHIATRIC-DISORDERS; PHYSICAL-ACTIVITY; MAJOR DEPRESSION; POPULATION; MILD; ANXIETY; EPIDEMIOLOGY; ASSOCIATION	Objectives: To determine whether self-reported traumatic brain injuries (TBIs) are associated with "cases" of clinically significant depression in the general community. To examine interactions between variables previously linked to depression after a TBI. Setting: Population-based community study (Canberra and Queanbeyan, Australia). Participants and Design: Three age cohorts: young, middle-aged, and older adults (aged 20-24, 40-44, and 6064 years at baseline) randomly selected from the electoral roll and followed across 3 waves (4 years apart). A total of 7397, 6621, and 6042 people provided their TBI history in waves 1 to 3. Measures: Lifetime (TBIlifetime: sustained at any time since birth), recent (TBIrecent: in the preceding 4 years), and multiple (TBImultiple: more than 1) TBIs, current depression, and known risk factors for depression (age, sex, marital/employment status, prior history of depression, medical conditions, recent life events, alcohol consumption, social support, physical activity). Results: Generalized estimating equations demonstrated a significant association between sustaining a TBI and experiencing clinically significant depression (cases), even after controlling for multiple demographic and health/lifestyle factors. Conclusion: There is an enduring association between depression and TBI, suggesting that, following a TBI, individuals should be monitored and supported to optimize their long-term psychological health.	[Osborn, A. J.; Mathias, J. L.; Fairweather-Schmidt, A. K.] Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia; [Fairweather-Schmidt, A. K.] Flinders Univ S Australia, Sch Psychol, Bedford Pk, SA, Australia; [Anstey, K. J.] Australian Natl Univ, Ctr Res Ageing Hlth & Wellbeing, Canberra, ACT, Australia		Mathias, JL (corresponding author), Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia.	jane.mathias@adelaide.edu.au	Anstey, Kaarin/A-3852-2008	Anstey, Kaarin/0000-0002-9706-9316			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anstey KJ, 2012, INT J EPIDEMIOL, V41, P951, DOI 10.1093/ije/dyr025; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Ashman T, 2014, J HEAD TRAUMA REHAB, V29, P467, DOI 10.1097/HTR.0000000000000098; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x; Butterworth P, 2009, SOC SCI MED, V69, P229, DOI 10.1016/j.socscimed.2009.05.008; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Clarke DM, 2009, MED J AUSTRALIA, V190, pS54; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Deb S, 1999, AM J PSYCHIAT, V156, P374; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Driver S, 2005, BRAIN INJURY, V19, P1067, DOI 10.1080/02699050500149338; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; e-hub Mental Health, 2015, GOLDB DEPR ANX SCAL; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; GIUFFRA LA, 1994, PSYCHOL MED, V24, P375, DOI 10.1017/S0033291700027355; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Horner MD, 2008, J HEAD TRAUMA REHAB, V23, P74, DOI 10.1097/01.HTR.0000314526.01006.c8; Jacka FN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087657; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Jorge Ricardo E, 2015, Handb Clin Neurol, V128, P613, DOI 10.1016/B978-0-444-63521-1.00038-8; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kiely KM, 2015, PSYCHIAT RES, V225, P291, DOI 10.1016/j.psychres.2014.12.023; Koenigs M, 2008, J NEUROSCI, V28, P12341, DOI 10.1523/JNEUROSCI.2324-08.2008; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.987.848; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P478, DOI 10.1093/arclin/acu027; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Patten SB, 2003, SOC PSYCH PSYCH EPID, V38, P290, DOI 10.1007/s00127-003-0649-9; Pawlowski J, 2013, ARCH PHYS MED REHAB, V94, P1184, DOI 10.1016/j.apmr.2013.01.005; Ponsford J., 2003, Z NEUROPSYCHOL, V14, P155, DOI [10.1024/1016-264X.14.3.155, DOI 10.1024/1016-264X.14.3.155]; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Ruddle Jean Jean, 2011, SOCIAL CARE NEURODIS, V2, P200, DOI [10.1108/20420911111188452, DOI 10.1108/20420911111188452]; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SCHUSTER TL, 1990, AM J COMMUN PSYCHOL, V18, P423, DOI 10.1007/BF00938116; Schwandt M, 2012, J HEAD TRAUMA REHAB, V27, P99, DOI 10.1097/HTR.0b013e31820e6858; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Seel RT, 2011, EUR NEUROL REV, V6, P25; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wegner M, 2014, CNS NEUROL DISORD-DR, V13, P1002, DOI 10.2174/1871527313666140612102841; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140	67	8	8	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2018	33	1					62	72		10.1097/HTR.0000000000000311			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GB0QS	WOS:000428752300015	28520661				2022-02-06	
J	Potteiger, KL; Potteiger, AJ; Pitney, WA; Wright, PM				Potteiger, Kelly L.; Potteiger, Adam J.; Pitney, William A.; Wright, Paul M.			An Examination of Concussion Legislation in the United States	INTERNET JOURNAL OF ALLIED HEALTH SCIENCES AND PRACTICE			English	Article							MANAGEMENT	There is legislation in the United States designed to protect children and adolescents from the risks associated with concussion. The scope and reach of these laws vary greatly. Purpose: It is important that health care professionals are aware of the limitations of each law. Since 2009, every state in the nation and the District of Columbia passed legislation designed to protect student-athletes who suffer from concussions resulting from participation in sport. Method: Therefore, select components of state policies were identified including: 1) Affected entities, 2) Stipulations for concussion awareness/education, 3) Requirements for removal/return to play, and 4) Requirements for return to the classroom. Results: There is significant variance between the laws and not all children/adolescents are protected equally. Conclusion: Concussion policies are a minimum standard and, when available, best practices should be followed.	[Potteiger, Kelly L.; Wright, Paul M.] Northern Illinois Univ, De Kalb, IL 60115 USA; [Pitney, William A.] Northern Illinois Univ, Res Resources & Innovat, Coll Educ, De Kalb, IL USA; [Potteiger, Adam J.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA		Potteiger, KL (corresponding author), Northern Illinois Univ, De Kalb, IL 60115 USA.	kelpotteiger@gmail.com; apotteiger@luriechildrens.org; wpitney@niu.edu; pwright@niu.edu					Alder RH, 2011, PHYS MED REH CLIN N, V22, P721; Alvarez B, 2014, PUBLIC HLTH ISSUE GE; [Anonymous], 2013, HEADS 10 YEARS ANN V; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bruce SL, 2016, ATHL TRAIN ED J, V11, P194, DOI DOI 10.4085/1104194; Buckner MM, 2013, CIN-COMPUT INFORM NU, V31, P229, DOI 10.1097/NXN.0b013e31828a0dda; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Cuff S, AM MED SOC SPORTS ME; Erickson MA, 2000, J ATHL TRAINING, V35, P134; Faul M, 2010, TRAUMATIC BRAIN INJU; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Injury Prevention & Control: Traumatic Brain Injury & Concussion, TBI GET THE FACTS; Kasamatsu T, 2016, J ATHL TRAINING, V51, P153, DOI 10.4085/1062-6050-51.4.02; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Manning PK, 1994, HDB QUALITATIVE RES; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; Patel DR, 2017, TRANSL PEDIATR, V6, P121, DOI 10.21037/tp.2017.03.09; Potteiger A, 2015, ILLINOIS PEDIAT  WIN, P7; Raab Edward L, 2004, Trans Am Ophthalmol Soc, V102, P225; Zirkel P, 2016, PHYS DISABIL, V35, P1	27	8	8	0	1	NOVA SOUTHEASTERN UNIV	FORT LAUDERDALE	3200 S UNIVERSITY DR, FORT LAUDERDALE, FL 33328 USA	1540-580X			INTERNET J ALLIED HE	Internet J. Allied Health Sci. Pract.		2018	16	2							6				9	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	GC2LH	WOS:000429613400002					2022-02-06	
J	Rau, HK; Hendrickson, RC; Roggenkamp, HC; Peterson, S; Parmenter, B; Cook, DG; Peskind, E; Pagulayan, KF				Rau, Holly K.; Hendrickson, Rebecca C.; Roggenkamp, Hannah C.; Peterson, Sarah; Parmenter, Brett; Cook, David G.; Peskind, Elaine; Pagulayan, Kathleen F.			Fatigue - but not mTBI history, PTSD, or sleep quality - directly contributes to reduced prospective memory performance in Iraq and Afghanistan era Veterans	CLINICAL NEUROPSYCHOLOGIST			English	Article						Prospective memory; mild traumatic brain injury; posttraumatic stress disorder; sleep; fatigue	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; OEF/OIF VETERANS; SERVICE MEMBERS; BLAST EXPOSURE; POSTCONCUSSION SYNDROME; MENTAL-HEALTH; MILD; SYMPTOMS	Objective: Memory problems that affect daily functioning are a frequent complaint among Veterans reporting a history of repetitive mild traumatic brain injury (mTBI), especially in cohorts with comorbid PTSD. Here, we test the degree to which subjective sleep impairment and daytime fatigue account for the association of PTSD and self-reported mTBI history with prospective memory. Method: 82 Veterans with and without personal history of repeated blast-related mTBI during deployment were administered the Clinician Administered PTSD Scale (CAPS), Memory for Intentions Test (MIST), Patient Health Questionnaire-9 (PHQ-9), Neurobehavioral Symptom Inventory (NSI), and the Pittsburgh Sleep Quality Index (PSQI). Relationships between self-reported mTBI, PTSD, self-reported poor sleep and daytime fatigue, and MIST performance were modeled using partial least squares structural equation modeling (PLS-SEM). Results: Reported daytime fatigue was strongly associated with poorer prospective memory performance. Poor subjective sleep quality was strongly and positively associated with reported daytime fatigue, but had no significant direct effect on prospective memory performance. PTSD diagnosis and self-reported mTBI history were only associated with prospective memory via their impact on subjective sleep quality and daytime fatigue. Conclusions: Results suggest that daytime fatigue may be a mediating factor by which both mTBI and PTSD can interfere with prospective memory. Additional attention should be given to complaints of daytime fatigue, independent of subjective sleep quality, in the clinical care of those with a self-reported history of mTBI, and/or PTSD. Further research into whether interventions that decrease daytime fatigue lead to improvement in prospective memory and subjective cognitive functioning is warranted.	[Rau, Holly K.; Hendrickson, Rebecca C.; Roggenkamp, Hannah C.; Peterson, Sarah; Parmenter, Brett; Peskind, Elaine; Pagulayan, Kathleen F.] VA Puget Sound Hlth Care Syst, Res Educ & Clin Ctr MIRECC, Vet Affairs VA Northwest Network VISN Mental Illn, Seattle, WA 98108 USA; [Hendrickson, Rebecca C.; Roggenkamp, Hannah C.; Parmenter, Brett; Peskind, Elaine; Pagulayan, Kathleen F.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Cook, David G.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Cook, David G.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Cook, David G.] Vet Affairs Puget Sound Hlth Care Syst, GRECC, Seattle, WA USA		Rau, HK (corresponding author), VA Puget Sound Hlth Care Syst, Res Educ & Clin Ctr MIRECC, Vet Affairs VA Northwest Network VISN Mental Illn, Seattle, WA 98108 USA.	holly.rau@va.gov	Pagulayan, Kati/AAR-9225-2020; Hendrickson, Rebecca/I-4923-2017	Hendrickson, Rebecca/0000-0003-2377-823X	Department of Veterans Affairs VA Clinical Science Research and Development Career Development Award [IK2 CX000516]; Department of Veterans Rehabilitation Research and Development Service Merit Review Award [I01 RX000521]; VA VISN 20 Northwest Network MIRECC; US Department of Veterans Affairs Medical Research ServiceUS Department of Veterans Affairs; University of Washington Royalty Research FundUniversity of Washington; Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and TreatmentUS Department of Veterans Affairs; Medical Research Service of the Puget Sound Veterans Affairs Health Care System; Puget Sound Veterans Affairs Health Care System Mental Illness Research, Education, and Clinical Center (MIRECC); Department of Veterans Affairs Rehabilitation Research and Development ServiceUS Department of Veterans Affairs; Veterans AffairsUS Department of Veterans Affairs [I01RX001612, I01RX000521] Funding Source: NIH RePORTER	This work was supported by the Department of Veterans Affairs VA Clinical Science Research and Development Career Development Award IK2 CX000516 (to KFP); Department of Veterans Rehabilitation Research and Development Service Merit Review Award I01 RX000521 (to ERP); VA VISN 20 Northwest Network MIRECC (HKR, RCH, HCR, SKP, ERP, KFP); US Department of Veterans Affairs Medical Research Service (DGC); University of Washington Royalty Research Fund (DGC); Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment, the Medical Research Service of the Puget Sound Veterans Affairs Health Care System, the Puget Sound Veterans Affairs Health Care System Mental Illness Research, Education, and Clinical Center (MIRECC); Department of Veterans Affairs Rehabilitation Research and Development Service (ERP); and an anonymous foundation.	Attree EA, 2009, CYBERPSYCHOL BEHAV, V12, P379, DOI 10.1089/cpb.2009.0002; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bellesi M., 2015, SLEEP; Berger Ann Malone, 2008, J Natl Compr Canc Netw, V6, P3; Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassel C, 1999, J APPL STAT, V26, P435, DOI 10.1080/02664769922322; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clinton JM, 2011, J CLIN SLEEP MED, V7, pS38, DOI 10.5664/JCSM.1360; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Drummond SPA, 2006, J SLEEP RES, V15, P261, DOI 10.1111/j.1365-2869.2006.00535.x; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Fabbri M, 2015, BEHAV SLEEP MED, V13, P231, DOI 10.1080/15402002.2013.860896; Fabbri M, 2014, BIOL RHYTHM RES, V45, P115, DOI 10.1080/09291016.2013.830510; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Goerke M, 2017, J NEURAL TRANSM, V124, pS163, DOI 10.1007/s00702-015-1476-3; Guo M, 2012, ASIAN PAC J TROP MED, V5, P323, DOI 10.1016/S1995-7645(12)60048-0; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hair J., 2017, PRIMER PARTIAL LEAST; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hein AM, 2009, MOL NEUROBIOL, V40, P15, DOI 10.1007/s12035-009-8066-z; Hendrickson RC, 2016, EXP NEUROL, V284, P181, DOI 10.1016/j.expneurol.2016.05.014; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; INMAN DJ, 1990, J TRAUMA STRESS, V3, P429, DOI DOI 10.1007/BF00974782; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kamat R, 2014, ASSESSMENT, V21, P742, DOI 10.1177/1073191114530774; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Kolakowsky-Hayner SA, 2017, NEUROPSYCHOL REHABIL, V27, P1002, DOI 10.1080/09602011.2016.1229680; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lal SKL, 2001, BIOL PSYCHOL, V55, P173, DOI 10.1016/S0301-0511(00)00085-5; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lindqvist D, 2014, BRAIN BEHAV IMMUN, V42, P81, DOI 10.1016/j.bbi.2014.06.003; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Newsome MR, 2015, NEUROIMAGE-CLIN, V8, P543, DOI 10.1016/j.nicl.2015.04.024; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Ohayon MM, 2002, ARCH INTERN MED, V162, P201, DOI 10.1001/archinte.162.2.201; Ouyang M, 2004, J NEUROPHYSIOL, V92, P2071, DOI 10.1152/jn.00226.2004; Pace-Schott EF, 2015, PSYCHOL BULL, V141, P835, DOI 10.1037/bul0000014; Pagulayan K. F., 2014, J INT NEUROPSYCH SOC, V20, P39; Papadopoulos AS, 2012, NAT REV ENDOCRINOL, V8, P22, DOI 10.1038/nrendo.2011.153; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Prasad KN, 2015, BRAIN RES, V1599, P103, DOI 10.1016/j.brainres.2014.12.038; Raskin S., 2001, INT NEUR SOC CHIC IL; Raskin S, 2004, J INT NEUROPSYCHO S1, V10, P110, DOI DOI 10.1017/S1355617704040019; Raskin S., 2010, MEMORY INTENTIONS TE; Raskin SA, 2009, BRAIN IMPAIR, V10, P23, DOI 10.1375/brim.10.1.23; RINGLE CM, 2015, SMARTPLS 3 0; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Scott JC, 2016, J INT NEUROPSYCH SOC, V22, P724, DOI 10.1017/S1355617716000564; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Shen JH, 2006, SLEEP MED REV, V10, P63, DOI 10.1016/j.smrv.2005.05.004; Steiger A, 2002, SLEEP MED REV, V6, P125, DOI 10.1053/smrv.2001.0159; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Defense and Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TBI; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Twamley EW, 2008, SCHIZOPHR RES, V106, P42, DOI 10.1016/j.schres.2007.10.030; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Verfaellie M, 2016, J HEAD TRAUMA REHAB, V31, P309, DOI 10.1097/HTR.0000000000000197; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; von Kanel R, 2007, J PSYCHIATR RES, V41, P744, DOI 10.1016/j.jpsychires.2006.06.009; Walker M. P., 2009, NATURE REV NEUROSCIE, V11, P114; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Woods SP, 2008, CLIN NEUROPSYCHOL, V22, P864, DOI 10.1080/13854040701595999; Zhang L, 2006, AM J NEURORADIOL, V27, P2000	90	8	8	1	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2018	32	7					1319	1336		10.1080/13854046.2017.1381277			18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	HC7YQ	WOS:000452018400006	29029579				2022-02-06	
J	Rios, C; Santander, I; Mendez-Armenta, M; Nava-Ruiz, C; Orozco-Suarez, S; Islas, M; Baron-Flores, V; Diaz-Ruiz, A				Rios, Camilo; Santander, Ivan; Mendez-Armenta, Marisela; Nava-Ruiz, Concepcion; Orozco-Suarez, Sandra; Islas, Marcela; Baron-Flores, Veronica; Diaz-Ruiz, Araceli			Metallothionein-I plus II Reduces Oxidative Damage and Apoptosis after Traumatic Spinal Cord Injury in Rats	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							FOCAL BRAIN-INJURY; CELL-DEATH; LIPID-PEROXIDATION; NEURITE GROWTH; TNF-ALPHA; EXPRESSION; ANTIOXIDANT; ACTIVATION; CASPASE-3; NEURONS	After spinal cord injury (SCI), some self-destructive mechanisms start leading to irreversible neurological deficits. It is known that oxidative stress and apoptosis play a major role in increasing damage after SCI. Metallothioneins I and II (MT) are endogenous peptides with known antioxidant, neuroprotective capacities. Taking advantage of those capacities, we administered exogenous MT to rats after SCI in order to evaluate the protective effects of MT on the production of reactive oxygen species (ROS) and lipid peroxidation (LP), as markers of oxidative stress. The activities of caspases-9 and -3 and the number of annexin V and TUNELpositive cells in the spinal cord tissue were also measured as markers of apoptosis. Rats were subjected to either sham surgery or SCI and received vehicle or two doses of MT (10 mu g per rat) at 2 and 8h after surgical procedure. The results showed a significant increase in levels of MT protein by effect of SCI and SCI plus treatment at 12h, while at 24h an increase of MT was observed only in the injury plus treatment group (p < 0.05). ROS production was decreased by effect of MT in lesioned tissue; likewise, we observed diminished LP levels by MT effect both in the sham group and in the group with SCI. Also, the results showed an increase in the activity of caspase-9 due to SCI, without changes by effect of MT, as compared to the sham group. Caspase-3 activity was increased by SCI, and again, MT treatment reduced this effect only at 24 h after injury. Finally, the results of the number of cells positive to annexin V and TUNEL showed a reduction due to MT treatment both at 24 and 72 h after the injury. With the findings of this work, we conclude that exogenously administered MT has antioxidant and antiapoptotic effects after SCI.	[Rios, Camilo; Baron-Flores, Veronica] Univ Autonoma Metropolitana, Dept Sistemas Biol, Unidad Xochimilco Ciudad Mexico, Ciudad De Mexico, Mexico; [Santander, Ivan; Islas, Marcela; Diaz-Ruiz, Araceli] Inst Nacl Neurol & Neurocirugia Manuel Velasco Su, Dept Neuroquim, Ciudad De Mexico, Mexico; [Mendez-Armenta, Marisela; Nava-Ruiz, Concepcion] Inst Nacl Neurol & Neurocirugia Manuel Velasco Su, Lab Patol Expt, Ciudad De Mexico, Mexico; [Orozco-Suarez, Sandra] Ctr Med Nacl Siglo XXI, Unidad Invest Med Enfermedades Neurol, Hosp Especialidades, Ciudad De Mexico, Mexico		Diaz-Ruiz, A (corresponding author), Inst Nacl Neurol & Neurocirugia Manuel Velasco Su, Dept Neuroquim, Ciudad De Mexico, Mexico.	adiaz@innn.edu.mx		Mendez-Armenta, Marisela/0000-0002-4690-5847; Diaz-Ruiz, Araceli/0000-0002-1481-0966; Nava-Ruiz, Concepcion/0000-0002-3910-3838	PRODEP/SEP; CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [183667]	This study was supported by PRODEP/SEP and CONACYT grant 183667. The authors thank Ricardo Gaxiola for his technical assistance.	Arellano-Ruiz S, 2012, NEUROSCI LETT, V514, P102, DOI 10.1016/j.neulet.2012.02.068; Aschner M, 2005, J ALZHEIMERS DIS, V8, P139; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Besio W, 2013, EPILEPSY BEHAV, V28, P432, DOI 10.1016/j.yebeh.2013.06.021; Cai L, 2003, TOXICOL LETT, V136, P193, DOI 10.1016/S0378-4274(02)00359-4; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; Chung RS, 2008, J NEUROCHEM, V104, P14, DOI 10.1111/j.1171-4159.2007.05026.x; Chung RS, 2009, NEUROTOX RES, V15, P381, DOI 10.1007/s12640-009-9044-y; Chung RS, 2003, J NEUROSCI, V23, P3336; Diaz-Ruiz A, 1999, NEUROSCI LETT, V266, P61, DOI 10.1016/S0304-3940(99)00255-4; Diaz-Ruiz A, 2002, NEUROSCI LETT, V319, P129, DOI 10.1016/S0304-3940(01)02540-X; Diaz-Ruiz A, 2004, NEUROSCI LETT, V357, P49, DOI 10.1016/j.neulet.2003.12.042; Diaz-Ruiz A, 2008, J NEUROSCI RES, V86, P3410, DOI 10.1002/jnr.21775; Diaz-Ruiz A, 2009, NEUROSCI LETT, V452, P56, DOI 10.1016/j.neulet.2009.01.020; Duan Yajiao, 2018, OXIDATIVE MED CELLUL, V2018; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fitzgerald M, 2007, EXP BRAIN RES, V183, P171, DOI 10.1007/s00221-007-1032-y; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Hall ED, 2016, J BIOENERG BIOMEMBR, V48, P169, DOI 10.1007/s10863-015-9600-5; Hozumi I, 2013, CURR PHARM BIOTECHNO, V14, P408, DOI 10.2174/1389201011314040004; Juarez-Rebollar D, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5828056; Kondo Y, 1997, MOL PHARMACOL, V52, P195, DOI 10.1124/mol.52.2.195; Leung JYK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1070-3; Leung JYK, 2012, CELL MOL LIFE SCI, V69, P809, DOI 10.1007/s00018-011-0790-7; Liu DX, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-23; Liu XZ, 1997, J NEUROSCI, V17, P5395; Ma FY, 2011, ARQ NEURO-PSIQUIAT, V69, P105, DOI 10.1590/S0004-282X2011000100020; Pedersen MO, 2009, BIOFACTORS, V35, P315, DOI 10.1002/biof.44; Penkowa M, 2005, J NEUROSCI RES, V79, P522, DOI 10.1002/jnr.20387; Penkowa M, 2001, EXP NEUROL, V170, P1, DOI 10.1006/exnr.2001.7675; Perez-Navarro E, 2005, J NEUROCHEM, V92, P678, DOI 10.1111/j.1471-4159.2004.02904.x; Perez-Severiano F, 2004, NEUROCHEM RES, V29, P729, DOI 10.1023/B:NERE.0000018843.83770.4b; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Portera-Cailliau C, 1997, J COMP NEUROL, V378, P10, DOI DOI 10.1002/(SICI)1096-9861(19970203)378:110::AID-CNE43.0.CO;2-N; Prado J, 2013, NEUROCHEM INT, V62, P70, DOI 10.1016/j.neuint.2012.11.008; Precht TA, 2005, CELL DEATH DIFFER, V12, P255, DOI 10.1038/sj.cdd.4401552; Rios C, 2015, NEUROCHEM RES, V40, P1243, DOI 10.1007/s11064-015-1588-z; Rojas P, 1997, NEUROCHEM RES, V22, P17, DOI 10.1023/A:1027312901477; Romero-Isart N, 2002, J INORG BIOCHEM, V88, P388, DOI 10.1016/S0162-0134(01)00347-6; SANTAMARIA A, 1993, NEUROSCI LETT, V159, P51, DOI 10.1016/0304-3940(93)90796-N; SCHEUHAMMER AM, 1986, TOXICOL APPL PHARM, V82, P417, DOI 10.1016/0041-008X(86)90277-2; SCHMECHEL DE, 1999, CRC METH NEUROSCI S, P23; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Stankovic RK, 2007, INT J BIOCHEM CELL B, V39, P484, DOI 10.1016/j.biocel.2006.09.010; Torres S, 2010, NEUROPATHOLOGY, V30, P36, DOI 10.1111/j.1440-1789.2009.01037.x; Trendelenburg G, 2002, J NEUROSCI, V22, P5879; TRIGGS WJ, 1984, J NEUROCHEM, V42, P976, DOI 10.1111/j.1471-4159.1984.tb12699.x; Wanpen S, 2004, BRAIN RES, V1005, P67, DOI 10.1016/j.brainres.2004.01.054; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O	51	8	8	0	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.		2018	2018								3265918	10.1155/2018/3265918			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	HB0QY	WOS:000450723400001	30524652	Green Published, Green Submitted, gold			2022-02-06	
J	Sabesan, VJ; Prey, B; Smith, R; Lombardo, DJ; Borroto, WJ; Whaley, JD				Sabesan, Vani J.; Prey, Beau; Smith, Ryan; Lombardo, Daniel J.; Borroto, Wilfredo J.; Whaley, James D.			Concussion rates and effects on player performance in Major League Baseball players	OPEN ACCESS JOURNAL OF SPORTS MEDICINE			English	Article						baseball; epidemiology; head injuries/concussion; MLB; performance	RETURN	Background: Major League Baseball (MLB) players arc throwing the ball faster and hitting harder than ever before. Although some safety measures have been implemented, by decreasing the 15 days on the disabled list (DL) to the 7 days on the DL, concussion rates remain high across positions and may impact player performance. Our hypothesis was, there would be an increase in concussion incidence following implementation of the 7 day DL, but this would not have a negative impact on player's postconcussion performance. Study design: This is a descriptive epidemiology study. Methods: The concussed players from 2005 to 2016 were identified from the MLB DL and verified using established new sources. Position-specific performance metrics from before and after injuries were gathered and compared to assess effects of the injury. Postconcussion performance metrics were compared before and after the 7-day DL rule implementation. Results: A total of 112 concussed players were placed on the DL. For all position players, the batting average (BA) and on-base percentage (OBP) showed a nonsignificant decline after injury (P=0.756). Although performance statistics for pitchers declined on average, the trend was not statistically significant. Postinjury BA and OBP did not significantly change before (0.355) and after (0.313) the 7-day DL rule change in 2011 (P=0.162). Conclusion: The incidence of reported concussion has increased with the 7-day DL rule change. Concussion incidence was highest in catchers and pitchers compared with all other players. The most common causes identified as being hit by pitch or struck by a foul ball or foul tip. While new league rules prevent collisions with catchers at home plate, injury by a foul tip was the most common cause for concussion. The shortened time spent on the DL did not negatively impact player's performance. Further research on protective helmets for catchers may reduce concussion incidence.	[Sabesan, Vani J.] Cleveland Clin Florida, Levitetz Dept Orthopaed Surg, 2950 Cleveland Clin Blvd, Weston, FL 33331 USA; [Prey, Beau] Western Michigan Univ, Sch Med, Kalamazoo, MI 49008 USA; [Smith, Ryan; Lombardo, Daniel J.] Wayne State Univ, Sch Med, Dept Orthopaed Surg, Detroit, MI USA; [Borroto, Wilfredo J.] Ponce Sch Med & Hlth Sci, Ponce, PR USA; [Whaley, James D.] Beaumont Hlth Syst, Detroit, MI USA		Sabesan, VJ (corresponding author), Cleveland Clin Florida, Levitetz Dept Orthopaed Surg, 2950 Cleveland Clin Blvd, Weston, FL 33331 USA.	sabes001@gmail.com		Borroto, Wilfredo/0000-0001-9247-231X			[Anonymous], 2014, TSN MLB; [Anonymous], 2014, MAJOR LEAGUE BASEBAL; [Anonymous], 2014, NCAA REACHES PROPOSE; Athiviraham A, 2012, AM J SPORT MED, V40, P2808, DOI 10.1177/0363546512461754; CISION Prnewswire, 2012, MLB PLAY DEB NEW RAW; Erickson BJ, 2014, AM J SPORT MED, V42, P536, DOI 10.1177/0363546513510890; Green GA, 2015, AM J SPORT MED, V43, P1118, DOI 10.1177/0363546514568089; Hagen P, 2014, MLB APPROVES NEW PAD; Hagen P, 2013, MLB VOTES ELIMINATE; Hutchinson MR., 2014, ANN ORTHOP RHEUMATOL, V2, P1022; Jones I. S., 1984, HEAD IMPACT TOLERANC; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Lukas P, 2009, BETTER LOOK GOOD FEE; Lukas P, 2005, MLB MIDSEASON FASHIO; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Mihoces G, 2014, NFL CONCUSSION SETTL; Posner M, 2011, AM J SPORT MED, V39, P1676, DOI 10.1177/0363546511411700; Rosenthal K, 2014, MLB STUDYING HEADGEA; Sawchik T., 2014, TRIB LIVE; Schwartz A., 2011, 7 DAY DL ESTABLISHED; Waldstein D., 2009, NEW YORK TIMES  0812, pB11; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Yengo-Kahn AM, 2016, PHYSICIAN SPORTSMED, V44, P297, DOI 10.1080/00913847.2016.1200956; Zuckerman SL, 2017, CONCUSSIONS ATHLETIC, P211	26	8	8	0	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1543			OPEN ACCESS J SPORTS	Open Access J. Sports Med.		2018	9						253	260		10.2147/OAJSM.S157433			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	HA6PR	WOS:000450402400001	30519128	Green Published, gold			2022-02-06	
J	Sahlabadi, M; Khodaei, S; Jezler, K; Hutapea, P				Sahlabadi, Mohammad; Khodaei, Seyedvahid; Jezler, Kyle; Hutapea, Parsaoran			Insertion mechanics of bioinspired needles into soft tissues	MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES			English	Article						Surgical needle; insertion force; biomimetic; minimally invasive procedure; bioinspired needle	PROSTATE BRACHYTHERAPY; FORCE; BRAIN; FRICTION; SIMULATION; STRESS; DAMAGE; ROBOT; MODEL	Introduction: Most studies to date confirm that any increase in the needle insertion force increases the damage to the tissue. When it comes to brain tissue, even minor damage can cause a long-lasting traumatic brain injury. Thus there is a great demand for innovative minimally invasive needles among the medical community. In our previous studies a novel bioinspired needle design with specially designed barbs was used to perform insertion tests into Polyvinyl chloride (PVC) tissue-mimicking gels, in which it decreased the insertion force by as much as 25%. Material and methods: In this work, bioinspired needles were designed using a CAD software, and were then manufactured using a 3D printer. The insertion tests into bovine brain and liver were then performed to further investigate the performance of our bioinspired needles in real tissues. Results: Our results show that there was a 10-25% decrease in the insertion force for insertions into bovine brain, and a 35-45% reduction in the insertion force for insertions into bovine liver using the proposed bioinspired needles. Conclusion: The reduction in the insertion force is due to the decrease in the friction force of the bioinspired needle with the bovine tissues, and its results are consistent with our previous results.	[Sahlabadi, Mohammad; Khodaei, Seyedvahid; Jezler, Kyle; Hutapea, Parsaoran] Temple Univ, Dept Mech Engn, Philadelphia, PA 19122 USA		Hutapea, P (corresponding author), Temple Univ, Dept Mech Engn, Philadelphia, PA 19122 USA.	hutapea@temple.edu	Hutapea, Parsaoran/AAA-5196-2022	Hutapea, Parsaoran/0000-0001-6917-1252; khodaei, seyedvahid/0000-0002-1311-9006	Temple University's Center of Excellence in Traumatic Brain Injury Research	The authors would like to acknowledge the financial support of Temple University's Center of Excellence in Traumatic Brain Injury Research.	Abolhassani N, 2007, INT J MED ROBOT COMP, V3, P140, DOI 10.1002/rcs.136; Abolhassani N, 2007, MED ENG PHYS, V29, P413, DOI 10.1016/j.medengphy.2006.07.003; Abolhassani N, 2006, MINIM INVASIV THER, V15, P165, DOI 10.1080/13645700600771645; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Bjornsson CS, 2006, J NEURAL ENG, V3, P196, DOI 10.1088/1741-2560/3/3/002; Bucki M., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P25, DOI 10.1080/10255840701479057; Casanova F, 2014, J NEUROSCI METH, V237, P79, DOI 10.1016/j.jneumeth.2014.08.012; Clement RS, 2016, J AM ASSOC LAB ANIM, V55, P204; Crouch JR, 2005, LECT NOTES COMPUT SC, V3750, P624; DiMaio SP, 2003, IEEE T ROBOTIC AUTOM, V19, P864, DOI 10.1109/TRA.2003.817044; Frick TB, 2001, J BIOMECH, V34, P1335, DOI 10.1016/S0021-9290(01)00099-9; Healey AE, 2005, STUD HEALTH TECHNOL, V111, P178; Hing JT, 2006, IEEE INT CONF ROBOT, P619, DOI 10.1109/ROBOT.2006.1641779; Howard MA, 1999, IEEE T BIO-MED ENG, V46, P891, DOI 10.1109/10.771205; Kemper AR, 2010, ANN ADV AUTOMOT MED, V54, P1; Khalaji I, 2013, IEEE INT C INT ROBOT, P4099, DOI 10.1109/IROS.2013.6696943; Ling JT, 2017, J MECH BEHAV BIOMED, V68, P173, DOI 10.1016/j.jmbbm.2017.01.040; Mahvash Mohsen, 2009, 2009 IEEE International Conference on Robotics and Automation (ICRA), P3097, DOI 10.1109/ROBOT.2009.5152617; Mahvash M, 2010, IEEE T BIO-MED ENG, V57, P934, DOI 10.1109/TBME.2009.2036856; Meltsner MA, 2007, PHYS MED BIOL, V52, P6027, DOI 10.1088/0031-9155/52/19/021; O'Leary MD, 2003, IEEE INT CONF ROBOT, P1774, DOI 10.1109/ROBOT.2003.1241851; Okamura AM, 2004, IEEE T BIO-MED ENG, V51, P1707, DOI 10.1109/TBME.2004.831542; Podder T, 2006, MED PHYS, V33, P2915, DOI 10.1118/1.2218061; Podder TK, 2012, MED PHYS, V39, P1887, DOI 10.1118/1.3694110; Sahlabadi M, 2017, SMART MAT SMASIS BIO; Sahlabadi M, 2017, DESIGN MED DEVICES; Sahlabadi M, 2017, BIOM ENG SOC ANN M B, P1; Sparks JL, 2007, STAPP CAR CRASH JO, V51, P401; Urrea FA, 2016, J MECH BEHAV BIOMED, V56, P98, DOI 10.1016/j.jmbbm.2015.11.024; van Gerwen DJ, 2012, MED ENG PHYS, V34, P665, DOI 10.1016/j.medengphy.2012.04.007; Wu JN, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105567, 10.1371/journal.pone.0103823]	31	8	8	2	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1364-5706	1365-2931		MINIM INVASIV THER	Minim. Invasive Ther. Allied Technol.		2018	27	5					284	291		10.1080/13645706.2017.1418753			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GS8XH	WOS:000443997700006	29271289				2022-02-06	
S	Seifert, T		Hainline, B; Stern, RA		Seifert, Tad			The relationship of migraine and other headache disorders to concussion	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC HEADACHE; RISK; EPIDEMIOLOGY; ACTIVATION; CGRP; PAIN; PERFORMANCE; PREVALENCE; MECHANISMS	Concussion and migraine share many similar pathophysiologic mechanisms, including cortical spreading depression and failure in brain ion homeostasis. Migraine may predispose to concussion, and migraine and posttraumatic headache are common following concussion. This overlap may interfere with proper diagnosis following sport injury, thereby delaying either appropriate treatment or return-to-play. Posttraumatic headache is the most common symptom following concussion, and although symptoms are indistinguishable from migraine, persistent posttraumatic headache may be a unique entity that is more refractory to traditional headache management. There are few studies investigating the diagnosis and treatment of posttraumatic headache. This chapter provides a broad overview of migraine and other headache disorders in sport, with a specific focus on emerging treatment paradigms for posttraumatic headache.	[Seifert, Tad] Norton Healthcare, Sports Neurol Program, Louisville, KY USA		Seifert, T (corresponding author), Norton Healthcare, Sports Concuss Program, Louisville, KY 40202 USA.	Tad.Seifert@nortonhealthcare.org					Adams F, 1861, GENUINE WORKS HIPPOC, P1796; Aurora SK, 2004, J HEADACHE PAIN, V5, P204; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bigal ME, 2001, HEADACHE, V41, P710, DOI 10.1046/j.1526-4610.2001.041007710.x; BOGDUK N, 1982, SPINE, V7, P319, DOI 10.1097/00007632-198207000-00001; Bogduk N, 2001, Curr Pain Headache Rep, V5, P382, DOI 10.1007/s11916-001-0029-7; Bogduk N, 1981, Clin Exp Neurol, V17, P167; BOVIM G, 1991, SPINE, V16, P475, DOI 10.1097/00007632-199104000-00017; Bramley H, 2015, PEDIATR NEUROL, V52, P493, DOI 10.1016/j.pediatrneurol.2015.01.008; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Conidi FX, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0570-z; Cornelison LE, 2017, HEADACHE, V57, P203; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Couch JR, 2017, AM AC NEUR ANN M; Deen M, 2017, J HEAD PAIN; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Dubrovsky AS, 2014, HEADACHE, V54, P878, DOI 10.1111/head.12334; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Eckner JT, 2017, CLIN J SPORT MED, V27, P266, DOI 10.1097/JSM.0000000000000346; Edvinsson L, 2017, HEADACHE, V57, P47, DOI 10.1111/head.13081; ELMALLAKH RS, 1987, HEADACHE, V27, P442; Eross E, 2007, HEADACHE, V47, P213, DOI 10.1111/j.1526-4610.2006.00688.x; Evans Randolph W., 2017, PRACT NEUROL; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Florencio LL, 2017, HEADACHE, V57, P158; Gilkey SJ, 1997, HEADACHE, V37, P583, DOI 10.1046/j.1526-4610.1997.3709583.x; Goadsby PJ, 2008, CEPHALALGIA, V28, P1, DOI 10.1111/j.1468-2982.2008.01606.x; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hershey AD, 2017, NEW ENGL J MED, V377, P2190, DOI 10.1056/NEJMe1712559; Karian VE, 2017, HEADACHE, V57, P137; Kazemi H, 2012, IRAN J BASIC MED SCI, V15, P926; Kontos AP, 2016, BRAIN IMAGING BEHAV, V10, P594, DOI 10.1007/s11682-015-9412-6; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lauritzen M, 1994, BRAIN, V117, p119 210; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Le Doare K, 2006, NEUROSCI LETT, V403, P73, DOI 10.1016/j.neulet.2006.04.049; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Loder E, 2002, CLIN J PAIN, V18, pS169, DOI 10.1097/00002508-200211001-00009; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mathew NT, 2011, HEADACHE, V51, P84, DOI 10.1111/j.1526-4610.2011.01955.x; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Pertwee RG, 2001, PROG NEUROBIOL, V63, P569, DOI 10.1016/S0301-0082(00)00031-9; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P270, DOI 10.1016/j.pediatrneurol.2014.10.015; Piovesan Elcio J, 2003, Curr Pain Headache Rep, V7, P377, DOI 10.1007/s11916-003-0037-x; Piper BJ, 2017, J PSYCHOPHARMACOL, V31, P569, DOI 10.1177/0269881117699616; Santoro H, 2017, HEADACHE, V57, P209; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Seifert T, 2017, HEADACHE, V57, P877, DOI 10.1111/head.13104; Sussman WI, 2017, CLIN J SPORT MED, V27, pe6, DOI 10.1097/JSM.0000000000000325; Tejani AS, 2017, HEADACHE S, V57; Tejani AS, 2017, HEADACHE, V57; Thorlund K, 2014, CEPHALALGIA, V34, P258, DOI 10.1177/0333102413508661; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tso AR, 2017, CURR TREAT OPTION NE, V19, DOI 10.1007/s11940-017-0463-4; Tyburski AL, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0726-1; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x; Yerry JA, 2015, HEADACHE, V55, P395, DOI 10.1111/head.12495; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	68	8	8	0	1	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						119	126		10.1016/B978-0-444-63954-7.00012-4			8	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100014	30482339				2022-02-06	
J	Singh, R; Humphries, T; Mason, S; Lecky, F; Dawson, J; Sinha, S				Singh, Rajiv; Humphries, Thomas; Mason, Suzanne; Lecky, Fiona; Dawson, Jeremy; Sinha, Saurabh			The incidence of anosmia after traumatic brain injury: the SHEFBIT cohort	BRAIN INJURY			English	Article						TBI; anosmia; severity; depression; cohort	OLFACTORY FUNCTION; HEAD-INJURY; SYSTEMATIC BIAS; DYSFUNCTION; IDENTIFICATION; QUALITY; LESIONS; SCALE; SMELL; CARE	Background: While anosmia is common after Traumatic Brain Injury(TBI) (prevalence 4%-68%),studies differ in the associations found with other variables.Aims: To assess the incidence of anosmia within a large, mixed TBI cohort and examine relationships with other injury or demographic features, including depression and global outcome(GOSE).Design, Subjects and Setting: 774 consecutive TBI admissions over 2years, assessed within a specialist neurorehabilitation clinic.Methods: All patients assessed at 6-8weeks and 1year. Tools included the Extended Glasgow Outcome Scale(GOSE), Rivermead Head Injury Follow-up Questionnaire, Rivermead Post-Concussion Symptoms and the Hospital Anxiety and Depression Score. Olfactory function assessed with sensitivity to coffee granules.Results: The overall incidence of anosmia was 19.7%; mild TBI (9.55%), moderate (20.01%), and severe (43.5%). On a logistic regression, features of TBI severity (p<0.001 (95% CI 0.098-0.438)), medical comorbidities (p=0.026 (95% CI 0.301-0.927)) and depression (p=0.006 (95% CI 1.202-2.981)) were significant. Sixty percent of patients with anosmia at 1year were found to be clinically depressed, compared to 36% of patients without anosmia.Conclusion: In the largest prospective study of post-TBI anosmia, the incidence increased with TBI severity and other medical illness. The presence of anosmia should also raise the clinical suspicion of depression.	[Singh, Rajiv] Sheffield Teaching Hosp, Dept Rehabil Med, Osborn Neurorehabil Unit, Sheffield S5 7AU, S Yorkshire, England; [Singh, Rajiv; Mason, Suzanne; Lecky, Fiona] Univ Sheffield, Fac Med Dent & Hlth, Sch Hlth & Related Res ScHARR, Hlth Serv Res, Sheffield, S Yorkshire, England; Univ Sheffield, Med Sch, Sheffield, S Yorkshire, England; [Humphries, Thomas] Univ Sheffield, Management Sch, Inst Work Psychol, Sheffield, S Yorkshire, England; [Dawson, Jeremy] Sheffield Teaching Hosp, Dept Neurosurg, Sheffield, S Yorkshire, England		Singh, R (corresponding author), Sheffield Teaching Hosp, Dept Rehabil Med, Osborn Neurorehabil Unit, Sheffield S5 7AU, S Yorkshire, England.	rajiv.singh@sth.nhs.uk		Sinha, Saurabh/0000-0001-7453-9576; singh, rajiv/0000-0002-3173-9591			Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Costanzo R. M., 1992, J HEAD TRAUMA REHAB, V7, P15, DOI DOI 10.1097/00001199-199203000-00005; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; Daroff R.B., 2015, BRADLEYS NEUROLOGY C; de Guise E, 2015, BRAIN INJURY, V29, P730, DOI 10.3109/02699052.2015.1004748; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; DOTY RL, 1994, PERCEPT PSYCHOPHYS, V56, P701, DOI 10.3758/BF03208363; Doty RL, 2003, J HYPERTENS, V21, P1805, DOI 10.1097/00004872-200310000-00003; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Drevets WC, 2007, ANN NY ACAD SCI, V1121, P499, DOI 10.1196/annals.1401.029; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Frasnelli J, 2016, CLIN NEUROL NEUROSUR, V140, P68, DOI 10.1016/j.clineuro.2015.11.013; Gouveri E, 2014, ANGIOLOGY, V65, P869, DOI 10.1177/0003319714520956; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Humphries T, 2018, BRAIN INJURY, V32, P557, DOI 10.1080/02699052.2018.1434237; Kasper D, 2015, HARRISONS PRINCIPLES, V19th; Keller A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-122; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Lawton M, 2016, PARKINSONISM RELAT D, V33, P96, DOI 10.1016/j.parkreldis.2016.09.023; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Neuland C, 2011, LARYNGOSCOPE, V121, P867, DOI 10.1002/lary.21387; Patel RM, 2014, CLIN ANAT, V27, P54, DOI 10.1002/ca.22338; Proskynitopoulos Phileas J, 2016, Surg Neurol Int, V7, pS263, DOI 10.4103/2152-7806.181981; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ropper A.H., 2014, ADAMS VICTORS PRINCI, V10e; Sigurdardottir S, 2016, NEUROPSYCHOLOGY, V30, P98, DOI 10.1037/neu0000206; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Singh R, 2013, ARCH TRAUMA RES, V2, P103, DOI 10.5812/atr.13665; Singh R, 2012, DISABIL REHABIL, V34, P439, DOI 10.3109/09638288.2011.608146; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Webb TS, 2015, BRAIN INJURY, V29, P430, DOI 10.3109/02699052.2014.989904; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xydakis MS, 2015, NEUROLOGY, V84, P1559, DOI 10.1212/WNL.0000000000001475; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	8	9	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	9					1122	1128		10.1080/02699052.2018.1483028			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GL0ZJ	WOS:000436823600009	29874472	Green Accepted			2022-02-06	
J	Steenstrup, SE; Bakken, A; Bere, T; Patton, DA; Bahr, R				Steenstrup, Sophie Elspeth; Bakken, Arnhild; Bere, Tone; Patton, Declan Alexander; Bahr, Roald			Head injury mechanisms in FIS World Cup alpine and freestyle skiers and snowboarders	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							SYSTEMATIC VIDEO ANALYSIS; INCIDENT ANALYSIS; SPORTS INJURIES; 6-YEAR COHORT; CONCUSSION; RISK; STABILITY; ILLNESSES; LACROSSE; IMPACT	Introduction Head injuries represent a concern in skiing and snowboarding, with traumatic brain injuries being the most common cause of death. Aim To describe the mechanisms of head and face injuries among World Cup alpine and freestyle skiers and snowboarders. Methods We performed a qualitative analysis of videos obtained of head and face injuries reported through the International Ski Federation Injury Surveillance System during 10 World Cup seasons (2006-2016). We analysed 57 head impact injury videos (alpine n=29, snowboard n=13, freestyle n=15), first independently and subsequently in a consensus meeting. Results During the crash sequence, most athletes (84%) impacted the snow with the skis or board first, followed by the upper or lower extremities, buttocks/pelvis, back and, finally, the head. Alpine skiers had sideways (45%) and backwards pitching falls (35%), with impacts to the rear (38%) and side (35%) of the helmet. Freestyle skiers and snowboarders had backwards pitching falls (snowboard 77%, freestyle 53%), mainly with impacts to the rear of the helmet (snowboard 69%, freestyle 40%). There were three helmet ejections among alpine skiers (10% of cases), and 41% of alpine skiing injuries occurred due to inappropriate gate contact prior to falling. Athletes had one (47%) or two (28%) head impacts, and the first impact was the most severe (71%). Head impacts were mainly on snow (83%) on a downward slope (63%). Conclusion This study has identified several characteristics of the mechanisms of head injuries, which may be addressed to reduce risk.	[Steenstrup, Sophie Elspeth; Bakken, Arnhild; Patton, Declan Alexander; Bahr, Roald] Norwegian Sch Sport Sci, Dept Sports Med, Oslo Sports Trauma Res Ctr, N-0863 Oslo, Norway; [Bere, Tone] Univ Oslo, Hosp Ullevaal, Orthopaed Dept, Oslo, Norway; [Patton, Declan Alexander] Federat Univ Australia, ACRISP, Ballarat, Vic, Australia		Steenstrup, SE (corresponding author), Norwegian Sch Sport Sci, Dept Sports Med, Oslo Sports Trauma Res Ctr, N-0863 Oslo, Norway.	s.e.steenstrup@nih.no			Royal Norwegian Ministry of Culture; South-Eastern Norway Regional Health Authority; International Olympic Committee; Norwegian Olympic and Paralympic Committee and Confederation of Sport; Norsk Tipping AS; International Ski Federation; DJO	The Oslo Sports Trauma Research Center has been established at the Norwegian School of Sport Sciences through generous grants from the Royal Norwegian Ministry of Culture, the South-Eastern Norway Regional Health Authority, the International Olympic Committee, the Norwegian Olympic and Paralympic Committee and Confederation of Sport, and Norsk Tipping AS. The FIS Injury Surveillance System is supported by the International Ski Federation and was established through a generous grant from DJO.	Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Bailly N, 2017, SCAND J MED SCI SPOR, V27, P964, DOI 10.1111/sms.12699; Bailly N, 2017, MED SCI SPORT EXER, V49, P1, DOI 10.1249/MSS.0000000000001078; Bakken A, 2011, BRIT J SPORT MED, V45, P1315, DOI 10.1136/bjsports-2011-090527; Bere T, 2014, SCAND J MED SCI SPOR, V24, P667, DOI 10.1111/sms.12038; Bere T, 2014, BRIT J SPORT MED, V48, P36, DOI 10.1136/bjsports-2013-092206; Bere T, 2011, AM J SPORT MED, V39, P1421, DOI 10.1177/0363546511405147; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Davies SC, 2015, J CLIN SPORT PSYCHOL, V9, P101, DOI 10.1123/jcsp.2014-0037; Engebretsen L, 2010, BRIT J SPORT MED, V44, P772, DOI 10.1136/bjsm.2010.076992; FIS, 2016, SPEC COMP EQ COMM MA; Florenes TW, 2012, SCAND J MED SCI SPOR, V22, P58, DOI 10.1111/j.1600-0838.2010.01147.x; Florenes TW, 2011, SCAND J MED SCI SPOR, V21, P196, DOI 10.1111/j.1600-0838.2009.01048.x; Florenes TW, 2009, BRIT J SPORT MED, V43, P973, DOI 10.1136/bjsm.2009.068759; Florenes TW, 2010, BRIT J SPORT MED, V44, P803, DOI 10.1136/bjsm.2009.071159; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Gassner R, 2000, ENDOD DENT TRAUMATOL, V16, P122; Gilgien M, 2014, BRIT J SPORT MED, V48, P742, DOI 10.1136/bjsports-2013-092994; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Greve MW, 2009, WILD ENVIRON MED, V20, P234, DOI 10.1580/08-WEME-OR-244R1.1; Hagel BE, 2004, EPIDEMIOLOGY, V15, P279, DOI 10.1097/01.ede.0000120044.62029.b4; Hubbard M, 2012, SKIING TRAUMA SAFETY, P19; Hubbard M., 2009, J ASTM INT, V6, P1; Kim S, 2012, AM J SPORT MED, V40, P770, DOI 10.1177/0363546511433279; Koyama S, 2011, AM J SPORT MED, V39, P2656, DOI 10.1177/0363546511422331; Krosshaug T, 2005, BRIT J SPORT MED, V39, P330, DOI 10.1136/bjsm.2005.018358; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Major DH, 2014, BRIT J SPORT MED, V48, P18, DOI 10.1136/bjsports-2013-092573; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McNeil JA, 2012, SPORTS ENG, V15, P1, DOI 10.1007/s12283-012-0083-x; McNeil JA, 2009, SPORTS ENG, V11, P159, DOI 10.1007/s12283-009-0013-8; Mecham MD, 1999, J APPL BIOMECH, V15, P27, DOI 10.1123/jab.15.1.27; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; Nakaguchi H, 2002, J NEUROSURG, V97, P542, DOI 10.3171/jns.2002.97.3.0542; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Richards Darrin, 2008, Journal of ASTM International, V5, DOI 10.1520/JAI101406; Ruedl G, 2011, WILD ENVIRON MED, V22, P326, DOI 10.1016/j.wem.2011.06.008; Scher I., 2006, Journal of ASTM International (JAI), V3, pJAI14203, DOI 10.1520/JAI14203; Schindelwig K, 2015, SCAND J MED SCI SPOR, V25, P797, DOI 10.1111/sms.12300; Siu TLT, 2004, J CLIN NEUROSCI, V11, P236, DOI 10.1016/j.jocn.2003.08.003; Soligard T, 2015, BRIT J SPORT MED, V49, P441, DOI 10.1136/bjsports-2014-094538; Sporri J, 2012, BRIT J SPORT MED, V46, P1059, DOI 10.1136/bjsports-2012-091048; Steenstrup SE, 2017, BR J SPORTS IN PRESS; Steenstrup SE, 2017, BR J SPORTS MED; Steenstrup SE, 2014, BRIT J SPORT MED, V48, P41, DOI 10.1136/bjsports-2013-093145; Stewart D, 2010, Journal of ASTM International, V7, DOI 10.1520/JAI102821; Swaren M, 2013, SPORTS TECH, V6, P43; Thai KT, 2015, TRAFFIC INJ PREV, V16, P276, DOI 10.1080/15389588.2014.934366; Thai KT, 2015, TRAFFIC INJ PREV, V16, P268, DOI 10.1080/15389588.2014.931948; Tuli T, 2010, J ORAL MAXIL SURG, V68, P293, DOI 10.1016/j.joms.2009.09.072; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Yamazaki J, 2015, MED SCI SPORT EXER, V47, P1113, DOI 10.1249/MSS.0000000000000511	56	8	13	3	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2018	52	1					61	+		10.1136/bjsports-2017-098240			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FR5UC	WOS:000419130700012	29133295	Green Submitted, Bronze			2022-02-06	
J	Stevens, A; Schmidt, D; Hautzinger, M				Stevens, Andreas; Schmidt, Diana; Hautzinger, Martin			Major depression - a study on the validity of clinicians' diagnoses in medicolegal assessment	JOURNAL OF FORENSIC PSYCHIATRY & PSYCHOLOGY			English	Article						Major depression; diagnostic accuracy; embitterment; response bias	CONCUSSION SYMPTOMS QUESTIONNAIRE; NONVERBAL BEHAVIOR; RELIABILITY; INTERVIEWS; INVENTORY; DISORDER; FAKING; TESTS	Major depression ranges among the most frequently diagnosed psychiatric disorders. Accordingly, diagnoses of depression are often underlying insurance, compensation or disability claims. This report evaluates the validity of clinicians' diagnoses of major depression in a sample of claimants. In 2015, n=127 consecutive cases were examined for medicolegal assessment. For all of them, a diagnosis of major depression had been established by clinicians. All testees underwent a psychiatric interview, a physical examination, they answered questionnaires for depressive symptoms according to DSM-5, embitterment disorder, post concussion syndrome (PCS) and unspecific somatic complaints. Performance and symptom validity tests were administered. Only 31% fulfilled the diagnostic criteria for DSM-5 major depression according to self-report, while none did so according to psychiatric assessment. Negative response bias was found in 64% of cases, feigned neurologic symptoms in 22%. Symptom exaggeration was indiscriminate rather than depression-specific. By self-report, 64% of the participants qualified for embitterment disorder and 93% for PCS. In conclusion, clinicians' diagnoses of depression seem often confounded by improper assessment of the diagnostic criteria, confusion of depression with bereavement or embitterment and also by response bias.	[Stevens, Andreas] Univ Tubingen, Dept Psychiat, Tubingen, Germany; [Stevens, Andreas; Schmidt, Diana] Med Begutachtungsinst Tubingen, Tubingen, Germany; [Hautzinger, Martin] Univ Tubingen, Dept Psychol, Tubingen, Germany		Stevens, A (corresponding author), Univ Tubingen, Dept Psychiat, Tubingen, Germany.; Stevens, A (corresponding author), Med Begutachtungsinst Tubingen, Tubingen, Germany.	stevens@med-begutachtung.de					American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; Annen S, 2012, J NERV MENT DIS, V200, P26, DOI 10.1097/NMD.0b013e31823e653b; Bauer MS, 2002, HARVARD REV PSYCHIAT, V10, P138, DOI 10.1093/hrp/10.3.138; Bodenburg S, 2011, NERVENARZT, V82, P910, DOI 10.1007/s00115-010-3128-z; Boone K., 2002, DOT COUNTING TEST; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Croskerry P, 2002, ACAD EMERG MED, V9, P1184, DOI 10.1197/aemj.9.11.1184; DAHLSTROM WG, 1990, J PERS ASSESS, V55, P224, DOI 10.1207/s15327752jpa5501&2_22; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Aragones E, 2006, FAM PRACT, V23, P363, DOI 10.1093/fampra/cmi120; Fiquer JT, 2013, J AFFECT DISORDERS, V150, P1114, DOI 10.1016/j.jad.2013.05.002; Frances A., 2013, SAVING NORMAL INSIDE; Garb H. N., 2003, SCI PSEUDOSCIENCE CL, P17; Garb HN., 1998, STUDYING CLIN JUDGME, DOI [10.1037/10299-000, DOI 10.1037/10299-000]; GARB HN, 2003, HDB PSYCHOL, P27; Green P., 2003, GREENS WORD MEMORY T; Hathaway SR, 2000, MINNESOTA MULTIPHASI; Hautzinger M., 2012, ADS ALLGEMEINE DEPRE, V2nd; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Hofler M., 2000, INT, V9, P110, DOI [10.1002/mpr.85, DOI 10.1002/MPR.85]; Jacobi F, 2016, NERVENARZT, V87, P88, DOI 10.1007/s00115-015-4458-7; Jacobi F, 2002, NERVENARZT, V73, P651, DOI 10.1007/s00115-002-1299-y; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Linden M, 2003, PSYCHOTHER PSYCHOSOM, V72, P195, DOI 10.1159/000070783; Merckelbach H, 2011, J CLIN EXP NEUROPSYC, V33, P131, DOI 10.1080/13803395.2010.495055; Merten T., 2010, GERMAN J PSYCHIAT, V13, P150; Merten T, 2016, PSYCHOL INJ LAW, V9, P102, DOI 10.1007/s12207-016-9257-3; Mitchell A. J., 2011, BRIT J GEN PRACT, V61, P583; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Rebscher H., 2016, DAK GESUNDHEITSREPOR; Regier DA, 2013, AM J PSYCHIAT, V170, P59, DOI 10.1176/appi.ajp.2012.12070999; Rettew DC, 2009, INT J METH PSYCH RES, V18, P169, DOI 10.1002/mpr.289; Selbmann HK, 2005, PSYCHIATRIE, V2, P33; Sjoberg L, 2015, SCAND J PSYCHOL, V56, P582, DOI 10.1111/sjop.12231; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Stevens A., 2013, GERMAN J PSYCHIAT, V16, P87; Techniker Krankenkasse (TKK), 2014, TKK GES 2014 VER ZUM, V29; Thompson C, 2016, BRAIN INJURY, V30, P770; UNESCO Institute for Statistics, 2012, INT STAND CLASS ED I; Von dem Knesebeck O., 2010, PSYCHOTHERAPIE PSYCH, V60, P98, DOI [10.1055/s-0029-1202270, DOI 10.1055/S-0029-1202270]; Wakefield J.C, 2007, LOSS SADNESS PSYCHIA; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wittchen H.-U., 1997, STRUKTURIERTES KLIN; Young G, 2014, PSYCHOL INJ LAW, V7, P206, DOI 10.1007/s12207-014-9202-2; Znoj H., 2008, BERNER VERBITTERUNGS	45	8	8	1	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1478-9949	1478-9957		J FORENSIC PSYCHI PS	J. Forensic Psychiatry Psychol.		2018	29	5					794	809		10.1080/14789949.2018.1477974			16	Criminology & Penology; Psychiatry	Social Science Citation Index (SSCI)	Criminology & Penology; Psychiatry	GT0BX	WOS:000444093900009					2022-02-06	
J	Yang, ZY; Fan, R; Sun, P; Cui, HJ; Peng, WJ; Luo, JK; Zhang, CH; Xiong, XG; Huang, W; Liu, W				Yang, Zhaoyu; Fan, Rong; Sun, Peng; Cui, Hanjin; Peng, Weijun; Luo, Jiekun; Zhang, Chunhu; Xiong, Xingui; Huang, Wei; Liu, Wei			Rhubarb Attenuates Cerebral Edema via Inhibition of the Extracellular Signal-regulated Kinase Pathway Following Traumatic Brain Injury in Rats	PHARMACOGNOSY MAGAZINE			English	Article						Brain edema; extracellular signal-regulated kinase; rhubarb; traditional Chinese medicine; traumatic brain injury	PERFORMANCE LIQUID-CHROMATOGRAPHY; ACTIVATED PROTEIN-KINASES; MATRIX METALLOPROTEINASES; MOUSE MODEL; BARRIER; MATRIX-METALLOPROTEINASE-9; ERYTHROPOIETIN; HEMORRHAGE; DEFICITS; EXTRACT	Background: Rhubarb is a traditional Chinese medicine for treating traumatic brain injury (TBI). Purpose: The purpose of this study is to elucidate the potential mechanism of rhubarb by suppressing extracellular signal-regulated kinase (ERK) to ameliorate brain edema. Materials and Methods: Sprague-Dawley rats were separated into four groups at random. One group received 3 g/kg rhubarb, and another group received 12 g/kg rhubarb, and the vehicle group and sham group were administered the same dose of saline solution. The blood-brain barrier disruption and edema were detected by Evans blue extravasation and water content, respectively. ERK, Matrix metalloproteinase 9 (MMP-9), and zonula occluden-1 (ZO-1) in the damaged tissue were measured by western blot analysis and quantitative real-time polymerase chain reaction. Results: Rhubarb attenuated the brain edema after TBI, especially at the dose of 12 g/kg. Rhubarb significantly suppressed ERK, down-regulated MMP-9, and up-regulated ZO-1. Rhubarb might be a prospective therapeutic regimen to decrease edema in TBI. Conclusions: Rhubarb alleviates the edema by restraining the ERK signaling pathway. Our results contribute to the validation of the traditional use of rhubarb in the treatment of TBI and its mechanism.	[Yang, Zhaoyu; Fan, Rong; Cui, Hanjin; Luo, Jiekun; Zhang, Chunhu; Xiong, Xingui; Huang, Wei] Cent S Univ, Xiangya Hosp, Dept Integrated Tradit Chinese Med, Changsha 410008, Hunan, Peoples R China; [Sun, Peng] Shangdong Univ Tradit Chinese Med, Minist Educ, Dept Key Lab Tradit Chinese Med Class Theory, Jinan 250355, Shandong, Peoples R China; [Peng, Weijun] Cent S Univ, Dept Integrated Tradit Chinese & Western Med, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Liu, Wei] Cent S Univ, Dept Cardiovasc Surg, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China		Liu, W (corresponding author), Cent S Univ, Dept Cardiovasc Surg, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China.	lwei2001@tom.com			Natural Science Foundation of the Hunan Province, ChinaNatural Science Foundation of Hunan Province [2017jj2376]	The project was supported by the Natural Science Foundation of the Hunan Province, China (Grant No. 2017jj2376).	Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Bouzat P, 2011, CRIT CARE MED, V39, P2099, DOI 10.1097/CCM.0b013e31821cb7b2; Chen CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115694; Cui JK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-21; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; Gu JW, 2000, CHINESE MED J-PEKING, V113, P529; Hakon J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120074; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu K, 2015, MOL MED REP, V12, P2689, DOI 10.3892/mmr.2015.3693; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; Luo CL, 2013, BRAIN RES, V1502, P1, DOI 10.1016/j.brainres.2013.01.037; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Otani N, 2007, J CLIN NEUROSCI, V14, P42, DOI 10.1016/j.jocn.2005.11.044; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Rossi JL, 2015, J NEUROTRAUM, V32, P1101, DOI 10.1089/neu.2014.3611; Shao AW, 2014, CNS NEUROSCI THER, V20, P182, DOI 10.1111/cns.12194; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang T, 2013, J NEUROSURG, V118, P390, DOI 10.3171/2012.8.JNS12736; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37098; Wang Y, 2015, J SEP SCI, V38, P1100, DOI 10.1002/jssc.201401197; Wang Y, 2012, CHIN J INTEGR MED, V18, P690, DOI 10.1007/s11655-012-1053-7; Yang Y, 2015, BRAIN RES, V1623, P30, DOI 10.1016/j.brainres.2015.04.024; Zhang MA, 2016, ENERGY STORAGE MATER, V4, P1, DOI 10.1016/j.ensm.2016.02.001	28	8	10	2	14	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0973-1296	0976-4062		PHARMACOGN MAG	Pharmacogn. Mag.	JAN-MAR	2018	14	53					134	139		10.4103/pm.pm_218_17			6	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FX3MB	WOS:000425975000023	29576714	Green Published			2022-02-06	
J	Yelden, K; Duport, S; James, LM; Kempny, A; Farmer, SF; Leff, AP; Playford, ED				Yelden, Kudret; Duport, Sophie; James, Leon M.; Kempny, Agnieszka; Farmer, Simon F.; Leff, Alex P.; Playford, E. Diane			Late recovery of awareness in prolonged disorders of consciousness - a cross-sectional cohort study	DISABILITY AND REHABILITATION			English	Article						Disorders of consciousness; vegetative state; minimally conscious state; recovery; consciousness; unresponsive wakefulness syndrome	LONG-TERM OUTCOMES; VEGETATIVE STATE; VISUAL PURSUIT; BRAIN-INJURY; SCALE; COMA	Purpose: To detect any improvement of awareness in prolonged disorders of consciousness in the long term. Methods: A total of 34 patients with prolonged disorders of consciousness (27 vegetative state and seven minimally conscious state; 16 males; aged 21-73) were included in the study. All patients were initially diagnosed with vegetative/minimally conscious state on admission to our specialist neurological rehabilitation unit. Re-assessment was performed 2-16 years later using Coma Recovery Scale-Revised. Results: Although remaining severely disabled, 32% of the patients showed late improvement of awareness evidenced with development of non-reflexive responses such as reproducible command following and localization behaviors. Most of the late recoveries occurred in patients with subarachnoid hemorrhage (5/11, 45.5%). The ages of patients within the late recovery group (Mean =45, SD =11.4) and non-recovery group (Mean = 43, SD = 15.5) were not statistically different (p = 0.76). Conclusions: This study shows that late improvements in awareness are not exceptional in non-traumatic prolonged disorders of consciousness cases. It highlights the importance of long-term follow up of patients with prolonged disorders of consciousness, regardless of the etiology, age, and time passed since the brain injury. Long-term follow up will help clinicians to identify patients who may benefit from further assessment and rehabilitation. Although only one patient achieved recovery of function, recovery of awareness may have important ethical implications especially where withdrawal of artificial nutrition and hydration is considered.	[Yelden, Kudret; Duport, Sophie; Kempny, Agnieszka; Playford, E. Diane] Royal Hosp Neurodisabil, Res Dept, London, England; [Yelden, Kudret; Kempny, Agnieszka; Leff, Alex P.; Playford, E. Diane] UCL, Inst Neurol, Dept Brain Repair & Rehabil, London, England; [James, Leon M.] Cromwell Hosp, Neurophysiol Dept, London, England; [Farmer, Simon F.] Natl Hosp Neurol & Neurosurg, Dept Neurol, London, England; [Leff, Alex P.] UCL, Inst Cognit Neurosci, London, England		Yelden, K (corresponding author), Royal Hosp Neurodisabil, London, England.	kyelden@rhn.org.uk	Yelden, Kudret C./J-8470-2019; Farmer, Simon F/D-1969-2012	Farmer, Simon F/0000-0001-5193-8195; Playford, E Diane/0000-0001-7314-787X; Leff, Alexander/0000-0002-0831-3541	Neuro-disability Research Trust; National Institute for Health Services Research; University College London Hospitals Biomedical Research Centre (UCLH BRC)	This work was supported by The Neuro-disability Research Trust. Dr. Simon Farmer acknowledges support from the National Institute for Health Services Research and the University College London Hospitals Biomedical Research Centre (UCLH BRC).	Bekinschtein TA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00005; ARTS WFM, 1985, J NEUROL NEUROSUR PS, V48, P1300, DOI 10.1136/jnnp.48.12.1300; Avesani R, 2006, BRAIN INJURY, V20, P333, DOI 10.1080/02699050500487605; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Bruno MA, 2011, CURR OPIN CRIT CARE, V17, P146, DOI 10.1097/MCC.0b013e328343476d; Childs NL, 1996, NEW ENGL J MED, V334, P24, DOI 10.1056/NEJM199601043340105; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Demertzi A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00245; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2014, ARCH PHYS MED REHAB, V95, P711, DOI 10.1016/j.apmr.2013.11.004; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GillThwaites H, 1997, BRAIN INJURY, V11, P723, DOI 10.1080/026990597123098; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; McMillan TM, 2004, BRAIN INJURY, V18, P935, DOI 10.1080/02699050410001675915; Mohonk Report: a report to congress improving outcomes for individuals with disorders of consciousness assessment treatment and research needs, 2006, MOHONK REPORT REPORT; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Royal College of Physicians of London, 2013, PROL DIS CONSC NAT C; Samanta J, 2016, CONT ISSUES LAW, V14, P63; Sancisi E, 2009, BRAIN INJURY, V23, P163, DOI 10.1080/02699050802660446; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Steppacher I, 2014, ANN CLIN TRANSL NEUR, V1, P401, DOI 10.1002/acn3.63; Thonnard M, 2014, BRAIN INJURY, V28, P1164, DOI 10.3109/02699052.2014.920521; Vanhaudenhuyse A, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.121624; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Yelden K, 2018, NEUROPSYCHOL REHABIL, V28, P1415, DOI 10.1080/09602011.2017.1310657	31	8	8	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2018	40	20					2433	2438		10.1080/09638288.2017.1339209			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GR2NH	WOS:000442411400010	28633545	Green Submitted			2022-02-06	
J	Yoshida, K; Ogawa, K; Mototani, T; Inagaki, Y; Sawamura, D; Ikoma, K; Sakai, S				Yoshida, Kazuki; Ogawa, Keita; Mototani, Takuroh; Inagaki, Yuji; Sawamura, Daisuke; Ikoma, Katsunori; Sakai, Shinya			Flow experience enhances the effectiveness of attentional training: A pilot randomized controlled trial of patients with attention deficits after traumatic brain injury	NEUROREHABILITATION			English	Article						Flow state; attention; brain injury; randomized controlled trial; rehabilitation; psychological effects	INTRINSIC MOTIVATION; OUTCOME MEASURES; HEAD-INJURY; REHABILITATION; RELIABILITY; SCHIZOPHRENIA; QUESTIONNAIRE; AWARENESS; SCALE	BACKGROUND: Flow is an optimal psychological state when people engage in a training task, and it is a theory explaining the absorbed state. OBJECTIVE: To investigate the additional effect of flow on attention deficits for chronic patients after traumatic brain injury. METHODS: Twenty patients were randomly assigned to the flow group (n = 10) or the control group. Patients performed a video game task, one inducing flow (flow group) and the other not (control group) for 4 weeks, and they were assessed with the flow state scale for occupational tasks (FSSOT) regularly and neuropsychological tests at baseline, after intervention, and at 4 weeks after intervention (follow-up). RESULTS: Although both groups significantly improved their attentional function after intervention, patients in the flow group tended to show more improvement of attention. The effect size of the neuropsychological test of attention was positive, and its value was small to medium. There was a significant positive correlation between improvement of attention and the FSSOT score. CONCLUSIONS: Attention training with induction of the flow was associated with greater improvement of attention. The results of this study may provide provisional evidence of the effectiveness of rehabilitation considering the patient's psychological state.	[Yoshida, Kazuki; Sakai, Shinya] Hokkaido Univ, Fac Hlth Sci, Dept Functioning & Disabil, Sapporo, Hokkaido, Japan; [Ogawa, Keita; Mototani, Takuroh; Inagaki, Yuji] Hokkaido Univ Hosp, Dept Rehabil, Sapporo, Hokkaido, Japan; [Sawamura, Daisuke] Hokkaido Univ, Hlth Sci, Sch Rehabil Sci, Dept Occupat Therapy, Sapporo, Hokkaido, Japan; [Ikoma, Katsunori] Hokkaido Univ Hosp, Dept Rehabil Med, Sapporo, Hokkaido, Japan		Yoshida, K (corresponding author), Hokkaido Univ, Fac Hlth Sci, Dept Functioning & Disabil, Kita Ku, N12-W5, Sapporo, Hokkaido 0600812, Japan.	ot-k-yoshida@huhp.hokudai.ac.jp	Sawamura, Daisuke/AAK-3975-2021; Sakai, Shinya/D-7474-2012	Sawamura, Daisuke/0000-0003-3180-3474; 	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [26750196]	This work was partly supported by Japan Society for the Promotion of Science Grants-in-Aid for Young Scientist (B) (26750196 to K.Y.). The authors have no conflicts of interests.	BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Chelazzi L, 2013, VISION RES, V85, P58, DOI 10.1016/j.visres.2012.12.005; Choi J, 2010, SCHIZOPHR RES, V118, P12, DOI 10.1016/j.schres.2009.08.001; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Csikszentmihalyi M., 1990, FLOW PSYCHOL OPTIMAL; Csikszentmihalyi M., 2000, BOREDOM ANXIETY; Csikszentmihalyi M., 2010, EFFORTLESS ATTENTION, P179, DOI DOI 10.7551/MITPRESS/9780262013840.003.0009; Csikszentmihalyi M., 1988, OPTIMAL EXPERIENCE P, P266; de Manzano O, 2013, NEUROIMAGE, V67, P1, DOI 10.1016/j.neuroimage.2012.10.072; Hallock H, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00537; Heaton PDRK., 1993, WISCONSIN CARD SORTI; JENNETT B, 1977, LANCET, V1, P878; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klasen M, 2012, SOC COGN AFFECT NEUR, V7, P485, DOI 10.1093/scan/nsr021; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nakagami E, 2010, SCHIZOPHRENIA BULL, V36, P935, DOI 10.1093/schbul/sbq043; Nakamura J., 2002, HDB POSITIVE PSYCHOL, P89, DOI DOI 10.1007/978-94-017-9088-8_; Namiki J, 2007, NIPPON RINSYO KYUKYU, V10, P20; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Sawada M, 2015, SCIENCE, V350, P98, DOI 10.1126/science.aab3825; Sawamura D, 2012, HIGHER BRAIN FUNCTIO, V33, P533; Schmidt M., 1996, REY AUDITORY VERBAL; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Smith A., 1968, LEARN DISORD, V3, P83, DOI 10.1080/13803390591004428; Sugavanam T, 2013, DISABIL REHABIL, V35, P177, DOI 10.3109/09638288.2012.690501; Tasky KK, 2008, J APPL BEHAV ANAL, V41, P261, DOI 10.1901/jaba.2008.41-261; Tatla SK, 2014, BRAIN INJURY, V28, P1022, DOI 10.3109/02699052.2014.890747; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Ulrich M, 2014, NEUROIMAGE, V86, P194, DOI 10.1016/j.neuroimage.2013.08.019; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; Virk S, 2015, NEUROREHABILITATION, V36, P367, DOI 10.3233/NRE-151225; Weicker J, 2016, NEUROPSYCHOLOGY, V30, P190, DOI 10.1037/neu0000227; Whyte J, 2008, ARCH PHYS MED REHAB, V89, P966, DOI 10.1016/j.apmr.2007.12.031; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Yoshida K, 2014, HONG KONG J OCCUP TH, V24, P81, DOI 10.1016/j.hkjot.2015.01.001; Yoshida K, 2014, NEUROSCI LETT, V573, P30, DOI 10.1016/j.neulet.2014.05.011; Yoshida K, 2013, HONG KONG J OCCUP TH, V23, P54, DOI 10.1016/j.hkjot.2013.09.002	42	8	8	2	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	43	2					183	193		10.3233/NRE-172396			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GS1MK	WOS:000443290000008	30040757	Green Submitted			2022-02-06	
S	Zetterberg, H; Blennow, K		Hainline, B; Stern, RA		Zetterberg, Henrik; Blennow, Kaj			Chronic traumatic encephalopathy: fluid biomarkers	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							SPECTRIN BREAKDOWN PRODUCTS; SERUM NEUROFILAMENT LIGHT; ALPHA-II-SPECTRIN; BRAIN-INJURY; CEREBROSPINAL-FLUID; POSTCONCUSSION SYNDROME; TAU PROTEINS; DIAGNOSIS; DISEASE; BLOOD	Chronic traumatic encephalopathy (CTE) is a neuropathologic condition that has been described in individuals who have been exposed to repetitive head impacts, including concussions and subconcussive trauma. CTE cannot currently be diagnosed during life. Clinical symptoms of CTE (including changes in mood, behavior, and cognition) are nonspecific and may develop after a latency phase following the injuries. Differential diagnosis based solely on clinical features is, therefore, difficult. For example, some younger patients who do not experience the latency phase (i.e., symptoms of CTE may begin while still being exposed to the repetitive head impacts) may be clinically diagnosed with postconcussive syndrome, a vaguely defined condition that is described in a minority of concussed patients. Some older patients whose initial features of CTE include memory and executive dysfunction and progress to impaired activities of daily living may be clinically diagnosed with Alzheimer disease or another dementia. Although concussions are common in athletes and nonathletes, contact/collision sport athletes, such as boxers, American football players, and ice hockey players, are at greater risk of exposure to both concussion and repetitive subconcussive head impacts. Biomarkers for CTE pathophysiology would be of great value to study and improve our understanding of when and how the disease process starts and develops, as well as how it can be prevented or treated. Here, we review the literature regarding fluid biomarkers for repetitive subconcussive impacts, concussion, postconcussive syndrome, and CTE. We also discuss technical issues and potential pathways forward regarding how to move the most promising biomarker candidates into clinical laboratory practice.	[Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, S-43180 Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England		Zetterberg, H (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, S-43180 Molndal, Sweden.	henrik.zetterberg@gu.se			European Research CouncilEuropean Research Council (ERC)European Commission; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Medical Research Council (UK)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Swedish State Support for Clinical Research; Torsten Soderberg Foundation; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation; VINNOVAVinnova; Wolfson Foundation	Work in the authors' laboratories is supported by the European Research Council, the Swedish Research Council, the Medical Research Council (UK), Swedish State Support for Clinical Research, the Torsten Soderberg Foundation, the Knut and Alice Wallenberg Foundation, VINNOVA, and the Wolfson Foundation.	Alosco M, ALZHEIMERS DEMENT; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Apweiler R, 2009, CLIN CHEM LAB MED, V47, P724, DOI 10.1515/CCLM.2009.167; Babcock L, 2013, PEDIATR EMERG CARE, V29, P458, DOI 10.1097/PEC.0b013e31828a202d; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bolstad N, 2013, BEST PRACT RES CL EN, V27, P647, DOI 10.1016/j.beem.2013.05.011; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Chen AQ, 2016, NEUROBIOL AGING, V38, P56, DOI 10.1016/j.neurobiolaging.2015.10.021; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Devic I, 2011, BRAIN, V134, DOI 10.1093/brain/awr015; Duits FH, 2016, ALZHEIMERS DEMENT, V12, P154, DOI 10.1016/j.jalz.2015.08.003; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Ghidoni R, 2018, J ALZHEIMERS DIS, V62, P1507, DOI 10.3233/JAD-170953; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; Hampel H, 2004, ARCH GEN PSYCHIAT, V61, P95, DOI 10.1001/archpsyc.61.1.95; Heslegrave A, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0071-x; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Kricka LJ, 1999, CLIN CHEM, V45, P942; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Portelius E, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0152-5; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Schulte S, 2016, EPMA J, V7, DOI 10.1186/s13167-016-0050-x; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2017, NEUROLOGY, V88, P1400, DOI 10.1212/WNL.0000000000003816; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shi M, 2011, J ALZHEIMERS DIS, V27, P299, DOI 10.3233/JAD-2011-110731; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Sundman M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00334; Todd J, 2007, CLIN CHEM, V53, P1990, DOI 10.1373/clinchem.2007.091181; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Yoshimura T, 2008, TUMOR BIOL, V29, P224, DOI 10.1159/000152940; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	83	8	9	0	1	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						323	333		10.1016/B978-0-444-63954-7.00030-6			11	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100032	30482360				2022-02-06	
J	Zhang, R; Liang, Y; Wei, SX				Zhang, Ran; Liang, Yi; Wei, Shuxiang			The expressions of NGF and VEGF in the fracture tissues are closely associated with accelerated clavicle fracture healing in patients with traumatic brain injury	THERAPEUTICS AND CLINICAL RISK MANAGEMENT			English	Article						traumatic brain injury; fracture healing; clavicle fracture; NGF; VEGF; angiogenesis	NERVE GROWTH-FACTOR; BONE-FORMATION; REGENERATION; CELLS; NEUROTROPHINS; CARTILAGE; VESSEL; REPAIR; ROLES	Background: Angiogenesis and bone formation are vital for fracture healing. Nerve growth factor (NGF) not only promotes neuronal survival but also enhances the proliferation and differentiation of osteoblasts. Vascular endothelial growth factor (VEGF) plays an important role in angiogenesis. However, the potential correlation of NGF and VEGF levels with fracture healing in patients with traumatic brain injury (TBI) remains unclear. Methods: This study enrolled 22 patients with clavicle fracture and concomitant TBI (CFT group) and 25 patients with clavicle fracture alone (CF group). Serum NGF levels were measured with ELISA. The expressions of NGF, VEGF, and CD31 in callus tissues were measured with immunohistochemistry. Results: The fracture healing time in CFT group (82.22 +/- 13.61 days) was significantly shorter than that in CF group (127 +/- 25.05 days; P<0.001). The expression of CD31, marker of blood vessels, in callus tissues of CFT group was higher compared with that of CF group. Serum NGF levels and the expression of NGF in callus tissues of CFT group were higher than those in CF group (P< 0.01). The expressions of CD31, NGF, and VEGF are correlated with shorter fracture healing time. Conclusion: The formation of blood vessels was increased in CFT group compared with CF group. NGF and VEGF levels were higher in CFT group than in CF group and correlated with shorter fracture healing time. Accelerated fracture healing in patients with TBI may be due to NGF- and VEGF-mediated angiogenesis at the fracture site.	[Zhang, Ran; Liang, Yi; Wei, Shuxiang] Liuzhou Gen Hosp, Dept Orthoped, 8 Wenchang Rd, Liuzhou 545006, Guangxi, Peoples R China; [Zhang, Ran] Guangxi Univ Technol, Affiliated Liuzhou Gen Hosp, Dept Orthoped, Liuzhou 545006, Guangxi, Peoples R China		Zhang, R (corresponding author), Liuzhou Gen Hosp, Dept Orthoped, 8 Wenchang Rd, Liuzhou 545006, Guangxi, Peoples R China.	zr7971@126.com	Liang, Yi/ABD-9785-2021	Liang, Yi/0000-0002-6440-6144	Science and Technology Program of Liuzhou [2015 J030524]	The study was supported by the Science and Technology Program of Liuzhou (No 2015 J030524).	Aiga A, 2006, ACTA MED OKAYAMA, V60, P267; Baht GS, 2018, CURR OSTEOPOROS REP, V16, P138, DOI 10.1007/s11914-018-0423-2; Bajwa NM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00115; Bei Chaoyong, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P570; Bracci-Laudiero L, 2016, CURR TOP BEHAV NEURO, V29, P125, DOI 10.1007/7854_2015_420; Brohlin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045052; Cao J, 2012, OR SURG OR MED OR PA, V113, P48, DOI 10.1016/j.tripleo.2011.01.021; Clarkin CE, 2013, CELL BIOCHEM FUNCT, V31, P1, DOI 10.1002/cbf.2911; D'Amore PA, 2007, AM J PATHOL, V171, P14, DOI 10.2353/ajpath.2007.070385; Frey SP, 2012, CLIN ORTHOP RELAT R, V470, P3607, DOI 10.1007/s11999-012-2456-7; Jin P, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.173; Kawamoto K, 2004, PROG BRAIN RES, V146, P369; Kolostova K, 2012, EUR ARCH OTO-RHINO-L, V269, P1763, DOI 10.1007/s00405-011-1821-6; Lienau J, 2009, J ORTHOP RES, V27, P1133, DOI 10.1002/jor.20870; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Majuta LA, 2015, PAIN, V156, P157, DOI 10.1016/j.pain.0000000000000017; Matsumoto K, 2014, J BIOCHEM, V156, P1, DOI 10.1093/jb/mvu031; Mecollari V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00328; Minnone G, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051028; Pajarinen J, BIOMATERIALS; Peng SP, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/8273648; Raychaudhuri SK, 2001, ARCH DERMATOL RES, V293, P291, DOI 10.1007/s004030100224; Sang QL, 2018, BIOMED PHARMACOTHER, V103, P1146, DOI 10.1016/j.biopha.2018.04.116; Schlundt C, 2018, BONE, V106, P78, DOI 10.1016/j.bone.2015.10.019; Seemann R, 2018, J MUSCULOSKEL NEURON, V18, P32; Su YW, 2018, J CELL PHYSIOL, V233, P2133, DOI 10.1002/jcp.25936; Su YW, 2016, J BONE MINER RES, V31, P1258, DOI 10.1002/jbmr.2786; Sun WJ, 2009, BIOMATERIALS, V30, P4649, DOI 10.1016/j.biomaterials.2009.05.037; Taghi GM, 2012, CELL BIOL INT, V36, P1239, DOI 10.1042/CBI20110618; Tomlinson RE, 2017, P NATL ACAD SCI USA, V114, pE3632, DOI 10.1073/pnas.1701054114; Wang H, 2017, J ETHNOPHARMACOL, V209, P13, DOI 10.1016/j.jep.2017.06.040; Wilson SS, 2015, J ORTHOP RES, V33, P1364, DOI 10.1002/jor.22898; Yang TY, 2012, J BONE JOINT SURG BR, V94B, P227, DOI 10.1302/0301-620X.94B2.28193; Zhang J, 2017, ONCOTARGET, V8, P73529, DOI 10.18632/oncotarget.19867; Zheng YN, 2018, BRAIN RES BULL, V139, P211, DOI 10.1016/j.brainresbull.2018.03.005	36	8	9	0	4	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-203X			THER CLIN RISK MANAG	Therap. Clin. Risk Manag.		2018	14						2315	2322		10.2147/TCRM.S182325			8	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	HB7SX	WOS:000451282300002	30538487	Green Published, gold, Green Submitted			2022-02-06	
J	Zhang, WL; Cao, YA; Xia, J; Tian, L; Yang, L; Peng, CS				Zhang, Wen-Luo; Cao, Yue-An; Xia, Jing; Tian, Li; Yang, Lu; Peng, Chao-Sheng			Neuroprotective effect of tanshinone IIA weakens spastic cerebral palsy through inflammation, p38MAPK and VEGF in neonatal rats	MOLECULAR MEDICINE REPORTS			English	Article						tanshinone IIA; spastic cerebral palsy; inflammation; p38 mitogen-activated protein kinase; vascular endothelial growth factor	TRAUMATIC BRAIN-INJURY; PLACENTAL INFLAMMATION; NEUROPATHIC PAIN; PRETERM INFANTS; UP-REGULATION; MOUSE MODEL; CELLS; INHIBITION; PATHWAY; DEATH	As one of main active ingredients of salvia miltiorrhizae, which is a traditional Chinese medicine, tanshinone IIA is the basis of its pharmacological activities. In the present study, the effect of tanshinone IIA on weakening spastic cerebral palsy (SCP) in neonatal rats was investigated. Radial arm water maze and holding tests were used to measure the alterations of spastic cerebral palsy, inflammation was measured using an ELISA kit, and western blot analysis was used to analyze the protein expression of p-p38 mitogen-activated protein kinase (MAPK) and vascular endothelial growth factor (VEGF). The central mechanisms involved in the mediation or modulation of inflammation, p-p38 MAPK and VEGF were also investigated. Treatment with tanshinone IIA effectively inhibited spastic cerebral palsy, and the activities of interleukin (IL)-1, IL-6, tumor necrosis factor-, monocyte chemoattractant protein 1, cyclooxygenase-2 and prostaglandin E2 in a neonatal rat model of SCP. Tanshinone IIA effectively suppressed the protein expression of inducible nitric oxide synthase (NOS), phosphorylated (p-) nuclear factor (NF)-B, p-p38MAPK and VEGF, and activated the phosphorylation of inhibitor of NF-B and the protein expression of neuronal NOS in the SCP rat model. These results suggested that the neuroprotective effect of tanshinone IIA weakened SCP through inflammation, p38MAPK and VEGF in the neonatal rats.	[Zhang, Wen-Luo; Cao, Yue-An; Xia, Jing; Tian, Li; Yang, Lu; Peng, Chao-Sheng] Navy Gen Hosp, Dept Special Med Div, 6 Fucheng Rd, Beijing 100048, Peoples R China		Peng, CS (corresponding author), Navy Gen Hosp, Dept Special Med Div, 6 Fucheng Rd, Beijing 100048, Peoples R China.	pengcscsbj@163.com					Bai YQ, 2016, EXP THER MED, V11, P1085, DOI 10.3892/etm.2016.2984; Beloosesky R., 2013, AM J OBSTET GYNECOL, V208, pe1; Choi DC, 2012, EXP NEUROL, V236, P268, DOI 10.1016/j.expneurol.2012.05.014; Colson SB, 2013, J PEDIATR GASTR NUTR, V56, pE50, DOI 10.1097/MPG.0b013e318291fd7c; Dashti SR, 2015, J NEUROSURG-PEDIATR, V15, P20, DOI 10.3171/2014.9.PEDS14198; Destot-Wong KD, 2009, NEUROPHARMACOLOGY, V57, P277, DOI 10.1016/j.neuropharm.2009.05.010; El Ghazi F, 2012, NEUROBIOL DIS, V45, P871, DOI 10.1016/j.nbd.2011.12.003; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Goldenberg RL, 2016, BJOG-INT J OBSTET GY, V123, P1964, DOI 10.1111/1471-0528.14210; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Huetz N, 2016, BJOG-INT J OBSTET GY, V123, P1956, DOI 10.1111/1471-0528.14177; Jacobsson B, 2004, EUR J OBSTET GYN R B, V115, P159, DOI 10.1016/j.ejogrb.2003.11.014; Jiang CM, 2016, AM J CHINESE MED, V44, P737, DOI 10.1142/S0192415X16500403; Jin XL, 2014, MICROCIRCULATION, V21, P171, DOI 10.1111/micc.12103; Kerkum YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142878; Kuypers E, 2012, EARLY HUM DEV, V88, P931, DOI 10.1016/j.earlhumdev.2012.09.011; Lee KF, 2014, INT J MOL SCI, V15, P15073, DOI 10.3390/ijms150915073; Lin JY, 2015, PHYTOMEDICINE, V22, P929, DOI 10.1016/j.phymed.2015.06.012; Liu X, 2013, BIOMATERIALS, V34, P6893, DOI 10.1016/j.biomaterials.2013.05.021; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lu BL, 2016, NEUROREPORT, V27, P883, DOI 10.1097/WNR.0000000000000618; Qi YC, 2014, ASIAN PAC J TROP MED, V7, P492, DOI 10.1016/S1995-7645(14)60081-X; Qiu SH, 2016, BIOORG MED CHEM LETT, V26, P2503, DOI 10.1016/j.bmcl.2016.03.097; Ragin AB, 2006, NEUROLOGY, V66, P1255, DOI 10.1212/01.wnl.0000208433.34723.65; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Srivastava IN, 2016, NEUROBIOL DIS, V85, P144, DOI 10.1016/j.nbd.2015.10.001; Su JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120707; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Tang J, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0279-7; Wang CX, 2015, BRAIN RES, V1594, P245, DOI 10.1016/j.brainres.2014.10.014; Wang ZR, 2016, ASIAN PAC J TROP MED, V9, P269, DOI 10.1016/j.apjtm.2016.01.027; Xu ZH, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-331; Yang H, 2012, NEUROCHEM INT, V61, P175, DOI 10.1016/j.neuint.2012.04.020; Zhang KJ, 2016, BLOOD CELL MOL DIS, V56, P46, DOI 10.1016/j.bcmd.2015.10.007; Zheng XR, 2012, BEHAV BRAIN RES, V230, P108, DOI 10.1016/j.bbr.2012.01.026	35	8	12	0	11	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JAN	2018	17	1					2012	2018		10.3892/mmr.2017.8069			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	FT8WG	WOS:000423433300256	29257210	Bronze			2022-02-06	
J	Qin, HL; Qin, J; Hu, JM; Huang, H; Ma, LT				Qin, Hailin; Qin, Jie; Hu, Junmin; Huang, He; Ma, Lianting			Malva Sylvestris Attenuates Cognitive Deficits in a Repetitive Mild Traumatic Brain Injury Rat Model by Reducing Neuronal Degeneration and Astrocytosis in the Hippocampus	MEDICAL SCIENCE MONITOR			English	Article						Astrocytes; Brain Injuries; Neurodegenerative Diseases	CELL-DEATH; INFLAMMATION; DISEASE; DAMAGE; BLAST	Background: The aim of our study was to evaluate the effect of Malva sylvestris (MS) on cognitive dysfunction in a repetitive mild traumatic brain injury (MTBI). Material/Methods: MTBI was induced in all the study animals by hitting a metallic pendulum near the parietal-occipital area of the skull three times a day for ten days. Animals were treated with MS (250 mg/kg and 500 mg/kg) intragastrically per day for seven consecutive days. Cognitive function was estimated by the Morris water maze (MWM) method. Histopathology studies were performed on the hippocampal region by Nissl staining and anti GFAP staining. Concentrations of reactive oxygen species (ROS), and oxidative parameters including superoxide dismutase (SOD), catalase (CAT), and lipid peroxidation (LPO), and inflammatory cytokines in the brain tissues were measured. Result: Treatment with MS significantly improved cognitive function compared to the negative control. Histopathology studies suggested that treatment with MS significantly decreased (p< 0.01) the count of neurodegenerative cells and induction of astrocytosis in the MTBI treated group compared to the negative control group. However, the concentrations of ROS and LPO, and the activities of SOD and CAT were significantly decreased in the MS treated groups of MTBI rats compared to the negative control group. Inflammatory cytokines, such as IL-1b, IL6, and TNF-alpha were significantly decreased (p< 0.01) in the brain tissues of the MTBI treated group compared to the control group of rats. Conclusions: This study concluded that treatment with MS significantly improved cognitive dysfunction by reducing neurodegeneration and astrocytosis in brain tissues via decreasing oxidative stress and inflammation in neuronal cells.	[Qin, Hailin; Ma, Lianting] Southern Med Univ, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Qin, Hailin; Qin, Jie; Hu, Junmin; Huang, He; Ma, Lianting] Wuhan Gen Hosp PLA, Dept Neurosurg, Wuhan, Hubei, Peoples R China		Ma, LT (corresponding author), Southern Med Univ, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China.; Ma, LT (corresponding author), Wuhan Gen Hosp PLA, Dept Neurosurg, Wuhan, Hubei, Peoples R China.	liantingma@hotmail.com			Major High-Tech Clinical Projects of PLA [2010gxjs034]	Major High-Tech Clinical Projects of PLA (Project No: 2010gxjs034)	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Blostein PA, 1997, J NEUROTRAUM, V14, P171, DOI 10.1089/neu.1997.14.171; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Cheng Cui-lin, 2006, Journal of Forestry Research (Harbin), V17, P83, DOI 10.1007/s11676-006-0020-6; Chkhikvishvili I, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/456253; Cooper C, 2013, BRIT J PSYCHIAT, V203, P255, DOI 10.1192/bjp.bp.113.127811; Esopenko C, 2015, J NEUROTRAUM, V32, P209, DOI 10.1089/neu.2014.3506; Esteves PF, 2009, LAT AM J PHARM, V28, P454; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Min JY, 2011, NEUROSCI LETT, V500, P157, DOI 10.1016/j.neulet.2011.05.048; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Prudente AS, 2013, FOOD CHEM TOXICOL, V58, P324, DOI 10.1016/j.fct.2013.04.042; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rossi D, 2015, PROG NEUROBIOL, V130, P86, DOI 10.1016/j.pneurobio.2015.04.003; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Song H, 2016, NEUROSCI LETT, V622, P95, DOI 10.1016/j.neulet.2016.04.048; Tsai YD, 2013, BRAIN INJURY, V27, P361, DOI 10.3109/02699052.2012.750738; Wang C, 2012, J NEUROCHEM, V121, P1007, DOI 10.1111/j.1471-4159.2012.07744.x; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040	23	8	8	0	11	INT SCIENTIFIC LITERATURE, INC	SMITHTOWN	361 FOREST LANE, SMITHTOWN, NY 11787 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	DEC 25	2017	23						6099	6106		10.12659/MSM.905429			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FQ8OM	WOS:000418622100001	29276216	Green Published, Green Submitted			2022-02-06	
J	Wang, LG; Wang, LB; Dai, ZB; Wu, P; Shi, HZ; Zhao, SG				Wang, Ligang; Wang, Libo; Dai, Zhibo; Wu, Pei; Shi, Huaizhang; Zhao, Shiguang			Lack of mitochondrial ferritin aggravated neurological deficits via enhancing oxidative stress in a traumatic brain injury murine model	BIOSCIENCE REPORTS			English	Article							N-ACETYLCYSTEINE; DAMAGE; NEUROPROTECTION	Oxidative stress has been strongly implicated in the pathogenesis of traumatic brain injury (TBI). Mitochondrial ferritin (Ftmt) is reported to be closely related to oxidative stress. However, whether Ftmt is involved in TBI-induced oxidative stress and neurological deficits remains unknown. In the present study, the controlled cortical impact model was established in wild-type and Ftmt knockout mice as a TBI model. The Ftmt expression, oxidative stress, neurological deficits, and brain injury were measured. We found that Ftmt expression was gradually decreased from 3 to 14 days post-TBI, while oxidative stress was gradually increased, as evidenced by reduced GSH and superoxide dismutase levels and elevated malondialdehyde and nitric oxide levels. Interestingly, the extent of reduced Ftmt expression in the brain was linearly correlated with oxidative stress. Knockout of Ftmt significantly exacerbated TBI-induced oxidative stress, intracerebral hemorrhage, brain infarction, edema, neurological severity score, memory impairment, and neurological deficits. However, all these effects in Ftmt knockout mice were markedly mitigated by pharmacological inhibition of oxidative stress using an antioxidant, N-acetylcysteine. Taken together, these results reveal an important correlation between Ftmt and oxidative stress after TBI. Ftmt deficiency aggravates TBI-induced brain injuries and neurological deficits, which at least partially through increasing oxidative stress levels. Our data suggest that Ftmt may be a promising molecular target for the treatment of TBI.	[Wang, Ligang; Dai, Zhibo; Wu, Pei; Shi, Huaizhang; Zhao, Shiguang] Harbin Med Univ, Affiliated Hosp 1, Dept Neurosurg, Harbin 150001, Heilongjiang, Peoples R China; [Wang, Libo] Mudanjiang Chinese Tradit Med Hosp, Dept Med & Management, Mudanjiang 157000, Peoples R China		Zhao, SG (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Neurosurg, Harbin 150001, Heilongjiang, Peoples R China.	guangsz@yeah.net			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401009]; Nature Science Foundation of Heilongjiang Province, China [QC2013C088]	This study was supported by National Nature Science Foundation of China [grant number 81401009] and Nature Science Foundation of Heilongjiang Province, China [grant number QC2013C088].	Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Asevedo E, 2014, REV BRAS PSIQUIATR, V36, P168, DOI 10.1590/1516-4446-2013-1244; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Buhmann CB, 2014, DAN MED J, V61; Campanella A, 2009, HUM MOL GENET, V18, P1, DOI 10.1093/hmg/ddn308; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Darvesh AS, 2010, EXPERT REV NEUROTHER, V10, P729, DOI 10.1586/ERN.10.42; Drysdale J, 2002, BLOOD CELL MOL DIS, V29, P376, DOI 10.1006/bcmd.2002.0577; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Laskowitz DT, 2017, SCI REP-UK, V7, DOI 10.1038/srep46461; Levi S, 2004, INT J BIOCHEM CELL B, V36, P1887, DOI 10.1016/j.biocel.2003.10.020; Levi S, 2001, J BIOL CHEM, V276, P24437, DOI 10.1074/jbc.C100141200; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ozay R, 2017, WORLD NEUROSURG, V104, P634, DOI 10.1016/j.wneu.2017.04.136; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Santambrogio P, 2007, J HISTOCHEM CYTOCHEM, V55, P1129, DOI 10.1369/jhc.7A7273.2007; Senol N, 2014, NEUROCHEM RES, V39, P685, DOI 10.1007/s11064-014-1255-9; Shi ZH, 2010, ANTIOXID REDOX SIGN, V13, P783, DOI 10.1089/ars.2009.3018; Simon D, 2015, BRAIN INJURY, V29, P612, DOI 10.3109/02699052.2014.995228; Wang LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022325; Wang P., 2017, OXID MED CELL LONGEV, V2017, DOI DOI 10.1155/2017/1020357; Wang W, 2010, BBA-GEN SUBJECTS, V1800, P760, DOI 10.1016/j.bbagen.2010.03.011; WHO, 2014, WHO 2014 AMR REP, P1; Wu WS, 2013, ANTIOXID REDOX SIGN, V18, P158, DOI 10.1089/ars.2011.4285; Yang HK, 2015, J ALZHEIMERS DIS, V45, P797, DOI 10.3233/JAD-142595; Yang HK, 2013, NEUROSCI RES, V77, P1, DOI 10.1016/j.neures.2013.07.005; You LH, 2015, NEUROSCIENCE, V284, P234, DOI 10.1016/j.neuroscience.2014.09.071	29	8	9	2	11	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0144-8463	1573-4935		BIOSCIENCE REP	Biosci. Rep.	DEC 22	2017	37		6						BSR20170942	10.1042/BSR20170942			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FN2ON	WOS:000415833300006	28963372	Green Submitted, gold, Green Published			2022-02-06	
J	Huang, CY; Lee, YC; Li, PC; Liliang, PC; Lu, K; Wang, KW; Chang, LC; Shiu, LY; Chen, MF; Sun, YT; Wang, HK				Huang, Chih-Yuan; Lee, Yi-Che; Li, Ping-Chia; Liliang, Po-Chou; Lu, Kang; Wang, Kuo-Wei; Chang, Li-Ching; Shiu, Li-Yen; Chen, Ming-Feng; Sun, Yuan-Ting; Wang, Hao-Kuang			TDP-43 proteolysis is associated with astrocyte reactivity after traumatic brain injury in rodents	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Astrocyte; Astrogliosis; Traumatic brain injury; Transactivation response DNA-binding protein 43	AMYOTROPHIC-LATERAL-SCLEROSIS; NEUROPATHOLOGY; EXPRESSION; DEATH; RATS; PROTEINOPATHY; AGGREGATION; ACTIVATION; TOXICITY; DEMENTIA	The aggregation and deposition of transactivation response DNA-binding protein 43 (TDP-43) in neurons and astrocytes is characteristic in a number of neurodegenerative diseases including Alzheimer's disease, frontotemporal lobar degeneration, and amyotrophic lateral sclerosis. Nevertheless, the exact role of TDP-43 in astrocytes is unknown. Recently, TDP-43 was identified in neurons but not astrocytes after traumatic brain injury (TBI) in humans. In the present study, we evaluated TDP-43 expression and proteolysis in astrocytes in a rat model of TBI. We assessed TDP-43 fragment expression, astrocyte morphology, neuronal population numbers, and motor function after TBI with or without intracerebroventricular administration of a caspase-3 inhibitor. Motor dysfunction was observed after TBI in potential association astrocytic TDP-43 short fragment mislocalization and accumulation, astrogliosis, and neuronal loss. Notably, caspase-3 inhibition prevented these changes after TBI. Our findings suggest that TDP-43 proteolysis in astrocytes is related to astrogliosis and subsequent neuronal loss in TBI, and that TDP-43 may be an important therapeutic target for preventing motor dysfunction after TBI.	[Huang, Chih-Yuan] Natl Cheng Kung Univ Hosp, Dept Surg, Neurosurg Serv, Tainan, Taiwan; [Lee, Yi-Che] I Shou Univ, E Da Hosp, Dept Nephrol, Kaohsiung, Taiwan; [Li, Ping-Chia; Liliang, Po-Chou; Lu, Kang; Wang, Kuo-Wei; Chang, Li-Ching; Wang, Hao-Kuang] I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan; [Liliang, Po-Chou; Lu, Kang; Wang, Kuo-Wei; Wang, Hao-Kuang] I Shou Univ, E Da Hosp, Dept Neurosurg, 1 Yida Rd, Kaohsiung 82445, Taiwan; [Shiu, Li-Yen; Chen, Ming-Feng] I Shou Univ, E Da Hosp, Dept Med Res, Cell Therapy & Res Ctr, Kaohsiung, Taiwan; [Sun, Yuan-Ting] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Neurol, Coll Med, Tainan, Taiwan		Wang, HK (corresponding author), I Shou Univ, E Da Hosp, Dept Neurosurg, 1 Yida Rd, Kaohsiung 82445, Taiwan.	ed101393@edah.org.tw		Wang, Hao-Kuang/0000-0002-1928-7502	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [103-2314-B-214-007-MY2]; E-da hospital, Kaohsiung, Taiwan [EDAHP-101026, EDAHP-103012, EDPJ103075, EDPJ104072]	This study was supported in part by grants from the Ministry of Science and Technology, Taiwan (103-2314-B-214-007-MY2) and the E-da hospital, Kaohsiung, Taiwan (EDAHP-101026, EDAHP-103012, EDPJ103075 and EDPJ104072).	Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Che MX, 2011, FASEB J, V25, P2344, DOI 10.1096/fj.10-174482; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; Fang YS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5824; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gendron TF, 2013, J ALZHEIMERS DIS, V33, pS35, DOI 10.3233/JAD-2012-129036; Haidet-Phillips AM, 2013, EXP NEUROL, V250, P250, DOI 10.1016/j.expneurol.2013.10.004; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Liliang PC, 2010, RESUSCITATION, V81, P1205, DOI 10.1016/j.resuscitation.2010.05.016; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Moisse K, 2009, BRAIN RES, V1296, P176, DOI 10.1016/j.brainres.2009.07.023; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Rojas F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00024; Serio A, 2013, P NATL ACAD SCI USA, V110, P4697, DOI 10.1073/pnas.1300398110; Sieben A, 2012, ACTA NEUROPATHOL, V124, P353, DOI 10.1007/s00401-012-1029-x; Tong JB, 2013, EMBO J, V32, P1917, DOI 10.1038/emboj.2013.122; Wang HK, 2015, NEUROSCIENCE, V300, P94, DOI 10.1016/j.neuroscience.2015.05.013; Wang LF., 2012, P NATL ACAD SCI US; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	28	8	9	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	DEC 15	2017	313						61	68		10.1016/j.jneuroim.2017.10.011			8	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	FT2WM	WOS:000423006700009	29153610				2022-02-06	
J	Esenaliev, RO				Esenaliev, Rinat O.			Optoacoustic Monitoring of Physiologic Variables	FRONTIERS IN PHYSIOLOGY			English	Article						optoacoustic; photoacoustic; monitoring; imaging; sensing; physiologic	CEREBRAL BLOOD OXYGENATION; IN-VIVO; HEMOGLOBIN CONCENTRATION; REAL-TIME; LASER; DIAGNOSTICS; TISSUES; SYSTEM; SENSITIVITY; TOMOGRAPHY	Optoacoustic (photoacoustic) technique is a novel diagnostic platform that can be used for noninvasive measurements of physiologic variables, functional imaging, and hemodynamic monitoring. This technique is based on generation and time-resolved detection of optoacoustic (thermoelastic) waves generated in tissue by short optical pulses. This provides probing of tissues and individual blood vessels with high optical contrast and ultrasound spatial resolution. Because the optoacoustic waves carry information on tissue optical and thermophysical properties, detection, and analysis of the optoacoustic waves allow for measurements of physiologic variables with high accuracy and specificity. We proposed to use the optoacoustic technique for monitoring of a number of important physiologic variables including temperature, thermal coagulation, freezing, concentration of molecular dyes, nanoparticles, oxygenation, and hemoglobin concentration. In this review we present origin of contrast and high spatial resolution in these measurements performed with optoacoustic systems developed and built by our group. We summarize data obtained in vitro, in experimental animals, and in humans on monitoring of these physiologic variables. Our data indicate that the optoacoustic technology may be used for monitoring of cerebral blood oxygenation in patients with traumatic brain injury and in neonatal patients, central venous oxygenation monitoring, total hemoglobin concentration monitoring, hematoma detection and characterization, monitoring of temperature, and coagulation and freezing boundaries during thermotherapy.	[Esenaliev, Rinat O.] Univ Texas Med Branch, Lab Opt Sensing & Monitoring, Dept Neurosci & Cell Biol, Dept Anesthesiol,Ctr Biomed Engn, Galveston, TX 77555 USA		Esenaliev, RO (corresponding author), Univ Texas Med Branch, Lab Opt Sensing & Monitoring, Dept Neurosci & Cell Biol, Dept Anesthesiol,Ctr Biomed Engn, Galveston, TX 77555 USA.	riesenal@utmb.edu	Esenaliev, Rinat/Y-4361-2019	Esenaliev, Rinat/0000-0002-2848-5906	NIH from the National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB00763, U54EB007954]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044345, R21NS40531]; Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R41HD076568, R43HD075551]; National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R41HL10309501]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R41HD076568, R43HD075551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB000763, U54EB007954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044345] Funding Source: NIH RePORTER	The author thanks Drs. Donald S. Prough, Yuriy Petrov, Irene Y. Petrov, Claudia S. Robertson, C. Joan Richardson, other members of the Department of Anesthesiology, Department of Pediatrics and Neonatal Intensive Care Unit at UTMB, and the Department of Neurosurgery and Neurointensive Care Unit of Baylor College of Medicine. Grant support: NIH grants #R01EB00763 and #U54EB007954 from the National Institute of Biomedical Imaging and Bioengineering, #R01NS044345 and #R21NS40531 from the National Institute of Neurological Disorders and Stroke, #R41HD076568 and #R43HD075551 form the Eunice Kennedy Shriver National Institute of Child Health & Human Development, and #R41HL10309501 from the National Heart, Lung and Blood Institute, contracts from Noninvasix, Inc., the Texas Emerging Technology Fund, and the Moody Center for Brain and Spinal Cord Injury Research/Mission Connect of UTMB. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIBIB or NIH.	Bourantas CV, 2017, EUR HEART J, V38, P400, DOI 10.1093/eurheartj/ehw097; Brecht HP, 2007, OPT EXPRESS, V15, P16261, DOI 10.1364/OE.15.016261; Cai CZ, 2016, CYTOM PART A, V89A, P531, DOI 10.1002/cyto.a.22854; Choi SSS, 2016, BIOMED OPT EXPRESS, V7, P2586, DOI 10.1364/BOE.7.002586; Daoudi K, 2014, OPT EXPRESS, V22, P26365, DOI 10.1364/OE.22.026365; Ellwood R, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.12.126012; Esenaliev R.O., 2000, U.S. Patent, Patent No. 6165440; Esenaliev R. O., 2004, Continuous optoacoustic monitoring of hemoglobin concentration and hematorcit, Patent No. [6, 751, 490, 6751490]; Esenaliev R. O., 2016, Systems and methods for measuring fetal cerebral oxygenation, Patent No. [9, 380, 967, 9380967]; Esenaliev R. O., 1999, SPIE, V3601, P166; Esenaliev R. O., 2002, Patent No, Patent No. [6, 498, 942, 6498942]; Esenaliev R. O., 1998, P SOC PHOTO-OPT INS, V3726, P560; Esenaliev R. O., 2007, SPIE P, V6437; Esenaliev R. O., 2016, USPTO patent, Patent No. [9,504,824, 9504824]; Esenaliev RO, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.9.091512; Esenaliev RO, 1997, P SOC PHOTO-OPT INS, V2979, P71, DOI 10.1117/12.280213; Esenaliev RO, 1999, IEEE J SEL TOP QUANT, V5, P981, DOI 10.1109/2944.796320; Esenaliev RO, 1998, P SOC PHOTO-OPT INS, V3254, P294, DOI 10.1117/12.308176; Esenaliev RO, 2004, APPL OPTICS, V43, P3401, DOI 10.1364/AO.43.003401; Esenaliev RO, 2002, APPL OPTICS, V41, P4722, DOI 10.1364/AO.41.004722; ESENALIEV RO, 1993, LASER SURG MED, V13, P470, DOI 10.1002/lsm.1900130412; Esenaliev RO, 1996, P SOC PHOTO-OPT INS, V2676, P84, DOI 10.1117/12.238817; Herrmann S, 2017, PROC SPIE, V10064, DOI 10.1117/12.2256170; Jaeger M, 2013, PHOTOACOUSTICS, V1, P19, DOI 10.1016/j.pacs.2013.07.002; Larin K, 2001, PROC SPIE, V4256, P147, DOI 10.1117/12.429301; Larin KV, 2005, J PHYS D APPL PHYS, V38, P2645, DOI 10.1088/0022-3727/38/15/017; Larin KV, 2002, QUANTUM ELECTRON+, V32, P953, DOI 10.1070/QE2002v032n11ABEH002327; Larina IV, 2005, J PHYS D APPL PHYS, V38, P2633, DOI 10.1088/0022-3727/38/15/015; O'Donnell M, 2013, ANN BIOMED ENG, V41, P2237, DOI 10.1007/s10439-013-0901-8; Oraevsky A. A., 1998, US Patent, Patent No. [5,840,023, 5840023]; Patrikeev I, 2007, APPL OPTICS, V46, P4820, DOI 10.1364/AO.46.004820; Petrov A, 2014, PHOTOACOUSTICS, V2, P75, DOI 10.1016/j.pacs.2014.04.001; Petrov IY, 2012, OPT EXPRESS, V20, P4159, DOI 10.1364/OE.20.004159; Petrov IY, 2012, BIOMED OPT EXPRESS, V3, P125, DOI 10.1364/BOE.3.000125; Petrov I. Y., 2016, SPIE P; Petrov I. Y., 2017, P SPIE; Petrov Y., 2017, P SPIE, P10064; Petrov YY, 2006, OPT LETT, V31, P1827, DOI 10.1364/OL.31.001827; Petrov YY, 2005, ANESTHESIOLOGY, V102, P69, DOI 10.1097/00000542-200501000-00014; Petrova IY, 2009, OPT EXPRESS, V17, P7285, DOI 10.1364/OE.17.007285; Petrova IY, 2005, OPT LETT, V30, P1677, DOI 10.1364/OL.30.001677; Prough D. S., 2008, Patent No. [20080255433A1, 20080255433, US 2008/0255433.2008]; Su R, 2013, NUCL INSTRUM METH A, V720, P58, DOI 10.1016/j.nima.2012.12.035; Taruttis A, 2015, CANCER RES, V75, P1548, DOI 10.1158/0008-5472.CAN-14-2522; Tuchin V., 2016, HDB OPTICAL BIOMEDIC, V2; Tuchin V.V., 2016, HDB OPTICAL BIOMEDIC, V1; Welch AJ, 2011, OPTICAL THERMAL RESPONSE OF LASER-IRRADIATED TISSUE, SECOND EDITION, P1, DOI 10.1007/978-90-481-8831-4; Yao JJ, 2014, PHOTOACOUSTICS, V2, P87, DOI 10.1016/j.pacs.2014.04.002	48	8	8	3	7	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-042X			FRONT PHYSIOL	Front. Physiol.	DEC 12	2017	8								1030	10.3389/fphys.2017.01030			6	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	FP6LN	WOS:000417737700005	29311964	gold, Green Published			2022-02-06	
J	Thomschewski, A; Strohlein, A; Langthaler, PB; Schmid, E; Potthoff, J; Holler, P; Leis, S; Trinka, E; Holler, Y				Thomschewski, Aljoscha; Stroehlein, Anja; Langthaler, Patrick B.; Schmid, Elisabeth; Potthoff, Jonas; Hoeller, Peter; Leis, Stefan; Trinka, Eugen; Hoeller, Yvonne			Imagine There Is No Plegia. Mental Motor Imagery Difficulties in Patients with Traumatic Spinal Cord Injury	FRONTIERS IN NEUROSCIENCE			English	Article						spinal cord injury (SCI); motor imagery (MI); movement imagination; rehabilitation; neuroprostheses	BRAIN-COMPUTER INTERFACE; FUNCTIONAL ELECTRICAL-STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; NEUROPATHIC PAIN; DEPRESSION; REHABILITATION; MOVEMENTS; EEG; TETRAPLEGIA; INDIVIDUALS	In rehabilitation of patients with spinal cord injury (SCI), imagination of movement is a candidate tool to promote long-term recovery or to control futuristic neuroprostheses. However, little is known about the ability of patients with spinal cord injury to perform this task. It is likely that without the ability to effectively perform the movement, the imagination of movement is also problematic. We therefore examined, whether patients with SCI experience increased difficulties in motor imagery (MI) compared to healthy controls. We examined 7 male patients with traumatic spinal cord injury (aged 23-70 years, median 53) and 20 healthy controls (aged 21-54 years, median 30). All patients had incomplete SCI, with AIS (ASIA Impairment Scale) grades of C or D. All had cervical lesions, except one who had a thoracic injury level. Duration after injury ranged from 3 to 314 months. We performed the Movement Imagery Questionnaire Revised as well as the Beck Depression Inventory in all participants. The self-assessed ability of patients to visually imagine movements ranged from 7 to 36 (Md = 30) and tended to be decreased in comparison to healthy controls (ranged 16-49, Md = 42.5; W = 326.5, p = 0.055). Also, the self-assessed ability of patients to kinesthetically imagine movements (range = 7-35, Md = 31) differed significantly from the control group (range = 23-49, Md = 41; W = 337.5, p = 0.0047). Two patients yielded tendencies for depressive mood and they also reported most problems with movement imagination. Statistical analysis however did not confirm a general relationship between depressive mood and increased difficulty in MI across both groups. Patients with spinal cord injury seem to experience difficulties in imagining movements compared to healthy controls. This result might not only have implications for training and rehabilitation programs, but also for applications like brain-computer interfaces used to control neuroprostheses, which are often based on the brain signals exhibited during the imagination of movements.	[Thomschewski, Aljoscha; Stroehlein, Anja; Langthaler, Patrick B.; Schmid, Elisabeth; Potthoff, Jonas; Hoeller, Peter; Leis, Stefan; Trinka, Eugen; Hoeller, Yvonne] Paracelsus Med Univ, Dept Neurol, Christian Doppler Med Ctr, Salzburg, Austria; [Thomschewski, Aljoscha; Stroehlein, Anja; Langthaler, Patrick B.; Schmid, Elisabeth; Potthoff, Jonas; Hoeller, Peter; Leis, Stefan; Trinka, Eugen; Hoeller, Yvonne] Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria; [Thomschewski, Aljoscha; Schmid, Elisabeth; Hoeller, Yvonne] Paris Lodron Univ Salzburg, Dept Psychol, Salzburg, Austria; [Langthaler, Patrick B.] Paris Lodron Univ Salzburg, Dept Math, Salzburg, Austria; [Trinka, Eugen; Hoeller, Yvonne] Ctr Cognit Neurosci Salzburg, Salzburg, Austria		Thomschewski, A (corresponding author), Paracelsus Med Univ, Dept Neurol, Christian Doppler Med Ctr, Salzburg, Austria.; Thomschewski, A (corresponding author), Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria.; Thomschewski, A (corresponding author), Paris Lodron Univ Salzburg, Dept Psychol, Salzburg, Austria.	a.thomschewski@salk.at	Holler, Yvonne/I-8928-2017; cohorts, Doctoral College Imaging the Mind - all/I-4689-2018; delete, Doctoral College Imaging the Mind - to/E-5040-2018	Holler, Yvonne/0000-0002-1727-8557; Potthoff, Jonas/0000-0002-3927-7192; Thomschewski, Aljoscha/0000-0002-1811-5469; Trinka, Eugen/0000-0002-5950-2692	Spinal Cord Injury and Tissue Regeneration Center Salzburg, Austria	The research was solely funded by the Spinal Cord Injury and Tissue Regeneration Center Salzburg, Austria.	Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Alkadhi H, 2005, CEREB CORTEX, V15, P131, DOI 10.1093/cercor/bhh116; Barbonetti A, 2017, ARCH PHYS MED REHAB, V98, P940, DOI 10.1016/j.apmr.2016.11.006; Bennabi D, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00413; Blokland Y, 2014, IEEE T NEUR SYS REH, V22, P222, DOI 10.1109/TNSRE.2013.2292995; BRASILNETO JP, 1993, BRAIN, V116, P511, DOI 10.1093/brain/116.3.511; Braun SM, 2006, ARCH PHYS MED REHAB, V87, P842, DOI 10.1016/j.apmr.2006.02.034; COHEN RM, 1982, ARCH GEN PSYCHIAT, V39, P593; Cramer SC, 2007, EXP BRAIN RES, V177, P233, DOI 10.1007/s00221-006-0662-9; Decety J, 1996, BEHAV BRAIN RES, V72, P127; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; DECETY J, 1990, EUR ARCH PSY CLIN N, V240, P39, DOI 10.1007/BF02190091; Deiber MP, 1998, NEUROIMAGE, V7, P73, DOI 10.1006/nimg.1997.0314; Di Rienzo F, 2014, NEUROSCIENCE, V274, P82, DOI 10.1016/j.neuroscience.2014.05.021; Di Rienzo F, 2015, EXP BRAIN RES, V233, P291, DOI 10.1007/s00221-014-4114-7; Di Rienzo F, 2014, NEUROCASE, V20, P524, DOI 10.1080/13554794.2013.826685; Di Rienzo F, 2014, NEUROPSYCHOL REV, V24, P116, DOI 10.1007/s11065-014-9257-6; Dickstein R, 2007, PHYS THER, V87, P942, DOI 10.2522/ptj.20060331; Do AH, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-111; Elliott TR, 1996, ARCH PHYS MED REHAB, V77, P816, DOI 10.1016/S0003-9993(96)90263-4; Fiori F, 2014, J NEUROPSYCHOL, V8, P199, DOI 10.1111/jnp.12020; Foldes ST, 2017, J NEUROPHYSIOL, V118, P2412, DOI 10.1152/jn.00878.2016; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Fusco G, 2016, RESTOR NEUROL NEUROS, V34, P815, DOI 10.3233/RNN-160660; GOSS S, 1986, MEM COGNITION, V14, P469, DOI 10.3758/BF03202518; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grangeon M, 2012, SPINAL CORD, V50, P766, DOI 10.1038/sc.2012.41; Grangeon M, 2010, ARCH PHYS MED REHAB, V91, P1143, DOI 10.1016/j.apmr.2010.04.011; Gregg M, 2005, SPORT PSYCHOL, V19, P93, DOI 10.1123/tsp.19.1.93; Gregg M, 2010, EVID-BASED COMPL ALT, V7, P249, DOI 10.1093/ecam/nem170; Gustin SM, 2008, PAIN, V137, P237, DOI 10.1016/j.pain.2007.08.032; HALL C, 1985, HUM MOVEMENT SCI, V4, P107, DOI 10.1016/0167-9457(85)90006-5; HOLM S, 1979, SCAND J STAT, V6, P65; Hotz-Boenden-Naker S, 2008, NEUROIMAGE, V39, P383, DOI 10.1016/j.neuroimage.2007.07.065; Hoyek N, 2009, LEARN INDIVID DIFFER, V19, P555, DOI 10.1016/j.lindif.2009.07.003; Isaac A.R., 1986, J MENTAL IMAGERY, V10, P23, DOI DOI 10.1037/T07980-000; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; Janelle C., 2001, HDB SPORT PSYCHOL, P529; JUDD FK, 1991, PARAPLEGIA, V29, P91, DOI 10.1038/sc.1991.12; Kennedy P, 2016, REHABIL PSYCHOL, V61, P92, DOI 10.1037/rep0000066; King CE, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-77; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Konietschke F., 2016, RANKFD RANK BASED TE; Kraft R, 2015, J SPINAL CORD MED, V38, P571, DOI 10.1179/2045772314Y.0000000295; Kuhner C, 2006, BECK DEPRESSIONS INV; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Malouin Francine, 2007, J Neurol Phys Ther, V31, P20; Malouin F, 2010, ARCH PHYS MED REHAB, V91, P1122, DOI 10.1016/j.apmr.2010.03.007; Martin KA, 1999, SPORT PSYCHOL, V13, P245, DOI 10.1123/tsp.13.3.245; Mateo S, 2015, RESTOR NEUROL NEUROS, V33, P543, DOI 10.3233/RNN-140466; McLeod AI, 2011, Kendall: Kendall rank correlation and Mann-Kendall trend test; Mellet E, 1998, NEUROIMAGE, V8, P129, DOI 10.1006/nimg.1998.0355; Moseley GL, 2007, PAIN, V130, P294, DOI 10.1016/j.pain.2007.01.007; Muller-Putz GR, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035011; Mulder T, 2007, J NEURAL TRANSM, V114, P1265, DOI 10.1007/s00702-007-0763-z; Munroe KJ, 2000, SPORT PSYCHOL, V14, P119, DOI 10.1123/tsp.14.2.119; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Olsson CJ, 2012, EXP NEUROL, V236, P46, DOI 10.1016/j.expneurol.2012.03.022; Personnier P, 2010, BEHAV BRAIN RES, V206, P184, DOI 10.1016/j.bbr.2009.09.011; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 2005, EURASIP J APPL SIG P, V2005, P3152, DOI 10.1155/ASP.2005.3152; Pfurtscheller G, 2009, Comput Intell Neurosci, P104180, DOI 10.1155/2009/104180; R Core Team, 2017, R LANG ENV STAT COMP; Rock PL, 2014, PSYCHOL MED, V44, P2029, DOI 10.1017/S0033291713002535; RODGERS W, 1991, J APPL SPORT PSYCHOL, V3, P109, DOI DOI 10.1080/10413209108406438; Rohm M, 2013, ARTIF INTELL MED, V59, P133, DOI 10.1016/j.artmed.2013.07.004; Roosink M, 2016, RESTOR NEUROL NEUROS, V34, P227, DOI 10.3233/RNN-150563; Rupp R, 2013, BIOMED ENG-BIOMED TE, V58, DOI 10.1515/bmt-2013-4440; Saimpont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006714; Scandola M, 2017, J NEUROPSYCHOL, V11, P305, DOI 10.1111/jnp.12098; Schuster C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-75; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Stinear CM, 2006, EXP BRAIN RES, V168, P157, DOI 10.1007/s00221-005-0078-y; Thomschewski A, 2017, FRONT NEUROSCI-SWITZ, V11, P3, DOI 10.3389/fnins.2017.00362; Vuckovic A, 2015, J NEUROL PHYS THER, V39, P3, DOI 10.1097/NPT.0000000000000063; Wei GX, 2010, BRAIN RES, V1341, P52, DOI 10.1016/j.brainres.2009.08.014; Williams R, 2015, ARCH PHYS MED REHAB, V96, P133, DOI 10.1016/j.apmr.2014.08.016	78	8	8	1	11	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	DEC 11	2017	11								689	10.3389/fnins.2017.00689			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FP4QW	WOS:000417602500001	29311771	gold, Green Published			2022-02-06	
J	Mu, XP; Wang, HB; Cheng, X; Yang, L; Sun, XY; Qu, HL; Zhao, SS; Zhou, ZK; Liu, TT; Xiao, T; Song, B; Jolkkonen, J; Zhao, CS				Mu, X. P.; Wang, H. B.; Cheng, X.; Yang, L.; Sun, X. Y.; Qu, H. L.; Zhao, S. S.; Zhou, Z. K.; Liu, T. T.; Xiao, T.; Song, B.; Jolkkonen, J.; Zhao, C. S.			INHIBITION OF NKCC1 PROMOTES AXONAL GROWTH AND MOTOR RECOVERY IN ISCHEMIC RATS	NEUROSCIENCE			English	Article						axonal growth; bumetanide; NKCC1; stroke; functional recovery	GENE-EXPRESSION; CORTICOSPINAL NEURONS; COTRANSPORTER KCC2; TRAUMATIC BRAIN; DOWN-REGULATION; STEM-CELLS; NOGO-A; STROKE; INJURY; PLASTICITY	Bumetanide is a selective inhibitor of the Na+-K+-Cl--co-transporter 1(NKCC1). We studied whether bumetanide could affect axonal growth and behavioral outcome In stroke rats. Adult male Wistar rats were randomly assigned to four groups: sham-operated rats treated with vehicle or bumetanide, and ischemic rats treated with vehicle or bumetanide. Endothelin-1 was used to induce focal cerebral ischemia. Bumetanide administration (i.c.v.) started on postoperative day 7 and continued for 3 weeks. Biotinylated dextran amine (BDA) was Injected into the right imotor cortex on postoperative day 14 to trace corticospinal tract (CST) fibers sprouting into the denervated cervical spinal cord. Nogo-A, NKCC1, KCC2 and BDNF in the perilesional cortex and BDA, PSD-95 and vGlut1 in the denervated spinal cord were measured by immunohistochemistry and/or Western blot. Behavioral outcome of rats was assessed by the beam walking and cylinder tests. The total length of CST fibers sprouting into the denervated cervical spinal cord significantly increased after stroke and bumetanide further increased this sprouting. Bumetanide treatment also decreased the expressions of NKCC1 and Nogo-A, increased the expressions of KCC2 and BDNF in the perilesional cortex and enhanced the synaptic plasticity in the denervated cervical spinal cord after cerebral ischemia. The behavioral performance of ischemic rats was significantly improved by bumetanide. In conclusion, bumetanide promoted post-stroke axonal sprouting together accompanied by an improved behavioral outcome possibly through restoring and maintaining neuronal chloride homeostasis and creating a recovery-promoting microenvironment by overcoming the axonal growth inhibition encountered after cerebral ischemia in rats. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.	[Mu, X. P.; Wang, H. B.; Cheng, X.; Zhao, S. S.; Zhao, C. S.] China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang, Liaoning, Peoples R China; [Mu, X. P.] China Med Univ, Affiliated Hosp 4, Dept Neurol, Shenyang, Liaoning, Peoples R China; [Yang, L.] Shenyang Med Coll, Affiliated Ctr Hosp, Dept Cardiol, Shenyang, Liaoning, Peoples R China; [Sun, X. Y.; Qu, H. L.; Liu, T. T.] Peoples Hosp Liaoning Prov, Dept Neurol, Shenyang, Liaoning, Peoples R China; [Zhou, Z. K.] China Med Univ, Affiliated Hosp 1, Dept Geriatr, Shenyang, Liaoning, Peoples R China; [Xiao, T.] China Med Univ, Affiliated Hosp 1, Dept Dermatol, Shenyang, Liaoning, Peoples R China; [Xiao, T.] Minist Educ, Minist Hlth, Key Lab Immunodermatol, Shenyang, Liaoning, Peoples R China; [Song, B.] Cardiff Univ, Sch Dent, Regenerat Med, Cardiff Inst Tissue Engn & Repair, Cardiff, S Glam, Wales; [Jolkkonen, J.] Univ Eastern Finland, Inst Clin Med Neurol, POB 1627, Kuopio 70211, Finland		Zhao, CS (corresponding author), 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China.	cszhao@mail.cmu.edu.cn	Qu, Huiling/AAY-6953-2021		National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81372104, 30872736, 81401002]; Shenyang Population and Health Technical Critical Special Project [F16-206-9-01]; National Science Foundation of Liaoning Province of China [2014021074]; Program of the Distinguished Professor of Liaoning Province, Neurology	This study was supported by the National Natural Science Foundation of China (NSFC) (No. 81372104, No. 30872736, No. 81401002), the Shenyang Population and Health Technical Critical Special Project (No. F16-206-9-01); the Program of the Distinguished Professor of Liaoning Province, Neurology. National Science Foundation of Liaoning Province of China (No. 2014021074).	Baldwin KT, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00023; Baudel MASMA, 2017, J NEUROCHEM, V140, P195, DOI 10.1111/jnc.13901; Begum G, 2015, STROKE, V46, P1956, DOI 10.1161/STROKEAHA.115.008939; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Blesch A, 2007, J NEUROSCI, V27, P10535, DOI 10.1523/JNEUROSCI.1903-07.2007; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Brock JH, 2010, J NEUROSCI, V30, P9728, DOI 10.1523/JNEUROSCI.1924-10.2010; Caleo M, 2015, NEUROSCIENCE, V311, P180, DOI 10.1016/j.neuroscience.2015.10.029; Carmichael ST, 2017, EXP NEUROL, V287, P384, DOI 10.1016/j.expneurol.2016.02.007; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Carmichael ST, 2003, CURR OPIN NEUROL, V16, P699, DOI 10.1097/00019052-200312000-00009; Cheatwood JL, 2008, STROKE, V39, P2091, DOI 10.1161/STROKEAHA.107.507426; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Cook DJ, 2017, J CEREBR BLOOD F MET, V37, P1030, DOI 10.1177/0271678X16649964; Di Filippo M, 2008, NEUROPHARMACOLOGY, V55, P353, DOI 10.1016/j.neuropharm.2008.01.012; Domeniconi M, 2005, J NEUROL SCI, V233, P43, DOI 10.1016/j.jns.2005.03.023; Garraway SM, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9857201; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; He BL, 2013, NEUROPEPTIDES, V47, P1, DOI 10.1016/j.npep.2012.06.001; Hinman JD, 2013, STROKE, V44, P182, DOI 10.1161/STROKEAHA.112.668749; Huie JR, 2017, J NEUROTRAUM, V34, P1831, DOI 10.1089/neu.2016.4562; Jaenisch N, 2010, STROKE, V41, pE151, DOI 10.1161/STROKEAHA.109.570424; Jain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016135; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Lake EMR, 2015, J CEREBR BLOOD F MET, V35, P1601, DOI 10.1038/jcbfm.2015.86; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lu KT, 2006, EUR J PHARMACOL, V548, P99, DOI 10.1016/j.ejphar.2006.07.048; Lynskey JV, 2006, J NEUROTRAUM, V23, P617, DOI 10.1089/neu.2006.23.617; Mazarati A, 2009, EPILEPSIA, V50, P2117, DOI 10.1111/j.1528-1167.2009.02048.x; Nabekura J, 2002, J NEUROSCI, V22, P4412, DOI 10.1523/JNEUROSCI.22-11-04412.2002; Ollivier-Lanvin K., 2014, NEUROREHABILITATION, V29, P90; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Qu HL, 2014, RESTOR NEUROL NEUROS, V32, P597, DOI 10.3233/RNN-130374; Rossini PM, 2003, LANCET NEUROL, V2, P493, DOI 10.1016/S1474-4422(03)00485-X; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Seiler S, 2016, BIOCHEM PHARMACOL, V100, P28, DOI 10.1016/j.bcp.2015.08.113; Shulga A, 2012, J NEUROSCI, V32, P1757, DOI 10.1523/JNEUROSCI.3282-11.2012; Soleman S, 2010, EXP NEUROL, V222, P13, DOI 10.1016/j.expneurol.2009.11.007; Sun XY, 2016, J MOL NEUROSCI, V58, P233, DOI 10.1007/s12031-015-0662-y; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087; Wang GB, 2014, INT J CLIN EXP PATHO, V7, P1487; Windle V, 2005, BRAIN RES, V1044, P25, DOI 10.1016/j.brainres.2005.02.060; Xu WS, 2017, MOL NEUROBIOL, V54, P2406, DOI 10.1007/s12035-016-9819-0; Yan YP, 2003, BRAIN RES, V961, P22, DOI 10.1016/S0006-8993(02)03832-5; Young SZ, 2011, EUR J NEUROSCI, V33, P1123, DOI 10.1111/j.1460-9568.2011.07611.x; Zai LL, 2009, J NEUROSCI, V29, P8187, DOI 10.1523/JNEUROSCI.0414-09.2009; Zhao CS, 2005, BEHAV BRAIN RES, V156, P85, DOI 10.1016/j.bbr.2004.05.011; Zhao SS, 2013, STROKE, V44, P1698, DOI 10.1161/STROKEAHA.111.000361	54	8	10	3	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	DEC 4	2017	365						83	93		10.1016/j.neuroscience.2017.09.036			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FN4HP	WOS:000415966200008	28964752				2022-02-06	
J	Azim, A; Jehan, FS; Rhee, P; O'Keeffe, T; Tang, A; Vercruysse, G; Kulvatunyou, N; Latifi, R; Joseph, B				Azim, Asad; Jehan, Faisal S.; Rhee, Peter; O'Keeffe, Terence; Tang, Andrew; Vercruysse, Gary; Kulvatunyou, Narong; Latifi, Rifat; Joseph, Bellal			Big for small: Validating brain injury guidelines in pediatric traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	30th Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma (EAST)	JAN 10-14, 2017	Hollywood, FL	Eastern Assoc Surg Trauma		Brain Injury Guidelines; traumatic brain injury; head injury; intracranial hemorrhage; pediatric; neurosurgical consultation; repeat head CT scan	COMPUTED-TOMOGRAPHY; MANAGEMENT; CT	BACKGROUND Brain injury guidelines (BIG) were developed to reduce overutilization of neurosurgical consultation (NC) as well as computed tomography (CT) imaging. Currently, BIG have been successfully applied to adult populations, but the value of implementing these guidelines among pediatric patients remains unassessed. Therefore, the aim of this study was to evaluate the established BIG (BIG-1 category) for managing pediatric traumatic brain injury (TBI) patients with intracranial hemorrhage (ICH) without NC (no-NC). METHODS We prospectively implemented the BIG-1 category (normal neurologic examination, ICH 4 mm limited to one location, no skull fracture) to identify pediatric TBI patients (age, 21 years) that were to be managed no-NC. Propensity score matching was performed to match these no-NC patients to a similar cohort of patients managed with NC before the implementation of BIG in a 1:1 ratio for demographics, severity of injury, and type as well as size of ICH. Our primary outcome measure was need for neurosurgical intervention. RESULTS A total of 405 pediatric TBI patients were enrolled, of which 160 (NC, 80; no-NC, 80) were propensity score matched. The mean age was 9.03 7.47 years, 62.1% (n = 85) were male, the median Glasgow Coma Scale score was 15 (13-15), and the median head Abbreviated Injury Scale score was 2 (2-3). A subanalysis based on stratifying patients by age groups showed a decreased in the use of repeat head CT (p = 0.02) in the no-NC group, with no difference in progression (p = 0.34) and the need for neurosurgical intervention (p = 0.9) compared with the NC group. CONCLUSION The BIG can be safely and effectively implemented in pediatric TBI patients. Reducing repeat head CT in pediatric patients has long-term sequelae. Likewise, adhering to the guidelines helps in reducing radiation exposure across all age groups. LEVEL OF EVIDENCE Therapeutic/care management, level III.	[Azim, Asad; Jehan, Faisal S.; Rhee, Peter; O'Keeffe, Terence; Tang, Andrew; Vercruysse, Gary; Kulvatunyou, Narong; Latifi, Rifat; Joseph, Bellal] Univ Arizona, Dept Surg, Div Trauma Crit Care Burns & Acute Care Surg, 1501N,Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care Burns & Acute Care Surg, 1501N,Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu		Latifi, Rifat/0000-0003-1091-3682			American Association of Neurological Surgeons, 2012, ENS AD NEUR WORKF 21; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DI, 2002, PEDIATR RADIOL, V32, P42; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; CDC Injury Center, 2016, TBI GET FACTS CONC T; CDC Injury Center, 2016, TRAUM BRAIN INJ US A; Data and Reports-Workforce-Data and Analysis-AAMC, 2016, DAT REP WORKF DAT AN; Joseph B, 2015, ANN SURG, V262, P440, DOI 10.1097/SLA.0000000000001418; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Velmahos GC, 2006, J TRAUMA, V60, P9; Zhao T, 2016, J TRAUMA ACUTE CARE, V81, P743, DOI 10.1097/TA.0000000000001088	16	8	8	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2017	83	6					1200	1204		10.1097/TA.0000000000001611			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	FO4RL	WOS:000416832700030	28590352				2022-02-06	
J	Brooks, BL; Holdnack, JA; Iverson, GL				Brooks, Brian L.; Holdnack, James A.; Iverson, Grant L.			Reliable Change on Memory Tests is Common in Healthy Children and Adolescents	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Test-retest; Psychometrics; RCI; Cognition; Multivariate	NEUROPSYCHOLOGICAL TEST BATTERIES; WECHSLER-INTELLIGENCE-SCALE; LOW SCORES; INTERPRETING CHANGE; CLINICAL-SAMPLES; WISC-IV; PREVALENCE; CONCUSSION; SPORTS; ADULTS	Objective: Neuropsychologists interpret a large number of scores in their assessments, including numerous retest scores to determine change over time. The rate at which healthy children and adolescents obtain reliably improved or declined memory scores when retested has yet to be explored. The purpose of this study was to illustrate the prevalence of reliable change scores on memory test batteries in healthy children and adolescents. Methods: Participants were children and adolescents from test-retest samples from two published memory test batteries (ChAMP and CMS). Reliable change scores (RCI with 90% confidence interval and practice effects) were calculated for the indexes and subtests of each battery. Multivariate base rates involved considering all change scores simultaneously within each battery and calculating the frequencies of healthy children obtaining one or more reliably declined or one or more reliably improved scores. Results: Across both memory batteries, one or more reliably changed index or subtest score was common; however, reliable change on three or more scores was uncommon (i.e., found in <5% of the samples). Base rates of change scores did not differ by parent education. Conclusions: Having a single reliably changed score on retest is common when interpreting these memory batteries. Multivariate interpretation is necessary when determining cognitive decline and cognitive recovery. Further research is warranted with other measures, other samples, and different retest intervals.	[Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program Brain Injury & Rehabil, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Paediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Holdnack, James A.] Pearson Clin Assessment, San Antonio, TX USA; [Iverson, Grant L.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Mass Gen Hosp, Children Sport Concuss Program, Boston, MA USA		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Neurosci Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@ahs.ca		Iverson, Grant/0000-0001-7348-9570	Neurosciences program at the Alberta Children's Hospital; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Mooney-Reed Charitable Foundation; Heinz Family Foundation; ImPACT Applications, Inc.; TBI Endpoints Development Initiative	No grant funding was provided for this study. Salary support for this research was provided to Brian Brooks by the Neurosciences program at the Alberta Children's Hospital (Conny Betuzzi) and the Canadian Institutes of Health Research (CIHR) Embedded Clinician Researcher Salary Award. Grant Iverson acknowledges support from the Mooney-Reed Charitable Foundation, the Heinz Family Foundation, ImPACT Applications, Inc., and the TBI Endpoints Development Initiative (i.e., a grant entitled Development and Validation of a Cognition Endpoint for Traumatic Brain Injury Clinical Trials).	Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Brooks BL, 2016, ARCH CLIN NEUROPSYCH, V31, P1026, DOI 10.1093/arclin/acw079; Brooks BL, 2013, PRACT RESOUR MENT, P75, DOI 10.1016/B978-0-12-386934-0.00002-X; Brooks BL, 2013, APPL NEUROPSYCH-CHIL, V2, P70, DOI 10.1080/21622965.2012.742792; Brooks BL, 2011, CHILD NEUROPSYCHOL, V17, P281, DOI 10.1080/09297049.2010.537255; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Brooks BL, 2010, PSYCHOL ASSESSMENT, V22, P650, DOI 10.1037/a0019781; Brooks BL, 2010, ARCH CLIN NEUROPSYCH, V25, P14, DOI 10.1093/arclin/acp100; Brooks BL, 2009, ARCH CLIN NEUROPSYCH, V24, P647, DOI 10.1093/arclin/acp061; Brooks BL, 2009, J INT NEUROPSYCH SOC, V15, P613, DOI 10.1017/S1355617709090651; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Crawford JR, 2007, NEUROPSYCHOLOGY, V21, P419, DOI 10.1037/0894-4105.21.4.419; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Iverson G. L., 2012, PEDIAT FORENSIC NEUR, P89; Iverson G. L., 2008, NEUROPSYCHOLOGY HDB, P279; Iverson G. L., 1999, J COGNITIVE REHA JUL, P16; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 1998, INT J GERIATR PSYCH, V13, P661, DOI 10.1002/(SICI)1099-1166(1998100)13:10<661::AID-GPS838>3.0.CO;2-0; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Sherman E.M.S., 2015, CHILD ADOLESCENT MEM; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P83, DOI 10.1016/j.acn.2005.07.008	27	8	8	1	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2017	32	8					1001	1009		10.1093/arclin/acx028			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FN7AS	WOS:000416170000009	28383636	Bronze, Green Published			2022-02-06	
J	Calviello, LA; de Riva, N; Donnelly, J; Czosnyka, M; Smielewski, P; Menon, DK; Zeiler, FA				Calviello, Leanne A.; de Riva, Nicolas; Donnelly, Joseph; Czosnyka, Marek; Smielewski, Peter; Menon, David K.; Zeiler, Frederick A.			Relationship Between Brain Pulsatility and Cerebral Perfusion Pressure: Replicated Validation Using Different Drivers of CPP Change	NEUROCRITICAL CARE			English	Article						Neurocritical care; Traumatic brain injury; Pulsatility index; Intracranial pressure; Cerebral perfusion pressure; Transcranial doppler	MULTIDISCIPLINARY CONSENSUS CONFERENCE; TRANSCRANIAL DOPPLER SONOGRAPHY; BLOOD-FLOW-VELOCITY; INTRACRANIAL-PRESSURE; NEUROCRITICAL CARE; PLATEAU WAVES; AUTOREGULATION; INDEX; STATEMENT; INJURY	Determination of relationships between transcranial Doppler (TCD)-based spectral pulsatility index (sPI) and pulse amplitude (AMP) of intracranial pressure (ICP) in 2 groups of severe traumatic brain injury (TBI) patients (a) displaying plateau waves and (b) with unstable mean arterial pressure (MAP). We retrospectively reviewed patients with severe TBI and continuous TCD monitoring displaying either plateau waves or unstable MAP from 1992 to 1998. We utilized linear and nonlinear regression techniques to describe both cohorts: cerebral perfusion pressure (CPP) versus AMP, CPP versus sPI, mean ICP versus ICP AMP, mean ICP versus sPI, and AMP versus sPI. Nonlinear regression techniques were employed to analyze the relationships with CPP. In plateau wave and unstable MAP patients, CPP versus sPI displayed an inverse nonlinear relationship (R (2) = 0.820 vs. R (2) = 0.610, respectively), with the CPP versus sPI relationship best modeled by the following function in both cases: PI = a + (b/CPP). Similarly, in both groups, CPP versus AMP displayed an inverse nonlinear relationship (R (2) = 0.610 vs. R (2) = 0.360, respectively). Positive linear correlations were displayed in both the plateau wave and unstable MAP cohorts between: ICP versus AMP, ICP versus sPI, AMP versus sPI. There is an inverse relationship through nonlinear regression between CPP versus AMP and CPP versus sPI display. This provides evidence to support a previously-proposed model of TCD pulsatility index. ICP shows a positive linear correlation with AMP and sPI, which is also established between AMP and sPI.	[Calviello, Leanne A.; Donnelly, Joseph; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [de Riva, Nicolas] Univ Barcelona, Hosp Clin, Dept Anesthesiol, Div Neuroanesthesia, Barcelona, Spain; [Menon, David K.; Zeiler, Frederick A.] Univ Cambridge, Addenbrookes Hosp, Div Anesthet, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Clinician Investigator Program, Winnipeg, MB, Canada; [Menon, David K.] Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge, England; [Menon, David K.] Queens Coll, Cambridge, England; [Menon, David K.] Natl Inst Hlth Res, Cambridge, England		Calviello, LA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England.	leannecalviello@gmail.com; nderiva@clinic.cat; donnellyj87@gmail.com; mc141@medschl.cam.ac.uk; ps10011@cam.ac.uk; dkm13@cam.ac.uk; umzeiler@myumanitoba.ca	Donnelly, Joseph/E-9235-2018; Donnelly, Joseph/N-6803-2019; de Riva, Nicolas/AAN-3347-2020	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; de Riva, Nicolas/0000-0003-2691-5770; Zeiler, Frederick/0000-0003-1737-0510; Smielewski, Peter/0000-0001-5096-3938	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986] Funding Source: UKRI		AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Brain Trauma Foundation, 2016, BRAIN TRAUM FDN GUID; Cardim D, 2016, NEUROCRIT CARE; Cardim D, 2016, J NEUROTRAUM, V33, P792, DOI 10.1089/neu.2015.4134; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; CZOSNYKA M, 1994, NEUROSURGERY, V35, P287, DOI 10.1227/00006123-199408000-00015; CZOSNYKA M, 1994, ACTA NEUROCHIR, P468; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; Donnelly J, 2016, J CEREB BLOOD FLOW M; Le Roux P, 2014, NEUROCRIT CARE, V21, P297, DOI 10.1007/s12028-014-0081-x; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Morgalla MH, 2016, J CLIN ULTRASOUND, V44, P40, DOI 10.1002/jcu.22279; Richards HK, 1998, ACT NEUR S, V71, P229; Ursino M, 1998, J NEUROSURG, V89, P255, DOI 10.3171/jns.1998.89.2.0255; Varsos GV, 2013, NEUROCRIT CARE, V18, P341, DOI 10.1007/s12028-013-9830-5	17	8	9	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2017	27	3					392	400		10.1007/s12028-017-0404-9			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FN7DT	WOS:000416179300012	28547321	Green Published, hybrid			2022-02-06	
J	Day, NL; Carle, MS; Floyd, CL				Day, Nicole L.; Carle, Matthew S.; Floyd, Candace L.			Post-injury administration of a combination of memantine and 17 beta-estradiol is protective in a rat model of traumatic brain injury	NEUROCHEMISTRY INTERNATIONAL			English	Article						Cognitive deficits; Anxiety/ disinhibition; Morris water maze; Estrogen; Hippocampal cell death	SPINAL-CORD-INJURY; LATERAL FLUID-PERCUSSION; SEX STEROID-HORMONES; NMDA RECEPTOR; CELL-DEATH; NEURONAL DEGENERATION; ANIMAL-MODEL; FEMALE RATS; OPEN-FIELD; NEUROPROTECTION	Traumatic brain injury (TBI) often leads to substantial adverse cognitive and health outcomes, including permanent disability and death. Preventing these outcomes requires attenuation of the secondary biochemical damage that follows the initial biomechanical insult, but a clinically proven pharmaco-therapeutic capable of such has not been identified. In fact, the heterogeneous nature of TBI and the complexity of secondary injury cascades suggest a polytherapeutic approach that targets multiple pathways might be necessary. We and others have reported that 17 beta-estradiol (E2) is neuroprotective in models of central nervous system injury. Although E2 is neuroprotective and favorably modulates several key components of secondary injury, it does not effectively block the destructive excitotoxic cascade. Thus, administering E2 in combination with a second drug that targets excitotoxicity, such as the FDA-approved uncompetitive NMDA receptor antagonist memantine hydrochloride, may provide additional benefits. Here, we assessed the neuroprotective potential of an acutely administered intravenous bolus dose of a combination of memantine and E2 after induction of experimental TBI in the clinically relevant lateral fluid percussion model. Our results indicate that the combination of these drugs conferred neuroprotection by increasing neuronal survival and decreasing neuronal degeneration in the hippo-campus and cortex ipsilateral to injury. Furthermore, administration of this combination improved vestibulomotor deficits and modestly reduced anxiety. We conclude that further investigation of the neuroprotective potential of memantine administered with E2 is warranted. Published by Elsevier Ltd.	[Day, Nicole L.; Floyd, Candace L.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL 35249 USA; [Carle, Matthew S.] Univ Alabama Birmingham, Sch Med, Birmingham, AL 35249 USA		Floyd, CL (corresponding author), Univ Alabama Birmingham, Dept Phys Med & Rehabil, Spain Rehabil Ctr 529C, 1717 6th Ave South, Birmingham, AL 35249 USA.	nicoledayphd@gmail.com; Msc4705@uab.edu; candacefloyd@uabmc.edu		Day, Nicole/0000-0003-3490-4908	Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-08-2-0153]; U.S. Army Medical Research Acquisition Activity, Fort Detrick MD;  [P30 NS47466]	The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5 014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award number W81XWH-08-2-0153. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense (DHP funds.) This work is also supported in part by P30 NS47466. The authors would also like to thank Mr. Joseph Robin for his assistance with the behavioral experiments.	Aenlle KK, 2009, NEUROBIOL AGING, V30, P932, DOI 10.1016/j.neurobiolaging.2007.09.004; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Annweiler C, 2014, NEUROBIOL AGING, V35, P331, DOI 10.1016/j.neurobiolaging.2013.07.029; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bisagno V, 2003, ENDOCRINE, V21, P33, DOI 10.1385/ENDO:21:1:33; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Carson FL, 2009, HISTOTECHNOLOGY SELF, V3rd; Chaovipoch P, 2006, J NEUROTRAUM, V23, P830, DOI 10.1089/neu.2006.23.830; Chen CM, 2008, J NEUROSCI RES, V86, P2696, DOI 10.1002/jnr.21706; Creeley C, 2006, J NEUROSCI, V26, P3923, DOI 10.1523/JNEUROSCI.4883-05.2006; Culmsee C, 2004, STROKE, V35, P1197, DOI 10.1161/01.STR.0000125855.17686.6d; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dogan A, 1999, ACTA NEUROCHIR, V141, P1107, DOI 10.1007/s007010050491; Effgen GB, 2017, J NEUROTRAUM, V34, P934, DOI 10.1089/neu.2016.4528; Ennaceur A, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.223; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrario CR, 2013, J NEUROPHYSIOL, V110, P131, DOI 10.1152/jn.01011.2012; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hartman RE, 2011, TRANSL STROKE RES, V2, P433, DOI 10.1007/s12975-011-0132-y; Huang CY, 2015, MOL NEUROBIOL, V51, P1038, DOI 10.1007/s12035-014-8767-9; Johnson JW, 2006, CURR OPIN PHARMACOL, V6, P61, DOI 10.1016/j.coph.2005.09.007; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kachadroka S, 2010, J NEUROTRAUM, V27, P611, DOI 10.1089/neu.2009.1069; Kelestemur T, 2016, NEUROSCI LETT, V612, P92, DOI 10.1016/j.neulet.2015.11.043; Kocka A, 2014, BEHAV SCI, V4, P352, DOI 10.3390/bs4040352; Kornhuber J, 1997, BIOL PSYCHIAT, V41, P135, DOI 10.1016/S0006-3223(96)00047-9; Kotermanski SE, 2009, J PHYSIOL-LONDON, V587, P4589, DOI 10.1113/jphysiol.2009.176297; Kutzing MK, 2012, ANN BIOMED ENG, V40, P1170, DOI 10.1007/s10439-011-0494-z; Lamprecht MR, 2015, J NEUROTRAUM, V32, P1361, DOI 10.1089/neu.2015.3912; Lapanantasin S, 2006, SYNAPSE, V60, P406, DOI 10.1002/syn.20308; Lebesgue D, 2006, J NEUROTRAUM, V23, P1814, DOI 10.1089/neu.2006.23.1814; Lipton SA, 2007, CURR DRUG TARGETS, V8, P621, DOI 10.2174/138945007780618472; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Olsen ML, 2010, BRAIN, V133, P1013, DOI 10.1093/brain/awq049; Ozsuer H, 2005, NEUROSURG REV, V28, P143, DOI 10.1007/s10143-004-0374-1; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Rao VLR, 2001, BRAIN RES, V911, P96; RINK A, 1995, AM J PATHOL, V147, P1575; Rodgers KM, 2014, J NEUROTRAUM, V31, P487, DOI [10.1089/NEU.2013.3090, 10.1089/neu.2013.3090]; Rodgers KM, 2012, J NEUROTRAUM, V29, P1886, DOI 10.1089/neu.2011.2273; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sencer A, 2008, NEUROL RES, V30, P497, DOI 10.1179/016164107X251664; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Sinn DI, 2007, NEUROSCI LETT, V411, P238, DOI 10.1016/j.neulet.2006.10.050; Siriphorn A, 2012, J COMP NEUROL, V520, P2630, DOI 10.1002/cne.23056; Siriphorn A, 2010, J NEUROCHEM, V115, P864, DOI 10.1111/j.1471-4159.2010.06770.x; Soltani Z, 2016, J PHYSIOL BIOCHEM, V72, P33, DOI 10.1007/s13105-015-0453-5; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vink R, 2010, NEUROTHERAPEUTICS, V7, P1, DOI 10.1016/j.nurt.2009.12.001; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	74	8	8	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	DEC	2017	111				SI		57	68		10.1016/j.neuint.2017.04.018			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FR3OS	WOS:000418976600007	28472639				2022-02-06	
J	Douglas, JM				Douglas, Jacinta M.			"So that's the way it is for me - always being left out." Acquired Pragmatic Language Impairment and Social Functioning following Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						brain injury; pragmatic impairment; social function; relationship; couples; friends	MONTREAL COGNITIVE ASSESSMENT; ANXIETY STRESS SCALES; ASSISTIVE TECHNOLOGY; STROKE; MEMORY; REHABILITATION; PEOPLE; INDIVIDUALS; DEPRESSION; EFFICACY	Our ability to interact appropriately in everyday interpersonal situations is fundamental to successful social integration. Impaired pragmatic competence correlates significantly and substantially with indices of social function across several domains for adults with acquired neurological disorders. In particular, evidence supports the negative impact of pragmatic impairments on the development and maintenance of relationships and community integration more generally. Pragmatic language competence sits in a complex, multifactorial space characterised by interacting associations with cognitive and psychological functions and social and environmental parameters. This complexity is evident in much of the research seeking to unravel the nature and magnitude of interactions between pragmatic language competence and social outcomes in adults with acquired neurological disorders. Over recent years our understanding of the impact of pragmatic impairments on social outcome has benefited substantially from inclusion of the insider's perspective in our research evidence base. Indeed, a methodological inclusion of constructivist paradigms has enabled the development of a rich understanding of the devastating social impact of impaired pragmatic competence. The aim of this paper is to review pragmatic language impairment in the context of traumatic brain injury (TBI) and detail its impact on social functioning from the perspectives of people with TBI and their intimate partners/spouses and friends. With these perspectives as background, the paper concludes with consideration of therapeutic developments and a brief look at a novel intervention designed to reduce the negative impact of pragmatic deficits and improve functional language use following TBI.	[Douglas, Jacinta M.] La Trobe Univ, Sch Allied Hlth, Living Disabil Res Ctr, Bundoora, Vic 3086, Australia; [Douglas, Jacinta M.] Summer Fdn, Box Hill, Vic, Australia		Douglas, JM (corresponding author), La Trobe Univ, Sch Allied Hlth, Living Disabil Res Ctr, Bundoora, Vic 3086, Australia.	J.Douglas@latrobe.edu.au		Douglas, Jacinta/0000-0003-0940-6624			Andrew NE, 2014, INT J STROKE, V9, P106, DOI 10.1111/ijs.12325; Australian Communications and Media Authority, 2013, COMM REP 2012 13; Barker-Collo S, 2016, BRAIN IMPAIR, V17, P111, DOI 10.1017/BrImp.2016.17; Boosman H, 2014, BRAIN INJURY, V28, P959, DOI 10.3109/02699052.2014.888763; Brandenburg C, 2016, APHASIOLOGY, V30, P320, DOI 10.1080/02687038.2015.1028329; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Charters E, 2015, NEUROPSYCHOL REHABIL, V25, P82, DOI 10.1080/09602011.2014.942672; Cumming TB, 2011, STROKE, V42, P2642, DOI 10.1161/STROKEAHA.111.619486; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; das Nair R, 2015, NEUROPSYCHOL REHABIL, V25, P479, DOI 10.1080/09602011.2014.971820; de Joode EA, 2012, BRAIN INJURY, V26, P1257, DOI 10.3109/02699052.2012.667590; Dowds MM, 2011, J HEAD TRAUMA REHAB, V26, P339, DOI 10.1097/HTR.0b013e3181f2bf1d; Ferguson S, 2015, BRAIN INJURY, V29, P583, DOI 10.3109/02699052.2014.1002109; Freitas S, 2012, J INT NEUROPSYCH SOC, V18, P1031, DOI 10.1017/S135561771200077X; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; GREGOR P, 2002, P 5 INT ACM C ASS TE; Hart T, 2004, J HEAD TRAUMA REHAB, V19, P351, DOI 10.1097/00001199-200409000-00001; Jamieson M, 2017, NEUROPSYCHOL REHABIL, V27, P919, DOI 10.1080/09602011.2015.1103760; Jamieson M, 2014, NEUROPSYCHOL REHABIL, V24, P419, DOI 10.1080/09602011.2013.825632; Jokinen H, 2015, EUR J NEUROL, V22, P1288, DOI 10.1111/ene.12743; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Lindqvist E, 2012, DISABIL REHABIL-ASSI, V7, P364, DOI 10.3109/17483107.2011.638036; Lovibond SH, 2004, MANUAL DEPRESSION AN; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; National Stroke Foundation, 2010, CLIN GUID MAN 2010; Pollock A, 2012, LANCET NEUROL, V11, P209, DOI 10.1016/S1474-4422(12)70029-7; Strauss E., 2006, COMPENDIUM NEUROPSYC, P59; Svoboda E, 2012, NEUROPSYCHOL REHABIL, V22, P408, DOI 10.1080/09602011.2011.652498; Taylor GH, 2013, TOP STROKE REHABIL, V20, P270, DOI 10.1310/tsr2003-270; Thilarajah S, 2016, BRAIN IMPAIR, V17, P34, DOI 10.1017/BrImp.2016.1; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Wong D, 2017, DISABIL REHABIL, V39, P2387, DOI 10.1080/09638288.2016.1226434; Wong D, 2013, BRAIN INJURY, V27, P1377, DOI 10.3109/02699052.2013.823662; Zajicek M., 2001, P 2001 EC NSF WORKSH	34	8	8	0	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2017	18	3					321	331		10.1017/BrImp.2017.20			11	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	FS0YI	WOS:000419499900009		Bronze			2022-02-06	
J	Han, JLXG; See, AAQ; Gandhi, M; King, NKK				Han, Julian Xinguang; See, Angela An Qi; Gandhi, Mihir; King, Nicolas Kon Kam			Models of Mortality and Morbidity in Severe Traumatic Brain Injury: An Analysis of a Singapore Neurotrauma Database	WORLD NEUROSURGERY			English	Article						Prediction models; Prognosis; Traumatic brain injury	PROGNOSTIC VALUE; IMPACT; COAGULOPATHY; METAANALYSIS; TOMOGRAPHY; VALIDATION; DIAGNOSIS; COHORT	OBJECTIVE: Current prognostic models for traumatic brain injury (TBI) are developed from diverse historical data sets. We aimed to construct a prognostication tool for patients with severe TBI, as this group would benefit most from an accurate model. METHODS: Model development was based on a cohort of 300 patients with severe TBI (Glasgow Coma Scale score <= 8) consecutively admitted to a neurosurgical intensive care unit at the National Neuroscience Institute (NNI), Singapore, between February 2006 and December 2009. We analyzed prospectively collected data of admission characteristics using univariate and multivariate logistic regressions to predict 14-day and 6-month mortality and 6month unfavorable outcome. Comparison with Corticosteroid Randomization After Significant Head Injury (CRASH) and Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT) models was done using Akaike information criterion. RESULTS: Two prediction models, NNI Clinical (age, Glasgow Coma Scale score, pupillary reactivity) and NNI+(NNI Clinical model with addition of obliteration of third ventricle or basal cisterns, presence of subdural hemorrhage, hypoxia, and coagulopathy), were derived from this data set. Both models predicted well across 3 outcome measures with area under the curve values of 0.84-0.91, with adequate calibration. Comparison with CRASH and IMPACT models showed better performance by both derived models with lower Akaike information criterion and higher area under the curve values. CONCLUSIONS: Two accurate prognostic models, NNI Clinical and NNI+, were developed from our cohort of patients with severe TBI. Both models are specific to severe TBI and could be better alternatives to current available models. External validation is required to assess performance of models in a different setting.	[Han, Julian Xinguang; See, Angela An Qi; King, Nicolas Kon Kam] Natl Neurosci Inst, Dept Neurosurg, Singapore, Singapore; [Gandhi, Mihir] Duke NUS Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Gandhi, Mihir] Singapore Clin Res Inst, Dept Biostat, Singapore, Singapore; [Gandhi, Mihir] Univ Tampere, Tampere Ctr Child Hlth Res, Tampere, Finland; [Gandhi, Mihir] Tampere Univ Hosp, Tampere, Finland		King, NKK (corresponding author), Natl Neurosci Inst, Dept Neurosurg, Singapore, Singapore.	nicolas.kon.k.k@singhealth.com.sg		Kon Kam King, Nicolas/0000-0002-6009-4411			Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hosmer DW, 1997, STAT MED, V16, P965; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Lesko MM, 2013, J NEUROTRAUM, V30, P2021, DOI 10.1089/neu.2013.2988; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Rizoli S, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0098-x; Sobuwa S, 2014, SAMJ S AFR MED J, V104, P492, DOI [10.7196/SAMJ.7720, 10.7196/samj.7720]; Steyerberg, 2019, CLIN PREDICTION MODE; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640	22	8	8	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2017	108						885	+		10.1016/j.wneu.2017.08.147			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN3CU	WOS:000415874900115	28867312				2022-02-06	
J	Honda, M; Ichibayashi, R; Suzuki, G; Yokomuro, H; Seiki, Y; Sase, S; Kishi, T				Honda, Mitsuru; Ichibayashi, Ryo; Suzuki, Ginga; Yokomuro, Hiroki; Seiki, Yoshikatsu; Sase, Shigeru; Kishi, Taichi			Consideration of the Intracranial Pressure Threshold Value for the Initiation of Traumatic Brain Injury Treatment: A Xenon CT and Perfusion CT Study	NEUROCRITICAL CARE			English	Article						ICP; Cerebral circulation disturbance; CBF; MTT	CEREBRAL-BLOOD-FLOW; CLOSED-HEAD INJURY; COMPUTED-TOMOGRAPHY; SUBARACHNOID HEMORRHAGE; MANAGEMENT; VASOSPASM; HYPERTENSION; CIRCULATION; DISTURBANCE; REACTIVITY	Monitoring of intracranial pressure (ICP) is considered to be fundamental for the care of patients with severe traumatic brain injury (TBI) and is routinely used to direct medical and surgical therapy. Accordingly, some guidelines for the management of severe TBI recommend that treatment be initiated for ICP values > 20 mmHg. However, it remained to be accounted whether there is a scientific basis to this instruction. The purpose of the present study was to clarify whether the basis of ICP values > 20 mmHg is appropriate. We retrospectively reviewed 25 patients with severe TBI who underwent neuroimaging during ICP monitoring within the first 7 days. We measured cerebral blood flow (CBF), mean transit time (MTT), cerebral blood volume (CBV), and ICP 71 times within the first 7 days. Although the CBF, MTT, and CBV values were not correlated with the ICP value at ICP values ae<currency>20 mmHg, the CBF value was significantly negatively correlated with the ICP value (r = -0.381, P < 0.05) at ICP values > 20 mmHg. The MTT value was also significantly positively correlated with the ICP value (r = 0.638, P < 0.05) at ICP values > 20 mmHg. The cerebral circulation disturbance increased with the ICP value. We demonstrated the cerebral circulation disturbance at ICP values > 20 mmHg. This study suggests that an ICP > 20 mmHg is the threshold to initiate treatments. An active treatment intervention would be required for severe TBI when the ICP was > 20 mmHg.	[Honda, Mitsuru; Ichibayashi, Ryo; Suzuki, Ginga; Yokomuro, Hiroki] Toho Univ, Med Ctr, Omori Hosp, Dept Crit Care Ctr,Ota Ku, 6-11-1 Omori Nishi, Tokyo 1438541, Japan; [Seiki, Yoshikatsu; Sase, Shigeru] Toho Univ, Med Ctr, Omori Hosp, Dept Neurosurg, Tokyo, Japan; [Kishi, Taichi] Toho Univ, Sch Med, Fac Med, Dept Educ Planning & Dev, Tokyo, Japan		Honda, M (corresponding author), Toho Univ, Med Ctr, Omori Hosp, Dept Crit Care Ctr,Ota Ku, 6-11-1 Omori Nishi, Tokyo 1438541, Japan.	mhonda@toho-u.ac.jp					Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Araki Yuzo, 2002, No To Shinkei, V54, P581; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Honda M, 2016, NEUROL MED-CHIR, V56, P501, DOI 10.2176/nmc.oa.2015-0341; Honda M, 2012, NEUROL MED-CHIR, V52, P488, DOI 10.2176/nmc.52.488; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; MARSHALL LF, 1983, J NEUROSURG, V58, P566, DOI 10.3171/jns.1983.58.4.0566; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Mclntosh TK, 1992, J CEREBR BLOOD F MET, V12, P697; Muizelaar JP, 1997, STROKE, V28, P1998, DOI 10.1161/01.STR.28.10.1998; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; OLDENDORF WH, 1967, J NUCL MED, V8, P570; PLOUGMANN J, 1994, J NEUROSURG, V81, P822, DOI 10.3171/jns.1994.81.6.0822; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Sase S, 2005, J COMPUT ASSIST TOMO, V29, P270, DOI 10.1097/01.rct.0000156400.40836.68; Sase S, 2002, J COMPUT ASSIST TOMO, V26, P471, DOI 10.1097/01.RCT.0000014442.08104.F7; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Varelas PN, 2006, J NEUROSURG, V104, P713, DOI 10.3171/jns.2006.104.5.713; White R P, 1990, Neurosurg Clin N Am, V1, P401; Wintermark M, 2006, AM J NEURORADIOL, V27, P26; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	38	8	8	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2017	27	3					308	315		10.1007/s12028-017-0432-5			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FN7DT	WOS:000416179300002	28762185				2022-02-06	
J	Jang, SH; Kwon, HG				Jang, Sung Ho; Kwon, Hyeok Gyu			Injury of the cortico-ponto-cerebellar tract in a patient with mild traumatic brain injury A case report	MEDICINE			English	Article						ataxia; cortico-ponto-cerebellar tract; diffusion tensor imaging; mild traumatic brain injury; tremor	DIFFUSION TENSOR TRACTOGRAPHY; INDUCED AXONAL INJURY; DISEASE	Rationale: We report on a patient with injury of the cortico-ponto-cerebellar tract (CPCT) following mild traumatic brain injury (TBI), diagnosed by diffusion tensor tractography (DTT). Patient concerns: A 53-year-old female patient was injured in a car crash. While under treatment at a local medical center for headache, mild motor weakness, and cognitive impairment that developed following the car crash, she fell, hitting her head on the ground, about six weeks after the car crash. Diagnoses: Approximately three months after the car crash, she began to show tremor on both hands and mild truncal ataxia. Twenty months after the car crash, when she underwent neurological evaluation at the rehabilitation department of a university hospital, she presented with mild resting and intentional tremor on both hands, and mild truncal ataxia. Interventions: N/A. Outcomes: On 20-month DTT, the left CPCT showed tearing at the level of the subcortical white matter and pons, and discontinuation at the cerebellar portion. However, the integrity of the DRTT was well-preserved in both hemispheres. Lessons: Using DTT, injury of the CPCT was demonstrated in a patient with ataxia and tremor following mild TBI.	[Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Gyeongsangbuk Do, South Korea; [Kwon, Hyeok Gyu] Catholic Univ Pusan, Coll Hlth Sci, Dept Phys Therapy, 57 Oryundae Ro, Pusan 46252, South Korea		Kwon, HG (corresponding author), Catholic Univ Pusan, Coll Hlth Sci, Dept Phys Therapy, 57 Oryundae Ro, Pusan 46252, South Korea.	khg0715@hanmail.net			National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A4A01020385]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A4A01020385).	Afifi AK, 2005, FUNCTIONAL NEUROANAT; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; D'souza Maria M, 2015, Indian J Radiol Imaging, V25, P404, DOI 10.4103/0971-3026.169445; Hong JH, 2011, NEURAL REGEN RES, V6, P76, DOI 10.3969/j.issn.1673-5374.2011.01.013; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; JANG SH, 2016, MEDICINE, V95, DOI DOI 10.1097/MD.0000000000005590; Jang SH, 2015, BRAIN INJURY, V29, P1725, DOI 10.3109/02699052.2015.1075170; Javalkar V, 2014, NEUROL CLIN, V32, P871, DOI 10.1016/j.ncl.2014.07.012; Kitamura K, 2008, NEURORADIOLOGY, V50, P285, DOI 10.1007/s00234-007-0351-9; Kwon HG, 2011, NEURORADIOLOGY, V53, P787, DOI 10.1007/s00234-011-0878-7; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Mendoza J., 2007, CLIN NEUROANATOMY NE; Min Y, 2012, ANN REHABIL MED-ARM, V36, P887, DOI 10.5535/arm.2012.36.6.887; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Ripoll MA, 2004, NEURORADIOLOGY, V46, P435, DOI 10.1007/s00234-004-1191-5; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Schulz R, 2017, CEREB CORTEX, V27, P635, DOI 10.1093/cercor/bhv251; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Weyer A, 2007, MOVEMENT DISORD, V22, P1633, DOI 10.1002/mds.21544; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; 장성호, 2016, [Brain & NeuroRehabilitation, 뇌신경재활], V9, P1	26	8	8	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	DEC	2017	96	49							e8749	10.1097/MD.0000000000008749			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT0GB	WOS:000422799500019	29245230	Green Published, gold			2022-02-06	
J	Jehan, F; Azim, A; Rhee, P; Khan, M; Gries, L; O'Keeffe, T; Kulvatunyou, N; Tang, A; Joseph, B				Jehan, Faisal; Azim, Asad; Rhee, Peter; Khan, Muhammad; Gries, Lynn; O'Keeffe, Terence; Kulvatunyou, Narong; Tang, Andrew; Joseph, Bellal			Decompressive craniectomy versus craniotomy only for intracranial hemorrhage evacuation: A propensity matched study	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	47th Annual Meeting of the Western-Trauma-Association (WTA)	MAR 05-10, 2017	Snowbird, UT	Western Trauma Assoc		Decompressive craniectomy; craniotomy; TBI; intracranial hemorrhage evacuation	TRAUMATIC BRAIN-INJURY; MANAGEMENT; SCORE	BACKGROUND Decompressive craniectomy (DC) is often performed in conjunction with evacuation of intracranial hemorrhage (ICH) to control intracranial pressure (ICP) in patients with a traumatic brain injury (TBI). The efficacy of DC in lowering ICP is well established; however, its effect on clinical outcomes remains controversial. The aim of our study is to assess outcomes in TBI patients undergoing DC versus craniotomy only (CO) for the evacuation of ICH. METHODS We performed a 5-year retrospective analysis of TBI patients with ICH who underwent craniotomy or craniectomy for traumatic ICH. Patients were divided into two groups, those who underwent CO and those who underwent DC. Propensity scoring matched patients in a 1:2 ratio for demographics, admission Glasgow Coma Scale (GCS) score, severity of injury, type and size of ICH, and anticoagulant use. Outcome measures included mortality, adverse discharge disposition (skilled nursing facility), discharge GCS and Glasgow Outcome Scale scores, and complications. RESULTS We reviewed 1,831 patients with TBI, of which 155 underwent craniotomy and/or craniectomy. After propensity score matching, we included 99 of those patients in our study (DC, 33; CO, 66). Matched groups were similar in age (p = 0.68), admission GCS score (p = 0.50), Injury Severity Score (p = 0.70), head Abbreviated Injury Scale score (p = 0.32), and intracranial bleeding characteristics. Overall, 26.3% (n = 26) of the patients died and 62.6% (n = 62) were discharged to Rehab/skilled nursing facility. There was no difference in the mortality rate (27.3% vs. 25.0%; p = 0.99), adverse discharge disposition (45% vs. 33%; p = 0.66), GCS score (p = 0.53), and Glasgow Outcome Scale (p = 0.80) at discharge between the DC and the CO groups. However, patients in DC group had higher complication rates and ventilator days. CONCLUSION This study showed no significant difference in clinical outcomes for patients undergoing evacuation of ICH regardless of the procedure performed. DC did not appear to be superior to craniotomy alone for the treatment of acute ICH. LEVEL OF EVIDENCE Therapeutic, level III.	[Jehan, Faisal; Azim, Asad; Khan, Muhammad; Gries, Lynn; O'Keeffe, Terence; Kulvatunyou, Narong; Tang, Andrew; Joseph, Bellal] Univ Arizona, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ USA; [Rhee, Peter] Grady Mem Hosp, Dept Surg, Div Acute Care Surg, Atlanta, GA USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care & Emergency Surg, Room 5411,1501N Campbell Ave,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu					Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Bratton S. L., 2006, J NEUROTRAUM, V24, pS77; BRITT RH, 1978, J NEUROSURG, V2, P195; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Control CfD, 2010, CDC; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper P R, 1976, Surg Neurol, V5, P25; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; Faul M, 2010, TRAUMATIC BRAIN INJU; Gnanalingham KK, 2002, J NEUROSURG, V97, P821, DOI 10.3171/jns.2002.97.4.0821; Guerra WKW, 1999, INTENS CARE MED, V25, P1327; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Joseph B, 2015, CURR OPIN CRIT CARE, V21, P506, DOI 10.1097/MCC.0000000000000247; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Nirula R, 2014, J TRAUMA ACUTE CARE, V76, P944, DOI 10.1097/TA.0000000000000194; Paci GM, 2009, J TRAUMA, V67, P531, DOI 10.1097/TA.0b013e3181b840e8; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; SHIGEMORI M, 1980, ACTA NEUROCHIR, V54, P61, DOI 10.1007/BF01401944; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Soukiasian HJ, 2002, AM SURGEON, V68, P1066; Timofeev I, 1800, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	28	8	8	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2017	83	6					1148	1153		10.1097/TA.0000000000001658			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	FO4RL	WOS:000416832700022	28715363				2022-02-06	
J	Jindal, A; Mahesh, R; Bhatt, S; Pandey, D				Jindal, Ankur; Mahesh, Radhakrishnan; Bhatt, Shvetank; Pandey, Dilip			Molecular modifications by regulating cAMP signaling and oxidant-antioxidant defence mechanisms, produce antidepressant-like effect: A possible mechanism of etazolate aftermaths of impact accelerated traumatic brain injury in rat model	NEUROCHEMISTRY INTERNATIONAL			English	Article						Etazolate; Traumatic brain injury; HPA axis; cAMP signaling cascade; Oxidant/antioxidant system	UNPREDICTABLE MILD STRESS; OLFACTORY BULBECTOMY; MAJOR DEPRESSION; OXIDATIVE STRESS; HEAD-INJURY; INHIBITOR; BEHAVIOR; ANXIETY; MODULATION; PREFERENCE	Traumatic brain injury (TBI) is one of the leading cause of psychiatric conditions in patients, amongst which, depression and anxiety are more frequent. Despite the preclinical antidepressant-like effects, clinical development of Phospodiesterase-4 (PDE4) enzyme inhibitors has been hampered due to serious side effect profiles, such as nausea and vomiting. Etazolate (ETZ) is a new generation PDE4 inhibitor with encouraging safety and tolerance profiles. In our previous studies we have addressed that ETZ produces antidepressant-like effects in animal models of depression, however, the underlying mechanism(s) following TBI have not been completely explored. Impact accelerated TBI by weight drop method causes depression-like behavioral deficits in modified open field exploration, hyper-emotionality and sucrose consumption paradigms. TBI not only causes immediate mechanical damage to the brain, but also induces biochemical changes that lead to delayed neural cell loss leading to a secondary injury. The present study examines the antidepressant effects of ETZ on the TBI-induced depression-like behavior deficits and attempts to explore the underlying mechanism. In order to understand the underlying pathology of TBI and mechanism(s) of ETZ in TBI molecular markers namely, brain cAMP, cAMP response element binding protein (pCREB) and brain-derived neurotrophic factor (BDNF) were estimated. Additionally, the level of oxidative (lipid peroxidation) & nitrosative (nitrite) stress markers, along with antioxidant enzymes markers, such as, reduced glutathione (GSH), superoxide dismutase (SOD) and catalase (CAT) were measured. Furthermore, the involvement of hypothalamic-pituitary adrenal (HPA) axis activity in underlying mechanism was also investigated by measuring serum corticosterone (CORT) level. The results revealed that TBI significantly altered cAMP, pCREB and BDNF levels. Moreover, a significant increase in oxidative-nitrosative stress markers levels, while, significant decreases in antioxidant enzymes markers level were observed. However, no significant change was observed in serum CORT level. Chronic ETZ (0.5 and 1 mg/kg) treatment significantly attenuated TBI-induced behavioral deficits and restored the TBI induced derangements in molecular and biochemical markers. This study indicates that ETZ modulates cAMP signaling and oxidative/antioxidant markers in the TBI model suggesting its prospect as a potential candidate for the pharmacotherapy of depression. (C) 2016 Elsevier Ltd. All rights reserved.	[Jindal, Ankur; Mahesh, Radhakrishnan; Bhatt, Shvetank] Birla Inst Technol & Sci, Dept Pharm, Pilani 333031, Rajasthan, India; [Pandey, Dilip] Lupin Res Pk, In Vivo Pharmacol, Novel Drug Discovery & Dev, Pune 411042, Maharashtra, India; [Bhatt, Shvetank] MS Ramaiah Univ Appl Sci, Fac Pharm, Dept Pharmacol, Bangalore 560054, Karnataka, India		Jindal, A (corresponding author), Birla Inst Technol & Sci, Dept Pharm, Pilani 333031, Rajasthan, India.	kumarjindal26@gmail.com	bhatt, shvetank/E-7440-2019		Council of Scientific and Industrial ResearchCouncil of Scientific & Industrial Research (CSIR) - India; Department of Biotechnology of India [BT/PR12691/Med/30/203/2009]	This study was financially supported by grants from the Department of Biotechnology of India (BT/PR12691/Med/30/203/2009). Ankur Jindal also wishes to thank the Council of Scientific and Industrial Research for providing fellowship.	Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Drott J, 2010, EUR J PHARMACOL, V634, P95, DOI 10.1016/j.ejphar.2010.02.036; EDWARDS DA, 1990, PHYSIOL BEHAV, V48, P447, DOI 10.1016/0031-9384(90)90342-2; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Eren I, 2007, NEUROCHEM RES, V32, P497, DOI 10.1007/s11064-006-9258-9; Feuerstein GZ, 1997, ANN NY ACAD SCI, V825, P179, DOI 10.1111/j.1749-6632.1997.tb48428.x; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; HOROVITZ ZP, 1972, PSYCHOSOMATICS, V13, P85; Houslay MD, 2001, PROG NUCLEIC ACID RE, V69, P249, DOI 10.1016/S0079-6603(01)69049-4; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; Jindal A, 2015, PHARMACOL BIOCHEM BE, V132, P20, DOI 10.1016/j.pbb.2015.02.017; Jindal A, 2015, PSYCHOPHARMACOLOGY, V232, P623, DOI 10.1007/s00213-014-3705-0; Jindal A, 2013, PHARMACOL BIOCHEM BE, V105, P63, DOI 10.1016/j.pbb.2013.01.020; Jindal A, 2012, EUR J PHARMACOL, V689, P125, DOI 10.1016/j.ejphar.2012.05.051; Jorge R, 2002, NEUROREHABILITATION, V17, P311; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; KING FA, 1958, J NERV MENT DIS, V126, P57, DOI 10.1097/00005053-195801000-00006; Kulkarni S., 1977, INDIAN J PHARM, V9, P241; Maas AIR, 2012, LANCET NEUROL, V11, P12, DOI 10.1016/S1474-4422(11)70267-8; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P117; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P676, DOI 10.1016/j.pnpbp.2010.05.004; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; O'Donnell JM, 2004, TRENDS PHARMACOL SCI, V25, P158, DOI 10.1016/j.tips.2004.01.003; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Pandey DK, 2008, J PHARM PHARMACOL, V60, P1643, DOI 10.1211/jpp/60.12.0010; Park HK, 1999, CRIT REV NEUROSURG, V9, P44, DOI 10.1007/s003290050108; Ramamoorthy R, 2008, BEHAV PHARMACOL, V19, P29, DOI 10.1097/FBP.0b013e3282f3cfd4; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; SCHNEIDER HH, 1986, EUR J PHARMACOL, V127, P105, DOI 10.1016/0014-2999(86)90210-4; SCUVEEMOREAU J, 1987, ARCH INT PHARMACOD T, V288, P43; SHIBATA S, 1994, BRAIN RES, V665, P147, DOI 10.1016/0006-8993(94)91165-7; Simpson GK, 2007, MED J AUSTRALIA, V187, P229, DOI 10.5694/j.1326-5377.2007.tb01206.x; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Siopi E, 2013, NEUROPHARMACOLOGY, V67, P183, DOI 10.1016/j.neuropharm.2012.11.009; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vidal R, 2011, CURR PHARM DESIGN, V17, P521, DOI 10.2174/138161211795164086; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; WILLS ED, 1966, BIOCHEM J, V99, P667, DOI 10.1042/bj0990667; Zafir A, 2009, PROG NEURO-PSYCHOPH, V33, P220, DOI 10.1016/j.pnpbp.2008.11.010	51	8	8	1	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	DEC	2017	111				SI		3	11		10.1016/j.neuint.2016.12.004			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FR3OS	WOS:000418976600002	27988361				2022-02-06	
J	McMahon, MJ; Sheikh, KL; Andrada, TF; Holley, AB				McMahon, Michael J.; Sheikh, Karen L.; Andrada, Teotimo F.; Holley, Aaron B.			Using the STOPBANG questionnaire and other pre-test probability tools to predict OSA in younger, thinner patients referred to a sleep medicine clinic	SLEEP AND BREATHING			English	Article						Sleep apnea; Sleep disordered breathing; Diagnosis; Pre-test probability	INSOMNIA SEVERITY INDEX; BANG QUESTIONNAIRE; CARDIOVASCULAR-DISEASE; BERLIN QUESTIONNAIRE; APNEA SYNDROME; SCREEN; VALIDATION; IMPACT; ADULTS; RISK	The STOPBANG questionnaire is used to predict the presence of obstructive sleep apnea (OSA). We sought to assess the performance of the STOPBANG questionnaire in younger, thinner patients referred to a sleep medicine clinic. We applied the STOPBANG questionnaire to patients referred for level I polysomnography (PSG) at our sleep center. We calculated likelihood ratios and area under the receiver operator characteristic (AUROC) curve and performed sensitivity analyses. We performed our analysis on 338 patients referred for PSG. Only 17.2% (n = 58) were above age 50 years, and 30.5 and 6.8% had a BMI above 30 and 35 years, respectively. The mean apnea-hypopnea index (AHI) was 12.9 +/- 16.4 and 63.9% had an AHI ae5. The STOPBANG (threshold ae3) identified 83.1% of patients as high risk for an AHI ae5, and sensitivity, specificity, positive (PPV), and negative predictive values (NPV) were 83.8, 18.0, 64.4, and 38.0%, respectively. Positive and negative likelihood ratios were poor at 1.02-1.11 and 0.55-0.90, respectively, across AHI thresholds (AHI ae5, AHI ae15 and AHI ae30), and AUROCs were 0.52 (AHI ae5) and 0.56 (AHI ae15). Sensitivity analyses adjusting for insomnia, combat deployment, traumatic brain injury, post-traumatic stress disorder, clinically significant OSA (ESS > 10 and/or co-morbid disease), and obesity did not significantly alter STOPBANG performance. In a younger, thinner population with predominantly mild-to-moderate OSA, the STOPBANG Score does not accurately predict the presence of obstructive sleep apnea.	[McMahon, Michael J.; Sheikh, Karen L.; Andrada, Teotimo F.; Holley, Aaron B.] Walter Reed Natl Mil Med Ctr, 8901 Wisconsin Ave, Bethesda, MD 20889 USA		Holley, AB (corresponding author), Walter Reed Natl Mil Med Ctr, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.	mcmahon725@gmail.com; karen.sheikh@gmail.com; teotimo.f.andrada.civ@mail.mil; aholley9@gmail.com					Abrishami A, 2010, CAN J ANAESTH, V57, P423, DOI 10.1007/s12630-010-9280-x; BaHammam AS, 2014, SLEEP BREATH, V18, P767, DOI 10.1007/s11325-014-0939-3; Bouloukaki I, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-6; Boynton GVA, 2013, J SLEEP DISORD TREAT, V2, P2, DOI DOI 10.4172/2325-9639.1000121; Brown LK, 2007, J CLIN SLEEP MED, V3, P259; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Chung F, 2016, CHEST, V149, P631, DOI 10.1378/chest.15-0903; Chung F, 2014, J CLIN SLEEP MED, V10, P951, DOI 10.5664/jcsm.4022; Collop N, 2014, J CLIN SLEEP MED, V10, P125, DOI 10.5664/jcsm.3434; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; CROCKER BD, 1990, AM REV RESPIR DIS, V142, P14, DOI 10.1164/ajrccm/142.1.14; El-Sayed IH, 2012, EGYPT J CHEST DIS TU, V61, P433, DOI 10.1016/j.ejcdt.2012.07.003; Farney RJ, 2011, J CLIN SLEEP MED, V7, P459, DOI 10.5664/JCSM.1306; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Gagnon C, 2013, J AM BOARD FAM MED, V26, P701, DOI 10.3122/jabfm.2013.06.130064; Guilleminault C, 2009, SLEEP BREATH, V13, P341, DOI 10.1007/s11325-009-0253-7; GUILLEMINAULT C, 1993, CHEST, V104, P781, DOI 10.1378/chest.104.3.781; Ha SCN, 2014, SLEEP BREATH, V18, P715, DOI 10.1007/s11325-013-0889-1; Hartenbaum N, 2006, J OCCUP ENVIRON MED, V48, pS1, DOI 10.1097/00043764-200609001-00001; Jaoude P, 2015, ANN AM THORAC SOC, V12, P259, DOI 10.1513/AnnalsATS.201407-299FR; Korotinsky A, 2016, SLEEP BREATH; Kunisaki Ken M, 2014, Ann Am Thorac Soc, V11, P192, DOI 10.1513/AnnalsATS.201305-134OC; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Leeflang MMG, 2009, J CLIN EPIDEMIOL, V62, P5, DOI 10.1016/j.jclinepi.2008.04.007; Lettieri CJ, 2016, CHEST, V149, P483, DOI 10.1378/chest.15-0693; Luo JM, 2014, CHINESE MED J-PEKING, V127, P3065, DOI 10.3760/cma.j.issn.0366-6999.20141196; Luyster FS, 2010, J CLIN SLEEP MED, V6, P196; McNicholas WT, 2007, EUR RESPIR J, V29, P156, DOI 10.1183/09031936.00027406; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Myers KA, 2013, JAMA-J AM MED ASSOC, V310, P731, DOI 10.1001/jama.2013.276185; Nagappa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143697; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Ong TH, 2010, SLEEP BREATH, V14, P371, DOI 10.1007/s11325-010-0350-7; Pataka A, 2014, SLEEP MED, V15, P776, DOI 10.1016/j.sleep.2014.03.012; Peker Y, 2012, AM J RESP CRIT CARE, V186, P583, DOI 10.1164/rccm.201208-1400ED; Peppard PE, 2009, AM J RESP CRIT CARE, V180, P788, DOI 10.1164/rccm.200905-0773OC; Pereira EJ, 2013, J CLIN SLEEP MED, V9, P1259, DOI 10.5664/jcsm.3264; Quan S, 2007, AASM MANUAL SCORING, V1; Reis R, 2015, REV PORT PNEUMOL, V21, P61, DOI 10.1016/j.rppnen.2014.04.009; Rosenthal LD, 2008, J NERV MENT DIS, V196, P429, DOI 10.1097/NMD.0b013e31816ff3bf; Rowley JA, 2000, SLEEP, V23, P929, DOI 10.1093/sleep/23.7.929; Ruehland WR, 2009, SLEEP, V32, P150, DOI 10.1093/sleep/32.2.150; U.S. Armed Forces, 2000, MED SURVEILLANCE MON, V17, P1; Vaughn BV, 2015, AASM MANUAL SCORING; VINER S, 1991, ANN INTERN MED, V115, P356, DOI 10.7326/0003-4819-115-5-356; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Young T, 2000, SLEEP, V23, pS122; Young Terry, 2009, WMJ, V108, P246	48	8	9	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1520-9512	1522-1709		SLEEP BREATH	Sleep Breath.	DEC	2017	21	4					869	876		10.1007/s11325-017-1498-1			8	Clinical Neurology; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Respiratory System	FN7DZ	WOS:000416179900009	28421376				2022-02-06	
J	Sproule, DW; Campolettano, ET; Rowson, S				Sproule, David W.; Campolettano, Eamon T.; Rowson, Steven			Football helmet impact standards in relation to on-field impacts	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Youth football; head acceleration; helmet standards; adult football; impact testing	YOUTH FOOTBALL; HEAD IMPACTS; EXPOSURE; PLAYERS; CONCUSSION	Youth football helmets currently undergo the same impact testing and must satisfy the same criteria as varsity helmets, although youth football players differ from their adult counterparts in anthropometry, physiology, and impact exposure. This study aimed to relate football helmet standards testing to on-field head impact magnitudes for youth and varsity football helmets. Head impact data, filtered to include only impacts to locations in the current National Operating Committee on Standards for Athletic Equipment standard, were collected for 48 collegiate players (ages 18-23years) and 25 youth players (ages 9-11years) using helmet-mounted accelerometer arrays. These on-field data were compared to a series of National Operating Committee on Standards for Athletic Equipment standard drop tests with a youth and varsity Riddell Speed helmet. In the on-field data, the adult players had a higher frequency of impact than the youth players, and a significant difference in head acceleration magnitude only existed at the top location (p<0.001). In the laboratory drop tests, the only significant difference between the youth and varsity helmets was at the 3.46m/s (61cm) impact to the front location (p=0.0421). Drop tests generated head accelerations within the top 10% of measured on-field impacts, at all locations and drop heights, demonstrating that drop tests are representative of the most severe head impacts experienced by youth and adult football players on the field. Current standards have been very effective at eliminating skull fracture and severe brain injury in both populations. This analysis suggests that there is not currently a need for a youth-specific drop test standard. However, there may be such a need if helmet testing standards are updated to address concussion, paired with a better understanding of differences in concussion tolerance between youth and adult populations.	[Sproule, David W.; Campolettano, Eamon T.; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, 343 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA		Rowson, S (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, 343 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	rowson@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R01NS094410. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; NOCSAE, 2011, STAND PERF SPEC NEWL; NOCSAE, 2011, STAND PERF IN PRESS; NOCSAE (National Operating Committee on Standards for Athletic Equipment), 2011, STAND TEST METH EQ U; Olvey SE, 2006, 2006013656 SAE; Riddell, RIDD SPEED HELM; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Rowson S, 2016, SPORTS MED ARTHROSC, V24, P100, DOI 10.1097/JSA.0000000000000121; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	20	8	8	1	10	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	DEC	2017	231	4					317	323		10.1177/1754337117703019			7	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	FO1VW	WOS:000416557100008	30740141	Green Accepted			2022-02-06	
J	Suleiman, A; Lithgow, B; Dastghieb, Z; Mansouri, B; Moussavi, Z				Suleiman, Abdelbaset; Lithgow, Brian; Dastghieb, Zeinab; Mansouri, Behzad; Moussavi, Zahra			Quantitative measurement of post-concussion syndrome Using Electrovestibulography	SCIENTIFIC REPORTS			English	Article							TRAUMATIC-BRAIN-INJURY; COMPOUND ACTION-POTENTIALS; MINOR HEAD-INJURY; NEUROVASCULAR COMPRESSION; SODIUM-CHANNELS; CRANIAL NERVE; AMYLOID-BETA; GUINEA-PIG; SYMPTOMS; DISEASE	In this study, a noninvasive quantitative measure was used to identify short and long term post-concussion syndrome (PCS) both from each other and from healthy control populations. We used Electrovestibulography (EVestG) for detecting neurophysiological PCS consequent to a mild traumatic brain injury (mTBI) in both short-term (N = 8) and long-term (N = 30) (beyond the normal recovery period) symptomatic individuals. Peripheral, spontaneously evoked vestibuloacoustic signals incorporating - and modulated by - brainstem responses were recorded using EVestG, while individuals were stationary (no movement stimulus). Tested were 38 individuals with PCS in comparison to those of 33 age-and-gender-matched healthy controls. The extracted features were based on the shape of the averaged extracted field potentials (FPs) and their detected firing pattern. Linear discriminant analysis classification, incorporating a leave-one-out routine, resulted in (A) an unbiased 84% classification accuracy for separating healthy controls from a mix of long and short-term symptomatology PCS sufferers and (B) a 79% classification accuracy for separating between long and short-term symptomatology PCS sufferers. Comparatively, short-term symptomatology PCS was generally detected as more distal from controls. Based on the results, the EVestG recording shows promise as an assistive objective tool for detecting and monitoring individuals with PCS after normal recovery periods.	[Suleiman, Abdelbaset; Lithgow, Brian; Dastghieb, Zeinab; Mansouri, Behzad; Moussavi, Zahra] Univ Manitoba, Biomed Engn Program, Winnipeg, MB, Canada; [Mansouri, Behzad] Univ Manitoba, Dept Internal Med Neurol, Winnipeg, MB, Canada; [Lithgow, Brian] Monash Univ, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia		Moussavi, Z (corresponding author), Univ Manitoba, Biomed Engn Program, Winnipeg, MB, Canada.	Zahra.Moussavi@umanitoba.ca			MITACS; Manitoba Public Insurance (MPI); Neural Diagnostics Canada Ltd.; Riverview Health Centre Foundation	This study was supported by MITACS in two separate projects one in partnership with Manitoba Public Insurance (MPI) and the other in partnership with Neural Diagnostics Canada Ltd. and Riverview Health Centre Foundation.	Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Brown DJ, 2010, HEARING RES, V267, P12, DOI 10.1016/j.heares.2010.03.091; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; CHARPIER S, 1994, J NEUROPHYSIOL, V72, P531, DOI 10.1152/jn.1994.72.2.531; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Daroff R.B., 2015, BRADLEYS NEUROLOGY C; Dastgheib ZA, 2016, ANN BIOMED ENG, V44, P1672, DOI 10.1007/s10439-015-1441-1; DOLAN DF, 1989, J ACOUST SOC AM, V86, P2167, DOI 10.1121/1.398477; Duda RO, 2012, PATTERN CLASSIFICATI, V2; Eatock RA, 2008, J EXP BIOL, V211, P1764, DOI 10.1242/jeb.017350; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; GOLDBERG JM, 1971, J NEUROPHYSIOL, V34, P635, DOI 10.1152/jn.1971.34.4.635; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Haneef Z, 2013, J NEUROTRAUM, V30, P653, DOI 10.1089/neu.2012.2585; Headache Classification Committee of the International Headache Society (IHS, 2013, IHS INT CLASS HEAD D; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; JANNETTA PJ, 1980, ANN SURG, V192, P518, DOI 10.1097/00000658-198010000-00010; Jones TA, 1999, HEARING RES, V136, P75, DOI 10.1016/S0378-5955(99)00110-0; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kisilevski V, 2001, Int Tinnitus J, V7, P118; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lithgow B, 2012, ANN BIOMED ENG, V40, P1835, DOI 10.1007/s10439-012-0526-3; Lithgow BJ, 2015, WORLD J BIOL PSYCHIA, V16, P334, DOI 10.3109/15622975.2015.1014410; Lithgow BJ, 2015, J NEUROL SCI, V353, P49, DOI 10.1016/j.jns.2015.03.050; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; MARLINSKY VV, 1995, NEUROSCIENCE, V69, P661, DOI 10.1016/0306-4522(95)00231-7; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; MOLLER AR, 1983, EXP NEUROL, V80, P633, DOI 10.1016/0014-4886(83)90313-8; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Ryu H, 1999, ACTA NEUROCHIR, V141, P495, DOI 10.1007/s007010050330; Schmitt Sarah, 2015, Handb Clin Neurol, V127, P319, DOI 10.1016/B978-0-444-52892-6.00021-0; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shera CA, 2003, J ACOUST SOC AM, V114, P244, DOI 10.1121/1.1575750; Shumway-Cook A, 1990, J HEAD TRAUMA REHAB, V5, P51, DOI DOI 10.1097/00001199-199012000-00007; SIEGEL JH, 1986, HEARING RES, V22, P245, DOI 10.1016/0378-5955(86)90101-2; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Subbian V, 2016, ACAD EMERG MED, V23, P382, DOI 10.1111/acem.12906; Suleiman A., 2015, ENG MED BIOL SOC EMB; Surmeli T, 2017, CLIN EEG NEUROSCI, V48, P217, DOI 10.1177/1550059416654849; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; vanEmst MG, 1996, HEARING RES, V102, P70, DOI 10.1016/S0378-5955(96)00149-9; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001	65	8	8	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 27	2017	7								16371	10.1038/s41598-017-15487-2			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN8WL	WOS:000416307400021	29180620	gold, Green Published			2022-02-06	
J	Ghaffary, S; Ghaeli, P; Talasaz, AH; Karimi, A; Noroozian, M; Salehiomran, A; Jalali, A				Ghaffary, Saba; Ghaeli, Padideh; Talasaz, Azita Hajhossein; Karimi, Abbasali; Noroozian, Maryam; Salehiomran, Abbas; Jalali, Arash			Effect of memantine on post-operative cognitive dysfunction after cardiac surgeries: a randomized clinical trial	DARU-JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						Post-operative cognition dysfunction (POCD); Glutamate; Wechsler memory test (WMT); Memantine; Cardiac surgeries	TRAUMATIC BRAIN INJURY; NEUROCOGNITIVE FUNCTION; BYPASS-SURGERY; NEURONAL DEATH; GLUTAMATE; NEURODEGENERATION; NEUROPROTECTION; TEMPERATURE; ANTAGONISTS; ASPARTATE	Background: Post-operative cognitive dysfunction (POCD) is an important complication of cardiac surgeries. Glutamate plays a critical role in physiologic and pathologic conditions in the brain. Due to the role of glutamate in ischemia, this study is designed to identify the effect of memantine in prevention of POCD early and late after cardiac surgeries. Methods: In this randomized clinical trial, 172 patients with ages 45-75 years old who underwent elective cardiac surgery were enrolled. For patients in memantine group, 5 mg of memantine per day administered at least 48 h before surgery and increased to 10 mg per day during the first 24 h after surgery and continued for 3 months. A brief Wechsler memory test (WMT) was administered before, three to 5 days after, and 3 months after surgery for both groups. Results: Both groups demonstrate standard pattern of cognitive dysfunction after surgery and in follow up. Pre- and post-operative WMT score showed significant improvement in memantine compared to control group (P < 0.001) both in unadjusted and adjusted with confounding factor analysis. Unadjusted pre-, post-operative, and follow up WMT score improved significantly after 3 months in memantine group (P = 0.006). Conclusion: Pre-operative administration of memantine protects patients from POCD following cardiac surgeries. In addition, it improves cognitive function 3 months after surgery.	[Ghaffary, Saba] Tabriz Univ Med Sci, Hematol & Oncol Res Ctr, Tabriz, Iran; [Ghaeli, Padideh; Talasaz, Azita Hajhossein] Univ Tehran Med Sci, Dept Pharmacotherapy, Fac Pharm, Tehran, Iran; [Talasaz, Azita Hajhossein; Karimi, Abbasali; Salehiomran, Abbas; Jalali, Arash] Univ Tehran Med Sci, Tehran Heart Ctr, Tehran, Iran; [Noroozian, Maryam] Univ Tehran Med Sci, Roozbeh Hosp, Memory & Behav Neurol Dept, Tehran, Iran		Talasaz, AH (corresponding author), Univ Tehran Med Sci, Dept Pharmacotherapy, Fac Pharm, Tehran, Iran.; Talasaz, AH (corresponding author), Univ Tehran Med Sci, Tehran Heart Ctr, Tehran, Iran.	a-talasaz@tums.ac.ir	Jalali, Arash/N-8145-2014; Talasaz, Azita Hajhossein/I-2677-2013; Ghaffary, Saba/M-5811-2017	Jalali, Arash/0000-0003-3225-8498; Talasaz, Azita Hajhossein/0000-0003-1839-3685; Ghaffary, Saba/0000-0003-1336-6039			ALBIN RL, 1992, NEUROLOGY, V42, P733, DOI 10.1212/WNL.42.4.733; Ali MS, 2005, ANAESTHESIA, V60, P365, DOI 10.1111/j.1365-2044.2005.04112.x; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013; Ghaffary Saba, 2015, J Tehran Heart Cent, V10, P85; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; Hudetz JA, 2009, ACTA ANAESTH SCAND, V53, P864, DOI 10.1111/j.1399-6576.2009.01978.x; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Koroshetz WJ, 1996, TRENDS PHARMACOL SCI, V17, P227, DOI 10.1016/0165-6147(96)10020-1; Lee KH., 2015, ANESTH PAIN MED, V5; Li XM, 2014, J ZHEJIANG UNIV-SC B, V15, P870, DOI 10.1631/jzus.B1400130; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Miguel-Hidalgo JJ, 2002, BRAIN RES, V958, P210, DOI 10.1016/S0006-8993(02)03731-9; Newman MF, 2001, STROKE, V32, P2874, DOI 10.1161/hs1201.099803; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Parfenova H, 2006, AM J PHYSIOL-CELL PH, V290, pC1399, DOI 10.1152/ajpcell.00386.2005; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Selnes OA, 2001, ARCH NEUROL-CHICAGO, V58, P598, DOI 10.1001/archneur.58.4.598; van Harten AE, 2012, ANAESTHESIA, V67, P280, DOI 10.1111/j.1365-2044.2011.07008.x	25	8	10	0	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2008-2231			DARU	DARU	NOV 21	2017	25								24	10.1186/s40199-017-0190-0			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FN5PW	WOS:000416061100001	29157293	Green Published, hybrid			2022-02-06	
J	Kuo, C; Wu, LC; Ye, PP; Laksari, K; Camarillo, DB; Kuhl, E				Kuo, Calvin; Wu, Lyndia C.; Ye, Patrick P.; Laksari, Kaveh; Camarillo, David B.; Kuhl, Ellen			Pilot Findings of Brain Displacements and Deformations during Roller Coaster Rides	JOURNAL OF NEUROTRAUMA			English	Article						brain modeling; head kinematics; traumatic brain injury; wearable sensors	SUBDURAL-HEMATOMA; HEAD; INJURY; ACCELERATIONS; MICROTUBULES; MOUTHGUARD; MECHANICS; RESPONSES; BREAKING; TRAUMA	With 300,000,000 riders annually, roller coasters are a popular recreational activity. Although the number of roller coaster injuries is relatively low, the precise effect of roller coaster rides on our brains remains unknown. Here we present the quantitative characterization of brain displacements and deformations during roller coaster rides. For two healthy adult male subjects, we recorded head accelerations during three representative rides, and, for comparison, during running and soccer headers. From the recordings, we simulated brain displacements and deformations using rigid body dynamics and finite element analyses. Our findings show that despite having lower linear accelerations than sports head impacts, roller coasters may lead to brain displacements and strains comparable to mild soccer headers. The peak change in angular velocity on the rides was 9.9 rad/sec, which was higher than the 5.6 rad/sec in soccer headers with ball velocities reaching 7 m/sec. Maximum brain surface displacements of 4.0 mm and maximum principal strains of 7.6% were higher than in running and similar to soccer headers, but below the reported average concussion strain. Brain strain rates during roller coaster rides were similar to those in running, and lower than those in soccer headers. Strikingly, on the same ride and at a similar position, the two subjects experienced significantly different head kinematics and brain deformation. These results indicate that head motion and brain deformation during roller coaster rides are highly sensitive to individual subjects. Although our study suggests that roller coaster rides do not present an immediate risk of acute brain injury, their long-term effects require further longitudinal study.	[Kuo, Calvin; Camarillo, David B.; Kuhl, Ellen] Stanford Univ, Dept Mech Engn, 443 Via Ortega,Shriram Ctr Room 202, Stanford, CA 94305 USA; [Wu, Lyndia C.; Ye, Patrick P.; Laksari, Kaveh; Camarillo, David B.; Kuhl, Ellen] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA		Kuo, C (corresponding author), Stanford Univ, Dept Mech Engn, 443 Via Ortega,Shriram Ctr Room 202, Stanford, CA 94305 USA.	calvink@stanford.edu	Kuhl, Ellen/G-4444-2011; Wu, Lyndia/AAQ-1106-2020; Kuo, Calvin/AAH-1933-2019	Kuhl, Ellen/0000-0002-6283-935X; Wu, Lyndia/0000-0002-8236-032X; Kuo, Calvin/0000-0001-8401-9136	Stanford Bio-X Graduate Research Fellowship Program; Stanford Child Health Research Institute, Lucile Packard Foundation for Children's Health, Stanford CTSA [UL1 TR001085]; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001085] Funding Source: NIH RePORTER	We thank Dr. Svein Kleiven for providing the KTH brain model, which was used to compute brain deformations. This work was mainly supported by the Stanford Bio-X Graduate Research Fellowship Program, the Stanford Child Health Research Institute, Lucile Packard Foundation for Children's Health, Stanford CTSA (UL1 TR001085), and the Natural Sciences and Engineering Research Council of Canada.	Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; BOABBAS Y, 1995, NEW ENGL J MED, V332, P1585, DOI 10.1056/NEJM199506083322317; Braksiek RJ, 2002, ANN EMERG MED, V39, P65, DOI 10.1067/mem.2002.120127; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Famaey N, 2015, J MECH BEHAV BIOMED, V41, P222, DOI 10.1016/j.jmbbm.2014.06.009; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; FERNANDES CMB, 1994, J TRAUMA, V37, P1007, DOI 10.1097/00005373-199412000-00024; Fukutake T, 2000, NEUROLOGY, V54, P264, DOI 10.1212/WNL.54.1.264; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Goriely A, 2015, ADV APPL MECH, V48, P79, DOI 10.1016/bs.aams.2015.10.002; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Levenson M.S., 2002, AMUSEMENT RIDE RELAT; Low Tah C., 1987, P INT RES COUNC BIOM, V15; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Nencini P, 2000, JAMA-J AM MED ASSOC, V284, P832, DOI 10.1001/jama.284.7.832; Olympia RP, 2011, J EMERG MED, V41, P14, DOI 10.1016/j.jemermed.2008.04.052; Pelletier AR, 2005, INJURY PREV, V11, P309, DOI 10.1136/ip.2005.008425; Pfister BJ, 2009, AM J FOREN MED PATH, V30, P339, DOI 10.1097/PAF.0b013e318187e0c9; Roldan-Valadeza E, 2006, EUR J PAEDIATR NEURO, V10, P194, DOI 10.1016/j.ejpn.2006.07.001; Rooij R. de, 2015, APPL MECH REV, V68, P1; Scranton RA, 2016, HEADACHE, V56, P372, DOI 10.1111/head.12717; SENEGOR M, 1991, J NEUROSURG, V75, P475, DOI 10.3171/jns.1991.75.3.0475; Smith DH, 2002, J NEUROTRAUM, V19, P1117, DOI 10.1089/08977150260337921; Snyder RW, 1997, AM J MED, V102, P488, DOI 10.1016/S0002-9343(97)89445-4; Suarez J.I., 2011, NEW ENGL J MED, V18, P388; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Thompson MC, 2013, CLIN PEDIATR, V52, P433, DOI 10.1177/0009922813476341; van den Bedem H, 2015, BIOPHYS J, V109, P2215, DOI 10.1016/j.bpj.2015.10.020; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; Weickenmeier J, 2017, COMPUT METHOD APPL M, V314, P180, DOI 10.1016/j.cma.2016.08.011; Williams K, 2009, AM J EMERG MED, V27; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Wu LC, 2014, IEEE T BIO-MED ENG, V61, P2659, DOI 10.1109/TBME.2014.2320153; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239	54	8	8	1	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2017	34	22					3198	3205		10.1089/neu.2016.4893			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FL9GC	WOS:000414560000016	28683585	Green Published			2022-02-06	
J	Czorlich, P; Dreimann, M; Emami, P; Westphal, M; Lefering, R; Hoffmann, M				Czorlich, Patrick; Dreimann, Marc; Emami, Pedram; Westphal, Manfred; Lefering, Rolf; Hoffmann, Michael			Body Mass Index > 35 as Independent Predictor of Mortality in Severe Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Body mass index; Mortality; Obesity; Outcome; Traumatic brain injury	DIFFICULT AIRWAY; IMPACT; OBESITY; OUTCOMES; INTUBATION; RISK; TBI; AGE	OBJECTIVE: Severe traumatic brain injury (TBI) has a major influence on polytrauma outcome. The aim of this study was to evaluate the impact of body mass index (BMI) on mortality and early neurologic outcome in patients suffering from severe TBI with a special focus on obesity classes II and III (BMI >= 35). METHODS: A retrospective cohort analysis of patients suffering from a leading, at least severe TBI and registered in the TraumaRegister DGU was conducted. Patients alive on admission with full status documentation on Glasgow Coma Scale, height, and weight were classified into 4 BMI subgroups. Early neurologic outcome was classified using the Glasgow Outcome Scale. - RESULTS: A total of 1634 patients met the inclusion criteria. Lowest mortality was documented for BMI group 1 (15.2%, BMI 25.0-29.9918.5). Highest mortality was found in BMI group 5 (25.6%, BMI >= 35). BMI >= 35 was an independent predictor of mortality with an odds ratio of 3.15 (95% confidence interval [1.06-9.36], P= 0.039). Further independent mortality predictors were > 65 years of age, a Glasgow Coma Scale of <= 13, an Abbreviated Injury Scale(head) >= 5, prehospital cardiopulmonary resuscitation, and a prehospital blood pressure of < 90 mm Hg. In terms of good early neurologic outcomes, no differences were recorded between the BMI groups (range 59.0% L62.6%, P = 0.087). CONCLUSIONS: In this study a BMI >= 35 is an independent predictor of mortality and is associated with an inferior early functional neurologic outcome.	[Czorlich, Patrick; Emami, Pedram; Westphal, Manfred] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Dreimann, Marc] Univ Med Ctr Hamburg Eppendorf, Div Spine Surg, Hamburg, Germany; [Lefering, Rolf] Witten Herdecke Univ, Inst Res Operat Med, Cologne, Germany; [Hoffmann, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Trauma Hand & Reconstruct Surg, Hamburg, Germany; [Hoffmann, Michael] Clin Orthoped, Holstein, Germany		Czorlich, P (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany.	p.czorlich@uke.de	Dreimann, Marc/AAZ-6962-2020; Czorlich, Patrick/H-8934-2019		European Journal of Trauma	Rolf Lefering was paid for statistical reviews by the European Journal of Trauma. He is employed at the University of Witten/Herdecke, which has a service agreement with the AUC/German Trauma Society for scientific assistance, annual audit reports, etc. All other authors confirm that there are no known conflicts of interest associated with this publication, and there has been no significant financial support for this work that could have influenced its outcome.	Bochicchio GV, 2006, J AM COLL SURGEONS, V203, P533, DOI 10.1016/j.jamcollsurg.2006.07.001; Brown CVR, 2005, J TRAUMA, V59, P1048, DOI 10.1097/01.ta.0000189047.65630.c5; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chabok SY, 2014, EUR J TRAUMA EMERG S, V40, P51, DOI 10.1007/s00068-013-0314-2; CHOBAN PS, 1991, J TRAUMA, V31, P1253, DOI 10.1097/00005373-199109000-00009; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Frat JP, 2008, INTENS CARE MED, V34, P1991, DOI 10.1007/s00134-008-1245-y; Gaither Joshua B, 2015, Air Med J, V34, P343, DOI 10.1016/j.amj.2015.06.001; Gaither JB, 2014, J EMERG MED, V47, P294, DOI 10.1016/j.jemermed.2014.04.021; Hoffmann M, 2017, J NEUROSURG ANESTH, V29, P161, DOI 10.1097/ANA.0000000000000275; Hoffmann M, 2012, INJURY, V43, P184, DOI 10.1016/j.injury.2011.05.029; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Joseph B, 2017, OBES RES CLIN PRACT, V11, P72, DOI 10.1016/j.orcp.2016.03.003; Lefering R, 2009, EUR J TRAUMA EMERG S, V35, P437, DOI 10.1007/s00068-009-9122-0; Liu T, 2013, INJURY, V44, P1145, DOI 10.1016/j.injury.2012.10.038; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2015, EUR J TRAUMA EMERG S, V41, P651, DOI 10.1007/s00068-014-0490-8; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Mica L, 2014, EUR J TRAUMA EMERG S, V40, P573, DOI 10.1007/s00068-013-0300-8; Neville AL, 2004, ARCH SURG-CHICAGO, V139, P983, DOI 10.1001/archsurg.139.9.983; Newell MA, 2007, J AM COLL SURGEONS, V204, P1056, DOI 10.1016/j.jamcollsurg.2006.12.042; Popkin BM, 2013, OBES REV, V14, P11, DOI 10.1111/obr.12102; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Sifri ZC, 2008, J TRAUMA, V65, P396, DOI 10.1097/TA.0b013e31817f97fd; Tagliaferri F, 2009, J TRAUMA, V66, P727, DOI 10.1097/TA.0b013e31815edefd; Toevs CC, 2010, CRIT CARE CLIN, V26, P689, DOI 10.1016/j.ccc.2010.06.010; Toshniwal G, 2014, J CLIN ANESTH, V26, P360, DOI 10.1016/j.jclinane.2014.01.010; Wirth A, 2014, DTSCH ARZTEBL INT, V111, P705, DOI 10.3238/arztebl.2014.0705	31	8	8	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2017	107						515	521		10.1016/j.wneu.2017.08.010			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN2XV	WOS:000415860500071	28823658				2022-02-06	
J	Gokcen, E; Caltekin, I; Savrun, A; Korkmaz, H; Savrun, ST; Yildirim, G				Gokcen, Emre; Caltekin, Ibrahim; Savrun, Atakan; Korkmaz, Hilal; Savrun, Seyda Tuba; Yildirim, Gokhan			Alterations in optic nerve sheath diameter according to cerebrovascular disease sub-groups	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Cerebrovascular disease; Optic nerve sheath diameter; Intracranial pressure	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; COMPUTED-TOMOGRAPHY; ISCHEMIC-STROKE; CLASSIFICATION; HYPOTHERMIA; INFARCTION; THROMBOLYSIS; HEMORRHAGE; ULTRASOUND	Background: ONSD (optic nerve sheath diameter) is a method used for indirect measurement of the increased intracranial pressure. In previous studies, the relation between the increased intracranial pressure and ONSD was analyzed in the patients suffering from cerebrovascular diseases (CVD). In our study, the patients suffering from ischemic CVD were categorized into 4 subgroups according to Oxfordshire Community Stroke Project classification (OCSP); the relationship between each group and ONSD, and the influence on each eye were analyzed.& para;& para; Methods: The study included the patients over the age of 18 applying to the emergency department of Malatya State Hospital with the symptoms of stroke between the dates of 1/1/2015 and 1/9/2016 . The patients diagnosed with stroke by means of clinical and neuroradiological imaging were examined in 4 subgroups according to Oxfordshire Community Stroke Project, The aim of the study is to predict the intracranial pressure (ICP) levels of the patients through ONSD measurement and CT images.& para;& para; Results: In the comparison of The right and left optic nerve sheath diameters of CVD group and control group, the obtained results were found to be statistically significant (p < 0.001). When the CVD subgroups were compared with the control group in terms of right and left optic nerve sheath diameters, the highest right-left optic nerve sheath diameter was detected to be in TACI (Total Anterior Circulation Infarction) group (p < 0.001).& para;& para; Discussion/conclusion: In the early cases of CVD, mortality and morbidity can be decreased through the early diagnosis of the possible existence of ICP increase according to ONSD level. (C) 2017 Elsevier Inc. All rights reserved.	[Gokcen, Emre; Caltekin, Ibrahim] Malatya State Hosp, Emergency Dept, Malatya, Turkey; [Savrun, Atakan] Dr Nafiz Korez Sincan State Hosp, Emergency Dept, Ankara, Turkey; [Korkmaz, Hilal] Hacettepe Univ, Physiol Dept, Ankara, Turkey; [Savrun, Seyda Tuba] Ataturk Training & Res Hosp, Emergency Dept, Ankara, Turkey; [Yildirim, Gokhan] Malatya State Hosp, Radiol Dept, Malatya, Turkey		Gokcen, E (corresponding author), Malatya State Hosp, Emergency Dept, Malatya, Turkey.	emregokcenacl@gmail.com	korkmaz, hilal/AAR-6656-2020; Caltekin, Ibrahim/AAA-4365-2021; Gokcen, Emre/AAA-4677-2021	korkmaz, hilal/0000-0002-9097-1024; Caltekin, Ibrahim/0000-0002-3973-0655; Gokcen, Emre/0000-0002-6018-6105			BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bekerman I, 2016, J NEUROL SCI, V368, P285, DOI 10.1016/j.jns.2016.07.023; Bekerman I, 2016, J CLIN NEUROSCI, V30, P106, DOI 10.1016/j.jocn.2016.01.018; Dubourg J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-62; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; Hassen GW, 2015, J EMERG MED, V48, P450, DOI 10.1016/j.jemermed.2014.09.060; Kalantari H, 2013, AM J EMERG MED, V31, P1595, DOI 10.1016/j.ajem.2013.07.028; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; MORLEY NC, 2002, COCHRANE DB SYST REV, V3; Murtha LA, 2014, INT J STROKE, V9, P553, DOI 10.1111/ijs.12181; Murtha LA, 2015, J CEREBR BLOOD F MET, V35, P592, DOI 10.1038/jcbfm.2014.230; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Rickert K., 2003, OPER TECH GEN SURG, V5, P170; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P26, DOI 10.1001/archneur.1984.04050130032017; Safak KY, 2015, OKMEYDANI TIP DERGIS, V31, P71; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Shevlin C., 2015, CRIT CARE HORIZONS, V1, P22; Sung SF, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-39; Vaiman M, 2016, J NEUROTRAUMA; Yang YL, 2016, THER CLIN RISK MANAG, V12, P1049, DOI 10.2147/TCRM.S107053; Young AMH, 2017, PEDIATR RES, V81, P443, DOI 10.1038/pr.2016.165	23	8	8	3	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	NOV	2017	35	11					1607	1611		10.1016/j.ajem.2017.04.073			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FM6WJ	WOS:000415201700004	28473274				2022-02-06	
J	Maria, K				Maria, Katharina			Nosocomial Infections in the Neurointensive Care Unit	NEUROLOGIC CLINICS			English	Article						Nosocomial infections; Hospital-acquired pneumonia; Ventriculitis; Urinary tract infection; EVD-related infection	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; LENGTH-OF-STAY; VENTILATOR-ASSOCIATED PNEUMONIA; HOSPITAL-ACQUIRED PNEUMONIA; DELAYED CEREBRAL-ISCHEMIA; NEUROSURGICAL BACTERIAL-MENINGITIS; ANEURYSMAL SUBARACHNOID HEMORRHAGE; VENTRICULOSTOMY-RELATED INFECTIONS; CLOSTRIDIUM-DIFFICILE INFECTIONS	Infectious complications in the neurointensive care unit (neuro-ICU) are common, including pneumonia, urinary tract infection, bloodstream infection, and intracranial infection. The neuro-ICU population poses a specific challenge in the diagnosis of infections, because of the high incidence of fever in acutely brain-injured patients. Furthermore, susceptibility to infections is likely enhanced by brain injury (induced immune modulation). This article reviews the concept of brain injury induced immune modulation, and summarizes available data and knowledge on nosocomial meningitis and ventriculitis, and systemic infectious complications in patients with traumatic brain injury, ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, and status epilepticus.	[Maria, Katharina] Univ Florida, Coll Med, McKnight Brain Inst, Dept Neurol, L3-100,1149 Newell Dr, Gainesville, FL 32610 USA		Maria, K (corresponding author), Univ Florida, Coll Med, McKnight Brain Inst, Dept Neurol, L3-100,1149 Newell Dr, Gainesville, FL 32610 USA.	Katharina.busl@neurology.ufl.edu					Ala-Kokko TI, 2006, ANAESTH INTENS CARE, V34, P639, DOI 10.1177/0310057X0603400509; Alleyne CH, 2000, NEUROSURGERY, V47, P1124, DOI 10.1097/00006123-200011000-00020; Alsumrain M, 2013, J INTENSIVE CARE MED, V28, P118, DOI 10.1177/0885066612437512; Arabi Y, 2005, AM J INFECT CONTROL, V33, P137, DOI 10.1016/j.ajic.2004.11.008; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; AUCOIN PJ, 1986, AM J MED, V80, P369, DOI 10.1016/0002-9343(86)90708-4; Badjatia N, 2010, NEUROSURGERY, V66, P696, DOI 10.1227/01.NEU.0000367618.42794.AA; Bakovic D, 2013, CLIN PHYSIOL FUNCT I, V33, P30, DOI 10.1111/j.1475-097X.2012.01156.x; Beer R, 2008, J NEUROL, V255, P1617, DOI 10.1007/s00415-008-0059-8; Beer R, 2010, CURR OPIN CRIT CARE, V16, P117, DOI 10.1097/MCC.0b013e328338cb5f; Beer R, 2009, NEUROCRIT CARE, V10, P363, DOI 10.1007/s12028-008-9155-y; Bellinger DL, 2008, CELL IMMUNOL, V252, P27, DOI 10.1016/j.cellimm.2007.09.005; Bercault N, 2001, CRIT CARE MED, V29, P2303, DOI 10.1097/00003246-200112000-00012; Berger C, 2002, CRIT CARE MED, V30, P1778, DOI 10.1097/00003246-200208000-00017; Bhimraj A, 2012, CLEV CLIN J MED, V79, P393, DOI 10.3949/ccjm.79gr.12003; Bleck TP, 2010, EPILEPSY CURR, V10, P31, DOI 10.1111/j.1535-7511.2009.01345.x; Blomstedt G C, 1992, Neurosurg Clin N Am, V3, P375; Bobo LD, 2011, CHEST, V140, P1643, DOI 10.1378/chest.11-0556; Bociaga-Jasik M, 2012, ADV MED SCI-POLAND, V57, P142, DOI 10.2478/v10039-012-0013-y; Boehme AK, 2013, J STROKE CEREBROVASC, V22, pE582, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.020; BOHR V, 1984, ARCH NEUROL-CHICAGO, V41, P1045, DOI 10.1001/archneur.1984.04050210043012; Bratzler Dale W, 2013, Am J Health Syst Pharm, V70, P195, DOI 10.2146/ajhp120568; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Brouwer MC, 2012, LANCET, V380, P1684, DOI 10.1016/S0140-6736(12)61185-4; Brown EM, 2000, BRIT J NEUROSURG, V14, P7; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Camacho EF, 2011, INFECTION, V39, P47, DOI 10.1007/s15010-010-0073-5; Cardozo Júnior Luis Carlos Maia, 2014, Rev. bras. ter. intensiva, V26, P148, DOI 10.5935/0103-507X.20140022; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; Cazzadori A, 1997, RESP MED, V91, P193, DOI 10.1016/S0954-6111(97)90038-X; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chamorro A, 2007, J NEUROL SCI, V252, P29, DOI 10.1016/j.jns.2006.10.001; Chang LL, 2011, BRAIN BEHAV IMMUN, V25, P260, DOI 10.1016/j.bbi.2010.09.017; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chauv S, 2016, NEUROCRIT CARE, V25, P128, DOI 10.1007/s12028-016-0254-x; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101961; Chen YY, 2005, INFECT CONT HOSP EP, V26, P281, DOI 10.1086/502540; Chen ZQ, 2012, CLIN CHIM ACTA, V413, P1512, DOI 10.1016/j.cca.2012.06.018; Chumbler NR, 2010, NEUROEPIDEMIOLOGY, V34, P193, DOI 10.1159/000289350; Cinotti R, 2014, EUR J CLIN MICROBIOL, V33, P823, DOI 10.1007/s10096-013-2020-8; Citerio G, 2015, CRIT CARE MED, V43, P1630, DOI 10.1097/CCM.0000000000001019; Commichau C, 2003, NEUROLOGY, V60, P837, DOI 10.1212/01.WNL.0000047344.28843.EB; Conen A, 2008, CLIN INFECT DIS, V47, P73, DOI 10.1086/588298; Cordaro M, 2016, J NEUROTRAUM, V33, P132, DOI 10.1089/neu.2014.3460; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Coutinho LG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-326; Crabtree SJ, 2011, BURNS, V37, P42, DOI 10.1016/j.burns.2010.06.008; Croce MA, 2013, J TRAUMA ACUTE CARE, V74, P354, DOI 10.1097/TA.0b013e31827a0c65; Davenport RJ, 1996, STROKE, V27, P415, DOI 10.1161/01.STR.27.3.415; de Almeida SM, 2009, CLIN CHEM LAB MED, V47, P755, DOI 10.1515/CCLM.2009.160; Dellit TH, 2014, INFECT CONT HOSP EP, V35, P589, DOI 10.1086/675828; Desai A, 2009, J NEUROS-PEDIATR, V4, P184, DOI 10.3171/2009.4.PEDS08279; Dettenkofer M, 1999, ACTA NEUROCHIR, V141, P1303, DOI 10.1007/s007010050434; Dettenkofer M, 2001, J NEUROL, V248, P959, DOI 10.1007/s004150170048; Dhar R, 2008, NEUROCRIT CARE, V8, P253, DOI 10.1007/s12028-007-9020-4; Ding RY, 2000, DYSPHAGIA, V15, P51, DOI 10.1007/s004550010001; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Divani AA, 2015, NEUROCRIT CARE, V22, P234, DOI 10.1007/s12028-014-0065-x; Douds GL, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/479865; Dziedzic T, 2007, J NEUROL SCI, V252, P53, DOI 10.1016/j.jns.2006.10.007; Dziewas R, 2004, J NEUROL NEUROSUR PS, V75, P852, DOI 10.1136/jnnp.2003.019075; Emerson CB, 2012, INFECT CONT HOSP EP, V33, P539, DOI 10.1086/665725; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Enderson BL, 2007, J TRAUMA, V62, P33; Fichtner J, 2010, J NEUROSURG, V112, P840, DOI 10.3171/2009.8.JNS091297; Flibotte JJ, 2004, NEUROCRIT CARE, V1, P61, DOI 10.1385/NCC:1:1:61; Foreman PM, 2016, J NEUROSURG, V125, P1383, DOI 10.3171/2015.10.JNS151959; Frontera JA, 2008, NEUROSURGERY, V62, P80, DOI 10.1227/01.NEU.0000311064.18368.EA; Fukui MB, 2001, AM J NEURORADIOL, V22, P1510; Garey KW, 2008, J HOSP INFECT, V70, P142, DOI 10.1016/j.jhin.2008.06.026; Glance LG, 2011, ARCH SURG-CHICAGO, V146, P794, DOI 10.1001/archsurg.2011.41; Grau AJ, 1999, J NEUROL SCI, V171, P115, DOI 10.1016/S0022-510X(99)00261-0; Griesshammer M, 1999, J INTERN MED, V245, P295, DOI 10.1046/j.1365-2796.1999.00452.x; Haeusler KG, 2008, CEREBROVASC DIS, V25, P50, DOI 10.1159/000111499; Hallevi H, 2008, NEUROLOGY, V70, P848, DOI 10.1212/01.wnl.0000304930.47751.75; Hamidon B. B., 2003, SMJ Singapore Medical Journal, V44, P344; Hanna H, 2004, INFECT CONT HOSP EP, V25, P646, DOI 10.1086/502455; Hannawi Y, 2013, CEREBROVASC DIS, V35, P430, DOI 10.1159/000350199; Heimes J, 2011, SURG INFECT, V12, P99, DOI 10.1089/sur.2009.028; Higgins TL, 2003, CRIT CARE MED, V31, P45, DOI 10.1097/00003246-200301000-00007; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Hinduja A, 2015, AM J CRIT CARE, V24, P227, DOI 10.4037/ajcc2015422; Hoefnagel D, 2008, ACTA NEUROCHIR, V150, P209, DOI 10.1007/s00701-007-1458-9; Hoffmann S, 2012, STROKE, V43, P2617, DOI 10.1161/STROKEAHA.112.653055; Holevar M, 2009, J TRAUMA, V67, P870, DOI 10.1097/TA.0b013e3181b5a960; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Hopkins SJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-255; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Howitz MF, 2014, EPIDEMIOL INFECT, V142, P1300, DOI 10.1017/S0950268813001878; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Hull E, 2017, CLIN NEUROL NEUROSUR, V157, P95, DOI 10.1016/j.clineuro.2017.03.021; Hwang BY, 2010, NEUROCRIT CARE, V13, P141, DOI 10.1007/s12028-010-9382-x; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; Jacobs DG, 1998, J NATL MED ASSOC, V90, P417; Ji RJ, 2014, STROKE, V45, P2620, DOI 10.1161/STROKEAHA.114.005023; Ji RJ, 2013, CRIT CARE, V17, DOI 10.1186/cc13130; Ji RJ, 2013, STROKE, V44, P1303, DOI 10.1161/STROKEAHA.111.000598; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jovanovic B, 2015, INT J INFECT DIS, V38, P46, DOI 10.1016/j.ijid.2015.07.005; Kammersgaard L P, 2001, J Stroke Cerebrovasc Dis, V10, P217, DOI 10.1053/jscd.2001.30366; Kasius KM, 2010, CEREBROVASC DIS, V29, P576, DOI 10.1159/000306645; Katzan IL, 2007, NEUROLOGY, V68, P1938, DOI 10.1212/01.wnl.0000263187.08969.45; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Kenneally C, 2007, CHEST, V132, P418, DOI 10.1378/chest.07-0202; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kestle JRW, 2006, J NEUROSURG, V105, P177, DOI 10.3171/ped.2006.105.3.177; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kim JH, 2012, WORLD NEUROSURG, V77, P135, DOI 10.1016/j.wneu.2011.04.017; Klehmet J, 2009, NEUROSCIENCE, V158, P1184, DOI 10.1016/j.neuroscience.2008.07.044; Korinek AM, 1997, NEUROSURGERY, V41, P1073, DOI 10.1097/00006123-199711000-00010; KORINEK AM, 1992, ANN FR ANESTH, V11, P711, DOI 10.1016/S0750-7658(05)80795-6; Korinek AM, 2006, NEUROSURGERY, V59, P126, DOI 10.1227/01.NEU.0000220477.47323.92; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kourbeti IS, 2015, J NEUROSURG, V122, P1113, DOI 10.3171/2014.8.JNS132557; Kourbeti IS, 2011, BRIT J NEUROSURG, V25, P9, DOI 10.3109/02688697.2010.500411; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Kwan J, 2007, ACTA NEUROL SCAND, V115, P331, DOI 10.1111/j.1600-0404.2006.00783.x; Kwon HM, 2006, AM J INFECT CONTROL, V34, P64, DOI 10.1016/j.ajic.2005.06.011; Laban KG, 2015, INT J STROKE, V10, P763, DOI 10.1111/ijs.12494; LABORDE G, 1993, ANAESTHESIST, V42, P724; Lackner P, 2008, NEUROCRIT CARE, V8, P360, DOI 10.1007/s12028-008-9071-1; Lakshminarayan K, 2010, STROKE, V41, P2849, DOI 10.1161/STROKEAHA.110.597039; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Launey Y, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0689-4; Leib SL, 1999, CLIN INFECT DIS, V29, P69, DOI 10.1086/520184; Li YR, 2015, CLIN BIOCHEM, V48, P50, DOI 10.1016/j.clinbiochem.2014.10.007; Liu ZH, 2015, CRIT CARE MED, V43, P2416, DOI 10.1097/CCM.0000000000001188; Lo CH, 2007, J NEUROSURG, V106, P378, DOI 10.3171/jns.2007.106.3.378; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Lozier AP, 2008, NEUROSURGERY, V62, P688, DOI [10.1227/01.neu.0000316273.35833.7c, 10.1227/01.NEU.0000017465.78245.6C]; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Lyke KE, 2001, CLIN INFECT DIS, V33, P2028, DOI 10.1086/324492; MAHE V, 1995, ANN FR ANESTH, V14, P8, DOI 10.1016/S0750-7658(05)80144-3; Maramattom BV, 2006, NEUROCRIT CARE, V5, P115, DOI 10.1385/NCC:5:2:115; Marciniak C, 2009, AM J PHYS MED REHAB, V88, P30, DOI 10.1097/PHM.0b013e3181909b73; Marra AR, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-42; Martinez R, 2002, INTENS CARE MED, V28, P208, DOI 10.1007/s00134-001-1176-3; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; May Addison K, 2006, Surg Infect (Larchmt), V7, P409, DOI 10.1089/sur.2006.7.409; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; McClelland S, 2007, CLIN INFECT DIS, V45, P55, DOI 10.1086/518580; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; McMahon CJ, 2013, J NEUROINTERV SURG, V5, P512, DOI 10.1136/neurintsurg-2012-010386; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; MOLLMAN HD, 1986, J NEUROSURG, V64, P902, DOI 10.3171/jns.1986.64.6.0902; Monton C, 1999, CRIT CARE MED, V27, P1745, DOI 10.1097/00003246-199909000-00008; Moore F, 2013, J TRAUMA ACUTE CARE, V74, P360; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mracsko E, 2014, BRAIN BEHAV IMMUN, V41, P200, DOI 10.1016/j.bbi.2014.05.015; Munoz-Gomez S, 2015, HEART LUNG, V44, P158, DOI 10.1016/j.hrtlng.2015.01.003; Muroi C, 2013, NEUROSURGERY, V72, P367, DOI 10.1227/NEU.0b013e31828048ce; Musa SA, 2010, NEUROCRIT CARE, V13, P87, DOI 10.1007/s12028-010-9374-x; Musa SA, 2011, J CARDIOTHOR VASC AN, V25, P263, DOI 10.1053/j.jvca.2010.05.004; MUSTAFA MM, 1989, J PEDIATR-US, V115, P208, DOI 10.1016/S0022-3476(89)80067-8; Muttaiyah S, 2008, J MED MICROBIOL, V57, P207, DOI 10.1099/jmm.0.47518-0; NAROTAM PK, 1994, NEUROSURGERY, V34, P409, DOI 10.1227/00006123-199403000-00004; Oda S, 2005, CYTOKINE, V29, P169, DOI 10.1016/j.cyto.2004.10.010; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; OHGA S, 1994, ARCH DIS CHILD, V70, P123, DOI 10.1136/adc.70.2.123; Ohwaki K, 2008, NEUROCRIT CARE, V8, P271, DOI 10.1007/s12028-007-9007-1; Ovbiagele Bruce, 2006, J Stroke Cerebrovasc Dis, V15, P209; PATIR R, 1992, ACTA NEUROCHIR, V119, P80, DOI 10.1007/BF01541786; Maskin LP, 2013, CLIN NEUROL NEUROSUR, V115, P1820, DOI 10.1016/j.clineuro.2013.05.034; Pegoli M, 2015, J NEUROSURG, V122, P414, DOI 10.3171/2014.10.JNS14290; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Pfausler B, 2004, ACTA NEUROCHIR, V146, P477, DOI 10.1007/s00701-004-0258-8; Pfisterer W, 2003, J NEUROL NEUROSUR PS, V74, P929, DOI 10.1136/jnnp.74.7.929; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Poon WS, 1998, ACT NEUR S, V71, P146; Prasad R, 2014, PEDIATR NEUROL, V50, P60, DOI 10.1016/j.pediatrneurol.2013.08.016; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Prass K, 2006, STROKE, V37, P2607, DOI 10.1161/01.STR.0000240409.68739.2b; Raad I, 2007, LANCET INFECT DIS, V7, P645, DOI 10.1016/S1473-3099(07)70235-9; Ramanan M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0712-z; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Razine Rachid, 2012, Int Arch Med, V5, P26, DOI 10.1186/1755-7682-5-26; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; Reichert MCF, 2002, AM J INFECT CONTROL, V30, P158, DOI 10.1067/mic.2002.119925; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Rincon-Ferrari MD, 2004, J TRAUMA, V57, P1234, DOI 10.1097/01.TA.0000119200.70853.23; Riquelme R, 1996, AM J RESP CRIT CARE, V154, P1450, DOI 10.1164/ajrccm.154.5.8912763; Robinson TG, 2003, STROKE, V34, P705, DOI 10.1161/01.STR.0000058493.94875.9F; Roos YBWEM, 2000, J NEUROL NEUROSUR PS, V68, P337, DOI 10.1136/jnnp.68.3.337; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Saloheimo P, 2006, STROKE, V37, P487, DOI 10.1161/01.STR.0000198868.78546.fc; Saposnik G, 2008, STROKE, V39, P2522, DOI 10.1161/STROKEAHA.107.507145; Savardekar Amey, 2013, Surg Neurol Int, V4, P24, DOI 10.4103/2152-7806.107894; Schade RP, 2006, J NEUROSURG, V104, P101, DOI 10.3171/jns.2006.104.1.101; Schade RP, 2005, J NEUROSURG, V102, P229, DOI 10.3171/jns.2005.102.2.0229; Schirmer-Mikalsen K, 2013, ACTA ANAESTH SCAND, V57, P46, DOI 10.1111/j.1399-6576.2012.02785.x; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schoch B, 2008, ZBL NEUROCHIR, V69, P80, DOI 10.1055/s-2007-1022559; Schultz M, 1993, J Neurosci Nurs, V25, P158; Seguin P, 2014, CRIT CARE MED, V42, P1, DOI 10.1097/CCM.0b013e3182a2770f; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; Sellars C, 2007, STROKE, V38, P2284, DOI 10.1161/STROKEAHA.106.478156; SHAFER SQ, 1993, J NATL MED ASSOC, V85, P31; Singh TD, 2017, J NEUROSURG SCI, V61, P117, DOI 10.23736/S0390-5616.16.03298-7; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; Stenehjem E, 2012, INFECT DIS CLIN N AM, V26, P89, DOI 10.1016/j.idc.2011.09.006; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Sykora M, 2008, CRIT CARE MED, V36, P3074, DOI 10.1097/CCM.0b013e31818b306d; Sykora M, 2011, STROKE, V42, P1218, DOI 10.1161/STROKEAHA.110.604637; Takahashi W, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.02.020; Tang RB, 2001, CHILD NERV SYST, V17, P453, DOI 10.1007/s003810000422; Tarkowski E, 1998, SCAND J IMMUNOL, V47, P30; Titsworth WL, 2013, STROKE, V44, P3154, DOI 10.1161/STROKEAHA.111.000204; Tripathy S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00082; Upadya A, 2004, J CRIT CARE, V19, P16, DOI 10.1016/j.jcrc.2004.02.004; van de Beek D, 2009, ARCH NEUROL-CHICAGO, V66, P1076, DOI 10.1001/archneurol.2009.176; Vargas M, 2006, STROKE, V37, P461, DOI 10.1161/01.STR.0000199138.73365.b3; Vergouwen MDI, 2011, STROKE, V42, P3093, DOI 10.1161/STROKEAHA.111.619510; Vergouwen MDI, 2011, STROKE, V42, P924, DOI 10.1161/STROKEAHA.110.597914; Viallon A, 2011, CRIT CARE, V15, DOI 10.1186/cc10254; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Walter U, 2013, EUR J NEUROL, V20, P153, DOI 10.1111/j.1468-1331.2012.03818.x; Walter U, 2007, J NEUROL, V254, P1323, DOI 10.1007/s00415-007-0520-0; Wang F, 2013, APMIS, V121, P197, DOI 10.1111/j.1600-0463.2012.02956.x; Wang JP, 2015, BRAIN BEHAV IMMUN, V43, P172, DOI 10.1016/j.bbi.2014.07.022; Wang KW, 2013, J NEUROSURG, V118, P358, DOI 10.3171/2012.10.JNS127; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Weimar C, 2002, EUR NEUROL, V48, P133, DOI 10.1159/000065512; Weisfelt M, 2007, J HOSP INFECT, V66, P71, DOI 10.1016/j.jhin.2007.02.017; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wong GK, 2008, J CLIN NEUROSCI, V15, P654, DOI 10.1016/j.jocn.2007.03.011; Yang CC, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-289; Zabramski JM, 2003, J NEUROSURG, V98, P725, DOI 10.3171/jns.2003.98.4.0725; Zarrouk V, 2007, CLIN INFECT DIS, V44, P1555, DOI 10.1086/518169; Ziai WC, 2006, CRIT CARE CLIN, V22, P661, DOI 10.1016/j.ccc.2006.11.009; Zolldann D, 2005, INFECT CONT HOSP EP, V26, P726, DOI 10.1086/502610; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	237	8	11	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	NOV	2017	35	4					785	+		10.1016/j.ncl.2017.06.012			24	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL6UU	WOS:000414382500013	28962814				2022-02-06	
J	Miljic, D; Doknic, M; Stojanovic, M; Nikolic-Djurovic, M; Petakov, M; Popovic, V; Pekic, S				Miljic, Dragana; Doknic, Mirjana; Stojanovic, Marko; Nikolic-Djurovic, Marina; Petakov, Milan; Popovic, Vera; Pekic, Sandra			Impact of etiology, age and gender on onset and severity of hyponatremia in patients with hypopituitarism: retrospective analysis in a specialised endocrine unit	ENDOCRINE			English	Article						Secondary adrenal insufficiency; Pituitary; Cortisol; Sodium	TRAUMATIC BRAIN-INJURY; ARGININE-VASOPRESSIN; ADRENAL INSUFFICIENCY; PITUITARY-TUMORS; GLUCOCORTICOID DEFICIENCY; ANTIDIURETIC-HORMONE; CLOSE ASSOCIATION; DYSFUNCTION; SECRETION; AQUAPORIN-2	Hyponatremia can unmask hypopituitarism and secondary adrenal insufficiency. This is important, since the need to screen for steroid deficiency, in patients with hyponatremia is often neglected. In a retrospective study, twenty-five patients (13f/12m, age 58.9 +/- 18.6 years) with hyponatremia (119.7 +/- 10.5 mmol/L) were identified among 260 in-patients treated for hypopituitarism in our specialized endocrine unit, over the last decade. We analyzed clinical characteristics, etiology, and severity of hypopituitarism in patients who presented with hyponatremia. Hyponatremia was recorded in 9.6% of our patients with hypopituitarism. In 80.7% it was the key to diagnosis of hypopituitarism. All patients with hyponatremia were steroid deficient with complete hypopituitarism compared to 75% (steroid deficient) and 60% (complete hypopituitarism) of the patients in the cohort. The most common etiology of hypopituitarism was non-functioning pituitary macro adenoma (NFPA) (n = 128, 49.2%). Patients with hyponatremia were divided into two groups, based on the etiology of hypopituitarism: Group 1. with NFPA n = 15 (5F/10M), mean age 71.47 +/- 4.8 years, who were significantly older compared to patients with hyponatremia from other rare causes of hypopituitarism in Group 2. n = 10 (8F/2M), mean age 40.2 +/- 15.3 years (p < 0.01), such as: congenital hypopituitarism(n = 2), Sheehan's syndrome (n = 2), intracranial aneurysm (n = 2), lymphocytic hypophysitis (n = 1), traumatic brain injury (n = 1), surgery and radiotherapy for astrocytoma (n = 1), pituitary metastasis from bronchial carcinoma (n = 1). Hyponatremia was more severe in Group 2. compared to Group 1. (113.5 +/- 10.9 mmol/L vs. 124.3 +/- 8.1 mmol/L, p < 0.01). Older age (p = 0.0001) and number of endocrine deficiencies (p < 0.05) were identified as predictive factors for hyponatremia by multivariate analysis in patients with hypopituitarism. Hyponatremia is an important presenting feature of pituitary disease and a strong indicator of life-threatening steroid deficiency. Old age and severity of hypopituitarism are major risk factors for hyponatremia. In older patients NFPA is the most common etiology, while other rare causes of hypopituitarism are more prevalent in younger patients with hyponatremia.	[Miljic, Dragana; Doknic, Mirjana; Stojanovic, Marko; Nikolic-Djurovic, Marina; Petakov, Milan; Pekic, Sandra] Clin Ctr Serbia, Clin Endocrinol Diabet & Metab Dis, Dept Neuroendocrinol, Belgrade, Serbia; [Miljic, Dragana; Doknic, Mirjana; Stojanovic, Marko; Nikolic-Djurovic, Marina; Petakov, Milan; Popovic, Vera; Pekic, Sandra] Univ Belgrade, Sch Med, Belgrade, Serbia		Miljic, D (corresponding author), Clin Ctr Serbia, Clin Endocrinol Diabet & Metab Dis, Dept Neuroendocrinol, Belgrade, Serbia.; Miljic, D (corresponding author), Univ Belgrade, Sch Med, Belgrade, Serbia.	draganamiljic@yahoo.com	Pekic, Sandra/S-7175-2016				Agha A, 2005, QJM-INT J MED, V98, P463, DOI 10.1093/qjmed/hci075; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Asano T, 2012, ENDOCR J, V59, P1015, DOI 10.1507/endocrj.EJ12-0067; Behr TW, 2012, INTERN MED J, V42, P306, DOI 10.1111/j.1445-5994.2010.02306.x; BETHUNE JE, 1965, NEW ENGL J MED, V272, P771, DOI 10.1056/NEJM196504152721504; Bordo G, 2014, ENDOCR PRACT, V20, P1178, DOI 10.4158/EP13370.OR; Burman P, 2013, J CLIN ENDOCR METAB, V98, P1466, DOI 10.1210/jc.2012-4059; Chanson P, 2003, EUR J ENDOCRINOL, V149, P177, DOI 10.1530/eje.0.1490177; COHEN DL, 1989, AGE AGEING, V18, P247, DOI 10.1093/ageing/18.4.247; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; Croal BL, 1997, LANCET, V350, P1402, DOI 10.1016/S0140-6736(05)65181-1; Cuesta M, 2016, CLIN ENDOCRINOL, V85, P836, DOI 10.1111/cen.13128; Diederich S, 2003, EUR J ENDOCRINOL, V148, P609, DOI 10.1530/eje.0.1480609; Erkut ZA, 1998, J CLIN ENDOCR METAB, V83, P2066, DOI 10.1210/jc.83.6.2066; Faustini-Fustini M, 2006, J ENDOCRINOL INVEST, V29, P267, DOI 10.1007/BF03345553; Foppiani L, 2008, Curr Aging Sci, V1, P42; Hahner S, 2015, J CLIN ENDOCR METAB, V100, P407, DOI 10.1210/jc.2014-3191; Hannon MJ, 2014, J CLIN ENDOCR METAB, V99, P291, DOI 10.1210/jc.2013-3032; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; ISHIKAWA S, 1991, ENDOCRINOL JAPON, V38, P325; Ishikawa S, 1996, ENDOCR J, V43, P101, DOI 10.1507/endocrj.43.101; Ishikawa SE, 2001, J CLIN ENDOCR METAB, V86, P1665, DOI 10.1210/jc.86.4.1665; KAMOI K, 1993, J CLIN ENDOCR METAB, V77, P1584, DOI 10.1210/jc.77.6.1584; Katoch C D S, 2013, Med J Armed Forces India, V69, P237, DOI 10.1016/j.mjafi.2013.01.003; Kim JK, 2001, BIOCHEM BIOPH RES CO, V289, P1252, DOI 10.1006/bbrc.2001.6114; KIMURA T, 1992, ACTA ENDOCRINOL-COP, V126, P217, DOI 10.1530/acta.0.1260217; Liamis G, 2017, EUR J ENDOCRINOL, V176, pR15, DOI 10.1530/EJE-16-0493; LINAS SL, 1980, KIDNEY INT, V18, P58, DOI 10.1038/ki.1980.110; Miljic D, 2003, J ENDOCRINOL INVEST, V26, P450, DOI 10.1007/BF03345201; Minniti G, 2005, EUR J ENDOCRINOL, V153, P723, DOI 10.1530/eje.1.02030; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; Nigro N, 2015, J AM GERIATR SOC, V63, P470, DOI 10.1111/jgs.13325; Nishizawa S, 2000, NEUROL MED-CHIR, V40, P249, DOI 10.2176/nmc.40.249; OELKERS W, 1989, NEW ENGL J MED, V321, P492, DOI 10.1056/NEJM198908243210802; Pekic S, 2011, ENDOCRINE, V40, P325, DOI 10.1007/s12020-011-9516-8; Pekic-Djurdjevic S., 2016, DIFFERENCES PITUITAR; RAFF H, 1987, AM J PHYSIOL, V252, pR635, DOI 10.1152/ajpregu.1987.252.4.R635; Saito T, 2000, AM J PHYSIOL-RENAL, V279, pF502, DOI 10.1152/ajprenal.2000.279.3.F502; SCHRIER RW, 1979, AM J PHYSIOL, V236, pF321, DOI 10.1152/ajprenal.1979.236.4.F321; SEIF SM, 1978, ENDOCRINOLOGY, V103, P1009, DOI 10.1210/endo-103-4-1009; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; Turner HE, 1999, EUR J ENDOCRINOL, V140, P383, DOI 10.1530/eje.0.1400383; Tzoulis P, 2015, CLIN MED, V15, P20, DOI 10.7861/clinmedicine.15-1-20; Verbalis JG, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2015.11.005; Yamamoto T, 1998, CLIN ENDOCRINOL, V49, P785, DOI 10.1046/j.1365-2265.1998.00621.x; Yatagai T, 2003, EUR J ENDOCRINOL, V148, P221, DOI 10.1530/eje.0.1480221	50	8	8	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1355-008X	1559-0100		ENDOCRINE	Endocrine	NOV	2017	58	2					312	319		10.1007/s12020-017-1415-1			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	FL8MK	WOS:000414503700013	28913704				2022-02-06	
J	O'Neill, TJ; Davenport, EM; Murugesan, G; Montillo, A; Maldjian, JA				O'Neill, Thomas J.; Davenport, Elizabeth M.; Murugesan, Gowtham; Montillo, Albert; Maldjian, Joseph A.			Applications of Resting State Functional MR Imaging to Traumatic Brain Injury	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article						Resting state; BOLD; fMR imaging; TBI; Graph theory; Machine learning; Magnetoencephalography	DEFAULT-MODE NETWORK; HEAD-INJURY; CONNECTIVITY; MILD; MAGNETOENCEPHALOGRAPHY; FMRI; ESTROGEN; OUTCOMES	Traumatic brain injury (TBI) is an important public health issue. TBI includes a broad spectrum of injury severities and abnormalities. Functional MR imaging (fMR imaging), both resting state (rs) and task, has been used often in research to study the effects of TBI. Although rs-fMR imaging is not currently applicable in clinical diagnosis of TBI, computer-aided tools are making this a possibility for the future. Specifically, graph theory is being used to study the change in networks after TBI. Machine learning methods allow researchers to build models capable of predicting injury severity and recovery trajectories.	[O'Neill, Thomas J.; Davenport, Elizabeth M.; Murugesan, Gowtham; Montillo, Albert; Maldjian, Joseph A.] Univ Texas Southwestern, Radiol, 23 Harry Hines Blvd, Dallas, TX 75390 USA		Maldjian, JA (corresponding author), Univ Texas Southwestern, Radiol, 23 Harry Hines Blvd, Dallas, TX 75390 USA.	joseph.maldjian@utsouthwestern.edu	O'Neill, Thomas J./H-6253-2019	O'Neill, Thomas J./0000-0002-2975-7459	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091602, R01NS082453] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS091602, R01 NS082453] Funding Source: Medline		ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Alhourani A, 2016, J NEUROPHYSIOL, V116, P1840, DOI 10.1152/jn.00513.2016; Antonakakis M, 2016, INT J PSYCHOPHYSIOL, V102, P1, DOI 10.1016/j.ijpsycho.2016.02.002; Banks SD, 2016, ARCH PHYS MED REHAB, V97, P1254, DOI 10.1016/j.apmr.2016.03.013; Birn RM, 2013, NEUROIMAGE, V83, P550, DOI 10.1016/j.neuroimage.2013.05.099; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Caeyenberghs K., 2016, NEUROIMAGE; Champion H.R., 2012, ENCY INTENSIVE CARE, P1; COHEN D, 1972, SCIENCE, V175, P664, DOI 10.1126/science.175.4022.664; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Faul M, 2010, TRAUMATIC BRAIN INJU; Funke M, 2009, CLIN EEG NEUROSCI, V40, P271, DOI 10.1177/155005940904000409; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Hart MG, 2016, J NEUROSURG, V124, P1665, DOI 10.3171/2015.4.JNS142683; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hillebrand A, 2005, INT REV NEUROBIOL, V68, P149, DOI 10.1016/S0074-7742(05)68006-3; Huang MX, 2017, J NEUROTRAUM, V34, P1412, DOI 10.1089/neu.2016.4581; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Iraji A, 2016, NEUROIMAGE-CLIN, V12, P100, DOI 10.1016/j.nicl.2016.06.012; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Liu DQ, 2013, NEUROINFORMATICS, V11, P469, DOI 10.1007/s12021-013-9187-0; Lu M, 2016, BRAIN DEV-JPN, V38, P893, DOI 10.1016/j.braindev.2016.05.004; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McLean A. J., 1997, HEAD INJURY, P25; Murugesan G, 2017, 2017 IEEE 14TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI 2017), P464, DOI 10.1109/ISBI.2017.7950561; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nugent AC, 2017, HUM BRAIN MAPP, V38, P779, DOI 10.1002/hbm.23417; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Ravishankar H, 2016, IEEE ENG MED BIO, P4071, DOI 10.1109/EMBC.2016.7591621; Rigon A, 2016, J NEUROTRAUM, V33, P977, DOI 10.1089/neu.2014.3847; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shumskaya E, 2017, EXP BRAIN RES, V235, P799, DOI 10.1007/s00221-016-4841-z; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Tewarie P, 2016, NEUROIMAGE, V142, P314, DOI 10.1016/j.neuroimage.2016.07.057; Toklu H.Z., 2015, BRAIN NEUROTRAUMA MO, P43, DOI [10.1201/b18126, DOI 10.1201/B18126]; Vakorin VA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004914; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Van Veen B. D., 1988, IEEE ASSP Magazine, V5, P4, DOI 10.1109/53.665; Vanderweyen D, 2015, MACHINE LEARNING MED, V9352, P229; Velmurugan J, 2014, ANN INDIAN ACAD NEUR, V17, pS113, DOI 10.4103/0972-2327.128678; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Xiong KL, 2016, NEURORADIOLOGY, V58, P733, DOI 10.1007/s00234-016-1675-0; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	54	8	8	1	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	NOV	2017	27	4					685	+		10.1016/j.nic.2017.06.006			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FL5KF	WOS:000414275000012	28985937	Green Accepted			2022-02-06	
J	Orlando, A; Levy, AS; Carrick, MM; Tanner, A; Mains, CW; Bar-Or, D				Orlando, Alessandro; Levy, A. Stewart; Carrick, Matthew M.; Tanner, Allen; Mains, Charles W.; Bar-Or, David			Epidemiology of Mild Traumatic Brain Injury with Intracranial Hemorrhage: Focusing Predictive Models for Neurosurgical Intervention	WORLD NEUROSURGERY			English	Article						Adult; Intracranial hemorrhage; Mild; Neurosurgical intervention; Traumatic brain injury	CT HEAD RULE; NEW-ORLEANS CRITERIA; GLASGOW COMA SCALE; SUBARACHNOID HEMORRHAGE; COMPUTED-TOMOGRAPHY; CARE; CONSULTATION; VALIDATION; MANAGEMENT; PROGNOSIS	OBJECTIVE: To outline differences in neurosurgical intervention (NI) rates between intracranial hemorrhage (ICH) types in mild traumatic brain injuries and help identify which ICH types are most likely to benefit from creation of predictive models for NI. METHODS: A multicenter retrospective study of adult patients spanning 3 years at 4 U.S. trauma centers was performed. Patients were included if they presented with mild traumatic brain injury (Glasgow Coma Scale score 13-15) with head CT scan positive for ICH. Patients were excluded for skull fractures, "unspecified hemorrhage," or coagulopathy. Primary outcome was NI. Stepwise multi-variable logistic regression models were built to analyze the independent association between ICH variables and outcome measures. RESULTS: The study comprised 1876 patients. NI rate was 6.7%. There was a significant difference in rate of NI by ICH type. Subdural hematomas had the highest rate of NI (15.5%) and accounted for 78% of all NIs. Isolated subarachnoid hemorrhages had the lowest, nonzero, NI rate (0.19%). Logistic regression models identified ICH type as the most influential independent variable when examining NI. A model predicting NI for isolated subarachnoid hemorrhages would require 26,928 patients, but a model predicting NI for isolated subdural hematomas would require only 328 patients. CONCLUSIONS: This study highlighted disparate NI rates among ICH types in patients with mild traumatic brain injury and identified mild, isolated subdural hematomas as most appropriate for construction of predictive NI models. Increased health care efficiency will be driven by accurate understanding of risk, which can come only from accurate predictive models.	[Orlando, Alessandro; Bar-Or, David] Swedish Med Ctr, Trauma Res Dept, Englewood, CO 80110 USA; [Levy, A. Stewart] St Anthony Hosp, Dept Neurosurg, Lakewood, CO USA; [Orlando, Alessandro; Mains, Charles W.; Bar-Or, David] St Anthony Hosp, Trauma Res Dept, Lakewood, CO 80228 USA; [Orlando, Alessandro; Carrick, Matthew M.; Bar-Or, David] Med City Plano, Trauma Serv Dept, Plano, TX 75075 USA; [Orlando, Alessandro; Tanner, Allen; Bar-Or, David] Penrose Community Hosp, Trauma Serv Dept, Colorado Springs, CO 80907 USA; [Bar-Or, David] Rocky Vista Univ, Coll Osteopath Med, Parker, CO 80134 USA		Bar-Or, D (corresponding author), Swedish Med Ctr, Trauma Res Dept, Englewood, CO 80110 USA.; Bar-Or, D (corresponding author), St Anthony Hosp, Trauma Res Dept, Lakewood, CO 80228 USA.; Bar-Or, D (corresponding author), Med City Plano, Trauma Serv Dept, Plano, TX 75075 USA.; Bar-Or, D (corresponding author), Penrose Community Hosp, Trauma Serv Dept, Colorado Springs, CO 80907 USA.; Bar-Or, D (corresponding author), Rocky Vista Univ, Coll Osteopath Med, Parker, CO 80134 USA.	dbaror@ampiopharma.com	Bar-Or, David/AAE-9328-2020				BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chong SL, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0015-0; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Faul M, 2010, TRAUMATIC BRAIN INJU; Gates M, 2017, WORLD NEUROSURG, V100, P417, DOI 10.1016/j.wneu.2017.01.046; Huynh T, 2006, AM SURGEON, V72, P1162; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Lemeshow S, 2000, APPL LOGISTIC REGRES; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Rughani AI, 2010, J NEUROSURG, V113, P585, DOI 10.3171/2009.11.JNS09857; Shih FY, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0069-2; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	33	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2017	107						94	102		10.1016/J.WNEU.2017.07.130			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN2XV	WOS:000415860500015	28774762				2022-02-06	
J	Tiryaki, M; Saygi, G; Yildiz, SO; Yildirim, Z; Erdemir, U; Yucel, T				Tiryaki, Murat; Saygi, Gunce; Yildiz, Sevda O.; Yildirim, Zuhal; Erdemir, Ugur; Yucel, Taner			Prevalence of dental injuries and awareness regarding mouthguards among basketball players and coaches	JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS			English	Article						Athletic injuries; Brain concussion; Cerebral hemorrhage; Mouth protectors	OROFACIAL INJURIES; CONTACT SPORTS; TRAUMA; SWITZERLAND; PREVENTION; KNOWLEDGE; INFORMATION; TURKEY; LEVEL	BACKGROUND: Dental injuries are frequently occurred by an impact to facial area among basketball players. In fact. mouthguards are able to absorb the power of impacts and protect teeth from excessive forces, it is crucial for players even at training to wear mouthguards. To determine the prevalence of dental injuries and investigate the awareness about the use of mouthguards among basketball players and coaches. METHODS: A 14-item questionnaire was designed and tested among licensed basketball players and coaches, all of whom were continuously exposed to the risk of dental injuries. The questions focused on the prevalence of dental injuries and attitudes and knowledge regarding the use of mouthguards among the players and coaches. Data were calculated using descriptive statistics and chi 2 tests. RESULTS: A total of 53 coaches (18-69 years) and 351 players (12-38 years) participated. Of these, 124 players (35% of the total sample) had experienced oral injuries, including soft tissue lacerations (80.6%), fractures (17.7%) and avulsions (1.6%). Although the players had sustained dental injuries, 95% of them found mouthguards to be protective, and only 6.3% (N.=22) actually used a mouthguard. The rate of mouthguard use among players who had experienced an oral injury was significantly higher than that among players without any history of injury (P<0.05). Although 98% of the coaches believed that mouthguards could prevent dental injuries, only 47% of them suggested their use to their players. The most common reasons for not using a mouthguard were discomfort (37.7%) and difficulty in breathing (7.3%) or talking (6.4%). CONCLUSIONS: This study showed that the use of mouthguards among basketball players is very rare, with inadequate knowledge among the coaches. Consequently, more information is required through sports associations and dentists.	[Tiryaki, Murat; Saygi, Gunce; Erdemir, Ugur; Yucel, Taner] Istanbul Univ, Dept Operat Dent, Fac Dent, Istanbul, Turkey; [Yildiz, Sevda O.] Istanbul Univ, Dept Biostat & Med Informat, Fac Med, Istanbul, Turkey; [Yildirim, Zuhal] Istanbul Univ, Restorat Dent Specialty Program, Fac Dent, Istanbul, Turkey		Tiryaki, M (corresponding author), Istanbul Univ, Dept Operat Dent, Fac Dent, TR-34093 Fatih Istanbul, Turkey.	murattiryaki8@hotmail.com	Tiryaki, Murat/AAT-3473-2020; Saygi, Gunce/AAD-2949-2020; Yildiz, Sevda Ozel/AAA-6196-2020; Erdemir, Ugur/ABH-2939-2021	Saygi, Gunce/0000-0003-1018-3173; Yildiz, Sevda Ozel/0000-0003-1357-6933; Erdemir, Ugur/0000-0002-4673-8284			Akar GC, 2007, EU DISHEK FAK DERG, V28, P9; Andrade RA, 2010, DENT TRAUMATOL, V26, P248, DOI 10.1111/j.1600-9657.2010.00884.x; [Anonymous], 2013, MOST COMPREHENSIVE S; Azodo CC, 2011, INT DENT J, V61, P43, DOI 10.1111/j.1875-595X.2011.00009.x; Badel T., 2007, KINESIOL, V39, P97; Cohenca N, 2007, J AM DENT ASSOC, V138, P1121, DOI 10.14219/jada.archive.2007.0326; Cornwell H, 2003, DENT TRAUMATOL, V19, P193, DOI 10.1034/j.1600-9657.2003.00202.x; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Duymus ZY, 2009, DENT TRAUMATOL, V25, P318, DOI 10.1111/j.1600-9657.2009.00769.x; Ferrari CH, 2002, DENT TRAUMATOL, V18, P144, DOI 10.1034/j.1600-9657.2002.00017.x; FLANDERS RA, 1995, J AM DENT ASSOC, V126, P491, DOI 10.14219/jada.archive.1995.0213; Gardiner D M, 2000, Dent Clin North Am, V44, P53; Hersberger S, 2012, DENT TRAUMATOL, V28, P287, DOI 10.1111/j.1600-9657.2011.01083.x; HICKEY JC, 1967, J AM DENT ASSOC, V74, P735, DOI 10.14219/jada.archive.1967.0145; Kvittem B, 1998, J PUBLIC HEALTH DENT, V58, P288, DOI 10.1111/j.1752-7325.1998.tb03011.x; Lang B, 2002, DENT TRAUMATOL, V18, P329, DOI 10.1034/j.1600-9657.2002.00123.x; Lieger O, 2006, DENT TRAUMATOL, V22, P1, DOI 10.1111/j.1600-9657.2006.00328.x; Ma WL, 2008, DENT TRAUMATOL, V24, P430, DOI 10.1111/j.1600-9657.2008.00586.x; Maestrello-de Moya MG, 1989, ASDC J DENT CHILD, V36, P36; McClelland C, 1999, BRIT J SPORT MED, V33, P186, DOI 10.1136/bjsm.33.3.186; Onyeaso CO, 2003, DENT TRAUMATOL, V19, P204, DOI 10.1034/j.1600-9657.2003.00163.x; Patrick DG, 2005, BRIT J SPORT MED, V39, P278, DOI 10.1136/bjsm.2004.012658; Perunski S, 2005, DENT TRAUMATOL, V21, P195, DOI 10.1111/j.1600-9657.2005.00310.x; Raaii F, 2011, CLIN J SPORT MED, V21, P320, DOI 10.1097/JSM.0b013e31821f5cd7; Schildknecht S, 2012, DENT TRAUMATOL, V28, P465, DOI 10.1111/j.1600-9657.2012.01115.x; Sepet E, 2014, DENT TRAUMATOL, V30, P391, DOI 10.1111/edt.12105; Tiryaki M, 2013, J DENT FAC ATATURK U, P87; Tulunoglu I, 2006, DENT TRAUMATOL, V22, P242, DOI 10.1111/j.1600-9657.2006.00386.x	28	8	8	0	12	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0022-4707	1827-1928		J SPORT MED PHYS FIT	J. Sports Med. Phys. Fit.	NOV	2017	57	11					1541	1547		10.23736/S0022-4707.17.06790-1			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GE7PN	WOS:000431425400020	28116877				2022-02-06	
J	Falkenberg, L; Zeckey, C; Mommsen, P; Winkelmann, M; Zelle, BA; Panzica, M; Pape, HC; Krettek, C; Probst, C				Falkenberg, Lisa; Zeckey, Christian; Mommsen, Philipp; Winkelmann, Marcel; Zelle, Boris A.; Panzica, Martin; Pape, Hans-Christoph; Krettek, Christian; Probst, Christian			Long-term outcome in 324 polytrauma patients: what factors are associated with posttraumatic stress disorder and depressive disorder symptoms?	EUROPEAN JOURNAL OF MEDICAL RESEARCH			English	Article							MOTOR-VEHICLE ACCIDENTS; TRAUMATIC BRAIN-INJURY; ROAD TRAFFIC ACCIDENT; SEVERE MULTIPLE TRAUMA; QUALITY-OF-LIFE; MAJOR TRAUMA; FOLLOW-UP; SEVERITY SCORE; GENDER-DIFFERENCES; HOSPITAL ANXIETY	Background: Physical impairment is well-known to last for many years after a severe injury, and there is a high impact on the quality of the survivor's life. The purpose of this study was to examine if this is also true for psychological impairment with symptoms of posttraumatic stress disorder or depression after polytrauma. Design: Retrospective cohort outcome study. Setting: Level I trauma centre. Population: 637 polytrauma trauma patients who were treated at our Level I trauma centre between 1973 and 1990. Minimum follow-up was 10 years after the injury. Methods: Patients were asked to fill in a questionnaire, including parts of the Posttraumatic Stress Diagnostic Scale, the Impact of Event Scale-Revised and the German Hospital Anxiety and Depression Scale, to evaluate mental health. Clinical outcome was assessed before by standardised scores. Results: Three hundred and twenty-four questionnaires were evaluated. One hundred and forty-nine (45.9%) patients presented with symptoms of mental impairment. Quality of life was significantly higher in the mentally healthy group, while the impaired group achieved a lower rehabilitation status. Conclusions: Mental impairment can be found in multiple trauma victims, even after 10 years or more. Treating physicians should not only focus on early physical rehabilitation but also focus on early mental rehabilitation to prevent long-term problems in both physical and mental disability.	[Falkenberg, Lisa; Zeckey, Christian; Mommsen, Philipp; Winkelmann, Marcel; Panzica, Martin; Krettek, Christian] Hannover Med Sch, Trauma Dept, Hannover, Germany; [Zeckey, Christian] Ludwig Maximilians Univ Munchen, Dept Gen Trauma & Reconstruct Surg, Munich, Germany; [Zelle, Boris A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Orthopaed Surg, Div Orthopaed Traumatol, San Antonio, TX 78229 USA; [Pape, Hans-Christoph] Univ Hosp Zurich, Dept Trauma Surg, Zurich, Switzerland; [Probst, Christian] Univ Witten Herdecke, Cologne Merheim Med Ctr, Dept Trauma & Orthopaed Surg, Cologne, Germany		Zeckey, C (corresponding author), Hannover Med Sch, Trauma Dept, Hannover, Germany.; Zeckey, C (corresponding author), Ludwig Maximilians Univ Munchen, Dept Gen Trauma & Reconstruct Surg, Munich, Germany.	christian.zeckey@med.unimuenchen.de	Mommsen, Philipp/ABC-3510-2020	Pape, Hans-Christoph/0000-0002-2059-4980	Hannover Life Re Insurance	Industrial and financial support was supplied by Hannover Life Re Insurance.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baranyi A, 2010, PSYCHOSOMATICS, V51, P237, DOI 10.1176/appi.psy.51.3.237; Bardenheuer M, 2000, UNFALLCHIRURG, V103, P355, DOI 10.1007/s001130050550; Beck JG, 2006, J BEHAV THER EXP PSY, V37, P256, DOI 10.1016/j.jbtep.2005.04.001; Bisson JI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub4; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bleich A, 1997, BRIT J PSYCHIAT, V170, P479, DOI 10.1192/bjp.170.5.479; Bokszczanin A, 2007, J TRAUMA STRESS, V20, P347, DOI 10.1002/jts.20220; Brenneman FD, 1997, J TRAUMA, V42, P778, DOI 10.1097/00005373-199705000-00004; Breslau Naomi, 2002, J Gend Specif Med, V5, P34; BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N; Chossegros L, 2011, ACCIDENT ANAL PREV, V43, P471, DOI 10.1016/j.aap.2010.10.004; de Jongh A, 2016, DEPRESS ANXIETY, V33, P359, DOI 10.1002/da.22469; Dougall AL, 2001, PSYCHOSOM MED, V63, P402, DOI 10.1097/00006842-200105000-00009; Egerod I, 2011, CRIT CARE MED, V39, P1922, DOI 10.1097/CCM.0b013e31821e89c8; Eytan A, 2012, EUR J PUBLIC HEALTH, V22, P638, DOI 10.1093/eurpub/ckr096; Flesher MR, 2001, BRAIN INJURY, V15, P879, DOI 10.1080/02699050110065682; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Frommberger UH, 1998, EUR ARCH PSY CLIN N, V248, P316, DOI 10.1007/s004060050057; Gawlytta R, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014363; GELLIS LA, 2010, PRIM CARE COMPANION, V12; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Haagsma JA, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-1; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Hoffman KP, 2016, EUR J PHYS REHAB MED, V52, P331; Holbrook TL, 2002, J TRAUMA, V53, P882, DOI 10.1097/00005373-200211000-00012; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; Holbrook TL, 2001, J TRAUMA, V50, P270, DOI 10.1097/00005373-200102000-00012; JENNETT B, 1975, LANCET, V1, P480; Jensen JF, 2015, INTENS CARE MED, V41, P763, DOI 10.1007/s00134-015-3689-1; Kinzl L, 1996, Unfallchirurgie, V22, P179; Klein E, 2003, CAN J PSYCHIAT, V48, P28, DOI 10.1177/070674370304800106; Knaevelsrud C, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-13; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lim Debbie, 2000, J Ment Health Policy Econ, V3, P139, DOI 10.1002/mhp.93; Macke C, 2017, BONE JOINT J, V99B, P255, DOI 10.1302/0301-620X.99B2.37999; Maercker A, 2008, NERVENARZT, V79, P577, DOI 10.1007/s00115-008-2467-5; Maercker A, 1998, DIAGNOSTICA, V44, P130; Mayland EC, 2015, DISABIL REHABIL, V37, P1753, DOI 10.3109/09638288.2014.976719; Mayou R, 2002, PSYCHOL MED, V32, P671, DOI 10.1017/S0033291702005470; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Mayou RA, 2002, BEHAV RES THER, V40, P665, DOI 10.1016/S0005-7967(01)00069-9; MELLMAN TA, 1992, AM J PSYCHIAT, V149, P1568; Meyer EC, 2012, PSYCHOL SERV, V9, P1, DOI 10.1037/a0026414; Norman SB, 2011, J TRAUMA STRESS, V24, P390, DOI 10.1002/jts.20669; OESTERN HJ, 1985, UNFALLCHIRURG, V88, P465; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Pape HC, 2006, INJURY, V37, P1197, DOI 10.1016/j.injury.2006.07.032; Quale AJ, 2009, INJURY, V40, P498, DOI 10.1016/j.injury.2008.11.006; REGEL G, 1995, J TRAUMA, V38, P70, DOI 10.1097/00005373-199501000-00020; Ruchholtz S, 2008, DTSCH ARZTEBL INT, V105, P225, DOI 10.3238/arztebl.2008.0225; Ryb Gabriel E, 2009, Ann Adv Automot Med, V53, P177; Sadeghi-Bazargani H, 2011, NEUROPSYCH DIS TREAT, V7, P425, DOI 10.2147/NDT.S23041; Sittaro N A, 2007, Versicherungsmedizin, V59, P20; Soberg HL, 2010, ARCH PHYS MED REHAB, V91, P481, DOI 10.1016/j.apmr.2009.11.007; Soderstrom CA, 1997, J TRAUMA, V43, P925; Stalp M, 2001, CHIRURG, V72, P312, DOI 10.1007/s001040051312; Taylor Steven, 2007, Am J Disaster Med, V2, P217; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; TraumaRegister DGU-Jahresbericht, 2011, SEKT NOTF INT; Tuchner M, 2010, ISR J PSYCHIATR REL, V47, P269; Walilko T, 2009, J TRAUMA, V67, P1311, DOI 10.1097/TA.0b013e31819adc36; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weber K, 2002, ORTHOPADE, V31, P582, DOI 10.1007/s00132-002-0311-3; Yasan A, 2009, PSYCHOPATHOLOGY, V42, P236, DOI 10.1159/000218521; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158; Zettl RP, 2004, NOTFALL RETTUNGSMED, V7, P547; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	70	8	8	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	0949-2321	2047-783X		EUR J MED RES	Eur. J. Med. Res.	OCT 30	2017	22								44	10.1186/s40001-017-0282-9			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	FL2QF	WOS:000414062400001	29084612	Green Accepted, Green Published, gold			2022-02-06	
J	Sugimoto, K; Suehiro, E; Shinoyama, M; Sadahiro, H; Haji, K; Fujiyama, Y; Kawano, R; Nishioka, M; Suzuki, M				Sugimoto, Kazutaka; Suehiro, Eiichi; Shinoyama, Mizuya; Sadahiro, Hirokazu; Haji, Kouhei; Fujiyama, Yuichi; Kawano, Reo; Nishioka, Mitsuaki; Suzuki, Michiyasu			D-Dimer Elevation as a Blood Biomarker for Detection of Structural Disorder in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; CT; D-dimer; mild TBI; structural disorder	RADIATION-EXPOSURE; COAGULOPATHY; PROTEIN	CT scans are useful in patients with traumatic brain injury (TBI), but the potential risks associated with ionizing radiation are unknown. Further, CT scans are not commonly available in developing countries. In this study, coagulopathy and abnormal fibrinolysis were investigated as blood biomarkers for detection of structural disorder in mild traumatic brain injury (TBI). A total of 88 patients with mild and isolated TBI (Glasgow Coma Scale [GCS] score 14-15) were admitted to Kenwakai Ootemachi Hospital between October 2014 and March 2016. After exclusion of those treated with oral antiplatelet agents and anticoagulants, 73 patients were included in this study. Patients were classified into those with (lesion [+]) and without (lesion [-]) intracranial structural disorder, based on CT scans at admission and follow-up CT or MRI. Age, GCS score, and blood test findings (platelet count, international normalized ratio of prothrombin time [PT-INR], activated partial thromboplastin time [APTT], fibrinogen, fibrin/fibrinogen degradation products [FDP], and D-dimer) on admission were compared between the two groups. The lesion(+) and lesion(-) groups comprised 54 (74%) and 19 patients (26%), respectively. In multivariate logistic regression analysis, D-dimer (3.6 vs. 0.8 mu g/mL) was the only significant independent risk factor for structural disorder (p < 0.001). Platelet counts (23.9 vs. 23.5 x 10(4)/mu L), PT-INR (1.05 vs. 1.07), APTT (29.3 vs. 31.7 sec), FDP (12 vs. 2.4 mu g/mL), and fibrinogen levels (260.6 vs. 231.3mg/dL) were not associated with structural disorder. These results show that D-dimer is associated with intracranial structural disorder in mild TBI.	[Sugimoto, Kazutaka; Suehiro, Eiichi; Sadahiro, Hirokazu; Haji, Kouhei; Fujiyama, Yuichi; Suzuki, Michiyasu] Yamaguchi Univ, Sch Med, Dept Neurosurg, 1-1-1 Minamikogishi, Ube, Yamaguchi 7558505, Japan; [Suehiro, Eiichi; Shinoyama, Mizuya] Kenwakai Ootemachi Hosp, Dept Neurosurg, Kitakyushu, Fukuoka, Japan; [Kawano, Reo] Yamaguchi Univ, Ctr Clin Res, Ube, Yamaguchi, Japan; [Nishioka, Mitsuaki] Yamaguchi Univ, Div Lab, Ube, Yamaguchi, Japan		Suehiro, E (corresponding author), Yamaguchi Univ, Sch Med, Dept Neurosurg, 1-1-1 Minamikogishi, Ube, Yamaguchi 7558505, Japan.	suehiro-nsu@umin.ac.jp	Kawano, Reo/M-2661-2018; Suehiro, Eiichi/I-5852-2019	Kawano, Reo/0000-0001-8699-3768; 	JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [16K10725]	We thank Yukino Nakasako (Division of Laboratory Sciences, Kenwakai Ootemachi Hospital, Fukuoka, Japan) for her contribution to collection of data. This work was supported by JSPS KAKENHI Grant Number 16K10725.	Brohi K, 2011, RESUSCITATION, V82, P1128, DOI 10.1016/j.resuscitation.2011.06.022; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Kamiya K, 2015, LANCET, V386, P469, DOI 10.1016/S0140-6736(15)61167-9; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; NOLAN TE, 1993, OBSTET GYNECOL, V81, P235; Parr MJ, 2008, J TRAUMA, V65, P766, DOI 10.1097/TA.0b013e31818606d2; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Riley RS, 2016, LAB MED, V47, P90, DOI 10.1093/labmed/lmw001; Salehpour F, 2011, J CRIT CARE, V26, P352, DOI 10.1016/j.jcrc.2010.12.005; Shaw P, 2011, J VASC SURG, V53, p28S, DOI 10.1016/j.jvs.2010.05.140; Suehiro E, 2014, CLIN NEUROL NEUROSUR, V127, P97, DOI 10.1016/j.clineuro.2014.10.007; Theusinger OM, 2009, CURR OPIN ANESTHESIO, V22, P305, DOI 10.1097/ACO.0b013e3283212c7c; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149	21	8	9	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2017	34	23					3245	3248		10.1089/neu.2017.5240		OCT 2017	4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FN9HM	WOS:000414457600001	28895444				2022-02-06	
J	Lindemann, C; Langner, I; Banaschewski, T; Garbe, E; Mikolajczyk, RT				Lindemann, Christina; Langner, Ingo; Banaschewski, Tobias; Garbe, Edeltraut; Mikolajczyk, Rafael T.			The risk of hospitalizations with injury Diagnoses in a Matched cohort of children and adolescents with and without attention Deficit/hyperactivity Disorder in germany: a Database study	FRONTIERS IN PEDIATRICS			English	Article						attention deficit/hyperactivity disorder; injuries; subtype of injuries; sex differences; administrative data; claims data; Germany	DEFICIT-HYPERACTIVITY DISORDER; PHARMACOEPIDEMIOLOGIC RESEARCH DATABASE; POPULATION-BASED COHORT; CHILDHOOD BEHAVIOR DISORDERS; UNINTENTIONAL INJURY; HEALTH INTERVIEW; DRUG-TREATMENT; ADHD; PREVALENCE; KIGGS	Background: Attention deficit/hyperactivity disorder (ADHD) is a common neuropsychiatric disorder in children and adolescents worldwide, and children with ADHD have elevated risk of injuries. Our aim was to assess the risk of hospitalizations with injury diagnoses and their various subtypes in children and adolescents with newly diagnosed ADHD compared to those without ADHD, as well as to study sex effects on this risk in the setting of the German health care system. Methods: The German Pharmacoepidemiological Research Database, in which 20 million insured from four statutory health insurances in Germany are included, was used to set up a matched cohort study of 3- to 17-year-old children and adolescents with and without ADHD. We calculated age-specific incidence rates and used Cox regression to obtain hazard ratios (HRs) for hospitalizations with injury diagnoses. We used the injury mortality diagnosis matrix for classification of injuries. Results: The matched cohort comprised a total of 75,300 children. The age-specific incidence rates for hospitalization with injury diagnosis for males with ADHD displayed a u-shaped form with highest incidences in the in the age groups 3-6 years [26.2 per 1,000 person-years; 95% confidence interval (CI) 20.5-33.0] and 18-21 years (28.6; 22.4-36.0). Girls with ADHD were less affected in younger age-groups, but the incidence rate for 18-21 year olds was similar to boys with ADHD (26.4; 17.4-38.4). The adjusted HR for children with ADHD was 1.40 (95% CI 1.30-1.49) compared to non-affected children. With respect to nature of injury, ADHD was associated with hospitalization with injury diagnoses of the internal organs, open wounds, and contusions but not with other injuries. With respect to body regions, children with ADHD were more prone to hospitalizations with injuries of the abdomen, traumatic brain injuries, other head injuries, and system-wide injuries such as poisoning and intoxication. No significant associations were seen for the other body regions. Differences between sexes were only seen for system-wide injuries. Conclusion: Children and adolescents with ADHD are at an increased risk for hospitalizations with diagnoses of injuries compared to non-affected children. Despite differences in health-care systems, the risk increase is at a similar level in Germany as in other countries.	[Lindemann, Christina; Langner, Ingo; Garbe, Edeltraut] Leibniz Inst Prevent Res & Epidemiol BIPS, Dept Clin Epidemiol, Bremen, Germany; [Lindemann, Christina; Mikolajczyk, Rafael T.] Med Sch Hannover, Hannover, Germany; [Banaschewski, Tobias] Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany; [Garbe, Edeltraut] Univ Bremen, Core Sci Area Hlth Sci, Bremen, Germany; [Mikolajczyk, Rafael T.] Helmholtz Ctr Infect Res, ESME Epidemiol & Stat Methods Res Grp, Braunschweig, Germany; [Mikolajczyk, Rafael T.] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biometr & Comp Sci, Halle, Saale, Germany		Mikolajczyk, RT (corresponding author), Med Sch Hannover, Hannover, Germany.; Mikolajczyk, RT (corresponding author), Helmholtz Ctr Infect Res, ESME Epidemiol & Stat Methods Res Grp, Braunschweig, Germany.; Mikolajczyk, RT (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biometr & Comp Sci, Halle, Saale, Germany.	ram12@helmholtz-hzi.de	Mikolajczyk, Rafael/ABB-5259-2021; Banaschewski, Tobias/ABE-5985-2020	Banaschewski, Tobias/0000-0003-4595-1144; Mikolajczyk, Rafael/0000-0003-1271-7204	Federal Ministry of Education and Research of GermanyFederal Ministry of Education & Research (BMBF) [01ER0817]	The study was funded by grant 01ER0817 from the Federal Ministry of Education and Research of Germany.	Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Bruce B, 2007, PAED CHILD HEALT-CAN, V12, P749, DOI 10.1093/pch/12.9.749; Bruchmuller K, 2012, J CONSULT CLIN PSYCH, V80, P128, DOI 10.1037/a0026582; Chou IC, 2014, EUR PSYCHIAT, V29, P523, DOI 10.1016/j.eurpsy.2014.05.006; Chou IC, 2014, DEV MED CHILD NEUROL, V56, P1111, DOI 10.1111/dmcn.12501; Dalsgaard S, 2015, LANCET PSYCHIAT, V2, P702, DOI 10.1016/S2215-0366(15)00271-0; Dalsgaard S, 2015, LANCET, V385, P2190, DOI 10.1016/S0140-6736(14)61684-6; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; Fingerhut LA, 2006, INJURY PREV, V12, P24, DOI 10.1136/ip.2005.009076; Garbe E, 2012, J CHILD ADOL PSYCHOP, V22, P452, DOI 10.1089/cap.2012.0022; Garzon DL, 2008, ARCH PSYCHIAT NURS, V22, P288, DOI 10.1016/j.apnu.2007.12.006; Hawton K, 2012, EUR CHILD ADOLES PSY, V21, P369, DOI 10.1007/s00787-012-0269-6; Hoare P, 2003, EUR J EMERG MED, V10, P98, DOI 10.1097/01.mej.0000072631.17469.71; Kahl H, 2007, BUNDESGESUNDHEITSBLA, V50, P718, DOI 10.1007/s00103-007-0233-7; Kang JH, 2013, ACTA PAEDIATR, V102, P640, DOI 10.1111/apa.12213; Kraut AA, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-11; Lahti A, 2014, J PSYCHIATR RES, V58, P123, DOI 10.1016/j.jpsychires.2014.07.020; Lange H, 2016, J ATTEN DISORD, V20, P501, DOI 10.1177/1087054713518237; Langner I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062177; Laursen B, 2008, EUR J PUBLIC HEALTH, V18, P366, DOI 10.1093/eurpub/ckn034; Lindemann C, 2012, J CHILD ADOL PSYCHOP, V22, P307, DOI 10.1089/cap.2011.0064; Marcus SC, 2008, J ATTEN DISORD, V12, P64, DOI 10.1177/1087054707305168; McMahon EM, 2014, SOC PSYCH PSYCH EPID, V49, P1929, DOI 10.1007/s00127-014-0907-z; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; NEWCOMBE RG, 2001, STAT CONFIDENCE, P45; Nigg JT, 2013, CLIN PSYCHOL REV, V33, P215, DOI 10.1016/j.cpr.2012.11.005; Ohlmeier C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1943-7; Pigeot I, 2008, PHARMACOEPIDEM DR S, V17, P215, DOI 10.1002/pds.1545; Polanczyk G, 2007, CURR OPIN PSYCHIATR, V20, P386, DOI 10.1097/YCO.0b013e3281568d7a; Polanczyk GV, 2014, INT J EPIDEMIOL, V43, P434, DOI 10.1093/ije/dyt261; Raman SR, 2013, INJURY PREV, V19, P164, DOI 10.1136/injuryprev-2012-040483; Roick C, 2015, PSYCHIAT PRAX, V42, P21, DOI 10.1055/s-0033-1349516; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Sass AC, 2014, BUNDESGESUNDHEITSBLA, V57, P789, DOI 10.1007/s00103-014-1977-5; Scharnetzky E, 2004, PHARMACOEPIDEM DR S, V13, P93; Schink T, 2010, PHARMACOEPIDEM DR S, V19, pS178; Schink T, 2010, PHARMACOEPIDEM DR S, V19, pS294; Schlack R, 2007, BUNDESGESUNDHEITSBLA, V50, P827, DOI 10.1007/s00103-007-0246-2; Schlander M, 2010, NERVENARZT, V81, P289, DOI 10.1007/s00115-009-2888-9; Schubert I, 2010, DTSCH ARZTEBL INT, V107, P615, DOI 10.3238/arztebl.2010.0615; Schwandt H, 2016, LABOUR ECON, V43, P72, DOI 10.1016/j.labeco.2016.05.018; Swensen, 2004, J ADOLESCENT HEALTH, V35, DOI [DOI 10.1016/J.JAD0HEALTH.2003.12.003, 10.1016/j.jadohealth.2003.12.003]; Tai YM, 2013, RES DEV DISABIL, V34, P1100, DOI 10.1016/j.ridd.2012.11.027; Thapar A, 2016, LANCET, V387, P1240, DOI 10.1016/S0140-6736(15)00238-X; van den Ban E, 2014, EUR CHILD ADOLES PSY, V23, P95, DOI 10.1007/s00787-013-0432-8; WHO, 2011, INT CLASS DIS REL HL, V2010	48	8	8	0	1	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	2296-2360			FRONT PEDIATR	Front. Pediatr.	OCT 24	2017	5								220	10.3389/fped.2017.00220			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	FK4EA	WOS:000413441100001	29114538	Green Published, gold			2022-02-06	
J	Biswas, RK; Kabir, E; King, R				Biswas, Raaj Kishore; Kabir, Enamul; King, Rachel			Effect of sex and age on traumatic brain injury: a geographical comparative study	ARCHIVES OF PUBLIC HEALTH			English	Article						Public health; Glasgow outcome scale; Health geography; Bangladesh; Ordinal outcome scale	GENDER-DIFFERENCES; OUTCOME SCALES; HEAD-INJURY; TRIALS; PROGNOSIS; DESIGN; IMPACT; WORSE	Background: Traumatic brain injury (TBI) is a much researched topic in medical health, which requires additional studies to understand various effects of demographic and geographic factors that can assist in developing the most effective treatments. Thousands of people of different ages are suffering from lifelong disabilities, either mild or severe, from TBI and the number is increasing. This study aims to increase our understanding of the effect of sex and age by applying five different statistical methods to evaluate the effect of these covariates on two independent TBI data sets representing patients from different geographical cohorts. A primary data was collected from Bangladesh and it was compared with CRASH (Corticosteroid Randomisation after Significant Head Injury) data, representing various countries around the world. Methods: The outcome variable for TBI considered in this paper is Glasgow Outcome Scale, which is a four point scale. It was converted to a binary outcome scale for fitting of Fisher's exact test, a test of proportions and a binary linear model. For analyzing ordinal outcomes, the proportional odds model and the sliding dichotomy model were fitted. As the sample size of the Bangladeshi data set was small, parametric bootstrapping was applied for the consistency of results. Results: Females were the worse sufferers of TBI compared to men, according to CRASH data set. The old (aged above 58 years) followed by adults (age 25 to 58) were the most vulnerable victims. Interaction effects concluded that old women tended to endure the worst outcomes of TBI. This conclusion came from the CRASH data set representing the world in general, whereas such effects were not present in the Bangladesh data set. Additional application of parametric bootstrapping for the smaller Bangladesh data set did not result into any significant outcome. Conclusion: The effect of gender and age could be stronger in some countries than others which is driving the significance in CRASH and was not found in Bangladesh. It reflects the necessity of incorporating geographic patterns as well as demographic features of patients while developing treatments and designing clinical trials.	[Biswas, Raaj Kishore] Univ Southern Queensland, Fac Hlth Engn & Sci HES, Toowoomba, Qld 4350, Australia; [Kabir, Enamul; King, Rachel] Univ Southern Queensland, Sch Agr Computat & Environm Sci, Toowoomba, Qld 4350, Australia		Biswas, RK (corresponding author), Univ Southern Queensland, Fac Hlth Engn & Sci HES, Toowoomba, Qld 4350, Australia.	RaajKishore.Biswas@usq.edu.au	Biswas, Raaj Kishore/K-4256-2018	Biswas, Raaj Kishore/0000-0003-4294-6323; King, Rachel/0000-0002-3302-0919			Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; COX DR, 1972, J R STAT SOC B, V34, P187; CRASH, 2005, CRASH CORT RAD SIGN; Dobson AJ, INTRO GEN LINEAR MOD; Edwards P, 2005, LANCET, V365, P1957; Eisenstadt S., 1956, GENERATION GENERATIO; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Guralnik JM, 1996, ANN EPIDEMIOL, V6, P376, DOI 10.1016/S1047-2797(96)00060-9; HEISKANEN O, 1970, ACTA NEUROL SCAND, V46, P343, DOI 10.1111/j.1600-0404.1970.tb05798.x; Hosmer D. W., 2004, APPL LOGISTIC REGRES; Ilodigwe D, 2013, J NEUROSURG, V118, P3, DOI 10.3171/2012.9.JNS111383; JENNETT B, 1975, LANCET, V1, P480; KLAUBER MR, 1981, NEUROSURGERY, V9, P236, DOI 10.1227/00006123-198109000-00003; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Lakatta Edward G, 2002, Heart Fail Rev, V7, P29; Liu I, 2004, PROPORTIONAL ODDS MO; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; National Center for Injury Prevention and Control (US), 2003, REP C MILD TRAUM BRA; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Price M, 2013, CLIN TRIALS, V10, P924, DOI 10.1177/1740774512458601; Reeves RH, 2000, REHABIL PSYCHOL, V45, P205; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Seeman T E, 1989, J Aging Health, V1, P50, DOI 10.1177/089826438900100104; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890; van Reekum R, 1999, J PSYCHIATR NEUROSCI, V24, P413; Varrone A, 2013, EUR J NUCL MED MOL I, V40, P213, DOI 10.1007/s00259-012-2276-8; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	46	8	8	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0778-7367	2049-3258		ARCH PUBLIC HEALTH	Arch. PUblic Health	OCT 9	2017	75								43	10.1186/s13690-017-0211-y			11	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FJ6PQ	WOS:000412880300001	29043082	gold, Green Published, Green Accepted			2022-02-06	
J	Irimia, A; Goh, SYM; Wade, AC; Patel, K; Vespa, PM; Van Horn, JD				Irimia, Andrei; Goh, Sheng-Yang Matthew; Wade, Adam C.; Patel, Kavi; Vespa, Paul M.; Van Horn, John D.			Traumatic Brain Injury Severity, Neuropathophysiology, and Clinical Outcome: Insights from Multimodal Neuroimaging	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; clinical outcome; Glasgow Coma Scale; Glasgow Outcome Score; post-traumatic seizures; neuroimaging; magnetic resonance imaging	SURFACE-BASED ANALYSIS; CORTICAL THICKNESS; ANGULAR GYRUS; FRONTAL GYRUS; CORTEX; SEGMENTATION; SENSITIVITY; PERFORMANCE; INHIBITION; ACTIVATION	Background: The relationship between the acute clinical presentation of patients with traumatic brain injury (TBI), long-term changes in brain structure prompted by injury and chronic functional outcome is insufficiently understood. In this preliminary study, we investigate how acute Glasgow coma score (GCS) and epileptic seizure occurrence after TBIs are statistically related to functional outcome (as quantified using the Glasgow Outcome Score) and to the extent of cortical thinning observed 6 months after the traumatic event. Methods: Using multivariate linear regression, the extent to which the acute GCS and epileptic seizure occurrence (predictor variables) correlate with structural brain changes (relative cortical atrophy) was examined in a group of 33 TBI patients. The statistical significance of the correlation between relative cortical atrophy and the Glasgow Outcome Score was also investigated. Results: A statistically significant correlative relationship between cortical thinning and the predictor variables (acute GCS and seizure occurrence) was identified in the study sample. Regions where the statistical model was found to have highest statistical reliability in predicting both gray matter atrophy and neurological outcome include the frontopolar, middle frontal, postcentral, paracentral, middle temporal, angular, and lingual gyri. In addition, relative atrophy and GOS were also found to be significantly correlated over large portions of the cortex. Conclusion: This study contributes to our understanding of the relationship between clinical descriptors of acute TBI, the extent of injury-related chronic brain changes and neurological outcome. This is partly because the brain areas where cortical thinning was found to be correlated with GCS and with seizure occurrence are implicated in executive control, sensory function, motor acuity, memory, and language, all of which may be affected by TBI. Thus, our quantification suggests the existence of a statistical relationship between acute clinical presentation, on the one hand, and structural/functional brain features which are particularly susceptible to post-injury degradation, on the other hand.	[Irimia, Andrei] Univ Southern Calif, USC Leonard Davis Sch Gerontol, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90007 USA; [Goh, Sheng-Yang Matthew; Wade, Adam C.; Patel, Kavi; Van Horn, John D.] Univ Southern Calif, Keck Sch Med, Lab Neuro Imaging, Mark & Mary Stevens Neuroimaging & Informat Inst, Los Angeles, CA 90033 USA; [Vespa, Paul M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA		Irimia, A (corresponding author), Univ Southern Calif, USC Leonard Davis Sch Gerontol, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90007 USA.	irimia@usc.edu	Irimia, Andrei/B-8275-2008	Irimia, Andrei/0000-0002-9254-9388; Van Horn, John/0000-0003-1537-0816	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 100973, U54 EB 005149, R41 NS 081792, P01 NS 058489, P41 EB 015922]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015922, U54EB005149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489, R41NS081792, R01NS100973] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health, grants R01 NS 100973 (to AI), U54 EB 005149 (sub-award to JH), R41 NS 081792 (sub-award to JH), P01 NS 058489 (to PV), and P41 EB 015922.	Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Cohen J, 1998, STAT POWER ANAL BEHA; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Grabner RH, 2009, NEUROPSYCHOLOGIA, V47, P604, DOI 10.1016/j.neuropsychologia.2008.10.013; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Irimia A, 2015, J CLIN NEUROSCI, V22, P627, DOI 10.1016/j.jocn.2014.09.019; Irimia Andrei, 2012, Front Neurol, V3, P10, DOI 10.3389/fneur.2012.00010; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Menon V, 2000, NEUROIMAGE, V12, P357, DOI 10.1006/nimg.2000.0613; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Mohanraj R, 2005, SEIZURE-EUR J EPILEP, V14, P318, DOI 10.1016/j.seizure.2005.04.002; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Perucca P, 2014, BRAIN, V137, P183, DOI 10.1093/brain/awt299; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Puce A, 1996, J NEUROSCI, V16, P5205; Rencher Alvan C., 2002, METHODS MULTIVARIATE; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Roux FE, 2003, J NEUROSURG, V99, P716, DOI 10.3171/jns.2003.99.4.0716; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6	40	8	8	0	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 5	2017	8								530	10.3389/fneur.2017.00530			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FI9HQ	WOS:000412317200001	29051745	Green Published, gold			2022-02-06	
J	Bendinelli, C; Cooper, S; Evans, T; Bivard, A; Pacey, D; Parson, M; Balogh, ZJ				Bendinelli, Cino; Cooper, Shannon; Evans, Tiffany; Bivard, Andrew; Pacey, Dianne; Parson, Mark; Balogh, Zsolt J.			Perfusion Abnormalities are Frequently Detected by Early CT Perfusion and Predict Unfavourable Outcome Following Severe Traumatic Brain Injury	WORLD JOURNAL OF SURGERY			English	Article; Proceedings Paper	75th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery	SEP 14-17, 2016	Waikoloa, HI	Amer Assoc Surg Trauma			CEREBRAL-BLOOD-FLOW; COMPUTED-TOMOGRAPHY; XENON-CT; PROGNOSTIC VALUE; IMPACT; CLASSIFICATION; MORTALITY; VOLUME	In patients with severe traumatic brain injury (TBI), early CT perfusion (CTP) provides additional information beyond the non-contrast CT (NCCT) and may alter clinical management. We hypothesized that this information may prognosticate functional outcome. Five-year prospective observational study was performed in a level-1 trauma centre on consecutive severe TBI patients. CTP (obtained in conjunction with first routine NCCT) was interpreted as: abnormal, area of altered perfusion more extensive than on NCCT, and the presence of ischaemia. Six months Glasgow Outcome Scale-Extended of four or less was considered an unfavourable outcome. Logistic regression analysis of CTP findings and core variables [preintubation Glasgow Coma Scale (GCS), Rotterdam score, base deficit, age] was conducted using Bayesian model averaging to identify the best predicting model for unfavourable outcome. Fifty patients were investigated with CTP (one excluded for the absence of TBI) [male: 80%, median age: 35 (23-55), prehospital intubation: 7 (14.2%); median GCS: 5 (3-7); median injury severity score: 29 (20-36); median head and neck abbreviated injury scale: 4 (4-5); median days in ICU: 10 (5-15)]. Thirty (50.8%) patients had an unfavourable outcome. GCS was a moderate predictor of unfavourable outcome (AUC = 0.74), while CTP variables showed greater predictive ability (AUC for abnormal CTP = 0.92; AUC for area of altered perfusion more extensive than NCCT = 0.83; AUC for the presence of ischaemia = 0.81). Following severe TBI, CTP performed at the time of the first follow-up NCCT, is a non-invasive and extremely valuable tool for early outcome prediction. The potential impact on management and its cost effectiveness deserves to be evaluated in large-scale studies. Prospective study.	[Bendinelli, Cino; Cooper, Shannon; Balogh, Zsolt J.] Univ Newcastle, John Hunter Hosp, Dept Traumatol, Newcastle, NSW, Australia; [Bivard, Andrew; Parson, Mark] Univ Newcastle, John Hunter Hosp, Dept Neurol, Newcastle, NSW, Australia; [Pacey, Dianne] Univ Newcastle, John Hunter Hosp, Dept Rehabil, Newcastle, NSW, Australia; [Evans, Tiffany] Hunter Med Res Inst, Clin Res Design Informat Technol & Stat Support, Newcastle, NSW, Australia		Balogh, ZJ (corresponding author), Univ Newcastle, John Hunter Hosp, Dept Traumatol, Newcastle, NSW, Australia.	cino.bendinelli@hnehealth.nsw.gov.au; Shannon.Cooper@hnehealth.nsw.gov.au; tiffany.evans@hmri.org.au; andrew.bivard@newcastle.edu.au; dpacboo@ozemail.com.au; mark.parson@hnehealth.nsw.gov.au; zsolt.balogh@hnehealth.nsw.gov.au	Balogh, Zsolt J/A-2002-2010	Balogh, Zsolt J/0000-0002-0277-4822			ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; Bendinelli C, 2013, INJURY, V44, P1208, DOI 10.1016/j.injury.2013.03.039; Bivard A, 2015, BRAIN, V138, P1919, DOI 10.1093/brain/awv071; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chieregato A, 2004, J NEUROTRAUM, V21, P655, DOI 10.1089/0897715041269669; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Fridley J, 2015, J NEUROTRAUM, V32, P75, DOI 10.1089/neu.2014.3350; Furuya Y, 2003, NEUROSURGERY, V52, P340, DOI 10.1227/01.NEU.0000043931.83041.AA; Garnett MR, 2001, J NEUROTRAUM, V18, P585, DOI 10.1089/089771501750291828; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hattori N, 2003, ACTA NEUROCHIR SUPPL, V86, P49; Honda M, 2016, NEUROL MED-CHIR, V56, P501, DOI 10.2176/nmc.oa.2015-0341; Huang APH, 2014, J NEUROSURG, V120, P473, DOI 10.3171/2013.10.JNS13103; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kubal WS, 2012, RADIOL CLIN N AM, V50, P15, DOI 10.1016/j.rcl.2011.08.010; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Marini CP, 2014, AM J SURG, V208, P1071, DOI 10.1016/j.amjsurg.2014.08.003; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Metting Z, 2014, BRAIN COGNITION, V86, P24, DOI 10.1016/j.bandc.2014.01.012; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Olivecrona Z, 2015, BRAIN INJURY, V29, P446, DOI 10.3109/02699052.2014.989403; Osler T, 2016, INJURY, V47, P1879, DOI 10.1016/j.injury.2016.04.016; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Soustiel JF, 2008, NEURORADIOLOGY, V50, P189, DOI 10.1007/s00234-007-0337-7; Takahashi S, 2015, J STROKE CEREBROVASC, V24, P635, DOI 10.1016/j.jstrokecerebrovasdis.2014.10.010; van der Ploeg T, 2016, J CLIN EPIDEMIOL, V78, P83, DOI 10.1016/j.jclinepi.2016.03.002; Wen L, 2015, BRAIN INJURY, V29, P1654, DOI 10.3109/02699052.2015.1075248; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008	34	8	8	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	OCT	2017	41	10					2512	2520		10.1007/s00268-017-4030-7			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	FG8QK	WOS:000410700100013	28455815				2022-02-06	
J	Chu, YC; Wu, SY; Tsai, YJ; Liao, YL; Chu, HY				Chu, Yen-Chang; Wu, Shu-Ya; Tsai, Yueh-Ju; Liao, Yi-Lin; Chu, Hsueh-Yen			Early Versus Late Canalicular Laceration Repair Outcomes	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							SCALE SCORE LESS-THAN-9; TIMING FRACTURE REPAIR; BRAIN-INJURY; FIXATION; INTUBATION; MANAGEMENT; SURGERY	PURPOSE: To determine whether delayed repair of traumatic canalicular laceration affects the final outcome. DESIGN: Retrospective case series. METHODS: The medical records of 334 patients who underwent primary traumatic canalicular laceration repair were retrospectively reviewed. Patients were divided into 2 groups according to the surgical timing within 48 hours (early) or after 48 hours (delayed). The anatomic results were compared between these 2 groups. The causes of delayed repair and the mean operation time were also analyzed. RESULTS: There were 23 failed cases among 301 patients (7.6%) who had a repair within 48 hours and 3 failed cases among 33 patients (9.1%) who had a repair after 48 hours (P = .732). The mean operation time was 62 minutes in the early group and 66.3 minutes in the delayed group, which showed no significant difference (P = .371). The major cause of delayed surgery was traumatic brain injury, followed by facial or orbital fracture, long bone fracture, and chest injury. CONCLUSIONS: Delayed canalicular repair in unstable patients did not lead to poor results. An elective scheduling surgery, instead of an urgent repair, is feasible for an experienced surgeon. (C) 2017 Elsevier Inc. All rights reserved.	Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; Chang Gung Univ, Taoyuan, Taiwan		Chu, YC (corresponding author), Chang Gung Mem Hosp, Dept Ophthalmol, 5 Fusing St, Taoyuan 333, Taiwan.	umbo2003@gmail.com					BAYLIS HI, 1978, OPHTHALMOLOGY, V85, P1271; DORTZBACH RK, 1985, OPHTHALMIC SURG LAS, V16, P639; FAKHRY SM, 1994, J TRAUMA, V37, P255, DOI 10.1097/00005373-199408000-00018; HANSELMAYER H, 1973, OPHTHALMOLOGICA, V166, P175, DOI 10.1159/000306808; Jaicks RR, 1997, J TRAUMA, V42, P1, DOI 10.1097/00005373-199701000-00001; Jordan DR, 2002, CAN J OPHTHALMOL, V37, P245, DOI 10.1016/S0008-4182(02)80116-8; Nahm NJ, 2014, J TRAUMA ACUTE CARE, V77, P268, DOI 10.1097/TA.0000000000000283; Pape HC, 2009, J AM ACAD ORTHOP SUR, V17, P541, DOI 10.5435/00124635-200909000-00001; PAPE HC, 1993, J TRAUMA, V34, P540, DOI 10.1097/00005373-199304000-00010; REIFLER DM, 1991, SURV OPHTHALMOL, V36, P113, DOI 10.1016/0039-6257(91)90125-Y; Riu R, 1964, Bull Soc Ophtalmol Fr, V64, P1107; SAUNDERS DH, 1978, OPHTHALMIC SURG LAS, V9, P33; Shackford SR, 1998, J TRAUMA, V44, P982; Townsend RN, 1998, J TRAUMA, V44, P977, DOI 10.1097/00005373-199806000-00008; Wang MC, 2007, J TRAUMA, V62, P1250, DOI 10.1097/01.ta.0000215581.50234.56; Wu SY, 2010, JPN J OPHTHALMOL, V54, P24, DOI 10.1007/s10384-009-0755-7	16	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	OCT	2017	182						155	159		10.1016/j.ajo.2017.08.006			5	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	FI4DW	WOS:000411920900020	28844640				2022-02-06	
J	Kerr, K; Oram, J; Tinson, H; Shum, D				Kerr, Katelyn; Oram, Joanne; Tinson, Helen; Shum, David			Health Care Workers' Experiences of Aggression	ARCHIVES OF PSYCHIATRIC NURSING			English	Article						Aggression; Brain injuries; Nurses; Rehabilitation; Violence	TRAUMATIC BRAIN-INJURY; PATIENT AGGRESSION; NURSES; VIOLENCE; BEHAVIOR; ASSAULT; EMERGENCY; SETTINGS; STRESS; STAFF	PRIMARY OBJECTIVE: To identify the prevalence of patient aggression against health care workers, the consequences and coping mechanisms. DESIGN: Retrospective cross-sectional design. SUBJECTS: 50 participants comprised 37 nurses, 1 ward staff, 12 allied health staff employed in two brain injury wards with experience ranging from 3 months to 34 years. SETTING: Neurosciences and Brain Injury Rehabilitation wards of a metropolitan tertiary hospital in Brisbane. MAIN OUTCOME MEASURES: Researcher designed self-report questionnaire. RESULTS: 98% of respondents had experienced aggression during their health care careers with an average of 143.93 events. Physical injuries had been sustained by 40% of staff, psychological injury by 82%, but only 12% sought treatment. Verbal aggression related to receiving a psychological injury (r = 0.305, p < 0.05). Experiencing one type of aggression made it more likely the person would also experience the other types of aggression. Verbal aggression was correlated with physical aggression (r = 0.429, p < 0.01) and non-verbal aggression (r = 0.286, p < 0.05), and physical aggression was correlated with non-verbal aggression (r = 0333, p < 0.05). The majority of staff used informal debriefing with others as their main coping strategy which was considered effective. CONCLUSIONS: Patient aggression is prevalent and of serious concern for staff working in hospital settings. (C) 2017 Elsevier Inc. All rights reserved.	[Kerr, Katelyn; Shum, David] Gnffith Univ, Sch Psychol, Griffith Hlth Inst, Brisbane, Qld, Australia; [Kerr, Katelyn; Shum, David] Gnffith Univ, Behav Basis Hlth Program, Griffith Hlth Inst, Brisbane, Qld, Australia; [Kerr, Katelyn] Gnffith Univ, Life Promot Clin, Australian Inst Suicide Res & Prevent, Brisbane, Qld, Australia; [Kerr, Katelyn] Toowong Private Hosp, 496 Milton Rd, Toowong, Australia; [Oram, Joanne; Tinson, Helen] Princess Alexandra Hosp, Dept Psychol, Brisbane, Qld, Australia		Kerr, K (corresponding author), Toowong Private Hosp, 496 Milton Rd, Milton, Qld 4066, Australia.	katelynk@toowongprivatehospital.com.au; joanne_Oram@health.qld.gov.au; Helen_Tinson@health.qld.gov.au; D.Shum@griffith.edu.au	Shum, David H. K./A-3914-2008	Shum, David H. K./0000-0002-4810-9262			Australian Institute of Health and Welfare, 2007, DIS AUSTR ACQ BRAIN; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Deans C., 2004, WHO CARES NURSES LIV; Demir D, 2012, J NURS SCHOLARSHIP, V44, P376, DOI 10.1111/j.1547-5069.2012.01472.x; Farrell GA, 1999, J ADV NURS, V29, P532, DOI 10.1046/j.1365-2648.1999.00920.x; Gates DM, 2011, NURS ECON, V29, P59; Jansen GJ, 2006, AGGRESSIVE BEHAV, V32, P44, DOI 10.1002/ab.20106; Jones J., 2000, PERCEPTIONS PREVALEN; Kerr K, 2011, BRAIN INJURY, V25, P729, DOI 10.3109/02699052.2011.580315; Lam L T., 2014, J ADVANCEMENT MENTAL, V1, P89; McCann TV, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-80; McKenna BG, 2003, INT J MENT HEALTH NU, V12, P56, DOI 10.1046/j.1440-0979.2003.00269.x; McKinnon B, 2008, INT J MENT HEALTH NU, V17, P9, DOI 10.1111/j.1447-0349.2007.00499.x; McMillan I, 1995, Nurs Times, V91, P40; Minium EW, 1993, STAT REASONING PSYCH; Morphet J, 2014, AUST HEALTH REV, V38, P194, DOI 10.1071/AH13189; Needham I, 2005, J ADV NURS, V49, P283, DOI 10.1111/j.1365-2648.2004.03286.x; O'Connell B, 2000, J CLIN NURS, V9, P602, DOI 10.1046/j.1365-2702.2000.00401.x; Phoenix Australia-Centre for Posttraumatic Mental Health, 2013, AUSTR GUID TREATM AC; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Reininghaus U, 2007, PERS INDIV DIFFER, V42, P397, DOI 10.1016/j.paid.2006.07.013; *SPSS INC, 2005, STAT PACK SOC SCI WI; Swain N, 2014, NEW ZEAL MED J, V127, P10; Visscher AJM, 2011, J CLIN NURS, V20, P3414, DOI 10.1111/j.1365-2702.2011.03800.x; Winstanley S, 2002, ACTA PSYCHIAT SCAND, V106, P144, DOI 10.1034/j.1600-0447.106.s412.31.x; WOOD RL, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P153	27	8	8	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9417	1532-8228		ARCH PSYCHIAT NURS	Arch. Psychiatr. Nurs.	OCT	2017	31	5					457	462		10.1016/j.apnu.2017.06.011			6	Nursing; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Psychiatry	FI3ZS	WOS:000411909500006	28927509				2022-02-06	
J	Lauridsen, E; Blanche, P; Amaloo, C; Andreasen, JO				Lauridsen, Eva; Blanche, Paul; Amaloo, Catharina; Andreasen, Jens O.			The risk of healing complications in primary teeth with concussion or subluxation injuryA retrospective cohort study	DENTAL TRAUMATOLOGY			English	Article						concussion; dental trauma; premature tooth loss; primary teeth; pulp necrosis; subluxation	PRIMARY DENTITION; CHILDREN; TRAUMA; SEQUELAE; INCISORS	Background/AimTraumatic dental injuries in the primary dentition occur frequently. Long-term complications may potentially cause damage to the permanent successor. The aim of this study was to report the risk of pulp necrosis (PN), pulp canal obliteration (PCO), repair-related resorption (RRR), infection-related resorption (IRR), ankylosis-related resorption (ARR), and premature tooth loss (PTL) in primary teeth following concussion and subluxation injuries, and to identify possible risk factors for PN, PCO, and PTL following subluxation. Material and methodsThe study was a retrospective analysis of a cohort comprising 31 patients (36 teeth) with concussion injury and 174 patients (241 teeth) with subluxation injury. No treatment was performed. The follow-up program included examination after 4weeks, 8weeks, 6months, 1year, and when the patients were 6years of age. Minimum follow up was 1year or until the time of tooth loss. Statistics: Kaplan-Meier and Aalen-Johansen methods and Cox regression analysis. Level of significance was set at 5%. ResultsRisk estimated after one year. Concussion: PCO 8.6% (95% CI: 0-17.9), PN 5.7% (95% CI: 0-13.4), PTL 5.6% (95% CI: 0-13.4). Subluxation: PCO 23.2% (95% CI: 17.8-28.6), PN 8.3% (95% CI: 4.8-11.8), IRR 2.6% (95% CI: 0.5-4.6), PTL 9.5% (95% CI: 5.0-14.1). Most complications (95%) were diagnosed within the first year. Most cases of PN (65%) and PTL (85%) were seen in patients aged 4years or more. ConclusionPrimary teeth with concussion or subluxation injury carry a low risk of PN and infection with periapical inflammation, root resorption, and PTL. Nearly all complications were diagnosed within the first year after the injury. The risk of PTL was highest in patients more than 4years of age at the time of injury.	[Lauridsen, Eva; Andreasen, Jens O.] Rigshosp, Copenhagen Univ Hosp, Resource Ctr Rare Oral Dis, Dept Oral & Maxillofacial Surg, Copenhagen, Denmark; [Blanche, Paul] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Amaloo, Catharina] Univ Copenhagen, Dept Odontol, Pediat Dent & Clin Genet, Copenhagen, Denmark		Lauridsen, E (corresponding author), Rigshosp, Copenhagen Univ Hosp, Resource Ctr Rare Oral Dis, Dept Oral & Maxillofacial Surg, Copenhagen, Denmark.	eva.lauridsen@regionh.dk		Blanche, Paul/0000-0003-1415-7976	Augustinus Fonden; Velux FondenVelux Fonden; Danish Regions Research Foundation	Augustinus Fonden; Velux Fonden; Danish Regions Research Foundation	AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; ANDREASEN F M, 1986, Endodontics and Dental Traumatology, V2, P90; Andreasen J O, 1972, Int J Oral Surg, V1, P235, DOI 10.1016/S0300-9785(72)80042-5; [Anonymous], 2010, R LANG ENV STAT COMP; BERGGREN U, 1984, J AM DENT ASSOC, V109, P247, DOI 10.14219/jada.archive.1984.0328; Borum MK, 1998, ENDOD DENT TRAUMATOL, V14, P31; BROOK AH, 1975, BRIT DENT J, V139, P9, DOI 10.1038/sj.bdj.4803488; Cardoso M, 2002, DENT TRAUMATOL, V18, P129, DOI 10.1034/j.1600-9657.2002.00030.x; Chuang SK, 2001, J DENT RES, V80, P2016, DOI 10.1177/00220345010800111301; Assuncao LRD, 2011, BRAZ ORAL RES, V25, P150, DOI 10.1590/S1806-83242011000200009; Gerds TA., 2009, STAT METHODOLOGICAL, P259, DOI [10.1002/9780470744116.ch15, DOI 10.1002/9780470744116.CH15]; Glendor U, 2008, DENT TRAUMATOL, V24, P603, DOI 10.1111/j.1600-9657.2008.00696.x; Haavikko K, 1970, Suom Hammaslaak Toim, V66, P103; HELM S, 1974, COMMUNITY DENT ORAL, V2, P122, DOI 10.1111/j.1600-0528.1974.tb01669.x; Holan G, 2004, DENT TRAUMATOL, V20, P276, DOI 10.1111/j.1600-9657.2004.00285.x; Holan Gideon, 1996, Pediatric Dentistry, V18, P224; Holan Gideon, 1999, Pediatric Dentistry, V21, P242; Lauridsen E, 2012, DENT TRAUMATOL, V28, P371, DOI 10.1111/j.1600-9657.2011.01101.x; McCormick J, 1967, J Dent Child, V34, P501; Mendoza-Mendoza A, 2015, DENT TRAUMATOL, V31, P144, DOI 10.1111/edt.12147; Pugliesi DMC, 2004, DENT TRAUMATOL, V20, P139, DOI 10.1111/j.1600-4469.2004.00242.x; Qassem A, 2014, DENT TRAUMATOL, V30, P227, DOI 10.1111/edt.12072; Schroder U, 1977, Swed Dent J, V1, P95; Skaare AB, 2005, DENT TRAUMATOL, V21, P315, DOI 10.1111/j.1600-9657.2005.00362.x; SOXMAN JA, 1984, J DENT CHILD, V51, P282; VALDERHAUG J, 1974, INT J ORAL MAXILLOF, V3, P171, DOI 10.1016/S0300-9785(74)80022-0; van Houwelingen HC, 2014, STAT MED, V33, P5223, DOI 10.1002/sim.6282	27	8	9	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	OCT	2017	33	5					337	344		10.1111/edt.12342			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	FH3FX	WOS:000411031700003	28371334				2022-02-06	
J	Lecky, FE; Russell, W; McClelland, G; Pennington, E; Fuller, G; Goodacre, S; Han, K; Curran, A; Holliman, D; Chapman, N; Freeman, J; Byers, S; Mason, S; Potter, H; Coats, T; Mackway-Jones, K; Peters, M; Shewan, J				Lecky, Fiona Elizabeth; Russell, Wanda; McClelland, Graham; Pennington, Elspeth; Fuller, Gordon; Goodacre, Steve; Han, Kyee; Curran, Andrew; Holliman, Damian; Chapman, Nathan; Freeman, Jennifer; Byers, Sonia; Mason, Suzanne; Potter, Hugh; Coats, Timothy; Mackway-Jones, Kevin; Peters, Mary; Shewan, Jane			Bypassing nearest hospital for more distant neuroscience care in head-injured adults with suspected traumatic brain injury: findings of the head injury transportation straight to neurosurgery (HITS-NS) pilot cluster randomised trial	BMJ OPEN			English	Article							ACCURACY; CHILDREN; ENGLAND	Objective Reconfiguration of trauma services, with direct transport of patients with traumatic brain injury (TBI) to specialist neuroscience centres (SNCs)-bypassing non-specialist acute hospitals (NSAHs), could improve outcomes. However, delays in stabilisation of airway, breathing and circulation (ABC) may worsen outcomes when compared with selective secondary transfer from nearest NSAH to SNC. We conducted a pilot cluster randomised controlled trial to determine the feasibility and plausibility of bypassing suspected patients with TBI -directly into SNCs-producing a measurable effect. Setting Two English Ambulance Services. Participants 74 clusters (ambulance stations) were randomised within pairs after matching for important characteristics. Clusters enrolled head-injured adults-injured nearest to an NSAH-with internationally accepted TBI risk factors and stable ABC. We excluded participants attended by Helicopter Emergency Medical Services or who were injured more than 1 hour by road from nearest SNC. Interventions Intervention cluster participants were transported directly to an SNC bypassing nearest NSAH; control cluster participants were transported to nearest NSAH with selective secondary transfer to SNC. Outcomes Trial recruitment rate (target n=700 per annum) and percentage with TBI on CT scan (target 80%) were the primary feasibility outcomes. 30-day mortality, 6-month Extended Glasgow Outcome Scale and quality of life were secondary outcomes. Results 56 ambulance station clusters recruited 293 patients in 12 months. The trial arms were similar in terms of age, conscious level and injury severity. Less than 25% of recruited patients had TBI on CT (n=70) with 7%(n=20) requiring neurosurgery. Complete case analysis showed similar 30-day mortality in the two trial arms (control=8.8 (2.7-14.0)% vs intervention=9.4(2.3-14.0)%). Conclusion Bypassing patients with suspected TBI to SNCs gives an overtriage (false positive) ratio of 13: 1 for neurosurgical intervention and 4: 1 for TBI. A measurable effect from a full trial of early neuroscience care following bypass is therefore unlikely.	[Lecky, Fiona Elizabeth; Fuller, Gordon; Goodacre, Steve; Chapman, Nathan; Freeman, Jennifer; Mason, Suzanne] Univ Sheffield, Sch Hlth & Related Res ScHARR, Hlth Serv Res, Ctr Urgent & Emergency Care Res CURE Grp, Sheffield, S Yorkshire, England; [Russell, Wanda] Univ Manchester, Inst Populat, Ctr Occupat & Environm Hlth, Trauma Audit & Res Network, Manchester, Lancs, England; [McClelland, Graham; Han, Kyee; Byers, Sonia] North East Ambulance Serv NHS Fdn Trust, Res & Dev Dept, Newcastle Upon Tyne, Tyne & Wear, England; [Pennington, Elspeth; Curran, Andrew; Mackway-Jones, Kevin; Peters, Mary] North West Ambulance Serv, Res & Dev Dept, Carlisle, England; [Holliman, Damian] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Neurosurg, Newcastle Upon Tyne, Tyne & Wear, England; [Potter, Hugh] Potter Rees Serious Injury Solicitors LLP, Manchester, Lancs, England; [Coats, Timothy] Univ Leicester, Univ Hosp Leicester NHS Trust, Dept Cardiovasc Sci, Leicester, Leics, England; [Shewan, Jane] Yorkshire Ambulance Serv NHS Trust, Res & Dev Dept, Wakefield, England		Lecky, FE (corresponding author), Univ Sheffield, Sch Hlth & Related Res ScHARR, Hlth Serv Res, Ctr Urgent & Emergency Care Res CURE Grp, Sheffield, S Yorkshire, England.	f.e.lecky@sheffield.ac.uk	Coats, Timothy/AAW-1254-2021; Russell, Wanda/O-9051-2014	Coats, Timothy/0000-0003-2736-2784; McClelland, Graham/0000-0002-4502-5821; Fuller, Gordon Ward/0000-0001-8532-3500; Mason, Suzanne/0000-0002-1701-0577; Lecky, Fiona/0000-0001-6806-0921; Chapman, Nathan/0000-0002-5600-5439; Russell, Wanda/0000-0003-2671-1938; Pennington, Elspeth/0000-0002-9187-0524	National Institute of Health Research Health TechnologyAssessment ProgrammeNational Institute for Health Research (NIHR) [HTA08/116/85]; NIHR Doctoral Research Fellowship; National Institute for Health ResearchNational Institute for Health Research (NIHR) [CL-2015-04-005, 08/116/85] Funding Source: researchfish	The study was funded by the National Institute of Health Research Health TechnologyAssessment Programme HTA08/116/85. GF was also supported by an NIHR Doctoral Research Fellowship.	Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Caterino JM, 2011, ACAD EMERG MED, V18, P1014, DOI 10.1111/j.1553-2712.2011.01164.x; Cheung R, 2013, EMERG MED J, V30, P476, DOI 10.1136/emermed-2012-201324; Fuller G, 2016, EUR J EMERG MED, V23, P61, DOI 10.1097/MEJ.0000000000000327; Fuller G, 2014, EMERG MED J, V31, P914, DOI 10.1136/emermed-2013-202575; Fuller G, 2014, BRIT J NEUROSURG, V28, P452, DOI 10.3109/02688697.2013.865708; Group NZG, 2007, REHABILITATION; Intercollegiate S, 2009, EARLY MANAGEMENT PAT; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Pickering A, SYSTEMATIC REV CLIN; Pickering A, 2012, EMERG MED J, V29, P451, DOI 10.1136/emj.2010.094755; Ruff LM, 2013, BRIT J NEUROSURG, V27, P19, DOI 10.3109/02688697.2012.709555; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	17	8	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	OCT	2017	7	10							e016355	10.1136/bmjopen-2017-016355			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS7VN	WOS:000422617500078	28982816	Green Accepted, Green Published, gold			2022-02-06	
J	Liu, BJ; Wang, L; Cao, Y; Xu, WQ; Shi, FX; Tian, Q; Zhou, XW				Liu, Bingjin; Wang, Lin; Cao, Yun; Xu, Weiqi; Shi, Fangxiao; Tian, Qing; Zhou, Xinwen			Hypothermia pretreatment improves cognitive impairment via enhancing synaptic plasticity in a traumatic brain injury model	BRAIN RESEARCH			English	Article						Traumatic brain injury (TBI); hypothermia (HT); Cognition deficit	CONTROLLED CORTICAL IMPACT; THERAPEUTIC HYPOTHERMIA; ALZHEIMERS-DISEASE; RISK-FACTORS; HEAD-INJURY; ADULT MICE; IN-VIVO; NEURODEGENERATION; RATS; PHOSPHORYLATION	Posttraumatic hypothermia attenuates cognitive deficits caused by TBI when it is administered at an early stage. However, little is known regarding the effect of hypothermia pretreatment on cognitive deficits one month after TBI. In the current study, the behavior test revealed that hypothermia pretreatment mitigates the learning and memory impairment induced by TBI in mice. Hypothermia treatment significantly increased the expression of PSD93, PSD95 and NR2B one month after TBI in the cortex and hippocampus compared with the normothermia group. Hypothermia pretreatment also restored the decreased spine number and the impairment in LTP and decreased the number of activated microglia one month after TBI. On the other hand, hypothermia pretreatment increased glucose metabolism in TBI mice. Taken together, these data suggested that hypothermia pretreatment is an effective method with which to prevent spine loss, maintain normal LTP and preserve learning and memory function after TBI. The neuroprotective role might be associated with the preservation of postsynaptic protein expression, the inhibition of activated microglia and the increase in glucose metabolism. (C) 2017 Elsevier B.V. All rights reserved.	[Liu, Bingjin; Wang, Lin; Cao, Yun; Xu, Weiqi; Shi, Fangxiao; Tian, Qing; Zhou, Xinwen] Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Neurol Dis, Educ Minist,Dept Pathophysiol, Wuhan 430030, Hubei, Peoples R China		Tian, Q; Zhou, XW (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Neurol Dis, Educ Minist,Dept Pathophysiol, Wuhan 430030, Hubei, Peoples R China.	tianq@mail.hust.edu.cn; zhouxinwen@hust.edu.cn			National Nature Scientific Fund of China [81671262, 81171196]; HUST; Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST	This work was supported by the National Nature Scientific Fund of China (81671262 and 81171196) and Self-innovation fund of HUST and Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST.	Badshah H, 2014, NEUROCHEM INT, V74, P8, DOI 10.1016/j.neuint.2014.04.009; Barneoud P, 1997, NEUROREPORT, V8, P2861, DOI 10.1097/00001756-199709080-00012; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Carvalho C, 2013, J ALZHEIMERS DIS, V35, P623, DOI 10.3233/JAD-130005; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cheng XS, 2013, J ALZHEIMERS DIS, V36, P185, DOI 10.3233/JAD-122173; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Costa MS, 2008, NEUROCHEM INT, V53, P89, DOI 10.1016/j.neuint.2008.06.006; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Desai A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0714-4; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; Dunkley S, 2017, NURS CRIT CARE, V22, P150, DOI 10.1111/nicc.12242; First MB, 2013, J NERV MENT DIS, V201, P727, DOI 10.1097/NMD.0b013e3182a2168a; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Frederick C, 2015, J ALZHEIMERS DIS, V44, P1145, DOI 10.3233/JAD-142097; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lan KM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030289; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lazorthes G, 1964, Clin Neurosurg, V12, P293; Li HL, 2007, P NATL ACAD SCI USA, V104, P3591, DOI 10.1073/pnas.0609303104; Li X, 2016, MOL NEUROBIOL; Li XH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.180; Li YN, 2017, ONCOTARGET, V8, P30956, DOI 10.18632/oncotarget.16042; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Matsui T, 2012, INTENS CARE MED, V38, P1392, DOI 10.1007/s00134-012-2591-3; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; McCarthy MM, 2003, EXP NEUROL, V184, P40, DOI 10.1016/j.expneurol.2003.08.020; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Peretti D, 2015, NATURE, V518, P236, DOI 10.1038/nature14142; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Severini C, 2015, SCI REP-UK, V5, DOI 10.1038/srep15301; Shim SS, 2016, J NEUROTRAUM, V33, P2065, DOI 10.1089/neu.2015.4177; Thiel A, 2011, STROKE, V42, P507, DOI 10.1161/STROKEAHA.110.598821; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Wang CB, 2016, SCI REP-UK, V6, DOI 10.1038/srep26526; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11935	52	8	8	1	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 1	2017	1672						18	28		10.1016/j.brainres.2017.07.008			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FH6SJ	WOS:000411306700003	28729191				2022-02-06	
J	Martinez-Pernia, D; Nunez-Huasaf, J; del Blanco, A; Ruiz-Tagle, A; Velasquez, J; Gomez, M; Blesius, CR; Ibanez, A; Fernandez-Manjon, B; Slachevsky, A				Martinez-Pernia, David; Nunez-Huasaf, Javier; del Blanco, Angel; Ruiz-Tagle, Amparo; Velasquez, Juan; Gomez, Mariela; Blesius, Carl Robert; Ibanez, Agustin; Fernandez-Manjon, Baltasar; Slachevsky, Andrea			Using game authoring platforms to develop screen-based simulated functional assessments in persons with executive dysfunction following traumatic brain injury	JOURNAL OF BIOMEDICAL INFORMATICS			English	Article						Functional evaluation; Naturalistic activities; Executive functions; Prefrontal cortex; Neuropsychological assessment; eAdventure	ECOLOGICAL VALIDITY; VIRTUAL-REALITY; NEUROPSYCHOLOGICAL ASSESSMENT; NEUROCOGNITIVE DEFICITS; COGNITIVE FUNCTION; SIMPLIFIED VERSION; DAILY-LIFE; ACCEPTANCE; TECHNOLOGY; COMMUNITY	The assessment of functional status is a critical component of clinical neuropsychological evaluations used for both diagnostic and therapeutic purposes in patients with cognitive brain disorders. There are, however, no widely adopted neuropsychological tests that are both ecologically valid and easily administered in daily clinical practice. This discrepancy is a roadblock to the widespread adoption of functional assessments. In this paper, we propose a novel approach using a serious game authoring platform (eAdventure) for creating screen-based simulated functional assessments. We created a naturalistic functional task that consisted of preparing a cup of tea (SBS-COT) and applied the assessment in a convenience sample of eight dyads of therapists/patients with mild executive dysfunction after traumatic brain injury. We had three main aims. First, we performed a comprehensive review of executive function assessment in activities of daily living. Second, we were interested in measuring the feasibility of this technology with respect to staffing, economic and technical requirements. Third, a serious game was administered to patients to study the feasibility of this technology in the clinical context (pre-screening test). In addition, quantitative (Technology Acceptance Model (TAM) questionnaires) and qualitative (semistructured interviews) evaluations were applied to obtain user input. Our results suggest that the staffing, economic and technical requirements of the SBS-COT are feasible. The outcomes of the pre-screening test provide evidence that this technology is useful in the functional assessment of patients with executive dysfunction. In relation to subjective data, the TAM questionnaire showed good user acceptability from a professional perspective. Interview analyses with professionals and patients showed positive experiences related to the use of the SBS-COT. Our work indicates that the use of these types of authoring platforms could have positive long-term implications for neuropsychological research, opening the door to more reproducible, cooperative and efficient research by allowing the facilitated production, reuse and sharing of neuropsychological assessment tools. (C) 2017 Elsevier Inc. All rights reserved.	[Martinez-Pernia, David; Ruiz-Tagle, Amparo; Gomez, Mariela; Slachevsky, Andrea] Univ Chile, Ctr Adv Res Educ CIAE, Av Salvador 486, Santiago 8330014, Chile; [Martinez-Pernia, David; Slachevsky, Andrea] Gerosci Ctr Brain Hlth & Metab GERO, Santiago, Chile; [Martinez-Pernia, David; Ibanez, Agustin] Univ Adolfo Ibanez, CSCN, Sch Psychol, Santiago, Chile; [Martinez-Pernia, David] Fdn Polibea, Experiential Neurorehabil Res Dept, Tres Cantos, Spain; [Nunez-Huasaf, Javier] Los Muermos Primary Care Ctr & Reloncavi Hlth Ser, Los Muermos, Chile; [del Blanco, Angel; Fernandez-Manjon, Baltasar] Univ Complutense Madrid, Fac Informat, Dept Ingn Software & Inteligencia Artificial, Madrid, Spain; [Velasquez, Juan] Univ Chile, Dept Ingn Ind, Fac Ciencias Fis & Matemat, Santiago, Chile; [Blesius, Carl Robert] Harvard Med Sch, Massachusetts Gen Hosp, Lab Comp Sci, Boston, MA USA; [Ibanez, Agustin] Favaloro Univ, INECO Fdn, Inst Cognit & Translat Neurosci INCYT, Buenos Aires, DF, Argentina; [Ibanez, Agustin] Natl Sci & Tech Res Council, CONICET, Buenos Aires, DF, Argentina; [Ibanez, Agustin] Univ Autonoma Caribe, Barranquilla, Colombia; [Ibanez, Agustin] Australian Res Council ACR, Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Slachevsky, Andrea] Univ Chile, Fac Med, Dept Neurosci, Physiopathol Dept,ICBM, Ave Salvador 486, Santiago, Chile; [Slachevsky, Andrea] Univ Chile, Fac Med, East Neurosci Dept, Ave Salvador 486, Santiago, Chile; [Slachevsky, Andrea] Hosp Salvador, Neurol Dept, Cognit Neurol & Dementia, Av Salvador 386, Santiago, Chile; [Slachevsky, Andrea] Univ Desarrollo, Clin Alemana, Dept Med, Serv Neurol, Santiago, Chile		Slachevsky, A (corresponding author), Univ Chile, Ctr Adv Res Educ CIAE, Av Salvador 486, Santiago 8330014, Chile.	andrea.slachevsky@uchile.cl	Hidayat, Ima/ABF-6870-2021; Fernandez-Manjon, Baltasar/A-5281-2011; Martinez-Pernia, David/V-4455-2019; Velasquez, Juan D/H-3859-2013; Ibanez, Agustin/H-7976-2015	Fernandez-Manjon, Baltasar/0000-0002-8200-6216; Martinez-Pernia, David/0000-0003-2830-7920; Velasquez, Juan D/0000-0003-4819-9680; Ibanez, Agustin/0000-0001-6758-5101; Ruiz-Tagle, Amparo/0000-0003-4689-9536	Associative Research Program of CONICYT [FB 0003]; FONDAP ProgramComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP [15150012]; Conicyt/FondecytComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT [1140423, 1100175, 1170010]; Regional Government of Madrid [eMadrid] [S2013/ICE-2715]; Ministry of Education [TIN2013-46149-C2-1-R]; European CommissionEuropean CommissionEuropean Commission Joint Research Centre [RAGE H2020-ICT-2014-1-644187]; CONICETConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); INECO foundation; FONCyT-PICTANPCyTFONCyT [2012-0412, 2012-1309]	Basal Funds for Centers of Excellence, Project FB 0003 from the Associative Research Program of CONICYT; FONDAP Program Grant 15150012; Conicyt/Fondecyt Regular/1140423 & 1100175. David Rockefeller Center for Latin American Studies. Regional Government of Madrid [eMadrid S2013/ICE-2715], by the Ministry of Education [TIN2013-46149-C2-1-R], and by the European Commission [RAGE H2020-ICT-2014-1-644187]. Al is partially supported by CONICET, the INECO foundation, CONICYT/FONDECYT regular (1170010); FONCyT-PICT (2012-0412 and 2012-1309), and FONDAP Program Grant 15150012.	Adams E., 2010, FUNDAMENTALS GAME DE; Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Alonso-Fernandez C, 2017, IEEE GLOB ENG ED C E; Barker LA, 2010, NEUROPSYCHOLOGIA, V48, P2550, DOI 10.1016/j.neuropsychologia.2010.05.001; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Besnard J, 2016, APPL NEUROPSYCH-ADUL, V23, P223, DOI 10.1080/23279095.2015.1048514; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Bilder RM, 2011, J INT NEUROPSYCH SOC, V17, P7, DOI 10.1017/S1355617710001396; Boulay M, 2011, TECHNOL HEALTH CARE, V19, P233, DOI 10.3233/THC-2011-0628; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bureau of Labor Statistics, OCC EMPL STAT; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P., 1997, METHODOLOGY FRONTAL, P81; Burgess PW, 2009, RESTOR NEUROL NEUROS, V27, P493, DOI 10.3233/RNN-2009-0511; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chen IJ, 2008, INT J NURS STUD, V45, P869, DOI 10.1016/j.ijnurstu.2006.11.011; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; COLE MW, 2013, BEHAV NEUROSCI, V13, P1, DOI DOI 10.3758/S13415-012-0125-7; Collerton J, 2007, J AM GERIATR SOC, V55, P1630, DOI 10.1111/j.1532-5415.2007.01379.x; Cumin D, 2007, ANAESTHESIA, V62, P151, DOI 10.1111/j.1365-2044.2006.04902.x; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; del Blanco A., 2017, NURSE ED TODAY; del Blanco A, 2010, INT J DIST EDUC, V8, P1, DOI 10.4018/jdet.2010070101; Dickey MD, 2005, ETR&D-EDUC TECH RES, V53, P67, DOI 10.1007/BF02504866; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Draper K., 2008, NEUROPSYCHOLOGY, V22, P618; Dreher JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003227; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Dubois B, 1995, Adv Neurol, V65, P29; DUFFY JD, 1994, J NEUROPSYCH CLIN N, V6, P379; Eddy CM, 2012, PSYCHIAT RES, V200, P46, DOI 10.1016/j.psychres.2012.05.023; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Falautano M, 2010, NEUROL SCI, V31, P223, DOI 10.1007/s10072-010-0371-9; Fernandez-Calvo B, 2011, PSICOTHEMA, V23, P44; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Freire M., 2016, LEARNING DESIGN TECH, P1, DOI DOI 10.1007/978-3-319-17727-4_21-1; Gasca-Salas C, 2014, J PARKINSON DIS, V4, P677, DOI 10.3233/JPD-140398; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Giovannetti T, 2002, NEUROPSYCHOLOGIA, V40, P1220, DOI 10.1016/S0028-3932(01)00229-9; Giovannetti T., 2008, NEUROPSYCHOLOGY, V22, P235; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Goel V, 1997, BRAIN, V120, P1805, DOI 10.1093/brain/120.10.1805; Goldstein, 1996, ECOLOGICAL VALIDITY, P75; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Green MF, 1996, AM J PSYCHIAT, V153, P321; Holden RJ, 2012, J AM MED INFORM ASSN, V19, P1050, DOI 10.1136/amiajnl-2011-000754; Holden RJ, 2010, J BIOMED INFORM, V43, P159, DOI 10.1016/j.jbi.2009.07.002; Hosenbocus S, 2012, J CAN ACAD CHILD ADO, V21, P223; Hua P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108574; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Iverson GL, 2009, J CLIN EXP NEUROPSYC, V31, P594, DOI 10.1080/13803390802372125; Jen WY, 2010, TELEMED J E-HEALTH, V16, P490, DOI 10.1089/tmj.2009.0126; JOHNSON DM, 2005, 1832 US ARM RES I BE; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Kemp AH, 2009, CNS SPECTRUMS, V14, P118; Kim J, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2143; Klinger E, 2004, CYBERPSYCHOL BEHAV, V7, P292; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; Knight RG, 2009, BRAIN IMPAIR, V10, P3, DOI 10.1375/brim.10.1.3; Kowitlawakul Y, 2011, CIN-COMPUT INFORM NU, V29, P411, DOI 10.1097/NCN.0b013e3181f9dd4a; Kuo K.M., 2013, BMC MED INFORM DEC M, V13, P88; Legouverneur G., 2011, ALZHEIMERS DEMENTIA, V7, pS500; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Lo Priore C, 2003, CYBERPSYCHOL BEHAV, V6, P281, DOI 10.1089/109493103322011579; Long, 1996, ECOLOGICAL VALIDITY, P15; Lopez MC, 2016, REV NEUROL-FRANCE, V172, P270, DOI 10.1016/j.neurol.2016.01.399; LURIA AR, 1964, NEUROPSYCHOLOGIA, V2, P257, DOI 10.1016/0028-3932(64)90034-X; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Manera V, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00024; Marchiori E. J., 2012, 2012 IEEE 4th International Conference on Digital Game and Intelligent Toy Enhanced Learning (DIGITEL 2012), P72, DOI 10.1109/DIGITEL.2012.20; Marie R.M., 2003, VRIC 2003; Martinez-Pernia D, 2017, PHYSIOTHER THEOR PR, V33, P89, DOI 10.1080/09593985.2016.1266720; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McGeorge P, 2001, PRESENCE-TELEOP VIRT, V10, P375, DOI 10.1162/1054746011470235; McShane KE, 2013, INT J CIRCUMPOL HEAL, V72, DOI 10.3402/ijch.v72i0.20573; MESULAM MM, 1986, ANN NEUROL, V19, P320, DOI 10.1002/ana.410190403; Moreno-Ger P, 2008, COMPUTER, V41, P24, DOI 10.1109/MC.2008.73; Moreno-Ger P, 2010, INT J MED INFORM, V79, P459, DOI 10.1016/j.ijmedinf.2010.01.017; Morton N, 2010, J INT NEUROPSYCH SOC, V16, P1089, DOI 10.1017/S1355617710000925; Nakao T, 2014, PSYCHIAT CLIN NEUROS, V68, P587, DOI 10.1111/pcn.12195; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Nybo T, 1999, BRAIN INJURY, V13, P759; Padala Kalpana P, 2012, J Aging Res, V2012, P597573, DOI 10.1155/2012/597573; Pai FY, 2011, TECHNOL FORECAST SOC, V78, P650, DOI 10.1016/j.techfore.2010.11.007; Parsey CM, 2013, CLIN NEUROPSYCHOL, V27, P1328, DOI 10.1080/13854046.2013.834971; Parsons TD, 2008, CYBERPSYCHOL BEHAV, V11, P17, DOI 10.1089/cpb.2007.9934; Parsons TD, 2011, STUD COMPUT INTELL, V337, P271; Perry RJ, 2000, NEUROLOGY, V54, P2277, DOI 10.1212/WNL.54.12.2277; Phillips LH, 2014, J CLIN EXP NEUROPSYC, V36, P831, DOI 10.1080/13803395.2014.946891; Rand D, 2005, ANN REV CYBERTHERAPY, V3, P193; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; RAWSTORNE P, 2000, P 21 INT C INFORM SY, P00035; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Rizzo M., 2003, P 2 INT DRIV S HUM F, P21; Robert P.H., 2014, FRONT AGING NEUROSCI, V6, P54; Robinson E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-639; Robinson KE, 2014, NEUROPSYCHOLOGY, V28, P791, DOI 10.1037/neu0000077; Rosen AC, 2011, J ALZHEIMERS DIS, V26, P349, DOI 10.3233/JAD-2011-0009; Royall DR, 2007, J NEUROPSYCH CLIN N, V19, P249, DOI 10.1176/appi.neuropsych.19.3.249; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Sahariego C., 2015, PLOS ONE, V10; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P395, DOI 10.1097/00001199-200210000-00003; Schwartz MF, 2002, NEUROPSYCHOL REHABIL, V12, P311, DOI 10.1080/09602010244000084; Serrano-Laguna A, 2017, COMPUT STAND INTER, V50, P116, DOI 10.1016/j.csi.2016.09.014; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Stanney K. M., 2002, Proceedings of the Human Factors and Ergonomics Society 46th Annual Meeting, P2114; Stavros Z., 2010, P 3 INT C PERV TECHN, P21; Torrente Javier, 2010, 2010 IEEE Education Engineering 2010 - The Future of Global Learning Engineering Education (EDUCON 2010), P1121, DOI 10.1109/EDUCON.2010.5493056; Torrente J, 2014, IEEE T LEARN TECHNOL, V7, P69, DOI 10.1109/TLT.2013.35; Van Schaik P, 2002, BEHAV INFORM TECHNOL, V21, P47, DOI 10.1080/01449290110107236; Ward T., 1994, TEST EVERYDAY ATTENT; Werner P, 2009, DEMENT GERIATR COGN, V27, P301, DOI 10.1159/000204915; Weybright EH, 2010, THER RECREAT J, V44, P271; Wichers M, 2011, ACTA PSYCHIAT SCAND, V124, P262, DOI 10.1111/j.1600-0447.2011.01749.x; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Woo E, 2008, CNS SPECTRUMS, V13, P14, DOI 10.1017/S1092852900026985; World Health Organization, 1993, INT CLASS IMP DIS HA; Xu JQ, 2014, SCHIZOPHR RES, V159, P465, DOI 10.1016/j.schres.2014.08.022; Yamaguchi H, 2011, INT PSYCHOGERIATR, V23, P674, DOI 10.1017/S1041610210001912; Zhang L, 2001, AM J PHYS MED REHAB, V80, P597, DOI 10.1097/00002060-200108000-00010	129	8	8	2	15	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1532-0464	1532-0480		J BIOMED INFORM	J. Biomed. Inform.	OCT	2017	74						71	84		10.1016/j.jbi.2017.08.012			14	Computer Science, Interdisciplinary Applications; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Medical Informatics	FX6UA	WOS:000426221600007	28842292	Bronze, Green Submitted			2022-02-06	
J	Momenyan, S; Mousavi, SM; Dadkhahtehrani, T; Sarvi, F; Heidarifar, R; Kabiri, F; Mohebi, E; Koohbor, M				Momenyan, Somayeh; Mousavi, Sey Mojtaba; Dadkhahtehrani, Tahmineh; Sarvi, Fatemeh; Heidarifar, Reza; Kabiri, Faezeh; Mohebi, Erfan; Koohbor, Mohammad			Predictive Validity and Inter-Rater Reliability of the Persian Version of Full Outline of Unresponsiveness Among Unconscious Patients with Traumatic Brain Injury in an Intensive Care Unit	NEUROCRITICAL CARE			English	Article						Full Outline of Unresponsiveness score; Acute brain injury; Coma scale; Outcome predictor; Glasgow Coma Scale; Persian; Iran	GLASGOW COMA SCALE; 4 SCORE; EMERGENCY-DEPARTMENT; VALIDATION; CONSCIOUSNESS; STROKE	The Glasgow Coma Scale (GCS) has some limitations when evaluating the unconscious patient. This study aims to validate the Persian version of the FOUR (Full Outline of Unresponsiveness) score as a proposed substitute. Two nurses, two nursing students, and two physicians scored the prepared Persian version of the FOUR and GCS in 84 patients with acute brain injury. The inter-rater agreement for the FOUR and the GCS scores was evaluated by the weighted kappa (kappa (w)). The outcome prediction power of the scales was assessed by the area under the curve (AUC) in the ROC curve. The inter-rater agreement of the FOUR was excellent (kappa (w) = 0.923, 95 % CI, 0.874-0.971) and comparable with the one of the GCS (kappa (w) = 0.938, 95 % CI, 0.889-0.987). The area under the curve (AUC) for predicting in-hospital mortality (modified Rankin Scale: 6) was 0.835 for the FOUR (95 % CI, 0.739-0.907) and 0.772 for the GCS (95 % CI, 0.668-0.856) (P = 0.01). AUC for predicting poor outcome (modified Rankin Scale: 3-6) for the total FOUR score was 0.983 (95 % CI, 0.928-0.999), which is comparable with 0.987 for the total GCS score (95 % CI, 0.934-1.000). The researchers conclude that the Persian version of the FOUR score is a reliable and valid scale to assess unconscious patients with traumatic brain injury and can be substituted for the GCS.	[Momenyan, Somayeh] Qom Univ Med Sci, Epidemiol & Biostat Dept, Qom, Iran; [Mousavi, Sey Mojtaba; Mohebi, Erfan; Koohbor, Mohammad] Qom Univ Med Sci, Qom, Iran; [Dadkhahtehrani, Tahmineh] Isfahan Univ Med Sci, Midwifery, Fac Nursing & Midwifery, Midwifery Dept, Esfahan, Iran; [Sarvi, Fatemeh] Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Hamadan, Iran; [Heidarifar, Reza] Bagiyatallah Univ Med Sci, Med Quran & Hadith Res Ctr, Tehran, Iran; [Kabiri, Faezeh] Qom Branch Azad Univ, Qom, Iran		Momenyan, S (corresponding author), Qom Univ Med Sci, Epidemiol & Biostat Dept, Qom, Iran.	somy.momenyan@gmail.com	Tehrani, Tahmineh Dadkhah/X-2504-2019; sarvi, fatemeh/AAH-8557-2021; Mousavi, Seyed Mojtaba/E-7747-2018	Tehrani, Tahmineh Dadkhah/0000-0001-6105-4465; Momenyan, Somayeh/0000-0001-6708-6070	Qom University of Medical Sciences	This research was supported by Qom University of Medical Sciences. Thanks to the physicians, nurses, and nursing students for their sincere cooperation. In addition, we are grateful to the patients who participated in this study.	Akavipat P, 2011, ACTA MED OKAYAMA, V65, P205; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bruno MA, 2011, NEUROCRIT CARE, V15, P447, DOI 10.1007/s12028-011-9547-2; Cohen J, 2009, J NEUROSCI NURS, V41, P261, DOI 10.1097/JNN.0b013e3181b2c766; Fischer M, 2010, RES INTERRATER RELIA; Gill M, 2007, ANN EMERG MED, V49, P403, DOI 10.1016/j.annemergmed.2006.03.031; Idrovo L, 2010, EUR NEUROL, V63, P364, DOI 10.1159/000292498; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Laureys S, 2007, CONSCIOUS COGN, V16, P722, DOI 10.1016/j.concog.2007.04.004; Marcati E, 2012, INTERN EMERG MED, V7, P145, DOI 10.1007/s11739-011-0583-x; RANKIN J, 1957, Scott Med J, V2, P200; Reith FCM, 2016, J NEUROTRAUM, V33, P89, DOI 10.1089/neu.2014.3843; Schnakers C, 2006, ANN NEUROL, V60, P744, DOI 10.1002/ana.20919; STANCZAK DE, 1984, J NEUROSURG, V60, P955, DOI 10.3171/jns.1984.60.5.0955; Stead LG, 2009, NEUROCRIT CARE, V10, P50, DOI 10.1007/s12028-008-9145-0; TEASDALE G, 1974, LANCET, V2, P81; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Weiss N, 2009, REV NEUROL-FRANCE, V165, P796, DOI 10.1016/j.neurol.2009.01.045; Wijdicks EFM, 2010, NEUROLOGY, V74, P1911, DOI 10.1212/WNL.0b013e3181e242a8; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wolf CA, 2007, MAYO CLIN PROC, V82, P435, DOI 10.4065/82.4.435	21	8	9	1	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2017	27	2					229	236		10.1007/s12028-016-0324-0			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FJ4VC	WOS:000412739900011	28054286				2022-02-06	
J	Patterson, F; Fleming, J; Doig, E; Griffin, J				Patterson, Freyr; Fleming, Jennifer; Doig, Emmah; Griffin, Janelle			Participant evaluation of an inpatient occupational therapy groups programme in brain injury rehabilitation	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						brain injury; group; occupational therapy; programme evaluation; rehabilitation	PERFORMANCE-MEASURE; INTERVENTIONS; UTILITY	Background/aim: Therapy groups are commonly used in brain injury rehabilitation yet patient perceptions of participation in groups are largely uninvestigated. This paper describes the occupational therapy groups programme at an inpatient brain injury rehabilitation unit and presents an evaluation from the patient's perspective. Methods: Participants were in patients with traumatic brain injury who participated in the groups programme and completed a customised self-report questionnaire measuring perceptions about and satisfaction with four occupational therapy groups. Data were analysed descriptively and comparisons made between groups with a functional focus (meal preparation and community access) and an impairment focus (cognitive and upper limb) using Z scores. Results: Thirty-five participants (30 males, five females) completed a total of 83 questionnaires. Over 90% of responses agreed or strongly agreed that working with others was enjoyable, that the groups provided feedback and individualised treatment, and were useful for them. There were no significant differences in perceptions about the functional and impairment-focussed groups. An illustrative case example of participation in the groups programme is presented. Conclusions: Overall, consumer feedback on different aspects of the occupational therapy groups programme in brain injury rehabilitation was positive. Further in-depth investigation of patient perceptions of groups including processes that facilitate or challenge participation is warranted.	[Patterson, Freyr; Fleming, Jennifer; Griffin, Janelle] Univ Queensland, Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld, Australia; [Patterson, Freyr; Fleming, Jennifer; Doig, Emmah] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Fleming, Jennifer; Doig, Emmah] Queensland Hlth, Ctr Functioning & Hlth Res, Buranda, Qld, Australia		Patterson, F (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	freyr.patterson@uqconnect.edu.au	Doig, Emmah/AAG-6674-2021	Doig, Emmah/0000-0002-7020-053X			American Occupational Therapy Association-AOTA, 2014, AM J OCCUP THER, V68, ps01, DOI [10.5014/ajot.2014.682006, DOI 10.5014/AJOT.2014.682006]; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Bertisch H, 2011, J SPEC GROUP WORK, V36, P264, DOI 10.1080/01933922.2011.613901; Boynton PM, 2004, BRIT MED J, V328, P1312, DOI 10.1136/bmj.328.7451.1312; Carswell Anne, 2004, Can J Occup Ther, V71, P210; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cole MB, 2012, GROUP DYNAMICS IN OCCUPATIONAL THERAPY: THE THEORETICAL BASIS AND PRACTICE APPLICATION OF GROUP INTERVENTION, FOURTH EDITION, P1; Cooper B., 1996, CAN J OCCUP THER, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; Doig E, 2010, AM J OCCUP THER, V64, P904, DOI 10.5014/ajot.2010.08156; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Drum D, 2011, J SPEC GROUP WORK, V36, P247, DOI 10.1080/01933922.2011.613902; Forssmann-Falck R, 1989, Psychiatr Med, V7, P43; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS282, DOI 10.1016/j.apmr.2014.11.029; Higgins S., 2014, GROUP, V38, P317, DOI DOI 10.13186/GROUP.38.4.0317; Jenkinson N, 2007, BRAIN INJURY, V21, P1283, DOI 10.1080/02699050701739531; Malec JF., 2014, HDB NEUROPSYCHOLOGY, P283; McCarthy CJ, 2011, J SPEC GROUP WORK, V36, P352, DOI 10.1080/01933922.2011.614143; McColl E, 2001, Health Technol Assess, V5, P1; Meyer A., 1922, ARCH OCCUP THER, V1, P1, DOI [DOI 10.1192/BJP.68.283.421, 10.1300/J004v02n03_05, DOI 10.1300/J004V02N03_05]; Occupational Therapy Board of Australia, 2014, COD COND REG HLTH PR; Pagan E, 2015, BRAIN IMPAIR, V16, P173, DOI 10.1017/BrImp.2015.34; Patterson F, 2016, DISABIL REHABIL, V38, P1961, DOI 10.3109/09638288.2015.1111436; Pollock N., 2005, CANADIAN OCCUPATIONA; Scanlan JN, 2015, AUST OCCUP THER J, V62, P333, DOI 10.1111/1440-1630.12234; Schwartzberg, 1993, OCCUPATIONAL THERAPY, V12, P3, DOI [https://doi.org/10.1300/J004v12n01_02, DOI 10.1300/J004V12N01_02]; Schwartzberg SL., 2008, GROUPS APPL FUNCTION GROUPS APPL FUNCTION; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sohlberg MM, 1996, J HEAD TRAUMA REHAB, V11, P65, DOI 10.1097/00001199-199604000-00007; Strong S, 1999, Can J Occup Ther, V66, P122; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Torkelson Lynch R., 1995, J SPEC GROUP WORK, V20, P108, DOI [10.1080/01933929508411333, DOI 10.1080/01933929508411333]; World Health Organization, 2007, INT CLASS FUNCT DIS; Yalom I. D., 2005, THEORY PRACTICE GROU, V5th	34	8	8	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	OCT	2017	64	5					408	418		10.1111/1440-1630.12392			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	FK2YW	WOS:000413351100016	28568481				2022-02-06	
J	Rangaprakash, D; Dretsch, MN; Yan, WJ; Katz, JS; Denney, TS; Deshpande, G				Rangaprakash, D.; Dretsch, Michael N.; Yan, Wenjing; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna			Hemodynamic response function parameters obtained from resting-state functional MRI data in soldiers with trauma	DATA IN BRIEF			English	Article; Data Paper						Brain imaging; Functional magnetic resonance imaging; Hemodynamic variability; Hemodynamic response function parameters; Reliability of fMRI; Posttraumatic stress disorder		Functional magnetic resonance imaging (fMRI) is an indirect measure of brain activity, i.e. it is a convolution of the latent (unmeasured) neural signal and the hemodynamic response function (HRF). As such, the HRF has been shown to vary across brain regions and individuals. The shape of the HRF is controlled by both neural and non-neural factors. The shape of the HRF can be characterized by three parameters (response height, time-to-peak and full-width at half-max). The data presented here provides the three HRF parameters at every voxel, obtained from U.S. Army soldiers (N=87) diagnosed with posttraumatic stress disorder (PTSD), with comorbid PTSD and mild-traumatic brain injury (mTBI), and matched healthy combat controls. Findings from this data and further interpretations are available in our recent research study (Rangaprakash et al., 2017) [1]. This data is a valuable asset in studying the impact of HRF variability on fMRI data analysis, specifically resting state functional connectivity. (C) 2017 The Authors. Published by Elsevier lnc.	[Rangaprakash, D.; Yan, Wenjing; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Dept Elect & Comp Engn, AU MRI Res Ctr, Auburn, AL 36849 USA; [Rangaprakash, D.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA USA; [Dretsch, Michael N.] HQ TRADOC, Human Dimens Div, Ft Eustis, VA USA; [Dretsch, Michael N.] US Army Aeromed Res Lab, Ft Rucker, AL USA; [Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA; [Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Alabama Adv Imaging Consortium, Auburn, AL 36849 USA; [Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Univ Alabama Birmingham, Birmingham, AL USA		Deshpande, G (corresponding author), Auburn Univ, 560 Devall Dr,Suite 266D, Auburn, AL 36849 USA.	rzd0016@auburn.edu; gopi@auburn.edu		Denney, Thomas/0000-0002-6695-4777; Rangaprakash, D/0000-0001-9553-1354	U.S. Army Medical Research and Materiel Command (MRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [00007218]	The authors acknowledge financial support for this work from the U.S. Army Medical Research and Materiel Command (MRMC) (Grant #00007218). The views, opinions, and/or findings contained in this article are those of the authors and should not be interpreted as representing the official views or policies, either expressed or implied, of the U.S. Army or the Department of Defense (DoD). The funders had no role in the design of data acquisition protocol, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank the personnel at the TBI clinic (specifically Dr. Wolf) and behavioral health clinic, Fort Benning, GA, USA and the US Army Aeromedical Research Laboratory, Fort Rucker, AL, USA, and most of all, the soldiers who participated in this data acquisition. The authors thank Julie Rodiek and Wayne Duggan for facilitating data acquisition.	Amico E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100012; Boly M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125337; Busija DW, 2007, BRAIN RES REV, V56, P89, DOI 10.1016/j.brainresrev.2007.05.011; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Dickstein B.D., 2014, ASSESSMENT; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Lamichhane B, 2014, BRAIN CONNECT, V4, P619, DOI 10.1089/brain.2014.0243; Muthukumaraswamy SD, 2012, HUM BRAIN MAPP, V33, P455, DOI 10.1002/hbm.21223; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Rangaprakash D., 2017, NEUROIMAGE CLIN; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Weathers F.W, 2015, PTSD CHECKLIST DSM 5; Wu GR, 2013, MED IMAGE ANAL, V17, P365, DOI 10.1016/j.media.2013.01.003; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013	17	8	8	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2352-3409			DATA BRIEF	Data Brief	OCT	2017	14						558	562		10.1016/j.dib.2017.07.072			5	Multidisciplinary Sciences	Emerging Sources Citation Index (ESCI)	Science & Technology - Other Topics	HE5GZ	WOS:000453406500079	28861454	Green Published, gold			2022-02-06	
J	Rosellini, AJ; Stein, MB; Benedek, DM; Bliese, PD; Chiu, WT; Hwang, I; Monahan, J; Nock, MK; Petukhova, MV; Sampson, NA; Street, AE; Zaslavsky, AM; Ursano, RJ; Kessler, RC				Rosellini, A. J.; Stein, M. B.; Benedek, D. M.; Bliese, P. D.; Chiu, W. T.; Hwang, I.; Monahan, J.; Nock, M. K.; Petukhova, M. V.; Sampson, N. A.; Street, A. E.; Zaslavsky, A. M.; Ursano, R. J.; Kessler, R. C.		Army STARRS Collaborators	Using self-report surveys at the beginning of service to develop multi-outcome risk models for new soldiers in the US Army	PSYCHOLOGICAL MEDICINE			English	Article						Army; disciplinary problems; mental health; military; predictive modeling; risk assessment; violence	MENTAL-DISORDERS; SUBSTANCE USE; MILITARY PERSONNEL; SUICIDE ATTEMPTS; PREVENTION; VIOLENCE; ABUSE; HOSPITALIZATION; RELIGIOSITY; PREVALENCE	Background. The U.S. Army uses universal preventives interventions for several negative outcomes (e.g. suicide, violence, sexual assault) with especially high risks in the early years of service. More intensive interventions exist, but would be cost-effective only if targeted at high-risk soldiers. We report results of efforts to develop models for such targeting from self-report surveys administered at the beginning of Army service. Methods. 21 832 new soldiers completed a self-administered questionnaire (SAQ) in 2011-2012 and consented to link administrative data to SAQ responses. Penalized regression models were developed for 12 administratively-recorded outcomes occurring by December 2013: suicide attempt, mental hospitalization, positive drug test, traumatic brain injury (TBI), other severe injury, several types of violence perpetration and victimization, demotion, and attrition. Results. The best-performing models were for TBI (AUC = 0.80), major physical violence perpetration (AUC = 0.78), sexual assault perpetration (AUC = 0.78), and suicide attempt (AUC = 0.74). Although predicted risk scores were significantly correlated across outcomes, prediction was not improved by including risk scores for other outcomes in models. Of particular note: 40.5% of suicide attempts occurred among the 10% of new soldiers with highest predicted risk, 57.2% of male sexual assault perpetrations among the 15% with highest predicted risk, and 35.5% of female sexual assault victimizations among the 10% with highest predicted risk. Conclusions. Data collected at the beginning of service in self-report surveys could be used to develop risk models that define small proportions of new soldiers accounting for high proportions of negative outcomes over the first few years of service.	[Rosellini, A. J.; Chiu, W. T.; Hwang, I.; Petukhova, M. V.; Sampson, N. A.; Zaslavsky, A. M.; Kessler, R. C.] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Stein, M. B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Stein, M. B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Stein, M. B.] VA San Diego Healthcare Syst, San Diego, CA USA; [Benedek, D. M.; Ursano, R. J.] Uniformed Serv Univ Hlth Sci, Sch Med, Ctr Study Traumat Stress, Dept Psychiat, Bethesda, MD USA; [Bliese, P. D.] Univ South Carolina, Darla Moore Sch Business, Columbia, SC USA; [Monahan, J.] Univ Virginia, Sch Law, Charlottesville, VA 22903 USA; [Nock, M. K.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Street, A. E.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Street, A. E.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA		Kessler, RC (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	Kessler@hcp.med.harvard.edu	Ursano, Robert/ABE-6533-2020; Nock, Matthew/AAE-8330-2019	Ursano, Robert/0000-0002-1861-9173; Monahan, John/0000-0003-4431-3028; Bliese, paul/0000-0002-5384-8879; Street, Amy/0000-0003-4554-9075	Department of the Army; U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health (NIH/NIMH) [U01MH087981]; Department of Defense (USUHS) [HU0001-15-2-0004]; Department of Defense, Office of the Assistant Secretary for Defense for Health Affairs, Defense Health Program (OASD/HA) - U.S. Army Medical Research & Materiel Command (USAMRMC), at Fort Detrick, MD [W81XWH-12-2-0113, W81XWH-13-1-0037]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH087981] Funding Source: NIH RePORTER	Army STARRS was sponsored by the Department of the Army and funded under cooperative agreement (R.J.U. & M.B.S., cooperative agreement number U01MH087981) (2009-2015) with the U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health (NIH/NIMH); Subsequently, STARRS-LS was sponsored and funded by the Department of Defense (R.J.U. & M.B.S., USUHS grant number HU0001-15-2-0004); This research was also funded by the Department of Defense, Office of the Assistant Secretary for Defense for Health Affairs, Defense Health Program (OASD/HA), awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC), at Fort Detrick, MD (R.C.K., under contract numbers W81XWH-12-2-0113, W81XWH-13-1-0037); and Dr Street's effort was supported with resources and the use of facilities at VA Boston Healthcare System, Boston, MA.	Afifi TO, 2016, JAMA PSYCHIAT, V73, P229, DOI 10.1001/jamapsychiatry.2015.2732; Back MD, 2009, J PERS SOC PSYCHOL, V97, P533, DOI 10.1037/a0016229; Booth-Kewley S, 2010, J NERV MENT DIS, V198, P91, DOI 10.1097/NMD.0b013e3181cc45e9; Bulzacchelli MT, 2014, AM J PREV MED, V47, P813, DOI 10.1016/j.amepre.2014.08.008; Canham-Chervak M, 2010, AM J PREV MED, V38, pS11, DOI 10.1016/j.amepre.2009.10.003; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Dahlberg LL, 1998, AM J PREV MED, V14, P259, DOI 10.1016/S0749-3797(98)00009-9; Department of Defense, 2014, DEP DEF 2014 2016 SE; Department of Defense, 2014, DOD WORKPL VIOL PREV; Department of the Army, 2015, AR60024 DEP ARM; Department of the Army, 2015, AR60063 DEP ARM; Department of the US Army, 2010, ARM HLTH PROM RISK R; Department of the US Army, 2012, ARM 2020 GEN HLTH DI; Drasgow F, 2012, 1311 US ARM RES I BE; Elbogen EB, 2010, CLIN PSYCHOL REV, V30, P595, DOI 10.1016/j.cpr.2010.03.009; Elmasry H, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000229; Foster EM, 2006, ARCH GEN PSYCHIAT, V63, P1284, DOI 10.1001/archpsyc.63.11.1284; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fuentes D, 2006, J INT NEUROPSYCH SOC, V12, P907, DOI 10.1017/S1355617706061091; Golubnitschaja O, 2012, EPMA J, V3, DOI 10.1186/1878-5085-3-14; Halli S. S., 1992, ADV TECHNIQUES POPUL; Herman-Stahl MA, 2007, ADDICT BEHAV, V32, P1003, DOI 10.1016/j.addbeh.2006.07.010; Huntjens RJC, 2014, J BEHAV THER EXP PSY, V45, P1, DOI 10.1016/j.jbtep.2013.07.001; Institute of Medicine, 2010, RET HOM IR AFGH PREL; Iribarren C, 2000, SOC PSYCH PSYCH EPID, V35, P288, DOI 10.1007/s001270050241; JEFFORDS CR, 1984, SEX ROLES, V11, P543, DOI 10.1007/BF00287477; Kapp L., 2013, RECRUITING RETENTION; Kaufman KR, 2000, AM J PREV MED, V18, P54, DOI 10.1016/S0749-3797(00)00114-8; Kessler RC, 2015, JAMA PSYCHIAT, V72, P49, DOI 10.1001/jamapsychiatry.2014.1754; Kilpatrick DG, 2000, J CONSULT CLIN PSYCH, V68, P19, DOI 10.1037/0022-006X.68.1.19; Kirst M, 2014, SUBST USE MISUSE, V49, P1795, DOI 10.3109/10826084.2014.933240; Knapik JJ, 2004, 12HF01Q3A04 USACHPPM; Kubisiak UC, 2009, 200913 ARI; MacManus D, 2012, PSYCHOL MED, V42, P1663, DOI 10.1017/S0033291711002327; MacManus D, 2012, SOC PSYCH PSYCH EPID, V47, P1353, DOI 10.1007/s00127-011-0443-z; Miller L, 2000, J AM ACAD CHILD PSY, V39, P1190, DOI 10.1097/00004583-200009000-00020; Moore TM, 2017, ASSESSMENT; Niebuhr DW, 2013, PSYCHOL SERV, V10, P378, DOI 10.1037/a0032783; Nock MK, 2013, PSYCHIATRY, V76, P97, DOI 10.1521/psyc.2013.76.2.97; Nonnemaker JM, 2003, SOC SCI MED, V57, P2049, DOI 10.1016/S0277-9536(03)00096-0; Parkkari J, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-35; Ritchie MD, 2005, NEUROSURG FOCUS, V19, P1; Rosellini AJ, 2016, PSYCHOL MED, V46, P303, DOI 10.1017/S0033291715001774; Rosellini AJ, 2015, DEPRESS ANXIETY, V32, P13, DOI 10.1002/da.22316; Rudd MD, 2015, AM J PSYCHIAT, V172, P441, DOI 10.1176/appi.ajp.2014.14070843; Rytila-Manninen M, 2014, CHILD ABUSE NEGLECT, V38, P2021, DOI 10.1016/j.chiabu.2014.10.008; Salas-Wright CP, 2012, J YOUTH ADOLESCENCE, V41, P1560, DOI 10.1007/s10964-012-9761-z; SAS Institute Inc, 2010, SAS STATR SOFTW; Schensul JJ, 2005, J DRUG ISSUES, V35, P379, DOI 10.1177/002204260503500208; Senn CY, 2015, NEW ENGL J MED, V372, P2326, DOI 10.1056/NEJMsa1411131; Shea MT, 2013, BEHAV RES THER, V51, P607, DOI 10.1016/j.brat.2013.05.013; Street AE, 2016, CLIN PSYCHOL SCI, V4, P939, DOI 10.1177/2167702616639532; Suris A, 2008, TRAUMA VIOLENCE ABUS, V9, P250, DOI 10.1177/1524838008324419; Theodoroff SM, 2015, EPIDEMIOL REV, V37, P71, DOI 10.1093/epirev/mxu005; Turchik JA, 2010, AGGRESS VIOLENT BEH, V15, P267, DOI 10.1016/j.avb.2010.01.005; U. S. Department of Justice, 2011, 30799 ICPSR US DEP J; Upstill-Goddard R, 2013, BRIEF BIOINFORM, V14, P251, DOI 10.1093/bib/bbs024; Ursano RJ, 2014, PSYCHIATRY, V77, P107, DOI 10.1521/psyc.2014.77.2.107; Vungkhanching M, 2007, J HEAD TRAUMA REHAB, V22, P167, DOI 10.1097/01.HTR.0000271117.19652.98; WILLETT JB, 1993, J CONSULT CLIN PSYCH, V61, P952, DOI 10.1037/0022-006X.61.6.952; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	61	8	8	3	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0033-2917	1469-8978		PSYCHOL MED	Psychol. Med.	OCT	2017	47	13					2275	2287		10.1017/S003329171700071X			13	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	FG6MK	WOS:000410494200006	28374665	Green Accepted			2022-02-06	
J	Vadas, D; Kalichman, L; Hadanny, A; Efrati, S				Vadas, Dor; Kalichman, Leonid; Hadanny, Amir; Efrati, Shai			Hyperbaric Oxygen Environment Can Enhance Brain Activity and Multitasking Performance	FRONTIERS IN INTEGRATIVE NEUROSCIENCE			English	Article						HBOT; hyperbaric oxygenation; dual tasking; oxygen limitation; enhancing brain activity	POST-CONCUSSION SYNDROME; MOTOR-ASSESSMENT SCALE; DEAD-SEA; LOW-ALTITUDE; TASK; REHABILITATION	Background: The Brain uses 20% of the total oxygen supply consumed by the entire body. Even though, <10% of the brain is active at any given time, it utilizes almost all the oxygen delivered. In order to perform complex tasks or more than one task (multitasking), the oxygen supply is shifted from one brain region to another, via blood perfusion modulation. The aim of the present study was to evaluate whether a hyperbaric oxygen (HBO) environment, with increased oxygen supply to the brain, will enhance the performance of complex and/or multiple activities. Methods: A prospective, double-blind randomized control, crossover trial including 22 healthy volunteers. Participants were asked to perform a cognitive task, a motor task and a simultaneous cognitive-motor task (multitasking). Participants were randomized to perform the tasks in two environments: (a) normobaric air (1 ATA 21% oxygen) (b) HBO (2 ATA 100% oxygen). Two weeks later participants were crossed to the alternative environment. Blinding of the normobaric environment was achieved in the same chamber with masks on while hyperbaric sensation was simulated by increasing pressure in the first minute and gradually decreasing to normobaric environment prior to tasks performance. Results: Compared to the performance at normobaric conditions, both cognitive and motor single tasks scores were significantly enhanced by HBO environment (p < 0.001 for both). Multitasking performance was also significantly enhanced in HBO environment (p = 0.006 for the cognitive part and p = 0.02 for the motor part). Conclusions: The improvement in performance of both single and multi-tasking while in an HBO environment supports the hypothesis which according to, oxygen is indeed a rate limiting factor for brain activity. Hyperbaric oxygenation can serve as an environment for brain performance. Further studies are needed to evaluate the optimal oxygen levels for maximal brain performance.	[Vadas, Dor] Israeli Rehabil Ctr Stroke & Brain Injury, Rehovot, Israel; [Kalichman, Leonid] Ben Gurion Univ Negev, Recanati Sch Community Hlth Profess, Fac Hlth Sci, Dept Phys Therapy, Beer Sheva, Israel; [Hadanny, Amir; Efrati, Shai] Asaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, Zerifin, Israel; [Hadanny, Amir; Efrati, Shai] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Hadanny, Amir] Bar Ilan Univ, Galilee Fac Med, Ramat Gan, Israel; [Efrati, Shai] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel		Vadas, D (corresponding author), Israeli Rehabil Ctr Stroke & Brain Injury, Rehovot, Israel.; Efrati, S (corresponding author), Asaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, Zerifin, Israel.; Efrati, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.; Efrati, S (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.	dorvadas@gmail.com; efratishai@013.net	Kalichman, Leonid/C-6266-2008; Kalichman, Leonid/Q-7547-2019	Kalichman, Leonid/0000-0003-2987-4396; Kalichman, Leonid/0000-0003-2987-4396			Austin D, 1998, LANCET, V351, P1815, DOI 10.1016/S0140-6736(05)78781-X; Boussi-Gross R, 2015, NEUROPSYCHOLOGY, V29, P610, DOI 10.1037/neu0000149; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Carrier LM, 2009, COMPUT HUM BEHAV, V25, P483, DOI 10.1016/j.chb.2008.10.012; Chisholm CD, 2000, ACAD EMERG MED, V7, P1239, DOI 10.1111/j.1553-2712.2000.tb00469.x; Choi MH, 2013, GERIATR GERONTOL INT, V13, P384, DOI 10.1111/j.1447-0594.2012.00911.x; Dickinson D, 2007, ARCH GEN PSYCHIAT, V64, P532, DOI 10.1001/archpsyc.64.5.532; Donohue SE, 2012, ATTEN PERCEPT PSYCHO, V74, P803, DOI 10.3758/s13414-012-0323-y; Efrati S, 2014, EXPERT REV NEUROTHER, V14, P233, DOI 10.1586/14737175.2014.884928; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Falk B, 2006, PEDIATR PULM, V41, P234, DOI 10.1002/ppul.20342; Goldbart AD, 2007, ISR MED ASSOC J, V9, P806; GOLDING F C, 1960, Br J Ind Med, V17, P167; Hadanny A, 2015, RESTOR NEUROL NEUROS, V33, P471, DOI 10.3233/RNN-150517; Hadanny A, 2016, EXPERT REV NEUROTHER, V16, P875, DOI 10.1080/14737175.2016.1205487; Hadanny A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1034-2; Han SW, 2013, ATTEN PERCEPT PSYCHO, V75, P1395, DOI 10.3758/s13414-013-0513-2; Hinton-Bayre A, 2005, PSYCHOL ASSESSMENT, V17, P237, DOI 10.1037/1040-3590.17.2.237; Kramer MR, 1998, CHEST, V113, P571, DOI 10.1378/chest.113.3.571; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Lieberman P, 2005, AVIAT SPACE ENVIR MD, V76, pB198; Malle C, 2013, AVIAT SPACE ENVIR MD, V84, P773, DOI 10.3357/ASEM.3482.2013; McCaffrey R J, 1988, Arch Clin Neuropsychol, V3, P181, DOI 10.1016/0887-6177(88)90062-5; Mendez-Balbuena I, 2015, J NEUROPHYSIOL, V114, P2132, DOI 10.1152/jn.00457.2015; Mortazavi A, 2003, AVIAT SPACE ENVIR MD, V74, P922; Moss MC, 1996, PSYCHOPHARMACOLOGY, V124, P255, DOI 10.1007/BF02246665; Parmenter BA, 2007, MULT SCLER J, V13, P52, DOI 10.1177/1352458506070750; POOLE JL, 1988, ARCH PHYS MED REHAB, V69, P195; Shanker Thom, 2011, NEW MILITARY DATA OV; Shukitt-Hale B, 1998, INT J AVIAT PSYCHOL, V8, P319, DOI 10.1207/s15327108ijap0804_1; Smith A., 1973, SYMBOL DIGIT MODAITY; SOKOLOFF L, 1955, J CLIN INVEST, V34, P1101, DOI 10.1172/JCI103159; SPELKE E, 1976, COGNITION, V4, P215, DOI 10.1016/0010-0277(76)90018-4; Strauss E., 2006, PSYCHOL TESTS ADM NO; Tal S, 2015, RESTOR NEUROL NEUROS, V33, P943, DOI 10.3233/RNN-150585; Tombu MN, 2011, P NATL ACAD SCI USA, V108, P13426, DOI 10.1073/pnas.1103583108; West JB, 2003, HIGH ALT MED BIOL, V4, P389, DOI 10.1089/152702903769192340; West JB, 2002, HIGH ALT MED BIOL, V3, P223, DOI 10.1089/15270290260131948; Yu Rh, 2015, CLIN NEUROPHYSIOL, V126, P2058, DOI 10.1016/j.clinph.2015.01.010; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	41	8	8	1	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5145			FRONT INTEGR NEUROSC	Front. Integr. Neurosci.	SEP 27	2017	11								25	10.3389/fnint.2017.00025			6	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FI4LQ	WOS:000411943100001	29021747	gold, Green Published			2022-02-06	
J	Phillips, CJ; LeardMann, CA; Vyas, KJ; Crum-Cianflone, NF; White, MR				Phillips, Christopher J.; LeardMann, Cynthia A.; Vyas, Kartavya J.; Crum-Cianflone, Nancy F.; White, Martin R.			Risk Factors Associated With Suicide Completions Among US Enlisted Marines	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						deployment; depressive disorder; suicide; survival analysis; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; ADVERSE CHILDHOOD EXPERIENCES; MENTAL-HEALTH PROBLEMS; MILITARY PERSONNEL; CAGE QUESTIONNAIRE; ENDURING FREEDOM; IRAQI FREEDOM; ALCOHOL-USE; AFGHANISTAN	US enlisted Marines have experienced a substantial increase in suicide rates. We sought to identify risk factors for suicide completions among male Marines who entered basic training in San Diego, California, between June 2001 and October 2010. Suicides that occurred during active-duty military service were counted from June 1, 2001, through June 30, 2012. A total of 108,930 male Marines (66,286 deployers and 42,644 never deployed) were followed for 467,857 person-years of active-duty service time. Of the 790 deaths, 123 (15.6%) were suicides. In the final multivariate hazard model, preservice characteristics of not being a high-school graduate (hazard ratio (HR) = 2.17, 95% confidence interval (CI): 1.28, 3.68) and being a smoker at the time of enlistment (HR = 1.91, 95% CI: 1.32, 2.76) were significantly associated with a higher risk for suicide completion. Diagnosed with traumatic brain injury (HR = 4.09, 95% CI: 2.08, 8.05), diagnosed with depression (HR = 2.36, 95% CI: 1.22, 4.58), and received relationship counseling (HR = 3.71, 95% CI: 1.44, 9.54) during military service were significant risks for suicide death. Deployment alone was not significantly associated with a risk for suicide death (HR = 0.53, 95% CI: 0.26, 1.05).	[Phillips, Christopher J.; LeardMann, Cynthia A.; Vyas, Kartavya J.; Crum-Cianflone, Nancy F.; White, Martin R.] Naval Hlth Res Ctr, Deployment Hlth Res Dept, 140 Sylvester Rd,Bldg 322, San Diego, CA 92106 USA		Phillips, CJ (corresponding author), Naval Hlth Res Ctr, Deployment Hlth Res Dept, 140 Sylvester Rd,Bldg 322, San Diego, CA 92106 USA.	christopher.j.phillips12.civ@mail.mil			Bureau of Medicine and Surgery [60002]	This work was supported by the Bureau of Medicine and Surgery (Work Unit 60002).	[Anonymous], 2009, Medical Surveillance Montly Report, V16, P2; Armed Forces Health Surveillance Center (AFHSC), 2012, MSMR, V19, P7; Armed Forces Health Surveillance Center (AFHSC), 2012, MSMR, V19, P2; Servies Tammy, 2012, MSMR, V19, P11; Bachynski KE, 2012, INJURY PREV, V18, P405, DOI 10.1136/injuryprev-2011-040112; Beautrais AL, 1996, J AM ACAD CHILD PSY, V35, P1174, DOI 10.1097/00004583-199609000-00015; Black SA, 2011, MIL PSYCHOL, V23, P433, DOI 10.1080/08995605.2011.590409; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Cao LQ, 1997, CRIMINOLOGY, V35, P629, DOI 10.1111/j.1745-9125.1997.tb01233.x; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Dhalla S, 2007, CLIN INVEST MED, V30, P33, DOI 10.25011/cim.v30i1.447; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Haley RW, 1998, AM J EPIDEMIOL, V148, P315, DOI 10.1093/oxfordjournals.aje.a009645; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Healthcare Cost and Utilization Project, 2015, HCUP CLIN CLASS SOFT; HELMKAMP JC, 1995, MIL MED, V160, P45, DOI 10.1093/milmed/160.2.45; Hepburn L, 2007, INJURY PREV, V13, P15, DOI 10.1136/ip.2006.013607; Heuer J., 2006, USMC MENTORSHIP PROG; Hilton SM, 2009, 0915 NHRC; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holmes EK, 1998, PSYCHOL REP, V83, P3, DOI 10.2466/PR0.83.5.3-11; Hourani LL, 2001, 0122 NHRC; Hyams KC, 2002, MIL MED, V167, P44, DOI 10.1093/milmed/167.1.44; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Joiner TE, 2005, ANNU REV PSYCHOL, V56, P287, DOI 10.1146/annurev.psych.56.091103.070320; Kang HK, 2015, ANN EPIDEMIOL, V25, P96, DOI 10.1016/j.annepidem.2014.11.020; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; LANE SE, 2002, 0217 NHRC; LeardMann CA, 2013, JAMA-J AM MED ASSOC, V310, P496, DOI 10.1001/jama.2013.65164; Lonnqvist JK, 2000, INT HDB SUICIDE ATTE, P107; Luxton D.D., 2010, DEP DEFENSE SUICIDE; MacGregor AJ, 2012, AM J PUBLIC HEALTH, V102, pS55, DOI 10.2105/AJPH.2011.300341; Mental Health Advisory Team VI, 2009, MENT HLTH ADV TEAM M; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Pompili Maurizio, 2008, Neuropsychiatr Dis Treat, V4, P247; Reger MA, 2015, JAMA PSYCHIAT, V72, P561, DOI 10.1001/jamapsychiatry.2014.3195; RICH CL, 1986, ARCH GEN PSYCHIAT, V43, P577; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schoenbaum M, 2014, JAMA PSYCHIAT, V71, P493, DOI 10.1001/jamapsychiatry.2013.4417; Scoville SL, 2007, MIL MED, V172, P1024, DOI 10.7205/MILMED.172.10.1024; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Smolenski D. J., 2013, DEP DEFENSE SUICIDE; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Wilson ALG, 2009, SOC PSYCH PSYCH EPID, V44, P473, DOI 10.1007/s00127-008-0461-7; Young SYN, 2006, ARCH PEDIAT ADOL MED, V160, P1207, DOI 10.1001/archpedi.160.12.1207; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc	51	8	8	0	9	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0002-9262	1476-6256		AM J EPIDEMIOL	Am. J. Epidemiol.	SEP 15	2017	186	6					668	678		10.1093/aje/kwx117			11	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FG8ZV	WOS:000410728500007	28595355				2022-02-06	
J	Marshall, J; Szmydynger-Chodobska, J; Rioult-Pedotti, MS; Lau, K; Chin, AT; Kotla, SKR; Tiwari, RK; Parang, K; Threlkeld, SW; Chodobski, A				Marshall, John; Szmydynger-Chodobska, Joanna; Rioult-Pedotti, Mengia S.; Lau, Kara; Chin, Andrea T.; Kotla, Siva K. Reddy; Tiwari, Rakesh Kumar; Parang, Keykavous; Threlkeld, Steven W.; Chodobski, Adam			TrkB-enhancer facilitates functional recovery after traumatic brain injury	SCIENTIFIC REPORTS			English	Article							LONG-TERM POTENTIATION; CONTROLLED CORTICAL IMPACT; CLOSED-HEAD INJURY; MORRIS WATER MAZE; GAP DETECTION; NEUROTROPHIC FACTOR; SIGNALING PATHWAYS; MICROGYRIC RATS; CYCLIC PEPTIDE; NMDA RECEPTOR	Brain-derived neurotrophic factor (BDNF), a key player in regulating synaptic strength and learning, is dysregulated following traumatic brain injury (TBI), suggesting that stimulation of BDNF signaling pathways may facilitate functional recovery. This study investigates whether CN2097, a peptidomimetic ligand which targets the synaptic scaffold protein, postsynaptic density protein 95, to enhance downstream signaling of tropomyosin-related kinase B, a receptor for BDNF, can improve neurological function after TBI. Moderate to severe TBI elicits neuroinflammation and c-Jun-N-terminal kinase (JNK) activation, which is associated with memory deficits. Here we demonstrate that CN2097 significantly reduces the post-traumatic synthesis of proinflammatory mediators and inhibits the post-traumatic activation of JNK in a rodent model of TBI. The recordings of field excitatory post-synaptic potentials in the hippocampal CA1 subfield demonstrate that TBI inhibits the expression of long-term potentiation (LTP) evoked by high-frequency stimulation of Schaffer collaterals, and that CN2097 attenuates this LTP impairment. Lastly, we demonstrate that CN2097 significantly improves the complex auditory processing deficits, which are impaired after injury. The multifunctionality of CN2097 strongly suggests that CN2097 could be highly efficacious in targeting complex secondary injury processes resulting from neurotrauma.	[Marshall, John; Rioult-Pedotti, Mengia S.; Lau, Kara] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Szmydynger-Chodobska, Joanna; Chin, Andrea T.; Chodobski, Adam] Brown Univ, Alpert Med Sch, Neurotrauma & Brain Barriers Res Lab, Dept Emergency Med, Providence, RI 02903 USA; [Kotla, Siva K. Reddy; Tiwari, Rakesh Kumar; Parang, Keykavous] Chapman Univ, Sch Pharm, Ctr Targeted Drug Delivery, Dept Biomed & Pharmaceut Sci, Irvine, CA 92618 USA; [Threlkeld, Steven W.] Regis Coll, Dept Neurosci, Weston, MA 02493 USA		Marshall, J (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	John_Marshall@Brown.edu	Rioult-Pedotti, Mengia-Seraina/AAF-1377-2021; Parang, Keykavous/ABC-1584-2021	Parang, Keykavous/0000-0001-8600-0893	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094440, R21NS099605, R21MH104252]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R15HD077544]; Department of Emergency Medicine at the Alpert Medical School of Brown University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R15HD077544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH104252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094440, R21NS099605] Funding Source: NIH RePORTER	Funding for this work came from the NINDS R01NS094440 (A.C. and J.M) and R21NS099605 (A.C.), and R21MH104252 (J.M), and NICHD R15HD077544 (S.T.). This work was also supported by funds from Diane N. Weiss and from the Department of Emergency Medicine at the Alpert Medical School of Brown University (J.S.C. and A.C.). We also thank Dr. Dennis Goebel (Wayne State) for his valuable advice and Ms. Julie Sarri for her technical assistance.	Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Curran BP, 2003, NEUROSCIENCE, V118, P347, DOI 10.1016/S0306-4522(02)00941-7; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Darwish S, 2017, TETRAHEDRON LETT, V58, P3053, DOI 10.1016/j.tetlet.2017.06.066; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Fitch RH, 2008, BRAIN RES BULL, V76, P1, DOI 10.1016/j.brainresbull.2007.07.013; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; Friedman JT, 2004, DEV BRAIN RES, V152, P83, DOI 10.1016/j.devbrainres.2004.06.007; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Harris NG, 2013, J NEUROTRAUM, V30, P1137, DOI 10.1089/neu.2012.2785; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Kaipio ML, 2013, NEUROREPORT, V24, P440, DOI 10.1097/WNR.0b013e32836164b4; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kolarow R, 2007, J NEUROSCI, V27, P10350, DOI 10.1523/JNEUROSCI.0692-07.2007; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Leal G, 2015, BRAIN RES, V1621, P82, DOI 10.1016/j.brainres.2014.10.019; LeBlanc BW, 2010, NEUROSCIENCE, V167, P490, DOI 10.1016/j.neuroscience.2010.02.031; Lynch MA, 2015, BRAIN RES, V1621, P197, DOI 10.1016/j.brainres.2014.08.040; Marshall J, 2015, J BIOL CHEM, V290, P22030, DOI 10.1074/jbc.M115.662791; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MOSER E, 1993, J NEUROSCI, V13, P3916; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Panja D, 2014, NEUROPHARMACOLOGY, V76, P664, DOI 10.1016/j.neuropharm.2013.06.024; Park HY, 2014, INT J MOL MED, V33, P1027, DOI 10.3892/ijmm.2014.1652; Pei DS, 2006, BRAIN, V129, P465, DOI 10.1093/brain/awh700; Peiffer AM, 2004, DEV BRAIN RES, V152, P93, DOI 10.1016/j.devbrainres.2004.06.003; Peiffer AM, 2002, DEV BRAIN RES, V138, P187, DOI 10.1016/S0165-3806(02)00472-8; Piserchio A, 2004, CHEM BIOL, V11, P469, DOI 10.1016/j.chembiol.2004.03.013; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Provencio JJ, 2016, BRAIN BEHAV IMMUN, V54, P233, DOI 10.1016/j.bbi.2016.02.007; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; REEVES TM, 1995, EXP BRAIN RES, V106, P248; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Savinainen A, 2001, J BIOL CHEM, V276, P11382, DOI 10.1074/jbc.M100190200; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Skelton RW, 2000, J CLIN EXP NEUROPSYC, V22, P157, DOI 10.1076/1380-3395(200004)22:2;1-1;FT157; Smith NA, 2006, J SPEECH LANG HEAR R, V49, P1104, DOI 10.1044/1092-4388(2006/079); Soriano FX, 2008, J NEUROSCI, V28, P10696, DOI 10.1523/JNEUROSCI.1207-08.2008; Szmydynger-Chodobska J., 2015, HLTH AND DIS, V2, P156; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Tallal P, 2004, NAT REV NEUROSCI, V5, P721, DOI 10.1038/nrn1499; Thompson HJ, 2006, RESTOR NEUROL NEUROS, V24, P109; Threlkeld SW, 2008, NEUROREPORT, V19, P893, DOI 10.1097/WNR.0b013e3283013d7e; Threlkeld SW, 2006, BRAIN RES, V1109, P22, DOI 10.1016/j.brainres.2006.06.022; Threlkeld SW, 2012, BEHAV BRAIN RES, V235, P130, DOI 10.1016/j.bbr.2012.07.031; Threlkeld SW, 2009, INT J DEV NEUROSCI, V27, P321, DOI 10.1016/j.ijdevneu.2009.03.007; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; Voelbel G, 2014, ARCH CLIN NEUROPSYCH, V29; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; Zhao S, 2016, J NEUROTRAUM, V33, P2055, DOI 10.1089/neu.2015.4036; Zhou L, 2010, NAT MED, V16, P1439, DOI 10.1038/nm.2245	70	8	8	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 8	2017	7								10995	10.1038/s41598-017-11316-8			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG1VI	WOS:000409841100057	28887487	gold, Green Published			2022-02-06	
J	Buitendag, JJP; Kong, VY; Bruce, JL; Laing, GL; Clarke, DL; Brysiewicz, P				Buitendag, J. J. P.; Kong, V. Y.; Bruce, J. L.; Laing, G. L.; Clarke, D. L.; Brysiewicz, P.			The spectrum and outcome of paediatric traumatic brain injury in KwaZulu-Natal Province, South Africa has not changed over the last two decades	SAMJ SOUTH AFRICAN MEDICAL JOURNAL			English	Article							HEAD-INJURIES; SURVEILLANCE SYSTEM; CHILDREN; BURDEN; DISEASE	Objectives. This retrospective review of a prospectively entered and maintained hybrid electronic trauma registry was intended to develop a comprehensive overview of traumatic brain injury (TBI) in children and adolescents and to compare it with previous audits from our local environment and from other developing world centres. All TBI patients admitted to hospital were included in this study. We reviewed the age, gender, outcomes, radiological findings and treatment of the patients. Methods. All patients aged <= 18 years old who were admitted by the Pietermaritzburg Metropolitan Trauma Service (PMTS) with TBI between December 2012 and December 2016 were included in this audit. Results. During the 4-year period under review, a total of 563 children and adolescents were treated for TBI by the PMTS. The median age was 6.4 years and 29% (n=165) were females. The mechanism of TBI was blunt trauma in 96% (n=544) of cases, with 4% (n=19) suffering penetrating trauma. The penetrating mechanisms included impalement by a cow horn and miscellaneous injuries due to saws, axes, barbed wire, spades, stones and knives. The blunt mechanisms included falls (n=102), assaults (n=108), collapse of a building (n=28), bicyclerelated injury (n=14), falling off a moving vehicle (n=280), motor vehicle accident (MVA; n=59), pedestrian vehicle accident (PVA; n=183) and animal-related injuries (n=8). There were 454 (80%) mild, 67 (12%) moderate and 42 (7%) severe cases of TBI. A total of 48 patients were admitted to the intensive care unit and 23 were admitted to the high care unit. Nine patients died. All the deaths were in the MVA and PVA group. The spectrum of TBI as diagnosed on computed tomography scans was nonspecific cerebral contusion (n=92), depressed skull fracture (n=70), sub-arachnoid haemorrhage (n=60), extradural haemorrhage (n=41), intracerebral haemorrhage (n=19), free air (n=19), subdural haemorrhage (n=13), intraventricular haemorrhage (n=9). A total of 62 (11%) patients required surgery. Conclusion. There is a significant burden of paediatric TBI in Pietermaritzburg. The majority of TBI was related to blunt trauma and assaults were very common. Although the short-term outcomes are good, the long-term consequences are poorly understood. Injury prevention programmes are needed to help reduce this burden of disease and a nationwide trauma registry is long overdue.	[Buitendag, J. J. P.; Kong, V. Y.; Bruce, J. L.; Laing, G. L.; Clarke, D. L.] Univ KwaZulu Natal, Dept Surg, Pietermaritzburg Metropolitan Trauma Serv, Durban, South Africa; [Clarke, D. L.] Univ Witwatersrand, Fac Hlth Sci, Dept Surg, Johannesburg, South Africa; [Brysiewicz, P.] Univ KwaZulu Natal, Coll Hlth Sci, Sch Nursing & Publ Hlth, Durban, South Africa		Buitendag, JJP (corresponding author), Univ KwaZulu Natal, Dept Surg, Pietermaritzburg Metropolitan Trauma Serv, Durban, South Africa.	johan_buitendag@yahoo.com	Buitendag, Johan/AAB-7077-2019	Buitendag, Johan/0000-0001-7169-129X; Laing, Grant/0000-0001-8075-0386; Clarke, Damian/0000-0002-8467-1455			Butchart A, 2001, S AFR MED J, V91, P408; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Hardcastle T, 2011, SAMJ S AFR MED J, V101, P160, DOI 10.7196/SAMJ.4578; Hardcastle TC, 2013, WORLD J SURG, V37, P1550, DOI 10.1007/s00268-012-1889-1; Hardcastle TC, 2013, WORLD J SURG, V37, P1513, DOI 10.1007/s00268-012-1852-1; Hardcastle TC, 2011, SAMJ S AFR MED J, V101, P189, DOI 10.7196/SAMJ.4682; Isaac KN, 2015, INT J INJ CONTROL SA, V22, P352, DOI 10.1080/17457300.2014.912236; KIBEL SM, 1990, S AFR MED J, V78, P387; KNOBEL GJ, 1984, S AFR MED J, V66, P795; Laing GL, 2014, WORLD J SURG, V38, P1388, DOI 10.1007/s00268-013-2438-2; Lalloo R, 2004, SAMJ S AFR MED J, V94, P544; Lutge E, 2016, INJURY, V47, P135, DOI 10.1016/j.injury.2015.08.020; Manchev V, 2015, ANN ROY COLL SURG, V97, P274, DOI 10.1308/003588414X14055925061595; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Matzopoulos Richard G, 2006, Int J Inj Contr Saf Promot, V13, P49, DOI 10.1080/15660970500036382; Moodley NB, 2014, S AFR J SURG, V52, P101, DOI [10.7196/sajs.1995, 10.7196/SAJS.1995]; MUCKART DJJ, 1991, S AFR MED J, V79, P93; Okyere-Dede EK, 2013, TROP DOCT, V43, P1, DOI 10.1177/0049475513480490; PEACOCK WJ, 1984, S AFR MED J, V66, P789; Peden M, 1999, S AFRICAN HLTH REV, P265; Schrieff L E, 2013, SAMJ, S. Afr. med. j., V103, P616, DOI 10.7196/samj.7137; Semple PL, 1998, S AFR MED J, V88, P440; Zulu BMW, 2007, INJURY, V38, P576, DOI 10.1016/j.injury.2007.01.002	23	8	8	0	2	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0256-9574	2078-5135		SAMJ S AFR MED J	SAMJ S. Afr. Med. J.	SEP	2017	107	9					777	780		10.7196/SAMJ.2017.v107i9.12394			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FM4RM	WOS:000415009200024	28875887	gold, Green Submitted			2022-02-06	
J	Jendoubi, A; Abbes, A; Ghedira, S; Houissa, M				Jendoubi, Ali; Abbes, Ahmed; Ghedira, Salma; Houissa, Mohamed			Pain Measurement in Mechanically Ventilated Patients with Traumatic Brain Injury: Behavioral Pain Tools versus Analgesia Nociception Index	INDIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Behavioral pain scale; Intensive Care Unit; pain assessment; traumatic brain injury	CRITICALLY-ILL; POSTOPERATIVE PAIN; VALIDATION; SCALE	Introduction: Pain is highly prevalent in critically ill trauma patients, especially those with a traumatic brain injury (TBI). Behavioral pain tools such as the behavioral pain scale (BPS) and critical-care pain observation tool are recommended for sedated noncommunicative patients. Analysis of heart rate variability (HRV) is a noninvasive method to evaluate autonomic nervous system activity. The analgesia nociception index (ANI) device (Physiodoloris (R), MDoloris Medical Systems, Loos, France) allows noninvasive HRV analysis. The ANI assesses the relative parasympathetic tone as a surrogate for antinociception/nociception balance in sedated patients. The primary aim of our study was to evaluate the effectiveness of ANI in detecting pain in TBI patients. The secondary aim was to evaluate the impact of norepinephrine use on ANI effectiveness and to determine the correlation between ANI and BPS. Methods: We performed a prospective observational study in 21 deeply sedated TBI patients. Exclusion criteria were nonsinus cardiac rhythm; presence of pacemaker; atropine or isoprenaline treatment; neuromuscular blocking agents; and major cognitive impairment. Heart rate, blood pressure, and ANI were continuously recorded using the Physiodoloris (R) device at rest (T1), during (T2), and after the end (T3) of the painful stimulus (tracheal suctioning). Results: In total, 100 observations were scored. ANI was significantly lower at T2 (Median [min - max] 54.5 [22-100]) compared with T1 (90.5 [50-100], P < 0.0001) and T3 (82 [36-100], P < 0.0001). Similar results were found in the subgroups of patients with (65 measurements) or without (35) norepinephrine. During procedure, a negative linear relationship was observed between ANI and BPS (r(2) = -0.469, P < 0.001). At the threshold of 50, the sensitivity and specificity of ANI to detect patients with BPS >= 5 were 73% and 62%, respectively, with a negative predictive value of 86%. Discussion: Our results suggest that ANI is effective in detecting pain in ventilated sedated TBI patients, including those patients treated with norepinephrine.	[Jendoubi, Ali; Abbes, Ahmed; Ghedira, Salma; Houissa, Mohamed] Univ Tunis El Manar, Charles Nicolle Hosp Tunis, Fac Med Tunis, Dept Anaesthesia & Intens Care, Tunis, Tunisia		Jendoubi, A (corresponding author), Univ Tunis El Manar, Charles Nicolle Hosp Tunis, Fac Med Tunis, Dept Anaesthesia & Intens Care, Tunis, Tunisia.	jendoubi_ali@yahoo.fr	JENDOUBI, Ali/W-9982-2019	JENDOUBI, Ali/0000-0002-2731-4793			Aissaoui Y, 2005, ANESTH ANALG, V101, P1470, DOI 10.1213/01.ANE.0000182331.68722.FF; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Berben SAA, 2008, INJURY, V39, P578, DOI 10.1016/j.injury.2007.04.013; Boselli E, 2014, BRIT J ANAESTH, V112, P715, DOI 10.1093/bja/aet407; Broucqsault-Dedrie C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147720; Gelinas C, 2006, AM J CRIT CARE, V15, P420; Herr K, 2006, PAIN MANAG NURS, V7, P44, DOI 10.1016/j.pmn.2006.02.003; Ledowski T, 2013, BRIT J ANAESTH, V111, P627, DOI 10.1093/bja/aet111; Logier R, 2010, IEEE ENG MED BIO, P1194, DOI 10.1109/IEMBS.2010.5625971; Payen JF, 2001, CRIT CARE MED, V29, P2258, DOI 10.1097/00003246-200112000-00004; Skrobik Y, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-9	11	8	8	0	4	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0972-5229	1998-359X		INDIAN J CRIT CARE M	Indian J. Crit. Care Med.	SEP	2017	21	9					585	588		10.4103/ijccm.IJCCM_419_16			4	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	FH7TA	WOS:000411393500007	28970658	Bronze, Green Published, Green Submitted			2022-02-06	
J	Khalili, H; Ahl, R; Cao, Y; Paydar, S; Sjolin, G; Niakan, A; Dabiri, G; Mohseni, S				Khalili, Hosseinali; Ahl, Rebecka; Cao, Yang; Paydar, Shahram; Sjolin, Gabriel; Niakan, Amin; Dabiri, Gholamreza; Mohseni, Shahin			Early selenium treatment for traumatic brain injury: Does it improve survival and functional outcome?	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Selenase; Functional outcome	INFLAMMATORY RESPONSE SYNDROME; OXIDATIVE STRESS; RATS; PRETREATMENT; BIOMARKERS; DISEASE	Background: Traumatic brain injury (TBI) is a major cause of death and debility following trauma. The initial brain tissue insult is worsened by secondary reactive responses including oxidative stress reactions, inflammatory changes and subsequent permanent neurologic deficits. Effective agents to improve functional outcome and survival following TBI are scarce. Selenium is an antioxidant which has shown to reduce oxidative stress. This study examines the effect of intravenous selenium (Selenase (R)) treatment in patients with severe TBI on functional outcome and survival in a prospective study design. Methods: Patients sustaining TBI were prospectively identified during a 12-month period at an academic urban trauma center. Study inclusion criteria applied were: age >= 18 years, blunt injury mechanism and admission to neurosurgical intensive care unit (NICU). Early deaths (<= 48 h) and patients suffering extracranial injuries requiring invasive interventions or surgery were excluded. All consecutive admissions during a six-month period were administered intravenous Selenase (R) for a maximum 10-day period and constituted cases. Patient demographics and outcomes up to six-months post-discharge were collected for analysis. Results: A total of 307 patients met inclusion criteria of which 125 were administered Selenase (R). Stepwise Poisson regression analysis identified five common predictors of poor functional outcome and in-hospital mortality: GCS <= 8, age <= 55 years, hypotension at admission, high Rotterdam score and invasive neurosurgical intervention. Selenase (R) significantly reduced the risk of unfavourable functional outcomes, defined as GOS-E <= 4, at both discharge (adjusted RR 0.69, 95% CI 0.51-0.92, p = 0.012) and at six months follow-up (adjusted RR 0.61, 95% CI 0.44-0.83, p = 0.002). Following adjustment for significant group differences similar results were seen for functional outcome. Selenase (R) did not improve survival (adjusted RR 1.12, 95% CI 0.62-2.02, p = 0.709). Conclusion: Intravenous Selenase (R) treatment demonstrates a significant improvement in functional neurologic outcome. This effect is sustained at six months following discharge. (C) 2017 Elsevier Ltd. All rights reserved.	[Khalili, Hosseinali; Paydar, Shahram; Niakan, Amin] Shiraz Univ Med Sci, Trauma Res Ctr, Shahid Rajaee Emtiaz Trauma Hosp, Shiraz, Iran; [Khalili, Hosseinali; Niakan, Amin] Shiraz Univ Med Sci, Dept Neurosurg, Shiraz, Iran; [Ahl, Rebecka] Karolinska Univ Hosp, Div Trauma & Emergency Surg, Dept Surg, Stockholm, Sweden; [Ahl, Rebecka; Cao, Yang; Sjolin, Gabriel; Mohseni, Shahin] Orebro Univ, Sch Med Sci, Orebro, Sweden; [Cao, Yang] Karolinska Inst, Inst Environm Med, Unit Biostat, Stockholm, Sweden; [Sjolin, Gabriel; Mohseni, Shahin] Orebro Univ Hosp, Div Trauma & Emergency Surg, Dept Surg, Orebro, Sweden; [Dabiri, Gholamreza] Shiraz Univ Med Sci, Shahid Rajaee Emtiaz Trauma Hosp, Shiraz, Iran		Mohseni, S (corresponding author), Orebro Univ Hosp, Dept Surg, S-70185 Orebro, Sweden.	khalilih@yahoo.com; rebecka.ahl@karolinska.se; yang.cao@ki.se; paydarsh@gmail.com; gabriel.sjolin@gmail.com; aniakan@sums.ac.ir; drdabirighr@yahoo.com; mohsenishahin@yahoo.com	Khalili, Hosseinali/I-1087-2016; Ahl, Rebecka/AAG-4162-2020; paydar, shahram/U-3074-2018; Cao, Yang/C-6185-2008; niakan, amin/A-6818-2019	Khalili, Hosseinali/0000-0002-3390-4212; Ahl, Rebecka/0000-0001-7930-3845; paydar, shahram/0000-0002-6980-2576; Cao, Yang/0000-0002-3552-9153; niakan, amin/0000-0003-2644-8543			Angstwurm MWA, 1999, CRIT CARE MED, V27, P1807, DOI 10.1097/00003246-199909000-00017; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Berger MM, 1996, J TRAUMA, V40, P103, DOI 10.1097/00005373-199601000-00019; Brodska H, 2015, J TRACE ELEM MED BIO, V31, P25, DOI 10.1016/j.jtemb.2015.02.005; Demirci K, 2017, METAB BRAIN DIS, V32, P321, DOI 10.1007/s11011-016-9903-1; DIGBY PGN, 1983, BIOMETRICS, V39, P753, DOI 10.2307/2531104; Fink K, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0774-3; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; HAWKER FH, 1990, CRIT CARE MED, V18, P442, DOI 10.1097/00003246-199004000-00020; Maddox JF, 1999, J LEUKOCYTE BIOL, V65, P658, DOI 10.1002/jlb.65.5.658; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Moghaddam OM, 2017, INDIAN J CRIT CARE M, V21, P75, DOI [10.4103/ijccm.IJCCM_391_16, 10.4103/ijccm.ijccm_391_16]; Reisinger J, 2009, AM J EMERG MED, V27, P176, DOI 10.1016/j.ajem.2008.01.020; Senol N, 2014, NEUROCHEM RES, V39, P685, DOI 10.1007/s11064-014-1255-9; Steinbrenner H, 2016, INFLAMMATION, V39, P1363, DOI 10.1007/s10753-016-0368-5; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teixeira PG, 2013, J TRAUMA ACUTE CARE, V75, P596, DOI 10.1097/TA.0b013e31829bb976; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yazici A, 2015, INT J OPHTHALMOL-CHI, V8, P263, DOI 10.3980/j.issn.2222-3959.2015.02.09; Yeo JE, 2007, BBA-MOL BASIS DIS, V1772, P1199, DOI 10.1016/j.bbadis.2007.09.004; Zheng L, 2016, SCI REP-UK, V6, DOI 10.1038/srep39290; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	23	8	8	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2017	48	9					1922	1926		10.1016/j.injury.2017.07.005			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FE2LA	WOS:000408046600012	28711170				2022-02-06	
J	Lah, S; Black, C; Gascoigne, MB; Gott, C; Epps, A; Parry, L				Lah, Suncica; Black, Carly; Gascoigne, Michael B.; Gott, Chloe; Epps, Adrienne; Parry, Louise			Accelerated Long-Term Forgetting Is Not Epilepsy Specific: Evidence from Childhood Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						children; memory; TBI	TEMPORAL-LOBE EPILEPSY; IDIOPATHIC GENERALIZED EPILEPSY; MEMORY CONSOLIDATION; 1ST YEAR; AMNESIA; CHILDREN; RECOVERY; NEUROSCIENCE; ASSOCIATION; ADOLESCENTS	Accelerated long-term forgetting (ALF) is characterized by adequate recall after short, but not long delays. ALF is not detected by standardized neuropsychological memory tests. Currently, the prevailing conceptualization of ALF is of a temporal lobe seizure-related phenomenon. Nevertheless, Mayes and colleagues (2003) proposed that ALF may occur when any of the components of the brain network involved in long-term memory formation, or their interaction, is disrupted. This disruption does not have to be caused by temporal lobe seizures for ALF to occur. Here, we investigate this possibility in a group of school-age children who have sustained traumatic brain injury (TBI) (n = 28), as TBI typically disrupts the brain network that is important for long-term memory formation and recall. Healthy control children (n = 62) also participated. Contrary to the dominant conceptualization of ALF being a seizure-related phenomenon, children with TBI showed ALF. Sustaining a severe TBI and diffuse subcortical damage was related to ALF. Individually, 8 of the 13 children with severe TBI presented with ALF. ALF would remain undetected on standardized testing in six of these eight children. One child had the opposite pattern of dissociation, an impaired score on standardized testing, but an average long-term memory score. This is the first study, to our knowledge, to show ALF in patients with TBI, which has remained undiagnosed and untreated in this patient population. Our study also challenges the dominant hypothesis of ALF being a temporal lobe seizure-related phenomenon, and raises a possibility that short-term and long-term memory systems may be independent.	[Lah, Suncica; Black, Carly; Gascoigne, Michael B.; Gott, Chloe] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Lah, Suncica; Gascoigne, Michael B.] Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Epps, Adrienne; Parry, Louise] Sydney Childrens Hosp, Brain Injury Rehabil Program, Rehab2Kids, Randwick, NSW, Australia		Lah, S (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	suncica.lah@sydney.edu.au		Gascoigne, Michael/0000-0002-2786-7355; Lah, Suncica/0000-0003-2282-4812	Memory Node of the ARC Centre of Excellence in Cognition and its Disorders; University of Sydney Thompson Fellowship	This work was in part supported by the Memory Node of the ARC Centre of Excellence in Cognition and its Disorders and by The University of Sydney Thompson Fellowship awarded to S.L. We thank the staff from the brain injury programs at Sydney Children's Hospital (Randwick) who assisted with recruitment. We also express our gratitude to the families who participated in this study.	AHERN GL, 1994, NEUROLOGY, V44, P1270, DOI 10.1212/WNL.44.7.1270; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Blake RV, 2000, BRAIN, V123, P472, DOI 10.1093/brain/123.3.472; Butler CR, 2008, BRAIN, V131, P2243, DOI 10.1093/brain/awn127; Butler CR, 2007, ANN NEUROL, V61, P587, DOI 10.1002/ana.21111; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Davidson M, 2007, EPILEPSY BEHAV, V11, P394, DOI 10.1016/j.yebeh.2007.05.004; Delis DC., 1994, CALIFORNIA VERBAL LE; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Elliott G, 2014, CORTEX, V54, P16, DOI 10.1016/j.cortex.2014.02.001; Fitzgerald Z, 2013, EPILEPSIA, V54, P819, DOI 10.1111/epi.12090; Gascoigne MB, 2014, NEUROPSYCHOLOGIA, V59, P93, DOI 10.1016/j.neuropsychologia.2014.04.012; Gascoigne MB, 2012, EPILEPSIA, V53, P2135, DOI 10.1111/j.1528-1167.2012.03719.x; Geurts S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00752; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Ho J, 2011, NEUROPSYCHOL REHABIL, V21, P183, DOI 10.1080/09602011.2010.547345; Hotting K, 2010, J INT NEUROPSYCH SOC, V16, P574, DOI 10.1017/S1355617710000275; Jokeit H, 2001, NEUROLOGY, V57, P125, DOI 10.1212/WNL.57.1.125; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kapur N, 1997, BRAIN COGNITION, V35, P58, DOI 10.1006/brcg.1997.0927; Kemp S, 2012, EPILEPSY BEHAV, V24, P382, DOI 10.1016/j.yebeh.2012.04.119; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Lah S, 2014, J CLIN EXP NEUROPSYC, V36, P158, DOI 10.1080/13803395.2013.874405; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; Macmillan NA., 1991, DETECTION THEORY USE; Mameniskiene R, 2006, EPILEPSY BEHAV, V8, P278, DOI 10.1016/j.yebeh.2005.11.003; Manes F, 2005, J NEUROL NEUROSUR PS, V76, P1387, DOI 10.1136/jnnp.2004.036582; Martin R.C., 1991, NEUROPSYCHOLOGY, V5, P3, DOI [10.1037/0894-4105.5.1.3, DOI 10.1037/0894-4105.5.1.3]; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Mayes AR, 2003, CORTEX, V39, P567, DOI 10.1016/S0010-9452(08)70855-4; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGibbon T, 2013, NEUROPSYCHOLOGIA, V51, P114, DOI 10.1016/j.neuropsychologia.2012.11.004; Midorikawa A, 2007, NEUROCASE, V13, P385, DOI 10.1080/13554790701851536; Miller LA, 2015, EPILEPSY BEHAV, V45, P205, DOI 10.1016/j.yebeh.2015.01.024; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Mosbah A, 2014, EPILEPSIA, V55, P699, DOI 10.1111/epi.12565; Muhlert N, 2011, NEUROPSYCHOLOGIA, V49, P2417, DOI 10.1016/j.neuropsychologia.2011.04.018; Muhlert N, 2010, NEUROPSYCHOLOGIA, V48, P3235, DOI 10.1016/j.neuropsychologia.2010.07.001; Narayanan J, 2012, EPILEPSY BEHAV, V25, P622, DOI 10.1016/j.yebeh.2012.06.038; OConnor M, 1997, BRAIN COGNITION, V35, P71, DOI 10.1006/brcg.1997.0928; Phillips NL, 2017, CHILD NEUROPSYCHOL, V23, P26, DOI 10.1080/09297049.2015.1085500; Ricci M, 2015, EPILEPSY BEHAV, V51, P104, DOI 10.1016/j.yebeh.2015.06.016; Sheslow DA, 2003, WIDE RANGE ASSESSMEN; Smith ML, 2006, CHILD NEUROPSYCHOL, V12, P151, DOI 10.1080/09297040591001076; Smith ML, 2011, NEUROPSYCHOLOGY, V25, P634, DOI 10.1037/a0023770; Squire L. R., 1984, MEMORY CONSOLIDATION, P185; Tramoni E, 2011, BRAIN, V134, P816, DOI 10.1093/brain/awr002; UNGERLEIDER LG, 1995, SCIENCE, V270, P769, DOI 10.1126/science.270.5237.769; Ward H, 2004, BRAIN INJURY, V18, P471, DOI 10.1080/02699050310001646107; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 2005, WECHSLER INTELLIGENC; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weingartner H., 1984, MEMORY CONSOLIDATION; Wilkinson H, 2012, CORTEX, V48, P317, DOI 10.1016/j.cortex.2011.01.002; Winocur G, 2010, NEUROPSYCHOLOGIA, V48, P2339, DOI 10.1016/j.neuropsychologia.2010.04.016; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2003, HDB REY OSTERRIETH C, P83; Zeman AZJ, 1998, J NEUROL NEUROSUR PS, V64, P435, DOI 10.1136/jnnp.64.4.435	62	8	8	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34	17					2536	2544		10.1089/neu.2016.4872			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FE6HI	WOS:000408310200006	28482744				2022-02-06	
J	Meyers, T				Meyers, Tina			Prevention of Heel Pressure Injuries and Plantar Flexion Contractures With Use of a Heel Protector in High-Risk Neurotrauma, Medical, and Surgical Intensive Care Units A Randomized Controlled Trial	JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING			English	Article						Critical care; Foot drop; Heel protector; Hospital-acquired pressure ulcer; Hospital-acquired pressure injury; Plantar flexion contracture; Prevention	ULCERS; FACILITY	PURPOSE: The purpose of this study was to compare the use of a heel protector to standard of care (pillows) in the prevention of hospital-acquired pressure injuries (HAPI) of the heels and prevention of plantar fl exion contractures. DESIGN: Randomized controlled trial. SUBJECTS AND SETTING: The study took place on a surgical intensive care unit, medical intensive care unit, and neurotrauma intensive care unit. Inclusion criteria were a minimum of 5 days of sedation related to care for a critical illness, immobility for 6 to 8 hours before study initiation, a Braden Scale for Pressure Sore Risk score 18 or less, and a mobility subscale score 2 or less. Patients were included if they had preexisting heel pressure injury or plantar fl exion contracture. The sample comprised 54 subjects; 37 were randomly allocated to the intervention group and 17 to the control group. Their average age-mean (standard deviation)-was 40.7 (14.96) years in the control group and 44.6 (17.15) years in the intervention group. METHODS: Data were collected from patients' electronic medical records. We recorded subject demographics, presence of diabetes mellitus or peripheral vascular disease, Glasgow Coma Scale scores (every shift), Braden Scale for Pressure Sore Risk scores (every shift), heel skin assessments (every shift), goniometric measurements (every other day), and adverse events (every shift). Assessments and measurements were continued until the patient was discharged from the study. RESULTS: None of the patients in the intervention group developed HAPI of the heels, as compared to 7 in the control group (0% vs 41%, P <.001). Patients in the intervention group had a signifi cantly greater decrease in goniometric scores (mean decrease = 1.4 +/- 2.25) compared to the control group by day 3 (mean decrease = 0.1 +/- 0.52 P =.004) and the last study day (mean decrease = 2.0 +/- 3.02 for the intervention group vs 0.07 +/- 0.96 for the control group; P <.001). CONCLUSIONS: Study fi ndings indicate that a heel protector that ensures off-loading and maintains the foot in a neutral position is more effective for prevention of HAPI of the heel and contractures as compared to standard care using pillows to position the heel and redistribute pressure.	[Meyers, Tina] Harris Hlth Syst, 3 Landscape Court, Conroe, TX 77301 USA		Meyers, T (corresponding author), Harris Hlth Syst, 3 Landscape Court, Conroe, TX 77301 USA.	meyers588@gmail.com			Sage Products LLC	Sage Products LLC provided a $600.00 grant to cover incidental costs associated with the study. No member of the research team or their family members had a relevant financial relationship with Sage Products. All aspects of the study, including planning, implementation, and data analysis, were controlled exclusively by the research associates. Sage Products provided support for manuscript development, but the authors maintained total editorial control. The author would like to acknowledge the expertise of Dr JoAnn Mick for her role of assisting with the design of the study. The author would like to thank Dr Rose Byrne and Kersten Hammond for medical writing and editing services, and Michelle Secic for biostatistical analysis.	Amlung S R, 2001, Adv Skin Wound Care, V14, P297, DOI 10.1097/00129334-200111000-00012; [Anonymous], 2001, Adv Skin Wound Care, V14, P208; [Anonymous], 2005, PHYS MED REHABILITAT; Baath C, 2016, APPL NURS RES, V30, P170, DOI 10.1016/j.apnr.2015.10.003; Berlowitz D., 2014, PRESSURE ULCERS AGIN; Cadue JF, 2008, PRESSE MED, V37, P30, DOI 10.1016/j.lpm.2007.07.009; Centers for Medicare & Medicaid Services, 2008, CMS MAN SYST GUID SU; Centers for Medicare & Medicaid Services, 2006, EL SER PREV COSTL ME; Chauhan VS., 2005, J WOUND CARE, V14, P36, DOI [10.12968/jowc.2005.14.1.26724, DOI 10.12968/JOWC.2005.14.1.26724]; Clavet H, 2008, CAN MED ASSOC J, V178, P691, DOI 10.1503/cmaj.071056; Clegg Rosie, 2014, Br J Nurs, V23 Suppl 20, pS4, DOI 10.12968/bjon.2014.23.Sup20.S4; Connolly B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008632.pub2; Cooper KL, 2013, CRIT CARE NURSE, V33, P57, DOI 10.4037/ccn2013985; Fowler E, 2008, OSTOMY WOUND MANAG, V54, P42; Gleeson Deborah, 2015, Br J Nurs, V24, pS26, DOI 10.12968/bjon.2015.24.Sup6.S26; Haesler E., 2014, PREV TREATM PRESS UL; Hanna-Bull D, 2016, J WOUND OSTOMY CONT, V43, P129, DOI 10.1097/WON.0000000000000181; Houghton PE, 2004, OSTOMY WOUND MANAG, V50, P36; Houghton PE, 2004, OSTOMY WOUND MANAG, V50, P26; Ichioka S, 2005, J Wound Care, V14, P301; Kallman U, 2014, ADV SKIN WOUND CARE, V27, P70, DOI 10.1097/01.ASW.0000439059.72199.41; Meyers TR, 2010, J WOUND OSTOMY CONT, V37, P372, DOI 10.1097/WON.0b013e3181e3990b; Reddy M, 2006, JAMA-J AM MED ASSOC, V296, P974, DOI 10.1001/jama.296.8.974; Santamaria N, 2015, INT WOUND J, V12, P302, DOI 10.1111/iwj.12101; TEASDALE G, 1974, LANCET, V2, P81; Vanderwee K, 2007, J CLIN NURS, V16, P325, DOI 10.1111/j.1365-2702.2005.01429.x; Walsh JS, 2007, J WOUND OSTOMY CONT, V34, P178, DOI 10.1097/01.WON.0000264832.33979.4e; Whittington Kathy T, 2004, Adv Skin Wound Care, V17, P490, DOI 10.1097/00129334-200411000-00016; Woodbury M Gail, 2004, Ostomy Wound Manage, V50, P22; Woodbury MG, 2004, OSTOMY WOUND MANAG, V50, P34; Woodbury MG, 2004, OSTOMY WOUND MANAG, V50, P30; Woodbury MG, 2004, OSTOMY WOUND MANAG, V50, P32; Woodbury MG, 2004, OSTOMY WOUND MANAG, V50, P22	33	8	8	3	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1071-5754	1528-3976		J WOUND OSTOMY CONT	J. Wound Ostomy Cont. Nurs.	SEP-OCT	2017	44	5					429	433		10.1097/WON.0000000000000355			5	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	FG2OA	WOS:000409948400006	28877108				2022-02-06	
J	Nichols, JN; Hagan, KL; Floyd, CL				Nichols, Jessica N.; Hagan, Kenton L.; Floyd, Candace L.			Evaluation of Touchscreen Chambers To Assess Cognition in Adult Mice: Effect of Training and Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; behavioral assessments; cognitive function; learning and memory; traumatic brain injury	COLLEGIATE FOOTBALL PLAYERS; SPATIAL-PATTERN SEPARATION; LEARNING PAL TASK; NEUROCOGNITIVE PERFORMANCE; OPERANT PLATFORM; GENE-EXPRESSION; TESTING METHOD; DENTATE GYRUS; RODENT MODEL; MOUSE MODEL	Cognitive impairments are often experienced after a mild traumatic brain injury (mTBI). In the clinical arena, neuropsychological assessments are used frequently to detect cognitive deficits. Animal models of mTBI, however, rely on an assortment of behavioral tasks to assess cognitive outcome. Computer-based touchscreen systems have been developed for rodents and are hypothesized to offer a translational approach to evaluate cognitive function because of the similarities of tasks performed in rodents to those implemented in humans. While these touchscreen systems have been used in preclinical models of neurodegenerative diseases and psychiatric disorders, their use in assessing cognitive impairment after mTBI has not been investigated. We hypothesized that mTBI would result in impaired cognitive performance on touchscreen tasks, particularly those with hippocampal-based learning components, including the paired associate learning (PAL) task and the location discrimination (LD) task. Adult male, C57BL/6 mice received a single impact-acceleration mTBI. We found that training mice before injury to perform to criteria is arduous and that performance is sensitive to many environmental variables. Despite extensive optimization and training, mice failed to perform better than chance in the PAL paradigm. Alternatively, mice demonstrated some capacity to learn in the LD paradigm, but only with the easier stages of the task. The mTBI did not affect performance in the LD paradigm, however. Thus, we concluded that under the conditions presented here, the PAL and LD touchscreen tasks are not robust outcome measures for the evaluation of cognitive performance in C57BL/6 mice after a single impact-acceleration mTBI.	[Nichols, Jessica N.; Floyd, Candace L.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Hagan, Kenton L.] Univ Penn, Dept Phys Med & Rehabil, Philadelphia, PA 19104 USA		Floyd, CL (corresponding author), 529C Spain Rehabil Ctr, 1717 6th Ave South, Birmingham, AL 35233 USA.	candacefloyd@uabmc.edu	Hagan, Kenton/X-6278-2019		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS075162]; NINDS Research Fellowship [1F31NS093717]; NFL Charities Medical Research Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS075162] Funding Source: NIH RePORTER	This research was supported by the National Institutes of Health, NINDS R01NS075162 (to CLF), NINDS Research Fellowship 1F31NS093717 (to JNN), and NFL Charities Medical Research Grant. We thank the UAB Neuroscience Behavioral Assessment Core (P30 NS47466) for the use of the touchscreen operant chambers and Alok Deshane for assistance with experiments.	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bartko SJ, 2011, PSYCHOPHARMACOLOGY, V214, P537, DOI 10.1007/s00213-010-2050-1; Bauer RM, 2012, CLIN NEUROPSYCHOL, V26, P177, DOI 10.1080/13854046.2012.663001; Berron D, 2016, J NEUROSCI, V36, P7569, DOI 10.1523/JNEUROSCI.0518-16.2016; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; Bussey TJ, 2008, LEARN MEMORY, V15, P516, DOI 10.1101/lm.987808; Campden Instruments, 2011, INSTR MAN CS616 CS62, P1; Cho YE, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00168; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Cohen SJ, 2015, BEHAV BRAIN RES, V285, P105, DOI 10.1016/j.bbr.2014.08.002; Connery AK, 2016, PHYS MED REH CLIN N, V27, P475, DOI 10.1016/j.pmr.2015.12.001; Covassin T, 2010, OPEN ACCESS J SPORTS, V1, P55; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; Delotterie D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100817; Denayer T, 2014, NEW HORIZ TRANSL MED, V2, P5, DOI 10.1016/j.nhtm.2014.08.001; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Godlove JM, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046025; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; Graybeal C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087745; Guegan T, 2013, EUR NEUROPSYCHOPHARM, V23, P146, DOI 10.1016/j.euroneuro.2012.04.004; Haluk DM, 2010, BEHAV BRAIN RES, V207, P394, DOI 10.1016/j.bbr.2009.10.025; Heath CJ, 2015, PSYCHOPHARMACOLOGY, V232, P4043, DOI 10.1007/s00213-015-4009-8; Heiderstadt KM, 2000, LAB ANIM, V34, P20, DOI 10.1258/002367700780578028; Honaker JA, 2014, OTOL NEUROTOL, V35, P1111, DOI 10.1097/MAO.0000000000000432; Honce JM, 2016, PHYS MED REH CLIN N, V27, P411, DOI 10.1016/j.pmr.2016.01.002; Horner AE, 2013, NAT PROTOC, V8, P1961, DOI 10.1038/nprot.2013.122; Kim CH, 2015, PSYCHOPHARMACOLOGY, V232, P3899, DOI 10.1007/s00213-015-3949-3; Koerte IK, 2016, TRANSLATIONAL RES TR; Lederle L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015536; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Loncarevic-Vasiljkovic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037215; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Mallien AS, 2016, HORM BEHAV, V81, P97, DOI 10.1016/j.yhbeh.2016.03.009; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McTighe SM, 2009, NEUROREPORT, V20, P881, DOI 10.1097/WNR.0b013e32832c5eb2; Moore DW, 2010, NEUROPSYCHOL REHABIL, V20, P340, DOI 10.1080/09602010903250928; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Olfe Jakob, 2010, BMC Physiology, V10, P2, DOI 10.1186/1472-6793-10-2; Oomen CA, 2013, NAT PROTOC, V8, P2006, DOI 10.1038/nprot.2013.124; Pani G, 2015, SEMIN CELL DEV BIOL, V40, P106, DOI 10.1016/j.semcdb.2015.03.004; Pankevich DE, 2010, J NEUROSCI, V30, P16399, DOI 10.1523/JNEUROSCI.1955-10.2010; Papa L., 2015, BRAIN NEUROTRAUMA MO; Perez-Polo JR, 2016, J NEUROSCI RES, V94, P27, DOI 10.1002/jnr.23617; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Rich NJ, 2010, J NEUROSCI RES, V88, P2933, DOI 10.1002/jnr.22443; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; Roedel A, 2006, LAB ANIM-UK, V40, P371, DOI 10.1258/002367706778476343; Romberg C, 2013, NEUROBIOL AGING, V34, P731, DOI 10.1016/j.neurobiolaging.2012.08.006; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Swan AA, 2014, HIPPOCAMPUS, V24, P1581, DOI 10.1002/hipo.22337; Talpos JC, 2009, PSYCHOPHARMACOLOGY, V205, P157, DOI 10.1007/s00213-009-1526-3; Teske JA, 2014, AM J PHYSIOL-REG I, V306, pR714, DOI 10.1152/ajpregu.00479.2013; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Vincis R, 2016, ELIFE, V5, DOI 10.7554/eLife.16420; Vonder Haar C, 2014, J NEUROTRAUM, V31, P1711, DOI 10.1089/neu.2014.3459; Vonder Haar C, 2014, BRAIN INJURY, V28, P235, DOI 10.3109/02699052.2013.860473; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	71	8	8	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34	17					2481	2494		10.1089/neu.2017.4998			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FE6HI	WOS:000408310200001	28558476	Green Published			2022-02-06	
J	Oku, H; Morishita, S; Horie, T; Kida, T; Mimura, M; Kojima, S; Ikeda, T				Oku, Hidehiro; Morishita, Seita; Horie, Taeko; Kida, Teruyo; Mimura, Masashi; Kojima, Shota; Ikeda, Tsunehiko			P7C3 Suppresses Neuroinflammation and Protects Retinal Ganglion Cells of Rats from Optic Nerve Crush	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						P7C3; rapamycin; mTOR; optic nerve crush; NAD	TRAUMATIC BRAIN-INJURY; REACTIVE ASTROCYTES; MULTIPLE-SCLEROSIS; ADULT-RATS; MTOR; METABOLISM; EXPRESSION; NEURONS; DEATH; MACROPHAGE/MICROGLIA	PURPOSE. To determine whether P7C3-A20 can inhibit the phosphorylation of the mammalian target of rapamycin (mTOR), depress neuroinflammation, and protect retinal ganglion cells (RGCs) of rats from optic nerve crush (ONC). METHODS. The left optic nerve was crushed, and 5.0 mg/kg/d of P7C3-A20, 1.0 mg/kg/d of rapamycin, or their vehicle was injected intraperitoneally for 3 consecutive days beginning 1 day before the ONC. The protective effects on the RGCs were determined by immunohistochemical staining for Tuj-1. The level of phosphorylated mTOR was determined by immunoblotting. The neuroinflammation in the optic nerve was determined by changes in the expression of CD68, TNF-alpha, MCP-1, and iNOS. RESULTS. The density of Tuj-1-stained cells in the control was 2010 +/- 81.5/mm(2) and 1842 6 80.4/mm 2 on days 7 and 14 after the sham operation. These levels were lower at 995 +/- 122/mm(2) and 450 +/- 52.4 mm(2) on days 7 and 14 after the ONC, respectively. Rapamycin and P7C3-A20 preserved the density at significantly higher levels on both days (P < 0.05, Scheffe test). The level of phosphorylated mTOR increased by 1.56-fold above the control level on day 7. Rapamycin and P7C3 significantly lowered the level of phosphorylated mTOR to 0.89-fold and 0.67-fold of the control, respectively. There was an accumulation of CD68_ cells that were immunoreactive to TNF-a at the crush site. The expression of MCP-1 and iNOS was increased chiefly in the astrocytes around the lesion. These inflammatory events were suppressed by both rapamycin and P7C3. CONCLUSIONS. P7C3-A20 can inhibit mTOR phosphorylation in the crushed optic nerve, which may suppress neuroinflammation and preserve the RGCs.	[Oku, Hidehiro; Morishita, Seita; Horie, Taeko; Kida, Teruyo; Mimura, Masashi; Kojima, Shota; Ikeda, Tsunehiko] Osaka Med Coll, Dept Ophthalmol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan		Oku, H (corresponding author), Osaka Med Coll, Dept Ophthalmol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	hidehirooku@aol.com	Oku, Hidehiro/AAD-5029-2019	Oku, Hidehiro/0000-0003-4359-4219	KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [16K11336]	Supported by Grant-in-Aid for Scientific Research (KAKENHI) (Grant No. 16K11336).	Babcock AA, 2003, J NEUROSCI, V23, P7922; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Codeluppi S, 2009, J NEUROSCI, V29, P1093, DOI 10.1523/JNEUROSCI.4103-08.2009; Dello Russo C, 2013, GLIA, V61, P301, DOI 10.1002/glia.22433; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Giaume C, 2007, CELL DEATH DIFFER, V14, P1324, DOI 10.1038/sj.cdd.4402144; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Hu Y, 2012, NEURON, V73, P445, DOI 10.1016/j.neuron.2011.11.026; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jiang SM, 2015, INT J OPHTHALMOL-CHI, V8, P643, DOI 10.3980/j.issn.2222-3959.2015.04.01; Kitaoka Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.391; Kurimoto T, 2006, NEUROREPORT, V17, P1525, DOI 10.1097/01.wnr.0000234749.80936.54; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Lisi L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-1; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Morgan-Warren PJ, 2016, INVEST OPHTH VIS SCI, V57, P429, DOI 10.1167/iovs.15-17511; Morishita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084387; Nakazawa T, 2005, MOL VIS, V11; Oku H, 2017, JPN J OPHTHALMOL, V61, P195, DOI 10.1007/s10384-016-0493-6; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; ROSENMAN SJ, 1995, J IMMUNOL, V154, P1888; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Sharma RK, 2007, BRAIN RES, V1176, P11, DOI 10.1016/j.brainres.2007.07.090; Shimazawa M, 2007, MOL VIS, V13, P578; SNOW RL, 1995, EXP NEUROL, V134, P13, DOI 10.1006/exnr.1995.1032; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Stewart VC, 2000, J NEUROCHEM, V75, P694, DOI 10.1046/j.1471-4159.2000.0750694.x; Su WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099719; Tamsett TJ, 2009, J NEUROSCI, V29, P5127, DOI 10.1523/JNEUROSCI.0859-09.2009; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Tonari M, 2012, INVEST OPHTH VIS SCI, V53, P3490, DOI 10.1167/iovs.11-9415; Van der Voorn P, 1999, AM J PATHOL, V154, P45, DOI 10.1016/S0002-9440(10)65249-2; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; WINKLER BS, 1972, VISION RES, V12, P1183, DOI 10.1016/0042-6989(72)90106-X; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie LK, 2014, J IMMUNOL, V192, P6009, DOI 10.4049/jimmunol.1303492	44	8	8	0	0	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	SEP	2017	58	11					4877	4888		10.1167/iovs.17-22179			12	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	FL5II	WOS:000414267700025	28973334	gold			2022-02-06	
J	Pinto, SM; Twichell, MF; Henry, LC				Pinto, Shanti M.; Twichell, Maria F.; Henry, Luke C.			Predictors of Pharmacological Intervention in Adolescents With Protracted Symptoms After Sports-Related Concussion	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; POSTTRAUMATIC HEADACHE; BASE-LINE; NEUROCOGNITIVE PERFORMANCE; PROLONGED RECOVERY; CONTROLLED-TRIAL; MILD CONCUSSION; METHYLPHENIDATE; AMANTADINE	Background: Although recovery after concussion is spontaneous and typically occurs within 2-3 weeks, a subset of adolescents develop persistent symptoms after a sports-related concussion. Medications are frequently prescribed as part of a comprehensive treatment approach to alleviate these symptoms; however, there are no guidelines for prescription of pharmacologic therapy after concussion. Objective: To investigate common factors that are associated with the use of medications (antiepileptic, antidepressant, neurostimulant, or sleeping medication) during recovery from a sports-related concussion. Design: Retrospective observational study. Setting: Single-center specialty concussion center. Participants: A total of 100 adolescents, between the ages of 12 and 18 years, who sustained concussion due to sports. Assessment of Risk Factors: Independent variables collected included age at the time of concussion, gender, sports played, personal history of prior concussion or mental health disorder, and personal or family history of headache (eg, migraines) or seizure disorder. Main Outcome Measure: Prescription of medications for treatment of concussion. Results: Twenty-four patients (24%) were prescribed medications in this study, all of whom reported headache at the time of medication prescription. Amantadine was the most commonly prescribed medication, with amitriptyline and melatonin also being prescribed. Among the demographic information collected, only age and gender met criteria for inclusion in the regression model. Logistic regression analysis demonstrated that the odds that female participants were prescribed medications was 3.790 (95% confidence interval = 1.262-11.380) higher than male participants. A higher symptom score on the initial Post Concussion Symptom Scale (PCSS) was associated with increased odds of being prescribed medications (odds ratio = 1.031, 95% CI = 1.0091.052). Conclusions: The current study found that initial symptom severity and female gender were associated with use of medication in recovery from sports-related concussion among variables available for study.	[Pinto, Shanti M.; Twichell, Maria F.] Univ Pittsburgh, Med Ctr, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Twichell, Maria F.] UPMC Mercy Hosp, UPMC Rehabil Inst, 1400 Locust St, Pittsburgh, PA 15219 USA; [Henry, Luke C.] Univ Pittsburgh, Med Ctr, Sports Concuss Program, Pittsburgh, PA USA		Twichell, MF (corresponding author), Univ Pittsburgh, Med Ctr, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA.; Twichell, MF (corresponding author), UPMC Mercy Hosp, UPMC Rehabil Inst, 1400 Locust St, Pittsburgh, PA 15219 USA.	twichellmf@upmc.edu					Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Beers SR, 2005, J HEAD TRAUMA REHAB, V20, P450, DOI 10.1097/00001199-200509000-00006; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Benromano T, 2015, EUR J PAIN, V19, P621, DOI 10.1002/ejp.583; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bruce JM, 2004, NEUROLOGY, V63, P1516; Buscemi N, 2005, J GEN INTERN MED, V20, P1151, DOI 10.1111/j.1525-1497.2005.0243.x; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Flanagan SR, 2007, J HEAD TRAUMA REHAB, V22, P67, DOI 10.1097/00001199-200701000-00009; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Leone H, 2005, J CLIN PHARM THER, V30, P101, DOI 10.1111/j.1365-2710.2005.00628.x; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; Maldonado MD, 2007, J PINEAL RES, V42, P1, DOI 10.1111/j.1600-079X.2006.00376.x; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Packard RC, 2000, HEADACHE, V40, P736, DOI 10.1046/j.1526-4610.2000.00128.x; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Rapoport MJ, 2008, J PSYCHOPHARMACOL, V22, P860, DOI 10.1177/0269881107083845; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Ruff RL, 2016, F1000RESEARCH, V5, P1533; Samantaray S, 2009, J PINEAL RES, V47, P134, DOI 10.1111/j.1600-079X.2009.00703.x; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002	64	8	8	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	SEP	2017	9	9					847	855		10.1016/j.pmrj.2016.12.009			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FL7PN	WOS:000414440500002	28093374				2022-02-06	
J	Tsaousides, T; Spielman, L; Kajankova, M; Guetta, G; Gordon, W; Dams-O'Connor, K				Tsaousides, Theodore; Spielman, Lisa; Kajankova, Maria; Guetta, Gabrielle; Gordon, Wayne; Dams-O'Connor, Kristen			Improving Emotion Regulation Following Web-Based Group Intervention for Individuals With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						emotion regulation; group treatment; telerehabilitation; traumatic brain injury; videoconferencing	COGNITIVE-BEHAVIORAL THERAPY; SCHEDULED TELEPHONE INTERVENTION; QUALITY-OF-LIFE; EXECUTIVE DYSFUNCTION; MALADAPTIVE BEHAVIOR; REHABILITATION; MANAGEMENT; TELEREHABILITATION; PSYCHOTHERAPY; SATISFACTION	Objective: Preliminary evaluation of the efficacy of a Web-based group intervention (Online EmReg) to improve emotion regulation (ER) in individuals with traumatic brain injury (TBI). Design: Pre-/post-within-subject design with baseline, end-of-treatment, and 12-week follow-up assessments. Participants: Ninety-one individuals with TBI and deficits in ER. Intervention: Twenty-four sessions of training in ER skills delivered by group videoconference. Measures: Difficulties in Emotion Regulation Scale (DERS), Positive Affect Negative Affect Schedule (PANAS), Satisfaction With Life Scale (SWLS), Problem Solving Inventory (PSI), Social Problem Solving Inventory-Revised: Short Form (SPSI-R: S), and Dysexecutive Questionnaire (DEX). Results: Significant changes with large effect sizes were found for the DERS at the 12-week follow-up assessment. Significant and moderate changes were found on the SWLS, DEX, PSI, and subscales of the PANAS and SPSI-R:S. Conclusions: Online EmReg appears to be a promising method of delivering a group intervention to improve ER following TBI.	[Tsaousides, Theodore; Spielman, Lisa; Kajankova, Maria; Guetta, Gabrielle; Gordon, Wayne; Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, One Gustave L Levy Pl,Box 1240, New York, NY 10029 USA		Tsaousides, T (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, One Gustave L Levy Pl,Box 1240, New York, NY 10029 USA.	theodore.tsaousides@mssm.edu			National Institute on Disability, Independent Living and Rehabilitation ResearchUnited States Department of Health & Human Services [H133A120084]	This research was funded by National Institute on Disability, Independent Living and Rehabilitation Research (grant H133A120084) and carried out at the Brain Injury Research Center, Department of Rehabilitation Medicine, Icahn School of Medicine at Mount Sinai.	Aeschleman S. R., 1999, J RATION-EMOT COGN-B, V17, P51, DOI DOI 10.1023/A:1023073130972; Arundine A, 2012, J HEAD TRAUMA REHAB, V27, P104, DOI 10.1097/HTR.0b013e3182125591; Ashman T, 2014, J HEAD TRAUMA REHAB, V29, P467, DOI 10.1097/HTR.0000000000000098; Backhaus A, 2012, PSYCHOL SERV, V9, P111, DOI 10.1037/a0027924; Beer J. S., 2007, HDB EMOTION REGULATI; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bergquist T, 2008, BRAIN INJURY, V22, P891, DOI 10.1080/02699050802405487; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Brennan David M, 2011, Telemed J E Health, V17, P662, DOI 10.1089/tmj.2011.0036; Brown RA, 1998, PSYCHOL ADDICT BEHAV, V12, P101, DOI 10.1037/0893-164X.12.2.101; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; Chen J, 2015, J STROKE CEREBROVASC, V24, P2660, DOI 10.1016/j.jstrokecerebrovasdis.2015.09.014; Coetzer R, 2007, J HEAD TRAUMA REHAB, V22, P39, DOI 10.1097/00001199-200701000-00005; Conrad N, 2010, CLIN REHABIL, V24, P431, DOI 10.1177/0269215509358930; Corrigan J., 2000, SATISFACTION LIFE SC; D'Zurilla T.J., 2002, SOCIAL PROBLEM SOLVI; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Ducharme JM, 2000, CLIN PSYCHOL REV, V20, P405, DOI 10.1016/S0272-7358(98)00102-0; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Forducey PG, 2003, NEUROREHABILITATION, V18, P103; GLASS GV, 1972, REV EDUC RES, V42, P237, DOI 10.2307/1169991; Gordon W.A., 1999, BRAIN INJURY SCREENI; Gordon WA, 2006, J HEAD TRAUMA REHAB, V21, P156, DOI 10.1097/00001199-200603000-00008; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Gross JJ., 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Guyatt GH, 2002, J CLIN EPIDEMIOL, V55, P900, DOI 10.1016/S0895-4356(02)00435-3; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Harrison A, 2010, PSYCHOL MED, V40, P1887, DOI 10.1017/S0033291710000036; Hart T, 2015, CONTEMP CLIN TRIALS, V40, P180, DOI 10.1016/j.cct.2014.12.005; HARWELL MR, 1992, J EDUC STAT, V17, P315, DOI 10.3102/10769986017004315; Hegel MT, 2000, BEHAV MODIF, V24, P94, DOI 10.1177/0145445500241005; HEPPNER PP, 1982, J COUNS PSYCHOL, V29, P66, DOI 10.1037/0022-0167.29.1.66; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; IBM Corp, 2013, IBM SPSS STAT WIND; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; King VL, 2009, J SUBST ABUSE TREAT, V36, P331, DOI 10.1016/j.jsat.2008.06.011; Lane-Brown A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006341.pub2; Laver KE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010255.pub2; Lix LM, 1996, REV EDUC RES, V66, P579, DOI 10.3102/00346543066004579; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; Man DWK, 2004, BRAIN INJURY, V18, P577, DOI 10.1080/02699050310001646143; Morland LA, 2010, J CLIN PSYCHIAT, V71, P855, DOI 10.4088/JCP.09m05604blu; Mukherjee D, 2003, WOMEN THER, V26, P3, DOI 10.1300/J015v26n01_01; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P286, DOI 10.1097/HTR.0000000000000277; Ng EMW, 2013, BRAIN INJURY, V27, P548, DOI 10.3109/02699052.2013.766927; Oei TPS, 1999, AUST NZ J PSYCHIAT, V33, P748, DOI 10.1080/j.1440-1614.1999.00628.x; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Radley DC, 2012, NEW ENGL J MED, V367, P3, DOI 10.1056/NEJMp1204516; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Schlund MW, 1999, BRAIN INJURY, V13, P889; Schoenberg MR, 2008, PROF PSYCHOL-RES PR, V39, P169, DOI 10.1037/0735-7028.39.2.169; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; Staples AM, 2012, J ANXIETY DISORD, V26, P385, DOI 10.1016/j.janxdis.2012.01.005; Thompson R A, 1994, Monogr Soc Res Child Dev, V59, P25, DOI 10.2307/1166137; Topolovec-Vranic J, 2010, BRAIN INJURY, V24, P762, DOI 10.3109/02699051003709599; Tornas S, 2016, ARCH PHYS MED REHAB, V97, P1841, DOI 10.1016/j.apmr.2016.06.014; Tornas S, 2016, J INT NEUROPSYCH SOC, V22, P436, DOI 10.1017/S1355617715001344; Tsaousides T, 2017, NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK, P447; Tsaousides T, 2014, NEUROPSYCHOL REHABIL, V24, P784, DOI 10.1080/09602011.2014.907186; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2009, J PEDIATR PSYCHOL, V34, P517, DOI 10.1093/jpepsy/jsn081; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Werner K., 2010, EMOTION REGULATION P; Williams AD, 2012, BRIT J CLIN PSYCHOL, V51, P223, DOI 10.1111/j.2044-8260.2011.02022.x; Wilson B, 1996, BEHAV ASSESSMENT DYS, P75; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Zelazo P.D., 2007, HDB EMOTION REGULATI, P135	79	8	9	1	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2017	32	5					354	365		10.1097/HTR.0000000000000345			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FG2DW	WOS:000409893800015	28891909				2022-02-06	
J	Gomez, R; Skilbeck, C; Thomas, M; Slatyer, M				Gomez, Rapson; Skilbeck, Clive; Thomas, Matt; Slatyer, Mark			Growth Mixture Modeling of Depression Symptoms Following Traumatic Brain Injury	FRONTIERS IN PSYCHOLOGY			English	Article						latent class growth modeling; traumatic brain injury; depression; outcome	LATENT CLASS ANALYSIS; HOSPITAL ANXIETY; AXIS-I; PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; SCALE; TRAJECTORIES; MILD; MODERATE; PSYCHOPATHOLOGY	Growth Mixture Modeling (GMM) was used to investigate the longitudinal trajectory of groups (classes) of depression symptoms, and how these groups were predicted by the covariates of age, sex, severity, and length of hospitalization following Traumatic Brain Injury (TBI) in a group of 1074 individuals (696 males, and 378 females) from the Royal Hobart Hospital, who sustained a TBI. The study began in late December 2003 and recruitment continued until early 2007. Ages ranged from 14 to 90 years, with a mean of 35.96 years (SD = 16.61). The study also examined the associations between the groups and causes of TBI. Symptoms of depression were assessed using the Hospital Anxiety and Depression Scale within 3 weeks of injury, and at 1, 3, 6, 12, and 24 months post-injury. The results revealed three groups: low, high, and delayed depression. In the low group depression scores remained below the clinical cut-off at all assessment points during the 24-months post-TBI, and in the high group, depression scores were above the clinical cut-off at all assessment points. The delayed group showed an increase in depression symptoms to 12 months after injury, followed by a return to initial assessment level during the following 12 months. Covariates were found to be differentially associated with the three groups. For example, relative to the low group, the high depression group was associated with more severe TBI, being female, and a shorter period of hospitalization. The delayed group also had a shorter period of hospitalization, were younger, and sustained less severe TBI. Our findings show considerable fluctuation of depression over time, and that a non-clinical level of depression at any one point in time does not necessarily mean that the person will continue to have non-clinical levels in the future. As we used GMM, we were able to show new findings and also bring clarity to contradictory past findings on depression and TBI. Consequently, we recommend the use of this approach in future studies in this area.	[Gomez, Rapson] Federat Univ, Sch Hlth Sci, Ballarat, Vic, Australia; [Skilbeck, Clive; Slatyer, Mark] Univ Tasmania, Sch Med, Psychol, Hobart, Tas, Australia; [Thomas, Matt] Charles Sturt Univ, Sch Psychol, Bathurst, NSW, Australia		Gomez, R (corresponding author), Federat Univ, Sch Hlth Sci, Ballarat, Vic, Australia.	rapson.gomez@federation.edu.au					Akaike H., 1973, P 2 INT S INF THEOR, V1973, P267, DOI 10.1007/978-1-4612-1694-0; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Bauer DJ, 2003, PSYCHOL METHODS, V8, P338, DOI 10.1037/1082-989X.8.3.338; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Chin WS, 2017, EUR ARCH PSY CLIN N, V267, P507, DOI 10.1007/s00406-016-0762-x; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Deb S, 1999, AM J PSYCHIAT, V156, P374; Demakis GJ, 2010, APPL NEUROPSYCHOL, V17, P183, DOI 10.1080/09084282.2010.499752; DeRoon-Cassini TA, 2010, REHABIL PSYCHOL, V55, P1, DOI 10.1037/a0018601; Fleminger S, 2003, NEUROPSYCHOL REHABIL, V13, P65, DOI 10.1080/09602010244000354; FORTUNE N, 1999, DEFINITION INCIDENCE; HABERMAN S, 1978, SOC SCI MED-MED SOC, V12, P147; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hillier SL, 1997, BRAIN INJURY, V11, P649; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jennett B, 1981, MANAGEMENT HEAD INJU; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kaplan D., 2004, SAGE HDB QUANTITATIV, P345, DOI DOI 10.4135/9781412986311.N19; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; MAROSSZEKY NEV, 1993, CLIN NEUROPSYCHOL, V7, P85, DOI 10.1080/13854049308401890; Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x; Muthen B, 2003, PSYCHOL METHODS, V8, P369, DOI 10.1037/1082-989X.8.3.369; Muthen B, 2006, INFANT CHILD DEV, V15, P623, DOI 10.1002/icd.482; Muthen L. K., 1998, MPLUS USERS GUIDE, V7th; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Nelson H.E., 1982, NATL ADULT READING T; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46; Peleg G, 2009, BRAIN INJURY, V23, P800, DOI 10.1080/02699050903196696; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ranby KW, 2012, J CLIN CHILD ADOLESC, V41, P261, DOI 10.1080/15374416.2012.654465; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rapoport M, 2010, PSYCHIAT ANN, V40, P581, DOI 10.3928/00485713-20101015-08; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Reinecke J, 2006, METODOLOSKI ZVEZKI, V3, P121; Rindskopf D, 2003, PSYCHOL METHODS, V8, P364, DOI 10.1037/1082-989X.8.3.364; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SCLOVE SL, 1987, PSYCHOMETRIKA, V52, P333, DOI 10.1007/BF02294360; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Skilbeck C, 2011, BRAIN IMPAIR, V12, P22, DOI 10.1375/brim.12.1.22; THOMSEN PH, 1991, ACTA PSYCHIAT SCAND, V84, P391, DOI 10.1111/j.1600-0447.1991.tb03165.x; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	62	8	9	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	AUG 22	2017	8								1320	10.3389/fpsyg.2017.01320			14	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	FE4RI	WOS:000408200600001	28878700	Green Published, gold			2022-02-06	
J	Dachtyl, SA; Morales, P				Dachtyl, Sarah A.; Morales, Pedro			A Collaborative Model for Return to Academics After Concussion: Athletic Training and Speech-Language Pathology	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN INJURY; SCHOOL; SPORT; MANAGEMENT; STUDENT	Purpose: In this article, we describe an academic concussion management protocol designed for grades Pre-K to 12, called Cognitive Return to Exertion (CoRTEx). Collaboration between the speech-language pathologist (SLP) and athletic trainer (AT) is highlighted. Method: A description of CoRTEx is provided, and the need for collaboration is emphasized. A case study illustrates an example of how CoRTEx can be implemented at the individual student level. Results: A total of 165 students went through CoRTEx from the pilot in April 2014 through December 2016. Referrals to CoRTEx were highest for football, blows to the head, and soccer. Anecdotal evidence suggests that CoRTEx provided necessary support for students and their families, although research is needed to provide objective data. Conclusions: CoRTEx and other similar protocols can be used as models for SLPs to create their own academic concussion management protocols. For cases in which the injured student is an athlete, the SLP-AT collaboration is critical to carefully coordinate return to academics and return to play so that students are successful in school, as well as ready to safely return to sport. Suggestions are made for designing research studies that can provide empirical evidence for the efficacy of such academic concussion management protocols.	[Dachtyl, Sarah A.; Morales, Pedro] Sahuarita Unified Sch Dist, Sahuarita, AZ 85629 USA; [Dachtyl, Sarah A.] No Arizona Univ, Flagstaff, AZ 86011 USA		Dachtyl, SA (corresponding author), Sahuarita Unified Sch Dist, Sahuarita, AZ 85629 USA.; Dachtyl, SA (corresponding author), No Arizona Univ, Flagstaff, AZ 86011 USA.	Sarah.Dachtyl@nau.edu					Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; American Speech-Language-Hearing Association, 2016, COD OF ETH; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Bradley-Klug K., 2015, SCH PSYCHOL FORUM, V9, P184; Brady D., 2011, NASP COMMUNIQUE, V39; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Canto A., 2015, SCH PSYCHOL FORUM RE, V9, P162; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Collins M., 2016, CONC 2016 C SCOTTSD; Davies S., 2011, NASP COMMUNIQUE, V39; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Doss R., 2013, DIFFERENCES RATE REC; Duff M., 2012, ASHA PERSPECTIVES, V13, P87; Duff MC., 2009, ASHA LEADER, V14, P10, DOI [10.1044/leader.FTR1.14092009.10, DOI 10.1044/LEADER.FTR1.14092009.10]; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2009, TOP LANG DISORD, V29, P266, DOI 10.1097/TLD.0b013e3181b5322b; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gottfried M. A., 2013, TEACH COLL REC, V115, P1; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Hux K, 1996, INTERV SCH CLIN, V31, P158, DOI 10.1177/105345129603100305; Kasamatsu T, 2016, J ATHL TRAINING, V51, P153, DOI 10.4085/1062-6050-51.4.02; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McAvoy K., REAP BENEFITS GOOD C; McAvoy K., 2012, NASP COMMUNIQUE, V40; McAvoy K., 2012, CONCUSSION MANAGEMEN; McCrory P, 2008, S AFR J SPORTS MED, V21, P36; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McSwan K., 2016, CONC 2016 C SCOTTSD; Nationwide Childrens Hospital, SCH ADM GUID AC CONC; Parsons JT, 2013, BRIT J SPORT MED, V47, pe1; Pierson E., 2015, SCH PSYCHOL FORUM RE, V9, P249; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Porter KK, 2014, AM J SPEECH-LANG PAT, V23, P507, DOI 10.1044/2014_AJSLP-13-0126; Raikes A., 2015, CURRENT RES CONCUSSI, V2, P25; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Rose S. C., 2015, CONCUSSION, V1; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sirmon-Taylor B., 2012, ASHA PERSPECTIVES, V13, P70; Sohlberg MM, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-14-0128; Stewart GW, 2012, INT J SPORTS PHYS TH, V7, P433; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966	50	8	8	0	14	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	AUG	2017	26	3					716	728		10.1044/2017_AJSLP-16-0138			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	FI2WY	WOS:000411812300003	28793153				2022-02-06	
J	Dutta, D; Hickey, K; Salifu, M; Fauer, C; Willingham, C; Stabenfeldt, SE				Dutta, D.; Hickey, K.; Salifu, M.; Fauer, C.; Willingham, C.; Stabenfeldt, S. E.			Spatiotemporal presentation of exogenous SDF-1 with PLGA nanoparticles modulates SDF-1/CXCR4 signaling axis in the rodent cortex	BIOMATERIALS SCIENCE			English	Article							TRAUMATIC BRAIN-INJURY; ENDOTHELIAL GROWTH-FACTOR; NEURAL PROGENITOR CELLS; STEM-CELLS; SUBVENTRICULAR ZONE; NEUROTROPHIC FACTOR; CHEMOKINE RECEPTORS; CONTROLLED-RELEASE; DOWN-REGULATION; ADULT BRAIN	Stromal cell-derived factor-1 (SDF-1) and its key receptor CXCR4 have been implicated in directing cellular recruitment for several pathological/disease conditions thus also gained considerable attention for regenerative medicine. One regenerative approach includes sustained release of SDF-1 to stimulate prolonged stem cell recruitment. However, the impact of SDF-1 sustained release on the endogenous SDF1/CXCR4 signaling axis is largely unknown as auto-regulatory mechanisms typically dictate cytokine/receptor signaling. We hypothesize that spatiotemporal presentation of exogenous SDF-1 is a key factor in achieving long-term manipulation of endogenous SDF-1/CXCR4 signaling. Here in the present study, we sought to probe our hypothesis using a transgenic mouse model to contrast the spatial activation of endogenous SDF-1 and CXCR4 in response to exogenous SDF-1 injected in bolus or controlled release (PLGA nanoparticles) form in the adult rodent cortex. Our data suggests that the manner of SDF-1 presentation significantly affected initial CXCR4 cellular activation/recruitment despite having similar protein payloads over the first 24 h (similar to 30 ng for both bolus and sustained release groups). Yet, one week postinjection, this response was negligible. Therefore, the transient nature CXCR4 recruitment/activation in response to bolus or controlled release SDF-1 indicated that cytokine/receptor auto-regulatory mechanisms may demand more complex release profiles (i.e. delayed and/or pulsed release) to achieve sustained cellular response.	[Dutta, D.; Hickey, K.; Salifu, M.; Fauer, C.; Willingham, C.; Stabenfeldt, S. E.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA		Stabenfeldt, SE (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA.	Sarah.Stabenfeldt@asu.edu		Dutta, Dipankar/0000-0001-9864-1452; Hickey, Kassondra/0000-0002-3133-5714	NSF CBETNational Science Foundation (NSF) [1454282]; NIH NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1DP2HD084067]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [DP2HD084067] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp SysNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [1454282] Funding Source: National Science Foundation	The authors acknowledge Amanda Witten for assistance with graphic design. This work was supported by NSF CBET 1454282 (SES) and NIH NICHD 1DP2HD084067 (SES).	Abe P, 2014, DEVELOPMENT, V141, P1857, DOI 10.1242/dev.104224; Addington CP, 2015, BIOMARK INSIGHTS, V10, P43, DOI [10.4137/BMI.S20062, 10.4137/BMIMI.S20062]; Aprili D, 2009, ANESTHESIOLOGY, V111, P1346, DOI 10.1097/ALN.0b013e3181bfab9a; Belmadani A, 2009, DIFFERENTIATION, V77, P395, DOI 10.1016/j.diff.2008.10.015; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Bhattacharyya BJ, 2008, J NEUROSCI, V28, P6720, DOI 10.1523/JNEUROSCI.1677-08.2008; Bonavia R, 2003, TOXICOL LETT, V139, P181, DOI 10.1016/S0378-4274(02)00432-0; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Cai YP, 2014, INT J NANOMED, V9, P3527, DOI 10.2147/IJN.S63507; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Christie KJ, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00070; Cooke MJ, 2011, BIOMATERIALS, V32, P5688, DOI 10.1016/j.biomaterials.2011.04.032; Cross DP, 2011, PHARM RES-DORDR, V28, P2477, DOI 10.1007/s11095-011-0474-x; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Dixon KJ, 2015, J NEUROTRAUM, V32, P753, DOI 10.1089/neu.2014.3390; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Dutta D, 2017, J MATER CHEM B, V5, P4487, DOI [10.1039/c7tb00138j, 10.1039/C7TB00138J]; Dutta D, 2015, J MATER CHEM B, V3, P7963, DOI 10.1039/c5tb00935a; Dutta D, 2016, J BIOMED MATER RES A, V104, P688, DOI 10.1002/jbm.a.35608; Finch AR, 2009, AM J PHYSIOL-CELL PH, V297, pC591, DOI 10.1152/ajpcell.00166.2009; Fujio M, 2011, BONE, V49, P693, DOI 10.1016/j.bone.2011.06.024; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Henderson PW, 2011, WOUND REPAIR REGEN, V19, P420, DOI 10.1111/j.1524-475X.2011.00687.x; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Holt JE, 2006, DEV BIOL, V293, P449, DOI 10.1016/j.ydbio.2006.02.012; Hong WX, 2014, ADV WOUND CARE, V3, P390, DOI 10.1089/wound.2013.0520; Huang F, 2013, NEUROREPORT, V24, P101, DOI 10.1097/WNR.0b013e32835c93c5; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Ji JF, 2004, NEUROSCI LETT, V355, P236, DOI 10.1016/j.neulet.2003.11.024; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Laursen T, 2004, GROWTH HORM IGF RES, V14, P16, DOI 10.1016/j.ghir.2003.10.001; LEFEBVRE PJ, 1987, DIABETOLOGIA, V30, P443, DOI 10.1007/BF00279610; Li L, 2010, GLIA, V58, P1610, DOI 10.1002/glia.21033; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Liang Z, 2007, BIOCHEM BIOPH RES CO, V359, P716, DOI 10.1016/j.bbrc.2007.05.182; Liu KKY, 2009, J NEUROIMMUNOL, V215, P49, DOI 10.1016/j.jneuroim.2009.08.003; Liu XL, 2011, PROTEIN CELL, V2, P845, DOI 10.1007/s13238-011-1097-z; Mao WF, 2016, NEUROCHEM RES, V41, P1315, DOI 10.1007/s11064-016-1831-2; McCandless EE, 2009, J IMMUNOL, V183, P613, DOI 10.4049/jimmunol.0802258; MENEI P, 1993, BIOMATERIALS, V14, P470, DOI 10.1016/0142-9612(93)90151-Q; Misra P, 2008, J NUCL MED, V49, P963, DOI 10.2967/jnumed.107.050054; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Mufson EJ, 1996, NEUROSCIENCE, V71, P179, DOI 10.1016/0306-4522(95)00431-9; Olanow CW, 2000, ANN NEUROL, V47, pS167; Overstreet DJ, 2012, J POLYM SCI POL PHYS, V50, P881, DOI 10.1002/polb.23081; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Prokoph S, 2012, BIOMATERIALS, V33, P4792, DOI 10.1016/j.biomaterials.2012.03.039; Rabbany SY, 2010, CELL TRANSPLANT, V19, P399, DOI 10.3727/096368909X481782; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Sharp CD, 2006, FASEB J, V20, pA202; Singh AK, 2013, CYTOKINE GROWTH F R, V24, P41, DOI 10.1016/j.cytogfr.2012.08.007; Sohn JH, 2015, J NEUROSCI, V35, P3756, DOI 10.1523/JNEUROSCI.3454-14.2015; Stumm RK, 2002, J NEUROSCI, V22, P5865; Sun CR, 2013, J NEUROSCI, V33, P17314, DOI 10.1523/JNEUROSCI.2129-13.2013; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Sun WF, 2014, INFLAMM RES, V63, P287, DOI 10.1007/s00011-013-0699-8; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tran PB, 2007, J COMP NEUROL, V500, P1007, DOI 10.1002/cne.21229; Weiss JM, 2013, IMMUNOBIOLOGY, V218, P373, DOI 10.1016/j.imbio.2012.05.006; Wolak DJ, 2013, MOL PHARMACEUT, V10, P1492, DOI 10.1021/mp300495e; Wurth R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00144; Yi X, 2014, J CONTROL RELEASE, V190, P637, DOI 10.1016/j.jconrel.2014.06.017; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070306; Zamani M, 2015, J COLLOID INTERF SCI, V451, P144, DOI 10.1016/j.jcis.2015.04.005; Zamproni LN, 2017, INT J PHARMACEUT, V519, P323, DOI 10.1016/j.ijpharm.2017.01.036; Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52, DOI 10.1038/71916	69	8	8	0	14	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2047-4830	2047-4849		BIOMATER SCI-UK	Biomater. Sci.	AUG 1	2017	5	8					1640	1651		10.1039/c7bm00489c			12	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	FB7LI	WOS:000406321700030	28703822	Green Accepted			2022-02-06	
J	Lu, HJ; Jiang, R; Tao, XL; Duan, CW; Huang, J; Huan, W; He, YF; Ge, JB; Ren, JB				Lu, Hongjian; Jiang, Rui; Tao, Xuelei; Duan, Chengwei; Huang, Jie; Huan, Wei; He, Yunfen; Ge, Jianbin; Ren, Jianbing			Expression of Dixdc1 and its Role in Astrocyte Proliferation after Traumatic Brain Injury	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Dixdc1; Traumatic brain injury; Astrocyte proliferation; Rat	PI3K PATHWAY ACTIVATION; SPINAL-CORD; CELL-CYCLE; COGNITIVE RECOVERY; DIFFERENTIATION; NEUROGENESIS; REGULATOR; INFUSION; P21	DIX domain containing 1 (Dixdc1), a positive regulator of Wnt signaling pathway, is recently reported to play a role in the neurogenesis. However, the distribution and function of Dixdc1 in the central nervous system (CNS) after brain injury are still unclear. We used an acute traumatic brain injury (TBI) model in adult rats to investigate whether Dixdc1 is involved in CNS injury and repair. Western blot analysis and immunohistochemistry showed a time-dependent up-regulation of Dixdc1 expression in ipsilateral cortex after TBI. Double immunofluorescent staining indicated a colocalization of Dixdc1 with astrocytes and neurons. Moreover, we detected a colocalization of Ki-67, a cell proliferation marker with GFAP and Dixdc1 after TBI. In primary cultured astrocytes stimulated with lipopolysaccharide, we found enhanced expression of Dixdc1 in parallel with up-regulation of Ki-67 and cyclin A, another cell proliferation marker. In addition, knockdown of Dixdc1 expression in primary astrocytes with Dixdc1-specific siRNA transfection induced G0/G1 arrest of cell cycle and significantly decreased cell proliferation. In conclusion, all these data suggest that up-regulation of Dixdc1 protein expression is potentially involved in astrocyte proliferation after traumatic brain injury in the rat.	[Lu, Hongjian; Tao, Xuelei; Duan, Chengwei; Ge, Jianbin; Ren, Jianbing] Nantong Univ, Affiliated Nantong Peoples Hosp 2, Dept Neurosurg, 43 Xinglong Rd, Nantong 226001, Jiangsu, Peoples R China; [Jiang, Rui; Huang, Jie; Huan, Wei; He, Yunfen] Nantong Univ, Affiliated Hosp, Dept Neurosurg, 20 Xisi Rd, Nantong 226001, Jiangsu, Peoples R China		Lu, HJ (corresponding author), Nantong Univ, Affiliated Nantong Peoples Hosp 2, Dept Neurosurg, 43 Xinglong Rd, Nantong 226001, Jiangsu, Peoples R China.	luhongjian2016@163.com					Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Chen X, 2012, J MOL NEUROSCI, V47, P158, DOI 10.1007/s12031-011-9704-2; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jing XT, 2009, CELL MOL NEUROBIOL, V29, P55, DOI 10.1007/s10571-008-9295-9; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; KONIGSMARK BW, 1970, NATURE, V228, P1335, DOI 10.1038/2281335a0; Lin YC, 2016, CELL MOL NEUROBIOL, V36, P27, DOI 10.1007/s10571-015-0217-3; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; Luo W, 2005, J BIOL CHEM, V280, P5054, DOI 10.1074/jbc.M412340200; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Shi W, 2012, J MOL HISTOL, V43, P37, DOI 10.1007/s10735-011-9366-y; Singh KK, 2010, NEURON, V67, P33, DOI 10.1016/j.neuron.2010.06.002; Soma K, 2006, GENE EXPR PATTERNS, V6, P325, DOI 10.1016/j.modgep.2005.06.013; Tawfik VL, 2006, GLIA, V54, P193, DOI 10.1002/glia.20365; Tian DS, 2006, J NEUROSCI RES, V84, P1053, DOI 10.1002/jnr.20999; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Wang L, 2009, CANCER SCI, V100, P1801, DOI 10.1111/j.1349-7006.2009.01246.x; Wang XS, 2006, BIOCHEM BIOPH RES CO, V347, P22, DOI 10.1016/j.bbrc.2006.06.050; White RE, 2008, RESTOR NEUROL NEUROS, V26, P197; Wu WJ, 2016, BIOCHEM BIOPH RES CO, V478, P956, DOI 10.1016/j.bbrc.2016.08.058; Xu T, 2014, INT J MOL SCI, V15, P3299, DOI 10.3390/ijms15023299; YAO L, 2014, J APPL MATH, V2014, P1, DOI DOI 10.1007/S12035-014-9049-2; Zhang HY, 2014, J MOL NEUROSCI, V54, P653, DOI 10.1007/s12031-014-0363-y; Zhang WD, 2016, MOL NEUROBIOL, V53, P6342, DOI 10.1007/s12035-015-9531-5; Zhao W, 2013, J MOL NEUROSCI, V51, P687, DOI 10.1007/s12031-013-0049-x	34	8	8	0	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	AUG	2017	37	6					1131	1139		10.1007/s10571-016-0446-0			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	EZ3WA	WOS:000404640100016	27873129				2022-02-06	
J	Maxwell, AK; Hartl, RMB; Greene, NT; Benichoux, V; Mattingly, JK; Cass, SP; Tollin, DJ				Maxwell, Anne K.; Hartl, Renee M. Banakis; Greene, Nathaniel T.; Benichoux, Victor; Mattingly, Jameson K.; Cass, Stephen P.; Tollin, Daniel J.			Semicircular Canal Pressure Changes During High-intensity Acoustic Stimulation	OTOLOGY & NEUROTOLOGY			English	Article						Air conduction; Bone conduction; Energy transfer; Pressure waves; Semicircular canals; Vestibular system	MIDDLE-EAR IMPLANT; EVOKED MYOGENIC POTENTIALS; BONE-CONDUCTED SOUND; INDUCED HEARING-LOSS; EXPOSURE VESTIBULAR CONSEQUENCES; NOISE EXPOSURE; IMPULSE NOISE; GUINEA-PIG; ELECTRODE INSERTION; FREQUENCY SOUND	Hypothesis: Acoustic stimulation generates measurable sound pressure levels in the semicircular canals. Background: High-intensity acoustic stimuli can cause hearing loss and balance disruptions. To examine the propagation of acoustic stimuli to the vestibular end-organs, we simultaneously measured fluid pressure in the cochlea and semicircular canals during both air- and bone-conducted sound presentation. Methods: Five full-cephalic human cadaveric heads were prepared bilaterally with a mastoidectomy and extended facial recess. Vestibular pressures were measured within the superior, lateral, and posterior semicircular canals, and referenced to intracochlear pressure within the scala vestibuli with fiber-optic pressure probes. Pressures were measured concurrently with laser Doppler vibrometry measurements of stapes velocity during stimulation with both air-and bone-conduction. Stimuli were pure tones between 100 Hz and 14 kHz presented with custom closed-field loudspeakers for air-conducted sounds and via commercially available boneanchored device for bone-conducted sounds. Results: Pressures recorded in the superior, lateral, and posterior semicircular canals in response to sound stimulation were equal to or greater in magnitude than those recorded in the scala vestibuli (up to 20 dB higher). The pressure magnitudes varied across canals in a frequency-dependent manner. Conclusion: High sound pressure levels were recorded in the semicircular canals with sound stimulation, suggesting that similar acoustical energy is transmitted to the semicircular canals and the cochlea. Since these intralabyrinthine pressures exceed intracochlear pressure levels, our results suggest that the vestibular end-organs may also be at risk for injury during exposure to high-intensity acoustic stimuli known to cause trauma in the auditory system.	[Maxwell, Anne K.; Hartl, Renee M. Banakis; Mattingly, Jameson K.; Cass, Stephen P.; Tollin, Daniel J.] Univ Colorado, Sch Med, Dept Otolaryngol, 12631 E 17th Ave,B205, Aurora, CO 80045 USA; [Greene, Nathaniel T.; Benichoux, Victor; Tollin, Daniel J.] Univ Colorado, Sch Med, Dept Physiol & Biophys, Aurora, CO 80045 USA		Maxwell, AK (corresponding author), Univ Colorado, Sch Med, Dept Otolaryngol, 12631 E 17th Ave,B205, Aurora, CO 80045 USA.	anne.maxwell@ucdenver.edu		Greene, Nathaniel/0000-0001-5872-9169	NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [T32 DC012280] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [T32DC012280] Funding Source: NIH RePORTER		Akdogan O, 2009, AURIS NASUS LARYNX, V36, P2, DOI 10.1016/j.anl.2008.03.003; Akin FW, 2012, EAR HEARING, V33, P458, DOI 10.1097/AUD.0b013e3182498c5f; Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Baloh R.W., 2001, CLIN NEUROPHYSIOLOGY, V3rd ed.; Biedron S, 2010, OTOL NEUROTOL, V31, P731, DOI 10.1097/MAO.0b013e3181d27b5e; CAZALS Y, 1983, ACTA OTO-LARYNGOL, V95, P211, DOI 10.3109/00016488309130937; Curthoys IS, 2015, EXP BRAIN RES, V233, P691, DOI 10.1007/s00221-014-4192-6; Deveze A, 2013, OTOL NEUROTOL, V34, P158, DOI 10.1097/MAO.0b013e3182785261; Deveze A, 2010, OTOL NEUROTOL, V31, P1027, DOI 10.1097/MAO.0b013e3181edb6d1; Fetoni AR, 2009, INT J AUDIOL, V48, P804, DOI 10.3109/14992020903023140; Golz A, 2001, AM J OTOLARYNG, V22, P190, DOI 10.1053/ajot.2001.23428; Greene NT, 2016, OTOL NEUROTOL, V37, P1541, DOI 10.1097/MAO.0000000000001232; Greene NT, 2015, OTOL NEUROTOL, V36, P1554, DOI 10.1097/MAO.0000000000000838; Halmagyi GM, 2005, ANN NY ACAD SCI, V1039, P54, DOI 10.1196/annals.1325.006; Hartl RMB, 2016, OTOL NEUROTOL, V37, P1291, DOI 10.1097/MAO.0000000000001184; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hsu WC, 2008, ARCH OTOLARYNGOL, V134, P1099, DOI 10.1001/archotol.134.10.1099; KILBURN KH, 1992, BRIT J IND MED, V49, P138; Lupo JE, 2014, OTOL NEUROTOL, V35, P470, DOI 10.1097/MAO.0b013e318299aa37; Mattingly JK, 2015, OTOL NEUROTOL, V36, P1403, DOI 10.1097/MAO.0000000000000814; McCABE B F, 1958, Acta Otolaryngol, V49, P147; McCauley RD, 2003, J ACOUST SOC AM, V113, P638, DOI 10.1121/1.1527962; MCCUE MP, 1994, J NEUROSCI, V14, P6058; Minor LB, 2000, AM J OTOL, V21, P9; Nakajima HH, 2009, JARO-J ASSOC RES OTO, V10, P23, DOI 10.1007/s10162-008-0150-y; Olson ES, 1999, NATURE, V402, P526, DOI 10.1038/990092; Oosterveld W J, 1982, Br J Audiol, V16, P227; Park HJ, 2010, CLIN NEUROPHYSIOL, V121, P85, DOI 10.1016/j.clinph.2009.10.003; Pisano DV, 2012, AUDIOL NEURO-OTOL, V17, P338, DOI 10.1159/000339653; RIBARIC K, 1992, ACTA OTO-LARYNGOL, V112, P221, DOI 10.1080/00016489.1992.11665408; RIBARIC K, 1992, ACTA OTO-LARYNGOL, V112, P45, DOI 10.3109/00016489209100781; Rosowski JJ, 2007, AUDIOL NEURO-OTOL, V12, P265, DOI 10.1159/000101474; Sazgar AA, 2006, EUR ARCH OTO-RHINO-L, V263, P608, DOI 10.1007/s00405-006-0038-6; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; SHUPAK A, 1994, ACTA OTO-LARYNGOL, V114, P579, DOI 10.3109/00016489409126109; Stenfelt S, 2004, HEARING RES, V198, P10, DOI 10.1016/j.heares.2004.07.008; Stenfelt S, 2004, J ACOUST SOC AM, V115, P797, DOI 10.1121/1.1639903; Stewart C, 2016, HEARING RES, V335, P118, DOI 10.1016/j.heares.2016.03.002; Taylor RL, 2012, AUDIOL NEURO-OTOL, V17, P207, DOI 10.1159/000336959; Thorne M, 1999, LARYNGOSCOPE, V109, P1661, DOI 10.1097/00005537-199910000-00021; Todd NPM, 2009, NEUROSCI LETT, V451, P175, DOI 10.1016/j.neulet.2008.12.055; Tringali S, 2010, AUDIOL NEURO-OTOL, V15, P291, DOI 10.1159/000283006; Tseng CC, 2013, EUR ARCH OTO-RHINO-L, V270, P2021, DOI 10.1007/s00405-012-2270-6; Wang YP, 2006, OTOL NEUROTOL, V27, P956, DOI 10.1097/01.mao.0000231590.57348.4b; Welgampola MS, 2003, J NEUROL NEUROSUR PS, V74, P771, DOI 10.1136/jnnp.74.6.771; Winters SM, 2012, AUDIOL NEURO-OTOL, V17, P12, DOI 10.1159/000324858; WIT HP, 1981, ACTA OTO-LARYNGOL, V92, P409, DOI 10.3109/00016488109133280; Wu CC, 2009, INT J AUDIOL, V48, P655, DOI 10.1080/14992020903012481; Wysocki J, 1999, HEARING RES, V135, P39, DOI 10.1016/S0378-5955(99)00088-X; YLIKOSKI J, 1988, ACTA OTO-LARYNGOL, V105, P558, DOI 10.3109/00016488809119520; YLIKOSKI J, 1987, ACTA OTO-LARYNGOL, V103, P415; YOUNG ED, 1977, ACTA OTO-LARYNGOL, V84, P352, DOI 10.3109/00016487709123977; Zhang AS, 2012, EXP BRAIN RES, V223, P51, DOI 10.1007/s00221-012-3240-3; Zhang AS, 2012, J APPL PHYSIOL, V112, P1279, DOI 10.1152/japplphysiol.01024.2011; Zhu H, 2014, JARO-J ASSOC RES OTO, V15, P73, DOI 10.1007/s10162-013-0428-6; Zhu H, 2011, J NEUROPHYSIOL, V106, P754, DOI 10.1152/jn.00003.2011	56	8	9	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	AUG	2017	38	7					1043	1051		10.1097/MAO.0000000000001456			9	Clinical Neurology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology	FA4DG	WOS:000405393400022	28570420	Green Accepted			2022-02-06	
J	O'Rourke, DJ; Smith, RE; Punt, S; Coppel, DB; Breiger, D				O'Rourke, Daniel J.; Smith, Ronald E.; Punt, Stephanie; Coppel, David B.; Breiger, David			Psychosocial Correlates of Young Athletes' Self-Reported Concussion Symptoms During the Course of Recovery	SPORT EXERCISE AND PERFORMANCE PSYCHOLOGY			English	Article						concussion; youth sport; athletic identity; motivation; performance anxiety	HEAD-INJURY; ANXIETY SENSITIVITY; SOCIAL SUPPORT; BRAIN-INJURY; SPORT; PREDICTORS; MILD; SCALE; RISK; VALIDATION	Fifty-one youth athletes (n = 27 female, age = 14.53 years, SD = 1.85) presented to a local hospital outpatient concussion clinic on average 7.67 days postconcussion for standard medical assessment, including the self-report Sport-Concussion Assessment Tool-2 (Time 1). They completed follow-up symptom assessments at Time 2 (7.48 +/- 1.24 days after Time 1) and Time 3 (7.63 +/- 1.42 days after Time 2). We assessed the relations between theoretically relevant personal and situational variables, assessed at Time 2, and concussion symptom reports at Time 2 and Time 3. Using hierarchical regression, we also assessed relations between personal/situational factors and changes in symptom intensity from Time 1 to Time 2, Time 1 to Time 3, and Time 2 to Time 3, controlling for Time 1 postconcussion symptom intensity, age, gender, concussion history over the past 12 months, and the number of days since sustaining the current concussion. Controlling for these factors, the combined influence of the psychosocial factors predicted 43% of the variance in symptom expression at Time 3. Psychosocial factors also accounted for 27% of the variance in symptom change from Time 1 to Time 2, and 23% of the variance in symptom change from Time 1 to Time 3. Athletic identity, performance anxiety, and amotivation were the most consistent and influential person variables, each being related to more intense symptom reports and slower recovery. Results suggest the potential importance of psychological factors in concussion recovery.	[O'Rourke, Daniel J.; Smith, Ronald E.] Univ Washington, Dept Psychol, Guthrie Hall 119A,Box 351525, Seattle, WA 98195 USA; [Punt, Stephanie] Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA; [Coppel, David B.] Univ Washington, Med Ctr, Dept Neurol Surg, Seattle, WA 98195 USA; [Breiger, David] Seattle Childrens Res Inst, Seattle, WA USA; [Breiger, David] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		O'Rourke, DJ (corresponding author), Univ Washington, Dept Psychol, Guthrie Hall 119A,Box 351525, Seattle, WA 98195 USA.	djo13@uw.edu					Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; ASMUNDSON GJG, 1995, BEHAV RES THER, V33, P771, DOI 10.1016/0005-7967(95)00012-M; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Brewer B.W., 2001, ACAD ATHLETIC J, V16, P103; Brewer BW, 2010, PSYCHOL SPORT EXERC, V11, P1, DOI 10.1016/j.psychsport.2009.09.005; BREWER BW, 1993, INT J SPORT PSYCHOL, V24, P237; CAUCE AM, 1982, AM J COMMUN PSYCHOL, V10, P417, DOI 10.1007/BF00893980; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Cumming SP, 2008, PSYCHOL SPORT EXERC, V9, P686, DOI 10.1016/j.psychsport.2007.09.003; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Duda J. L., 2005, HDB COMPETENCE MOTIV, P313; DUDA JL, 1998, ADV SPORT EXERCISE P, P20; EVANS L, 2006, LIT REV SPORT PSYCHO, P289; Franklin CC, 2012, CURR OPIN PEDIATR, V24, P64, DOI 10.1097/MOP.0b013e32834ec618; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hutchinson M., 2014, BRIT J SPORT MED, V48, P610; Jenewein J, 2009, J PSYCHOSOM RES, V66, P119, DOI 10.1016/j.jpsychores.2008.07.011; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Mor N, 2002, PSYCHOL BULL, V128, P638, DOI 10.1037//0033-2909.128.4.638; PELLETIER LG, 1995, J SPORT EXERCISE PSY, V17, P35, DOI 10.1123/jsep.17.1.35; Podlog L, 2007, PSYCHOL SPORT EXERC, V8, P535, DOI 10.1016/j.psychsport.2006.07.008; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; Rees T, 2010, PSYCHOL SPORT EXERC, V11, P505, DOI 10.1016/j.psychsport.2010.07.002; Sarrazin P, 2002, EUR J SOC PSYCHOL, V32, P395, DOI 10.1002/ejsp.98; SMITH RE, 1990, J PERS SOC PSYCHOL, V58, P360, DOI 10.1037/0022-3514.58.2.360; Smith RE, 2008, J APPL SPORT PSYCHOL, V20, P116, DOI 10.1080/10413200701790558; Smith RE, 2006, J SPORT EXERCISE PSY, V28, P479, DOI 10.1123/jsep.28.4.479; Vallerand RJ, 1997, J PERS SOC PSYCHOL, V72, P1161, DOI 10.1037/0022-3514.72.5.1161; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wiese-Bjornstal DM, 2010, SCAND J MED SCI SPOR, V20, P103, DOI 10.1111/j.1600-0838.2010.01195.x; Wiese-Bjornstal DM, 1998, J APPL SPORT PSYCHOL, V10, P46, DOI 10.1080/10413209808406377; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	45	8	8	0	10	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	2157-3905	2157-3913		SPORT EXERC PERFORM	Sport Exerc. Perform. Psychol.	AUG	2017	6	3					262	276		10.1037/spy0000097			15	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	FD8RW	WOS:000407792800006					2022-02-06	
J	Pasquesi, SA; Margulies, SS				Pasquesi, Stephanie A.; Margulies, Susan S.			Failure and Fatigue Properties of Immature Human and Porcine Parasagittal Bridging Veins	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Brain injury; Abusive head trauma; Hemorrhage; Pediatric trauma; Child abuse; Mechanical properties	MECHANICAL-PROPERTIES; HEAD-INJURY; SUBDURAL HEMORRHAGE; RETINAL HEMORRHAGE; PHYSICAL INJURY; INFANT SKULL; BRAIN-INJURY; SHAKING; FRESH; ENCEPHALOPATHY	Tearing of the parasagittal bridging veins (BVs) is thought to be a source of extra-axial hemorrhage (EAH) associated with abusive traumatic brain injuries (TBIs) in children. However, the pediatric BV mechanical properties are unknown. We subjected porcine adult, porcine newborn, and human infant BVs to either a low rate pull to failure, a high rate pull to failure, or 30 s of cyclic loading followed by a pull to failure. An additional subset of human infant BVs was examined for viscoelastic recovery between two cycling episodes. We found that human infant BVs are stronger than porcine BVs, and BV mechanical properties are rate dependent, but not age dependent. Successive cyclic loading to a uniform level of stretch softened BVs with decaying peak stresses, and shifted their stress-stretch relationship. These data are critical in understanding BV tissue behavior in accidental and abusive trauma scenarios, which in turn may clarify circumstances that may be injurious to young children.	[Pasquesi, Stephanie A.; Margulies, Susan S.] Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 South 33rd St, Philadelphia, PA 19104 USA		Margulies, SS (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 South 33rd St, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu		Margulies, Susan/0000-0002-3615-7902	American Heart AssociationAmerican Heart Association [12PRE12040315]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 HD078842]; Children's Hospital of Philadelphia Critical Care Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD078842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679, U01NS069545] Funding Source: NIH RePORTER	We are grateful to the families who consented to provide autopsy specimens of their young children for research purposes. We would also like to thank Dr. Lucy Rorke-Adams, Jill Ralston, George Bratinov, and Kevin Browne for their technical assistance procuring vessels. Support was provided by the American Heart Association (12PRE12040315), the National Institutes of Health (R21 HD078842), and the Children's Hospital of Philadelphia Critical Care Fund.	Adham M, 1996, J SURG RES, V64, P32, DOI 10.1006/jsre.1996.0302; Bell ED, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00002; Bennell KL, 1996, BRIT J SPORT MED, V30, P200, DOI 10.1136/bjsm.30.3.200; Bia D, 2005, TRANSPL INT, V18, P1346, DOI 10.1111/j.1432-2277.2005.00220.x; Bia Daniel, 2006, Cell and Tissue Banking, V7, P183, DOI 10.1007/s10561-005-0655-0; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; CAFFEY J, 1974, PEDIATRICS, V54, P396; Chapurlat RD, 2009, OSTEOPOROSIS INT, V20, P1299, DOI 10.1007/s00198-009-0899-9; Coats B., 2003, IRCOBI C LISB PORT, P57; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Coats B, 2017, J NEUROTRAUM, V34, P235, DOI 10.1089/neu.2015.4352; Delye Hans, 2006, Stapp Car Crash J, V50, P625; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; EISELE SA, 1993, J BONE JOINT SURG AM, V75A, P290, DOI 10.2106/00004623-199302000-00019; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Faul M, 2010, TRAUMATIC BRAIN INJU; Garcia A, 2012, BIORHEOLOGY, V49, P271, DOI 10.3233/BIR-2012-0606; Garcia A, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023371; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; Herman BE, 2011, PEDIATR EMERG CARE, V27, P65, DOI 10.1097/PEC.0b013e31820349db; itny R., 2010, B APPL MECH, V6, P1, DOI DOI 10.1007/978-3-642-13039-7_194; Jaspan T, 2008, PEDIATR RADIOL, V38, pS378, DOI 10.1007/s00247-008-0896-8; Jones GL, 2006, CLIN SPORT MED, V25, P159, DOI 10.1016/j.csm.2005.08.008; Komatsu K, 2007, J BIOMECH, V40, P634, DOI 10.1016/j.jbiomech.2006.01.026; Langerak SE, 2001, TRANSPLANT INT, V14, P248, DOI 10.1007/s001470100309; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; LOWENHIELM P, 1974, Z RECHTSMED, V74, P55, DOI 10.1007/BF01869185; Maher E, 2012, J BIOMECH, V45, P1393, DOI 10.1016/j.jbiomech.2012.02.026; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Martin RB, 2003, CALCIFIED TISSUE INT, V73, P101, DOI 10.1007/s00223-002-1059-9; Masson I, 2009, MED ENG PHYS, V31, P825, DOI 10.1016/j.medengphy.2009.03.009; Meaney D. F., 1991, BIOENGINEERING; Miller KS, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006340; Monea AG, 2014, J MECH BEHAV BIOMED, V32, P155, DOI 10.1016/j.jmbbm.2013.12.007; Monson KL, 2005, J BIOMECH, V38, P737, DOI 10.1016/j.jbiomech.2004.05.004; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Morison C. N., 2002, MANUFACTURING MECH E; Nadarasa J, 2014, PEDIATR RADIOL, V44, P565, DOI 10.1007/s00247-014-3168-9; Pasquesi S. A., 2016, BIOENGINEERING; Pasquesi SA, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4033883; Peris P, 2003, BEST PRACT RES CL RH, V17, P1043, DOI 10.1016/j.berh.2003.09.006; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Pukacki F, 2000, EUR J VASC ENDOVASC, V20, P21, DOI 10.1053/ejvs.2000.1120; Quinn KP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004205; Rorke-Adams L, 2011, J PRIM HEALTH CARE, V3, P161, DOI 10.1071/HC11161; Squier W, 2011, J PRIM HEALTH CARE, V3, P159, DOI 10.1071/HC11159; Stemper BD, 2007, J SURG RES, V139, P236, DOI 10.1016/j.jss.2006.09.001; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Warden Stuart J, 2006, Curr Osteoporos Rep, V4, P103; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121; Yassi A, 1997, LANCET, V349, P943, DOI 10.1016/S0140-6736(96)07221-2; Zhang K, 2009, J MECH BEHAV BIOMED, V2, P93, DOI 10.1016/j.jmbbm.2008.05.005	56	8	8	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	AUG	2017	45	8					1877	1889		10.1007/s10439-017-1833-5			13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	FB7VW	WOS:000406349100005	28405773	Green Accepted			2022-02-06	
J	Sanchez-Guerrero, A; Mur-Bonet, G; Vidal-Jorge, M; Gandara-Sabatini, D; Chocron, I; Cordero, E; Poca, MA; Mullen, K; Sahuquillo, J				Sanchez-Guerrero, Angela; Mur-Bonet, Gemma; Vidal-Jorge, Marian; Gandara-Sabatini, Dario; Chocron, Ivette; Cordero, Esteban; Poca, Maria-Antonia; Mullen, Katharine; Sahuquillo, Juan			Reappraisal of the reference levels for energy metabolites in the extracellular fluid of the human brain	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Brain metabolism; cerebral microdialysis; lactate; reference intervals; traumatic brain injury	ANEURYSMAL SUBARACHNOID HEMORRHAGE; CLINICAL CEREBRAL MICRODIALYSIS; POSITRON-EMISSION-TOMOGRAPHY; ISOFLURANE ANESTHESIA; LACTATE LEVELS; AMINO-ACIDS; GLUCOSE; INJURY; HYPERGLYCEMIA; PROPOFOL	Cerebral microdialysis is widely used in neurocritical care units. The goal of this study was to establish the reference interval for the interstitial fluid concentrations of energy metabolites and glycerol by using the extrapolation to zero-flow methodology in anesthetized patients and by constant perfusion at 0.3 mu L/min in awake patients. A CMA-71 probe was implanted during surgery in normal white matter of patients with posterior fossa or supratentorial lesions, and the perfusion flow rate was randomized to 0.1, 0.3, 0.6, 1.2, and 2.4 mu L/min. Within 24 h of surgery, perfusion was restarted at a constant 0.3 mL/min in fully awake patients. The actual interstitial fluid metabolite concentrations were calculated using the zero-flow methodology. In vitro experiments were also conducted to evaluate the reproducibility of the in vivo methodology. Nineteen patients (seven males) with a median age of 44 years (range: 21-69) were included in the in vivo study. The median (lower-upper) reference interval values were 1.57 (1.15-4.13 mmol/L) for glucose, 2.01 (1.30-5.31 mmol/L) for lactate, 80.0 (54.4-197.0 mmol/L) for pyruvate, and 49.9 (23.6-227.3 mmol/L) for glycerol. The reference intervals reported raises the need to reconsider traditional definitions of brain metabolic disturbances and emphasize the importance of using different thresholds for awake patients and patients under anesthesia.	[Sanchez-Guerrero, Angela; Mur-Bonet, Gemma; Vidal-Jorge, Marian; Poca, Maria-Antonia; Sahuquillo, Juan] Univ Autonoma Barcelona, Neurotraumatol & Neurosurg Res Unit UNINN, Vall dHebron Res Inst, Paseo Vall dHebron 119-129, Barcelona 08035, Spain; [Gandara-Sabatini, Dario; Cordero, Esteban; Poca, Maria-Antonia; Sahuquillo, Juan] Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Chocron, Ivette] Vall dHebron Univ Hosp, Dept Anesthesiol, Barcelona, Spain; [Mullen, Katharine] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA		Sahuquillo, J (corresponding author), Univ Autonoma Barcelona, Neurotraumatol & Neurosurg Res Unit UNINN, Vall dHebron Res Inst, Paseo Vall dHebron 119-129, Barcelona 08035, Spain.	sahuquillo@neurotrauma.net	Sabatini, Dario Fabian Gandara/AAB-6699-2019; Sahuquillo, Juan/B-3577-2008; Poca, Maria A./B-8475-2008	Sabatini, Dario Fabian Gandara/0000-0003-1303-9847; Sahuquillo, Juan/0000-0003-0713-5875; Poca, Maria A./0000-0002-3831-0536; Cordero Asanza, Esteban/0000-0003-0464-3014	Department d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya [SGR 2014-844]; Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III)Instituto de Salud Carlos III [FIS PI11/00700]; European Regional Development Fund (ERDF)European Commission; Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [FI12/00074]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The Neurotraumatology and Neurosurgery Research Unit is supported by a Grant from the Department d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya (SGR 2014-844). This work has been supported in part by the Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III) with grant FIS PI11/00700, which was co-financed by the European Regional Development Fund (ERDF) and awarded to Dr J. Sahuquillo. A. Sanchez-Guerrero is the recipient of personal pre-doctoral grant from the Instituto de Salud Carlos III (grant number FI12/00074).	Abi-Saab WM, 2002, J CEREBR BLOOD F MET, V22, P271, DOI 10.1097/00004647-200203000-00004; Alkire MT, 1997, ANESTHESIOLOGY, V86, P549, DOI 10.1097/00000542-199703000-00006; Baty F, 2015, J STAT SOFTW, V66, P1; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; BENVENISTE H, 1989, J NEUROCHEM, V52, P1667, DOI 10.1111/j.1471-4159.1989.tb07243.x; BITO L, 1966, J NEUROCHEM, V13, P1057, DOI 10.1111/j.1471-4159.1966.tb04265.x; Cavus I, 2005, ANN NEUROL, V57, P226, DOI 10.1002/ana.20380; Chefer Vladimir I, 2009, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0701s47; CLSI, 2008, EP28 A3C DEF EST VER; Evans WA, 1942, ARCH NEURO PSYCHIATR, V47, P931, DOI 10.1001/archneurpsyc.1942.02290060069004; Hamaoui K, 2016, J SURG RES, V200, P332, DOI 10.1016/j.jss.2015.07.004; Horn PS, 2001, CLIN CHEM, V47, P2137; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; Horn PS, 1998, CLIN CHEM, V44, P622; Horn T, 2010, NEUROCHEM INT, V57, P940, DOI 10.1016/j.neuint.2010.09.014; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; Hutchinson PJA, 2002, ACT NEUR S, V81, P359; Ibarz A, 2003, UNIT OPERATIONS FOOD, P265; Inoue S, 2015, NEUROANESTHESIA CERE, P93; JACOBSON I, 1985, J NEUROSCI METH, V15, P263, DOI 10.1016/0165-0270(85)90107-4; Janle E M, 1996, Curr Sep, V15, P31; Kozai TDY, 2015, ACS CHEM NEUROSCI, V6, P48, DOI 10.1021/cn500256e; Langemann H, 2001, NEUROL RES, V23, P531, DOI 10.1179/016164101101198785; Leen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042745; LONNROTH P, 1987, AM J PHYSIOL, V253, pE228, DOI 10.1152/ajpendo.1987.253.2.E228; Makaryus R, 2011, J CEREBR BLOOD F MET, V31, P1432, DOI 10.1038/jcbfm.2011.1; Martinez-Valverde T, 2017, J NEUROTRAUM, V34, P74, DOI 10.1089/neu.2015.4334; Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P7, DOI 10.1089/neu.2014.3473; MENACHERRY S, 1992, ANAL CHEM, V64, P577, DOI 10.1021/ac00030a003; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; MEYERSON BA, 1990, LIFE SCI, V46, P301, DOI 10.1016/0024-3205(90)90037-R; minpack, LM R INT LEV MARQ NO; Mishima Y, 2015, NEUROANESTHESIA CERE, P83; Nordstrom CH, 2010, CHILD NERV SYST, V26, P465, DOI 10.1007/s00381-009-1035-z; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PRICHARD J, 1991, P NATL ACAD SCI USA, V88, P5829, DOI 10.1073/pnas.88.13.5829; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Rogers ML, 2013, ACS CHEM NEUROSCI, V4, P799, DOI 10.1021/cn400047x; Sahuquillo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102540; Sanchez Jose J, 2013, Acta Neurochir Suppl, V118, P223, DOI 10.1007/978-3-7091-1434-6_42; Schlenk F, 2008, INTENS CARE MED, V34, P1200, DOI 10.1007/s00134-008-1044-5; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; SONG LF, 1995, J CHEM SOC FARADAY T, V91, P3389, DOI 10.1039/ft9959103389; Sun X, 2008, J INT MED RES, V36, P1305, DOI 10.1177/147323000803600618; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Ungerstedt U, 2007, HDB MICRODIALYSIS ME, P697; Vilalta A, 2011, J NEUROTRAUM, V28, P1139, DOI 10.1089/neu.2010.1720	51	8	8	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	AUG	2017	37	8					2742	2755		10.1177/0271678X16674222			14	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	FC0FO	WOS:000406514300008	27742889	Green Published, Bronze			2022-02-06	
J	Zhou, X; Liu, Y; Huang, Y; Zhu, SB; Zhu, J; Wang, RP				Zhou, Xiang; Liu, Yong; Huang, Yang; Zhu, ShuiBo; Zhu, Jian; Wang, RongPing			Hypertonic saline infusion suppresses apoptosis of hippocampal cells in a rat model of cardiopulmonary resuscitation	SCIENTIFIC REPORTS			English	Article							HOSPITAL CARDIAC-ARREST; AMERICAN-HEART-ASSOCIATION; HEALTH-CARE PROFESSIONALS; TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; ISCHEMIA-REPERFUSION; EXPRESSION; GUIDELINES; STATEMENT; PROPOFOL	Hypertonic saline (HS) attenuates cerebral edema, improves microcirculation perfusion and alleviates inflammation. However, whether the beneficial effect of HS on neurological function after cardiopulmonary resuscitation (CPR) in rat model of asphyxial cardiac arrest (CA) is mediated via attenuating apoptosis of neurons is not known. We studied the neuroprotective effect of HS in rats after CA and CPR, and explored the likely underlying mechanisms. Animals were randomly assigned to 4 equal groups (n = 15 each) according to the different infusions administered during resuscitation: control (C), normal saline (NS), hypertonic saline (HS), and hydroxyethyl starch (HES) groups. NDS at 12, 24, 48 and 72 h post-ROSC in the HS group were significantly higher than those in the NS and HES groups. Western blot analysis demonstrated a significant increase in Bcl-2 expression in HS, as compared to that in the NS and HES groups. However, Bax and Caspase-3 expressions in HS were significantly lower than that in the NS and HES groups. The apoptosis rate in HS was significantly lower than that in the NS and HES groups, suggesting HS treatment during resuscitation could effectively suppress neuronal cell apoptosis in hippocampal CA1 post-ROSC and improve neuronal function.	[Zhou, Xiang; Huang, Yang; Zhu, ShuiBo] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Zhou, Xiang; Liu, Yong; Zhu, ShuiBo; Zhu, Jian; Wang, RongPing] Wuhan Gen Hosp Peoples Liberat Army China, Dept Thorac Cardiovasc Surg, Guangzhou, Guangdong, Peoples R China		Zhu, SB (corresponding author), Southern Med Univ, Guangzhou, Guangdong, Peoples R China.; Zhu, SB (corresponding author), Wuhan Gen Hosp Peoples Liberat Army China, Dept Thorac Cardiovasc Surg, Guangzhou, Guangdong, Peoples R China.	whzyyzsb@126.com	Liu, Yong/AAF-9125-2021; Liu, Yong/AAT-9830-2021	Liu, Yong/0000-0002-4048-5837; Zhou, Xiang/0000-0001-9635-8741; Zhu, Jian/0000-0002-1768-5312	national natural science foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471831]	This work was part of the Program funded under the national natural science foundation of China, grant number 81471831. We thank the Laboratory of cardiac surgery of Tongji Medical College of HuaZhong University of Science and Thchnology for the help of Providing experimental equipment and technical guidance.	Breil M, 2003, RESUSCITATION, V56, P307, DOI 10.1016/S0300-9572(02)00377-5; Breil M, 2012, RESUSCITATION, V83, P347, DOI 10.1016/j.resuscitation.2011.09.005; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Cao C., 2012, CRITICAL CARE, V16, P1; Chalkias A, 2012, J NEUROL SCI, V315, P1, DOI 10.1016/j.jns.2011.12.007; Chen M, 2016, NEUROCHEM RES, V41, P3095, DOI 10.1007/s11064-016-2032-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Council N, 1974, GUIDE CARE USE LAB, V327, P41; Feng K., 2015, J CLIN MED PRACTICE, V19, P5; Gao CJ, 2010, NEUROSCIENCE, V168, P531, DOI 10.1016/j.neuroscience.2010.02.025; Hahn C, 2014, RESUSCITATION, V85, P628, DOI 10.1016/j.resuscitation.2013.12.033; Hossmann KA, 2008, NEUROPHARMACOLOGY, V55, P257, DOI 10.1016/j.neuropharm.2007.12.004; [胡晓露 Hu Xiaolu], 2015, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V35, P1014; Hua W, 2009, J AM COLL CARDIOL, V54, P1110, DOI 10.1016/j.jacc.2009.06.016; Huang C, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-129; Idris AH, 1996, CIRCULATION, V94, P2324, DOI 10.1161/01.CIR.94.9.2324; Jarnum H, 2009, RESUSCITATION, V80, P425, DOI 10.1016/j.resuscitation.2009.01.004; Jia XF, 2008, CRIT CARE MED, V36, P1909, DOI 10.1097/CCM.0b013e3181760eb5; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Krep H, 2004, RESUSCITATION, V63, P73, DOI 10.1016/j.resuscitation.2004.03.023; Li H, 2011, BRAIN RES, V1368, P59, DOI 10.1016/j.brainres.2010.10.073; Li JB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174596; Li J, 2010, BRAIN RES, V1356, P11, DOI 10.1016/j.brainres.2010.08.012; Li Wei, 2015, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V27, P197, DOI 10.3760/cma.j.issn.2095-4352.2015.03.008; Liu GY, 2013, BIOMED REP, V1, P861, DOI 10.3892/br.2013.153; Liu S, 2011, CRIT CARE MED, V39, P1467, DOI 10.1097/CCM.0b013e3182120d13; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; Moore J. C., 2017, CURR OPIN CRIT CARE, V24; MORIMOTO Y, 1993, CRIT CARE MED, V21, P104, DOI 10.1097/00003246-199301000-00020; Motaharinia J., 2015, DARU, V23, P1; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Nakayama S, 2016, CRIT CARE MED, V44, pE702, DOI 10.1097/CCM.0000000000001671; Namura S, 2013, ANN NY ACAD SCI, V1278, P25, DOI 10.1111/nyas.12087; Nga VDW, 2015, TISSUE ENG PT A, V21, P647, DOI [10.1089/ten.TEA.2013.0779, 10.1089/ten.tea.2013.0779]; Niizuma K, 2010, BBA-MOL BASIS DIS, V1802, P92, DOI 10.1016/j.bbadis.2009.09.002; Noppens RR, 2012, CRIT CARE MED, V40, P2149, DOI 10.1097/CCM.0b013e31824e6750; Siniscalchi Antonio, 2014, Journal of Basic and Clinical Physiology and Pharmacology, V25, P131, DOI 10.1515/jbcpp-2013-0121; Sugawara T, 2000, BRAIN RES, V877, P281, DOI 10.1016/S0006-8993(00)02684-6; Surani S., 2013, J INTENSIVE CARE MED, V41, P149; Vaagenes P, 1996, CRIT CARE MED, V24, pS57; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; Xi HJ, 2011, BRAIN RES, V1410, P24, DOI 10.1016/j.brainres.2011.06.060; Yan H., 2015, BEIJING MED J, V37, P1089; Yang L, 2014, RESUSCITATION, V85, P299, DOI 10.1016/j.resuscitation.2013.10.022	44	8	8	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 19	2017	7								5783	10.1038/s41598-017-05919-4			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1HK	WOS:000405894200001	28724904	Green Published, gold			2022-02-06	
J	Schurman, LD; Smith, TL; Morales, AJ; Lee, NN; Reeves, TM; Phillips, LL; Lichtman, AH				Schurman, Lesley D.; Smith, Terry L.; Morales, Anthony J.; Lee, Nancy N.; Reeves, Thomas M.; Phillips, Linda L.; Lichtman, Aron H.			Investigation of left and right lateral fluid percussion injury in C57BL6/J mice: In vivo functional consequences	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Lateral fluid percussion injury; Spatial memory; Reversal learning; Behavioral flexibility; Functional asymmetry	TRAUMATIC BRAIN-INJURY; LEFT-RIGHT ASYMMETRY; BARRIER BREAKDOWN; WATER MAZE; MOUSE; MODEL; SYNAPSES; RAT; NEUROTRAUMA; INHIBITION	Although rodent models of traumatic brain injury (TBI) reliably produce cognitive and motor disturbances, behavioral characterization resulting from left and right hemisphere injuries remains unexplored. Here we examined the functional consequences of targeting the left versus right parietal cortex in lateral fluid percussion injury, on Morris water maze (MWM) spatial memory tasks (fixed platform and reversal) and neurological motor deficits (neurological severity score and rotarod). In the MWM fixed platform task, right lateral injury produced a small delay in acquisition rate compared to left. However, injury to either hemisphere resulted in probe trial deficits. In the MWM reversal task, left-right performance deficits were not evident, though left lateral injury produced mild acquisition and probe trial deficits compared to sham controls. Additionally, left and right injury produced similar neurological motor task deficits, impaired righting times, and lesion volumes. Injury to either hemisphere also produced robust ipsilateral, and modest contralateral, morphological changes in reactive microglia and astrocytes. In conclusion, left and right lateral TBI impaired MWM performance, with mild fixed platform acquisition rate differences, despite similar motor deficits, histological damage, and glial cell reactivity. Thus, while both left and right lateral TBI produce cognitive deficits, laterality in mouse MWM learning and memory merits consideration in the investigation of TBI-induced cognitive consequences. (C) 2017 Published by Elsevier Ireland Ltd.	[Schurman, Lesley D.; Morales, Anthony J.; Lichtman, Aron H.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Hermes A Kontos Med Sci Bldg,1217 E Marshal St, Richmond, VA 23298 USA; [Smith, Terry L.; Lee, Nancy N.; Reeves, Thomas M.; Phillips, Linda L.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Hermes A Kontos Med Sci Bldg,1217 E Marshal St, Richmond, VA 23298 USA		Lichtman, AH (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Hermes A Kontos Med Sci Bldg,1217 E Marshal St, Richmond, VA 23298 USA.	aron.lichtman@vcuhealth.org		O'Brien (nee Schurman), Lesley/0000-0002-5877-3976	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS057758, NS056247, T32DA007027, 1F31NS095628-01A1, DA032933]; NIH-NIND Center Core [5 P30 NS047463]; NIH-NCI Cancer Center SupportUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA016059]; VCU School of Pharmacy start-up funds; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS047463, R01NS056247, R01NS057758, F31NS095628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA007027, R01DA032933] Funding Source: NIH RePORTER	National Institutes of Health [T32DA007027, 1F31NS095628-01A1 (LDS), DA032933 (AHL)]. Surgical, histological, and IHC evaluation was supported by National Institutes of Health [NS057758 (TMR) and NS056247 (LLP)]. Microscopy was funded in part by NIH-NIND Center Core (5 P30 NS047463), and by the NIH-NCI Cancer Center Support (P30 CA016059). This research was all supported by VCU School of Pharmacy start-up funds.	BERNASCONIGUASTALLA S, 1994, HIPPOCAMPUS, V4, P53, DOI 10.1002/hipo.450040107; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; El-Gaby M, 2015, NEUROSCIENTIST, V21, P490, DOI 10.1177/1073858414550658; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Gerlai RT, 2002, BRAIN RES BULL, V57, P3, DOI 10.1016/S0361-9230(01)00630-X; Goto K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015468; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Gutierrez H, 1999, NEUROSCIENCE, V89, P751, DOI 10.1016/S0306-4522(98)00360-1; Hartl R, 1997, ACT NEUR S, V70, P240; Hayes R L, 1987, Brain Inj, V1, P93, DOI 10.3109/02699058709034449; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Kohl MM, 2011, NAT NEUROSCI, V14, P1413, DOI 10.1038/nn.2915; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Reeves TM, 2016, EXP NEUROL, V283, P188, DOI 10.1016/j.expneurol.2016.06.011; Schopke R, 1991, Hippocampus, V1, P315, DOI 10.1002/hipo.450010322; Shinohara Y, 2012, HIPPOCAMPUS, V22, P117, DOI 10.1002/hipo.20886; Shinohara Y, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.010.2009; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Shipton OA, 2014, P NATL ACAD SCI USA, V111, P15238, DOI 10.1073/pnas.1405648111; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Townend J, 2013, PRACTICAL STAT ENV B; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; WAITE JJ, 1994, EXP NEUROL, V130, P214, DOI 10.1006/exnr.1994.1200; WHISHAW IQ, 1987, BEHAV BRAIN RES, V24, P125, DOI 10.1016/0166-4328(87)90250-6; Wu Y, 2005, J NEUROSCI, V25, P9213, DOI 10.1523/JNEUROSCI.2134-05.2005; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	34	8	8	1	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUL 13	2017	653						31	38		10.1016/j.neulet.2017.05.032			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FA0VE	WOS:000405153900006	28527714	Green Accepted			2022-02-06	
J	Jabbour, G; Al-Hassani, A; El-Menyar, A; Abdelrahman, H; Peralta, R; Ellabib, M; Al-Jogol, H; Asim, M; Al-Thani, H				Jabbour, Gaby; Al-Hassani, Ammar; El-Menyar, Ayman; Abdelrahman, Husham; Peralta, Ruben; Ellabib, Mohamed; Al-Jogol, Hisham; Asim, Mohammad; Al-Thani, Hassan			Clinical and Radiological Presentations and Management of Blunt Splenic Trauma: A Single Tertiary Hospital Experience	MEDICAL SCIENCE MONITOR			English	Article						Abdominal Injuries; Spleen; Wounds, Nonpenetrating	NONOPERATIVE MANAGEMENT; NONSURGICAL MANAGEMENT; EASTERN ASSOCIATION; ABDOMINAL-TRAUMA; SPLEEN INJURIES; LIVER; EMBOLIZATION; SURGERY; ADULTS; POPULATION	Background: Splenic injury is the leading cause of major bleeding after blunt abdominal trauma. We examined the clinical and radiological presentations, management, and outcome of blunt splenic injuries (BSI) in our institution. Material/Methods: A retrospective study of BSI patients between 2011 and 2014 was conducted. We analyzed and compared management and outcome of different splenic injury grades in trauma patients. Results: A total of 191 BSI patients were identified with a mean (SD) age of 26.9 years (13.1); 164 (85.9%) were males. Traffic-related accident was the main mechanism of injury. Splenic contusion and hematoma (77.2%) was the most frequent finding on initial computerized tomography (CT) scans, followed by shattered spleen (11.1%), blush (11.1%), and devascularization (0.6%). Repeated CT scan revealed 3 patients with pseudoaneurysm who underwent angioembolization. Nearly a quarter of patients were managed surgically. Non-operative management failed in 1 patient who underwent splenectomy. Patients with grade V injury presented with higher mean ISS and abdominal AIS, required frequent blood transfusion, and were more likely to be FAST-positive (p= 0.001). The majority of low-grade (I-III) splenic injuries were treated conservatively, while patients with high-grade (IV and V) BSI frequently required splenectomy (p=0.001). Adults were more likely to have grade I, II, and V BSI, blood transfusion, and prolonged ICU stay as compared to pediatric BSI patients. The overall mortality rate was 7.9%, which is mainly association with traumatic brain injury and hemorrhagic shock; half of the deaths occurred within the first day after injury. Conclusions: Most BSI patients had grade I-III injuries that were successfully treated non-operatively, with a low failure rate. The severity of injury and presence of associated lesions should be carefully considered in developing the management plan. Thorough clinical assessment and CT scan evaluation are crucial for appropriate management of BSI.	[Jabbour, Gaby; Al-Hassani, Ammar; Abdelrahman, Husham; Peralta, Ruben; Ellabib, Mohamed; Al-Jogol, Hisham; Al-Thani, Hassan] Hamad Med Corp, Dept Surg, Doha, Qatar; [El-Menyar, Ayman; Asim, Mohammad] Hamad Med Corp, Dept Surg, Clin Res, Trauma Surg, Doha, Qatar; [El-Menyar, Ayman] Weill Cornell Med Coll, Dept Clin Med, Doha, Qatar		El-Menyar, A (corresponding author), Hamad Med Corp, Dept Surg, Clin Res, Trauma Surg, Doha, Qatar.; El-Menyar, A (corresponding author), Weill Cornell Med Coll, Dept Clin Med, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X			Al-Qahtani Mohammed S, 2004, West Afr J Med, V23, P1; Arumugam Suresh, 2015, J Emerg Trauma Shock, V8, P193, DOI 10.4103/0974-2700.166590; Bhullar IS, 2013, J TRAUMA ACUTE CARE, V74, P105, DOI 10.1097/TA.0b013e3182788cd2; Bhullar IS, 2015, AAST 2015; Bradburn EH, 2010, JLGH, V4, P124; Cadeddu M, 2006, CAN J SURG, V49, P386; Dehli T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0163-6; Dent D, 2004, J TRAUMA, V56, P1063, DOI 10.1097/01.TA.0000123037.66867.F2; Di Saverio S, 2012, WORLD J EMERG SURG, V7, DOI 10.1186/1749-7922-7-3; El-Matbouly M, 2016, SURG-J R COLL SURG E, V14, P52, DOI 10.1016/j.surge.2015.08.001; Fernandes Thaís Marconi, 2013, Rev. Col. Bras. Cir., V40, P323; Fleming S, 2012, INT J SURG, V10, P470, DOI 10.1016/j.ijsu.2012.05.011; Frandon J, 2015, DIAGN INTERV RADIOL, V21, P327, DOI 10.5152/dir.2015.14800; Frumiento C, 2000, J PEDIATR SURG, V35, P985, DOI 10.1053/jpsu.2000.6948; Hamidi Mazen I, 2007, Sultan Qaboos Univ Med J, V7, P41; Hamlat CA, 2012, ANN SURG, V255, P165, DOI 10.1097/SLA.0b013e31823840ca; Iribhogbe P E, 2009, West Afr J Med, V28, P308; KOHN JS, 1994, J TRAUMA, V36, P385, DOI 10.1097/00005373-199403000-00018; Lippert SJ, 2013, J SURG RES, V182, P17, DOI 10.1016/j.jss.2012.07.036; Notash AY, 2008, EMERG MED J, V25, P210, DOI 10.1136/emj.2007.054684; Ochsner MG, 2001, WORLD J SURG, V25, P1393, DOI 10.1007/s00268-001-0138-9; Olthof DC, 2013, J TRAUMA ACUTE CARE, V74, P546, DOI 10.1097/TA.0b013e31827d5e3a; Peitzman AB, 2000, J TRAUMA, V49, P177, DOI 10.1097/00005373-200008000-00002; Richardson JD, 2005, J AM COLL SURGEONS, V200, P648, DOI 10.1016/j.jamcollsurg.2004.11.005; SCLAFANI SJA, 1995, J TRAUMA, V39, P818, DOI 10.1097/00005373-199511000-00004; Sharma OP, 2005, AM SURGEON, V71, P379; Sinha S, 2008, ANN ROY COLL SURG, V90, P109, DOI 10.1308/003588408X242033; SMITH JS, 1992, J TRAUMA, V33, P363, DOI 10.1097/00005373-199209000-00005; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS294, DOI 10.1097/TA.0b013e3182702afc; Stein Deborah M, 2006, J Intensive Care Med, V21, P296, DOI 10.1177/0885066606290854; Tugnoli G, 2015, SURG TODAY, V45, P1210, DOI 10.1007/s00595-014-1084-0; van der Vlies CH, 2012, CARDIOVASC INTER RAD, V35, P76, DOI 10.1007/s00270-011-0132-z; Weinberg JA, 2007, J TRAUMA, V62, P1143, DOI 10.1097/TA.0b013e318047b7c2; Yanar H, 2008, J TRAUMA, V64, P943, DOI 10.1097/TA.0b013e3180342023	34	8	10	0	2	INT SCIENTIFIC LITERATURE, INC	SMITHTOWN	361 FOREST LANE, SMITHTOWN, NY 11787 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	JUL 12	2017	23						3383	3392		10.12659/MSM.902438			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FA5PD	WOS:000405494800003	28700540	Green Published, Green Submitted			2022-02-06	
J	Algarra, NN; Lele, AV; Prathep, S; Souter, MJ; Vavilala, MS; Qiu, Q; Sharma, D				Algarra, Nelson N.; Lele, Abhijit V.; Prathep, Sumidtra; Souter, Michael J.; Vavilala, Monica S.; Qiu, Qian; Sharma, Deepak			Intraoperative Secondary Insults During Orthopedic Surgery in Traumatic Brain Injury	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						traumatic brain injury; intraoperative; secondary insult; extracranial surgery; hypotension; anesthesia	VENTRICULAR DIASTOLIC FUNCTION; SEVERE HEAD-INJURIES; CEREBRAL-BLOOD-FLOW; RISK-FACTORS; PREHOSPITAL VENTILATION; FRACTURE FIXATION; PROPOFOL; SEVOFLURANE; HYPOTENSION; IMPACT	Background: Secondary insults worsen outcomes after traumatic brain injury (TBI). However, data on intraoperative secondary insults are sparse. The primary aim of this study was to examine the prevalence of intraoperative secondary insults during orthopedic surgery after moderate-severe TBI. We also examined the impact of intraoperative secondary insults on postoperative head computed tomographic scan, intracranial pressure (ICP), and escalation of care within 24 hours of surgery. Materials and Methods: We reviewed medical records of TBI patients 18 years and above with Glasgow Coma Scale score <13 who underwent single orthopedic surgery within 2 weeks of TBI. Secondary insults examined were: systemic hypotension (systolic blood pressure < 90mm Hg), intracranial hypertension (ICP > 20mm Hg), cerebral hypotension (cerebral perfusion pressure < 50mm Hg), hypercarbia (end-tidal CO2 > 40mm Hg), hypocarbia (end-tidal CO2 < 30mm Hg in absence of intracranial hypertension), hyperglycemia (glucose > 200 mg/dL), hypoglycemia (glucose < 60 mg/dL), and hyperthermia (temperature > 38 degrees C). Results: A total of 78 patients (41 [18 to 81] y, 68% male) met the inclusion criteria. The most common intraoperative secondary insults were systemic hypotension (60%), intracranial hypertension and cerebral hypotension (50% and 45%, respectively, in patients with ICP monitoring), hypercarbia (32%), and hypocarbia (29%). Intraoperative secondary insults were associated with worsening of head computed tomography, postoperative decrease of Glasgow Coma Scale score by >= 2, and escalation of care. After Bonferroni correction, association between cerebral hypotension and postoperative escalation of care remained significant (P< 0.001). Conclusions: Intraoperative secondary insults were common during orthopedic surgery in patients with TBI and were associated with postoperative escalation of care. Strategies to minimize intraoperative secondary insults are needed.	[Algarra, Nelson N.] Univ Florida, Dept Anesthesiol, Gainesville, FL USA; [Lele, Abhijit V.; Prathep, Sumidtra; Souter, Michael J.; Vavilala, Monica S.; Sharma, Deepak] Univ Washington, Dept Anesthesiol & Pain Med, 325 Ninth Ave,POB 359724, Seattle, WA 98104 USA; [Sharma, Deepak] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Prathep, Sumidtra; Vavilala, Monica S.; Qiu, Qian] Harborview Injury Prevent & Res Ctr, Seattle, WA USA		Sharma, D (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, 325 Ninth Ave,POB 359724, Seattle, WA 98104 USA.	dsharma@u.washington.edu	Souter, Michael/ABE-1890-2020		Diversity Committee of the American Society of Anesthesiologists (ASA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER	Mentoring Program Award of the Diversity Committee of the American Society of Anesthesiologists (ASA) to D.S. and N.N.A.	Bhagat H, 2009, ANN CARD ANAESTH, V12, P149, DOI 10.4103/0971-9784.53446; Bolliger D, 2010, BRIT J ANAESTH, V104, P547, DOI 10.1093/bja/aeq066; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; BRATTON SL, 2007, J NEUROTRAUMA S1, V24, pS87; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Conti A, 2006, BRIT J ANAESTH, V97, P333, DOI 10.1093/bja/ael169; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P27, DOI 10.4103/2229-5151.79279; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Engelhard K, 2006, CURR OPIN ANESTHESIO, V19, P504, DOI 10.1097/01.aco.0000245275.76916.87; Faul M, 2010, TRAUMATIC BRAIN INJU; Filipovic M, 2005, BRIT J ANAESTH, V94, P186, DOI 10.1093/bja/aei028; Finkelstein E., 2006, INCIDENCE EC BURDEN; FORTUNE JB, 1995, J TRAUMA, V39, P463; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Grunsfeld Alexander, 2005, Curr Neurol Neurosci Rep, V5, P488, DOI 10.1007/s11910-005-0039-7; Haure P, 2003, J NEUROSURG ANESTH, V15, P297, DOI 10.1097/00008506-200310000-00001; Jaicks RR, 1997, J TRAUMA, V42, P1, DOI 10.1097/00005373-199701000-00001; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Kalb DC, 1998, SURGERY, V124, P739, DOI 10.1067/msy.1998.91395; Kawaguchi M, 1996, J NEUROSURG ANESTH, V8, P117, DOI 10.1097/00008506-199604000-00003; Kawano Y, 2004, J NEUROSURG ANESTH, V16, P6, DOI 10.1097/00008506-200401000-00002; Kinoshita K, 2004, RESUSCITATION, V60, P151, DOI 10.1016/j.resuscitation.2003.07.005; Lenhardt R, 2008, BEST PRAC RES-CL ANA, V22, P669, DOI 10.1016/j.bpa.2007.11.001; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Miller P, 2006, ANESTH ANALG, V103, P869, DOI 10.1213/01.ane.0000237327.12205.dc; Pecha T, 2011, ANESTH ANALG, V30, P1; Petersen KD, 2002, ACT NEUR S, V81, P89; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Sharma D, 2012, J NEUROSURG ANESTH, V24, P178, DOI 10.1097/ANA.0b013e318254fb70; Sharma D, 2009, ANESTH ANALG, V108, P81, DOI 10.1213/ane.0b013e31818a6f32; Steiner LA, 2003, ANESTH ANALG, V97, P572, DOI 10.1213/01.ANE.0000070234.17226.B0; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Townsend RN, 1998, J TRAUMA, V44, P977, DOI 10.1097/00005373-199806000-00008; UCHIDA M, 1982, CRIT CARE MED, V10, P5, DOI 10.1097/00003246-198201000-00002; Velmahos GC, 1998, AM J SURG, V176, P324, DOI 10.1016/S0002-9610(98)00208-6; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; YOSHIHARA M, 1995, J NEUROSURG, V82, P386, DOI 10.3171/jns.1995.82.3.0386	43	8	8	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2017	29	3					228	235		10.1097/ANA.0000000000000292			8	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	EX4UJ	WOS:000403230100004	26954768	Green Accepted			2022-02-06	
J	Barilaro, G; Masala, IF; Parracchini, R; Lesu, C; Caddia, G; Sarzi-Puttini, P; Atzeni, F				Barilaro, Giuseppe; Masala, Ignazio Francesco; Parracchini, Renato; Lesu, Cesare; Caddia, Giulia; Sarzi-Puttini, Piercarlo; Atzeni, Fabiola			The Role of Hyperbaric Oxygen Therapy in Orthopedics and Rheumatological Diseases	ISRAEL MEDICAL ASSOCIATION JOURNAL			English	Article; Proceedings Paper	5th Israel-Italy Meeting on Advances in Rheumatology and Autoimmunity	DEC 15, 2016	Techn Israel Inst Technol, Rappaport Fac Med, Haifa, ISRAEL		Techn Israel Inst Technol, Rappaport Fac Med	hyperbaric oxygen therapy; trauma; ulcers; mandibular fractures; vasculitis	NEUROPATHIC PAIN; RATS; FRACTURES; MODEL; FIBROMYALGIA; ULCERS; INJURY; MICE	Hyperbaric oxygen therapy (HBOT) has been investigated as a primary/adjunctive treatment for a number of injuries and medical conditions including traumatic ischemia, necrotizing soft tissue injuries, non-healing ulcers and osteoradionecrosis, but the results are controversial. There is insufficient evidence to support or reject the use of HBOT to quicken healing or to treat the established non-union of fractures. However, in patients with fibromyalgia, HBOT reduces brain activity in the posterior cortex and increases it in the frontal, cingulate, medial temporal and cerebellar cortices, thus leading to beneficial changes in brain areas that are known to function abnormally. Moreover, the amelioration of pain induced by HBOT significantly decreases the consumption of analgesic medications. In addition, HBOT has anti-inflammatory and oxygenatory effects in patients with primary or secondary vasculitis. This review analyzes the efficacy and limitations of HBOT in orthopedic and rheumatologic patients.	[Barilaro, Giuseppe] IRCCS San Raffaele Pisana, Dept Internal Med, Rome, Italy; [Masala, Ignazio Francesco] Santissima Trinita Unit Hosp, Orthoped Unit, Cagliari, Italy; [Parracchini, Renato] Santissima Trinita Unit Hosp, Maxillofacial Unit, Cagliari, Italy; [Lesu, Cesare; Caddia, Giulia] Marino Hosp, Hyperbar Unit, Cagliari, Italy; [Sarzi-Puttini, Piercarlo] Sacco Univ Hosp, Rheumatol Unit, Via GB Grassi 74, I-20157 Milan, Italy; [Atzeni, Fabiola] IRCCS Galeazzi Orthoped Inst, Milan, Italy		Atzeni, F (corresponding author), Sacco Univ Hosp, Rheumatol Unit, Via GB Grassi 74, I-20157 Milan, Italy.	atzenifabiola@hotmail.com	Sarzi-Puttini, Piercarlo/S-6457-2017	Sarzi-Puttini, Piercarlo/0000-0002-8673-5133; Barilaro, Giuseppe/0000-0003-2085-0099			Al Hadi H, 2013, J ORTHOP RES, V31, P1839, DOI 10.1002/jor.22443; Al-Moraissi EA, 2015, J ORAL MAXIL SURG, V73, P482, DOI 10.1016/j.joms.2014.09.027; Alcarsu S, 2013, UNDERSEA HYPERBAR M, V40, P197; Atesalp AS, 2002, MIL MED, V167, P978; Bennett MH, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005219.pub3; Bouachour G, 1996, J TRAUMA, V41, P333, DOI 10.1097/00005373-199608000-00023; Cazzola M, 2008, REUMATISMO, V60, P3, DOI 10.4081/reumatismo.2008.1s.3; Chia HY, 2014, INT WOUND J, V11, P601, DOI 10.1111/iwj.12012; Efrati S, 2007, CLIN EXP DERMATOL, V32, P12, DOI 10.1111/j.1365-2230.2006.02240.x; Efrati S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127012; Gu N, 2012, EUR J PAIN, V16, P1094, DOI 10.1002/j.1532-2149.2012.00113.x; Guedj E, 2008, J NUCL MED, V49, P1798, DOI 10.2967/jnumed.108.053264; Han G, 2013, PAIN RES MANAG, V18, P137, DOI 10.1155/2013/147043; Heeman JH, 2013, BRAIN RES, V1540, P42, DOI 10.1016/j.brainres.2013.09.050; Hsu RWW, 2004, J TRAUMA, V57, P1060, DOI 10.1097/01.TA.0000149247.63934.12; Ishii Y, 2002, J ORTHOP RES, V20, P353, DOI 10.1016/S0736-0266(01)00094-8; Ishii Y, 1999, TISSUE ENG, V5, P279, DOI 10.1089/ten.1999.5.279; Kawashima M, 2004, UNDERSEA HYPERBAR M, V31, P155; Kemmer A, 2006, HDB HYPERBARIC MED, P305; Koren L, 2015, ORTHOPEDICS, V38, pE200, DOI 10.3928/01477447-20150305-57; Kranke P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004123.pub4; Li FH, 2011, ANESTH ANALG, V113, P626, DOI 10.1213/ANE.0b013e31821f9544; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Lindstrom T, 1998, UNDERSEA HYPERBAR M, V25, P87; Macfarlane GJ, 2017, ANN RHEUM DIS, V76, P318, DOI 10.1136/annrheumdis-2016-209724; Marker P, 2000, BRIT J ORAL MAX SURG, V38, P417, DOI 10.1054/bjom.2000.0317; Millar IL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008381; NASSER M, 2013, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD006087.PUB3; Niinikoski J, 1996, INT JOINT M HYP UND; Opasanon Supaporn, 2014, J Am Coll Clin Wound Spec, V6, P9, DOI 10.1016/j.jccw.2015.03.003; Sarzi-Puttini P, 2015, BEST PRACT RES CL RH, V29, P1, DOI 10.1016/j.berh.2015.05.004; Savage S., 2010, J TENNESSEE MED ASS, V103, P39; Strauss M, 2004, HYPERBARIC MED PRACT, P753; Sutherland AM, 2016, PAIN PRACT, V16, P620, DOI 10.1111/papr.12312; Wilson HD, 2007, J PAIN, V8, P924, DOI 10.1016/j.jpain.2007.06.005; YABLON IG, 1968, J TRAUM, V8, P186, DOI 10.1097/00005373-196803000-00007; Yao S, 2014, J CRANIOFAC SURG, V25, P2077, DOI 10.1097/SCS.0000000000001010; Yildiz S, 2004, J INT MED RES, V32, P263; Zamboni WA, 2004, HYPERBARIC MED PRACT, P779; Zelinski LM, 2009, J PAIN, V10, P167, DOI 10.1016/j.jpain.2008.08.003	40	8	10	1	11	ISRAEL MEDICAL ASSOC JOURNAL	RAMAT GAN	2 TWIN TOWERS, 11TH FL, 35 JABOTINSKY ST, PO BOX 3604, RAMAT GAN 52136, ISRAEL	1565-1088			ISR MED ASSOC J	Isr. Med. Assoc. J.	JUL	2017	19	7					429	434					6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	FD9VN	WOS:000407870300008	28786258				2022-02-06	
J	Curvello, V; Hekierski, H; Riley, J; Vavilala, M; Armstead, WM				Curvello, Victor; Hekierski, Hugh; Riley, John; Vavilala, Monica; Armstead, William M.			Sex and age differences in phenylephrine mechanisms and outcomes after piglet brain injury	PEDIATRIC RESEARCH			English	Article							ACTIVATED PROTEIN-KINASE; CEREBRAL AUTOREGULATION; UP-REGULATION; HIPPOCAMPAL NECROSIS; JUVENILE PIGS; ERK MAPK; NOREPINEPHRINE; HYPOTENSION; CHILDREN; NEWBORN	BACKGROUND: Traumatic brain injury (TBI) is the leading cause of injury-related death in children, with boys and children under 4 years of age having particularly poor outcomes. Cerebral autoregulation is often impaired after TBI, contributing to poor outcome. In prior studies on newborn pigs, phenylephrine (Phe) preferentially protected cerebral autoregulation in female but not in male subjects after TBI. We hypothesized that, in contrast to the newborn, Phe prevents impairment of autoregulation and tissue injury following TBI in both sexes of older pigs. METHODS: Cerebral autoregulation, cerebrospinal fluid (CSF) extracellular signal-related kinase (ERK) and endothelin, and histopathology were determined after moderate fluid percussion brain injury (FPI) in male and female juvenile pigs after Phe. RESULTS: Autoregulation was more impaired in male than in female subjects. Phe protects autoregulation in both sexes after FPI, blocks ERK and endothelin, and decreases the number of necrotic neurons in male and female subjects after FPI. CONCLUSIONS: These data indicate that Phe protects autoregulation and limits neuronal necrosis via blockage of ERK and endothelin after FPI in male and female subjects. Together with prior observations in newborn pigs where Phe protected autoregulation in female but not in male subjects, these data suggest that use of Phe to improve outcomes after TBI is both sex- and age-dependent.	[Curvello, Victor; Hekierski, Hugh; Riley, John; Armstead, William M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Vavilala, Monica] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.; Armstead, WM (corresponding author), Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu		Riley, John/0000-0002-7932-8935	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS090998]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS090998] Funding Source: NIH RePORTER	This work was supported by NIH R01 NS090998.	Armstead W.M., 2014, VASCULAR MECH CNS TR, P269; Armstead WM, 2007, J CEREBR BLOOD F MET, V27, P1702, DOI 10.1038/sj.jcbfm.9600473; Armstead WM, 2016, J NEUROTRAUM, V33, P1761, DOI 10.1089/neu.2015.4290; Armstead WM, 2016, PEDIATR CRIT CARE ME, V17, pe130, DOI 10.1097/PCC.0000000000000603; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1080/713773978; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Dobbing J., 1981, SCI F PAEDIATRICS, P744; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Girling KJ, 1999, ANESTH ANALG, V89, P175, DOI 10.1097/00000539-199907000-00031; Ishikawa S, 2009, ANESTH ANALG, V108, P1631, DOI 10.1213/ane.0b013e31819d94e3; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS24, DOI 10.1097/PCC.0b013e31823f4450; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Newacheck PW, 2004, PEDIATRICS, V114, P79, DOI 10.1542/peds.114.1.79; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6	19	8	8	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	JUL	2017	82	1					108	113		10.1038/pr.2017.83			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	FB6MB	WOS:000406256000018	28355201	Green Accepted, Bronze			2022-02-06	
J	Mitchell, RJ; Cameron, CM; McClure, R				Mitchell, Rebecca J.; Cameron, Cate M.; McClure, Rod			Patterns of health care use of injured adults: A population-based matched cohort study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Injury; Health service use; Length of stay; Comorbidity	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; BURN INJURY; COMORBIDITY; EPIDEMIOLOGY; MORTALITY; LENGTH; RISK; AUSTRALIA; OUTCOMES	Background: Healthcare use by traumatically injured individuals prior to and subsequent to their injury are not often explored for different types of injuries. This study aims to describe health care use 12 months preceding and 12 months following a traumatic injury by injury type and injury severity. Method: Hospital and mortality data from three Australian states were linked in a population-based matched cohort study. Individuals >= 18 years who had an injury-related hospital admission in 2009 were identified as the injured cohort. A comparison cohort of non-injured people, matched 1:1 on age, gender and postcode of residence, was randomly selected from the electoral roll. Twelve-month pre- and post-index injury health service use was examined. Rates, adjusted rate ratios and attributable risk proportions were calculated by injury type and severity. Results: The injury cohort experienced higher 12-month pre- and post-injury hospital admissions than the non-injured group. By 6 to 7 months post-injury, the injury cohort had largely returned to their pre-injury health service use levels, except for injuries involving dislocations, sprains and strains and injury to nerves and spinal cord. Hip fracture (17.69 per 100 person-months) and poisoning (16.09 per 100 person-months) had the highest rates of post-injury hospitalisation in the injured cohort. The adjusted rate ratios (ARR) for post-injury hospitalisation were highest for poisoning (ARR: 3.77; 95% CI: 3.38-4.21) and injury to nerves and spinal cord (ARR: 2.73; 95% CI: 2.27-3.28). Poisoning also had the highest ARR for post-injury LOS (ARR: 5.31; 95% CI: 4.51-6.27). Conclusions: After sustaining a traumatic injury, many individuals are readmitted to hospital and require ongoing care up to 12 months post-injury. That injured individuals post-injury largely return to their pre-index injury hospital use by 6 to 7 months could imply a return to pre- injury function and/or that other measures of health service use should be explored. Trauma services should consider long-term follow-up and support services for seriously injured patients post-hospital discharge. (C) 2017 Elsevier Ltd. All rights reserved.	[Mitchell, Rebecca J.] Macquarie Univ, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, N Ryde, NSW 2109, Australia; [Cameron, Cate M.] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld, Australia; [McClure, Rod] Harvard Univ, Harvard Sch Publ Hlth, Harvard Injury Control Res Ctr, Cambridge, MA 02138 USA		Mitchell, RJ (corresponding author), Macquarie Univ, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, N Ryde, NSW 2109, Australia.	r.mitchell@mq.edu.au	Mitchell, Rebecca/Z-5476-2019	Mitchell, Rebecca/0000-0003-1939-1761; Cameron, Cate/0000-0003-1476-5744; McClure, Roderick/0000-0002-9067-8282	Public Health Fellowship from the National Health and Medical Research Council (NHMRC) AustraliaNational Health and Medical Research Council of Australia [428254]; Population Health Research Network; Australian Government National Collaborative Research Infrastructure StrategyAustralian GovernmentDepartment of Industry, Innovation and Science; Western Australian Minister for Science and Innovation	The authors wish to thank the New South Wales (NSW) Ministry of Health, the Queensland Department of Health and the South Australian Department of Health and Ageing for providing access to their emergency department presentation and admitted patient data collections, the NSW, Queensland and South Australian Registries of Births Deaths and Marriages for providing access to mortality data, and the NSW, Queensland and South Australian electoral commissions for providing access to their electoral rolls. The authors would also like to thank the Centre for Health Record Linkage (CHeReL), the Statistical Services Branch of the Queensland Department of Health, SA-NT DataLink, and the Centre for Data Linkage for conducting the record linkage. CC was supported by a Public Health Fellowship (ID 428254) from the National Health and Medical Research Council (NHMRC) Australia. The research was supported by the Population Health Research Network with funding from the Australian Government National Collaborative Research Infrastructure Strategy and the Western Australian Minister for Science and Innovation.	Australian Bureau of Statistics, 2011, 1270 0 55 005 AUSTR; Australian Bureau of Statistics (ABS), 2011, CENS POP HOUS SOC IN; Australian Institute of Health and Welfare, 2015, ADM PAT CAR 2013 14; Australian Institute of Health and Welfare, 2010, HLTH WELF EXP SER, V36; Bergeron E, 2005, CAN J SURG, V48, P361; Bouillon B, 2002, RESTOR NEUROL NEUROS, V20, P125; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Cameron CM, 2006, B WORLD HEALTH ORGAN, V84, P802, DOI 10.2471/BLT.06.030833; Collie A, 2013, INJURY, V44, P1514, DOI 10.1016/j.injury.2013.03.006; Cryer C, 2006, INJURY PREV, V12, P202, DOI 10.1136/ip.2006.011635; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; Dayal S., 2008, MAPPING INJURY SEVER; Dryden DM, 2004, SPINAL CORD, V42, P513, DOI 10.1038/sj.sc.3101629; Dryden DM, 2003, CAN J NEUROL SCI, V30, P113, DOI 10.1017/S0317167100053373; Duke JM, 2015, B WORLD HEALTH ORGAN, V93, P400, DOI 10.2471/BLT.14.149146; Hong J, 2013, ACCIDENT ANAL PREV, V52, P44, DOI 10.1016/j.aap.2012.12.007; Krassioukov AV, 2003, J NEUROTRAUM, V20, P391, DOI 10.1089/089771503765172345; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laursen B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001521; MACKENZIE EJ, 1988, J TRAUMA, V28, P281, DOI 10.1097/00005373-198803000-00003; Majdan M, 2015, EUR SPINE J; Miller TR, 2001, ALCOHOL CLIN EXP RES, V25, P54, DOI 10.1111/j.1530-0277.2001.tb02127.x; Mitchell RJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013266; Mitchell RJ, 2014, AUST NZ J PUBL HEAL, V38, P275, DOI 10.1111/1753-6405.12234; Munce SEP, 2009, SPINAL CORD, V47, P470, DOI 10.1038/sc.2008.173; National Centre for Classification in Health, 2006, ICD 10 AM; Niven DJ, 2012, AM J SURG, V204, P151, DOI 10.1016/j.amjsurg.2012.02.014; Pearce N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i969; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; Pirouzmand F, 2010, J NEUROSURG-SPINE, V12, P131, DOI 10.3171/2009.9.SPINE0943; Pointer S., 2015, TRENDS HOSPITALISED; Preen DB, 2006, J CLIN EPIDEMIOL, V59, P940, DOI 10.1016/j.jclinepi.2005.12.013; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Royal Australasian College of Surgeons, 2009, AUSTR TRAUM VER PROG; SAS Institute, 2014, SAS STAT SOFTW VERS; Savic G, 2000, SPINAL CORD, V38, P371, DOI 10.1038/sj.sc.3101019; Stephenson S, 2003, DIAGNOSIS BASED INJU; Wan JJ, 2006, J TRAUMA, V61, P1299, DOI 10.1097/01.ta.0000240460.35245.1a; Wasiak J, 2014, INJURY, V45, P1459, DOI 10.1016/j.injury.2014.02.018; Woodward M., 2005, EPIDEMIOLOGY STUDY D; Zahl DL, 2004, BRIT J PSYCHIAT, V185, P70, DOI 10.1192/bjp.185.1.70	41	8	8	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JUL	2017	48	7					1393	1399		10.1016/j.injury.2017.04.014			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FB2TW	WOS:000405997100018	28442203				2022-02-06	
J	Sufrinko, A; McAllister-Deitrick, J; Womble, M; Kontos, A				Sufrinko, Alicia; McAllister-Deitrick, Jamie; Womble, Melissa; Kontos, Anthony			Do Sideline Concussion Assessments Predict Subsequent Neurocognitive Impairment After Sport-Related Concussion?	JOURNAL OF ATHLETIC TRAINING			English	Article						sideline measures; neurocognitive testing; balance testing	STANDARDIZED ASSESSMENT; PROTRACTED RECOVERY; POSTURAL STABILITY; STATEMENT; SYMPTOMS; SYSTEM	Context: Comprehensive, multidomain assessment is the standard of care after sport-related concussion. However, the relationship between performance on sideline concussion-assessment tools and in-office computerized neurocognitive testing has received little attention, and the prognostic utility of sideline measures is unknown. Objective: To evaluate concurrent impairment on commonly used concussion measures 24 to 48 hours postinjury while also determining the predictive utility of sideline measures on computerized neurocognitive testing in the acute to subacute recovery periods postinjury. Design: Case-control study. Setting: High school and collegiate athletics. Patients or Other Participants: A total of 125 high school and college-aged athletes (85 males, 40 females) 14 to 23 (16.8 +/- 2.21) years old. Main Outcome Measure(s): Participants were administered sideline concussion-assessment measures (ie, Immediate Post-Concussion Assessment and Cognitive Testing [ImPACT], Standardized Assessment of Concussion [SAC], and Balance Error Scoring System [BESS]) 24 to 48 hours postinjury and completed ImPACT and the Post-Concussion Symptom Scale 5 to 7 and 10 to 14 days postinjury. Outcome measures were the ImPACT composite (verbal memory, visual memory, reaction time, visual-motor speed), SAC, and BESS scores and total symptom score on the Post-Concussion Symptom Scale. Results: Participants demonstrated heterogeneous patterns of impairment on measures 24 to 48 hours postinjury, with the most common pattern being impairment on ImPACT and the SAC. Performance on the SAC and BESS at 24 to 48 hours after injury did not distinguish between those with and those without impairment on ImPACT at 5 to 7 days postinjury (chi(2) = 5.076, P = .079) or 10 to 14 days postinjury (chi(2) = 2.04, P = .361). Conclusions: More than 90% of athletes were impaired on at least 1 sideline or neurocognitive measure 24 to 48 hours after sport-related concussion. Although sideline measures are useful for concussion diagnosis, they are not suitable for prognostication of impairment or the presence of symptoms 1 to 2 weeks postinjury.	[Sufrinko, Alicia; McAllister-Deitrick, Jamie; Womble, Melissa; Kontos, Anthony] Univ Pittsburgh, UPMC, Ctr Sports Med, Pittsburgh, PA 15260 USA		Sufrinko, A (corresponding author), UPMC, Ctr Sports Med, 3200 South Water St, Pittsburgh, PA 15203 USA.	sufrinkoam@upmc.edu		Kontos, Anthony/0000-0002-3749-4310			Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Elbin RJ, 2013, TRANSL STROKE RES, V4, P425, DOI 10.1007/s12975-012-0237-y; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2009, J ATHL TRAINING, V44, P663, DOI 10.4085/1062-6050-44.6.663; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	28	8	8	0	7	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2017	52	7					676	681		10.4085/1062-6050-52.4.01			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FB4RH	WOS:000406128700007	28535099	Green Published			2022-02-06	
J	Tucker, MS; Degeneffe, CE				Tucker, Mark S.; Degeneffe, Charles Edmund			Predictors of Employment Following Postsecondary Education for Vocational Rehabilitation Participants With Traumatic Brain Injury	REHABILITATION COUNSELING BULLETIN			English	Article						traumatic brain injury; postsecondary education; vocational rehabilitation	SERVICES; OUTCOMES; CONSUMERS; QUALITY; COLLEGE; INCOME; WORK; LIFE; RACE	The purpose of this study was to identify vocational rehabilitation (VR) services associated with employment outcomes of individuals with traumatic brain injury (TBI) who received college training and increased their highest level of postsecondary education completed. The participants were 1,221 individuals with TBI who increased their highest level of postsecondary education while receiving VR services. A logistic regression model containing five demographic and six VR service variables correctly classified 75.4% of cases as competitively employed or not competitively employed. The model explained approximately 10.0% of the variance in competitive employment. Significant predictors associated with competitive employment were the demographic characteristics of ethnicity and age at application. VR service variables that were significant predictors of competitive employment were (a) vocational rehabilitation counseling and guidance, (b) job readiness training, (c) job placement assistance, and (d) personal assistance services. While demographic characteristics and VR services explained a relatively small proportion of the variance in employment outcomes, more robust measurements of the variables have the potential to enhance prediction of outcomes. Provision of job readiness training and personal assistance services should be investigated further to determine the extent to which they serve as indicators of the presence of additional barriers to competitive employment.	[Tucker, Mark S.; Degeneffe, Charles Edmund] San Diego State Univ, 5500 Campanile Dr,MC 1127, San Diego, CA 92182 USA		Tucker, MS (corresponding author), San Diego State Univ, 5500 Campanile Dr,MC 1127, San Diego, CA 92182 USA.	mtucker@mail.sdsu.edu					Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Bolton BF, 2000, REHABIL COUNS BULL, V44, P10, DOI 10.1177/003435520004400103; Boutin D., 2009, J APPL REHABILITATIO, V40, P13; Boutin DL, 2009, REHABIL COUNS BULL, V52, P156, DOI 10.1177/0034355208320074; Capella-McDonnall ME, 2005, J VISUAL IMPAIR BLIN, V99, P303; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Chan JYC, 2011, REHABIL RES POL EDUC, V25, P135, DOI 10.1891/216866511805001019; Cooper RA, 2003, ACAD MED, V78, P864, DOI 10.1097/00001888-200309000-00004; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Degeneffe C.E., 2014, MILITARY DEPLOYMENT, P293; Degeneffe C.E., 2008, J APPL REHABIL COUS, V39, P42; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; DEGENEFFE CE, 2015, FAMILIES REHABILITAT, P213; Gamble D, 2003, J REHABIL, V69, P31; Hosmer D, 1989, APPL LOGISTIC REGRES; JAMES M, 1993, REHABIL PSYCHOL, V38, P151, DOI 10.1037/0090-5550.38.3.151; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Kim J, 2012, RES HIGH EDUC, V53, P123, DOI 10.1007/s11162-011-9244-1; Lee, 2015, FAMILIES REHABILITAT, P153; Lemeshow S, 2000, APPL LOGISTIC REGRES; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Mertler C, 2005, ADV MULTIVARIATE STA; NAKAJI D, 2014, THESIS; PRIGATANO GP, 1995, J HEAD TRAUMA REHAB, V10, P87; Roessler RT, 2004, REHABIL COUNS BULL, V47, P96, DOI 10.1177/00343552030470020401; Rogers JB, 2005, J REHABIL, V71, P5; Tabachnick B.G., 2001, USING MULTIVARIATE S; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Waghorn G, 2002, J REHABIL, V68, P40; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wheaton JE, 1996, REHABIL COUNS BULL, V40, P116; Willmott C, 2014, J HEAD TRAUMA REHAB, V29, P248, DOI 10.1097/HTR.0000000000000014; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	45	8	8	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0034-3552	1538-4853		REHABIL COUNS BULL	Rehabil. Couns. Bull.	JUL	2017	60	4					215	226		10.1177/0034355216660279			12	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	EY0LC	WOS:000403648600003					2022-02-06	
J	Vogel, EW; Morales, FN; Meaney, DF; Bass, CR; Morrison, B				Vogel, Edward W., III; Morales, Fatima N.; Meaney, David F.; Bass, Cameron R.; Morrison, Barclay, III			Phosphodiesterase-4 inhibition restored hippocampal long term potentiation after primary blast	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Blast injury; Military injury; Memory; Long-term potentiation; Phosphodiesterase; Electrophysiology; Therapeutic; In vitro; Hippocampus	TRAUMATIC BRAIN-INJURY; FLUID-PERCUSSION MODEL; BINDING PROTEIN-PHOSPHORYLATION; IN-VITRO; SYNAPTIC PLASTICITY; AMPA RECEPTORS; SLICE CULTURES; MOUSE MODEL; CYCLIC-AMP; CELL-DEATH	Due to recent military conflicts and terrorist attacks, blast-induced traumatic brain injury (bTBI) presents a health concern for military and civilian personnel alike. Although secondary blast (penetrating injury) and tertiary blast (inertia-driven brain deformation) are known to be injurious, the effects of primary blast caused by the supersonic shock wave interacting with the skull and brain remain debated. Our group previously reported that in vitro primary blast exposure reduced long-term potentiation (LTP), the electrophysiological correlate of learning and memory, in rat organotypic hippocampal slice cultures (OHSCs) and that primary blast affects key proteins governing LTP. Recent studies have investigated phosphodiesterase-4 (PDE4) inhibition as a therapeutic strategy for reducing LIP deficits following inertia-driven TBI. We investigated the therapeutic potential of PDE4 inhibitors, specifically roflumilast, to ameliorate primary blast-induced deficits in LTP. We found that roflumilast at concentrations of 1 nM or greater prevented deficits in neuronal plasticity measured 24 h post-injury. We also observed a therapeutic window of at least 6 h, but <23 h. Additionally, we investigated molecular mechanisms that could elucidate this therapeutic effect. Roflumilast treatment (1 nM delivered 6 h post-injury) significantly increased total AMPA glutamate receptor 1 (G1uR1) subunit expression, phosphorylation of the GiuR1 subunit at the serine-831 site, and phosphorylation of stargazin at the serine-239/240 site upon LTP induction, measured 24 h following injury. Roflumilast treatment significantly increased PSD-95 regardless of LTP induction. These findings indicate that further investigation into the translation of PDE4 inhibition as a therapy following bTBI is warranted. (C) 2017 Elsevier Inc. All rights reserved.	[Vogel, Edward W., III; Morales, Fatima N.; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, 1210 Amsterdam Ave, New York, NY 10027 USA; [Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Bass, Cameron R.] Duke Univ, Dept Biomed Engn, Durham, NC 27705 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864; Meaney, David/0000-0002-0954-4122	Multidisciplinary University Research Initiative from the Army Research Office [W911NF-10-1-0526]; National Defense Science & Engineering Graduate Fellowship from the Department of Defense; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088176] Funding Source: NIH RePORTER	This work was supported in part by a Multidisciplinary University Research Initiative from the Army Research Office (W911NF-10-1-0526) and by a National Defense Science & Engineering Graduate Fellowship from the Department of Defense (EWV-2012).	Ahmed T, 2003, NEUROSCIENCE, V117, P627, DOI 10.1016/S0306-4522(02)00838-2; Andreetta F, 2016, BRIT J PHARMACOL, V173, P1438, DOI 10.1111/bph.13432; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Castro LRV, 2010, J NEUROSCI, V30, P6143, DOI 10.1523/JNEUROSCI.5851-09.2010; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cherry JA, 1999, J COMP NEUROL, V407, P287; Choi JH, 2006, IEEE T BIO-MED ENG, V53, P738, DOI 10.1109/TBME.2006.870239; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Dhillon HS, 1995, J NEUROTRAUM, V12, P1035, DOI 10.1089/neu.1995.12.1035; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DVBIC, 2016, DEP DEF NUMB TRAUM B; Eakin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082016; Effgen G.B., 2016, J NEUROTRAUMA; Effgen G. B., 2012, FRONT NEUROL, V3, P1; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Heuschkel MO, 2002, J NEUROSCI METH, V114, P135, DOI 10.1016/S0165-0270(01)00514-3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hue CD, 2014, J NEUROTRAUM, V31, P951, DOI 10.1089/neu.2013.3149; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Kang W.H., 2014, BIOMECH MODEL MECHAN; Kang W.H., 2014, J NEUROTRAUMA; Kang W. H., 2015, BIOMECH MODEL MECHAN, P1; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Li XL, 2007, J NEUROPHYSIOL, V98, P3341, DOI 10.1152/jn.00977.2007; Li XL, 2010, BIOPHYS J, V98, P1733, DOI 10.1016/j.bpj.2010.01.013; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Mao LM, 2007, BRAIN RES BULL, V72, P302, DOI 10.1016/j.brainresbull.2007.01.009; Maxwell CR, 2004, NEUROSCIENCE, V129, P101, DOI 10.1016/j.neuroscience.2004.07.038; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mizuno T, 2004, NEUROPHARMACOLOGY, V46, P404, DOI 10.1016/j.neuropharm.2003.09.009; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Niedringhaus M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057144; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Panzer M.B., 2012, FRONT NEUROL, V3; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Patel TP, 2015, J NEUROSCI METH, V243, P26, DOI 10.1016/j.jneumeth.2015.01.020; Patel TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00349; Patel TP, 2012, ANN BIOMED ENG, V40, P23, DOI 10.1007/s10439-011-0390-6; Perez-Torres S, 2000, J CHEM NEUROANAT, V20, P349, DOI 10.1016/S0891-0618(00)00097-1; RANDT CT, 1982, PHARMACOL BIOCHEM BE, V17, P677, DOI 10.1016/0091-3057(82)90344-6; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Ribeiro LF, 2014, P NATL ACAD SCI USA, V111, pE149, DOI 10.1073/pnas.1313798111; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Roberson ED, 1999, J NEUROSCI, V19, P4337; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Rutten K, 2008, EUR J NEUROSCI, V28, P625, DOI 10.1111/j.1460-9568.2008.06349.x; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Silverberg N.D., 2016, J NEUROTRAUMA; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Titus DJ, 2015, CURR PHARM DESIGN, V21, P332; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Vanmierlo T, 2016, BEHAV BRAIN RES, V303, P26, DOI 10.1016/j.bbr.2016.01.031; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Vogel III E.W., 2016, J NEUROTRAUMA; Wang C, 2012, INT J NEUROPSYCHOPH, V15, P749, DOI 10.1017/S1461145711000836; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wiescholleck V, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.17; Wilson NM, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00005; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009	85	8	8	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2017	293						91	100		10.1016/j.expneurol.2017.03.025			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EV5EC	WOS:000401784300009	28366471	Bronze, Green Accepted			2022-02-06	
J	Wada, T; Yasunaga, H; Doi, K; Matsui, H; Fushimi, K; Kitsuta, Y; Nakajima, S				Wada, Tomoki; Yasunaga, Hideo; Doi, Kent; Matsui, Hiroki; Fushimi, Kiyohide; Kitsuta, Yoichi; Nakajima, Susumu			Relationship between hospital volume and outcomes in patients with traumatic brain injury: A retrospective observational study using a national inpatient database in Japan	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Neurosurgery; Trauma system	UNITED-STATES; EMERGENCY-DEPARTMENTS; MORTALITY; CENTERS; TRENDS; CARE; SURVIVAL	Background: The relationship between hospital volume and outcome after traumatic brain injury (TBI) is not completely understood in a real clinical setting. We investigated whether patients admitted with TBI achieved better outcomes in high-volume hospitals than in low-volume hospitals using a national inpatient database in Japan. Methods: This retrospective cohort study used the Diagnosis Combination Procedure database in Japan. We included patients with TBI admitted to hospitals with a Japan Coma Scale (JCS) score >= 2 between April 1, 2013 and March 31, 2014. Hospital volume was defined as the annual number of all admissions with TBI in individual hospitals. The hospital volume was categorized into four volume groups: low (<= 60 admissions per hospital), medium-low (61-120 admissions per hospital), medium-high (121-180 admissions per hospital) and high (>= 181 admissions per hospital). The outcomes of interest included 28-day mortality and survival discharge with complete dependency defined as a Barthel Index score of 0 at discharge. We used multivariate logistic regression models fitted with generalized estimating equations to evaluate relationships between the hospital volume and the outcomes. The hospital volume was evaluated both as categorical variables defined above and as continuous variables. Results: The analysis dataset consisted of 20,146 eligible patients. Of these, 2,784 died within 28 days (13.8%) and 3,409 were completely dependent among 16,996 patients discharged alive (20.1%). Multivariate analyses found that there was no significant difference between the high-volume and low-volume groups for 28-day mortality (adjusted odds ratio [OR] 0.79, 95% confidence interval [CI] 0.58-1.06 for the high-volume group) or complete dependency at discharge (adjusted OR 0.94, 95% CI 0.71-1.23 for the high-volume group). The results were the same when the hospital volume was evaluated as a continuous variable. Conclusions: Hospital volume did not appear to influence outcomes in patients with TBI. High-volume hospitals may not be necessarily beneficial for patients with TBI exhibiting impaired consciousness as a whole. (C) 2017 Elsevier Ltd. All rights reserved.	[Wada, Tomoki; Doi, Kent; Kitsuta, Yoichi; Nakajima, Susumu] Univ Tokyo Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, Tokyo, Japan; [Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Dept Hlth Policy & Informat, Tokyo, Japan		Wada, T (corresponding author), Univ Tokyo Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	wadat-eme@h.u-tokyo.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Research on Policy Planning and Evaluation from the Ministry of Health, Labour and Welfare, Japan [H27-Policy-Designated-009, H27-Policy-Strategy-011]	This work was supported by grants for Research on Policy Planning and Evaluation from the Ministry of Health, Labour and Welfare, Japan (grant nos. H27-Policy-Designated-009 and H27-Policy-Strategy-011).	[Anonymous], 2015, JAPAN TRAUMA CARE RE; [Anonymous], 2014, MINISTRY INTERNAL AF; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Calland JF, 2016, INJURY, V47, P1072, DOI 10.1016/j.injury.2015.11.017; Caputo LM, 2014, INJURY, V45, P478, DOI 10.1016/j.injury.2013.09.038; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Derlet RW, 2000, ANN EMERG MED, V35, P63, DOI 10.1016/S0196-0644(00)70105-3; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Gagne M, 2016, J TRAUMA ACUTE CARE, V80, P419, DOI 10.1097/TA.0000000000000944; Gedeborg R, 2014, J TRAUMA ACUTE CARE, V76, P358, DOI 10.1097/TA.0b013e3182a9cd31; Glance LG, 2012, ARCH SURG-CHICAGO, V147, P732, DOI 10.1001/archsurg.2012.1138; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; MAHONEY F I, 1965, Md State Med J, V14, P61; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Minei JP, 2014, ANN SURG, V260, P456, DOI 10.1097/SLA.0000000000000873; Nagata I, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009599; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Odetola FO, 2016, PREHOSP DISASTER MED, V31, P4, DOI 10.1017/S1049023X15005191; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shi HY, 2013, J NEUROSURG, V118, P732, DOI 10.3171/2012.12.JNS12693; Shigematsu K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002736; Sise RG, 2014, J TRAUMA ACUTE CARE, V76, P913, DOI 10.1097/TA.0000000000000169; SMITH RF, 1990, J TRAUMA, V30, P1066, DOI 10.1097/00005373-199009000-00002; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Tanigawa K, 2006, RESUSCITATION, V69, P365, DOI 10.1016/j.resuscitation.2006.04.001; Teig M, 2010, J NEUROSURG ANESTH, V22, P357, DOI 10.1097/ANA.0b013e3181f0dada; Tepas JJ, 2013, J TRAUMA ACUTE CARE, V74, P143, DOI 10.1097/TA.0b013e3182788b5a; Yasunaga H, 2013, ASIAN PAC J DIS MANA, V7, P19, DOI DOI 10.7223/APJDM.7.19	36	8	8	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JUL	2017	48	7					1423	1431		10.1016/j.injury.2017.05.003			9	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FB2TW	WOS:000405997100023	28511965				2022-02-06	
J	Wan, XY; Zhao, K; Wang, S; Zhang, HQ; Zeng, L; Wang, Y; Han, L; Beejadhursing, R; Shu, K; Lei, T				Wan, Xueyan; Zhao, Kai; Wang, Sheng; Zhang, Huaqiu; Zeng, Liang; Wang, Yu; Han, Lin; Beejadhursing, Rajluxmee; Shu, Kai; Lei, Ting			Is It Reliable to Predict the Outcome of Elderly Patients with Severe Traumatic Brain Injury Using the IMPACT Prognostic Calculator?	WORLD NEUROSURGERY			English	Article						Elderly; IMPACT prognostic calculator; Prognosis; Therapeutic approach; Traumatic brain injury	SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; MORTALITY; AGE; MANAGEMENT; HEMATOMA; OLDER	BACKGROUND: Many investigators endeavor to predict the outcome based on admission characteristics using some established models to determine which management should be applied. However, the efficacy and applicability of the models using in the geriatric patients with severe traumatic brain injury (TBI) have not yet been evaluated. METHODS: A total of 137 geriatric severe TBI patients were enrolled in this retrospective study. Receiver operating characteristic (ROC) curves were constructed to evaluate the efficacy and usability of the International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT) prognostic model in evaluating the prognosis for these patients. RESULTS: The observed mortality and unfavorable outcomes at 6 months in patients with severe TBI were 54.7% and 70.8%, respectively, slightly lower than the predicted outcomes using the IMPACT model. ROC curve analysis showed areas under the curve (AUCs) for mortality of 0.76 and for unfavorable outcome of 0.80 in the Core model, of 0.76 and 0.79, respectively, in the Extended model, and of 0.73 and 0.77, respectively, in the Lab model. When expected risk of fatal outcome was >90% in any model, the true positive rate was 100%. Moreover, when the predicted risk for unfavorable outcomes was >70% in any model, the actual rate of unfavorable outcomes was >80%. CONCLUSIONS: The IMPACT prognosis calculator showed just fair discrimination when predicting the outcome of the elderly patients with severe TBI. Management decisions should be made on a case-by-case basis rather than by relying on the predicted risks identified by this model; conservative treatment might be preferable when expected risk of fatal outcome is >90%.	[Wan, Xueyan; Zhao, Kai; Wang, Sheng; Zhang, Huaqiu; Zeng, Liang; Wang, Yu; Han, Lin; Shu, Kai; Lei, Ting] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Neurosurg, Wuhan, Peoples R China; [Beejadhursing, Rajluxmee] Huazhong Univ Sci & Technol, Tongji Med Coll, Clin Sch 2, Wuhan, Peoples R China		Lei, T (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Neurosurg, Wuhan, Peoples R China.	naowai1@tjh.tjmu.edu.cn	Beejadhursing, Rajluxmee/AAZ-4338-2020	Beejadhursing, Rajluxmee/0000-0002-9087-2288; Wan, Xueyan/0000-0002-7148-9857	National Clinical Key Specialty Construction Project	This work was supported by the National Clinical Key Specialty Construction Project. The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Honeybul S, 2011, J NEUROTRAUM, V28, P13, DOI 10.1089/neu.2010.1584; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Olivecrona M, 2013, J CLIN NEUROSCI, V20, P996, DOI 10.1016/j.jocn.2012.09.015; Olivecrona M, 2012, ACTA NEUROCHIR, V154, P1567, DOI 10.1007/s00701-012-1351-z; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Wan XY, 2016, WORLD NEUROSURG, V89, P147, DOI 10.1016/j.wneu.2016.01.084	26	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2017	103						584	590		10.1016/j.wneu.2017.04.069			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FA5JR	WOS:000405479900076	28433847				2022-02-06	
J	Azabou, E; Rohaut, B; Heming, N; Magalhaes, E; Morizot-Koutlidis, R; Kandelman, S; Allary, J; Moneger, G; Polito, A; Maxime, V; Annane, D; Lofaso, F; Chretien, F; Mantz, J; Porcher, R; Sharshar, T				Azabou, Eric; Rohaut, Benjamin; Heming, Nicholas; Magalhaes, Eric; Morizot-Koutlidis, Regine; Kandelman, Stanislas; Allary, Jeremy; Moneger, Guy; Polito, Andrea; Maxime, Virginie; Annane, Djillali; Lofaso, Frederic; Chretien, Fabrice; Mantz, Jean; Porcher, Raphael; Sharshar, Tarek			Early impairment of intracranial conduction time predicts mortality in deeply sedated critically ill patients: a prospective observational pilot study	ANNALS OF INTENSIVE CARE			English	Article						Prognostic; Outcome; Deep sedation; Evoked potentials; ICU; Brain dysfunction; Neurophysiological assessment; Delirium; Altered mental status	SOMATOSENSORY-EVOKED-POTENTIALS; INTENSIVE-CARE-UNIT; MECHANICALLY VENTILATED PATIENTS; TRAUMATIC BRAIN-INJURY; PROGNOSTIC VALUE; SEPTIC SHOCK; MULTICENTER COHORT; COMA; DELIRIUM; VALIDITY	Background: Somatosensory (SSEP) and brainstem auditory (BAEP) evoked potentials are neurophysiological tools which, respectively, explore the intracranial conduction time (ICCT) and the intrapontine conduction time (IPCT). The prognostic values of prolonged cerebral conduction times in deeply sedated patients have never been assessed. Sedated patients are at risk of developing new neurological complications, undetected. In this prospective observational bi-center pilot study, we investigated whether early impairment of SSEP's ICCT and/or BAEP's IPCT could predict in-ICU mortality or altered mental status (AMS), in deeply sedated critically ill patients. Methods: SSEP by stimulation of the median nerve and BAEP were assessed in critically ill patients receiving deep sedation on day 3 following ICU admission. Deep sedation was defined by a Richmond Assessment sedation Scale (RASS) <-3. Mean left-and right-side ICCT and IPCT were measured for each patient. Primary and secondary outcomes were, respectively, in-ICU mortality and AMS defined as the occurrence of delirium and/or delayed awakening after discontinuation of sedation. Results: Eighty-six patients were studied of which 49 (57%) were non-brain-injured and 37 (43%) were brain-injured. Impaired ICCT was a predictor of in-ICU mortality after adjustment on the global Sequential Organ Failure Assessment score (SOFA) [OR (95% CI) = 2.69 (1.05-6.85); p = 0.039] and on the non-neurological SOFA components [2.67 (1.056.81); p = 0.040]. IPCT was more frequently delayed in the subgroup of patients who developed post-sedation AMS (24%) compared those without AMS (0%). However, this difference did not reach statistical significance (p = 0.053). Impairment rates of ICCT and IPCT were not found to be significantly different between non-brain-and brain-injured subgroups of patients. Conclusion: In critically ill patients receiving deep sedation, early ICCT impairment was associated with mortality. Somatosensory and brainstem auditory evoked potentials may be useful early warning indicators of brain dysfunction as well as prognostic markers in deeply sedated critically ill patients.	[Azabou, Eric; Lofaso, Frederic] Univ Versailles St Quentin En Yvelines, Raymond Poincare Hosp, AP HP, Dept Physiol,INSERM U1179, Garches, France; [Azabou, Eric; Heming, Nicholas; Magalhaes, Eric; Moneger, Guy; Polito, Andrea; Maxime, Virginie; Annane, Djillali; Sharshar, Tarek] Univ Versailles St Quentin En Yvelines, Raymond Poincare Hosp, AP HP, Gen Intens Care Unit,INSERM U1173, Garches, France; [Rohaut, Benjamin; Morizot-Koutlidis, Regine] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurol, Intens Care Unit, Paris, France; [Rohaut, Benjamin; Morizot-Koutlidis, Regine] UPMC Univ Paris 06, Fac Med Pitie Salpetriere, Sorbonne Univ, Paris, France; [Kandelman, Stanislas; Allary, Jeremy] Univ Paris 07, Beaujon Hosp, Dept Anesthesiol & Intensive Care Med, Clichy, France; [Chretien, Fabrice; Mantz, Jean; Sharshar, Tarek] Inst Pasteur, Lab Human Histopathol & Anim Models, 28 Rue Dr Roux, F-75015 Paris, France; [Mantz, Jean] Paris Descartes Univ, European Hosp Georges Pompidou, Dept Anesthesiol & Intens Care Med, Paris, France; [Porcher, Raphael] Univ Paris 05, Hotel Dieu Hosp, AP HP, Ctr Clin Epidemiol,INSERM U1153, Paris, France; [Sharshar, Tarek] Univ Versailles St Quentin En Yvelines, Raymond Poincare Hosp, AP HP, Gen Intens Care Med, 104 Blvd Raymond Poincare, F-92380 Garches, France		Sharshar, T (corresponding author), Univ Versailles St Quentin En Yvelines, Raymond Poincare Hosp, AP HP, Gen Intens Care Med, 104 Blvd Raymond Poincare, F-92380 Garches, France.	Tarek.Sharshar@aphp.fr	Chretien, fabrice B/D-4035-2018; Rohaut, Benjamin/O-9250-2017; Lofaso, Frederic/R-6100-2018; Sharshar, Tarek/ABF-4117-2021; Annane, Djillali/R-7947-2019	Chretien, fabrice B/0000-0002-2794-1383; Rohaut, Benjamin/0000-0001-6752-8756; AZABOU, Eric/0000-0002-9747-9972; Porcher, Raphael/0000-0002-5277-4679	"Master 2 Bourse" Grant	EM was supported by a "Master 2 Bourse" Grant allocated by French Intensive Care Society (FICS)/Societe de Reanimation de Langue Francaise (SRLF) in 2012.	Amantini A, 2008, EUR J ANAESTH, V25, P196, DOI 10.1017/S0265021507003183; Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; Annane D, 2015, LANCET RESP MED, V3, P61, DOI 10.1016/S2213-2600(14)70246-2; [Anonymous], 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P1; Azabou E, 2017, NEUROL SCI, V38, P715, DOI 10.1007/s10072-017-2824-x; Azabou E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139969; Balzer F, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0929-2; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Boisseau N, 2002, BRIT J ANAESTH, V88, P785, DOI 10.1093/bja/88.6.785; Bouwes A, 2013, NEUROCRIT CARE, V19, P25, DOI 10.1007/s12028-013-9856-8; Constantin JM, 2016, ANAESTH CRIT CARE PA, V35, P7, DOI 10.1016/j.accpm.2015.06.012; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Facco E., 1993, Neurophysiologie Clinique, V23, P237, DOI 10.1016/S0987-7053(05)80233-3; Fischer C, 2006, CRIT CARE MED, V34, P1520, DOI 10.1097/01.CCM.0000215823.36344.99; FISCHER C, 1994, NEUROSURGERY, V35, P45, DOI 10.1227/00006123-199407000-00007; Fossi S, 2006, NEUROPHYSIOL CLIN, V36, P195, DOI 10.1016/j.neucli.2006.09.001; Frenette AJ, 2016, INTENS CARE MED, V42, P122, DOI 10.1007/s00134-015-3964-1; Grap MJ, 2012, AM J CRIT CARE, V21, pE53, DOI 10.4037/ajcc2012301; Guerit J M, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P117; Guerit JM, 2009, NEUROPHYSIOL CLIN, V39, P71, DOI 10.1016/j.neucli.2009.03.002; Guerit J. M., 1993, Neurophysiologie Clinique, V23, P209, DOI 10.1016/S0987-7053(05)80231-X; Guerit JM, 2004, ANN FR ANESTH, V23, P99, DOI 10.1016/j.annfar.2004.01.002; Haupt WF, 1995, ACTA NEUROCHIR, V137, P146, DOI 10.1007/BF02187186; Klistorner A, 2013, NEUROLOGY, V80, P242, DOI 10.1212/WNL.0b013e31827deb39; Koenig MA, 2015, J CLIN NEUROPHYSIOL, V32, P472, DOI 10.1097/WNP.0000000000000215; Lang M, 2002, J NEUROSURG ANESTH, V14, P141, DOI 10.1097/00008506-200204000-00009; Lee CM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0600-3; Liu EHC, 2005, BRIT J ANAESTH, V94, P193, DOI 10.1093/bja/aei003; Logi F, 2003, CLIN NEUROPHYSIOL, V114, P1615, DOI 10.1016/S1388-2457(03)00086-5; Longrois D, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-56; Mantz J, 2011, EUR J ANAESTH, V28, P3, DOI 10.1097/EJA.0b013e32833e266d; Pandharipande PP, 2014, NEW ENGL J MED, V370, P185, DOI 10.1056/NEJMc1313886; Pandharipande PP, 2010, CRIT CARE, V14, DOI 10.1186/cc8916; PARRY GJ, 1987, NEUROLOGY, V37, P313, DOI 10.1212/WNL.37.2.313; Pisani MA, 2009, CRIT CARE MED, V37, P177, DOI 10.1097/CCM.0b013e318192fcf9; Polito A, 2013, CRIT CARE, V17, DOI 10.1186/cc12899; Rattay F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079256; Rohaut B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176012; Salluh JIF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2538; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Sharshar T, 2002, CRIT CARE MED, V30, P2371, DOI 10.1097/00003246-200210000-00031; Sharshar T, 2007, INTENS CARE MED, V33, P798, DOI 10.1007/s00134-007-0598-y; Sharshar T, 2011, CRIT CARE MED, V39, P1960, DOI 10.1097/CCM.0b013e31821b843b; Shehabi Y, 2013, CRIT CARE, V17, DOI 10.1186/cc12679; Shehabi Y, 2013, INTENS CARE MED, V39, P910, DOI 10.1007/s00134-013-2830-2; Tanaka LMS, 2014, CRIT CARE, V18, DOI 10.1186/cc13995; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; WALSH JC, 1984, J NEUROL NEUROSUR PS, V47, P197, DOI 10.1136/jnnp.47.2.197; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Zammit Christopher, 2013, Emerg Med Pract, V15, P1; Zanatta P, 2014, J NEUROSURG ANESTH, V26, P161, DOI 10.1097/ANA.0000000000000016; Zauner C, 2000, CRIT CARE MED, V28, P1310, DOI 10.1097/00003246-200005000-00009; Zauner C, 2002, CRIT CARE MED, V30, P1136, DOI 10.1097/00003246-200205000-00030; ZENTNER J, 1988, EUR ARCH PSY CLIN N, V237, P184, DOI 10.1007/BF00451288; Zhang Y, 2011, J CLIN NEUROPHYSIOL, V28, P497, DOI 10.1097/WNP.0b013e318231c852	56	8	8	0	6	SPRINGEROPEN	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2110-5820			ANN INTENSIVE CARE	Ann. Intensive Care	JUN 12	2017	7								63	10.1186/s13613-017-0290-5			12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5QQ	WOS:000404772900003	28608136	gold, Green Published			2022-02-06	
J	Thomas, AW; Watts, R; Filippi, CG; Nickerson, JP; Andrews, T; Lieberman, G; Naylor, MR; Eppstein, MJ; Freeman, K				Thomas, Alexander W.; Watts, Richard; Filippi, Christopher G.; Nickerson, Joshua P.; Andrews, Trevor; Lieberman, Gregory; Naylor, Magdalena R.; Eppstein, Margaret J.; Freeman, Kalev			Dynamic changes in diffusion measures improve sensitivity in identifying patients with mild traumatic brain injury	PLOS ONE			English	Article							AXONAL INJURY; WHITE-MATTER; FRACTIONAL ANISOTROPY; BIDIRECTIONAL CHANGES; TENSOR; CONCUSSION; MODEL; MR; REPRODUCIBILITY; ABNORMALITIES	The goal of this study was to investigate patterns of axonal injury in the first week after mild traumatic brain injury (mTBI). We performed a prospective cohort study of 20 patients presenting to the emergency department with mTBI, using 3.0T diffusion tensor MRI immediately after injury and again at 1 week post-injury. Corresponding data were acquired from 16 controls over a similar time interval. Fractional anisotropy (FA) and other diffusion measures were calculated from 11 a priori selected axon tracts at each time-point, and the change across time in each region was quantified for each subject. Clinical outcomes were determined by standardized neurocognitive assessment. We found that mTBI subjects were significantly more likely to have changes in FA in those 11 regions of interest across the one week time period, compared to control subjects whose FA measurements were stable across time. Longitudinal imaging was more sensitive to these subtle changes in white matter integrity than cross-sectional assessments at either of two time points, alone. Analyzing the sources of variance in our control population, we show that this increased sensitivity is likely due to the smaller within-subject variability obtained by longitudinal analysis with each subject as their own control. This is in contrast to the larger between-subject variability obtained by cross-sectional analysis of each individual subject to normalized data from a control group. We also demonstrated that inclusion of all a priori ROIs in an analytic model as opposed to measuring individual ROIs improves detection of white matter changes by overcoming issues of injury heterogeneity. Finally, we employed genetic programming (a bio-inspired computational method for model estimation) to demonstrate that longitudinal changes in FA have utility in predicting the symptomatology of patients with mTBI. We conclude concussive brain injury caused acute, measurable changes in the FA of white matter tracts consistent with evolving axonal injury and/or edema, which may contribute to post-concussive symptoms.	[Thomas, Alexander W.; Freeman, Kalev] Univ Vermont, Dept Surg, Burlington, VT 05405 USA; [Watts, Richard; Nickerson, Joshua P.; Andrews, Trevor] Univ Vermont, Dept Radiol, Burlington, VT USA; [Filippi, Christopher G.] Univ Vermont, Dept Neurol, Burlington, VT USA; [Filippi, Christopher G.] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA; [Andrews, Trevor] Philips HealthTech, Cleveland, OH USA; [Lieberman, Gregory; Naylor, Magdalena R.] Univ Vermont, Dept Psychiat, Burlington, VT USA; [Lieberman, Gregory] US Army, Res Lab, Human Res & Engn Directorate, Aberdeen, MD USA; [Eppstein, Margaret J.] Univ Vermont, Dept Comp Sci, Burlington, VT USA		Freeman, K (corresponding author), Univ Vermont, Dept Surg, Burlington, VT 05405 USA.	Kalev.Freeman@med.uvm.edu	Filippi, Christopher/AAA-5493-2021	Andrews, Trevor/0000-0003-0331-1798	National institute of healthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1K08GM098795]	Funded by National institute of health: 1K08GM098795 for author KF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of our authors, TA, has a commercial affiliation with Philips HealthTech, but this did not play any role in the study. The commercial sponsor had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier N, 2015, NONLINEAR FUNCTIONAL; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Faul M, 2010, TRAUMATIC BRAIN INJU; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Herrera J.J., 2016, J NEUROTRAUMA; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Koehler R, 2011, COGNITIVE REHABILITATION THERAPY FOR TRAUMATIC BRAIN INJURY: EVALUATING THE EVIDENCE, P1; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Muller HP, 2009, MAGN RESON IMAGING, V27, P324, DOI 10.1016/j.mri.2008.07.003; Nickerson JP, 2009, CLIN NEURORADIOL, V19, P129, DOI 10.1007/s00062-009-8040-1; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schmidt M., 2013, EUREQA VERSION 0 98; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Setsompop K, 2012, NEUROIMAGE, V63, P569, DOI 10.1016/j.neuroimage.2012.06.033; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Watts R, 2014, RADIOLOGY, V272, P217, DOI 10.1148/radiol.14131856; White T, 2009, PSYCHIAT RES-NEUROIM, V174, P110, DOI 10.1016/j.pscychresns.2009.04.014	46	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0178360	10.1371/journal.pone.0178360			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	WOS:000403088400014	28604837	Green Published, Green Submitted, gold			2022-02-06	
J	Blanco, P; Blaivas, M				Blanco, Pablo; Blaivas, Michael			Applications of Transcranial Color-Coded Sonography in the Emergency Department	JOURNAL OF ULTRASOUND IN MEDICINE			English	Article						emergency; head injury; stroke; subarachnoid hemorrhage; transcranial Doppler; ultrasound	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; DOPPLER ULTRASONOGRAPHY; DUPLEX-SONOGRAPHY; PULSATILITY INDEX; INTRACEREBRAL HEMORRHAGE; MIDLINE SHIFT; ARTERIOVENOUS-MALFORMATIONS; INTRACRANIAL-PRESSURE; ULTRASOUND	Transcranial color-coded Doppler sonography is a noninvasive bedside ultrasound application that combines both imaging of parenchymal structures and Doppler assessment of intracranial vessels. It may aid in rapid diagnoses and treatment decision making of patients with intracranial emergencies in point-of-care settings. This pictorial essay illustrates the technical aspects and emergency department applications of transcranial color-coded Doppler sonography, and provides some rationale for implementation of this technique into the emergency department practice.	[Blanco, Pablo] Hosp Dr Emilio Ferreyra, Intens Care Unit, Necochea, Argentina; [Blaivas, Michael] Univ South Carolina, Sch Med, Piedmont Hosp, Dept Emergency Med, Newnan, GA USA		Blanco, P (corresponding author), Hosp Dr Emilio Ferreyra, Intens Care Unit, 4801,59 St, RA-7630 Buenos Aires, DF, Argentina.	ohtusabes@gmail.com					Abadal J.M., 2007, Med. Intensiva, V31, P510; Aminmansour B, 2009, J RES MED SCI, V14, P343; [Anonymous], 2008, ACEP EMERGENCY ULTRA; Baldwin ME, 2004, STROKE, V35, P2506, DOI 10.1161/01.STR.0000144654.79393.cf; Bartels E, 2005, J ULTRAS MED, V24, P1511, DOI 10.7863/jum.2005.24.11.1511; BECKER G, 1994, NEURORADIOLOGY, V36, P585, DOI 10.1007/BF00600414; Blanco P, 2015, J ULTRASOUND, V18, P201, DOI 10.1007/s40477-015-0164-3; Blanco P, 2015, J ULTRAS MED, V34, P1337, DOI 10.7863/ultra.34.7.1337; Blanco Pablo, 2015, Ann Emerg Med, V65, pe1, DOI 10.1016/j.annemergmed.2014.08.042; Caricato A, 2010, INTENS CARE MED, V36, P1091, DOI 10.1007/s00134-010-1801-0; Caricato A, 2014, WORLD J RADIOL, V6, P636, DOI 10.4329/wjr.v6.i9.636; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Consensus Group on Transcranial Doppler in the Diagnosis of Brain Death, 2014, REV BRAS TER INTENSI, V26, P240; Conti A, 2009, NEUROCRIT CARE, V10, P326, DOI 10.1007/s12028-009-9199-7; de Oliveira Ricardo Santos, 2003, Neurosurg Focus, V15, pECP3; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; Eder KE, 2012, NEUROLOGY, V79, pE79, DOI 10.1212/WNL.0b013e318266fc89; Gerriets T, 1999, NEUROLOGY, V52, P45, DOI 10.1212/WNL.52.1.45; Gerriets T, 2001, STROKE, V32, P442, DOI 10.1161/01.STR.32.2.442; Gura M, 2012, TURK NEUROSURG, V22, P411, DOI 10.5137/1019-5149.JTN.4201-11.1; Gura M, 2011, TURK NEUROSURG, V21, P210, DOI 10.5137/1019-5149.JTN.3574-10.1; Kiphuth IC, 2011, NEUROLOGY, V76, P858, DOI 10.1212/WNL.0b013e31820f2e0f; Kirsch JD, 2013, RADIOGRAPHICS, V33, pE1, DOI 10.1148/rg.331125071; Kukulska-Pawluczuk B, 2012, EUR J RADIOL, V81, P1253, DOI 10.1016/j.ejrad.2011.02.066; Llompart-Pou JA, 2013, TRANSCRANIAL SONOGRA; Hernandez NL, 2007, NEUROLOGIA, V22, P507; Marshall SA, 2010, NEUROSURG CLIN N AM, V21, P291, DOI 10.1016/j.nec.2009.10.010; Matsumoto N, 2011, J NEUROIMAGING, V21, P355, DOI 10.1111/j.1552-6569.2010.00559.x; Maurer M, 1998, STROKE, V29, P2563, DOI 10.1161/01.STR.29.12.2563; Meyer K, 2001, J NEUROIMAGING, V11, P287, DOI 10.1111/j.1552-6569.2001.tb00048.x; Nedelmann M, 2009, STROKE, V40, P3238, DOI 10.1161/STROKEAHA.109.555169; Niesen WD, 2006, ULTRASCHALL MED, V27, P251, DOI 10.1055/s-2006-926544; Perez ES, 2009, STROKE, V40, P987, DOI 10.1161/STROKEAHA.108.524249; Pou JAL, 2004, INTENS CARE MED, V30, P1672, DOI 10.1007/s00134-004-2348-8; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Rigamonti A, 2008, CAN J ANAESTH, V55, P112, DOI 10.1007/BF03016323; Saqqur M, 2007, CRIT CARE MED, V35, pS216, DOI 10.1097/01.CCM.0000260633.66384.FB; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; Tang SC, 2006, J ULTRAS MED, V25, P203, DOI 10.7863/jum.2006.25.2.203; Thompson BB, 2014, NEUROCRIT CARE, V21, P534, DOI 10.1007/s12028-014-9979-6; Uggowitzer MM, 1999, AM J NEURORADIOL, V20, P101; Wakerley BR, 2013, NEUROSURGERY, V72, pE319, DOI 10.1227/NEU.0b013e31827bc199; Wang LS, 2012, J CLIN ULTRASOUND, V40, P535, DOI 10.1002/jcu.21911; Westra SJ, 1998, J ULTRAS MED, V17, P561; White H, 2006, INTENS CARE MED, V32, P981, DOI 10.1007/s00134-006-0173-y; Zipper SG, 2002, EUR J NEUROL, V9, P1, DOI 10.1046/j.1468-1331.2002.00272.x; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	47	8	8	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0278-4297	1550-9613		J ULTRAS MED	J. Ultrasound Med.	JUN	2017	36	6					1251	1266		10.7863/ultra.16.04050			16	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	EV6WF	WOS:000401914600020	28240783				2022-02-06	
J	Borges, A; Raab, S; Lininger, M				Borges, Amanda; Raab, Scot; Lininger, Monica			A COMPREHENSIVE INSTRUMENT FOR EVALUATING MILD TRAUMATIC BRAIN INJURY (MTBI)/CONCUSSION IN INDEPENDENT ADULTS: A PILOT STUDY	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Balance; C3 Logix; Computerized; ImPACT; King Devick	MONTREAL COGNITIVE ASSESSMENT; MENTAL-STATE-EXAMINATION; TEST-RETEST RELIABILITY; SCREENING TOOL; CONCUSSION; SYSTEM; SENSITIVITY; MANAGEMENT	Background: One common component of concussion rehabilitation is a computerized cognitive test free of concomitant physical demands. Healthcare professionals may be able to provide more patient-centered care after a diagnosed concussion if specific areas of impairment are identified and treated, such as the physical aspect of neurocognitive function. Hypothesis/Purpose: To evaluate the test-retest reliability of a unique combination of neurocognitive assessment tools currently utilized in concussion assessments into one single, inclusive instrument that measures both neurocognitive function and physical capability. Study Design: Original research - diagnostic tests. Methods: Fourteen individuals (nine males, age: 29 + 17.9, five females, age: 46.0 +/- 21.5 years) either with normal cognitive function (NBI) without history of a health event (e.g. cerebral vascular accident/stroke, mTBI) that resulted in brain injury within one year of the study, or who had suffered a health event that has resulted in a medically documented brain injury (BI) participated in the study. Participants completed the full hybrid assessment instrument for a baseline test, then completed a follow-up test using the same instrument within 72-96 hours of baseline. Test-retest reliability was measured using Pearson product-moment correlations of the first and second testing sessions, and a two-way ANOVA (group between factor: NBI and BI and time within factor: session 1 and session 2) was performed on the summative scores to determine differences between each group. Results: Test-retest reliability was strong and statistical significant for both the NBI (r = .858, p = .014) and the BI (r = .967, p =. 033) groups. There was a significant difference between summative scores for the NBI and BI groups (F-1,F-20 = 42.325, p < .0001). Conclusion: The newly created Comprehensive Instrument for Evaluating Mild Traumatic Brain Injury (CIEMTBI) demonstrates good test-retest reliability and was able to discriminate the results between individuals in the NBI and BI groups. Further research, specifically with different samples, is needed to better determine the reliability and diagnostic accuracy of the instrument.	[Borges, Amanda; Raab, Scot; Lininger, Monica] No Arizona Univ, Flagstaff, AZ 86011 USA		Lininger, M (corresponding author), No Arizona Univ, Athlet Training Educ Program, POB 15094, Flagstaff, AZ 86011 USA.	monica.lininger@nau.edu					Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; Alsalaheen BA, 2015, CLIN J SPORT MED; Antonucci MM, FRONTIERS NEUROLOGY; Baciu M, 2016, AGE DORDR, V38; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Cleveland Clinic, 1995, CLEV CLIN C3LOGIX; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2013, TRANSL STROKE RES, V4, P420, DOI 10.1007/s12975-012-0228-z; DELEON J, 1993, ACTA PSYCHIAT SCAND, V88, P188; Erickson GB, 2011, OPTOMETRY, V82, P528, DOI 10.1016/j.optm.2011.01.012; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gaudet CE, 2017, CLIN NEUROPSYCHOL, V31, P43, DOI 10.1080/13854046.2016.1220622; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kao CL, 2010, SENSORS-BASEL, V10, P7602, DOI 10.3390/s100807602; Kirova AM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/748212; Kontos AP, 2016, AM J SPORTS MED; MacDonald J, 2015, CLIN J SPORT MED, V25, P367, DOI 10.1097/JSM.0000000000000139; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nasreddine Z, MONTREAL COGNITIVE A; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nelson LD, 2013, NEUROPSYCHOL REV, V23, P285, DOI 10.1007/s11065-013-9240-7; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; SCAT3, 2013, BRIT J SPORT MED, V47, P259; Schatz P, 2015, ASSESSMENT, V22, P405, DOI 10.1177/1073191114566622; Schweizer TA, 2012, J NEUROL SCI, V316, P137, DOI 10.1016/j.jns.2012.01.003; Strauss E, 2006, COMPENDIUM NEUROPSYC, P1240; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Treleaven J, 2006, AUST J PHYSIOTHER, V52, P67, DOI 10.1016/S0004-9514(06)70070-8; Vereeck L, 2007, OTOLOGY NEUROTOLOGY, V28; Vital D, 2010, ARCH OTOLARYNGOL, V136, P686, DOI 10.1001/archoto.2010.99; Zasler ND, 2015, BRAIN INJURY, V29, P207, DOI 10.3109/02699052.2014.965213	40	8	8	0	7	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	JUN	2017	12	3					381	389					9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	EY6ZT	WOS:000404135400008	28593091				2022-02-06	
J	Kline, D; Andridge, R; Kaizar, E				Kline, David; Andridge, Rebecca; Kaizar, Eloise			Comparing multiple imputation methods for systematically missing subject-level data	RESEARCH SYNTHESIS METHODS			English	Article						multiple imputation; research synthesis; longitudinal data; systematic missing data	TRAUMATIC BRAIN-INJURY; METAANALYSIS; MODELS	When conducting research synthesis, the collection of studies that will be combined often do not measure the same set of variables, which creates missing data. When the studies to combine are longitudinal, missing data can occur on the observation-level (time-varying) or the subject-level (non-time-varying). Traditionally, the focus of missing data methods for longitudinal data has been on missing observation-level variables. In this paper, we focus on missing subject-level variables and compare two multiple imputation approaches: a joint modeling approach and a sequential conditional modeling approach. We find the joint modeling approach to be preferable to the sequential conditional approach, except when the covariance structure of the repeated outcome for each individual has homogenous variance and exchangeable correlation. Specifically, the regression coefficient estimates from an analysis incorporating imputed values based on the sequential conditional method are attenuated and less efficient than those from the joint method. Remarkably, the estimates from the sequential conditional method are often less efficient than a complete case analysis, which, in the context of research synthesis, implies that we lose efficiency by combining studies. Copyright (C) 2015 John Wiley & Sons, Ltd.	[Kline, David] Ohio State Univ, Dept Biomed Informat, Ctr Biostat, Columbus, OH 43210 USA; [Andridge, Rebecca] Ohio State Univ, Div Biostat, Coll Publ Hlth, Columbus, OH 43210 USA; [Kaizar, Eloise] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA		Kline, D (corresponding author), Ohio State Univ, Dept Biomed Informat, Ctr Biostat, Columbus, OH 43210 USA.	david.kline@osumc.edu	Kline, David/K-8372-2019	Kline, David/0000-0001-6183-3303	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD080033]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD080033] Funding Source: NIH RePORTER	The authors thank Drs Terry Stancin, H. Gerry Taylor, Shari Wade, and Keith Yeates for providing data and assistance related to the example, and an associate editor and two reviewers for their helpful comments. This work was supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development under award number R03HD080033. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achenbach T., 1991, INTEGRATIVE GUIDE 19; Carpenter JR, 2013, MULTIPLE IMPUTATION, V1st; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Daniels MJ, 2002, BIOMETRIKA, V89, P553, DOI 10.1093/biomet/89.3.553; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Gelman A., 2004, BAYESIAN DATA ANAL, VVolume 2; Higgins JPT, 2001, STAT MED, V20, P2219, DOI 10.1002/sim.918; Hollingshead A. B, 1975, 4 FACTOR INDEX UNPUB; Jolani S, 2015, STAT MED, V34, P1841, DOI 10.1002/sim.6451; Jones AP, 2009, CLIN TRIALS, V6, P16, DOI 10.1177/1740774508100984; Little R. J., 2019, STAT ANAL MISSING DA, V793; Liu MZ, 2000, BIOMETRICS, V56, P1157, DOI 10.1111/j.0006-341X.2000.01157.x; Raghunathan T.E., 2001, SURV METHODOL, V27, P85, DOI DOI 10.1002/SIM.1186; Resche-Rigon M, 2013, STAT MED, V32, P4890, DOI 10.1002/sim.5894; Schafer JL, 2002, J COMPUT GRAPH STAT, V11, P437, DOI 10.1198/106186002760180608; Schafer JL, 1997, ANAL INCOMPLETE MULT; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Van Buuren S., 2012, FLEXIBLE IMPUTATION; vansBuuren S., 2011, J STAT SOFTW, V45, P1, DOI DOI 10.18637/JSS.V045.I03; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yucel RM, 2008, PHILOS T R SOC A, V366, P2389, DOI 10.1098/rsta.2008.0038	21	8	8	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1759-2879	1759-2887		RES SYNTH METHODS	Res. Synth. Methods	JUN	2017	8	2					136	148		10.1002/jrsm.1192			13	Mathematical & Computational Biology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Science & Technology - Other Topics	EX5YB	WOS:000403317900002	26679326				2022-02-06	
J	Maia, PD; Kutz, JN				Maia, Pedro D.; Kutz, J. Nathan			Reaction time impairments in decision-making networks as a diagnostic marker for traumatic brain injuries and neurological diseases	JOURNAL OF COMPUTATIONAL NEUROSCIENCE			English	Article						Alzheimer; Focal Axonal Swellings; Cognitive deficits; Decision making; Neural networks; Neurological diseases; Multiple sclerosis; Parkinson; Traumatic brain injury	DIFFUSE AXONAL INJURY; MILD COGNITIVE IMPAIRMENT; IN-VITRO; PARKINSONS-DISEASE; NERVE-FIBERS; PATHOLOGY; DEGENERATION; DEMENTIA; MODELS; BETA	The presence of diffuse Focal Axonal Swellings (FAS) is a hallmark cellular feature in many neurological diseases and traumatic brain injury. Among other things, the FAS have a significant impact on spike-train encodings that propagate through the affected neurons, leading to compromised signal processing on a neuronal network level. This work merges, for the first time, three fields of study: (i) signal processing in excitatory-inhibitory (EI) networks of neurons via population codes, (ii) decision-making theory driven by the production of evidence from stimulus, and (iii) compromised spike-train propagation through FAS. As such, we demonstrate a mathematical architecture capable of characterizing compromised decision-making driven by cellular mechanisms. The computational model also leads to several novel predictions and diagnostics for understanding injury level and cognitive deficits, including a key finding that decision-making reaction times, rather than accuracy, are indicative of network level damage. The results have a number of translational implications, including that the level of network damage can be characterized by the reaction times in simple cognitive and motor tests.	[Maia, Pedro D.; Kutz, J. Nathan] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA		Maia, PD (corresponding author), Univ Washington, Dept Appl Math, Seattle, WA 98195 USA.	pedro.doria.maia@gmail.com; kutz@uw.edu		D. Maia, Pedro/0000-0002-3335-4257			Adalbert R, 2009, BRAIN, V132, P402, DOI 10.1093/brain/awn312; Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Adle-Biassette H, 1999, NEUROPATH APPL NEURO, V25, P123; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Daianu M., 2016, SPIE P, V9784, P1; Dayan P, 2001, THEORETICAL NEUROSCI; Del Razo MJ, 2016, SIAM J SCI COMPUT, V38, pB347, DOI 10.1137/15M1010750; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Ditterich J, 2006, NEURAL NETWORKS, V19, P981, DOI 10.1016/j.neunet.2006.05.042; Edlow BL, 2016, NEUROCRIT CARE, V24, P342, DOI 10.1007/s12028-015-0216-8; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Faul M, 2010, TRAUMATIC BRAIN INJU; Fayaz I, 2000, J NEUROSCI METH, V102, P69, DOI 10.1016/S0165-0270(00)00282-X; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Hellman AN, 2010, LAB CHIP, V10, P2083, DOI 10.1039/b927153h; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Herwerth M, 2016, ANN NEUROL, V79, P794, DOI 10.1002/ana.24630; Higham DJ, 2001, SIAM REV, V43, P525, DOI 10.1137/S0036144500378302; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jones LM, 2007, P NATL ACAD SCI USA, V104, P18772, DOI 10.1073/pnas.0705546104; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Karlsson P, 2016, SCAND J PAIN, V10, P28, DOI 10.1016/j.sjpain.2015.08.007; Katz LN, 2016, NATURE, V535, P285, DOI 10.1038/nature18617; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kolaric KV, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.59; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; Lachance M, 2014, J COMPUT NEUROSCI, V37, P523, DOI 10.1007/s10827-014-0521-9; Laukka J. J., 2016, NEUROSCIENCE LETT; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lauria G, 2003, NEUROLOGY, V61, P631, DOI 10.1212/01.WNL.0000070781.92512.A4; Liberski PP, 1999, ACTA NEUROPATHOL, V97, P329, DOI 10.1007/s004010050995; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; Louis ED, 2009, MOVEMENT DISORD, V24, P1600, DOI 10.1002/mds.22567; Magdesian MH, 2016, J NEUROSCI, V36, P979, DOI 10.1523/JNEUROSCI.1667-15.2016; Magdesian MH, 2012, BIOPHYS J, V103, P405, DOI 10.1016/j.bpj.2012.07.003; Maia PD, 2015, J NEUROSCI METH, V253, P233, DOI 10.1016/j.jneumeth.2015.06.022; Maia PD, 2014, J COMPUT NEUROSCI, V37, P317, DOI 10.1007/s10827-014-0504-x; Maia PD, 2014, J COMPUT NEUROSCI, V36, P141, DOI 10.1007/s10827-013-0459-3; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Patterson BW, 2015, ANN NEUROL, V78, P439, DOI 10.1002/ana.24454; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Rabinovich M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.068102; Rabinovich MI, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000072; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Riffell JA, 2014, SCIENCE, V344, P1515, DOI 10.1126/science.1251041; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Rudy S., 2016, J SYSTEMS INTEGRATIV; Shadlen M. N., 2007, SPEED ACCURACY SIMPL; Shadlen MN, 2016, NEURON, V90, P927, DOI 10.1016/j.neuron.2016.04.036; Shadlen MN, 2013, NEURON, V80, P791, DOI 10.1016/j.neuron.2013.10.047; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shlizerman E, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00070; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith DH, 1999, J NEUROSCI, V19, P4263; Tagliaferro P, 2016, J PARKINSON DIS, V6, P1, DOI 10.3233/JPD-150769; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wulfram Gerstner Werner M., 2014, NEURONAL DYNAMICS; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	96	8	8	1	8	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5313	1573-6873		J COMPUT NEUROSCI	J. Comput. Neurosci.	JUN	2017	42	3					323	347		10.1007/s10827-017-0643-y			25	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Neurosciences & Neurology	ET2CZ	WOS:000400077500007	28393281				2022-02-06	
J	Manikas, V; Babl, FE; Hearps, S; Dooley, J; Anderson, V				Manikas, Vicky; Babl, Franz E.; Hearps, Stephen; Dooley, Julian; Anderson, Vicki			Impact of Exercise on Clinical Symptom Report and Neurocognition after Concussion in Children and Adolescents	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; head trauma; outcome measures; pediatric brain injury; recovery	REFERRAL CENTER; SPORTS; RELIABILITY; RETURN; PLAY; RECOVERY; VICTORIA; INJURY; ZURICH; SCHOOL	Recovery from concussion in childhood is poorly understood, despite its importance in decisions regarding return to normal activity. Resolution of post-concussive symptoms (PCS) is widely employed as a marker of recovery in clinical practice; however, it is unclear whether subtle impairments persist only to re-emerge in the context of increased physical or cognitive demands. This study aimed to examine the effect of strenuous exercise on clinical symptom report and neurocognition in children and adolescents after PCS resolution after concussion. We recruited children and adolescents with concussion (n = 30) on presentation to an Emergency Department (ED). At Day 2 and Day 10 post-self-reported symptom resolution, participants completed a strenuous exercise protocol, and pre- and post-exercise assessment of PCS and neurocognition. Results demonstrated an overall reduction in PCS from Day 2 to Day 10 post-symptom resolution, with no evidence of symptom increase after strenuous exercise at either time point. Neurocognitive performance was linked to task complexity: on less cognitively demanding tasks, processing speed was slower post-exercise and, unexpectedly, slower on Day 10 than Day 2, while for more demanding tasks (new learning), Day 2 exercise resulted in faster responses, but Day 10 processing speed post-exercise was slower. In summary, we found the expected recovery pattern for PCS, regardless of exercise, while for neurocognition, recovery was dependent on the degree of cognitive demand, and there was an unexpected reduction in performance from Day 2 to Day 10. Findings provide some suggestion that premature return to normal activities (e.g., school) may slow neurocognitive recovery.	[Manikas, Vicky; Hearps, Stephen; Dooley, Julian; Anderson, Vicki] Murdoch Childrens Res Inst, Dept Child Neuropsychol, Melbourne, Vic, Australia; [Babl, Franz E.] Murdoch Childrens Res Inst, Dept Emergency Res, Melbourne, Vic, Australia; [Manikas, Vicky; Babl, Franz E.; Anderson, Vicki] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Anderson, Vicki] Univ Melbourne, Dept Psychol Sci, Melbourne, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Med, Melbourne, Vic, Australia; [Dooley, Julian] Cuyahoga Cty Court Psychiat Clin, Cleveland, OH USA		Babl, FE (corresponding author), Level 4 West Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	franz.babl@rch.org.au	Hearps, Stephen/L-6853-2016	Hearps, Stephen/0000-0003-2984-1172	Victorian Government Operational Infrastructure grant; NHMRC Senior Practitioner FellowshipNational Health and Medical Research Council of Australia; Royal Children's Hospital Foundation	This study was supported by the Victorian Government Operational Infrastructure grant to the Murdoch Childrens Research Institute. Dr. Anderson is supported by an NHMRC Senior Practitioner Fellowship. Dr. Babl is part funded by a grant from the Royal Children's Hospital Foundation.	Audiffren M, 2009, ACTA PSYCHOL, V132, P85, DOI 10.1016/j.actpsy.2009.06.008; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Bar-Or O., 1983, PHYSL PRINCIPLES CLI; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2010, EMERG MED AUSTRALAS, V22, P56, DOI 10.1111/j.1742-6723.2009.01249.x; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA IP, 2000, BEHAV RATING INVENTO; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; TEASDALE G, 1974, LANCET, V2, P81; Waters E, 2000, AUST NZ J PUBL HEAL, V24, P207, DOI 10.1111/j.1467-842X.2000.tb00145.x; Wechsler D., 2011, WECHSLER ABBREVIATED; Whelan R, 2008, PSYCHOL REC, V58, P475, DOI 10.1007/BF03395630	33	8	8	0	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2017	34	11					1932	1938		10.1089/neu.2016.4762			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EV4KD	WOS:000401727500003	28228043				2022-02-06	
J	O'Neil, ME; Callahan, M; Carlson, KF; Roost, M; Laman-Maharg, B; Twamley, EW; Iverson, GL; Storzbach, D				O'Neil, Maya Elin; Callahan, Megan; Carlson, Kathleen F.; Roost, Mai; Laman-Maharg, Benjamin; Twamley, Elizabeth W.; Iverson, Grant L.; Storzbach, Daniel			Postconcussion symptoms reported by Operation Enduring Freedom/Operation Iraqi Freedom veterans with and without blast exposure, mild traumatic brain injury, and posttraumatic stress disorder	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Blast exposure; Concussion; Factor analysis; Head trauma; Posttraumatic stress disorder; Traumatic brain injury; Veterans Affairs	OEF/OIF VETERANS; CONCUSSION; QUESTIONNAIRE; DEPRESSION; SAMPLE	Objective: This study examined symptom reporting related to the 10th Edition of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) criteria for postconcussional syndrome (PCS) in Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) Veterans. Our aims were to: (a) examine relationships among PCS symptoms by identifying potential subscales of the British Columbia Postconcussion Symptom Inventory (BC-PSI); and (b) examine group differences in BC-PSI items and subscales in Veterans with and without blast exposure, mild traumatic brain injury (mTBI), and posttraumatic stress disorder (PTSD). Method: Our sample included Veterans with blast-related mTBI history (n=47), with blast exposure but no mTBI history (n=20), and without blast exposure (n=23). Overall, 37 Veterans had PTSD, and 53 did not. We conducted an exploratory factor analysis (EFA) of the BC-PSI followed by multivariate analysis of variance to examine differences in BC-PSI subscale scores by blast exposure, mTBI history, and PTSD. Results: BC-PSI factors were interpreted as cognitive, vestibular, affective, anger, and somatic. Items and factor scores were highest for Veterans with blast exposure plus mTBI, and lowest for controls. Vestibular, affective, and somatic factors were significantly higher for Veterans with blast exposure plus mTBI than for controls, but not significantly different for those with blast exposure but no mTBI. These results remained significant when PTSD symptom severity was included as a covariate. Cognitive, anger, and somatic subscales were significantly higher for Veterans with PTSD, though there was no interaction effect of PTSD and mTBI or blast history. Conclusions: EFA-derived subscales of the BC-PSI differentiated Veterans based on blast exposure, mTBI history, and PTSD.	[O'Neil, Maya Elin; Storzbach, Daniel] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [O'Neil, Maya Elin] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [O'Neil, Maya Elin; Callahan, Megan; Carlson, Kathleen F.; Roost, Mai; Laman-Maharg, Benjamin; Storzbach, Daniel] VA Portland Hlth Care Syst, Portland, OR USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Twamley, Elizabeth W.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Charlestown, MA USA; [Iverson, Grant L.] Red Sox Fdn, Home Base, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Iverson, Grant L.] MassGeneral Hosp Children Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Storzbach, Daniel] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA		O'Neil, ME (corresponding author), Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA.	Maya.ONeil@va.gov		Iverson, Grant/0000-0001-7348-9570	U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development, VA Merit Review Award [B5060R]; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, Center of Innovation [CIN 13-404]; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1 K12 HS019456 01]; Agency for Healthcare Research and Quality PCOR K12 award [K12HS022981]; INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium - Department of Defense Psychological Health/Traumatic Brain Injury Research Program [X81XWH-07-CC-CSDoD]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981] Funding Source: NIH RePORTER	This work was supported by the U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development, VA Merit Review Award [grant number B5060R to D.S.]; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, Center of Innovation [grant number CIN 13-404]; Agency for Healthcare Research and Quality [grant number 1 K12 HS019456 01]; and an Agency for Healthcare Research and Quality PCOR K12 award to M.E.O. [grant number K12HS022981]. This material is the result of work supported with resources and the use of facilities at the Veterans Affairs Portland Health Care System, Portland, Oregon. G.L.I. acknowledges support from the INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium funded by the Department of Defense Psychological Health/Traumatic Brain Injury Research Program [grant number X81XWH-07-CC-CSDoD]. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. G.L.I. developed the BC-PSI and holds the copyright. The test is not sold commercially. No additional competing financial interests exist. G.L.I. has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mTBI and sport-related concussion at meetings, scientific conferences, and symposiums. He has a clinical practice in forensic neuropsychology involving individuals who have sustained mild TBIs. He has received grant funding from pharmaceutical companies to do psychometric research using neuropsychological tests. He has received research support from neuropsychological test publishing companies in the past (not in the past 5 years). All other authors declare no conflicts of interests involved in the research presented in the manuscript.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; [Anonymous], 2010, IBM SPSS WIND REL 19; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; IVERSON G, 2004, TRAUMATIC BRAIN INJU; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Murphy KR, 2004, STAT POWER ANAL; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Preacher K. J., 2003, UNDERSTANDING STAT, V2, P13, DOI DOI 10.1207/S15328031US0201_02; Sheehan D., 2006, MINI INT NEUROPSYCHI; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; World Health Organization, 2004, ICD 10 INT STAT CLAS	33	8	8	0	17	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUN	2017	39	5					449	458		10.1080/13803395.2016.1232699			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	ES4BA	WOS:000399472800003	27681407				2022-02-06	
J	Sivakumar, S; Taccone, FS; Rehman, M; Hinson, H; Naval, N; Lazaridis, C				Sivakumar, Sanjeev; Taccone, Fabio S.; Rehman, Mohammed; Hinson, Holly; Naval, Neeraj; Lazaridis, Christos			Hemodynamic and neuro-monitoring for neurocritically ill patients: An international survey of intensivists	JOURNAL OF CRITICAL CARE			English	Article						Hemodynamics; Survey; Monitoring, neuromonitoring; Physiologic; Brain injuries	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; SUBARACHNOID HEMORRHAGE; CARE; MANAGEMENT	Purpose: To investigate multimodality systemic and neuro-monitoring practices in acute brain injury (ABI) and to analyze differences among "neurointensivists" (NI; clinical practice comprised > 1/3 by neurocritical care), and other intensivists (OI). Methods: Anonymous 22-question Web-based survey among physician members of SCCM and ESICM. Results: Six hundred fifty-five responded (66% completion rate); 422 (65%) were OI, and 226 (35%) were NI. More NI follow hemodynamic protocols for TBI (44.5% vs 33%, P = .007) and SAH (38% vs 21%, P < .001). For CPP optimization, NI use more arterial-waveform-analysis (AWA) (45% vs 35%, P = .019), and ultrasound (37.5% vs 28%, P =. 023); NI use more PbtO(2) (28% vs 10%, P < .001). In the case scenario of raised ICP/low PbtO(2), most employ analgesia and/or sedation (47%) and osmotherapy (38%). More NI use pressure reactivity (vasopressor use OI 23% vs NI 34.5%, P =. 014). For DCI, more NI target cardiac index (CI) (35% vs 21%, P < .001), and fluid responsiveness (62.5% vs 53%, P = .03). Also, NI use more angiography (57% vs 43.5%, P = .004), TCD (56.5% vs 38%, P < .001), CTP (32% vs16%, P < .001), and PbtO(2) (18% vs 7.5%, P = .001). Conclusions: Intensivists with exposure to ABI patients employ more neuro- and hemodynamic monitoring. We found large heterogeneity and low overall use of advanced brain-physiology parameters. (C) 2017 Elsevier Inc. All rights reserved.	[Sivakumar, Sanjeev; Lazaridis, Christos] Baylor Coll Med, Dept Neurol Neurocrit Care, Houston, TX 77030 USA; [Taccone, Fabio S.] Erasmus Hosp, Dept Intens Care, Brussels, Belgium; [Rehman, Mohammed] Henry Ford Hosp, Dept Neurol Neurocrit Care, Detroit, MI 48202 USA; [Hinson, Holly] Oregon Hlth & Sci Univ, Dept Neurol Neurocrit Care, Portland, OR 97201 USA; [Naval, Neeraj] Baptist Med Ctr, Neurocrit Care, Jacksonville, FL USA		Lazaridis, C (corresponding author), Baylor Coll Med, Med Ctr, McNair Campus 7200 Cambridge St,9th Floor, Houston, TX 77030 USA.	lazaridi@bcm.edu	Hinson, Holly/Q-2268-2019; Rehman, Mohammed/AAN-3273-2020	Hinson, Holly/0000-0003-1598-9782; Rehman, Mohammed/0000-0001-7405-2661; Sivakumar, Sanjeev/0000-0002-4846-4301			Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Kim DH, 2003, NEUROSURGERY, V53, P1044, DOI 10.1227/01.NEU.0000088567.59324.78; Kramer AH, 2011, CRIT CARE, V15, DOI 10.1186/cc9977; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; Lazaridis C, 2012, NEUROCRIT CARE, V16, P163, DOI 10.1007/s12028-011-9568-x; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Markandaya M, 2012, NEUROCRIT CARE, V16, P72, DOI 10.1007/s12028-011-9628-2; Meyer R, 2011, NEUROCRIT CARE, V14, P24, DOI 10.1007/s12028-010-9437-z; Mutoh T, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0482-4; Mutoh T, 2014, STROKE, V45, P1280, DOI 10.1161/STROKEAHA.114.004739; Mutoh T, 2009, STROKE, V40, P2368, DOI 10.1161/STROKEAHA.109.547463; Shutter L, 2014, ANN M NEUR CAR SOC; Stevens RD, 2009, INTENS CARE MED, V35, P1556, DOI 10.1007/s00134-009-1533-1; Stocchetti N, 2013, CRIT CARE, V17, DOI 10.1186/cc11513; Taccone FS, 2014, NEUROCRIT CARE, V21, P38, DOI 10.1007/s12028-014-0033-5	22	8	8	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	JUN	2017	39						40	47		10.1016/j.jcrc.2017.01.005			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW4KR	WOS:000402470900009	28171804				2022-02-06	
J	Thomsen, GM; Ko, A; Harada, MY; Ma, A; Wyss, L; Haro, P; Vit, JP; Avalos, P; Dhillon, NK; Cho, N; Shelest, O; Ley, EJ				Thomsen, Gretchen M.; Ko, Ara; Harada, Megan Y.; Ma, Annie; Wyss, Livia; Haro, Patricia; Vit, Jean-Philippe; Avalos, Pablo; Dhillon, Navpreet K.; Cho, Noell; Shelest, Oksana; Ley, Eric J.			Clinical correlates to assist with chronic traumatic encephalopathy diagnosis: Insights from a novel rodent repeat concussion model	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	75th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery	SEP 14-17, 2016	Waikoloa, HI	Amer Assoc Surg Trauma		Chronic traumatic encephalopathy; motor deficits; tauopathy; traumatic brain injury	BRAIN-INJURY; TAU PATHOLOGY; TAUOPATHY; AFTERMATH; PATHWAY; DISEASE; SYSTEM; RATS; MICE	INTRODUCTION: Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease linked to repetitive head injuries. Chronic traumatic encephalopathy symptoms include changes in mood, behavior, cognition, and motor function; however, CTE is currently diagnosed only postmortem. Using a rat model of recurrent traumatic brain injury (TBI), we demonstrate rodent deficits that predict the severity of CTE-like brain pathology. METHODS: Bilateral, closed-skull, mild TBI was administered once per week to 35 wild-type rats; eight rats received two injuries (2 x TBI), 27 rats received five injuries (5 x TBI), and 13 rats were sham controls. To determine clinical correlates for CTE diagnosis, TBI rats were separated based on the severity of rotarod deficits and classified as "mild" or "severe" and further separated into "acute," "short," and "long" based on age at euthanasia (90, 144, and 235 days, respectively). Brain atrophy, phosphorylated tau, and inflammation were assessed. RESULTS: All eight 2 x TBI cases had mild rotarod deficiency, 11 5 x TBI cases had mild deficiency, and 16 cases had severe deficiency. In one cohort of rats, tested at approximately 235 days of age, balance, rearing, and grip strength were significantly worse in the severe group relative to both sham and mild groups. At the acute time period, cortical thinning, phosphorylated tau, and inflammation were not observed in either TBI group, whereas corpus callosum thinning was observed in both TBI groups. At later time points, atrophy, tau pathology, and inflammation were increased in mild and severe TBI groups in the cortex and corpus callosum, relative to sham controls. These injury effects were exacerbated over time in the severe TBI group in the corpus callosum. CONCLUSIONS: Our model of repeat mild TBI suggests that permanent deficits in specific motor function tests correlate with CTE-like brain pathology. Assessing balance and motor coordination over time may predict CTE diagnosis. Copyright (C) 2017 American Association for the Surgery of Trauma. All rights reserved.)	[Thomsen, Gretchen M.; Ma, Annie; Wyss, Livia; Haro, Patricia; Cho, Noell; Shelest, Oksana] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA; [Thomsen, Gretchen M.; Vit, Jean-Philippe] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Vit, Jean-Philippe] Cedars Sinai Med Ctr, Biobehav Res Core, Los Angeles, CA 90048 USA; [Ko, Ara; Harada, Megan Y.; Dhillon, Navpreet K.; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, 8700 Beverly Blvd,Suite 8215 N, Los Angeles, CA 90048 USA.	Eric.Ley@cshs.org	vit, jean-philippe/Q-7286-2019	Vit, Jean-Philippe/0000-0001-5057-8554	Board of Governors Regenerative Medicine Institute; Department of Surgery, Cedars-Sinai Medical Center; ALS Finding a Cure Foundation	This work was supported by the Board of Governors Regenerative Medicine Institute and the Department of Surgery, Cedars-Sinai Medical Center and the ALS Finding a Cure Foundation.	Afifi A, 2003, COMPUTER AIDED MULTI; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Galgano MA, 2016, CUREUS, V8, DOI 10.7759/cureus.532; Goldstein LB, 2003, ILAR J, V44, P125, DOI 10.1093/ilar.44.2.125; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Qin  Y., 2016, BEHAV BRAIN RES; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Thomsen GM, 2016, J TRAUMA ACUTE CARE, V81, P1070, DOI 10.1097/TA.0000000000001248; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00222; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528	37	8	8	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2017	82	6					1039	1047		10.1097/TA.0000000000001443			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	EV5MV	WOS:000401811900012	28520686				2022-02-06	
J	Neuhaus, W; Kramer, T; Neuhoff, A; Golz, C; Thal, SC; Forster, CY				Neuhaus, Winfried; Kraemer, Tobias; Neuhoff, Anja; Goelz, Christina; Thal, Serge C.; Foerster, Carola Y.			Multifaceted Mechanisms of WY-14643 to Stabilize the Blood-Brain Barrier in a Model of Traumatic Brain Injury	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						pirinixic acid; PPAR alpha; stroke; traumatic brain injury; ischemia; blood-brain barrier	ACTIVATED RECEPTOR-ALPHA; MICROVASCULAR ENDOTHELIAL-CELLS; SEVERE HEAD-INJURY; PPAR-ALPHA; CEREBRAL-ISCHEMIA; PROTEIN-KINASE; MATRIX-METALLOPROTEINASE; HYPOXIA-REOXYGENATION; OXIDATIVE STRESS; CLINICAL-TRIAL	The blood-brain barrier (BBB) is damaged during ischemic insults such as traumatic brain injury or stroke. This contributes to vasogenic edema formation and deteriorate disease outcomes. Enormous efforts are pursued to understand underlying mechanisms of ischemic insults and develop novel therapeutic strategies. In the present study the effects of PPAR a agonist WY-14643 were investigated to prevent BBB breakdown and reduce edema formation. WY-14643 inhibited barrier damage in a mouse BBB in vitro model of traumatic brain injury based on oxygen/glucose deprivation in a concentration dependent manner. This was linked to changes of the localization of tight junction proteins. Furthermore, WY-14643 altered phosphorylation of kinases ERK1/ 2, p38, and SAPK/JNK and was able to inhibit proteosomal activity. Moreover, addition of WY-14643 upregulated PAI-1 leading to decreased t-PA activity. Mouse in vivo experiments showed significantly decreased edema formation in a controlled cortical impact model of traumatic brain injury after WY-14643 application, which was not found in PAI-1 knockout mice. Generally, data suggested that WY-14643 induced cellular responses which were dependent as well as independent from PPAR alpha mediated transcription. In conclusion, novel mechanisms of a PPAR alpha agonist were elucidated to attenuate BBB breakdown during traumatic brain injury in vitro.	[Neuhaus, Winfried] AIT Austrian Inst Technol AIT GmbH, Competence Unit Mol Diagnost, Competence Ctr Hlth & Bioresources, Vienna, Austria; [Kraemer, Tobias; Goelz, Christina; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, Mainz, Germany; [Neuhoff, Anja; Foerster, Carola Y.] Univ Hosp Wurzburg, Ctr Operat Med, Dept Anesthesia & Crit Care, Wurzburg, Germany		Neuhaus, W (corresponding author), AIT Austrian Inst Technol AIT GmbH, Competence Unit Mol Diagnost, Competence Ctr Hlth & Bioresources, Vienna, Austria.	winfried.neuhaus@ait.ac.at	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729; Kramer, Tobias/0000-0001-6900-3486; Neuhaus, Winfried/0000-0002-6552-7183	European Union Seventh Framework Programme (FP7) [HEALTH-F2-2009-241778]	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant agreement No. HEALTH-F2-2009-241778 to CF.	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Adibhatla RM, 2008, CNS NEUROL DISORD-DR, V7, P243, DOI 10.2174/187152708784936608; Amarenco P, 2009, LANCET NEUROL, V8, P453, DOI 10.1016/S1474-4422(09)70058-4; Atlee J, 2007, COMPLICATIONS ANESTH; Baethmann A, 2002, EUR SURG RES, V34, P42, DOI 10.1159/000048886; Banfi C, 2003, THROMB HAEMOSTASIS, V90, P611, DOI 10.1160/TH03-01-0059; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Bernardes A, 2013, J MOL BIOL, V425, P2878, DOI 10.1016/j.jmb.2013.05.010; Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Bordet R, 2006, BIOCHEM SOC T, V34, P1341, DOI 10.1042/BST0341341; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bulhak AA, 2009, AM J PHYSIOL-HEART C, V296, pH719, DOI 10.1152/ajpheart.00394.2008; Canfield SG, 2017, J NEUROCHEM, V140, P874, DOI 10.1111/jnc.13923; Castilla-Guerra L, 2015, EUR J INTERN MED, V26, P148, DOI 10.1016/j.ejim.2015.01.004; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Collino M, 2006, FREE RADICAL BIO MED, V41, P1619, DOI 10.1016/j.freeradbiomed.2006.09.013; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; Cunard R, 2002, J IMMUNOL, V169, P6806, DOI 10.4049/jimmunol.169.12.6806; Cunard R, 2002, J IMMUNOL, V168, P2795, DOI 10.4049/jimmunol.168.6.2795; Cuzzocrea S, 2004, SHOCK, V22, P340, DOI 10.1097/01.shk.0000136704.26372.2d; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Deplanque D, 2003, J NEUROSCI, V23, P6264; Deplanque D, 2011, CURR ATHEROSCLER REP, V13, P306, DOI 10.1007/s11883-011-0186-z; el Azzouzi H, 2011, J BIOL CHEM, V286, P14598, DOI 10.1074/jbc.M111.220525; Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6; Ferrer I, 2003, ACTA NEUROPATHOL, V105, P425, DOI 10.1007/s00401-002-0661-2; Finnie JW, 2014, VET RES COMMUN, V38, P297, DOI 10.1007/s11259-014-9616-z; Fischer S, 2005, EUR J CELL BIOL, V84, P687, DOI 10.1016/j.ejcb.2005.03.002; Frieden T., 2014, REPORT C TRAUMATIC B; Fruchart JC, 1999, CURR OPIN LIPIDOL, V10, P245, DOI 10.1097/00041433-199906000-00007; Gautier S, 2015, PPAR RES, V2015, DOI 10.1155/2015/246329; Gelosa P, 2010, J PHARMACOL EXP THER, V335, P324, DOI 10.1124/jpet.110.171090; Gray H., 2011, ANN QUEENSTOWN UPDAT, P51; GRUMME T, 1995, RES EXP MED, V195, P217, DOI 10.1007/BF02576791; Guo QM, 2010, J CEREBR BLOOD F MET, V30, P70, DOI 10.1038/jcbfm.2009.185; Huang W, 2014, J CEREBR BLOOD F MET, V34, P646, DOI 10.1038/jcbfm.2013.240; Huang W, 2011, FASEB J, V25, P3979, DOI 10.1096/fj.11-188607; Huang W, 2009, FASEB J, V23, P1596, DOI 10.1096/fj.08-121624; Inoue H, 2003, NEUROSCI LETT, V352, P203, DOI 10.1016/j.neulet.2003.09.001; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Jiao HX, 2011, J MOL NEUROSCI, V44, P130, DOI 10.1007/s12031-011-9496-4; Joo F, 1996, PROG NEUROBIOL, V48, P255, DOI 10.1016/0301-0082(95)00046-1; Kleinschnitz C, 2011, STROKE, V42, P1081, DOI 10.1161/STROKEAHA.110.592238; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Labreuche J, 2010, ATHEROSCLEROSIS, V212, P9, DOI 10.1016/j.atherosclerosis.2010.02.011; Lawes CMM, 2004, STROKE, V35, P776, DOI 10.1161/01.STR.0000116869.64771.5A; Lee SR, 2003, STROKE, V34, P2704, DOI 10.1161/01.STR.0000096540.40826.BA; Lo EH, 2001, BRAIN RES REV, V38, P140, DOI 10.1016/S0165-0173(01)00083-2; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Losey P, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0295-7; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Minshall R. D., 2006, V176, P107; Montaner J, 2008, EUR J NEUROL, V15, P82, DOI 10.1111/j.1468-1331.2007.02015.x; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Mysiorek C, 2009, CURR NEUROVASC RES, V6, P181, DOI 10.2174/156720209788970081; Nemcekova M, 2013, PHYSIOL RES, V62, P577, DOI 10.33549/physiolres.932591; Neuhaus W, 2009, TRANSPORTERS DRUG CA, P263; Neuhaus W, 2006, PHARM RES, V23, P1491, DOI 10.1007/s11095-006-0256-z; Neuhaus W, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00352; Neuhaus W, 2012, DIFFERENTIATION, V84, P294, DOI 10.1016/j.diff.2012.08.006; Neuhaus W, 2012, NEUROSCI LETT, V506, P44, DOI 10.1016/j.neulet.2011.10.045; Neuhaus W, 2008, J PHARM SCI-US, V97, P5158, DOI 10.1002/jps.21371; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Novakova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086806; Okaya T, 2004, AM J PHYSIOL-GASTR L, V286, pG606, DOI 10.1152/ajpgi.00191.2003; Ouk T, 2014, J CEREBR BLOOD F MET, V34, P542, DOI 10.1038/jcbfm.2013.233; Ouk T, 2009, VASC PHARMACOL, V51, P323, DOI 10.1016/j.vph.2009.08.002; Pfefferkorn T, 2003, STROKE, V34, P2025, DOI 10.1161/01.STR.0000083051.93319.28; Rizvi YQ, 2013, VASC PHARMACOL, V59, P144, DOI 10.1016/j.vph.2013.09.001; Salvador E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00323; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Silwedel C, 2006, J NEUROIMMUNOL, V179, P37, DOI 10.1016/j.jneuroim.2006.06.019; Sivarajah Ahila, 2002, Med Sci Monit, V8, pBR532; Srivastava K, 2013, J CEREBR BLOOD F MET, V33, P1928, DOI 10.1038/jcbfm.2013.151; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; Su EJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00385; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Thal SC, 2009, J NEUROSURG, V111, P988, DOI 10.3171/2009.3.JNS08412; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Turner RC, 2013, J NEUROSURG, V118, P1072, DOI 10.3171/2012.11.JNS12408; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; Verma A, 2000, J HEAD TRAUMA REHAB, V15, P1149, DOI 10.1097/00001199-200010000-00008; Von Knethen A, 2001, FASEB J, V15, P535, DOI 10.1096/fj.00-0187com; Wallace BK, 2012, AM J PHYSIOL-CELL PH, V302, pC505, DOI 10.1152/ajpcell.00261.2011; Wayman NS, 2002, FASEB J, V16, P1027, DOI 10.1096/fj.01-0793com; Witt KA, 2003, AM J PHYSIOL-HEART C, V285, pH2820, DOI 10.1152/ajpheart.00589.2003; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yue TL, 2003, CIRCULATION, V108, P2393, DOI 10.1161/01.CIR.0000093187.42015.6C; Yuen N, 2014, AM J PHYSIOL-CELL PH, V306, pC931, DOI 10.1152/ajpcell.00021.2013; Yurkewicz L, 2005, J NEUROTRAUM, V22, P1428, DOI 10.1089/neu.2005.22.1428; Zhang YH, 2007, AM J PHYSIOL-HEART C, V292, pH2573, DOI 10.1152/ajpheart.01098.2006; Zhou YH, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-1; Zhu YH, 2003, STROKE, V34, P2483, DOI 10.1161/01.STR.0000088644.60368.ED	103	8	8	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	MAY 26	2017	10								149	10.3389/fnmol.2017.00149			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EV9MA	WOS:000402108900001	28603485	Green Published, gold			2022-02-06	
J	Albrecht, JS; Peters, ME; Smith, GS; Rao, V				Albrecht, Jennifer S.; Peters, Matthew E.; Smith, Gordon S.; Rao, Vani			Anxiety and Posttraumatic Stress Disorder Among Medicare Beneficiaries After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anxiety; older adults; posttraumatic stress disorder; traumatic brain injury	OLDER-ADULTS; MAJOR DEPRESSION; PSYCHIATRIC-DISORDERS; AGE; OUTCOMES; CONSEQUENCES; EPIDEMIOLOGY; COMORBIDITY; MODERATE; ALCOHOL	Objective: To estimate rates of anxiety and posttraumatic stress disorder (PTSD) diagnoses after traumatic brain injury (TBI) among Medicare beneficiaries, quantify the increase in rates relative to the pre-TBI period, and identify risk factors for diagnosis of anxiety and PTSD. Participants: A total of 96 881 Medicare beneficiaries hospitalized with TBI between June 1, 2006 and May 31, 2010. Design: Retrospective cohort study. Measures: Diagnosis of anxiety (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] codes 300.0x) and/or PTSD (ICD-9-CM code 309.81). Results: After TBI, 16 519 (17%) beneficiaries were diagnosed with anxiety and 269 (0.3%) were diagnosed with PTSD. Rates of anxiety and PTSD diagnoses were highest in the first 5 months post-TBI and decreased over time. Pre-TBI diagnosis of anxiety disorder was significantly associated with post-TBI anxiety (risk ratio, 3.55; 95% confidence interval, 3.42-3.68) and pre-TBI diagnosis of PTSD was significantly associated with post-TBI PTSD (risk ratio 70.09; 95% confidence interval 56.29-111.12). Conclusion: This study highlights the increased risk of anxiety and PTSD after TBI. Routine screening for anxiety and PTSD, especially during the first 5 months after TBI, may help clinicians identify these important and treatable conditions, especially among patients with a history of psychiatric illness.	[Albrecht, Jennifer S.; Smith, Gordon S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, MSTF 334C, Baltimore, MD 21201 USA; [Peters, Matthew E.; Rao, Vani] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Smith, Gordon S.] Univ Maryland, Natl Study Ctr Trauma & Emergency Med Serv, Shock Trauma & Anesthesiol Res Organized Res Ctr, College Pk, MD 20742 USA		Albrecht, JS (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, MSTF 334C, Baltimore, MD 21201 USA.	jalbrecht@epi.umaryland.edu		Smith, Gordon/0000-0002-2911-3071; Albrecht, Jennifer/0000-0003-4838-2274	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12HD43489, R01AA18707]; AHRQUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1K01HS024560]; DODUnited States Department of Defense [W81XWH-13-1-0469]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD043489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [UG3DA044825] Funding Source: NIH RePORTER	Dr Albrecht was supported by NIH grant K12HD43489 (Tracey, PI) and AHRQ grant 1K01HS024560. Dr Smith was supported by NIH grant R01AA18707. Dr Rao was supported by DOD grant W81XWH-13-1-0469.	Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; Albrecht JS, 2014, JAMA INTERN MED, V174, P1244, DOI 10.1001/jamainternmed.2014.2534; Allison PD, 1995, SURVIVAL ANAL USING; Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Bombardier CH, 2006, J NEUROPSYCHIATRY CL, V18, P4; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Centers for Medicaid and Medicare Services, 2012, CHRON COND MED BEN C; Centers for Medicare & Medicaid Services, CHRON COND DAT WAR; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Deb S, 1999, AM J PSYCHIAT, V156, P374; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M, 2010, TRAUMATIC BRAIN INJU; GRANT BF, 1995, DRUG ALCOHOL DEPEN, V39, P197, DOI 10.1016/0376-8716(95)01160-4; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Marr A., 2004, CENTRAL NERVOUS SYST; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Motzkin Julian C, 2015, Handb Clin Neurol, V128, P633, DOI 10.1016/B978-0-444-63521-1.00039-X; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rapoport MJ, 2003, AM J GERIAT PSYCHIAT, V11, P365, DOI 10.1176/appi.ajgp.11.3.365; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman DJ., 1995, GUIDELINES SURVEILLA; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	32	8	8	2	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2017	32	3					178	184		10.1097/HTR.0000000000000266			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EV4GM	WOS:000401716900004	28476057	Green Accepted			2022-02-06	
J	Demirel, OF; Cetin, I; Turan, S; Saglam, T; Yildiz, N; Duran, A				Demirel, Omer Faruk; Cetin, Ihsan; Turan, Senol; Saglam, Tarik; Yildiz, Nazim; Duran, Alaattin			Decreased Expression of alpha-Synuclein, Nogo-A and UCH-L1 in Patients with Schizophrenia: A Preliminary Serum Study	PSYCHIATRY INVESTIGATION			English	Article						alpha-synudein; Nogo-A; UCH-L1; Schizophrenia; Biomarkers	C-TERMINAL HYDROLASE; UBIQUITIN-PROTEASOME SYSTEM; TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; BIPOLAR DISORDER; CORTEX; GENES; METAANALYSIS; BIOMARKER	Objective alpha-synuclein, Nogo-A and Ubiquitin C-terminal hydrolase L1 (UCH-L1) have neuromodulatory roles for human brain. Therefore, abnormalities of these molecules are associated with neuropsychiatric disorders. Although some serum studies in the other disorders have been made, serum study of a-synuclein, Nogo-A and UCH-L1 is not present in patients with schizophrenia and healthy controls. Therefore, our aim was to compare serum levels of a-synuclein, Nogo-A and UCH-L1 of the patients with schizophrenia and healthy controls. Methods Forty-four patients with schizophrenia who is followed by psychotic disorders unit, and 40 healthy control were included in this study. Socio-demographic form and Positive and Negative Syndrome Scale (PANSS) was applied to patients, and sociodemographic form was applied to control group. Fasting bloods were collected and the serum levels of a-synuclein, Nogo-A and UCH-L1 were measured by ELISA method. Results Serum a-synuclein [patient: 12.73 (5.18-31.84) ng/mL; control: 41.77 (15.12-66.98) ng/mL], Nogo-A [patient: 33.58 (3.09-77.26) ng/mL; control: 286.05 (136.56-346.82) ng/mL] and UCH-L1 [patient: 5.26 (1.64-10.87) ng/mL; control: 20.48 (11.01-20.81) ng/mL] levels of the patients with schizophrenia were significianly lower than healthy controls (p < 0.001). Conclusion Our study results added new evidence for explaining the etiopathogenesis of schizophrenia on the basis of neurochemical markers.	[Demirel, Omer Faruk; Turan, Senol; Saglam, Tarik; Yildiz, Nazim; Duran, Alaattin] Istanbul Univ, Cerrahpasa Fac Med, Dept Psychiat, Cerrahpasa Cd 53, TR-34096 Istanbul, Turkey; [Cetin, Ihsan] Batman Univ, Hlth High Sch, Dept Nutr & Dietet, Batman, Turkey		Demirel, OF (corresponding author), Istanbul Univ, Cerrahpasa Fac Med, Dept Psychiat, Cerrahpasa Cd 53, TR-34096 Istanbul, Turkey.	ofdmed@yahoo.com	demirel, omer faruk/AAB-2989-2020; TURAN, SENOL/AAH-9403-2019	TURAN, SENOL/0000-0002-8684-2617; demirel, omer faruk/0000-0003-3012-1252	scientific research project unit of Batman University [BTUBAP-2016-SYO-1]	This research was supported by the scientific research project unit of Batman University (Project Number: BTUBAP-2016-SYO-1).	Al-Wandi A, 2010, NEUROBIOL AGING, V31, P796, DOI 10.1016/j.neurobiolaging.2008.11.001; Altar CA, 2005, BIOL PSYCHIAT, V58, P85, DOI 10.1016/j.biopsych.2005.03.031; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Aston C, 2004, J NEUROSCI RES, V77, P858, DOI 10.1002/jnr.20208; Barley K, 2009, SCHIZOPHR RES, V112, P54, DOI 10.1016/j.schres.2009.04.019; Bennett MC, 2005, PHARMACOL THERAPEUT, V105, P311, DOI 10.1016/j.pharmthera.2004.10.010; Bousman CA, 2010, AM J MED GENET B, V153B, P1336, DOI 10.1002/ajmg.b.31106; Bousman CA, 2010, AM J MED GENET B, V153B, P494, DOI 10.1002/ajmg.b.31006; Chalak LF, 2014, J PEDIATR-US, V164, P468, DOI 10.1016/j.jpeds.2013.10.067; Coon H, 1998, MOL PSYCHIATR, V3, P521, DOI 10.1038/sj.mp.4000453; DaoCastellana MH, 1997, SCHIZOPHR RES, V23, P167, DOI 10.1016/S0920-9964(96)00102-8; Galvin JE, 2006, ACTA NEUROPATHOL, V112, P115, DOI 10.1007/s00401-006-0096-2; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Howes OD, 2009, ARCH GEN PSYCHIAT, V66, P13, DOI 10.1001/archgenpsychiatry.2008.514; Jellinger KA, 2009, ACTA NEUROPATHOL, V117, P423, DOI 10.1007/s00401-009-0492-5; Jitoku D, 2011, AM J MED GENET B, V156B, P581, DOI 10.1002/ajmg.b.31199; Kazantsev AG, 2008, ARCH NEUROL-CHICAGO, V65, P1577, DOI 10.1001/archneur.65.12.1577; Kobayashi H, 2004, ANN NY ACAD SCI, V1025, P325, DOI 10.1196/annals.1316.040; Kostakoglu E, 1999, TURK PSIKOL DERG, V14, P23; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Li J, 2015, AM J EMERG MED, V33, P1191, DOI 10.1016/j.ajem.2015.05.023; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; Mondello S, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-85; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; Novak G, 2002, MOL BRAIN RES, V107, P183, DOI 10.1016/S0169-328X(02)00492-8; Novak G, 2006, BRAIN RES, V1120, P161, DOI 10.1016/j.brainres.2006.08.071; Pang L, 2014, CLIN BIOCHEM, V47, P72, DOI 10.1016/j.clinbiochem.2013.09.015; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Rubio MD, 2013, NEUROPSYCHOPHARMACOL, V38, P1910, DOI 10.1038/npp.2013.84; Scarr E, 2006, BIPOLAR DISORD, V8, P133, DOI 10.1111/j.1399-5618.2006.00300.x; Schmandke A, 2014, NEUROSCIENTIST, V20, P372, DOI 10.1177/1073858413516800; Schmitt A, 2004, BIOL PSYCHIAT, V56, P41, DOI 10.1016/j.biopsych.2004.03.019; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Siever LJ, 2004, AM J PSYCHIAT, V161, P398, DOI 10.1176/appi.ajp.161.3.398; Singleton AB, 2005, TRENDS NEUROSCI, V28, P416, DOI 10.1016/j.tins.2005.05.009; Sui YP, 2015, NEUROCHEM RES, V40, P1767, DOI 10.1007/s11064-015-1671-5; Tan HY, 2008, J CLIN INVEST, V118, P2200, DOI [10.1172/JCI3472S, 10.1172/JCI34725]; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Uranova N, 2001, BRAIN RES BULL, V55, P597, DOI 10.1016/S0361-9230(01)00528-7; Vawter MP, 2001, BRAIN RES BULL, V55, P641, DOI 10.1016/S0361-9230(01)00522-6; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16	46	8	8	0	7	KOREAN NEUROPSYCHIATRIC ASSOC	SEOUL	RN 522, G-FIVE CENTRAL PLAZA 1685-8 SEOCHO 4-DONG, SEOCHO-GU, SEOUL, 137-882, SOUTH KOREA	1738-3684	1976-3026		PSYCHIAT INVEST	Psychiatry Investig.	MAY	2017	14	3					344	349		10.4306/pi.2017.14.3.344			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EV8HL	WOS:000402021200013	28539953	Green Published, gold, Green Submitted			2022-02-06	
J	Gardner, AJ; Shih, SL; Adamov, EV; Zafonte, RD				Gardner, Andrew J.; Shih, Shirley L.; Adamov, Elizabeth V.; Zafonte, Ross D.			Research Frontiers in Traumatic Brain Injury Defining the Injury	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Research; Neuroimaging; Serum biomarkers; Blood biomarkers; Genetics; Physiology; Phenotypes	POSTTRAUMATIC-STRESS-DISORDER; DEFICIT HYPERACTIVITY DISORDER; DIFFUSE AXONAL INJURY; FIBRILLARY ACIDIC PROTEIN; TENSOR IMAGING FINDINGS; APOLIPOPROTEIN-E; AMYLOID-BETA; COGNITIVE REHABILITATION; CEREBROSPINAL-FLUID; CLINICAL-OUTCOMES	With the continued advancement in technology, such as increasingly sophisticated neuroimaging parameters, and the ongoing development of various scientific fields, like serum and blood biomarkers, genetics, and physiology, traumatic brain injury (TBI) research is a dynamic field of study. TBI remains a significant public health concern and research has continued to grow exponentially over the past decade. This review provides an overview of the frontiers of TBI research, from sports concussion to severe TBI, from acute and subacute injury to long-term/chronic outcomes, from assessment and management to prognosis, specifically examining recent neuroimaging, biomarkers, genetics, and physiologic studies.	[Gardner, Andrew J.] Univ Newcastle, Hunter New England Local Hlth Dist, Ctr Stroke & Brain Injury, Sports Concuss Program,Sch Med & Publ Hlth, Univ Dr, Callaghan, NSW 2308, Australia; [Shih, Shirley L.; Adamov, Elizabeth V.; Zafonte, Ross D.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 1st Ave, Boston, MA 02129 USA; [Zafonte, Ross D.] Massachusetts Gen Hosp, Brigham & Womens Hosp, Home Base Program, Red Sox Fdn, Boston, MA 02129 USA		Gardner, AJ (corresponding author), Hunter New England Local Hlth Dist, Calvary Mater Hosp, Sports Concuss Program, Level 5 McAuley Bldg, Waratah, NSW 2298, Australia.	Andrew.Gardner@neurogard.com.au		Gardner, Andrew/0000-0001-5031-5586	Australian Football League (AFL); HMRI; NSW Sporting Injuries Committee; Brain Foundation; Hunter Medical Research Institute (HMRI)	A.J. Gardner has a clinical practice in neuropsychology involving individuals who have sustained sport-related concussion (including current and former athletes). He serves, in a voluntary capacity, as a member of the Australian Rugby Union (ARU) concussion advisory group. He has also served as a consultant to the ARU in a remunerated role from July 2016. He has received travel funding from the Australian Football League (AFL) to present at the Concussion in Football Conference in 2013. Previous grant funding includes the NSW Sporting Injuries Committee, the Brain Foundation and the Hunter Medical Research Institute (HMRI), supported by Jennie Thomas. He is currently receiving research funding through the HMRI, supported by Anne Greaves. S.L. Shih, E.V. Adamov, and R.D. Zafonte have nothing to disclose.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ariza M, 2006, J NEUROPSYCH CLIN N, V18, P39, DOI 10.1176/appi.neuropsych.18.1.39; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Bouvier D, 2013, ANN BIOL CLIN-PARIS, V71, P145, DOI 10.1684/abc.2013.0812; Brenner T, 2003, PEDIATR NEUROL, V28, P104, DOI 10.1016/S0887-8994(02)00491-5; Bruce JM, 2004, NEUROLOGY, V63, P1516; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Cazalis F, 2006, BRAIN INJURY, V20, P1019, DOI 10.1080/02699050600664384; Centers for Disease Control and Prevention, 2001, INJ PREV CONTR TRAUM; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; DeFazio MV, 2014, WORLD NEUROSURG, V81, P151, DOI 10.1016/j.wneu.2013.01.015; Dutcher SA, 2001, NEUROL RES, V23, P203, DOI 10.1179/016164101101198343; Faul M, 2010, TRAUMATIC BRAIN INJU; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gosseries Olivia, 2016, Open Neuroimag J, V10, P52, DOI 10.2174/1874440001610010052; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2016, PSYCHONEUROENDOCRINO, V63, P398, DOI 10.1016/j.psyneuen.2015.02.008; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Ilie G, 2015, J PSYCHIATR RES, V69, P174, DOI 10.1016/j.jpsychires.2015.08.004; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; Kehoe AD, 2008, EMERG MED J, V25, P759, DOI 10.1136/emj.2006.045336; Kellermann I, 2016, CLIN NEUROL NEUROSUR, V145, P79, DOI 10.1016/j.clineuro.2016.04.005; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000162; Lam L T, 2002, J Atten Disord, V6, P77, DOI 10.1177/108705470200600204; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Li LZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002028; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; Padgett CR, 2016, NEUROPSYCHOLOGY, V30, P775, DOI 10.1037/neu0000270; Padgett CR, 2016, J CLIN EXP NEUROPSYC, V38, P551, DOI 10.1080/13803395.2015.1137557; Pastor PN, 2006, AMBUL PEDIATR, V6, P38, DOI 10.1016/j.ambp.2005.07.002; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Raheja A, 2016, J NEUROSURG, V125, P631, DOI 10.3171/2015.6.JNS15674; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rhine T, 2016, BRAIN INJURY, V30, P1231, DOI 10.1080/02699052.2016.1178396; Rodriguez-Rodriguez A, 2016, NEUROL RES, V38, P130, DOI 10.1080/01616412.2016.1144410; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; RUDMAN D, 1976, NEW ENGL J MED, V295, P635, DOI 10.1056/NEJM197609162951202; Sakai K, 2014, AM J FOREN MED PATH, V35, P38, DOI 10.1097/PAF.0000000000000067; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Scott G, 2016, NEUROLOGY, V32, P342; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Soddu A, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.424; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Swan AR, 2015, J NEUROTRAUM, V32, P1510, DOI 10.1089/neu.2014.3654; Swensen, 2004, J ADOLESCENT HEALTH, V35, DOI [DOI 10.1016/J.JAD0HEALTH.2003.12.003, 10.1016/j.jadohealth.2003.12.003]; Tasci A, 2003, NEUROL RES, V25, P871, DOI 10.1179/016164103771953998; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Trainor TP, 1999, J SYNCHROTRON RADIAT, V6, P618, DOI 10.1107/S0909049598017038; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; White H, 2011, CRIT CARE, V15, DOI 10.1186/cc10020; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Willmott C, 2014, J NEUROTRAUM, V31, P1507, DOI 10.1089/neu.2013.3308; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; World Health Organization, 2006, NEUROLOGICAL DISORDE, P164; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698	113	8	9	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2017	28	2					413	+		10.1016/j.pmr.2016.12.014			20	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EU5AJ	WOS:000401043700016	28390522				2022-02-06	
J	Hill, EP; Stiles, PJ; Reyes, J; Nold, RJ; Helmer, SD; Haan, JM				Hill, E. Patricia; Stiles, P. J.; Reyes, Jared; Nold, R. Joseph; Helmer, Stephen D.; Haan, James M.			Repeat head imaging in blunt pediatric trauma patients: Is it necessary?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	46th Annual Meeting of the Western-Trauma-Association	FEB 28-MAR 04, 2016	CA	Western Trauma Assoc		Pediatric; repeat cranial CT scans; traumatic brain injury; intracranial hemorrhage; CT scan	COMPUTED-TOMOGRAPHY; BRAIN-INJURY; CT; MILD	BACKGROUND Children with confirmed brain injury usually undergo follow-up computed tomography (CT) scan of the head within 24 hours of admission. To date, no evidence exists to validate the diagnostic or therapeutic value of these repeat CTs. The purpose of this study was to (1) evaluate progression of traumatic brain injuries, (2) determine if routine repeat imaging changes management, and (3) compare the efficacy of recognizing worsening hemorrhage with serial neurological examination versus repeat imaging. METHODS A 5-year retrospective review was conducted of all patients aged under 18 years with blunt traumatic head injury (n = 95). Data included demographics, type and size of intracranial hemorrhage, exam findings, diagnostic and management changes, and hospital outcomes. RESULTS Most patients (68.4%) had at least one repeat CT; of these, 67.7% (n = 44) showed no change or reduced hemorrhage. In only one patient did a repeat CT scan result in a surgical procedure; however, that CT scan was prompted by a change in neurological status. Among patients with more than two repeat head CTs, 42.9% led to a change in management, most frequently an additional CT scan. Presence of neurological symptoms was associated with having repeat CT scans (p = 0.025). Changes in Glasgow Coma Scale score were associated with increased hemorrhage (p = 0.012) but not repeat scans (p = 0.496). In the majority of cases, increased hemorrhage only resulted in an additional head CT and prolonged intensive care unit stay. Excluding patients who arrived with brain death, there was no difference in mortality between patients with and without repeat imaging. CONCLUSION Findings from this study support a selective approach for repeating head CTs with emphasis on changes in neurological symptoms and Glasgow Coma Scale score. Prospective studies on timing and indications for repeat CT scans are needed to support development of clinical guidelines. LEVEL OF EVIDENCE Therapeutic study, level III.	[Hill, E. Patricia; Stiles, P. J.; Reyes, Jared; Nold, R. Joseph; Helmer, Stephen D.; Haan, James M.] Univ Kansas, Dept Surg, Sch Med Wichita, Wichita, KS USA; [Nold, R. Joseph; Haan, James M.] Via Christi Hosp St Francis, Dept Trauma Serv, Room 2514,929 N St Francis St, Wichita, KS 67214 USA; [Helmer, Stephen D.] Via Christi Hosp St Francis, Dept Med Educ, Room 2514,929 N St Francis St, Wichita, KS 67214 USA		Haan, JM (corresponding author), Via Christi Hosp St Francis, Dept Trauma Serv, Room 2514,929 N St Francis St, Wichita, KS 67214 USA.	James.Haan.Research@viachristi.org					AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Bata SC, 2014, ANZ J SURG, V84, P438, DOI 10.1111/ans.12582; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; KOBAYASHI S, 1983, SURG NEUROL, V20, P25, DOI 10.1016/0090-3019(83)90101-5; Schonfeld D, 2015, POSTGRAD MED J, V91, P634, DOI 10.1136/postgradmedj-2013-305004rep; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162	13	8	8	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2017	82	5					896	900		10.1097/TA.0000000000001406			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	EU0GJ	WOS:000400687400009	28248802				2022-02-06	
J	Johansson, J; de Boussard, CN; Seimyr, GO; Pansell, T				Johansson, Jan; de Boussard, Catharina Nygren; Seimyr, Gustaf Oqvist; Pansell, Tony			The effect of spectacle treatment in patients with mild traumatic brain injury: a pilot study	CLINICAL AND EXPERIMENTAL OPTOMETRY			English	Article						Convergence Insufficiency Symptom Survey (CISS); International Reading Speed Texts (IReST); mild traumatic brain injury; post-commotio; post-concussive symptoms; reading performance; reading speed; spectacle treatment; visual dysfunction	INSUFFICIENCY SYMPTOM SURVEY; CONVERGENCE INSUFFICIENCY; OCULOMOTOR REHABILITATION; READING PERFORMANCE; VISION ANOMALIES; DYSFUNCTIONS; PREVALENCE; RELIABILITY; VERGENCE; VALIDITY	Background: Visual symptoms and dysfunctions may be a part of the long-term issues following mild traumatic brain injury. These issues may have an impact on near work and reading, and thus affect activities of daily life and the ability to return to work. The purpose of the study was to assess the effect of spectacle treatment on near work-related visual symptoms, visual function and reading performance in patients with persisting symptoms after mild traumatic brain injury. Methods: Eight patients with persisting symptoms after mild traumatic brain injury and anomalies of binocular function were included. Binocular function, visual symptoms and reading performance were assessed before and after spectacle treatment. Reading eye movements were recorded with eye tracking. Results: Four patients showed a considerable symptom reduction along with minor improvement in clinical visual measures. Reading performance improved in four patients; however, the relationship to symptom reduction was inconsistent. The improvement was correlated to reduced average number of fixations per word (r = -0.89, p = 0.02), reduced proportion of regressive saccades (r = -0.93, p = 0.01) and a significant increase of mean progressive saccade length (p = 0.03). Conclusion: This pilot study found that spectacle treatment, specifically directed at optimising near task visual function, significantly reduced symptoms in 50 per cent of patients and improved reading performance in 50 per cent. While promising, lack of placebo control and lack of correlation between reading performance and symptom improvements means we cannot decipher mechanisms without further study.	[Johansson, Jan; de Boussard, Catharina Nygren; Seimyr, Gustaf Oqvist; Pansell, Tony] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden		Johansson, J (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	jan.johansson.1@ki.se	Pansell, Tony/L-9487-2017	Johansson, Jan/0000-0002-1093-4179			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CASSIDY JD, 2014, ARCH PHYS MED REHAB, V95, P132; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Ciuffreda Kenneth J, 2002, Optometry, V73, P735; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; GRABOW JD, 1984, AM J PUBLIC HEALTH, V74, P710, DOI 10.2105/AJPH.74.7.710; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Grisham J D, 1986, J Am Optom Assoc, V57, P44; GRISHAM JD, 1993, OPTOMETRY VISION SCI, V70, P384, DOI 10.1097/00006324-199305000-00008; GROSVENOR T, 1977, J AM OPTOM ASSOC, V48, P510; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Hartvigsen J, 2014, ARCH PHYS MED REHAB, V95, P286; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Hokoda S C, 1985, J Am Optom Assoc, V56, P560; Jainta S, 2014, CURR BIOL, V24, P526, DOI 10.1016/j.cub.2014.01.014; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johansson J, 2014, CLIN EXP OPTOM, V97, P341, DOI 10.1111/cxo.12137; Johansson J, 2014, J VISION, V14, DOI 10.1167/14.5.8; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lara F, 2001, OPHTHAL PHYSL OPT, V21, P70, DOI 10.1046/j.1475-1313.2001.00540.x; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Porcar E, 1997, OPTOMETRY VISION SCI, V74, P111, DOI 10.1097/00006324-199702000-00023; Raymond MJ, 1996, NEUROREHABILITATION, V6, P229, DOI 10.3233/NRE-1996-6309; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rosenfield M, 2012, OPHTHAL PHYSL OPT, V32, P142, DOI 10.1111/j.1475-1313.2011.00887.x; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Rouse MW, 1999, OPTOMETRY VISION SCI, V76, P643, DOI 10.1097/00006324-199909000-00022; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Scheiman M., 2014, CLIN MANAGEMENT BINO; Sheese ALN, 2014, PROG NEUROL SURG, V28, P149, DOI 10.1159/000358775; Simons H D, 1987, J Am Optom Assoc, V58, P578; SIMONS HD, 1993, OPTOMETRY VISION SCI, V70, P369, DOI 10.1097/00006324-199305000-00005; SIMONS HD, 1988, AM J OPTOM PHYS OPT, V65, P893; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Thiagarajan P, 2014, BRAIN INJURY, V28, P930, DOI 10.3109/02699052.2014.888761; Thiagarajan P, 2014, NEUROREHABILITATION, V34, P129, DOI 10.3233/NRE-131025; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235; Trauzettel-Klosinski S, 2012, INVEST OPHTH VIS SCI, V53, P5452, DOI 10.1167/iovs.11-8284; Yadav NK, 2014, BRAIN INJURY, V28, P922, DOI 10.3109/02699052.2014.887227	54	8	8	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0816-4622	1444-0938		CLIN EXP OPTOM	Clin. Exp. Optom.	MAY	2017	100	3					234	242		10.1111/cxo.12458			9	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	ET4YH	WOS:000400290500006	27624444				2022-02-06	
J	Lewis, PC; Camou, E; Wofford, K				Lewis, Paul C.; Camou, Elsa; Wofford, Kenneth			The Impact of Cigarette Smoking on the Formation of Heterotopic Ossification Among Service Members With a Traumatic Amputation	MILITARY MEDICINE			English	Article							COMBAT-RELATED AMPUTATIONS; TOBACCO USE; MILITARY DEPLOYMENT; RISK-FACTORS; BONE; NICOTINE; PREVALENCE; US; COMPLICATIONS; EXCISION	Background: Heterotopic ossification (HO), the abnormal formation of lamellar bone in soft nonosseous tissue, has been identified as a potential complication following a traumatic amputation or traumatic brain injury (TBI). HO occurs at a dramatically higher rate among military casualties than among civilian casualties. Most investigators agree that in order for HO to form three conditions must be present: (1) osteogenic precursor cells, (2) an inducing agent or event, and 3) an environment conducive to ostoegenesis. Therefore impacting on any of these three conditions should impact on the formation of HO. Anecdotal clinical reports seem to show a decreased incidence of HO among cigarette smokers. The negative effect of smoking on bone growth as well as poor healing overall is well established in the literature. It makes intuitive sense that tobacco smoking would negatively impact on an environment conducive for HO. A review of the literature found no published work that evaluated a possible link between HO and tobacco use. This study sought to determine if a relationship exists between tobacco use and the formation of HO. Methods: A retrospective data review was conducted of military medical records for service members (SMs) who have experienced a traumatic amputation. Cases were matched to controls on the basis of factors known to be associated with the development of HO including age, gender, comorbid TBI, and deployment status. Bivariate logistic regression models were used to test for associations between age, gender, TBI, and deployment status with tobacco use. Results: A total of 3,132 records of SMs with an amputation were included for analysis with 18% overall developing HO. Those that developed HO were more likely to be younger, have sustained a TBI and to use tobacco compared to those that did not develop HO. An odds ratio analysis found that SMs who experienced a deployment-related traumatic amputation were 7.34 times more likely, SMs with a TBI were 6.45 times more likely, and smokers were 1.27 times more likely to develop HO when compared to nondeployment-related amputations. Older age and female gender were found to be protective against developing HO. In the final model after matching on potential confounders, tobacco use was not related to HO among this sample. Discussion: The incidence of HO among SMs with a traumatic amputation or TBI was similar to that found in other research. Also found in this study and supported in the literature is age as a confounder for HO and the prevalence of tobacco use among SMs who have deployed. However, female gender as protective against the development of HO was an unexpected finding mainly because there are so few studies of SMs with traumatic amputations including women in the analysis. In the final analysis, given all the literature on the negative impact of smoking on bone healing, it seems counterintuitive that HO formation is unrelated to smoking status. The methodology used in this study has inherent limitations and a prospective study should be conducted to validate results.	[Lewis, Paul C.] Womack Army Med Ctr, Ctr Nursing Sci & Clin Inquiry, 2817 Reilly Rd, Ft Bragg, NC 28310 USA; [Camou, Elsa] Brooke Army Med Ctr, Ctr Nursing Sci & Clin Inquiry, 3851 Roger Brooke Rd, San Antonio, TX 78234 USA; [Wofford, Kenneth] Uniformed Serv Univ Hlth Sci, Grad Sch Nursing, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Lewis, PC (corresponding author), Womack Army Med Ctr, Ctr Nursing Sci & Clin Inquiry, 2817 Reilly Rd, Ft Bragg, NC 28310 USA.		Wofford, Kenneth/F-4861-2015	Wofford, Kenneth/0000-0001-5696-0690			Alfieri KA, 2015, CLIN ORTHOP RELAT R, V473, P2807, DOI 10.1007/s11999-015-4302-1; Anderson Morgan K, 2015, US Army Med Dep J, P42; [Anonymous], 2007, MED SURV MONTHL REP, V14, p[2002, 7]; Arredondo J, 2003, LAB INVEST, V83, P207, DOI 10.1097/01.LAB.0000053917.46614.12; Atkinson GJ, 2010, AM J PHYS MED REHAB, V89, P245, DOI 10.1097/PHM.0b013e3181c5657c; Bakhshaie J, 2016, PSYCHIAT RES, V237, P67, DOI 10.1016/j.psychres.2016.01.073; Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613; Brown KV, 2010, J TRAUMA, V69, pS116, DOI 10.1097/TA.0b013e3181e44cc7; Burd TA, 2003, J BONE JOINT SURG BR, V85B, P700, DOI 10.1302/0301-620X.85B5.13970; Castillo RC, 2005, J ORTHOP TRAUMA, V19, P151, DOI 10.1097/00005131-200503000-00001; Cesar-Neto JB, 2003, J PERIODONTOL, V74, P1454, DOI 10.1902/jop.2003.74.10.1454; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36, DOI 10.1302/0301-620X.57B1.36; Deng YH, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/798274; Edwards DS, 2016, J ORTHOP TRAUMA, V30, pS27, DOI 10.1097/BOT.0000000000000666; El-Zawawy HB, 2006, J ORTHOP RES, V24, P2150, DOI 10.1002/jor.20263; Forsberg Jonathan Agner, 2010, J Surg Orthop Adv, V19, P54; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; Gullihorn L, 2005, J ORTHOP TRAUMA, V19, P17, DOI 10.1097/00005131-200501000-00004; Harvey E J, 2002, Am J Orthop (Belle Mead NJ), V31, P518; Hermes EDA, 2012, ADDICTION, V107, P983, DOI 10.1111/j.1360-0443.2011.03737.x; Japuntich SJ, 2016, PSYCHOL TRAUMA-US, V8, P123, DOI 10.1037/tra0000093; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Kwong FNK, 2008, J AM ACAD ORTHOP SUR, V16, P619, DOI 10.5435/00124635-200811000-00001; Mitchell EJ, 2010, J ORTHOP TRAUMA, V24, P530, DOI 10.1097/BOT.0b013e3181ed147b; Moller AM, 2003, J BONE JOINT SURG BR, V85B, P178, DOI 10.1302/0301-620X.85B2.13717; MOSELY LH, 1977, HAND, V9, P97, DOI 10.1016/S0072-968X(77)80001-6; Pape HC, 2004, J BONE JOINT SURG BR, V86B, P783, DOI 10.1302/0301-620X.86B6.15356; Pavey GJ, 2015, CLIN ORTHOP RELAT R, V473, P2814, DOI 10.1007/s11999-015-4266-1; Potter Benjamin K, 2006, J Am Acad Orthop Surg, V14, pS191; Potter BK, 2007, J BONE JOINT SURG AM, V89A, P476, DOI 10.2106/JBJS.F.00412; Potter BK, 2010, J BONE JOINT SURG AM, V92A, P74, DOI 10.2106/JBJS.J.00776; Raikin SM, 1998, CLIN ORTHOP RELAT R, P231; Reece DH, 1996, J COMMUN HEALTH, V21, P389, DOI 10.1007/BF01702790; SAWYER JR, 1991, CALCIFIED TISSUE INT, V49, P208, DOI 10.1007/BF02556120; Schmitz MA, 1999, CLIN ORTHOP RELAT R, P184, DOI 10.1097/00003086-199908000-00024; Shehab D, 2002, J NUCL MED, V43, P346; Smith B, 2008, AM J PREV MED, V35, P539, DOI 10.1016/j.amepre.2008.07.009; Smith TC, 2014, J ADDICT MED, V8, P271, DOI 10.1097/ADM.0000000000000050; Snyder HB, 2002, J PERIODONTOL, V73, P505, DOI 10.1902/jop.2002.73.5.505; Szatkowski L, 2012, J EPIDEMIOL COMMUN H, V66, P791, DOI 10.1136/jech.2010.120154; Talcott GW, 2013, NICOTINE TOB RES, V15, P1348, DOI 10.1093/ntr/nts267; Ueng SWN, 1999, J TRAUMA, V47, P752, DOI 10.1097/00005373-199910000-00023; Ueng SWN, 1999, J TRAUMA, V46, P110, DOI 10.1097/00005373-199901000-00018	43	8	10	0	1	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY-JUN	2017	182	5-6					E1742	E1748		10.7205/MILMED-D-16-00350			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW4RC	WOS:000402487600017	29087919	Bronze			2022-02-06	
J	Miao, Q; Ge, MH; Huang, LL				Miao, Qi; Ge, Meihong; Huang, Lili			Up-regulation of GBP2 is Associated with Neuronal Apoptosis in Rat Brain Cortex Following Traumatic Brain Injury	NEUROCHEMICAL RESEARCH			English	Article						GBP2; Traumatic brain injury; Apoptosis; P-Stat1	GUANYLATE-BINDING-PROTEINS; TARGETED DISRUPTION; GAMMA-INTERFERON; IFN-GAMMA; ACTIVATION; GENE; GTPASES; INDUCTION; IMMUNITY; PATHWAY	Guanylate binding protein 2 (GBP2) is one member of GBP family. Recently, GBP2 has been proposed to be a novel target of anti-cancer drugs. However, the role of GBP2 in the traumatic brain injury (TBI) is very limited. In this study, we sought to define GBP2's role in brain injury. GBP2 protein levels were significantly increased in the brain 3 days after injury, suggesting a functional role for GBP2 in TBI. Neuronal cells overexpressing GBP2 exhibited up-regulation of co-location of GBP2 and NeuN following TBI, suggesting that GBP2 potentiates the neuron apoptosis. To confirm the role of GBP2 in neuron apoptosis process, we employed a highly potent inhibitor of GBP2 (GBP2 RNAi). In H2O2-stimulated PC12 cells, in vitro blockade of GBP2 activity using GBP2 RNAi markedly attenuated the neuron apoptosis number. GBP2 RNAi also inhibited the expression levels of active caspase3 and p-Stat1. Furthermore, we found the expression of p-Stat1 in line with GBP2 and GBP2 interacted with p-Stat1 following TBI. The Jak2 inhibitor, AG490 inhibited this interaction and decreased the active caspase3 expression as well as promoted the functional recovery. Taken together, these data suggest that GBP2 RNAi has a protective effect in a rat TBI. This study demonstrates that GBP2 is an important positive regulator of TBI and is a promising therapeutic target for brain injury.	[Miao, Qi] Second Peoples Hosp Nantong, Dept Educ & Sci, Nantong, Jiangsu, Peoples R China; [Ge, Meihong] Second Peoples Hosp Nantong, ICU, Nantong, Jiangsu, Peoples R China; [Huang, Lili] Nantong Univ, ICU, Nantong, Jiangsu, Peoples R China		Huang, LL (corresponding author), Nantong Univ, ICU, Nantong, Jiangsu, Peoples R China.	HLLfy123456@163.com					Balasubramanian S, 2011, J BIOL CHEM, V286, P20054, DOI 10.1074/jbc.M111.249326; Boehm U, 1998, J IMMUNOL, V161, P6715; BRIKEN V, 1995, MOL CELL BIOL, V15, P975; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; CHENG YSE, 1988, J INTERFERON RES, V8, P385, DOI 10.1089/jir.1988.8.385; Christian SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044267; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DECKER T, 1989, EMBO J, V8, P2009, DOI 10.1002/j.1460-2075.1989.tb03608.x; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Ferreri AJM, 2010, NAT REV CLIN ONCOL, V7, DOI 10.1038/nrclinonc.2010.9-c1; LEW DJ, 1991, MOL CELL BIOL, V11, P182, DOI 10.1128/MCB.11.1.182; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Man SM, 2016, J LEUKOCYTE BIOL; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Messmer-Blust AF, 2010, MOL BIOL CELL, V21, P2514, DOI 10.1091/mbc.E09-04-0344; Meunier E, 2015, NAT IMMUNOL, V16, P476, DOI 10.1038/ni.3119; Moon JM, 2011, ANAT CELL BIOL, V44, P98, DOI 10.5115/acb.2011.44.2.98; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Rowe RK, 2016, DEV NEUROSCI; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Vestal DJ, 1998, J INTERF CYTOK RES, V18, P977, DOI 10.1089/jir.1998.18.977; Wan CH, 2014, J NEUROSCI RES, V92, P1, DOI 10.1002/jnr.23305; Wang ZT, 2013, J MOL NEUROSCI, V49, P409, DOI 10.1007/s12031-012-9908-0; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001	28	8	9	1	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAY	2017	42	5					1515	1523		10.1007/s11064-017-2208-x			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	ES9UD	WOS:000399906000025	28239766				2022-02-06	
J	Mouthon, AL; Meyer-Heim, A; Kurth, S; Ringli, M; Pugin, F; van Hedel, HJA; Huber, R				Mouthon, Anne-Laure; Meyer-Heim, Andreas; Kurth, Salome; Ringli, Maya; Pugin, Fiona; van Hedel, Hubertus J. A.; Huber, Reto			High-Density Electroencephalographic Recordings During Sleep in Children and Adolescents With Acquired Brain Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						sleep; EEG; slow wave activity; acquired brain injury	NEUROLOGICAL OUTCOME SCALE; SLOW-WAVE ACTIVITY; NEURAL PLASTICITY; EEG; MOTOR; STROKE; NEUROPLASTICITY; TRAJECTORIES; MATURATION; NETWORKS	Background. Acquired brain injuries (ABI) such as traumatic brain injury (TBI) or stroke can result in motor, language, or cognitive impairments. Although a considerable number of studies have investigated functional recovery, underlying brain reorganization remains poorly understood. Accumulating evidence indicates that plastic processes in the brain are linked to changes in electroencephalographic (EEG) slow wave activity (SWA) during deep sleep (EEG spectral power 1-4.5 Hz). Objective. We investigated sleep SWA in children and adolescents with ABI. Methods. We used high-density EEG (128 electrodes) to record sleep in 22 young patients with ABI (age range = 4-16 years). We compared patients to 52 previously measured typically developing children and adolescents (age range = 4-16 years). Results. The pattern of alterations in SWA differed between particular patient groups. In patients with bilateral stroke, SWA was globally reduced across the entire scalp. Patients with unilateral stroke showed a local reduction in SWA over lesion areas and an increase over perilesional and contralateral brain areas. In patients with severe TBI, we found a reduction in SWA over the midline and an increase over lateral brain areas. We found no consistent pattern in patients with mild to moderate TBI. Conclusions. Sleep SWA seems to be a sensitive measure to assess individual alterations in neural activity after ABI. Deviations from age norms might indirectly indicate plastic processes that have occurred since injury. Improving our understanding of neural activity after ABI could optimize clinical prognosis and guide the development of novel therapeutic interventions.	[Mouthon, Anne-Laure; Kurth, Salome; Ringli, Maya; Pugin, Fiona; Huber, Reto] Univ Childrens Hosp Zurich, Child Dev Ctr, Steinwiesstr 75, CH-8032 Zurich, Switzerland; [Mouthon, Anne-Laure; Kurth, Salome; Ringli, Maya; Pugin, Fiona; Huber, Reto] Univ Childrens Hosp Zurich, Pediat Sleep Disorders Ctr, Steinwiesstr 75, CH-8032 Zurich, Switzerland; [Mouthon, Anne-Laure; Meyer-Heim, Andreas; van Hedel, Hubertus J. A.] Univ Childrens Hosp Zurich, Rehabil Ctr Affoltern Albis, Zurich, Switzerland; [Mouthon, Anne-Laure; Meyer-Heim, Andreas; Kurth, Salome; Ringli, Maya; Pugin, Fiona; van Hedel, Hubertus J. A.; Huber, Reto] Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland; [Huber, Reto] Univ Zurich, Hosp Psychiat, Dept Child & Adolescent Psychiat & Psychotherapy, Zurich, Switzerland; [Kurth, Salome] Univ Colorado Boulder, Dept Integrat Physiol, Boulder, CO USA		Huber, R (corresponding author), Univ Childrens Hosp Zurich, Child Dev Ctr, Steinwiesstr 75, CH-8032 Zurich, Switzerland.; Huber, R (corresponding author), Univ Childrens Hosp Zurich, Pediat Sleep Disorders Ctr, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	reto.huber@kispi.uzh.ch	Kurth, Salome/AAS-8067-2021; Kurth, Salome/M-4227-2017; van Hedel, Hubertus/AAL-3818-2021	Kurth, Salome/0000-0003-1432-4367; Kurth, Salome/0000-0003-1432-4367; Mouthon, Anne-Laure/0000-0002-8462-3939; Huber, Reto/0000-0002-1400-9466; van Hedel, Hubertus/0000-0002-9577-5049	Anna-Muller Grocholski Foundation; Maxi Foundation; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [P00P3-135438]; Clinical Research Priority Program "Sleep and Health" of the University of Zurich	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Anna-Muller Grocholski Foundation, the Maxi Foundation, the Swiss National Science Foundation (Grant P00P3-135438), and the Clinical Research Priority Program "Sleep and Health" of the University of Zurich.	Amlie-Lefond C, 2008, LANCET NEUROL, V7, P425, DOI 10.1016/S1474-4422(08)70086-3; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Campbell IG, 2009, P NATL ACAD SCI USA, V106, P5177, DOI 10.1073/pnas.0812947106; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Chung MG, 2015, ARCH PHYS MED REHAB, V96, pS129, DOI 10.1016/j.apmr.2014.10.013; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Grefkes C, 2014, NEUROSCIENTIST, V20, P56, DOI 10.1177/1073858413491147; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Huber R, 2000, NEUROREPORT, V11, P3321, DOI 10.1097/00001756-200010200-00012; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huynh W, 2013, CEREBELLUM, V12, P826, DOI 10.1007/s12311-013-0493-8; Iber C., 2007, AASM MANUAL SCORING, P7; Ichord RN, 2011, STROKE, V42, P613, DOI 10.1161/STROKEAHA.110.607192; Kretschmann H, 2007, ATLAS MAGNETRESONANZ; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Kurth S, 2012, NEUROIMAGE, V63, P959, DOI 10.1016/j.neuroimage.2012.03.053; Kurth S, 2010, J NEUROSCI, V30, P13211, DOI 10.1523/JNEUROSCI.2532-10.2010; McCauley SR, 2010, J NEUROTRAUM, V27, P991, DOI 10.1089/neu.2009.1195; Mouthon AL, 2016, NEUROIMAGE-CLIN, V11, P468, DOI 10.1016/j.nicl.2016.03.012; Ottenbacher KJ, 1999, DEV MED CHILD NEUROL, V41, P186, DOI 10.1017/S0012162299000377; Poryazova R, 2015, J SLEEP RES, V24, P54, DOI 10.1111/jsr.12208; Pugin F, 2015, SLEEP, V38, P607, DOI 10.5665/sleep.4580; Sarasso S, 2014, NEUROREHAB NEURAL RE, V28, P129, DOI 10.1177/1545968313498651; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Sultan F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1912; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; von Monakow C., 1914, LOKALISATION GROSSHI; Ward NS, 2005, PROG BRAIN RES, V150, P527, DOI 10.1016/S0079-6123(05)50036-0; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; Wilhelm I, 2014, J NEUROSCI, V34, P12568, DOI 10.1523/JNEUROSCI.0962-14.2014	37	8	8	1	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	MAY	2017	31	5					462	474		10.1177/1545968316688794			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	ES7EE	WOS:000399711600007	28162033	Bronze			2022-02-06	
J	Nathan, DE; Bellgowan, JAF; French, LM; Wolf, J; Oakes, TR; Mielke, J; Sham, EB; Liu, W; Riedy, G				Nathan, Dominic E.; Bellgowan, Julie A. Frost; French, Louis M.; Wolf, Jonathan; Oakes, Terrence R.; Mielke, Jeannine; Sham, Elyssa B.; Liu, Wei; Riedy, Gerard			Assessing the Impact of Post-Traumatic Stress Symptoms on the Resting-State Default Mode Network in a Military Chronic Mild Traumatic Brain Injury Sample	BRAIN CONNECTIVITY			English	Article						default mode network; function MRI; mild traumatic brain injury; post-traumatic stress disorder (PTSD); resting-state functional connectivity	INDEPENDENT COMPONENT ANALYSIS; MEDIAL TEMPORAL-LOBE; ANTERIOR CINGULATE CORTEX; COMBAT-RELATED PTSD; FUNCTIONAL CONNECTIVITY; PREFRONTAL CORTEX; PSYCHOMETRIC PROPERTIES; HEAD-INJURY; DISORDER; MEMORY	The relationship between post-traumatic stress disorder (PTSD) and chronic symptoms of mild traumatic brain injury (mTBI) is difficult to discern and poorly understood. An accurate differential diagnosis, assessment, and treatment of mTBI and PTSD are challenging due to significant symptom overlap and the absence of clearly established biomarkers. The objective of this work is to examine how post-traumatic stress influences task-free default mode network in chronic mTBI subjects. Control subjects (N= 44) were compared with chronic mTBI subjects with low (N= 58, PTSD Checklist-Civilian Version [PCL-C] total < 30), medium (N=124, PCL-C total = 31-49), and high (N= 105, PCL-C total >= 60) post-traumatic stress symptoms (PTSS). The results indicate significant differences in Brodmann area 10 for all mTBI subject groups, indicating potential mTBI-related disruptions with regulation of emotions and decision-making. The effects of PTSS were observed in the anterior cingulate and parahippocampus, suggesting possible disruptions pertaining to memory regulation, encoding, and retrieval. The overall results indicate the presence of aberrant connectivity patterns between controls and chronic mTBI subjects with low, medium, and high PTSS. Furthermore, the findings suggest a disruption in attention relating to a network of brain regions involved with emotional regulation and memory coding, rather than a fear-related response. Taken together, the results suggest these regions form a network that could be a target for future research pertaining to PTSD and chronic mTBI. Furthermore, the use of clinical measures, task-based imaging studies, or multimodal imaging could help further elucidate specific neural correlates of PTSS and mTBI.	[Nathan, Dominic E.; Bellgowan, Julie A. Frost; French, Louis M.; Wolf, Jonathan; Oakes, Terrence R.; Mielke, Jeannine; Sham, Elyssa B.; Liu, Wei; Riedy, Gerard] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence NICoE, Bethesda, MD 20889 USA; [Nathan, Dominic E.; Bellgowan, Julie A. Frost; Sham, Elyssa B.; Liu, Wei] North Tide LLC, Dulles, VA USA; [Nathan, Dominic E.; Riedy, Gerard] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA; [French, Louis M.] CNRM, Bethesda, MD USA		Nathan, DE (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Dept Neuroimaging, Bethesda, MD 20889 USA.	dominic.nathan@gmail.com	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604	Congressionally Directed Medical Research ProgramUnited States Department of Defense [DM130132]	The views expressed in this article are those of the authors and do not reflect the policy of the United States Department of the Army, Navy, Air Force, Department of Defense, or the United States Government. This study was supported through the Congressionally Directed Medical Research Program, grant number DM130132. The authors are grateful to Mr. David Joy, BS, Dr. Joseph Hennessey, PhD, Mr. Andrew Bryant, Mr. Alex Kubli, BS, Mr. John Morissette, Mrs. Jamie Harper, MPH, Mr. Justin Senseney, MS, Ms. Rachel Wolfowitz, BS, Mr. Arman Taheri, the participants and their families, and to the clinicians and staff at the National Intrepid Center of Excellence.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Brooks JCW, 2008, NEUROIMAGE, V39, P680, DOI 10.1016/j.neuroimage.2007.09.018; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bruce SE, 2013, NEUROIMAGE-CLIN, V2, P43, DOI 10.1016/j.nicl.2012.11.003; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carp J, 2013, NEUROIMAGE, V76, P436, DOI 10.1016/j.neuroimage.2011.12.061; Cifu D., 2010, TRAUMATIC BRAIN INJU; Cox R.W., 2016, AFNI CLUSTERING FALS; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Franklin TR, 2011, DRUG ALCOHOL DEPEN, V117, P176, DOI 10.1016/j.drugalcdep.2011.01.015; Geuze E, 2008, J PSYCHIATR RES, V42, P659, DOI 10.1016/j.jpsychires.2007.06.007; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276; Handwerker DA, 2012, NEUROIMAGE, V63, P1712, DOI 10.1016/j.neuroimage.2012.06.078; Harvey AG, 2001, J TRAUMA STRESS, V14, P277, DOI 10.1023/A:1011108816888; Hayes JP, 2011, J PSYCHIATR RES, V45, P660, DOI 10.1016/j.jpsychires.2010.10.007; Hyvarinen A., 2004, INDEPENDENT COMPONEN, V46; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; Lanius RA, 2002, BIOL PSYCHIAT, V52, P305, DOI 10.1016/S0006-3223(02)01367-7; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Marmar C.R., 2002, TRAUMA MEMORY DISSOC, V54; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Nathan DR, 2015, ORG HUM BRAIN MAPP A; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; Pruim RHR, 2015, NEUROIMAGE, V112, P278, DOI 10.1016/j.neuroimage.2015.02.063; Rabinak Christine A, 2011, Front Psychiatry, V2, P62, DOI 10.3389/fpsyt.2011.00062; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Roitman P, 2013, J TRAUMA STRESS, V26, P727, DOI 10.1002/jts.21862; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Sakamoto H, 2005, NEUROIMAGE, V26, P813, DOI 10.1016/j.neuroimage.2005.02.032; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shaw ME, 2009, PSYCHIAT RES-NEUROIM, V172, P235, DOI 10.1016/j.pscychresns.2008.07.014; Shim G, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-58; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Simmons A, 2008, NEUROREPORT, V19, P1033, DOI 10.1097/WNR.0b013e328305b722; Smith S.M., 2009, NEUROIMAGE, V47, pS148; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Sripada RK, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00672; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Thomaes K, 2009, PSYCHIAT RES-NEUROIM, V171, P44, DOI 10.1016/j.pscychresns.2008.03.003; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vlassenko A, 2004, J NEUROPSYCH CLIN N, V16, P360, DOI 10.1176/appi.neuropsych.16.3.360; Ward B. D., 2002, DECONVOLUTION ANAL F; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wessely S, 2003, BRIT J PSYCHIAT, V183, P314, DOI 10.1192/bjp.183.4.314; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan XD, 2013, NEUROSCI LETT, V547, P1, DOI 10.1016/j.neulet.2013.04.032; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035	73	8	8	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	MAY	2017	7	4					236	249		10.1089/brain.2016.0433			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY0NC	WOS:000448216700003	28316248				2022-02-06	
J	Pauelsen, M; Nyberg, G; Tegner, C; Tegner, Y				Pauelsen, Mascha; Nyberg, Gusten; Tegner, Cecilia; Tegner, Yelverton			Concussion in Ice Hockey-A Cohort Study Across 29 Seasons	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						athletic injuries; brain concussion; incidence rate; ice hockey	TRAUMATIC BRAIN-INJURY; CONSENSUS STATEMENT; RISK; SPORT; HEAD; MENS; DISEASE; LEAGUE; 7-YEAR	Objective: The aim of this study was to analyze the concussion incidence rate ratios across 29 seasons in a Swedish Hockey League team. Design: Cohort study over 29 seasons within one Swedish elite series ice hockey team. Participants: All players who were part of one Swedish elite ice hockey team during the research period gave consent for participation in the study. Independent Variables: Exposure to top-level Swedish ice hockey. Main Outcome Measures: Incidence rate ratio for concussion and rehabilitation periods due to concussion were calculated and analyzed. Results: During the research period, 267 players in total were part of the team. A total of 1638 traumatic injuries were registered, of which 162 were concussions. Incidence rates (IRs) ranged from 0/1000 games during the first season to 118/1000 games for the final recorded season. The incidence rate ratio was 1.06 (confidence interval, 1.03-1.10) for the entire research period. A shift toward longer rehabilitation periods was discovered. Conclusions: This study showed a significant increase of concussion IR and a trend toward longer rehabilitation periods due to concussion. Possible risk factors were discussed. Risk behavior and rehabilitation protocols should be prioritized areas in the research of concussion in ice hockey.	[Pauelsen, Mascha] Lulea Univ Technol, Div Hlth & Rehabil, Dept Hlth Sci, Lulea, Sweden; [Nyberg, Gusten] Linkoping Univ Hosp, Dept Radiol, Linkoping, Sweden; [Tegner, Cecilia] Swedish Univ Agr Sci, Uppsala, Sweden; [Tegner, Yelverton] Lulea Univ Technol, Div Med Sci, Dept Hlth Sci, Lulea, Sweden		Pauelsen, M (corresponding author), Lulea Univ Technol, Div Rehabil, Dept Hlth Sci, S-97187 Lulea, Sweden.	mascha.pauelsen@ltu.se	Pauelsen, Mascha/W-6667-2019; Pauelsen, Mascha/AAF-1203-2020	Pauelsen, Mascha/0000-0002-2510-7571; Tegner, Yelverton/0000-0003-3628-0705			Agel J, 2010, CAN J SURG, V53, P319; Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Biasca N., 2005, EUR J TRAUMA, V31, P396; Cook AW, 1966, CLIN NEUROSURG, V12, P386; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Hagglund M, 2009, BRIT J SPORT MED, V43, P483, DOI 10.1136/bjsm.2008.056937; Jacobson I, 2007, SCAND J MED SCI SPOR, V17, P84, DOI 10.1111/j.1600-0838.2006.00524.x; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; King DA, 2010, SPORTS MED, V40, P163, DOI 10.2165/11319740-000000000-00000; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kuzuhara K, 2009, J ATHL TRAINING, V44, P208, DOI 10.4085/1062-6050-44.2.208; LORENTZON R, 1988, AM J SPORT MED, V16, P392, DOI 10.1177/036354658801600415; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; PATTERSSON M, 1993, BRIT J SPORT MED, V27, P251, DOI 10.1136/bjsm.27.4.251; Quinney HA, 2008, APPL PHYSIOL NUTR ME, V33, P753, DOI 10.1139/H08-051; Rishiraj N, 2009, J SPORT MED PHYS FIT, V49, P159; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sedeaud A, 2014, J SPORT SCI, V32, P1146, DOI 10.1080/02640414.2014.889841; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Tegner Y, 1991, Br J Sports Med, V25, P87; Tegner Y, 1996, BRIT J SPORT MED, V30, P251, DOI 10.1136/bjsm.30.3.251; Tegner Y., 2004, BRIT J SPORT MED, V38, P663; TORG JS, 1979, JAMA-J AM MED ASSOC, V241, P1477, DOI 10.1001/jama.241.14.1477; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Tuominen M, 2015, BRIT J SPORT MED, V49, P30, DOI 10.1136/bjsports-2014-093688	34	8	9	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2017	27	3					283	287		10.1097/JSM.0000000000000347			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	ET9NV	WOS:000400635100008	28449005				2022-02-06	
J	Rowland, JA; Miskey, HM; Brearly, TW; Martindale, SL; Shura, RD				Rowland, Jared A.; Miskey, Holly M.; Brearly, Timothy W.; Martindale, Sarah L.; Shura, Robert D.			Word Memory Test Performance Across Cognitive Domains, Psychiatric Presentations, and Mild Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Performance validity; Veterans; Symptom validity; Attention; Post-deployment; Assessment	SYMPTOM VALIDITY TEST; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TEST-SCORES; NEUROPSYCHOLOGICAL ASSESSMENT; POOR EFFORT; ADULTS; VETERANS; CONCUSSION; FAILURE; EXAGGERATION	Objective: The current study addressed two aims: (i) determine how Word Memory Test (WMT) performance relates to test performance across numerous cognitive domains and (ii) evaluate how current psychiatric disorders or mild traumatic brain injury (mTBI) history affects performance on the WMT after excluding participants with poor symptom validity. Method: Participants were 235 Iraq and Afghanistan-era veterans (M-age = 35.5) who completed a comprehensive neuropsychological battery. Participants were divided into two groups based on WMT performance (Pass = 193, Fail = 42). Tests were grouped into cognitive domains and an average z-score was calculated for each domain. Results: Significant differences were found between those who passed and those who failed the WMT on the memory, attention, executive function, and motor output domain z-scores. WMT failure was associated with a larger performance decrement in the memory domain than the sensation or visuospatial-construction domains. Participants with a current psychiatric diagnosis or mTBI history were significantly more likely to fail the WMT, even after removing participants with poor symptom validity. Conclusions: Results suggest that the WMT is most appropriate for assessing validity in the domains of attention, executive function, motor output and memory, with little relationship to performance in domains of sensation or visuospatial-construction. Comprehensive cognitive batteries would benefit from inclusion of additional performance validity tests in these domains. Additionally, symptom validity did not explain higher rates of WMT failure in individuals with a current psychiatric diagnosis or mTBI history. Further research is needed to better understand how these conditions may affect WMT performance.	[Rowland, Jared A.; Miskey, Holly M.; Brearly, Timothy W.; Martindale, Sarah L.; Shura, Robert D.] WG Bill Hefner Vet Affairs Med Ctr, Midatlantic Mental Illness Res Educ & Clin Ctr, 11M-2 MH BS,1601 Brenner Ave, Salisbury, NC 28144 USA; [Rowland, Jared A.] WG Bill Hefner Vet Affairs Med Ctr, Res & Acad Affairs Serv Line, 11M-2 MH BS,1601 Brenner Ave, Salisbury, NC 28144 USA; [Rowland, Jared A.; Miskey, Holly M.; Brearly, Timothy W.; Martindale, Sarah L.; Shura, Robert D.] Wake Forest Sch Med, Dept Psychiat & Behav Sci, Winston Salem, NC USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA; [Miskey, Holly M.; Brearly, Timothy W.; Martindale, Sarah L.; Shura, Robert D.] WG Bill Hefner Vet Affairs Med Ctr, Mental Hlth & Behav Sci Serv Line, Salisbury, NC USA		Rowland, JA (corresponding author), WG Bill Hefner Vet Affairs Med Ctr, Midatlantic Mental Illness Res Educ & Clin Ctr, 11M-2 MH BS,1601 Brenner Ave, Salisbury, NC 28144 USA.; Rowland, JA (corresponding author), WG Bill Hefner Vet Affairs Med Ctr, Res & Acad Affairs Serv Line, 11M-2 MH BS,1601 Brenner Ave, Salisbury, NC 28144 USA.	Jared.Rowland@va.gov	Martindale, Sarah L/O-8553-2018; Shura, Robert D/J-6749-2019; Rowland, Jared A./AAN-3030-2021; Brearly, Timothy/T-1739-2019	Martindale, Sarah L/0000-0002-0059-3454; Rowland, Jared A./0000-0002-3655-3411; Brearly, Timothy/0000-0002-6320-0654; Miskey, Holly/0000-0002-5139-4586; Shura, Robert/0000-0002-9505-0080	W.G. "Bill" Hefner Veterans Affairs Medical Center; Mid-Atlantic Mental Illness Research Education and Clinical Center; Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and TreatmentUS Department of Veterans Affairs	This work was supported by resources of the W.G. "Bill" Hefner Veterans Affairs Medical Center; the Mid-Atlantic Mental Illness Research Education and Clinical Center; and the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Benedict R., 1997, BRIEF VISUOSPATIAL M; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Conners C.K., 2004, CONNERS CONTINUOUS P; Delis D.C., 2000, CALIFORNIA VERBAL LE; Doty RL, 1995, SMELL IDENTIFICATION, Vthird; Egeland J, 2015, APPL NEUROPSYCH-ADUL, V22, P215, DOI 10.1080/23279095.2014.910212; First M.B., 1996, STRUCTURED CLIN INTE; Golden CJ., 2002, STROOP COLOR WORD TE; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Greve KW, 2001, CLIN NEUROPSYCHOL, V15, P228, DOI 10.1076/clin.15.2.228.1901; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Heaton R.K., 1981, WISCONSIN CARD SORTI; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heyanka DJ, 2015, ARCH CLIN NEUROPSYCH, V30, P369, DOI 10.1093/arclin/acv025; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lansbergen MM, 2007, NEUROPSYCHOLOGY, V21, P251, DOI 10.1037/0894-4105.21.2.251; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meyers JE., 1995, REY COMPLEX FIGURE T; Miller H.A., 2001, MILLER FORENSIC ASSE; Morey, 1991, PERSONALITY ASSESSME; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Oosterman JM, 2010, CLIN NEUROPSYCHOL, V24, P203, DOI 10.1080/13854040903482848; *PSYCH CORP, 2001, WECHSL TEST AD READ; Reitan R. M, 1985, HALLSTED REITAN NEUR; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; Rohling ML, 2010, CLIN NEUROPSYCHOL, V24, P119, DOI 10.1080/13854040903307243; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Russo AC, 2012, ARCH CLIN NEUROPSYCH, V27, P840, DOI 10.1093/arclin/acs090; Sherer M, 2015, CLIN NEUROPSYCHOL, V29, P522, DOI 10.1080/13854046.2015.1052763; Silver JM, 2015, NEUROREHABILITATION, V36, P463, DOI 10.3233/NRE-151234; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suhr J, 2008, ARCH CLIN NEUROPSYCH, V23, P521, DOI 10.1016/j.acn.2008.05.003; Suhr JA, 2011, ARCH CLIN NEUROPSYCH, V26, P1, DOI 10.1093/arclin/acq094; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Wisdom NM, 2014, CLIN NEUROPSYCHOL, V28, P128, DOI 10.1080/13854046.2013.863977; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083; Zakzanis KK, 2012, APPL NEUROPSYCH-ADUL, V19, P98, DOI 10.1080/09084282.2011.644099	58	8	8	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2017	32	3					306	315		10.1093/arclin/acw107			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EU2WN	WOS:000400890700006	27998904	hybrid			2022-02-06	
J	Xue, ZL; Song, ZF; Wan, YF; Wang, K; Mo, LJ; Wang, YR				Xue, Zhaoliang; Song, Zhengfei; Wan, Yingfeng; Wang, Kun; Mo, Lianjie; Wang, Yirong			Calcium-sensing receptor antagonist NPS2390 attenuates neuronal apoptosis though intrinsic pathway following traumatic brain injury in rats	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Traumatic brain injury; Calcium-sensing receptor (CaSR); NPS2390; Neuronal apoptosis	CELL-DEATH; HOMEOSTASIS; FAMILY; MICE	Traumatic brain injury (TBI) initiates a complex cascade of neurochemical and signaling changes that leads to neuronal apoptosis, which contributes to poor outcomes for patients with TBI. Previous study indicates that calcium-sensing receptor (CaSR) activation contributes to neuron death in focal cerebral ischemia-reperfusion mice, however, its role in neuronal apoptosis after TBI is not well-established. Using a controlled cortical impact model in rats, the present study was designed to determine the effect of CaSR inhibitor NPS2390 upon neuronal apoptosis after TBI. Rats were randomly distributed into three groups undergoing the sham surgery or TBI procedure, and NPS2390 (1.5 mg/kg) was infused subcutaneously at 30 min and 120 min after TBI. All rats were sacrificed at 24 h after TBI. Our data indicated that NPS2390 significantly reduced the brain edema and improved the neurological function after TBI. In addition, NPS2390 decreased caspase-3 levels and the number of apoptotic neurons. Furthermore, NPS2390 up-regulated anti-apoptotic protein Bcl-2 expression and down-regulated proapoptotic protein Box, and reduced subsequent release of cytochrome c into the cytosol. In summary, this study indicated that inhibition of CaSR by NPS2390 attenuates neuronal apoptosis after TBI, in part, through modulating intrinsic apoptotic pathway. (C) 2017 Elsevier Inc. All rights reserved.	[Xue, Zhaoliang; Song, Zhengfei; Wan, Yingfeng; Wang, Kun; Mo, Lianjie; Wang, Yirong] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China		Wang, YR (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China.	s2012neurosurgery@163.com		Wan, Yingfeng/0000-0002-1176-2065	Project of Technology Office in Zhejiang Province [201503217]; National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81402004]; Nature Science Foundation of Zhejiang Province of China [LY14H160017]	This work was supported by The Project of Technology Office in Zhejiang Province (201503217), National Nature Science Foundation of China (81402004) and Nature Science Foundation of Zhejiang Province of China (LY14H160017).	Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Ji W., 2016, CELL MOL NEUROBIOL, P1; Kale J, 2012, CELL, V151, P1179, DOI 10.1016/j.cell.2012.11.013; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kim JY, 2013, J NEUROTRAUM, V30, P1170, DOI 10.1089/neu.2012.2691; Li P., 2004, CELL, V116, pS59; Piao CS, 2012, NEUROBIOL DIS, V46, P745, DOI 10.1016/j.nbd.2012.03.018; Riccardi D, 2012, ANNU REV PHYSIOL, V74, P271, DOI 10.1146/annurev-physiol-020911-153318; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruat M, 2013, BEST PRACT RES CL EN, V27, P429, DOI 10.1016/j.beem.2013.03.001; Umschweif G, 2015, J CEREBR BLOOD F MET, V35, P1901, DOI 10.1038/jcbfm.2015.207; Wang H, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0103-6; Wee HY, 2015, J SURG RES, V197, P382, DOI 10.1016/j.jss.2015.04.052; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Wu YJ, 2016, CURR PHARM DESIGN, V22, P4700, DOI 10.2174/1381612822666160506125937; Ying GY, 2016, NEUROSURGERY, V79, P286, DOI 10.1227/NEU.0000000000001264; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhen YL, 2016, AM J TRANSL RES, V8, P911	21	8	10	4	15	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	APR 29	2017	486	2					589	594		10.1016/j.bbrc.2017.03.097			6	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	ES1AV	WOS:000399261200057	28336431				2022-02-06	
J	Cnossen, MC; Polinder, S; Vos, PE; Lingsma, HF; Steyerberg, EW; Sun, YM; Ye, PP; Duan, LL; Haagsma, JA				Cnossen, Maryse C.; Polinder, Suzanne; Vos, Pieter E.; Lingsma, Hester F.; Steyerberg, Ewout W.; Sun, Yanming; Ye, Pengpeng; Duan, Leilei; Haagsma, Juanita A.			Comparing health-related quality of life of Dutch and Chinese patients with traumatic brain injury: do cultural differences play a role?	HEALTH AND QUALITY OF LIFE OUTCOMES			English	Article						Quality of life; SF-36; Traumatic brain injury; Cultural comparison; Health domains	POSTTRAUMATIC-STRESS-DISORDER; PSYCHOMETRIC EVALUATION; PSYCHIATRIC-DISORDERS; FOLLOW-UP; MILD; TRANSLATION; VALIDATION; VERSION; PREVALENCE; COMMUNITY	Background: There is growing interest in health related quality of life (HRQoL) as an outcome measure in international trials. However, there might be differences in the conceptualization of HRQoL across different sociocultural groups. The objectives of current study were: (I) to compare HRQoL, measured with the short form (SF)-36 of Dutch and Chinese traumatic brain injury (TBI) patients 1 year after injury and; (II) to assess whether differences in SF-36 profiles could be explained by cultural differences in HRQoL conceptualization. TBI patients are of particular interest because this is an important cause of diverse impairments and disabilities in functional, physical, emotional, cognitive, and social domains that may drastically reduce HRQoL. Methods: A prospective cohort study on adult TBI patients in the Netherlands (RUBICS) and a retrospective cohort study in China were used to compare HRQoL 1 year post-injury. Differences on subscales were assessed with the Mann-Whitney U-test. The internal consistency, interscale correlations, item-internal consistency and item-discriminate validity of Dutch and Chinese SF-36 profiles were examined. Confirmatory factor analysis was performed to assess whether Dutch and Chinese data fitted the SF-36 two factor-model (physical and mental construct). Results: Four hundred forty seven Dutch and 173 Chinese TBI patients were included. Dutch patients obtained significantly higher scores on role limitations due to emotional problems (p <.001) and general health (p <.001), while Chinese patients obtained significantly higher scores on physical functioning (p <.001) and bodily pain (p =.001). Scores on these subscales were not explained by cultural differences in conceptualization, since item-and scale statistics were all sufficient. However, differences among Dutch and Chinese patients were found in the conceptualization of the domains vitality, mental health and social functioning. Conclusions: One year after TBI, Dutch and Chinese patients reported a different pattern of HRQoL. Further, there might be cultural differences in the conceptualization of some of the SF-36 subscales, which has implications for outcome evaluation in multi-national trials.	[Cnossen, Maryse C.; Polinder, Suzanne; Lingsma, Hester F.; Steyerberg, Ewout W.; Haagsma, Juanita A.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Sci, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Vos, Pieter E.] Slingeland Hosp, Dept Neurol, Doetinchem, Netherlands; [Sun, Yanming] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Ye, Pengpeng; Duan, Leilei] China CDC, NCDC, Beijing, Peoples R China; [Duan, Leilei; Haagsma, Juanita A.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA		Cnossen, MC (corresponding author), Erasmus MC, Dept Publ Hlth, Ctr Med Decis Sci, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.c.cnossen@erasmusmc.nl			European Union FP 7th Framework program [602150]	The authors Maryse Cnossen, Suzanne Polinder, Hester Lingsma, Ewout Steyerberg and Juanita Haagsma were supported by the European Union FP 7th Framework program (grant 602150).	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Al Sayah F, 2013, QUAL LIFE RES, V22, P213, DOI 10.1007/s11136-012-0129-3; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; *ASS ADV AUT MED, 1998, ABBR INJ SCAL AIS 19; Azen SP, 1999, J AGING HEALTH, V11, P240, DOI 10.1177/089826439901100206; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V84; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Durbin D R, 2001, Inj Prev, V7, P96, DOI 10.1136/ip.7.2.96; Fuh JL, 2000, QUAL LIFE RES, V9, P675, DOI 10.1023/A:1008993821633; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hinton DE, 2007, J PSYCHOPATHOL BEHAV, V29, P39, DOI 10.1007/s10862-006-9022-0; HOWARD KI, 1962, EDUC PSYCHOL MEAS, V22, P731, DOI 10.1177/001316446202200407; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Li CH, 2016, BEHAV RES METHODS, V48, P936, DOI 10.3758/s13428-015-0619-7; Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; MCHORNEY CA, 1994, MED CARE, V32, P551, DOI 10.1097/00005650-199406000-00002; Meng QY, 2015, LANCET, V386, P1484, DOI 10.1016/S0140-6736(15)00342-6; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P161; Ngo-Metzger Q, 2008, J AGING HEALTH, V20, P420, DOI 10.1177/0898264308315855; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Ren XHS, 1998, J CLIN EPIDEMIOL, V51, P1129, DOI 10.1016/S0895-4356(98)00104-8; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Scott NW, 2007, QUAL LIFE RES, V16, P115, DOI 10.1007/s11136-006-9120-1; SIBBALD B, 1994, BRIT J GEN PRACT, V44, P297; Sivak S, 2016, BRATISL MED J, V117, P22, DOI 10.4149/BLL_2016_005; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Sun Y, 2016, FUNCTIONAL OUTCOME O; Tang C, 2014, ETHNIC DIS, V24, P302; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Thumboo J, 2013, QUAL LIFE RES, V22, P2501, DOI 10.1007/s11136-013-0381-1; Torsch VL, 2000, QUAL HEALTH RES, V10, P471, DOI 10.1177/104973200129118589; Tseng Hsu-Min, 2003, Health Qual Life Outcomes, V1, P72, DOI 10.1186/1477-7525-1-72; von Steinbuechel N, 2005, CURR OPIN NEUROL, V18, P681, DOI 10.1097/01.wco.0000194140.56429.75; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wang WR, 2014, EUR J CARDIOVASC NUR, V13, P48, DOI 10.1177/1474515113476995; Ware J.E., 1994, SF 36 PHYS MENTAL SU; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; WU X, 2004, J TRAUMA ACUTE CARE, V64, P1313	57	8	10	2	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1477-7525			HEALTH QUAL LIFE OUT	Health Qual. Life Outcomes	APR 14	2017	15								72	10.1186/s12955-017-0641-9			10	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	ER9ZE	WOS:000399184900002	28410593	Green Published, gold			2022-02-06	
J	Zhao, ZA; Ning, YL; Li, P; Yang, N; Peng, Y; Xiong, RP; Zhao, Y; Liu, D; Zeng, XJ; Chen, JF; Zhou, YG				Zhao, Zi-Ai; Ning, Ya-Lei; Li, Ping; Yang, Nan; Peng, Yan; Xiong, Ren-Ping; Zhao, Yan; Liu, Dong; Zeng, Xu-Jia; Chen, Jiang-Fan; Zhou, Yuan-Guo			Widespread hyperphosphorylated tau in the working memory circuit early after cortical impact injury of brain (Original study)	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Controlled cortical impact; Tau protein	AXONAL-TRANSPORT; ALZHEIMERS-DISEASE; IN-VIVO; PROTEIN; PHOSPHORYLATION; STRESS; CORTEX; MICE; ACCUMULATION; ASSOCIATION	A series of neurological and psychiatric symptoms occur after traumatic brain injury (TBI), with cognitive dysfunction being one of the most prominent sequela. Given that tau hyperphosphorylation is an important cause of cognitive impairment in patients of Alzheimer's disease, our present study detected the presence of hyperphosphorylated tau (p-tau), mainly at Ser404, in multiple brain regions, including the ipsilateral parietal cortex, contralateral hippocampus and prefrontal cortex, immediately after the injury in a mouse TBI model; these changes lasted for at least 4w. All of these brain regions play important roles in working memory. Hyperphosphorylated tau protein was primarily located in neurons and was accompanied by axonal injury and dendritic spine degeneration. Our study demonstrated that p-tau spreads gradually and selectively from the injured cortex to other brain regions after TBI and that all of the affected regions are part of the working memory circuit. These findings provide experimental support for the role of p-tau in cognitive impairment in the early phase after TBI. (C) 2017 Elsevier B.V. All rights reserved.	[Zhao, Zi-Ai; Ning, Ya-Lei; Li, Ping; Yang, Nan; Peng, Yan; Xiong, Ren-Ping; Zhao, Yan; Zeng, Xu-Jia; Zhou, Yuan-Guo] Third Mil Med Univ, Ctr Mol Biol, State Key Lab Trauma Burn & Combined Injury, Inst Surg Res, Chongqing 400042, Peoples R China; [Zhao, Zi-Ai; Ning, Ya-Lei; Li, Ping; Yang, Nan; Peng, Yan; Xiong, Ren-Ping; Zhao, Yan; Liu, Dong; Zeng, Xu-Jia; Zhou, Yuan-Guo] Third Mil Med Univ, Daping Hosp, Chongqing 400042, Peoples R China; [Liu, Dong] Third Mil Med Univ, Ctr Trauma, State Key Lab Trauma Burn & Combined Injury, Inst Surg Res, Chongqing 400042, Peoples R China; [Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol & Pharmacol, Boston, MA 02118 USA		Zhou, YG (corresponding author), Third Mil Med Univ, Ctr Mol Biol, State Key Lab Trauma Burn & Combined Injury, Inst Surg Res, Chongqing 400042, Peoples R China.; Zhou, YG (corresponding author), Third Mil Med Univ, Daping Hosp, Chongqing 400042, Peoples R China.	zhaoziai@hotmail.com; leona.ning@gmail.com; Ping_ping0074@sina.com; yangnan831113@163.com; pengyan1006@126.com; xiong_ren_ping@163.com; zhaoyanname@hotmail.com; liudong1107@live.cn; zengxujial@yeah.net; chenjf@bu.edu; yuanguo.zhou@gmail.com	Li, ping/J-6507-2019		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471109]; Natural Science Foundation of ChongqingNatural Science Foundation of Chongqing [cstc2012jjA10107]	This work was supported by the National Natural Science Foundation of China (No. 81471109) and Natural Science Foundation of Chongqing (No. cstc2012jjA10107)	Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; Bibow S, 2011, J AM CHEM SOC, V133, P15842, DOI 10.1021/ja205836j; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Carlyle BC, 2014, P NATL ACAD SCI USA, V111, P5036, DOI 10.1073/pnas.1322360111; Carroll JC, 2010, BRAIN RES, V1366, P233, DOI 10.1016/j.brainres.2010.10.009; Cowan CM, 2010, ACTA NEUROPATHOL, V120, P593, DOI 10.1007/s00401-010-0716-8; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; de Bourbon-Teles J, 2014, CURR BIOL, V24, P993, DOI 10.1016/j.cub.2014.03.024; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hains AB, 2009, P NATL ACAD SCI USA, V106, P17957, DOI 10.1073/pnas.0908563106; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Jin JJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00170; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kambe T, 2011, NEUROBIOL DIS, V42, P404, DOI 10.1016/j.nbd.2011.02.002; Kanaan NM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.006; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Kauser H, 2013, NEUROSCIENCE, V254, P110, DOI 10.1016/j.neuroscience.2013.09.023; Laricchiuta D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21205; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Liu F, 2007, EUR J NEUROSCI, V26, P3429, DOI 10.1111/j.1460-9568.2007.05955.x; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Love R, 2001, LANCET, V358, P645, DOI 10.1016/S0140-6736(01)05825-1; Mandelkow EM, 1996, ANN NY ACAD SCI, V777, P96, DOI 10.1111/j.1749-6632.1996.tb34407.x; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MCKENZIE JE, 1994, NEUROREPORT, V6, P161, DOI 10.1097/00001756-199412300-00041; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Ning YL, 2013, J CEREBR BLOOD F MET, V33, P1789, DOI 10.1038/jcbfm.2013.127; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; Pike CJ, 2017, J NEUROSCI RES, V95, P671, DOI 10.1002/jnr.23827; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858	41	8	9	1	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	APR 14	2017	323						146	153		10.1016/j.bbr.2017.02.002			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	EP4SB	WOS:000397369100018	28163095				2022-02-06	
J	Canchi, S; Sarntinoranont, M; Hong, Y; Flint, JJ; Subhash, G; King, MA				Canchi, Saranya; Sarntinoranont, Malisa; Hong, Yu; Flint, Jeremy J.; Subhash, Ghatu; King, Michael A.			Simulated blast overpressure induces specific astrocyte injury in an ex vivo brain slice model	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; VISCOELASTIC PROPERTIES; REACTIVE ASTROGLIOSIS; INTRACRANIAL-PRESSURE; DEATH; RATS; MECHANISMS; EXPRESSION; EXPOSURE; LESIONS	Exposure to explosive blasts can produce functional debilitation in the absence of brain pathology detectable at the scale of current diagnostic imaging. Transient (ms) overpressure components of the primary blast wave are considered to be potentially damaging to the brain. Astrocytes participate in neuronal metabolic maintenance, blood-brain barrier, regulation of homeostatic environment, and tissue remodeling. Damage to astrocytes via direct physical forces has the potential to disrupt local and global functioning of neuronal tissue. Using an ex vivo brain slice model, we tested the hypothesis that viable astrocytes within the slice could be injured simply by transit of a single blast wave consisting of overpressure alone. A polymer split Hopkinson pressure bar (PSHPB) system was adapted to impart a single positive pressure transient with a comparable magnitude to those that might be present inside the head. A custom built test chamber housing the brain tissue slice incorporated revised design elements to reduce fluid space and promote transit of a uniform planar waveform. Confocal microscopy, stereology, and morphometry of glial fibrillary acidic protein (GFAP) immunoreactivity revealed that two distinct astrocyte injury profiles were identified across a 4 hr post-test survival interval: (a) presumed conventional astrogliosis characterized by enhanced GFAP immunofluorescence intensity without significant change in tissue area fraction and (b) a process comparable to clasmatodendrosis, an autophagic degradation of distal processes that has not been previously associated with blast induced neurotrauma. Analysis of astrocyte branching revealed early, sustained, and progressive differences distinct from the effects of slice incubation absent overpressure testing. Astrocyte vulnerability to overpressure transients indicates a potential for significant involvement in brain blast pathology and emergent dysfunction. The testing platform can isolate overpressure injury phenomena to provide novel insight on physical and biological mechanisms.	[Canchi, Saranya; Sarntinoranont, Malisa; Hong, Yu; Subhash, Ghatu] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; [Flint, Jeremy J.] Univ Florida, Mcknight Brain Inst, Gainesville, FL 32611 USA; [King, Michael A.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA; [King, Michael A.] North Florida South Georgia VA Med Ctr, Gainesville, FL 32611 USA		King, MA (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA.; King, MA (corresponding author), North Florida South Georgia VA Med Ctr, Gainesville, FL 32611 USA.	making@ufl.edu	Subhash, Ghatu/J-4851-2017	Subhash, Ghatu/0000-0002-5996-0909	Army Research Office [W911NF-10-1-0276]	Support was provided by the Army Research Office award number W911NF-10-1-0276 to GS (PI), MS, and MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; AMADUCCI L, 1981, NEUROSCI LETT, V21, P27, DOI 10.1016/0304-3940(81)90052-5; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; BUTT AM, 1989, GLIA, V2, P470, DOI 10.1002/glia.440020609; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Duchen L. W., 1992, GREENFIELDS NEUROPAT, P1; ENG LF, 1989, GLIA, V2, P308, DOI 10.1002/glia.440020504; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Giffard RG, 2005, GLIA, V50, P299, DOI 10.1002/glia.20167; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; INAGAKI M, 1994, BRAIN PATHOL, V4, P239, DOI 10.1111/j.1750-3639.1994.tb00839.x; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Katano H, 2001, NEUROSCI LETT, V306, P101, DOI 10.1016/S0304-3940(01)01832-8; Kim DS, 2008, J COMP NEUROL, V511, P581, DOI 10.1002/cne.21851; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Lee SJ, 2014, J MECH BEHAV BIOMED, V29, P213, DOI 10.1016/j.jmbbm.2013.08.026; Lee SJ, 2011, J BIOMED MATER RES B, V97B, P84, DOI 10.1002/jbm.b.31789; Leonardi AD, 2013, ANN BIOMED ENG, V41, P2488, DOI 10.1007/s10439-013-0850-2; Liu QL, 2006, MECH MATER, V38, P1105, DOI 10.1016/j.mechmat.2006.01.001; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MCLENDON RE, 1994, BRAIN PATHOL, V4, P221, DOI 10.1111/j.1750-3639.1994.tb00837.x; Miller W, 2013, STAT MEASUREMENT CON; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; NAKAMURA Y, 1991, GLIA, V4, P101, DOI 10.1002/glia.440040112; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Renner NA, 2013, J CELL PHYSIOL, V228, P1284, DOI 10.1002/jcp.24283; Ryu HJ, 2011, CELL MOL NEUROBIOL, V31, P1071, DOI 10.1007/s10571-011-9706-1; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Sakai K, 2013, BRAIN INJURY, V27, P1692, DOI 10.3109/02699052.2013.837198; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Sarntinoranont M, 2012, J NEUROTRAUM, V29, P418, DOI 10.1089/neu.2011.1772; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scorcioni R, 2008, NAT PROTOC, V3, P866, DOI 10.1038/nprot.2008.51; Shridharani J, 2012, FRONT NEUROL, V3; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Subhash G., 2000, MECH TEST EVAL, P497, DOI [10.31399/asm.hb.v08, DOI 10.31399/ASM.HB.V08]; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Takano T, 2014, GLIA, V62, P78, DOI 10.1002/glia.22588; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tomimoto H, 1997, ACTA NEUROPATHOL, V94, P146, DOI 10.1007/s004010050686; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003	59	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175396	10.1371/journal.pone.0175396			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	WOS:000399955200060	28403239	Green Submitted, gold, Green Published			2022-02-06	
J	Dlamini, N; Yau, I; Westmacott, R; Psych, C; Shroff, M; Armstrong, D; Logan, W; Mikulis, D; deVeber, G; Kassner, A				Dlamini, Nomazulu; Yau, Ivanna; Westmacott, Robyn; Psych, C.; Shroff, Manohar; Armstrong, Derek; Logan, William; Mikulis, David; deVeber, Gabrielle; Kassner, Andrea			Cerebrovascular Reactivity and Intellectual Outcome in Childhood Stroke With Transient Cerebral Arteriopathy	PEDIATRIC NEUROLOGY			English	Article						cerebrovascular reactivity; CVR; transient cerebral arteriopathy; outcome; neuropsychology; stroke; arteriopathy	ARTERIAL ISCHEMIC-STROKE; UNILATERAL INTRACRANIAL ARTERIOPATHY; POSITRON-EMISSION-TOMOGRAPHY; LABELING PERFUSION MRI; TRAUMATIC BRAIN-INJURY; MOYAMOYA-DISEASE; BLOOD-FLOW; SURGICAL REVASCULARIZATION; PREDICTS STROKE; CT ANGIOGRAPHY	BACKGROUND: Hypercapnic-challenge blood oxygen level dependent magnetic resonance imaging cerebrovascular reactivity (CVR), measures the regional perfusion response to altered carbon dioxide. CVR correlates with the tissue-level microvascular dysfunction and ischemic risk. Among children with arterial ischemic stroke, transient cerebral arteriopathy (TCA) is a frequent, nonprogressive unilateral intracranial arteriopathy, which typically results in basal ganglia infarction and chronic cerebral artery stenosis. Therefore TCA provides a model for studying the consequences of chronic nonprogressive stenosis using CVR and intellectual outcome. We hypothesized that children with TCA and chronic nonprogressive intracranial artery stenosis have impaired CVR distal to the stenosis and associated cognitive impairment. METHODS: We studied children with a prior diagnosis of TCA as defined by infarction limited to the basal ganglia, internal capsule, or both; and significant (greater than 50% diameter) residual stenosis of the supraclinoid internal carotid artery, its proximal branches or both. All children had CVR, intellectual function, and infarct volumes quantified. RESULTS: We performed CVR studies in five children at mean 8.96 years (3.33 to 14.58 years) poststroke. Impaired CVR was limited to the infarct zone and adjacent white matter in most children. Intellectual function was broadly average in all but one subject. CONCLUSIONS: In children with typical TCA, ipsilateral cortical CVR and intellectual function seem to be preserved despite persistent arterial stenosis in the majority. These findings suggest that chronic revascularization strategies in these children may not be indicated and require further exploration in a larger cohort of children. (C) 2017 Elsevier Inc. All rights reserved.	[Dlamini, Nomazulu; Yau, Ivanna; Logan, William; deVeber, Gabrielle] Hosp Sick Children, Dept Neurol, Toronto, ON M5G 1X8, Canada; [Westmacott, Robyn] Hosp Sick Children, Dept Psychol, Toronto, ON, Canada; [Shroff, Manohar; Armstrong, Derek] Hosp Sick Children, Dept Radiol, Toronto, ON, Canada; [Mikulis, David] Univ Toronto, Dept Radiol, Toronto, ON, Canada; [Kassner, Andrea] Univ Toronto, Dept Med Phys, Toronto, ON, Canada		Dlamini, N (corresponding author), Hosp Sick Children, Dept Neurol, Toronto, ON M5G 1X8, Canada.	nomazulu.dlamini@sickkids.ca	Mikulis, David J/H-5167-2019; Shroff, Manohar/AAM-2418-2020	Mikulis, David/0000-0003-3956-0892			Amlie-Lefond C, 2009, CIRCULATION, V119, P1417, DOI 10.1161/CIRCULATIONAHA.108.806307; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; Blauwblomme T, 2016, AM J NEURORADIOL, V37, P706, DOI 10.3174/ajnr.A4592; Braun KPJ, 2009, BRAIN, V132, P544, DOI 10.1093/brain/awn313; Bulder MMM, 2014, CEREBROVASC DIS, V37, P14, DOI 10.1159/000355889; Chabrier S, 1998, J CHILD NEUROL, V13, P27, DOI 10.1177/088307389801300105; Chen J, 2009, J MAGN RESON IMAGING, V29, P282, DOI 10.1002/jmri.21641; Dlamini N, 2011, J CHILD NEUROL, V26, P1203, DOI 10.1177/0883073811408904; Fan YL, 2014, VASC ENDOVASC SURG, V48, P305, DOI 10.1177/1538574414525863; Fierstra J, 2011, STROKE, V42, P1631, DOI 10.1161/STROKEAHA.110.608521; Fierstra J, 2010, J NEUROL NEUROSUR PS, V81, P290, DOI 10.1136/jnnp.2009.188078; Fullerton HJ, 2007, PEDIATRICS, V119, P495, DOI 10.1542/peds.2006-2791; Fullerton HJ, 2016, STROKE, V47, P53, DOI 10.1161/STROKEAHA.115.011173; Gonzalez NR, 2013, NEUROSURG REV, V36, P175, DOI 10.1007/s10143-012-0432-z; Han JS, 2011, STROKE; Heyn C, 2010, AM J NEURORADIOL, V31, P862, DOI 10.3174/ajnr.A1922; Hogan AM, 2005, DEV MED CHILD NEUROL, V47, P824, DOI 10.1017/S001216220500174X; IKEZAKI K, 1994, J NEUROSURG, V81, P843, DOI 10.3171/jns.1994.81.6.0843; ISHII R, 1984, STROKE, V15, P873, DOI 10.1161/01.STR.15.5.873; Kaewlai R, 2012, AM J ROENTGENOL, V199, pW17, DOI 10.2214/AJR.11.8144; Kanda T, 2016, JPN J RADIOL, V34, P3, DOI 10.1007/s11604-015-0503-5; Kanda T, 2014, RADIOLOGY, V270, P834, DOI 10.1148/radiol.13131669; Kim JA, 2016, BRAIN RES, V1642, P263, DOI 10.1016/j.brainres.2016.03.041; Kuwabara Y, 1997, CLIN NEUROL NEUROSUR, V99, pS74, DOI 10.1016/S0303-8467(97)00061-9; Kuwabara Y, 1997, STROKE, V28, P701, DOI 10.1161/01.STR.28.4.701; Leung J, 2016, J MAGN RESON IMAGING, V43, P1191, DOI 10.1002/jmri.25063; Lima FO, 2014, JAMA NEUROL, V71, P151, DOI 10.1001/jamaneurol.2013.5007; Lin MS, 2011, STROKE, V42, P2850, DOI 10.1161/STROKEAHA.111.613133; Maas MB, 2009, STROKE, V40, P3001, DOI 10.1161/STROKEAHA.109.552513; Markus H, 2001, BRAIN, V124, P457, DOI 10.1093/brain/124.3.457; Mikulis DJ, 2005, J NEUROSURG, V103, P347, DOI 10.3171/jns.2005.103.2.0347; Ng J, 2012, CHILD NERV SYST, V28, P1041, DOI 10.1007/s00381-012-1743-7; Ohtaki M, 1998, ACTA NEUROCHIR, V140, P1043, DOI 10.1007/s007010050213; Reinhard M, 2014, NEUROLOGY, V83, P1424, DOI 10.1212/WNL.0000000000000888; Scott RM, 2004, J NEUROSURG, V100, P142, DOI 10.3171/ped.2004.100.2.0142; Sebire G, 2006, LANCET, V368, P8, DOI 10.1016/S0140-6736(06)68944-7; Sebire G, 2004, CURR OPIN PEDIATR, V16, P617; Thomason ME, 2005, NEUROIMAGE, V25, P824, DOI 10.1016/j.neuroimage.2004.12.026; Tzika AA, 1997, PEDIATR RADIOL, V27, P727, DOI 10.1007/s002470050212; van den Wijngaard IR, 2016, AM J NEURORADIOL, V37, P1231, DOI 10.3174/ajnr.A4746; VARGHAKHADEM F, 1992, BRAIN, V115, P315, DOI 10.1093/brain/115.1.315; Vernieri F, 1999, STROKE, V30, P593, DOI 10.1161/01.STR.30.3.593; Westmacott R, 2009, STROKE, V40, P2012, DOI 10.1161/STROKEAHA.108.533976; Wu Wen-Chau, 2010, Top Magn Reson Imaging, V21, P65, DOI 10.1097/RMR.0b013e31821e570a; YONAS H, 1993, J NEUROSURG, V79, P483, DOI 10.3171/jns.1993.79.4.0483	46	8	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	APR	2017	69						71	78		10.1016/j.pediatrneurol.2017.01.001			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	ER2UD	WOS:000398648400008	28258787				2022-02-06	
J	Grusser, L; Blaumeiser-Debarry, R; Krings, M; Kremer, B; Holling, A; Rossaint, R; Coburn, M				Gruesser, Linda; Blaumeiser-Debarry, Rosmarie; Krings, Matthias; Kremer, Benedikt; Hoelling, Anke; Rossaint, Rolf; Coburn, Mark			Argon attenuates the emergence of secondary injury after traumatic brain injury within a 2-hour incubation period compared to desflurane: an in vitro study	MEDICAL GAS RESEARCH			English	Article						argon; desflurane; traumatic brain injury; neuroprotection; organotypic hippocampal brain slices; in vitro model; secondary injury; propidium iodide	NOBLE-GAS ARGON; ORGANOTYPIC HIPPOCAMPAL SLICES; INCOMPLETE CEREBRAL-ISCHEMIA; GENERAL-ANESTHETICS; NEUROPROTECTION; MODEL; RATS; SEVOFLURANE; ISOFLURANE; CULTURES	Despite years of research, treatment of traumatic brain injury (TBI) remains challenging. Considerable data exists that some volatile anesthetics might be neuroprotective. However, several studies have also revealed a rather neurotoxic profile of anesthetics. In this study, we investigated the effects of argon 50%, desflurane 6% and their combination in an in vitro TBI model with incubation times similar to narcotic time slots in a daily clinical routine. Organotypic hippocampal brain slices of 5-to 7-day-old mice were cultivated for 14 days before TBI was performed. Slices were eventually incubated for 2 hours in an atmosphere containing no anesthetic gas, argon 50% or desflurane 6% or both. Trauma intensity was evaluated via fluorescent imagery. Our results show that neither argon 50% nor desflurane 6% nor their combination could significantly reduce the trauma intensity in comparison to the standard atmosphere. However, in comparison to desflurane 6%, argon 50% displayed a rather neuroprotective profile within the first 2 hours after a focal mechanical trauma (P = 0.015). A 2-hour incubation in an atmosphere containing both gases, argon 50% and desflurane 6%, did not result in significant effects in comparison to the argon 50% group or the desflurane 6% group. Our findings demonstrate that within a 2-hour incubation time neither argon nor desflurane could affect propidium iodide-detectable cell death in an in vitro TBI model in comparison to the standard atmosphere, although cell death was less with argon 50% than with desflurane 6%. The results show that within this short time period processes concerning the development of secondary injury are already taking place and may be manipulated by argon.	[Gruesser, Linda; Blaumeiser-Debarry, Rosmarie; Rossaint, Rolf; Coburn, Mark] RWTH Aachen Univ Hosp, Dept Anesthesiol, Aachen, Germany; [Krings, Matthias] Med Zentrum StaedteReg Aachen, Dept Anesthesiol & Intens Care, Wurselen, Germany; [Kremer, Benedikt; Hoelling, Anke] RWTH Aachen Univ Hosp, Dept Neurosurg, Aachen, Germany		Grusser, L (corresponding author), RWTH Aachen Univ Hosp, Dept Anesthesiol, Aachen, Germany.	linda.gruesser@googlemail.com					Abraini JH, 2003, ANESTH ANALG, V96, P746, DOI 10.1213/01.ANE.0000050282.14291.38; Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Bahr BA, 1995, HIPPOCAMPUS, V5, P425, DOI 10.1002/hipo.450050505; Bickler PE, 2003, ANESTH ANALG, V97, P564, DOI 10.1213/01.ANE.0000068880.82739.7B; Brilcken A, 2013, BR J ANAESTH S1, V110, pi106; Brucken A, 2014, RESUSCITATION, V85, P826, DOI 10.1016/j.resuscitation.2014.02.014; Chiao S, 2014, BRAIN SCI, V4, P273, DOI 10.3390/brainsci4020273; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Coburn M, 2012, EUR J ANAESTH, V29, P549, DOI 10.1097/EJA.0b013e328357bfdd; Dart R., 2004, MED TOXICOLOGY; David HN, 2013, N-S ARCH PHARMACOL, V386, P91, DOI 10.1007/s00210-012-0809-0; David HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030934; Deng J, 2014, PROG NEUROBIOL, V115, P210, DOI 10.1016/j.pneurobio.2014.01.001; Engelhard K, 1999, BRIT J ANAESTH, V83, P415, DOI 10.1093/bja/83.3.415; Erdem AF, 2005, SAUDI MED J, V26, P1424; Fahlenkamp AV, 2012, EUR J PHARMACOL, V674, P104, DOI 10.1016/j.ejphar.2011.10.045; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Hollig A, 2016, CRIT CARE MED, V44, pE520, DOI 10.1097/CCM.0000000000001561; Hoellig A, 2014, INT J MOL SCI, V15, P18175, DOI 10.3390/ijms151018175; Istaphanous GK, 2011, ANESTHESIOLOGY, V114, P578, DOI 10.1097/ALN.0b013e3182084a70; Jawad N, 2009, NEUROSCI LETT, V460, P232, DOI 10.1016/j.neulet.2009.05.069; Jevtovic-Todorovic V, 2013, BRIT J ANAESTH, V111, P143, DOI 10.1093/bja/aet177; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Jevtovic-Todorovic V, 2005, J NEUROSURG ANESTH, V17, P204, DOI 10.1097/01.ana.0000178111.26972.16; Jorch G, 2015, DIVI JB; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Krings M, 2016, MED GAS RES, V6, P3, DOI 10.4103/2045-9912.179338; Li Q, 2016, MOL NEUROBIOL, V53, P4226, DOI 10.1007/s12035-015-9362-4; Liu JJ, 2014, EUR J ANAESTH, V31, P669, DOI 10.1097/EJA.0000000000000073; Loepke AW, 2008, ANESTH ANALG, V106, P1681, DOI 10.1213/ane.0b013e318167ad77; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; McAuliffe JJ, 2009, ANESTHESIOLOGY, V111, P533, DOI 10.1097/ALN.0b013e3181b060d3; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Nowrangi DS, 2014, MED GAS RES, V4, DOI 10.1186/2045-9912-4-3; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Park SJ, 2015, EUR J PHARMACOL, V757, P84, DOI 10.1016/j.ejphar.2015.03.058; Roehl AB, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-97; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Ryang YM, 2011, CRIT CARE MED, V39, P1448, DOI 10.1097/CCM.0b013e31821209be; Schallner N, 2014, ANESTH ANALG, V119, P1429, DOI 10.1213/ANE.0000000000000488; Schoeler M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-20; Schwartz-Bloom RD, 2000, NEUROSCIENCE, V98, P471, DOI 10.1016/S0306-4522(00)00144-5; Soviet's first Nobelist, 1974, NEW SCI, P732; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; TBI care, 2016, EV BAS DIAGN TREATM; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wang CB, 2007, BRAIN RES, V1152, P201, DOI 10.1016/j.brainres.2007.03.030; Wise-Faberowski L, 2003, J NEUROSURG ANESTH, V15, P193, DOI 10.1097/00008506-200307000-00006; Zhang B, 2008, ANESTH ANALG, V106, P1242, DOI 10.1213/ane.0b013e318164f2a5; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164	56	8	8	0	1	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	2045-9912			MED GAS RES	Med. Gas Res.	APR-JUN	2017	7	2					93	100		10.4103/2045-9912.208512			8	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	EZ5EQ	WOS:000404736000003	28744361	Green Published			2022-02-06	
J	Gupta, M; Mishra, SK; Kumar, BSH; Khushu, S; Rana, P				Gupta, Mamta; Mishra, Sushanta Kumar; Kumar, B. S. Hemanth; Khushu, Subash; Rana, Poonam			Early Detection of Whole Body Radiation Induced Microstructural and Neuroinflammatory Changes in Hippocampus: A Diffusion Tensor Imaging and Gene Expression Study	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						radiation exposure; hippocampus; DTI; neuroinflammation; systemic inflammatory response; AB_305808; SCR_003070; SCR_003210	TRAUMATIC BRAIN-INJURY; INFLAMMATORY RESPONSE; NERVOUS-SYSTEM; IRRADIATION; RAT; MRI; CYCLOOXYGENASE-2; DEGENERATION; CAUDATE; MODEL	Ionizing radiation is known to a cause systemic inflammatory response within hours of exposure that may affect the central nervous system (CNS). The present study was carried out to look upon the influence of radiation induced systemic inflammatory response in hippocampus within 24 hr of whole body radiation exposure. A Diffusion Tensor Imaging (DTI) study was conducted in mice exposed to a 5-Gy radiation dose through a 60 Co source operating at 2.496 Gy/min at 3 hr and 24 hr post irradiation and in sham-irradiated controls using 7 T animal MRI system. The results showed a significant decrease in Mean Diffusivity (MD), Radial Diffusivity (RD), and Axial Diffusivity (AD) in hippocampus at 24 hr compared with controls. Additionally, marked change in RD was observed at 3 hr. Increased serum C-Reactive Protein (CRP) level depicted an increased systemic/peripheral inflammation. The neuroinflammatory response in hippocampus was characterized by increased mRNA expression of IL-1b, IL-6, and Cox-2 at the 24 hr time point. Additionally, in the irradiated group, reactive astrogliosis was illustrated, with noticeable changes in GFAP expression at 24 hr. Altered diffusivity and enhanced neuroinflammatory expression in the hippocampal region showed peripheral inflammation induced changes in brain. Moreover, a negative correlation between gene expression and DTI parameters depicted a neuroinflammation induced altered microenvironment that might affect water diffusivity. The study showed that there was an influence of whole body radiation exposure on hippocampus even during the early acute phase that could be reflected in terms of neuroinflammatory response as well as microstructural changes. (C) 2016 Wiley Periodicals, Inc.	[Gupta, Mamta; Mishra, Sushanta Kumar; Kumar, B. S. Hemanth; Khushu, Subash; Rana, Poonam] Inst Nucl Med & Allied Sci, NMR Res Ctr, Delhi 110054, India		Rana, P (corresponding author), Inst Nucl Med & Allied Sci, NMR Res Ctr, Delhi 110054, India.	poonamrana27@gmail.com	Mishra, Sushanta Kumar/N-5958-2019	Mishra, Sushanta/0000-0002-3403-6891	Defence Research and Development Organization (DRDO), IndiaDefence Research & Development Organisation (DRDO) [INM 311 (4.1)]	Contract grant sponsor: Defence Research and Development Organization (DRDO), India; Contract grant number: S & T project INM 311 (4.1)	Ballesteros-Zebadua P, 2012, CNS NEUROL DISORD-DR, V11, P937, DOI 10.2174/1871527311201070937; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Brown WR, 2005, RADIAT RES, V164, P662, DOI 10.1667/RR3453.1; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Chan KC, 2009, J MAGN RESON IMAGING, V29, P1013, DOI 10.1002/jmri.21736; Chanraud S, 2010, NEUROPSYCHOL REV, V20, P209, DOI 10.1007/s11065-010-9129-7; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Coleman C. Norman, 2003, Radiation Research, V159, P812, DOI 10.1667/RR3021; Eklund CM, 2009, ADV CLIN CHEM, V48, P111, DOI 10.1016/S0065-2423(09)48005-3; Gass A, 2001, J NEUROL SCI, V186, pS15, DOI 10.1016/S0022-510X(01)00487-7; Gourmelon P., 2005, BRIT J RADIOL, V78, P62, DOI [10.1259/bjr/15393845, DOI 10.1259/BJR/15393845]; Hall E J, 2006, RADIOBIOLOGY RADIOLO, V6; Hannoun S, 2012, AM J NEURORADIOL, V33, P1363, DOI 10.3174/ajnr.A2983; Hayashi T, 2003, INT J RADIAT BIOL, V79, P129, DOI 10.1080/0955300021000038662; Jackson IL, 2010, RADIAT RES, V173, P10, DOI 10.1667/RR1911.1; Kim JH, 2007, MAGN RESON MED, V58, P253, DOI 10.1002/mrm.21316; Kumar M, 2016, J NEUROPATH EXP NEUR, V75, P35, DOI 10.1093/jnen/nlv007; Kumar M, 2013, EXP NEUROL, V248, P360, DOI 10.1016/j.expneurol.2013.06.005; Kyrkanides S, 2002, MOL BRAIN RES, V104, P159, DOI 10.1016/S0169-328X(02)00353-4; Kyrkanides S, 1999, J NEUROIMMUNOL, V95, P95, DOI 10.1016/S0165-5728(98)00270-7; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Malik GK, 2008, BRAIN DEV-JPN, V30, P334, DOI 10.1016/j.braindev.2007.10.002; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Moravan MJ, 2011, RADIAT RES, V176, P459, DOI 10.1667/RR2587.1; Munshi Anupama, 2013, Genes Cancer, V4, P401, DOI 10.1177/1947601913485414; Parfenova H, 1997, AM J PHYSIOL-CELL PH, V273, pC277, DOI 10.1152/ajpcell.1997.273.1.C277; Peiffer AM, 2010, BRAIN RES, V1351, P23, DOI 10.1016/j.brainres.2010.06.049; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Ryan NS, 2013, BRAIN, V136, P1399, DOI 10.1093/brain/awt065; Saksena S, 2008, J GASTROEN HEPATOL, V23, pE111, DOI 10.1111/j.1440-1746.2007.05158.x; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; Schiller KR, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-45; Serrano GE, 2011, J NEUROSCI, V31, P14850, DOI 10.1523/JNEUROSCI.3922-11.2011; Sun SW, 2008, NEUROIMAGE, V40, P1, DOI 10.1016/j.neuroimage.2007.11.049; Takayama H, 2000, CLIN NEUROL NEUROSUR, V102, P135, DOI 10.1016/S0303-8467(00)00079-2; Thiel A, 2010, J NUCL MED, V51, P1404, DOI 10.2967/jnumed.110.076612; Thomson CA, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-73; Trivedi R, 2012, J NEUROSCI RES, V90, P2009, DOI 10.1002/jnr.23073; Tyburski JB, 2008, RADIAT RES, V170, P1, DOI 10.1667/RR1265.1; Vorisek I, 2002, MAGNET RESON MED, V48, P994, DOI 10.1002/mrm.10305; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yuan H, 2006, INT J RADIAT ONCOL, V66, P860, DOI 10.1016/j.ijrobp.2006.06.043	49	8	8	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2017	95	4					1067	1078		10.1002/jnr.23833			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ8DP	WOS:000393455500012	27436454				2022-02-06	
J	Larpthaveesarp, A; Gonzalez, FF				Larpthaveesarp, Amara; Gonzalez, Fernando F.			Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Medicine; Issue 122; Neonatal stroke; MCAO; reperfusion; ischemia; animals models; brain injury	FOCAL ISCHEMIA; SUTURE; MRI	A number of animal models have been used to study hypoxic-ischemic injury, traumatic injury, global hypoxia, or permanent ischemia in both the immature and mature brain. Stroke occurs commonly in the perinatal period in humans, and transient ischemia-reperfusion is the most common form of stroke in neonates. The reperfusion phase is a critical component of injury progression, which occurs over a period of days to weeks, and of the endogenous response to injury. This postnatal day 10 (p10) rat model of transient middle cerebral artery occlusion (tMCAO) creates a unilateral, non-hemorrhagic focal ischemia-reperfusion injury that can be utilized to study the mechanisms of focal injury and repair in the full-term- equivalent brain. The injury pattern that is produced by tMCAO is consistent and highly reproducible and can be confirmed with MRI or histological analyses. The severity of injury can be manipulated through changes in occlusion time and other methods that will be discussed.	[Larpthaveesarp, Amara; Gonzalez, Fernando F.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA		Larpthaveesarp, A (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	larpa@peds.ucsf.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08 NS064094]; UCSF REAC grants	Funding was provided by the NIH K08 NS064094 and UCSF REAC grants. The authors would like to acknowledge Nikita Derguin, Zinalda Vexler, and Joel Faustino for their assistance in the development of this technique.	Bouley J, 2007, NEUROSCI LETT, V412, P185, DOI 10.1016/j.neulet.2006.11.003; Derugin N, 2005, BRAIN RES, V1066, P49, DOI 10.1016/j.brainres.2005.10.043; Derugin N, 1998, NEUROSCI RES, V32, P349, DOI 10.1016/S0168-0102(98)00096-0; Dudink J, 2009, AM J NEURORADIOL, V30, P998, DOI 10.3174/ajnr.A1480; Dzietko M, 2011, J CHILD NEUROL, V26, P1145, DOI 10.1177/0883073811408308; Gonzalez FF, 2013, STROKE, V44, P753, DOI 10.1161/STROKEAHA.111.000104; Gonzalez FF, 2009, DEV NEUROSCI-BASEL, V31, P403, DOI 10.1159/000232558; Grunt S, 2015, PEDIATRICS, V135, pE1220, DOI 10.1542/peds.2014-1520; Kasdorf E, 2013, PEDIATR NEUROL, V49, P8, DOI 10.1016/j.pediatrneurol.2012.12.026; Kirton A, 2015, LANCET NEUROL, V14, P92, DOI 10.1016/S1474-4422(14)70227-3; Koizumi, 1986, JPN J STROKE, V8, P8, DOI [10.3995/jstroke.8.1, DOI 10.3995/jstroke.8.1]; Labat-gest V, 2013, JOVE-J VIS EXP, DOI 10.3791/50370; Larpthaveesarp A., 2016, NEUROBIOL DIS; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mancuso A, 2000, BRAIN RES, V887, P34, DOI 10.1016/S0006-8993(00)02963-2; Nelson KB, 2007, STROKE, V38, P742, DOI 10.1161/01.STR.0000247921.97794.5e; Perlman JM, 2006, CLIN THER, V28, P1353, DOI 10.1016/j.clinthera.2006.09.005; Renolleau S, 1998, STROKE, V29, P1454, DOI 10.1161/01.STR.29.7.1454; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rutherford MA, 2012, ARCH DIS CHILD-FETAL, V97, pF377, DOI 10.1136/fetalneonatal-2010-196451; Shimamura N, 2006, J NEUROSCI METH, V156, P161, DOI 10.1016/j.jneumeth.2006.02.017; van der Aa NE, 2014, ACTA PAEDIATR, V103, P356, DOI 10.1111/apa.12555	22	8	8	0	1	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	APR	2017		122							e54830	10.3791/54830			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU5NC	WOS:000401077600006	28518065	Green Published, Green Submitted, Bronze			2022-02-06	
J	Livny, A; Biegon, A; Kushnir, T; Harnof, S; Hoffmann, C; Fruchter, E; Weiser, M				Livny, Abigail; Biegon, Anat; Kushnir, Tammar; Harnof, Sagi; Hoffmann, Chen; Fruchter, Eyal; Weiser, Mark			Cognitive Deficits Post-Traumatic Brain Injury and Their Association with Injury Severity and Gray Matter Volumes	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; MRI; neuropsychology; traumatic brain injury	VOXEL-BASED MORPHOMETRY; PREMORBID INTELLIGENCE; NEUROPSYCHOLOGICAL OUTCOMES; LONGITUDINAL CHANGES; ANTERIOR INSULA; HEAD-INJURY; WAIS-R; MILD; METAANALYSIS; PERFORMANCE	Traumatic brain injury (TBI) is known to have a substantial though highly variable impact on cognitive abilities. Due to the wide range of cognitive abilities among healthy individuals, an objective assessment of TBI-related cognitive loss requires an accurate measurement of pre-morbid cognitive performance. To address this problem, we recruited 50 adults who sustained a TBI and had performed a cognitive baseline assessment in adolescence as part of the aptitude tests mandated by the Israeli Defense Forces. This group was matched with non-injured controls (n = 35). Pre-and post-injury cognitive assessments consisted of three domains-namely, verbal abstraction, mathematical reasoning, and non-verbal abstract reasoning (from the Wechsler Adult Intelligence Scale-Third Edition). The difference between post-and pre-injury scores was calculated as a measure of domain-specific cognitive decline. Voxel-based regression was used to correlate cognitive decline with modulated gray matter probability maps controlling for age, Glasgow Coma Scale, and total intracranial volume. Using objectively assessed cognitive scores, we found that abstract reasoning declined in both moderate-severe and mild TBI patients, whereas verbal abstraction declined only in the moderate-severe group. Mathematical reasoning was not affected by TBI. In the TBI patients, non-verbal abstract reasoning post-pre-injury change scores were negatively correlated with the volume of the insula. We conclude that access to pre-morbid neuropsychological data may have facilitated the discovery of the effects of mild TBI on abstract reasoning, as well as a significant correlation between TBI-related decline in this cognitive domain and the volume of the bilateral insula, both of which had not been appreciated in the past.	[Livny, Abigail; Kushnir, Tammar; Hoffmann, Chen] Sheba Med Ctr, Dept Diagnost Imaging, IL-52621 Tel Hashomer, Israel; [Livny, Abigail] Sheba Med Ctr, J Sagol Neurosci Ctr, Tel Hashomer, Israel; [Harnof, Sagi] Sheba Med Ctr, Dept Neurosurg, Tel Hashomer, Israel; [Weiser, Mark] Sheba Med Ctr, Dept Psychiat, Tel Hashomer, Israel; [Biegon, Anat] SUNY Stony Brook, Dept Neurol, Stony Brook, NY 11794 USA; [Biegon, Anat] SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA; [Livny, Abigail; Kushnir, Tammar; Harnof, Sagi; Hoffmann, Chen; Weiser, Mark] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Fruchter, Eyal] Israel Def Forces, Med Corps, Dept Mental Hlth, Tel Aviv, Israel		Livny, A (corresponding author), Sheba Med Ctr, Dept Diagnost Imaging, IL-52621 Tel Hashomer, Israel.	abigail.livnyezer@gmail.com	fruchter, eyal/AAE-2325-2020	Livny, Abigail/0000-0003-2216-7357			Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bergeson AG, 2004, CLIN NEUROPSYCHOL, V18, P509, DOI 10.1080/1385404049052414; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Bright P, 2002, J INT NEUROPSYCH SOC, V8, P847, DOI 10.1017/S1355617702860131; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Caspi A, 2003, SCHIZOPHR RES, V65, P87, DOI 10.1016/S0920-9964(03)00056-2; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; CRAWFORD JR, 1988, BRIT J PSYCHIAT, V153, P178, DOI 10.1192/bjp.153.2.178; Freeman J, 2000, BRIT J CLIN PSYCHOL, V39, P95, DOI 10.1348/014466500163130; Gal R., 1986, PORTRAIT ISRAEL SOLD, P77; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gao BL, 2000, J NEUROPSYCH CLIN N, V12, P385, DOI 10.1176/appi.neuropsych.12.3.385; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Hoofien D, 2000, J CLIN EXP NEUROPSYC, V22, P305, DOI 10.1076/1380-3395(200006)22:3;1-V;FT305; Ibanez A, 2010, BRAIN STRUCT FUNCT, V214, P397, DOI 10.1007/s00429-010-0256-y; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; JAMES RP, 1984, VOLTA REV, V86, P336; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Niemann H, 1996, NEUROPSYCHOL REV, V6, P11, DOI 10.1007/BF01875418; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; OLEARY UM, 1991, J CLIN PSYCHOL, V47, P277, DOI 10.1002/1097-4679(199103)47:2<277::AID-JCLP2270470215>3.0.CO;2-I; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Raven J., 1992, PROGR MATRICES VOCAB; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; TEASDALE G, 1974, LANCET, V2, P81; Tops M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00330; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Vannorsdall TD, 2010, J NEUROPSYCH CLIN N, V22, P173, DOI 10.1176/appi.neuropsych.22.2.173; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	52	8	8	3	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1466	1472		10.1089/neu.2016.4598			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600016	27750571				2022-02-06	
J	Martin, C; Thony, F; Rodiere, M; Bouzat, P; Lavagne, P; Durand, M; Chavanon, O				Martin, Cecile; Thony, Frederic; Rodiere, Mathieu; Bouzat, Pierre; Lavagne, Pierre; Durand, Michel; Chavanon, Olivier			Long-term results following emergency stent graft repair for traumatic rupture of the aortic isthmus	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Aorta; Trauma; Blunt; Endovascular procedure; Outcomes	LEFT SUBCLAVIAN ARTERY; ENDOVASCULAR REPAIR; THORACIC AORTA; BRAIN-INJURY; TRANSECTION; EXPERIENCE; MANAGEMENT; COVERAGE	OBJECTIVES: Endovascular repair of traumatic injury of the aortic isthmus is a safe technique that has shown good short-term results. However, the future of these stent grafts remains unexamined, especially in relation to young patients. METHOD: Between January 2000 and December 2014, 60 patients were treated with endovascular aortic stent graft for injury of the aortic isthmus. Follow-up was done by computed tomography scans with intravenous contrast or magnetic resonance imaging associated with a chest X-ray in order to control the stent graft. RESULTS: In total, 48 men (80%) were included; the average age was 43 +/- 17 years [17; 79]. The median time between the accident and endovascular repair was 6 h. Endovascular repair was successful in all cases with no cerebrovascular or paraplegia after treatment. Seventeen patients (27.3%) received a total coverage of the left subclavian artery; one of them received a subclavian carotid bypass. Mean follow-up was 5 years with a maximum of 14 years. There was no repeat surgery related to the aorta during follow-up. No stent graft failure, neurological or ischaemic event related to the stent graft was noted. One patient had a type 1 endoleak without any reintervention. The survival rate was 86.5% in 1 year, 81.6% in 5 years and 75.3% in 10 years. CONCLUSIONS: Treatment of injuries of the aortic isthmus with stent graft seems to be a safe long-term technique; we did not notice any event related to the stent graft during the follow-up.	[Martin, Cecile; Chavanon, Olivier] Grenoble Univ Hosp, Thorac & Vasc Ctr, Cardiac Surg Clin, Grenoble, France; [Thony, Frederic; Rodiere, Mathieu] Grenoble Univ Hosp, Cent Radiol & Med Imaging Serv, Grenoble, France; [Bouzat, Pierre; Lavagne, Pierre] Grenoble Univ Hosp, Surg Polyvalent Intens Care Unit, Grenoble, France; [Durand, Michel] Grenoble Univ Hosp, Cardiovasc & Thorac Intens Care Unit, Grenoble, France; [Chavanon, Olivier] Univ Grenoble Alpes, Lab HP2, Grenoble, France		Martin, C (corresponding author), CHU Grenoble, Hop Nord, Serv Chirurg Cardiaque, CS 10217, F-38043 Grenoble 9, France.	cmartin2@chu-grenoble.fr	Chavanon, Olivier/AAC-8171-2019; Bouzat, Pierre/L-6881-2014; Bouzat, Pierre/AAC-4105-2019	Chavanon, Olivier/0000-0001-8625-691X; Bouzat, Pierre/0000-0003-4667-6738			Antonello M, 2013, J VASC SURG, V57, P684, DOI 10.1016/j.jvs.2012.08.119; Azizzadeh A, 2009, J VASC SURG, V49, P1403, DOI 10.1016/j.jvs.2009.02.234; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Broux C, 2006, INTENS CARE MED, V32, P770, DOI 10.1007/s00134-006-0115-8; Caffarelli AD, 2010, J THORAC CARDIOV SUR, V140, P598, DOI 10.1016/j.jtcvs.2010.02.056; Canaud L, 2008, J VASC SURG, V47, P733, DOI 10.1016/j.jvs.2007.12.008; Canaud L, 2015, J THORAC CARDIOV SUR, V149, P825, DOI 10.1016/j.jtcvs.2014.10.113; Erbel R, 2014, EUR HEART J, V35, P2873, DOI 10.1093/eurheartj/ehu281; Estrera AL, 2013, J THORAC CARDIOV SUR, V145, pS154, DOI 10.1016/j.jtcvs.2012.11.074; Fox N, 2015, J TRAUMA ACUTE CARE, V78, P136, DOI 10.1097/TA.0000000000000470; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Khashram M, 2016, WORLD J SURG, V40, P1763, DOI 10.1007/s00268-016-3457-6; Kidane B, 2015, J VASC SURG, V61, P1624, DOI 10.1016/j.jvs.2015.02.017; Klocker J, 2014, J VASC SURG, V60, P64, DOI 10.1016/j.jvs.2014.01.060; Kolbeck Kenneth J, 2011, Semin Intervent Radiol, V28, P98, DOI 10.1055/s-0031-1273944; Matsumura JS, 2010, J VASC SURG, V52, p65S, DOI 10.1016/j.jvs.2010.07.003; McBride CL, 2015, J VASC SURG, V61, P73, DOI 10.1016/j.jvs.2014.05.099; Mosquera VX, 2011, J THORAC CARDIOV SUR, V142, P614, DOI 10.1016/j.jtcvs.2010.10.044; Murad MH, 2011, J VASC SURG, V53, P193, DOI 10.1016/j.jvs.2010.08.028; Pacini D, 2005, J THORAC CARDIOV SUR, V129, P880, DOI 10.1016/j.jtcvs.2004.10.012; Paul JS, 2011, J TRAUMA, V71, P1519, DOI 10.1097/TA.0b013e31823b9811; Rabin J, 2014, ANN THORAC SURG, V98, P46, DOI 10.1016/j.athoracsur.2014.04.025; Rheaume P, 2010, J VASC SURG, V51, P763, DOI 10.1016/j.jvs.2009.12.014; Serra R, 2015, J CARDIOTHORAC SURG, V10, DOI 10.1186/s13019-015-0388-5; Steuer J, 2015, EUR J VASC ENDOVASC, V50, P460, DOI 10.1016/j.ejvs.2015.05.012	25	8	9	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	APR	2017	51	4					767	772		10.1093/ejcts/ezw369			6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery	ER1NS	WOS:000398558800025	28043994	Bronze			2022-02-06	
J	Ogier, M; Belmeguenai, A; Lieutaud, T; Georges, B; Bouvard, S; Carre, E; Canini, F; Bezin, L				Ogier, Michaeel; Belmeguenai, Amor; Lieutaud, Thomas; Georges, Beatrice; Bouvard, Sandrine; Carre, Emilie; Canini, Frederic; Bezin, Laurent			Cognitive Deficits and Inflammatory Response Resulting from Mild-to-Moderate Traumatic Brain Injury in Rats Are Exacerbated by Repeated Pre-Exposure to an Innate Stress Stimulus	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; behavioral assessments; cognitive function; inflammation; traumatic brain injury	LONG-TERM POTENTIATION; ACUTE RESTRAINT STRESS; CHAIN EXPRESSION; MESSENGER-RNA; DISORDER; ERYTHROPOIETIN; CORTICOSTERONE; HIPPOCAMPUS; CYTOKINES; MEMORY	Traumatic brain injury (TBI) is common in both military and civilian populations, and often results in neurobehavioral sequelae that impair quality of life in both patients and their families. Although individuals who are chronically exposed to stress are more likely to experience TBI, it is still unknown whether pre-injury stress influences the outcome after TBI. The present study tested whether behavioral and cognitive long-term outcome after TBI in rats is affected by prior exposure to an innate stress stimulus. Young adult male Sprague-Dawley rats were exposed to the predator odor 2,5-dihydro-2,4,5-trimethylthiazoline (TMT) or to water (WAT); exposure was repeated eight times at irregular intervals over a 2-week period. Rats were subsequently subjected to either mild-to-moderate bilateral brain injury (lateral fluid percussion [LFP]) or sham surgery (Sham). Four experimental groups were studied: Sham-WAT, Sham-TMT, LFP-WAT and LFP-TMT. Compared with Sham-WAT rats, LFP-WAT rats exhibited transient locomotor hyperactivity without signs of anxiety, minor spatial learning acquisition and hippocampal long-term potentiation deficits, and lower baseline activity of the hypothalamicpituitary-adrenal axis with slightly stronger reactivity to restraint stress. Exposure to TMT had only negligible effects on Sham rats, whereas it exacerbated all deficits in LFP rats except for locomotor hyperactivity. Early brain inflammatory response (8 h post-trauma) was aggravated in rats pre-exposed to TMT, suggesting that increased brain inflammation may sustain functional deficits in these rats. Hence, these data suggest that pre-exposure to stressful conditions can aggravate longterm deficits induced by TBI, leading to severe stress response deficits, possibly due to dysregulated inflammatory response.	[Ogier, Michaeel; Carre, Emilie; Canini, Frederic] Inst Rech Biomed Armees, Bretigny Sur Orge, France; [Ogier, Michaeel; Belmeguenai, Amor; Lieutaud, Thomas; Georges, Beatrice; Bouvard, Sandrine; Bezin, Laurent] Univ Claude Bernard Lyon 1, Bron, France; [Ogier, Michaeel; Belmeguenai, Amor; Lieutaud, Thomas; Georges, Beatrice; Bouvard, Sandrine; Bezin, Laurent] IDEE, Inst Epilepsy, Bron, France; [Canini, Frederic] Ecole Val de Grace, Paris, France		Ogier, M (corresponding author), Inst Rech Biomedi Armees, Unite Neurophysiol Stress, BP 73, F-91223 Bretigny Sur Orge, France.	michael_ogier@hotmail.com			Direction Generale del'Armement (French Ministry of Defense)	This work was supported by a grant from the Direction Generale del'Armement (French Ministry of Defense).	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Ayers LW, 2013, BEHAV BRAIN RES, V253, P54, DOI 10.1016/j.bbr.2013.06.034; Balanc B, 2016, J NEUROSCI RES, V94, P39, DOI 10.1002/jnr.23676; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Conrad CD, 2010, PROG NEURO-PSYCHOPH, V34, P742, DOI 10.1016/j.pnpbp.2009.11.003; Davies DR, 2016, FRONT BEHAV NEUROSCI, V10, DOI [10.3389/fnbeh.2016.00071, 10.3339/fnbeh.2015.00071]; de Kloet CS, 2006, J PSYCHIATR RES, V40, P550, DOI 10.1016/j.jpsychires.2005.08.002; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Deppermann S, 2014, NEUROSCIENCE, V283, P166, DOI 10.1016/j.neuroscience.2014.08.037; DIAMOND DM, 1992, HIPPOCAMPUS, V2, P421, DOI 10.1002/hipo.450020409; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Donzis EJ, 2014, NEUROBIOL LEARN MEM, V115, P68, DOI 10.1016/j.nlm.2014.08.008; Drouet JB, 2015, NEUROSCIENCE, V285, P155, DOI 10.1016/j.neuroscience.2014.10.058; Endres T, 2009, J EXP BIOL, V212, P2324, DOI 10.1242/jeb.028498; FAN L, 1995, MOL BRAIN RES, V30, P125; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Fares RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053888; FEE CRA, 1988, ARCH EMERG MED, V5, P12; FOY MR, 1987, BEHAV NEURAL BIOL, V48, P138, DOI 10.1016/S0163-1047(87)90664-9; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Hussain ZM, 2012, J NEUROTRAUM, V29, P1785, DOI 10.1089/neu.2011.2286; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; LEVIN BE, 1995, BRAIN RES, V674, P307, DOI 10.1016/0006-8993(95)00032-L; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; McEwen BS, 2002, PSYCHIAT CLIN N AM, V25, P469, DOI 10.1016/S0193-953X(01)00009-0; McEwen BS, 2002, METABOLISM, V51, P2, DOI 10.1053/meta.2002.33183; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Morales A, 2006, BRAIN RES, V1109, P164, DOI 10.1016/j.brainres.2006.06.075; Nadam J, 2007, NEUROBIOL DIS, V25, P412, DOI 10.1016/j.nbd.2006.10.009; Navarro FP, 2008, J NEUROCHEM, V105, P34, DOI 10.1111/j.1471-4159.2007.05116.x; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Pace TWW, 2011, BRAIN BEHAV IMMUN, V25, P6, DOI 10.1016/j.bbi.2010.10.003; Reus GZ, 2015, NEUROSCIENCE, V300, P141, DOI 10.1016/j.neuroscience.2015.05.018; Rosen JB, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00292; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; Sanchez PE, 2009, P NATL ACAD SCI USA, V106, P9848, DOI 10.1073/pnas.0901840106; Sanchez PE, 2009, J COMP NEUROL, V514, P403, DOI 10.1002/cne.22020; Sherer M, 2014, HDB NEUROPSYCHOLOGY; Skelton RW, 2000, J CLIN EXP NEUROPSYC, V22, P157, DOI 10.1076/1380-3395(200004)22:2;1-1;FT157; Spiers JG, 2016, PSYCHONEUROENDOCRINO, V67, P104, DOI 10.1016/j.psyneuen.2016.02.005; Stankiewicz AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142195; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Williamson LL, 2013, BRAIN BEHAV IMMUN, V30, P186, DOI 10.1016/j.bbi.2013.01.077; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zardooz H, 2010, PHYSIOL RES, V59, P973, DOI 10.33549/physiolres.931896; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	65	8	8	1	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1645	1657		10.1089/neu.2016.4741			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500016	27901414				2022-02-06	
J	Paniccia, MJ; Reed, NP				Paniccia, Melissa J.; Reed, Nick P.			Dove and hawk profiles in youth concussion: Rethinking occupational performance	CANADIAN JOURNAL OF OCCUPATIONAL THERAPY-REVUE CANADIENNE D ERGOTHERAPIE			English	Article						Mild traumatic brain injury; Pediatric; Recovery model; Rehabilitation; Return to activity	TRAUMATIC BRAIN-INJURY; ACTIVE REHABILITATION; SPORT; CHILDREN; SYMPTOMS; BENEFITS; RECOVER; STRESS; SCHOOL; REST	Background. Youth concussion and its subsequent recovery have been described as heterogeneous; no one injury is the same, and each youth is different in how he or she recovers. Purpose. This paper proposes a theoretical perspective on the management of youth with persistent concussion symptoms. Key Issues. When managing concussion within youth, further consideration of person, occupation, and environment factors may provide insight on (a) the differential spectrum of profiles that exist among youth who have experienced a concussion and (b) how these profiles can support client-centred rehabilitation. Passive-dove and active-hawk stress profiles from evolutionary literature will be used to contextualize return to occupational performance. An innovative, novel model-the Dove-Hawk Model of Allostatic Load for Youth With Persistent Concussion Symptoms-is proposed to illustrate these concepts, and approaches to rehabilitation across the spectrum of profiles are offered. Implications. Viewing persistent youth concussion recovery in this way may elucidate different approaches to client-centred rehabilitation.	[Paniccia, Melissa J.; Reed, Nick P.] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Concuss Ctr, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada; [Paniccia, Melissa J.; Reed, Nick P.] Univ Toronto, Fac Med, Rehabil Sci Inst, Toronto, ON, Canada; [Reed, Nick P.] Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Paniccia, MJ (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Concuss Ctr, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	melissa.paniccia@utoronto.ca					Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Iverson GL, 2016, PHYS MED REH CLIN N, V27, P429, DOI 10.1016/j.pmr.2015.12.002; JOHNS G., 2002, HDB MENTAL HLTH WORK, P437, DOI DOI 10.4135/9781452229386; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lee Bruce, 2005, NeuroRx, V2, P372; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Ontario Ministry of Education, 2014, 158 ONT MIN ED; Polatajko Helene J., 2001, Physical and Occupational Therapy in Pediatrics, V20, P83, DOI 10.1300/J006v20n02_06; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Prabhu SP, 2011, CLIN SPORT MED, V30, P103, DOI 10.1016/j.csm.2010.09.003; Reed N, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008468; Reed N, 2014, JOVE-J VIS EXP, DOI 10.3791/51892; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; WHO, 1992, INT STAT CLASS DIS R; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	26	8	8	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0008-4174	1911-9828		CAN J OCCUP THER	Can. J. Occup. Ther.	APR	2017	84	2					111	118		10.1177/0008417416688302			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EU0PA	WOS:000400712500007	28462668				2022-02-06	
J	Ruzas, CM; DeWitt, PE; Bennett, KS; Chapman, KE; Harlaar, N; Bennett, TD				Ruzas, Christopher M.; DeWitt, Peter E.; Bennett, Kimberly S.; Chapman, Kevin E.; Harlaar, Nicole; Bennett, Tellen D.			EEG Monitoring and Antiepileptic Drugs in Children with Severe TBI	NEUROCRITICAL CARE			English	Article						Seizures; Traumatic brain injury; Electroencephalography; Anticonvulsant; Pediatric	TRAUMATIC BRAIN-INJURY; EARLY POSTTRAUMATIC SEIZURES; HEAD-INJURY; EPILEPSY; LEVETIRACETAM; CONVULSIONS; PROPHYLAXIS; VARIABILITY; THERAPY; CARE	Traumatic brain injury (TBI) causes substantial morbidity and mortality in US children. Post-traumatic seizures (PTS) occur in 11-42% of children with severe TBI and are associated with unfavorable outcome. Electroencephalographic (EEG) monitoring may be used to detect PTS and antiepileptic drugs (AEDs) may be used to treat PTS, but national rates of EEG and AED use are not known. The purpose of this study was to describe the frequency and timing of EEG and AED use in children hospitalized after severe TBI. Retrospective cohort study of 2165 children at 30 hospitals in a probabilistically linked dataset from the National Trauma Data Bank (NTDB) and the Pediatric Health Information Systems (PHIS) database, 2007-2010. We included children (age < 18 years old at admission) with linked NTDB and PHIS records, severe (Emergency Department [ED] Glasgow Coma Scale [GCS] < 8) TBI, hospital length of stay > 24 h, and non-missing disposition. The primary outcomes were EEG and AED use. Overall, 31.8% of the cohort had EEG monitoring. Of those, 21.8% were monitored on the first hospital day. The median duration of EEG monitoring was 2.0 (IQR 1.0, 4.0) days. AEDs were prescribed to 52.0% of the cohort, of whom 61.8% received an AED on the first hospital day. The median duration of AED use was 8.0 (IQR 4.0, 17.0) days. EEG monitoring and AED use were more frequent in children with known risk factors for PTS. EEG monitoring and AED use were not related to hospital TBI volume. EEG use is relatively uncommon in children with severe TBI, but AEDs are frequently prescribed. EEG monitoring and AED use are more common in children with known risk factors for PTS.	[Ruzas, Christopher M.; Bennett, Kimberly S.; Bennett, Tellen D.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Pediat Crit Care, 13199 E Montview Blvd,Suite 300,Campus Mail F443, Aurora, CO 80045 USA; [DeWitt, Peter E.] Colorado Sch Publ Hlth, Bioinformat & Biostat, Aurora, CO USA; [Chapman, Kevin E.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Pediat Neurol, Aurora, CO USA; [Harlaar, Nicole] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat,Kempe Ctr Prevent & Treatment Child A, Aurora, CO USA; [Bennett, Tellen D.] Univ Colorado, Childrens Hosp Colorado, Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO 80045 USA		Bennett, TD (corresponding author), Univ Colorado, Sch Med, Childrens Hosp Colorado, Pediat Crit Care, 13199 E Montview Blvd,Suite 300,Campus Mail F443, Aurora, CO 80045 USA.; Bennett, TD (corresponding author), Univ Colorado, Childrens Hosp Colorado, Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO 80045 USA.	tell.bennett@ucdenver.edu		Bennett, Tellen/0000-0003-1483-4236; DeWitt, Peter/0000-0002-6391-0795	Eunice Kennedy Shriver National Institute for Child Health and Human Development at the National Institutes of Health [K23HD074620]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620] Funding Source: NIH RePORTER	This work was supported by the Eunice Kennedy Shriver National Institute for Child Health and Human Development at the National Institutes of Health (Grant K23HD074620 to TB).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; American College of Surgeons - Committee on Trauma, NAT TRAUM DAT BANK R; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2016, J CHILD NEUROL, V31, P46, DOI 10.1177/0883073814562249; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Ates O, 2006, CHILD NERV SYST, V22, P279, DOI 10.1007/s00381-005-1177-6; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Bennett KS, 2016, PEDIATR CRIT CARE ME, DOI [10.1097/PCC.0000000000000948, DOI 10.1097/PCC.0000000000000948.]; Bennett TD, 2015, METHOD INFORM MED, V54, P328, DOI 10.3414/ME14-01-0093; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Bennett TD, 2012, CRIT CARE MED, V40, P208, DOI 10.1097/CCM.0b013e31822e9d31; Bratton SL, 2012, PEDIATR CRIT CARE ME, V13, P407, DOI 10.1097/PCC.0b013e318238b428; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, P46; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Conway PH, 2009, J PEDIATR-US, V154, P789, DOI 10.1016/j.jpeds.2009.01.010; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Emanuelson I, 2009, BRAIN INJURY, V23, P612, DOI 10.1080/02699050902973913; Faul M, 2010, TRAUMATIC BRAIN INJU; Gerber JS, 2010, PEDIATRICS, V126, P1067, DOI 10.1542/peds.2010-1275; Goldstein JL, 2011, NEUROCRIT CARE, V15, P63, DOI 10.1007/s12028-010-9468-5; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Kaindl AM, 2006, CELL MOL LIFE SCI, V63, P399, DOI 10.1007/s00018-005-5348-0; Kee VR, 2012, PHARMACOEPIDEM DR S, V21, P183, DOI 10.1002/pds.2329; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Kurz JE, 2016, PEDIATR CRIT CARE ME, V17, P649, DOI 10.1097/PCC.0000000000000765; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Olney JW, 2004, TRENDS PHARMACOL SCI, V25, P135, DOI 10.1016/j.tips.2004.01.002; Ong LC, 1996, J PAEDIATR CHILD H, V32, P173, DOI 10.1111/j.1440-1754.1996.tb00917.x; Ostahowski PJ, 2016, J NEUROSURG PEDIAT, V3, P1; R Core Team, 2014, R LANG ENV STAT COMP; Ratan SK, 1999, PEDIATR NEUROSURG, V30, P127, DOI 10.1159/000028779; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Slonim AD, 2010, PEDIATRICS, V125, P1208, DOI 10.1542/peds.2009-1451; Sundararajan K, 2015, ANAESTH INTENS CARE, V43, P646, DOI 10.1177/0310057X1504300515; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Therneau TM., survival: a package for survival analysis in R. R package version 3.2-7; Tri- Analytics Inc. and The Johns Hopkins University, 1997, ICDMAP90 J HOPK U TR; Van Cleve W, 2013, NEUROSURGERY, V73, P746, DOI 10.1227/NEU.0000000000000097	45	8	8	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2017	26	2					256	266		10.1007/s12028-016-0329-8			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EN5EV	WOS:000396029300014	27873234	Green Accepted			2022-02-06	
J	Szczygielski, J; Muller, A; Mautes, AE; Sippl, C; Glameanu, C; Schwerdtfeger, K; Steudel, WI; Oertel, J				Szczygielski, Jacek; Mueller, Andreas; Mautes, Angelika E.; Sippl, Christoph; Glameanu, Cosmin; Schwerdtfeger, Karsten; Steudel, Wolf-Ingo; Oertel, Joachim			Selective Brain Hypothermia Mitigates Brain Damage and Improves Neurological Outcome after Post-Traumatic Decompressive Craniectomy in Mice	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; closed head injury; decompressive craniectomy; focal cooling; hypothermia; mouse; traumatic brain injury	CONTROLLED CORTICAL IMPACT; CEREBRAL-BLOOD-FLOW; CLOSED-HEAD-INJURY; TRAUMATIC AXONAL INJURY; OVEREXPRESSING SUPEROXIDE-DISMUTASE; MICROTUBULE-ASSOCIATED PROTEIN-2; MILD HYPOTHERMIA; MODERATE HYPOTHERMIA; FLUID-PERCUSSION; THERAPEUTIC HYPOTHERMIA	Hypothermia and decompressive craniectomy (DC) have been considered as treatment for traumatic brain injury. The present study investigates whether selective brain hypothermia added to craniectomy could improve neurological outcome after brain trauma. Male CD-1 mice were assigned into the following groups: sham; DC; closed head injury (CHI); CHI followed by craniectomy (CHI+DC); and CHI+DC followed by focal hypothermia (CHI+DC+H). At 24 h post-trauma, animals were subjected to Neurological Severity Score (NSS) test and Beam Balance Score test. At the same time point, magnetic resonance imaging using a 9.4 Tesla scanner and subsequent volumetric evaluation of edema and contusion were performed. Thereafter, the animals were sacrificed and subjected to histopathological analysis. According to NSS, there was a significant impairment among all the groups subjected to trauma. Animals with both trauma and craniectomy performed significantly worse than animals with craniectomy alone. This deleterious effect disappeared when additional hypothermia was applied. BBS was significantly worse in the CHI and CHI+DC groups, but not in the CHI+DC+H group, compared to the sham animals. Edema and contusion volumes were significantly increased in CHI+DC animals, but not in the CHI+DC+H group, compared to the DC group. Histopathological analysis showed that neuronal loss and contusional blossoming could be attenuated by application of selective brain hypothermia. Selective brain cooling applied post-trauma and craniectomy improved neurological function and reduced structural damage and may be therefore an alternative to complication-burdened systemic hypothermia. Clinical studies are recommended in order to explore the potential of this treatment.	[Szczygielski, Jacek; Mautes, Angelika E.; Sippl, Christoph; Glameanu, Cosmin; Schwerdtfeger, Karsten; Steudel, Wolf-Ingo; Oertel, Joachim] Saarland Univ, Med Ctr, Dept Neurosurg, Kirrberger Str,Bldg 90-5, D-66421 Homburg, Germany; [Szczygielski, Jacek; Mueller, Andreas; Mautes, Angelika E.; Sippl, Christoph; Glameanu, Cosmin; Schwerdtfeger, Karsten; Steudel, Wolf-Ingo; Oertel, Joachim] Saarland Univ, Fac Med, Homburg, Germany; [Mueller, Andreas] Saarland Univ, Med Ctr, Dept Radiol, Homburg, Germany		Szczygielski, J (corresponding author), Saarland Univ, Med Ctr, Dept Neurosurg, Kirrberger Str,Bldg 90-5, D-66421 Homburg, Germany.	jacek.szczygielski@uks.eu	Szczygielski, Jacek/AAV-4791-2021; Oertel, Joachim/AAO-5012-2021	Szczygielski, Jacek/0000-0002-3157-2824; Muller, Andreas/0000-0003-0924-3490	voluntary association "Friends of Saarland University Medical Center"	This work has been supported by financial award of voluntary association "Friends of Saarland University Medical Center" ( for J.S.).	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Abdullah J, 2005, ACT NEUR S, V95, P311; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Bauer R, 2000, CRIT CARE MED, V28, P1128, DOI 10.1097/00003246-200004000-00036; Bian JY, 2006, NEUROSURG REV, V29, P168, DOI 10.1007/s10143-005-0010-8; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Brodhun M, 2001, ACTA NEUROPATHOL, V101, P424; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Celik SE, 2006, J NEUROTRAUM, V23, P1355, DOI 10.1089/neu.2006.23.1355; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cheng GQ, 2011, EARLY HUM DEV, V87, P109, DOI 10.1016/j.earlhumdev.2010.11.007; Chio CC, 2007, SHOCK, V28, P284, DOI 10.1097/SHK.0b013e3180311e60; Clark DL, 2007, J CEREBR BLOOD F MET, V27, P115, DOI 10.1038/sj.jcbfm.9600327; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Diao CG, 2003, ANN BIOMED ENG, V31, P346, DOI 10.1114/1.1554924; Diao CG, 2006, MED PHYS, V33, P2565, DOI 10.1118/1.2208918; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Doerfler A, 1996, J NEUROSURG, V85, P853, DOI 10.3171/jns.1996.85.5.0853; Doerfler A, 2001, STROKE, V32, P2675, DOI 10.1161/hs1101.098369; Doll H, 2010, J NEUROTRAUM, V27, P2245, DOI 10.1089/neu.2010.1505; Doll H, 2009, J NEUROTRAUM, V26, P235, DOI 10.1089/neu.2008.0741; Dvilevicius AE, 2008, ARQ NEURO-PSIQUIAT, V66, P391, DOI 10.1590/S0004-282X2008000300021; Els T, 2006, CEREBROVASC DIS, V21, P79, DOI 10.1159/000090007; FORSTING M, 1995, STROKE, V26, P259, DOI 10.1161/01.STR.26.2.259; Gaida B.J., 2008, EUR J ANAESTHESI S43, V25, P11; Gelman B, 1996, CRIT CARE MED, V24, P1009, DOI 10.1097/00003246-199606000-00022; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Haranishi Y, 2005, EUR J ANAESTH, V22, P140, DOI 10.1017/S0265021505000268; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; Hashimoto Takashi, 2003, Kobe Journal of Medical Sciences, V49, P83; Heegaard W, 1997, ACAD EMERG MED, V4, P33, DOI 10.1111/j.1553-2712.1997.tb03640.x; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Huh PW, 2000, J NEUROSURG, V92, P91, DOI 10.3171/jns.2000.92.1.0091; Iatrou CC, 2002, ANAESTH INTENS CARE, V30, P167, DOI 10.1177/0310057X0203000207; Idris Zamzuri, 2014, Asian J Neurosurg, V9, P115, DOI 10.4103/1793-5482.142690; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Jiang JY, 2004, NEUROSURGERY, V54, P713, DOI 10.1227/01.NEU.0000109535.58429.49; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kahveci FS, 2001, SURG NEUROL, V56, P206, DOI 10.1016/S0090-3019(01)00555-9; Kawanishi Masahiko, 2008, J Stroke Cerebrovasc Dis, V17, P187, DOI 10.1016/j.jstrokecerebrovasdis.2008.01.003; Kim J. G., 2014, T MAT PROCESSING, V23, P23; King C, 2010, J NEUROTRAUM, V27, P1895, DOI 10.1089/neu.2009.1178; Kinoshita K, 2002, J NEUROSURG, V97, P945, DOI 10.3171/jns.2002.97.4.0945; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; Kollmar R, 2010, STROKE, V41, P1684, DOI 10.1161/STROKEAHA.110.587758; Koo JS, 2004, NEUROSCI RES COMMUN, V35, P73, DOI 10.1002/nrc.20022; KULUZ JW, 1992, STROKE, V23, P1792, DOI 10.1161/01.STR.23.12.1792; KULUZ JW, 1993, AM J PHYSIOL, V265, pH824, DOI 10.1152/ajpheart.1993.265.3.H824; Kuo JR, 2010, J TRAUMA, V69, P1467, DOI 10.1097/TA.0b013e3181f31b06; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Ma M, 2009, EXP NEUROL, V215, P119, DOI 10.1016/j.expneurol.2008.09.024; MacLellan CL, 2004, J CEREBR BLOOD F MET, V24, P432, DOI 10.1097/00004647-200404000-00008; Maekawa T., 2015, J NEUROTRAUM, V32; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Markgraf CG, 2001, J NEUROTRAUM, V18, P175, DOI 10.1089/08977150150502604; Masaoka Hiroyuki, 2010, Journal of Medical and Dental Sciences, V57, P133; Matsuno A, 2003, SURG NEUROL, V60, P23, DOI 10.1016/S0090-3019(03)00023-5; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; Mautes AEM, 2000, EXP NEUROL, V166, P254, DOI 10.1006/exnr.2000.7520; Mautes AEM, 2000, BRAIN RES, V883, P233, DOI 10.1016/S0006-8993(00)02846-8; Mautes AEM, 1998, BRAIN RES, V795, P17, DOI 10.1016/S0006-8993(98)00230-3; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Mink S, 2011, NEUROCRIT CARE, V15, P107, DOI 10.1007/s12028-010-9451-1; O'Phelan Kristine H, 2015, World J Crit Care Med, V4, P296, DOI 10.5492/wjccm.v4.i4.296; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Prandini Mirto Nelso, 2002, Acta Cir. Bras., V17, P232, DOI 10.1590/S0102-86502002000400006; Qiu WS, 2006, J CLIN NEUROSCI, V13, P995, DOI 10.1016/j.jocn.2006.02.027; Sakoh M, 2003, AM J PHYSIOL-HEART C, V285, pH17, DOI 10.1152/ajpheart.01112.2002; Schwerdtfeger K, 1999, ACTA NEUROCHIR, V141, P647, DOI 10.1007/s007010050355; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Suehiro E, 2011, NEUROL MED-CHIR, V51, P551, DOI 10.2176/nmc.51.551; Szczygielski J, 2016, J NEUROTRAUM, V33, P122, DOI 10.1089/neu.2014.3835; Szczygielski J, 2010, ACTA NEUROCHIR SUPPL, V106, P225, DOI 10.1007/978-3-211-98811-4_42; Tadler SC, 1998, ACAD EMERG MED, V5, P25, DOI 10.1111/j.1553-2712.1998.tb02570.x; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thoresen M, 2001, PEDIATR RES, V49, P594, DOI 10.1203/00006450-200104000-00024; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Tomura S, 2012, J CEREBR BLOOD F MET, V32, P1939, DOI 10.1038/jcbfm.2012.99; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Wagner KR, 2005, NEUROL RES, V27, P238, DOI 10.1179/016164105X25261; Wang CC, 2013, J SURG RES, V185, P753, DOI 10.1016/j.jss.2013.07.002; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Weinzierl M, 2004, BRAIN RES, V1030, P125, DOI 10.1016/j.brainres.2004.09.060; Weinzierl M, 2003, NEUROSCI LETT, V336, P13, DOI 10.1016/S0304-3940(02)01233-8; Whalen MJ, 1997, ACT NEUR S, V70, P260; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P7, DOI 10.2176/nmc.33.7; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X; Yao CP, 2011, J NEUROTRAUM, V28, P1237, DOI 10.1089/neu.2010.1678; Zhao Z, 2007, NEUROCRIT CARE, V7, P263, DOI 10.1007/s12028-007-0074-0; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	138	8	8	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1623	1635		10.1089/neu.2016.4615			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500014	27799012				2022-02-06	
J	Whitesides, LW; Baren, JM; Biros, MH; Fleischman, RJ; Govindarajan, PR; Jones, EB; Pancioli, AM; Pentz, RD; Scicluna, VM; Wright, DW; Dickert, NW				Whitesides, Louisa W.; Baren, Jill M.; Biros, Michelle H.; Fleischman, Ross J.; Govindarajan, Prasanthi R.; Jones, Elizabeth B.; Pancioli, Arthur M.; Pentz, Rebecca D.; Scicluna, Victoria M.; Wright, David W.; Dickert, Neal W.			Impact of individual clinical outcomes on trial participants' perspectives on enrollment in emergency research without consent	CLINICAL TRIALS			English	Article						Research ethics; bioethics; informed consent; acute care research; emergency research; traumatic brain injury	TRAUMATIC BRAIN-INJURY; COMMUNITY CONSULTATION; INFORMED-CONSENT; PATIENTS EXPERIENCES; RESUSCITATION; PROGESTERONE; PERCEPTIONS; EXCEPTION; SETTINGS; CARE	Background: Evidence suggests that patients are generally accepting of their enrollment in trials for emergency care conducted under exception from informed consent. It is unknown whether individuals with more severe initial injuries or worse clinical outcomes have different perspectives. Determining whether these differences exist may help to structure post-enrollment interactions. Methods: Primary clinical data from the Progesterone for the Treatment of Traumatic Brain Injury trial were matched to interview data from the Patients' Experiences in Emergency Research-Progesterone for the Treatment of Traumatic Brain Injury study. Answers to three key questions from Patients' Experiences in Emergency Research-Progesterone for the Treatment of Traumatic Brain Injury study were analyzed in the context of enrolled patients' initial injury severity (initial Glasgow Coma Scale and Injury Severity Score) and principal clinical outcomes (Extended Glasgow Outcome Scale and Extended Glasgow Outcome Scale relative to initial injury severity). The three key questions from Patients' Experiences in Emergency Research-Progesterone for the Treatment of Traumatic Brain Injury study addressed participants' general attitude toward inclusion in the Progesterone for the Treatment of Traumatic Brain Injury trial (general trial inclusion), their specific attitude toward being included in Progesterone for the Treatment of Traumatic Brain Injury trial under the exception from informed consent (personal exception from informed consent enrollment), and their attitude toward the use of exception from informed consent in the Progesterone for the Treatment of Traumatic Brain Injury trial in general (general exception from informed consent enrollment). Qualitative analysis of interview transcripts was performed to provide contextualization and to determine the extent to which respondents framed their attitudes in terms of clinical experience. Results: Clinical data from Progesterone for the Treatment of Traumatic Brain Injury trial were available for all 74 patients represented in the Patients' Experiences in Emergency Research-Progesterone for the Treatment of Traumatic Brain Injury study (including 46 patients for whom the surrogate was interviewed due to the patient's cognitive status or death). No significant difference was observed regarding acceptance of general trial inclusion or acceptance of general exception from informed consent enrollment between participants with favorable neurological outcomes and those with unfavorable outcomes relative to initial injury. Agreement with personal enrollment in Progesterone for the Treatment of Traumatic Brain Injury trial under exception from informed consent, however, was significantly higher among participants with favorable outcomes compared to those with unfavorable outcomes (89% vs 59%, p = 0.003). There was also a statistically significant relationship between more severe initial injury and increased acceptance of personal exception from informed consent enrollment (p = 0.040) or general exception from informed consent use (p = 0.034) in Progesterone for the Treatment of Traumatic Brain Injury trial. Many individuals referenced personal experience as a basis for their attitudes, but these references were not used to support negative views. Conclusion: Patients and surrogates of patients with unfavorable clinical outcomes were somewhat less accepting of their own inclusion in the Progesterone for the Treatment of Traumatic Brain Injury trial under exception from informed consent than were patients or surrogates of patients with favorable clinical outcomes. These findings suggest a need to identify optimal strategies for communicating with patients and their surrogates regarding exception from informed consent enrollment when clinical outcomes are poor.	[Whitesides, Louisa W.] Hosp Univ Penn, Dept Internal Med, 3400 Spruce St, Philadelphia, PA 19104 USA; [Baren, Jill M.] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA; [Biros, Michelle H.] Univ Minnesota, Hennepin Cty Med Ctr, Sch Med, Dept Emergency Med, Minneapolis, MN USA; [Fleischman, Ross J.] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Govindarajan, Prasanthi R.] Univ Calif San Francisco, Sch Med, Dept Emergency Med, San Francisco, CA 94143 USA; [Jones, Elizabeth B.] Univ Texas Med Sch Houston, Dept Emergency Med, Houston, TX USA; [Pancioli, Arthur M.] Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH USA; [Pentz, Rebecca D.] Emory Univ, Sch Med, Dept Hematol & Oncol, Atlanta, GA 30322 USA; [Scicluna, Victoria M.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Wright, David W.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA; [Dickert, Neal W.] Emory Univ, Sch Med, Dept Med, Div Cardiol, 1462 Clifton Rd,508, Atlanta, GA 30322 USA; [Dickert, Neal W.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA		Dickert, NW (corresponding author), Emory Univ, Sch Med, Dept Med, Div Cardiol, 1462 Clifton Rd,508, Atlanta, GA 30322 USA.	njr@emory.edu			Greenwall Foundation; National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5U01NS062778]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U10NS059032, U01NS062778] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Greenwall Foundation. The parent trial was supported by the National Institute for Neurological Disorders and Stroke (5U01NS062778).	Abboud PA, 2006, J MED ETHICS, V32, P468, DOI 10.1136/jme.2005.012633; Biros MH, 2009, RESUSCITATION, V80, P1382, DOI 10.1016/j.resuscitation.2009.08.019; Dickert NW, 2015, CRIT CARE MED, V43, P603, DOI 10.1097/CCM.0000000000000747; Dickert NW, 2014, CRIT CARE MED, V42, P272, DOI 10.1097/CCM.0b013e3182a27759; Dickert NW, 2013, RESUSCITATION, V84, P1416, DOI 10.1016/j.resuscitation.2013.04.006; Dickert NW, 2009, SOC SCI MED, V68, P183, DOI 10.1016/j.socscimed.2008.10.001; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Kamarainen A, 2012, RESUSCITATION, V83, P81, DOI 10.1016/j.resuscitation.2011.07.018; Kasner SE, 2011, ANN EMERG MED, V57, P346, DOI 10.1016/j.annemergmed.2010.07.009; Largent EA, 2010, ARCH INTERN MED, V170, P668, DOI 10.1001/archinternmed.2010.80; Lecouturier Jan, 2008, BMC Med Ethics, V9, P9, DOI 10.1186/1472-6939-9-9; Lo B, 2006, CRIT CARE MED, V34, P2236, DOI 10.1097/01.CCM.0000229632.85246.3A; Lynch CA, 2011, ACAD EMERG MED, V18, P972, DOI 10.1111/j.1553-2712.2011.01153.x; Potter JE, 2013, INTENS CARE MED, V39, P472, DOI 10.1007/s00134-012-2732-8; United States Food and Drug Administration, 2004, TITL 21 COD FED REG; van Belle G, 2015, RESUSCITATION, V91, P76, DOI 10.1016/j.resuscitation.2014.11.029; Woolfall K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008522; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	18	8	8	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1740-7745	1740-7753		CLIN TRIALS	Clin. Trials	APR	2017	14	2					180	186		10.1177/1740774516677276			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EQ2XL	WOS:000397934800009	28359192	Green Accepted			2022-02-06	
J	Sweidan, AJ; Leung, A; Kaiser, CJ; Strube, SJ; Dokukin, AN; Romansky, S; Farjami, S				Sweidan, Alexander J.; Leung, Anthony; Kaiser, Cassandra J.; Strube, Sarah J.; Dokukin, Andrei N.; Romansky, Stephen; Farjami, Sassan			A Case of Statin-Associated Autoimmune Myopathy	CLINICAL MEDICINE INSIGHTS-CASE REPORTS			English	Article						HMGCR; statin complications; statin myopathy; statin failure; statin-associated autoimmune myopathy		A 70-year-old previously independent man developed progressive proximal leg weakness resulting in a fall at home suffering traumatic brain injury. He was prescribed a statin medication two years prior, but this was discontinued on admission to the hospital due to concern for statin myopathy. His weakness continued to progress while in acute rehabilitation, along with the development of dysphagia requiring placement of gastrostomy tube and respiratory failure requiring tracheostomy. Corticosteroids and intravenous immunoglobulin were administered without response. Nerve conduction study demonstrated no evidence of neuropathy; electromyography revealed spontaneous activity suggestive of myopathy. A muscle biopsy was performed and demonstrated myonecrosis. Serology was positive for autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), verifying our diagnosis of statin-associated autoimmune myopathy (SAM). The patient was subsequently treated with rituximab and methotrexate and demonstrated mild clinical improvement. He was eventually liberated from the ventilator. However, later in the course of treatment, he developed respiratory distress and required ventilator support. The patient was discharged to long-term acute care two months after his initial presentation and died due to ventilator -acquired pneumonia three months later. Since their introduction 30 years ago, statin medications have been widely prescribed to prevent cardiovascular diseases. Myalgias and/or myopathic symptoms are among the most recognized side effects of the medication. Statin-associated autoimmune myopathy is a very rare complication of statin use and estimated to affect two to three for every 100,000 patients treated. Clinically, the condition presents as progressive symmetric weakness, muscle enzyme elevations, necrotizing myopathy on muscle biopsy, and the presence of autoantibodies to HMGCR. These findings will often persist and even progress despite discontinuation of the statin. Very few cases of SAM have been described in the literature. Describing this rare condition and the ultimately fatal outcome of our patient, we aim to further understanding of SAM, its presentation and clinical course to promote earlier diagnosis and prompt management.	St Mary Hosp, Dept Internal Med, Long Beach, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA		Sweidan, AJ (corresponding author), Univ Calif Los Angeles, Dept Internal Med, 1050 Linden Ave, Long Beach, CA 90813 USA.; Sweidan, AJ (corresponding author), St Mary Hosp, 1050 Linden Ave, Long Beach, CA 90813 USA.	ajsweidan@gmail.com					Babu S, 2014, CURR OPIN RHEUMATOL, V26, P679, DOI [10.1097/BOR.0000000000000106, DOI 10.1097/B0R.0000000000000106]; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Dimachkie MM, 2011, J NEUROIMMUNOL, V231, P32, DOI 10.1016/j.jneuroim.2010.10.013; Drouot L, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4468; Fulcher J, 2015, LANCET, V385, P1397, DOI 10.1016/S0140-6736(14)61368-4; Ge YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141616; Hamann PDH, 2013, AUTOIMMUN REV, V12, P1177, DOI 10.1016/j.autrev.2013.07.001; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Mammen AL, 2016, NEW ENGL J MED, V374, P664, DOI 10.1056/NEJMra1515161; Mammen AL, 2015, NEW ENGL J MED, V373, P1680, DOI 10.1056/NEJMc1506163; Mammen AL, 2012, ARTHRIT CARE RES, V64, P269, DOI 10.1002/acr.20662; Ramanathan S, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000096; Sirvent P, 2008, CURR OPIN PHARMACOL, V8, P333, DOI 10.1016/j.coph.2007.12.010	13	8	8	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-5476			CLIN MED INSIGHT-CAS	Clin. Med. Insights-Case Rep.	MAR 30	2017	10								1179547616688231	10.1177/1179547616688231			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	EQ0LG	WOS:000397762100001	28469499	Green Published, gold			2022-02-06	
J	Hogard, ML; Lunte, CE; Lunte, SM				Hogard, Michael L.; Lunte, Craig E.; Lunte, Susan M.			Detection of reactive aldehyde biomarkers in biological samples using solid-phase extraction pre-concentration and liquid chromatography with fluorescence detection	ANALYTICAL METHODS			English	Article							OXIDATIVE STRESS; LIPID-PEROXIDATION; 3-MERCAPTOPROPIONIC ACID; MASS-SPECTROMETRY; RAT MODEL; MALONDIALDEHYDE; DANSYLHYDRAZINE; ANTIOXIDANTS; ACROLEIN; DAMAGE	Reactive aldehyde species are important byproducts of lipid peroxidation and oxidative stress due to their role in the secondary damage caused by traumatic events such as epileptic seizures and brain injury. In this study, a liquid chromatography/fluorescence method was developed to determine 4-hydroxynonenal, acrolein, and malondialdehyde in urine samples. These analytes react with dansylhydrazine to produce fluorescent dansyl derivatives with experimentally determined excitation and emission wavelengths of 250 and 550 nm, respectively, which were dependent on the organic composition of the mobile phase. Using a solid-phase extraction pre-concentration method prior to LC-FL resulted in limits of detection ranging from 6 nM to 200 nM for the three compounds. This method was then demonstrated for the detection of the compounds in urine samples. The method was then applied to the analysis of rat urine samples obtained following a chemically induced seizure. A statistically significant increase in acrolein concentration was observed. There was no change in 4-hydroxynonenal concentration, and the results for malondialdehyde were inconclusive. The method will be applied in the future to monitor lipid oxidation in different brain regions using microdialysis sampling during epileptic seizures.	[Hogard, Michael L.; Lunte, Craig E.; Lunte, Susan M.] Univ Kansas, Ralph N Adams Inst Bioanalyt Chem, Lawrence, KS 66045 USA; [Hogard, Michael L.; Lunte, Craig E.; Lunte, Susan M.] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA; [Lunte, Susan M.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA		Lunte, SM (corresponding author), Univ Kansas, Ralph N Adams Inst Bioanalyt Chem, Lawrence, KS 66045 USA.; Lunte, SM (corresponding author), Univ Kansas, Dept Chem, Lawrence, KS 66045 USA.; Lunte, SM (corresponding author), Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA.	slunte@ku.edu	Lunte, Susan M/G-2263-2018		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS066466]	This work is supported by funding from the National Institutes of Health under Grant No. R01-NS066466. The authors would also like to thank Nancy Harmony for her editorial assistance.	Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; Burcham PC, 2002, TOXICOLOGY, V181, P229, DOI 10.1016/S0300-483X(02)00287-1; Catala A, 2010, BIOCHEM BIOPH RES CO, V399, P318, DOI 10.1016/j.bbrc.2010.07.087; Cooley JC, 2011, ELECTROPHORESIS, V32, P2994, DOI 10.1002/elps.201100143; Crick EW, 2007, EPILEPSY RES, V74, P116, DOI 10.1016/j.eplepsyres.2007.02.003; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FUNG K, 1981, ANAL CHEM, V53, P168, DOI 10.1021/ac00225a009; Giera M, 2011, ANALYST, V136, P2763, DOI 10.1039/c1an15254h; GOLDRING C, 1993, LIPIDS, V28, P141, DOI 10.1007/BF02535778; Greenough MA, 2013, NEUROCHEM INT, V62, P540, DOI 10.1016/j.neuint.2012.08.014; HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; HARRISON FW, 1976, HISTOCHEMISTRY, V49, P349, DOI 10.1007/BF00496139; Hatzinikolaou DG, 2006, ANAL CHEM, V78, P4509, DOI 10.1021/ac052004y; Herrington J, 2005, J ENVIRON MONITOR, V7, P969, DOI 10.1039/b502063h; Hu CH, 2013, PLAST RECONSTR SURG, V132, p530E, DOI 10.1097/PRS.0b013e3182a0141f; HYSLOP PA, 1988, J BIOL CHEM, V263, P1665; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Li H, 2004, J TOXICOL ENV HEAL A, V67, P513, DOI 10.1080/15287390490276539; MARES P, 1993, EPILEPSY RES, V16, P11, DOI 10.1016/0920-1211(93)90034-5; Mateos R, 2005, J CHROMATOGR B, V827, P76, DOI 10.1016/j.jchromb.2005.06.035; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Nam TG, 2011, TOX RESEARCH, V27, P1, DOI 10.5487/TR.2011.27.1.001; NONDEK L, 1992, ENVIRON SCI TECHNOL, V26, P1174, DOI 10.1021/es50002a605; Pisoschi AM, 2015, EUR J MED CHEM, V97, P55, DOI 10.1016/j.ejmech.2015.04.040; RODLER DR, 1993, ENVIRON SCI TECHNOL, V27, P2814; Sani M, 2015, REDOX REP, V20, DOI 10.1179/1351000214Y.0000000102; SHARA MA, 1992, J CHROMATOGR-BIOMED, V576, P221, DOI 10.1016/0378-4347(92)80196-W; Shin EJ, 2011, NEUROCHEM INT, V59, P122, DOI 10.1016/j.neuint.2011.03.025; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; Takamoto S, 2001, J CHROMATOGR B, V758, P123, DOI 10.1016/S0378-4347(01)00152-9; TOMITA M, 1990, ARCH TOXICOL, V64, P590, DOI 10.1007/BF01971840; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; WEBER P, 1975, HISTOCHEMISTRY, V45, P271, DOI 10.1007/BF00492629; Zanardi E, 2002, J AGR FOOD CHEM, V50, P5268, DOI 10.1021/jf020201h; Zhang I, 2000, ENVIRON SCI TECHNOL, V34, P2601	36	8	8	4	40	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1759-9660	1759-9679		ANAL METHODS-UK	Anal. Methods	MAR 28	2017	9	12					1848	1854		10.1039/c6ay03327j			7	Chemistry, Analytical; Food Science & Technology; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Food Science & Technology; Spectroscopy	ER4YE	WOS:000398807500003					2022-02-06	
J	Nonaka, T; Yamada, T; Ishimura, T; Zuo, DY; Moffett, JR; Neale, JH; Yamamoto, T				Nonaka, Takahiro; Yamada, Toshihiko; Ishimura, Tatsuhiro; Zuo, Daiying; Moffett, John R.; Neale, Joseph H.; Yamamoto, Tatsuo			A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA	MOLECULAR PAIN			English	Article						N-acetylaspartylglutamate; glutamate carboxypeptidase II; inflammatory pain; locus coeruleus; metabotropic glutamate receptor; N-methyl-D-aspartate receptor	GLUTAMATE CARBOXYPEPTIDASE-II; ACIDIC DIPEPTIDASE NAALADASE; TRAUMATIC BRAIN-INJURY; RAT FORMALIN TEST; ACETYLASPARTATE IMMUNOREACTIVITIES; INFLAMMATORY PAIN; NEUROPATHIC PAIN; NAAG; SCHIZOPHRENIA; MGLUR3	N-acetylaspartylglutamate (NAAG) is the third most prevalent and widely distributed neurotransmitter in the mammalian nervous system. NAAG activates a group II metabotropic glutamate receptor (mGluR3) and is inactivated by an extracellular enzyme, glutamate carboxypeptidase II (GCPII) in vivo. Inhibitors of this enzyme are analgesic in animal models of inflammatory, neuropathic and bone cancer pain. NAAG and GCPII are present in the locus coeruleus, a center for the descending noradrenergic inhibitory pain system. In the formalin footpad model, systemic treatment with GCPII inhibitors reduces both phases of the inflammatory pain response and increases release of spinal noradrenaline. This analgesic efficacy is blocked by systemic injection of a group II mGluR antagonist, by intrathecal (spinal) injection of an alpha 2 adrenergic receptor antagonist and by microinjection of an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor antagonist directly into the contralateral locus coeruleus. Footpad inflammation increases release of glutamate in the contralateral locus coeruleus and systemic treatment with a GCPII inhibitor blocks this increase. Direct injection of GCPII inhibitors into the contralateral or ipsilateral locus coeruleus reduces both phases of the inflammatory pain response in a dose-dependent manner and the contralateral effect also is blocked by intrathecal injection of an alpha 2 adrenergic receptor antagonist. These data support the hypothesis that the analgesic efficacy of systemically administered GCPII inhibitors is mediated, at least in part, by the contralateral locus coeruleus via group II mGluR, AMPA and alpha 2 adrenergic receptors.	[Nonaka, Takahiro; Yamada, Toshihiko; Ishimura, Tatsuhiro; Yamamoto, Tatsuo] Kumamoto Univ, Sch Med Sci, Dept Anesthesiol, Kumamoto, Japan; [Zuo, Daiying] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang, Peoples R China; [Moffett, John R.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Neale, Joseph H.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA		Yamamoto, T (corresponding author), Kumamoto Univ, Dept Anesthesiol, Sch Med Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto, Kumamoto 8608556, Japan.	yamyam@kumamoto-u.ac.jp			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [17K09036] Funding Source: KAKEN	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Tatsuo Yamamoto was supported by the Grant-in-Aid for Scientific Research (C). JHN supported by grants from the NIH and generous gifts from Nancy and Daniel Paduano.	Bacich DJ, 2005, J NEUROCHEM, V95, P314, DOI 10.1111/j.1471-4159.2005.03361.x; Cao Y, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0251-1; Fricker AC, 2009, NEUROPHARMACOLOGY, V56, P1060, DOI 10.1016/j.neuropharm.2009.03.002; FUHRMAN S, 1994, J NEUROCHEM, V62, P275; Gao Y, 2015, J NEUROCHEM, V134, P340, DOI 10.1111/jnc.13123; Hayashida KI, 2008, ANESTHESIOLOGY, V109, P1077, DOI 10.1097/ALN.0b013e31818dac9c; Khacho P, 2016, ADV PHARMACOL, V79, P311; Khacho P, 2015, NEUROBIOL DIS, V82, P580, DOI 10.1016/j.nbd.2015.08.017; Khakpay R, 2010, BEHAV BRAIN RES, V214, P409, DOI 10.1016/j.bbr.2010.06.012; Kimura M, 2015, ANESTHESIOLOGY, V123, P899, DOI 10.1097/ALN.0000000000000796; Kozikowski AP, 2004, J MED CHEM, V47, P1729, DOI 10.1021/jm0306226; Llorca-Torralba M, 2016, NEUROSCIENCE, V338, P93, DOI 10.1016/j.neuroscience.2016.05.057; Losi G, 2004, NEUROPHARMACOLOGY, V46, P490, DOI 10.1016/j.neuropharm.2003.10.007; Milhaud D, 2000, NEUROPHARMACOLOGY, V39, P2244, DOI 10.1016/S0028-3908(00)00085-X; MOFFETT JR, 1993, J HISTOCHEM CYTOCHEM, V41, P559, DOI 10.1177/41.4.8450195; MOFFETT JR, 1995, J NEUROCYTOL, V24, P409, DOI 10.1007/BF01181604; Monn JA, 1999, J MED CHEM, V42, P1027, DOI 10.1021/jm980616n; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Neale JH, 2011, J NEUROCHEM, V119, P891, DOI 10.1111/j.1471-4159.2011.07380.x; Neale JH, 2011, J NEUROCHEM, V118, P490, DOI 10.1111/j.1471-4159.2011.07338.x; OHISHI H, 1993, J COMP NEUROL, V335, P252, DOI 10.1002/cne.903350209; Olszewski RT, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.68; Olszewski RT, 2012, SCHIZOPHR RES, V136, P160, DOI 10.1016/j.schres.2012.01.007; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Saito O, 2006, CAN J ANAESTH, V53, P891, DOI 10.1007/BF03022832; Sanabria ERG, 2004, J NEUROPHYSIOL, V91, P182, DOI 10.1152/jn.00465.2003; Slusher BS, 1999, NAT MED, V5, P1396, DOI 10.1038/70971; SLUSHER BS, 1992, J COMP NEUROL, V315, P217; Tsukamoto T, 2007, DRUG DISCOV TODAY, V12, P767, DOI 10.1016/j.drudis.2007.07.010; Yamada T, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-67; Yamamoto T, 2004, EUR J NEUROSCI, V20, P483, DOI 10.1111/j.1460-9568.2004.03504.x; Yamamoto T, 2001, BRAIN RES, V909, P138, DOI 10.1016/S0006-8993(01)02650-6; Yamamoto T, 2001, NEUROSCIENCE, V102, P473, DOI 10.1016/S0306-4522(00)00502-9; Yamamoto T, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-31; Zhao J, 2001, EUR J NEUROSCI, V13, P340, DOI 10.1046/j.1460-9568.2001.01396.x; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zuo DY, 2012, J BIOL CHEM, V287, P21773, DOI 10.1074/jbc.M112.363226	37	8	8	1	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1744-8069			MOL PAIN	Mol. Pain	MAR 8	2017	13								1744806917697008	10.1177/1744806917697008			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ES9TA	WOS:000399902500001	28326936	Green Published, gold			2022-02-06	
J	Beaulieu-Bonneau, S; Fortier-Brochu, E; Ivers, H; Morin, CM				Beaulieu-Bonneau, Simon; Fortier-Brochu, Emilie; Ivers, Hans; Morin, Charles M.			Attention following traumatic brain injury: Neuropsychological and driving simulator data, and association with sleep, sleepiness, and fatigue	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Cognition; Sleep disturbances; Neuropsychological tests; Driving simulator	CLOSED-HEAD INJURY; DIVIDED ATTENTION; MENTAL EFFORT; DEFICITS; DISORDERS; TESTS; DIFFICULTIES; METAANALYSIS; PERFORMANCE; PREVALENCE	The objectives of this study were to compare individuals with traumatic brain injury (TBI) and healthy controls on neuropsychological tests of attentionand driving simulation performance, and explore their relationships with participants' characteristics, sleep, sleepiness, and fatigue. Participants were 22 adults with moderate or severe TBI (time since injury one year) and 22 matched controls. They completed three neuropsychological tests of attention, a driving simulator task, night-time polysomnographic recordings, and subjective ratings of sleepiness and fatigue. Results showed that participants with TBI exhibited poorer performance compared to controls on measures tapping speed of information processing and sustained attention, but not on selective attention measures. On the driving simulator task, a greater variability of the vehicle lateral position was observed in the TBI group. Poorer performance on specific subsets of neuropsychological variables was associated with poorer sleep continuity in the TBI group, and with a greater increase in subjective sleepiness in both groups. No significant relationship was found between cognitive performance and fatigue. These findings add to the existing evidence that speed of information processing is still impaired several years after moderate to severe TBI. Sustained attention could also be compromised. Attention seems to be associated with sleep continuity and daytime sleepiness; this interaction needs to be explored further.	[Beaulieu-Bonneau, Simon; Fortier-Brochu, Emilie; Ivers, Hans; Morin, Charles M.] Univ Laval, Ecole Psychol, Pavillon F-A Savard,2325 Rue Bibliotheques, Quebec City, PQ G1V 0A6, Canada		Beaulieu-Bonneau, S (corresponding author), Univ Laval, Ecole Psychol, Pavillon F-A Savard,2325 Rue Bibliotheques, Quebec City, PQ G1V 0A6, Canada.	simon.beaulieu-bonneau.1@ulaval.ca	Lang, Steven/AAE-8102-2021; Morin, Charles M./A-4700-2008	Lang, Steven/0000-0003-1669-9146; Morin, Charles M./0000-0002-8649-8895; Beaulieu-Bonneau, Simon/0000-0002-9544-5023	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); NovartisNovartis; Valeant	The first author, Dr. Beaulieu-Bonneau, was supported by a doctoral fellowship award by the Canadian Institutes of Health Research. Dr. Morin has received research support from Novartis and Valeant and has served as a consultant for Novartis, Merck, and Valeant.	Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Brouwer WH, 2002, J HEAD TRAUMA REHAB, V17, P1, DOI 10.1097/00001199-200202000-00003; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chaumet G, 2008, NEUROLOGY, V71, P1609, DOI 10.1212/01.wnl.0000334753.49193.48; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Conners C.K., 2004, CONNERS CONTINUOUS P; Cooper JM, 2013, HUM FACTORS, V55, P1001, DOI 10.1177/0018720813480177; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Cullen N, 2014, BRAIN INJURY, V28, P38, DOI 10.3109/02699052.2013.849005; Cyr AA, 2009, J CLIN EXP NEUROPSYC, V31, P472, DOI 10.1080/13803390802255627; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Du HJ, 2015, TRAFFIC INJ PREV, V16, P468, DOI 10.1080/15389588.2014.971155; Faul M, 2010, TRAUMATIC BRAIN INJU; Fidell L. S., 2012, USING MULTIVARIATE S; Galski T, 2000, J HEAD TRAUMA REHAB, V15, P895, DOI 10.1097/00001199-200006000-00004; IBM, 2010, IBM SPSS STAT VERS 1; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Lengenfelder J, 2002, J HEAD TRAUMA REHAB, V17, P26, DOI 10.1097/00001199-200202000-00005; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Masson M, 2013, BRAIN INJURY, V27, P538, DOI 10.3109/02699052.2013.766926; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McCullagh S., 2011, TRAUMATIC BRAIN INJU, P279; Ministere de la sante et des services sociaux du Quebec & Societe d'assurance automobile du Quebec, 2005, OR MIN TRAUM CRAN LE; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Pace-Schott EF, 2011, PROG BRAIN RES, V191, P75, DOI 10.1016/B978-0-444-53752-2.00012-6; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; Pigeon WR, 2003, J PSYCHOSOM RES, V54, P61, DOI 10.1016/S0022-3999(02)00542-1; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Riese H, 1999, NEUROPSYCHOL REHABIL, V9, P189, DOI 10.1080/713755600; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; SPSS Inc, 2005, TECHNICAL REPORT; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 1988, CLIN NEUROPSYCHOL, V2, P246, DOI [DOI 10.1080/13854048808520107, 10.1080/13854048808520107]; TEASDALE G, 1974, LANCET, V2, P81; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; Verster JC, 2011, INT J GEN MED, V4, P359, DOI 10.2147/IJGM.S19639; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	52	8	8	3	18	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR	2017	27	2					216	238		10.1080/09602011.2015.1077145			23	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	EK4CD	WOS:000393873800003	26299758	Green Accepted			2022-02-06	
J	Dumke, HA				Dumke, Heike Andrea			Posttraumatic Headache and Its Impact on Return to Work After Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; craniocerebral trauma; employment; head injury; mild traumatic brain injury; headache; prognosis; rehabilitation; return to work; work	NEUROPSYCHOLOGICAL STATUS RBANS; PAIN RATING-SCALE; LOGISTIC-REGRESSION; REPEATABLE BATTERY; NUMERIC PAIN; PERFORMANCE; CONCUSSION; VALIDITY; QUESTIONNAIRE; DEPRESSION	Objective: To examine the value of posttraumatic headaches in predicting return to work (RTW) in patients with mild traumatic brain injury (MTBI). Setting and Participants: A total of 109 participants recruited from an outpatient head injury rehabilitation center, British Columbia, Canada. Design: Logistic regression analyses of secondary data. Main Measure: The Numerical Pain Rating Scale (NPRS), measure of headache intensity. Nine resulting NPRS scores were used to predict successful versus unsuccessful RTW. Results: The largest effect size [odds ratio Exp(B)] value of 0.474] indicated that the odds of returning to work successfully are more than cut in half for each unit increase in NPRS rating. Conclusion: To the author's knowledge, this is the first study of the impact of headache intensity on RTW for patients withMTBI. Posttraumatic headache severity after MTBI should be taken into account when developing models to predict RTW for this population. Headache intensity may act as a confounding variable for at least some injury characteristics (eg, cognitive functioning) and may add to the inconsistencies in the TBI and MTBI literature. Results may be utilized to guide rehabilitation efforts in planning RTW for patients with MTBI.	[Dumke, Heike Andrea] HeadWise Rehabil Inc, 7525 King George, Surrey, BC V3W 5A8, Canada; [Dumke, Heike Andrea] Univ British Columbia, Fac Med, Vancouver, BC, Canada		Dumke, HA (corresponding author), HeadWise Rehabil Inc, 7525 King George, Surrey, BC V3W 5A8, Canada.	dumke@alumni.ubc.ca		Dumke, Heike A./0000-0002-0050-2962	HeadWise Rehabilitation Inc	The author acknowledges the support of HeadWise Rehabilitation Inc for this study. The author thanks all the reviewers for their helpful comments on earlier versions of this article, including Dr Hendre Viljoen for bringing up the idea of investigating the impact of posttraumatic headache on return towork, Dr Sylvia Nay for reviewing the initial paper, and Yan Lim for statistical assistance. Lastly, I acknowledge my graduate supervisor, Dr Stuart Ross, and committee at Newman University College (now Newman University Birmingham) for supporting me in completing my MSc thesis, which forms the basis of this article.	Andary MT, 1997, CLIN J PAIN, V13, P244, DOI 10.1097/00002508-199709000-00010; Austin PC, 2017, STAT METHODS MED RES, V26, P796, DOI 10.1177/0962280214558972; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chao-Ying Joanne Peng, 2002, Understanding Statistics, V1, P31; Cheung GW, 2008, ORGAN RES METHODS, V11, P296, DOI 10.1177/1094428107300343; Childs JD, 2005, SPINE, V30, P1331, DOI 10.1097/01.brs.0000164099.92112.29; Cleland JA, 2008, ARCH PHYS MED REHAB, V89, P69, DOI 10.1016/j.apmr.2007.08.126; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; David Howell, 2002, STAT METHODS PSYCHOL; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Ezrachi O, 1992, NEUROPSYCHOLOGY, V6, P371; Fayers P., 2007, QUALITY LIFE ASSESSM, V2; Field A., 2009, DISCOVERING STAT USI, V3rd ed; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Hobart MP, 1999, AM J PSYCHIAT, V156, P1951; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; IBM Corporation, 2013, IBM SPSS STAT WINDOW; Iverson GL, 2004, PSYCHOL REP, V95, P1241, DOI 10.2466/pr0.95.3f.1241-1247; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2002, PSYCHOL REP, V90, P1091, DOI 10.2466/PR0.90.4.1091-1096; Iverson GL, 2004, STUD NEUROPSYCHOL DE, P323; Iverson GL, 2003, J COGN REHABIL   SUM, P28; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Jensen MP, 1999, PAIN, V83, P157, DOI 10.1016/S0304-3959(99)00101-3; JENSEN MP, 1994, PAIN, V58, P387, DOI 10.1016/0304-3959(94)90133-3; Kahl C, 2005, PHYS THER REV, V10, P123, DOI 10.1179/108331905X55776; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lara-Munoz C, 2004, ARCH MED RES, V35, P43, DOI 10.1016/j.arcmed.2003.07.007; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McCaffery M, 1989, PAIN CLIN MANUAL NUR; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; Meares S, 2015, ARCH PHYS MED REHAB, V96, P956, DOI 10.1016/j.apmr.2014.12.014; Monteith TS, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-013-0428-2; O'Bryant SE, 2004, ARCH CLIN NEUROPSYCH, V19, P489, DOI 10.1016/j.acn.2003.07.001; Ontario Neurotrauma Foundation, 2013, GUID MILD TRAUM BRAI, P1, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Packard RC, 2008, CURR PAIN HEADACHE R, V12, P67, DOI 10.1007/s11916-008-0013-6; Pallant J.F., 2007, SPSS SURVIVAL MANUAL; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; PRESS SJ, 1978, J AM STAT ASSOC, V73, P699, DOI 10.2307/2286261; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Reed D, 2011, NSW MINIST HEAL GUID, V2, P1; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Soureshjani M, 2012, AFR J BUS MANAGE, V7, P1414, DOI [10.5897/AJBM11.394, DOI 10.5897/AJBM11.394]; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; TZELGOV J, 1991, PSYCHOL BULL, V109, P524, DOI 10.1037/0033-2909.109.3.524; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Wegener ST, 2011, PAIN, V152, P1349, DOI 10.1016/j.pain.2011.02.020; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	75	8	8	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2017	32	2					E55	E65		10.1097/HTR.0000000000000244			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EN3YU	WOS:000395944700007	27323219				2022-02-06	
J	Grover, F; Weston, J; Weston, M				Grover, Fred, Jr.; Weston, Jon; Weston, Michael			Acute Effects of Near Infrared Light Therapy on Brain State in Healthy Subjects as Quantified by qEEG Measures	PHOTOMEDICINE AND LASER SURGERY			English	Article						brain stimulation; concussion; LED light therapy; light therapy; near infrared light; traumatic brain injury	CEREBRAL-BLOOD-FLOW; NITRIC-OXIDE; CONCUSSION; INJURY; PERMEABILITY; INCREASE; LASER	Objective: Recent investigation suggests that near infrared (NIR) light may improve symptoms from mild traumatic brain injury. In addition, quantitative electroencephalography (qEEG) has shown measures correlating with concussion: P300, reaction time, and amplitude. The objective of this study was to determine whether NIR light treatment has an acute effect on brain state in healthy patients as measured by EEG. Methods: A total of 31 healthy volunteers, between the ages of 14 and 65, underwent qEEG event-related response tests before and after a 20-min NIR light head treatment. The treatment device is composed of 784 NIR GaAIAs LEDs covering 360cm(2) on the head in a cap covering occipital, left temporal, right temporal frontal, and parietal lobes. The fluence rate was 1J/cm(2)<bold>min for a power density of </bold>16.67mW/cm(2). Peak spectral wavelength at steady-state temperature (42.2 degrees C) is 903nm. The device delivered a total dose of 20J/cm(2). Two to four months later, 18 subjects returned for a second round of qEEG measurements, with a 20-min rest period in place of the NIR light treatment as a control arm. Results: Change in reaction time significantly differed between treated and control, with a mean of 23.8msec improvement compared with controls (p=0.035). Amplitude increased an average of 0.81V in treatment versus 0.22V in controls and did not reach significance. However, subanalysis of 14 treated subjects and 8 controls displaying initially low amplitude showed a mean increase in amplitude of 1.83V (30%) in treated subjects versus 0V in controls (p=0.08). P300 measures did not show significant differences between groups. Conclusions: The data suggest that NIR light may have an acute effect on reaction time and amplitude in certain subject subsets. There were no adverse events registered across the 31 subjects in the treatment group, nor in the 18 evaluable control group subjects.	[Grover, Fred, Jr.] Univ Colorado, Revolutionary MD, Denver, CO 80202 USA; [Weston, Jon] BioCare Syst Inc, 10940 S Parker Rd,Suite 107, Parker, CO 80134 USA; [Weston, Michael] Northwestern Univ, BioCare Syst Inc, Evanston, IL USA		Weston, J (corresponding author), BioCare Syst Inc, 10940 S Parker Rd,Suite 107, Parker, CO 80134 USA.	jweston@biocaresystems.com					Agrawal D, 2005, J NEUROSURG, V102, P167, DOI 10.3171/jns.2005.102.2.0167; Ances BM, 2004, J CEREBR BLOOD F MET, V24, P1, DOI 10.1097/01.WCB.0000103920.96801.12; Belletti S, 2015, LASER MED SCI, V30, P375, DOI 10.1007/s10103-014-1651-z; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; CHANCE B, 1988, P NATL ACAD SCI USA, V85, P4971, DOI 10.1073/pnas.85.14.4971; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; DUNCAN A, 1995, PHYS MED BIOL, V40, P295, DOI 10.1088/0031-9155/40/2/007; Gerberding JL, 2015, REP C MILD TRAUM BRA; Giza CC, 2001, J ATHL TRAINING, V36, P228; Ingber L, 2014, J THEOR BIOL, V343, P138, DOI 10.1016/j.jtbi.2013.11.002; JULIAN FJ, 1962, J GEN PHYSIOL, V46, P297, DOI 10.1085/jgp.46.2.297; KARU T, 1989, Journal of Photochemistry and Photobiology B Biology, V3, P638, DOI 10.1016/1011-1344(89)80088-0; Kendric CS, 1991, LASER THERAPY, V3, P19; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lohr NL, 2009, J MOL CELL CARDIOL, V47, P256, DOI 10.1016/j.yjmcc.2009.03.009; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Nawashiro H, 2012, PHOTOMED LASER SURG, V30, P231, DOI 10.1089/pho.2011.3044; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Povlishock JT, 1996, ACT NEUR S, V66, P81; Radegran G, 1999, AM J PHYSIOL-HEART C, V276, pH1951, DOI 10.1152/ajpheart.1999.276.6.H1951; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; SMITH KC, 1969, MOL PHOTOBIOLOGY INA, P179; Tanielian T, 2008, INVISIBLE WOUNDS WAR, P13; Uozumi Y, 2010, LASER SURG MED, V42, P566, DOI 10.1002/lsm.20938; VILLRINGER A, 1995, CEREBROVAS BRAIN MET, V7, P240; Wecksler S, 2004, J AM CHEM SOC, V126, P13566, DOI 10.1021/ja045710+; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454	30	8	8	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1549-5418	1557-8550		PHOTOMED LASER SURG	Photomed. Laser Surg.	MAR	2017	35	3					136	141		10.1089/pho.2015.4036			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	EM8OK	WOS:000395570600003	27855264				2022-02-06	
J	Ha, AY; Mangham, W; Frommer, SA; Choi, D; Klinge, P; Taylor, HO; Oyelese, AA; Sullivan, SR				Ha, Austin Y.; Mangham, William; Frommer, Sarah A.; Choi, David; Klinge, Petra; Taylor, Helena O.; Oyelese, Adetokunbo A.; Sullivan, Stephen R.			Interdisciplinary Management of Minimally Displaced Orbital Roof Fractures: Delayed Pulsatile Exophthalmos and Orbital Encephalocele	CRANIOMAXILLOFACIAL TRAUMA & RECONSTRUCTION			English	Article						orbital roof fractures; orbital encephalocele; pulsatile exophthalmos; management algorithm	FISTULAS	Traumatic orbital roof fractures are rare and are managed nonoperatively inmost cases. They are typically associated with severe mechanisms of injury and may be associated with significant neurologic or ophthalmologic compromise including traumatic brain injury and vision loss. Rarely, traumatic encephalocele or pulsatile exophthalmos may be present at the time of injury or develop in delayed fashion, necessitating close observation of these patients. In this article, we describe two patients with minimally displaced blow-in type orbital roof fractures that were later complicated by orbital encephalocele and pulsatile exophthalmos, prompting urgent surgical intervention. We also suggest a management algorithm for adult patients with orbital roof fractures, emphasizing careful observation and interdisciplinary management involving plastic surgery, neurosurgery, and ophthalmology.	[Ha, Austin Y.] Brown Univ, Warren Alpert Med Sch, Div Plast & Reconstruct Surg, Providence, RI 02912 USA; [Mangham, William] Brown Univ, Warren Alpert Med Sch, Dept Neurosurg, Providence, RI 02912 USA; [Frommer, Sarah A.] Rhode Isl Hosp, Dept Plast & Reconstruct Surg, Providence, RI USA; [Choi, David; Klinge, Petra; Oyelese, Adetokunbo A.] Rhode Isl Hosp, Dept Neurosurg, Providence, RI USA; [Taylor, Helena O.; Sullivan, Stephen R.] Mt Auburn Hosp, Div Plast & Reconstruct Surg, Cambridge, MA 02138 USA		Sullivan, SR (corresponding author), Mt Auburn Hosp, Div Plast & Reconstruct Surg, Cambridge, MA 02138 USA.	srsulliv@mah.harvard.edu	Ha, Austin/K-5683-2019	Ha, Austin/0000-0001-7113-1903			Antonelli V, 2002, SURG NEUROL, V57, P117, DOI 10.1016/S0090-3019(01)00667-X; ANTONYSHYN O, 1989, PLAST RECONSTR SURG, V84, P10, DOI 10.1097/00006534-198907000-00002; Ashrafian H, 2006, INT J CARDIOL, V107, P421, DOI 10.1016/j.ijcard.2005.01.060; BOLLING JP, 1987, ANN OPHTHALMOL, V19, P75; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cossman JP, 2014, PLAST RECONSTR SURG, V133, p335E, DOI 10.1097/01.prs.0000438051.36881.e0; Dale EL, 2014, ANN PLAS SURG, V72, pS107, DOI 10.1097/SAP.0000000000000090; Ding D, 2014, J CLIN NEUROSCI, V21, P522, DOI 10.1016/j.jocn.2013.05.006; Fulcher TP, 2003, OPHTHALMIC PLAST REC, V19, P359, DOI 10.1097/01.IOP.0000083646.20672.6B; Haug RH, 2002, ORAL SURG ORAL MED O, V93, P238, DOI 10.1067/moe.2002.120975; Jaiswal M, 2013, J NEUROSCI RURAL PRA, V4, P467, DOI 10.4103/0976-3147.120209; Kim JW, 2012, ARCH PLAST SURG-APS, V39, P31, DOI 10.5999/aps.2012.39.1.31; Lee Huey-Jen, 2004, Emerg Radiol, V10, P168, DOI 10.1007/s10140-003-0282-7; LEWIS AI, 1995, NEUROSURGERY, V36, P239, DOI 10.1227/00006123-199502000-00001; Liang Wen, 2007, J Trauma, V63, P1014; Martello JY, 1997, ANN PLAS SURG, V38, P223, DOI 10.1097/00000637-199703000-00006; Mokal NJ, 2012, CRANIOMAX TRAUM REC, V5, P11, DOI 10.1055/s-0031-1300958; Park Eun Suk, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P251, DOI 10.7461/jcen.2013.15.3.251; PENFOLD CN, 1992, BRIT J ORAL MAX SURG, V30, P97, DOI 10.1016/0266-4356(92)90078-W; PIOTROWSKI WP, 1995, J CRANIO MAXILL SURG, V23, P6, DOI 10.1016/S1010-5182(05)80247-1; Righi S, 2015, ORAL MAXILLOFAC SURG, V19, P1, DOI 10.1007/s10006-015-0482-9; Scholsem M, 2008, NEUROSURGERY, V62, P463, DOI [10.1227/01.NEU.0000297037.51609.07, 10.1227/01.neu.0000316014.97926.82, 10.1227/01.neu.0000325884.05871.aa]; Stam LHM, 2014, CRANIOMAX TRAUM REC, V7, P294, DOI 10.1055/s-0034-1378188; SULLIVAN WG, 1991, PLAST RECONSTR SURG, V87, P657, DOI 10.1097/00006534-199104000-00008	25	8	8	0	4	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	1943-3875	1943-3883		CRANIOMAX TRAUM REC	Craniomaxillofacial Trauma Reconstr.	MAR	2017	10	1					11	15		10.1055/s-0036-1584395			5	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	EQ4WD	WOS:000398080400002	28210402	Green Published			2022-02-06	
J	Hode, L; Madougou, S; Fatigba, HO; Hounnou, P; Ebassa, K; Moevi, AAH; Assouto, P				Hode, Luphin; Madougou, Soumaila; Fatigba, Holden O.; Hounnou, Phileas; Ebassa, Karl; Moevi, A. Aristote Hans; Assouto, Pamphile			The Direct Cost of Treatment of Traumatic Brain Injury in a Sub-Saharan African Country (Benin)	WORLD NEUROSURGERY			English	Article						Africa; Benin; Cost; Traumatic brain injury		OBJECTIVES: This is the first socioeconomic study on traumatic brain injury (TBI) undertaken to determine the sociodemographic factors implicated in the occurrence of TBI and to assess the value of the direct cost of the management of TBI at the initial phase in the Hubert Koutoukou Maga National Teaching Hospital of Cotonou. METHODS: This was a prospective study with descriptive and analytic aim that took place from January 1 to July 31, 2014. An individual approach of each patient's expenditure was undertaken via the use of a questionnaire on which all expenses were identified systematically. The dependent variable was the global direct cost of care. The independent variables were the type of accident, severity of the TBI, the structures of care, the stay in the resuscitation unit, the duration of hospitalization. RESULTS: There were 297 patients with TBI: 258 men (86.9%) and 39 women (13.1%), with a sex ratio of 6.61. The average age of patients was 34.3 +/- 12.39 years. The average direct cost of care for TBI was is an element of 285.67 +/- 310.15. The average cost for severe TBI was is an element of 522.08 +/- 439.91 versus is an element of 188.19 +/- 164.83 for mild TBI (odds ratio 5.52; standard deviation: 0.0527-0.6222). The average cost was increased significantly more when the patients went through a peripheral hospital (odds ratio 3.65; standard deviation: 1.819-7.3245). CONCLUSIONS: The organization of Benin's health system did not allow for the optimum management of TBI. It seems imperative to develop an insurance system that will allow a proper and effective support for victims of traffic accidents.	[Hode, Luphin; Assouto, Pamphile] Hubert Koutoukou Maga Natl Teaching Hosp, Emergency Unit Ward, Cotonou, Benin; [Madougou, Soumaila; Hounnou, Phileas; Moevi, A. Aristote Hans] Hubert Koutoukou Maga Natl Teaching Hosp, Traumatol & Orthopaedy Unit, Cotonou, Benin; [Fatigba, Holden O.] Univ Hosp Ctr Parakou, Neurosurg Unit, Parakou, Benin; [Ebassa, Karl] Hubert Koutoukou Maga Natl Teaching Hosp Cotonou, Paediat Surg Unit, Cotonou, Benin		Hode, L (corresponding author), Hubert Koutoukou Maga Natl Teaching Hosp, Emergency Unit Ward, Cotonou, Benin.	luphin@gmail.com					Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Emejulu J K C, 2008, Afr J Med Med Sci, V37, P383; Fatigba HO, 2013, WORLD NEUROSURG, V80, P246, DOI 10.1016/j.wneu.2011.09.016; Fatigba OH, 2010, AFR J NEUROL SCI, V20; Fatigba Olatoundji Holden, 2011, Tunis Med, V89, P837; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gnonlonfoun DD, 2013, WORLD J NEUROSCI, V3, P287; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Institut National de la Statistique et de l'Analyse Economique, TABL BORD SOC 2012, V1; Masson F, 2000, ANN FR ANESTH, V19, P261; Mathe JF, 2005, ANN FR ANESTH, V24, P688, DOI 10.1016/j.annfar.2005.03.029; Meyer AA, 1998, J TRAUMA, V44, P1, DOI 10.1097/00005373-199801000-00001; World Bank, 2014, BEN COUNTR GLANC	14	8	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2017	99						210	213		10.1016/j.wneu.2016.11.083			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EP2CH	WOS:000397190100032	27916720				2022-02-06	
J	Honan, CA; Allen, SK; Fisher, A; Osborne-Crowley, K; McDonald, S				Honan, Cynthia A.; Allen, Samantha K.; Fisher, Alana; Osborne-Crowley, Katherine; McDonald, Skye			Social Disinhibition: Piloting a New Clinical Measure in Individuals with Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						social cognition; traumatic brain injury; social disinhibition; theory of mind	BARRATT IMPULSIVENESS SCALE; EXECUTIVE FUNCTION; HEAD-INJURY; NEUROPSYCHIATRIC INVENTORY; EMOTION RECOGNITION; MIND; DEFICITS; AWARENESS; BEHAVIOR; REHABILITATION	Social disinhibition difficulties are common following traumatic brain injury (TBI). However, clinically sensitive tools to objectively assess the difficulties are lacking. This study aimed to pilot a new clinical measure of social disinhibition, the social disinhibition task (SDT). Whether social disinhibition is dependent on the type of social information judgements required and whether disinhibited responses can be adjusted with additional guidance were also examined. Participants were 31 adults (25 Male) with moderate-to-severe TBI and 22 adult (17 Male) healthy control participants. Participants viewed scenes of complex social situations and were asked to describe a character in them (Part A), describe a character while inhibiting inappropriate or negative responses (Part B), and describe a character while not only inhibiting negative responses, but also providing positive responses (Part C). One-half of the items contained a faux pas requiring participants to make inferences about a character'smental state. TBI and control participants responded similarly to Part A, although control participants responded less positively than TBI participants in the faux pas items. TBI participants were significantly impaired on Part B indicating they experienced difficulties in inhibiting automatic responding. TBI participants were however able to adjust their responding in Part C so that they respond similarly to the control participants. Between group differences were not detected in reaction time. Overall, the SDT appears to be suitable to detect social inhibition difficulties in clinical settings and provides a new direction for remediation of the difficulties in individuals with TBI.	[Honan, Cynthia A.] Univ Tasmania, Sch Med, Dept Psychol, Launceston, Tas, Australia; [Allen, Samantha K.] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia; [Fisher, Alana] Univ Sydney, Sch Psychol, Ctr Med Psychol & Evidence Based Decis Making CeM, Sydney, NSW, Australia; [Osborne-Crowley, Katherine; McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Honan, Cynthia A.; McDonald, Skye] Moving Ahead NHMRC Ctr Res Excellence Brain Recov, Sydney, NSW, Australia		Honan, CA (corresponding author), Univ Tasmania, Sch Med, Dept Psychol, Launceston, Tas, Australia.; Honan, CA (corresponding author), Moving Ahead NHMRC Ctr Res Excellence Brain Recov, Sydney, NSW, Australia.	cynthia.honan@utas.edu.au	Fisher, Alana/T-1869-2019; Honan, Cynthia/O-6332-2017	Fisher, Alana/0000-0002-6027-659X; Honan, Cynthia/0000-0001-5735-4270; Osborne-Crowley, Katherine/0000-0003-0295-1849	University of New South Wales Science Faculty Early Career Research Grant	This research was funded by a University of New South Wales Science Faculty Early Career Research Grant.	Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Barrett RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076916; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Benton AL, 1994, MULTILINGUAL APHASIA; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Brownell H, 1988, RIGHT HEMISPHERE LAN, P309; Burgess P.W., 1997, HAYLING BRIXTON TEST; Monsalve BC, 2012, REV PSIQUIATR SALUD, V5, P160, DOI 10.1016/j.rpsm.2012.02.004; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Cohen J., 2013, STAT POWER ANAL BEHA; Conners C. K., 2000, CONNERS CONTINUOUS P; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; ELSASS L, 1989, P 14 ANN BRAIN IMP C; Enders CK, 2011, REHABIL PSYCHOL, V56, P267, DOI 10.1037/a0025579; Grace J., 2001, FRSE FRONTAL SYSTEMS; Greve KW, 2001, BRAIN INJURY, V15, P255; Honan CA, 2016, CLIN NEUROPSYCHOL, V30, P243, DOI 10.1080/13854046.2015.1136691; Honan CA, 2015, BRAIN LANG, V150, P69, DOI 10.1016/j.bandl.2015.08.007; Hooker CI, 2006, ORBITOFRONTAL CORTEX, P307, DOI [DOI 10.1093/ACPROF:OSO/9780198565741.003.0012, 10.1093/acprof:oso/9780198565741.001.0001/acprof-9780198565741-chapter-12]; Kilmer RP, 2006, REHABIL PSYCHOL, V51, P232, DOI 10.1037/0090-5550.51.3.232; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Knutson KM, 2015, J NEUROPSYCH CLIN N, V27, P193, DOI 10.1176/appi.neuropsych.14060126; Lee TMC, 2010, NEUROPSYCHOLOGIA, V48, P1670, DOI 10.1016/j.neuropsychologia.2010.02.012; LOVIBOND PF, 1995, MANUAL DEPRESSION AN; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S., 2011, AWARENESS SOCIAL INF; McDonald S., 2013, SOCIAL COMMUNICATION, P119; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Ochsner KN, 2001, AM PSYCHOL, V56, P717, DOI 10.1037//0003-066X.56.9.717; Osborne-Crowley K, 2016, J CLIN EXP NEUROPSYC, V38, P341, DOI 10.1080/13803395.2015.1115824; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Reitan RM, 1992, TRAIL MAKING TEST; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Trenerry MR, 1989, PSYCHOL ASSESSMENT R; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	56	8	8	0	7	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAR	2017	18	1					74	87		10.1017/BrImp.2016.27			14	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	EQ3SZ	WOS:000397994400007		Bronze, Green Submitted			2022-02-06	
J	Kong, V; Odendaal, J; Sartorius, B; Clarke, D; Brysiewicz, P; Jerome, E; Bruce, J; Laing, G				Kong, Victor; Odendaal, Jocinta; Sartorius, Benn; Clarke, Damian; Brysiewicz, Petra; Jerome, Ellen; Bruce, John; Laing, Grant			Civilian cerebral gunshot wounds: a South African experience	ANZ JOURNAL OF SURGERY			English	Article						cerebral; civilian; gunshot wounds; mortality; outcome disparity	HEAD; TRAUMA; BRAIN	BackgroundCerebral gunshot wounds represent one of the most lethal forms of traumatic brain injury, but there is a paucity of literature on the topic, especially from the developing world. We reviewed our experience and describe the spectrum and outcome of civilian cerebral gunshot wounds in a major metropolitan trauma centre in South Africa. MethodsThis was a retrospective study of all patients with isolated cerebral gunshot wounds managed by the Pietermaritzburg Metropolitan Trauma Service over a 5-year period from 2010 to 2014. ResultsOne hundred and two patients were included, 92% (94/102) were male and the mean age was 29 years. Fifty-four per cent (55/102) of all patients were from urban areas. The mean time from injury to arrival was 6h (standard deviation: 5) for urban patients and 15h (standard deviation: 5.2) for rural patients (P<0.001). Ninety-four per cent (94/102) of all injuries were related to interpersonal violence and involved low velocity firearms. Twenty per cent of all patients (20/102) had a Glasgow Coma Scale 3-8, 20% (20/102) 9-12 and 61% (61/102) 12-15. All 102 patients underwent computed tomography scans. Thirty per cent (31/102) required neurosurgical interventions. The overall mortality rate was 22% (22/102). There was a significant difference in mortality between urban and rural patients (9% versus 36%, P<0.001). ConclusionsCerebral gunshot wounds are associated with significant mortality and protracted delay to definitive care is common in our setting. Those who survive the delayed transfer to definitive care generally do well and have reasonably good clinical outcomes.	[Kong, Victor; Odendaal, Jocinta; Clarke, Damian; Brysiewicz, Petra; Jerome, Ellen; Bruce, John; Laing, Grant] Univ KwaZulu Natal, Dept Surg, Pietermaritzburg Metropolitan Trauma Serv, Durban, South Africa; [Sartorius, Benn] Univ KwaZulu Natal, Dept Publ Hlth Med, Coll Hlth Sci, Durban, South Africa; [Clarke, Damian] Univ Witwatersrand, Dept Surg, Johannesburg, South Africa		Kong, V (corresponding author), Nelson R Mandela Sch Med, Dept Surg, Pietermaritzburg Metropolitan Trauma Serv, 719 Umbilo Rd, ZA-4013 Durban, South Africa.	victorywkong@yahoo.com		, bennsartorius/0000-0001-6761-2325; Odendaal, Jocinta/0000-0002-5547-4831; Laing, Grant/0000-0001-8075-0386; Clarke, Damian/0000-0002-8467-1455			Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; Ambrosi PB, 2012, NEUROSURG REV, V35, P429, DOI 10.1007/s10143-012-0377-2; CAVALIERE R, 1988, ACTA NEUROCHIR, V94, P133, DOI 10.1007/BF01435866; Glapa M, 2009, AM SURGEON, V75, P223; Gomez D, 2010, J TRAUMA, V69, P633, DOI 10.1097/TA.0b013e3181b8ef81; Hardcastle TC, 2013, WORLD J SURG, V37, P1513, DOI 10.1007/s00268-012-1852-1; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P199, DOI 10.1007/BF01808959; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Lin DJ., 2012, SURG NEUROL INT, V3, P98, DOI [DOI 10.4103/2152-7806, 10.4103/2152-7806.100187, DOI 10.4103/2152-7806.100187]; Lipsky Ari M, 2014, J Emerg Trauma Shock, V7, P41, DOI 10.4103/0974-2700.125639; MUCKART DJJ, 1991, S AFR MED J, V79, P93; Murano T, 2005, AM SURGEON, V71, P1009; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; POLIN RS, 1995, NEUROSURG CLIN N AM, V6, P689; Stoffel M, 2009, ANZ J SURG, V79, P789, DOI 10.1111/j.1445-2197.2009.05096.x; STONE JL, 1995, NEUROSURGERY, V37, P1104, DOI 10.1227/00006123-199512000-00010	18	8	8	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1445-1433	1445-2197		ANZ J SURG	ANZ J. Surg.	MAR	2017	87	3					186	189		10.1111/ans.13846			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	EM5IX	WOS:000395346300019	27871133				2022-02-06	
J	McGuire, C; Kristman, VL; Martin, L; Bedard, M				McGuire, Connor; Kristman, Vicki L.; Martin, Lynn; Bedard, Michel			Characteristics and Incidence of Traumatic Brain Injury in Older Adults Using Home Care in Ontario from 2003-2013	CANADIAN GERIATRICS JOURNAL			English	Article						cohort; TBI; aged	MINIMUM DATA SET; UNITED-STATES; SOCIAL-CLASS; HEAD-INJURY; FALLS; PEOPLE; RISK; EPIDEMIOLOGY; POPULATION; AMERICAN	Objectives Describe the characteristics and determine the annual cumulative incidence of traumatic brain injury (TBI) in older adults receiving home care in Ontario from 2003 to 2013. Methods A retrospective cohort study of longitudinal data from the Ontario Association of Community Care Access Centers (N= 554,313). TBI, demographic variables, depression, neurological conditions, and recent falls were measured from the Resident Assessment Instrument-Home Care. Comparisons were made between service users with and without TBI using odds ratios. Standardized incidence rates were calculated and the 10-year trend of annual cumulative incidence rates was examined. Results Characteristics associated with TBI: male sex (OR: 1.54), aboriginal origin (OR: 1.98), increasing age (low of OR: 1.22, in 70-74 years; high of OR: 2.31, in 90 years and older; comparison 65-69 years), being widowed (OR: 1.59), having one or more falls (OR: 2.31), the use of antidepressants (OR: 1.49) and the presence of depression (OR: 1.57), dementia (OR: 1.65), hemiplegia (OR: 4.34), multiple sclerosis (OR: 3.19) or parkinsonism (OR: 1.22). TBI incidence was significantly higher than rates previously reported in the literature. There was no change in the overall annual cumulative incidence over the 10-year period (p=.13). Conclusions Certain demographic characteristics, neurological diseases, antidepressant use, and a recent fall are associated with TBI. Incidence of TBI is higher than previous estimates and the overall incidence is not changing over time. These results can be used to improve care of the elderly and to generate hypotheses for future research regarding TBI in the home care setting.	[McGuire, Connor; Kristman, Vicki L.; Martin, Lynn; Bedard, Michel] Lakehead Univ, Dept Hlth Sci, 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada; [Kristman, Vicki L.] Inst Work & Hlth, Toronto, ON, Canada; [Kristman, Vicki L.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Kristman, Vicki L.; Bedard, Michel] Lakehead Univ, Northern Ontario Sch Med, Thunder Bay, ON, Canada; [Kristman, Vicki L.; Bedard, Michel] St Josephs Care Grp, Ctr Appl Hlth Res, Thunder Bay, ON, Canada; [Bedard, Michel] Lakehead Univ, Ctr Res Safe Driving, Thunder Bay, ON, Canada		McGuire, C (corresponding author), Lakehead Univ, Dept Hlth Sci, 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada.	connor.mcguire@dal.ca			Canadian Institutes of Health Research New Investigator Award in Community-based Primary Health CareCanadian Institutes of Health Research (CIHR)	Dr. Kristman is supported by a Canadian Institutes of Health Research New Investigator Award in Community-based Primary Health Care.	Arfken CL, 2001, INT PSYCHOGERIATR, V13, P85, DOI 10.1017/S1041610201007487; Blackmer J, 1999, BRAIN INJURY, V13, P627; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burrows AB, 2000, AGE AGEING, V29, P165, DOI 10.1093/ageing/29.2.165; Carpenter I, 2004, AGING CLIN EXP RES, V16, P259; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chi I, 2006, AGING MENT HEALTH, V10, P33, DOI 10.1080/13607860500307712; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Foebel AD, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-457; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Government of Canada, 2014, TRIC POL STAT ETH CO; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; InterRAI, 2009, HOM CAR HC ASS US MA; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Landi F, 2000, MED CARE, V38, P1184, DOI 10.1097/00005650-200012000-00005; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; Morris JN, 1997, J AM GERIATR SOC, V45, P1017, DOI 10.1111/j.1532-5415.1997.tb02975.x; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Office of the Auditor General of Ontario, 2010, 2010 ANN REP; Office of the Auditor General of Ontario, 2012, 2012 ANN REP; Ontario Ministry of Health and Long-Term Care, 2006, CCAC CLIENT SERV POL; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; RUTHAZER R, 1993, AM J PUBLIC HEALTH, V83, P746, DOI 10.2105/AJPH.83.5.746; Rutland-Brown W, 2005, J HEAD TRAUMA REHAB, V20, P205, DOI 10.1097/00001199-200505000-00004; SAS Institute Inc, 2015, SAS SOFTW VERS 9 4 C; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; SYME SL, 1976, AM J EPIDEMIOL, V104, P1; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tousignant M, 2007, HEALTH SOC CARE COMM, V15, P1, DOI 10.1111/j.1365-2524.2006.00645.x; Wiese B., 2011, B C MED J, V53, P341; WINKLEBY MA, 1990, PREV MED, V19, P1, DOI 10.1016/0091-7435(90)90001-Z; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183	43	8	8	1	3	MULTIMED INC	TORONTO	66 MARTIN ST, TORONTO, ON L9T 2R2, CANADA		1925-8348		CAN GERIATR J	Can. Geriatr. J.	MAR	2017	20	1					2	9		10.5770/cgj.20.228			8	Geriatrics & Gerontology	Emerging Sources Citation Index (ESCI)	Geriatrics & Gerontology	GQ6CW	WOS:000441790800002	28396703	Green Submitted, gold, Green Published			2022-02-06	
J	Petrov, D; Uohara, MY; Ichord, R; Ali, Z; Jastrzab, L; Lang, SS; Billinghurst, L				Petrov, Dmitriy; Uohara, Michael Y.; Ichord, Rebecca; Ali, Zarina; Jastrzab, Laura; Lang, Shih-Shan; Billinghurst, Lori			Pediatric cerebral sinovenous thrombosis following cranial surgery	CHILDS NERVOUS SYSTEM			English	Article						CSVT; Pediatric stroke; Cranial surgery	VENOUS SINUS THROMBOSIS; CLOSED-HEAD INJURY; RISK-FACTORS; CHILDREN; THROMBOEMBOLISM; ANTICOAGULANTS; ASSOCIATION; PITFALLS; THERAPY; STROKE	Purpose Pediatric cerebral sinovenous thrombosis (CSVT) is an important, though less common subtype of pediatric stroke. It has been linked to several risk factors, including cranial procedures, with few studies highlighting this relationship. The aim of this study was to characterize the diagnosis and treatment of CSVT after cranial surgery. Methods An institutional pediatric stroke research database was used to identify all CSVTcases diagnosed within 30 days of cranial surgery from November 2004 to December 2014. Thirteen subjects were retrospectively analyzed for clinical presentation, surgical details, radiographic characteristics, laboratory study results, treatment, and outcome. Diagnostic testing and treatment adhered to a consensus-based institutional stroke protocol. Results Cranial vault reconstruction, subdural empyema evacuation, and tumor resection were each observed in three subjects. Eleven (85%) subjects had sinus exposure during surgery, and eight (73%) developed thrombus in a sinus within or adjacent to the operative field. Two (15%) had documented iatrogenic sinus injury. On post-operative testing, ten (77%) subjects had prothrombotic abnormalities. Seven (54%) were treated with anti-coagulation therapy (ACT) starting on a median of post-operative day (POD) 3 (IQR 1-3) for a median of 2.9 months (IQR 2.4-5.4). Median time to imaging evidence of partial or complete recanalization was 2.4 months (IQR 0.7-5.1). No symptomatic hemorrhagic complications were encountered. Conclusions Pediatric CSVT may be encountered after cranial surgery, and decisions related to anti- coagulation are challenging. The risk of CSVT should be considered in presurgical planning and post-operative evaluation of cases with known risk factors. In our study, judicious use of ACT was safe in the post-operative period.	[Petrov, Dmitriy; Ali, Zarina; Lang, Shih-Shan] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Uohara, Michael Y.] Temple Univ, Sch Med, Philadelphia, PA 19122 USA; [Ichord, Rebecca; Jastrzab, Laura; Billinghurst, Lori] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Lang, Shih-Shan] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA		Billinghurst, L (corresponding author), Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA.	billinghurstl@email.chop.edu			American Pediatric Society and Society for Pediatric Research Award	This study was supported by an American Pediatric Society and Society for Pediatric Research Award.	Athale U, 2008, PEDIATR BLOOD CANCER, V51, P792, DOI 10.1002/pbc.21734; Bracken J, 2013, PEDIATR RADIOL, V43, P219, DOI 10.1007/s00247-012-2402-6; Coutinho JM, 2015, STROKE, V46, P2735, DOI 10.1161/STROKEAHA.115.009843; deVeber G, 2001, NEW ENGL J MED, V345, P417, DOI 10.1056/NEJM200108093450604; Dlamini N, 2010, NEUROSURG CLIN N AM, V21, P511, DOI 10.1016/j.nec.2010.03.006; Erdogan B, 2004, CHILD NERV SYST, V20, P239, DOI 10.1007/s00381-003-0845-7; Hung PL, 2013, AM J THER, V20, pE726, DOI 10.1097/MJT.0b013e31822b562e; Ichord RN, 2015, ARCH DIS CHILD, V100, P174, DOI 10.1136/archdischild-2014-306382; Jensen AW, 2007, J PEDIAT HEMATOL ONC, V29, P156, DOI 10.1097/MPH.0b013e3180377b9c; Leach JL, 2006, RADIOGRAPHICS, V26, pS19, DOI 10.1148/rg.26si055174; Martinuzzo ME, 2014, INT J LAB HEMATOL, V36, P144, DOI 10.1111/ijlh.12138; Matsushige T, 2009, J TRAUMA, V66, P1599, DOI 10.1097/TA.0b013e3181a3a8e6; Moharir MD, 2010, ANN NEUROL, V67, P590, DOI 10.1002/ana.21936; Monagle P, 2012, CHEST, V141, pE737S, DOI 10.1378/chest.11-2308; Roach ES, 2008, STROKE, V39, P2644, DOI 10.1161/STROKEAHA.108.189696; Sebire G, 2005, BRAIN, V128, P477, DOI 10.1093/brain/awh412; Shroff M, 2003, NEUROIMAG CLIN N AM, V13, P115, DOI 10.1016/S1052-5149(02)00064-3; Tabori U, 2004, PEDIATR BLOOD CANCER, V43, P633, DOI 10.1002/pbc.20149; Vieira JP, 2010, EUR J PAEDIATR NEURO, V14, P80, DOI 10.1016/j.ejpn.2008.12.004; Xavier F, 2014, PEDIATR BLOOD CANCER, V61, P2037, DOI 10.1002/pbc.25168	20	8	8	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2017	33	3					491	497		10.1007/s00381-016-3329-2			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	EQ4JB	WOS:000398041500015	28091816				2022-02-06	
J	Tchantchou, F; Fourney, WL; Leiste, UH; Vaughan, J; Rangghran, P; Puche, A; Fiskum, G				Tchantchou, Flaubert; Fourney, William L.; Leiste, Ulrich H.; Vaughan, Joshua; Rangghran, Parisa; Puche, Adam; Fiskum, Gary			Neuropathology and neurobehavioral alterations in a rat model of traumatic brain injury to occupants of vehicles targeted by underbody blasts	EXPERIMENTAL NEUROLOGY			English	Article						Acceleration; Apoptosis; Inflammation; Anxiety; Synapse	IMPROVES FUNCTIONAL RECOVERY; VON-WILLEBRAND-FACTOR; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; OXIDATIVE STRESS; MOUSE MODEL; INFLAMMATION; NEUROTRAUMA; PATHOPHYSIOLOGY; CONCUSSION	Many victims of blast-induced traumatic brain injury are occupants of military vehicles targeted by land mines. Recently improved vehicle designs protect these individuals against blast overpressure, leaving acceleration as the main force potentially responsible for brain injury. We recently developed a unique rat model of under-vehicle blast-induced hyperacceleration where exposure to acceleration as low as 50G force results in histopathological evidence of diffuse axonal injury and astrocyte activation, with no evidence of neuronal cell death. This study investigated the effects of much higher blast-induced accelerations (1200 to 2800G) on neuronal cell death, neuro-inflammation, behavioral deficits and mortality. Adult male rats were subjected to this range of accelerations, in the absence of exposure to blast overpressure, and evaluated over 28 days for working memory (Y maze) and anxiety (elevated plus maze). In addition, brains obtained from rats at one and seven days post-injury were used for neuropathology and neurochemical assays. Sixty seven percent of rats died soon after being subjected to blasts resulting in 2800G acceleration. All rats exposed to 2400G acceleration survived and exhibited transient deficits in working memory and long-term anxiety like behaviors, while those exposed to 1200 acceleration G force only demonstrated increased anxiety. Behavioral deficits were associated with acute microglia/macrophage activation, increased hippocampal neuronal death, and reduced levels of tight junction-and synapse-associated proteins. Taken together, these results suggest that exposure of rats to high underbody blast-induced G forces results in neurologic injury accompanied by neuronal apoptosis, neuroinflammation and evidence for neurosynaptic alterations. (C) 2016 Elsevier Inc. All rights reserved.	[Tchantchou, Flaubert; Vaughan, Joshua; Rangghran, Parisa; Fiskum, Gary] Univ Maryland, Sch Med, Dept Anesthesiol, Ctr Shock Trauma & Anesthesiol Res STAR, 685 W Baltimore St, Baltimore, MD 21201 USA; [Fourney, William L.; Leiste, Ulrich H.] Univ Maryland, Sch Engn, Dept Aerosp Engn, 1131 Glenn L Martin Hall, College Pk, MD 20742 USA; [Puche, Adam] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Hlth Sci Facil 2,Room 255, Baltimore, MD 21201 USA		Fiskum, G (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Ctr Shock Trauma & Anesthesiol Res STAR, 685 W Baltimore St, Baltimore, MD 21201 USA.	ftchantchou@anes.umm.edu; four@umd.edu; uleiste@umd.edu; vaughan1009@gmail.com; prangghran@anes.umm.edu; apuche@umaryland.edu; gflskum@anes.umm.edu			U.S. Department of DefenseUnited States Department of Defense [W81-xWH-13-1-0016]; U.S. Air Force Medical Service [FA8650-11-2-6D04]	This research was supported by grants from the U.S. Department of Defense (W81-xWH-13-1-0016) and from the U.S. Air Force Medical Service (FA8650-11-2-6D04).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Adachi M, 2009, PLOS ONE, V4, pA57, DOI 10.1371/journal.pone.0007719; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chen Y, 2013, J NEUROPSYCH CLIN N, V25, P103, DOI 10.1176/appi.neuropsych.12030058; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; De Oliveira CO, 2007, J NEUROTRAUM, V24, P1331, DOI 10.1089/neu.2006.0159; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Foley LM, 2008, J NEUROTRAUM, V25, P299, DOI 10.1089/neu.2007.0471; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Goldstein LE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0064-3; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Jaffee CMS, 2009, CLIN NEUROPSYCHOL, V23, P1291, DOI 10.1080/13854040903307250; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kim N, 2015, NEUROSCIENCE, V284, P912, DOI 10.1016/j.neuroscience.2014.11.010; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; Maurice T, 2009, NEUROBIOL AGING, V30, P987, DOI 10.1016/j.neurobiolaging.2007.09.006; Mellor S G, 1988, Br J Hosp Med, V39, P536; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Proctor JL, 2014, J TRAUMA ACUTE CARE, V77, pS83, DOI 10.1097/TA.0000000000000340; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schultz BA, 2011, NEUROREHABILITATION, V28, P309, DOI 10.3233/NRE-2011-0659; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Stancu IC, 2014, FASEB J, V28, P2620, DOI 10.1096/fj.13-246702; Tchantchou F., 2013, J NEUROTRAUMA; Tchantchou F, 2007, FASEB J, V21, P2400, DOI 10.1096/fj.06-7649com; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Valiyaveettil M, 2013, NEUROSCI LETT, V539, P1, DOI 10.1016/j.neulet.2013.01.028; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Walls MK, 2015, J NEUROSURG, P1; Yokota H, 2002, J NEUROTRAUM, V19, P1007, DOI 10.1089/089771502760341929; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488; Zhao X, 2013, INT J IMPACT ENG, V54, P31, DOI 10.1016/j.ijimpeng.2012.10.016	58	8	8	1	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2017	289						9	20		10.1016/j.expneurol.2016.12.001			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ9JF	WOS:000393541700002	27923561	Bronze			2022-02-06	
J	Jussen, D; Krenzlin, H; Papaioannou, C; Ens, S; Kempski, O; Alessandri, B				Jussen, Daniel; Krenzlin, Harald; Papaioannou, Chrysostomos; Ens, Swetlana; Kempski, Oliver; Alessandri, Beat			Blood Aggravates Histological and Functional Damage after Acute Subdural Hematoma in Rats	JOURNAL OF NEUROTRAUMA			English	Article						behavior; controlled cortical impact; intracranial pressure; rat; traumatic brain injury	BRAIN-BARRIER PERMEABILITY; INTRACEREBRAL HEMORRHAGE; EDEMA FORMATION; SUBARACHNOID HEMORRHAGE; NEUROLOGICAL DEFICITS; SURGICAL EVACUATION; THROMBIN RECEPTORS; EPIDURAL HEMATOMA; ISCHEMIC DAMAGE; INJURY	Acute subdural hematoma (ASDH) is associated with high morbidity and mortality. Whether the volume effect of the hematoma and increase of intracranial pressure (ICP) or the local effect of blood are responsible for this severe pathophysiology is unclear. Therefore, we compared subdural infusion of autologous blood and paraffin oil in a rat model of ASDH. In a histological study, we investigated the effects on acute ICP, cerebral perfusion pressure (CPP), cerebral blood flow (CBF), tissue oxygen changes, and brain damage at 2, 24, and 96 h post-infusion. Inflammatory reaction was analyzed by immuno-staining for microglia (ionized calcium binding adaptor molecule 1 [Iba1]) and activated astrocytes (glial fibrillary acidic protein [GFAP]). Besides acute ICP and CBF changes, we investigated the development of behavior (neuroscore and beamwalk test) for up to 4 days after injury in a behavioral study. Despite comparably increased ICP, there was a more pronounced lesion growth in the blood infusion group during the first 96 h. Further, there was an increased perilesional immunoreactive area of Iba1 and GFAP 96 h post-infusion, primarily in the blood infusion group, whereas hippocampal damage was comparable in both infusion groups. In the behavioral evaluation, paraffin-infused animals showed a better recovery, compared with the blood infusion group. In conclusion, comparable acute time-course of ICP, CPP, and CBF clearly indicates that the differences in lesion size, inflammatory reaction, and behavioral deficits after blood-and paraffin oil-induced ASDH are partially due to blood constituents. Therefore, current data suggest that subdural hematomas should be completely removed as quickly as possible; decompression alone may not be sufficient to prevent secondary brain damage.	[Jussen, Daniel; Krenzlin, Harald] HELIOS Dr Horst Schmidt Kliniken, Dept Neurosurg, D-65199 Wiesbaden, Germany; [Jussen, Daniel; Krenzlin, Harald; Papaioannou, Chrysostomos; Ens, Swetlana; Kempski, Oliver; Alessandri, Beat] Univ Med Ctr Mainz, Inst Neurosurg Pathophysiol, Mainz, Germany		Jussen, D (corresponding author), HELIOS Dr Horst Schmidt Kliniken, Dept Neurosurg, D-65199 Wiesbaden, Germany.	daniel.jussen@helios-kliniken.de	Krenzlin, Harald/AAS-7602-2020; Krenzlin, Harald/AAM-5444-2020		Deutsche Forschungsgesellschaft (DFG)German Research Foundation (DFG) [KE338/6-1]	The study was supported by Deutsche Forschungsgesellschaft (DFG) grant KE338/6-1. Data are part of doctoral thesis of CP and SE. We thank A. Ehlert, B. Koehler, and M. Malzahn for their excellent technical assistance.	Alessandri B, 2006, BRAIN RES, V1111, P196, DOI 10.1016/j.brainres.2006.06.105; Alessandri B., 2012, ACTA NEUROCHIR, P373; Baechli H, 2010, J CEREBR BLOOD F MET, V30, P576, DOI 10.1038/jcbfm.2009.230; Balikci M, 2008, NEUROL RES, V30, P450, DOI 10.1179/016164107X251637; Bhasin RR, 2002, ACTA NEUROCHIR SUPPL, V81, P249; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; DUHAIME AC, 1994, J NEUROTRAUM, V11, P669, DOI 10.1089/neu.1994.11.669; Fujimoto S, 2007, NEUROSCIENCE, V144, P694, DOI 10.1016/j.neuroscience.2006.09.049; Fujimoto S, 2006, NEUROBIOL DIS, V22, P130, DOI 10.1016/j.nbd.2005.10.008; FUJISAWA H, 1994, ACT NEUR S, V60, P193; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Gong Y, 2005, ACT NEUR S, V95, P389; Guo FY, 2012, TRANSL STROKE RES, V3, P130, DOI 10.1007/s12975-011-0106-0; Hellewell SC, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/356494; Isaeva E, 2012, ANN NEUROL, V72, P192, DOI 10.1002/ana.23587; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; JENKINS A, 1990, British Journal of Neurosurgery, V4, P45, DOI 10.3109/02688699009000681; Jussen D, 2008, CRIT CARE MED, V36, P543, DOI 10.1097/01.CCM.0B013E3181620A0F; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Krenzlin H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010084; KURODA Y, 1992, NEUROSURGERY, V31, P1062, DOI 10.1227/00006123-199212000-00012; KURODA Y, 1992, J NEUROSURG, V76, P471, DOI 10.3171/jns.1992.76.3.0471; Kwon MS, 2015, INT J MOL SCI, V16, P5028, DOI 10.3390/ijms16035028; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Loftspring MC, 2010, MED HYPOTHESES, V74, P63, DOI 10.1016/j.mehy.2009.08.002; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nedelmann M, 2007, BRAIN RES, V1130, P188, DOI 10.1016/j.brainres.2006.10.087; Nedjat MR, 2013, NEUROSCIENCE, V238, P125, DOI 10.1016/j.neuroscience.2013.01.067; Noppens RR, 2006, CRIT CARE MED, V34, P2194, DOI 10.1097/01.CCM.0000228915.94169.B1; Orlin JR, 1997, ACTA RADIOL, V38, P610; Ramos-Mandujano G, 2007, GLIA, V55, P917, DOI 10.1002/glia.20513; Rice RA, 2015, J NEUROSCI, V35, P9977, DOI 10.1523/JNEUROSCI.0336-15.2015; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; Sawauchi S, 2004, J NEUROTRAUM, V21, P563, DOI 10.1089/089771504774129892; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sokolova E, 2008, THROMB HAEMOSTASIS, V100, P576, DOI 10.1160/TH08-03-0131; Timaru-Kast R, 2008, J NEUROTRAUM, V25, P1107, DOI 10.1089/neu.2008.0517; Uchida K, 2001, EUR J ANAESTH, V18, P295, DOI 10.1046/j.0265-0215.2000.00825.x; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wasserman JK, 2007, BRAIN RES, V1180, P140, DOI 10.1016/j.brainres.2007.08.058; Wu X, 2011, NEUROGASTROENT MOTIL, V23, pe123; Xi GH, 2002, NEUROSURG CLIN N AM, V13, P371, DOI 10.1016/S1042-3680(02)00007-4; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Xiong XY, 2014, TRANSL STROKE RES, V5, P429, DOI 10.1007/s12975-013-0317-7; Yabluchanskiy A, 2010, INT J NEUROSCI, V120, P765, DOI 10.3109/00207454.2010.523129; Yang Y, 2015, BEHAV BRAIN FUNCT, V11, DOI 10.1186/s12993-015-0075-7; Yilmazlar S, 1997, J Neurosurg Sci, V41, P379	51	8	8	2	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					906	913		10.1089/neu.2016.4464			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200018	27178700				2022-02-06	
J	Bymaster, A; Chung, J; Banke, A; Choi, HJ; Laird, C				Bymaster, Angela; Chung, Joyce; Banke, Andrea; Choi, Hee Jae; Laird, Chelsea			A Pediatric Profile of a Homeless Patient in San Jose, California	JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED			English	Article						Homelessness; adverse childhood events; adverse childhood experiences; traumatic brain injury; trauma; abuse; child abuse; foster care; homeless children; homeless youth; homeless people	ADVERSE CHILDHOOD EXPERIENCES; ADULT PSYCHIATRIC-DISORDERS; RISK-FACTORS	The causes of homelessness are complex and poorly understood. This paper describes the homeless population in Santa Clara County, California in terms of Adverse Childhood Events, Traumatic Brain Injuries (TBIs), and family breakdown. Respondents reported severely traumatic childhoods; 78.7% grew up in a household with a person with drug or alcohol dependence and 64.6% endured psychological abuse as a child. Seventy-six percent of subjects recalled at least one TBI, 58.4% with loss of consciousness. Nineteen percent were in foster care as children and 40.2% reported having someone other than a parent as a primary caregiver. Fifty-three percent felt they had moved too much as children, and 37.5% had experienced homelessness as children. Santa Clara County has both the highest median income and the highest rate of unsheltered homelessness in the nation. Leaders and community members should work together to improve the lives of the homeless and to prevent another generation of homeless people.	[Bymaster, Angela; Banke, Andrea; Choi, Hee Jae; Laird, Chelsea] Santa Clara Valley Med Ctr, San Jose, CA 95128 USA; [Chung, Joyce] Vet Adm, Palo Alto, CA USA		Bymaster, A (corresponding author), Valley Homeless Healthcare Program, 2101 Alexian Dr Ste D, San Jose, CA 95116 USA.	angela@bymaster.org					[Anonymous], 2011, 2011 SANT CLAR COUNT; Avalos G., 2014, MERCURY NEWS    0810; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; CATON CLM, 1994, AM J PUBLIC HEALTH, V84, P265, DOI 10.2105/AJPH.84.2.265; Centers for Disease Control and Prevention, 2016, ADV CHILDH EXP ACES; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1609; Centers for Disease Control and Prevention (CDC), 2015, NAT HOM PERS MEM DAY; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Henery M, 2014, 2014 ANN HOMELESS AS; Herman DB, 1997, AM J PUBLIC HEALTH, V87, P249, DOI 10.2105/AJPH.87.2.249; McLaughlin KA, 2010, ARCH GEN PSYCHIAT, V67, P124, DOI 10.1001/archgenpsychiatry.2009.187; Ohio State University, 2012, TBI ID METH SHORT FO; Patterson ML, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-350; Sullivan G, 2000, SOC PSYCH PSYCH EPID, V35, P444, DOI 10.1007/s001270050262; Tam TW, 2003, AM J DRUG ALCOHOL AB, V29, P829, DOI 10.1081/ADA-120026263; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; Tsai J, 2011, J HEALTH CARE POOR U, V22, P853, DOI 10.1353/hpu.2011.0081; U S Environmental Protection Agency, 2015, CLEAN COY CREEK WAT; van den Bree MBM, 2009, J ADOLESCENT HEALTH, V45, P571, DOI 10.1016/j.jadohealth.2009.03.027; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; You Gotta Believe, 2014, ITS NEV TOO LAT FAM	24	8	8	0	10	JOHNS HOPKINS UNIV PRESS	BALTIMORE	JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD 21218-4363 USA	1049-2089	1548-6869		J HEALTH CARE POOR U	J. Health Care Poor Underserved	FEB	2017	28	1					582	595		10.1353/hpu.2017.0041			14	Health Policy & Services; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	EL6JU	WOS:000394729200042	28239020				2022-02-06	
J	Finger, T; Prinz, V; Schreck, E; Pinczolits, A; Bayerl, S; Liman, T; Woitzik, J; Vajkoczy, P				Finger, Tobias; Prinz, Vincent; Schreck, Evelyn; Pinczolits, Alexandra; Bayerl, Simon; Liman, Thomas; Woitzik, Johannes; Vajkoczy, Peter			Impact of timing of cranioplasty on hydrocephalus after decompressive hemicraniectomy in malignant middle cerebral artery infarction	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Hemicraniectomy; Malignant middle cerebral artery infarction; Shunt dependence; Cranioplasty; Hydrocephalus	AGITATION-SEDATION SCALE; TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC HYDROCEPHALUS; SURGICAL DECOMPRESSION; PARADOXICAL HERNIATION; CRANIECTOMY; STROKE; COMPLICATIONS; RELIABILITY; TRIAL	Objective: Patients with malignant middle cerebral artery infarction frequently develop hydrocephalus after decompressive hemicraniectomy. Hydrocephalus itself and known shunt related complications after ventriculo-peritoneal shunt implantation may negatively impact patientsi outcome. Here, we aimed to identify factors associated with the development of hydrocephalus after decompressive hemicraniectomy in malignant middle cerebral artery infarction. Patients and methods: A total of 99 consecutive patients with the diagnosis of large hemispheric infarctions and the indication for decompressive hemicraniectomy were included. We retrospectively evaluated patient characteristics (gender, age and selected preoperative risk factors), stroke characteristics (side, stroke volume and existing mass effect) and surgical characteristics (size of the bone flap, initial complication rate, time to cranioplasty, complication rate following cranioplasty, type of implant, number of revision surgeries and mortality). Results: Frequency of hydrocephalus development was 10% in our cohort. Patients who developed a hydrocephalus had an earlier time point of bone flap reimplantation compared to the control group (no hydrocephalus = 164 +/- 104 days, hydrocephalus = 108 +/- 52 days, p < 0.05). Additionally, numbers of revision surgeries after cranioplasty was associated with hydrocephalus with a trend towards significance (p = 0.08). Conclusion: Communicating hydrocephalus is frequent in patients with malignant middle cerebral artery infarction after decompressive hemicraniectomy. A later time point of cranioplasty might lead to a lower incidence of required shunting procedures in general as we could show in our patient cohort. (C) 2016 Elsevier B.V. All rights reserved.	[Finger, Tobias; Prinz, Vincent; Schreck, Evelyn; Pinczolits, Alexandra; Bayerl, Simon; Woitzik, Johannes; Vajkoczy, Peter] Univ Med Charite, Dept Neurosurg, Berlin, Germany; [Liman, Thomas] Univ Med Charite, Dept Neurol, Berlin, Germany		Finger, T (corresponding author), Charite Univ Med Berlin, Dept Neurosurg, Augustenburger Pl 1, D-13353 Berlin, Germany.	tobias.finger@charite.de		Woitzik, Johannes/0000-0002-1865-4606; Liman, Thomas/0000-0002-8471-8049	Charite - Universitatsmedizin Berlin; Berlin Institute of Health	Vincent Prinz is participant in the Charite Clinical Scientist Program funded by the Charite - Universitatsmedizin Berlin and the Berlin Institute of Health.	Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Fotakopoulos G., 2015, J NEUROL SURG A; Gadde Judith, 2012, Del Med J, V84, P213; Geurts M, 2013, STROKE, V44, P2506, DOI 10.1161/STROKEAHA.113.002014; Ghandehari K, 2013, J RES MED SCI, V18, P906; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Jabbarli R, 2016, EUR J NEUROL, V23, P912, DOI 10.1111/ene.12962; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kwah LK, 2014, J PHYSIOTHER, V60, P61, DOI 10.1016/j.jphys.2013.12.012; Lee MH, 2012, CLIN NEUROL NEUROSUR, V114, P555, DOI 10.1016/j.clineuro.2011.11.027; Liao CC, 2002, J CLIN NEUROSCI, V9, P553, DOI 10.1054/jocn.2002.1116; LORENZO A V, 1970, Brain Behavior and Evolution, V93, P679, DOI 10.1093/brain/93.4.679; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Nalbach SV, 2012, J CLIN NEUROSCI, V19, P1222, DOI 10.1016/j.jocn.2012.01.016; Rahme R, 2010, NEUROSURGERY, V67, P675, DOI 10.1227/01.NEU.0000383142.10103.0B; Ropper AE, 2012, J CLIN NEUROSCI, V19, P231, DOI 10.1016/j.jocn.2011.08.004; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Takeuchi Satoru, 2013, Acta Neurochir Suppl, V118, P289, DOI 10.1007/978-3-7091-1434-6_56; Takeuchi S, 2013, J CLIN NEUROSCI, V20, P377, DOI 10.1016/j.jocn.2012.03.035; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; WATTERS G V, 1969, Transactions of the American Neurological Association, V94, P153; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; WEINGARTEN S, 1990, STROKE, V21, P1280, DOI 10.1161/01.STR.21.9.1280; Williams H, 2008, MED HYPOTHESES, V70, P743, DOI 10.1016/j.mehy.2007.08.013; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yu A, 2013, CRIT CARE MED, V41, P2002, DOI 10.1097/CCM.0b013e31828e96c0; Zanaty M, 2015, J NEUROSURG, V123, P182, DOI 10.3171/2014.9.JNS14405	39	8	9	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	FEB	2017	153						27	34		10.1016/j.clineuro.2016.12.001			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EL4ZY	WOS:000394632300006	28012353				2022-02-06	
J	Molteni, E; Rocca, MA; Strazzer, S; Pagani, E; Colombo, K; Arrigoni, F; Boffa, G; Copetti, M; Pastore, V; Filippi, M				Molteni, Erika; Rocca, Maria A.; Strazzer, Sandra; Pagani, Elisabetta; Colombo, Katia; Arrigoni, Filippo; Boffa, Giacomo; Copetti, Massimiliano; Pastore, Valentina; Filippi, Massimo			A diffusion tensor magnetic resonance imaging study of paediatric patients with severe non-traumatic brain injury	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							VEGETATIVE STATE; WHITE-MATTER; CORPUS-CALLOSUM; CONNECTIVITY; RECOVERY; CHILDREN	AimIn this observational study using 3T magnetic resonance imaging (MRI) and diffusion tensor, we investigated the differential effects of pathology, stage of disease, state of consciousness, and aetiology on the modifications of supra- and infra-tentorial white matter tracts and their correlations with clinical scales in paediatric patients with severe non-traumatic brain injury. MethodDiffusion tensor magnetic resonance imaging (DT-MRI) was obtained from seven children with unresponsive wakefulness syndrome (UWS; five males, two females; age at event 5y; standard deviation [SD] 2y 1mo), six children in a minimally conscious state (MCS; three males, three females; age at event 5y 10mo; SD 5y), and 10 healthy children as controls(two males, eight females; age at study 10y 10mo; SD 2y 10mo). Fractional anisotropy, mean, axial, and radial diffusivities were calculated for the corpus callosum, inferior, middle (MCP), and superior cerebellar peduncles (SCP). ResultsDT-MRI parameters from corpus callosum and SCP differed between patients and controls. MCP abnormalities were detected in patients presenting non-traumatic composite aetiology (n=4) versus those suffering from pure anoxia (n=9). The supra-tentorial compartment was more damaged (i.e. decreased fractional anisotropy and increased diffusivities) than the infra-tentorial one. Correlations were found between DT-MRI abnormalities and Glasgow Outcome Scale scores. InterpretationIn paediatric UWS/MCS, the severity of clinical disability correlates with white matter tract abnormalities. this issue.	[Molteni, Erika; Strazzer, Sandra; Colombo, Katia; Arrigoni, Filippo; Pastore, Valentina] Sci Inst IRCCS Eugenio Medea, Acquired Brain Injury Unit, Bosisio Parini, LC, Italy; [Rocca, Maria A.; Pagani, Elisabetta; Boffa, Giacomo; Filippi, Massimo] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Neuroimaging Res Unit, Inst Expt Neurol,Div Neurosci, Milan, Italy; [Copetti, Massimiliano] IRCCS Casa Sollievo Sofferenza, Unit Biostat, San Giovanni Rotondo, FG, Italy		Filippi, M (corresponding author), Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Neuroimaging Res Unit, Inst Expt Neurol,Div Neurosci, Milan, Italy.	filippi.massimo@hsr.it	Pagani, Elisabetta/X-9219-2019; Strazzer, Sandra/AAH-5712-2019; Pastore, Valentina/AAH-6831-2019; Molteni, Erika/P-4564-2016; COPETTI, MASSIMILIANO/AAG-1473-2021; Colombo, Katia/ABE-5754-2020; Filippi, Massimo/K-1755-2018; ARRIGONI, FILIPPO/G-5828-2011; Rocca, Maria Assunta/K-1619-2018	Pagani, Elisabetta/0000-0002-1850-1175; Strazzer, Sandra/0000-0001-8414-6565; Pastore, Valentina/0000-0002-3170-3070; Molteni, Erika/0000-0001-7773-8140; COPETTI, MASSIMILIANO/0000-0002-7960-5947; Colombo, Katia/0000-0002-5390-106X; Filippi, Massimo/0000-0002-5485-0479; ARRIGONI, FILIPPO/0000-0002-5508-1149; Rocca, Maria Assunta/0000-0003-2358-4320; BOFFA, GIACOMO/0000-0003-2220-9422	Ministero della Salute, ItalyMinistry of Health, Italy; Italian Ministry of Health and Fondazione Italiana Sclerosi Multipla; Biogen IdecBiogen; Teva Pharmaceutical IndustriesTeva Pharmaceutical Industries; NovartisNovartis; Italian Ministry of HealthMinistry of Health, Italy; Fondazione Italiana Sclerosi MultiplaFondazione Italiana Sclerosi Multipla (FISM); Cure PSP; Alzheimer's Drug Discovery Foundation (ADDF); Jacques and Gloria Gossweiler Foundation (Switzerland); ARiSLA (Fondazione Italiana di Ricerca per la SLA)	This study was partially funded with a grant from Ministero della Salute, Italy, Project Ricerca Finalizzata years 2010 to 2012, and Ricerca Corrente years 2015 to 2016, to Scientific Institute "E. Medea', awarded to Sandra Strazzer as Principal Investigator. The funder had no role in the conduction of the research and in the preparation of the manuscript. The authors declare no conflict of interest regarding the submitted work. Potential competing interests outside the submitted work are as follows: Erika Molteni, Elisabetta Pagani, Sandra Strazzer, Katia Colombo, Filippo Arrigoni, Giacomo Boffa, Massimiliano Copetti, and Valentina Pastore have nothing to disclose; Maria Assunta Rocca received speakers honoraria from Biogen Idec, Novartis, and ExceMed and receives research support from the Italian Ministry of Health and Fondazione Italiana Sclerosi Multipla; Massimo Filippi is Editor-in-Chief of the Journal of Neurology, serves on a scientific advisory board for Teva Pharmaceutical Industries, has received compensation for consulting services and/or speaking activities from Biogen Idec, Excemed, Novartis, and Teva Pharmaceutical Industries, and receives research support from Biogen Idec, Teva Pharmaceutical Industries, Novartis, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, Cure PSP, Alzheimer's Drug Discovery Foundation (ADDF), The Jacques and Gloria Gossweiler Foundation (Switzerland), and ARiSLA (Fondazione Italiana di Ricerca per la SLA).	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Andronikou S, 2015, PEDIATR RADIOL, V45, P258, DOI 10.1007/s00247-014-2998-9; Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; ASHWAL S, 1995, NEW ENGL J MED, V333, P130, DOI 10.1056/NEJM199507133330216; Bates D, 2003, CLIN MED, V3, P249; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Flannery J, 1993, Appl Nurs Res, V6, P167; Ford AA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00400; HYND GW, 1991, J LEARN DISABIL, V24, P141, DOI 10.1177/002221949102400302; JENNETT B, 1975, LANCET, V1, P480; Kurowski B, 2009, J PEDIATR REHAB MED, V2, P273, DOI 10.3233/PRM-2009-0093; Laureys S, 2005, CURR OPIN NEUROL, V18, P726, DOI 10.1097/01.wco.0000189874.92362.12; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; Saksena S, 2008, CEREBELLUM, V7, P392, DOI 10.1007/s12311-008-0041-0; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698	25	8	8	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	FEB	2017	59	2					199	206		10.1111/dmcn.13332			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	EI9LQ	WOS:000392830000022	27910995	Green Published			2022-02-06	
J	Ozevren, H; Irtegun, S; Deveci, E; Ozgur, ME; Asir, F; Tekin, MA; Deveci, S				Ozevren, Huseyin; Irtegun, Sevgi; Deveci, Engin; Ozgur, Mustafa Esref; Asir, Firat; Tekin, Mehmet Ali; Deveci, Senay			Neuroprotective Effects of Potentilla Fulgens on Traumatic Brain Injury in Rats	ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY			English	Article						cinquefoil; craniocerebral injuries; head injury; head trauma; Potentilla; Potentilla fulgens; rats, laboratory; silverweed; traumatic brain injury; traumatic encephalopathy	CONTROLLED CORTICAL IMPACT; CEREBROSPINAL-FLUID; ENDOTHELIN-1; PEPTIDE; PLASMA; INHIBITION; ASTROCYTES; EXPRESSION; MICROGLIA; NEURONS	OBJECTIVE: To investigate if Potentilla fulgens (P. fulgens) has any neuroprotective effects on traumatic brain injury in rats. STUDY DESIGN: Sprague-Dawley rats were subjected to traumatic brain injury with a weight-drop device using 300 g(-1) m weight-height impact. Sixty-four rats were divided into 4 groups: group 1 (vehicle-treated control), group 2 (P. fulgens 400 mg/kg/day, intraperitoneally [i.p.]), group 3 (vehicle-treated trauma), and group 4 (trauma+P. fulgens 400 mg/kg/day, i.p.). Distilled water was used as vehicle. All rats were decapitated 5 days after the induction of trauma, and the protective effects of P. fulgens were evaluated by histological, immunohistochemical, and biochemical analyses. RESULTS: Administration of P. fulgens at a dose of 400 mg/kg/day provided significant improvement in all of the histological, biochemical, and immunohistochemical analyses after the induction of traumatic brain injury. CONCLUSION: Although further studies are necessary to evaluate the time-and dose-dependent neuroprotective effects of P. fulgens, it may be a beneficial therapeutic agent for prevention of secondary neuronal damage following diffuse traumatic brain injury.	[Ozevren, Huseyin] Dicle Univ, Sch Med, Dept Neurosurg, Diyarbakir, Turkey; [Irtegun, Sevgi; Tekin, Mehmet Ali] Dicle Univ, Fac Med, Dept Med Biol, Diyarbakir, Turkey; [Deveci, Engin; Asir, Firat] Dicle Univ, Fac Med, Dept Histol & Embryol, TR-21280 Diyarbakir, Turkey; Alsancak Oral & Dent Hlth, Dept Ortodonti, Izmir, Turkey; [Deveci, Senay] Ataturk Hlth High Sch, Dept Histol & Embryol, Diyarbakir, Turkey; [Ozgur, Mustafa Esref] Alsancak Oral & Dent Hlth Hosp, Izmir, Turkey		Deveci, E (corresponding author), Dicle Univ, Fac Med, Dept Histol & Embryol, TR-21280 Diyarbakir, Turkey.	devecie@mynet.com	Asir, Firat/A-8341-2017; Ozevren, Huseyin/AAC-1236-2021	Asir, Firat/0000-0002-6384-9146; Ozevren, Huseyin/0000-0002-5437-4003			Amat JA, 1996, GLIA, V16, P368, DOI 10.1002/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W; Cederberg HHC, 2014, ARCH MED RES, V45, P639, DOI 10.1016/j.arcmed.2014.11.004; Chantsoulis M, 2015, ANN AGR ENV MED, V22, P368, DOI 10.5604/12321966.1152097; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen W, 2005, WORLD J GASTROENTERO, V11, P6477, DOI 10.3748/wjg.v11.i41.6477; Chew LJ, 2006, MENT RETARD DEV D R, V12, P105, DOI 10.1002/mrdd.20102; COCKS TM, 1991, EUR J PHARMACOL, V196, P177, DOI 10.1016/0014-2999(91)90425-P; EHRENREICH H, 1992, RES EXP MED, V192, P257, DOI 10.1007/BF02576282; FUJIMORI A, 1990, LANCET, V336, P633, DOI 10.1016/0140-6736(90)93432-O; GIAID A, 1989, P NATL ACAD SCI USA, V86, P7634, DOI 10.1073/pnas.86.19.7634; Gumerlock MK, 1996, PRACTICE NEUROSURGER, P4; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; Kaul K, 2010, INDIAN J NAT PROD RE, V2, P298; Krum JM, 2003, EXP NEUROL, V181, P241, DOI 10.1016/S0014-4886(03)00039-6; Lee S, 2015, INT J MOL SCI, V16, P19657, DOI 10.3390/ijms160819657; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Ostrow LW, 2005, BRAIN RES REV, V48, P488, DOI 10.1016/j.brainresrev.2004.09.005; Petrov T, 2009, CAN J PHYSIOL PHARM, V87, P379, DOI [10.1139/Y09-022, 10.1139/y09-022]; Preston GW, 2016, ANAL BIOANAL CHEM, V408, P2187, DOI 10.1007/s00216-016-9334-1; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Sohrab G, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.28551; Stefani A, 1997, EXP NEUROL, V147, P115, DOI 10.1006/exnr.1997.6554; SUZUKI R, 1992, J NEUROSURG, V77, P96, DOI 10.3171/jns.1992.77.1.0096; Syiem D., 2003, INDIAN DRUGS, V40, P124; Syiem D, 2009, PHARM ONLINE, V2, P787; Tatsumi K, 2005, NEUROCHEM INT, V46, P381, DOI 10.1016/j.neuint.2004.12.007; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yang Li, 2007, Neurosci Bull, V23, P307, DOI 10.1007/s12264-007-0046-6; Yu HM, 2004, NEUROPATHOLOGY, V24, P136, DOI 10.1111/j.1440-1789.2003.00539.x; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027	36	8	8	0	6	SCI PRINTERS & PUBL INC	ST LOUIS	PO DRAWER 12425 8342 OLIVE BLVD, ST LOUIS, MO 63132 USA	0884-6812			ANAL QUANT CYTOPATHO	Anal. Quant. Cytopathol. Histopathol.	FEB	2017	39	1					35	44					10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EQ5NY	WOS:000398130900003					2022-02-06	
J	Tanriverdi, F; Kelestimur, F				Tanriverdi, F.; Kelestimur, F.			Classical and non-classical causes of GH deficiency in adults	BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article						growth hormone deficiency; hypopituitarism; traumatic brain injury; sports-related head trauma; Sheehan's syndrome	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ANTERIOR-PITUITARY FUNCTION; GROWTH-HORMONE DEFICIENCY; SHEEHANS-SYNDROME; REPLACEMENT THERAPY; ISCHEMIC-STROKE; HEAD TRAUMA; LONG-TERM; HIGH-RISK	Growth hormone deficiency (GHD) can develop due to a variety of conditions, and may occur either as isolated or multiple pituitary hormone deficiencies. It has been previously demonstrated that GH is one of the most frequent hormonal deficiencies in adult patients with hypopituitarism. The most frequent classical causes of adult-onset GHD (AO-GHD) are pituitary adenomas and/or their treatment. However, during the last decade an increasing number of studies from different parts of the world have revealed that nontumoural causes of hypopituitarism are more common than previously known. Therefore, in this review our aim is to briefly summarize the classical and non-classical acquired causes of GHD in adults. (C) 2017 Elsevier Ltd. All rights reserved.	[Tanriverdi, F.; Kelestimur, F.] Erciyes Univ, Sch Med, Dept Endocrinol & Metab, TR-38039 Kayseri, Turkey		Tanriverdi, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol & Metab, TR-38039 Kayseri, Turkey.	fatihtan@erciyes.edu.tr	kelestimur, f/ABE-9873-2021				Abs R, 1999, CLIN ENDOCRINOL, V50, P703, DOI 10.1046/j.1365-2265.1999.00695.x; Adamson P., 1996, PROGR NATIONS 1996 C; ARAFAH PM, 1986, J CLIN ENDOCR METAB, V62, P1173, DOI 10.1210/jcem-62-6-1173; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2006, J CLIN ENDOCR METAB, V91, P3928, DOI 10.1210/jc.2006-1040; Bondanelli M, 2010, J CLIN ENDOCR METAB, V95, P4660, DOI 10.1210/jc.2010-0611; Brabant G, 2009, EUR J ENDOCRINOL, V161, pS25, DOI 10.1530/EJE-09-0273; De Marinis L, 2006, J ENDOCRINOL INVEST, V29, P516, DOI 10.1007/BF03344141; Elumir-Mamba L.A.S., 2010, PHILIPP J INTERN MED, V48, P23; Fernandez-Rodriguez E, 2013, CLIN ENDOCRINOL, V78, P278, DOI 10.1111/j.1365-2265.2012.04516.x; Gartland S, 2001, BRIT J SPORT MED, V35, P308, DOI 10.1136/bjsm.35.5.308; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Kelestimur F, 2005, EUR J ENDOCRINOL, V152, P581, DOI 10.1530/eje.1.01881; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; KELESTIMUR F, 1995, CLIN ENDOCRINOL, V42, P443, DOI 10.1111/j.1365-2265.1995.tb02658.x; Kelestimur Fahrettin, 2005, Pituitary, V8, P259, DOI 10.1007/s11102-006-6051-3; Kelestimur Fahrettin, 2003, Pituitary, V6, P181, DOI 10.1023/B:PITU.0000023425.20854.8e; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kristjansdottir HL, 2011, EUR J ENDOCRINOL, V164, P349, DOI 10.1530/EJE-10-1004; Kronvall E, 2015, WORLD NEUROSURG, V83, P574, DOI 10.1016/j.wneu.2014.12.007; LITTLEY MD, 1989, Q J MED, V70, P145; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Powell JW, 2001, J ATHL TRAINING, V36, P307; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Sassolas G, 1999, EUR J ENDOCRINOL, V141, P595, DOI 10.1530/eje.0.1410595; Schaefer S, 2008, EUR J ENDOCRINOL, V158, P3, DOI 10.1530/EJE-07-0484; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; SHEEHAN H L, 1965, J Obstet Gynaecol Br Commonw, V72, P103; Sheehan HL, 1937, J PATHOL BACTERIOL, V45, P189, DOI 10.1002/path.1700450118; Simsek Y, 2014, J ENDOCRINOL INVEST, V37, P1057, DOI 10.1007/s40618-014-0142-1; Stochholm K, 2006, EUR J ENDOCRINOL, V155, P61, DOI 10.1530/eje.1.02191; Stojanovic M, 2008, J CLIN ENDOCR METAB, V93, P2722, DOI 10.1210/jc.2008-0311; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2008, J ENDOCRINOL INVEST, V31, P489, DOI 10.1007/BF03346395; Tanriverdi F, 2005, GROWTH HORM IGF RES, V15, P231, DOI 10.1016/j.ghir.2005.03.005; Tanriverdi F, 2014, ENDOCRINE, V47, P198, DOI 10.1007/s12020-013-0127-4; Tanriverdi F, 2012, PITUITARY, V15, P579, DOI 10.1007/s11102-011-0371-7; Tanriverdi F, 2011, J ENDOCRINOL INVEST, V34, P541, DOI 10.3275/7805; Tanriverdi F, 2008, J NEUROTRAUM, V25, P1071, DOI 10.1089/neu.2007.0456; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Theadom A, 2014, J SCI MED SPORT, V17, P591, DOI 10.1016/j.jsams.2014.02.001; TOOGOOD AA, 1995, CLIN ENDOCRINOL, V43, P97, DOI 10.1111/j.1365-2265.1995.tb01898.x; Tsiakalos A, 2010, J CLIN ENDOCR METAB, V95, P3277, DOI 10.1210/jc.2010-0144; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Zargar AH, 2005, FERTIL STERIL, V84, P523, DOI 10.1016/j.fertnstert.2005.02.022; Zazryn TR, 2003, BRIT J SPORT MED, V37, P448, DOI 10.1136/bjsm.37.5.448; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	64	8	8	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1521-690X	1532-1908		BEST PRACT RES CL EN	Best Pract. Res. Clin. Endoc. Metab.	FEB	2017	31	1					3	11		10.1016/j.beem.2017.02.001			9	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	EW1CO	WOS:000402227700002	28477730				2022-02-06	
J	Wan, XY; Fan, T; Wang, S; Zhang, SJ; Liu, SW; Yang, HK; Shu, K; Lei, T				Wan, Xueyan; Fan, Ting; Wang, Sheng; Zhang, Suojun; Liu, Shengwen; Yang, Hongkuan; Shu, Kai; Lei, Ting			Progressive hemorrhagic injury in patients with traumatic intracerebral hemorrhage: characteristics, risk factors and impact on management	ACTA NEUROCHIRURGICA			English	Article						Coagulopathy; Progressive hemorrhagic injury; Risk factors; Therapeutic approach; Traumatic brain injury	BRAIN-INJURY; HEAD TRAUMA; INTRACRANIAL HEMORRHAGE; COAGULATION DISORDERS; FACTOR-VII; COAGULOPATHY; HYPERTENSION	Progressive hemorrhagic injury (PHI) is a common occurrence in clinical practice; however, how PHI affects clinical management remains unclear. We attempt to evaluate the characteristics and risk factors of PHI and also investigate how PHI influences clinical management in traumatic intracerebral hemorrhage (TICH) patients. This retrospective study included a cohort of 181 patients with TICH who initially underwent conservative treatment and they were dichotomized into a PHI group and a non-PHI group. Clinical data were reviewed for comparison. Multivariate logistic regression analysis was applied to identify predictors of PHI and delayed operation. Overall, 68 patients (37.6%) experienced PHI and 27 (14.9%) patients required delayed surgery. In the PHI group, 17 patients needed late operation; in the non-PHI group, 10 patients received decompressive craniectomy. Compared to patients with non-PHI, the PHI group was more likely to require late operation (P = 0.005, 25.0 vs 8.8%), which took place within 48 h (P = 0.01, 70.6 vs 30%). Multivariate logistic regression identified past medical history of hypertension (odds ratio [OR] = 4.56; 95% confidence interval [CI] = 2.04-10.45), elevated international normalized ratio (INR) (OR = 20.93; 95% CI 7.72-71.73) and linear bone fracture (OR = 2.11; 95% CI = 1.15-3.91) as independent risk factors for PHI. Hematoma volume of initial CT scan > 5 mL (OR = 3.80; 95% CI = 1.79-8.44), linear bone fracture (OR = 3.21; 95% CI = 1.47-7.53) and PHI (OR = 3.49; 95% CI = 1.63-7.77) were found to be independently associated with delayed operation. Past medical history of hypertension, elevated INR and linear bone fracture were predictors for PHI. Additionally, the latter was strongly predictive of delayed operation in the studied cohort.	[Wan, Xueyan; Fan, Ting; Wang, Sheng; Zhang, Suojun; Liu, Shengwen; Yang, Hongkuan; Shu, Kai; Lei, Ting] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Neurosurg, Tongji Med Coll, Wuhan 430030, Peoples R China		Wang, S (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Neurosurg, Tongji Med Coll, Wuhan 430030, Peoples R China.	wangsheng@tjh.tjmu.edu.cn		Wang, Sheng/0000-0002-7195-2100; Wan, Xueyan/0000-0002-7148-9857	Science and Technology Department of Hubei Province form of Natural Science Foundation of Hubei, China [2014CFB151]; National Health and Family Planning Commission of the People's Republic of China form of the National Clinical Key Specialty Construction Project	The Science and Technology Department of Hubei Province provided financial support in the form of Natural Science Foundation of Hubei, China (No. 2014CFB151) funding, and the National Health and Family Planning Commission of the People's Republic of China provided financial support in the form of the National Clinical Key Specialty Construction Project. The sponsor had no role in the design or conduct of this research.	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Bullock MR, 2006, NEUROSURGERY, V58, pS1; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; da Luz LT, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-29; Dzik WH, 2007, TRANSFUSION MED, V17, P367, DOI 10.1111/j.1365-3148.2007.00795.x; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hunt H, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010438.pub2; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Manolio TA, 2003, CURR HYPERTENS REP, V5, P255, DOI 10.1007/s11906-003-0029-6; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pires PW, 2013, AM J PHYSIOL-HEART C, V304, pH1598, DOI 10.1152/ajpheart.00490.2012; R Core Team, 2014, R LANG ENV STAT COMP; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Tong WS, 2011, NEURORADIOLOGY, V53, P305, DOI 10.1007/s00234-010-0659-8; Wan XY, 2016, WORLD NEUROSURG, V89, P147, DOI 10.1016/j.wneu.2016.01.084; Wu X, 2014, J TRAUMA ACUTE CARE, V76, P114, DOI 10.1097/TA.0b013e3182a8fe48; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233	31	8	12	0	5	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	FEB	2017	159	2					227	235		10.1007/s00701-016-3043-6			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EJ2EG	WOS:000393022200004	27943076				2022-02-06	
J	Wendling-Keim, DS; Konig, A; Dietz, HG; Lehner, M				Wendling-Keim, Danielle S.; Koenig, Adriana; Dietz, Hans-Georg; Lehner, Markus			Ambulatory or inpatient management of mild TBI in children: a post-concussion analysis	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Mild traumatic brain injury (TBI); Concussion; Questionnaire	MINOR HEAD TRAUMA; SYMPTOMS QUESTIONNAIRE; INJURY; YOUNGER; EPIDEMIOLOGY; PREDICT	Diagnosis and treatment of children with mild traumatic brain injury (mTBI) remain a challenge since initial signs and symptoms do not always indicate the severity of the trauma. Therefore, guidelines regarding the decision upon imaging methods and ambulatory or hospitalized treatment are needed. The goal of our study was to investigate if the standard that was allied from the PECARN rules and is applied in this study can ensure that patients with clinically important brain injury are recognized and leads to outcomes with a low complication rate, a high patient satisfaction and minimal post-concussion syndrome incidence. We enrolled 478 children with mTBI and contacted their families with a questionnaire. Out of these, 267 valid questionnaires were received. Patient records and questionnaires were analyzed yielding a number of 140 ambulatory and 127 hospitalized patients. Patients with mild TBI were admitted according to the above-mentioned guidelines or sent home for observation through their parents after thorough patient examination and information. Among ambulatory patients only 13 children (9%) underwent any imaging procedure; however, none of those showed any pathological findings. Next, in 41 of 127 hospitalized patients (32.2%) an imaging study was performed and of these only 3 according to 2.4% of hospitalized patients showed pathological findings, namely a skull fracture, two of them in combination with an intracranial hemorrhage. The duration of inpatient observation was 48 h in most cases (55.3%). Moreover, a majority of all patients (72.4%) did not seek any follow-up visit and did not need any further treatment. Of all patients in the study, only 10 patients according to 3.7% developed a post-concussion syndrome. Patient satisfaction was very high in both, the ambulatory and hospitalized patient group. This study confirms that PECARN rules as administered in this study can ensure safe decision-making regarding ambulatory or inpatient treatment.	[Wendling-Keim, Danielle S.; Koenig, Adriana; Dietz, Hans-Georg; Lehner, Markus] Ludwig Maximilian Univ Munich, Dr von Hauner Childrens Hosp, Pediat Surg, Lindwurmstr 4, D-80337 Munich, Germany		Wendling-Keim, DS (corresponding author), Ludwig Maximilian Univ Munich, Dr von Hauner Childrens Hosp, Pediat Surg, Lindwurmstr 4, D-80337 Munich, Germany.	Danielle.Wendling@med.uni-muenchen.de; adriana.koenig@luks.ch; Hans-Georg.Dietz@med.uni-muenchen.de; Markus.Lehner@med.uni-muenchen.de	Lehner, Markus/B-9955-2019	Lehner, Markus/0000-0002-8176-8067			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS68; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS53; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS5; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS31; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS9; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS34; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS49; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS56; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS60; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS38; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS45; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS28; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Boran BO, 2006, PEDIATR NEUROSURG, V42, P203, DOI 10.1159/000092355; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CASEY R, 1986, PEDIATRICS, V78, P497; Cheng TA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2721; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; PIETRZAK M, 1991, AM J EMERG MED, V9, P153, DOI 10.1016/0735-6757(91)90179-N; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Rusticali B, 2008, MINERVA ANESTESIOL, V74, P583; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Stocchetti N, 2010, MINERVA ANESTESIOL, V76, P1052; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	43	8	8	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	FEB	2017	33	2					249	261		10.1007/s00383-016-4021-z			13	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	EK5JL	WOS:000393962600019	27858189				2022-02-06	
J	Qi, ZH; Zhang, HQ; Fu, CH; Liu, X; Chen, B; Dang, YW; Chen, HY; Liu, LJ				Qi, Zhihua; Zhang, Huiqin; Fu, Chuhua; Liu, Xiao; Chen, Bo; Dang, Yanwei; Chen, Huayun; Liu, Lijun			Prolonged hydrocephalus induced by intraventricular hemorrhage in rats is reduced by curcumin therapy	NEUROSCIENCE LETTERS			English	Article						Intraventricular hemorrhage; Hydrocephalus; Curcumin; Blood brain barrier	NEONATAL POSTHEMORRHAGIC HYDROCEPHALUS; TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; IRON; EXPRESSION; DEFEROXAMINE; INHIBITION; LYSIS; MICE	Prolonged hydrocephalus is a major cause of severe disability and death of intraventricular hemorrhage (IVH) patients. However, the therapeutic options to minimize the detrimental effects of post-hemorrhagic hydrocephalus are limited. Curcumin has been reported to confer neuroprotective effects in numerous neurological diseases and injuries, but its role in IVH-induced hydrocephalus has not been determined. The aim of present study was to determine whether curcumin treatment ameliorates blood brain barrier (BBB) damage and reduces the incidence of post-hemorrhagic hydrocephalus in IVH rat model. Autologous blood intraventricular injection was used to establish the IVH model. Our results revealed that repeated intraperitoneal injection of curcumin ameliorated IVH-induced learning and memory deficits as determined by Morris water maze and reduced the incidence of post-hemorrhagic hydrocephalus in a dose-dependent manner at 28 d post-IVH induction. Further, the increased BBB permeability and brain edema induced by IVH were significantly reduced by curcumin administration. In summary, these findings highlighted the important role of curcumin in improving neurological function deficits and protecting against BBB disruption via promoting the neurovascular unit restoration, and thus it reduced the severity of post-hemorrhagic hydrocephalus in the long term. It is believed that curcumin might prove to be an effective therapeutic component in prevent the post-IVH hydrocephalus in the near future. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Qi, Zhihua; Zhang, Huiqin; Fu, Chuhua; Liu, Xiao; Chen, Bo; Dang, Yanwei; Chen, Huayun; Liu, Lijun] Hubei Med Coll, Affiliated Xiangyang Peoples Hosp 1, Wuhan, Peoples R China		Liu, LJ (corresponding author), Hubei Med Coll, Affiliated Xiangyang Peoples Hosp 1, Wuhan, Peoples R China.	15823540630@163.com					Badria FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134156; CARDIA E, 1995, CHILD NERV SYST, V11, P511, DOI 10.1007/BF00822840; Chen M, 2007, J NEUROCHEM, V103, P2015, DOI 10.1111/j.1471-4159.2007.04885.x; Chen QW, 2015, STROKE, V46, P2902, DOI 10.1161/STROKEAHA.115.009713; Chen Z, 2011, STROKE, V42, P465, DOI 10.1161/STROKEAHA.110.602755; Cherian S, 2004, BRAIN PATHOL, V14, P305; Dairam A, 2008, J AGR FOOD CHEM, V56, P3350, DOI 10.1021/jf0734931; Fukumizu M, 1996, BRAIN DEV-JPN, V18, P40, DOI 10.1016/0387-7604(95)00103-4; Gaberel T, 2014, NEUROPHARMACOLOGY, V85, P158, DOI 10.1016/j.neuropharm.2014.05.001; Gaberel T, 2012, NEUROSURG REV, V35, P485, DOI 10.1007/s10143-012-0399-9; Gao C, 2014, J CEREBR BLOOD F MET, V34, P1070, DOI 10.1038/jcbfm.2014.56; Gao F, 2016, ACTA NEUROCHIR SUPPL, V121, P373, DOI 10.1007/978-3-319-18497-5_64; Gu W, 2016, CELL MOL BIOL, V62, P59, DOI 10.14715/cmb/2016.62.4.11; Hallevi H, 2008, NEUROLOGY, V70, P848, DOI 10.1212/01.wnl.0000304930.47751.75; Huge V., 2016, MED KLIN INTENSIVMED; Meng H, 2015, BRAIN RES, V1602, P44, DOI 10.1016/j.brainres.2014.08.039; Okauchi M, 2009, STROKE, V40, P1858, DOI 10.1161/STROKEAHA.108.535765; Raza H, 2008, TOXICOL APPL PHARM, V226, P161, DOI 10.1016/j.taap.2007.09.002; Schneider U, 2015, ACTA NEUROPATHOL, V130, P215, DOI 10.1007/s00401-015-1440-1; Simard P., 2011, TRANSL STROKE RES, V2; Sun YH, 2011, J NEUROTRAUM, V28, P2513, DOI 10.1089/neu.2011.1958; Tan L, 2015, BEHAV BRAIN RES, V279, P274, DOI 10.1016/j.bbr.2014.10.037; Tomte O, 2011, CRIT CARE MED, V39, P443, DOI 10.1097/CCM.0b013e318206b80f; Wang BF, 2015, ACTA PHARMACOL SIN, V36, P939, DOI 10.1038/aps.2015.47; Whitelaw A, 2001, Semin Neonatol, V6, P135, DOI 10.1053/siny.2001.0047; Xu H, 2012, NEUROSCIENCE, V218, P317, DOI 10.1016/j.neuroscience.2012.05.004; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59; Ziai WC, 2014, INT J STROKE, V9, P536, DOI 10.1111/ijs.12097; Ziai WC, 2009, CEREBROVASC DIS, V27, P403, DOI 10.1159/000209241	29	8	8	0	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 10	2017	637						120	125		10.1016/j.neulet.2016.11.038			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EI8XA	WOS:000392790300021	27876499				2022-02-06	
J	Adhikari, S; Stark, DE				Adhikari, Sam; Stark, David E.			Video-based eye tracking for neuropsychiatric assessment	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES			English	Article						eye tracking; quantitative phenotyping; neuropsychiatric assessment; digital health; diagnostic; computational imaging	SLEEP-DEPRIVATION; MENTAL-HEALTH; SYNCHRONIZATION; CONCUSSION; ATTENTION; BRAIN	This paper presents a video-based eye-tracking method, ideally deployed via amobile device or laptop-based webcam, as a tool for measuringbrain function. Eye movements and pupillary motility are tightly regulated by brain circuits, are subtly perturbed by many disease states, and are measurable using video-based methods. Quantitative measurement of eye movement by readily available webcams may enable early detection and diagnosis, as well as remote/serial monitoring, of neurological and neuropsychiatric disorders. We successfully extracted computational and semantic features for 14 testing sessions, comprising 42 individual video blocks and approximately 17,000 image frames generated across several days of testing. Here, we demonstrate the feasibility of collecting video-based eye-tracking data from a standard webcam in order to assess psychomotor function. Furthermore, we were able to demonstrate through systematic analysis of this data set that eye-tracking features (in particular, radial and tangential variance on a circular visual-tracking paradigm) predict performance on well-validated psychomotor tests.	[Adhikari, Sam] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Adhikari, Sam] Rutgers State Univ, Dept Management Sci & Informat Syst, Newark, NJ 07102 USA; [Adhikari, Sam] Sysoft Corp, Div Intelligent Syst, Whitehouse Stn, NJ USA; [Stark, David E.] Icahn Sch Med Mt Sinai, Inst Next Generat Healthcare, New York, NY 10029 USA; [Stark, David E.] Icahn Sch Med Mt Sinai, Dept Hlth Syst Design & Global Hlth, New York, NY 10029 USA		Adhikari, S (corresponding author), Rutgers State Univ, Dept Management Sci & Informat Syst, Newark, NJ 07102 USA.; Stark, DE (corresponding author), Icahn Sch Med Mt Sinai, Inst Next Generat Healthcare, New York, NY 10029 USA.; Stark, DE (corresponding author), Icahn Sch Med Mt Sinai, Dept Hlth Syst Design & Global Hlth, New York, NY 10029 USA.	sadhikari@sysoft.com; david.stark@mssm.edu					Baldevbhai J., 2012, IOSR J ELECT COMMUN, V1, P24; Chandhok C., 2012, IJIT, V1, P11; Heaton KJ, 2014, AVIAT SPACE ENVIR MD, V85, P497, DOI 10.3357/ASEM.3882.2014; Insel TR, 2006, MOL PSYCHIATR, V11, P11, DOI 10.1038/sj.mp.4001777; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Lagun D, 2011, J NEUROSCI METH, V201, P196, DOI 10.1016/j.jneumeth.2011.06.027; Maruta J, 2014, PROG NEUROL SURG, V28, P226, DOI 10.1159/000358786; Maruta J, 2014, MIL MED, V179, P619, DOI 10.7205/MILMED-D-13-00420; Maruta J, 2013, BEHAV RES METHODS, V45, P289, DOI 10.3758/s13428-012-0248-3; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Meeker M., 2013, D11 C; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Stark DE, 2016, APPL CLIN INFORM, V7, P290, DOI 10.4338/ACI-2015-12-LE-0176; Steinhubl SR, 2013, JAMA-J AM MED ASSOC, V310, P2395, DOI 10.1001/jama.2013.281078	14	8	8	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0077-8923	1749-6632		ANN NY ACAD SCI	Ann. N.Y. Acad. Sci.	JAN	2017	1387	1			SI		145	152		10.1111/nyas.13305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER4VR	WOS:000398800200014	28122120				2022-02-06	
S	Alaaeddine, R; Fayad, M; Nehme, E; Bahmad, HF; Kobeissy, F		ElKhamisy, S		Alaaeddine, Rana; Fayad, Mira; Nehme, Eliana; Bahmad, Hisham F.; Kobeissy, Firas			The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma	PERSONALISED MEDICINE: LESSONS FROM NEURODEGENERATION TO CANCER	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						Post-translational modifications; Neurodegenerative diseases; Brain injury; Neurotrauma; Personalized medicine; Alzheimer's disease; proteomics	TRAUMATIC BRAIN-INJURY; AMYLOID PROTEIN DEPOSITION; ALZHEIMERS-DISEASE; REDOX PROTEOMICS; MASS-SPECTROMETRY; OXIDATIVE STRESS; SYSTEMS BIOLOGY; COGNITIVE IMPAIRMENT; BIOMARKERS; NEUROPROTEOMICS	Inter-individual variability in response to pharmacotherapy has provoked a higher demand to personalize medical decisions. As the field of pharmacogenomics has served to translate personalized medicine from concept to practice, the contribution of the "omics" disciplines to the era of precision medicine seems to be vital in improving therapeutic outcomes. Although we have observed significant advances in the field of genomics towards personalized medicine, the field of proteomics-with all its capabilities-is still in its infancy towards the area of personalized precision medicine. Neurodegenerative diseases and neurotrauma are among the areas where the implementation of neuroproteomics approaches has enabled neuroscientists to broaden their understanding of neural disease mechanisms and characteristics. It has been shown that the influence of epigenetics, -genetics and environmental factors were among the recognized factors contributing to the diverse presentation of a single disease as well as its treatment establishing the factor-disease interaction. Thus, management of these variable single disease presentation/ outcome necessitated the need for factoring the influence of epigenetics, genetics, epigenetics, and other factors on disease progression to create a custom treatment plan unique to each individual. In fact, neuroproteomics with its high ability to decipher protein alterations along with their post translational modifications (PTMs) can be an ideal tool for personalized medicine goals including: discovery of molecular mechanisms underlying disease pathobiology, development of novel diagnostics, enhancement of pharmacological neurotherapeutic approaches and finally, providing a "proteome identity" for patients with certain disorders and diseases. So far, neuroproteomics approaches have excelled in the areas of biomarker discovery arena where several diagnostic, prognostic and injury markers have been identified with a direct impact on the neurodegenerative diseases and neurotrauma. However, other applications in proteomics such as "individual" proteome sequencing with its signature PTMs, have not been fully investigated as compared to the achievements in the genomics discipline This infers that proteomics research work has promising potential, yet to be discovered, in the precision medicine and comprises a major component of the personalized medicine infrastructure as it allows individual characterization of disease at the protein level. To conclude, the field of proteomics-based personalized medicine is still in its infancy compared to genomics field due to several technical and instrumentation-based obstacles; however, we anticipate to have this initiative leading in the coming future. This chapter will discuss briefly how neuroproteomics can impact personalized medicine in the fields of neurodegenerative disorders particularly in Alzheimer's disease and brain injury.	[Alaaeddine, Rana] Amer Univ Beirut, Dept Pharmacol & Therapeut, Fac Med, Beirut, Lebanon; [Fayad, Mira] Amer Univ Beirut, Biomed Engn Program, Fac Engn & Architecture, Beirut, Lebanon; [Fayad, Mira] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Nehme, Eliana; Kobeissy, Firas] Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon; [Bahmad, Hisham F.] Amer Univ Beirut, Dept Anat Cell Biol & Physiol Sci, Fac Med, Beirut, Lebanon		Kobeissy, F (corresponding author), Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon.; Bahmad, HF (corresponding author), Amer Univ Beirut, Dept Anat Cell Biol & Physiol Sci, Fac Med, Beirut, Lebanon.	hfbahmad@gmail.com; firasko@gmail.com	Bahmad, Hisham/A-5369-2019; Kobeissy, Firas/E-7042-2017	Bahmad, Hisham/0000-0003-3799-2595; Kobeissy, Firas/0000-0002-5008-6944			Abou-Abbass H, 2016, ELECTROPHORESIS, V37, P1549, DOI 10.1002/elps.201500585; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Ashley EA, 2016, NAT REV GENET, V17, P507, DOI 10.1038/nrg.2016.86; Bayes A, 2009, NAT REV NEUROSCI, V10, P635, DOI 10.1038/nrn2701; Beretta G, 2010, ANAL BIOANAL CHEM, V398, P67, DOI 10.1007/s00216-010-3829-y; Brinkmalm A, 2015, BBA-PROTEINS PROTEOM, V1854, P769, DOI 10.1016/j.bbapap.2015.01.009; Butterfield DA, 2008, EXPERT REV PROTEOMIC, V5, P157, DOI 10.1586/14789450.5.2.157; Butterfield DA, 2016, PROTEOM CLIN APPL, V10, P1191, DOI 10.1002/prca.201600003; Butterfield DA, 2012, ANTIOXID REDOX SIGN, V17, P1487, DOI 10.1089/ars.2012.4742; Chang RYK, 2013, ALZHEIMERS DEMENT, V9, P499, DOI 10.1016/j.jalz.2012.04.009; Colinge J, 2012, PROTEOM CLIN APPL, V6, P102, DOI 10.1002/prca.201100077; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; Crawford F, 2012, J NEUROTRAUM, V29, P246, DOI 10.1089/neu.2011.1789; D'Alessandro A, 2011, J PROTEOMICS, V74, P2575, DOI 10.1016/j.jprot.2011.01.001; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Di Domenico F, 2016, FREE RADICAL BIO MED, V91, P1, DOI 10.1016/j.freeradbiomed.2015.12.004; Duarte TT, 2016, PROTEOMES, V4, DOI 10.3390/proteomes4040029; Federico VR, 2016, J NEUROL NEUROSCI, V7, pS2; Gerson J, 2016, J NEUROTRAUM, V33, P2034, DOI 10.1089/neu.2015.4262; Gozal YM, 2009, J PROTEOME RES, V8, P5069, DOI 10.1021/pr900474t; Guest FL, 2016, BIOMARK MED, V10, P431, DOI 10.2217/bmm-2015-0055; Henderson M, 2016, PROTEOM CLIN APPL, V10, P1218, DOI 10.1002/prca.201600004; Heron M., 2016, CANCER, V400, P600; Jaber Z, 2016, METHODS MOL BIOL, V1462, P157, DOI 10.1007/978-1-4939-3816-2_10; Jauch EC, 2006, STROKE, V37, P2508, DOI 10.1161/01.STR.0000242290.01174.9e; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Juengst E, 2016, HASTINGS CENT REP, V46, P21, DOI 10.1002/hast.614; Keeney JTR, 2013, PROTEOM CLIN APPL, V7, P109, DOI 10.1002/prca.201200087; Keller JN, 2005, NEUROLOGY, V64, P1152, DOI 10.1212/01.WNL.0000156156.13641.BA; Kitamura Y, 2017, NEUROL RES, V39, P231, DOI 10.1080/01616412.2017.1281195; Kobeissy FH, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00198; Kovacech B, 2009, CELL MOL NEUROBIOL, V29, P799, DOI 10.1007/s10571-009-9358-6; Lazarus RC, 2015, FREE RADICAL BIO MED, V78, P89, DOI 10.1016/j.freeradbiomed.2014.10.507; Lehmann S, 2016, INT J CLIN CHEM; Li KW, 2010, ANAL BIOANAL CHEM, V397, P3195, DOI 10.1007/s00216-010-3658-z; Lia LJ, 2004, J BIOL CHEM, V279, P37061, DOI 10.1074/jbc.M403672200; Lovestone S, 2007, EXPERT REV PROTEOMIC, V4, P227, DOI 10.1586/14789450.4.2.227; McDonagh B, 2008, MAR ENVIRON RES, V66, P193, DOI 10.1016/j.marenvres.2008.02.069; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Montine TJ, 2015, J EXP MED, V212, P601, DOI 10.1084/jem.20150656; Moya-Alvarado G, 2016, MOL CELL PROTEOMICS, V15, P409, DOI 10.1074/mcp.R115.053330; Musunuri S, 2014, J PROTEOME RES, V13, P2056, DOI 10.1021/pr401202d; Ozdemir V, 2017, J NEURAL TRANSM, V124, P25, DOI 10.1007/s00702-015-1489-y; Prince M., 2016, IMPROVING HEALTHCARE; Raby CA, 1998, J NEUROCHEM, V71, P2505; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Roberts Stephanie, 2016, Healthc Manage Forum, V29, P158, DOI 10.1177/0840470416642773; Schelke MW, 2016, ANN NY ACAD SCI, V1367, P50, DOI 10.1111/nyas.13070; Scherl A, 2015, METHODS, V81, P3, DOI 10.1016/j.ymeth.2015.02.015; Seneviratne U, 2016, P NATL ACAD SCI USA, V113, P4152, DOI 10.1073/pnas.1521318113; Sheehan D, 2010, EXPERT REV PROTEOMIC, V7, P1, DOI [10.1586/epr.09.98, 10.1586/EPR.09.98]; Shoemaker LD, 2012, NEUROSURGERY, V70, P518, DOI 10.1227/NEU.0b013e3182333a26; Thelin EP, 2016, BEHAV BRAIN RES; Thomas SN, 2012, ACTA NEUROPATHOL, V123, P105, DOI 10.1007/s00401-011-0893-0; Troncone L, 2016, J AM COLL CARDIOL, V68, P2395, DOI 10.1016/j.jacc.2016.08.073; Veenstra TD, 2016, PROTEOMICS, V16, P2847, DOI 10.1002/pmic.201600211; Xu BH, 2016, BRAIN RES, V1642, P344, DOI 10.1016/j.brainres.2016.04.008; Yu CG, 2015, J NEUROSCI RES, V93, P199, DOI 10.1002/jnr.23503; Zali H, 2013, J PARAMED SCI, V4, P111	60	8	8	0	8	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-319-60733-7; 978-3-319-60731-3	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2017	1007						59	70		10.1007/978-3-319-60733-7_4	10.1007/978-3-319-60733-7		12	Biochemistry & Molecular Biology; Genetics & Heredity; Medicine, Research & Experimental	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Genetics & Heredity; Research & Experimental Medicine	BK4ZD	WOS:000437927100005	28840552				2022-02-06	
J	Armstrong, EM; Ciccone, N; Hersh, D; Katzenellebogen, J; Coffin, J; Thompson, S; Flicker, L; Hayward, C; Woods, D; McAllister, M				Armstrong, Elizabeth M.; Ciccone, Natalie; Hersh, Deborah; Katzenellebogen, Judith; Coffin, Juli; Thompson, Sandra; Flicker, Leon; Hayward, Colleen; Woods, Deborah; McAllister, Meaghan			Development of the Aboriginal Communication Assessment After Brain Injury (ACAABI): A screening tool for identifying acquired communication disorders in Aboriginal Australians	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article; Proceedings Paper	Speech-Pathology-Australia National Conference	2016	Perth, AUSTRALIA	Speech Pathol Australia		acquired communication disorder; aboriginal Australians; screening tool	ADDENBROOKES COGNITIVE EXAMINATION; FUNCTIONAL OUTCOME QUESTIONNAIRE; REVISED ACE-R; INDIGENOUS AUSTRALIANS; PSYCHOMETRIC EVALUATION; STROKE SURVIVORS; TEST BATTERY; APHASIA; SCALE; VALIDATION	Purpose: Acquired communication disorders (ACD), following stroke and traumatic brain injury, may not be correctly identified in Aboriginal Australians due to a lack of linguistically and culturally appropriate assessment tools. Within this paper we explore key issues that were considered in the development of the Aboriginal Communication Assessment After Brain Injury (ACAABI) - a screening tool designed to assess the presence of ACD in Aboriginal populations. Method: A literature review and consultation with key stakeholders were undertaken to explore directions needed to develop a new tool, based on existing tools and recommendations for future developments. Result: The literature searches revealed no existing screening tool for ACD in these populations, but identified tools in the areas of cognition and social-emotional wellbeing. Articles retrieved described details of the content and style of these tools, with recommendations for the development and administration of a new tool. The findings from the interview and focus group views were consistent with the approach recommended in the literature. Conclusions: There is a need for a screening tool for ACD to be developed but any tool must be informed by knowledge of Aboriginal language, culture and community input in order to be acceptable and valid.	[Armstrong, Elizabeth M.; Ciccone, Natalie; Hersh, Deborah; McAllister, Meaghan] Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia; [Katzenellebogen, Judith] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA, Australia; [Coffin, Juli] Univ Notre Dame, Off Dean, Broome, Australia; [Thompson, Sandra] Univ Western Australia, Western Australian Ctr Rural Hlth, Geraldton, Australia; [Flicker, Leon] Univ Western Australia, Western Australian Ctr Hlth & Ageing, Ctr Med Res, Perth, WA, Australia; [Hayward, Colleen] Edith Cowan Univ, Ctr Indigenous Australian Educ & Res, Kurongkurl Katitjin, Joondalup, Australia; [Woods, Deborah] Geraldton Reg Aboriginal Med Serv, Geraldton, Australia		Armstrong, EM (corresponding author), Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia.	b.armstrong@ecu.edu.au	Thompson, Sandra/H-5955-2014	Thompson, Sandra/0000-0003-0327-7155; Hersh, Deborah/0000-0003-2466-0225; Flicker, Leon/0000-0002-3650-0475; Armstrong, Elizabeth/0000-0003-4469-1117; Katzenellenbogen, Judith/0000-0001-5287-5819; Ciccone, Natalie/0000-0002-1822-7217	University of Western Australia Seeding Grant; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1046228]	This work was supported by the University of Western Australia Seeding Grant and the National Health and Medical Research Council Grant # 1046228. We also wish to acknowledge the participants in this study, and research assistants Susan Matson, Belinda Goodale, and John Woods for their diligence in assisting with the data collection.	Abbott Patrick J, 2011, Curr Drug Abuse Rev, V4, P210; Armstrong E, 2015, BRAIN IMPAIR, V16, P145, DOI 10.1017/BrImp.2015.15; Armstrong E, 2015, DISABIL REHABIL, V37, P1462, DOI 10.3109/09638288.2014.972581; Armstrong E, 2012, INT J SPEECH-LANG PA, V14, P271, DOI 10.3109/17549507.2011.663790; Benton AL, 1994, MULTILINGUAL APHASIA; Campbell A, 2008, AUST J RURAL HEALTH, V16, P124, DOI 10.1111/j.1440-1584.2007.00930.x; Coffin Juli, 2007, ABORIGINAL ISLANDER, V31, P22; D'Aprano A, 2016, QUAL HEALTH RES, V26, P613, DOI 10.1177/1049732314562891; D'Aprano AL, 2011, J PAEDIATR CHILD H, V47, P12, DOI 10.1111/j.1440-1754.2010.01883.x; Dalemans R, 2009, CLIN REHABIL, V23, P948, DOI 10.1177/0269215509337197; Dingwall K, 2014, BMC PSYCHOL, V2, DOI [DOI 10.1186/2050-7283-2-13, 10.1186/2050-7283-2-13]; Dingwall Kylie, 2009, Australas Psychiatry, V17 Suppl 1, pS47, DOI 10.1080/10398560902948670; Dingwall KM, 2011, DRUG ALCOHOL REV, V30, P33, DOI 10.1111/j.1465-3362.2010.00194.x; Dingwall KM, 2010, AUST NZ J PSYCHIAT, V44, P20, DOI 10.3109/00048670903393670; Doesborgh SJC, 2003, J NEUROL, V250, P977, DOI 10.1007/s00415-003-1134-9; Donovan NJ, 2008, AM J SPEECH-LANG PAT, V17, P335, DOI 10.1044/1058-0360(2008/07-0010); Doyle PJ, 2004, J CLIN EPIDEMIOL, V57, P997, DOI 10.1016/j.jclinepi.2003.11.016; Drew N., 2000, WORKING INDIGENOUS A, P325; Drummond SS, 2004, BRAIN INJURY, V18, P41, DOI 10.1080/0269905031000149461; Edwards S, 2007, CLINICAL APHASIOLOGY: FUTURE DIRECTIONS, P245; Elbourn E, 2017, INT J SPEECH-LANG PA, V19, P1, DOI 10.1080/17549507.2016.1193896; Enderby P M, 1987, Int Rehabil Med, V8, P166; Fitzpatrick JP, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-33; Flamand-Roze C, 2011, STROKE, V42, P1224, DOI 10.1161/STROKEAHA.110.609503; Gaber TAZK, 2011, AUSTRALAS J AGEING, V30, P156, DOI 10.1111/j.1741-6612.2010.00466.x; Glascoe FP, 2002, J DEV BEHAV PEDIATR, V23, DOI 10.1097/00004703-200206000-00003; Glueckauf RL, 2003, NEUROREHABILITATION, V18, P281; Goodglass H., 2000, BOSTON DIAGNOSTIC AP; Gould J., 2008, CHILDRENS LANGUAGE M, P194; Helm-Estabrooks N, 2002, J COMMUN DISORD, V35, P171, DOI 10.1016/S0021-9924(02)00063-1; Hersh D, 2015, INT J SPEECH-LANG PA, V17, P74, DOI 10.3109/17549507.2014.923510; Hilari K, 2003, STROKE, V34, P1944, DOI 10.1161/01.STR.0000081987.46660.ED; Hilari K, 2001, INT J LANG COMM DIS, V36, P86, DOI 10.3109/13682820109177864; Ivanova MV, 2013, APHASIOLOGY, V27, P891, DOI 10.1080/02687038.2013.805728; Janca A, 2015, AUSTRALAS PSYCHIATRY, V23, P287, DOI 10.1177/1039856215584514; Kalbe E, 2005, J CLIN EXP NEUROPSYC, V27, P779, DOI 10.1080/13803390490918273; Katzenellenbogen JM, 2016, INT J STROKE, V11, P103, DOI 10.1177/1747493015607521; Katzenellenbogen JM, 2011, STROKE, V42, P1515, DOI 10.1161/STROKEAHA.110.601799; Kertesz A., 2006, W APHASIA BATTERY; Ketterson TU, 2008, REHABIL PSYCHOL, V53, P215, DOI 10.1037/0090-5550.53.2.215; Kotz J, 2016, CONTEMP NURSE, V52, P42, DOI 10.1080/10376178.2016.1198710; Kowal Emma, 2007, Int J Equity Health, V6, P18, DOI 10.1186/1475-9276-6-18; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; LoGiudice D, 2011, AUSTRALAS J AGEING, V30, P215, DOI 10.1111/j.1741-6612.2010.00486.x; LOMAS J, 1989, J SPEECH HEAR DISORD, V54, P113, DOI 10.1044/jshd.5401.113; Long AF, 2008, CLIN REHABIL, V22, P1083, DOI 10.1177/0269215508090091; Long A, 2009, CLIN REHABIL, V23, P846, DOI 10.1177/0269215509336055; McAuliffe MJ, 2010, BRAIN INJURY, V24, P1408, DOI 10.3109/02699052.2010.511590; Menzies School of Health Research, 2013, STRONG SOULS; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mitchell CM, 2011, PSYCHOL ASSESSMENT, V23, P752, DOI 10.1037/a0023288; Nakase-Thompson R, 2005, BRAIN INJURY, V19, P685, DOI 10.1080/02699050400025331; PAUL D.R., 2004, QUALITY COMMUNICATIO; Robin RW, 2004, SUBST USE MISUSE, V39, P601, DOI 10.1081/JA-120030062; Salter C, 2013, AUST REV APPL LINGUI, V36, P316, DOI 10.1075/aral.36.3.06sal; Salter K, 2006, BRAIN INJURY, V20, P559, DOI 10.1080/02699050600744087; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Schlesinger CM, 2007, DRUG ALCOHOL REV, V26, P109, DOI 10.1080/09595230601146611; Smith K, 2007, AUSTRALAS J AGEING, V26, P115, DOI 10.1111/j.1741-6612.2007.00234.x; Squires J., 2009, AGES STAGES QUESTION, V3; Sutcliffe LM, 1998, CLIN REHABIL, V12, P506, DOI 10.1191/026921598672167702; Thommessen B, 1999, DISABIL REHABIL, V21, P110, DOI 10.1080/096382899297846; Thrift AG, 2011, STROKE, V42, P1501, DOI 10.1161/STROKEAHA.111.617746; Vindigni D, 2006, Rural Remote Health, V6, P321; Walshe M, 2009, INT J LANG COMM DIS, V44, P693, DOI 10.1080/13682820802317536; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Whurr R, 2011, APHASIA SCREENING TE; WILLIAMS JM, 1986, J CLIN PSYCHOL, V42, P156, DOI 10.1002/1097-4679(198601)42:1<156::AID-JCLP2270420126>3.0.CO;2-L; Wylie K, 2013, INT J SPEECH-LANG PA, V15, P1, DOI 10.3109/17549507.2012.745164; You JQ, 2015, INT J STROKE, V10, P716, DOI 10.1111/ijs.12429	70	8	8	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1754-9507	1754-9515		INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.		2017	19	3			SI		297	308		10.1080/17549507.2017.1290136			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	EV4MH	WOS:000401733900010	28425776	Green Submitted			2022-02-06	
J	Armstrong, RA; McKee, AC; Cairns, NJ				Armstrong, Richard A.; McKee, Ann C.; Cairns, Nigel J.			Pathology of the Superior Colliculus in Chronic Traumatic Encephalopathy	OPTOMETRY AND VISION SCIENCE			English	Article						chronic traumatic encephalopathy (CTE); superior colliculus; neurofibrillary tangles (NFT); neuronal loss; laminar distribution	PROGRESSIVE SUPRANUCLEAR PALSY; CREUTZFELDT-JAKOB-DISEASE; ALZHEIMERS-DISEASE; BRAIN-STEM; CORTICOBASAL DEGENERATION; HEAD-INJURY; NEUROPATHOLOGY; DEMENTIA; SPECTRUM; DEPOSITS	Purpose. To investigate neuropathological changes in the superior colliculus in chronic traumatic encephalopathy. Methods. The densities of the tau-immunoreactive neurofibrillary tangles, neuropil threads, dot-like grains, astrocytic tangles, and neuritic plaques, together with abnormally enlarged neurons, typical neurons, vacuolation, and frequency of contacts with blood vessels, were studied across the superior colliculus from pia mater to the periaqueductal gray in eight chronic traumatic encephalopathy and six control cases. Results. Tau-immunoreactive pathology was absent in the superior colliculus of controls but present in varying degrees in all chronic traumatic encephalopathy cases, significant densities of tau-immunoreactive neurofibrillary tangles, NT, or dot-like grains being present in three cases. No significant differences in overall density of the tau-immunoreactive neurofibrillary tangles, neuropil threads, dot-like grains, enlarged neurons, vacuoles, or contacts with blood vessels were observed in control and chronic traumatic encephalopathy cases, but chronic traumatic encephalopathy cases had significantly lower mean densities of neurons. The distribution of surviving neurons across the superior colliculus suggested greater neuronal loss in intermediate and lower laminae in chronic traumatic encephalopathy. Changes in density of the tauimmunoreactive pathology across the laminae were variable, but in six chronic traumatic encephalopathy cases, densities of tau-immunoreactive neurofibrillary tangles, neuropil threads, or dot-like grains were significantly greater in intermediate and lower laminae. Pathological changes were not correlated with the distribution of blood vessels. Conclusions. The data suggest significant pathology affecting the superior colliculus in a proportion of chronic traumatic encephalopathy cases with a laminar distribution which could compromise motor function rather than sensory analysis.	[Armstrong, Richard A.] Aston Univ, Vis Sci, Birmingham B4 7ET, W Midlands, England; [McKee, Ann C.] VA Boston Healthcare Syst, Dept Pathol & Lab Med, Boston, MA USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Cairns, Nigel J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Cairns, Nigel J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA		Armstrong, RA (corresponding author), Aston Univ, Vis Sci, Birmingham B4 7ET, W Midlands, England.	R.A.Armstrong@aston.ac.uk	Cairns, Nigel/AAB-9713-2020; Lang, Steven/AAE-8102-2021; Armstrong, Richard/AAU-4580-2020; Armstrong, Richard A/H-4557-2012	Cairns, Nigel/0000-0001-9858-3344; Lang, Steven/0000-0003-1669-9146; Armstrong, Richard/0000-0002-5046-3199; Armstrong, Richard A/0000-0002-5046-3199	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1UO1NS086659-01]; Department of Veterans AffairsUS Department of Veterans Affairs; Veterans Affairs Biorepository [CSP 501]; Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS); Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; National Institute of Aging Boston University Alzheimer's Disease Center [P30AG13846, 0572063345-5]; Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO from the National Institute on Aging [P50 AG05681, P01 AG03991]	The authors thank the use of the resources and facilities at the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, MA). We also gratefully acknowledge the help of all members of the chronic traumatic encephalopathy center at Boston University School of Medicine, VA Boston, and the Bedford VA and the individuals and families whose participation and contributions made this work possible. This work was supported by the National Institute of Neurological Disorders and Stroke (1UO1NS086659-01), Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501), the Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS), Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C), and the National Institute of Aging Boston University Alzheimer's Disease Center (P30AG13846; supplement 0572063345-5). This work was supported by the Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO (P50 AG05681 and P01 AG03991 from the National Institute on Aging). The authors have no associations, stock ownership, equity interests, patents, or licenses that could be perceived as a conflict of interest.	Armstrong R, 1999, NEUROPATHOLOGY, V19, P64, DOI 10.1046/j.1440-1789.1999.00219.x; Armstrong RA, 2007, J NEURAL TRANSM, V114, P1569, DOI 10.1007/s00702-007-0796-3; Armstrong RA, 2009, NEUROPATH APPL NEURO, V35, P36, DOI 10.1111/j.1365-2990.2008.00979.x; Armstrong RA, 2003, NEUROPATHOLOGY, V23, P245, DOI 10.1046/j.1440-1789.2003.00516.x; Armstrong RA, 2001, NEUROPATHOLOGY, V21, P266, DOI 10.1046/j.1440-1789.2001.00406.x; Armstrong RA, 1996, NEUROPATH APPL NEURO, V22, P527, DOI 10.1111/j.1365-2990.1996.tb01131.x; Armstrong RA, 2000, EXP NEUROL, V163, P348, DOI 10.1006/exnr.2000.7392; Armstrong RA, 2011, STAT ANAL MICROBIOLO; Armstrong RA, 2014, J NEURAL TRANSM, V121, P171, DOI 10.1007/s00702-013-1084-z; Armstrong RA, 2013, CLIN NEUROPATHOL, V32, P128, DOI 10.5414/NP300516; Brodal A., 1981, NEUROLOGICAL ANATOMY; Dugger BN, 2011, NEUROSCI LETT, V491, P122, DOI 10.1016/j.neulet.2011.01.020; DUYCKAERTS C, 1986, ACTA NEUROPATHOL, V70, P249, DOI 10.1007/BF00686079; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Hattori M, 2003, ACTA NEUROPATHOL, V106, P143, DOI 10.1007/s00401-003-0711-4; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Keller EL, 2008, PROG BRAIN RES, V171, P107, DOI 10.1016/S0079-6123(08)00614-6; Kieman PT, 2015, SEMIN NEUROL, V35, P20; Klier EM, 2003, J NEUROPHYSIOL, V89, P2839, DOI 10.1152/jn.00763.2002; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; LEUBA G, 1995, NEUROPATH APPL NEURO, V21, P410, DOI 10.1111/j.1365-2990.1995.tb01078.x; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Morcinek K, 2013, BRAIN RES, V1497, P73, DOI 10.1016/j.brainres.2012.12.016; Overk CR, 2009, NEUROBIOL DIS, V35, P415, DOI 10.1016/j.nbd.2009.06.004; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Snedecor G.W., 1980, STAT METHODS, V7th; Sprague JM, 1996, PROG BRAIN RES, V112, P1; Terao Y, 2013, CLIN NEUROPHYSIOL, V124, P354, DOI 10.1016/j.clinph.2012.07.008; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	44	8	8	4	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JAN	2017	94	1					33	42		10.1097/OPX.0000000000000911			10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	EM5ZZ	WOS:000395393900006	27391531	Green Accepted			2022-02-06	
J	Bedell, GM; Wade, SL; Turkstra, LS; Haarbauer-Krupa, J; King, JA				Bedell, Gary M.; Wade, Shari L.; Turkstra, Lyn S.; Haarbauer-Krupa, Juliet; King, Jessica A.			Informing design of an app-based coaching intervention to promote social participation of teenagers with traumatic brain injury	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Adolescents; rehabilitation; technology; tele-health; youth	MENTORING PROGRAM; CHILDREN; ADOLESCENTS; SCHOOL; YOUTH; COMPETENCE; PARENTS; COMMUNITY; TRIAL; RECOMMENDATIONS	Objective: To examine perspectives of multiple stakeholders to inform the design of an app-based coaching intervention to promote social participation in teenagers with traumatic brain injury (TBI).Methods: Teenagers and college students with and without TBI and parents of teenagers with TBI were recruited from two children's hospitals and two universities in the USA (n = 39). Data were collected via interviews, focus groups, and surveys and examined using descriptive statistics and content analyses. Results: Teenagers with TBI reported more social participation barriers and fewer strategies for addressing these barriers than teenagers without TBI. There was consensus across groups about the value of college student coaches and use of smartphones and apps. Participants expressed mixed views on the use of chat rooms and degree of parent involvement. Conclusion: Results provided insights about the possible benefits of the intervention, and informed its initial design (e.g., desired coach qualities, and type of coach training and supervision).	[Bedell, Gary M.] Tufts Univ, Dept Occupat Therapy, 574 Boston Ave,Room 216L, Medford, MA 02155 USA; [Wade, Shari L.; King, Jessica A.] Cincinnati Childrens Hosp & Med Ctr, Dept Phys Med & Rehabil, Cincinnati, OH USA; [Turkstra, Lyn S.] Univ Wisconsin, Neurosci Training Program, Dept Commun Sci & Disorders, Dept Surg, Madison, WI 53706 USA; [Haarbauer-Krupa, Juliet] Childrens Healthcare Atlanta, Div Rehabil Serv, Atlanta, GA USA		Bedell, GM (corresponding author), Tufts Univ, Dept Occupat Therapy, 574 Boston Ave,Room 216L, Medford, MA 02155 USA.	gary.bedell@tufts.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921; Bedell, Gary/0000-0002-9555-8861	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133G130272]; Center within the Administration for Community Living (ACL); Department of Health and Human Services (DHHS)	This research was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR, grant # H133G130272), a Center within the Administration for Community Living (ACL), Department of Health and Human Services (DHHS).	Agnihotri S, 2010, DEV NEUROREHABIL, V13, P369, DOI 10.3109/17518423.2010.499409; Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Baum F, 2006, J EPIDEMIOL COMMUN H, V60, P854, DOI 10.1136/jech.2004.028662; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bedell G, 2012, DEV SOCIAL NEUROSCIE, P185; Bedell GM, 2005, AM J OCCUP THER, V59, P273, DOI 10.5014/ajot.59.3.273; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; BERNDT TJ, 1979, DEV PSYCHOL, V15, P608, DOI 10.1037/0012-1649.15.6.608; Biklen S.K., 1997, QUALITATIVE RES ED; Boxer Paul, 2005, J Prim Prev, V26, P383, DOI 10.1007/s10935-005-0005-9; Braga LW, 2012, NEUROREHABILITATION, V30, P205, DOI 10.3233/NRE-2012-0746; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; DeMatteo CA, 2008, ARCH PHYS MED REHAB, V89, P1803, DOI 10.1016/j.apmr.2008.02.025; Dumas HM, 2003, INT J REHABIL RES, V26, P303, DOI 10.1097/00004356-200312000-00008; Eccles JS, 2003, J SOC ISSUES, V59, P865, DOI 10.1046/j.0022-4537.2003.00095.x; Epstein RM, 2011, ANN FAM MED, V9, P100, DOI 10.1370/afm.1239; Fraas M, 2010, BRAIN INJURY, V24, P50, DOI 10.3109/02699050903446781; Gan C, 2010, BRAIN INJURY, V24, P651, DOI 10.3109/02699051003692142; Gauvin-Lepage J, 2010, BRAIN INJURY, V24, P1087, DOI 10.3109/02699052.2010.494593; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; Graham F, 2009, AUST OCCUP THER J, V56, P16, DOI 10.1111/j.1440-1630.2008.00736.x; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Johnson K, 1998, BEHAV MODIF, V22, P502, DOI 10.1177/01454455980224004; Keller Thomas E, 2005, J Prim Prev, V26, P169, DOI 10.1007/s10935-005-1850-2; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kilov AM, 2010, BRAIN INJURY, V24, P1135, DOI 10.3109/02699052.2010.490511; Kolakowsky-Hayner SA, 2012, NEUROREHABILITATION, V31, P63, DOI 10.3233/NRE-2012-0775; Larson RW, 1999, PSYCHOL BULL, V125, P701, DOI 10.1037/0033-2909.125.6.701; Law M, 2011, BRAIN INJURY, V25, P587, DOI 10.3109/02699052.2011.572945; Lenhart A, 2015, TEEN SOCIAL MEDIA TE; Lincoln, 2002, QUALITATIVE INQUIRY, P327; Mahoney JL, 2003, J EDUC PSYCHOL, V95, P409, DOI 10.1037/0022-0663.95.2.409; McIntyre A., 2007, PARTICIPATORY ACTION; Mealings M, 2010, BRAIN IMPAIR, V11, P1, DOI 10.1375/brim.11.1.1; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Moreno MA, 2012, PEDIATR CLIN N AM, V59, P601, DOI 10.1016/j.pcl.2012.03.023; Moreno MA, 2011, DEPRESS ANXIETY, V28, P447, DOI 10.1002/da.20805; Mosa AM, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-67; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Palisano RJ, 2012, DISABIL REHABIL, V34, P1041, DOI 10.3109/09638288.2011.628740; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Rhodes JE, 2006, J COMMUNITY PSYCHOL, V34, P691, DOI 10.1002/jcop.20124; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Schulz R, 2012, P IEEE, V100, P2397, DOI 10.1109/JPROC.2012.2200558; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Struchen MA, 2014, HDB NEUROPSYCHOLOGY, P213, DOI DOI 10.1007/978; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Sumsion Thelma, 2006, Can J Occup Ther, V73, P153; TEASDALE G, 1974, LANCET, V2, P81; TURKSTRA L, 2007, NEUROPHYSIOLOGY NEUR, V17, P15, DOI DOI 10.1044/NNSLD17.3.15; van der Velden M, 2013, J AM MED INFORM ASSN, V20, P16, DOI 10.1136/amiajnl-2012-000949; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Williams RM, 2012, J HEAD TRAUMA REHAB, V27, P261, DOI 10.1097/HTR.0b013e3182585cb6; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Zand DH, 2009, J ADOLESCENCE, V32, P1, DOI 10.1016/j.adolescence.2007.12.006	63	8	8	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2017	20	7					408	417		10.1080/17518423.2016.1237584			10	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	FH8XS	WOS:000411489400002	27792407				2022-02-06	
J	Bottari, C; Gosselin, N; Chen, JK; Ptito, A				Bottari, Carolina; Gosselin, Nadia; Chen, Jen-Kai; Ptito, Alain			The impact of symptomatic mild traumatic brain injury on complex everyday activities and the link with alterations in cerebral functioning: Exploratory case studies	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Cognitive deficits; Neuropsychology; Brain injuries; Rehabilitation; Concussion	DORSOLATERAL PREFRONTAL CORTEX; SPORTS-RELATED CONCUSSION; MINOR HEAD-INJURY; WORKING-MEMORY; PSYCHOMETRIC PROPERTIES; IADL PROFILE; SCALE; INDEXES; ABNORMALITIES; DISABILITY	The objective of the study was to explore the neurophysiological correlates of altered functional independence using functional magnetic resonance imaging (fMRI) and event-related potentials (ERP) after a mild traumatic brain injury (mTBI). The participants consisted of three individuals with symptomatic mTBI (3.9 +/- 3.6 months post-mTBI) and 12 healthy controls. The main measures used were the Instrumental Activities of Daily Living (IADL) Profile observation-based assessment; a visual externally ordered working memory task combined to event-related potentials (ERP) and fMRI recordings; neuropsychological tests; post-concussion symptoms questionnaires; and the Activities of Daily Living (ADL) Profile interview. Compared to normal controls, all three patients had difficulty with a real-world complex budgeting activity due to deficits in planning, ineffective strategy use and/or a prolonged time to detect and correct errors. Reduced activations in the right mid-dorsolateral prefrontal cortex on fMRI as well as abnormal frontal or parietal components of the ERP occurred alongside these deficits. Results of this exploratory study suggest that reduced independence in complex everyday activities in symptomatic mTBI may be at least partly explained by a decrease in brain activation in the prefrontal cortex, abnormal ERP, or slower reaction times on working memory tasks. The study presents an initial attempt at combining research in neuroscience with ecological real-world evaluation research to further our understanding of the difficulties in complex everyday activities experienced by individuals with mTBI.	[Bottari, Carolina] Univ Montreal, Sch Rehabil, Montreal, PQ, Canada; [Bottari, Carolina] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Gosselin, Nadia] Montreal Sacred Heart Hosp Res Ctr, Montreal, PQ, Canada; [Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Chen, Jen-Kai; Ptito, Alain] Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ, Canada; [Chen, Jen-Kai; Ptito, Alain] McGill Univ, Dept Psychol, Ctr Hlth, Montreal, PQ, Canada; [Ptito, Alain] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada		Bottari, C (corresponding author), Univ Montreal, Sch Rehabil, Montreal, PQ, Canada.; Bottari, C (corresponding author), Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada.	carolina.bottari@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-86509]; Fonds de recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec	This work was supported by the Canadian Institutes of Health Research [Grant MOP-86509] to A.P. and fellowships to C.B. and N.G. and by the Fonds de recherche du Quebec-Sante (fellowship to J.K.C.).	*ADJ GEN OFF, 1944, MAN DIR SCOR; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Bottari C, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/837301; Bottari C, 2011, BRAIN INJURY, V25, P1306, DOI 10.3109/02699052.2011.624570; Bottari C, 2010, ARCH PHYS MED REHAB, V91, P734, DOI 10.1016/j.apmr.2009.12.023; Bottari C, 2009, NEUROPSYCHOL REHABIL, V19, P177, DOI 10.1080/09602010802188435; Bottari C, 2009, BRAIN INJURY, V23, P322, DOI 10.1080/02699050902788436; Bottari CL, 2010, CAN J OCCUP THER, V77, P90, DOI 10.2182/cjot.2010.77.2.5; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Culbertson WC., 2001, TOWER LONDON DREXEL; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Dutil E., 2005, ADL PROFILE DESCRIPT, V1; Dutil E., 1994, WORLD FED OCC THER 1; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jorn A. F., 2004, GENDER DIFFERENCES C, V32, P7, DOI [10.1016/j.intell.2003.08.001, DOI 10.1016/J.INTELL.2003.08.001]; Kaller CP, 2011, CEREB CORTEX, V21, P307, DOI 10.1093/cercor/bhq096; Kashindi G., 1998, COMPARAISON DEUX INS; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Luria A.R., 1973, WORKING BRAIN INTRO; PETRIDES M, 1995, J NEUROSCI, V15, P359; Petrides M, 2000, EXP BRAIN RES, V133, P44, DOI 10.1007/s002210000399; Petrides M, 2000, J NEUROSCI, V20, P7496; Piche J., 1998, 12 INT C WORLD FED O; Preece MHW, 2011, J NEUROL NEUROSUR PS, V82, P447, DOI 10.1136/jnnp.2010.215228; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D., 1955, MANUAL WECHSLER ADUL; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933	57	8	8	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2017	27	5			SI		871	890		10.1080/09602011.2015.1110528			20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	EU3IT	WOS:000400923300013	26648094				2022-02-06	
J	Brands, I; Custers, M; van Heugten, C				Brands, Ingrid; Custers, Maud; van Heugten, Caroline			Self-efficacy and quality of life after low-intensity neuropsychological rehabilitation: A pre-post intervention study	NEUROREHABILITATION			English	Article						Self-efficacy; neuropsychological rehabilitation; cognition; quality of life	RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; COGNITIVE RESERVE; SOCIAL-PARTICIPATION; STROKE PATIENTS; MANAGEMENT; PROGRAM; INDIVIDUALS; DISABILITY; BEHAVIOR	BACKGROUND: Being highly self-efficacious is a key factor in successful chronic disease self-management. It is unknown whether neuropsychological rehabilitation improves self-efficacy in managing the consequences of brain injury. OBJECTIVE: To investigate whether levels of general and brain injury specific self-efficacy and quality of life (QoL) increased after neuropsychological rehabilitation and whether cognitive performance was associated with self-efficacy. METHODS: We conducted a retrospective clinical cohort study of 62 patients with acquired brain injury and cognitive complaints with measurements before start and after completion of treatment. QoL was measured with the visual analogue scale (EQ VAS) of the EuroQol (EQ-5D); self-efficacy with the TBI Self-efficacy Questionnaire (SEsx) and the General Self-efficacy Scale (GSES). Cognitive performance was measured as a compound score of tests for memory, attention and information processing speed. RESULTS: Self-efficacy for managing brain injury-specific symptoms and QoL increased significantly after neuropsychological rehabilitation. Both general and brain injury-specific self-efficacy were positively associated with QoL after completion of the programme. Cognitive performance was not associated with self-efficacy for managing brain injury-specific symptoms nor with general self-efficacy. CONCLUSIONS: Self-efficacy and QoL improve after treatment. Further research is needed to identify the specific ingredients responsible for improvement of self-efficacy in patients with cognitive complaints.	[Brands, Ingrid; Custers, Maud] Libra Rehabil Med & Audiol, Dept Neurorehabil, Eindhoven, Netherlands; [Custers, Maud; van Heugten, Caroline] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [van Heugten, Caroline] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Maastricht, Netherlands		Brands, I (corresponding author), POB 1355, NL-5602 BJ Eindhoven, Netherlands.	i.brands@libranet.nl					Aben L, 2014, NEUROREHAB NEURAL RE, V28, P199, DOI 10.1177/1545968313478487; Aben L, 2013, NEUROREHAB NEURAL RE, V27, P110, DOI 10.1177/1545968312455222; Aben L, 2011, CEREBROVASC DIS, V31, P566, DOI 10.1159/000324627; Bandura A., 1997, SELF EFFICACY EXERCI; BOSSCHER RJ, 1997, NEDERLANDS TIJDSCHRI, V0052; Brands IMH, 2013, NEUROPSYCHOL REHABIL, V23, P202, DOI 10.1080/09602011.2012.734039; Brands I, 2014, ARCH PHYS MED REHAB, V95, P2327, DOI 10.1016/j.apmr.2014.06.006; Brands I, 2014, J REHABIL MED, V46, P869, DOI 10.2340/16501977-1849; Brands IMH, 2012, CLIN REHABIL, V26, P840, DOI 10.1177/0269215511432018; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Devlin NJ, 2007, EQ 5D VALUE SETS INV; Driver S, 2016, ARCH PHYS MED REHAB, V97, pS194, DOI 10.1016/j.apmr.2015.06.023; Driver S, 2012, BRAIN INJURY, V26, P1482, DOI 10.3109/02699052.2012.694568; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; Johnston M, 2007, DISABIL REHABIL, V29, P1117, DOI 10.1080/03323310600950411; Jones F, 2011, DISABIL REHABIL, V33, P797, DOI 10.3109/09638288.2010.511415; Jones F, 2009, CLIN REHABIL, V23, P522, DOI 10.1177/0269215508101749; Jongen PJ, 2015, MULT SCLER INT, V2015, DOI 10.1155/2015/960282; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Rey A, 1958, LEXAMEN CLINIQUE PSY; Rutterford NA, 2006, J INT NEUROPSYCH SOC, V12, P359, DOI 10.1017/S1355617706060450; Saan R. J., 1996, NEUROPSYCHOLOGISCHE; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Sheeran P, 2016, HEALTH PSYCHOL, V35, P1178, DOI 10.1037/hea0000387; SHERER M, 1982, PSYCHOL REP, V51, P663, DOI 10.2466/pr0.1982.51.2.663; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Warner G, 2015, DISABIL REHABIL, V37, P2141, DOI 10.3109/09638288.2014.996674; Wechsler D., 2008, WECHSLER ADULT INTEL; Wentink MM, 2016, NEUROPSYCHOL REHABIL, V26, P847, DOI 10.1080/09602011.2016.1162175; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	36	8	8	0	17	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2017	40	4					587	594		10.3233/NRE-171446			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EX7SC	WOS:000403447500014	28211828	Green Published			2022-02-06	
J	Brenner, LA; Hostetter, TA; Barnes, SM; Stearns-Yoder, KA; Soberay, KA; Forster, JE				Brenner, Lisa A.; Hostetter, Trisha A.; Barnes, Sean M.; Stearns-Yoder, Kelly A.; Soberay, Kelly A.; Forster, Jeri E.			Traumatic brain injury, psychiatric diagnoses, and suicide risk among Veterans seeking services related to homelessness	BRAIN INJURY			English	Article						Traumatic brain injury; suicide; homelessness; veterans	TBI IDENTIFICATION METHOD; SERIOUS MENTAL-ILLNESS; SUBSTANCE USE; US VETERANS; HEALTH-CARE; INDIVIDUALS; PEOPLE; RELIABILITY; BEHAVIORS; IDEATION	Objectives: To explore the differences in negative psychiatric outcomes (i.e. type and number of psychiatric diagnoses, suicide risk) among Veterans with and without a history of traumatic brain injury (TBI) seeking homeless services.& para;& para;Methods: Observational design with data collected at one time-point. Veterans seeking homeless services from two Veteran Affairs (VA) Medical Centres completed study measures (n = 309; 282 with a history of TBI and 27 without a history of TBI). Veterans participated in structured clinical interviews regarding psychiatric and TBI histories.& para;& para;Results: Those with a history of TBI met the criteria for significantly more psychiatric diagnoses (p = 0.0003), and were more likely to be at risk for suicide (p = 0.007) than those without a history of TBI.& para;& para;Conclusions: Even among the high-risk cohort of homeless Veterans, those with a history of TBI were found to be at even greater risk for negative psychiatric outcomes. Further research is required to determine if and how the history of TBI contributes to the inability to maintain stable housing. Moreover, the findings highlight both the importance of assessing for history of TBI among this cohort, and educating providers regarding how to address the needs related to injury sequelae.	[Brenner, Lisa A.; Hostetter, Trisha A.; Barnes, Sean M.; Stearns-Yoder, Kelly A.; Soberay, Kelly A.; Forster, Jeri E.] Denver Vet Affairs Med Ctr VAMC, Rocky Mt Mental Illness Res Educ & Clin Ctr MIRECC, Denver, CO USA; [Brenner, Lisa A.; Barnes, Sean M.] Univ Colorado, Sch Med, Dept Psychiat, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Neurol, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.; Stearns-Yoder, Kelly A.; Forster, Jeri E.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Soberay, Kelly A.] Mil Suicide Res Consortium, Denver, CO USA; [Forster, Jeri E.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA		Brenner, LA (corresponding author), Eastern Colorado Hlth Care Syst, Rocky Mt MIRECC, 1055 Clermont St, Denver, CO 80220 USA.	lisa.brenner@va.gov	Brenner, Lisa A./AAG-2442-2019		Rocky Mountain MIRECC	This work was supported by the Rocky Mountain MIRECC [N/A];	Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Barnes SM, 2015, J HEALTH CARE POOR U, V26, P92, DOI 10.1353/hpu.2015.0010; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Burt MR, 2001, HOUS POLICY DEBATE, V12, P737, DOI 10.1080/10511482.2001.9521428; Centers for Disease Control and Prevention  National Center for Injury Prevention and Control, 2010, TRAUMATIC BRAIN INJU; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Desai RA, 2003, J NERV MENT DIS, V191, P365, DOI 10.1097/00005053-200306000-00003; Douyon R, 1998, J NEUROPSYCH CLIN N, V10, P210, DOI 10.1176/jnp.10.2.210; Dunne EM, 2015, AM J ADDICTION, V24, P676, DOI 10.1111/ajad.12289; Ending Veteran Homelessness (US), 2015, HOM VET PROGR RES; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kushel MB, 2003, ARCH INTERN MED, V163, P2492, DOI 10.1001/archinte.163.20.2492; Lecrubier, 2010, MINI INT NEUROPSYCHI; LePage JP, 2014, PUBLIC HEALTH, V128, P985, DOI 10.1016/j.puhe.2014.07.004; O'Toole TP, 2003, J GEN INTERN MED, V18, P929, DOI 10.1046/j.1525-1497.2003.21209.x; Office of Community Planning and Development (US), 2013, 2014 ANN HOM ASS REP; Olson-Madden JH, 2014, ARCH PHYS MED REHAB, V95, P925, DOI 10.1016/j.apmr.2014.01.008; Olson-Madden JH, 2012, J HEAD TRAUMA REHAB, V27, P370, DOI 10.1097/HTR.0b013e318268d496; Padgett DK, 2006, RES SOCIAL WORK PRAC, V16, P74, DOI 10.1177/1049731505282593; Pearson C, 2009, J COMMUNITY PSYCHOL, V37, P404, DOI 10.1002/jcop.20303; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Russell LM, 2013, AM J PUBLIC HEALTH, V103, pS211, DOI 10.2105/AJPH.2013.301485; Schinka JA, 2012, AM J PUBLIC HEALTH, V102, pS147, DOI 10.2105/AJPH.2011.300436; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; Tsai J, 2015, EPIDEMIOL REV, V37, P177, DOI 10.1093/epirev/mxu004; United States Census Bureau (US), 2013, SEL SOC CHAR US 2013	32	8	8	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1731	1735		10.1080/02699052.2017.1376758			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500004	29064288				2022-02-06	
J	Bryson, CN; Cramer, RJ; Schmidt, AT				Bryson, Claire N.; Cramer, Robert J.; Schmidt, Adam T.			Traumatic brain injury and lifetime suicidality: Applying the interpersonal-psychological theory perspective	DEATH STUDIES			English	Article							MODERATED MULTIPLE-REGRESSION; PSYCHOMETRIC PROPERTIES; ACQUIRED CAPABILITY; CONSTRUCT-VALIDITY; BEHAVIOR; QUESTIONNAIRE; BELONGINGNESS; POPULATION; IDEATION; ADULTS	The present article investigates the traumatic brain injury (TBI)-suicide link, assessing whether (a) TBI accounts for variance in suicide risk, and (b) the interpersonal-psychological theory of suicide can be applied to TBI status. Matched case-control procedures applied to archival college student health data identified TBI and non-TBI subsamples (84 total). Individuals with a TBI possessed higher suicide risk than those without. Even accounting for the relative influence of strong suicide risk factors (i.e., depression, perceived burdensomeness, thwarted belongingness, and acquired capability), TBI was robustly associated with suicide risk. TBI history would be valuable to ascertain in assessing suicide risk.	[Bryson, Claire N.] Sam Houston State Univ, Dept Psychol & Philosophy, 1901 Ave 1,Suite 390, Huntsville, TX 77340 USA; [Cramer, Robert J.] Old Dominion Univ, Sch Community & Environm Hlth, Norfolk, VA USA; [Schmidt, Adam T.] Texas Tech Univ, Dept Psychol Sci, Lubbock, TX 79409 USA		Bryson, CN (corresponding author), Sam Houston State Univ, Dept Psychol & Philosophy, 1901 Ave 1,Suite 390, Huntsville, TX 77340 USA.	cnb023@shsu.edu		Cramer, Robert/0000-0001-9105-5565			Abramson LY., 2002, SUICIDE SCI, P17, DOI DOI 10.1007/0-306-47233-3_3; Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Beck A T, 1986, Ann N Y Acad Sci, V487, P90, DOI 10.1111/j.1749-6632.1986.tb27888.x; Bryan C, 2011, J CLIN PSYCHOL, V67, P856, DOI 10.1002/jclp.20808; Cramer RJ, 2016, DEATH STUD, V40, P383, DOI 10.1080/07481187.2016.1166161; Dalal DK, 2012, ORGAN RES METHODS, V15, P339, DOI 10.1177/1094428111430540; Dawson JF, 2006, J APPL PSYCHOL, V91, P917, DOI 10.1037/0021-9010.91.4.917; Dennis JP, 2011, J HEAD TRAUMA REHAB, V26, P244, DOI 10.1097/HTR.0b013e3182225528; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Hosmer DW, 2005, APPL LOGISTIC REGRES; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Niven Daniel J, 2012, Clin Epidemiol, V4, P99, DOI 10.2147/CLEP.S30816; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Ream GL, 2016, SUICIDE LIFE-THREAT, V46, P239, DOI 10.1111/sltb.12188; Ribeiro JD, 2013, J PSYCHOTHER INTEGR, V23, P207, DOI 10.1037/a0031416; Ribeiro JD, 2014, PSYCHOL ASSESSMENT, V26, P115, DOI 10.1037/a0034858; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Smith PN, 2013, PSYCHOL SERV, V10, P97, DOI 10.1037/a0030817; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tellier A, 1999, BRAIN INJURY, V13, P463; Van Orden KA, 2008, SUICIDE LIFE-THREAT, V38, P427, DOI 10.1521/suli.2008.38.4.427; Van Orden KA, 2008, J CONSULT CLIN PSYCH, V76, P72, DOI 10.1037/0022-006X.76.1.72; Van Orden KA, 2012, PSYCHOL ASSESSMENT, V24, P197, DOI 10.1037/a0025358; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613	33	8	8	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0748-1187	1091-7683		DEATH STUD	Death Stud.		2017	41	7					399	405		10.1080/07481187.2017.1320340			7	Psychology, Multidisciplinary; Social Issues; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Psychology; Social Issues; Biomedical Social Sciences	FN9ZB	WOS:000416400700001	28426348				2022-02-06	
J	Collings, LJ; Cook, NE; Porter, S; Kusch, C; Sun, J; Virji-Babul, N; Iverson, GL; Panenka, WJ				Collings, Laurel J.; Cook, Nathan E.; Porter, Shaun; Kusch, Cody; Sun, Jonathan; Virji-Babul, Naznin; Iverson, Grant L.; Panenka, William J.			Attention-deficit/hyperactivity disorder is associated with baseline child sport concussion assessment tool third edition scores in child hockey players	BRAIN INJURY			English	Article						Brain; concussion; Child-SCAT3; traumatic brain injury; cognition	DEFICIT HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; CLINICAL ARTICLE; TEST-PERFORMANCE; UNITED-STATES; ADHD; SYMPTOMS; RECOVERY; SCAT2	Objectives: The objectives of this study were to report baseline, preseason data for the Child-SCAT3, stratified by attention deficit hyperactivity disorder (ADHD) status, and examine group differences in Child-SCAT3 performance between children with and without ADHD.Design: Cross-sectional study.Methods: Young male hockey players (n=304), aged 8-12years, were administered the Child-SCAT3 during pre-season. Child-SCAT3 measures included a 20-item symptom scale, a Standardised Assessment of Concussion Child Version (SAC-C), a modified Balance Error Scoring System (m-BESS), a tandem gait task, and a coordination test.Results: Children with ADHD (n=20) endorsed significantly more symptoms (d=0.95) and greater symptom severity (d=1.13) compared to children without ADHD. No statistically significant differences were found between groups on Child-SCAT3 measures of cognitive or physical functioning (e.g. balance and coordination).Conclusions: ADHD should be considered when interpreting Child-SCAT3 scores, especially symptom reporting, in the context of concussion assessment. Better understanding of symptom reporting in uninjured child athletes with ADHD can inform the clinical interpretation of symptoms at baseline and following an actual or suspected concussion. Normative data for the Child-SCAT3 that is not stratified by or otherwise accounts for ADHD status should be used with caution when appraising performance of children with ADHD.	[Collings, Laurel J.; Iverson, Grant L.; Panenka, William J.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Collings, Laurel J.; Virji-Babul, Naznin; Panenka, William J.] Child & Family Res Inst, Vancouver, BC, Canada; [Cook, Nathan E.; Iverson, Grant L.] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Cook, Nathan E.] Massachusetts Gen Hosp, Dept Psychiat, Learning & Emot Assessment Program, Boston, MA 02114 USA; [Cook, Nathan E.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Porter, Shaun; Virji-Babul, Naznin] Djavad Mowafaghian Ctr Brain Hlth, Dept Phys Therapy, Vancouver, BC, Canada; [Kusch, Cody; Sun, Jonathan] Seafair Minor Hockey Assoc, Richmond, ON, Canada; [Virji-Babul, Naznin] Dajavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] Home Base, Boston, MA USA		Collings, LJ (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.; Collings, LJ (corresponding author), Child & Family Res Inst, Vancouver, BC, Canada.	laurel.collings@alumni.ubc.ca	Collings, Laurel/Q-8758-2018	Collings, Laurel/0000-0002-0989-005X; Iverson, Grant/0000-0001-7348-9570; Panenka, William/0000-0001-7143-6512; Virji-Babul, Naznin/0000-0002-8984-5848	ERIN fund, British Columbia Neuropsychiatry Program	This work was supported by the ERIN fund, British Columbia Neuropsychiatry Program.	Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; [Anonymous], 2013, Br J Sports Med, V47, P263; [Anonymous], 2013, DIAGN STAT MAN MENT, DOI 10.1176/appi.books.9780890425596; Biederman J, 1999, BIOL PSYCHIAT, V46, P1234, DOI 10.1016/S0006-3223(99)00192-4; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Brewer TL, 2002, RES NURS HEALTH, V25, P269, DOI 10.1002/nur.10045; Brooks BL, 2016, APPL NEUROPSYCH-CHIL, V5, P119, DOI 10.1080/21622965.2014.1003066; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cook NE, 2016, PM&R, V8, P1, DOI [10.1016/j.pmrj.2016.07.032, DOI 10.1016/J.PMRJ.2016.07.032]; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Ellis P. D, 2009, EFFECT SIZE CALCULAT; Farrar R, 2001, Optometry, V72, P441; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Gorman M, 2016, APPL NEUROPSYCH-CHIL, V2965, P1; Granet DB, 2005, STRABISMUS, V13, P163, DOI 10.1080/09273970500455436; Iverson GL, 2015, JAMA PEDIAT, V169, P1; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Jennings D, 2015, INT J SPORTS PHYS TH, V10, P667; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Miano S, 2016, CNS NEUROSCI THER, V22, P906, DOI 10.1111/cns.12573; Patel AV, 2007, J ATHL TRAINING, V42, P66; Porreca F, 2009, PAIN MED, V10, P654, DOI 10.1111/j.1526-4637.2009.00583.x; Porter S., 2015, BMJ OPEN SPORT EXERC, V1, DOI [10.1136/bmjsem-2015-000029, DOI 10.1136/BMJSEM-2015-000029]; Russell Vivienne Ann, 2011, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0935s54; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Spruyt K, 2011, EXPERT REV NEUROTHER, V11, P565, DOI [10.1586/ERN.11.7, 10.1586/ern.11.7]; Viggiano Davide, 2004, Neural Plasticity, V11, P97, DOI 10.1155/NP.2004.97; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	35	8	8	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	11					1479	1485		10.1080/02699052.2017.1377351			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GB	WOS:000415961200010	28980829				2022-02-06	
J	Dean, MP; Della Sala, S; Beschin, N; Cocchini, G				Dean, Michael P.; Della Sala, Sergio; Beschin, Nicoletta; Cocchini, Gianna			Anosognosia and self-correction of naming errors in aphasia	APHASIOLOGY			English	Article						Anosognosia; awareness; metacognition; executive function; self-monitoring; error detection	TRAUMATIC BRAIN-INJURY; SPEECH PRODUCTION; METACOGNITIVE KNOWLEDGE; IMPLICIT AWARENESS; ONLINE-AWARENESS; MOTOR IMPAIRMENT; COMPREHENSION; DEFICITS; STROKE; UNAWARENESS	Background: There has been comparatively little research into anosognosia for aphasia (a lack of awareness of acquired language deficits). Direct assessments of metacognitive awareness tend to rely on high levels of verbal competence and are difficult for people with aphasia to complete. Therefore, indirect measures of awareness have been considered, notably the person's self-correction of his or her naming errors. Different mechanisms for self-correction based in comprehension or production skills have been proposed. In addition, in other areas of cognition, the relationships between direct and indirect measures and underlying forms of awareness have not been clearly established. Aims: The aims of this study were: (a) to investigate the relationship between a direct and an indirect measure of awareness of aphasia, (b) to examine the role of executive functioning in performance on both assessment types, and (c) to examine the relationship between these measures and underlying language comprehension and production skills. Methods & Procedures: A total of 48 people with aphasia participated, drawn from rehabilitation hospital caseloads. Participants were assessed on a language battery, a non-verbal test of executive function, a direct measure of awareness (ratings of difficulties), and had self-correction behaviour examined in a 40-item naming test. Outcomes & Results: There was a trend relationship between performance on the direct and indirect measures. Both related to overall severity of language impairment, with more severely impaired people being less aware of their difficulties. The two measures, however, dissociated with respect to single-word production and comprehension scores: the direct measure related to production and not comprehension, while the indirect measure related to comprehension and not production. Executive functioning related only to the direct measure of metacognitive awareness. Within production scores, the rate of correction success rather than pre-correction naming rate was associated with metacognitive awareness. Conclusions: This study revealed different underlying bases, in language processes and executive function, for two measures of anosognosia for aphasia. When used to assess awareness of deficits, direct and indirect methods should not be regarded as equivalent.	[Dean, Michael P.] UCL, Div Psychol & Language Sci, London, England; [Della Sala, Sergio] Univ Edinburgh, Human Cognit Neurosci, Edinburgh, Midlothian, Scotland; [Della Sala, Sergio] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Psychol, Edinburgh, Midlothian, Scotland; [Beschin, Nicoletta] Gallarate Hosp, Neuropsychol Ctr, Rehabil Dept, Gallarate, Italy; [Cocchini, Gianna] Goldsmiths Univ London, Psychol Dept, London, England; [Cocchini, Gianna] Blackheath Brain Injury Rehabil & Disabil Serv, London, England		Cocchini, G (corresponding author), Goldsmiths Univ London, Psychol Dept, London, England.; Cocchini, G (corresponding author), Blackheath Brain Injury Rehabil & Disabil Serv, London, England.	g.cocchini@gold.ac.uk		Dean, Michael/0000-0003-2690-641X			Al Banna M, 2016, J NEUROL NEUROSUR PS, V87, P161, DOI 10.1136/jnnp-2015-310305; Alderson-Day B, 2015, PSYCHOL BULL, V141, P931, DOI 10.1037/bul0000021; Appelros P, 2007, ACTA NEUROL SCAND, V116, P15, DOI 10.1111/j.1600-0404.2006.00756.x; Barnes S, 2015, APHASIOLOGY, V29, P315, DOI 10.1080/02687038.2013.874547; Berti A, 1996, J Int Neuropsychol Soc, V2, P426; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Burgess P.W., 1997, HAYLING BRIXTON TEST; Canzano L, 2014, CORTEX, V61, P148, DOI 10.1016/j.cortex.2014.05.015; Cocchini G, 2013, J CLIN EXP NEUROPSYC, V35, P337, DOI 10.1080/13803395.2013.776008; Cocchini G, 2010, CLIN NEUROPSYCHOL, V24, P1379, DOI 10.1080/13854046.2010.524167; Cocchini G, 2010, NEUROPSYCHOLOGIA, V48, P1489, DOI 10.1016/j.neuropsychologia.2010.01.019; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; de Jong-Hagelstein M, 2012, J INT NEUROPSYCH SOC, V18, P1064, DOI 10.1017/S1355617712000811; Della Sala S, 2009, CLIN NEUROPSYCHOL, V23, P406, DOI 10.1080/13854040802251393; Dockree PM, 2015, J INT NEUROPSYCH SOC, V21, P473, DOI 10.1017/S1355617715000594; Fillingham JK, 2006, NEUROPSYCHOL REHABIL, V16, P129, DOI 10.1080/09602010443000254; Fotopoulou A, 2010, BRAIN, V133, P3564, DOI 10.1093/brain/awq233; Gasquoine PG, 2016, NEUROPSYCHOL REHABIL, V26, P261, DOI 10.1080/09602011.2015.1011665; Gauvin HS, 2016, NEUROIMAGE, V126, P96, DOI 10.1016/j.neuroimage.2015.11.037; Goverover Y, 2014, NEUROREHABILITATION, V35, P315, DOI 10.3233/NRE-141113; Hartsuiker RJ, 2001, COGNITIVE PSYCHOL, V42, P113, DOI 10.1006/cogp.2000.0744; Hernandez-Sacristan C, 2012, APHASIOLOGY, V26, P199, DOI 10.1080/02687038.2011.630456; Hesketh A, 2011, APHASIOLOGY, V25, P291, DOI 10.1080/02687038.2010.507818; Hoerold D, 2013, NEUROPSYCHOLOGIA, V51, P385, DOI 10.1016/j.neuropsychologia.2012.11.019; Jenkinson PM, 2011, J CLIN EXP NEUROPSYC, V33, P1079, DOI 10.1080/13803395.2011.596822; Kay J., 1992, PSYCHOLINGUISTIC ASS; Kertesz A., 2010, STUDY ANOSOGNOSIA; Koriat A, 2007, CAMB HANDB PSYCHOL, P289; LEBRUN Y, 1987, CORTEX, V23, P251, DOI 10.1016/S0010-9452(87)80035-7; Levelt W.J.M., 1989, SPEAKING INTENTION A; Logie RH, 2016, Q J EXP PSYCHOL, V69, P2093, DOI 10.1080/17470218.2015.1136657; Luzzatti C., 1991, AACHENER APHASIE TES; MacPherson S. E., 2015, HDB FRONTAL ASSESSME; MAHER LM, 1994, BRAIN LANG, V46, P402, DOI 10.1006/brln.1994.1022; Marshall J, 1998, BRAIN LANG, V63, P79, DOI 10.1006/brln.1997.1936; MARSHALL RC, 1982, BRAIN LANG, V15, P292, DOI 10.1016/0093-934X(82)90061-X; Mattioli F., 1992, NEUROPSYCHOL REHABIL, V2, P169, DOI [10.1080/09602019208401406, DOI 10.1080/09602019208401406]; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; Miller N, 2000, APHASIOLOGY, V14, P683, DOI 10.1080/026870300410946; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mograbi DC, 2013, COGN NEUROSCI-UK, V4, P181, DOI 10.1080/17588928.2013.833899; Moro V, 2011, BEHAV BRAIN RES, V225, P259, DOI 10.1016/j.bbr.2011.07.010; NICKELS L, 1995, CORTEX, V31, P209, DOI 10.1016/S0010-9452(13)80360-7; Nozari N, 2011, COGNITIVE PSYCHOL, V63, P1, DOI 10.1016/j.cogpsych.2011.05.001; Nurmi ME, 2014, CORTEX, V61, P43, DOI 10.1016/j.cortex.2014.04.008; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Postma A, 2000, COGNITION, V77, P97, DOI 10.1016/S0010-0277(00)00090-1; Prigatano G.P., 2010, STUDY ANOSOGNOSIA; Rautakoski P, 2008, APHASIOLOGY, V22, P1269, DOI 10.1080/02687030802374788; Rusch N, 2002, PSYCHIATR REHABIL J, V26, P23, DOI 10.2975/26.2002.23.32; Savage SA, 2015, J ALZHEIMERS DIS, V46, P187, DOI 10.3233/JAD-142703; SCHACTER DL, 1990, J CLIN EXP NEUROPSYC, V12, P155, DOI 10.1080/01688639008400962; SCHLENCK KJ, 1987, BRAIN LANG, V30, P226, DOI 10.1016/0093-934X(87)90100-3; Shimamura AP, 2000, CONSCIOUS COGN, V9, P313, DOI 10.1006/ccog.2000.0450; SHUREN JE, 1995, NEUROLOGY, V45, P376, DOI 10.1212/WNL.45.2.376; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Tompkins CA, 2006, APHASIOLOGY, V20, P684, DOI 10.1080/02687030500334076; Wilkinson R, 2007, J PRAGMATICS, V39, P542, DOI 10.1016/j.pragma.2006.07.010	60	8	8	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2017	31	7			SI		725	740		10.1080/02687038.2016.1239014			16	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	EV0VY	WOS:000401465700002		Green Accepted, Green Submitted			2022-02-06	
J	Deepika, A; Devi, BI; Shukla, D				Deepika, Akhil; Devi, B. Indira; Shukla, Dhaval			Predictive validity of disability rating scale in determining functional outcome in patients with severe traumatic brain injury	NEUROLOGY INDIA			English	Article						Disability rating scale; Glasgow outcome scale extended; traumatic brain injury	STRUCTURED INTERVIEWS; RELIABILITY	Background: Most patients with severe traumatic brain injury (TBI) are discharged when they have still not recovered completely. Many such patients are not available for follow up. Aims: We conducted this study to determine whether the condition at discharge from acute care setting, as assessed with disability rating scale (DRS), correlates with functional outcome at follow up. Settings and Design: This study was conducted at a Neurosurgical intensive care unit (ICU) of a tertiary care referral center. This was a prospective observational study. Materials and Methods: Patients admitted to ICU with a diagnosis of severe TBI were enrolled for the study. On the day of discharge, all patients underwent DRS assessment. A final assessment was performed using Glasgow outcome scale extended (GOSE) at 6 months after discharge from the hospital. Statistical Analysis: The correlation between the DRS scores at the time of discharge with DRS scores and GOSE categories at 6 months after discharge was determined using Spearman's rho correlation coefficient. Results: A total of 88 patients were recruited for the study. The correlation coefficient of DRS at discharge for DRS at 6 months was 0.536 and for GOSE was -0.553. The area under the curve of DRS score at discharge for predicting unfavorable outcome and mortality at 6 months was 0.770 and 0.820, respectively. Conclusion: The predictive validity of DRS is fair to good in determining GOSE at follow-up. Pending availability of a more accurate outcome assessment tool, DRS at discharge can be used as a surrogate outcome for GOSE at follow up.	[Deepika, Akhil] Natl Inst Mental Hlth & Neurosci, Dept Clin Neurosci, Bengaluru, Karnataka, India; [Devi, B. Indira; Shukla, Dhaval] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bengaluru 560029, Karnataka, India		Shukla, D (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bengaluru 560029, Karnataka, India.	neurodhaval@rediffmail.com					GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Gupta A, 2012, ANN INDIAN ACAD NEUR, V15, P120, DOI 10.4103/0972-2327.94995; Lu J, 2010, J NEUROTRAUM, V27, P843, DOI 10.1089/neu.2010.1293; McMillan TM, 2013, J NEUROTRAUM, V30, P970, DOI 10.1089/neu.2012.2703; NOVACK TA, 1991, J HEAD TRAUMA REHAB, V6, P69, DOI DOI 10.1097/00001199-199112000-00014; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SCRANTON J, 1970, Archives of Physical Medicine and Rehabilitation, V51, P1; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wright J, 2000, DISABILITY RATING SC	12	8	8	0	1	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	JAN-FEB	2017	65	1					83	86		10.4103/0028-3886.198228			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EM6DU	WOS:000395403800020	28084245				2022-02-06	
J	Dexheimer, JW; Kurowski, BG; Anders, SH; McClanahan, N; Wade, SL; Babcock, L				Dexheimer, Judith W.; Kurowski, Brad G.; Anders, Shilo H.; McClanahan, Nicole; Wade, Shari L.; Babcock, Lynn			Usability evaluation of the SMART application for youth with mTBI	INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS			English	Article						User-computer interface; Brain injuries; Tele health; Adolescents	PROBLEM-SOLVING INTERVENTION; PRELIMINARY EFFICACY; FAMILY INTERVENTION; SAMPLE-SIZES; ADOLESCENTS; CONCUSSION; CHILDREN; PROGRAM; INJURY; CARE	Objective: There is a dearth of evidence-based treatments available to address the significant morbidity associated with mild traumatic brain injury (mTBI). To address this gap, we designed a novel user-friendly, web-based application. We describe the preliminary evaluation of feasibility and usability of the application to promote recovery following mTBI in youth, the Self-Monitoring Activity-Restriction and Relaxation Treatment (SMART). SMART incorporates real-time recommendations for individualized symptom management and activity restriction along with training in cognitive-behavioral coping strategies. Methods: We conducted a usability evaluation to assess and modify the SMART system prior to further study and deployment. Children ages 11-18 years presenting to the emergency department were recruited after symptoms resolved. Usability was assessed using a 60-min think-aloud protocol of teens and parents describing their interaction with the application. Upon completion of the tasks, each participant also completed the system usability scale (SUS). Results: We performed tests with 4 parent/child dyads. The average age of the children was 13 years (standard deviation = 1.8). The parents were an average of 41.5 years old (standard deviation = 6.2). Research revealed that the participants were enthusiastic about the interactive portions of the tool particularly the video based sessions. Parents were concerned about the speed at which their child might move through the program and the children thought that the system required large amounts of reading. Based on user feedback, researchers modified SMART to include an audio file in every module and improved the system's aesthetic properties. The mean SUS score was 85, with high SUS scores (>68) indicating satisfactory usability. Conclusion: High initial usability and favorable user feedback provide a foundation for further iterative development and testing of the SMART application as a tool for managing recovery from concussion. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Dexheimer, Judith W.; McClanahan, Nicole; Babcock, Lynn] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, MLC 2008,3333 Burnet Ave, Cincinnati, OH 45229 USA; [Dexheimer, Judith W.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Kurowski, Brad G.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Anders, Shilo H.] Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA		Dexheimer, JW (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, MLC 2008,3333 Burnet Ave, Cincinnati, OH 45229 USA.	Judith.Dexheimer@cchmc.org		Babcock, Lynn/0000-0002-2658-6893	Ohio Department of Public Safety; Cincinnati Children's Research Foundation Place Outcomes Grant; National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683-01A1]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425, UL1TR000077, KL2TR001426] Funding Source: NIH RePORTER	This work was supported by the Ohio Department of Public Safety, Cincinnati Children's Research Foundation Place Outcomes Grant, National Institute for Child Health and Human DevelopmentK23HD074683-01A1, and Grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH).	Association for the Advancement of Medical Instrumentaiton (AAMI), 2009, HE75 ANSIAAMI; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Brooke J., 1996, USABILITY EVALUATION, P189, DOI DOI 10.1002/HBM.20701; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Carroll L. J., 2004, J REHABIL MED, V11, P3; Carroll L. J., 2004, J REHABIL MED, V8, P4; Centers for Disease Control and Prevention (CDC), 2003, C MILD TRAUM BRAIN I; Chrimes D, 2014, INT J MED INFORM, V83, P636, DOI 10.1016/j.ijmedinf.2014.05.002; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Eden J., 2006, EVALUATING HRSA TRAU; Faul M, 2010, TRAUMATIC BRAIN INJU; Faulkner L, 2003, BEHAV RES METH INS C, V35, P379, DOI 10.3758/BF03195514; Fritz F, 2012, INT J MED INFORM, V81, P303, DOI 10.1016/j.ijmedinf.2011.12.008; Goldberg L, 2011, AM J PREV MED, V40, pS187, DOI 10.1016/j.amepre.2011.01.009; Gormley GJ, 2011, MED TEACH, V33, pE522, DOI 10.3109/0142159X.2011.599889; Hevner A. R., 2007, SCANDINAVIAN J INFOR, V19, P4; (ISO) IOfS, 2008, 924110 ISO IOFS IEC; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kurowski B. G., 2015, J HEAD TRAUMA REHABI; LEWIS JR, 1994, HUM FACTORS, V36, P368, DOI 10.1177/001872089403600215; LEWIS JR, 2006, INTERACTIONS, V13, P29, DOI DOI 10.1145/1167948.1167973; Li AC, 2012, INT J MED INFORM, V81, P761, DOI 10.1016/j.ijmedinf.2012.02.009; Lovell M, 2000, IMPACT IMMEDIATE POS; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maroon JC, 2000, NEUROSURGERY, V47, P69; Meldrum D, 2012, DISABIL REHABIL-ASSI, V7, P205, DOI 10.3109/17483107.2011.616922; Nielsen J., 1994, USABILITY INSPECTION; Or CKL, 2009, J AM MED INFORM ASSN, V16, P550, DOI 10.1197/jamia.M2888; Patterson ES, 2006, HUM FACTORS, V48, P15, DOI 10.1518/001872006776412234; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Sauro J, 2012, QUANTIFYING THE USER EXPERIENCE: PRACTICAL STATISTICS FOR USER RESEARCH, P1; Sharp H., 2007, INTERACTION DESIGN H; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Standardization IOF, 1998, 924111 ISO; Stinson J, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1349; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2009, J PEDIATR PSYCHOL, V34, P517, DOI 10.1093/jpepsy/jsn081; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wade SL, 2004, BEHAV RES METH INS C, V36, P261, DOI 10.3758/BF03195572	44	8	8	1	30	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1386-5056	1872-8243		INT J MED INFORM	Int. J. Med. Inform.	JAN	2017	97						163	170		10.1016/j.ijmedinf.2016.10.007			8	Computer Science, Information Systems; Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Health Care Sciences & Services; Medical Informatics	EF7BQ	WOS:000390485500017	27919376	Green Accepted			2022-02-06	
J	Drapaca, CS				Drapaca, Corina S.			FRACTIONAL CALCULUS IN NEURONAL ELECTROMECHANICS	JOURNAL OF MECHANICS OF MATERIALS AND STRUCTURES			English	Article						fractional derivatives of variable order; entangled scales; Hamilton's principle; fractional calculus; Hodgkin-Huxley model; neuronal electromechanics; TBI	VARIABLE-ORDER; HAMILTONS PRINCIPLE; GLIAL-CELLS; OPERATORS; INJURY	Traumatic brain injuries (TBI) are among the leading causes of death and permanent disability worldwide. Recent experimental observations suggest that damage in brain tissue involves complex local as well as nonlocal chemomechanical interactions that happen on multiple spatiotemporal scales. Biomechanical models of TBI existing in the literature do not incorporate either electrochemical or multiscaling features. Given that neurons are the brain cells responsible for electrochemical signaling on multiplexed temporal scales we propose a novel mathematical model of neuronal electromechanics that uses a constrained Lagrangian formulation and Hamilton's principle to couple Newton's law of motion for a linear viscoelastic Kelvin-Voigt solid-state neuron and the classic Hodgkin-Huxley equations of the electronic neuron. We will use fractional order derivatives of variable order to model multiple temporal scales. Numerical simulations of possible damage dynamics in neurons due to mechanical trauma will be presented and discussed.	[Drapaca, Corina S.] Penn State Univ, Dept Engn Sci & Mech, University Pk, PA 16802 USA		Drapaca, CS (corresponding author), Penn State Univ, Dept Engn Sci & Mech, University Pk, PA 16802 USA.	csd12@psu.edu					Almeida R, 2013, SCI WORLD J, DOI 10.1155/2013/915437; Atanackovic TM, 2011, FRACT CALC APPL ANAL, V14, P94, DOI 10.2478/s13540-011-0007-7; Baleanu D., 2012, SERIES COMPLEXITY NO, V3; Centers for Disease Control and Prevention, 2016, TBI GET FACTS; Chicone C, 2002, ANN PHYS-BERLIN, V11, P309, DOI 10.1002/1521-3889(200204)11:4<309::AID-ANDP309>3.0.CO;2-A; Coimbra CFM, 2003, ANN PHYS-BERLIN, V12, P692, DOI 10.1002/andp.200310032; Coimbra CFM, 2002, J FLUID MECH, V469, P257, DOI 10.1017/S0022112002001829; Corbin EA, 2014, ANAL CHEM, V86, P4864, DOI 10.1021/ac5000625; Dayan P, 2001, THEORETICAL NEUROSCI; Doi M., 1988, THEORY POLYM DYNAMIC, V73; Drapaca CS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00271; Eisert J, 2010, REV MOD PHYS, V82, P277, DOI 10.1103/RevModPhys.82.277; Faul M, 2015, J HEAD TRAUMA REHAB, V30, pE96; Galley C. R., 2014, PRINCIPLE STATIONARY; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Grevesse T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09475; Hilfer R, 2001, APPL FRACTIONAL CALC; Hille B, 2001, ION CHANNELS EXCITAB, V3rd; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Koenig H., 1961, ELECTROMECHANICAL SY; Lorenzo CF, 2002, NONLINEAR DYNAM, V29, P57, DOI 10.1023/A:1016586905654; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Lundstrom BN, 2008, NAT NEUROSCI, V11, P1335, DOI 10.1038/nn.2212; Milici C., 2015, NEW METHODS PROBLEMS; Oldham K. B., 2006, FRACTIONAL CALCULUS; Park K, 2010, P NATL ACAD SCI USA, V107, P20691, DOI 10.1073/pnas.1011365107; Podlubny I., 1999, FRACTIONAL DIFFERENT; Samko S., 1993, FRACTIONAL INTEGRALS; Schiff SJ, 2012, COMPUT NEUROSCI-MIT, P1; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; SHAMPINE LF, 1989, SIAM J SCI STAT COMP, V10, P1010, DOI 10.1137/0910060; Sherief H, 2012, FRACT DYN CONTROL, P275; Soon CM, 2005, ANN PHYS-BERLIN, V14, P378, DOI 10.1002/andp.200410140; Sun HG, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S021812741250085X; Tarasov VE, 2011, NONLINEAR PHYS SCI, P1; Wei YN, 2014, J NEUROSCI, V34, P11733, DOI 10.1523/JNEUROSCI.0516-14.2014; West B. J., 2015, FRACTIONAL CALCULUS; Zou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073499	39	8	8	0	1	MATHEMATICAL SCIENCE PUBL	BERKELEY	UNIV CALIFORNIA, DEPT MATHEMATICS, BERKELEY, CA 94720-3840 USA	1559-3959			J MECH MATER STRUCT	J. Mech. Mater. Struct.	JAN	2017	12	1					35	55		10.2140/jomms.2017.12.35			21	Materials Science, Multidisciplinary; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Mechanics	EE5NN	WOS:000389655000004					2022-02-06	
J	Dunkel, J; Roth, C; Erbguth, F; Dietrich, W; Hugens-Penzel, M; Ferbert, A				Dunkel, Juliane; Roth, Christian; Erbguth, Frank; Dietrich, Wenke; Huegens-Penzel, Monika; Ferbert, Andreas			Cerebral Fat Embolism: Clinical Presentation, Diagnostic Steps and Long-Term Follow-Up	EUROPEAN NEUROLOGY			English	Article						Fat embolism; Outcome; Brain biopsy; MRI; Cerebral fat embolism	RESONANCE-IMAGING FINDINGS; DIFFUSION; EDEMA; MRI	Objective: Symptomatic cerebral fat embolism (CFE) is a rare complication that occurs after a traumatic injury or orthopaedic surgery and is diagnostically challenging. No data is currently available concerning long-term follow-up. Methods: We identified from medical records 9 patients with CFE and revised the clinical signs and the diagnostic process. We then analysed long-term follow-up data, targeting clinical course after discharge, neurological impairment, and current quality of life, using the Barthel index and the modified Rankin Scale. Results: All 9 patients initially showed severe neurological deficits, including disturbance of consciousness ranging from somnolence to coma. During the follow-up period for 3-58 months after the insult 2 patients had died. The 7 patients who remained alive had either recovered completely or showed only minor neurological deficits after rehabilitation. They were nearly independent in daily life and needed only minimal assistance. We performed the first brain biopsy in a patient with CFE. Conclusion: Most patients had a good outcome after long-term follow-up. In patients with an unexplained altered state of consciousness after a traumatic injury or an orthopaedic surgery, an MRI with diffusion-weighted imaging must be performed to uncover the characteristic pattern of disseminated hyperintense lesions in the white matter that are associated with CFE. (C) 2017 S. Karger AG, Basel	[Dunkel, Juliane; Roth, Christian; Ferbert, Andreas] Klinikum Kassel, Dept Neurol, Monchebergstr 41-43, DE-34125 Kassel, Germany; [Erbguth, Frank; Dietrich, Wenke] Klinikum Nurnberg Sud, Dept Neurol, Nurnberg, Germany; [Huegens-Penzel, Monika] Klinikum Kassel, Dept Neuroradiol, Kassel, Germany		Dunkel, J (corresponding author), Klinikum Kassel, Dept Neurol, Monchebergstr 41-43, DE-34125 Kassel, Germany.	juliane.dunkel@klinikum-kassel.de					Butteriss DJA, 2006, AM J NEURORADIOL, V27, P620; BYRICK RJ, 1994, AM J RESP CRIT CARE, V150, P1416, DOI 10.1164/ajrccm.150.5.7952570; Gurd A R, 1970, J Bone Joint Surg Br, V52, P732; GURD AR, 1972, LANCET, V2, P231; Johnson MJ, 1996, ORTHOPEDICS, V19, P41; KAMENAR E, 1980, STROKE, V11, P477, DOI 10.1161/01.STR.11.5.477; Karapanayiotides T, 2009, J NEUROL, V256, P1171, DOI 10.1007/s00415-009-5066-x; Kellogg RG, 2013, J NEUROSURG, V119, P1263, DOI 10.3171/2013.7.JNS13363; Kim HJ, 2002, AM J NEURORADIOL, V23, P1516; Kim HJ, 2001, INVEST RADIOL, V36, P460, DOI 10.1097/00004424-200108000-00005; Kuo KH, 2014, AM J NEURORADIOL, V35, P1052, DOI 10.3174/ajnr.A3605; Kwiatt Michael E, 2013, Int J Crit Illn Inj Sci, V3, P64, DOI 10.4103/2229-5151.109426; Marshall GB, 2004, CAN J NEUROL SCI, V31, P417, DOI 10.1017/S0317167100003565; Parizel PM, 2001, STROKE, V32, P2942, DOI 10.1161/str.32.12.2942; Pfeffer G, 2010, CAN J NEUROL SCI, V37, P128, DOI 10.1017/S0317167100009793; Ryu CW, 2005, ACTA RADIOL, V46, P528, DOI 10.1080/02841850510021481; SAKAMOTO T, 1983, NEURORADIOLOGY, V24, P283, DOI 10.1007/BF00333182; Simon AD, 2003, AM J NEURORADIOL, V24, P97; Stein PD, 2008, AM J MED SCI, V336, P472, DOI 10.1097/MAJ.0b013e318172f5d2; Suh SI, 2009, ARCH NEUROL-CHICAGO, V66, P1170, DOI 10.1001/archneurol.2009.173; Takahashi M, 1999, J TRAUMA, V46, P324, DOI 10.1097/00005373-199902000-00021	21	8	9	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0014-3022	1421-9913		EUR NEUROL	Eur. Neurol.		2017	78	3-4					181	187		10.1159/000479002			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH8YV	WOS:000411492900010	28898867				2022-02-06	
J	Francis, HM; Osborne-Crowley, K; McDonald, S				Francis, Heather M.; Osborne-Crowley, Katherine; McDonald, Skye			Validity and reliability of a questionnaire to assess social skills in traumatic brain injury: A preliminary study	BRAIN INJURY			English	Article						Social skills; social function; traumatic brain injury (TBI); questionnaire	CLOSED-HEAD-INJURY; FOLLOW-UP; PSYCHIATRIC SYMPTOMATOLOGY; EXECUTIVE DYSFUNCTION; EMOTION RECOGNITION; INHIBITORY CONTROL; PERCEPTION; SCALE; ADJUSTMENT; BEHAVIOR	Objective: To describe the reliability and validity of a new measure, the Soda! Skills Questionnaire for Traumatic Brain Injury (SSQ-TBI). Methods: Fifty-one adults with severe TBI completed the SSQ-TBI questionnaire. Scores were compared to informant- and self-report on questionnaires addressing frontal lobe mediated behaviour, as well as performance on an objective measure of social cognition and neuropsychological tasks, in order to provide evidence of concurrent, divergent and predictive validity. Results: Internal consistency was excellent at alpha = 0.90. Convergent validity was good, With informant ratings on the SSQ-TBI significantly correlated with Neuropsychiatric Inventory Disinhibition sub-scales (r = 0.50-63), the Current Behaviour Scale (r = 0.39-0.48) and Frontal Systems Behaviour Scale = 0.60-0:83). However, no relationship was seen with an objective measure of social skills or neuropsychological tasks of disinhibition. There was a significant relationship with real-world psychosocial outcomes on the Sydney Psythosocid Reintegration Scale-2 (r=-0.38-0.69) Conclusions: This study provides preliminary findings of good internal consistency and convergent and predictive validity of a social skills questionnaire adapted to be appropriate for individuals with TBI: Further assessment of psychometric, properties such as test-re-test reliability and factor structure is warranted.	[Francis, Heather M.; Osborne-Crowley, Katherine; McDonald, Skye] Univ New South Wales, Sch Psychol, Matthews Bldg, Sydney, NSW 2052, Australia		Francis, HM (corresponding author), Univ New South Wales, Sch Psychol, Matthews Bldg, Sydney, NSW 2052, Australia.	h.francis@unsw.edu.au		Osborne-Crowley, Katherine/0000-0003-0295-1849; Francis, Heather/0000-0002-7223-7782			ARBUCKLE TY, 1993, J GERONTOL, V48, pP225, DOI 10.1093/geronj/48.5.P225; Bigler E D, 1989, Brain Inj, V3, P73, DOI 10.3109/02699058909008077; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Monsalve BC, 2012, REV PSIQUIATR SALUD, V5, P160, DOI 10.1016/j.rpsm.2012.02.004; Cattran C, 2011, J CLIN EXP NEUROPSYC, V33, P672, DOI 10.1080/13803395.2010.550603; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Elsass L, 1989, DEV SCALE MEASURING; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Helps Y., 2008, HOSP SEPARATIONS DUE; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Hynes CA, 2011, SOC NEUROSCI-UK, V6, P599, DOI 10.1080/17470919.2011.584447; JOHNSON DA, 1987, BRIT J CLIN PSYCHOL, V26, P289, DOI 10.1111/j.2044-8260.1987.tb01362.x; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Long CJ, 1997, ADV MED PSYCHOTHERAP, V8, P59; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; LOWE MR, 1978, BEHAV THER, V9, P535, DOI 10.1016/S0005-7894(78)80126-9; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; McDonald S, 2010, J CLIN EXP NEUROPSYC, V32, P855, DOI 10.1080/13803391003596405; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; MILLER LS, 1984, BEHAV ASSESS, V6, P33; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Osborne-Crowley K, 2016, J CLIN EXP NEUROPSYC, V38, P341, DOI 10.1080/13803395.2015.1115824; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Roberts AC, 2000, CEREB CORTEX, V10, P252, DOI 10.1093/cercor/10.3.252; Roth RM, 2005, BRIEF A BEHAV RATING; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Stone VE, 2011, OXFORM HDB SOCIAL NE; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Velligan DI, 2002, PSYCHIAT RES, V113, P227, DOI 10.1016/S0165-1781(02)00264-0; von Hippel W, 2005, PSYCHOL SCI, V16, P497, DOI 10.1111/j.0956-7976.2005.01563.x; von Hippel W, 2000, PERS SOC PSYCHOL B, V26, P523, DOI 10.1177/0146167200267001; WALLANDER JL, 1985, BEHAV ASSESS, V7, P137; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; WechslerD, 2001, WECHSLER TEST ADULT; Whiteneck GG, 1992, GUIDE USE CHART CRAI; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson BA, 1996, BEHAV ASSESSEMENT DY	61	8	9	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					336	343		10.1080/02699052.2016.1250954			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900008	28102714	Green Submitted			2022-02-06	
J	Fu, YQ; Chong, SL; Lee, JH; Liu, CJ; Fu, S; Loh, TF; Ng, KC; Xu, F				Fu, Yue-qiang; Chong, Shu-Ling; Lee, Jan Hau; Liu, Cheng-jun; Fu, Sheng; Loh, Tsee Foong; Ng, Kee Chong; Xu, Feng			The impact of early hyperglycaemia on children with traumatic brain injury	BRAIN INJURY			English	Article						Children; hyperglycaemia; mortality; paediatric; traumatic brain injury	PERSISTENT HYPERGLYCEMIA; INTENSIVE-CARE; HEAD-INJURY; PREDICTOR; SEVERITY; SCORE	Objective: Hyperglycaemia is common amongst children with traumatic brain injury (TBI). We aim to investigate the association between early hyperglycaemia and poor clinical outcomes in children With Moderate to severe TBI. Methods: We performed a retrospective study in a tertiary paediatric hospital between May 2012 and October 2014 of all patients with TBI who were aged <16 years with a Glasgow Coma Scale (GCS) of <= 13. The primary outcome was death: Secondary outcomes were 14 ventilation-free, 14 paediatric intensive care unit (PICU)-free and 28 hospital-free days. We defined hyperglycaemia as glucose >11.1 mmol/L (200 mg/dL). Results: There were 109 patients with a median age of 54 months [inter-quartile range (IQR): 17-82]. Median glucose on arrival was 6.1 mmol/L (IQR: 5,2-9.8). Median GCS in Our cohort was 8 (IQR: 6-12). Multivariate logistic regression demonstrated that initial hyperglycaemia [odds ratio (OR): 15.23; 95% confidence interval (CI): 3.74-62.00; P < 0.001], and GCS <8 (OR: 13.02; 95% CI: 2.31-73.33; P = 0.004) were risk factors for Mortality. Multivariate linear regression showed that initial hyperglycaemia was a risk factor for reduced ventilation-free, PICU-free and hospital-free days. Conclusions: Early hyperglycaemia predicts for in-hospital mortality, reduced ventilation-free, PICU-free and hospital-free days in children with moderate to severe TBI.	[Fu, Yue-qiang; Liu, Cheng-jun; Xu, Feng] Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, Chongqing, Peoples R China; [Chong, Shu-Ling; Ng, Kee Chong] KK Womens & Childrens Hosp, Dept Childrens Emergency, Singapore, Singapore; [Chong, Shu-Ling; Lee, Jan Hau; Loh, Tsee Foong; Ng, Kee Chong] Duke NUS Med Sch, Singapore, Singapore; [Lee, Jan Hau; Loh, Tsee Foong] KK Womens & Childrens Hosp, Childrens Intens Care Unit, 100 Bukit Timah Rd, Singapore 229899, Singapore; [Fu, Sheng] KK Womens & Childrens Hosp, Dept Paediat, Singapore, Singapore		Lee, JH (corresponding author), KK Womens & Childrens Hosp, Childrens Intens Care Unit, 100 Bukit Timah Rd, Singapore 229899, Singapore.	lee.jan.hau@singhealth.com.sg		Lee, Jan Hau/0000-0002-8430-4217			Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Chong SL, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/719476; Elkon B, 2014, PEDIATR CRIT CARE ME, V15, P623, DOI 10.1097/PCC.0000000000000170; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Macrae D, 2014, NEW ENGL J MED, V370, P107, DOI 10.1056/NEJMoa1302564; Melo JRT, 2010, ACTA NEUROCHIR, V152, P1559, DOI 10.1007/s00701-010-0680-z; Muehlschlegel S, 2013, NEUROCRIT CARE, V18, P318, DOI 10.1007/s12028-013-9817-2; PARISH RA, 1988, J TRAUMA, V28, P517, DOI 10.1097/00005373-198804000-00017; Prisco L, 2012, J NEUROSURG SCI, V56, P131; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Saadat SMS, 2012, CHILD NERV SYST, V28, P1773, DOI 10.1007/s00381-012-1753-5; Salim A, 2009, AM SURGEON, V75, P25; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Stewart TC, 2013, J TRAUMA ACUTE CARE, V75, P836, DOI 10.1097/TA.0b013e3182a685b0; TEPAS JJ, 1988, J TRAUMA, V28, P425, DOI 10.1097/00005373-198804000-00001; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac	24	8	8	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					396	400		10.1080/02699052.2016.1264629			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900017	28296528				2022-02-06	
J	Gaasedelen, OJ; Whiteside, DM; Basso, M				Gaasedelen, Owen J.; Whiteside, Douglas M.; Basso, Michael			Exploring the sensitivity of the Personality Assessment Inventory symptom validity tests in detecting response bias in a mixed neuropsychological outpatient sample	CLINICAL NEUROPSYCHOLOGIST			English	Article						Personality Assessment Inventory; symptom validity; performance validity	TRAUMATIC BRAIN-INJURY; SUBOPTIMAL COGNITIVE EFFORT; NEGATIVE DISTORTION SCALE; FEIGNED MENTAL-DISORDERS; HENRY-HEILBRONNER INDEX; MEMORY MALINGERING TOMM; LARGE CLINICAL-SAMPLE; FAKE BAD SCALE; CLASSIFICATION ACCURACY; SUSPECT EFFORT	Objective: Few studies have evaluated the symptom validity tests (SVTs) within the Personality Assessment Inventory (PAI) in a neuropsychological assessment context. Accordingly, the present study explored the accuracy of PAI SVTs in identifying exaggerated cognitive dysfunction in a mixed sample of outpatients referred for neuropsychological assessment. Method: Participants who failed two or more Performance Validity Tests (PVTs) were classified as having exaggerated cognitive dysfunction (n=49). Their responses on PAI SVTs were compared to examinees who did not fail PVTs (n=257). Results: Multivariate analysis of variance indicated the Negative Impression Management (NIM) scale most strongly discriminated between those with exaggerated cognitive dysfunction from honest responders (Cohen's d=.58). Nonetheless, its classification accuracy was low (area under the curve [AUC]=.65). A k-means cluster analysis and a subsequent multinomial logistic regression indicated evidence for two distinct groups of exaggerators. In particular, one group seemed to exaggerate symptoms, whereas another presented in a defensive manner, implying that individuals with positive and NIM biases on the PAI were apt to display invalid performance on PVTs. Conclusions: Findings indicated that exaggerated cognitive dysfunction tends to be present when NIM is very high and that evidence exists for a defensive response style on the PAI in the context of PVT failure.	[Gaasedelen, Owen J.] Univ Iowa, Dept Psychol & Quantitat Fdn, Counseling Psychol, Iowa City, IA 52242 USA; [Whiteside, Douglas M.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Basso, Michael] Univ Tulsa, Dept Psychol, Tulsa, OK 74104 USA		Gaasedelen, OJ (corresponding author), Univ Iowa, Dept Psychol & Quantitat Fdn, Counseling Psychol, Iowa City, IA 52242 USA.	owen-gaasedelen@uiowa.edu	Basso, Michael/S-9587-2019; Whiteside, Douglas/AAK-6396-2020	Basso, Michael/0000-0002-0217-662X; Whiteside, Douglas/0000-0002-8454-4413			Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P101, DOI 10.1093/arclin/acr081; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Ben-Porath Y. S., 2012, INTERPRETING MMPI2RF, DOI 10.1076/jcen.26.1.125.23928; Boone K.B., 2007, ASSESSMENT FEIGNED C; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Butcher JN, 2001, MMPI 2 MANUAL ADM SC; Dionysus KE, 2011, ARCH CLIN NEUROPSYCH, V26, P81, DOI 10.1093/arclin/acq096; Duda R.O., 1973, PATTERN CLASSIFICATI; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2005, WORD MEMORY TEST WIN; Green P., 1996, WORD MEMORY TEST USE; Greiffenstein MF, 2003, CLIN NEUROPSYCHOL, V17, P561, DOI 10.1076/clin.17.4.561.27937; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P534, DOI 10.1080/13854040802232690; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Haggerty KA, 2007, CLIN NEUROPSYCHOL, V21, P917, DOI 10.1080/13854040600899724; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Iverson GL, 2007, CLIN NEUROPSYCHOL, V21, P532, DOI 10.1080/13854040600611392; Kaufman L., 1990, FINDING GROUPS DATA, DOI [10. 1002/SERIES1345, DOI 10.1002/SERIES1345]; Keiski MA, 2015, ASSESSMENT, V22, P233, DOI 10.1177/1073191114539380; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larrabee G. L., 2007, ASSESSMENT MALINGERE, P100; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Martin-Cannici C, 1995, ASSESSMENT, V2, P333, DOI [10.1177/1073191195002004004, DOI 10.1177/1073191195002004004]; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Mogge NL, 2010, J FORENSIC PSYCHI PS, V21, P77, DOI 10.1080/14789940903174253; Morey L.C., 2007, PERSONALITY ASSESSME; Patrick RE, 2014, ARCH CLIN NEUROPSYCH, V29, P754, DOI 10.1093/arclin/acu054; Rogers R, 1996, J PERS ASSESS, V67, P629, DOI 10.1207/s15327752jpa6703_15; Rogers R., 1992, THE SIRS TEST MANUAL; Rogers R, 2013, ASSESSMENT, V20, P36, DOI 10.1177/1073191112451493; Sumanti M, 2006, CLIN NEUROPSYCHOL, V20, P754, DOI 10.1080/13854040500428467; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Temple RO, 2003, CLIN NEUROPSYCHOL, V17, P402, DOI 10.1076/clin.17.3.402.18080; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Whiteside D, 2011, CLIN NEUROPSYCHOL, V25, P287, DOI 10.1080/13854046.2010.538436; Whiteside DM, 2015, CLIN NEUROPSYCHOL, V29, P788, DOI 10.1080/13854046.2015.1093660; Whiteside DM, 2009, CLIN NEUROPSYCHOL, V23, P523, DOI 10.1080/13854040802389169; Whitney KA, 2013, ARCH CLIN NEUROPSYCH, V28, P222, DOI 10.1093/arclin/act012; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P194, DOI 10.1093/arclin/acr015	48	8	8	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2017	31	5					844	856		10.1080/13854046.2017.1312700			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EY2WQ	WOS:000403833900003	28391774				2022-02-06	
J	Genova, HM; Genualdi, A; Goverover, Y; Chiaravalloti, ND; Marino, C; Lengenfelder, J				Genova, Helen M.; Genualdi, Andrew; Goverover, Yael; Chiaravalloti, Nancy D.; Marino, Cherylynn; Lengenfelder, Jeannie			An investigation of the impact of facial affect recognition impairments in moderate to severe TBI on fatigue, depression, and quality of life	SOCIAL NEUROSCIENCE			English	Article						Facial emotion identification task (FEIT); social cognition; emotional processing; traumatic brain injury; quality of life; fatigue	TRAUMATIC BRAIN-INJURY; EMOTION PERCEPTION; FUNCTIONAL OUTCOMES; INITIAL VALIDATION; SCHIZOPHRENIA; SATISFACTION; EXPRESSION	Individuals with moderate to severe traumatic brain injury (TBI) have been shown to experience significant problems in facial affect recognition (FAR). However, it is not known how these impairments relate to overall functioning and quality of life (QoL) following TBI. The aim of the current study was to test the hypothesis that worse performance on an FAR task would be associated with reduced QoL (related to social and emotional functioning), worse mood, and increased fatigue. Forty-seven individuals with TBI and 27 healthy controls (HCs) completed the facial emotion identification task (FEIT), as well as questionnaires assessing social and emotional QoL, mood, and fatigue. The TBI group performed significantly worse than HCs on the FEIT. A significant relationship between FAR and fatigue and QoL related to social and emotional functioning was documented, but in an unexpected direction: individuals who performed better on the FEIT reported poorer QoL and greater fatigue. Individuals who have better FAR may require increased effort to perform this task, and thus experience greater fatigue and poorer social and emotional QoL.	[Genova, Helen M.; Genualdi, Andrew; Goverover, Yael; Chiaravalloti, Nancy D.; Marino, Cherylynn; Lengenfelder, Jeannie] Kessler Fdn, W Orange, NJ USA; [Genova, Helen M.; Chiaravalloti, Nancy D.; Lengenfelder, Jeannie] Rutgers, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Goverover, Yael] NYU, Dept Occupat Therapy, New York, NY USA; [Marino, Cherylynn] Childrens Specialized Hosp, Mountainside, NJ USA		Genova, HM (corresponding author), 300 Execut Dr Suite 70, W Orange, NJ 07052 USA.	hgenova@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567	New Jersey Commission on Brain Injury Research (NJBIR) [10-3218-BIR-E-0, CBIR13IRG026]	This research was funded by the New Jersey Commission on Brain Injury Research (NJBIR): [research grants 10-3218-BIR-E-0 (JL) and CBIR13IRG026 (JL and HG)].	Biszak AM, 2014, BRAIN INJURY, V28, P97, DOI 10.3109/02699052.2013.856475; Chiou K. S., J HEAD TRAU IN PRESS; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Fischer JS, 1999, MULT SCLER J, V5, P251, DOI 10.1177/135245859900500410; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Fulford D, 2014, J AFFECT DISORDERS, V152, P491, DOI 10.1016/j.jad.2013.08.034; Goverover Y, 2014, BRAIN INJURY, V28, P174, DOI 10.3109/02699052.2013.860474; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hofer A, 2009, EUR PSYCHIAT, V24, P27, DOI 10.1016/j.eurpsy.2008.06.008; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KERR SL, 1993, J ABNORM PSYCHOL, V102, P312, DOI 10.1037/0021-843X.102.2.312; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Saban KL, 2016, BIOL RES NURS, V18, P50, DOI 10.1177/1099800414568661; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21	24	8	8	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1747-0919	1747-0927		SOC NEUROSCI-UK	Soc. Neurosci.		2017	12	3					303	307		10.1080/17470919.2016.1173584			5	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	ES5SF	WOS:000399603200007	27052026				2022-02-06	
J	Gu, M; Kawoos, U; McCarron, R; Chavko, M				Gu, Ming; Kawoos, Usmah; McCarron, Richard; Chavko, Mikulas			Protection against Blast-Induced Traumatic Brain Injury by Increase in Brain Volume	BIOMED RESEARCH INTERNATIONAL			English	Article							RAT MODEL; OXIDATIVE STRESS; ENDOTHELIN-1; SHOCK; MICROCIRCULATION; INFLAMMATION; EXPRESSION; MITIGATION; NONIMPACT; PATHOLOGY	Blast-induced traumatic brain injury (bTBI) is a leading cause of injuries in recent military conflicts and it is responsible for an increased number of civilian casualties by terrorist attacks. bTBI includes a variety of neuropathological changes depending on the intensity of blast overpressure (BOP) such as brain edema, neuronal degeneration, diffuse axonal damage, and vascular dysfunction with neurological manifestations of psychological and cognitive abnormalities. Internal jugular vein (IJV) compression is known to reduce intracranial compliance by causing an increase in brain volume and was shown to reduce brain damage during closed impact-induced TBI. We investigated whether IJV compression can attenuate signs of TBI in rats after exposure to BOP. Animals were exposed to three 110 perpendicular to 5 kPa BOPs separated by 30 min intervals. Exposure to BOP resulted in a significant decrease of neuronal nuclei (NeuN) together with upregulation of aquaporin-4 (AQP-4), 3-nitrotyrosine (3-NT), and endothelin 1 receptor A (ETRA) expression in frontal cortex and hippocampus one day following exposures. IJV compression attenuated this BOP-induced increase in 3-NT in cortex and ameliorated the upregulation of AQP-4 in hippocampus. These results suggest that elevated intracranial pressure and intracerebral volume have neuroprotective potential in blast-induced TBI.	[Gu, Ming; Kawoos, Usmah; McCarron, Richard; Chavko, Mikulas] US Navy, Med Res Ctr, NeuroTrauma Dept, Silver Spring, MD 20910 USA; [McCarron, Richard] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [McCarron, Richard] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA		Gu, M (corresponding author), US Navy, Med Res Ctr, NeuroTrauma Dept, Silver Spring, MD 20910 USA.	ming.gu.ctr@mail.mil			Office of Naval Research (ONR) Work UnitOffice of Naval Research [601152N.0000.000.A1308]	This work was supported by Office of Naval Research (ONR) Work Unit (601152N.0000.000.A1308).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Armstead WM, 2011, NEUROL RES, V33, P133, DOI 10.1179/016164111X12881719352174; Assari S., 2013, P 9 ANN INJ BIOM S C; Bachschmid MM, 2013, ANN MED, V45, P17, DOI 10.3109/07853890.2011.645498; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Carey ME, 2000, NEUROSURGERY, V47, P678, DOI 10.1097/00006123-200009000-00031; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Chavko M, 2008, J TRAUMA, V65, P1140, DOI 10.1097/TA.0b013e3181870a8c; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039353; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Chou CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059409; Curley KC, 2011, NEUROIMAGE, V54, pS14, DOI 10.1016/S1053-8119(10)01668-X; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Feng K, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00179; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Ibrahim R. A., 2001, APPL MECH REV, V54, P133, DOI DOI 10.1115/1.3097293; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kallakuri S, 2010, NEUROSCIENCE, V168, P820, DOI 10.1016/j.neuroscience.2010.01.018; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Leonardi AD, 2013, ANN BIOMED ENG, V41, P2488, DOI 10.1007/s10439-013-0850-2; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; Lucke-Wold B. P., 2015, TRANSL RES, V166; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; Rafols JA, 2007, NEUROL RES, V29, P339, DOI 10.1179/016164107X204648; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Sook-Kyung CK, 2011, FRONT NEUROL, V2, P1; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Steiner J, 2004, NITRIC OXIDE-BIOL CH, V10, P162, DOI 10.1016/j.niox.2004.03.005; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vuceljic Marina, 2006, Vojnosanit Pregl, V63, P545, DOI 10.2298/VSP0606545V; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zhang YM, 2014, NEUROCHEM RES, V39, P950, DOI 10.1007/s11064-014-1292-4	55	8	8	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2017	2017								2075463	10.1155/2017/2075463			10	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	EW1XF	WOS:000402288200001	28553646	Green Published, gold, Green Submitted			2022-02-06	
J	Hatefi, M; Behzadi, S; Dastjerdi, MM; Ghahnavieh, AA; Rahmani, A; Mahdizadeh, F; Ahmadi, MRH; Asadollahi, K				Hatefi, Masoud; Behzadi, Someyeh; Dastjerdi, Masoud Moghadas; Ghahnavieh, Alireza Abootalebi; Rahmani, Asghar; Mahdizadeh, Fatemeh; Ahmadi, Mohammad Reza Hafezi; Asadollahi, Khairollah			Correlation of Homocysteine with Cerebral Hemodynamic Abnormality, Endothelial Dysfunction Markers, and Cognition Impairment in Patients with Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Cerebral hemodynamics; Cognition impairment; Endothelial dysfunction; Homocysteine; Traumatic brain injury	TRANSCRANIAL DOPPLER; HEAD-INJURY; RISK-FACTOR; DISEASE; DISORDERS; HYPERHOMOCYSTEINEMIA; COMMUNICATION; CELLS	OBJECTIVE: This study aimed to assess any correlation between serum levels of homocysteine (Hcy) and markers of cerebral hemodynamics, endothelial dysfunction, and cognition impairment in patients with traumatic brain injury (TBI). METHODS: By a cross-sectional study, all clinical data and serum levels of homocysteine of 85 TBI patients were collected. The pulsatility indices (PIs) of the middle cerebral artery were recorded by transcranial color-coded Doppler ultrasonography and cerebrovascular reactivity was measured by the increase in middle cerebral artery flow velocity in response to 5% inhaled CO2. Serum levels of intercellular adhesion molecule-1 (ICAM-1) and vascular adhesion moleculee1 (VCAM-1), cognition status by Montreal Cognitive Assessment, and Mini-Mental State Examination were measured in all participants. RESULTS: Totally, 85 patients including 51.76% male and the mean age of 54.48 years were studied. The level of Hcy in patients who died in the hospital or during 6 months after TBI was significantly higher than in survivors (P = 0.045, P = 0.020, respectively). Also, the levels of ICAM-1, VCAM-1, and PI in deceased patients were higher than their figures in survivors in both hospital and 6-month follow-ups (P = 0.450, P = 0.000; P = 0.072, P = 0.000, P = 0.090, and P = 0.000, respectively). Cerebrovascular reactivity in deceased patients was significantly lower than that in alive individuals (P = 0.008 and P = 0.000, respectively). A significant correlation was found between Hcy with cognition impairment according to Montreal Cognitive Assessment, Mini-Mental State Examination, and cerebral hemodynamic status according to PI (P = 0.000 for all). Also, this correlation was shown between Hcy with ICAM-1 and VCAM-1 in hospital and 6-month follow-ups (P = 0.000 for both). CONCLUSION: Hcy has a significant correlation with markers of cerebrovascular, endothelial, and cognition abnormality in TBI patients.	[Hatefi, Masoud] Ilam Univ Med Sci, Fac Med, Dept Neurosurg, Ilam, Iran; [Behzadi, Someyeh] Ilam Univ Med Sci, Fac Med, Dept Radiol, Ilam, Iran; [Mahdizadeh, Fatemeh] Ilam Univ Med Sci, Fac Med, Dept Emergency Med, Ilam, Iran; [Ahmadi, Mohammad Reza Hafezi] Ilam Univ Med Sci, Fac Med, Dept Pathol, Ilam, Iran; [Asadollahi, Khairollah] Ilam Univ Med Sci, Fac Med, Dept Social Med, Ilam, Iran; [Dastjerdi, Masoud Moghadas; Ghahnavieh, Alireza Abootalebi] Isfahan Univ Med Sci, Fac Med, Dept Emergency Med, Esfahan, Iran; [Rahmani, Asghar] Ilam Univ Med Sci, Student Res Comm, Fac Med, Ilam, Iran		Ahmadi, MRH (corresponding author), Ilam Univ Med Sci, Fac Med, Dept Pathol, Ilam, Iran.	reza.ahmadi56@yahoo.com	Abootalebi, Alireza/AAW-6871-2021; asadollahi, khairollah/A-8011-2011; Asadollahi, Khairollah/AAB-9898-2020	Abootalebi, Alireza/0000-0003-0775-2910; asadollahi, khairollah/0000-0001-7701-1558; Asadollahi, Khairollah/0000-0001-7701-1558; Hatafi, Masoud/0000-0002-1529-2419	Ilam University of Medical Sciences, Ilam, Iran	Ilam University of Medical Sciences, Ilam, Iran, supported this study. The authors do not have any actual or potential conflict of interests in this study.	BOERS GHJ, 1985, NEW ENGL J MED, V313, P709, DOI 10.1056/NEJM198509193131201; Borgaro SR, 2004, BRAIN INJURY, V18, P33, DOI 10.1080/0269905031000110562; Bouzat P, 2011, NEUROSURGERY, V68, P1603, DOI 10.1227/NEU.0b013e31820cd43e; Brundel M, 2012, J DIABETES COMPLICAT, V26, P205, DOI 10.1016/j.jdiacomp.2012.03.021; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Deb S, 1999, AM J PSYCHIAT, V156, P374; Duthie SJ, 2002, AM J CLIN NUTR, V75, P908, DOI 10.1093/ajcn/75.5.908; Erol A, 2007, ENDOTHELIUM-J ENDOTH, V14, P157, DOI 10.1080/10623320701421487; HARKER LA, 1974, NEW ENGL J MED, V291, P537, DOI 10.1056/NEJM197409122911101; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Liang Huiying, 2015, Zhongguo Zhen Jiu, V35, P865; Lim MH, 2009, STROKE, V40, P3216, DOI 10.1161/STROKEAHA.109.558403; Lu CY, 2015, BIOSCI TRENDS, V9, P138, DOI 10.5582/bst.2015.01066; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Maron BA, 2009, ANNU REV MED, V60, P39, DOI 10.1146/annurev.med.60.041807.123308; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Marshall RS, 2003, STROKE, V34, P945, DOI 10.1161/01.STR.0000062351.66804.1C; Moreno J A, 2000, Neurosurg Focus, V8, pe8; Mudd SH, 2000, ARTERIOSCL THROM VAS, V20, P1704, DOI 10.1161/01.ATV.20.7.1704; Mujumdar VS, 2001, J CELL BIOCHEM, V82, P491, DOI 10.1002/jcb.1175; MUNDAY R, 1989, FREE RADICAL BIO MED, V7, P659, DOI 10.1016/0891-5849(89)90147-0; Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Petras M, 2014, J PHYSIOL PHARMACOL, V65, P15; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Rahmani A, 2016, WORLD NEUROSURG, V87, P507, DOI 10.1016/j.wneu.2015.09.016; Reutens S, 2002, INT J GERIATR PSYCH, V17, P859, DOI 10.1002/gps.723; Sachdev Perminder, 2004, Rev. Bras. Psiquiatr., V26, P50, DOI 10.1590/S1516-44462004000100013; Silverberg ND, 2013, ARCH CLIN NEUROPSYCH, V28, P485, DOI 10.1093/arclin/act023; Tsai SJ, 2009, PARKINSONISM RELAT D, V15, P94, DOI 10.1016/j.parkreldis.2008.03.007; Tyagi N, 2010, NEUROCHEM INT, V56, P301, DOI 10.1016/j.neuint.2009.11.002; Villalba N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001474; Wang KW, 2014, ANN CLIN LAB SCI, V44, P145; Yu GX, 2014, J NEUROTRAUM, V31, P739, DOI 10.1089/neu.2013.3187; Zhang FY, 1998, AM J PHYSIOL-REG I, V274, pR1704, DOI 10.1152/ajpregu.1998.274.6.R1704; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	41	8	8	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2017	97						70	79		10.1016/j.wneu.2016.09.080			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EO1HO	WOS:000396449400011	27693818				2022-02-06	
J	He, TR; Santhanam, AVR; Lu, T; d'Uscio, LV; Katusic, ZS				He, Tongrong; Santhanam, Anantha Vijay R.; Lu, Tong; d'Uscio, Livius V.; Katusic, Zvonimir S.			Role of prostacyclin signaling in endothelial production of soluble amyloid precursor protein-alpha in cerebral microvessels	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						ADAM10; APP; PPAR delta; sAPP alpha; endothelium	ACTIVATED-RECEPTOR-DELTA; NECROSIS-FACTOR-ALPHA; TRAUMATIC BRAIN-INJURY; FATTY-ACID OXIDATION; PROGENITOR CELLS; RAT-BRAIN; SECRETASE CLEAVAGE; ALZHEIMERS-DISEASE; INHIBITOR DOMAIN; TRANSGENIC MICE	We tested hypothesis that activation of the prostacyclin (PGI(2)) receptor (IP receptor) signaling pathway in cerebral microvessels plays an important role in the metabolism of amyloid precursor protein (APP). In human brain microvascular endothelial cells activation of IP receptor with the stable analogue of PGI(2), iloprost, stimulated expression of amyloid precursor protein and a disintegrin and metalloprotease 10 (ADAM10), resulting in an increased production of the neuroprotective and anticoagulant molecule, soluble APP alpha (sAPP alpha). Selective agonist of IP receptor, cicaprost, and adenylyl cyclase activator, forskolin, also enhanced expression of amyloid precursor protein and ADAM10. Notably, in cerebral microvessels of IP receptor knockout mice, protein levels of APP and ADAM10 were reduced. In addition, iloprost increased protein levels of peroxisome proliferator-activated receptor delta (PPAR delta) in human brain microvascular endothelial cells. PPAR delta-siRNA abolished iloprost-augmented protein expression of ADAM10. In contrast, GW501516 (a selective agonist of PPAR delta) upregulated ADAM10 and increased production of sAPP alpha. Genetic deletion of endothelial PPAR delta (ePPAR delta(-/-)) in mice significantly reduced cerebral microvascular expression of ADAM10 and production of sAPP alpha. In vivo treatment with GW501516 increased sAPP alpha content in hippocampus of wild type mice but not in hippocampus of ePPAR delta(-/-) mice. Our findings identified previously unrecognized role of IP-PPAR delta signal transduction pathway in the production of sAPP alpha in cerebral microvasculature.	[He, Tongrong; Santhanam, Anantha Vijay R.; d'Uscio, Livius V.; Katusic, Zvonimir S.] Mayo Clin, Dept Anesthesiol & Mol Pharmacol & Expt Therapeut, Coll Med, Rochester, MN USA; [Lu, Tong] Mayo Clin, Dept Internal Med, Coll Med, Rochester, MN USA		Katusic, ZS (corresponding author), Mayo Clin, Joseph Bldg 4-184,200 First St SW, Rochester, MN 55905 USA.	katusic.zvonimir@mayo.edu	Lu, Tong/A-7745-2009	Lu, Tong/0000-0002-2393-7643	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL-91867, HL-111062]; Mayo Foundation; American Diabetes AssociationAmerican Diabetes Association [1-12-BS-119]	This work was supported by National Institutes of Health (NIH) Grants HL-91867 and HL-111062 and the Mayo Foundation (to Z. S. Katusic), and American Diabetes Association Grant 1-12-BS-119 (to T. Lu).	ABE K, 1991, NEUROSCI LETT, V125, P172, DOI 10.1016/0304-3940(91)90020-T; Barbieri SS, 2012, CIRCULATION, V126, P1373, DOI 10.1161/CIRCULATIONAHA.112.097295; Barish GD, 2008, P NATL ACAD SCI USA, V105, P4271, DOI 10.1073/pnas.0711875105; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Chao XD, 2014, J STROKE CEREBROVASC, V23, P1396, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.021; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; d'Uscio LV, 2014, AM J PHYSIOL-HEART C, V306, pH1001, DOI 10.1152/ajpheart.00761.2013; d'Uscio LV, 2012, CARDIOVASC RES, V96, P504, DOI 10.1093/cvr/cvs266; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Ding Y, 2004, NEUROSCIENCE, V124, P583, DOI 10.1016/j.neuroscience.2003.12.029; Ehrenborg E, 2013, ATHEROSCLEROSIS, V231, P95, DOI 10.1016/j.atherosclerosis.2013.08.027; Erickson MA, 2014, J PHARMACOL EXP THER, V349, P497, DOI 10.1124/jpet.114.213074; Fang YC, 2006, J CEREBR BLOOD F MET, V26, P491, DOI 10.1038/sj.jcbfm.9600205; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Genini D, 2008, PPAR RES, V2008, DOI 10.1155/2008/195065; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Goldberg JS, 2009, REGEN MED, V4, P879, DOI 10.2217/RME.09.61; Guo Q, 1998, J BIOL CHEM, V273, P12341, DOI 10.1074/jbc.273.20.12341; Hansen JB, 2001, J BIOL CHEM, V276, P3175, DOI 10.1074/jbc.M005567200; HAYASHI Y, 1994, BIOCHEM BIOPH RES CO, V205, P936, DOI 10.1006/bbrc.1994.2755; He T, 2008, CIRC RES, V103, P80, DOI 10.1161/CIRCRESAHA.108.176057; He TR, 2011, HYPERTENSION, V58, P287, DOI 10.1161/HYPERTENSIONAHA.111.172189; He TR, 2009, MICROVASC RES, V78, P447, DOI 10.1016/j.mvr.2009.08.009; He TR, 2004, ARTERIOSCL THROM VAS, V24, P2021, DOI 10.1161/01.ATV.0000142810.27849.8f; Hikita A, 2009, BIOCHEM CELL BIOL, V87, P581, DOI [10.1139/O09-015, 10.1139/o09-015]; Iwashita A, 2007, J PHARMACOL EXP THER, V320, P1087, DOI 10.1124/jpet.106.115758; JEREMY JY, 1984, MICROCIRC ENDOTH LYM, V1, P629; Jin LH, 2011, J BIOL CHEM, V286, P31473, DOI 10.1074/jbc.M111.266023; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; KALARIA RN, 1993, NEUROREPORT, V4, P211, DOI 10.1097/00001756-199302000-00025; KALARIA RN, 1993, ANN NY ACAD SCI, V695, P190, DOI 10.1111/j.1749-6632.1993.tb23050.x; Kalinin S, 2009, CURR ALZHEIMER RES, V6, P431, DOI 10.2174/156720509789207949; Katusic ZS, 2012, TRENDS PHARMACOL SCI, V33, P559, DOI 10.1016/j.tips.2012.05.005; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kim MY, 2012, BIOCHEM PHARMACOL, V84, P1627, DOI 10.1016/j.bcp.2012.09.008; Kitazume S, 2012, J BIOL CHEM, V287, P40817, DOI 10.1074/jbc.M112.398578; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; Kobilo T, 2011, LEARN MEMORY, V18, P103, DOI 10.1101/lm.2001611; Kogel D, 2012, EXP BRAIN RES, V217, P471, DOI 10.1007/s00221-011-2932-4; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; LEFFLER CW, 1985, PEDIATR RES, V19, P1160, DOI 10.1203/00006450-198511000-00009; Lin H, 2002, CIRCULATION, V105, P1962, DOI 10.1161/01.CIR.0000015365.49180.05; Lucitti JL, 2012, CIRC RES, V111, P1539, DOI 10.1161/CIRCRESAHA.112.279109; Lundblad C, 2008, J CEREBR BLOOD F MET, V28, P367, DOI 10.1038/sj.jcbfm.9600533; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; McLaughlin M, 1999, J NEUROCHEM, V72, P273, DOI 10.1046/j.1471-4159.1999.720273.x; Merlos-Suarez A, 1998, J BIOL CHEM, V273, P24955, DOI 10.1074/jbc.273.38.24955; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Mottillo EP, 2012, J BIOL CHEM, V287, P25038, DOI 10.1074/jbc.M112.374041; Mucke L, 1996, ANN NY ACAD SCI, V777, P82, DOI 10.1111/j.1749-6632.1996.tb34405.x; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Okazaki M, 2010, ENDOCR J, V57, P403, DOI 10.1507/endocrj.K10E-004; PICKARD JD, 1981, J CEREBR BLOOD F MET, V1, P361, DOI 10.1038/jcbfm.1981.41; Ridder DA, 2011, J EXP MED, V208, P2615, DOI 10.1084/jem.20110398; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Saleem S, 2010, NEUROSCIENCE, V170, P317, DOI 10.1016/j.neuroscience.2010.06.060; Santhanam AVR, 2012, BRAIN RES, V1483, P89, DOI 10.1016/j.brainres.2012.09.012; Sastre M, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-25; Shakil H, 2013, BRAIN SCI, V3, P1095, DOI 10.3390/brainsci3031095; SHEPHERD JT, 1991, HYPERTENSION, V18, pS76; Small CI, 2005, NEUROBIOL DIS, V19, P400, DOI 10.1016/j.nbd.2005.01.013; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; SOLA C, 1993, MOL BRAIN RES, V17, P41, DOI 10.1016/0169-328X(93)90071-V; Theendakara V, 2013, P NATL ACAD SCI USA, V110, P18303, DOI 10.1073/pnas.1314145110; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Vingtdeux V, 2012, J NEUROCHEM, V120, P34, DOI 10.1111/j.1471-4159.2011.07477.x; Vorbrodt AW, 1995, FOLIA HISTOCHEM CYTO, V33, P229; Wang HZ, 2014, DISCOV MED, V18, P41; Wei G, 2008, NEUROSCIENCE, V156, P1111, DOI 10.1016/j.neuroscience.2008.07.073; Wu WM, 2012, BLOOD, V120, P671, DOI 10.1182/blood-2012-03-419523; Xu F, 2005, P NATL ACAD SCI USA, V102, P18135, DOI 10.1073/pnas.0507798102; Yin KJ, 2010, J NEUROSCI, V30, P6398, DOI 10.1523/JNEUROSCI.0780-10.2010	79	8	8	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2017	37	1					106	122		10.1177/0271678X15618977			17	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	EE5MY	WOS:000389653500008	26661245	Green Published, Bronze			2022-02-06	
J	Howard, BM; Rindler, RS; Holland, CM; Pradilla, G; Ahmad, FU				Howard, Brian M.; Rindler, Rima S.; Holland, Christopher M.; Pradilla, Gustavo; Ahmad, Faiz U.			Management and Outcomes of Isolated Tentorial and Parafalcine "Smear'' Subdural Hematomas at a Level-1 Trauma Center: Necessity of High Acuity Care	JOURNAL OF NEUROTRAUMA			English	Article						closed head injury; minor TBI; subdural hemorrhage; TBI; trauma	BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; SURGICAL-MANAGEMENT; EPIDEMIOLOGY; ADULTS; SCALE; SCORE; COMA	Data suggest that patients who present to trauma centers with mild traumatic brain injury (TBI) are admitted to an excessively high level of care and undergo myriad, unnecessary repeat radiographic and laboratory tests that do not affect outcome. Surprisingly, a paucity of data exists regarding the management of isolated, traumatic, parafalcine, or tentorial acute subdural hematoma (aSDH). Therefore, a retrospective, cohort study was completed to analyze factors associated with outcomes in patients who present to a high-volume, urban, level 1 trauma center with isolated parafalcine or tentorial aSDH after closed head injury. Out of 3097 patients admitted with TBI over the study period, 65 met inclusion criteria. More than 90% of patients were admitted to the intensive care unit (ICU), irrespective of Glasgow Coma Scale (GCS) score at presentation or the presence of systemic injury. Factors determined to be statistically associated with increased ICU and total length of stay were GCS <= 12 on presentation and presence of systemic injury. Depressed GCS, systemic injury, and being elderly were associated with poor discharge disposition; whereas being systemically injured, female, or elderly were associated with poor functional status at discharge. Although 94% of admitted patients underwent at least one repeat head computed tomography (CT) scan while hospitalized, not a single aSDH enlarged, including four patients on antiplatelet agents, anticoagulants, or both. Based on these data, young patients who present with GCS 13-15 without systemic injury following blunt trauma with an associated isolated parafalcine and tentorial aSDH may be safely admitted to a standard medical/surgical floor for observation.	[Howard, Brian M.; Rindler, Rima S.; Pradilla, Gustavo; Ahmad, Faiz U.] Emory Univ, Sch Med, Dept Neurosurg, 1365 Clifton Rd NE,Suite B6000, Atlanta, GA 30322 USA; [Holland, Christopher M.] Univ Utah Hlth Care, Dept Neurosurg, Salt Lake City, UT USA		Howard, BM (corresponding author), Emory Univ, Sch Med, Dept Neurosurg, 1365 Clifton Rd NE,Suite B6000, Atlanta, GA 30322 USA.	bhowar5@emory.edu					AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Aring CD, 1940, ARCH NEURO PSYCHIATR, V44, P1296, DOI 10.1001/archneurpsyc.1940.02280120143014; Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728; BARTELS RHMA, 1995, NEUROSURGERY, V36, P1210, DOI 10.1227/00006123-199506000-00026; BORZONE M, 1995, ZBL NEUROCHIR, V56, P51; Chase W. H., 1930, SURG GYNECOL OBSTET, V51, P31; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; FRUIN AH, 1984, J NEUROSURG, V60, P1300, DOI 10.3171/jns.1984.60.6.1300; GLISTA GG, 1978, SURG NEUROL, V10, P119; Holland E., 1922, BJOG, V29, P549; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kawoosa NN, 2011, IRAN RED CRESCENT ME, V13, P289; Kreitzer N, 2014, ACAD EMERG MED, V21, P1084, DOI 10.1111/acem.12479; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; Marion DW, 2006, NEUROSURGERY, V58, P655; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Matsumoto Keigo, 1996, Neurologia Medico-Chirurgica, V36, P377, DOI 10.2176/nmc.36.377; McKhann GM, 1996, NEUROTRAUMA, P103; Meyer Scott H., 1996, P1443; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; Rankin J., 1957, SCOTT MED J, V2, P200, DOI [10.1177/003693305700200504, DOI 10.1177/003693305700200504]; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; RIETH KG, 1979, J COMPUT ASSIST TOMO, V3, P331, DOI 10.1097/00004728-197906000-00005; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Shankar A, 2003, NEUROL INDIA, V51, P63; Sweis RT, 2015, J EMERG MED, V49, P679, DOI 10.1016/j.jemermed.2015.06.055; Takeuchi S, 2012, TURK NEUROSURG, V22, P305, DOI 10.5137/1019-5149.JTN.5178-11.2; TEASDALE G, 1974, LANCET, V2, P81; Umerani MS, 2014, TURK NEUROSURG, V24, P19, DOI 10.5137/1019-5149.JTN.7080-12.1; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; VAZ R, 1991, ACTA NEUROCHIR, V111, P128, DOI 10.1007/BF01400500; VIELVOYE GJ, 1982, NEURORADIOLOGY, V22, P259, DOI 10.1007/BF00342075; Wang YH, 2014, TURK NEUROSURG, V24, P228, DOI 10.5137/1019-5149.JTN.8377-13.0; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Woodford M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1142	39	8	8	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					128	136		10.1089/neu.2015.4270			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100016	27025978				2022-02-06	
J	Huang, MX; Swan, AR; Quinto, AA; Matthews, S; Harrington, DL; Nichols, S; Bruder, BJ; Snook, CC; Huang, CW; Baker, DG; Lee, RR				Huang, Ming-Xiong; Swan, Ashley Robb; Quinto, Annemarie Angeles; Matthews, Scott; Harrington, Deborah L.; Nichols, Sharon; Bruder, Barry J.; Snook, Corey C.; Huang, Charles W.; Baker, Dewleen G.; Lee, Roland R.			A pilot treatment study for mild traumatic brain injury: Neuroimaging changes detected by MEG after low-intensity pulse-based transcranial electrical stimulation	BRAIN INJURY			English	Article						Flexyx neurotherapy system; low energy neurofeedback system; magnetoencephalography; slow-wave	PERSISTENT POSTCONCUSSIVE SYMPTOMS; SIGNAL SPACE SEPARATION; SOURCE IMAGING APPROACH; DELTA WAVES; STRESS SYMPTOMS; HEAD-INJURY; NEUROTHERAPY; LOCALIZATION; ALGORITHMS; MECHANISMS	Background: Mild traumatic brain injury (mTBI) is a leading cause of sustained impairments in military service members, Veterans, and civilians. However, few treatments are available for mTBI, partially because the mechanism of persistent mTBI deficits is not fully understood.& para;& para;Methods: We used magnetoencephalography (MEG) to investigate neuronal changes in individuals with mTBI following a passive neurofeedback-based treatment programme called IASIS. This programme involved applying low-intensity pulses using transcranial electrical stimulation (LIP-tES) with electroencephalography monitoring. Study participants included six individuals with mTBI and persistent post-concussive symptoms (PCS). MEG exams were performed at baseline and follow-up to evaluate the effect of IASIS on brain functioning.& para;& para;Results: At the baseline MEG exam, all participants had abnormal slow-waves. In the follow-up MEG exam, the participants showed significantly reduced abnormal slow-waves with an average reduction of 53.6 +/- 24.6% in slow-wave total score. The participants also showed significant reduction o f PCS scores after IASIS treatment, with an average reduction of 52.76 +/- 26.4% in PCS total score.& para;& para;Conclusions: The present study demonstrates, for the first time, the neuroimaging-based documentation of the effect of LIP-tES treatment on brain functioning in mTBI. The mechanisms of LIP-tES treatment are discussed, with an emphasis on LIP-tES's potentiation of the mTBI healing process.	[Huang, Ming-Xiong; Swan, Ashley Robb; Quinto, Annemarie Angeles; Harrington, Deborah L.; Baker, Dewleen G.; Lee, Roland R.] VA San Diego Healthcare Syst, Radiol Res & Psychiat Serv, San Diego, CA USA; [Huang, Ming-Xiong; Swan, Ashley Robb; Quinto, Annemarie Angeles; Harrington, Deborah L.; Lee, Roland R.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Matthews, Scott; Baker, Dewleen G.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Matthews, Scott] VASDHS Residential Rehabil Treatment Program, ASPIRE Ctr, San Diego, CA USA; [Nichols, Sharon] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Bruder, Barry J.] IASIS Technol Inc, Los Angeles, CA USA; [Snook, Corey C.] Mind Brain Training Inst, Mt Dora, FL USA; [Huang, Charles W.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Baker, Dewleen G.] VA Ctr Excellence Stress & Mental Hlth, San Diego, CA USA		Huang, MX (corresponding author), Univ Calif San Diego, Radiol Imaging Lab, 3510 Dunhill St, San Diego, CA 92121 USA.	mxhuang@ucsd.edu	Baker, Dewleen/O-4957-2019	Baker, Dewleen/0000-0002-1736-9838	US Department of Veterans AffairsUS Department of Veterans Affairs [I01-CX000499, I01-RX001988, MHBA-010-14F, NURC-022-10F, NEUC-044-06S]; Veterans AffairsUS Department of Veterans Affairs [I01CX000499, I01RX001988, I01CX000146] Funding Source: NIH RePORTER	This work was supported in part by Merit Review Grants from the US Department of Veterans Affairs (PI: M.X. Huang, I01-CX000499, I01-RX001988, MHBA-010-14F, NURC-022-10F, NEUC-044-06S)	Abd Hamid AI, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00391; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Antal A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/3616807; Arnsten AFT, 2015, NEUROBIOL STRESS, V1, P89, DOI 10.1016/j.ynstr.2014.10.002; Assenza G, 2015, CLIN NEUROPHYSIOL, V126, P1221, DOI 10.1016/j.clinph.2014.09.029; BALL GJ, 1977, ELECTROEN CLIN NEURO, V43, P346, DOI 10.1016/0013-4694(77)90258-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cohen D, 2002, P 13 INT C BIOM, P919; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; del Rio MS, 2004, LANCET NEUROL, V3, P645, DOI 10.1016/S1474-4422(04)00904-4; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Fertonani A, 2017, NEUROSCIENTIST, V23, P109, DOI 10.1177/1073858416631966; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Haufe S, 2011, NEUROIMAGE, V54, P851, DOI 10.1016/j.neuroimage.2010.09.003; Huang CW, 2016, CLIN NEUROPHYSIOL, V127, P2308, DOI 10.1016/j.clinph.2016.02.007; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2014, NEUROIMAGE, V84, P585, DOI 10.1016/j.neuroimage.2013.09.022; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Huang MX, 2016, PSYCHONEUROENDOCRINO, V63, P398, DOI 10.1016/j.psyneuen.2015.02.008; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kandel E.R., 2013, PRINCIPLES NEURAL SC, V5th; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Larsen S., 2006, J NEUROTHERAPY, V10, P69, DOI [10.1300/J184v10n02_06, DOI 10.1300/J184V10N02_06]; Leahy RM, 1998, ELECTROEN CLIN NEURO, V107, P159, DOI 10.1016/S0013-4694(98)00057-1; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mander BA, 2015, NAT NEUROSCI, V18, P1051, DOI 10.1038/nn.4035; May A, 2007, NEUROL SCI, V28, pS101, DOI 10.1007/s10072-007-0760-x; May A, 1998, LANCET, V352, P275, DOI 10.1016/S0140-6736(98)02470-2; MCCARLEY RW, 1986, AM J PHYSIOL, V251, pR1011, DOI 10.1152/ajpregu.1986.251.6.R1011; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Morawska MM, 2016, J NEUROSCI, V36, P3422, DOI 10.1523/JNEUROSCI.3274-15.2016; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; Nelson DV, 2015, MIL MED, V180, pE1111, DOI 10.7205/MILMED-D-14-00696; Nelson DV, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0049-y; Nelson DV, 2012, J NEUROPSYCH CLIN N, V24, P237, DOI 10.1176/appi.neuropsych.11020041; Niedermeyer E., 2005, ELECTROENCEPHALOGRAP; Ochs L, 2006, J NEUROTHER, V10, P5, DOI DOI 10.1300/J184V10N02_02; Ochs L., 1997, FLEXYX NEUROTHERAPY; Ou W, 2008, LECT NOTES COMPUT SC, V5241, P26, DOI 10.1007/978-3-540-85988-8_4; Paulus W, 2011, NEUROPSYCHOL REHABIL, V21, P602, DOI 10.1080/09602011.2011.557292; Qiu EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057896; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rutherford W. H., 1989, MILD HEAD INJURY, P217; Schankin CJ, 2015, BRAIN MAPPING, P1123; Schaul N, 1998, ELECTROEN CLIN NEURO, V106, P101, DOI 10.1016/S0013-4694(97)00111-9; SCHAUL N, 1978, BRAIN RES, V143, P475, DOI 10.1016/0006-8993(78)90358-X; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schoenberger NE, 2001, J HEAD TRAUMA REHAB, V16, P260, DOI 10.1097/00001199-200106000-00005; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Snook C, 2013, Application, Patent No. [#20140330157, 20140330157]; Song T, 2008, MED BIOL ENG COMPUT, V46, P923, DOI 10.1007/s11517-007-0290-y; Sun W, 2012, BRAIN RES, V1485, P108, DOI 10.1016/j.brainres.2012.02.008; Swan AR, 2015, J NEUROTRAUM, V32, P1510, DOI 10.1089/neu.2014.3654; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Taulu S, 2004, Neurol Clin Neurophysiol, V2004, P35; TEASDALE G, 1974, LANCET, V2, P81; Tecchio F, 2007, J NEUROL, V254, P296, DOI 10.1007/s00415-006-0355-0; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	73	8	8	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1951	1963		10.1080/02699052.2017.1363409			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500030	28925734				2022-02-06	
B	Jeon, M		Jeon, M		Jeon, Myounghoon			Emotions in Driving	EMOTIONS AND AFFECT IN HUMAN FACTORS AND HUMAN-COMPUTER INTERACTION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; SITUATION AWARENESS; MOBILE PHONE; ROAD RAGE; ANGER; DRIVERS; RISK; PERFORMANCE; BEHAVIOR; ATTENTION		[Jeon, Myounghoon] Michigan Technol Univ, Houghton, MI 49931 USA		Jeon, M (corresponding author), Michigan Technol Univ, Houghton, MI 49931 USA.						Abdu R, 2012, TRANSPORT RES F-TRAF, V15, P575, DOI 10.1016/j.trf.2012.05.007; ADAMS JGU, 1985, RISK FREEDOM RECORD; Algoe SB, 2011, AM PSYCHOL, V66, P35, DOI 10.1037/a0021720; ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; BALL K, 1994, J APPL GERONTOL, V13, P20, DOI 10.1177/073346489401300103; BERKOWITZ L, 1990, AM PSYCHOL, V45, P494, DOI 10.1037/0003-066X.45.4.494; Blanchette I, 2010, COGNITION EMOTION, V24, P561, DOI 10.1080/02699930903132496; Bodenhausen G.V., 1993, AFFECT COGNITION STE, P13, DOI DOI 10.1016/B978-0-08-088579-7.50006-5; BODENHAUSEN GV, 1994, EUR J SOC PSYCHOL, V24, P45, DOI 10.1002/ejsp.2420240104; Borowsky A, 2010, ACCIDENT ANAL PREV, V42, P1240, DOI 10.1016/j.aap.2010.02.001; Braver Elisa R., 1992, Journal of Public Health Policy, V13, P341, DOI 10.2307/3342733; Brodsky W, 2012, TRANSPORT RES F-TRAF, V15, P162, DOI 10.1016/j.trf.2011.12.001; BRYSON SE, 1984, CAN J BEHAV SCI, V16, P107, DOI 10.1037/h0080795; Burns PC, 1999, J GERONTOL B-PSYCHOL, V54, pS49, DOI 10.1093/geronb/54B.1.S49; Burns RG, 2003, ENVIRON BEHAV, V35, P621, DOI 10.1177/0013916503254758; CARR D, 1992, J AM GERIATR SOC, V40, P567, DOI 10.1111/j.1532-5415.1992.tb02104.x; CORFITSEN MT, 1994, ACCIDENT ANAL PREV, V26, P617, DOI 10.1016/0001-4575(94)90023-X; Cowie R, 2001, IEEE SIGNAL PROC MAG, V18, P32, DOI 10.1109/79.911197; Czaja SJ, 2006, HDB HUMAN FACTORS ER, P32; Deery HA, 1999, HUM FACTORS, V41, P628, DOI 10.1518/001872099779656671; DEFFENBACHER JL, 1994, PSYCHOL REP, V74, P83, DOI 10.2466/pr0.1994.74.1.83; Deffenbacher JL, 2003, BEHAV RES THER, V41, P701, DOI 10.1016/S0005-7967(02)00046-3; Deffenbacher JL, 2001, PSYCHOL REP, V89, P535, DOI 10.2466/PR0.89.7.535-540; DOLAN RJ, 1992, J NEUROL NEUROSUR PS, V55, P768, DOI 10.1136/jnnp.55.9.768; Dollard J, 1939, FRUSTRATION AGGRESSI; DONGES E, 1978, HUM FACTORS, V20, P691, DOI 10.1177/001872087802000607; DORN L, 1995, EUR J PERSONALITY, V9, P25, DOI 10.1002/per.2410090103; DORN L, 2013, DRIVER DISTRACTION I; Dula CS, 2003, J SAFETY RES, V34, P559, DOI 10.1016/j.jsr.2003.03.004; Durso F.T., 1999, DOTFAAAM993 US DEP T; Eccles DW, 2011, HUM FACTORS, V53, P180, DOI 10.1177/0018720811403731; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; ELLSWORTH PC, 1988, MOTIV EMOTION, V12, P271, DOI 10.1007/BF00993115; ENDSLEY MR, 1995, HUM FACTORS, V37, P32, DOI 10.1518/001872095779049543; Evans L., 1985, HUMAN BEHAV TRAFFIC, P485; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Eyben F, 2010, ADV HUM-COMPUT INTER, V2010, DOI 10.1155/2010/263593; Ferguson SA, 2003, J SAFETY RES, V34, P71, DOI 10.1016/S0022-4375(02)00082-8; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Fuller R, 2005, ACCIDENT ANAL PREV, V37, P461, DOI 10.1016/j.aap.2004.11.003; FULLER R, 1984, ERGONOMICS, V27, P1139, DOI 10.1080/00140138408963596; Gable PA, 2008, PSYCHOL SCI, V19, P476, DOI 10.1111/j.1467-9280.2008.02112.x; Galovski TE, 2004, AGGRESS VIOLENT BEH, V9, P105, DOI 10.1016/S1359-1789(02)00118-0; Gasper K, 2002, PSYCHOL SCI, V13, P34, DOI 10.1111/1467-9280.00406; Girouard A, 2010, HUM-COMPUT INT-SPRIN, P221, DOI 10.1007/978-1-84996-272-8_13; Glotzbach Evelyn, 2011, Open Neuroimag J, V5, P33, DOI 10.2174/1874440001105010033; Gordon WA, 2006, J HEAD TRAUMA REHAB, V21, P156, DOI 10.1097/00001199-200603000-00008; Gras ME, 2007, ACCIDENT ANAL PREV, V39, P347, DOI 10.1016/j.aap.2006.08.006; Grimm M, 2007, LECT NOTES COMPUT SC, V4738, P126; Gross J. J., 2006, EMOTION REGULATION C; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI [DOI 10.1037/1089-2680.2.3.271, 10.1037/1089-2680.2.3.271]; GUGERTY L, 2011, HDB DRIV SIMUL ENG M, P1; GULIAN E, 1989, ERGONOMICS, V32, P585, DOI 10.1080/00140138908966134; HART SG, 2006, P HUMAN FACTORS ERGO; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; HELANDER MG, 2006, HDB HUMAN FACTORS ER, P543, DOI DOI 10.1002/0470048204.CH21; Hess R. A., 1990, IEEE Control Systems Magazine, V10, P3, DOI 10.1109/37.60415; HOLLAND CA, 1993, ACCIDENT ANAL PREV, V25, P431, DOI 10.1016/0001-4575(93)90072-5; Hudlicka E, 2003, INT J HUM-COMPUT ST, V59, P1, DOI 10.1016/S1071-5819(03)00047-8; Hudlicka E, 2002, USER MODEL USER-ADAP, V12, P1, DOI 10.1023/A:1013337427135; Jallais C, 2014, TRANSPORT RES F-TRAF, V23, P125, DOI 10.1016/j.trf.2013.12.023; JAMES L, 2000, ROAD RAGE AGGRESSIVE; Jefferies LN, 2008, PSYCHOL SCI, V19, P290, DOI 10.1111/j.1467-9280.2008.02082.x; Jeon M., 2011, ACM T ACCESSIBLE COM, V3, P11; Jeon M, 2016, INT J HUM-COMPUT INT, V32, P777, DOI 10.1080/10447318.2016.1198524; Jeon M, 2015, APPL ERGON, V50, P185, DOI 10.1016/j.apergo.2015.03.015; Jeon M, 2014, TRANSPORT RES F-TRAF, V24, P197, DOI 10.1016/j.trf.2014.04.003; Jeon M, 2014, PRESENCE-TELEOP VIRT, V23, P71, DOI 10.1162/PRES_a_00169; JOHNSON EJ, 1983, J PERS SOC PSYCHOL, V45, P20, DOI 10.1037/0022-3514.45.1.20; Johnson MB, 2009, TRAFFIC INJ PREV, V10, P354, DOI 10.1080/15389580902969765; Jones C, 2008, LECT NOTES COMPUT SC, V4868, P229, DOI 10.1007/978-3-540-85099-1_20; Lam LT, 2002, J SAFETY RES, V33, P411, DOI 10.1016/S0022-4375(02)00034-8; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Lazarus R.S., 1991, EMOTION ADAPTATION; Leng H, 2007, LECT NOTES COMPUT SC, V4566, P237; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Li XY, 2005, IEEE T SYST MAN CY A, V35, P93, DOI 10.1109/TSMCA.2004.838454; Lyznicki JM, 1998, JAMA-J AM MED ASSOC, V279, P1908, DOI 10.1001/jama.279.23.1908; Ma R, 2007, ERGONOMICS, V50, P1351, DOI 10.1080/00140130701318913; Ma RQ, 2005, INT J IND ERGONOM, V35, P939, DOI 10.1016/j.ergon.2005.04.002; MacDonald S, 2008, TRAFFIC INJ PREV, V9, P190, DOI 10.1080/15389580802040295; Marcus CL, 1996, SLEEP, V19, P763, DOI 10.1093/sleep/19.10.763; Mathews A., 1997, COGNITIVE PSYCHOL EM; Matthews G, 1998, HUM FACTORS, V40, P136, DOI 10.1518/001872098779480569; MATTHEWS ML, 1986, ACCIDENT ANAL PREV, V18, P299, DOI 10.1016/0001-4575(86)90044-8; Matthews ML, 2001, TRANSPORT RES REC, P26; Mauss I, 2009, COGNITION EMOTION, V23, P209, DOI 10.1080/02699930802204677; McCartt AT, 1996, ACCIDENT ANAL PREV, V28, P511, DOI 10.1016/0001-4575(96)00021-8; MCCORMICK IA, 1986, ACCIDENT ANAL PREV, V18, P205, DOI 10.1016/0001-4575(86)90004-7; MCRUER DT, 1977, HUM FACTORS, V19, P381, DOI 10.1177/001872087701900406; Megias A, 2011, SAFETY SCI, V49, P1388, DOI 10.1016/j.ssci.2011.06.001; Megias A, 2011, ACCIDENT ANAL PREV, V43, P813, DOI 10.1016/j.aap.2010.10.029; MINEKA S, 1992, PSYCHOL SCI, V3, P65, DOI 10.1111/j.1467-9280.1992.tb00260.x; Mizell L., 1997, AGGRESSIVE DRIVING 3; MORAY N, 1959, Q J EXP PSYCHOL, V11, P56, DOI 10.1080/17470215908416289; Nesbit SM, 2012, TRANSPORT RES F-TRAF, V15, P710, DOI 10.1016/j.trf.2012.07.003; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Pecher C, 2009, SAFETY SCI, V47, P1254, DOI 10.1016/j.ssci.2009.03.011; Picard R. W, 1997, AFFECTIVE COMPUTING; Picard RW, 2010, IEEE T AFFECT COMPUT, V1, P11, DOI 10.1109/T-AFFC.2010.10; Poysti L, 2005, ACCIDENT ANAL PREV, V37, P47, DOI 10.1016/j.aap.2004.06.003; Raghunathan R, 1999, ORGAN BEHAV HUM DEC, V79, P56, DOI 10.1006/obhd.1999.2838; REEVES B, 1996, MEDIA EQUATION HOW P; REID LD, 1981, ERGONOMICS, V24, P447, DOI 10.1080/00140138108924867; Roidl E, 2013, J SAFETY RES, V47, P47, DOI 10.1016/j.jsr.2013.08.002; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Rutkowski TM, 2011, ADVANCES IN COGNITIVE NEURODYNAMICS (II), P671, DOI 10.1007/978-90-481-9695-1_100; Salvucci DD, 2001, TRANSPORT RES REC, P9; Schwarz N, 2003, PSYCHOL INQ, V14, P296, DOI 10.1207/S15327965PLI1403&4_20; SCHWARZ N, 1991, HAPPY MINDLESS BUT S; SIVAK M, 1989, ACCIDENT ANAL PREV, V21, P371, DOI 10.1016/0001-4575(89)90028-6; Storbeck J, 2005, PSYCHOL SCI, V16, P785, DOI 10.1111/j.1467-9280.2005.01615.x; Summala H., 2007, MODELLING DRIVER BEH, P189, DOI DOI 10.1007/978-1-84628-618-6_11; SVENSON O, 1981, ACTA PSYCHOL, V47, P143, DOI 10.1016/0001-6918(81)90005-6; TAYLOR DH, 1964, ERGONOMICS, V7, P439, DOI 10.1080/00140136408930761; Tiedens LZ, 2001, J PERS SOC PSYCHOL, V81, P973, DOI 10.1037//0022-3514.81.6.973; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; Underwood G., 1999, TRANSPORT RES F-TRAF, VF 2, P55, DOI DOI 10.1016/S1369-8478(99)00006-6; Walker GH, 2006, ERGONOMICS, V49, P161, DOI 10.1080/00140130500448085; WALLER PF, 1991, HUM FACTORS, V33, P499, DOI 10.1177/001872089103300502; Watson D, 1999, J PERS SOC PSYCHOL, V76, P820, DOI 10.1037/0022-3514.76.5.820; Wells-Parker E, 2002, ACCIDENT ANAL PREV, V34, P271, DOI 10.1016/S0001-4575(01)00021-5; Wierwille WW, 1998, VISION IN VEHICLES - VI, P233; Wilde GJ., 1982, RISK ANAL, V2, P209, DOI [10.1111/j.1539-6924.1982.tb01384.x, DOI 10.1111/J.1539-6924.1982.TB01384.X]; Williams AF, 2003, J SAFETY RES, V34, P5, DOI 10.1016/S0022-4375(02)00075-0; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; Yoshino K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00882; Young K., 2008, DRIVER DISTRACTION T; Zeng ZH, 2009, IEEE T PATTERN ANAL, V31, P39, DOI 10.1109/TPAMI.2008.52; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	185	8	8	0	4	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND			978-0-12-801879-8; 978-0-12-801851-4				2017							437	474		10.1016/B978-0-12-801851-4.00017-3			38	Computer Science, Artificial Intelligence; Ergonomics; Psychology, Experimental	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Computer Science; Engineering; Psychology	BI9FL	WOS:000416034800018					2022-02-06	
J	Jones, M; Hocking, C; McPherson, K				Jones, Margaret; Hocking, Clare; McPherson, Kathryn			Communities with participation-enabling skills: A study of children with traumatic brain injury and their shared occupations	JOURNAL OF OCCUPATIONAL SCIENCE			English	Article						Participation; transaction; community; enabling; occupation	SCHOOL-AGE-CHILDREN; SOCIAL-PARTICIPATION; INTERVENTION; DISABILITIES; BARRIERS; SUPPORTS; NETWORK; CONTEXT; ADOLESCENTS; DEMENTIA	Many ideas about participation in rehabilitation literature focus inwards towards individuals, or individuals and their family, acting in but apart from their environment. Authors position individuals as "participating in" occupations or social settings, or point towards the outcomes for those who do or do not participate. This perspective arguably contributes to occupational injustices, hampering positive change. Literature has not furnished a broader gaze that appreciates individuals and their participation context as one. Actions that occur amongst people collectively with context, in an ongoing cycle of change, receive little attention. Guided by a Deweyan transactional perspective, six case studies exploring the participation of 9-12 year old children with traumatic brain injury generated more contextualised understandings. Interviews with children and community members, photographs, observations, and document-review provided information about actions and changes occurring amongst children and their environment, where these were seen as continuous with one another. This paper describes the Participation-enabling skills that were revealed amongst children and adults who shared in occupations. Community members demonstrated varying ability in using actions that facilitated both themselves and others to take part in occupations. The Participation-enabling skills were fostered during shared occupation. The congruence of the skills with themes in occupational science and therapy literature is explored, and their relevance to social change is proposed.	[Jones, Margaret; Hocking, Clare] Auckland Univ Technol, Dept Occupat Sci & Therapy, Auckland, New Zealand; [McPherson, Kathryn] Auckland Univ Technol, Sch Clin Sci, Auckland, New Zealand		Jones, M (corresponding author), Auckland Univ Technol, Dept Occupat Sci & Therapy, Auckland, New Zealand.	margjone@aut.ac.nz	Hocking, Clare/I-4709-2019; jones, margaret/ABG-4861-2020	Hocking, Clare/0000-0003-0364-5157; McPherson, Kath/0000-0003-0487-8497	Health Research Council of New ZealandHealth Research Council of New Zealand [HRC 06/621]	This work was supported by the Health Research Council of New Zealand under Grant HRC 06/621.	Aldrich R, 2016, J OCCUP SCI, V23, P51, DOI 10.1080/14427591.2015.1045014; Anaby D, 2013, DISABIL REHABIL, V35, P1589, DOI 10.3109/09638288.2012.748840; Anaby DR, 2016, CAN J OCCUP THER, V83, P83, DOI 10.1177/0008417415608653; Bailliard AL, 2016, J OCCUP SCI, V23, P3, DOI 10.1080/14427591.2014.957886; Bedell G, 2013, ARCH PHYS MED REHAB, V94, P315, DOI 10.1016/j.apmr.2012.09.024; Bedell GM, 2005, AM J OCCUP THER, V59, P273, DOI 10.5014/ajot.59.3.273; Carter E. W., 2009, PEER SUPPORT STRATEG; Case-Smith J, 2015, OCCUPATIONAL THERAPY, P65; Chleboun S, 2011, QUAL REP, V16, P764; Cohen S., 2000, SOCIAL INTEGRATION H; Colvin G., 2015, HUMANS ARE UNDERRATE; Coster W, 2013, CHILD CARE HLTH DEV, V39, P535, DOI 10.1111/cch.12046; Crooks VC, 2008, AM J PUBLIC HEALTH, V98, P1221, DOI 10.2105/AJPH.2007.115923; Cutchin MP., 2013, T PERSPECTIVES OCCUP, P1; Darrah J, 2011, DEV MED CHILD NEUROL, V53, P615, DOI 10.1111/j.1469-8749.2011.03959.x; Dewey J., 1998, ESSENTIAL DEWEY, P340; DEWEY J, 1981, J DEWEY LATER WORKS, V1; DEWEY J, 1988, J DEWEY LATER WORKS, V4; Dewey J., 1949, KNOWING KNOWN, P270; Dewey J., 1949, KNOWING KNOWN KNOWING KNOWN; Fisher A. G., 2014, WILLARD SPACKMANS OC, P249; Fisher A. G., 2008, EVALUATION SOCIAL IN; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Frederickson N, 2003, J SPEC EDUC, V36, P234, DOI 10.1177/002246690303600404; Gauvin-Lepage J, 2010, BRAIN INJURY, V24, P1087, DOI 10.3109/02699052.2010.494593; Gerst-Emerson K, 2015, AM J PUBLIC HEALTH, V105, P1013, DOI 10.2105/AJPH.2014.302427; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; Godeau E, 2010, DEV MED CHILD NEUROL, V52, pe236, DOI 10.1111/j.1469-8749.2010.03731.x; Hammel J, 2015, ARCH PHYS MED REHAB, V96, P578, DOI 10.1016/j.apmr.2014.12.008; Hammell KRW, 2015, SCAND J OCCUP THER, V22, P237, DOI 10.3109/11038128.2015.1004103; Harru, 2011, PSYCHOL BETTER WORLD; Hart EC, 2016, J OCCUP SCI, V23, P67, DOI 10.1080/14427591.2015.1020851; Heah Tom, 2007, Can J Occup Ther, V74, P38; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Humphry R, 2005, J OCCUP SCI, V12, P36, DOI 10.1080/14427591.2005.9686546; Imms C, 2008, DISABIL REHABIL, V30, P1867, DOI 10.1080/09638280701673542; Jones M. A., 2014, PARTICIPATION AOTEAR; Kang LJ, 2014, DISABIL REHABIL, V36, P1735, DOI 10.3109/09638288.2013.863392; King G, 2010, INT J DISABIL DEV ED, V57, P77, DOI 10.1080/10349120903537988; Law M, 2002, AM J OCCUP THER, V56, P640, DOI 10.5014/ajot.56.6.640; Law M, 1999, J OCCUPATIONAL SCI, V6, P102, DOI DOI 10.1080/14427591.1999.9686455; Law M, 2015, AUST OCCUP THER J, V62, P105, DOI [10.1111/1440-1630.12177, 10.1111/1440-1630.12188]; Law MC, 2011, DEV MED CHILD NEUROL, V53, P621, DOI 10.1111/j.1469-8749.2011.03962.x; Lindsay S, 2013, DISABIL REHABIL, V35, P623, DOI 10.3109/09638288.2012.702850; Lutgendorf SK, 2009, BRAIN BEHAV IMMUN, V23, P176, DOI 10.1016/j.bbi.2008.04.155; Maxwell JA, 2008, HDB EMERGENT METHODS; MOSEY AC, 1973, ACTIVITIES THERAPY; NORTHCOTT N, 1996, NURSING TIMES RES, V1, P456, DOI DOI 10.1177/174498719600100610; Oslo Coalition on Freedom of Religion or Belief & United Nations Educational Scientific and Cultural Organization, 2004, TEACH TOL RESP REC R; Parten MB, 1932, J ABNORM SOC PSYCH, V27, P243, DOI 10.1037/h0074524; Pierce D., 2009, J SOCIAL CHANGE, V16, P203, DOI [10.1080/14427591.2009.9686663, DOI 10.5590/JOSC.2014.06.1.0]; Pierce D, 2009, J OCCUP SCI, V16, P203, DOI 10.1080/14427591.2009.9686663; Pinker S., 2015, VILLAGE EFFECT WHY F; Polatajko H.J., 2013, ENABLING OCCUPATION, P87; Reed K, 2010, J OCCUP SCI, V17, P140, DOI 10.1080/14427591.2010.9686688; REYNOLDS P, 1990, BEHAV MED, V16, P101, DOI 10.1080/08964289.1990.9934597; Roscigno CI, 2011, BRAIN INJURY, V25, P882, DOI 10.3109/02699052.2011.581638; Simons H., 2009, CASE STUDY RES PRACT; Stake E. R., 2006, MULTIPLE CASE STUDY; Stake R., 1995, ART CASE STUDY RES; Statistics New Zealand, 2014, WE INT FAM FRIENDS; Stephan M.J., 2013, WHY CIVIL RESISTANCE; TEASDALE G, 1974, LANCET, V2, P81; *UN HIGH COMM HUM, 1989, CONV RIGHTS CHILD; VOGT TM, 1992, J CLIN EPIDEMIOL, V45, P659, DOI 10.1016/0895-4356(92)90138-D; Vroman K, 2015, OCCUPATIONAL THERAPY, P102; Wicks A., 2013, T PERSPECTIVES OCCUP, P119; World Health Organization, 2007, INT CLASS FUNCT DIS; World Health Organization, 2007, INT CLASS FUNCT DIS; Yin R., 1994, CASE STUDY RES DESIG, V2	70	8	8	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1442-7591			J OCCUP SCI	J. Occup. Sci.		2017	24	1			SI		88	104		10.1080/14427591.2016.1224444			17	Social Sciences, Interdisciplinary	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	EV8VW	WOS:000402063300009		hybrid			2022-02-06	
J	Kheirabadi, BS; Miranda, N; Terrazas, IB; Gonzales, MD; Grimm, RC; Dubick, MA				Kheirabadi, Bijan Shams; Miranda, Nahir; Terrazas, Irasema B.; Gonzales, Mary D.; Grimm, Rose C.; Dubick, Michael A.			Does small-volume resuscitation with crystalloids or colloids influence hemostasis and survival of rabbits subjected to lethal uncontrolled hemorrhage?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Prehospital resuscitation; Voluven; albumin; hypertonic saline; uncontrolled hemorrhage; rabbit	TRAUMATIC BRAIN-INJURY; FLUID RESUSCITATION; PLATELET-FUNCTION; HYPERTONIC RESUSCITATION; DILUTIONAL COAGULOPATHY; HYDROXYETHYL STARCHES; INCREASING HEMORRHAGE; FIBRIN POLYMER; ALBUMIN; METAANALYSIS	BACKGROUND: Prehospital, small-volume resuscitation of combat casualties with a synthetic colloid (6% hydroxyethyl starch [HES] 670/0.75) has been recommended when blood or blood components are unavailable. We studied hemostatic effects of a newer synthetic colloid (6% HES, 130/0.4) compared with either a natural colloid (albumin) or to crystalloids in an uncontrolled hemorrhage model. METHODS: Spontaneously breathing New Zealand white rabbits (3.4 +/- 0.1 kg) were anesthetized, instrumented, and subjected to a splenic injury with uncontrolled bleeding. Fifteen minutes after injury, rabbits were in shock (mean arterial pressure [MAP] = 26 +/- 1.3 mm Hg, and received colloids (6% HES, 130/0.4 or 5% albumin at 15 mL/kg), or crystalloids (normal saline at 30 mL/kg or 5% hypertonic saline at 7.5 mL/kg) for resuscitation in two intravenous bolus injections (15 minutes apart) to raise their MAP to 65 mm Hg, n = 9/group. Animals were monitored for 2.5 hours or until death, and blood losses were measured. Blood samples were analyzed for arterial blood gas, complete blood count, and coagulation measures. RESULTS: There were no differences among groups in baseline measures and initial hemorrhage volume (11.9 +/- 0.6 mL/kg) at 15 minutes postinjury. Twenty minutes after fluid resuscitation (1 hour postinjury), MAP was higher, shock indices were lower, and blood pH was higher in colloids versus. crystalloids groups (p < 0.05). Administration of 6% HES 130/0.4 colloid produced the largest hemodilution (54% decrease in hematocrit, p < 0.05 vs. hypertonic saline). Activated partial thromboplastin time increased approximately 35% above baseline in all groups except in 6% HES 130/0.4 group in which it doubled. Clot strength was reduced (15%) only in the 6% HES 130/0.4 group. 6% HES 130/0.4 resuscitation produced the largest blood loss and 33% survival rate that was not different than the crystalloid groups. Albumin produced the best hemostatic and survival outcomes (78%). CONCLUSION: Small-volume resuscitation with crystalloids appeared inadequate to treat hypovolemic shock and prevent death. 6% HES 130/0.4 was effective hemodynamically but detrimental to hemostasis. Albumin produced the best outcomes consistent with our previous observations. Further studies are needed to prove benefit of albumin solution as a possible resuscitation fluid for treating combat casualties at the point of injury. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.)	[Kheirabadi, Bijan Shams; Miranda, Nahir; Terrazas, Irasema B.; Gonzales, Mary D.; Grimm, Rose C.; Dubick, Michael A.] US Army, Inst Surg Res, 3650 Chambers Pass,BHT2,Bldg 3610, Houston, TX 78234 USA		Kheirabadi, BS (corresponding author), US Army, Inst Surg Res, 3650 Chambers Pass,BHT2,Bldg 3610, Houston, TX 78234 USA.	Bijan.s.kheirabadi.civ@mail.mil					Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Butler Frank K, 2014, J Spec Oper Med, V14, P13; Butler FK, 2012, J TRAUMA ACUTE CARE, V73, pS395, DOI 10.1097/TA.0b013e3182754850; Cada VJ, 2008, HOSP PHARM, V43, P396; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; de Jonge E, 2001, INTENS CARE MED, V27, P1825, DOI 10.1007/s001340101107; Deusch E, 2003, ANESTH ANALG, V97, P680, DOI 10.1213/01.ANE.0000073353.31894.BE; Dubick MA, 2013, CLINICS, V68, P883, DOI 10.6061/clinics/2013(06)25; Dubois MJ, 2006, CRIT CARE MED, V34, P2536, DOI 10.1097/01.CCM.0000239119.57544.0C; Duchesne JC, 2015, ANAESTH INTENSIVE TH, V47, P143, DOI 10.5603/AIT.a2014.0052; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Franz A, 2001, ANESTH ANALG, V92, P1402, DOI 10.1097/00000539-200106000-00008; Grocott MPW, 2002, VOX SANG, V82, P1, DOI 10.1046/j.1423-0410.2002.00123.x; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; Haase N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f839; Institute of Lab Animal Resources, 2011, GUIDE CARE USE LAB A; James MF, 2011, BR J ANESTH, V107, P683; Jamnicki M, 2000, ANESTHESIOLOGY, V93, P1231, DOI 10.1097/00000542-200011000-00016; Kheirabadi BS, 2008, J TRAUMA, V64, P1218, DOI 10.1097/TA.0b013e31816c5c6c; Kheirabadi BS, 2008, J TRAUMA, V64, P1228; Kheirabadi BS, 2015, J TRAUMA ACUTE CARE, V78, P752, DOI 10.1097/TA.0000000000000591; Kheirabadi BS, 2016, J TRAUMA ACUTE CARE, V81, P42, DOI 10.1097/TA.0000000000001091; Kozek-Langenecker SA, 2008, ANESTH ANALG, V107, P382, DOI 10.1213/ane.0b013e31817e6eac; Kramer G C, 1989, Prog Clin Biol Res, V299, P311; Kramer GC, 2003, J TRAUMA, V54, pS89, DOI 10.1097/01.TA.0000065609.82142.F1; MAZZONI MC, 1988, AM J PHYSIOL, V255, pH629, DOI 10.1152/ajpheart.1988.255.3.H629; McSwain E, 2006, PHTLS BASIC ADV PREH, P389; Mitra S, 2009, INDIAN J ANAESTH, V53, P592; Mizzi Anna, 2011, Anesthesiol Clin, V29, P547, DOI 10.1016/j.anclin.2011.05.012; Myburgh JA, 2015, J INTERN MED, V277, P58, DOI 10.1111/joim.12326; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myburgh JA, 2013, NEW ENGL J MED, V369, P1243, DOI 10.1056/NEJMra1208627; Nielsen VG, 2006, J SURG RES, V132, P17, DOI 10.1016/j.jss.2005.07.025; Nielsen VG, 2005, ACTA ANAESTH SCAND, V49, P1163, DOI 10.1111/j.1399-6576.2005.00733.x; Niemi TT, 2010, J ANESTH, V24, P913, DOI 10.1007/s00540-010-1034-y; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; Stogermuller B, 2000, ANESTH ANALG, V91, P823; Thaler U, 2005, ANAESTHESIA, V60, P554, DOI 10.1111/j.1365-2044.2005.04184.x; Van Aken HK, 2012, CURR OPIN ANESTHESIO, V25, P563, DOI 10.1097/ACO.0b013e3283572274; Vincent JL, 2009, BEST PRACT RES-CLIN, V23, P183, DOI 10.1016/j.bpa.2008.11.004; Vincent JL, 2014, CRIT CARE, V18, DOI 10.1186/cc13991; Vincent JL, 2003, ANN SURG, V237, P319, DOI 10.1097/00000658-200303000-00005; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430	44	8	8	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2017	82	1					156	164		10.1097/TA.0000000000001285			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	EH5ZT	WOS:000391852600032	27779578				2022-02-06	
J	Kommidi, H; Guo, H; Chen, N; Kim, D; He, B; Wu, AP; Aras, O; Ting, R				Kommidi, Harikrishna; Guo, Hua; Chen, Nandi; Kim, Dohyun; He, Bin; Wu, Amy P.; Aras, Omer; Ting, Richard			An [F-18]-Positron-Emitting, Fluorescent, Cerebrospinal Fluid Probe for Imaging Damage to the Brain and Spine	THERANOSTICS			English	Article						Positron emission tomography; imaging; optical imaging; radionuclide cisternography; myelography	SPONTANEOUS INTRACRANIAL HYPOTENSION; POSITRON-EMISSION-TOMOGRAPHY; DOSE INTRATHECAL FLUORESCEIN; CONTRAST AGENTS; MR MYELOGRAPHY; CISTERNA-MAGNA; BASE SURGERY; CSF LEAK; PET; ARYLTRIFLUOROBORATE	Fluorescein is modified to bear F-18 so that it can act as both a positron emitter, and a fluorophore, allowing detection by positron emission tomography (PET), scintillation, and fluorescent imaging (FL). [F-18]-2 is injected into the intrathecal space of rats and used to observe the cerebrospinal fluid (CSF) that bathes the brain and spine. Injury in three different applications is visualized with [F-18]-2: 1) detection of a 0.7 mm paranasal-sinus CSF leak (CSFL); 2) detection of 0.5 mm puncture damage to the thoracic spine (acute spinal cord injury); and 3) detection of intracerebral hemorrhage/edema because of traumatic brain injury. In all models, the location of injury is visualized with [F-18]-2 at high resolution. [F-18]-2 PET imaging may be a superior alternative to current clinical contrast myelography and I-131, In-111 or Tc-99m radionuclide cisternography. Like fluorescein, [F-18]-2 may also have other uses in diagnostic or fluorescence guided medicine.	[Kommidi, Harikrishna; Guo, Hua; Chen, Nandi; Ting, Richard] Weill Cornell Med Coll, Mol Imaging Innovat Inst MI3, Dept Radiol, 413 East 69th St, New York, NY 10065 USA; [Chen, Nandi] Hunan Univ, State Key Lab Chemo Biosensing & Chemometr, Coll Chem & Chem Engn, Key Lab Bionanotechnol & Mol Engn Hunan Prov, Changsha 410082, Hunan, Peoples R China; [Kim, Dohyun; He, Bin] Weill Cornell Med Coll, Dept Radiol, New York, NY 10065 USA; [Wu, Amy P.] Hofstra Northwell Sch Med, Northwell Hlth, Dept Otolaryngol Head & Neck Surg, New York, NY 10075 USA; [Aras, Omer] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA		Ting, R (corresponding author), Weill Cornell Med Coll, Mol Imaging Innovat Inst MI3, Dept Radiol, 413 East 69th St, New York, NY 10065 USA.; Aras, O (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA.	araso@mskcc.org; rct2001@med.cornell.edu	Aras, Omer/AAV-8557-2021	Aras, Omer/0000-0003-1758-0542	National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [K99/R00, EB013904]; NIH/NCI Cancer Center Support Grant [P30 CA008748]; NIH shared instrumentation grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD016320]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [K99EB013904, R00EB013904] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD016320] Funding Source: NIH RePORTER	R.T., K.H., and H.G. are funded by a National Institute of Biomedical Imaging and Bioengineering K99/R00 (EB013904). O.A. is funded in part through a NIH/NCI Cancer Center Support Grant P30 CA008748. NMR spectra were acquired with help of the WCMC NMR Core that is funded by a NIH shared instrumentation grant S10OD016320.	Ali SA, 1998, CLIN NUCL MED, V23, P152, DOI 10.1097/00003072-199803000-00004; An FF, 2016, AM J ROENTGENOL, V207, P266, DOI 10.2214/AJR.16.16181; ASHBURN WL, 1968, J NUCL MED, V9, P523; Bakker R, 2015, NEUROINFORMATICS, V13, P353, DOI 10.1007/s12021-014-9258-x; Chazen JL, 2014, AM J NEURORADIOL, V35, P2007, DOI 10.3174/ajnr.A3975; Cousins MJ, 2004, ANESTH ANALG, V98, P1794, DOI 10.1213/01.ANE.0000117225.31416.36; Felisati G, 2008, ACTA OTORHINOLARYNGO, V28, P159; Feng XD, 2010, NEUROTOXICOLOGY, V31, P391, DOI 10.1016/j.neuro.2010.04.003; GREITZ D, 1993, ACTA RADIOL, V34, P1; GROSFELD JL, 1974, PEDIATRICS, V54, P791; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Javadi SAH, 2013, ARCH IRAN MED, V16, P264, DOI 013165/AIM.004; JUNCK L, 1983, ANN NEUROL, V13, P469, DOI 10.1002/ana.410130502; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; Liu ZB, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500694; Liu ZB, 2015, NAT PROTOC, V10, P1423, DOI 10.1038/nprot.2015.090; Liu ZB, 2015, CHEM-EUR J, V21, P3924, DOI 10.1002/chem.201405829; Liu ZB, 2014, BIOCONJUGATE CHEM, V25, P1951, DOI 10.1021/bc5003357; Liu ZB, 2014, ANGEW CHEM INT EDIT, V53, P11876, DOI 10.1002/anie.201406258; Mahat MYA, 2012, J NEUROSCI METH, V211, P272, DOI 10.1016/j.jneumeth.2012.09.013; Marmor MF, 2011, ARCH OPHTHALMOL-CHIC, V129, P943, DOI 10.1001/archophthalmol.2011.160; Martin Timothy J, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P35, DOI 10.1097/MOO.0b013e3280123fce; MELAMED J, 1994, ALLERGY PROC, V15, P197, DOI 10.2500/108854194778702829; Nagayama M, 2002, AM J ROENTGENOL, V179, P515, DOI 10.2214/ajr.179.2.1790515; Nguyen QT, 2013, NAT REV CANCER, V13, P653, DOI 10.1038/nrc3566; Papisov M, 2015, J NUCL MED, V56; Pegg CC, 2010, J NEUROSCI METH, V187, P8, DOI 10.1016/j.jneumeth.2009.12.002; Placantonakis DG, 2007, NEUROSURGERY, V61, P161, DOI 10.1227/01.NEU.0000279993.65459.7B; Pogatzki EM, 2000, EUR J PAIN, V4, P111, DOI 10.1053/eujp.1999.0157; Rahmim A, 2008, NUCL MED COMMUN, V29, P193, DOI 10.1097/MNM.0b013e3282f3a515; Raslan Furat, 2012, Exp Transl Stroke Med, V4, P6, DOI 10.1186/2040-7378-4-6; Raza SM, 2016, J NEUROSURG, V124, P621, DOI 10.3171/2014.12.JNS14995; Rodriguez EA, 2016, BIOCONJUGATE CHEM, V27, P1390, DOI 10.1021/acs.bioconjchem.6b00164; SAINTEROSE C, 1992, PEDIATR NEUROSURG, V17, P2, DOI 10.1159/000120557; Schievink WI, 2006, JAMA-J AM MED ASSOC, V295, P2286, DOI 10.1001/jama.295.19.2286; Schievink WI, 2003, ARCH NEUROL-CHICAGO, V60, P1713, DOI 10.1001/archneur.60.12.1713; SCOTT M, 1955, J NEUROSURG, V12, P165, DOI 10.3171/jns.1955.12.2.0165; Seth R, 2010, OTOLARYNG HEAD NECK, V143, P626, DOI 10.1016/j.otohns.2010.07.011; Shetty PG, 1998, AM J NEURORADIOL, V19, P633; SKEDROS DG, 1993, J OTOLARYNGOL, V22, P341; Song Y, 2014, EUR SPINE J, V23, P1531, DOI 10.1007/s00586-014-3326-7; Takahashi M, 1996, MAGN RESON IMAGING, V14, P619, DOI 10.1016/0730-725X(96)00118-X; Tan XL, 2011, NEUROLOGY, V76, pE15, DOI 10.1212/WNL.0b013e3182088133; Ting R, 2005, J AM CHEM SOC, V127, P13094, DOI 10.1021/ja053293a; Ting R, 2008, J AM CHEM SOC, V130, P12045, DOI 10.1021/ja802734t; Ting R, 2008, J FLUORINE CHEM, V129, P349, DOI 10.1016/j.jfluchem.2008.01.011; Ting R, 2008, J ORG CHEM, V73, P4662, DOI 10.1021/jo800681d; Ting R, 2010, BIOCONJUGATE CHEM, V21, P1811, DOI 10.1021/bc1001328; Tsien RY, 2003, NAT REV MOL CELL BIO, pSS16, DOI 10.1038/nrm1196; Valdes-Hernandez Pedro Antonio, 2011, Front Neuroinform, V5, P26, DOI 10.3389/fninf.2011.00026; Vazquez A., 2015, ENDOSCOPIC CSF LEAK; Wang Y, 2017, J CEREBR BLOOD F MET, V37, P776, DOI 10.1177/0271678X16682510; Wormald PJ, 1997, J LARYNGOL OTOL, V111, P1042, DOI 10.1017/S0022215100139295; Wu AP, 2011, LARYNGOSCOPE, V121, P805, DOI 10.1002/lary.21411	54	8	8	1	12	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1838-7640			THERANOSTICS	Theranostics		2017	7	9					2377	2391		10.7150/thno.19408			15	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EY1DT	WOS:000403704900003	28744321	Green Published, Green Submitted, gold			2022-02-06	
J	Li, L; Chopp, M; Ding, GL; Qu, CS; Nejad-Davarani, SP; Davoodi-Bojd, E; Li, QJ; Mahmood, A; Jiang, Q				Li, Lian; Chopp, Michael; Ding, Guangliang; Qu, Changsheng; Nejad-Davarani, Siamak P.; Davoodi-Bojd, Esmaeil; Li, Qingjiang; Mahmood, Asim; Jiang, Quan			Diffusion-Derived Magnetic Resonance Imaging Measures of Longitudinal Microstructural Remodeling Induced by Marrow Stromal Cell Therapy after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion; diffusion entropy; FA; MSCs; white matter reorganization	PROMOTES AXONAL REGENERATION; BONE-MARROW; ADULT RATS; STEM-CELLS; STRUCTURAL PLASTICITY; FUNCTIONAL RECOVERY; EXPERIMENTAL STROKE; ISCHEMIC-STROKE; DOWN-REGULATION; TENSOR	Using magnetic resonance imaging (MRI) and an animal model of traumatic brain injury (TBI), we investigated the capacity and sensitivity of diffusion-derived measures, fractional anisotropy (FA), and diffusion entropy, to longitudinally identify structural plasticity in the injured brain in response to the transplantation of human bone marrow stromal cells (hMSCs). Male Wistar rats (300-350g, n = 30) were subjected to controlled cortical impact TBI. At 6 h or 1 week post-injury, these rats were intravenously injected with 1 mL of saline (at 6 h or 1 week, n = 5/group) or with hMSCs in suspension (similar to 3 x 10(6) hMSCs, at 6 h or 1 week, n = 10/group). In vivo MRI measurements and sensorimotor function estimates were performed on all animals pre-injury, 1 day post-injury, and weekly for 3 weeks post-injury. Bielschowsky's silver and Luxol fast blue staining were used to reveal the axon and myelin status, respectively, with and without cell treatment after TBI. Based on image data and histological observation, regions of interest encompassing the structural alterations were made and the values of FA and entropy were monitored in these specific brain regions. Our data demonstrate that administration of hMSCs after TBI leads to enhanced white matter reorganization particularly along the boundary of contusional lesion, which can be identified by both FA and entropy. Compared with the therapy performed at 1 week post-TBI, cell intervention executed at 6 h expedites the brain remodeling process and results in an earlier functional recovery. Although FA and entropy present a similar capacity to dynamically detect the microstructural changes in the tissue regions with predominant orientation of fiber tracts, entropy exhibits a sensitivity superior to that of FA, in probing the structural alterations in the tissue areas with complex fiber patterns.	[Li, Lian; Chopp, Michael; Ding, Guangliang; Nejad-Davarani, Siamak P.; Davoodi-Bojd, Esmaeil; Li, Qingjiang; Jiang, Quan] Henry Ford Hosp, Dept Neurol, B126,Educ & Res Bldg,2799 West Grand Blvd, Detroit, MI 48202 USA; [Qu, Changsheng; Mahmood, Asim] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael; Jiang, Quan] Oakland Univ, Dept Phys, Rochester, MI USA		Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, B126,Educ & Res Bldg,2799 West Grand Blvd, Detroit, MI 48202 USA.	QJIANG1@hfhs.org		Ding, Guangliang/0000-0003-1286-5901; Li, Lian/0000-0003-0097-1184	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS064134]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064134, R01NS062832, R01NS079612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG052735, R01AG037506] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health RO1 NS064134.	Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Arganda-Carreras I, 2008, J METHODS APPL; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bosnell R, 2008, DEV NEUROREHABIL, V11, P174, DOI 10.1080/17518420802289065; Chen Jieli, 2006, NeuroRx, V3, P466, DOI 10.1016/j.nurx.2006.07.007; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; Chopp M, 2011, TRANSL STROKE RES, V2, P241, DOI 10.1007/s12975-011-0090-4; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Dijkhuizen RM, 2012, TRANSL STROKE RES, V3, P36, DOI 10.1007/s12975-011-0143-8; Ding G., 2015, J CEREB BLO IN PRESS; Ding GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061241; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Fozouni N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076343; Gutierrez-Fernandez M, 2013, EXPERT OPIN BIOL TH, V13, P1479, DOI 10.1517/14712598.2013.824420; Haberg A. K., 2015, J NEUROSCI RES, V93, P1109; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Johansen-Berg H, 2007, CURR BIOL, V17, pR141, DOI 10.1016/j.cub.2006.12.022; Kou ZF, 2014, NEURAL REGEN RES, V9, P693, DOI 10.4103/1673-5374.131568; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lerner A, 2014, WORLD NEUROSURG, V82, P96, DOI 10.1016/j.wneu.2013.07.083; Li L, 2012, J CEREBR BLOOD F MET, V32, P2023, DOI 10.1038/jcbfm.2012.106; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Li L, 2009, STROKE, V40, P936, DOI 10.1161/STROKEAHA.108.527713; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2001, CELL TRANSPLANT, V10, P31; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2014, J NEUROSURG, V120, P1147, DOI 10.3171/2013.12.JNS131362; Mahmood A, 2014, BRAIN RES, V1542, P41, DOI 10.1016/j.brainres.2013.10.045; Metwalli Nader S, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2260; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Opydo-Chanek M, 2007, ACTA NEUROBIOL EXP, V67, P187; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Peredeny JV, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00017; Peterson DA, 2002, CURR OPIN PHARMACOL, V2, P34, DOI 10.1016/S1471-4892(01)00118-7; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Schaechter JD, 2009, HUM BRAIN MAPP, V30, P3461, DOI 10.1002/hbm.20770; Shannon CE, 1997, M D COMPUT, V14, P306; Sharma A, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0794-0; Shen LH, 2010, GLIA, V58, P1074, DOI 10.1002/glia.20988; Shen LH, 2008, GLIA, V56, P1747, DOI 10.1002/glia.20722; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; van der Zijden JP, 2008, EXP NEUROL, V212, P207, DOI 10.1016/j.expneurol.2008.03.027; van der Zijden JP, 2008, J CEREBR BLOOD F MET, V28, P832, DOI 10.1038/sj.jcbfm.9600576; Wang EY, 2012, J NEUROTRAUM, V29, P295, DOI 10.1089/neu.2011.2043; Wu HT, 2012, BRAIN RES, V1486, P121, DOI 10.1016/j.brainres.2012.09.039; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Zhang J, 2013, EXPERT OPIN BIOL TH, V13, P1229, DOI 10.1517/14712598.2013.804507; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	67	8	8	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					182	191		10.1089/neu.2015.4315			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100020	26993214	Green Published			2022-02-06	
J	Lin, HJ; Hsu, CC; Chio, CC; Tian, YF; Lin, MT; Lin, TW; Chang, CH; Chang, CP				Lin, Hung-Jung; Hsu, Chien-Chin; Chio, Chung-Ching; Tian, Yu-Feng; Lin, Mao-Tsun; Lin, Ting-Wei; Chang, Chih-Hsien; Chang, Ching-Ping			Gamma-Secretase Inhibitors Attenuate Neurotrauma and Neurogenic Acute Lung Injury in Rats by Rescuing the Accumulation of Hypertrophic Microglia	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Traumatic brain injury; gamma-secretase; Neurogenic acute lung injury; Microglia	TRAUMATIC BRAIN-INJURY; MOUSE MODEL; BLOOD-FLOW; ACTIVATION; CHF5074; CELLS; INFLAMMATION; MODULATOR; PATHOLOGY; PEPTIDE	Background/Aims: In response to traumatic brain injury (TBI), activated microglia exhibit changes in their morphology from the resting ramified phenotype toward the activated hypertrophic or amoeboid phenotype. Here, we provide the first description of the mechanism underlying the neuroprotective effects of gamma-secretase inhibitors on TBI outcomes in rats. Methods: The neuroprotective effects of gamma-secretase inhibitors such as LY411575 or CHF5074 on TBI-induced neurotoxicity were analysed using a neurological motor function evaluation, cerebral contusion assay, immunohistochemical staining for microglia phenotypes, lung injury score and Evans Blue dye extravasation assay of brain and lung oedema. Results: Hypertrophic or amoeboid microglia accumulated in the injured cortex, the blood-brain-barrier was disrupted and neurological deficits and acute lung injury were observed 4 days after TBI in adult rats. However, a subcutaneous injection of LY411575 (5 mg/kg) or CHF5074 (30 mg/kg) immediately after TBI and once daily for 3 consecutive days post-TBI significantly attenutaed the accumulation of hypertrophic microglia in the injured brain, neurological injury, and neurogenic acute lung injury. Conclusion: Gamma-secretase inhibitors attenuated neurotrauma and neurogenic acute lung injury in rats by reducing the accumulation of hypertrophic microglia in the vicinity of the lesion. (c) 2017 The Author(s) Published by S. Karger AG, Basel	[Lin, Hung-Jung; Hsu, Chien-Chin; Lin, Ting-Wei] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Lin, Hung-Jung; Hsu, Chien-Chin] Chi Mei Med Ctr, Dept Emergency Med, 901 Zhonghua Rd, Tainan, Taiwan; [Chio, Chung-Ching; Tian, Yu-Feng] Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan; [Tian, Yu-Feng] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan; [Lin, Mao-Tsun; Chang, Ching-Ping] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Chang, Chih-Hsien] Cheng Kung Univ, Sch Med, Dept Med, Tainan, Taiwan; [Chang, Ching-Ping] Taipei Med Univ, PhD Program Neural Regenerat Med, Taipei, Taiwan		Lin, HJ (corresponding author), Chi Mei Med Ctr, Dept Emergency Med, 901 Zhonghua Rd, Tainan, Taiwan.	hjlin52@gmail.com		Chang, Ching-Ping/0000-0003-0890-9414	Ministry of Science and Technology (Taiwan)Ministry of Science and Technology, Taiwan [MOST 104-2314-B-384-003-MY3, MOST 106-2314-B-384-001-MY3]; Chi Mei Medical Center (Taiwan) [CMFHT 10504]	This work was supported by grants from the Ministry of Science and Technology (Taiwan), MOST 104-2314-B-384-003-MY3 (to CCC) and MOST 106-2314-B-384-001-MY3 (to CCC), and a grant from the Chi Mei Medical Center (Taiwan), CMFHT 10504 (to CPC).	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Chang MW, 2008, J NEUROSCI METH, V168, P186, DOI 10.1016/j.jneumeth.2007.09.013; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Fumagalli S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00081; Gebel JM, 2000, STROKE, V31, P596, DOI 10.1161/01.STR.31.3.596; Giuliani A, 2013, J NEUROCHEM, V124, P613, DOI 10.1111/jnc.12136; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hasko G, 2006, CRIT CARE MED, V34, P1119, DOI 10.1097/01.CCM.0000206467.19509.C6; Henley DB, 2009, EXPERT OPIN PHARMACO, V10, P1657, DOI 10.1517/14656560903044982; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hu PJ, 2017, AM J PHYSIOL-LUNG C, V313, pL1, DOI 10.1152/ajplung.00485.2016; Imbimbo BP, 2009, BRIT J PHARMACOL, V156, P982, DOI 10.1111/j.1476-5381.2008.00097.x; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Imbimbo BP, 2010, J ALZHEIMERS DIS, V20, P159, DOI 10.3233/JAD-2010-1366; Jolivel V, 2015, ACTA NEUROPATHOL, V129, P279, DOI 10.1007/s00401-014-1372-1; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Kaner RJ, 2000, AM J RESP CELL MOL, V22, P657, DOI 10.1165/ajrcmb.22.6.3779; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lourbopoulos A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00054; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Masuda T, 2011, GLIA, V59, P1744, DOI 10.1002/glia.21220; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Nakajima T, 2010, J IMMUNOL, V184, P5835, DOI 10.4049/jimmunol.0903238; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Orr AG, 2009, NAT NEUROSCI, V12, P872, DOI 10.1038/nn.2341; Patel BV, 2012, EUR RESPIR J, V39, P1162, DOI 10.1183/09031936.00093911; Reino DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014829; Resende FFB, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2118-3; Reutershan J, 2007, J IMMUNOL, V179, P1254, DOI 10.4049/jimmunol.179.2.1254; Rogers J, 2001, NEUROCHEM INT, V39, P333, DOI 10.1016/S0197-0186(01)00040-7; Ross J, 2013, CURR ALZHEIMER RES, V10, P742, DOI 10.2174/13892037113149990144; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Sharma AK, 2010, J THORAC CARDIOV SUR, V139, P474, DOI 10.1016/j.jtcvs.2009.08.033; Sivilia S, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-44; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Torres-Platas SG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-12; Tsai MC, 2015, J NEUROIMMUNE PHARM, V10, P45, DOI 10.1007/s11481-014-9570-0; Weber DJ, 2014, SCI TRANSL MED, V6, P252; Wolfe MS, 2012, ADV PHARMACOL, V64, P127, DOI 10.1016/B978-0-12-394816-8.00004-0; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yang ST, 2014, AM J CHINESE MED, V42, P1357, DOI 10.1142/S0192415X14500852; Yasui H, 2016, AM J PHYSIOL-LUNG C, V311, pL74, DOI 10.1152/ajplung.00429.2015	54	8	8	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2017	44	5					1726	1740		10.1159/000485778			15	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	FU7DT	WOS:000424013000004	29227981	gold			2022-02-06	
J	Martin, PK; Hunter, BP; Rach, AM; Heinrichs, RJ; Schroeder, RW				Martin, Phillip K.; Hunter, Ben P.; Rach, Amanda M.; Heinrichs, Robin J.; Schroeder, Ryan W.			Excessive decline from premorbid functioning: detecting performance invalidity with the WAIS-IV and demographic predictions	CLINICAL NEUROPSYCHOLOGIST			English	Article						Wechsler Adult Intelligence Scale; Test of Premorbid Functioning (TOPF); malingering; effort; performance validity; excessive decline	TRAUMATIC BRAIN-INJURY; INTELLIGENCE SCALE-4TH EDITION; ALBANY CONSISTENCY INDEX; VALIDITY TEST FAILURE; RELIABLE DIGIT SPAN; WORD MEMORY TEST; CLASSIFICATION ACCURACY; CLINICAL UTILITY; SUSPECT EFFORT; SCORES	Objective: Excessive Decline from Premorbid Functioning (EDPF) is presented as a construct and defined as a discrepancy between predicted premorbid ability and current test performance that is so atypical of individuals with true neurocognitive impairment that it is likely the product of performance invalidity. New embedded PVTs (EDPF-FSIQ, EDPF-VW, and EDPF-PP) were derived by comparing scores from the WAIS-IV to TOPF demographically predicted premorbid estimates and then examined for classification accuracy. Participants and methods: After excluding for dementia, intellectual disability, and left-sided stroke, participants (n=230) were grouped according to number of PVTs failed. ROC analyses were conducted to determine the accuracy of EDPF indices in classifying patients as failing 0 or 2 PVTs within both a mixed neuropsychological outpatient sample and according to specific diagnostic criterion groups. Results: Significant group differences emerged for all EDPF indices (p<.001). EDPF-FSIQ resulted in an AUC of .837, classifying patients with 56% sensitivity at 90% specificity, and EDPF-VW resulted in an AUC of .850, classifying patients with 61% sensitivity at 90% specificity. Accuracy remained high across diagnostic groups (i.e. neurocognitive, moderate/severe TBI, and psychiatric) for EDPF-VW and EDPF-FSIQ, whereas specificity declined for EDPF-PP in patients with mixed neurocognitive disorders. Overall, classification accuracy rates exceeded those of Reliable Digit Span. Conclusions: Both EDPF-FSIQ and EDPF-VW demonstrated excellent discrimination between patients providing valid versus invalid test performance. Unique advantages of EDPF validity measures include incorporation of demographic estimates of premorbid ability and examination of performances on multiple tests spanning different cognitive domains.	[Martin, Phillip K.; Hunter, Ben P.; Rach, Amanda M.; Heinrichs, Robin J.; Schroeder, Ryan W.] Univ Kansas, Sch Med, Dept Psychiat & Behav Sci, Wichita, KS 67214 USA		Martin, PK (corresponding author), Univ Kansas, Sch Med, Dept Psychiat & Behav Sci, Wichita, KS 67214 USA.	pmartin820@gmail.com					Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Baxendale S, 2014, J CLIN EXP NEUROPSYC, V36, P137, DOI 10.1080/13803395.2013.870535; Boone K., 2002, DOT COUNTING TEST; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P850, DOI 10.1080/13854046.2012.686631; Demakis GJ, 2001, PSYCHOL ASSESSMENT, V13, P240, DOI 10.1037//1040-3590.13.2.240; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Fazio RL, 2015, ARCH CLIN NEUROPSYCH, V30, P293, DOI 10.1093/arclin/acv024; Green P., 2005, MANUAL WORD MEMORY T; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2008, APPL NEUROPSYCHOL, V15, P161, DOI 10.1080/09084280802324085; Gunner JH, 2012, ARCH CLIN NEUROPSYCH, V27, P1, DOI 10.1093/arclin/acr089; Hosmer D.W., 2000, APPL LOGISTIC REGRES, P375, DOI [10.1002/0471722146, DOI 10.1002/0471722146]; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Loring DW, 2016, ARCH CLIN NEUROPSYCH, V31, P313, DOI 10.1093/arclin/acw014; Martin P. K., 2016, RATES ABNORMALLY LOW, DOI [10.1177/1073191116656796, DOI 10.1177/1073191116656796]; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Martin PK, 2015, ARCH CLIN NEUROPSYCH, V30, P377, DOI 10.1093/arclin/acv032; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Pearson, 2009, ADV CLIN SOLUTIONS W; Peavy GM, 2001, J INT NEUROPSYCH SOC, V7, P535, DOI 10.1017/S1355617701755014; Ryan JJ, 2012, J CLIN EXP NEUROPSYC, V34, P571, DOI 10.1080/13803395.2012.666229; Sawyer RJ, 2014, CLIN NEUROPSYCHOL, V28, P756, DOI 10.1080/13854046.2014.920922; Schroeder RW, 2013, ARCH CLIN NEUROPSYCH, V28, P21, DOI 10.1093/arclin/acs094; Schroeder RW, 2016, CLIN NEUROPSYCHOL, V30, P515, DOI 10.1080/13854046.2016.1177118; Schroeder RW, 2012, COGN BEHAV NEUROL, V25, P139, DOI 10.1097/WNN.0b013e31826b71c1; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schroeder RW, 2010, CLIN NEUROPSYCHOL, V24, P326, DOI 10.1080/13854040903369441; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; Schutte C, 2011, CLIN NEUROPSYCHOL, V25, P454, DOI 10.1080/13854046.2010.550635; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Walter J, 2014, CLIN NEUROPSYCHOL, V28, P1197, DOI 10.1080/13854046.2014.960454; Wechsler, 2008, WAIS 4 ADM SCORING M; Whiteside DM, 2015, CLIN NEUROPSYCHOL, V29, P788, DOI 10.1080/13854046.2015.1093660; Whiteside DM, 2015, J CLIN EXP NEUROPSYC, V37, P220, DOI 10.1080/13803395.2014.1002758; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	45	8	8	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2017	31	5					829	843		10.1080/13854046.2017.1284265			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EY2WQ	WOS:000403833900002	28276862				2022-02-06	
B	Morrison, DR; Casper, MJ		Leonard, DJ; George, KB; Davis, W		Morrison, Daniel R.; Casper, Monica J.			Gender, violence, and brain injury in and out of the NFL What counts as harm?	FOOTBALL, CULTURE AND POWER	Routledge Research in Sport Culture and Society		English	Article; Book Chapter							INTIMATE PARTNER VIOLENCE; CHRONIC TRAUMATIC ENCEPHALOPATHY; CONSEQUENCE		[Morrison, Daniel R.] Vanderbilt Univ, Med Ctr, Ctr Biomed Eth & Soc, Nashville, TN 37235 USA; [Casper, Monica J.] Univ Arizona, Coll Social & Behav Sci, Acad Affairs, Tucson, AZ 85721 USA; [Casper, Monica J.] Univ Arizona, Gender & Womens Studies, Tucson, AZ 85721 USA		Morrison, DR (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Biomed Eth & Soc, Nashville, TN 37235 USA.						Adelman Ronald D, 2014, JAMA-J AM MED ASSOC, V311, P1051; [Anonymous], WHAT IS CTE; [Anonymous], 2016, MYTHS FACTS DOM VIOL; [Anonymous], DETECT STUD; [Anonymous], 2016, NEUR; Associated Press, 2013, CBS NEWS        409; Axson Scooby, 2015, SPORTS ILLUSTRA 0514; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Barra Allen, 2013, THE ATLANTIC    0831; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Belson Ken, 2015, NEW YORK TIMES  0422; Borden Sam, 2012, NEW YORK TIMES  0920; Branch J, 2014, BOY ICE LIFE DEATH D; Breslow Jason M, 2015, FRONTLINE       0918; Breslow Jason M., 2013, FRONTLINE       1031; Bumiller K., 2008, ABUSIVE STATE NEOLIB; Car Mary, 2000, INCREASING AWARENESS; Caspar Monica J., 2012, DISABILITY STUDIES Q, V32; Casper M.J., 2009, MISSING BODIES POLIT; Centers for Disease C Prevention, 2011, MMWR-MORBID MORTAL W, V60, P1337; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Cristene Chelsea, 2013, UPTOWN MAGAZINE 1014; Curtis Mary C., 2014, WASHINGTON POST 0930; Davidson Kavitha A., 2015, BLOOMBERG VIEW  0223; Eilperin Juliet, 2014, WASHINGTON POST 0529; Fainaru Steve, 2015, NO HELMET SENSORS NF; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Faul M, 2010, TRAUMATIC BRAIN INJU; Flood Brian, 2014, UIC POLICY EXPERT NA; Foster Tom, 2012, POPULAR SCI     1218; Fuhrmeister Chris, 2014, SB NATION       0328; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gosk Stephanie, 2013, NBC NEWS        1217; Gruley Bryan, 2015, BLOOMBERG BUSIN 0128; Holstein J.A., 2015, IS THERE LIFE FOOTBA; Hruby Patrick, 2014, WASHINGTONIAN   1202; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kaplan Daniel, 2015, SPORTS BUSINESS 0219; Kasperkevic Jana, 2014, GUARDIAN        1020; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Leavy J., 2012, WOMAN WHO WOULD SAVE; Leonard David J., 2014, FEMINIST WIRE   0908; Martel Brett, 2015, PRO332 HEAD HEA 0516; Martin Del., 1976, BATTERED WIVES; Martland H., 1928, JAMA-J AM MED ASSOC, V91, P1103, DOI DOI 10.1001/JAMA.1928.02700150029009; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mooney Brenda L, 2013, NEW CTE STUDY CATEGO; Moore Jack, 2015, VICE SPORTS     0213; Morris Benjamin, 2014, FIVETHIRTYEIGHT 0731; Morrison Daniel, 2011, FEMINIST WIRE   0202; Morrison Daniel R., 2012, FEMINIST WIRE   0512; Murray Christine E., 2015, TRAUMA VIOLENCE ABUS; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Packel Dan, 2012, LAW360          0618; Pennington Bill, 2013, NEW YORK TIMES  0731; Richie B., 1995, COMPELLED CRIME GEND; Schneider E. M., 2002, BATTERED WOMEN FEMIN; Segura Melissa, 2012, SPORTS ILLUSTRA 0910; Seltzer M, 1997, OCTOBER, P3; Shurley Jason P., 2012, KINESIOLOGY REV, V1, P170; SMITH BE, 1981, INT J HEALTH SERV, V11, P343, DOI 10.2190/LMPT-4G1J-15VQ-KWEK; Smith Will, 2015, CONCUSSION; Solomon Jon, 2014, CBS SPORTS      1002; Steinbach Paul, 2015, ATHLETIC BUSINES MAY; Terry J., 2009, WOMENS STUDIES Q, V37, P200, DOI DOI 10.1353/WSQ.0.0143; Toy Ozan, 2014, NEUROLOGY S, V82, pP5; Waldron Travis, 2014, NFL OWNER ADMITS LEA; Weir DR., 2009, NATL FOOTBALL LEAGUE; Wong JYH, 2014, TRAUMA VIOLENCE ABUS, V15, P22, DOI 10.1177/1524838013496333; Wu V, 2010, TRAUMA VIOLENCE ABUS, V11, P71, DOI 10.1177/1524838010367503; Zuckerman SL, 2015, WORLD NEUROSURG, V83, P1098, DOI 10.1016/j.wneu.2014.12.030	74	8	8	0	0	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-1-315-68501-4; 978-1-138-92356-0	ROUTL RES SPORT CULT			2017							156	175					20	Cultural Studies; Hospitality, Leisure, Sport & Tourism; Sociology	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Cultural Studies; Social Sciences - Other Topics; Sociology	BL2MQ	WOS:000449153700011					2022-02-06	
J	Moser, RS; Schatz, P; Grosner, E; Kollias, K				Moser, Rosemarie Scolaro; Schatz, Philip; Grosner, Emily; Kollias, Kelly			One year test-retest reliability of neurocognitive baseline scores in 10-to 12-year olds	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Baseline testing; concussion testing; ImPACT; neurocognitive testing	SPORT-RELATED CONCUSSION; AGE-RELATED DIFFERENCES; HIGH-SCHOOL; REACTION-TIME; ADOLESCENT BRAIN; RECOVERY; IMPACT; SPEED	How often youth athletes 10-12 years of age should undergo neurocognitive baseline testing remains an unanswered question. We sought to examine the test-retest reliability of annual ImPACT data in a sample of middle school athletes. Participants were 30 youth athletes, ages 10-12 years (Mean=11.6, SD=0.6) selected from a larger database of 10-18 year old athletes, who completed two consecutive annual baseline evaluations using the online version of ImPACT. Athlete assent and parental consent were obtained for all participants. Assessments were conducted either individually or in small groups of 2 to 3 athletes, under the supervision of a neuropsychologist or post-doctoral fellow. Test-retest coefficients were as follows: Verbal Memory .71, Visual Memory .35, Visual Motor Speed .69, Reaction Time .34. Intra-class Correlation Coefficients (single/average) were as follows: Verbal Memory .70/.83, Visual Memory .35/.52, Visual Motor Speed .69/.82, Reaction Time .34/.50. Regression-based measures to correct for practice effects revealed that only a small percentage of cases fell outside 90 and 95% confidence intervals, reflecting stability across assessments. Findings indicate that test-retest reliability of Verbal Memory and Visual Motor Speed are generally stable in 10-12 year old athletes. Nevertheless, Visual Memory Index, Reaction Time Index, and Symptom Checklist scores appear to be less reliable over time, especially compared to published data on high school athletes, suggesting the utility of re-testing on an annual basis in this younger age group.	[Moser, Rosemarie Scolaro] Sports Concuss Ctr NJ, 281 Witherspoon St,Ste 230, Princeton, NJ 08540 USA; [Moser, Rosemarie Scolaro] RSM Psychol Ctr LLC, Princeton, NJ USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; [Grosner, Emily] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Kollias, Kelly] Bancroft NeuroRehab, Mt Laurel, NJ USA		Moser, RS (corresponding author), Sports Concuss Ctr NJ, 281 Witherspoon St,Ste 230, Princeton, NJ 08540 USA.	Rmoser@rsmpsychology.com			Sports Concussion Center of New Jersey	Study was conducted with administrative office support by the private practice setting in which it was conducted: The Sports Concussion Center of New Jersey.	ANASTASI A, 1998, PSYCHOL TESTING; Blakemore SJ, 2012, NEUROIMAGE, V61, P397, DOI 10.1016/j.neuroimage.2011.11.080; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; CDC, 2015, SPORTS CONC POL LAWS; Chicchetti D. V., 1994, PSYCHOL ASSESSMENT, V6, P294, DOI DOI 10.1037//1040-3590.6.4.284; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Crawford JR, 2006, NEUROPSYCHOLOGY, V20, P259, DOI 10.1037/0894-4105.20.3.259; Echemendia R., 2013, INT C SPORTS CONC SP; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; FLEISHMAN J, 1987, EDUC PSYCHOL MEAS, V47, P925, DOI 10.1177/0013164487474008; Gardner A, 2010, ARCH CLIN NEUROPSYCH, V25, P174, DOI 10.1093/arclin/acq007; Gruber H., 1977, THE ESSENTIAL PIAGET; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Lovell M.R., 2011, IMPACT TECHNICAL MAN, V2013; MacDonald J, 2015, CLIN J SPORT MED, V25, P367, DOI 10.1097/JSM.0000000000000139; MacDonald J, 2015, CLIN J SPORT MED, V25, P43, DOI 10.1097/JSM.0000000000000096; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Randolph C, 2005, J ATHL TRAINING, V40, P139; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Wilk CM, 2002, AM J PSYCHIAT, V159, P838, DOI 10.1176/appi.ajp.159.5.838	32	8	8	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2017	6	2					166	171		10.1080/21622965.2016.1138310			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	ES4FG	WOS:000399485300008	27182767				2022-02-06	
J	Nikles, J; Mitchell, G; McKinlay, L; Waugh, MC; Epps, A; Carmont, SA; Schluter, PJ; Lloyd, O; Senior, H				Nikles, Jane; Mitchell, Geoffrey; McKinlay, Lynne; Waugh, Mary-Clare; Epps, Adrienne; Carmont, Sue-Ann; Schluter, Philip J.; Lloyd, Owen; Senior, Hugh			A series of n-of-1 trials of stimulants in brain injured children	NEUROREHABILITATION			English	Article						Paediatrics; traumatic brain injury; acquired brain injury	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; BRIEF FATIGUE INVENTORY; CANCER-PATIENTS; SECONDARY; HYPERACTIVITY; BEHAVIOR; SCALE	BACKGROUND: There is controversy about whether central nervous system stimulant (CNS) medication is an effective method of treating acquired attention deficits in children with acquired brain injury (ABI). OBJECTIVE: The primary objective was to determine the effectiveness of stimulants on attention, concentration and executive function in children with ABI. METHODS: Randomised, double-blind, placebo-controlled, multi-centre n-of-1 trials of stimulants assessing effect on attention, concentration and executive function in 53 children and adolescents with ABI who were outpatients of three tertiary hospitals in Australia. Trials consisted of 3 two-week cycles, each cycle consisting of stimulant medication at doses titrated by physician (1 week) and placebo (1 week) in random order. The effect on parent and teacher Conners' 3 and Behaviour Rating Inventory of Executive Function (BRIEF) was analysed using hierarchical Bayesian methods. RESULTS: Overall, Teacher Conners' Hyperactivity/Impulsivity and Teacher BRIEF Global Executive scales showed important improvement (T-score mean change 2.6; 95% credible interval (CI): 0.4, 4.9; posterior probability of mean change > 0 : 0.99; T-score mean change 3.1; 95% CI: -0.1, 6.4; posterior probability of mean change > 0 : 0.97). There were no important improvements in parent/guardian-reported primary outcomes. There was heterogeneity in response identified through individual results of the N-of-1 trials. CONCLUSIONS: N-of-1 trials have a clear role in identifying those children/adolescents with ABI and secondary Attention Deficit Hyperactivity Disorder (ADHD) who have important improvements, or worsening on stimulants. The results can only be generalized to children/adolescents who have an apparent pre-trial clinical effect from stimulants.	[Nikles, Jane; Mitchell, Geoffrey; Carmont, Sue-Ann; Schluter, Philip J.; Senior, Hugh] Univ Queensland, Brisbane, Qld, Australia; [McKinlay, Lynne; Lloyd, Owen] Lady Cilento Childrens Hosp, Brisbane, Qld, Australia; [Waugh, Mary-Clare] Childrens Hosp Westmead, Westmead, NSW, Australia; [Epps, Adrienne] Sydney Childrens Hosp, Sydney, NSW, Australia; [Schluter, Philip J.] Univ Canterbury, Christchurch, New Zealand; [Senior, Hugh] Massey Univ, Auckland, New Zealand		Nikles, J (corresponding author), Univ Queensland, Clin Res Ctr, Bldg 71-918,Royal Brisbane Womens Hosp Campus, Herston, Qld 4029, Australia.	uqjnikle@uq.edu.au	Carmont, Sue-Ann S/G-4769-2011; Nikles, Jane/F-4572-2010	Carmont, Sue-Ann S/0000-0001-6266-7757; Nikles, Jane/0000-0001-5356-2291; McKinlay, Lynne/0000-0002-6677-0628; Senior, Hugh/0000-0002-7081-2499			Bakker K., 2008, EFFICACY STIMULANT M; Bakker K., 2000, BRAIN IMPAIR, V1, P29; BARKLEY RA, 1981, HYPERACTIVE CHILDREN; BROWN GL, 1979, PSYCHOPHARMACOLOGY, V62, P133, DOI 10.1007/BF00427126; Brown RT, 2005, PEDIATRICS, V115, pE749, DOI 10.1542/peds.2004-2560; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Conners C. K., 2008, CONNORS; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P279, DOI 10.1023/A:1022606501530; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; GOYETTE CH, 1978, J ABNORM CHILD PSYCH, V6, P221, DOI 10.1007/BF00919127; Guiltier C. T., 1988, BRAIN INJURY, V2, P273; Harvey DW, 2012, ARCH DIS CHILD, V97, P755, DOI 10.1136/archdischild-2012-302250; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Mendoza TR, 2010, ONCOLOGY-BASEL, V79, P112, DOI 10.1159/000320607; Mendoza TR, 1999, CANCER-AM CANCER SOC, V85, P1186, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N; Nikles CJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-54; Novartis, 2010, RIT HYDR PROD INF SH; Ornstein TJ, 2014, J INT NEUROPSYCH SOC, V20, P971, DOI 10.1017/S1355617714000903; Schluter PJ, 2005, STAT MED, V24, P2625, DOI 10.1002/sim.2132; Senior HEJ, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-89; TEASDALE G, 1974, LANCET, V2, P81; Thummel KE, 2014, METHODS MOL BIOL, V1113, P363, DOI 10.1007/978-1-62703-758-7_17; Vance A, 2012, J PAEDIATR CHILD H, V48, pE33, DOI 10.1111/j.1440-1754.2010.01941.x; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zucker DR, 1997, J CLIN EPIDEMIOL, V50, P401, DOI 10.1016/S0895-4356(96)00429-5	29	8	9	1	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2017	40	1					11	21		10.3233/NRE-161386			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EN8RO	WOS:000396267700003	27814302				2022-02-06	
J	Roper, LS; Nightingale, P; Su, ZJ; Mitchell, JL; Belli, A; Sinclair, AJ				Roper, Louise S.; Nightingale, Peter; Su, Zhangjie; Mitchell, James L.; Belli, Antonio; Sinclair, Alexandra J.			Disability from posttraumatic headache is compounded by coexisting posttraumatic stress disorder	JOURNAL OF PAIN RESEARCH			English	Article						chronic headache; traumatic brain injury; neurotrauma	TRAUMATIC BRAIN-INJURY; VALIDATION; MIGRAINE; IMPACT; PAIN	Background: Posttraumatic headache (PTH) occurs in up to 82% of patients with traumatic brain injury (TBI). Posttraumatic stress disorder (PTSD) occurs in 39% of those with PTH. This study evaluates whether PTSD affects PTH disability. Methods: Eighty-six patients with TBI were prospectively evaluated in a secondary care trauma center. Headache disability was assessed using the Headache Impact Test version 6 and signs indicative of PTSD using the PTSD Check List Civilian version. Results: Increased PTSD-type symptoms were significantly associated with increased headache disability (p<0.001), as were employment status and loss of consciousness (p=0.049 and 0.016, respectively). Age was negatively correlated with headache disability (Spearman's correlation rho=0.361, p=0.001). Conclusion: Increased severity of PTSD-type symptoms is significantly associated with increased headache disability in patients with chronic PTH. Managing PTSD symptoms in patients with chronic PTH may facilitate headache management.	[Roper, Louise S.; Mitchell, James L.; Sinclair, Alexandra J.] Univ Birmingham, Coll Med & Dent Sci, Inst Metab & Syst Res, Birmingham B15 2TT, W Midlands, England; [Roper, Louise S.; Mitchell, James L.; Sinclair, Alexandra J.] Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England; [Roper, Louise S.; Mitchell, James L.; Sinclair, Alexandra J.] Univ Hosp Birmingham NHS Fdn Trust, Dept Neurol, Birmingham, W Midlands, England; [Nightingale, Peter] Univ Hosp Birmingham NHS Fdn Trust, Wolfson Comp Lab, Birmingham, W Midlands, England; [Su, Zhangjie; Belli, Antonio] Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Birmingham, W Midlands, England; [Su, Zhangjie; Belli, Antonio] Hlth Res Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England		Roper, LS (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Metab & Syst Res, Birmingham B15 2TT, W Midlands, England.	louisesarah.roper@nhs.net	Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933; Mitchell, James/0000-0001-6785-9352; Sinclair, Alexandra/0000-0003-2777-5132	NIHRNational Institute for Health Research (NIHR) [NIHR-CS-011-028]; Medical Research Council, UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K015184/1]; National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-CS-011-028, CL-2009-09-001, ACF-2014-09-004] Funding Source: researchfish	Dr Alexandra J Sinclair was financially supported by an NIHR Clinician Scientist Fellowship (NIHR-CS-011-028) and by the Medical Research Council, UK (MR/K015184/1). Professor Antonio Belli and Dr Zhangjie Su were financially supported by the National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health. The authors report no other conflicts of interest in this work.	Abu Bakar N, 2016, CEPHALALGIA, V36, P67, DOI 10.1177/0333102415580099; Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; [Anonymous], 2015, US PTSD CHECKL DSM 4; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hull Alastair M, 2016, Practitioner, V260, P19; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Martins KM, 2006, HEADACHE, V46, P312, DOI 10.1111/j.1526-4610.2006.00343.x; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Monteith TS, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-013-0428-2; NICE, 2005, NICE CLIN GUID; Peterlin BL, 2008, HEADACHE, V48, P517, DOI 10.1111/j.1526-4610.2008.00917.x; Rosenthal JF, 2013, HEADACHE, V53, P1564, DOI 10.1111/head.12200; Smith MY, 1999, J TRAUMA STRESS, V12, P485, DOI 10.1023/A:1024719104351; SOC, 2010, SOC2010, V1; Steiner TJ, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-1; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Watadani T, 2013, RADIOLOGY, V266, P936, DOI 10.1148/radiol.12112516; Yang M, 2011, CEPHALALGIA, V31, P357, DOI 10.1177/0333102410379890	27	8	8	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-7090			J PAIN RES	J. Pain Res.		2017	10						1991	1996		10.2147/JPR.S129808			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FE3CE	WOS:000408093200002	28860853	gold, Green Published, Green Submitted			2022-02-06	
J	Shojo, H; Borlongan, CV; Mabuchi, T				Shojo, Hideki; Borlongan, Cesario V.; Mabuchi, Tadashi			Genetic and Histological Alterations Reveal Key Role of Prostaglandin Synthase and Cyclooxygenase 1 and 2 in Traumatic Brain Injury-Induced Neuroinflammation in the Cerebral Cortex of Rats Exposed to Moderate Fluid Percussion Injury	CELL TRANSPLANTATION			English	Article						head trauma; brain injury model; neuroinflammation; neurodegeneration; cyclooxygenase; prostaglandin synthase	INFLAMMATORY RESPONSE; LIPID MEDIATORS; EXPRESSION; COX-2; RESOLUTION; INHIBITION; NEURONS; MICE; LIPOPOLYSACCHARIDE; MICROGLIA	After the initial insult in traumatic brain injury (TBI), secondary neurodegeneration occurs that is intimately associated with neuroinflammation. Prostaglandin (PG) synthases and cyclooxygenase (COX) 1 and 2 may contribute to inflammation in the brain. Temporal and spatial expression features of PG and COX1 and 2 following trauma may guide the development of antineuroinflammation strategies. Here, we examined PG synthase signaling and COX1 and 2 gene expression levels and COX-1-and 2-positive cell types and their temporal localization in TBI-induced brain in an effort to reveal their participation in the disease's evolving neuroinflammation. Using brain samples from the cerebral cortex of rats subjected to TBI model of lateral moderate fluid percussion injury (FPI), we sought to characterize the temporal (subacute TBI) and spatial (lateral cortical lesion) brain alterations accompanying the disease progression. Temporal gene expression changes of PG synthase signaling were compared between sham-operated and TBI-treated rats using microarray pathway analysis. Moreover, we examined COX1 and 2 expression patterns and their intracellular distribution in sham-operated and TBI-treated rats by immunohistochemistry. After FPI, COX1 and 2 gene expression levels, and PGE(2) synthase increased while PGD(2) synthase decreased, suggesting that PGE(2) and PGD(2) afforded contraindicative effects of inflammation and anti-inflammation, respectively. Immunohistochemical analyses showed that both COX1 and COX2 increased in a time-dependent manner in the brain, specifically in degenerating neurons of the cortex. Interestingly, the expression of COX cell type was cell-specific, in that COX1 was particularly increased in degenerating neurons whileCOX2 was expressed in macrophages. In view of the dynamic temporal and spatial expression of PG, COX1 and 2 gene expression and localization in the injured brain regulating PG synthase and COX1 and 2 activity will require a careful disease-specific tailoring of treatments to abrogate the neuroinflammation-plagued secondary cell death due to TBI.	[Shojo, Hideki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Legal Med, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan; [Borlongan, Cesario V.] Univ S Florida, Dept Neurosurg & Brain Repair, Morsani Coll Med, Tampa, FL USA; [Mabuchi, Tadashi] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Chuo Ku, Yamanashi, Japan		Shojo, H (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Legal Med, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	hshohjoh@yamanashi.ac.jp			Japan society for the promotion of science, JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [15K15260, 15H04797]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS071956, R01 NS090962, R21NS089851, R21 NS094087]; State of Florida, VA Merit Review [I01 BX001407]; SanBio Inc.; KMPHC; Karyopharm; International Stem Cell Corporation; NeuralStem Inc.; DODUnited States Department of Defense [W81XWH-11-1-0634]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS090962, R21NS094087, R01NS071956, R21NS089851] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX001407] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by Grants-in-Aid for Scientific Research (Nos. 15K15260 and 15H04797 to HS) from Japan society for the promotion of science, Japan. CVB is funded by NIH R01NS071956, NIH R01 NS090962, NIH R21NS089851, NIH R21 NS094087, DOD W81XWH-11-1-0634, the State of Florida, VA Merit Review I01 BX001407, SanBio Inc., KMPHC, Karyopharm, International Stem Cell Corporation, and NeuralStem Inc.	Ahmad M, 2008, J NEUROSCI RES, V86, P3605, DOI 10.1002/jnr.21809; Aid S, 2011, BIOCHIMIE, V93, P46, DOI 10.1016/j.biochi.2010.09.009; Aid S, 2010, J CEREBR BLOOD F MET, V30, P370, DOI 10.1038/jcbfm.2009.223; Aid S, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-17; Bertolini A, 2002, CURR MED CHEM, V9, P1033, DOI 10.2174/0929867024606650; Blais V, 2005, J NEUROCHEM, V95, P1563, DOI 10.1111/j.1471-4159.2005.03480.x; Bosetti F, 2004, J NEUROCHEM, V91, P1389, DOI 10.1111/j.1471-4159.2004.02829.x; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Candelario-Jalil E, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-25; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Chan MMY, 2010, J IMMUNOL, V184, P6418, DOI 10.4049/jimmunol.0903816; Choi SH, 2010, PHARMACOGENOMICS J, V10, P448, DOI 10.1038/tpj.2009.68; Choi SH, 2008, FASEB J, V22, P1491, DOI 10.1096/fj.07-9411com; Choi SH, 2006, J NEUROCHEM, V98, P801, DOI 10.1111/j.1471-4159.2006.03926.x; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Duchen L. W., 1992, GREENFIELDS NEUROPAT, P1; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; Garcia-Bueno B, 2009, J NEUROSCI, V29, P12970, DOI 10.1523/JNEUROSCI.2373-09.2009; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Gunther M, 2015, ACTA NEUROCHIR, V157, P649, DOI 10.1007/s00701-014-2331-2; Hoozemans JJM, 2001, ACTA NEUROPATHOL, V101, P2, DOI 10.1007/s004010000251; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; Morita I, 2002, PROSTAG OTH LIPID M, V68-9, P165, DOI 10.1016/S0090-6980(02)00029-1; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Nagai A, 2005, J NEUROSCI RES, V81, P342, DOI 10.1002/jnr.20478; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Niwa K, 2000, J NEUROSCI, V20, P763, DOI 10.1523/JNEUROSCI.20-02-00763.2000; Parfenova H, 2001, AM J PHYSIOL-CELL PH, V281, pC166, DOI 10.1152/ajpcell.2001.281.1.C166; Pepicelli O, 2005, J NEUROCHEM, V93, P1561, DOI 10.1111/j.1471-4159.2005.03150.x; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Pilipovic K, 2015, PROG NEURO-PSYCHOPH, V59, P8, DOI 10.1016/j.pnpbp.2015.01.003; Sanes JR, 2000, PRINCIPLES NEURAL SC, P1087; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Schwab JM, 2002, J NEUROSURG, V96, P892, DOI 10.3171/jns.2002.96.5.0892; Schwab JM, 2001, J NEUROTRAUM, V18, P881, DOI 10.1089/089771501750451802; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Skaper SD, 2007, ANN NY ACAD SCI, V1122, P23, DOI 10.1196/annals.1403.002; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Toscano CD, 2008, BRAIN RES BULL, V75, P598, DOI 10.1016/j.brainresbull.2007.10.004; Tuo JS, 2004, INVEST OPHTH VIS SCI, V45, P2306, DOI 10.1167/iovs.03-0756; Yang HW, 2008, CURR PHARM DESIGN, V14, P1443, DOI 10.2174/138161208784480144; Yermakova AV, 1999, J NEUROPATH EXP NEUR, V58, P1135, DOI 10.1097/00005072-199911000-00003	55	8	9	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2017	26	7					1301	1313		10.1177/0963689717715169			13	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	EZ4GO	WOS:000404671800016	28933223	gold, Green Published			2022-02-06	
J	Spencer, RJ; Waldron-Perrine, B; Drag, LL; Pangilinan, PH; Axelrod, BN; Bieliauskas, LA				Spencer, Robert J.; Waldron-Perrine, Brigid; Drag, Lauren L.; Pangilinan, Percival H.; Axelrod, Bradley N.; Bieliauskas, Linas A.			Neuropsychological test validity in Veterans presenting with subjective complaints of 'very severe' cognitive symptoms following mild traumatic brain injury	BRAIN INJURY			English	Article						Cognition; effort; insight; military; psychometrics; neuropsychological assessment; self-report; traumatic brain injury; veterans	TEST-PERFORMANCE; HEAD-INJURY; DIGIT SPAN; RESPONSE BIAS; WAIS-IV; CLAIMANTS; SAMPLE; INDIVIDUALS; INVENTORY; UTILITY	Objective: This study explored the utility of combining data from measures of performance validity and symptom validity arming Veterans undergoing neuropsychological evaluation for mild traumatic brain injury (mTBI). Background: Persistent cognitive impairments following mTBI are often reported by returning combat veterans. However, objectively-Measured cognitive deficits are not common among individuals with mTBI, raising the question of whether negative impression management influences self-ratings. Methods: Self-report ratings were obtained for memory, concentration, decision-making, and processing speed/organization using a 5-point scale ranging from 'none' to 'very severe'. Veterans also completed brief neuropsychological testing which included measures of performance validity. Results: Study 1 examined data from 122 participants and demonstrated that veterans reporting a 'very severe' cognitive deficit were over three times as likely to demonstrate poor effort on a validity test than those without a very severe rating. Study 2 replicated these findings in an independent ample of 127 veterans and also demonstrated that both severity of self-report ratings and performance on an embedded measure of effort were predictive of poor effort on a stand-alone performance validity test. Conclusion: Veterans with suspected mTBI who report 'very severe' cognitive impairment have a greater likelihood of putting forth sub-optimal effort on objective testing.	[Spencer, Robert J.; Waldron-Perrine, Brigid; Bieliauskas, Linas A.] VA Ann Arbor Healthcare Syst, Dept Mental Hlth Serv, Ann Arbor, MI USA; [Drag, Lauren L.] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Pangilinan, Percival H.] Univ Michigan Hlth Syst, Dept Phys Med & Rehabil, Ann Arbor, MI USA; [Axelrod, Bradley N.] John D Dingell Dept Vet Affairs Med Ctr, Mental Hlth Serv, Psychol Sect, Detroit, MI USA; [Bieliauskas, Linas A.] Univ Michigan Hlth Syst, Dept Psychiat, Ann Arbor, MI USA		Spencer, RJ (corresponding author), VA Ann Arbor Healthcare, Mental Hlth 116C, 2215 Fuller Rd, Ann Arbor, MI 48105 USA.	rspencer33@gmail.com					Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P725, DOI 10.1093/arclin/acs071; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P101, DOI 10.1093/arclin/acr081; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Ben-Porath YS, 2008, MMPI 2 RF MINNESOTA; Bieliauskas LA, 2015, REV NEUROPSYCHOLOGY, VII, P26; Bush S. S., 2012, NEUROPSYCHOLOGICAL P, P27; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1997, WORD MEMORY TEST USE; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kaemmer, 1989, MINNESOTA MULTIPHASI; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lees-Haley P. R., 1992, FORENSIC REPORTS, V5, P385; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; McCrea M., 2008, MILD TRAUMATIC BRAIN; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schutte C, 2012, MILD TRAUMATIC BRAIN, P159; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Spencer RJ, 2012, NEUROPSYCHOLOGICAL P, P77; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Stulemeijer M, 2007, BRAIN INJURY, V21, P309, DOI 10.1080/02699050701209980; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2012, ASSESSMENT MALINGERE, P131; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Van Dyke SA, 2010, ARCH CLIN NEUROPSYCH, V25, P634, DOI 10.1093/arclin/acq063; Waldron-Perrine B, 2012, MIL MED, V177, P1293, DOI 10.7205/MILMED-D-12-00169; Wechsler D., 2008, WECHSLER ADULT INTEL; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083	44	8	8	1	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	1					32	38		10.1080/02699052.2016.1218546			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EJ5KT	WOS:000393257600005	27819490				2022-02-06	
B	Stein, DG; Howard, RB; Sayeed, I		Heidenreich, KA		Stein, D. G.; Howard, R. B.; Sayeed, I.			Why Did the Phase III Clinical Trials for Progesterone in TBI Fail? An Analysis of Three Potentially Critical Factors	NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; DOSE-RESPONSE; BODY-SIZE; ISCHEMIC-STROKE; ANIMAL-MODELS; HUMANS; ALLOPREGNANOLONE; NEUROPROTECTION; RECOVERY; MODERATE		[Stein, D. G.; Howard, R. B.; Sayeed, I.] Emory Univ, Atlanta, GA 30322 USA		Stein, DG (corresponding author), Emory Univ, Atlanta, GA 30322 USA.		Stein, Donald/AAJ-5139-2020				Arevalo MA, 2013, HORM BEHAV, V63, P216, DOI 10.1016/j.yhbeh.2012.02.021; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; De Nicola AF, 2013, J NEUROENDOCRINOL, V25, P1095, DOI 10.1111/jne.12043; De Nicola AF, 2013, CNS NEUROL DISORD-DR, V12, P1205; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; Gilmer LK, 2008, J NEUROTRAUM, V25, P593, DOI 10.1089/neu.2007.0477; Goldstein F. C., 2016, J NEUROTRAUMA; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Guennoun R, 2015, J STEROID BIOCHEM, V146, P48, DOI 10.1016/j.jsbmb.2014.09.001; Hannay HJ, 1996, J HEAD TRAUMA REHAB, V11, P41, DOI 10.1097/00001199-199612000-00007; Harvey KA, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0005-6; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Hoppeler H, 2005, J EXP BIOL, V208, P1573, DOI 10.1242/jeb.01630; Howard R.B., 2015, J NEUROTRAU IN PRESS; Jickling GC, 2015, METAB BRAIN DIS, V30, P461, DOI 10.1007/s11011-014-9499-2; Johann S, 2013, J STEROID BIOCHEM, V137, P71, DOI 10.1016/j.jsbmb.2012.11.006; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Lou PH, 2015, ANESTH ANALG, V120, P329, DOI 10.1213/ANE.0000000000000558; Melcangi R. C., 2013, PROGR NEUROBIOLOGY; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Muller SH, 2015, J ANESTH, V29, P920, DOI 10.1007/s00540-015-2036-6; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002; Roozenbeek Bob, 2012, Clin Investig (Lond), V2, P153; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Schwamm LH, 2014, NEW ENGL J MED, V371, P2522, DOI 10.1056/NEJMe1412951; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Sharma V, 2009, BRIT J PHARMACOL, V157, P907, DOI 10.1111/j.1476-5381.2009.00267.x; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Spratt NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107752; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; Taftachi F, 2012, EUR REV MED PHARMACO, V16, P38; Turner J. M., 2015, J PARENTERAL ENTERAL; Wali B, 2014, BRAIN, V137, P486, DOI 10.1093/brain/awt319; Wong R, 2014, BMC NEUROSCI, V15, DOI 10.1186/s12868-014-0131-5; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2005, J CLIN PHARMACOL, V45, P640, DOI 10.1177/0091270005276201; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yousuf S, 2014, PSYCHOPHARMACOLOGY, V231, P3313, DOI 10.1007/s00213-014-3556-8	45	8	8	0	0	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND			9780-1-28-02701-1; 9780-1-28-02686-1				2017							3	18		10.1016/B978-0-12-802686-1.00001-8			16	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BI5ZM	WOS:000413002900004					2022-02-06	
J	Winter, L; Moriarty, HJ				Winter, Laraine; Moriarty, Helene J.			Quality of relationship between veterans with traumatic brain injury and their family members	BRAIN INJURY			English	Article						Traumatic brain injury; veterans; family caregiving; quality of relationship	RANDOMIZED CONTROLLED-TRIAL; CAREGIVER BURDEN; HEART-FAILURE; OF-LIFE; REHABILITATION; INTERVENTION; OUTCOMES; SELF; CARE; DISTRESS	Objectives: The quality of the relationship between patients with many illnesses and their family members has been shown to affect the well-being of both. Yet, relationship quality has not been studied in traumatic brain injury (TBI), and giving and receiving aspects have not been distinguished. The present study of veterans with TBI examined associations between relationship quality and care-giver burden, satisfaction with caregiving, and veterans' competence in interpersonal functioning, rated by veterans and family members. Method: In this cross-sectional study, 83 veterans and their family members were interviewed at home. Measures of quality of relationship, veterans' interpersonal competence and sociodemographics were collected for both, caregiver burden and satisfaction for family members only. Results: As predicted, veteran-rated Qrel/Giving was associated with family-rated Qrel/Receiving, and veteran-rated Qrel/Receiving with family-rated Qrel/Giving. Lower caregiver burden and higher caregiving satisfaction were associated with higher Qrel/Receiving scores but not with Qrel/Giving scores. Veterans' interpersonal competence was associated with total Qrel as rated by either veterans or family members. Conclusions: Relationship quality should be included in family research in TBI, and giving and receiving aspects should be differentiated. Findings suggest that lower caregiver burden and greater satisfaction should be more achievable by increasing caregivers' sense of benefits received from the relationship.	[Winter, Laraine; Moriarty, Helene J.] Corporal Michael J Crescenz Vet Affairs Med Ctr, Nursing Serv, Philadelphia, PA USA; [Winter, Laraine] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia Res & Educ Fdn, Philadelphia, PA 19104 USA; [Moriarty, Helene J.] Villanova Univ, Coll Nursing, Villanova, PA 19085 USA		Winter, L (corresponding author), Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia Res & Educ Fdn, Philadelphia, PA 19104 USA.	laraine.winter@gmail.com			Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD068857-01]	The authors report no conflicts of interest. The project described was supported by Award Number R21 HD068857-01 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development.	Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Ben Arzi N, 2000, BRAIN INJURY, V14, P725; Bigler E D, 1989, Brain Inj, V3, P73, DOI 10.3109/02699058909008077; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Burns R, 2003, GERONTOLOGIST, V43, P547, DOI 10.1093/geront/43.4.547; Chiang LC, 2012, INT J NURS STUD, V49, P1230, DOI 10.1016/j.ijnurstu.2012.04.013; CICIRELLI VG, 1993, PSYCHOL AGING, V8, P144, DOI 10.1037/0882-7974.8.2.144; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Clark Margret S., 2011, HDB THEORIES SOCIAL; CLARK MS, 1979, J PERS SOC PSYCHOL, V37, P12, DOI 10.1037/0022-3514.37.1.12; CLARK MS, 1993, PERS SOC PSYCHOL B, V19, P684, DOI 10.1177/0146167293196003; Damianakis T, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000178; Dausch BM, 2009, REHABIL PSYCHOL, V54, P279, DOI 10.1037/a0016809; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Gosling J, 1999, BRAIN INJURY, V13, P785; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hu XL, 2016, INT J NURS STUD, V62, P11, DOI 10.1016/j.ijnurstu.2016.07.006; Hubbard AA, 2016, J AFFECT DISORDERS, V200, P31, DOI 10.1016/j.jad.2016.04.013; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Liang J, 2001, PSYCHOL AGING, V16, P511, DOI 10.1037//0882-7974.16.3.511; Mahoney DF, 2003, GERONTOLOGIST, V43, P556, DOI 10.1093/geront/43.4.556; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; McPherson CJ, 2010, REHABIL PSYCHOL, V55, P194, DOI 10.1037/a0019359; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; Moriarty H, 2016, PM&R, V8, P495, DOI 10.1016/j.pmrj.2015.10.008; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Oddy M, 2003, NEUROPSYCHOL REHABIL, V13, P259, DOI 10.1080/09602010244000345; Park EO, 2014, NURS INQ, V21, P140, DOI 10.1111/nin.12032; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; Saban KL, 2015, REHABIL NURS, V40, P277, DOI 10.1002/rnj.182; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P1, DOI 10.1097/HTR.0b013e3182068588; Sandhaug M, 2012, DISABIL REHABIL, V34, P904, DOI 10.3109/09638288.2011.626484; Schumacher KL, 2008, ONCOL NURS FORUM, V35, P49, DOI 10.1188/08.ONF.49-56; Schumacher KL, 2007, NURS RES, V56, P425, DOI 10.1097/01.NNR.0000299852.75300.03; Stejskal TM, 2012, NEUROREHABILITATION, V31, P75, DOI 10.3233/NRE-2012-0776; Stevens LF, 2012, NEUROREHABILITATION, V31, P443, DOI 10.3233/NRE-2012-00815; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Thompson L, 1998, BASIC APPL SOC PSYCH, V20, P33, DOI 10.1207/s15324834basp2001_4; TOWNSEND AL, 1995, PSYCHOL AGING, V10, P343, DOI 10.1037/0882-7974.10.3.343; Tyerman A, 2001, NEUROREHABILITATION, V16, P59; U.S. Department of Veterans Affairs Epidemiology Program, 2014, AN VA HLTH CAR UT OP; Vandepitte S, 2016, INT J GERIATR PSYCH, V31, P1277, DOI 10.1002/gps.4504; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; WILLIAMSON GM, 1990, PSYCHOL AGING, V5, P502, DOI 10.1037/0882-7974.5.4.502; Williamson GM, 2001, PSYCHOL AGING, V16, P217, DOI 10.1037//0882-7974.16.2.217; WILLIAMSON GM, 1995, J APPL SOC PSYCHOL, V25, P93, DOI 10.1111/j.1559-1816.1995.tb01586.x; Winter L, 2015, DISABIL REHABIL, V28, P1; Winter L, 2016, BRAIN INJURY, V30, P373, DOI 10.3109/02699052.2016.1144080; Winter L, 2011, FAM RELAT, V60, P221, DOI 10.1111/j.1741-3729.2010.00644.x; Wisniewski SR, 2005, NEUROLOGY, V14, P1004	79	8	8	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	4					493	501		10.1080/02699052.2017.1283534			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ES9TD	WOS:000399902900008	28340316				2022-02-06	
J	Cheng, YJ; Wei, YX; Yang, WL; Cai, Y; Chen, B; Yang, GY; Shang, HB; Zhao, WG				Cheng, Yijun; Wei, Yongxu; Yang, Wenlei; Cai, Yu; Chen, Bin; Yang, Guoyuan; Shang, Hanbing; Zhao, Weiguo			Ghrelin Attenuates Intestinal Barrier Dysfunction Following Intracerebral Hemorrhage in Mice	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						intracerebral hemorrhage; ghrelin; intestinal barrier dysfunction; mucosa; intestinal permeability; tight junction; ICAM-1	TRAUMATIC BRAIN-INJURY; MUCOSA STRUCTURE ALTERATIONS; INFLAMMATORY-BOWEL-DISEASE; SUBARACHNOID HEMORRHAGE; ACYLATED PEPTIDE; EPITHELIAL-CELLS; TIGHT JUNCTIONS; RATS; GUT; EXPRESSION	Intestinal barrier dysfunction remains a critical problem in patients with intracerebral hemorrhage (ICH) and is associated with poor prognosis. Ghrelin, a brain-gut peptide, has been shown to exert protection in animal models of gastrointestinal injury. However, the effect of ghrelin on intestinal barrier dysfunction post-ICH and its possible underlying mechanisms are still unknown. This study was designed to investigate whether ghrelin administration attenuates intestinal barrier dysfunction in experimental ICH using an intrastriatal autologous blood infusion mouse model. Our data showed that treatment with ghrelin markedly attenuated intestinal mucosal injury at both histomorphometric and ultrastructural levels post-ICH. Ghrelin reduced ICH-induced intestinal permeability according to fluorescein isothiocyanate conjugated-dextran (FITC-D) and Evans blue extravasation assays. Concomitantly, the intestinal tight junction-related protein markers, Zonula occludens-1 (ZO-1) and claudin-5 were upregulated by ghrelin post-ICH. Additionally, ghrelin reduced intestinal intercellular adhesion molecule-1 (ICAM-1) expression at the mRNA and protein levels following ICH. Furthermore, ghrelin suppressed the translocation of intestinal endotoxin post-ICH. These changes were accompanied by improved survival rates and an attenuation of body weight loss post-ICH. In conclusion, our results suggest that ghrelin reduced intestinal barrier dysfunction, thereby reducing mortality and weight loss, indicating that ghrelin is a potential therapeutic agent in ICH-induced intestinal barrier dysfunction therapy.	[Cheng, Yijun; Wei, Yongxu; Yang, Wenlei; Cai, Yu; Chen, Bin; Shang, Hanbing; Zhao, Weiguo] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Neurosurg, Shanghai 200025, Peoples R China; [Yang, Guoyuan] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Neurol, Shanghai 200025, Peoples R China; [Yang, Guoyuan] Shanghai Jiao Tong Univ, Neurosci & Neuroengn Res Ctr, Med X Res Inst, Shanghai 200030, Peoples R China		Zhao, WG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Neurosurg, Shanghai 200025, Peoples R China.	jesny1988@163.com; weiyongxu@icloud.com; yangwenlei@hotmail.com; caiyu10746@sina.com; chenbinns@sjtu.edu.cn; yangguoyuan_neuro@163.com; hjshb@126.com; zwg_neurosurgery@yahoo.com			Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [14ZR1426000, 16ZR14212000]	This research was supported by the Natural Science Fund (No. 14ZR1426000; No. 16ZR14212000) from the Science and Technology Commission of Shanghai Municipality.	Ahmed SH, 2000, STROKE, V31, P193, DOI 10.1161/01.STR.31.1.193; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Chen LW, 1999, SHOCK, V11, P104, DOI 10.1097/00024382-199902000-00006; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; Diao L, 2012, WORLD J GASTROENTERO, V18, P1059, DOI 10.3748/wjg.v18.i10.1059; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; Feng D, 2007, J INT MED RES, V35, P644, DOI 10.1177/147323000703500509; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gong Y, 2016, J INTERF CYTOK RES, V36, P75, DOI 10.1089/jir.2015.0030; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; Hao XK, 2014, BRAIN RES, V1587, P15, DOI 10.1016/j.brainres.2014.08.069; Hosoda H, 2012, METHOD ENZYMOL, V514, P113, DOI 10.1016/B978-0-12-381272-8.00008-8; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Jin W, 2008, CYTOKINE, V44, P135, DOI 10.1016/j.cyto.2008.07.005; Jin W, 2009, J SURG RES, V157, P251, DOI 10.1016/j.jss.2008.08.003; JONES SC, 1995, GUT, V36, P724, DOI 10.1136/gut.36.5.724; Kalff JC, 1999, ARCH ORTHOP TRAUM SU, V119, P89, DOI 10.1007/s004020050363; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kellokoski E, 2009, METABOLISM, V58, P1572, DOI 10.1016/j.metabol.2009.05.009; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lang YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133215; LANGE S, 1994, SCAND J GASTROENTERO, V29, P38, DOI 10.3109/00365529409090435; Lee J, 2014, J TRAUMA ACUTE CARE, V77, P709, DOI 10.1097/TA.0000000000000445; Lippai D, 2014, ALCOHOL CLIN EXP RES, V38, P2217, DOI 10.1111/acer.12483; Liu YQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0177-4; Lopez NE, 2012, BRAIN RES, V1489, P140, DOI 10.1016/j.brainres.2012.10.031; Lu WY, 1997, NEUROSURGERY, V41, P416, DOI 10.1097/00006123-199708000-00017; Mei QA, 2011, ACTA PHARMACOL SIN, V32, P495, DOI 10.1038/aps.2010.225; Misra UK, 2005, J NEUROL SCI, V239, P5, DOI 10.1016/j.jns.2005.07.011; Misra UK, 2003, J NEUROL SCI, V208, P25, DOI 10.1016/S0022-510X(02)00415-X; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nakamura S., 1993, LAB INVEST, V69, P257; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Pan L, 2013, INT J MOL SCI, V14, P21689, DOI 10.3390/ijms141121689; Peeters TL, 2013, ENDOCR DEV, V25, P41, DOI 10.1159/000346051; Qi L, 2012, MOL MED, V18, P186, DOI 10.2119/molmed.2011.00390; Qiu WC, 2008, WORLD J GASTROENTERO, V14, P2572, DOI 10.3748/wjg.14.2572; Rynkowski MA, 2008, NAT PROTOC, V3, P122, DOI 10.1038/nprot.2007.513; Sangiao-Alvarellos S, 2010, INT J PEPT; Shibahara T, 2005, J GASTROENTEROL, V40, P878, DOI 10.1007/s00535-005-1631-y; Spencer SJ, 2013, BRAIN SCI, V3, P344, DOI 10.3390/brainsci3010344; Sumagin R, 2014, MUCOSAL IMMUNOL, V7, P905, DOI 10.1038/mi.2013.106; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Sun Z, 2001, SCAND J GASTROENTERO, V36, P55, DOI 10.1080/00365520150218066; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Wu RQ, 2009, CRIT CARE MED, V37, P2421, DOI 10.1097/CCM.0b013e3181a557a2; Xu XP, 2012, ANAT REC, V295, P307, DOI 10.1002/ar.21490; Yang TC, 2013, AM J MED SCI, V346, P279, DOI 10.1097/MAJ.0b013e318271a621; Zacharia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065969; Zhang M, 2015, FRONT BIOSCI-LANDMRK, V20, P604, DOI 10.2741/4325; Zhang X, 2015, JPEN-PARENTER ENTER, V39, P114, DOI 10.1177/0148607113501881; Zhao XD, 2011, J SURG RES, V171, pE47, DOI 10.1016/j.jss.2011.07.018; Zhao Y, 2014, INT J MOL SCI, V15, P1915, DOI 10.3390/ijms15021915; Zhou ML, 2007, J SURG RES, V137, P103, DOI 10.1016/j.jss.2006.06.023	60	8	10	0	8	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	DEC	2016	17	12							2032	10.3390/ijms17122032			14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	EI1XR	WOS:000392280500076		gold, Green Submitted, Green Published			2022-02-06	
J	Kim, YJ; Shin, SD; Park, HS; Song, KJ; Cho, JS; Lee, SC; Kim, SC; Park, JO; Ahn, KO; Park, YM				Kim, Yu Jin; Shin, Sang Do; Park, Hye Sook; Song, Kyoung Jun; Cho, Jin Sung; Lee, Seung Chul; Kim, Sung Chun; Park, Ju Ok; Ahn, Ki Ok; Park, Yu Mi			International Classification of Diseases 10th edition-based disability adjusted life years for measuring of burden of specific injury	CLINICAL AND EXPERIMENTAL EMERGENCY MEDICINE			English	Article						Disability adjusted life year; Wounds and injuries; International Classification of Diseases	TRAUMATIC BRAIN INJURY; GLOBAL BURDEN; RATING-SCALE; RISK-FACTORS; MAJOR TRAUMA; MORTALITY; HEALTH; WEIGHTS; KOREA	Objective We aimed to develop an International Classification of Diseases (ICD) 10th edition injury code-based disability-adjusted life year (DALY) to measure the burden of specific injuries. Methods Three independent panels used novel methods to score disability weights (DWs) of 130 indicator codes sampled from 1,284 ICD injury codes. The DWs were interpolated into the remaining injury codes (n=1,154) to estimate DWs for all ICD injury codes. The reliability of the estimated DWs was evaluated using the test-retest method. We calculated ICD-DALYs for individual injury episodes using the DWs from the Korean National Hospital Discharge Injury Survey (HDIS, n=23,160 of 2004) database and compared them with DALY based on a global burden of disease study (GBD-DALY) regarding validation, correlation, and agreement for 32 injury categories. Results Using 130 ICD 10th edition injury indicator codes, three panels determined the DWs using the highest reliability (person trade-off 1, Spearman r=0.724, 0.788, and 0.875 for the three panel groups). The test-retest results for the reliability were excellent (Spearman r=0.932) (P<0.001). The HDIS database revealed injury burden (years) as follows: GBD-DALY (138,548), GBD-years of life disabled (130,481), and GBD-years of life lost (8,117) versus ICD-DALY (262,246), ICD-years of life disabled (255,710), and ICD-years of life lost (6,537), respectively. Spearman's correlation coefficient of the DALYs between the two methods was 0.759 (P<0.001), and the Bland-Altman test displayed an acceptable agreement, with exception of two categories among 32 injury groups. Conclusion The ICD-DALY was developed to calculate the burden of injury for all injury codes and was validated with the GBD-DALY. The ICD-DALY was higher than the GBD-DALY but showed acceptable agreement.	[Kim, Yu Jin; Shin, Sang Do] Seoul Natl Univ, Coll Med, Dept Emergency Med, 101 Daehak Ro, Seoul 03080, South Korea; [Shin, Sang Do; Song, Kyoung Jun] Seoul Natl Univ Hosp, Dept Emergency Med, Seoul, South Korea; [Park, Hye Sook] Ewha Womans Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Cho, Jin Sung] Gachon Univ, Gil Hosp, Dept Emergency Med, Incheon, South Korea; [Lee, Seung Chul] Dongkuk Univ, Ilsan Hosp, Dept Emergency Med, Goyang, South Korea; [Kim, Sung Chun] Gyeongsang Natl Univ Hosp, Dept Emergency Med, Jinju, South Korea; [Park, Ju Ok] Hallym Univ, Coll Med, Dept Emergency Med, Dongtan, South Korea; [Ahn, Ki Ok] Seoul Natl Univ Hosp, Biomed Res Inst, Lab Emergency Med Serv, Seoul, South Korea; [Park, Yu Mi] Hallym Univ, Sch Publ Hlth, Chunchon, South Korea		Shin, SD (corresponding author), Seoul Natl Univ, Coll Med, Dept Emergency Med, 101 Daehak Ro, Seoul 03080, South Korea.	sdshin@snu.ac.kr	안, 기옥/L-5596-2019; Lee, Jae Hyuk/W-5616-2018	안, 기옥/0000-0002-8446-3269; Lee, Jae Hyuk/0000-0003-2429-4085	Ministry of Health, Welfare, and Family Affairs of Republic of the Korea [A0104208A00]	This study was supported by the Ministry of Health, Welfare, and Family Affairs of Republic of the Korea in 2008 (Health Promotion Fund A0104208A00).	Essink-Bot ML, 2002, B WORLD HEALTH ORGAN, V80, P644; Haagsma JA, 2008, INJURY PREV, V14, P5, DOI 10.1136/ip.2007.017178; Haagsma JA, 2009, QUAL LIFE RES, V18, P657, DOI 10.1007/s11136-009-9484-0; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Holtslag HR, 2008, B WORLD HEALTH ORGAN, V86, P111, DOI 10.2471/BLT.06.033803; Janssens L, 2008, QUAL LIFE RES, V17, P701, DOI 10.1007/s11136-008-9339-0; Jelsma J, 2002, DISABIL REHABIL, V24, P378, DOI 10.1080/09638280110096269; Kim J, 2009, ACAD EMERG MED, V16, P454, DOI 10.1111/j.1553-2712.2009.00412.x; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mathers CD, 2000, MED J AUSTRALIA, V172, P592, DOI 10.5694/j.1326-5377.2000.tb124125.x; Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076; Melse JM, 2000, AM J PUBLIC HEALTH, V90, P1241, DOI 10.2105/AJPH.90.8.1241; Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11; Murray CJL, 2004, BMJ-BRIT MED J, V329, P1096, DOI 10.1136/bmj.329.7474.1096; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Petersen M, 2003, DIABETES CARE, V26, P917; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; Ubel PA, 1998, HEALTH POLICY, V43, P33, DOI 10.1016/S0168-8510(97)00077-8; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Vlajinac H, 2006, EUR J CARDIOV PREV R, V13, P753, DOI 10.1097/01.hjr.0000238395.04600.b5; Walker CLF, 2009, EUR J CLIN NUTR, V63, P591, DOI 10.1038/ejcn.2008.9; Yoon SJ, 2007, J KOREAN MED SCI, V22, P518, DOI 10.3346/jkms.2007.22.3.518; Yoon SJ, 2002, J KOREAN MED SCI, V17, P604, DOI 10.3346/jkms.2002.17.5.604	26	8	8	0	3	SEOUL KOREAN SOC EMERGENCY MEDICINE	SEOUL	101-3305, BROWNSTONE SEOUL, 464 CHEONGPA-RO, JUNG-GU, SEOUL, 06351, SOUTH KOREA	2383-4625			CLIN EXP EMERG MED	Clin. Exp. Emerg. Med.	DEC	2016	3	4					219	238		10.15441/ceem.16.126			20	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	FH2TD	WOS:000410994200005	28168229	Green Published, hybrid, Green Submitted			2022-02-06	
J	Meyer, JM; Cummings, MA; Proctor, G; Stahl, SM				Meyer, Jonathan M.; Cummings, Michael A.; Proctor, George; Stahl, Stephen M.			Psychopharmacology of Persistent Violence and Aggression	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Aggression; Violence; Impulsivity; Pharmacology	DOPAMINE-D-2 RECEPTOR OCCUPANCY; HIGH-DOSE OLANZAPINE; ALZHEIMERS-DISEASE; NEUROPSYCHIATRIC SYMPTOMS; PSYCHOLOGICAL SYMPTOMS; ANTIPSYCHOTIC-DRUGS; BRAIN-INJURY; PHARMACOLOGICAL MANAGEMENT; PLASMA-LEVELS; ATYPICAL ANTIPSYCHOTICS	Persistent violence not due to acute psychosis or mania can be managed only after appropriate characterization of the aggressive episodes (psychotic, impulsive, or predatory/planned/instrumental). The type of violence combined with the psychiatric diagnosis dictates the evidence-based pharmacologic approaches for psychotically motivated and impulsive aggression, whereas instrumental violence mandates forensic/behavioral strategies. For nonacute inpatients, schizophrenia spectrum disorders, traumatic brain injury, and dementia comprise the majority of individuals who are persistently aggressive, with impulsive actions being the most common form of violence across all diagnoses. Neurobiological considerations combined with empirical data provide a comprehensive framework for systematic medication trials to manage persistently aggressive patients.	[Meyer, Jonathan M.; Cummings, Michael A.; Proctor, George] Calif Dept State Hosp DSH, Psychopharmacol Resource Network, DSH Patton, 3102 East Highland Ave, Patton, CA 92369 USA; [Meyer, Jonathan M.; Stahl, Stephen M.] Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr,MC 0603, La Jolla, CA 92093 USA; [Stahl, Stephen M.] Calif Dept State Hosp DSH, Bateson Bldg,1600 9th St,Room 400, Sacramento, CA 95814 USA		Meyer, JM (corresponding author), Calif Dept State Hosp DSH, Psychopharmacol Resource Network, DSH Patton, 3102 East Highland Ave, Patton, CA 92369 USA.; Meyer, JM (corresponding author), Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr,MC 0603, La Jolla, CA 92093 USA.	jmmeyer@ucsd.edu			Alkermes; Forum; MerckMerck & Company; Otsuka-USA; Sunovion; Acadia; Biomarin; Clintara; Eli-LillyEli Lilly; EnVivo; Forest; GenoMind; JayMac; LundbeckLundbeck Corporation; NovartisNovartis; Orexigen; PamLabs; PfizerPfizer; RCT Logic; ServierServier; Shire; Sprout; Sunovion-UK; Taisho; TakedaTakeda Pharmaceutical Company Ltd; TevaTeva Pharmaceutical Industries; Tonix; Trius	Dr M.A. Cummings and Proctor report no disclosures. Dr J.M Meyer reports having received speaking or advising fees from Alkermes, Forum, Merck, Otsuka-USA, and Sunovion. Dr S.M. Stahl reports having received advising fees, consulting fees, speaking fees, and/or research grants from Acadia, Alkermes, Biomarin, Clintara, Eli-Lilly, EnVivo, Forest, Forum, GenoMind, JayMac, Lundbeck, Merck, Novartis, Orexigen, Otsuka-USA, PamLabs, Pfizer, RCT Logic, Servier, Shire, Sprout, Sunovion, Sunovion-UK, Taisho, Takeda, Teva, Tonix, and Trius.	Akamine Y, 2015, J CLIN PHARM THER, V40, P480, DOI 10.1111/jcpt.12286; Ballard C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003476.pub2; Ballard C, 2016, AM J PSYCHIAT, V173, P252, DOI 10.1176/appi.ajp.2015.15010130; Ballard C, 2013, CURR OPIN PSYCHIATR, V26, P252, DOI 10.1097/YCO.0b013e32835f414b; Belin-Rauscent A, 2016, MOL PSYCHIATR, V21, P491, DOI [10.1038/mp.2015.140, 10.1038/mp.2016.32]; Bishara D, 2013, J CLIN PSYCHOPHARM, V33, P329, DOI 10.1097/JCP.0b013e31828b28d5; Bishara D, 2009, INT J GERIATR PSYCH, V24, P944, DOI 10.1002/gps.2200; Blair RJR, 2016, J CHILD ADOL PSYCHOP, V26, P4, DOI 10.1089/cap.2015.0088; Bleakley S., 2013, CLOZAPINE HDB; Brown D, 2014, CNS SPECTRUMS, V19, P391, DOI 10.1017/S1092852914000157; Citrome L., 2013, HDB TREATMENT RESIST; Citrome L, 2014, CNS SPECTRUMS, V19, P411, DOI 10.1017/S1092852914000054; Citrome L, 2011, CNS DRUGS, V25, P1009, DOI 10.2165/11596930-000000000-00000; Conley RR, 2003, J CLIN PSYCHOPHARM, V23, P668, DOI 10.1097/01.jcp.0000096246.29231.73; Cumbo E, 2014, J ALZHEIMERS DIS, V39, P477, DOI 10.3233/JAD-131190; Cummings J, 2016, CNS NEUROSCI THER, V22, P159, DOI 10.1111/cns.12484; de Leon J., 2012, PRACTITIONERS GUIDE; de Leon J, 2008, PSYCHOSOMATICS, V49, P347, DOI 10.1176/appi.psy.49.4.347; de Leon J, 2010, PSYCHOSOMATICS, V51, P80, DOI 10.1176/appi.psy.51.1.80; de Leon J, 2009, RES DEV DISABIL, V30, P613, DOI 10.1016/j.ridd.2008.10.010; Declercq T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007726.pub2; Dolder Christian R, 2012, J Pharm Pract, V25, P142, DOI 10.1177/0897190011424802; Eisai Inc, 2015, AR PACK INS; Elovic EP, 2008, J HEAD TRAUMA REHAB, V23, P132, DOI 10.1097/01.HTR.0000314532.07530.e5; ERESHEFSKY L, 1985, BIOL PSYCHIAT, V20, P329, DOI 10.1016/0006-3223(85)90063-0; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Forest Pharmaceuticals Inc, 2014, NAM XR PACK INS; Frogley C, 2012, INT J NEUROPSYCHOPH, V15, P1351, DOI 10.1017/S146114571100201X; Gallagher D, 2014, DRUGS, V74, P1747, DOI 10.1007/s40265-014-0293-6; Gareri P, 2014, J ALZHEIMERS DIS, V41, P633, DOI 10.3233/JAD-132735; Gefvert O, 2005, INT J NEUROPSYCHOPH, V8, P27, DOI 10.1017/S1461145704004924; Gillies D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003079.pub3; Goedhard LE, 2006, J CLIN PSYCHIAT, V67, P1013, DOI 10.4088/JCP.v67n0702; Grigorenko EL, 2010, AGGRESSIVE BEHAV, V36, P158, DOI 10.1002/ab.20339; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Haslemo T, 2006, EUR J CLIN PHARMACOL, V62, P1049, DOI 10.1007/s00228-006-0209-9; Herrmann N, 2013, ALZHEIMERS RES THER, V5, DOI [10.1186/alz193, 10.1186/alzrt201]; Hoptman MJ, 2015, CNS SPECTRUMS, V20, P280, DOI 10.1017/S1092852915000206; Jones RM, 2011, BRIT J PSYCHIAT, V198, P93, DOI 10.1192/bjp.bp.110.083030; Kales HC, 2012, AM J PSYCHIAT, V169, P71, DOI 10.1176/appi.ajp.2011.11030347; Kapur S, 1997, PSYCHOPHARMACOLOGY, V131, P148, DOI 10.1007/s002130050277; Katz I, 2007, INT J GERIATR PSYCH, V22, P475, DOI 10.1002/gps.1792; Kelly DL, 2006, HUM PSYCHOPHARM CLIN, V21, P393, DOI 10.1002/hup.781; Krakowski MI, 2006, ARCH GEN PSYCHIAT, V63, P622, DOI 10.1001/archpsyc.63.6.622; Krakowski MI, 2012, J CLIN PSYCHIAT, V73, P74, DOI 10.4088/JCP.11m07238; Langballe EM, 2014, AM J GERIAT PSYCHIAT, V22, P321, DOI 10.1016/j.jagp.2013.06.007; Leonpacher AK, 2016, AM J PSYCHIAT, V173, P473, DOI 10.1176/appi.ajp.2016.15020248; Maust DT, 2015, JAMA PSYCHIAT, V72, P438, DOI 10.1001/jamapsychiatry.2014.3018; McClam TD, 2015, HARVARD REV PSYCHIAT, V23, P377, DOI 10.1097/HRP.0000000000000097; McDermott BE, 2014, CNS SPECTRUMS, V19, P425, DOI 10.1017/S1092852914000224; Meyer JM, 2014, CNS SPECTRUMS, V19, P432, DOI 10.1017/S1092852914000236; MIDHA KK, 1994, J PSYCHIATR NEUROSCI, V19, P254; Miller BP, 2005, GEN HOSP PSYCHIAT, V27, P218, DOI 10.1016/j.genhosppsych.2005.02.001; Morrissette DA, 2014, CNS SPECTRUMS, V19, P439, DOI 10.1017/S1092852914000388; Muller-Oerlinghausen B, 2010, NEUROPSYCHOBIOLOGY, V62, P43, DOI 10.1159/000314309; Newman WJ, 2012, PSYCHIAT CLIN N AM, V35, P957, DOI 10.1016/j.psc.2012.08.009; Nolan KA, 2003, PSYCHIAT SERV, V54, P1012, DOI 10.1176/appi.ps.54.7.1012; Nyberg S, 1997, ARCH GEN PSYCHIAT, V54, P953; NYBERG S, 1995, AM J PSYCHIAT, V152, P173; Pavlov KA, 2012, J APPL GENET, V53, P61, DOI 10.1007/s13353-011-0069-6; Perry PJ, 2001, J CLIN PSYCHOPHARM, V21, P14, DOI 10.1097/00004714-200102000-00004; Plantier D, 2016, ANN PHYS REHABIL MED, V59, P42, DOI 10.1016/j.rehab.2015.10.003; Quanbeck CD, 2007, PSYCHIAT SERV, V58, P521, DOI 10.1176/appi.ps.58.4.521; Remington G, 2006, AM J PSYCHIAT, V163, P396, DOI 10.1176/appi.ajp.163.3.396; Remington G, 2013, PSYCHOPHARMACOLOGY, V225, P505, DOI 10.1007/s00213-012-2922-7; Richter T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008634.pub2; Rosell DR, 2015, CNS SPECTRUMS, V20, P254, DOI 10.1017/S109285291500019X; Rosenberg PB, 2015, INT PSYCHOGERIATR, V27, P2059, DOI 10.1017/S1041610215001106; Rostami-Hodjegan A, 2004, J CLIN PSYCHOPHARM, V24, P70, DOI 10.1097/01.jcp.0000106221.36344.4d; Sabaawi M, 2006, RES DEV DISABIL, V27, P309, DOI 10.1016/j.ridd.2005.05.002; Sami MB, 2015, ACTA NEUROPSYCHIATR, V27, P317, DOI 10.1017/neu.2015.17; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; Schneider LS, 2016, AM J PSYCHIAT, V173, P465, DOI 10.1176/appi.ajp.2015.15050648; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Seitz DP, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008191.pub2; Seo DJ, 2008, AGGRESS VIOLENT BEH, V13, P383, DOI 10.1016/j.avb.2008.06.003; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; SIMPSON GM, 1968, DIS NERV SYST, V29, P269; Skoretz P, 2016, CNS SPECTRUMS; Sparshatt A, 2010, J CLIN PSYCHIAT, V71, P1447, DOI 10.4088/JCP.09r05060gre; Stahl SM, 2013, POLYPHARMACY PSYCHIA, VI, P107; Stahl SM, 2014, CNS SPECTRUMS, V19, P449, DOI 10.1017/S1092852914000376; Stahl SM, 2014, CNS SPECTRUMS, V19, P357, DOI 10.1017/S1092852914000522; Suzuki H, 2015, PSYCHOGERIATRICS, V15, P32, DOI 10.1111/psyg.12085; Szabo KA, 2015, CNS SPECTRUMS, V20, P223, DOI 10.1017/S1092852914000820; Tampi RR, 2015, PSYCHOSOMATICS, V56, P36, DOI 10.1016/j.psym.2014.09.002; Tampi RR, 2014, AM J ALZHEIMERS DIS, V29, P565, DOI 10.1177/1533317514524813; Tangamornsuksan W, 2013, JAMA DERMATOL, V149, P1025, DOI 10.1001/jamadermatol.2013.4114; Tariot PN, 2004, J CLIN PSYCHIAT, V65, P11; Taylor DM, 2012, ACTA PSYCHIAT SCAND, V125, P15, DOI 10.1111/j.1600-0447.2011.01792.x; Teri L, 2000, NEUROLOGY, V55, P1271, DOI 10.1212/WNL.55.9.1271; Tsiouris JA, 2010, J INTELL DISABIL RES, V54, P1, DOI 10.1111/j.1365-2788.2009.01232.x; Uchida H, 2011, J CLIN PSYCHOPHARM, V31, P318, DOI 10.1097/JCP.0b013e318218d339; Victoroff J, 2014, J NEUROPSYCH CLIN N, V26, P283, DOI 10.1176/appi.neuropsych.13110335; Vieta E, 2010, J CLIN PSYCHIAT, V71, P14, DOI 10.4088/JCP.9096su1cc.03; Volavka J, 2014, CNS SPECTRUMS, V19, P374, DOI 10.1017/S1092852913000849; Volavka J, 2011, J CLIN PSYCHIAT, V72, P955, DOI 10.4088/JCP.10m06529; Wei FC, 1996, J CLIN PSYCHIAT, V57, P298; Zaccara G, 2014, EPILEPTIC DISORD, V16, P409, DOI 10.1684/epd.2014.0714	100	8	8	2	23	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	DEC	2016	39	4					541	+		10.1016/j.psc.2016.07.012			17	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	EG5IX	WOS:000391078600002	27836150				2022-02-06	
